,Unnamed: 0,Title,Session_Code,Authors_and_Affiliations,Text,Year,Email,Author,Affiliations,Sentence,Person-first,Identity-first,Person-first_lemmatized,Identy-first_lemmatized
1,150,Location of the first predisposing gene locus for Asperger syndrome on chromosome 1q21 22 ,C102., E. Jarvela1  T. Ylisaukko oja2  T. Nieminen3  E. Kempas1  M. Auranen1  L. Peltonen1 1National Public Health Institute  Helsinki  Finland  2National Public Health Insitute  Helsinki  Finland  3University of Helsinki  Dept of Child Neurology  Helsinki  F,Asperger syndrome (AS) was first described in 1944 by a Viennese physi cian Hans Asperger who reported a group of boys with autistic psychopa thy  whose clinical features resembled autism with some modifications. Itis characterised by difficulties in social interaction and stereotyped behav iour but in contrast to infantile autism by normal intelligence and usuallynormal language skills. In the pediatric age group the prevalence ofAsperger syndrome is around 4 7/1000 whereas the corresponding figurefor the infantile autism is 4/10000. Etiopathogenesis is unknown but thereis evidence for a strong genetic component. Based on clinical observationsAS is inherited in the same families as infantile autism but also as a sepa rate entity often transmitted from male to male. We report the analysis of13 candidate gene loci associated with autism and schizophrenia in 17Finnish AS families with autosomal dominant mode of inheritance. Linkageto the previously reported predisposing loci for autism could not be repli cated with Finnish AS families. By contrast  evidence for linkage wasobtained on 1q21 22 the region that has previously been linked to schizo phrenia (Brzustowicz et al.  2000) with the maximum two point lod score of2.70 with marker D1S484. Two families shared a common haplotype with in an 8.6 cM region between markers D1S2721 and D1S484. Our resultssuggest that AS and schizophrenia may have common genetic back ground. ,2001.0,irma.jarvela@hus.fi,,,Asperger syndrome (AS) was first described in 1944 by a Viennese physi cian Hans Asperger who reported a group of boys with autistic psychopa thy  whose clinical features resembled autism with some modifications.,,Asperger syndrome,[],"['Asperger', 'syndrome']"
1,150,Location of the first predisposing gene locus for Asperger syndrome on chromosome 1q21 22 ,C102., E. Jarvela1  T. Ylisaukko oja2  T. Nieminen3  E. Kempas1  M. Auranen1  L. Peltonen1 1National Public Health Institute  Helsinki  Finland  2National Public Health Insitute  Helsinki  Finland  3University of Helsinki  Dept of Child Neurology  Helsinki  F,Asperger syndrome (AS) was first described in 1944 by a Viennese physi cian Hans Asperger who reported a group of boys with autistic psychopa thy  whose clinical features resembled autism with some modifications. Itis characterised by difficulties in social interaction and stereotyped behav iour but in contrast to infantile autism by normal intelligence and usuallynormal language skills. In the pediatric age group the prevalence ofAsperger syndrome is around 4 7/1000 whereas the corresponding figurefor the infantile autism is 4/10000. Etiopathogenesis is unknown but thereis evidence for a strong genetic component. Based on clinical observationsAS is inherited in the same families as infantile autism but also as a sepa rate entity often transmitted from male to male. We report the analysis of13 candidate gene loci associated with autism and schizophrenia in 17Finnish AS families with autosomal dominant mode of inheritance. Linkageto the previously reported predisposing loci for autism could not be repli cated with Finnish AS families. By contrast  evidence for linkage wasobtained on 1q21 22 the region that has previously been linked to schizo phrenia (Brzustowicz et al.  2000) with the maximum two point lod score of2.70 with marker D1S484. Two families shared a common haplotype with in an 8.6 cM region between markers D1S2721 and D1S484. Our resultssuggest that AS and schizophrenia may have common genetic back ground. ,2001.0,irma.jarvela@hus.fi,,,Asperger syndrome (AS) was first described in 1944 by a Viennese physi cian Hans Asperger who reported a group of boys with autistic psychopa thy  whose clinical features resembled autism with some modifications.,,autistic psychopa,[],"['autistic', 'psychopa']"
5,443,Preliminary Findings In The Diagnostic Evaluation Of A Sample Of 103 Individuals With Pervasive DevelopmentDisorders,P0341., E. Steiner   M. M. Guerreiro  A. P. Marques de Faria Unicamp  Campinas  B,Pervasive development disorders (PDD) are a heterogeneous group ofneurobehavioral disorders of infancy. In order to identify etiologic factors ina sample of individuals with PDD  a total of 103 subjects (84 males and 19females) referred for autistic behavior were submitted to a protocol includ ing clinical evaluation  screening for inborn errors of metabolism  karyotypein folic acid deficient medium  and molecular test for the FRAXA mutation.Until now  the following conditions were detected  Down syndrome (n = 3) untreated phenylketonuria (n = 2)  Rett syndrome (n = 2)  tuberous sclero sis (n = 1)  fragile X syndrome (n = 1)  5 other dysmorphic conditions  2non genetic etiologies  and 2 individuals with chromosomal polymor phisms. Besides those  4 individuals presented no PDD and 3 individualshad infantile psychosis. These data suggest that  in at least 15% of thissample  a main etiologic factor could be identified. Although the diagnosisof a specific genetic condition do not modify the treatment of autistic indi viduals in most cases  it is of significant importance to the genetic coun seling of their relatives. For this reason  we reinforce the importance ofcareful dysmorphologic examination and complementary tests in any per son presenting with PDD  besides neurologic and psychiatric evaluation. ,2001.0,dgmfcm@unicamp.br,,,In order to identify etiologic factors ina sample of individuals with PDD  a total of 103 subjects (84 males and 19females) referred for autistic behavior were submitted to a protocol includ ing clinical evaluation  screening for inborn errors of metabolism  karyotypein folic acid deficient medium  and molecular test for the FRAXA mutation.Until now  the following conditions were detected  Down syndrome (n = 3) untreated phenylketonuria (n = 2)  Rett syndrome (n = 2)  tuberous sclero sis (n = 1)  fragile X syndrome (n = 1)  5 other dysmorphic conditions  2non genetic etiologies  and 2 individuals with chromosomal polymor phisms.,,autistic behavior,[],"['autistic', 'behavior']"
7,473,Detection of subtelomeric rearrangements by FISH in patients with idiopathic mental retardation or autism.,P0372., Ostergaard   J. M. Hahnemann  H. Hjalgrim  K. Nielsen  H. M. Nielsen  K. Brondum NielsenJohn F. Kennedy Institute  Glostrup  D,The subtelomeric regions are often involved in chromosomal rearrange 172 Posters: Clinical Genetics and Dysmorphologyments. They are gene rich and therefore rearrangements in these regions are more likely to have phenotypic consequences than rearrangements inother regions. The 41 subtelomeric regions were screened for rearrangements with fluo rescent in situ hybridization (FISH) using the Chromoprobe T Kit (Cytocell UK). Two groups of patients  all with normal standard chromosome analysis were investigated  One group consisted of 14 patients with autism  andwith at least one other relative affected with autism. DNA analysis for frag ile X was normal in all and no subtelomeric rearrangements were found. The other group consisted of 41 patients with idiopathic MR and dysmor phic features or a family history of MR. In this group five subtelomericrearrangements were found  A 1pter deletion  resulting in a well characterized del(1)(p36.3) syndrome was found in a girl born 1999. She had MR  growth retardation  and dys morphism. In a girl born 1986 a deletion of 4p was found. Using the FISH probe forWolf syndrome confirmed del(4)(p16.3p16.3). The girl had MR  epilepsy microcephaly  and dysmorphism  consistent with Wolf syndrome. A previously not described derivative chromosome 9 der(9)t(9 22)(q34.2q34.3 q13.2q13.3) was found in a girl born 1999. Shehad MR  microcephaly  an atrial septum defect  and dysmorphism. Herfather had a cryptic balanced reciprocal t(9 22) translocation. A recently described polymorphism of 2q was found in two patients.In conclusion three out of 41 (7.3%) patients with idiopathic MR were foundto have subtelomeric rearrangements  in concordance with the prevalence(5 10%) in previous studies. ,2001.0,els@kennedy.dk,,,Two groups of patients  all with normal standard chromosome analysis were investigated  One group consisted of 14 patients with autism  andwith at least one other relative affected with autism.,patients with autism,,"['patient', 'with', 'autism']",[]
9,538,Clinical cytogenetic and molecular analysis of two families with FRAXE mutation  implications for genetic coun selling and prenatal diagnosis,P0442., I. Tejada1  P. Botella2  M. A. L pez Ar ztegui3  F. Mozo de Rosales4  M. L pez V alverde4  M. L. Onaindia1  M. Molina1 1Genetic Unit  Basurto Hospital  Bilbao  Spain  2Dept. of Paediatrics  Txagorritxu Hospital  Vitoria  Spain  3Genetic Laboratory  Cruces Hospital  Baracaldo  Spain  4Dept. of Obstetrics and Gynaecology  Basurto Hospital  Bilbao  S,FRAXE full mutations are rare and appear to be associated with mild men tal retardation and with a fragile site in Xq28. This is due to an abnormalexpanded GCC repeat  adjacent to a methylated CpG island proximal tothe FMR2 gene. As part of a routine diagnosis  all individuals referred to usfor Fragile X Syndrome (FXS) study  and tested FRAXA negative  werestudied for FRAXE mutation. Among 485 index case patients  2 were iden tified with the FRAXE full mutation  both with cytogenetic expression of thefragile site (29 and 23% respectively) and with no history of mental retar dation. One of them has an autistic disorder with severe MR an a dysmor phic face similar to FXS. The second one is a nearly normal man with nor mal phenotype but who had learning difficulties at school when he was achild. Their families were also studied  with a total of 16 members at risktested. We found 6 of them normal (3 men and 3 women) and 10 carrierwomen (4 premutated and 6 fully mutated). None of these women presentany type of mental impairment. The last sample studied was a fully mutat ed female foetus that was spontaneously aborted after obtaining chorionicvilli for prenatal diagnosis. Although the GCC expansion was greater than0.8 kb  it was unmethylated in the majority of the tissues studied by us. So even though molecular study of FRAXE mutation is now available  furtherstudies are nedeed for the purpose of genetic counselling and prenataldiagnosis. ,2001.0,itejada@hbas.osakidetza.net,,,One of them has an autistic disorder with severe MR an a dysmor phic face similar to FXS.,,autistic disorder,[],"['autistic', 'disorder']"
10,571,Rett Syndrome  Phenotype Expansion and Broaden  ing Parameters for Diagnosis and DNA Testing ResultingFrom the Availability of Mutation Analysis.,P0483., R. Shapiro1 2  H. G. Taska2  R. V. Scott2  D. F. Kronn1 2 1New York Medical College  Valhalla  NY United States  2Westchester Medical Center  Valhalla  NY United S,"The diagnosis of Rett Syndrome prior to the availability of mutation analy sis by sequencing the MECP2 gene was based on rigid clinical criteria females who had normal development until 6 18 months of age with sub sequent regression characterized by loss of speech and loss of purposefuluse of hands  microcephaly  seizures  autistic behavior  ataxia  hyperven tilation and stereotypic hand movements. 4 patients (16  4  3.5  3 yearsold) who were found to have a MECP2 mutation exhibited an inconstantphenotype with incomplete clinical criteria  all (4/4) had regression follow ing normal initial development with loss of speech and stereotypic handmovements  (2/4) seizures  (2/4) loss of walking (0/4) microcephaly  (2/4)autistic behavior (2/4) ataxia and (1/4) hyperventilation. The absence ofmicrocephaly resulted in delay of diagnosis in 3/4 of the patients becausea number of physicians felt that microcephaly was a requisite criterion.While additional patients will be necessary to fully appreciate the changingphenotype of Rett Syndrome  the diagnosis should be considered andMECP2 gene sequencing for mutation analysis done when a developmen tally delayed female had normal early development followed by regressionwith the loss of speech  especially in the presence of stereotypic handmovements.Posters: Clinical Genetics and Dysmorphology 193P0484. Acromegaly in a patient with Turner syndrome  a rare disorder. G. Casti eyra   M. Guitelman  J. Herrera  S. Copelli  S. Fiszlejder  M. Zeller  A. Oneto Division of Endocrinology  Hospital Durand  Cedie  Buenos Aires   Argentina ', ' Acromegaly and Turner syndrome is not a frecuent clinical finding. Wepresent a case of 23 years old  is the first daughter of non consanguineousparents  family history is unremarkable. Clinical endocrinological cytoge netics and molecular studies are analyzied. Physical examination showheight 153(pc10) weight66(pc75)  HC 61(+4SD). The phenotype is TurnerSyndrome excluding facial features like overbite and nasal bone hypertro phy and prognatism. Acanthosis nigrans and hirsutism are clearly evidentand stature is in the 90pc for TS. Hormonal levels (IRMA RIA) GH 26ng/ml IGF1 400ng/m  insulin 200ugU/ml  FSH68mUI/ml  E2 15pg/ml Androstened. 2 9ng/ml  DHEAs 3000ng/ml  To 0 85ng/ml  PRL10ng/ml 17OHP4 1 2 ng/ml  Dynamic test OGGTshow not inhibition of GH.ACTHplus DXM8 inhibit the adrenal steroids. MR  an intrasuprasellar tumor withbilateral cavernous sinus expantion. US  absent gonads and hypoplasicuterus. RX  Cervical fusion (C1 2 3). Karyotype ( lymphocytes)  45X/46 X del (X) (q22 q ter)in 40% and 60% of cells respectively. DNA(leukocytes)  any sequence of SRY gene  centromere and heterochromat ic region of Y was detected by PCR. To our knowledge is the second casereported. Clinical findings  indicate the prevalence of the 45 X line  staturemay be influence by the presence of some genes in the Xq and GHexcess. The metabolic efects are potencialy altered  insulism resistance and the elevated levels of GH and IGF1 may act in the adrenal receptorproducing an increment of adrenal androgens. The understanding ofgenetic factors would be of great value and is our next step. Clinical courseand dificulties in clinical managment will be present. ",2001.0,lrskicker@msn.com,,,The diagnosis of Rett Syndrome prior to the availability of mutation analy sis by sequencing the MECP2 gene was based on rigid clinical criteria females who had normal development until 6 18 months of age with sub sequent regression characterized by loss of speech and loss of purposefuluse of hands  microcephaly  seizures  autistic behavior  ataxia  hyperven tilation and stereotypic hand movements.,,autistic behavior,[],"['autistic', 'behavior']"
11,593,Rett Syndrome  clinical manifestations in males with MECP2 mutations  germline mosaicism and implications forgenetic counseling and prenatal diagnosis,P0512., Orr Urtreger1  B. Ben Zeev2  C. N. Schanen3  H. Wolf1  N. Brandt2  N. Ginot4  R. Shomrat1  Y. Yaron1 1Tel Aviv Sourasky Medical Center  Tel Aviv  Israel  2Sheba Medical Cen  ter  Ramat Gan  Israel  3UCLA School of Medicine  Los Angeles  CA Unit  ed States  4Meir General Hospital  Kfar Saba  Israel ,Rett syndrome (RTT) is a neurodevelopmental disorder characterized bycognitive and adaptive regression with autistic features  loss of acquiredskills like speech and hand usage  stereotypic hand movements  epilepsy ataxia and deceleration of head growth that almost exclusively affectsfemales. Even before the causative gene for this syndrome was identified  pedigree studies indicated that it was likely to be an X linked dominantdisorder  with presumed lethality in males. Nonetheless  there were a fewdescriptions of males suspected of having Rett syndrome. These includesporadic cases meeting the clinical inclusion criteria  sporadic males withKlinefelter syndrome (47 XXY)  and males with severe neonatalencephalopathy in known Rett syndrome families. With the recent discov ery that the MECP2 gene on Xq28 is the gene responsible for most casesof Rett syndrome  it is possible to molecularly assess cases suspected ofhaving male Rett syndrome by direct sequencing analysis. We describethe first 4 cases of molecularly confirmed cases of Rett syndrome in Israel.One of the families presented here consists of a female having classicalRett syndrome and a male sibling with severe neonatal encephalopathy.Molecular analysis revealed that both sister and brother have the sameMECP2 gene mutation  however their mother does not  suggestinggermline mosaicism. The case emphasizes the point that maternalgermline mosaicism may lead to affected female or male offspring  whichshould be taken into consideration during genetic counseling regardingrecurrence risks  and suggests that prenatal diagnosis may be warrantedin siblings of apparently sporadic cases of Rett syndrome. It also highlightsthe importance of molecular diagnosis in every case of idiopathic neonatalencephalopathy in males. ,2001.0,aviorr@tasmc.health.gov.il,,,Rett syndrome (RTT) is a neurodevelopmental disorder characterized bycognitive and adaptive regression with autistic features  loss of acquiredskills like speech and hand usage  stereotypic hand movements  epilepsy ataxia and deceleration of head growth that almost exclusively affectsfemales.,,autistic features,[],"['autistic', 'feature']"
12,1083,Mutation analysis of the MECP2 gene in Italian Rett Patients using denaturing high performance liquid chro matography.,P1086., Carella1  R. Cattin1  B. Giometto2  B. Tavolato2  M. L. Giovannucci  Uzielli3  C. Lievore1  A. Marin1  P. Gasparini4  P. Nicolao2 1 1Department of Medical Genetics  Baschirotto Institute for Rare Diseases (BIRD EUROPE onlus)  Costozza di Longare (VI)  Italy  2Department of Neurological and Psychiatric Sciences  Second Neurological Clinic  PaduaUniversity  Padua  Italy   3Genetics and Molecular Medicine Unit  Depart  ment of Pediatrics  University of Florence  Azienda Meyer  Firenze  Italy  4Medical Genetics Service  IRCCS   CSS Hospital  San Giovanni Rotondo (FG)  I,Rett Syndrome is an X linked dominant neurodevelopmental disordercharacterized by several clinical abnormalities  such as progressiveencephalopathy  autistic behavior and stereotyped hand movements. Clas sical RS features seem to occur almost exclusively in females  with an esti mated prevalence of one in 10 000 15 000 female birth. The vast majori ties of Rett cases (99%) are sporadic in origin  and are due to de novomutations. Mutations in the Methyl CpG Binding protein 2 gene have been identified in roughly 75 % of classical Rett girls. We collected DNA samplesfrom 42 Italian classical Rett girls  and screened the MECP2 coding regionfor mutations by Denaturing High Performance Liquid Chromatography(DHPLC)  and subsequent direct sequencing. DHPLC is a recently devel oped method for mutation screening combining high sensitivity  reducedcost per run and high throughput. In our study  16 different de novoMECP2 mutations  seven of which were previously unreported  were foundin 32/42 Rett girls (76%). Seven recurrent mutations were characterized ina total of 22 unrelated cases. Initial DHPLC screening allowed the identifi cation of 14/16 different mutations (87%)  after optimal conditions wereestablished  this figure increased to 100%  with all recurrent MECP2 muta tions generating a characteristic chromatographic profile. Standardizationof DHPLC reagents and methods seems to be critical to the reliability andaccuracy of mutation prediction. Detailed analysis of signature shape retention time  and retention time differences between peaks will allow sig nature based sequence identification  at least for the most commonMECP2 mutations and SNPs. ,2001.0,talycarella@tigem.it,,,Rett Syndrome is an X linked dominant neurodevelopmental disordercharacterized by several clinical abnormalities  such as progressiveencephalopathy  autistic behavior and stereotyped hand movements.,,autistic behavior,[],"['autistic', 'behavior']"
15,1286,Multiplex Family Autism Research Resource,P1323., T. Johnson1  A. Mars2  J. C. Beck1 1Coriell Institute for Medical Research  Camden  NJ United States  2Robert Wood Johnson Medical School  New Brunswick  NJ United S,A genetic resource of DNA samples to support the study of autism in fam ilies where more than one child is affected or where one child is affectedand one demonstrates another significant and related developmental dis order has been built at the Coriell Institute for Medical Research in collab oration with the clinical services at the University of Medicine and DentistryRobert Wood Johnson Medical School. An open bank of anonymously col lected materials documented by a detailed clinical diagnosis forms thebasis of this growing database of information about the disease. Three cri teria were used to assess the autistic phenotype. These include the ADI(Autism Diagnostic Interview)  the ADOS (Autism Diagnostic Observation al Schedule Generic)  and the DSM IV Diagnostic Criteria for 299.00 Autis tic Disorder. All clinical interviews were conducted face to face. For eachdonor subject tested  a representative Autistic Diagnostic Criteria ScoreSheet used to collect data is provided. Currently  the resource contains 20families in which 41 individuals have been examined. Thirty three of theseindividuals have a diagnosis of autistic disorder by two or more criteria  28of these satisfy all three criteria. There are 20 affected sib pairs with a diag nosis of autistic disorder by two or more criteria  9 of these pairs meet thecriteria for autistic disorder by all three criteria. Further information aboutthis resource  including information on ordering  can be found athttp //locus.umdnj.edu/autism or by contact with the Coriell Cell Reposito ries. ,2001.0,tatesrjohnson@cimr.umdnj.edu,,,Three cri teria were used to assess the autistic phenotype.,,autistic phenotype,[],"['autistic', 'phenotype']"
15,1286,Multiplex Family Autism Research Resource,P1323., T. Johnson1  A. Mars2  J. C. Beck1 1Coriell Institute for Medical Research  Camden  NJ United States  2Robert Wood Johnson Medical School  New Brunswick  NJ United S,A genetic resource of DNA samples to support the study of autism in fam ilies where more than one child is affected or where one child is affectedand one demonstrates another significant and related developmental dis order has been built at the Coriell Institute for Medical Research in collab oration with the clinical services at the University of Medicine and DentistryRobert Wood Johnson Medical School. An open bank of anonymously col lected materials documented by a detailed clinical diagnosis forms thebasis of this growing database of information about the disease. Three cri teria were used to assess the autistic phenotype. These include the ADI(Autism Diagnostic Interview)  the ADOS (Autism Diagnostic Observation al Schedule Generic)  and the DSM IV Diagnostic Criteria for 299.00 Autis tic Disorder. All clinical interviews were conducted face to face. For eachdonor subject tested  a representative Autistic Diagnostic Criteria ScoreSheet used to collect data is provided. Currently  the resource contains 20families in which 41 individuals have been examined. Thirty three of theseindividuals have a diagnosis of autistic disorder by two or more criteria  28of these satisfy all three criteria. There are 20 affected sib pairs with a diag nosis of autistic disorder by two or more criteria  9 of these pairs meet thecriteria for autistic disorder by all three criteria. Further information aboutthis resource  including information on ordering  can be found athttp //locus.umdnj.edu/autism or by contact with the Coriell Cell Reposito ries. ,2001.0,tatesrjohnson@cimr.umdnj.edu,,,Thirty three of theseindividuals have a diagnosis of autistic disorder by two or more criteria  28of these satisfy all three criteria.,,autistic disorder,[],"['autistic', 'disorder']"
15,1286,Multiplex Family Autism Research Resource,P1323., T. Johnson1  A. Mars2  J. C. Beck1 1Coriell Institute for Medical Research  Camden  NJ United States  2Robert Wood Johnson Medical School  New Brunswick  NJ United S,A genetic resource of DNA samples to support the study of autism in fam ilies where more than one child is affected or where one child is affectedand one demonstrates another significant and related developmental dis order has been built at the Coriell Institute for Medical Research in collab oration with the clinical services at the University of Medicine and DentistryRobert Wood Johnson Medical School. An open bank of anonymously col lected materials documented by a detailed clinical diagnosis forms thebasis of this growing database of information about the disease. Three cri teria were used to assess the autistic phenotype. These include the ADI(Autism Diagnostic Interview)  the ADOS (Autism Diagnostic Observation al Schedule Generic)  and the DSM IV Diagnostic Criteria for 299.00 Autis tic Disorder. All clinical interviews were conducted face to face. For eachdonor subject tested  a representative Autistic Diagnostic Criteria ScoreSheet used to collect data is provided. Currently  the resource contains 20families in which 41 individuals have been examined. Thirty three of theseindividuals have a diagnosis of autistic disorder by two or more criteria  28of these satisfy all three criteria. There are 20 affected sib pairs with a diag nosis of autistic disorder by two or more criteria  9 of these pairs meet thecriteria for autistic disorder by all three criteria. Further information aboutthis resource  including information on ordering  can be found athttp //locus.umdnj.edu/autism or by contact with the Coriell Cell Reposito ries. ,2001.0,tatesrjohnson@cimr.umdnj.edu,,,There are 20 affected sib pairs with a diag nosis of autistic disorder by two or more criteria  9 of these pairs meet thecriteria for autistic disorder by all three criteria.,,autistic disorder,[],"['autistic', 'disorder']"
15,1286,Multiplex Family Autism Research Resource,P1323., T. Johnson1  A. Mars2  J. C. Beck1 1Coriell Institute for Medical Research  Camden  NJ United States  2Robert Wood Johnson Medical School  New Brunswick  NJ United S,A genetic resource of DNA samples to support the study of autism in fam ilies where more than one child is affected or where one child is affectedand one demonstrates another significant and related developmental dis order has been built at the Coriell Institute for Medical Research in collab oration with the clinical services at the University of Medicine and DentistryRobert Wood Johnson Medical School. An open bank of anonymously col lected materials documented by a detailed clinical diagnosis forms thebasis of this growing database of information about the disease. Three cri teria were used to assess the autistic phenotype. These include the ADI(Autism Diagnostic Interview)  the ADOS (Autism Diagnostic Observation al Schedule Generic)  and the DSM IV Diagnostic Criteria for 299.00 Autis tic Disorder. All clinical interviews were conducted face to face. For eachdonor subject tested  a representative Autistic Diagnostic Criteria ScoreSheet used to collect data is provided. Currently  the resource contains 20families in which 41 individuals have been examined. Thirty three of theseindividuals have a diagnosis of autistic disorder by two or more criteria  28of these satisfy all three criteria. There are 20 affected sib pairs with a diag nosis of autistic disorder by two or more criteria  9 of these pairs meet thecriteria for autistic disorder by all three criteria. Further information aboutthis resource  including information on ordering  can be found athttp //locus.umdnj.edu/autism or by contact with the Coriell Cell Reposito ries. ,2001.0,tatesrjohnson@cimr.umdnj.edu,,,There are 20 affected sib pairs with a diag nosis of autistic disorder by two or more criteria  9 of these pairs meet thecriteria for autistic disorder by all three criteria.,,autistic disorder,[],"['autistic', 'disorder']"
16,1287,Genome linkage analysis using affected sibling pairs for autism,P1324., H. Barnby1  I. M.G.S.A.C2 1The Wellcome Trust Centre for Human Genetics University of Oxford  Oxford  United Kingdom  2http //www.well.ox.ac.uk/~maestrin/iat.html  London  United K,Autism is a severe neurodevelopmental disorder characterised by defi ciencies in three domains  reciprocal interaction  communication andstereotyped/repetitive behaviour. Evidence for a strong genetic basis forthe disorder stems from twin studies and the increased rate of autism insiblings of autistic probands compared to the population prevalence.IMGSAC have previously published a whole genome screen for 36 sib pairs  with a subset of 175 markers typed in a further 49 sib pairs and 3sibling trios. Five regions were identified with multipoint Maximum LodScore (MLS) > 1 (chromosomes 4  7  10  16 and 22). These regions havebeen characterised further and the results are presented here along withnew findings. A whole genome screen has now been carried out for 86 sib pairs using 394 microsatellites. A subset of 119 markers have been typedin 153 sib pairs in 12 regions giving a multipoint MLS above 0.80. ThreePosters: Analysis of Disorders and Traits with Complex Inheritance 359chromosomes generated a multipoint MLS above 3 after 153 sib pairs had been genotyped  2q  7q and 16p. Chromosome 2 gave the highest resultwith a multipoint MLS of 3.58 at D2S2188 followed by chromosome 7 atD7S477 with a multipoint MLS of 3.37 and then chromosome 16 with amultipoint MLS of 3.08 at D16S3102. Analysis of linkage data on the basisof sib pair proband status has been carried out and the parental origin ofalleles contributing to linkage was also investigated across the regionsstudied. ,2001.0,ingdomgaby@well.ox.ac.uk,,,Evidence for a strong genetic basis forthe disorder stems from twin studies and the increased rate of autism insiblings of autistic probands compared to the population prevalence.IMGSAC have previously published a whole genome screen for 36 sib pairs  with a subset of 175 markers typed in a further 49 sib pairs and 3sibling trios.,,autistic probands,[],"['autistic', 'probands']"
18,1289,Molecular analysis of t(5 7) in a patient with autism,P1326., Tentler1  G. Anner n2  C. Gillberg3  C. Betancur4  G. Brandberg5  N. Dahl1 1Dep. of Genetics and Pathology  Uppsala University  Uppsala  Sweden  2Dep. of Genetics and Pathology  Uppsala University  Uppsala  Sweden  3Child Neuropsychiatry  Sahlgren University Hospital  G teborg  Sweden  4INSERM U. 513  Facult  de M decine de Cr teil  Paris  France  5Falun County Hospital  Falun  S,The results of several linkage studies have provided support for an autismsusceptibility locus on the long arm of chromosome 7. We report a girl withautistic features carrying a balanced translocation t(5 7)(q14 q34). Fluo rescent in situ hybridisation (FISH) analysis with chromosome 7q specificYAC clones showed that the chromosome 7 breakpoint is located betweenmarkers D7S684 and D7S661. The region coincides with the candidateregion for autism on chromosome 7 from previous linkage studies. A BACclone of 82 kb spanning the translocation breakpoint was identified  andthe breakpoint was mapped to 2 kb region within the BAC. Mutationscreening of the 2 genes closest to the breakpoint was performed in a setof 30 autistic patients. We found no sequence variant which predictsaminoacid alteration associated with the phenotype. Two polymorphicnucleotides were identified in one of the genes  and the significance of thepolymorphism in autism remains to be clarified. Study of the methylationpattern of the breakpoint region failed to find any difference betweenpatient with the translocation and normal individuals. A positional effect ofthe translocation is not excluded  and further investigation of the 7q methy lation pattern in the patient is in progress. ,2001.0,wedendmitry.tentler@genpat.uu.se,,,Mutationscreening of the 2 genes closest to the breakpoint was performed in a setof 30 autistic patients.,,autistic patients,[],"['autistic', 'patient']"
20,1291,De novo partial duplication of chromosome 7q in a male patient with infantile autism,P1328., S. Beyer   S. M. Klauck  A. Poustka Deutsches Krebsforschungszentrum  Molecular Genome Analysis  Heidel berg  G,Autism is a neurodevelopmental disorder with a strong genetic componentas shown in family studies. The disease is characterized by impairments inreciprocal social interaction and communication together with restrictedand stereotyped patterns of interests and activities. The genetics of the dis order is complex  probably involving the interaction of several genes. Theneurobiological basis of the disorder is unknown and there are no strongcandidate genes. Several genome screens were undertaken by differentautism consortia identifying different regions of interest  defined by a mul tipoint maximum lod score (MLS) greater than 1. A region on chromosome7q31 35 was the most significant region (MLS of 2.53) identified first by theInternational Molecular Genetic Study of Autism Consortium (IMGSAC) which we are part of. Meanwhile four other genome screens were pub lished showing positive linkage on different chromosomal regions. The onlycommon region of all analyses remained on chromosome 7q. One possi bility to narrow down the candidate region and to identify new candidategenes are systematic karyotype analyses of autistic patients. One malepatient showed a duplication on chromosome 7q in 11% of leukocytes inperipheral blood and in approximately 40% of the nuclei in the correspon ding lymphoblastoid cell line. In order to determine the exact localizationand orientation of the duplication FISH experiments using several YACswere performed. ,2001.0,ermanyk.beyer@dkfz.de,,,One possi bility to narrow down the candidate region and to identify new candidategenes are systematic karyotype analyses of autistic patients.,,autistic patients,[],"['autistic', 'patient']"
25,1676,A locus for autosomal dominant form of hemochro  irma.jarvela@hus.fi matosis on chromosome 2q. Asperger syndrome (AS) was first described in 1944 by a Viennese physi ,C100., T. Njajou  N. Vaessen  B. Berghuis  M. H. Breuning  W. P. T. Rutten  P. cian Hans Asperger who reported a group of boys with autistic psychopa  J. L. Snijders  J. Houwing Duistermaat  A. Hofman  B. A. Oostra  L. A. thy whose clinical features resembled autism with some modifications. It Sandkuijl  C. M. Van Duijn  P. Heutink is characterised by difficulties in social interaction and stereotyped behav  Erasmus University Medical Center  Rotterdam  The Netherlands iour but in contrast to infantile autism by normal intelligence and usually , normal language skills. In the pediatric age group the prevalence of Hemochromatosis is a common recessive disorder in populations of cau  Asperger syndrome is around 4 7/1000 whereas the corresponding figure casian origin. The disease is characterised by iron accumulation through  for the infantile autism is 4/10000. Etiopathogenesis is unknown but there out the body leading to widespread pathology including diabetes  cardio  is evidence for a strong genetic component. Based on clinical observations vascular diseases  stroke and cancer. Alocus for juvenile hemochromato  AS is inherited in the same families as infantile autism but also as a sepa  sis on chromosome 1q  mutations in HFE gene (6p22.1) and a locus on rate entity often transmitted from male to male. We report the analysis of 7q22 have been described. Still  not all hemochromatosis patients carry 13 candidate gene loci associated with autism and schizophrenia in 17 these mutations. This suggests that other genes are involved. To localise Finnish AS families with autosomal dominant mode of inheritance. Linkage other genes involved in hemochromatosis  we performed a genome search to the previously reported predisposing loci for autism could not be repli  in an extended pedigree (96 subjects) with multiple affected individuals (12 cated with Finnish AS families. By contrast  evidence for linkage was patients). Affected individuals in this family did not have a known mutation. obtained on 1q21 22 the region that has previously been linked to schizo  In this pedigree  hemochromatosis segragates as an autosomal dominant phrenia (Brzustowicz et al.  2000) with the maximum two point lod score of disease. 47 subjects (10 affected and 37 unaffected) were selected for a 2.70 with marker D1S484. Two families shared a common haplotype with  genome wide search and linkage analysis. Simulation studies were per  in an 8.6 cM region between markers D1S2721 and D1S484. Our results formed as described by Ott J (1989) and Weeks et al  (1990)  yielding a suggest that AS and schizophrenia may have common genetic back  maximum lod score of 3.24. Agenome screen was performed using 400 ground. polymorphic markers. Two point linkage analysis was performed using dis  ease frequency of 0.001 and an age dependent penetrance of 2%  60%  nan,2001.0,njajou@mailcity.com,,,In the pediatric age group the prevalence of Hemochromatosis is a common recessive disorder in populations of cau  Asperger syndrome is around 4 7/1000 whereas the corresponding figure casian origin.,,Asperger syndrome,[],"['Asperger', 'syndrome']"
28,1844,Triopia  the second case in the literature. 1Institut fr Medizinische Genetik  Zrich  Switzerland  2Kantonsspital ,P0417., Moretti Ferreira1  R. L. F. Lima2  J. Murray3  A. Richieri Costa4 Winterthur  Switzerland  3Stadtspital Waid  Zrich  Switzerland 1Dept of Genetics  IBB  UNESP  Botucatu  Brazil  2Dept. of Genetics  ," IBB/UNESP  Botucatu  Brazil  3Dept. of Pediatrics&Biological Sciences  Anal sphincter dysplasia (ASDP) has been described as anteriorly or ven  University of Iowa  Iowa City  United States  4Dept. of Cinical Genetics  trally displaced anus (OMIM 105563). Absent or incomplete fixation of the HRAC USP  Bauru  Brazil sphincter to the coccyx are demonstratable by computer tomography as ', ' well as by intraoperative dissection of the sphincter muscles. The range of Triopia (three eyes) is a very rare condition. It was first reported by Stel  symptoms included chronic constipation  severe straining at defecation  nicki et al. (1995). These authors interpreted the presence of two globes in encopresis  and chronic paradoxical diarrhea with fecal incontinence. This the left orbit as prosencephalon duplication. We have recently assessed a congenital malformation occurs often familial  and an autosomal dominant male patient  second child of a young  healthy  non consanguineous cou  mode of inheritance with reduced penetrance has been suggested. ple. The patient presented a complex malformation involving the central Recently  mutations in the HLXB9 homeobox gene have been described in nervous system  craniofacial structures and remarkedly the eyes. Main the DNA of patients with Currarino syndrome  an autosomal dominant clinical findings included broad and backward sloping forehead  plagio  inherited form of sacral agenesis. Because anorectal malformations are a brachycephaly  wide skull sutures  a large facial cleft extending upward to component of the Currarino syndrome  the HLXB9 gene was analyzed in the nose  a Tessier number 9 bilaterally  abnormally developed orbits with the DNAof 20 probands affected from ASDPwith several affected family two hypoplastic and colobamatous globes at right and a hypoplastic and members. The three exons of the HLXB9 gene were amplified using nine colobamatous eye at left (triopia)  and low set and posteriorly rotated ears. different primer pairs  and the PCR products were analyzed by single G banded chromosomes were normal. Molecular study of the gene PAX6 strand conformation polymorphism (SSCP) analysis. There was no evi  showed no mutation. MRI revealed no duplication of prosencephalie struc  dence for mutations in this gene in the analyzed DNAsamples. tures. The gestation was uneventful without any known ingestion of terato  gens by the mother. Up to now  we have been seeking for an embryologic  nan",2001.0,"hergie@medgen.unizh.ch', 'sag@fmb.unesp.br",,,Because anorectal malformations are a brachycephaly  wide skull sutures  a large facial cleft extending upward to component of the Currarino syndrome  the HLXB9 gene was analyzed in the nose  a Tessier number 9 bilaterally  abnormally developed orbits with the DNAof 20 probands affected from ASDPwith several affected family two hypoplastic and colobamatous globes at right and a hypoplastic and members.,,ASDPwith several affected family,[],"['ASDPwith', 'several', 'affected', 'family']"
29,1853,Clinical cytogenetic and molecular analysis of two both observed  so that many features of BRR Syndrome are also consid  families with FRAXE mutation  implications for genetic coun  ered as major and minor criteria for CS. We describe a 6 year old boy with selling and prenatal diagnosis mild mental retardation  who was seen for evaluation of muscular weak ,P0442., I. Tejada1  P. Botella2  M. A. Lpez Arztegui3  F. Mozo de Rosales4  M. ness. Because of the additional presence of lipomas and a mild macro  Lpez Valverde4  M. L. Onaindia1  M. Molina1 cephaly BRR was suspected. Mutation analysis revealed a heterozygous 1Genetic Unit  Basurto Hospital  Bilbao  Spain  2Dept. of Paediatrics  missence mutation G389Ain the PTEN gene  thus confirming diagnosis of Txagorritxu Hospital  Vitoria  Spain  3Genetic Laboratory  Cruces Hospital  BRR. The mutation was found in DNAfrom leucocytes as well as in DNA Baracaldo  Spain  4Dept. of Obstetrics and Gynaecology  Basurto Hospital  isolated from a lipoma. The mutation G389Ahas already been described Bilbao  Spain in a family with CS and is located in exon 5  a hotspot for CS mutations. , Our patient does not fulfill the recently revised diagnostic criteria for CS (J. FRAXE full mutations are rare and appear to be associated with mild men  Med. Genet. 2000  37 828 830) used for selecting patients suitable for tal retardation and with a fragile site in Xq28. This is due to an abnormal molecular analysis. The low mutation detection rate in BRR patients could expanded GCC repeat  adjacent to a methylated CpG island proximal to either be due to genetic heterogeneity or to the uncertainty concerning the the FMR2 gene. As part of a routine diagnosis  all individuals referred to us exact phenotype and clinical spectrum of BRR. More patients with macro  for Fragile X Syndrome (FXS) study  and tested FRAXAnegative  were cephaly  muscular weakness and presence of lipomas should be screened studied for FRAXE mutation. Among 485 index case patients  2 were iden  for mutations in the PTEN gene in order to determine the phenotypic vari  tified with the FRAXE full mutation  both with cytogenetic expression of the ability and try to establish diagnostic criteria for BRR. fragile site (29 and 23% respectively) and with no history of mental retar  dation. One of them has an autistic disorder with severe MR an a dysmor  nan,2001.0,itejada@hbas.osakidetza.net,,,One of them has an autistic disorder with severe MR an a dysmor  nan,,autistic disorder,[],"['autistic', 'disorder']"
30,1868,Neurocognitive Profile of Young Children with XXY L. R. Shapiro1 2  H. G. Taska2  R. V. Scott2  D. F. Kronn1 2 (Klinefleter syndrome) 1New York Medical College  Valhalla  NY United States  2Westchester,P0481., A. Samango Sprouse1  P. Law2 Medical Center  Valhalla  NYUnited States 1George Washington University  Washington  DC United States  2Johns ," Hopkins University  Baltimore  MD United States The diagnosis of Rett Syndrome prior to the availability of mutation analy  ', ' sis by sequencing the MECP2 gene was based on rigid clinical criteria  XXYoccurs 1 500 & the facets of the neurodevelopmental(ND)profile of females who had normal development until 6 18 months of age with sub  the young child with XXYhave not been well desribed in a large sample. sequent regression characterized by loss of speech and loss of purposeful There were 52 subjects with XXYprenatally diagnosed. Comprehensive use of hands  microcephaly  seizures  autistic behavior  ataxia  hyperven  ND assessments were completed using standardized tools to determine tilation and stereotypic hand movements. 4 patients (16  4  3.5  3 years the level of functioning in the five areas of development. The mean age old) who were found to have a MECP2 mutation exhibited an inconstant was 13m(r=2 48m). Parents were well educated with 25% having post  phenotype with incomplete clinical criteria  all (4/4) had regression follow  graduate degrees. Data was segregated and analyzed using Hottellings t  ing normal initial development with loss of speech and stereotypic hand test at p<.05 level. Speech(EL=85.7[sd=12.8] p<.001)& motor(PDI= movements  (2/4) seizures  (2/4) loss of walking (0/4) microcephaly  (2/4) 88.46[sd=12.39] p<.001)delays were significant with normal autistic behavior (2/4) ataxia and (1/4) hyperventilation. The absence of cognition(MDI= 97.6[sd=12.8]). 50% of the boys had abnormal muscle microcephaly resulted in delay of diagnosis in 3/4 of the patients because tonus in the trunk & extremeties. This profile is highly suggestive of an a number of physicians felt that microcephaly was a requisite criterion. infantile presentation of developmental dyspraxia(IDD) a motor planning While additional patients will be necessary to fully appreciate the changing disorder with speech  motor and attention conmpromised. This large study phenotype of Rett Syndrome  the diagnosis should be considered and on XXYwho were prenatally diagnosed reveals an infantile presentation of MECP2 gene sequencing for mutation analysis done when a developmen  a learning disorder which may be an predictive of an increased risk for edu  tally delayed female had normal early development followed by regression cational difficulties. Further follow up will determine the incidence of learn  with the loss of speech  especially in the presence of stereotypic hand ing disablilties and the predictive factors from these early findings. Prena  movements. tal counseling with families should discuus the possibility IDD  normal cog  nition and need for EI evaluation that are focused on specific weaknesses. This study further defines the natural history of a sex chromosome disor  der in early childhood years. Further studies are warranted to investigate if there are any correlations between ND performance and parental origin of194 Posters: Clinical Genetics and Dysmorphology ",2001.0,"lrskicker@msn.com', 'cssprouse@aol.com",,,Comprehensive use of hands  microcephaly  seizures  autistic behavior  ataxia  hyperven  ND assessments were completed using standardized tools to determine tilation and stereotypic hand movements.,,autistic behavior,[],"['autistic', 'behavior']"
30,1868,Neurocognitive Profile of Young Children with XXY L. R. Shapiro1 2  H. G. Taska2  R. V. Scott2  D. F. Kronn1 2 (Klinefleter syndrome) 1New York Medical College  Valhalla  NY United States  2Westchester,P0481., A. Samango Sprouse1  P. Law2 Medical Center  Valhalla  NYUnited States 1George Washington University  Washington  DC United States  2Johns ," Hopkins University  Baltimore  MD United States The diagnosis of Rett Syndrome prior to the availability of mutation analy  ', ' sis by sequencing the MECP2 gene was based on rigid clinical criteria  XXYoccurs 1 500 & the facets of the neurodevelopmental(ND)profile of females who had normal development until 6 18 months of age with sub  the young child with XXYhave not been well desribed in a large sample. sequent regression characterized by loss of speech and loss of purposeful There were 52 subjects with XXYprenatally diagnosed. Comprehensive use of hands  microcephaly  seizures  autistic behavior  ataxia  hyperven  ND assessments were completed using standardized tools to determine tilation and stereotypic hand movements. 4 patients (16  4  3.5  3 years the level of functioning in the five areas of development. The mean age old) who were found to have a MECP2 mutation exhibited an inconstant was 13m(r=2 48m). Parents were well educated with 25% having post  phenotype with incomplete clinical criteria  all (4/4) had regression follow  graduate degrees. Data was segregated and analyzed using Hottellings t  ing normal initial development with loss of speech and stereotypic hand test at p<.05 level. Speech(EL=85.7[sd=12.8] p<.001)& motor(PDI= movements  (2/4) seizures  (2/4) loss of walking (0/4) microcephaly  (2/4) 88.46[sd=12.39] p<.001)delays were significant with normal autistic behavior (2/4) ataxia and (1/4) hyperventilation. The absence of cognition(MDI= 97.6[sd=12.8]). 50% of the boys had abnormal muscle microcephaly resulted in delay of diagnosis in 3/4 of the patients because tonus in the trunk & extremeties. This profile is highly suggestive of an a number of physicians felt that microcephaly was a requisite criterion. infantile presentation of developmental dyspraxia(IDD) a motor planning While additional patients will be necessary to fully appreciate the changing disorder with speech  motor and attention conmpromised. This large study phenotype of Rett Syndrome  the diagnosis should be considered and on XXYwho were prenatally diagnosed reveals an infantile presentation of MECP2 gene sequencing for mutation analysis done when a developmen  a learning disorder which may be an predictive of an increased risk for edu  tally delayed female had normal early development followed by regression cational difficulties. Further follow up will determine the incidence of learn  with the loss of speech  especially in the presence of stereotypic hand ing disablilties and the predictive factors from these early findings. Prena  movements. tal counseling with families should discuus the possibility IDD  normal cog  nition and need for EI evaluation that are focused on specific weaknesses. This study further defines the natural history of a sex chromosome disor  der in early childhood years. Further studies are warranted to investigate if there are any correlations between ND performance and parental origin of194 Posters: Clinical Genetics and Dysmorphology ",2001.0,"lrskicker@msn.com', 'cssprouse@aol.com",,,Speech(EL=85.7[sd=12.8] p<.001)& motor(PDI= movements  (2/4) seizures  (2/4) loss of walking (0/4) microcephaly  (2/4) 88.46[sd=12.39] p<.001)delays were significant with normal autistic behavior (2/4) ataxia and (1/4) hyperventilation.,,autistic behavior,[],"['autistic', 'behavior']"
31,1877,Rett Syndrome  clinical manifestations in males with Spondylothoracic dysplasia (MIM#277300) is an autosomal recessive dis  MECP2 mutations  germline mosaicism and implications for order with high prevalence in Puerto Rican population that has been genetic counseling and prenatal diagnosis described as a lethal condition. Since Jarcho and Levin described it in,P0512., Orr Urtreger1  B. Ben Zeev2  C. N. Schanen3  H. Wolf1  N. Brandt2  N. 1938 has been referred to as Jarcho Levin syndrome (JLS)  costovertebral Ginot4  R. Shomrat1  Y. Yaron1 dysplasia and spondylothoracic dysostosis among other terms. We have 1Tel Aviv Sourasky Medical Center  Tel Aviv  Israel  2Sheba Medical Cen  prospectively characterized 20 patients with spondylothoracic dysplasia  ter  Ramat Gan  Israel  3UCLASchool of Medicine  Los Angeles  CAUnit  taken detail medical histories  performed physical examinations  pedigree ed States  4Meir General Hospital  Kfar Saba  Israel analysis  spine x rays  spinal 3 D reconstructive CT scans  virtual bron  , choscopies and pulmonary function tests (PFTs). Numerous vertebral Rett syndrome (RTT) is a neurodevelopmental disorder characterized by segmentation and formation defects were found. Characteristic vertebral cognitive and adaptive regression with autistic features  loss of acquired shapes that has not been described in the medical literature before was skills like speech and hand usage  stereotypic hand movements  epilepsy  also found. Eight out of these 20 patients has been born during our study ataxia and deceleration of head growth that almost exclusively affects and four have survived to 3 18 24 38 months respectively. The cause of females. Even before the causative gene for this syndrome was identified death in disease patients was respiratory insufficiency secondary to restric    pedigree studies indicated that it was likely to be an X linked dominant tive lung problems and pneumonia. Age of the remaining patients ranges disorder  with presumed lethality in males. Nonetheless  there were a few from 8 to 41 years. PFTs performed on individuals older than 6 years descriptions of males suspected of having Rett syndrome. These include showed a restrictive pattern that do not seems to exacerbate as patient sporadic cases meeting the clinical inclusion criteria  sporadic males with progresses in age. Mortality in our kindred was 50% of the identified new  Klinefelter syndrome (47 XXY)  and males with severe neonatal borns with JLS. This is an important finding since the vast majority of the encephalopathy in known Rett syndrome families. With the recent discov  JLS patients cited in the medical literature died in early newborn or child  ery that the MECP2 gene on Xq28 is the gene responsible for most cases hood periods. Their intellectual capacity and development is normal in all of Rett syndrome  it is possible to molecularly assess cases suspected of cases. This is the largest kindred of patients with JLS described in the having male Rett syndrome by direct sequencing analysis. We describe medical literature and so forth has allowed us to established a detail phe  the first 4 cases of molecularly confirmed cases of Rett syndrome in Israel. notype and natural progression of the disease. A genome wide linkage One of the families presented here consists of a female having classical analysis is currently undergoing to determine the locus (i) of JLS in Puerto Rett syndrome and a male sibling with severe neonatal encephalopathy. Rican population. Molecular analysis revealed that both sister and brother have the same MECP2 gene mutation  however their mother does not  suggesting  nan,2001.0,aviorr@tasmc.health.gov.il,,,Characteristic vertebral cognitive and adaptive regression with autistic features  loss of acquired shapes that has not been described in the medical literature before was skills like speech and hand usage  stereotypic hand movements  epilepsy  also found.,,autistic features,[],"['autistic', 'feature']"
33,2106,Mutation analysis of the MECP2 gene in Italian Rett genital muscle disease caused by mutations in the myotubularin gene. Patients using denaturing high performance liquid chro  This gene encodes for a dual specific phosphatase belonging to a large matography. gene family highly conserved through evolution. To date  133 mutations,P1086., Carella1  R. Cattin1  B. Giometto2  B. Tavolato2  M. L. Giovannucci  distributed in all exons of the MTM1 gene have been identified in a large Uzielli3  C. Lievore1  A. Marin1  P. Gasparini4  P. Nicolao2 1 number of families. Since the majority of MTM1 mutations are private and 1Department of Medical Genetics  Baschirotto Institute for Rare Diseases rare  their detection is difficult and labor extensive using traditional screen  (BIRD EUROPE onlus)  Costozza di Longare (VI)  Italy  2Department of ing approaches. We set up and formatted a denaturing high performance Neurological and Psychiatric Sciences  Second Neurological Clinic  Padua liquid chromatography (DHPLC) method to detect MTM1 mutations in all University  Padua  Italy  3Genetics and Molecular Medicine Unit  Depart  coding exons of the gene. Our protocol has revealed the pathogenic muta  ment of Pediatrics  University of Florence  Azienda Meyer  Firenze  Italy  tion in 8 XLMTM patients screened for the entire coding sequence of the 4Medical Genetics Service  IRCCS   CSS Hospital  San Giovanni Rotondo gene. DHPLC identified 7 point mutations previously described [R37X  (FG)  Italy T(191 11)A  646 647insA  T197I  R253X  G378R  G402R]. In addition  we , identified two novel mutations  one in exon 8 [P199S] and one in the donor Rett Syndrome is an X linked dominant neurodevelopmental disorder splice site of exon 14 (1644+2)insG. In conclusion  we provided that characterized by several clinical abnormalities  such as progressive DHPLC analysis is a sensitive and specific method to detect mutations in encephalopathy  autistic behavior and stereotyped hand movements. Clas  MTM1 gene. sical RS features seem to occur almost exclusively in females  with an esti  mated prevalence of one in 10 000 15 000 female birth. The vast majori  ties of Rett cases (99%) are sporadic in origin  and are due to de novo314 Posters: Genetic Services  Genetic Screening  and Public Policy ,2001.0,carella@tigem.it,,,In conclusion  we provided that characterized by several clinical abnormalities  such as progressive DHPLC analysis is a sensitive and specific method to detect mutations in encephalopathy  autistic behavior and stereotyped hand movements.,,autistic behavior,[],"['autistic', 'behavior']"
36,2304,Identification of Two Novel Missense Mutations in the romuscular functioning. Andersen syndrome is such a condition in which CSX Gene encoding a Cardiac Specific Transcription Factor cardiac arrythmias (long QT) and periodic paralysis are associated. Spo ,P1594., Gutierrez1  T. Sluysmans2  K. Devriendt3  M. Vikkula1 radic as well as familial cases have been reported but no gene has been 1Christian de Duve Institute of Cellular Pathology  Brussels  Belgium  2Uni  identified so far. Several long QTsyndromes (LQT) have been defined on versit catholique de Louvain  Brussels  Belgium  3Katholieke Universiteit a genetic basis. To date  six long QTgenes have been localized  five of Leuven  Leuven  Belgium them (LQT1 3  5 6) are now identified and encode potassium or sodium , channels. The LQT4 gene has been mapped to chromosome 4q25 q27 but Non syndromic cardiac septation defects are common  yet the responsible the critical region extends over 18 cM and the gene remains unknown. One genetic changes remain uncharacterised. However mutations in the patient with Andersen syndrome was detected. Cytogenetic studies CSX/Nkx2 5 gene encoding a cardiac specific homeobox transcription fac  revealed the existence of a de novo reciprocal translocation tor have been reported to cause atrial septal defects (ASD) associated with t(4 12)(q26 p12). Co localization of the breakpoint at 4q26 with the critical atrioventricular (AV) conduction block. The CSX gene is expressed in car  area defined for LQT4 syndrome at 4q25 q27 strongly suggested that both diac muscle during embryonic  fetal and adult life  and its Drosophila syndromes could be caused by different alterations of the same gene. The ortholog tinman  is essential for the formation of the dorsal vessel. Target  translocation breakpoint thus represented a very powerful tool to identify ed homozygous disruption of Nkx2 5 in mice causes lethality due to failure the disease gene. FISH experiments with YACs and PACs showed that the of heart looping. In man  eleven mutations in the CSX gene have been translocation breakpoint at 4q26 lies in a 120 kb area entirely comprised described in individuals with variable cardiac phenotypes. The majority has within the LQT4 critical region. Work is in progress in order to identify junc  ASD and/or atrioventricular conduction defects. In addition  ventricular tion fragments from cosmid clones encompassing the breakpoint. Molecu  septal defects (VSD)  tetralogy of Fallot (TOF)  subvalvular aortic stenosis  lar cloning of the breakpoint should lead to identification of a gene for both ventricular hypertrophy  pulmonary atresia  mitral valve abnormalities and the Andersen syndrome and the LQT4 syndrome. Identification of this Ebsteins anomaly are observed. Along our studies on non syndromic gene will be an important step towards the understanding of both periodic familial cardiopathies  we have collected two families with some members paralysis and long QTsyndromes. As the gene is likely to contribute the presenting ASD and AV block. In both families we identified a novel CSX QT interval variability between normal individuals  it could also play a mutation in the homeodomain Variable expressivity in the phenotype was major role in normal cardiac functioning. Once the gene is identified  large  observed in one of the families. In the first generation  pacemakers have scale genetic studies could be performed to test the involvement of the been implanted  in the second  two unaffected carriers and two members gene in various cardiac arrythmias. Moreover  functional studies and the with ASD secundum (ASDII) and TOF were identified. Finally  in the third establishment of cellular and animal models will represent powerful tools generation  members with ASDII  VSD  pulmonary stenosis  atrioventricu  to test various pharmacological and genetic therapeutic approaches  as lar septal defect and patent ductus arteriosus (PDA) were observed. Thus well as to better understand normal cardiac and muscular functioning. the phenotypes caused by CSX mutations vary from non expression  severe arrhythmia  to TOF and PDA. Importantly  mutation carriers do not ,2001.0,vikkula@bchm.ucl.ac.be,,,Moreover  functional studies and the with ASD secundum (ASDII) and TOF were identified.,,ASD secundum,[],"['ASD', 'secundum']"
37,23,The search for autism susceptibility genes,S11.,," Autism is characterised by impaired social interaction and  communication, and is accompanied by repetitive and stereotyped  behaviours and interests. Autism has an onset in the first three years,  persists throughout life, and is associated with mental handicap  and epilepsy although it can include milder, but related impairments  in individuals of normal intelligence. From family and twin studies  there is substantial evidence that autism has a strong yet complex  genetic component. In order to identify autism susceptibility genes  the IMGSAC has collected approximately 250 families with more than  one child or relative affected. 83 sibling pairs families with autism  were screened for linkage using a whole genome scan and areas  of increased allele sharing were genotyped with 119 markers in a  further 69 sibling pair families. Four regions of linkage were identifi ed  including chromosome 2q (MLS 3.74), 7q (MLS 3.20), 16p (MLS  2.93) and 17q (MLS 2.34), three of which have been replicated by  other groups. Candidate gene and association studies are now in  progress in order to isolate the susceptibility genes at these loci.  On chromosome 7q31, the FOXP2 gene is mutated in a severe  monogenic form of speech and language impairment and encodes a  transcription factor containing a polyglutamine tract and a forkhead  domain. FOXP2 was tested for association and mutation in both  complex language impairments and autism. No association or coding  region variants in FOXP2 were found and the gene is therefore  unlikely to play a major role in autism or more common forms of  language impairment.",2002.0,,"Monaco1, IMGSAC2, SLIC3","1Wellcome Trust Centre for Human Genetics, University of Oxford,  Oxford, United Kingdom, 2The International Molecular Genetic Study  of Autism Consortium (http://www.well.ox.ac.uk/~maestrin/iat.html),  United Kingdom, 3The Specific Language Impairment Consortium  (http://www.well.ox.ac.uk/monaco/dianne/index.shtml), United  Kingdom.",83 sibling pairs families with autism  were screened for linkage using a whole genome scan and areas  of increased allele sharing were genotyped with 119 markers in a  further 69 sibling pair families.,families with autism,,"['family', 'with', 'autism']",[]
38,109,Polymorphism in Serotonin Transporter Gene in  Autism,P0013.,,"The serotonin transporter gene is a likely candidate in autistic  disorder, based on efficacy of potent serotonin transporter inhibitors  in reducing rituals and routines and of elevated serotonin levels  been consistently found in 30%50% of autistic patients. The aim  of this study is to determine a possible association between the  polymorphism in serotonin transporter gene and autism. Materials and Methods : Blood samples were obtained from forty eight  individuals with autism (DSM IV) with no associated disorders, thirty  two mothers, twenty seven fathers (twenty three nuclear families)  and 49 normal controls. Each family was seen for a developmental assessment, and also by a  clinical geneticist for identification of eventually associated aetiology. Ages ranged between 3.6 and 41 years. Genotyping were performed by PCR methods. Chi square analysis  was applied to the results. Results: Within the three main possible alleles (9, 10, 12), we  only observed 10 and 12. There were no differences between the  frequencies distribution of autistic individuals and control group. In autistic individuals there was no prevalence of any specific  genotype. There was no difference in allele frequency between the  autistic group versus mothers, fathers, or mothers and fathers. We observed a preferential 12/12 genotype in patients with mothers  carrying the same genotype. This characteristic was not observed  regardind fathers genotype. Conclusions: In this study we did no found any association of autism  with the polymorphism in serotonin transporter gene . It seems to exist a preferential 12/12 genotype in autistic individuals  with mothers carrying the same genotype.",2002.0,,"Levy , J. Ferreira, L. Breitenfeld, M. Bicho","Genetic Laboratory, Medical School, University of Lisbon, Lisbon,  Portugal","The serotonin transporter gene is a likely candidate in autistic  disorder, based on efficacy of potent serotonin transporter inhibitors  in reducing rituals and routines and of elevated serotonin levels  been consistently found in 30%50% of autistic patients.",,autistic patients,[],"['autistic', 'patient']"
38,109,Polymorphism in Serotonin Transporter Gene in  Autism,P0013.,,"The serotonin transporter gene is a likely candidate in autistic  disorder, based on efficacy of potent serotonin transporter inhibitors  in reducing rituals and routines and of elevated serotonin levels  been consistently found in 30%50% of autistic patients. The aim  of this study is to determine a possible association between the  polymorphism in serotonin transporter gene and autism. Materials and Methods : Blood samples were obtained from forty eight  individuals with autism (DSM IV) with no associated disorders, thirty  two mothers, twenty seven fathers (twenty three nuclear families)  and 49 normal controls. Each family was seen for a developmental assessment, and also by a  clinical geneticist for identification of eventually associated aetiology. Ages ranged between 3.6 and 41 years. Genotyping were performed by PCR methods. Chi square analysis  was applied to the results. Results: Within the three main possible alleles (9, 10, 12), we  only observed 10 and 12. There were no differences between the  frequencies distribution of autistic individuals and control group. In autistic individuals there was no prevalence of any specific  genotype. There was no difference in allele frequency between the  autistic group versus mothers, fathers, or mothers and fathers. We observed a preferential 12/12 genotype in patients with mothers  carrying the same genotype. This characteristic was not observed  regardind fathers genotype. Conclusions: In this study we did no found any association of autism  with the polymorphism in serotonin transporter gene . It seems to exist a preferential 12/12 genotype in autistic individuals  with mothers carrying the same genotype.",2002.0,,"Levy , J. Ferreira, L. Breitenfeld, M. Bicho","Genetic Laboratory, Medical School, University of Lisbon, Lisbon,  Portugal","Materials and Methods : Blood samples were obtained from forty eight  individuals with autism (DSM IV) with no associated disorders, thirty  two mothers, twenty seven fathers (twenty three nuclear families)  and 49 normal controls.",individuals with autism,,"['individual', 'with', 'autism']",[]
38,109,Polymorphism in Serotonin Transporter Gene in  Autism,P0013.,,"The serotonin transporter gene is a likely candidate in autistic  disorder, based on efficacy of potent serotonin transporter inhibitors  in reducing rituals and routines and of elevated serotonin levels  been consistently found in 30%50% of autistic patients. The aim  of this study is to determine a possible association between the  polymorphism in serotonin transporter gene and autism. Materials and Methods : Blood samples were obtained from forty eight  individuals with autism (DSM IV) with no associated disorders, thirty  two mothers, twenty seven fathers (twenty three nuclear families)  and 49 normal controls. Each family was seen for a developmental assessment, and also by a  clinical geneticist for identification of eventually associated aetiology. Ages ranged between 3.6 and 41 years. Genotyping were performed by PCR methods. Chi square analysis  was applied to the results. Results: Within the three main possible alleles (9, 10, 12), we  only observed 10 and 12. There were no differences between the  frequencies distribution of autistic individuals and control group. In autistic individuals there was no prevalence of any specific  genotype. There was no difference in allele frequency between the  autistic group versus mothers, fathers, or mothers and fathers. We observed a preferential 12/12 genotype in patients with mothers  carrying the same genotype. This characteristic was not observed  regardind fathers genotype. Conclusions: In this study we did no found any association of autism  with the polymorphism in serotonin transporter gene . It seems to exist a preferential 12/12 genotype in autistic individuals  with mothers carrying the same genotype.",2002.0,,"Levy , J. Ferreira, L. Breitenfeld, M. Bicho","Genetic Laboratory, Medical School, University of Lisbon, Lisbon,  Portugal",There were no differences between the  frequencies distribution of autistic individuals and control group.,,autistic individuals,[],"['autistic', 'individual']"
38,109,Polymorphism in Serotonin Transporter Gene in  Autism,P0013.,,"The serotonin transporter gene is a likely candidate in autistic  disorder, based on efficacy of potent serotonin transporter inhibitors  in reducing rituals and routines and of elevated serotonin levels  been consistently found in 30%50% of autistic patients. The aim  of this study is to determine a possible association between the  polymorphism in serotonin transporter gene and autism. Materials and Methods : Blood samples were obtained from forty eight  individuals with autism (DSM IV) with no associated disorders, thirty  two mothers, twenty seven fathers (twenty three nuclear families)  and 49 normal controls. Each family was seen for a developmental assessment, and also by a  clinical geneticist for identification of eventually associated aetiology. Ages ranged between 3.6 and 41 years. Genotyping were performed by PCR methods. Chi square analysis  was applied to the results. Results: Within the three main possible alleles (9, 10, 12), we  only observed 10 and 12. There were no differences between the  frequencies distribution of autistic individuals and control group. In autistic individuals there was no prevalence of any specific  genotype. There was no difference in allele frequency between the  autistic group versus mothers, fathers, or mothers and fathers. We observed a preferential 12/12 genotype in patients with mothers  carrying the same genotype. This characteristic was not observed  regardind fathers genotype. Conclusions: In this study we did no found any association of autism  with the polymorphism in serotonin transporter gene . It seems to exist a preferential 12/12 genotype in autistic individuals  with mothers carrying the same genotype.",2002.0,,"Levy , J. Ferreira, L. Breitenfeld, M. Bicho","Genetic Laboratory, Medical School, University of Lisbon, Lisbon,  Portugal",In autistic individuals there was no prevalence of any specific  genotype.,,autistic individuals,[],"['autistic', 'individual']"
38,109,Polymorphism in Serotonin Transporter Gene in  Autism,P0013.,,"The serotonin transporter gene is a likely candidate in autistic  disorder, based on efficacy of potent serotonin transporter inhibitors  in reducing rituals and routines and of elevated serotonin levels  been consistently found in 30%50% of autistic patients. The aim  of this study is to determine a possible association between the  polymorphism in serotonin transporter gene and autism. Materials and Methods : Blood samples were obtained from forty eight  individuals with autism (DSM IV) with no associated disorders, thirty  two mothers, twenty seven fathers (twenty three nuclear families)  and 49 normal controls. Each family was seen for a developmental assessment, and also by a  clinical geneticist for identification of eventually associated aetiology. Ages ranged between 3.6 and 41 years. Genotyping were performed by PCR methods. Chi square analysis  was applied to the results. Results: Within the three main possible alleles (9, 10, 12), we  only observed 10 and 12. There were no differences between the  frequencies distribution of autistic individuals and control group. In autistic individuals there was no prevalence of any specific  genotype. There was no difference in allele frequency between the  autistic group versus mothers, fathers, or mothers and fathers. We observed a preferential 12/12 genotype in patients with mothers  carrying the same genotype. This characteristic was not observed  regardind fathers genotype. Conclusions: In this study we did no found any association of autism  with the polymorphism in serotonin transporter gene . It seems to exist a preferential 12/12 genotype in autistic individuals  with mothers carrying the same genotype.",2002.0,,"Levy , J. Ferreira, L. Breitenfeld, M. Bicho","Genetic Laboratory, Medical School, University of Lisbon, Lisbon,  Portugal","There was no difference in allele frequency between the  autistic group versus mothers, fathers, or mothers and fathers.",,autistic group,[],"['autistic', 'group']"
38,109,Polymorphism in Serotonin Transporter Gene in  Autism,P0013.,,"The serotonin transporter gene is a likely candidate in autistic  disorder, based on efficacy of potent serotonin transporter inhibitors  in reducing rituals and routines and of elevated serotonin levels  been consistently found in 30%50% of autistic patients. The aim  of this study is to determine a possible association between the  polymorphism in serotonin transporter gene and autism. Materials and Methods : Blood samples were obtained from forty eight  individuals with autism (DSM IV) with no associated disorders, thirty  two mothers, twenty seven fathers (twenty three nuclear families)  and 49 normal controls. Each family was seen for a developmental assessment, and also by a  clinical geneticist for identification of eventually associated aetiology. Ages ranged between 3.6 and 41 years. Genotyping were performed by PCR methods. Chi square analysis  was applied to the results. Results: Within the three main possible alleles (9, 10, 12), we  only observed 10 and 12. There were no differences between the  frequencies distribution of autistic individuals and control group. In autistic individuals there was no prevalence of any specific  genotype. There was no difference in allele frequency between the  autistic group versus mothers, fathers, or mothers and fathers. We observed a preferential 12/12 genotype in patients with mothers  carrying the same genotype. This characteristic was not observed  regardind fathers genotype. Conclusions: In this study we did no found any association of autism  with the polymorphism in serotonin transporter gene . It seems to exist a preferential 12/12 genotype in autistic individuals  with mothers carrying the same genotype.",2002.0,,"Levy , J. Ferreira, L. Breitenfeld, M. Bicho","Genetic Laboratory, Medical School, University of Lisbon, Lisbon,  Portugal",It seems to exist a preferential 12/12 genotype in autistic individuals  with mothers carrying the same genotype.,,autistic individuals,[],"['autistic', 'individual']"
40,123,Autistic Spectrum Disorder: A Case Study Using  High Resolution Microarray Based CGH,P0027.,,"Autism is a severe developmental disorder characterized by  impairment in social interactions and in language and communication  skills, and by restricted repetitive behaviors and activities.  The etiology of this disorder is poorly understood, although a  variety of etiologic mechanisms have been suggested, including  genetic, immunologic, infectious, neurologic and gastrointestinal  abnormalities. Family and genetic studies support a strong genetic  susceptibility to autistic spectrum disorders and a high incidence  in family members of nonautistic PDD variants. These studies  have been completed using karyotypic analysis which is limited  to detecting chromosomal aberrations greater than ~ 5 Mb (<650  band resolution). With this low resolution scan of the genome,  there is a high likelihood that smaller disease associated deletion  and duplication events are being missed. A modified CGH to BACs  immobilized on a glass slide (instead of metaphase chromosomes)  can provide a much higher resolution, potentially resolving to  the size of individual BACs. We developed a human genomic  array in which BACs are spaced at ~ 1 Mb intervals, on average,  throughout the genome. Clinical specimens and established cell  lines with a broad spectrum of known chromosomal abnormalities  were tested. Test and reference genomic DNAs were differentially  labeled with fluorochromes. After co hybridization of labeled test  and reference genomic DNAs, the BAC arrays were scanned and  analyzed with software developed specifically for this purpose.  Control hybridizations with normal male to male, male to female and  female to female reference samples were performed and showed  the expected results. This study details the results identified in the  screening of over 25 autistic patients.",2002.0,,"Shah1, M. Mohammed1, S. Damani1, R. Locker1, W. Yu1, J. Gregg2","1Spectral Genomics, Inc. , Houston, TX, 2University of California at  Davis, Davis, CA. ",Family and genetic studies support a strong genetic  susceptibility to autistic spectrum disorders and a high incidence  in family members of nonautistic PDD variants.,,autistic spectrum,[],"['autistic', 'spectrum']"
40,123,Autistic Spectrum Disorder: A Case Study Using  High Resolution Microarray Based CGH,P0027.,,"Autism is a severe developmental disorder characterized by  impairment in social interactions and in language and communication  skills, and by restricted repetitive behaviors and activities.  The etiology of this disorder is poorly understood, although a  variety of etiologic mechanisms have been suggested, including  genetic, immunologic, infectious, neurologic and gastrointestinal  abnormalities. Family and genetic studies support a strong genetic  susceptibility to autistic spectrum disorders and a high incidence  in family members of nonautistic PDD variants. These studies  have been completed using karyotypic analysis which is limited  to detecting chromosomal aberrations greater than ~ 5 Mb (<650  band resolution). With this low resolution scan of the genome,  there is a high likelihood that smaller disease associated deletion  and duplication events are being missed. A modified CGH to BACs  immobilized on a glass slide (instead of metaphase chromosomes)  can provide a much higher resolution, potentially resolving to  the size of individual BACs. We developed a human genomic  array in which BACs are spaced at ~ 1 Mb intervals, on average,  throughout the genome. Clinical specimens and established cell  lines with a broad spectrum of known chromosomal abnormalities  were tested. Test and reference genomic DNAs were differentially  labeled with fluorochromes. After co hybridization of labeled test  and reference genomic DNAs, the BAC arrays were scanned and  analyzed with software developed specifically for this purpose.  Control hybridizations with normal male to male, male to female and  female to female reference samples were performed and showed  the expected results. This study details the results identified in the  screening of over 25 autistic patients.",2002.0,,"Shah1, M. Mohammed1, S. Damani1, R. Locker1, W. Yu1, J. Gregg2","1Spectral Genomics, Inc. , Houston, TX, 2University of California at  Davis, Davis, CA. ",This study details the results identified in the  screening of over 25 autistic patients.,,autistic patients,[],"['autistic', 'patient']"
44,461,Breakpoints in 17p13 associated with Asperger  syndrome.,P0370.,,"Asperger syndrome (AS) is a severe developmental disorder  characterized by major difficulties in social interaction with unusual  responses to the environment similar to those in a mild form of  autism. 0.3 0.6% of the population will meet the criteria of AS. The clinical features includes paucity of empathy, difficulties to  form friendships with social isolation as a consequence. The  syndrome also includes pedantic and monotonic speech and highly  circumscribed interests in topics such as the weather and railway  tables or maps. We have identified two non related patients with AS both with  apparently balanced reciprocal translocations with breakpoints  in 17p13. Cytogenetic analysis revealed de novo  translocations  t(13;17)(q14;p13) and t(17;19)(p13;cen) respectively. Mapping the translocation breakpoints of the chromosomes 17p  was performed by FISH. Chromosome 17p13 specific clones were  hybridized to metaphase chromosomes of the two translocations.  The results demonstrated the two breakpoints to be located within a  region of 300 kb. The region is spanning 14 known genes. PCR  amplified fragments derived from or flanking 5 of the genes was  used as FISH probes to perform a closer definition of the breakpoints.",2002.0,,"Johannesson1, D. Tentler2, M. Johansson3, M. Rstam3, C.  Gillberg3, M. Nordling1, N. Dahl2, J. Wahlstrm1","1Dept of Clinical Genetics, Gothenburg University, Gothenburg,  Sweden, 2Dept.of Genetics and Pathology, Uppsala University,  Uppsala, Sweden, 3Dept. of Child Adolescent Psychiatry, Gothenburg  University, Gothenburg, Sweden. ",Asperger syndrome (AS) is a severe developmental disorder  characterized by major difficulties in social interaction with unusual  responses to the environment similar to those in a mild form of  autism.,,Asperger syndrome,[],"['Asperger', 'syndrome']"
48,781,Genotype / Phenotype Correlations In A Large  Series Of Rett Syndrome Patients,P0690.,,"Mutations in the human Xq28 linked MECP2 gene are responsible  for 70 to 80% of Rett syndrome cases and also for atypical clinical  presentations. We are presenting the results of our studies in a serie of 64 female  cases in which we looked for mutations in the MECP2 gene. These  patients were divided into three groups :   Group I (23 patients) with Rett syndrome diagnosed in our  multidisciplinary consultation.   Group II (28 patients) referred by external collaborators for a  suspicion of Rett syndrome   Group III (17 patients) from our center exhibiting a severe  encephalopathy with autistic behaviour. In the first group, 21 mutations were identified ; in the second, 8  mutations and zero in the third group. These results confirm that the  vast majority of mutations in the MECP2 gene lead to a classical Rett  syndrome phenotype. They also show that a large proportion of girls  with a severe mental handicap are not found to be associated with a  MECP2 mutation on the contrary to what was recently proposed in  the litterature. In addition, we did not find any genotype phenotype correlations for  the Rett syndrome patients taking into account the mutation type, the  functional domain affected by the mutation and the X chromosome  inactivation status of these patients except for the mutation involving  the C terminal domain associated with a  forme frustre  of the  disease. It is thus likely that a number of not yet identified factors are  responsible for the clinical variability of this syndrome.",2002.0,,"Moncla1, J. Mancini2, A. Kpebe3, B. Chabrol2, M. O. Livet2, N.  Philip1, L. Villard3","1Dpartement de Gntique Mdicale, Hopital des Enfants de la  Timone, Marseille, France, 2Service de Neuropdiatrie, Hopital  des Enfants de la Timone, Marseille, France, 3Unit de Recherche  INSERM 491, Facult de Mdecine, Marseille, France",Group II (28 patients) referred by external collaborators for a  suspicion of Rett syndrome   Group III (17 patients) from our center exhibiting a severe  encephalopathy with autistic behaviour.,,autistic behaviour,[],"['autistic', 'behaviour']"
50,807,FISH characterization of 16p11.2 p12.2 tandem  duplication in a dysmorphic patient with severe mental  retardation and autistic behaviuor.,P0717.,,"Chromosome 16p partial trisomy is a rare anomaly, described in Posters   Mental Retardation 226 227 the literature in less than 30 patients. We report on the genotype/ phenotype correlations drawn on a 23 years old dysmorphic  male affected by mental retardation and autistic behaviour, who  was found to have a 46,XY,add(16)(p13) karyotype, redefined  as 46,XY,dup(16)(p12.1p12.2). The detailed clinical evaluation  showed the presence of hypertelorism, broad nasal bridge and tip,  short phyltrum, macrostomia, thick lips, short stature, joint laxity .  FISH analysis by using a WCP and a PCP chromosome 16 probes  confirmed duplication of 16p11.2 12 region. FISH studies with YAC  probes belonging to",2002.0,,"Natacci1, P. Finelli2, G. Gottardi2, C. Zuccarini1, D. Giardino2, M.  Sala1, L. Larizza3","1Foundation Institute Sacra Famiglia, Cesano Boscone, Italy,  2Cytogenetic Laboratory,Istituto Auxologico Italiano, Milan, Italy,  3Department of Biology and Genetics, University of Milan, Milan, Italy","We report on the genotype/ phenotype correlations drawn on a 23 years old dysmorphic  male affected by mental retardation and autistic behaviour, who  was found to have a 46,XY,add(16)(p13) karyotype, redefined  as 46,XY,dup(16)(p12.1p12.2).",,autistic behaviour,[],"['autistic', 'behaviour']"
52,876,Mapping of a Candidate Region for Autism on  Chromosome 2q32.,P0787.,,"Autism is a relatively common primary developmental disorder, with a  significant genetic component. Routine investigations for the cause of  autism, including chromosome and fragile X analysis, almost always  are normal. There is a polygenic component to autism, and large sib  pair studies have been carried out by a number of groups worldwide.  Several groups have identified associations between autism and  a wide area of chromosome 2q, flanked by markers D2S364 and  D2S2188 (Buxbaum et al & the IMGSAC respectively) which shows  the strongest evidence for linkage. These results strongly suggest a  predisposing gene(s) to autism within the 2q region. We have recently identified a patient with high functioning autism,  who has a small but cytogenetically visible de novo deletion of  chromosome 2q32 which falls within these linkage findings. This  would appear to be the smallest known deletion of this part of  chromosome 2, suggesting that the deletion includes a predisposing  gene(s) for autism. Fine mapping of the deleted region was carried out using markers  from 2q32, to map the exact size of the deleted region. This  reduces the very large linkage region by >75% to approximately 8.7  megabases. The region contains approximately 16 known genes and  16 ESTs, a number of which are potential candidates for autism. We present results of a wider study for the presence of  submicroscopic microdeletions, and of candidate genes,  incorporating both linkage disequilibrium and mutational screening  approaches in a panel of 77 Irish families with autism within the  mapped region. Am J Hum Genet 2001 Jun;68(6):1514 20, Sep;69(3):570 81",2002.0,,"Ennis1,2, J. Ng Wanjing2, G. Kearney3, M. Fitzgerald3, R.  Stallings1,2, D. E. Barton1,2, A. J. Green1,2, L. Gallagher3, M. Gill3","1Department of Medical Genetics, University College Dublin, Dublin,  Ireland, 2National Centre for Medical Genetics, Our Ladys Hospital  for Sick Children, Crumlin, Dublin, Ireland, 3Department of Psychiatry,  Trinity Centre for Health Sciences, St. Jamess Hospital, Dublin,  Ireland. ","We have recently identified a patient with high functioning autism,  who has a small but cytogenetically visible de novo deletion of  chromosome 2q32 which falls within these linkage findings.",patient with high functioning autism,,"['patient', 'with', 'high', 'functioning', 'autism']",[]
52,876,Mapping of a Candidate Region for Autism on  Chromosome 2q32.,P0787.,,"Autism is a relatively common primary developmental disorder, with a  significant genetic component. Routine investigations for the cause of  autism, including chromosome and fragile X analysis, almost always  are normal. There is a polygenic component to autism, and large sib  pair studies have been carried out by a number of groups worldwide.  Several groups have identified associations between autism and  a wide area of chromosome 2q, flanked by markers D2S364 and  D2S2188 (Buxbaum et al & the IMGSAC respectively) which shows  the strongest evidence for linkage. These results strongly suggest a  predisposing gene(s) to autism within the 2q region. We have recently identified a patient with high functioning autism,  who has a small but cytogenetically visible de novo deletion of  chromosome 2q32 which falls within these linkage findings. This  would appear to be the smallest known deletion of this part of  chromosome 2, suggesting that the deletion includes a predisposing  gene(s) for autism. Fine mapping of the deleted region was carried out using markers  from 2q32, to map the exact size of the deleted region. This  reduces the very large linkage region by >75% to approximately 8.7  megabases. The region contains approximately 16 known genes and  16 ESTs, a number of which are potential candidates for autism. We present results of a wider study for the presence of  submicroscopic microdeletions, and of candidate genes,  incorporating both linkage disequilibrium and mutational screening  approaches in a panel of 77 Irish families with autism within the  mapped region. Am J Hum Genet 2001 Jun;68(6):1514 20, Sep;69(3):570 81",2002.0,,"Ennis1,2, J. Ng Wanjing2, G. Kearney3, M. Fitzgerald3, R.  Stallings1,2, D. E. Barton1,2, A. J. Green1,2, L. Gallagher3, M. Gill3","1Department of Medical Genetics, University College Dublin, Dublin,  Ireland, 2National Centre for Medical Genetics, Our Ladys Hospital  for Sick Children, Crumlin, Dublin, Ireland, 3Department of Psychiatry,  Trinity Centre for Health Sciences, St. Jamess Hospital, Dublin,  Ireland. ","We present results of a wider study for the presence of  submicroscopic microdeletions, and of candidate genes,  incorporating both linkage disequilibrium and mutational screening  approaches in a panel of 77 Irish families with autism within the  mapped region.",families with autism,,"['family', 'with', 'autism']",[]
57,280,True mosaicism in a case of Williams syndrome,P189.,,"Williams syndrome is a neurodevelopmental disorder with  multisystemic manifestations. Most patients (>96%) exhibit a  common 1,5 Mb de novo heterozygous deletion in 7q11.23 that  results from non allelic homologous recombination between regional  segmental duplications during meiosis. To our knowledge, mosaicism  has never been reported. We have studied a 5 year old Chilean patient with characteristic  facial features, supravalvular aortic stenosis, gastroesophageal  reflux, bilateral inguinal hernia, hoarse voice, severe psychomotor  retardation, characteristic autistic features, besides global delay  in language development and partial heterochromia of the left  iris. Repeated FISH analyses on two independent blood samples  showed the coexistence of cells with and without a heterozygous  deletion of the ELN probe (deletion of 46% and 41% out of 80 and  39 metaphases, respectively). Typing of short tandem repeats on  blood genomic DNA revealed biparental inheritance with a relative  dosage reduction of the paternally inherited allele (47 51%) at  HSB055XE5, ELN and D7S1870, while normal dosage ratios were  found at D7S672 and D7S2518. Our data indicate the presence of  somatic mosaicism in lymphocytes for the common WS deletion.  Other tissues are currently being analysed. Contrary to expected, the  phenotype of the patient is rather severe.",2003.0,,"Castillo1, X. Carrasco2, P. Rothhammer3, M. Aracena4, V. Daher1,  L. Prez Jurado5, M. del Campo5, L. Magano5, F. Aboitiz3","1Gentica, Hospital Clnico Universidad de Chile, Santiago, Chile,  2Instituto Ciencias Biomdicas, Universidad de Chile, Santiago,  Chile, 3Psiquiatra, Universidad Catlica de Chile, Santiago, Chile,  4Gentica, Hospital LCMackenna, Santiago, Chile, 5Gentica,  Universidad Pompeu Fabra, Barcelona, Spain","We have studied a 5 year old Chilean patient with characteristic  facial features, supravalvular aortic stenosis, gastroesophageal  reflux, bilateral inguinal hernia, hoarse voice, severe psychomotor  retardation, characteristic autistic features, besides global delay  in language development and partial heterochromia of the left  iris.",,autistic features,[],"['autistic', 'feature']"
58,314,Analysis of One Year of Referrals for Undiagnosed  Developmental Delay.,P223.,,"Undiagnosed developmental delay is a common reason for  referral to a genetics clinic. One year of referrals for undiagnosed  developmental delay to South West Thames Department of Clinical  Genetics was analysed to establish the overall diagnosis rate and  observe the types of diagnoses that are being made. In addition the  data has been examined to ascertain any variables in the history or  examination that may predict the department findind an underlying  aetiology. The investigations undertaken have also been scrutinised  to see which are giving a high diagnostic yield. The overall rate for establishibg a firm diagnosis was 29% with an  additional 12% of patients having tentative or partial diagnoses being  made. It is not suprising that a genetics department is not diagnosing  Downs syndrome, but perhaps unexpected that there is only one  case of a microdeletion syndrome in the list of patient diagnoses. Analysis of features evident from initial history of examination  that predict an aetiology being established show the presence of  dysmorphic features and a milder level of delay to be the only factors  with positive predictive value. The presence of autistic features,  positive neurology (inc. microcephaly, macrocephaly, epilepsy) other  system anomalies (eg cardiac etc)were all found not to have any  predictive value in whether or not a firm diagnosis would be made. Analysis of the investigations that had been useful in establishing  a diagnosis showed X rays, skin chromosomes, opthalmological  opinion and haematology to have been the most diagnostically  helpful, and telomeres the least.",2003.0,,C. Foulds,"St Georges Hospital, London, London, SW17 ORE, United Kingdom","The presence of autistic features,  positive neurology (inc. microcephaly, macrocephaly, epilepsy) other  system anomalies (eg cardiac etc)were all found not to have any  predictive value in whether or not a firm diagnosis would be made.",,autistic features,[],"['autistic', 'feature']"
59,316,A Genetic Study of 100 Patients with Autism  Spectrum Disorders,P225.,,"Clinical Genetics and Dysmorphology110 111 A known genetic condition was identified in several patients: five  males were diagnosed as the fragile X syndrome (with FMR1  gene expansion), three females as suspected Rett syndrome, two  patients as the Aarskog syndrome, and one patient each as the  Smith Magenis syndrome (confirmed by FISH), ring chromosome  17 syndrome, Borjeson Forssman Lehmann syndrome, suspected  Cornelia de Lange syndrome, an inborn error of metabolisms, and  preclinical familial hypothyreosis. The phenotype of most of the  remaining patients was not remarkable with the exception of several  patients with a non specific facial stigmatisation, macrocephaly, or  unusually shaped ears. In 14 individuals the pregnancy or the pre   or perinatal history were complicated. Three patients might have  suffered from foetal hydantoinate syndrome, and one patient from  herpetic encephalopathy. In five patients autism might be secondary  to deafness. Several patients had a family history of psychiatric  disorders. Behaviour in relatives typical of the broader autism  phenotype was reported for several patients, mainly those affected  by the Asperger syndrome or by highly functioning autism, possibly  reflecting a higher genetic load in these pedigrees. Cytogenetic  findings were normal in most of the patients. One patient had a  t(21;22) translocation, one a mosaic of ring chromosome 17, two  brothers a translocation t(9,17)(p13,q22), and one patient a mosaic  of chromosome 8 trisomy [1/50]. A possible increase of the frequency  of the ADA 8Asn allele was also analysed by molecular genetic  methods. It was very low and did not even reach the frequency  observed in control samples of the published studies.",2003.0,,"Havlovicova1, M. Hrdlicka2, D. Novotna1, Z. Musova1, E.  Kocarek1, L. Propper2, Z. Sedlacek1","1Institute of Biology and Medical Genetics, 2nd Medical School,  Charles University and Faculty Hospit, Prague, Czech Republic,  2Department of Child Psychiatry, 2nd Medical School, Charles  University and Faculty Hospit, Prague, Czech Republic","Behaviour in relatives typical of the broader autism  phenotype was reported for several patients, mainly those affected  by the Asperger syndrome or by highly functioning autism, possibly  reflecting a higher genetic load in these pedigrees.",,Asperger syndrome,[],"['Asperger', 'syndrome']"
61,328,Rett patients with both MECP2 mutation and 15q11  13 rearrangments.,P237.,,"Rett syndrome (RTT) and autism (A) are classified as separate  disorders. Recently, the identification of the Preserved Speech  Variant (PSV), where autistic behavior is usual, stressed the  phenotypic overlap between these two conditions. In 1999 it was  shown that about 80% of RTT cases have a de novo  mutation in  the transcriptional silencer MECP2  gene, classifying RTT as a  monogenic X L dominant disorder. Subsequently, we and others  provided evidence that this model was too simple and not sufficient  to explain why germline MECP2  mutations may result in X L mental  retardation in males while they may be silent in carrier females. On  the other hand, we and others have provided evidence that 15q11  q13 maternally inherited duplications are found in autistic children,  suggesting that an abnormal dosage of gene(s) within this region  might be responsible for A. Now we show that a proportion of RTT  patients are carriers of both a MECP2  mutation and a 15q11 q13  duplication and that other RTT patients are carriers of a MECP2   mutation and a 15q11 q13 duplication. Therefore, we hypothesize  a complex model in which a MECP2  mutation is necessary but not  sufficient to cause the RTT phenotype in females, based on the  status of a second gene which, at least in a proportion of cases, may  be abnormal dosage of one or more 15q11 q13 gene. In summary,  we provide preliminary evidence that A and RTT (clinically related for  a long time) may have a common overlapping molecular basis.",2003.0,,"Renieri1, I. Longo1, F. Ariani1, I. Meloni1, M. Zappella2, L. Russo3,  T. Giordano3, G. Neri3, F. Gurrieri3","1Medical Genetics, Dept. Mol.Biol., University of Siena, Siena, Italy,  2Neuropsichiatria Infantile   Az. Osp. Senese, Siena, Italy, 3Medical  Genetics, Universit Cattolica del Sacro Cuore, Roma, Italy.   ","Recently, the identification of the Preserved Speech  Variant (PSV), where autistic behavior is usual, stressed the  phenotypic overlap between these two conditions.",,autistic behavior,[],"['autistic', 'behavior']"
61,328,Rett patients with both MECP2 mutation and 15q11  13 rearrangments.,P237.,,"Rett syndrome (RTT) and autism (A) are classified as separate  disorders. Recently, the identification of the Preserved Speech  Variant (PSV), where autistic behavior is usual, stressed the  phenotypic overlap between these two conditions. In 1999 it was  shown that about 80% of RTT cases have a de novo  mutation in  the transcriptional silencer MECP2  gene, classifying RTT as a  monogenic X L dominant disorder. Subsequently, we and others  provided evidence that this model was too simple and not sufficient  to explain why germline MECP2  mutations may result in X L mental  retardation in males while they may be silent in carrier females. On  the other hand, we and others have provided evidence that 15q11  q13 maternally inherited duplications are found in autistic children,  suggesting that an abnormal dosage of gene(s) within this region  might be responsible for A. Now we show that a proportion of RTT  patients are carriers of both a MECP2  mutation and a 15q11 q13  duplication and that other RTT patients are carriers of a MECP2   mutation and a 15q11 q13 duplication. Therefore, we hypothesize  a complex model in which a MECP2  mutation is necessary but not  sufficient to cause the RTT phenotype in females, based on the  status of a second gene which, at least in a proportion of cases, may  be abnormal dosage of one or more 15q11 q13 gene. In summary,  we provide preliminary evidence that A and RTT (clinically related for  a long time) may have a common overlapping molecular basis.",2003.0,,"Renieri1, I. Longo1, F. Ariani1, I. Meloni1, M. Zappella2, L. Russo3,  T. Giordano3, G. Neri3, F. Gurrieri3","1Medical Genetics, Dept. Mol.Biol., University of Siena, Siena, Italy,  2Neuropsichiatria Infantile   Az. Osp. Senese, Siena, Italy, 3Medical  Genetics, Universit Cattolica del Sacro Cuore, Roma, Italy.   ","On  the other hand, we and others have provided evidence that 15q11  q13 maternally inherited duplications are found in autistic children,  suggesting that an abnormal dosage of gene(s) within this region  might be responsible for A.",,autistic children,[],"['autistic', 'child']"
65,391,"A t(10;13)(q24;q22)de novo in a patient with mental  retardation, epilepsy and ataxia.",P300.,,"We report a, at the cytogenetic level, balanced translocation  t(10;13)(q24;q22)de novo in a patient with mental retardation,  microcephaly, bilateral neurosensorial deafness, strabismus,  epilepsy, ataxia, autistic behaviour, advanced bone age and  precocious puberty. Part of this phenotype is similar to infantile onset  spinocerebellar ataxia (IOSCA) (OMIM 271245) described in 19 finish  families by Nikali et al. (1997) who found linkage between D10S192  and D10S1265, a narrow interval within 10q24 containing PAX2 and",2003.0,,"L. Engenheiro1, M. Pinto2, N. Tommerup1","1The Wilhelm Johannsen Centre for Functional Genome Research,  Copenhagen, Denmark, 2Instituto de Gentica Mdica Jacinto  Magalhes, Coimbra, Portugal","We report a, at the cytogenetic level, balanced translocation  t(10;13)(q24;q22)de novo in a patient with mental retardation,  microcephaly, bilateral neurosensorial deafness, strabismus,  epilepsy, ataxia, autistic behaviour, advanced bone age and  precocious puberty.",,autistic behaviour,[],"['autistic', 'behaviour']"
68,837,No evidence for an association with the serotonin  transporter gene polymorphisms (5 HTTVNTR and 5  HTTLPR) and autism,P748.,,"The serotonin transporter gene is a likely candidate in autistic  disorder. The aim of this study is to determine a possible association  between polymorphisms 5 HTTVNTR and 5 HTTLPR in serotonin  transporter gene and autism. Materials and Methods. 59 individuals with idiopathic autism,  47mothers, 33 fathers (28nuclear families), 59 controls. Ages  between 3.6 and 41y. We studied the two polymorphic regions :  promoter(5 HTTLPR) with a long or short allele and intron 2 (5  HTTVNTR) with fragments of 9, 10, 12 repeats. Results. There were no differences between the genotype and  allelic frequencies of autistic individuals and control group in both  polymorphisms. With both polymorphisms in patients and controls  there was no prevalence of any specific genotype, but there was a  predominance of the long allele (12 and L).There was no difference  in genotype and allelic frequency between the autistic group versus  mothers, fathers, or mothers and fathers. Confirming previous study  we observed a preferential 12/12 genotype in patients with mothers  carrying the same genotype. In both populations 5 HTTLPR and  5 HTTVNTR were in concordance, and there was a predominance  of long allele (L and 12), but although not significative, the difference Linkage Mapping and Polymorphism224 225 between frequency of L and S in patients was bigger. Conclusions. In this study we did no found any association of autism  with both polymorphisms in serotonin transporter gene. The existence  of a preferential 12/12 genotype in autistic individuals with mothers  carrying the same genotype was confirmed. There is a possible  predominance of the allele L in patients although actually still not  significative.",2003.0,,"Levy , J. Ferreira, M. Bicho","Genetic Laboratory,Medical Shool,University of Lisbon, Lisboa,  Portugal","59 individuals with idiopathic autism,  47mothers, 33 fathers (28nuclear families), 59 controls.",individuals with idiopathic autism,,"['individual', 'with', 'idiopathic', 'autism']",[]
68,837,No evidence for an association with the serotonin  transporter gene polymorphisms (5 HTTVNTR and 5  HTTLPR) and autism,P748.,,"The serotonin transporter gene is a likely candidate in autistic  disorder. The aim of this study is to determine a possible association  between polymorphisms 5 HTTVNTR and 5 HTTLPR in serotonin  transporter gene and autism. Materials and Methods. 59 individuals with idiopathic autism,  47mothers, 33 fathers (28nuclear families), 59 controls. Ages  between 3.6 and 41y. We studied the two polymorphic regions :  promoter(5 HTTLPR) with a long or short allele and intron 2 (5  HTTVNTR) with fragments of 9, 10, 12 repeats. Results. There were no differences between the genotype and  allelic frequencies of autistic individuals and control group in both  polymorphisms. With both polymorphisms in patients and controls  there was no prevalence of any specific genotype, but there was a  predominance of the long allele (12 and L).There was no difference  in genotype and allelic frequency between the autistic group versus  mothers, fathers, or mothers and fathers. Confirming previous study  we observed a preferential 12/12 genotype in patients with mothers  carrying the same genotype. In both populations 5 HTTLPR and  5 HTTVNTR were in concordance, and there was a predominance  of long allele (L and 12), but although not significative, the difference Linkage Mapping and Polymorphism224 225 between frequency of L and S in patients was bigger. Conclusions. In this study we did no found any association of autism  with both polymorphisms in serotonin transporter gene. The existence  of a preferential 12/12 genotype in autistic individuals with mothers  carrying the same genotype was confirmed. There is a possible  predominance of the allele L in patients although actually still not  significative.",2003.0,,"Levy , J. Ferreira, M. Bicho","Genetic Laboratory,Medical Shool,University of Lisbon, Lisboa,  Portugal",There were no differences between the genotype and  allelic frequencies of autistic individuals and control group in both  polymorphisms.,,autistic individuals,[],"['autistic', 'individual']"
68,837,No evidence for an association with the serotonin  transporter gene polymorphisms (5 HTTVNTR and 5  HTTLPR) and autism,P748.,,"The serotonin transporter gene is a likely candidate in autistic  disorder. The aim of this study is to determine a possible association  between polymorphisms 5 HTTVNTR and 5 HTTLPR in serotonin  transporter gene and autism. Materials and Methods. 59 individuals with idiopathic autism,  47mothers, 33 fathers (28nuclear families), 59 controls. Ages  between 3.6 and 41y. We studied the two polymorphic regions :  promoter(5 HTTLPR) with a long or short allele and intron 2 (5  HTTVNTR) with fragments of 9, 10, 12 repeats. Results. There were no differences between the genotype and  allelic frequencies of autistic individuals and control group in both  polymorphisms. With both polymorphisms in patients and controls  there was no prevalence of any specific genotype, but there was a  predominance of the long allele (12 and L).There was no difference  in genotype and allelic frequency between the autistic group versus  mothers, fathers, or mothers and fathers. Confirming previous study  we observed a preferential 12/12 genotype in patients with mothers  carrying the same genotype. In both populations 5 HTTLPR and  5 HTTVNTR were in concordance, and there was a predominance  of long allele (L and 12), but although not significative, the difference Linkage Mapping and Polymorphism224 225 between frequency of L and S in patients was bigger. Conclusions. In this study we did no found any association of autism  with both polymorphisms in serotonin transporter gene. The existence  of a preferential 12/12 genotype in autistic individuals with mothers  carrying the same genotype was confirmed. There is a possible  predominance of the allele L in patients although actually still not  significative.",2003.0,,"Levy , J. Ferreira, M. Bicho","Genetic Laboratory,Medical Shool,University of Lisbon, Lisboa,  Portugal","With both polymorphisms in patients and controls  there was no prevalence of any specific genotype, but there was a  predominance of the long allele (12 and L).There was no difference  in genotype and allelic frequency between the autistic group versus  mothers, fathers, or mothers and fathers.",,autistic group,[],"['autistic', 'group']"
68,837,No evidence for an association with the serotonin  transporter gene polymorphisms (5 HTTVNTR and 5  HTTLPR) and autism,P748.,,"The serotonin transporter gene is a likely candidate in autistic  disorder. The aim of this study is to determine a possible association  between polymorphisms 5 HTTVNTR and 5 HTTLPR in serotonin  transporter gene and autism. Materials and Methods. 59 individuals with idiopathic autism,  47mothers, 33 fathers (28nuclear families), 59 controls. Ages  between 3.6 and 41y. We studied the two polymorphic regions :  promoter(5 HTTLPR) with a long or short allele and intron 2 (5  HTTVNTR) with fragments of 9, 10, 12 repeats. Results. There were no differences between the genotype and  allelic frequencies of autistic individuals and control group in both  polymorphisms. With both polymorphisms in patients and controls  there was no prevalence of any specific genotype, but there was a  predominance of the long allele (12 and L).There was no difference  in genotype and allelic frequency between the autistic group versus  mothers, fathers, or mothers and fathers. Confirming previous study  we observed a preferential 12/12 genotype in patients with mothers  carrying the same genotype. In both populations 5 HTTLPR and  5 HTTVNTR were in concordance, and there was a predominance  of long allele (L and 12), but although not significative, the difference Linkage Mapping and Polymorphism224 225 between frequency of L and S in patients was bigger. Conclusions. In this study we did no found any association of autism  with both polymorphisms in serotonin transporter gene. The existence  of a preferential 12/12 genotype in autistic individuals with mothers  carrying the same genotype was confirmed. There is a possible  predominance of the allele L in patients although actually still not  significative.",2003.0,,"Levy , J. Ferreira, M. Bicho","Genetic Laboratory,Medical Shool,University of Lisbon, Lisboa,  Portugal",The existence  of a preferential 12/12 genotype in autistic individuals with mothers  carrying the same genotype was confirmed.,,autistic individuals,[],"['autistic', 'individual']"
69,856,Gene expression analysis in autism using cDNA  microarrays,P767.,,"There is strong evidence from twin and family studies for the  importance of genetic factors in idiopathic autism. The results from  independent reports suggest that the disease is caused by the  action of several genes, possibly acting epistatically. We have used  cDNA microarray technology to clarify the molecular mechanism  behind autism. Blood samples were obtained from affected sib pairs  co segregating for chromosome 7q31, previously shown to be a  candidate region for autism. The RNA was obtained from EBV  transformed B lymphocytes as the only RNA source available. mRNA  levels for approximately 7,700 genes were assessed by in house  produced cDNA microarrays. The microarray data was analysed  using dedicated computer software in order to identify significant up  or down regulation of specific genes. Several genes with small but  significant down regulation were identified in the samples derived  from individuals with autism. One of these genes encodes SEMA5A,  which is involved in axonal guidance.",2003.0,,"Larsson1, B. Carlsson1, H. Sderstrm2, C. Gillberg2, A.  Isaksson1, N. Dahl1","1Uppsala University, Uppsala, Sweden, 2Gothenburg University,  Gothenburg, Sweden",Several genes with small but  significant down regulation were identified in the samples derived  from individuals with autism.,individuals with autism,,"['individual', 'with', 'autism']",[]
70,876,FISH mapping of translocation breakpoints  associated with autism.,P787.,,"Autism is considered to be a neurodevelopmental disorder with major  but so far unknown genetic factors involved. Genome scans have  implied the existence of candidate loci in many chromosomal regions,  including: 1p13.2; 1p21.1; 2q21; 2q31.1; 3p25.3; 4p16.3; 5p13.1;  5p15.33; 6q16.3; 7p15.2; 7q21.2; 7q31.33 36.2; 10p12.1; 10q22.3;  13q12.3; 13q22.1; 15q12; 15q21.1; 16p13.12 13.2; 17p13.2;  18q22.1; 18q21.33; 19p13.12; 19q13.41; 22q11.21; 22q11.23;  Xq21.33; Xq26.1, where 7q31 34 and 16p13.1 13.2 are the most  consistent findings. Mendelian Cytogenetics Network (MCN) is a collaborative study to  identify disease associated balanced chromosomal rearrangements. MCN database (MCNdb, http://www.mcndb.org) at present contains  data on 51 patients with autism and a constitutional balanced  chromosomal rearrangement. Approximately twenty of these  patients have breakpoints coinciding with regions highlighted by the  genome scans. We are currently FISH mapping the breakpoints of Analysis of Disorders and Traits with Complex Inheritance232 233 three patients from MCNdb in our search for genes associated with  autism: A: 46,XY, t(4;16)(q24;p13.3); B: 46,XY, t(9;18)(p22;q21.1)pat,  inv(10)(p11.2q21.2)mat and C: 46,XX, t(5;18)(q34;q12.2)de novo.  The initial mapping of the 16p13.3 breakpoint of patient A has shown  that the breakpoint is outside of, and distal to the autism susceptibility  region indicated by the genome scans, but the candidate genes  identified at the 16p13 breakpoint as well as at the other breakpoints  will be analyzed in patients with autism.",2003.0,,"Gilling1, Z. Tmer1, I. Bache1, M. Bak1, E. Niebuhr1, M. Bugge1, R.  M. J. Cotterill2, K. Brndum Nielsen3, U. Kristoffersson4, H. Ropers5,  N. Tommerup1","1Wilhelm Johannsen Centre for Functional Genome Research,  Department of Medical Genetics, University of Copenhagen,  Copenhagen, Denmark, 2The Technical University of Denmark,  Lyngby, Denmark, 3The J. F. Kennedy Institute, Glostrup, Denmark,  4The University Hospital of Lund, Lund, Sweden, 5Max Planck  Institute of Molecular Genetics, Berlin, Germany.   ","MCN database (MCNdb, http://www.mcndb.org) at present contains  data on 51 patients with autism and a constitutional balanced  chromosomal rearrangement.",patients with autism,,"['patient', 'with', 'autism']",[]
70,876,FISH mapping of translocation breakpoints  associated with autism.,P787.,,"Autism is considered to be a neurodevelopmental disorder with major  but so far unknown genetic factors involved. Genome scans have  implied the existence of candidate loci in many chromosomal regions,  including: 1p13.2; 1p21.1; 2q21; 2q31.1; 3p25.3; 4p16.3; 5p13.1;  5p15.33; 6q16.3; 7p15.2; 7q21.2; 7q31.33 36.2; 10p12.1; 10q22.3;  13q12.3; 13q22.1; 15q12; 15q21.1; 16p13.12 13.2; 17p13.2;  18q22.1; 18q21.33; 19p13.12; 19q13.41; 22q11.21; 22q11.23;  Xq21.33; Xq26.1, where 7q31 34 and 16p13.1 13.2 are the most  consistent findings. Mendelian Cytogenetics Network (MCN) is a collaborative study to  identify disease associated balanced chromosomal rearrangements. MCN database (MCNdb, http://www.mcndb.org) at present contains  data on 51 patients with autism and a constitutional balanced  chromosomal rearrangement. Approximately twenty of these  patients have breakpoints coinciding with regions highlighted by the  genome scans. We are currently FISH mapping the breakpoints of Analysis of Disorders and Traits with Complex Inheritance232 233 three patients from MCNdb in our search for genes associated with  autism: A: 46,XY, t(4;16)(q24;p13.3); B: 46,XY, t(9;18)(p22;q21.1)pat,  inv(10)(p11.2q21.2)mat and C: 46,XX, t(5;18)(q34;q12.2)de novo.  The initial mapping of the 16p13.3 breakpoint of patient A has shown  that the breakpoint is outside of, and distal to the autism susceptibility  region indicated by the genome scans, but the candidate genes  identified at the 16p13 breakpoint as well as at the other breakpoints  will be analyzed in patients with autism.",2003.0,,"Gilling1, Z. Tmer1, I. Bache1, M. Bak1, E. Niebuhr1, M. Bugge1, R.  M. J. Cotterill2, K. Brndum Nielsen3, U. Kristoffersson4, H. Ropers5,  N. Tommerup1","1Wilhelm Johannsen Centre for Functional Genome Research,  Department of Medical Genetics, University of Copenhagen,  Copenhagen, Denmark, 2The Technical University of Denmark,  Lyngby, Denmark, 3The J. F. Kennedy Institute, Glostrup, Denmark,  4The University Hospital of Lund, Lund, Sweden, 5Max Planck  Institute of Molecular Genetics, Berlin, Germany.   ","The initial mapping of the 16p13.3 breakpoint of patient A has shown  that the breakpoint is outside of, and distal to the autism susceptibility  region indicated by the genome scans, but the candidate genes  identified at the 16p13 breakpoint as well as at the other breakpoints  will be analyzed in patients with autism.",patients with autism,,"['patient', 'with', 'autism']",[]
73,151,An unusual case of Bannayan Riley Ruvalcaba syndrome  with a mutation in the PTEN gene,P0031.,,"Bannayan Riley Ruvalcaba syndrome (BRRS) is characterised by macrocephaly, intestinal hamartomatous polyps, lipomas, speckled penis and mental retardation. Germline mutations in the tumor suppressor gene PTEN were described in patients with BRRS. Herein we report a case of BRRS with unusual clinical features and a novel mutation in PTEN gene He was born after uncomplicated pregnancy with birth weight and length at the 90th centile, head circumference at the 75th centile. At the rst observation (4.5 yrs) the patient has a height at the 90th centile, weight at the 50th centile and head circumference > +2 SD. He exhibited mild mental retardation and autistic features, joint hypermobility, macrocephaly, downward slanting palpebral ssures and multiple hyperpigmented macules on the shaft and glans penis. Colonscopy revealed multiple intestinal lymphoid polyps, greater orid in the ileocecal region. The intestinal mucosa shows macroscopically numerous grey nodules and microscopically prominent large germinal follicules with polymorphous population of cells including B and T cell without any atypia. Mutation analysis revealed the presence of a missense substitution I135R in heterozygosity anking to the phosphatase core motif at a position in which a I135V has been  already described.The peculiarity of our observation is related to the presence of intestinal lymphoid polyps, not yet described in BRRS, as well as the autistic features which have been rarely described in BRRS. Further studies are necessary to clarify the relationship existing between these  features and the mutation described in our patient.",2005.0,,"Boccone1, V. Dess2, S. Piga2, M. B. Piludu2, S. DeVirgiliis2, A. Cao3, G.  Loudianos1","1Ospedale Regionale Microcitemie, Cagliari, Italy, 2Dipartimento di Scienze  Biomediche e Biotecnologie USC Italy, Cagliari, Italy, 3Istituto di Neurogenetica  e Neurofarmacologia CNR cagliari Italy, Cagliari, Italy","He exhibited mild mental retardation and autistic features, joint hypermobility, macrocephaly, downward slanting palpebral ssures and multiple hyperpigmented macules on the shaft and glans penis.",,autistic features,[],"['autistic', 'feature']"
73,151,An unusual case of Bannayan Riley Ruvalcaba syndrome  with a mutation in the PTEN gene,P0031.,,"Bannayan Riley Ruvalcaba syndrome (BRRS) is characterised by macrocephaly, intestinal hamartomatous polyps, lipomas, speckled penis and mental retardation. Germline mutations in the tumor suppressor gene PTEN were described in patients with BRRS. Herein we report a case of BRRS with unusual clinical features and a novel mutation in PTEN gene He was born after uncomplicated pregnancy with birth weight and length at the 90th centile, head circumference at the 75th centile. At the rst observation (4.5 yrs) the patient has a height at the 90th centile, weight at the 50th centile and head circumference > +2 SD. He exhibited mild mental retardation and autistic features, joint hypermobility, macrocephaly, downward slanting palpebral ssures and multiple hyperpigmented macules on the shaft and glans penis. Colonscopy revealed multiple intestinal lymphoid polyps, greater orid in the ileocecal region. The intestinal mucosa shows macroscopically numerous grey nodules and microscopically prominent large germinal follicules with polymorphous population of cells including B and T cell without any atypia. Mutation analysis revealed the presence of a missense substitution I135R in heterozygosity anking to the phosphatase core motif at a position in which a I135V has been  already described.The peculiarity of our observation is related to the presence of intestinal lymphoid polyps, not yet described in BRRS, as well as the autistic features which have been rarely described in BRRS. Further studies are necessary to clarify the relationship existing between these  features and the mutation described in our patient.",2005.0,,"Boccone1, V. Dess2, S. Piga2, M. B. Piludu2, S. DeVirgiliis2, A. Cao3, G.  Loudianos1","1Ospedale Regionale Microcitemie, Cagliari, Italy, 2Dipartimento di Scienze  Biomediche e Biotecnologie USC Italy, Cagliari, Italy, 3Istituto di Neurogenetica  e Neurofarmacologia CNR cagliari Italy, Cagliari, Italy","Mutation analysis revealed the presence of a missense substitution I135R in heterozygosity anking to the phosphatase core motif at a position in which a I135V has been  already described.The peculiarity of our observation is related to the presence of intestinal lymphoid polyps, not yet described in BRRS, as well as the autistic features which have been rarely described in BRRS.",,autistic features,[],"['autistic', 'feature']"
76,232,Hyperphosphatasia with cognitive decit and seizures:  further syndrome delineation,P0115.,,"Hyperphosphatasia is a persistent elevation of serum alkaline phosphatase activity seen in many disorders, particularly those affecting bone turnover. There have been occasional reports of hyperphosphatasia associated with progressive postnatal neurodevelopmental disease and seizures (MIM#239300). Affected children exhibit consistently elevated alkaline phosphatase (ALPL) of uncertain origin. There are no other laboratory ndings of note and no evidence of any abnormality of bone or liver metabolism, or altered skeletal architecture. Affected siblings and/or consanguinity suggest autosomal recessive inheritance, but the underlying pathogenesis is  unknown.We describe a new case and review the clinical features in the context of 16 previously reported children. Our proband is a 5 yr old girl born to consanguineous parents, who presented with marked developmental delay and dysmorphic features (brachycephaly, coarse facies, hypertelorism, bulbous nose with prominent nasal bridge, and downturned corners of the mouth) at ve months of age. Subsequently, failure to thrive, acquired microcephaly, and autistic behaviours were observed. Seizures and an abnormal EEG were also seen. The hyperphosphatasia (86772 IU/L, n=7) is associated with decreased pyridoxal 5 phosphate (B 6), and the question of aberrant vitamin  B6 metabolism has been raised in this condition before. Pyridoxine  challenge (100 mg bolus) resulted in normalized EEG activity. The patients tonic clonic and absence seizures have not been evident since phenobarbital withdrawal and treatment with 100 mg pyridoxine daily. Our case illustrates two points: 1) alkaline phosphatase should be assayed in children presenting with similar ndings; 2) pyridoxine EEG challenge should be attempted to determine whether other affected children show pyridoxine responsiveness.",2005.0,,"M. Nezarati1,2, M. D. Thompson3, L. Dupuis1, A. E. Killoran4, P. A. Hwang5,  D. E. C. Cole1,3","1Hospital for Sick Children, Toronto, ON, Canada, 2University of Toronto, Toron   to, ON, Canada, 3Depts of Pathobiology & Laboratory Medicine, U of Toronto,  Toronto, ON, Canada, 4Faculty of Medicine, U of Dublin, Dublin, Ireland, 5North  York General Hospital, Toronto, ON, Canada","Subsequently, failure to thrive, acquired microcephaly, and autistic behaviours were observed.",,autistic behaviours,[],"['autistic', 'behaviour']"
77,237,Does Xp22.3 deletion cause mental retardation? The  contribution of VCX A  and NLGN 4  to cognitive development,P0120.,,"Patients with Xp22.3 interstitial and terminal deletions have been shown to be affected by mental retardation or autism. Previously,  VCX  A (variably charged protein X A), located at Xp22.3, was introduced as a gene for mental retardation and its presence was suggested to be sufcient to maintain normal mental development. Recent reports suggest that mutations in  NLGN4 (neuroligin 4), located at that same  region, are involved in autistic disorders and mental retardation.In the current study we describe a pedigree of 3 generations affected by contiguous gene syndrome that includes the clinical features of X linked ichthyosis and Kallmann syndrome. Molecular analysis revealed the presence of an interstitial deletion spanning approximately 3.5Mb at Xp22.3. The centromeric breakpoint was localized between markers DXS1467 and DXS8051, proximal to  KAL 1. The telomeric breakpoint  was localized within the coding region of",2005.0,,"Macarov1, J. P. Newman2, D. Strich3, V. Sury1, M. Zeigler1, V. Meiner1","1Department of Human Genetics, Hebrew University Hadassah Medical School  and Hadassah University Hospital, Jerusalem, Israel, 2Department of Neurol   ogy and the Agnes Ginges Center for Human Neurogenetics, Hebrew Univer   sity Hadassah Medical School and Hadassah University Hospital, Jerusalem,  Israel, 3Pediatric Specialty Clinics, Endocrinology and Diabetes, Clalit Health  Services, Jerusalem, Israel","Recent reports suggest that mutations in  NLGN4 (neuroligin 4), located at that same  region, are involved in autistic disorders and mental retardation.In the current study we describe a pedigree of 3 generations affected by contiguous gene syndrome that includes the clinical features of X linked ichthyosis and Kallmann syndrome.",,autistic disorders,[],"['autistic', 'disorder']"
79,292,Adolescental problems in KBG syndrome: our experience,P0175.,,"G. Moscati"" Hospital, Avellino, Italy. KBG syndrome is a rare, but underestimated, autosomal dominant disease (40 cases described), characterized by macro oligodontia, short stature, mild to medium mental retardation, skeletal defects and other clinical features. We report 7 sporadic cases, 3 M and 4 F, observed during adolescence.This period is characterized by the modication of previous relationships, that leads, to a possible change in the role and importance of the family and reference gures.The child grows and the chrysalis becomes buttery. The process seems complicated and difcult in KBG patient. He links supercially to other persons. His world remains limited to a biunivocal relation with the mother, that lasts longer than the other children, so remaining in a condition of passivity and greatest dependence. He understands he doesnt overtake the daily problems without help. He reacts isolating from the real life, taking refuge in a fantastic world. He closes himself in a autistic passivity as the only answer to his own inadequacy. The world outside seems to him full of hostility.More than ten years ago we chose, in favour of patients with genetic syndromes, a multidimensional and multidisciplinary approach coordinated by a clinical genetist. Therapeutical results have been  satisfactory in KBG patients.We noted: acceptance of their own body, more optimistic approach to life, improvement of school and working integration, higher control of  nutritional and drug addiction.This experience improved our life and our profession, allowing a deep and empathyc interaction between patient and physician, that  represents the true essence of every medical act.",2005.0,,"Biondi , D. De Brasi, A. R. Colucci, C. Rosania, M. G. D'Avanzo","Division of Medical Genetics ""S",He closes himself in a autistic passivity as the only answer to his own inadequacy.,,autistic passivity,[],"['autistic', 'passivity']"
82,356,"Clinical, cytogenetical and molecular analyses of Sotos  and Weaver syndrome in 50 patients",P0239.,,"Sotos syndrome is characterised by pre and post natal overgrowth with  advanced bone age, macrocephaly, characteristic facial dysmorphism, and variable mental retardation. Microdeletions of 5q35 region or mutations of NSD1 gene are observed in 60 90% Sotos syndrome and in some patients affected with Weaver syndrome. Furthermore Rio et al. reported 11p15 anomalies in 2 patients with Sotos syndrome.We report on clinical and molecular ndings in a cohort of 50 patients with Sotos and Weaver syndrome (age 5 months  25 years). Large deletions were observed in 5 patients (10%). In 25 patients (50%) we identied NSD1 anomalies. In 20 patients without 5q35 or NSD1 anomalies 11p15 region was studied and was normal. Phenotype genotype correlations were studied. As previously reported we observed more severe cognitive impairment in patients harbouring large deletions. One patient with a large deletion presented with a severe behavioural phenotype, autoagressiveness and autistic behaviour. No Renal, cardiac and ophthalmologic malformations were more frequent and more severe in the group with large deletions than in the group with NSD1 alterations. No tumor was observed in our cohort. Advanced bone age and overgrowth were inconstant features. Macrocephaly which was previously considered as a mandatory criterion was not  present in 1/30 patients.",2005.0,,"Burglen1,2, V. Malan3, P. Saugier Veber4, M. F. Portnoi3, V. Drouin Garraud4,  D. Feldmann5, J. L. Taillemite3, T. Frebourg4, M. P. Vazquez6","1Unite de genetique Hpital Trousseau, Paris, France, 2UPRES EA 3497, Paris  VI, France, 3Laboratoire de cytogenetique Hpital St Antoine, Paris, France,  4Laboratoire de genetique moleculaire et INSERM U614, Faculte de Medecine  et de Pharmacie, Service de Genetique, Rouen, France, 5Laboratoire de Bio   chimie Hpital Trousseau, Paris, France, 6Service de chirurgie maxillofaciale  Hpital Trousseau and UPRES EA 3497 Paris VI, Paris, France","One patient with a large deletion presented with a severe behavioural phenotype, autoagressiveness and autistic behaviour.",,autistic behaviour,[],"['autistic', 'behaviour']"
84,461,Delineation of a 5q35 microdeletion in congenital heart  disease: haploinsufciency of NKX2 5 can cause Ebstein  anomaly,P0345.,,"Congenital heart diseases (CHD) represent the most common group  of inborn malformations, with an incidence of almost 1%. One of the genes associated with CHD is the  NKX2 5 gene, which encodes a  cardiac homeobox transcription factor. Mutations of NKX2 5, which  is located at 5q35.1 have been identied in a subset of familial and sporadic cases of atrioventricular (AV) conduction block associated with a spectrum of structural heart defects, including atrial septal defect (ASD) and tetratology of Fallot. Functional studies of  NKX2  5 mutations have indicated that haploinsufciency determines the AV conduction block and ASD phenotypes. However, some studies suggest dominant negative effects and it has not been possible to correlate other  NKX2 5 phenotypes with a specic mechanism of the  mutation due to a small sample size.Here, we present delineation of a microdeletion in a patient with AV conduction block, ASD and tricuspid valve malformation (Ebstein anomaly) in addition to microcephaly, scoliosis and pectoral hypoplasia. FISH mapping of an apparently balanced inversion, 46, XY, inv(5)(q13q35) de novo, revealed a 2.2 megabase deletion  at the distal inversion breakpoint. This region contains 17 RefSeq genes, including  NKX2 5. This case gives therefore strong evidence  for haploinsufciency of NKX2 5 as the cause of Ebstein anomaly.  Microdeletions in the terminal part of 5q are rare and only 12 cases have been published so far. A genotype phenotype comparison with  previous cases will be presented.",2005.0,,"A. Larsen1, M. Bkvad Hansen1, A. Delicado2, V. Kalscheuer3, N. Tomm   erup1, Z. Tmer1","1Wilhelm Johannsen Centre for Functional Genome Research, Department of  Medical Biochemistry and Genetics, University of Copenhagen, Copenhagen,  Denmark, 2Department of Medical Genetics, Hospital Universitario La Paz,  Madrid, Spain, 3Max Planck Institute for Molecular Genetics, Berlin, Germany",Functional studies of  NKX2  5 mutations have indicated that haploinsufciency determines the AV conduction block and ASD phenotypes.,,ASD phenotypes,[],"['ASD', 'phenotype']"
85,482,Autistic phenotype associated with a 15q11 q13 maternal  triplication,P0366.,,"Here we report on a 4 years old boy with mild developmental delay, autistic behaviour and a chromosome rearrangement involving the 15q proximal region. A series of 8 BACs was used to characterise this rearrangement at the molecular level. A triplication was found. The triplicated segment was larger than the typical PWS/AS deleted region. The proximal breakpoint is located within BAC RP11 810K23, immediately proximal to",2005.0,,"Mougou Zrelli1, D. Sanlaville1, S. Lyonnet1, M. Prieur1, C. Estrade1, M. Le  Lorc'h1, D. Genevieve1, M. Waill1, C. Ozilou1, M. Mattei2, M. Vekemans1, T. Atti  Bitach1, S. Romana1, C. Turleau1","1Hpital Necker Enfants Malades, Paris, France, 2INSERM U491, Marseille,  France","Here we report on a 4 years old boy with mild developmental delay, autistic behaviour and a chromosome rearrangement involving the 15q proximal region.",,autistic behaviour,[],"['autistic', 'behaviour']"
86,485,"A chromosome 10 inversion, inv(10)(q11.22;q21.1),  associated with mental retardation and autism",P0369.,,"Neuropsychiatric disorders in childhood including mental retardation and autism may be caused by genetic factors. Different strategies can be undertaken for the identication of these genetic factors. One approach is based on a detailed mapping of chromosomal rearrangements associated with specic phenotypes. Candidate genes may subsequently be identied from breakpoint regions. We have identied four unrelated individuals with a paracentric inversion on 10q by conventional high resolution karyotyping. Patient I has attention decit hyperactivity disorder. Patient II has a mild mental retardation, autistic features and a congenital heart defect. Patient III has speech impairments, mild mental retardation and enlarged hands Cytogenetics159 and feet. Patient IV has a mild mental retardation. Fluorescence in situ   hybridization (FISH) with chromosome 10 derived BACs in patient I  and II conned the chromosome 10 inversion breakpoints to q11.22 and q21.1. The inverted segment is approximately 10 Mb. We suggest that the phenotype in these individuals is caused by the inversion. We hypothesize that the normal function for one or several genes in, or adjacent to, the inverted region is altered. Further experiments are in progress for the characterization of the breakpoints and, to identify  candidate genes.",2005.0,,"Entesarian1, B. Carlsson1, E. Stattin2, I. Golovleva3, N. Dahl1","1Department of Genetics and Pathology, Uppsala University, Uppsala, Sweden,  2Department of Pediatrics, Umea University Hospital, Umea, Sweden, 3Depart   ment of Clinical Genetics, Umea University Hospital, Umea, Sweden","Patient II has a mild mental retardation, autistic features and a congenital heart defect.",,autistic features,[],"['autistic', 'feature']"
87,490,Uncommon variants of Turner syndrome detected before  puberty,P0374.,,"Two ten years old girls was referred for cytogenetic examination  because of their featuresof Turner syndrome. One of them had also an additional autistic  disorder with moderate mental retardation.Chromosome studies on peripheral blood lymphocyte cultures, by conventional banding techniques, showed that they differ of classical Turner syndrome.In the rst case, after G  and C  banding, we nd a mosaic karyotype 45,X/46,XY withchromosome Y detected in 50% of cells. C staining method revealed  a large C  band sizeon two third of Yq arm, without ectopic C  heterochromatin in any autosomes. It is known that, only a proportion of subjects mosaic for Y material exhibit features of Turner syndrome, even in the presence of SRY gene. In the near future, our case must be investigated both for the presence of SRY gene, and for the evolution of her external  genitalia.The second case exhibit a 45,iXq karyotype. A structural abnormality such iso Xq is quite common, but the additional autistic disorder is unusual in Turner girls. However, different chromosomal disorders account for less than 5% of all cases of autism, which supports the hypothesis that the autistic disorder may develop as a consequence of a chromosomal abnormality.Cytogenetics160",2005.0,,"Stana1,2, M. Bari1, A. Arghir3, A. Lungeanu3","1""Filantropia"" Clinical Hospital, Bucharest, Romania, 2""Titu Maiorescu"" Universi   ty, Bucharest, Romania, 3""Victor Babes"" National Institute, Bucharest, Romania","A structural abnormality such iso Xq is quite common, but the additional autistic disorder is unusual in Turner girls.",,autistic disorder,[],"['autistic', 'disorder']"
87,490,Uncommon variants of Turner syndrome detected before  puberty,P0374.,,"Two ten years old girls was referred for cytogenetic examination  because of their featuresof Turner syndrome. One of them had also an additional autistic  disorder with moderate mental retardation.Chromosome studies on peripheral blood lymphocyte cultures, by conventional banding techniques, showed that they differ of classical Turner syndrome.In the rst case, after G  and C  banding, we nd a mosaic karyotype 45,X/46,XY withchromosome Y detected in 50% of cells. C staining method revealed  a large C  band sizeon two third of Yq arm, without ectopic C  heterochromatin in any autosomes. It is known that, only a proportion of subjects mosaic for Y material exhibit features of Turner syndrome, even in the presence of SRY gene. In the near future, our case must be investigated both for the presence of SRY gene, and for the evolution of her external  genitalia.The second case exhibit a 45,iXq karyotype. A structural abnormality such iso Xq is quite common, but the additional autistic disorder is unusual in Turner girls. However, different chromosomal disorders account for less than 5% of all cases of autism, which supports the hypothesis that the autistic disorder may develop as a consequence of a chromosomal abnormality.Cytogenetics160",2005.0,,"Stana1,2, M. Bari1, A. Arghir3, A. Lungeanu3","1""Filantropia"" Clinical Hospital, Bucharest, Romania, 2""Titu Maiorescu"" Universi   ty, Bucharest, Romania, 3""Victor Babes"" National Institute, Bucharest, Romania","However, different chromosomal disorders account for less than 5% of all cases of autism, which supports the hypothesis that the autistic disorder may develop as a consequence of a chromosomal abnormality.Cytogenetics160",,autistic disorder,[],"['autistic', 'disorder']"
88,509,Molecular cytogenetic characterisation of terminal  chromosome 2q37 deletion in patients recruited through the,P0394.,,"Studies have ascertained associations between autism or Albright  hereditary osteodystrophy like phenotype and terminal 2q deletion with the breakpoint within 2q37.3. Furthermore subtelomeric 2q37.3 deletions are often detected with FISH subtelomeric screening and most of those 2qtel deletions are considered polymorphisms as they are also observed in the parents. However some of them are de novo terminal deletions associated with an abnormal phenotype. We collected 14 observations from 10 new families through the A.C.L.F. (French Speeking Cytogenetician Association ) telomere network, in order to better characterise the different length of the 2q37 deletions observed. We analysed for each patient and his parents when available, the size of the deletion by molecular cytogenetic and molecular biology with STS markers. The size of the deleted segment was determined by mapping the region with specic BAC and PAC clones from 2q36 breakpoint to the subtelomeric 2q end, and with different polymorphic  markers from D2S125 to D2S2585.The children were aged from 18 months to 14 years. They were all investigated for developmental delay. They had all facial dysmorphic features but looked different from each other. At least 4 of them presented multiple malformations including, cardiac malformation, coloboma, syndactyly, brachydactyly , cryptorchydy, ano rectal malformation, or cleft palate . None of them were referred for Albright osteodystrophy like phenotype, and one had autistic behaviour.We present the clinical, chromosomal and molecular cytogenetic and genetic ndings of the affected children and their parents investigated, comparing our results with the literature data. (Study supported by the CHU Reims AOL 2003).",2005.0,,"C.L.F. telomere network. M. Doco Fenzy1, N. Leporrier2, L. Taine3, M. Holder4, A. Schneider1, N. Bed   nareck1, P. Sabouraud1, M. Mozelle1, M. Khoury5, B. Delobel6, J. Motte1, M.  Goossens7, D. Lacombe3, S. Briault8, D. Gaillard1","1CHU , UFR medecine, Reims, France, 2CHU, Caen, France, 3CHU, Bor   deaux, France, 4CHU, Lille, France, 5CHG, Laon, France, 6Hopital St Antoine,  Lille, France, 7Hopital Henri Mondor AP HP, Crteil, France, 8INSERM, Tours,  France","None of them were referred for Albright osteodystrophy like phenotype, and one had autistic behaviour.We present the clinical, chromosomal and molecular cytogenetic and genetic ndings of the affected children and their parents investigated, comparing our results with the literature data.",,autistic behaviour,[],"['autistic', 'behaviour']"
89,752,Mental retardation and autism associated with a 1.2 Mb  Xq25 duplication encompassing the glutamate receptor gene  GRIA3,P0637.,,"Chromosomal imbalances are a frequent cause of mental retardation (MR) but rearrangements smaller than 5 megabases (Mb) are frequently undetectable due to the limited resolution of routine chromosome analysis. Recently, genome wide screening for submicroscopic deletions and duplications has become possible with array based comparative genomic hybridisation (array CGH). In the course of a systematic screening for submicroscopic chromosome imbalances in children with syndromic MR by array CGH, we identied a small Xq25  microduplication in a boy with MR and autism.The patient, a 15 year old boy, was referred to our Department Molecular and biochemical basis of disease, and molecular diagnostics218 because of developmental delay, speech delay, autistic disorder  and sleep disturbances. He also presented facial dysmorphism and progressive scoliosis. High resolution karyotype and FRAXA screening were normal. We rst performed array CGH using a DNA microarray with ~1 Mb resolution. Gain of chromosomal material was detected for two clones in Xq25. This result was conrmed using a tiling path BAC microarray covering the whole X chromosome and the duplication was found to span 1.2 Mb between BACs RP6 64P14 and RP13 158L7. The duplication was also detected in the phenotypically normal mother. However, she had a biased X chromosome inactivation (81%/19%), supporting the involvement of the duplication in the patients phenotype.Interestingly, the duplicated region encompasses the glutamate receptor subunit gene",2005.0,,"Borck1, R. Redon2, M. C. de Blois1, N. P. Carter2, A. Munnich1, V. Cormier  Daire1, L. Colleaux1","1INSERM U393 and Dpartement de Gntique Mdicale, Hpital Necker   En   fants Malades, Paris, France, 2The Wellcome Trust Sanger Institute, Wellcome  Trust Genome Campus, Hinxton, Cambridge CB10 1SA, United Kingdom","In the course of a systematic screening for submicroscopic chromosome imbalances in children with syndromic MR by array CGH, we identied a small Xq25  microduplication in a boy with MR and autism.The patient, a 15 year old boy, was referred to our Department Molecular and biochemical basis of disease, and molecular diagnostics218 because of developmental delay, speech delay, autistic disorder  and sleep disturbances.",,autistic disorder,[],"['autistic', 'disorder']"
92,1173,"Association analysis of the candidate genes RELN,  LAMB1, CUTL1 and NRCAM for autism on chromosome 7q",P1060.,,"Autism is a severe neurodevelopmental disorder that usually occurs due to a complex genetic predisposition. It is characterized by impairments in reciprocal social interaction and communication, and restricted and stereotyped patterns of interests and activities. Previously linkage for autism has been found to chromosome 7q, which has been replicated by many groups. Four candidate genes present in chr7q22 31 have been screened for mutations and association with autism in the IMGSAC sample; RELN, LAMB1, CUTL1  and NRCAM. Several  missense mutations were found in RELN and new coding variants in  CUTL1 and",2005.0,,"H. Sykes1, J. A. Lamb1, G. Barnby1, E. Bonora2, A. J. Bailey3, A. P. Monaco1,  Int. Molecular Genetic Study of Autism Consortium(IMGSAC), www.well.ox.ac. uk/~maestrin/iat.html","1The Wellcome Trust Centre for Human Genetics, Oxford, United Kingdom,  2Unit di Genetica Medica, Bologna, Italy, 3Section of Child and Adolescent Psy   chiatry, University Department of Psychiatry, Oxford, United Kingdom","Four candidate genes present in chr7q22 31 have been screened for mutations and association with autism in the IMGSAC sample; RELN, LAMB1, CUTL1  and NRCAM.",association with autism,,"['association', 'with', 'autism']",[]
93,1285,Familial secundum atrial septal defect maps to  chromosome 15,P1172.,,"Atrial septum defect (ASD) is a common congenital heart defect affecting  4 in 100,000 individuals. ASD of the secundum type is characterised by an incomplete coverage of the ostium secundum resulting in a left to right shunting. The effects of the ASD range from subclinical to severe symptoms including pulmonary hypertension, arrhythmias and heart failure. ASD is mostly sporadic but several familial cases have been reported. We describe two extended Swedish families with isolated autosomal dominant ASD. Using polymorphic microsatellite markers, we performed a genome wide scan in search for chromosomal regions linked to ASD. Linkage to the previously described candidate loci including the  COMP and GATA4 genes were excluded for the two  families. We identied a 23 cM region on chromosome 15 (15p11 q13) which is linked to the disease phenotype. The region is restricted by recombination events between the markers D15S165 and D15S659 and we calculated a maximum cumulative LOD score for the two families of 3.6 assuming full penetrance. Candidate genes are now investigated in the linked region for structural mutations from affected  family members.",2005.0,,Matsson,"Uppsala university, Uppsala, Sweden","The effects of the ASD range from subclinical to severe symptoms including pulmonary hypertension, arrhythmias and heart failure.",,ASD range,[],"['ASD', 'range']"
94,1338,BARCODE: a new software for comparative dating of  haplotypic nested lineages,P1225.,,"We present a new software for comparative dating estimates of haplotypic lineages dened by Unique Event Polymorphisms (UEP), on the basis of linked STR diversity. BARCODE (Basic ASD Regression for COmparative Dating Estimates), applies a comparative dating approach free of assumptions on STR mutation rates to detect the linear accumulation of ASD over time. Its power relies on the exploitation of the UEP dened phylogeny, which provides a unique solution for the order of nodes in the tree to be analysed. The set of possible solutions to be tested for ASD TIME linearity is created through an algorithm specically created. The more the phylogeny has a nested shape, the more the dating result is robust. BARCODE allows to weight each lineage according to its frequency in the dataset, a fundamental option Normal variation, population genetics, genetic epidemiology348 when the sampled lineages include variants supposed to be ancestral  to a demographic expansion or when dealing with data unbalanced in  sample size.We report the results obtained by running BARCODE on published Y chromosomal data sets. The relative dating estimates are in general agreement with the absolute estimates originally published. The results also allow inferences on STR mutation rates (ASD TIME regression slopes): some critical loci emerged, which show variable mutation patterns across the data sets. However, most STR loci show a similar behaviour across the data sets, thus conrming their informativeness. The most commonly used STR loci can then be ranked in different classes, according to their mutation rates, independently on the  particular data set considered.Work supported by PRIN MIUR 2003.",2005.0,,"Luca1, M. Basile2, F. Di Giacomo3, A. Novelletto1","1Department of Cell Biology, University of Calabria, Rende, Italy, 2Department of  Mechanics, University of Calabria, Rende, Italy, 3Department of Biology, Univer   sity ""Tor Vergata"", Rome, Italy","BARCODE (Basic ASD Regression for COmparative Dating Estimates), applies a comparative dating approach free of assumptions on STR mutation rates to detect the linear accumulation of ASD over time.",,ASD Regression,[],"['ASD', 'Regression']"
95,1427,Microrrearrangements of human chromosome 15q11 q13  in families with autistic disorder,P1315.,,"Autism is a neurodevelopmental disorder exhibiting complex genetic etiology. Human chromosome 15q11 q13 is a candidate region to autism based on linkage, linkage disequilibrium, cytogenetic abnormalities, and maternal duplications at this locus in patients with autism and autism related phenotype. Chromosome 15q11 q13 contains several imprinted genes expressed in the brain, including small nucleolar RNA (snoRNA) genes, and is rich in segmental duplications. These sequences promote fairly frequent 15q11 q13 rearrangements resulting in Prader Willi syndrome, Angelman syndrome, mental retardation and autism spectrum disorder. Among plausible candidate genes for autism in this region is the cluster of the gamma aminobutiric acid (GABA) receptor genes. In order to detect possible duplicon mediated submicroscopic rearrangements of 15q11 q13, we have performed the analysis of microsatellite markers in Spanish autistic families, and multiplex families of autistic probands from the Autism Genetic Resource Exchange (AGRE) and control samples. We have found frequent microduplications at 15q11.2 region and at GABA locus Genomics, technology, gene function, bioinformatics367 in autistic patients and control samples. Two patients have a paternally  inherited microduplication between the genes GABRA5 and GABRG3 whereas other two patients have a maternally inherited duplication within the D15S1021 marker. All the other duplications are the novo microrearrangements. Using quantitative PCR, PFGE, additional microsatellites and single nucleotide polymorphisms in the region we are currently dening the size of these rearrangements, which should help to delineate the relationship between 15q11 q13 alterations and autistic disorder.",2005.0,,"Cerrato , M. Ogorelkova, M. Gratacs, X. Estivill","Centre de Regulaci Genmica, Barcelona, Spain","Human chromosome 15q11 q13 is a candidate region to autism based on linkage, linkage disequilibrium, cytogenetic abnormalities, and maternal duplications at this locus in patients with autism and autism related phenotype.",patients with autism,,"['patient', 'with', 'autism']",[]
95,1427,Microrrearrangements of human chromosome 15q11 q13  in families with autistic disorder,P1315.,,"Autism is a neurodevelopmental disorder exhibiting complex genetic etiology. Human chromosome 15q11 q13 is a candidate region to autism based on linkage, linkage disequilibrium, cytogenetic abnormalities, and maternal duplications at this locus in patients with autism and autism related phenotype. Chromosome 15q11 q13 contains several imprinted genes expressed in the brain, including small nucleolar RNA (snoRNA) genes, and is rich in segmental duplications. These sequences promote fairly frequent 15q11 q13 rearrangements resulting in Prader Willi syndrome, Angelman syndrome, mental retardation and autism spectrum disorder. Among plausible candidate genes for autism in this region is the cluster of the gamma aminobutiric acid (GABA) receptor genes. In order to detect possible duplicon mediated submicroscopic rearrangements of 15q11 q13, we have performed the analysis of microsatellite markers in Spanish autistic families, and multiplex families of autistic probands from the Autism Genetic Resource Exchange (AGRE) and control samples. We have found frequent microduplications at 15q11.2 region and at GABA locus Genomics, technology, gene function, bioinformatics367 in autistic patients and control samples. Two patients have a paternally  inherited microduplication between the genes GABRA5 and GABRG3 whereas other two patients have a maternally inherited duplication within the D15S1021 marker. All the other duplications are the novo microrearrangements. Using quantitative PCR, PFGE, additional microsatellites and single nucleotide polymorphisms in the region we are currently dening the size of these rearrangements, which should help to delineate the relationship between 15q11 q13 alterations and autistic disorder.",2005.0,,"Cerrato , M. Ogorelkova, M. Gratacs, X. Estivill","Centre de Regulaci Genmica, Barcelona, Spain","In order to detect possible duplicon mediated submicroscopic rearrangements of 15q11 q13, we have performed the analysis of microsatellite markers in Spanish autistic families, and multiplex families of autistic probands from the Autism Genetic Resource Exchange (AGRE) and control samples.",,autistic families,[],"['autistic', 'family']"
95,1427,Microrrearrangements of human chromosome 15q11 q13  in families with autistic disorder,P1315.,,"Autism is a neurodevelopmental disorder exhibiting complex genetic etiology. Human chromosome 15q11 q13 is a candidate region to autism based on linkage, linkage disequilibrium, cytogenetic abnormalities, and maternal duplications at this locus in patients with autism and autism related phenotype. Chromosome 15q11 q13 contains several imprinted genes expressed in the brain, including small nucleolar RNA (snoRNA) genes, and is rich in segmental duplications. These sequences promote fairly frequent 15q11 q13 rearrangements resulting in Prader Willi syndrome, Angelman syndrome, mental retardation and autism spectrum disorder. Among plausible candidate genes for autism in this region is the cluster of the gamma aminobutiric acid (GABA) receptor genes. In order to detect possible duplicon mediated submicroscopic rearrangements of 15q11 q13, we have performed the analysis of microsatellite markers in Spanish autistic families, and multiplex families of autistic probands from the Autism Genetic Resource Exchange (AGRE) and control samples. We have found frequent microduplications at 15q11.2 region and at GABA locus Genomics, technology, gene function, bioinformatics367 in autistic patients and control samples. Two patients have a paternally  inherited microduplication between the genes GABRA5 and GABRG3 whereas other two patients have a maternally inherited duplication within the D15S1021 marker. All the other duplications are the novo microrearrangements. Using quantitative PCR, PFGE, additional microsatellites and single nucleotide polymorphisms in the region we are currently dening the size of these rearrangements, which should help to delineate the relationship between 15q11 q13 alterations and autistic disorder.",2005.0,,"Cerrato , M. Ogorelkova, M. Gratacs, X. Estivill","Centre de Regulaci Genmica, Barcelona, Spain","In order to detect possible duplicon mediated submicroscopic rearrangements of 15q11 q13, we have performed the analysis of microsatellite markers in Spanish autistic families, and multiplex families of autistic probands from the Autism Genetic Resource Exchange (AGRE) and control samples.",,autistic probands,[],"['autistic', 'probands']"
95,1427,Microrrearrangements of human chromosome 15q11 q13  in families with autistic disorder,P1315.,,"Autism is a neurodevelopmental disorder exhibiting complex genetic etiology. Human chromosome 15q11 q13 is a candidate region to autism based on linkage, linkage disequilibrium, cytogenetic abnormalities, and maternal duplications at this locus in patients with autism and autism related phenotype. Chromosome 15q11 q13 contains several imprinted genes expressed in the brain, including small nucleolar RNA (snoRNA) genes, and is rich in segmental duplications. These sequences promote fairly frequent 15q11 q13 rearrangements resulting in Prader Willi syndrome, Angelman syndrome, mental retardation and autism spectrum disorder. Among plausible candidate genes for autism in this region is the cluster of the gamma aminobutiric acid (GABA) receptor genes. In order to detect possible duplicon mediated submicroscopic rearrangements of 15q11 q13, we have performed the analysis of microsatellite markers in Spanish autistic families, and multiplex families of autistic probands from the Autism Genetic Resource Exchange (AGRE) and control samples. We have found frequent microduplications at 15q11.2 region and at GABA locus Genomics, technology, gene function, bioinformatics367 in autistic patients and control samples. Two patients have a paternally  inherited microduplication between the genes GABRA5 and GABRG3 whereas other two patients have a maternally inherited duplication within the D15S1021 marker. All the other duplications are the novo microrearrangements. Using quantitative PCR, PFGE, additional microsatellites and single nucleotide polymorphisms in the region we are currently dening the size of these rearrangements, which should help to delineate the relationship between 15q11 q13 alterations and autistic disorder.",2005.0,,"Cerrato , M. Ogorelkova, M. Gratacs, X. Estivill","Centre de Regulaci Genmica, Barcelona, Spain","We have found frequent microduplications at 15q11.2 region and at GABA locus Genomics, technology, gene function, bioinformatics367 in autistic patients and control samples.",,autistic patients,[],"['autistic', 'patient']"
95,1427,Microrrearrangements of human chromosome 15q11 q13  in families with autistic disorder,P1315.,,"Autism is a neurodevelopmental disorder exhibiting complex genetic etiology. Human chromosome 15q11 q13 is a candidate region to autism based on linkage, linkage disequilibrium, cytogenetic abnormalities, and maternal duplications at this locus in patients with autism and autism related phenotype. Chromosome 15q11 q13 contains several imprinted genes expressed in the brain, including small nucleolar RNA (snoRNA) genes, and is rich in segmental duplications. These sequences promote fairly frequent 15q11 q13 rearrangements resulting in Prader Willi syndrome, Angelman syndrome, mental retardation and autism spectrum disorder. Among plausible candidate genes for autism in this region is the cluster of the gamma aminobutiric acid (GABA) receptor genes. In order to detect possible duplicon mediated submicroscopic rearrangements of 15q11 q13, we have performed the analysis of microsatellite markers in Spanish autistic families, and multiplex families of autistic probands from the Autism Genetic Resource Exchange (AGRE) and control samples. We have found frequent microduplications at 15q11.2 region and at GABA locus Genomics, technology, gene function, bioinformatics367 in autistic patients and control samples. Two patients have a paternally  inherited microduplication between the genes GABRA5 and GABRG3 whereas other two patients have a maternally inherited duplication within the D15S1021 marker. All the other duplications are the novo microrearrangements. Using quantitative PCR, PFGE, additional microsatellites and single nucleotide polymorphisms in the region we are currently dening the size of these rearrangements, which should help to delineate the relationship between 15q11 q13 alterations and autistic disorder.",2005.0,,"Cerrato , M. Ogorelkova, M. Gratacs, X. Estivill","Centre de Regulaci Genmica, Barcelona, Spain","Using quantitative PCR, PFGE, additional microsatellites and single nucleotide polymorphisms in the region we are currently dening the size of these rearrangements, which should help to delineate the relationship between 15q11 q13 alterations and autistic disorder.",,autistic disorder,[],"['autistic', 'disorder']"
106,278,"Autistic Regression in a child with Russell   silver syndrome and UPD of chromosome 7, a rare clinical  presentation",P0259.,,"Silver Russell syndrome (SRS) is a heterogeneous syndrome which is  characterized by severe intrauterine and postnatal growth retardation and typical dysmorphic features . In 7 10% of SRS patients, a maternal uniparental disomy of chromosome 7 (UPD7) can be detected .We describe a 4 .5 y old boy, with SRS and UPD of chromosome 7 .  Along with the clinical findings that are described in this syndrome he  had sever developmental delay which is not commonly found in these  patients and an autistic regression that was not described before in this syndrome . A possible explanation for the autistic regression might be the tendency for undetected hypoglycemic events in children with SRS . Another  explanation is that the autism is not a part of SRS but is due to the chromosomal abnormality  . A rare but important type of abnormality  that accounts for some of cases of autism is uniparental disomy (UPD) . There is a well established association of UPD with autism and  the imprinted 15q11 q13 Prader Willi/ Angelman syndrome (PW/AS) region . Recently there was a case with UPD of chromosome 1 and autism . This case suggests an association of autism with a locus on chromosome 7 . UPD can cause disease by two mechanisms . First,  imprinted genes are subject to selective expression that depends on the parental origin . Second, UPD can also cause disease by unmasking recessive mutations that fall within regions of isodisomy  .",2006.0,,"Vinkler1, O. Vardi2, M. Davidovich2, T. Sagie3, D. Lev1","1Institute of Clinical Genetics Wolfson Medical Center, Holon, Israel, 2Child  Development Center Maccabi Health Services, Rishon Lezion, Israel, 3Child  Neurology Unit Wolfson Medical Center, Holon, Israel",Along with the clinical findings that are described in this syndrome he  had sever developmental delay which is not commonly found in these  patients and an autistic regression that was not described before in this syndrome .,,autistic regression,[],"['autistic', 'regression']"
106,278,"Autistic Regression in a child with Russell   silver syndrome and UPD of chromosome 7, a rare clinical  presentation",P0259.,,"Silver Russell syndrome (SRS) is a heterogeneous syndrome which is  characterized by severe intrauterine and postnatal growth retardation and typical dysmorphic features . In 7 10% of SRS patients, a maternal uniparental disomy of chromosome 7 (UPD7) can be detected .We describe a 4 .5 y old boy, with SRS and UPD of chromosome 7 .  Along with the clinical findings that are described in this syndrome he  had sever developmental delay which is not commonly found in these  patients and an autistic regression that was not described before in this syndrome . A possible explanation for the autistic regression might be the tendency for undetected hypoglycemic events in children with SRS . Another  explanation is that the autism is not a part of SRS but is due to the chromosomal abnormality  . A rare but important type of abnormality  that accounts for some of cases of autism is uniparental disomy (UPD) . There is a well established association of UPD with autism and  the imprinted 15q11 q13 Prader Willi/ Angelman syndrome (PW/AS) region . Recently there was a case with UPD of chromosome 1 and autism . This case suggests an association of autism with a locus on chromosome 7 . UPD can cause disease by two mechanisms . First,  imprinted genes are subject to selective expression that depends on the parental origin . Second, UPD can also cause disease by unmasking recessive mutations that fall within regions of isodisomy  .",2006.0,,"Vinkler1, O. Vardi2, M. Davidovich2, T. Sagie3, D. Lev1","1Institute of Clinical Genetics Wolfson Medical Center, Holon, Israel, 2Child  Development Center Maccabi Health Services, Rishon Lezion, Israel, 3Child  Neurology Unit Wolfson Medical Center, Holon, Israel",A possible explanation for the autistic regression might be the tendency for undetected hypoglycemic events in children with SRS .,,autistic regression,[],"['autistic', 'regression']"
107,321,A detailed breakpoint analysis of 2 patients with rare  20q13.33 subtelomere deletion to define genotype/phenotype  correlations,P0302.,,"Pure constitutional deletions restricted to the very distal band of the long arm of chromosome 20, i .e ., 20q13 .33 have never been reported so far  . The 20q deletion syndrome is usually caused by a chromosomal  deletion encompassing the region of 20q13.12 20q13.32 and has  features of growth retardation, severe malformations of the limbs, short  neck, flat occiput, and mild facial dysmorphism All laboratories from  the Association des Cytognticiens de Langue Franaise (http://www  .eaclf .org) offering an appropriate cytogenetic service in France  were surveyed over a 10 year period (1994 2004) for cases where a submicroscopic telomeric abnormality had been ascertained . We report on the clinical phenotype of 2 patients with a de novo, isolated, subtelomeric 20q13 .33 deletion . The deletion is associated in  one child with global developmental delay, craniofacial dysmorphism,  and in the other one with more severe mental retardation and autistic behaviour  . Detailed breakpoint analysis in these 2 cases using FISH  with bacterial artificial chromosome (BAC) probes, microsatellite and  single nucleotide polymorphism (SNP) genotyping has identified a deleted region of approximately 1 .33Mb, with a 324kb difference between the two deletions . At least 30 genes are deleted . The precise  region of loss has been defined allowing us to identify genes that may contribute to the clinical phenotype through hemizygosity  . Assignment  of clinical features to specific breakpoints and refinement of predictive value may be useful in counselling .",2006.0,,"Bri Dexheimer1, M. Grgoire1, B. Leheup2, A. Toutain3, S. Briault3, K. Bro   chet1, P. Jonveaux1","1Laboratoire de gntique, CHU Nancy, Vandoeuvre les Nancy, France, 2Ser  vice mdecine infantile 3, CHU Nancy, Vandoeuvre les Nancy, France, 3Service  de gntique, Hpital Bretonneau, Tours, France","The deletion is associated in  one child with global developmental delay, craniofacial dysmorphism,  and in the other one with more severe mental retardation and autistic behaviour  .",,autistic behaviour,[],"['autistic', 'behaviour']"
109,405,clinical features in a girl with a mitotic abnormal  segregation of a chromosomal balanced translocation,P0386.,,"We report a 16 years old girl with an imbalanced mitotic segregation of a maternally inherited balanced translocation . Blood karyotype is 46,XX t(17;22)(p13;q12)mat (8%)/45,XX,  17, 22,der(17) (62%)/47,XX,t(17;22)(p13;q12) +der(22) (30%). Chromosome analysis on other tissues is currently in the pipeline .Pregnancy and delivery were uneventful . She had congenital hip  dislocation and delayed psychomotor development, but no major malformation . Growth was normal . She subsequently showed  refractory partial epilepsy, autistic trait, scoliosis, and a neurogenic detrusor dysfunction in the last months . No similar patients had been described in literature so far, since all  the cases reported with a chromosomal mosaicism (Dufke et al, 2001;  Kuharya et al, 2002), resulting from a parental balanced translocation,  presumably derived their abnormal karyotype from a meiotic error and a postzygotic rescue . Our patient clearly demonstrate that an  aberrant mitotic segregation can be a possible althoug rare outcome of a balanced translocation . This should remark the relevance of  performing an exhaustive cytogenetic analysis in mentally retarded  patients, especially when a chromosomal rearrangement is found within the family  . REFERENCES 1  Dufke A, Mayrhofer H, Enders H, Kaiser P, Leipoldt M . Unusual chromosomal mosaicism as a cause of mental retardation  and congenital malformations in a familial reciprocal translocation  carrier, t(17;22) (q24.2;q11.23). Cytogenet Cell Genet. 2001;93(3 4):168 70 . 2  Kulharya AS, Lovell CM, Flannery DB . Unusual  mosaic karyotype resulting from adjacent 1 segregation of t(11;22):  importance of performing skin fibroblast karyotype in patients with unexplained multiple congenital anomalies . Am J Med Genet . 2002  Dec 15;113(4):367 70.",2006.0,,"Forzano1, M. Pierluigi1, S. Cavani1, M. Malacarne1, C. Marciano1, V. Vias   solo1, M. Mogni1, C. Cuoco2, R. Curia3, F. Dagna Bricarelli1, F. Faravelli1","1Human Genetics, Galliera Hospital, Genova, Italy, 2Cytogenetics Laboratory,  G.Gaslini Institute, Genova, Italy, 3Paediatric Neuropsychiatry Unit, ASL 22,  Novi Ligure, Italy. ","She subsequently showed  refractory partial epilepsy, autistic trait, scoliosis, and a neurogenic detrusor dysfunction in the last months .",,autistic trait,[],"['autistic', 'trait']"
111,789,Phenotype associated with neurotrypsin mutation: a  preliminary report,P0771.,,"The importance of extracellular proteases and their inhibitors is well  documented in several human diseases (hemophilia B, alpha 1  antitrypsin deficiency, serpinopathies).Neurotrypsin belongs to the subfamily of trypsin like serine proteases .  It was localized in the presynaptic membrane and the presynaptic active zone of central nervous system synapses . Neurotrypsin is  expressed in the cerebral cortex, the hyppocampus and the amygdala, suggesting a role in learning, memory and emotion . Neurotrypsin (PRSS12) mutation is associated with autosomal recessive mental retardation . To date, seven patients from three  consanguineous families who are all originally from the same area of  Eastern Algeria have been identified with the same mutation (4 base  pair deletion in exon 7 of the PRSS12), suggesting a founder effect in this population . Clinical examination revealed impaired voluntary saccadic eye  movements in the horizontal and vertical direction whatever the nature of the stimulation (visual, auditory, somesthesic . Ophthalmological examination including FO and ERG was unremarkable . Ocular movement recording has ruled out ocular motor apraxia .Intrafamilial clinical expression of neurotrypsin mutation is variable .  However, we can distinguish 2 clinical pictures: one is characterized  by severe mental retardation, absence of language and autistic  features, the other one by moderate global mental retardation without autistic features . Further investigations will be required to objective abnormalities of voluntary eye movements in these patients .",2006.0,,"Philippe1, N. Boddaert2, M. Iba Zizen3, M. Rio4, M. Masure5, M. Barbeau6, D.  Cohen6, F. Molinari1, A. Munnich1, L. Colleaux1","1INSERM 781, Paris, France, 2Service de Radiologie, Hpital Necker Enfants  Malades, Paris, France, 3Service de Neuroradiologie, Hpital des Quinze Vingt,  Paris, France, 4Service de Gntique, Hpital necker Enfants Malades, Paris, France, 5LENA, Hpital de la Piti Salptrire, Paris, France, 6Service de P   dopsychiatrie, Hpital de la Piti Salptrire, Paris, France","However, we can distinguish 2 clinical pictures: one is characterized  by severe mental retardation, absence of language and autistic  features, the other one by moderate global mental retardation without autistic features .",,autistic features,[],"['autistic', 'feature']"
112,790,"mutated NLGN4 in a family with mental retardation,  autism and mood disorder",P0772.,,"Neuroligin 4  (NLGN4) belongs to the neuroligin family made up of  neuronal cell surface proteins located in synaptic structures and mostly enriched at excitatory synapses .  NLGN4 mutations were previously  associated with mental retardation and susceptibility to x linked autism .  We examined 6 siblings of which 3 males (ages 9   14 years) were  affected with mental retardation and autistic features and one female  (16 years) was diagnosed to have behavioral problems and suspected mood disorder  . The familial co segregation of mental retardation and  autistic features in males supported an X linked inheritance . Molecular  analysis was performed using markers (DXS1060 and DXS 996)  spanning the NLGN4  site located at Xp22 .33 . Following suggestive  NLGN4  linkage,  we screened the entire coding sequence of this gene  and identified a missense mutation N515S. This NLGN4  mutation was  present in the 3 male sibs with mental retardation and autism and also  in their sister who presented with behavioral and mood disturbances, yet not in two additional healthy sibs . Screening 100 chromosomes of  healthy individuals from a similar ethnic background did not detect this mutation . It may be proposed that not only types of autism and mental  retardation but also mood disorders may share a common genetic origin . Familial occurrence of autism and mood disturbances should  direct to NLGN4  as a predisposing genetic factor. These findings may  lead to better understanding of molecular pathways and possibly to  development of more specific treatment modalities.",2006.0,,"Silverstein , B. Glick, I. Lerer, M. Zeigler, D. Abeliovich, V. Meiner","Hadassah University Hospital, Jerusalem, Israel",We examined 6 siblings of which 3 males (ages 9   14 years) were  affected with mental retardation and autistic features and one female  (16 years) was diagnosed to have behavioral problems and suspected mood disorder  .,,autistic features,[],"['autistic', 'feature']"
112,790,"mutated NLGN4 in a family with mental retardation,  autism and mood disorder",P0772.,,"Neuroligin 4  (NLGN4) belongs to the neuroligin family made up of  neuronal cell surface proteins located in synaptic structures and mostly enriched at excitatory synapses .  NLGN4 mutations were previously  associated with mental retardation and susceptibility to x linked autism .  We examined 6 siblings of which 3 males (ages 9   14 years) were  affected with mental retardation and autistic features and one female  (16 years) was diagnosed to have behavioral problems and suspected mood disorder  . The familial co segregation of mental retardation and  autistic features in males supported an X linked inheritance . Molecular  analysis was performed using markers (DXS1060 and DXS 996)  spanning the NLGN4  site located at Xp22 .33 . Following suggestive  NLGN4  linkage,  we screened the entire coding sequence of this gene  and identified a missense mutation N515S. This NLGN4  mutation was  present in the 3 male sibs with mental retardation and autism and also  in their sister who presented with behavioral and mood disturbances, yet not in two additional healthy sibs . Screening 100 chromosomes of  healthy individuals from a similar ethnic background did not detect this mutation . It may be proposed that not only types of autism and mental  retardation but also mood disorders may share a common genetic origin . Familial occurrence of autism and mood disturbances should  direct to NLGN4  as a predisposing genetic factor. These findings may  lead to better understanding of molecular pathways and possibly to  development of more specific treatment modalities.",2006.0,,"Silverstein , B. Glick, I. Lerer, M. Zeigler, D. Abeliovich, V. Meiner","Hadassah University Hospital, Jerusalem, Israel",The familial co segregation of mental retardation and  autistic features in males supported an X linked inheritance .,,autistic features,[],"['autistic', 'feature']"
113,886,Locus heterogeneity in AsD associated with AV block,P0869.,,"The prevalence of congenital heart defects is approximately 1% of all live births . Identifying the genes responsible for cardiac malformation is  the first step to understand pathogenesis. Heterozygous mutations in  the CSX/NKX2 5 gene have been identified to cause atrial septal defect  (ASD) and/or atrioventricular conduction disturbance, characterized by progressive prolongation of the PR interval . There is great variability in expressivity of the phenotype . We screened 4 sporadic patients and 3 index cases of families with ASD and/or conduction defects . In one of them, a CSX/NKX2 5 mutation  was identified. This novel mutation (p.Tyr256X) was inherited in a  3 generation family causing 5 individuals to have cardiac anomalies ranging from ASD to arrhythmias . Surprisingly, no CSX/NKX2 5  mutation was found in the 2 other families presenting a characteristic phenotype of CSX/NKX2 5 mutated individuals . Moreover, an intragenic or whole gene deletion was excluded in one of the families . This suggests genetic heterogeneity for ASD with conduction defects . (vikkula@bchm.ucl.ac.be) (http://www.icp.ucl.ac.be/vikkula)Genetic analysis, linkage, and association",2006.0,,"De Roy1, I. Gutierrez Roelens2, C. Ovaert1, T. Sluymans1, K. Devriendt3, H.  G. Brunner4, M. Vikkula2",1Pediatric Cardiology and Cardiology dept,We screened 4 sporadic patients and 3 index cases of families with ASD and/or conduction defects .,families with ASD,,"['family', 'with', 'ASD']",[]
114,888,Identification of gene(s) involved in autosomal recessive autism spectrum disorder (AsD),P0871.,,"Autism is a complex neurodevelopmental disorder characterized by  deficits in social interaction, impaired communication, and unusual and repetitive behaviors and interests . Previous segregation analyses of  autism have revealed that some subsets of autism may be caused by autosomal recessive mechanism . Consanguineous pedigrees facilitate  the recognition and mapping of recessively inherited neurological disorders . The goal of this study is to use the Arabic Middle Eastern  populations to map and identify autosomal recessive autism spectrum  disorder (ASD) genes in order to better understand their classification, pathogenesis, and potential treatments . We so far have recruited 65  consanguineous families with autistic children, 20 out of which are multiplex families . SignatureChip Human Genome Microarray were  performed on probands from 35 families, and chromosomal anomalies  were detected in 6 cases; interestingly, all patients with chromosome  deletions or duplications were from families with one affected individual,  underscoring the importance of cytogenetic testings in ASD, especially in families with one affected child . Moreover, the male:female ratio in multiplex families was 2 .8:1 (37 males:13 females), which appears to be lower than the typical male:female ratio of 4:1 . These data support  our hypothesis that ASD in some families may be caused by autosomal recessive inheritance . Linkage analyses were conducted in multiplex families . One family maps to the  AUTS1  locus on chromosome 7q,  whereas others map to novel autism loci with multipoint LOD score of 2 .4 2 .78 generated from single families without pooling . The fact that linked loci differ in each family suggests genetic heterogeneity  .",2006.0,,"Yoo1,2, E. M. Morrow1,2, R. J. Ferland1,3, R. S. Hill1,2, A. Bodell1,2, K. Apse1,2, L.  A. Rappaport4, J. Ware5, E. G. LeClair5, R. M. Joseph6, S. Al Saad7, S. Balkhy8,  G. Gascon8,9, N. Motavalli10, A. Hashmi11, C. A. Walsh1,2","1Department of Neurology and Howard Hughes Medical Institute, BIDMC,  Boston, MA, United States, 2Division of Genetics, Childrens Hospital Boston  and Harvard Medical School, Boston, MA, United States, 3Department of Biol   ogy, Rensselaer Polytechnic Institute, Troy, NY, United States, 4Department of  Pediatrics, Childrens Hospital Boston and Harvard Medical School, Boston,  MA, United States, 5Department of Psychiatry, Childrens Hospital Boston and  Harvard Medical School, Boston, MA, United States, 6Department of Anatomy  and Neurobiology, Boston University School of Medicine, Boston, MA, United  States, 7Kuwait Center for Autism, Kuwait City, Kuwait, 8Department of Neuro   sciences and Pediatrics, King Faisal Specialist Hospital and Research Centre,  Jeddah, Saudi Arabia, 9Clinical Neurosciences & Pediatrics, Brown University  School of Medicine, Providence, RI, United States, 10Department of Child and  Adolescent Psychiatry, Istanbul University, Istanbul, Turkey, 11Department of  Pediatrics, Combined Military Hospital, Lahore, Pakistan","We so far have recruited 65  consanguineous families with autistic children, 20 out of which are multiplex families .",,autistic children,[],"['autistic', 'child']"
116,1020,Evidence of exclusion of NKX2 5 gene for atrial septal defect in a consanguineous t unisian family,P1003.,,"Atrial septal defect (ASD) is an autosomal dominant disease  characterized by left to right shunting and increased right ventricular  output . Approximately 5 10% of congenital heart diseases (CHD) are  due to ASD which is one of the most frequent CHD found in human  adults . The gene responsible for ASD has been mapped to chromosome 5q35 by genetic analysis in large pedigrees . This gene encodes the  transcription factor NKX2 5 important for regulation of septation during cardiac morphogenesis .  Nkx2.5, was among the first evidence of a  genetic cause for congenital heart disease and mutations were initially  found in pedigrees with autosomal dominant transmission of atrial septal defect . We report here clinical and molecular investigation of a Tunisian  consanguineous family with 4 affected members: the clinical features  of 2 patients among the 4 affected individual are characterized by ASD  with prolonged PR interval whereas the 2 others presented only a prolonged PR interval . Pedigree analysis is consist with an autosomal dominant inheritance of the disease .Genotyping of the ASD family with  2 microsatellite markers D5S394 and D5S2439 flanking Nkx2.5 gene  and Linkage analysis showed exclusion of linkage between the gene  responsible for ASD in this family and Nkx2.5  gene, thus confirming  genetic heterogeneity of this phenotype .",2006.0,,"I. Nouira1, I. Kamoun2, W. Smath3, S. Kachboura2, C. Charfedine1, S. Abdel   hak1","1Unit de Recherche 26/04 Exploration Molculaire des Maladies Orphelines  dOrigine Gntique, Institut Pasteur de Tunis, Tunis, Tunisia, 2Service de car   diologie de lHpital Abderhman Mami, Ariana, Tunisia, 3Service de cardiologie  de lHpital Abderhman Mami, Tunis, Tunisia","Pedigree analysis is consist with an autosomal dominant inheritance of the disease .Genotyping of the ASD family with  2 microsatellite markers D5S394 and D5S2439 flanking Nkx2.5 gene  and Linkage analysis showed exclusion of linkage between the gene  responsible for ASD in this family and Nkx2.5  gene, thus confirming  genetic heterogeneity of this phenotype .",,ASD family,[],"['ASD', 'family']"
121,167,Interstitial duplication 15q11 13 in a patient with Asperger  autism and seizures,P0029.,,"We present a boy who was diagnosed to have Asperger autism at the  age of 19 years. Furthermore the boy suffers from seizures since the age of 16 years.  Intelligence is in normal range. The patient finished non classical secondary school with good marks.  Afterwards he tried to graduate from expert school for social sciences which could not be  completed because of his special defects in social competence and  communication skills, and his deficiency of empathy which, at the end  of the initiated diagnostic procedure, led to the diagnosis of Asperger  autism. Since recent studies (1) were able to show a defined interstitial dupli   cation of chromosome15q11 13 in a few patients with autism disorder  (1 3%) we investigated this region with respect to this abnormality . We were able to show a duplication of the region of interest with the  proof of three alleles for the internal markers D15S122, D15S822 and  D15S1234. Furthermore we could confirm this result with FISH using the probe  GABRB3 (15q11 12),which showed three signals on meta  and inter   phase chromosomes. Parental investigations (FISH and molecular analysis) were inconspic   uous. Microsatellite analysis showed that the duplication did arise from  the boy`s maternal chromosome 15, as described in the literature (2). The proposed mechanism is misalignment in maternal meiotic recom   bination. The influence of parental imprinting on phenotype will be discussed; the  variation of the symptoms of the yet published cases will be shown.",2007.0,,"Oehl Jaschkowitz1, T. Martin1, E. Goettert1, A. Christmann1, C. Freitag2","1Praxis fuer Humangenetik, Homburg/Saar, Germany, 2Klinik fuer Kinder  und  Jugendmedizin, Universitaet des Saarlandes Homburg/Saar, Germany",We present a boy who was diagnosed to have Asperger autism at the  age of 19 years.,,Asperger autism,[],"['Asperger', 'autism']"
121,167,Interstitial duplication 15q11 13 in a patient with Asperger  autism and seizures,P0029.,,"We present a boy who was diagnosed to have Asperger autism at the  age of 19 years. Furthermore the boy suffers from seizures since the age of 16 years.  Intelligence is in normal range. The patient finished non classical secondary school with good marks.  Afterwards he tried to graduate from expert school for social sciences which could not be  completed because of his special defects in social competence and  communication skills, and his deficiency of empathy which, at the end  of the initiated diagnostic procedure, led to the diagnosis of Asperger  autism. Since recent studies (1) were able to show a defined interstitial dupli   cation of chromosome15q11 13 in a few patients with autism disorder  (1 3%) we investigated this region with respect to this abnormality . We were able to show a duplication of the region of interest with the  proof of three alleles for the internal markers D15S122, D15S822 and  D15S1234. Furthermore we could confirm this result with FISH using the probe  GABRB3 (15q11 12),which showed three signals on meta  and inter   phase chromosomes. Parental investigations (FISH and molecular analysis) were inconspic   uous. Microsatellite analysis showed that the duplication did arise from  the boy`s maternal chromosome 15, as described in the literature (2). The proposed mechanism is misalignment in maternal meiotic recom   bination. The influence of parental imprinting on phenotype will be discussed; the  variation of the symptoms of the yet published cases will be shown.",2007.0,,"Oehl Jaschkowitz1, T. Martin1, E. Goettert1, A. Christmann1, C. Freitag2","1Praxis fuer Humangenetik, Homburg/Saar, Germany, 2Klinik fuer Kinder  und  Jugendmedizin, Universitaet des Saarlandes Homburg/Saar, Germany",Since recent studies (1) were able to show a defined interstitial dupli   cation of chromosome15q11 13 in a few patients with autism disorder  (1 3%) we investigated this region with respect to this abnormality .,patients with autism,,"['patient', 'with', 'autism']",[]
124,278,Early neurological phenotype in 4 children with biallelic  PRODH  mutations,P0141.,,"Hyperprolinemia type I (HPI) results from a deficiency of proline oxi   dase (POX), involved in the first step in the conversion of proline to  glutamate. Diverse phenotypes were described in patients with HPI,  prior to the identification of the POX  gene ( PRODH) : whereas various  patients were asymptomatic, others had neurological and extraneuro   logical defects. PRODH  gene is located in the region deleted in velo   cardiofacial syndrome (VCFS). Heterozygous and homozygous mu   tations have been identified in patients with variable hyperprolinemia  and various features (patients with schizophrenia, chromosome 22q11  microdeletions and/or neurological defects). A functional study has di   vided the PRODH  missense mutations into three groups: those lead   ing to mild, moderate, or severe reduction of POX activity. In this study,  we report four unrelated children with HPI and a homogeneous se   vere neurological phenotype. We identified biallelic abnormalities in  PRODH  in these patients that led to severe reduction of POX activ   ity. These included missense and nonsense mutations, deletions of  PRODH and a 22q11 microdeletion. Four other children have been re   ported with severe biallelic PRODH mutations. The phenotype of these Clinical genetics eight patients associates early psychomotor development delay with  predominant cognitive defects, autistic features and epilepsy. Their  values of hyperprolinemia ranged from 400 to 2200 mol/L. Patients  with biallelic PRODH  alterations resulting in severely impaired POX  activity had an early onset and severe neurological features. Thus,  children with this phenotype and those with a microdeletion in chromo   some 22q11, especially those with mental retardation and autistic fea   tures, should be tested for hyperprolinemia. Hyperprolinemic patients  should be screened for PRODH  mutatio",2007.0,,"Afenjar1, M. Moutard1, D. Doummar1, L. Burglen2, D. Heron3, D. Campion4,  T. Billette de Villemeur1, D. Rodriguez1","1AP HP, Service de neuropdiatrie, Hpital Armand Trousseau, 75012 Paris,  France, 2AP HP, Service de gntique, Hpital Armand Trousseau, 75012  Paris, France, 3AP HP, Service de gntique, Hpital Piti Salptrire, 75012  Paris, France, 4INSERM U614 Facult de Mdecine, Rouen, France","The phenotype of these Clinical genetics eight patients associates early psychomotor development delay with  predominant cognitive defects, autistic features and epilepsy.",,autistic features,[],"['autistic', 'feature']"
125,297,Clinical report: a new case of macrocephaly/autism  syndrome ( MIM00 ) with a germline PTEN  tumor suppressor  gene mutation,P0160.,,"Macrocephaly is found in approximately 20% of patients with autism.  In a subset of 18 individuals with autism spectrum disorders and ex   treme macrocephaly, Butler et al. recently reported 3 young boys with a  germline missense PTEN  mutation ( J Med Genet 2005;42:318 ). Here,  we report on a 6 year old girl referred for global developmental delay,  language regression and pervasive developmental disorder. The asso   ciation with progressive macrocephaly (+3DS at birth and +5DS at 6y)  prompted us to perform a PTEN  gene analysis in the leucocyte DNA of  the patient. We identified a heterozygous G to A transition in exon 6 of  PTEN , resulting in an arginine173 to histidine (p.Arg173His) substitu   tion. Arginine173 is a highly evolutionarily conserved residue whose  subsitution by histidine has been shown to lead, in an in vitro  assay,  to a drastic reduction (95%) of the phosphatase activity of PTEN . In  terestingly, this p.Arg173His missense mutation has already been re   ported by several authors but only as a somatic mutation identified in  glioblastomas and astrocytomas. Initially, germline mutations of PTEN   have been found in patients with Cowden disease or Bannayan Riley  Ruvalcaba syndrome. However, as in the three previously reported  cases, the present patient had no mucocutaneous lesions suggestive  of these two hamartoma syndromes. The possibility of developing spe   cific alterations of Cowden disease during the second decade should  be considered. Our findings confirm that molecular testing for PTEN   mutation should be performed in patients with autistic behaviour and  macrocephaly.Clinical genetics1",2007.0,,"Bieth1, N. Svenet2, N. Chassaing1, C. Cances3, P. Calvas1, M. Longy2","1Hpital Purpan, Toulouse, France, 2Institut Bergoni, Bordeaux, France, 3Hpi  tal des Enfants, Toulouse, France",Macrocephaly is found in approximately 20% of patients with autism.,patients with autism,,"['patient', 'with', 'autism']",[]
125,297,Clinical report: a new case of macrocephaly/autism  syndrome ( MIM00 ) with a germline PTEN  tumor suppressor  gene mutation,P0160.,,"Macrocephaly is found in approximately 20% of patients with autism.  In a subset of 18 individuals with autism spectrum disorders and ex   treme macrocephaly, Butler et al. recently reported 3 young boys with a  germline missense PTEN  mutation ( J Med Genet 2005;42:318 ). Here,  we report on a 6 year old girl referred for global developmental delay,  language regression and pervasive developmental disorder. The asso   ciation with progressive macrocephaly (+3DS at birth and +5DS at 6y)  prompted us to perform a PTEN  gene analysis in the leucocyte DNA of  the patient. We identified a heterozygous G to A transition in exon 6 of  PTEN , resulting in an arginine173 to histidine (p.Arg173His) substitu   tion. Arginine173 is a highly evolutionarily conserved residue whose  subsitution by histidine has been shown to lead, in an in vitro  assay,  to a drastic reduction (95%) of the phosphatase activity of PTEN . In  terestingly, this p.Arg173His missense mutation has already been re   ported by several authors but only as a somatic mutation identified in  glioblastomas and astrocytomas. Initially, germline mutations of PTEN   have been found in patients with Cowden disease or Bannayan Riley  Ruvalcaba syndrome. However, as in the three previously reported  cases, the present patient had no mucocutaneous lesions suggestive  of these two hamartoma syndromes. The possibility of developing spe   cific alterations of Cowden disease during the second decade should  be considered. Our findings confirm that molecular testing for PTEN   mutation should be performed in patients with autistic behaviour and  macrocephaly.Clinical genetics1",2007.0,,"Bieth1, N. Svenet2, N. Chassaing1, C. Cances3, P. Calvas1, M. Longy2","1Hpital Purpan, Toulouse, France, 2Institut Bergoni, Bordeaux, France, 3Hpi  tal des Enfants, Toulouse, France","In a subset of 18 individuals with autism spectrum disorders and ex   treme macrocephaly, Butler et al.",individuals with autism,,"['individual', 'with', 'autism']",[]
125,297,Clinical report: a new case of macrocephaly/autism  syndrome ( MIM00 ) with a germline PTEN  tumor suppressor  gene mutation,P0160.,,"Macrocephaly is found in approximately 20% of patients with autism.  In a subset of 18 individuals with autism spectrum disorders and ex   treme macrocephaly, Butler et al. recently reported 3 young boys with a  germline missense PTEN  mutation ( J Med Genet 2005;42:318 ). Here,  we report on a 6 year old girl referred for global developmental delay,  language regression and pervasive developmental disorder. The asso   ciation with progressive macrocephaly (+3DS at birth and +5DS at 6y)  prompted us to perform a PTEN  gene analysis in the leucocyte DNA of  the patient. We identified a heterozygous G to A transition in exon 6 of  PTEN , resulting in an arginine173 to histidine (p.Arg173His) substitu   tion. Arginine173 is a highly evolutionarily conserved residue whose  subsitution by histidine has been shown to lead, in an in vitro  assay,  to a drastic reduction (95%) of the phosphatase activity of PTEN . In  terestingly, this p.Arg173His missense mutation has already been re   ported by several authors but only as a somatic mutation identified in  glioblastomas and astrocytomas. Initially, germline mutations of PTEN   have been found in patients with Cowden disease or Bannayan Riley  Ruvalcaba syndrome. However, as in the three previously reported  cases, the present patient had no mucocutaneous lesions suggestive  of these two hamartoma syndromes. The possibility of developing spe   cific alterations of Cowden disease during the second decade should  be considered. Our findings confirm that molecular testing for PTEN   mutation should be performed in patients with autistic behaviour and  macrocephaly.Clinical genetics1",2007.0,,"Bieth1, N. Svenet2, N. Chassaing1, C. Cances3, P. Calvas1, M. Longy2","1Hpital Purpan, Toulouse, France, 2Institut Bergoni, Bordeaux, France, 3Hpi  tal des Enfants, Toulouse, France",Our findings confirm that molecular testing for PTEN   mutation should be performed in patients with autistic behaviour and  macrocephaly.Clinical genetics1,,autistic behaviour,[],"['autistic', 'behaviour']"
126,304,Phenotypic features of males with mental retardation  (MR) and mutations of the MECP2 gene,P0167.,,"The MECP2 gene causes Rett syndrome (RS) (OMIM: 312750), a  well defined X linked dominant neurodevelopmental disorder affect   ing primarily girls. Until recently RS was considered lethal in males,  although now approximately 60 cases have been reported. Males with  MECP2 mutations present with a broad spectrum of phenotypes rang   ing from neonatal encephalopathy to non syndromic MR. Five males (aged 3 16 years) evaluated for MR, had normal karyotype  and four of them were evaluated for molecular variation associated  with the FMR1 locus, with negative results. Patient 1 presented with  features of FXS, including long face, protruding ears and behavioral  problems. Patient 2 had spasticity, pyramidal signs and trunk stereoty   pies, while his brother (Patient 3) showed slight psychomotor retarda  tion. Patients 4 and 5 presented with autistic features. MECP2 analysis  of the exons 3 and 4 was performed by Denaturant Gradient Gel Elec   trophoresis, sequencing and GAP PCR, using specifically designed  sets of primers. The polymorphism p.T203M was identified in Patient 1, but not in  his mother, raising questions about its contribution to the phenotype.  Patient 2 and 3 had a novel deletion at the deletion prone region of  MECP2 (c.1140del86) inherited from their unaffected carrier mother.  The GAP PCR in Patient 4 showed evidence of a large rearrangement  encompassing exons 3 and 4, which requires further evaluation. His  mother was normal. Patient 5 presented the p.R106W classic RS mu   tation, although his mother was unavailable for analysis. MECP2 mutations should be considered as a rare cause of MR in  males , although great phenotypic variation hinders genotype pheno   type correlation.",2007.0,,"Psoni , J. Traeger Synodinos, C. Sofocleous, S. Kitsiou Tzeli, A. Mavrou, E.  Kanavakis, H. Fryssira","Medical Genetics/Choremio Research Laboratory/Univ.of Athens/St Sophias  Childrens Hospital, Athens, Greece. ",Patients 4 and 5 presented with autistic features.,,autistic features,[],"['autistic', 'feature']"
130,387,Delayed speech development with facial asymmetry and  transverse earlobe creases,P0250.,,"Delayed speech is one of the most frequent features in patients with  MCA/MR phenotype. In 1993, Mehes described a Hungarian family  with three patients, a mother and her son and daughter, presenting  delayed speech development, facial asymmetry, strabismus and trans   verse earlobe creases (TEC). In 2005, four new unrelated Hungarian  children were reported with similar features. We describe a new patient, of Spanish and French origins, who pres   ents a similar phenotype. The girl was the eutrophic product of a 36 week gestation. No motor  delay was observed but delayed speech marked the development of  the girl. At 4 years autistic behaviour was suspected and psychiatric  therapy was instored. The proposita began to speak at 5 years and her  course was marked by mild mental retardation with anxious behaviour. At 20 years, weight, height and OFC are in the normal range. The  patient presents facial asymmetry, narrow down slanting palpebral fis   sures, low set ears with TEC. She has umbilical hernia and hyper   trophic small labia. Skeletal X rays were normal, cerebral MRI shows  abnormal signal of right putamen. Chromosome studies : metaphase karyotype, subtelomeric analysis (MLPA), and FISH studies (22q11.2,  11p15) showed no anomaly. Molecular analysis for Beckwith Wiede   mann syndrome was also normal. This new observation of a patient  with delayed speech development combined with facial asymmetry  and transverse earlobe creases confirms the existence of this new  syndrome. Transverse earlobe creases are a cardinal feature which  is easily found on physical examination. To date, inheritance is not  defined.",2007.0,,"Sarda , L. Pinson, C. Coubes, C. Abadie, P. Blanchet","Service de Gntique Mdicale, Montpellier, France",At 4 years autistic behaviour was suspected and psychiatric  therapy was instored.,,autistic behaviour,[],"['autistic', 'behaviour']"
133,440,Frequency of mosaic aneuploidy in children with  idiopathic autism,P0303.,,"It has been repeatedly suggested that numerous human diseases in   cluding major psychiatric disorders could be associated with mosaic  aneuploidy. Here, we have attempted to test this hypothesis concern   ing autism, a common childhood psychiatric disorder. About 5 10% of  autism cases are known to be caused by chromosomal abnormalities  or gene mutations. However, mosaic aneuploidy in autism has not ever  been studied. We surveyed stochastic aneuploidy in children with/with   out idiopathic autism by interphase multiprobe fluorescence in situ hy   bridization (mFISH). The rate of chromosome loss and gain involving  six arbitrarily selected autosomes (chromosomes 1, 9, 15, 16, 17, 18)  and sex chromosomes was assessed in peripheral blood cells of 60  unaffected male children and 116 male children with idiopathic autism.  Studying over 420,000 cells, we have determined the mean frequency  of stochastic aneuploidy in control and autism: Control Chromosome loss Chromosome gain Autosomes   Sex chromosomes0.58% (95% CI 0.42 0.75%)   _0.15% (95% CI 0.09 0.21%)   1.11% (95% CI 0.90 1.31%) Autism Autosomes   Sex chromosomes0.60% (95% CI 0.37 0.83%)   _0.22% (95% CI 0.14 0.30%)   1.01% (95% CI 0.85 1.17%) CI   confidence interval The difference of stochastic aneuploidy rate was insignificant. However, the frequency  of mosaic aneuploidy over the background level was found in 19 (16%) of 116 children  with idiopathic autism, while outlier values were not found in controls. These data  identify mosaic aneuploidy as a new autism genetic risk factor. Therefore, molecular  cytogenetic analysis of somatic mosaicism is warranted in children with idiopathic au   tism. Supported by INTAS and RGNF (060600639a).",2007.0,,"B. Yurov1,2, S. G. Vorsanova2,1, I. Y. Iourov1,2, I. A. Demidova2, A. K. Bere   sheva2, V. S. Kravets2, V. V. Monakhov1, A. D. Kolotii2, V. Y. Voinova Ulas2, N. L.  Gorbachevskaya1","1National Research Center of Mental Health, RAMS, Moscow, Russian Federa   tion, 2Institute of Pediatrics and Children Surgery, Roszdrav, Moscow, Russian  Federation","The rate of chromosome loss and gain involving  six arbitrarily selected autosomes (chromosomes 1, 9, 15, 16, 17, 18)  and sex chromosomes was assessed in peripheral blood cells of 60  unaffected male children and 116 male children with idiopathic autism.",children with idiopathic autism,,"['child', 'with', 'idiopathic', 'autism']",[]
136,797,Serotonin transporter gene polymorphisms and  intraplatelet serotonin concentration in autism,P0662.,,"Serotonin is released in pre synaptic membrane and can reach spe   cific receptors in post synaptic membrane or be partially reuptaked by  its specific transporter at the synaptic cleft. Serotonin circulating levels  and its effects depend on specific serotonin transporter activity whose  efficacy changes with its gene polymorphisms. In that way, serotonin transporter gene may be a likely candidate in autistic dis   order. The aim of this study is to determine a possible association  between serotonin tranporter gene polymorphisms 5 HTTVNTR and  5 HTTLPR and autism and to evaluate intraplatelet serotonin concen   tration. Patient group was made of 118 individuals (3,6 and 41 years) subdivid   ed in 82 with idiopathic autism, 15 with pathology associated autism,  15 with PPD Nos and 6 with Asperger syndrome. Control group was  made of 68 individuals (45,5711,23 years). We studied 5 HTTLPR and 5 HTTVNTR by PCR and intraplatelet se   rotonin concentration by ELISA. We found no significant differences in genotype and allelic frequencies between patient subgroups and between patient and control groups in  both polymorphisms. we found a significant higher serotonina concentration in the patient  group when compared with control individuals. We did not find sig   nificant differences between the different genotypes of both polymor   phisms and serotonin concentration. In this study we did no find any association between serotonin trans   porter gene polymorphisms and autism. Autistic patients have higher intraplatelet serotonin concentration,  which may contribute for their characteristic behaviour disturbances. Intraplatelet serotonin concentration is independent of serotonin trans   porter gene polymorphisms.",2007.0,,"Ferreira, P. Levy , M. Bicho","Genetics Laboratory, Lisbon Medical School, Lisbon, Portugal","Patient group was made of 118 individuals (3,6 and 41 years) subdivid   ed in 82 with idiopathic autism, 15 with pathology associated autism,  15 with PPD Nos and 6 with Asperger syndrome.",,Asperger syndrome,[],"['Asperger', 'syndrome']"
136,797,Serotonin transporter gene polymorphisms and  intraplatelet serotonin concentration in autism,P0662.,,"Serotonin is released in pre synaptic membrane and can reach spe   cific receptors in post synaptic membrane or be partially reuptaked by  its specific transporter at the synaptic cleft. Serotonin circulating levels  and its effects depend on specific serotonin transporter activity whose  efficacy changes with its gene polymorphisms. In that way, serotonin transporter gene may be a likely candidate in autistic dis   order. The aim of this study is to determine a possible association  between serotonin tranporter gene polymorphisms 5 HTTVNTR and  5 HTTLPR and autism and to evaluate intraplatelet serotonin concen   tration. Patient group was made of 118 individuals (3,6 and 41 years) subdivid   ed in 82 with idiopathic autism, 15 with pathology associated autism,  15 with PPD Nos and 6 with Asperger syndrome. Control group was  made of 68 individuals (45,5711,23 years). We studied 5 HTTLPR and 5 HTTVNTR by PCR and intraplatelet se   rotonin concentration by ELISA. We found no significant differences in genotype and allelic frequencies between patient subgroups and between patient and control groups in  both polymorphisms. we found a significant higher serotonina concentration in the patient  group when compared with control individuals. We did not find sig   nificant differences between the different genotypes of both polymor   phisms and serotonin concentration. In this study we did no find any association between serotonin trans   porter gene polymorphisms and autism. Autistic patients have higher intraplatelet serotonin concentration,  which may contribute for their characteristic behaviour disturbances. Intraplatelet serotonin concentration is independent of serotonin trans   porter gene polymorphisms.",2007.0,,"Ferreira, P. Levy , M. Bicho","Genetics Laboratory, Lisbon Medical School, Lisbon, Portugal","Autistic patients have higher intraplatelet serotonin concentration,  which may contribute for their characteristic behaviour disturbances.",,Autistic patients,[],"['Autistic', 'patient']"
138,981,"Q6NUR6 gene is overexpressed in an autistic patient with  a translocation (7,16) de novo.",P0848.,,"Based on the hypothesis that the autism has an important genetic  component, our goal is to map and identify the gene (or genes) that  predispose to autism. The proposed strategy is to test candidate re   gions identified by cytogenetic studies. We describe a 10 years old child with autistic disorder and a de novo  balanced (7,16) (p22.1,p16.2) translocation. G banded chromosomes  and fluorescent in situ hybridization (FISH) were used to examine the  patients karyotype as well as his parents. FISH with specific RP11  BAC clones mapping near 7p22.1 and 16p11.2 were used to refine the  location of the breakpoint The breakpoints spanning clone on 7p22.1 fully overlaps a human  known protein coding sequence corresponding to the Q6NUR6 gene  which was analyzed by TaqMan. The study demonstrated a signifi   cant overexpression of this gene in the patient. We postulate that the  rearrangement is responsible for the patients phenotype and for his  Q6NUR6 gene overexpression.",2007.0,,"Mrad1, N. Bayou1, A. Belhaj2, S. Briault3, L. Ben jemaa1, H. Daoud3, R.  Zemni4, M. Chaabouni1, F. Maazoul5, M. Hlayem2, H. Chaabouni1","1department of human genetics, faculty of medicine Tunis, Tunisia, 2department  of child psychiatry, Razi Hospital La Manouba, Tunisia, 3unit INSERM U619,  faculty of medicine Tours, France, 4department of human genetics, faculty of  medicine Sousse, Tunisia, 5department of human genetics, Charles Nicolle  hospital Tunis, Tunisia","We describe a 10 years old child with autistic disorder and a de novo  balanced (7,16) (p22.1,p16.2) translocation.",,autistic disorder,[],"['autistic', 'disorder']"
139,985,Mutations in the MECP2 gene in patients of Slavonic  origin with Rett syndrome,P0852.,,"Rett syndrome is an X linked dominant neurodevelopmental disorder  affecting almost exclusively females. It has an incidence of 1:10,000  female births and is characterized by apparently normal development  for the first 6 18 months of life followed by the loss of acquired motor  and language skills, autistic features, and development of stereotypic  hand movements. Rett syndrome is caused primarily by de novo mu   tations in the methyl CpG binding protein 2 gene (MECP2). Methyl  CpG binding protein 2 plays important roles in the regulation of gene  expression and RNA splicing. Here we report the mutational analysis  of the MECP2 gene in 95 patients from the Czech and Slovak Repub   lics and the Ukraine with classical Rett syndrome. The patients, all  girls, were screened for mutations by DNA sequencing of the entire  coding sequence and the exon/intron boundaries of the MECP2 gene.  RFLP analysis was performed to confirm the mutations that cause the  creation or abolition of the restriction site. Mutation negative cases  were subsequently examined by multiple ligation dependent probe  amplification (MLPA) to identify large deletions. Sequencing analysis  revealed 33 different mutations in 74 patients, and MLPA analysis re   vealed large deletions in two patients. The detection rate was 78%.  One mutation in exon 1 (c.48_55del8) has not been published yet. Our  results confirm the high frequency of MECP2 mutations in females with  Rett syndrome and provide data concerning the mutation heterogene   ity in the Slavonic population. The project was supported by grants  MSM0021620849 and IGA 8355 3.",2007.0,,"Zahorakova1, A. Baxova2, J. Zeman1, P. Martasek1","1Department of Pediatrics, First School of Medicine, Charles University, Prague,  Czech Republic, 2Institute of Biology and Clinical Genetics, General University  Hospital, Prague, Czech Republic","It has an incidence of 1:10,000  female births and is characterized by apparently normal development  for the first 6 18 months of life followed by the loss of acquired motor  and language skills, autistic features, and development of stereotypic  hand movements.",,autistic features,[],"['autistic', 'feature']"
140,1043,Evidence for association between HTR1B and males with  Autism Spectrum Disorders.,P0911.,,"Autism is a complex neurodevelopmental disorder characterized by  qualitative impairments in communication, social interaction, and  restricted and repetitive patterns of interests or behaviors. Onset is  generally before 3 years of age and results in life long disabilities for  affected children. From early 1960s, when hyperserotonemia was first  reported in autistic children, to the modeling of serotonergic deficits  seen in ASD using animal models, several different alterations in pro   cesses involving serotonergic innervation was found in ASD patients.  However, the role of serotonin receptors in its pathophisiology still re   mains poorly understood. In this study, we present results from a case  control association study within 14 polymorphisms in five serotonin  receptors genes (HTR1A, HTR1B, HTR1D, HTR2A, HTR2C).  Positive  results were found for HTR1B  haplotypes (p=0,0448) in a sample of  242 ASD patients. Transmission disequilibrium test (TDT) was then  performed for HTR1B , which shown evidence for transmission disequi   librium (p=0,0415) in a sample of 163 trios. A sex specific analysis  showed an increased effect in our male sample (p=0,0015, table 1),  and no effect in the female sample (p=0,3). Our results confirm previ   ous publications describing a sex specific genetic contribution in the  etiology of ASD. FAPESP Table1  Transmition disequilibrium test for HTR1B gene in a male  sample. Haplotypes* Transmited Non transmited TDT C A C G 14 20 G T C G 42 29 T A C C 35 33 T A C G 39 33 Others 2 17 Total 132 132 Gl  obal p=0,0015 *NCBI id rs11568817 rs130058 rs130057 rs6296",2007.0,,"M. Orabona1,2, K. G. Oliveira1,2, E. Vadasz3, E. S. Moreira4, V. N. O. Taka   hashi1, P. Otto1,2, S. R. Matioli2, M. R. Passos Bueno1,2","1Centro de Estudos do Genoma Humano, So Paulo, Brazil, 2Instituto de Bio   logia, So Paulo, Brazil, 3Hospital das Clnicas, So Paulo, Brazil, 4Instituto  Fleury, So Paulo, Brazil","From early 1960s, when hyperserotonemia was first  reported in autistic children, to the modeling of serotonergic deficits  seen in ASD using animal models, several different alterations in pro   cesses involving serotonergic innervation was found in ASD patients.",,autistic children,[],"['autistic', 'child']"
140,1043,Evidence for association between HTR1B and males with  Autism Spectrum Disorders.,P0911.,,"Autism is a complex neurodevelopmental disorder characterized by  qualitative impairments in communication, social interaction, and  restricted and repetitive patterns of interests or behaviors. Onset is  generally before 3 years of age and results in life long disabilities for  affected children. From early 1960s, when hyperserotonemia was first  reported in autistic children, to the modeling of serotonergic deficits  seen in ASD using animal models, several different alterations in pro   cesses involving serotonergic innervation was found in ASD patients.  However, the role of serotonin receptors in its pathophisiology still re   mains poorly understood. In this study, we present results from a case  control association study within 14 polymorphisms in five serotonin  receptors genes (HTR1A, HTR1B, HTR1D, HTR2A, HTR2C).  Positive  results were found for HTR1B  haplotypes (p=0,0448) in a sample of  242 ASD patients. Transmission disequilibrium test (TDT) was then  performed for HTR1B , which shown evidence for transmission disequi   librium (p=0,0415) in a sample of 163 trios. A sex specific analysis  showed an increased effect in our male sample (p=0,0015, table 1),  and no effect in the female sample (p=0,3). Our results confirm previ   ous publications describing a sex specific genetic contribution in the  etiology of ASD. FAPESP Table1  Transmition disequilibrium test for HTR1B gene in a male  sample. Haplotypes* Transmited Non transmited TDT C A C G 14 20 G T C G 42 29 T A C C 35 33 T A C G 39 33 Others 2 17 Total 132 132 Gl  obal p=0,0015 *NCBI id rs11568817 rs130058 rs130057 rs6296",2007.0,,"M. Orabona1,2, K. G. Oliveira1,2, E. Vadasz3, E. S. Moreira4, V. N. O. Taka   hashi1, P. Otto1,2, S. R. Matioli2, M. R. Passos Bueno1,2","1Centro de Estudos do Genoma Humano, So Paulo, Brazil, 2Instituto de Bio   logia, So Paulo, Brazil, 3Hospital das Clnicas, So Paulo, Brazil, 4Instituto  Fleury, So Paulo, Brazil","From early 1960s, when hyperserotonemia was first  reported in autistic children, to the modeling of serotonergic deficits  seen in ASD using animal models, several different alterations in pro   cesses involving serotonergic innervation was found in ASD patients.",,ASD patients,[],"['ASD', 'patient']"
140,1043,Evidence for association between HTR1B and males with  Autism Spectrum Disorders.,P0911.,,"Autism is a complex neurodevelopmental disorder characterized by  qualitative impairments in communication, social interaction, and  restricted and repetitive patterns of interests or behaviors. Onset is  generally before 3 years of age and results in life long disabilities for  affected children. From early 1960s, when hyperserotonemia was first  reported in autistic children, to the modeling of serotonergic deficits  seen in ASD using animal models, several different alterations in pro   cesses involving serotonergic innervation was found in ASD patients.  However, the role of serotonin receptors in its pathophisiology still re   mains poorly understood. In this study, we present results from a case  control association study within 14 polymorphisms in five serotonin  receptors genes (HTR1A, HTR1B, HTR1D, HTR2A, HTR2C).  Positive  results were found for HTR1B  haplotypes (p=0,0448) in a sample of  242 ASD patients. Transmission disequilibrium test (TDT) was then  performed for HTR1B , which shown evidence for transmission disequi   librium (p=0,0415) in a sample of 163 trios. A sex specific analysis  showed an increased effect in our male sample (p=0,0015, table 1),  and no effect in the female sample (p=0,3). Our results confirm previ   ous publications describing a sex specific genetic contribution in the  etiology of ASD. FAPESP Table1  Transmition disequilibrium test for HTR1B gene in a male  sample. Haplotypes* Transmited Non transmited TDT C A C G 14 20 G T C G 42 29 T A C C 35 33 T A C G 39 33 Others 2 17 Total 132 132 Gl  obal p=0,0015 *NCBI id rs11568817 rs130058 rs130057 rs6296",2007.0,,"M. Orabona1,2, K. G. Oliveira1,2, E. Vadasz3, E. S. Moreira4, V. N. O. Taka   hashi1, P. Otto1,2, S. R. Matioli2, M. R. Passos Bueno1,2","1Centro de Estudos do Genoma Humano, So Paulo, Brazil, 2Instituto de Bio   logia, So Paulo, Brazil, 3Hospital das Clnicas, So Paulo, Brazil, 4Instituto  Fleury, So Paulo, Brazil","Positive  results were found for HTR1B  haplotypes (p=0,0448) in a sample of  242 ASD patients.",,ASD patients,[],"['ASD', 'patient']"
143,116,mEcP2 gene mutation analysis in patients with Rett like features  in Latvia,P01.104,,"Rett syndrome (RTT), an X linked dominant neurodevelopmental  disorder mostly in females, with an incidence of 1 in 10 000 15 000 female births . Gene MECP2 (methyl CpG binding protein) gene has  been identified as the disease causing. RTT is one of the most com   mon causes of mental retardation in females . After a period of normal  development usually until 6 18 months of age, affected girls enter a  period of regression, losing speech and motor skills, coincident with  the onset of hand stereotypies, leading to loss of purposeful hand use, which is the hallmark of the disorder  . MECP2 gene is located on chromosome Xq28 and is subject to X in   activation. Gene mutations are identifiable in 80% of classic Rett syn   drome, but less frequently in atypical RTT  . First 10 unrelated patients (including 2 boys) with developmental delay and autistic features were referred for molecular diagnostic . Genomic  DNA was extracted from blood leukocytes . MECP2 coding exons 2, 3,  and partly exon 4, were amplified in 7 overlapping PCR fragments and  analyzed by direct sequencing on ABI 310 genetic analyzer  . No previ   ously reported mutations were found in analyzed fragments . Studies  of remaining part of MECP2 gene exon 4 for most common mutations in TRD domain are in progress . Additional mutation analysis of exon 1 will be performed after exons 2, 3 and 4 complete investigation . Novel  changes found in MECP2 gene exon 4 should be confirmed by restric   tion analysis .",2008.0,,"N. Pronina1,2, O. Sterna1,2, D. Bauze1, Z. Krumina1, B. Lace1,2, D. Locmele1, Z.  Daneberga1,2, R. Lugovska1,2","1Childrens University Hospital; Medical Genetics Clinic, Riga, Latvia, 2Riga  Stradins University, Riga, Latvia",First 10 unrelated patients (including 2 boys) with developmental delay and autistic features were referred for molecular diagnostic .,,autistic features,[],"['autistic', 'feature']"
144,120,Rett syndrome in two years old girl with Xp deletion   case  report,P01.108,,"Rett syndrome (RTT; OMIM#312750) is an early childhood neurode   velopmental disorder  . A girl at age of 2 years was referred to our labo   ratory for DNA analysis of Rett syndrome . She demonstrated some  of the symptoms, characteristic for Rett syndrome   arrested mental  development, loss of communication skills, speech delay and purpose   ful hand movements, appearance of autistic features . Under some cir   cumstances the child demonstrates aggressive behavior  . The performed cytogenetic analysis showed pathological karyotype   46,XX,del(X)(p1 .22) . About 85% of the cases with Rett syndrome were caused by mutations in the gene encoding methyl CpG binding protein 1 (MECP2) . In about  10% of the cases the disease causing mutation affects the gene for cyclin dependent kinase like 5 (CDKL5) . However, the causative muta   tion is still unknown in the remaining 5% of the cases . The complete sequencing of MECP2 and CDKL5 genes revealed no mutations in the affected girl . In addition we sequenced the Aristaless  related homeobox (ARX) gene, mutations in which have been shown  to cause mental retardation either isolated or associated with a broad spectrum of neurological problems . This gene has been mainly affect   ed in boys . As this gene is localized on the short arm of the X chromo   some (Xp22 .13), one of its copies was missing in our Xp deleted girl .  For that reason this gene seemed to be a good candidate for screening in our mentally retarded girl . The DNA analysis of ARX showed no pathological changes . We will appreciate any further comments and suggestions on the re   ported case .",2008.0,,"A. Todorova1, T. Todorov1, R. Tincheva2, D. Avdjieva2, I. Boneva2, V. Mitev1","1Department of Chemistry and Biochemistry, Medical University Sofia, Sofia,  Bulgaria, 2Paediatric Hospital, Medical University Sofia, Sofia, Bulgaria","She demonstrated some  of the symptoms, characteristic for Rett syndrome   arrested mental  development, loss of communication skills, speech delay and purpose   ful hand movements, appearance of autistic features .",,autistic features,[],"['autistic', 'feature']"
145,148,Holt Oram syndrome   case report,P01.136,,"Holt Oram syndrome (HOS) is an autosomal dominant condition with  variable expressivity characterized by the association of congenital heart defects and preaxial radial ray upper limb defects . We present a  new case in order to illustrate this rare entity and to discuss the vari   able expression and the management . Our proband is a 13,5 old male,  the only child of an unrelated couple . Father presents absence of the  left thumb, short left limb, cardiac failure . No fetal ultrasound scan was  performed . The proband was born naturally at 37 weeks gestation (Wt  2450g, Ht 46,5cm, HC 36 cm, Apgar score 7) . Postnatal development  was relatively normal . Physical examination (13y old) revealed: Wt   2,52 SD, short limbs with absence of forearms, bilateral absence of  thumbs, absence of left forefinger. Radiological examination showed  bilateral absence of radius and ulna . Echocardiography: ASD ostium  secundum; ECG: first degree atrioventricular block. We have estab   lished the diagnosis of HOS based on the characteristic association of congenital heart defects and upper limbs defects . Differential di   agnosis was done with other heart hand syndrome . The plan for the management and the genetic counseling will be presented . In conclu   sion, we present a case of HOS in order to illustrate this rare genetic  disorder but also to discuss the variable expression, the management and the genetic counseling .",2008.0,,"M. C. Panzaru , C. Rusu, M. Volosciuc, M. Covic","Medical Genetics Centre, Iasi, Romania",Echocardiography: ASD ostium  secundum; ECG: first degree atrioventricular block.,,ASD ostium,[],"['ASD', 'ostium']"
147,196,sOs1 mutation in a cFc patient,P01.184,,"After the CFC syndrome was originally published in 1986 it was con   tinuously debated whether it can be separated from the Noonan syn   drome . Molecular genetic studies have shown that at least one gene in the RAS pathway, KRAS can cause both syndromes . When SOS1  was described to be the second most common gene in Noonan it was emphasized that it usually does not cause the CFC syndrome . We describe a 4 y o boy with SOS1 exon 6 missense mutation c .797C>A  (p .T266K), earlier reported by Roberts et al in 2007 in a Noonan pa   tient . Parental studies were normal . He was born at after 37 weeks of  pregnancy complicated by fetal hydronephrosis and polyhydramnios  with birth weight 4000g, length 51 cm and OFC 36,5 cm  . There was  oedema, opistothonus, poor feeding, cryptorhidism, and umbilical her   nia . He has pulmonary and mild aortic stenosis, ASD secundum, and hypertrophy of the ventricular septum . His growth is on the  1 .2 SD curve and OFC +1 .5 SD . He started to walk at 18 months but is not  yet able to run. He spoke the first words at 3,5 years and mainly uses sign language . He has melatonin treatment for poor sleeping patterns .  Dysmorphic features are compatible with the CFC syndrome with bi   temporal constrictions, sparse hair, absent eyebrows, dystrophic nails and hyperkeratotic eczema on face and legs . SOS1 mutation found in  this patient with CFC phenotype further emphasizes the need of phe   notype genotype correlation studies in SOS1 mutation patients .",2008.0,,"M. Somer1, M. L. Visnen2, M. Lhde3, J. Ignatius2","1Dept Medical Genetics, The Family Federation of Finland, Helsinki, Finland,  2Oulu University Hospital, Oulu, Finland, 3North Carelian Central Hospital, Jo   ensuu, Finland","He has pulmonary and mild aortic stenosis, ASD secundum, and hypertrophy of the ventricular septum .",,ASD secundum,[],"['ASD', 'secundum']"
148,259,cADHERiN 11 as a possible candidate gene for autism,P01.247,,"Child Psychiatry, Leuven,  Belgium, 3University Center for Child and Youth Psychiatry, Antwerp, Belgium. Background: Positional cloning of chromosomal translocation breakpoints in autism  patients is a valuable strategy towards the identification of candidate  genes, especially in isolated autism, and when the aberration is de novo and family history is negative for autism . (1) Objectives:  We describe a nondysmorphic patient with autism and full scale IQ  of 76, who carries a complex translocation involving chromosomes 3,5,16 and a pericentromeric inversion on chromosome 4 . Methods:  1Mb BAC array CHG was performed to uncover possible submicro   scopic imbalances. The breakpoints were finemapped with FISH. Results: On array CGH, a ~1Mb microdeletion encompassing the clone NON   SC8G10 was detected . Only 1 gene, cadherin 11 ( CDH11 ) was locat   ed in this region . Of the remaining 6 breakpoints, one disrupted the  AK13094  gene, another was near GFOD  and RANBP10  . Conclusions: In this patient with a complex chromosomal aberration, the CDH11   gene was found to be heterozygously deleted . Cdh11  is expressed in  the lymbic system and hippocampus in mice and may play a role in the organisation of central synapses . (2) Interestingly, there is evidence that  altered synaptogenesis is implicated in the pathogenesis of autism .  For instance, the cell adhesion molecules NLGN 3  and  4 are impli   cated in autism through their role in the establishment of functional presynaptic terminals in contacting axons . (3) Thus, CHD11  represents  both a positional and functional candidate gene for autism . Mutation  screening in a larger cohort of autism patients is ongoing . (1) Castermans (2003) J Med Genet 40(5) 352 6 (2) Manabe (2000) J Mol Neurosci 15(6) 534 46 (3) Persico (2006) Trends Neurosci 29(7) 349 58",2008.0,,"A. Crepel1, H. Peeters1, J. R. Vermeesch1, J. Steyaert2, D. Walleghem3, K.  Devriendt1","1Center for Human Genetics, Leuven, Belgium, 2Dept","(1) Objectives:  We describe a nondysmorphic patient with autism and full scale IQ  of 76, who carries a complex translocation involving chromosomes 3,5,16 and a pericentromeric inversion on chromosome 4 .",patient with autism,,"['patient', 'with', 'autism']",[]
149,260,FMR1 gene: prevalence of premutation and intermediate/grey  zone alleles in an autistic Basque sample,P01.248,,"Fragile X Syndrome (FXS) is associated with an unstable CGG re   peat sequence in the 5 untranslated region of the first exon of the  FMR1 gene . The location of this gene coincides with a Fragile Site (FS) FRAXA . The CGG sequence is polymorphic with respect to size  and purity of the repeat . Although only the full mutation (>200 CGG) is  associated with clinical expression of FXS, premutation (55 200 CGG)  and intermediate/grey zone allele carriers (35 54 CGG) have been  also associated to distinctive phenotypes, one of these are mental re   tardation and/or autism . Autism is a behavioral disorder of early onset  marked by social and cognitive deficiencies. Our Previous studies of  chromosomal fragility in autistic and normal individuals show higher  frequency of FS and FRAXA full mutation in autistic individuals . The Clinical genetics aim of this study was to analyze a sample of autistic patient without  FRAXA full mutation to know the correlation of premutation and inter   mediate/grey zone size FMR1 alleles and autism . The results show  that the prevalence of premutation alleles is 2/10 in patients, however  we did not found intermediate/grey zone alleles . Beside the overall  repeat size and the AGG interspersion pattern suggest instability  .",2008.0,,"I. Arrieta Saez1, O. Peagarikano2, M. Tlez1, M. Barasoain1, I. Huerta1, J.  Ramrez1, B. Criado3, P. Flores4, A. Gonzlez5","1Dpto Genetica, Antropologa Fisica y Fisiologia animal Facultad de Ciencia y  Tecnologa, Bilbao, Spain, 2Emory University School of Medicine, Atlanta, GA,  United States, 3High School Da Maia, CESPU, Porto, Portugal, 4Dpto de enfer   mera, Escuela de Enfermera, Bilbao, Spain, 5Dpto Medicina Interna, Facultad  de Medicina, Bilbao, Spain",Our Previous studies of  chromosomal fragility in autistic and normal individuals show higher  frequency of FS and FRAXA full mutation in autistic individuals .,,autistic individuals,[],"['autistic', 'individual']"
149,260,FMR1 gene: prevalence of premutation and intermediate/grey  zone alleles in an autistic Basque sample,P01.248,,"Fragile X Syndrome (FXS) is associated with an unstable CGG re   peat sequence in the 5 untranslated region of the first exon of the  FMR1 gene . The location of this gene coincides with a Fragile Site (FS) FRAXA . The CGG sequence is polymorphic with respect to size  and purity of the repeat . Although only the full mutation (>200 CGG) is  associated with clinical expression of FXS, premutation (55 200 CGG)  and intermediate/grey zone allele carriers (35 54 CGG) have been  also associated to distinctive phenotypes, one of these are mental re   tardation and/or autism . Autism is a behavioral disorder of early onset  marked by social and cognitive deficiencies. Our Previous studies of  chromosomal fragility in autistic and normal individuals show higher  frequency of FS and FRAXA full mutation in autistic individuals . The Clinical genetics aim of this study was to analyze a sample of autistic patient without  FRAXA full mutation to know the correlation of premutation and inter   mediate/grey zone size FMR1 alleles and autism . The results show  that the prevalence of premutation alleles is 2/10 in patients, however  we did not found intermediate/grey zone alleles . Beside the overall  repeat size and the AGG interspersion pattern suggest instability  .",2008.0,,"I. Arrieta Saez1, O. Peagarikano2, M. Tlez1, M. Barasoain1, I. Huerta1, J.  Ramrez1, B. Criado3, P. Flores4, A. Gonzlez5","1Dpto Genetica, Antropologa Fisica y Fisiologia animal Facultad de Ciencia y  Tecnologa, Bilbao, Spain, 2Emory University School of Medicine, Atlanta, GA,  United States, 3High School Da Maia, CESPU, Porto, Portugal, 4Dpto de enfer   mera, Escuela de Enfermera, Bilbao, Spain, 5Dpto Medicina Interna, Facultad  de Medicina, Bilbao, Spain",The Clinical genetics aim of this study was to analyze a sample of autistic patient without  FRAXA full mutation to know the correlation of premutation and inter   mediate/grey zone size FMR1 alleles and autism .,,autistic patient,[],"['autistic', 'patient']"
150,272,Bannayan Riley Ruvalcaba syndrome confirmed by mutation in  PTEN  gene,P01.260,,"Bannayan Riley Ruvalcaba (BRRS) and Cowden (CS) syndromes are  autosomal dominant allelic multiple hamartoma syndromes, both in  60 80% cases due to germline mutations in tumor supressor PTEN  gene . Clinical signs in childhood have many similarities, early diagno   sis using molecular genetic analysis is important as syndromes give  increased risk for different tumors . We describe a family, where both young parents of our index patient  were treated due to tumors  mother had bladder carcinoma, treated  during pregnancy and father was treated due to embryonal testicular carcinoma . Proband is the first and only child in the family. His birth anthropom   etry (4020g/52cm, OFC 41cm) was above 97th centile. During the first  two years of his life he had psychomotor developmental problems,  hypotonia, seizures with EEG changes, autistic features, unilateral hy   drocele and macrocephaly  . Metabolic workshop excluded metabolic  disorders . At the age of three years three lipomas were (histologically proved)diagnosed  two subcutaneous and one pancreatic . The patient  had different skin symptoms, no pigmentation of the glans penis . He  had macrocephaly and mild mental retardation and some autistic fea   tures and speech problems . Mutation analysis of PTEN  gene was performed by Dr  .D .O .Robinsin  (Salisbury Health Care NHS Trust) . The patient is carring a C>A substi   tution at base 144, in exon 2 of the PTEN gene . This mutation impairs  the function of PTEN and is the cause of the patient`s symptoms . conclusion: clinical, pedigree data and results of moleculargenetic  investigations of the patient having Bannayan Riley Ruvalcaba syn   drome are presented. This is the first case of this syndrome in Estonia  confirmed  PTEN  gene mutation .",2008.0,,"R. Zordania , A. Lehtmets, H. Pder, K. Joost","Tallinn` Children`s Hospital, Tallinn, Estonia","During the first  two years of his life he had psychomotor developmental problems,  hypotonia, seizures with EEG changes, autistic features, unilateral hy   drocele and macrocephaly  .",,autistic features,[],"['autistic', 'feature']"
151,331,multiple minor congenital defects associated with autism  spectrum disorders,P01.319,,"Autism spectrum disorders represent a wide spectrum of conditions  characterized by abnormalities of social interactions and communica   tion, severely restricted interests and highly repetitive behavior  . They  have multiple genetic and nongenetic causes . In order to ascertain  the cause and the onset of the disorder, establishing a positive cor   relation with some markers would be useful . Minor congenital defects  result from either genetic or environmental causes that act during  pregnancy and are an indirect measure of abnormal embryo and fe   tal development . The purpose of the study was to see if patients with  autism spectrum disorders have more minor congenital defects than  healthy individuals and if so, if this finding correlates with the history of the patients . The incidence and media of minor congenital defects  were determined in 76 patients with autism spectrum disorders and in unrelated control subjects matched by age and sex . The frequency  of minor anomalies was not significantly different in the two groups, 14 .47% in autistic children and teenagers, compared to 14 .80% in healthy controls . The mean number of minor congenital anomalies  was significantly higher in the autistic group, 30.70 minor defects/pa   tient, compared to 1 .430 .36 minor defects/patient in controls . None of the control subjects had three or more minor anomalies . These results  support the idea that minor defects, especially multiple ones, may rep   resent markers of early prenatal factors that contribute to the adverse outcome .Clinical genetics0",2008.0,,"D. Stoicanescu1, M. Cevei2, E. Sirbu3","1University of Medicine and Pharmacy Victor Babes, Timisoara, Romania,  2University of Oradea, Oradea, Romania, 3West University of Timioara, Ti   misoara, Romania",The incidence and media of minor congenital defects  were determined in 76 patients with autism spectrum disorders and in unrelated control subjects matched by age and sex .,patients with autism,,"['patient', 'with', 'autism']",[]
151,331,multiple minor congenital defects associated with autism  spectrum disorders,P01.319,,"Autism spectrum disorders represent a wide spectrum of conditions  characterized by abnormalities of social interactions and communica   tion, severely restricted interests and highly repetitive behavior  . They  have multiple genetic and nongenetic causes . In order to ascertain  the cause and the onset of the disorder, establishing a positive cor   relation with some markers would be useful . Minor congenital defects  result from either genetic or environmental causes that act during  pregnancy and are an indirect measure of abnormal embryo and fe   tal development . The purpose of the study was to see if patients with  autism spectrum disorders have more minor congenital defects than  healthy individuals and if so, if this finding correlates with the history of the patients . The incidence and media of minor congenital defects  were determined in 76 patients with autism spectrum disorders and in unrelated control subjects matched by age and sex . The frequency  of minor anomalies was not significantly different in the two groups, 14 .47% in autistic children and teenagers, compared to 14 .80% in healthy controls . The mean number of minor congenital anomalies  was significantly higher in the autistic group, 30.70 minor defects/pa   tient, compared to 1 .430 .36 minor defects/patient in controls . None of the control subjects had three or more minor anomalies . These results  support the idea that minor defects, especially multiple ones, may rep   resent markers of early prenatal factors that contribute to the adverse outcome .Clinical genetics0",2008.0,,"D. Stoicanescu1, M. Cevei2, E. Sirbu3","1University of Medicine and Pharmacy Victor Babes, Timisoara, Romania,  2University of Oradea, Oradea, Romania, 3West University of Timioara, Ti   misoara, Romania","The frequency  of minor anomalies was not significantly different in the two groups, 14 .47% in autistic children and teenagers, compared to 14 .80% in healthy controls .",,autistic children,[],"['autistic', 'child']"
151,331,multiple minor congenital defects associated with autism  spectrum disorders,P01.319,,"Autism spectrum disorders represent a wide spectrum of conditions  characterized by abnormalities of social interactions and communica   tion, severely restricted interests and highly repetitive behavior  . They  have multiple genetic and nongenetic causes . In order to ascertain  the cause and the onset of the disorder, establishing a positive cor   relation with some markers would be useful . Minor congenital defects  result from either genetic or environmental causes that act during  pregnancy and are an indirect measure of abnormal embryo and fe   tal development . The purpose of the study was to see if patients with  autism spectrum disorders have more minor congenital defects than  healthy individuals and if so, if this finding correlates with the history of the patients . The incidence and media of minor congenital defects  were determined in 76 patients with autism spectrum disorders and in unrelated control subjects matched by age and sex . The frequency  of minor anomalies was not significantly different in the two groups, 14 .47% in autistic children and teenagers, compared to 14 .80% in healthy controls . The mean number of minor congenital anomalies  was significantly higher in the autistic group, 30.70 minor defects/pa   tient, compared to 1 .430 .36 minor defects/patient in controls . None of the control subjects had three or more minor anomalies . These results  support the idea that minor defects, especially multiple ones, may rep   resent markers of early prenatal factors that contribute to the adverse outcome .Clinical genetics0",2008.0,,"D. Stoicanescu1, M. Cevei2, E. Sirbu3","1University of Medicine and Pharmacy Victor Babes, Timisoara, Romania,  2University of Oradea, Oradea, Romania, 3West University of Timioara, Ti   misoara, Romania","The mean number of minor congenital anomalies  was significantly higher in the autistic group, 30.70 minor defects/pa   tient, compared to 1 .430 .36 minor defects/patient in controls .",,autistic group,[],"['autistic', 'group']"
154,424,complex genomic structure underlying an interrupted  microdeletion in 16p11.2 p12.1 with breakpoints mapping to non homologous LcRs,P02.042,,"The LCR rich proximal chromosome 16p has been shown recently to be associated with the novel genomic disorders: the 7 .1 8 .7 Mb microdeletion 16p11 .2 p12 .1, and the proximally adjacent, recurrent Cytogenetics0 593 kb microdeletion and microduplication in 16p11 .2 found in ~1%  of patients with autism . The recurrent 16p11 .2 rearrangements im   plicated in autism likely occur via nonallelic homologous recombina   tion (NAHR) between directly oriented LCRs . The breakpoints of the  16p11 .2 p12 .1 deletions were mapped to nonhomologous sequences;  however, the deletions were proposed to have arisen via NAHR . We  present a 17 year old patient with developmental delay, short stature, skeletal anomalies, and a normal G banding karyotype and M FISH .  Using metaphase HR CGH, we identified a deletion in 16p11.2 p12.1  and verified it by FISH with BAC clones. Whole genome array CGH  with ~385,000 oligonucleotide probes (NimbleGen) defined the dele   tion between ~22 .482 .580 29 .342 .610 bp (6 .8 Mb) . Unexpectedly, we  identified a second deletion ~600 kb in size, mapping ~750 kb distal to  the first one. The breakpoints of both deletions map within nonhomolo   gous sequences; breakpoint junction sequencing is in progress . We  propose that the deletions arose through recently reported Fork Stall   ing and Template Switching (FoSTeS) replication based mechanism (Lee at al . 2007) rather than NAHR . Phenotype genotype correlation with the previously reported cases will be also presented .",2008.0,,"B. Nowakowska1, A. Midro2, B. Panasiuk2, D. Rychter3, P. Stankiewicz4, E.  Bocian1","1Institute of Mother and Child, Warsaw, Poland, 2Medical University Biaystok,  Bialystok, Poland, 3University Hospital Leuven, Leuven, Belgium, 4Baylor Col   lege of Medicine, Houston, TX, United States","The LCR rich proximal chromosome 16p has been shown recently to be associated with the novel genomic disorders: the 7 .1 8 .7 Mb microdeletion 16p11 .2 p12 .1, and the proximally adjacent, recurrent Cytogenetics0 593 kb microdeletion and microduplication in 16p11 .2 found in ~1%  of patients with autism .",patients with autism,,"['patient', 'with', 'autism']",[]
156,433,Phenotypic variability in Angelman syndrome   report of two  cases,P02.051,,"Angelman syndrome is a complex neurodevelopmental disorder with a  difficult clinical diagnosis and heterogeneous genetic basis.Cytogenetics We herewith report two cases of Angelman syndrome with different  phenotypes . First case, a 12 year old girl, was admitted in our department for neu   rological evaluation because of severe progressive toraco lumbar sco   liosis, which occurred at the age of five. She also presented severe  mental retardation, absence of speech, autistic features, gait difficul   ties with ataxia, hyperventilation episodes, and epileptic seizures . The  second case, a 4 year old boy, was referred to our department for psy   chomotor retardation . He had happy puppet appearance, ataxic gait, and severe mental retardation . Both children were born from healthy non consanguineous parents . Clinical investigations included neurological evaluation, EEG, and MRI . Chromosomal studies were performed on peripheral blood lympho   cytes, by GTG banding. Locus specific BAC probes for critical region 15q11 13 and control probes were used for FISH analysis . Normal karyotype, and 15q microdeletion was demonstrated in both cases . In the second case, the phenotype was highly suggestive for Angel   man syndrome, while in the first case, a differential diagnosis with Rett  syndrome was considered, especially because of the severe vertebral scoliosis . A diagnosis of Angelman syndrome should be considered in patients  with Rett like phenotype. Molecular investigation of specific genetic  defect allowed, in our cases, the refinement of clinical diagnosis.Financial support: CEEX (Project 150/2006) . Acknowledgements: The authors thank Prof . Jean Michel Dupont and  Mrs . Dominique Blancho for kindly providing BAC probes and Mrs . Marioara Cristea for technical assistance .",2008.0,,"M. Budisteanu1,2, A. Arghir2, G. Cardos2, S. Chirieac2, S. Magureanu1, A. Lun   geanu2","1Clinical Hospital of Psychiatry Prof.Dr. Al. Obregia, Bucharest, Romania,  2Victor Babes National Institute, Bucharest, Romania. ","She also presented severe  mental retardation, absence of speech, autistic features, gait difficul   ties with ataxia, hyperventilation episodes, and epileptic seizures .",,autistic features,[],"['autistic', 'feature']"
157,449,Frequent 22q11 aberrations in patients with non syndromic autism spectrum disorders shown by sNP array based  segmental aneuploidy screening,P02.067,,"Autism spectrum disorders (ASD) are neurodevelopmental conditions  characterized by impaired reciprocal social interaction, communicative  deficits, and restricted behavioral patterns. ASD occurs in syndromic  forms and as non syndromic cases frequently involving cytogenetic abnormalities . Recently, array based genome wide screens have demonstrated frequent copy number variation in non syndromic ASD .  Screening 56 patients with autism and additional major or minor anom   alies with the Infinium HumanHap300 SNP platform (Illumina, Inc.,  San Diego, CA) we found in 16 patients 9 regions with deleted and 9 with duplicated signals . Aberrant signals were distributed among 16 distinct chromosomal loci . Apart from 14 patients with unique aberra   tions, 2 patients carried duplications and a 3rd patient a deletion within  the 22q11 region, of 0 .726, 2 .966, and 0 .388 Mb, respectively  . The  duplications were confirmed by multiplex ligation mediated probe am   plification and are likely to involve LCRs A, B and D. We conclude that  SNP array based screening of ASD patients uncovers an appreciable  number of CNVs, which in part overlap with loci already discovered by  other approaches. Our finding that 3 out of 56 ASD patients carried aberrations within the 22q11 region is highly unexpected . The rela   tively small size of CNVs found in this study may allow us to pinpoint candidate genes for ASD .",2008.0,,"M. Poot1, N. Verbeek1, R. van t Slot1, M. R. Nelen1, B. van der Zwaag2, E. van  Daalen3, M. V. de Jonge3, W. G. Staal3, J. A. S. Vorstman3, P. F. Ippel1, M. van  den Boogaard1, P. Terhal1, F. A. Beemer1, J. J. S. van der Smagt1, E. H. Brils   tra1, G. Visser4, H. van Engeland3, J. P. H. Burbach2, H. K. Ploos van Amstel1,  R. Hochstenbach1","1Department of Medical Genetics, Utrecht, The Netherlands, 2Rudolf Magnus  Institute of Neuroscience, Utrecht, The Netherlands, 3Department of Child and  Adolescent Psychiatry, Utrecht, The Netherlands, 4Department of Pediatrics,  Utrecht, The Netherlands","Screening 56 patients with autism and additional major or minor anom   alies with the Infinium HumanHap300 SNP platform (Illumina, Inc.,  San Diego, CA) we found in 16 patients 9 regions with deleted and 9 with duplicated signals .",patients with autism,,"['patient', 'with', 'autism']",[]
157,449,Frequent 22q11 aberrations in patients with non syndromic autism spectrum disorders shown by sNP array based  segmental aneuploidy screening,P02.067,,"Autism spectrum disorders (ASD) are neurodevelopmental conditions  characterized by impaired reciprocal social interaction, communicative  deficits, and restricted behavioral patterns. ASD occurs in syndromic  forms and as non syndromic cases frequently involving cytogenetic abnormalities . Recently, array based genome wide screens have demonstrated frequent copy number variation in non syndromic ASD .  Screening 56 patients with autism and additional major or minor anom   alies with the Infinium HumanHap300 SNP platform (Illumina, Inc.,  San Diego, CA) we found in 16 patients 9 regions with deleted and 9 with duplicated signals . Aberrant signals were distributed among 16 distinct chromosomal loci . Apart from 14 patients with unique aberra   tions, 2 patients carried duplications and a 3rd patient a deletion within  the 22q11 region, of 0 .726, 2 .966, and 0 .388 Mb, respectively  . The  duplications were confirmed by multiplex ligation mediated probe am   plification and are likely to involve LCRs A, B and D. We conclude that  SNP array based screening of ASD patients uncovers an appreciable  number of CNVs, which in part overlap with loci already discovered by  other approaches. Our finding that 3 out of 56 ASD patients carried aberrations within the 22q11 region is highly unexpected . The rela   tively small size of CNVs found in this study may allow us to pinpoint candidate genes for ASD .",2008.0,,"M. Poot1, N. Verbeek1, R. van t Slot1, M. R. Nelen1, B. van der Zwaag2, E. van  Daalen3, M. V. de Jonge3, W. G. Staal3, J. A. S. Vorstman3, P. F. Ippel1, M. van  den Boogaard1, P. Terhal1, F. A. Beemer1, J. J. S. van der Smagt1, E. H. Brils   tra1, G. Visser4, H. van Engeland3, J. P. H. Burbach2, H. K. Ploos van Amstel1,  R. Hochstenbach1","1Department of Medical Genetics, Utrecht, The Netherlands, 2Rudolf Magnus  Institute of Neuroscience, Utrecht, The Netherlands, 3Department of Child and  Adolescent Psychiatry, Utrecht, The Netherlands, 4Department of Pediatrics,  Utrecht, The Netherlands","The  duplications were confirmed by multiplex ligation mediated probe am   plification and are likely to involve LCRs A, B and D. We conclude that  SNP array based screening of ASD patients uncovers an appreciable  number of CNVs, which in part overlap with loci already discovered by  other approaches.",,ASD patients,[],"['ASD', 'patient']"
157,449,Frequent 22q11 aberrations in patients with non syndromic autism spectrum disorders shown by sNP array based  segmental aneuploidy screening,P02.067,,"Autism spectrum disorders (ASD) are neurodevelopmental conditions  characterized by impaired reciprocal social interaction, communicative  deficits, and restricted behavioral patterns. ASD occurs in syndromic  forms and as non syndromic cases frequently involving cytogenetic abnormalities . Recently, array based genome wide screens have demonstrated frequent copy number variation in non syndromic ASD .  Screening 56 patients with autism and additional major or minor anom   alies with the Infinium HumanHap300 SNP platform (Illumina, Inc.,  San Diego, CA) we found in 16 patients 9 regions with deleted and 9 with duplicated signals . Aberrant signals were distributed among 16 distinct chromosomal loci . Apart from 14 patients with unique aberra   tions, 2 patients carried duplications and a 3rd patient a deletion within  the 22q11 region, of 0 .726, 2 .966, and 0 .388 Mb, respectively  . The  duplications were confirmed by multiplex ligation mediated probe am   plification and are likely to involve LCRs A, B and D. We conclude that  SNP array based screening of ASD patients uncovers an appreciable  number of CNVs, which in part overlap with loci already discovered by  other approaches. Our finding that 3 out of 56 ASD patients carried aberrations within the 22q11 region is highly unexpected . The rela   tively small size of CNVs found in this study may allow us to pinpoint candidate genes for ASD .",2008.0,,"M. Poot1, N. Verbeek1, R. van t Slot1, M. R. Nelen1, B. van der Zwaag2, E. van  Daalen3, M. V. de Jonge3, W. G. Staal3, J. A. S. Vorstman3, P. F. Ippel1, M. van  den Boogaard1, P. Terhal1, F. A. Beemer1, J. J. S. van der Smagt1, E. H. Brils   tra1, G. Visser4, H. van Engeland3, J. P. H. Burbach2, H. K. Ploos van Amstel1,  R. Hochstenbach1","1Department of Medical Genetics, Utrecht, The Netherlands, 2Rudolf Magnus  Institute of Neuroscience, Utrecht, The Netherlands, 3Department of Child and  Adolescent Psychiatry, Utrecht, The Netherlands, 4Department of Pediatrics,  Utrecht, The Netherlands",Our finding that 3 out of 56 ASD patients carried aberrations within the 22q11 region is highly unexpected .,,ASD patients,[],"['ASD', 'patient']"
162,473,"A submicroscopic 5q11.2 deletion in a girl with autism, mild  mental retardation and mild facial dysmorphism",P02.092,,"We report on a female patient with autism spectrum disorder (ASD),  mild mental retardation, mild facial dysmorphism and a submicrosco   pic 5q11 .2 deletion detected by 1 Mb array CGH . In addition, a 2Mb maternally inherited duplication on Xp22 .31 (RP11 483M24 >RP11  323F16) was detected . Chromosomal imbalances (deletions or dupli   cations) appear to be present in about 25% of patients with syndromic  ASD . The deletion in the present patient is approximately 8 Mb in size  and is flanked by the clones CTD 2276024 and RP11 210O14. Inter   estingly, a similar but possibly slightly smaller deletion on has previ   ously been described in a boy with profound speech delay, obses   sional play and echolalia (K Prescott et al.  2005) . In contrast to the  patient we describe, this boy presented additional malformations like a  cardiac defect (tetralogy of Fallot), a bifid uvula, velopharyngeal insuffi   ciency and short stature . Since autistic behaviour is the only consistent  finding in 2 patients with a similar deletion 5q11.2, the location of this  deletion may identify a gene that is implicated in autism spectrum dis   orders . Furthermore our observation illustrates that array CGH should  be considered as an essential aspect in the genetic analysis of patients  with syndromic ASD .",2008.0,,"H. Peeters1, A. Crepel1, K. Devriendt1, P. De Cock2, J. Vermeesch1, J. P. Fryns1","1University of Leuven, Center for Human Genetics, B 3000 Leuven, Belgium,  2University of Leuven, Child Neurology Department, B 3000 Leuven, Belgium","We report on a female patient with autism spectrum disorder (ASD),  mild mental retardation, mild facial dysmorphism and a submicrosco   pic 5q11 .2 deletion detected by 1 Mb array CGH .",patient with autism,,"['patient', 'with', 'autism']",[]
162,473,"A submicroscopic 5q11.2 deletion in a girl with autism, mild  mental retardation and mild facial dysmorphism",P02.092,,"We report on a female patient with autism spectrum disorder (ASD),  mild mental retardation, mild facial dysmorphism and a submicrosco   pic 5q11 .2 deletion detected by 1 Mb array CGH . In addition, a 2Mb maternally inherited duplication on Xp22 .31 (RP11 483M24 >RP11  323F16) was detected . Chromosomal imbalances (deletions or dupli   cations) appear to be present in about 25% of patients with syndromic  ASD . The deletion in the present patient is approximately 8 Mb in size  and is flanked by the clones CTD 2276024 and RP11 210O14. Inter   estingly, a similar but possibly slightly smaller deletion on has previ   ously been described in a boy with profound speech delay, obses   sional play and echolalia (K Prescott et al.  2005) . In contrast to the  patient we describe, this boy presented additional malformations like a  cardiac defect (tetralogy of Fallot), a bifid uvula, velopharyngeal insuffi   ciency and short stature . Since autistic behaviour is the only consistent  finding in 2 patients with a similar deletion 5q11.2, the location of this  deletion may identify a gene that is implicated in autism spectrum dis   orders . Furthermore our observation illustrates that array CGH should  be considered as an essential aspect in the genetic analysis of patients  with syndromic ASD .",2008.0,,"H. Peeters1, A. Crepel1, K. Devriendt1, P. De Cock2, J. Vermeesch1, J. P. Fryns1","1University of Leuven, Center for Human Genetics, B 3000 Leuven, Belgium,  2University of Leuven, Child Neurology Department, B 3000 Leuven, Belgium","Since autistic behaviour is the only consistent  finding in 2 patients with a similar deletion 5q11.2, the location of this  deletion may identify a gene that is implicated in autism spectrum dis   orders .",,autistic behaviour,[],"['autistic', 'behaviour']"
163,476,"Autistic features with speech delay in a girl with an ~1.5 mb deletion in 6q16.1, including FUt9 and GPR63",P02.095,,"Recent studies have shown that up to 40% of the apparently balanced  reciprocal chromosome translocations in patients with abnormal phe   notype can be accompanied by a chromosome imbalance . We present  a 10 year old girl with mild mental retardation, abnormal EEG, and au   tistic behavior, who began to speak at 5 years . She had no dysmorphic features and her brain MRI was normal . Karyotype analysis revealed  a de novo apparently balanced translocation t(6;14)(q16;q22) . Whole  genome array CGH analysis with ~385,000 oligonucleotide probes  (NimbleGen) identified an ~1.48 Mb deletion in 6q16.1. FISH with  BAC clones mapping within and directly flanking the deleted segment  showed that the deletion arose at the translocation breakpoint . Inter   estingly, autism has been linked previously to chromosome 6q16 . The  deleted segment harbors FUT9, GPR63, FHL5, KLHL32, c6orf66, and AK091365 and two predicted genes c6orf167 and KIA0776 . GPR63  is expressed almost exclusively in the brain and encodes a G pro   tein coupled receptor for sphingosine 1 phosphate . The fucosyltrans   ferase 9 gene, FUT9, is highly conserved among humans, mice, rats, and hamsters and is highly expressed in brain during embryogenesis .  FUT9 is considered to be involved in cell cell interactions, differentia   tion, and neurodevelopmental processes. Our data confirm previous  observations that copy number variation is a significant factor respon   sible for autistic spectrum behavior and speech delay  .Cytogenetics",2008.0,,"K. W. Derwinska1,2, J. Bernaciak1, E. Obersztyn1, E. Bocian1, P. Stankiewicz1,2","1Institute of Mother and Child, Warsaw, Poland, 2Dept.of Molecular & Human  Genetics, Baylor College of Medicine, Houston, TX, United States. ",Our data confirm previous  observations that copy number variation is a significant factor respon   sible for autistic spectrum behavior and speech delay  .Cytogenetics,,autistic spectrum,[],"['autistic', 'spectrum']"
165,491,"CSMD , a candidate gene for autism found in two patients with  autistic disorder and balanced translocations",P02.110,,"The study of chromosomal rearrangements associated with abnormal  phenotypes has proven to be a powerful method for the identification of disease related genes . Recent studies estimated a rate of 3 5% of  cytogenetic abnormalities involving many different chromosomes in autistic spectrum disorders (ASDs) . We report here on two unrelated  males with de novo  translocations, autistic behaviour and psychomotor  delay  . They carry balanced chromosome translocations, respectively a  t(5;8)(q14 .3;q23 .3) and t(6;8)(q13;q23 .2) . A detailed physical map cov   ering the regions involved in the translocations was constructed and  FISH analyses were carried out using BAC clones mapping on chro   mosomes 5q14.3, 6q13 and 8q23. We fine mapped the two transloca   tion breakpoints on chromosomes 8 identifying their positions within a short 5 Mb genomic region . The results of these analyses showed that  breakpoints on chromosomes 8 in both patients do not interrupt any  known gene but both map in a region containing the CSMD3  gene .  No genes were interrupted on chromosomes 5q14 .3 and 6q13 . Tak   ing into account that CSMD3 is expressed in fetal and adult brain, our  observations suggest that this gene is a good candidate for the patho   genesis of ASDs . To exclude an over expression or under expression  of CSMD3  leaded by the rearrangement, we verified the expression  of this gene in the leukocytes of the translocated patient by RT PCR, but any transcript was detected . Future studies, including mutational  analysis of CSMD3 in a large number of patients affected by autism  and behavioural studies on a Csmd3  knockout mouse, will be neces   sary to confirm or decline this hypothesis.",2008.0,,"C. Floris1, S. Rassu2, L. Boccone3, D. Gasperini3, A. Cao1, L. Crisponi1","1Istituto di Neurogenetica e Neurofarmacologia INN CNR, Monserrato (CA),  Italy, 2Dipartimento di Scienze Biomediche e Biotecnologie, Universit degli  Studi di Cagliari, Cagliari, Italy, 3Ospedale Regionale per le Microcitemie, Clini   ca Pediatrica II, Azienda U.S.L. 8, Cagliari, Italy. ",Recent studies estimated a rate of 3 5% of  cytogenetic abnormalities involving many different chromosomes in autistic spectrum disorders (ASDs) .,,autistic spectrum,[],"['autistic', 'spectrum']"
165,491,"CSMD , a candidate gene for autism found in two patients with  autistic disorder and balanced translocations",P02.110,,"The study of chromosomal rearrangements associated with abnormal  phenotypes has proven to be a powerful method for the identification of disease related genes . Recent studies estimated a rate of 3 5% of  cytogenetic abnormalities involving many different chromosomes in autistic spectrum disorders (ASDs) . We report here on two unrelated  males with de novo  translocations, autistic behaviour and psychomotor  delay  . They carry balanced chromosome translocations, respectively a  t(5;8)(q14 .3;q23 .3) and t(6;8)(q13;q23 .2) . A detailed physical map cov   ering the regions involved in the translocations was constructed and  FISH analyses were carried out using BAC clones mapping on chro   mosomes 5q14.3, 6q13 and 8q23. We fine mapped the two transloca   tion breakpoints on chromosomes 8 identifying their positions within a short 5 Mb genomic region . The results of these analyses showed that  breakpoints on chromosomes 8 in both patients do not interrupt any  known gene but both map in a region containing the CSMD3  gene .  No genes were interrupted on chromosomes 5q14 .3 and 6q13 . Tak   ing into account that CSMD3 is expressed in fetal and adult brain, our  observations suggest that this gene is a good candidate for the patho   genesis of ASDs . To exclude an over expression or under expression  of CSMD3  leaded by the rearrangement, we verified the expression  of this gene in the leukocytes of the translocated patient by RT PCR, but any transcript was detected . Future studies, including mutational  analysis of CSMD3 in a large number of patients affected by autism  and behavioural studies on a Csmd3  knockout mouse, will be neces   sary to confirm or decline this hypothesis.",2008.0,,"C. Floris1, S. Rassu2, L. Boccone3, D. Gasperini3, A. Cao1, L. Crisponi1","1Istituto di Neurogenetica e Neurofarmacologia INN CNR, Monserrato (CA),  Italy, 2Dipartimento di Scienze Biomediche e Biotecnologie, Universit degli  Studi di Cagliari, Cagliari, Italy, 3Ospedale Regionale per le Microcitemie, Clini   ca Pediatrica II, Azienda U.S.L. 8, Cagliari, Italy. ","We report here on two unrelated  males with de novo  translocations, autistic behaviour and psychomotor  delay  .",,autistic behaviour,[],"['autistic', 'behaviour']"
168,511,De novo  cytptic deletion of 2q37 in a child with hypotonia and  congenital heart defect,P02.130,,"Unbalanced cryptic chromosomal rearrangement involving the telo   meric region is one of the major causes of complex genetic diseases resulting in mild to severe clinical conditions .We present here genetic  studies on a one month old female child with hypotonia, poor feed   ing and congenital heart defect who was referred for chromosomal studies . Cytogenetic and FISH studies showed a  de novo  and unbal   anced cryptic chromosomal rearrangement resulting from a transloca  tion between chromosomes 2q37.1 and 20p13. The final karyotypic and FISH results were interpreted as 46,XX,der(2)t(2;20)(q37 .1;p13) . ish der(2)(2ptel+,2qtel ,20ptel+)dn, leading to trisomy of 20pter and monosomy of 2qter  . Due to the severity of her condition she under   went cardiac surgery, but failed to survive . More than 60 cases of 2q37  terminal deletion have been reported so far with features ranging from  developmental delay, mental retardation, dysmorphism, autism, car   diac or renal abnormalities etc . A subset of patients with this distal  deletion, are reported to mimic Albright hereditary Osteodystrophy (AHO) . Recent array CGH studies by Lukusa et al (2004) correlated  2q37 .3 deletion with autism . Molecular cytogenetic studies using FISH  and array CGH should to be considered for patients presenting with  hypotonia, feeding difficulties and failure to thrive. Literature review  and geneotype phenotype correlation involving 2q37 microdeletion will  be discussed .",2008.0,,"S. K. Murthy , S. Naveed, E. E. M. Al Rowaished, S. Mani, S. M. Padariyakam,  P. S. Jacob, M. T. A. Ali","Molecular Cytogenetic Unit, Genetics Center, DOHMS, P.O.Box 9115, Dubai,  United Arab Emirates. ",Recent array CGH studies by Lukusa et al (2004) correlated  2q37 .3 deletion with autism .,deletion with autism,,"['deletion', 'with', 'autism']",[]
169,512,the facial dysmorphy in the newly recognised microdeletion  2p15 p16.1 refined to a 570 kb region in 2p15,P02.131,,"The implementation of new technologies such as array based compar   ative genomic hybridisation (aCGH) in the genetic diagnosis screening  of patients with mental retardation and multiple congenital anomalies  (MR/MCA) enabled the detection of novel subtle chromosomal imbal   ances, as well as the refinement of already known chromosomal imbal   ances and, in some cases, the identification of the respective genes.Recently a novel 6 .2 Mb microdeletion involving 2p15 p16 .1 was re   ported in two patients with autistic disorder (AD) and MR/MCA with recognisable dysmorphic features . While screening for genomic copy number variations with a 1 Mb reso   lution bacterial artificial chromosome (BAC) aCGH in patients referred  for the aetiological diagnosis of MR/MCA, a de novo 2p microdeletion  was detected and refined by fluorescence in situ hybridisation (FISH)  to a 570 kb region in 2p15 in a 16 year old boy presenting with mild  mental retardation and multiple congenital anomalies with facial dys   morphism, ecomorphic habitus, kyphoscoliosis and congenital heart  defect. In a first step, Marfan and Williams Beuren syndromes were  excluded by, respectively, FBN1  gene mutation screening and ELN  gene locus specific FISH probe. We compare our findings with those already reported and we discuss the phenotype genotype correlations . This report supports the evidence of a newly recognised microdele   tion syndrome involving 2p15 16 .1 . We show that this smallest 570 kb  deletion of 2p15 is most likely responsible for the characteristic facial dysmorphism in this syndrome .",2008.0,,"E. Chabchoub1, J. R. Vermeesch1, T. de Ravel1, P. de Cock2, J. P. Fryns1","1Centre for Human Genetics   University Hospital Gasthuisberg, Leuven, Bel   gium, 2Department of Neuropaediatrics   University Hospital Gasthuisberg,  Leuven, Belgium","The implementation of new technologies such as array based compar   ative genomic hybridisation (aCGH) in the genetic diagnosis screening  of patients with mental retardation and multiple congenital anomalies  (MR/MCA) enabled the detection of novel subtle chromosomal imbal   ances, as well as the refinement of already known chromosomal imbal   ances and, in some cases, the identification of the respective genes.Recently a novel 6 .2 Mb microdeletion involving 2p15 p16 .1 was re   ported in two patients with autistic disorder (AD) and MR/MCA with recognisable dysmorphic features .",,autistic disorder,[],"['autistic', 'disorder']"
171,540,"A complex chromosome 7q rearrangement identified in a patient  with mental retardation, anxiety disorder and autistic features",P02.161,,"We present a 15 year old girl, the second child of healthy parents .  The girl is mentally retarded, suffers from a severe anxiety disorder  and has autistic features . Her mean IQ was 48 .  She has a coordina   tion disorder and hypotonia. She has small palpebral fissures, simply  formed low set ears, abnormal palmar creases, scoliosis, long halluxes and her thumbs are proximally implanted . Length and skull circumfer   ence were  1 and  2,5 SD respectively  . G banding indicated a de novo   paracentric inversion 46,XX,inv(7)(q31 .3q34) . SNP array analysis,  however, revealed a ~10Mb, 7q21 .11 7q21 .3 deletion in the paternal  chromosome . Subsequent FISH analysis with  90 BAC/PAC clones  in the 7q21 q35 region confirmed this deletion, but the expected para   centric inversion turned out to be an intra chromosomal insertion of the fragment 7q31 .31 q35 into band 7q21 .3 . PAC clone RP4 545C24  spans the breakpoint in band 7q35, positioning the breakpoint between  the genes NOBOX  and TPK1.  The 7q31 .31 breakpoint disrupts clone  RP5 1047E14 and the predicted gene NP079189  . Six other patients with a deletion of 7q21 .1 q21 .3 have been reported  previously  . They share with our patient the following clinical features:  mental retardation/developmental delay, microcephaly, mild facial dys   morphism, hypotonia, ear anomalies and small palpebral fissures. Our  patient did not show any hearing loss, genital anomalies or growth  deficiency, found in all of the previously reported patients. However  none of the previous cases were reported to have anxiety disorder  and/or autistic features . Therefore it is possible that disruption of the  NP079189  gene contributes to the anxiety disorder and the autistic  features in our patient .",2008.0,,"J. G. Dauwerse , C. A. L. Ruivenkamp, K. B. M. Hansson, D. J. M. Peters, M.  H. Breuning, Y. Hilhorst Hofstee","LUMC, Leiden, The Netherlands","The girl is mentally retarded, suffers from a severe anxiety disorder  and has autistic features .",,autistic features,[],"['autistic', 'feature']"
171,540,"A complex chromosome 7q rearrangement identified in a patient  with mental retardation, anxiety disorder and autistic features",P02.161,,"We present a 15 year old girl, the second child of healthy parents .  The girl is mentally retarded, suffers from a severe anxiety disorder  and has autistic features . Her mean IQ was 48 .  She has a coordina   tion disorder and hypotonia. She has small palpebral fissures, simply  formed low set ears, abnormal palmar creases, scoliosis, long halluxes and her thumbs are proximally implanted . Length and skull circumfer   ence were  1 and  2,5 SD respectively  . G banding indicated a de novo   paracentric inversion 46,XX,inv(7)(q31 .3q34) . SNP array analysis,  however, revealed a ~10Mb, 7q21 .11 7q21 .3 deletion in the paternal  chromosome . Subsequent FISH analysis with  90 BAC/PAC clones  in the 7q21 q35 region confirmed this deletion, but the expected para   centric inversion turned out to be an intra chromosomal insertion of the fragment 7q31 .31 q35 into band 7q21 .3 . PAC clone RP4 545C24  spans the breakpoint in band 7q35, positioning the breakpoint between  the genes NOBOX  and TPK1.  The 7q31 .31 breakpoint disrupts clone  RP5 1047E14 and the predicted gene NP079189  . Six other patients with a deletion of 7q21 .1 q21 .3 have been reported  previously  . They share with our patient the following clinical features:  mental retardation/developmental delay, microcephaly, mild facial dys   morphism, hypotonia, ear anomalies and small palpebral fissures. Our  patient did not show any hearing loss, genital anomalies or growth  deficiency, found in all of the previously reported patients. However  none of the previous cases were reported to have anxiety disorder  and/or autistic features . Therefore it is possible that disruption of the  NP079189  gene contributes to the anxiety disorder and the autistic  features in our patient .",2008.0,,"J. G. Dauwerse , C. A. L. Ruivenkamp, K. B. M. Hansson, D. J. M. Peters, M.  H. Breuning, Y. Hilhorst Hofstee","LUMC, Leiden, The Netherlands",However  none of the previous cases were reported to have anxiety disorder  and/or autistic features .,,autistic features,[],"['autistic', 'feature']"
174,1154,Linkage and linkage disequilibrium scan for autism in an  extended pedigree from Finland,P06.033,,"As a part of the genetic study of autism spectrum disorders (ASDs)  in the Finnish population, an extensive genealogical search was con   ducted to find out whether a substantial fraction of the families would share the same ancestral lineage . Based on this search back to the  17th century, 18 ASD families (33 affected) were merged into one ex   tended pedigree . We hypothesized that this pedigree could expose rare ASD gene(s)  enriched to this internal subisolate, and performed a genome wide scan using 1107 STS markers (intermarker spacing ~3 .4cM) . A joint  analysis of linkage and linkage disequilibrium was performed with  Pseudomarker statistics and a traditional multipoint linkage analysis with Simwalk2 . Nine loci exceeded the chosen significance level of  log(p)>2.5. Of these, 1q21 23 (p,0 .00082) is one of the best loci in our previous ge   nome wide scans for autism and Asperger syndrome in Finland, while 15q11 13 (p,0 .00081) is a well recognized site for cytogenetic abnor   malities associated with autism . Best multipoint linkage was observed at 19p13 [ log(p),3 .57] . Regional candidate genes were chosen from these best loci at 1q23,  15q12 and 19p13, and analyzed with SNPs using additional 126  families with ASDs (281 affected). Most significant association was observed with five consecutive SNPs of ATP1A2  (1q23; p,0 .00055)  and with eight consecutive SNPs within a TLE gene cluster (19p13;  p,0 .000078) . This association evidence was not detected using the  nationwide sample, suggesting enrichment of these loci to our pedi   gree . We are currently performing a high resolution analysis of the  extent of shared chromosomal regions among the members of the pedigree with Illumina 317k platform .",2008.0,,"H. Kilpinen1, T. Ylisaukko oja1,2, K. Rehnstrm1,2, E. Gal1, J. A. Turunen1, E.  Kempas1, L. von Wendt3, T. Varilo1,2, L. Peltonen1,2,4","1Department of Molecular Medicine, National Public Health Institute, Helsinki,  Finland, 2Department of Medical Genetics, University of Helsinki, Helsinki, Fin   land, 3Unit of Child Neurology, Hospital for Children and Adolescents, Helsinki,  Finland, 4Wellcome Trust Sanger Institute, Cambridge, United Kingdom","Based on this search back to the  17th century, 18 ASD families (33 affected) were merged into one ex   tended pedigree .",,ASD families,[],"['ASD', 'family']"
174,1154,Linkage and linkage disequilibrium scan for autism in an  extended pedigree from Finland,P06.033,,"As a part of the genetic study of autism spectrum disorders (ASDs)  in the Finnish population, an extensive genealogical search was con   ducted to find out whether a substantial fraction of the families would share the same ancestral lineage . Based on this search back to the  17th century, 18 ASD families (33 affected) were merged into one ex   tended pedigree . We hypothesized that this pedigree could expose rare ASD gene(s)  enriched to this internal subisolate, and performed a genome wide scan using 1107 STS markers (intermarker spacing ~3 .4cM) . A joint  analysis of linkage and linkage disequilibrium was performed with  Pseudomarker statistics and a traditional multipoint linkage analysis with Simwalk2 . Nine loci exceeded the chosen significance level of  log(p)>2.5. Of these, 1q21 23 (p,0 .00082) is one of the best loci in our previous ge   nome wide scans for autism and Asperger syndrome in Finland, while 15q11 13 (p,0 .00081) is a well recognized site for cytogenetic abnor   malities associated with autism . Best multipoint linkage was observed at 19p13 [ log(p),3 .57] . Regional candidate genes were chosen from these best loci at 1q23,  15q12 and 19p13, and analyzed with SNPs using additional 126  families with ASDs (281 affected). Most significant association was observed with five consecutive SNPs of ATP1A2  (1q23; p,0 .00055)  and with eight consecutive SNPs within a TLE gene cluster (19p13;  p,0 .000078) . This association evidence was not detected using the  nationwide sample, suggesting enrichment of these loci to our pedi   gree . We are currently performing a high resolution analysis of the  extent of shared chromosomal regions among the members of the pedigree with Illumina 317k platform .",2008.0,,"H. Kilpinen1, T. Ylisaukko oja1,2, K. Rehnstrm1,2, E. Gal1, J. A. Turunen1, E.  Kempas1, L. von Wendt3, T. Varilo1,2, L. Peltonen1,2,4","1Department of Molecular Medicine, National Public Health Institute, Helsinki,  Finland, 2Department of Medical Genetics, University of Helsinki, Helsinki, Fin   land, 3Unit of Child Neurology, Hospital for Children and Adolescents, Helsinki,  Finland, 4Wellcome Trust Sanger Institute, Cambridge, United Kingdom","We hypothesized that this pedigree could expose rare ASD gene(s)  enriched to this internal subisolate, and performed a genome wide scan using 1107 STS markers (intermarker spacing ~3 .4cM) .",,ASD gene(s,[],"['ASD', 'gene(s']"
174,1154,Linkage and linkage disequilibrium scan for autism in an  extended pedigree from Finland,P06.033,,"As a part of the genetic study of autism spectrum disorders (ASDs)  in the Finnish population, an extensive genealogical search was con   ducted to find out whether a substantial fraction of the families would share the same ancestral lineage . Based on this search back to the  17th century, 18 ASD families (33 affected) were merged into one ex   tended pedigree . We hypothesized that this pedigree could expose rare ASD gene(s)  enriched to this internal subisolate, and performed a genome wide scan using 1107 STS markers (intermarker spacing ~3 .4cM) . A joint  analysis of linkage and linkage disequilibrium was performed with  Pseudomarker statistics and a traditional multipoint linkage analysis with Simwalk2 . Nine loci exceeded the chosen significance level of  log(p)>2.5. Of these, 1q21 23 (p,0 .00082) is one of the best loci in our previous ge   nome wide scans for autism and Asperger syndrome in Finland, while 15q11 13 (p,0 .00081) is a well recognized site for cytogenetic abnor   malities associated with autism . Best multipoint linkage was observed at 19p13 [ log(p),3 .57] . Regional candidate genes were chosen from these best loci at 1q23,  15q12 and 19p13, and analyzed with SNPs using additional 126  families with ASDs (281 affected). Most significant association was observed with five consecutive SNPs of ATP1A2  (1q23; p,0 .00055)  and with eight consecutive SNPs within a TLE gene cluster (19p13;  p,0 .000078) . This association evidence was not detected using the  nationwide sample, suggesting enrichment of these loci to our pedi   gree . We are currently performing a high resolution analysis of the  extent of shared chromosomal regions among the members of the pedigree with Illumina 317k platform .",2008.0,,"H. Kilpinen1, T. Ylisaukko oja1,2, K. Rehnstrm1,2, E. Gal1, J. A. Turunen1, E.  Kempas1, L. von Wendt3, T. Varilo1,2, L. Peltonen1,2,4","1Department of Molecular Medicine, National Public Health Institute, Helsinki,  Finland, 2Department of Medical Genetics, University of Helsinki, Helsinki, Fin   land, 3Unit of Child Neurology, Hospital for Children and Adolescents, Helsinki,  Finland, 4Wellcome Trust Sanger Institute, Cambridge, United Kingdom","Of these, 1q21 23 (p,0 .00082) is one of the best loci in our previous ge   nome wide scans for autism and Asperger syndrome in Finland, while 15q11 13 (p,0 .00081) is a well recognized site for cytogenetic abnor   malities associated with autism .",,Asperger syndrome,[],"['Asperger', 'syndrome']"
175,1155,the BDNF receptor gene NTRK  is a susceptibility gene for  autism,P06.034,,"Autism is a complex neurodevelopmental disorder likely determined by multiple genes . The  NTRK2  gene encodes a receptor, TrkB, for neu   rotrophin 4/5 and Brain Derived Neurotrophic Factor (BDNF), which  promotes neuronal differentiation and regulation of synaptic function in the developing and adult nervous system . Intriguing observations,  such as increased BDNF levels in autistic children and NTRK2  muta   tions in children with developmental delays, raise the hypothesis that  an abnormal function/expression of NTRK2  might be involved in au   tism . 38 tag SNPs, spanning the NTRK2  gene, were tested for as   sociation with autism in 323 Portuguese trios. We found significant  transmission disequilibrium of alleles at three markers in introns  5 6  and 15 16 (0 .011< P<0 .041) . Given this evidence for association, we  genotyped these markers in a second population sample of 168 Irish trios . In the combined sample (N,491) we found an association of the  same three SNPs at a more stringent P level (0 .006<P<0 .015), and  found nominal associations with four additional markers in intron  22  23 (0 .0211< P<0.043). Previously we have described a significant in   crease of plasma BDNF levels in approximately 30% of our patients .  We therefore screened NTRK2 exons  encoding ligand binding and  catalytic regions ( exons  6, 7, 12, 18, 20 24) for mutations in 20 autis   tic individuals with increased BDNF levels and 10 controls . No muta   tions were identified in these individuals, and there was no evidence  for association of NTRK2 with plasma BDNF distribution . The overall  results therefore suggest that NTRK2  may be a susceptibility gene  for autism, but its impact on autism is not mediated by the increased BDNF levels .",2008.0,,"C. Correia1,2, I. Sousa2, I. Peixeiro2, L. Loureno2, J. Almeida3, R. Lontro3, L.  Galllagher4,5, M. Gill4,5, S. Ennis6, G. Oliveira3, A. M. Vicente1,2","1Instituto Nacional de Sade Dr.Ricardo Jorge, Lisboa, Portugal, 2Instituto  Gulbenkian de Cincia, Oeiras, Portugal, 3Hospital Peditrico de Coimbra,  Coimbra, Portugal, 4Department of Genetics, Smurfit Institute, Trinity College,  Dublin, Ireland, 5Department of Psychiatry, Trinity College, Dublin, Ireland,  6School of Medicine and Medical Sciences, University College, Dublin, Ireland. ","Intriguing observations,  such as increased BDNF levels in autistic children and NTRK2  muta   tions in children with developmental delays, raise the hypothesis that  an abnormal function/expression of NTRK2  might be involved in au   tism .",,autistic children,[],"['autistic', 'child']"
175,1155,the BDNF receptor gene NTRK  is a susceptibility gene for  autism,P06.034,,"Autism is a complex neurodevelopmental disorder likely determined by multiple genes . The  NTRK2  gene encodes a receptor, TrkB, for neu   rotrophin 4/5 and Brain Derived Neurotrophic Factor (BDNF), which  promotes neuronal differentiation and regulation of synaptic function in the developing and adult nervous system . Intriguing observations,  such as increased BDNF levels in autistic children and NTRK2  muta   tions in children with developmental delays, raise the hypothesis that  an abnormal function/expression of NTRK2  might be involved in au   tism . 38 tag SNPs, spanning the NTRK2  gene, were tested for as   sociation with autism in 323 Portuguese trios. We found significant  transmission disequilibrium of alleles at three markers in introns  5 6  and 15 16 (0 .011< P<0 .041) . Given this evidence for association, we  genotyped these markers in a second population sample of 168 Irish trios . In the combined sample (N,491) we found an association of the  same three SNPs at a more stringent P level (0 .006<P<0 .015), and  found nominal associations with four additional markers in intron  22  23 (0 .0211< P<0.043). Previously we have described a significant in   crease of plasma BDNF levels in approximately 30% of our patients .  We therefore screened NTRK2 exons  encoding ligand binding and  catalytic regions ( exons  6, 7, 12, 18, 20 24) for mutations in 20 autis   tic individuals with increased BDNF levels and 10 controls . No muta   tions were identified in these individuals, and there was no evidence  for association of NTRK2 with plasma BDNF distribution . The overall  results therefore suggest that NTRK2  may be a susceptibility gene  for autism, but its impact on autism is not mediated by the increased BDNF levels .",2008.0,,"C. Correia1,2, I. Sousa2, I. Peixeiro2, L. Loureno2, J. Almeida3, R. Lontro3, L.  Galllagher4,5, M. Gill4,5, S. Ennis6, G. Oliveira3, A. M. Vicente1,2","1Instituto Nacional de Sade Dr.Ricardo Jorge, Lisboa, Portugal, 2Instituto  Gulbenkian de Cincia, Oeiras, Portugal, 3Hospital Peditrico de Coimbra,  Coimbra, Portugal, 4Department of Genetics, Smurfit Institute, Trinity College,  Dublin, Ireland, 5Department of Psychiatry, Trinity College, Dublin, Ireland,  6School of Medicine and Medical Sciences, University College, Dublin, Ireland. ","38 tag SNPs, spanning the NTRK2  gene, were tested for as   sociation with autism in 323 Portuguese trios.",sociation with autism,,"['sociation', 'with', 'autism']",[]
179,1457,Specific genetic diagnoses in Autism Spectrum Disorders. A 10  year genetic study of 159 patients from 5 psychiatric outpatient  care units,P07.014,,"Since 1998, a collaborative study has been undertaken between the  genetic department of Necker Enfants Malades hospital and 5 psychi   atric outpatient care units of le de France region . From 1998 to 2008,  159 patients with autistic spectrum disorders (ASDs) have undergone  on site genetic consultation gathering the following data: family and personal medical history, detailed psychiatric evaluation, dysmorpho   logical and neurological clinical examination . Blood and/or urine sam   ples were collected for genetic testing each time a specific disorder  was suggested after the first consultation, or for systematic screen   ing of common ASD related disorders . Systematic screening com   prised high resolution banding karyotype, with 22q13 and 15q11q13  FISH analyses, FMR1  gene triplet expansion testing, and metabolic  screening (blood aminoacid and urine organic acid chromatographies,  AICAR, urinary creatin and guanidinoacetate, N glycosylation, lactate,  pyruvate, ammonium). CGH array analysis was undertaken in 6% of  patients thus far  . Most of the 159 ASD patients (50 females and 106  males) had associated mental retardation ranging from mild to pro   found . 21 specific diagnoses were obtained for 30 patients: fragile X (8 pa   tients), 15q11q13 duplication (2 patients), 22qter deletion, 22q11 .2 de   letion, 1p36 deletion, Williams syndrome, trisomy X, Turner syndrome, interstitial 19q deletion, mosaic ring 15, 8q23q24 duplication, 17p11 .2  duplication, 1q31 duplication, 1q21 duplication, AP1S2  mutation,  Prader Willi, Cornelia de Lange, CHARGE and Rubinstein Taybi syn   dromes, creatin transporter deficiency (2 patients), GAMT deficiency, phenylketonuria, and histidinaemia . We present a cohort of 159 pa   tients with ASD. 23 specific genetic disorders were found in 32 patients (20,1 %) . These results emphasize the importance of on site evalua   tion of these patients .",2008.0,,"S. Lapuyade1, M. Assouline1, S. Martin1, J. Malen2, G. Rolland Manuel3, A.  Terkmani4, J. Lena5, J. Amiel5, J. Bonnefont5, L. Colleaux5, V. Cormier Daire5,  M. De Blois5, S. Lyonnet5, V. Malan5, A. Philippe5, O. Raoul5, M. Rio5, A. Mun   nich5, S. Whalen5","1Hpital de Jour Santos Dumont, Paris, France, 2Hpital de Jour Ssame Autis   me, Chevilly La Rue, France, 3Hpital de Jour dAntony, Antony, France, 4IME  Alternat, Antony, France, 5Dpartement de gntique, Hpital Necker Enfants  Malades, Paris, France","From 1998 to 2008,  159 patients with autistic spectrum disorders (ASDs) have undergone  on site genetic consultation gathering the following data: family and personal medical history, detailed psychiatric evaluation, dysmorpho   logical and neurological clinical examination .",,autistic spectrum,[],"['autistic', 'spectrum']"
179,1457,Specific genetic diagnoses in Autism Spectrum Disorders. A 10  year genetic study of 159 patients from 5 psychiatric outpatient  care units,P07.014,,"Since 1998, a collaborative study has been undertaken between the  genetic department of Necker Enfants Malades hospital and 5 psychi   atric outpatient care units of le de France region . From 1998 to 2008,  159 patients with autistic spectrum disorders (ASDs) have undergone  on site genetic consultation gathering the following data: family and personal medical history, detailed psychiatric evaluation, dysmorpho   logical and neurological clinical examination . Blood and/or urine sam   ples were collected for genetic testing each time a specific disorder  was suggested after the first consultation, or for systematic screen   ing of common ASD related disorders . Systematic screening com   prised high resolution banding karyotype, with 22q13 and 15q11q13  FISH analyses, FMR1  gene triplet expansion testing, and metabolic  screening (blood aminoacid and urine organic acid chromatographies,  AICAR, urinary creatin and guanidinoacetate, N glycosylation, lactate,  pyruvate, ammonium). CGH array analysis was undertaken in 6% of  patients thus far  . Most of the 159 ASD patients (50 females and 106  males) had associated mental retardation ranging from mild to pro   found . 21 specific diagnoses were obtained for 30 patients: fragile X (8 pa   tients), 15q11q13 duplication (2 patients), 22qter deletion, 22q11 .2 de   letion, 1p36 deletion, Williams syndrome, trisomy X, Turner syndrome, interstitial 19q deletion, mosaic ring 15, 8q23q24 duplication, 17p11 .2  duplication, 1q31 duplication, 1q21 duplication, AP1S2  mutation,  Prader Willi, Cornelia de Lange, CHARGE and Rubinstein Taybi syn   dromes, creatin transporter deficiency (2 patients), GAMT deficiency, phenylketonuria, and histidinaemia . We present a cohort of 159 pa   tients with ASD. 23 specific genetic disorders were found in 32 patients (20,1 %) . These results emphasize the importance of on site evalua   tion of these patients .",2008.0,,"S. Lapuyade1, M. Assouline1, S. Martin1, J. Malen2, G. Rolland Manuel3, A.  Terkmani4, J. Lena5, J. Amiel5, J. Bonnefont5, L. Colleaux5, V. Cormier Daire5,  M. De Blois5, S. Lyonnet5, V. Malan5, A. Philippe5, O. Raoul5, M. Rio5, A. Mun   nich5, S. Whalen5","1Hpital de Jour Santos Dumont, Paris, France, 2Hpital de Jour Ssame Autis   me, Chevilly La Rue, France, 3Hpital de Jour dAntony, Antony, France, 4IME  Alternat, Antony, France, 5Dpartement de gntique, Hpital Necker Enfants  Malades, Paris, France","Blood and/or urine sam   ples were collected for genetic testing each time a specific disorder  was suggested after the first consultation, or for systematic screen   ing of common ASD related disorders .",,ASD related disorders,[],"['ASD', 'related', 'disorder']"
179,1457,Specific genetic diagnoses in Autism Spectrum Disorders. A 10  year genetic study of 159 patients from 5 psychiatric outpatient  care units,P07.014,,"Since 1998, a collaborative study has been undertaken between the  genetic department of Necker Enfants Malades hospital and 5 psychi   atric outpatient care units of le de France region . From 1998 to 2008,  159 patients with autistic spectrum disorders (ASDs) have undergone  on site genetic consultation gathering the following data: family and personal medical history, detailed psychiatric evaluation, dysmorpho   logical and neurological clinical examination . Blood and/or urine sam   ples were collected for genetic testing each time a specific disorder  was suggested after the first consultation, or for systematic screen   ing of common ASD related disorders . Systematic screening com   prised high resolution banding karyotype, with 22q13 and 15q11q13  FISH analyses, FMR1  gene triplet expansion testing, and metabolic  screening (blood aminoacid and urine organic acid chromatographies,  AICAR, urinary creatin and guanidinoacetate, N glycosylation, lactate,  pyruvate, ammonium). CGH array analysis was undertaken in 6% of  patients thus far  . Most of the 159 ASD patients (50 females and 106  males) had associated mental retardation ranging from mild to pro   found . 21 specific diagnoses were obtained for 30 patients: fragile X (8 pa   tients), 15q11q13 duplication (2 patients), 22qter deletion, 22q11 .2 de   letion, 1p36 deletion, Williams syndrome, trisomy X, Turner syndrome, interstitial 19q deletion, mosaic ring 15, 8q23q24 duplication, 17p11 .2  duplication, 1q31 duplication, 1q21 duplication, AP1S2  mutation,  Prader Willi, Cornelia de Lange, CHARGE and Rubinstein Taybi syn   dromes, creatin transporter deficiency (2 patients), GAMT deficiency, phenylketonuria, and histidinaemia . We present a cohort of 159 pa   tients with ASD. 23 specific genetic disorders were found in 32 patients (20,1 %) . These results emphasize the importance of on site evalua   tion of these patients .",2008.0,,"S. Lapuyade1, M. Assouline1, S. Martin1, J. Malen2, G. Rolland Manuel3, A.  Terkmani4, J. Lena5, J. Amiel5, J. Bonnefont5, L. Colleaux5, V. Cormier Daire5,  M. De Blois5, S. Lyonnet5, V. Malan5, A. Philippe5, O. Raoul5, M. Rio5, A. Mun   nich5, S. Whalen5","1Hpital de Jour Santos Dumont, Paris, France, 2Hpital de Jour Ssame Autis   me, Chevilly La Rue, France, 3Hpital de Jour dAntony, Antony, France, 4IME  Alternat, Antony, France, 5Dpartement de gntique, Hpital Necker Enfants  Malades, Paris, France",Most of the 159 ASD patients (50 females and 106  males) had associated mental retardation ranging from mild to pro   found .,,ASD patients,[],"['ASD', 'patient']"
179,1457,Specific genetic diagnoses in Autism Spectrum Disorders. A 10  year genetic study of 159 patients from 5 psychiatric outpatient  care units,P07.014,,"Since 1998, a collaborative study has been undertaken between the  genetic department of Necker Enfants Malades hospital and 5 psychi   atric outpatient care units of le de France region . From 1998 to 2008,  159 patients with autistic spectrum disorders (ASDs) have undergone  on site genetic consultation gathering the following data: family and personal medical history, detailed psychiatric evaluation, dysmorpho   logical and neurological clinical examination . Blood and/or urine sam   ples were collected for genetic testing each time a specific disorder  was suggested after the first consultation, or for systematic screen   ing of common ASD related disorders . Systematic screening com   prised high resolution banding karyotype, with 22q13 and 15q11q13  FISH analyses, FMR1  gene triplet expansion testing, and metabolic  screening (blood aminoacid and urine organic acid chromatographies,  AICAR, urinary creatin and guanidinoacetate, N glycosylation, lactate,  pyruvate, ammonium). CGH array analysis was undertaken in 6% of  patients thus far  . Most of the 159 ASD patients (50 females and 106  males) had associated mental retardation ranging from mild to pro   found . 21 specific diagnoses were obtained for 30 patients: fragile X (8 pa   tients), 15q11q13 duplication (2 patients), 22qter deletion, 22q11 .2 de   letion, 1p36 deletion, Williams syndrome, trisomy X, Turner syndrome, interstitial 19q deletion, mosaic ring 15, 8q23q24 duplication, 17p11 .2  duplication, 1q31 duplication, 1q21 duplication, AP1S2  mutation,  Prader Willi, Cornelia de Lange, CHARGE and Rubinstein Taybi syn   dromes, creatin transporter deficiency (2 patients), GAMT deficiency, phenylketonuria, and histidinaemia . We present a cohort of 159 pa   tients with ASD. 23 specific genetic disorders were found in 32 patients (20,1 %) . These results emphasize the importance of on site evalua   tion of these patients .",2008.0,,"S. Lapuyade1, M. Assouline1, S. Martin1, J. Malen2, G. Rolland Manuel3, A.  Terkmani4, J. Lena5, J. Amiel5, J. Bonnefont5, L. Colleaux5, V. Cormier Daire5,  M. De Blois5, S. Lyonnet5, V. Malan5, A. Philippe5, O. Raoul5, M. Rio5, A. Mun   nich5, S. Whalen5","1Hpital de Jour Santos Dumont, Paris, France, 2Hpital de Jour Ssame Autis   me, Chevilly La Rue, France, 3Hpital de Jour dAntony, Antony, France, 4IME  Alternat, Antony, France, 5Dpartement de gntique, Hpital Necker Enfants  Malades, Paris, France",We present a cohort of 159 pa   tients with ASD.,tients with ASD,,"['tients', 'with', 'ASD']",[]
182,63,incomplete penetrance and variable expressivity in a series of 11  French patients with 15q13.3 recurrent microdeletion detected using array cGH.,C02.3,,"Since the large implementation of array CGH in the diagnostic work  up of mental retardation, novel microdeletion syndromes have been  described. In particular, the 15q13.3 microdeletion has been identi   fied in 0.2 0.3% of individuals with mental retardation and epilepsy,  schizophrenia, autism and other neuropsychiatric features. The criti   cal region between BP4 and BP5 contains at least seven genes, in   cluding CHRNA7 , which is considered a good candidate gene for the  epilepsy phenotype. We report a series of 11 patients (8 index cases  and 3 affected parents) presenting a developmental delay and a 1.5  Mb 15q13.3 recurrent microdeletion ascertained through 11 French  CGH array platforms. All 8 index cases presented mild to moderate  mental retardation with absent or non specific dysmorphic features.  Only two had seizures, 4 had an abnormal electroencephalogram and  none had an autistic behaviour. One patient presented a highly differ   ent phenotype, including hydrocephaly, joint dislocations, congenital  lymphoedema and notable dysmorphic features associated to men   tal retardation. Familial studies could be performed in 5/8 index pa   tients. Interestingly, all 15q13.3 microdeletions were inherited (3 from  the mother, 2 from the father). The affected parents had mild mental  retardation with epilepsy in one. In particular, the microdeletion was  found in 2 completely asymptomatic mothers. This study is in favour  of incomplete penetrance and more variable clinical expressivity than  previously published. Therefore, the 15q13.3 recurrent microdeletion  might be only considered as a risk factor for mental retardation. The  search for mutations on the second allele of the CHRNA7  gene is in  progress in order to explain this incomplete penetrance.",2009.0,,"A. Masurel Paulet1, J. Andrieux2, C. Le Caignec3, P. Callier4, M. P. Cordier5,  M. Beri6, B. Doray7, E. Flori7, O. Boute8, B. Delobel9, B. Isidor3, S. Jaillard10,  S. Odent11, C. Thauvin Robinet1, C. Bidon12, B. Aral13, F. Mugneret4, P. Jon   veaux14, D. Sanlaville15, L. Faivre1","1Centre de gntique, Hpital dEnfants, CHU, Dijon, France, 2Laboratoire de  gntique mdicale, Hpital Jeanne de Flandre, CHRU, Lille, France, 3Service  de gntique mdicale, CHU, Nantes, France, 4Service de cytogntique,  CHU, Dijon, France, 5Service de gntique, Hpital Edouard Herriot, CHRU,  Lyon, France, 6Laboratoire de gntique, CHU, Nancy, France, 7Service de  cytogntique, Hpital Hautepierre, CHU, Strasbourg, France, 8Service de  gntique clinique, Hpital Jeanne de Flandre, CHRU, Lille, France, 9Centre de  gntique chromosomique, Hpital Saint Vincent de Paul, CHRU, Lillle, France,  10Laboratoire de cytogntique, CHU Pontchaillou, Rennes, France, 11Service  de gntique mdicale, Hpital Sud, Rennes, France, 12Service de Biologie  molculaire, CHU, Dijon, France, 13Service de biologie molculaire, CHU, Dijon,  France, 14Service de gntique moleculaire, Hpital dadultes, CHU, Dijon,  France, 15laboratoire de cytogntique, Groupement hospitalier Est, CHU Lyon,  Bron, France","Only two had seizures, 4 had an abnormal electroencephalogram and  none had an autistic behaviour.",,autistic behaviour,[],"['autistic', 'behaviour']"
185,310,Novel Findings By Genome wide copy Number Analysis on chromosome 22 in a case with mild Facial Dysmorphology and Autistic/schizophrenic Behaviours,P02.104,,"Autism and schizophrenia are two neuro psychological disorders  which may occur superimposed on each other. They can be accompa   nied with some dysmorphic syndromes such as Fragile X syndrome,  Williams syndrome and Down syndrome.  We present a 13 year old  female case who showed autistic symptoms at first and followed by  positive schizophrenic symptoms. She also had multiple mild dysmor   phic features such as elfin like facial features, arched eyebrows, hy   pertelorism, depressed nasal bridge, bulbous nasal tip, downturned  corners of mouth, thick lower lip and joint laxity. Karyotyping and FISH  for Williams, Angelman and subtelomere of 22q were performed. We  performed whole genome copy number analysis by Affymetrix Gene  Chip 6.0 array for both case and parents. We showed inherited copy  number variations without any additional region. We also performed  LOH analysis and showed ~ 7Mb homozygosity at 22q11. No dysmorphic syndrome was identifiable; therefore she could be an  example of an unusual clinical picture with positive autistic, psychotic Clinical genetics and Dysmorphology symptoms, speech, language disability and multiple minor anomalies.",2009.0,,"E. Pariltay, O. Cogulu , A. Aykut, A. Alpman, B. Ozbaran, S. Erermis, C. Aydin,  F. Ozkinay","Ege University, Faculty of Medicine, Izmir, Turkey",We present a 13 year old  female case who showed autistic symptoms at first and followed by  positive schizophrenic symptoms.,,autistic symptoms,[],"['autistic', 'symptom']"
193,490,High resolution array analysis detects microdeletions of  chromosome region 16q22.1 in two unrelated individuals with  mR/ mcA syndrome,P03.082,,"Here we report a detailed clinical and molecular investigation of two un   related individuals, an 18 months old boy and a 13 years old girl with  de novo overlapping deletions of 16q22.1, sized 1.48Mb and 0.28Mb,  respectively. Clinically they both presented with dysmorphic features,  moderate developmental delay, sleeping disturbances, and abnormal  behaviour. The boy had low birth weight, short stature ( 4SD), micro   cephaly ( 4SD), high forehead, thin eyebrows with medial flaring,  strabismus, narrow flat nasal bridge, prominent columella, short flat  philtrum, thin lips, late erupted dysplastic teeth, dysplastic ears, short  fingers and toes, broad 1st toe, delayed skeletal age. He showed dis   tinct externalising behaviour, friendly and continuously smiling. The girl  had autistic behaviour, hypermetropia (+6), no signs of puberty at the  age of 13, and dysmorphism such as hypertelorism, thick eyebrows,  long eyelashes, epicanthic folds, wide pronounced nasal bridge, low  set posteriorly rotated dysplastic ears, long prominent philtrum, thin  lips, hairy skin, sandal gap, broad 1st toe. Chromosome aberrations  were detected by high resolution array analysis, 250k SNPs array (Af   fymetrix) for the 1.48Mb deletion and 244k CGH array (Agilent) for  the 0.28Mb deletion. Breakpoints on chromosome 16 were defined  as 65101151 66582496 (hg18) and 65958487 66235411 (hg18), re   spectively. Several possibly relevant genes are located in the over   lapping gene rich region such as CTCF, ZDHHC1, TPPP3, LRRC36,  and AGRP . Authors discuss reasons for partially overlapping/partially  distinct phenotypes of the two individuals. To our knowledge these  are the first two cases reported with microdeletions confined to the  16q22.1 region.",2009.0,,"T. Zagoras1, M. Kibaek2, M. Kirchhoff3, S. Kjaergaard3, J. Dahlgren4, A. Erlands   son1, M. Stefanova1","1Department of Clinical Genetics, Sahlgrenska University Hospital, Gothenburg,  Sweden, 2Department of Paediatrics, University Hospital of Odense, Odense,  Denmark, 3Department of Clinical Genetics, Rigshospitalet, University Hospital  of Copenhagen, Copenhagen, Denmark, 4Department of Paediatrics, Sahlgren   ska University Hospital, Gothenburg, Sweden","The girl  had autistic behaviour, hypermetropia (+6), no signs of puberty at the  age of 13, and dysmorphism such as hypertelorism, thick eyebrows,  long eyelashes, epicanthic folds, wide pronounced nasal bridge, low  set posteriorly rotated dysplastic ears, long prominent philtrum, thin  lips, hairy skin, sandal gap, broad 1st toe.",,autistic behaviour,[],"['autistic', 'behaviour']"
194,496,Whole genome array cGH screening in undiagnosed syndromic  patients: old syndromes revisited.,P03.088,,"Most microdeletional syndromes were presumed to be well defined  clinical entities. However, the introduction of whole genome screening  led not only to the description of new syndromes, but also to the rec   ognition of a broader spectrum of features for well known syndromes.  Here we report on 3 patients presenting with mental retardation and  normal standard karyotype. Patient 1 was a 37 year old male with pro   found mental retardation, severe psychiatric disturbances within the  autism spectrum, non specific dysmorphic features and bilateral reti   nal detachment. 105K array CGH Agilent permitted to diagnose a 1.6  Mb 17p11.2 microdeletion including the RAI1 gene, smaller than the  common microdeletion usually found in Smith Magenis syndrome. Pa   tient 2 was a 31 year old female with mild mental retardation, severe  anxiety, non specific dysmorphic features and short stature with micro   melia (142 cm) and X rays compatible with hypochondroplasia. 105K  array CGH Agilent revealed a 1.4 Mb 7q11.23 microdeletion, similar to  the deletion found in Williams syndrome. Patient 3 was a 6 year old  boy with mild mental retardation, non specific facial dysmorphism and  autistic features. BAC array (Integragen, 1Mb) also revealed a 7q11.23  microdeletion including the ELN gene. Reevaluation in the 3 patients  confirmed that the diagnosis was not possible on clinical grounds and  emphasize that well known genomic disorders can be phenotypically  heterogeneous and more variable than originally thought. The large  use of array CGH might lead that such patients may be more readily  achieved on the basis of genotype rather than phenotype.",2009.0,,"A. Mosca1, P. Callier1, L. Faivre2, N. Marle1, C. Thauvin Robinet2, A. Masurel  Paulet2, M. Beri3, E. Pipiras4, A. Delahaye4, E. Questiaux5, B. Benzacken4, P.  Jonveaux3, F. Mugneret1","1Laboratoire de Cytogntique, Dijon, France, 2Centre de Gntique, Dijon,  France, 3Laboratoire de Cytogntique, Nancy, France, 4Laboratoire de Cyto   gntique, Hpital Jean Verdier, Paris, France, 5Centre de Gntique, Hpital  Robert Ballanger, Aulnay sous bois, France","Patient 3 was a 6 year old  boy with mild mental retardation, non specific facial dysmorphism and  autistic features.",,autistic features,[],"['autistic', 'feature']"
196,503,"characterization of a supernumerary marker chromosome using  classical cytogenetics and acGH method : example of a partial  9p,15q trisomy and genetic/phenotypic correlations",P03.095,,"We report on a 1 year old patient with mild dysmorphism and devel   opmental delay. Born at term with normal growth parameters, he demonstrated since  the age of 6 months, growth and weight retardation. Delay in motor  milestones was observed as the child did not sit alone at 9 months. He  had also reduced social interactions. G banding showed the presence of a supernumerary chromosome  (47,XY,+mar), composed, as revealed by high resolution aCGH, of  27 Mb from region 9p24.3 to 9p21.2 and 12,3 Mb from 15q11.2 to  15q13.3. This derivative chromosome [der(15)t(9;15)(p21.2;q13.3)]  was subsequently found to derive from a maternal reciprocal trans   location, very likely originating from a meiotic missegregation of 3:1  tertiary type. Partial trisomy 9p21.2 9pter is not well defined but two patients with an  intrachromosomal duplication of chromosome arm 9p [dup(9)(p21p24)]  demonstrated classical clinical manifestations of 9p trisomy with, in  one case, features overlapping with Coffin Siris syndrome. Duplication of the 15q Prader Willi /Angelman syndrome region is  mainly associated with autistic behavior, mental retardation and de   velopmental delay. Most reported cases with associated clinical symp   toms have been linked to extra copies of 15q11 q13 from maternal  origin, paternally derived duplications being generally associated with  a normal phenotype. Our results also support this observation. Presence of potential extra copies of numerous genes from chromo   some 9p in addition to the duplicated 15q region renders a clinical  prognosis difficult. Further assessments and clinical evolution of the  patient will help to better define the spectrum of effects of the diverse  duplicated genes on the phenotype and on their interactions.",2009.0,,"F. Guerry, M. Addor, M. Pidoux, F. Niel, J. S. Beckmann, D. Martinet","Service de Gntique mdicale, CHUV, Lausanne, Switzerland","Duplication of the 15q Prader Willi /Angelman syndrome region is  mainly associated with autistic behavior, mental retardation and de   velopmental delay.",,autistic behavior,[],"['autistic', 'behavior']"
197,506,monozygotic twins discordant for submicroscopic chromosomal  anomalies detected by array cGH,P03.098,,"Although discordant phenotypes in monozygotic twins used to be con   sidered as an exception, an increasing number of reports indicate that  this phenomenon is not so rare. Most of reported patients have nu   merical chromosomal anomalies, with only few cases having structural  chromosomal anomalies. Here, we report on the clinical and cytoge   netic details of 4 year old female monozygotic twins with discordant  phenotypes. Twin 1 exhibited global developemental delay with walk at 35 months,  absence of speech, and hyperactivity. Twin 2 had an autistic spectrum  disorder without motor delay. Extensive investigations including blood  karyotype, metabolic screening and brain MRI were normal in both  twins. Molecular karyotyping in twin 1 identified a 2p25.3 deletion, further  confirmed by FISH analysis on leukocytes in all cells. Interestingly, ar   ray CGH was normal in twin 2 but FISH analysis performed on leuko   cytes using the same probes showed mosaicism with 33 % of deleted  cells, 33 % of duplicated cells, and 33% of normal cells. Genotyping  confirmed the monozygosity of the twins and ruled out uniparental di  Cytogenetics somy for chromosome 2. We propose that the discordant chromosome  imbalance may be due to a mitotic non allelic recombination occuring  during blastomeric divisions of a normal zygote. Such event will result  in 3 distinct cell populations whose proportion in each embryo formed  after separation from the inner cell mass, may differ, leading to dis   cordant chromosomal anomalies between twins. To our knowledge,  this is the first report of monozygotic twins with discordant phenotypes  ascribed to a distinct submicroscopic rearrangement detected by ar   ray CGH.",2009.0,,"M. Rio , V. Malan, C. Ozilou, S. Gobin, M. de Blois, A. Munnich, L. Colleaux, M.  Vekemans","Department of Genetic, Paris, France",Twin 2 had an autistic spectrum  disorder without motor delay.,,autistic spectrum,[],"['autistic', 'spectrum']"
199,587,Fourteen new cases contribute to the characterization of the  7q11.23 microduplication syndrome.,P03.181,,"Interstitial deletions of 7q11.23 cause Williams Beuren syndrome, one  of the best characterized microdeletion syndromes. The clinical phe   notype associated with the reciprocal duplication however is not well  defined, though speech delay is often mentioned. We present 14 new  7q11.23 cases with the reciprocal duplication of the Williams Beuren  syndrome critical region, 9 familial and 5 de novo . These were iden   tified by either array based MLPA or by array CGH/oligonucleotide  analysis in a series of patients with idiopathic mental retardation with  an estimated population frequency of 1:13.000 1:20.000. Interchromo   somal recombination is the preferred exchange mechanism by which  the duplication arises. The CYLN2  gene within the duplicated region  is approximately 2 times overexpressed in carriers of the duplication.  The expression of the GTF2I  gene, just on the boundary of the dupli   cated region and thus with only 2 intact copies present in patients, was  also significantly increased. Variable speech delay is a constant finding in our patient group, con   firming previous reports. Cognitive abilities range from normal to mod   erate mental retardation. The association with autism is present in five  patients and in one father who also carries the duplication. There is  an increased incidence of hypotonia and congenital anomalies: heart  defects (PDA), diaphragmatic hernia, cryptorchidism and non spe   cific brain abnormalities on MRI. Specific dysmorphic features were  noted in our patients, including a short philtrum, thin lips and straight  eyebrows. In summary, patients with the reciprocal duplication of the  Williams Beuren region have a number of features in common, sug   gestive of a clinically recognizable syndrome",2009.0,,"N. Van der Aa1, K. Storm1, G. Vandeweyer1, L. Rooms1, C. Romano2, G. Mort   ier3, B. Menten3, A. Destre4, K. Mnnik5, D. McMullan6, E. M. H. F. Bongers7,  S. Jacquemont8, C. Schrander Stumpel9, S. G. M. Frints9, B. W. M. van Bon7,  R. F. Kooy1","1Antwerp University Hospital, Wilrijk, Belgium, 2Oasi Institute (IRCCS), Troina,  Italy, 3Ghent University Hospital, Ghent, Belgium, 4Institut de Pathologie et de  Gntique, Gosselies, Belgium, 5University of Tartu, Tartu, Estonia, 6Birming   ham Womans Hospital, Birmingham, United Kingdom, 7Radboud University,  Nijmegen, The Netherlands, 8University of Lausanne, Lausanne, Switzerland,  9University Hospital AZM, Maastricht, The Netherlands",The association with autism is present in five  patients and in one father who also carries the duplication.,association with autism,,"['association', 'with', 'autism']",[]
200,1004,A 2.2mb microduplication in 1q42.2 including DISC  in 2  brothers with autism and mild mental retardation,P09.018,,"A growing number of copy number variations (CNV) are detected in  individuals with neurodevelopmental disorders. However, the interpre   tation is not always straightforward. We describe the identification and delineation of a 2.2Mb microdupli   cation in 1q42.2 in 2 brothers with autism and mild mental retardation. The duplication was detected by Array CGH with clones from the 1 Mb  BAC/PAC clone set (Sanger Institute Hinxton, UK). The aberration was  further delineated to 2.2Mb with a full tiling BAC array. By means of  quantitative real time PCR (qPCR) the breakpoints of the duplication  were mapped and segregation in the family was investigated. qPCR  was used to screen 260 patients with autism for DISC1  duplications. The 2.2Mb duplication was present in the proband, his affected brother  and the apparently unaffected father and paternal grandmother. Since  this duplication was not present in 1577 Belgian persons, it was con   sidered as a rare variant. Within this region the most interesting gene  with respect to autism is DISC1  (disrupted in schizophrenia 1 ) since  it is known to be involved in schizophrenia and has recently been as   sociated to autism and bipolar disorder. A group of 260 patients with  autism was studied for the occurrence of DISC1  duplications, but no  additional duplications were found. This study is a typical illustration of the difficult interpretation of causal   ity of a rare variant in neuropsychiatric disease. We conclude that the  DISC1  duplication is a rare variant that probably confers susceptibility  for autism in the current family.Complex traits and polygenic disorders",2009.0,,"A. Crepel1, J. Breckpot1, J. Fryns1, J. Steyaert2, K. Devriendt1, H. Peeters1","1Center for Human Genetics, Leuven, Belgium, 2Dept.Child Psychiatry, Leu   ven, Belgium. ",We describe the identification and delineation of a 2.2Mb microdupli   cation in 1q42.2 in 2 brothers with autism and mild mental retardation.,brothers with autism,,"['brother', 'with', 'autism']",[]
200,1004,A 2.2mb microduplication in 1q42.2 including DISC  in 2  brothers with autism and mild mental retardation,P09.018,,"A growing number of copy number variations (CNV) are detected in  individuals with neurodevelopmental disorders. However, the interpre   tation is not always straightforward. We describe the identification and delineation of a 2.2Mb microdupli   cation in 1q42.2 in 2 brothers with autism and mild mental retardation. The duplication was detected by Array CGH with clones from the 1 Mb  BAC/PAC clone set (Sanger Institute Hinxton, UK). The aberration was  further delineated to 2.2Mb with a full tiling BAC array. By means of  quantitative real time PCR (qPCR) the breakpoints of the duplication  were mapped and segregation in the family was investigated. qPCR  was used to screen 260 patients with autism for DISC1  duplications. The 2.2Mb duplication was present in the proband, his affected brother  and the apparently unaffected father and paternal grandmother. Since  this duplication was not present in 1577 Belgian persons, it was con   sidered as a rare variant. Within this region the most interesting gene  with respect to autism is DISC1  (disrupted in schizophrenia 1 ) since  it is known to be involved in schizophrenia and has recently been as   sociated to autism and bipolar disorder. A group of 260 patients with  autism was studied for the occurrence of DISC1  duplications, but no  additional duplications were found. This study is a typical illustration of the difficult interpretation of causal   ity of a rare variant in neuropsychiatric disease. We conclude that the  DISC1  duplication is a rare variant that probably confers susceptibility  for autism in the current family.Complex traits and polygenic disorders",2009.0,,"A. Crepel1, J. Breckpot1, J. Fryns1, J. Steyaert2, K. Devriendt1, H. Peeters1","1Center for Human Genetics, Leuven, Belgium, 2Dept.Child Psychiatry, Leu   ven, Belgium. ",qPCR  was used to screen 260 patients with autism for DISC1  duplications.,patients with autism,,"['patient', 'with', 'autism']",[]
201,1005,Role of serotonin transporter promoter length polymorphism in  autism: A south African population based study,P09.019,,"The serotonin transporter promoter length polymorphism (5 hydroxy   tryptamine transporter length polymorphism, 5 HTTLPR) has long  been implicated in autism and other psychiatric disorders. The use of  selective serotonin reuptake inhibitors (SSRIs) have shown to have  a positive effect in treating some symptoms of autism. The effects of  these drugs vary in individuals due to the presence of S or L alleles  of 5 HTTLPR. Studies performed on various autistic populations have  found different allele frequencies for the L and S alleles. In the present  study, allelic frequencies and genotypes of 110 South African (SA) au   tistic individuals (21 African, 48 Mixed and 41 Caucasian) were deter   mined and compared with the matching SA ethnic control populations.  The S/S genotype was found to be highly significantly associated with  all the SA autistic ethnic populations namely, Caucasian, 2 , 11.078;  Mixed, 2 , 18.512 and total group, 2 , 46.712 (df , 2; p < 0.001).  A highly significant increase in the S allele of the Mixed autistic group  ( 2 , 14.877, p < 0.001, df , 1) and the total autistic group ( 2 ,  17.742, p < 0.001, df , 1) was found when compared to the matching  control groups. The comparison of our data with studies of other au   tistic populations round the world showed highly significant differences  in allele numbers to French, Germans, Israelis, Portuguese and the  Americans (p < 0.005). It was less significant for the second French  group, Japanese and Korean populations (p < 0.05) and no difference  was observed between the Indian autistic population. This is the first  SA study of autistic individuals of different ethnic backgrounds show   ing significant differences of the allele and genotype frequencies of the  5 HTTLPR.",2009.0,,"Z. Arieff , M. Kaur, H. Gameeldien, M. Davids","University of the Western Cape, Bellville, South Africa",Studies performed on various autistic populations have  found different allele frequencies for the L and S alleles.,,autistic populations,[],"['autistic', 'population']"
201,1005,Role of serotonin transporter promoter length polymorphism in  autism: A south African population based study,P09.019,,"The serotonin transporter promoter length polymorphism (5 hydroxy   tryptamine transporter length polymorphism, 5 HTTLPR) has long  been implicated in autism and other psychiatric disorders. The use of  selective serotonin reuptake inhibitors (SSRIs) have shown to have  a positive effect in treating some symptoms of autism. The effects of  these drugs vary in individuals due to the presence of S or L alleles  of 5 HTTLPR. Studies performed on various autistic populations have  found different allele frequencies for the L and S alleles. In the present  study, allelic frequencies and genotypes of 110 South African (SA) au   tistic individuals (21 African, 48 Mixed and 41 Caucasian) were deter   mined and compared with the matching SA ethnic control populations.  The S/S genotype was found to be highly significantly associated with  all the SA autistic ethnic populations namely, Caucasian, 2 , 11.078;  Mixed, 2 , 18.512 and total group, 2 , 46.712 (df , 2; p < 0.001).  A highly significant increase in the S allele of the Mixed autistic group  ( 2 , 14.877, p < 0.001, df , 1) and the total autistic group ( 2 ,  17.742, p < 0.001, df , 1) was found when compared to the matching  control groups. The comparison of our data with studies of other au   tistic populations round the world showed highly significant differences  in allele numbers to French, Germans, Israelis, Portuguese and the  Americans (p < 0.005). It was less significant for the second French  group, Japanese and Korean populations (p < 0.05) and no difference  was observed between the Indian autistic population. This is the first  SA study of autistic individuals of different ethnic backgrounds show   ing significant differences of the allele and genotype frequencies of the  5 HTTLPR.",2009.0,,"Z. Arieff , M. Kaur, H. Gameeldien, M. Davids","University of the Western Cape, Bellville, South Africa","The S/S genotype was found to be highly significantly associated with  all the SA autistic ethnic populations namely, Caucasian, 2 , 11.078;  Mixed, 2 , 18.512 and total group, 2 , 46.712 (df , 2; p < 0.001).",,autistic ethnic populations,[],"['autistic', 'ethnic', 'population']"
201,1005,Role of serotonin transporter promoter length polymorphism in  autism: A south African population based study,P09.019,,"The serotonin transporter promoter length polymorphism (5 hydroxy   tryptamine transporter length polymorphism, 5 HTTLPR) has long  been implicated in autism and other psychiatric disorders. The use of  selective serotonin reuptake inhibitors (SSRIs) have shown to have  a positive effect in treating some symptoms of autism. The effects of  these drugs vary in individuals due to the presence of S or L alleles  of 5 HTTLPR. Studies performed on various autistic populations have  found different allele frequencies for the L and S alleles. In the present  study, allelic frequencies and genotypes of 110 South African (SA) au   tistic individuals (21 African, 48 Mixed and 41 Caucasian) were deter   mined and compared with the matching SA ethnic control populations.  The S/S genotype was found to be highly significantly associated with  all the SA autistic ethnic populations namely, Caucasian, 2 , 11.078;  Mixed, 2 , 18.512 and total group, 2 , 46.712 (df , 2; p < 0.001).  A highly significant increase in the S allele of the Mixed autistic group  ( 2 , 14.877, p < 0.001, df , 1) and the total autistic group ( 2 ,  17.742, p < 0.001, df , 1) was found when compared to the matching  control groups. The comparison of our data with studies of other au   tistic populations round the world showed highly significant differences  in allele numbers to French, Germans, Israelis, Portuguese and the  Americans (p < 0.005). It was less significant for the second French  group, Japanese and Korean populations (p < 0.05) and no difference  was observed between the Indian autistic population. This is the first  SA study of autistic individuals of different ethnic backgrounds show   ing significant differences of the allele and genotype frequencies of the  5 HTTLPR.",2009.0,,"Z. Arieff , M. Kaur, H. Gameeldien, M. Davids","University of the Western Cape, Bellville, South Africa","A highly significant increase in the S allele of the Mixed autistic group  ( 2 , 14.877, p < 0.001, df , 1) and the total autistic group ( 2 ,  17.742, p < 0.001, df , 1) was found when compared to the matching  control groups.",,autistic group,[],"['autistic', 'group']"
201,1005,Role of serotonin transporter promoter length polymorphism in  autism: A south African population based study,P09.019,,"The serotonin transporter promoter length polymorphism (5 hydroxy   tryptamine transporter length polymorphism, 5 HTTLPR) has long  been implicated in autism and other psychiatric disorders. The use of  selective serotonin reuptake inhibitors (SSRIs) have shown to have  a positive effect in treating some symptoms of autism. The effects of  these drugs vary in individuals due to the presence of S or L alleles  of 5 HTTLPR. Studies performed on various autistic populations have  found different allele frequencies for the L and S alleles. In the present  study, allelic frequencies and genotypes of 110 South African (SA) au   tistic individuals (21 African, 48 Mixed and 41 Caucasian) were deter   mined and compared with the matching SA ethnic control populations.  The S/S genotype was found to be highly significantly associated with  all the SA autistic ethnic populations namely, Caucasian, 2 , 11.078;  Mixed, 2 , 18.512 and total group, 2 , 46.712 (df , 2; p < 0.001).  A highly significant increase in the S allele of the Mixed autistic group  ( 2 , 14.877, p < 0.001, df , 1) and the total autistic group ( 2 ,  17.742, p < 0.001, df , 1) was found when compared to the matching  control groups. The comparison of our data with studies of other au   tistic populations round the world showed highly significant differences  in allele numbers to French, Germans, Israelis, Portuguese and the  Americans (p < 0.005). It was less significant for the second French  group, Japanese and Korean populations (p < 0.05) and no difference  was observed between the Indian autistic population. This is the first  SA study of autistic individuals of different ethnic backgrounds show   ing significant differences of the allele and genotype frequencies of the  5 HTTLPR.",2009.0,,"Z. Arieff , M. Kaur, H. Gameeldien, M. Davids","University of the Western Cape, Bellville, South Africa","A highly significant increase in the S allele of the Mixed autistic group  ( 2 , 14.877, p < 0.001, df , 1) and the total autistic group ( 2 ,  17.742, p < 0.001, df , 1) was found when compared to the matching  control groups.",,autistic group,[],"['autistic', 'group']"
201,1005,Role of serotonin transporter promoter length polymorphism in  autism: A south African population based study,P09.019,,"The serotonin transporter promoter length polymorphism (5 hydroxy   tryptamine transporter length polymorphism, 5 HTTLPR) has long  been implicated in autism and other psychiatric disorders. The use of  selective serotonin reuptake inhibitors (SSRIs) have shown to have  a positive effect in treating some symptoms of autism. The effects of  these drugs vary in individuals due to the presence of S or L alleles  of 5 HTTLPR. Studies performed on various autistic populations have  found different allele frequencies for the L and S alleles. In the present  study, allelic frequencies and genotypes of 110 South African (SA) au   tistic individuals (21 African, 48 Mixed and 41 Caucasian) were deter   mined and compared with the matching SA ethnic control populations.  The S/S genotype was found to be highly significantly associated with  all the SA autistic ethnic populations namely, Caucasian, 2 , 11.078;  Mixed, 2 , 18.512 and total group, 2 , 46.712 (df , 2; p < 0.001).  A highly significant increase in the S allele of the Mixed autistic group  ( 2 , 14.877, p < 0.001, df , 1) and the total autistic group ( 2 ,  17.742, p < 0.001, df , 1) was found when compared to the matching  control groups. The comparison of our data with studies of other au   tistic populations round the world showed highly significant differences  in allele numbers to French, Germans, Israelis, Portuguese and the  Americans (p < 0.005). It was less significant for the second French  group, Japanese and Korean populations (p < 0.05) and no difference  was observed between the Indian autistic population. This is the first  SA study of autistic individuals of different ethnic backgrounds show   ing significant differences of the allele and genotype frequencies of the  5 HTTLPR.",2009.0,,"Z. Arieff , M. Kaur, H. Gameeldien, M. Davids","University of the Western Cape, Bellville, South Africa","It was less significant for the second French  group, Japanese and Korean populations (p < 0.05) and no difference  was observed between the Indian autistic population.",,autistic population,[],"['autistic', 'population']"
201,1005,Role of serotonin transporter promoter length polymorphism in  autism: A south African population based study,P09.019,,"The serotonin transporter promoter length polymorphism (5 hydroxy   tryptamine transporter length polymorphism, 5 HTTLPR) has long  been implicated in autism and other psychiatric disorders. The use of  selective serotonin reuptake inhibitors (SSRIs) have shown to have  a positive effect in treating some symptoms of autism. The effects of  these drugs vary in individuals due to the presence of S or L alleles  of 5 HTTLPR. Studies performed on various autistic populations have  found different allele frequencies for the L and S alleles. In the present  study, allelic frequencies and genotypes of 110 South African (SA) au   tistic individuals (21 African, 48 Mixed and 41 Caucasian) were deter   mined and compared with the matching SA ethnic control populations.  The S/S genotype was found to be highly significantly associated with  all the SA autistic ethnic populations namely, Caucasian, 2 , 11.078;  Mixed, 2 , 18.512 and total group, 2 , 46.712 (df , 2; p < 0.001).  A highly significant increase in the S allele of the Mixed autistic group  ( 2 , 14.877, p < 0.001, df , 1) and the total autistic group ( 2 ,  17.742, p < 0.001, df , 1) was found when compared to the matching  control groups. The comparison of our data with studies of other au   tistic populations round the world showed highly significant differences  in allele numbers to French, Germans, Israelis, Portuguese and the  Americans (p < 0.005). It was less significant for the second French  group, Japanese and Korean populations (p < 0.05) and no difference  was observed between the Indian autistic population. This is the first  SA study of autistic individuals of different ethnic backgrounds show   ing significant differences of the allele and genotype frequencies of the  5 HTTLPR.",2009.0,,"Z. Arieff , M. Kaur, H. Gameeldien, M. Davids","University of the Western Cape, Bellville, South Africa",This is the first  SA study of autistic individuals of different ethnic backgrounds show   ing significant differences of the allele and genotype frequencies of the  5 HTTLPR.,,autistic individuals,[],"['autistic', 'individual']"
204,1098,"Recurrent rearrangements in synaptic and neurodevelopmental  genes support the existence of shared biological pathways  between schizophrenia, autism and mental retardation",P09.112,,"Comparative genomic hybridization (array CGH) studies have sug   gested that rare copy number variations (CNVs) at numerous loci are  involved in the aetiology of mental retardation (MR), autism (ASD)  and schizophrenia. We have investigated, using QMPSF (Quantita   tive Multiplex PCR of Short fluorescent Fragments), 28 candidate loci  previously identified by array CGH studies for gene dosage alteration  in 247 subjects with MR, 260 with ASD, 236 with schizophrenia or  schizoaffective disorder and 236 healthy controls. We show that the  collective frequency of CNVs at these loci is significantly increased in  autistic patients, patients with schizophrenia and patients with MR as  compared with controls (p<0.001, p,0.01 and p,0.001 respectively,  Fisher exact test). Individual significance (p,0.02) was reached for as   sociation between autism and a 350 kb deletion located in 22q11 and  spanning the PRODH gene. These results support the hypothesis that  weakly to moderately recurrent CNVs, either transmitted or occurring  de novo, are causing or contributory factors for these diseases. Sec   ond, we show that most of these CNVs, which contain genes involved  in neurotransmission or synapse formation and maintenance, are pres   ent in the 3 pathological conditions, supporting the existence of shared  biological pathways between these neurodevelopmental disorders.",2009.0,,"A. Guilmatre1, C. Dubourg2, A. Mosca1,3, S. Legallic1, A. Goldenberg4, V.  Drouin Garraud4, V. Layet5, A. Rosier6, S. Briault7, F. Bonnet Brilhault8, F. Lau   monnier8, S. Odent9, G. Le Vacon1, G. Joly Helas4, V. David2, C. Bendavid2,  C. Impallomeni10, E. Germano10, G. Di Rosa10, C. Barthelemy8, C. Andres11, L.  Faivre3, T. Frbourg1, P. Saugier Veber1, D. Campion1","1Inserm U614 and Rouen University Hospital, Rouen, France, 2UMR  6061CNRS, University of Rennes I, Rennes, France, 3Department of Genetics,  Dijon University Hospital, Dijon, France, 4Department of Genetics, Rouen Uni   versity Hospital, Rouen, France, 5Department of Genetics, Le Havre Hospital,  Le Havre, France, 6Centre de Ressources Autisme de Haute Normandie, Saint  Etienne du Rouvray, France, 7Department of Genetics, University Hospital,  Angers, France, 8Inserm U930, Universit Franois Rabelais and University  Hospital, Tours, France, 9Department of Genetics, University Hospital, Rennes,  France, 10Department of Medical and Surgical Pediatrics, University Hospital,  Messina, Italy, 11Inserm U 619, Tours, France","We show that the  collective frequency of CNVs at these loci is significantly increased in  autistic patients, patients with schizophrenia and patients with MR as  compared with controls (p<0.001, p,0.01 and p,0.001 respectively,  Fisher exact test).",,autistic patients,[],"['autistic', 'patient']"
207,11,"Neurogenetic pathways regulated by FOXP2, a gene  implicated in speech and language",PL3.1,,"People who carry rare heterozygous mutations disrupting the FOXP2   gene have problems mastering the complex sequences of mouth  movements needed for speech, along with deficits in many aspects  of expressive and receptive language. The gene encodes a highly  conserved transcription factor that helps regulate development and  function of neuronal subpopulations in a wide range of non speak   ing vertebrates, although evidence suggests that its role(s) may have  been modified during human evolution. It is emphasised that FOXP2   is not the mythical gene for speech, but represents one piece of a  complex puzzle. I will describe how FOXP2  can be used as a unique  window into key neurogenetic pathways via an array of complemen   tary approaches. For example, using functional genomic screening of  human neurons grown in the laboratory, we identified the CNTNAP2   gene (a member of the neurexin superfamily) as a downstream target directly regulated by FOXP2 . Intriguingly, we found that CNTNAP2  is  itself associated with common cases of language impairment; this tar   get has also been implicated in language delays of autistic children.  High throughput screening has enabled us to isolate additional pu   tative targets of FOXP2 , including multiple genes involved in neurite  outgrowth and synaptic plasticity. Moving to animal models of FOXP2   dysfunction, we have shown that point mutations implicated in human  speech deficits yield impaired motor skill learning in mutant mice.  Electrophysiological recording suggests that this may be mediated by  altered plasticity of Foxp2 expressing circuitry. Together with findings  from other model systems, these data indicate that the contributions  of FOXP2  to human speech and language are built on evolutionarily  ancient roles in neural circuits involved in sensorimotor integration and  motor skill learning. Overall, this work demonstrates how we can be   gin to bridge gaps between molecules, neurons and the brain, helping  us to build more sophisticated models of the relationships between  genes, speech and language.",2010.0,,S. E. Fisher,"Wellcome Trust Centre for Human Genetics, Oxford, United Kingdom","Intriguingly, we found that CNTNAP2  is  itself associated with common cases of language impairment; this tar   get has also been implicated in language delays of autistic children.",,autistic children,[],"['autistic', 'child']"
209,37,Genome Wide Association Studies in Autism Spectrum  Disorders,S08.2,,"Autism spectrum disorders (ASDs) represent a large group of child   hood neurodevelopmental, neuropsychiatric disorders characterized  by restricted and repetitive patterns of interests and behavior, limited  verbal communication and impairment of social interaction. Several  sources of evidence suggest strong a genetic component in the sus  ceptibility to ASDs; for instance, there are much higher concordance  rates for ASDs in monozygotic twins (92%) than dizygotic twins (10%),  while recent estimates for the sibling recurrence risk is greater than  15. Although ASDs are highly heritable disorders, they exhibit hetero   geneous clinical symptoms and genetic architecture which have hin   dered identification of common genetic susceptibility factors. Although  previous linkage studies, candidate gene association studies and cy   togenetic studies have implicated several chromosomal regions for the  presence of autism susceptibility loci they have failed to consistently  identify genes or genomic loci that increase risk of ASD presentations.  Using the genome wide association study (GWAS) approach, we  have recently identified common genetic variants between two cad   herin genes ( CDH10  and CDH9 ) as associated with ASDs (Wang et  al, Nature , 2009), as well as a collection of rare copy number variants  in neuronal cell adhesion genes (Glessner et al, Nature , 2009). The  discovery cohorts in the GWAS contains 780 families (3,101 subjects)  with affected children, and a second cohort of 1,204 affected subjects  and 6,491 control subjects, all of whom were genotyped by us in the  Childrens Hospital of Philadelphia (CHOP), representing the largest  ASDs genetics studies ever performed. The results from these studies  and our ongoing search for the causal variants and their potential influ   ence on the neuronal cell adhesion molecules in the pathogenesis of  ASDs will be presented.",2010.0,,H. Hakonarson,"Center for Applied Genomics, Childrens Hospital of Philadelphia, Philadelphia,  PA, United States","Although  previous linkage studies, candidate gene association studies and cy   togenetic studies have implicated several chromosomal regions for the  presence of autism susceptibility loci they have failed to consistently  identify genes or genomic loci that increase risk of ASD presentations.",,ASD presentations,[],"['ASD', 'presentation']"
209,37,Genome Wide Association Studies in Autism Spectrum  Disorders,S08.2,,"Autism spectrum disorders (ASDs) represent a large group of child   hood neurodevelopmental, neuropsychiatric disorders characterized  by restricted and repetitive patterns of interests and behavior, limited  verbal communication and impairment of social interaction. Several  sources of evidence suggest strong a genetic component in the sus  ceptibility to ASDs; for instance, there are much higher concordance  rates for ASDs in monozygotic twins (92%) than dizygotic twins (10%),  while recent estimates for the sibling recurrence risk is greater than  15. Although ASDs are highly heritable disorders, they exhibit hetero   geneous clinical symptoms and genetic architecture which have hin   dered identification of common genetic susceptibility factors. Although  previous linkage studies, candidate gene association studies and cy   togenetic studies have implicated several chromosomal regions for the  presence of autism susceptibility loci they have failed to consistently  identify genes or genomic loci that increase risk of ASD presentations.  Using the genome wide association study (GWAS) approach, we  have recently identified common genetic variants between two cad   herin genes ( CDH10  and CDH9 ) as associated with ASDs (Wang et  al, Nature , 2009), as well as a collection of rare copy number variants  in neuronal cell adhesion genes (Glessner et al, Nature , 2009). The  discovery cohorts in the GWAS contains 780 families (3,101 subjects)  with affected children, and a second cohort of 1,204 affected subjects  and 6,491 control subjects, all of whom were genotyped by us in the  Childrens Hospital of Philadelphia (CHOP), representing the largest  ASDs genetics studies ever performed. The results from these studies  and our ongoing search for the causal variants and their potential influ   ence on the neuronal cell adhesion molecules in the pathogenesis of  ASDs will be presented.",2010.0,,H. Hakonarson,"Center for Applied Genomics, Childrens Hospital of Philadelphia, Philadelphia,  PA, United States","The  discovery cohorts in the GWAS contains 780 families (3,101 subjects)  with affected children, and a second cohort of 1,204 affected subjects  and 6,491 control subjects, all of whom were genotyped by us in the  Childrens Hospital of Philadelphia (CHOP), representing the largest  ASDs genetics studies ever performed.",,ASDs genetics,[],"['ASDs', 'genetics']"
214,245,Detection of genomic imbalances by arraycGH in two  children with syndromic autism.,P02.024,,"Autism is a complex behaviorally defined disorder of the immature  brain. It is not a disease but a syndrome with multiple non genetic  and/or genetic causes. Autism spectrum disorders (ASD) are condi   tions which can be either isolated or syndromic, that is associated  with other clinical features such as facial dysmorphism, limb or vis   ceral malformations, and growth abnormalities. Currently, diagnosable  medical conditions, cytogenetic abnormalities, environmental factors,  and single gene defects associated with autism, together account for  10 20% of cases. We report two children with autistic behavior, mental retardation and  dysmorphic features. We have used genomic array CytoChip (BlueG   nome, Cambridge, UK), covering the entire genome at a median 565  kb, a resolution optimised to detect pathogenic imbalances while mini  Clinical genetics and Dysmorphology mizing polymorphisms. Array CGH  analysis revealed cryptic ampli   fication of 16p11.2 region spanning 1,362 Mb in first patient and an  amplification spanning 1,274Mb of 7p12.3 region in second patient.  The microdeletion and a reciprocal microduplication of 16p11.2 region  carry substantial susceptibility to autism and appear to account for ap   proximately 1% of cases. 7p12.3 is a region of shared genetic associa   tion between ASD and attention deficit hyperactivity disorder (ADHD). These data strongly support the idea that only a whole genome high  resolution analysis such as array CGH is able to provide an accurate  diagnosis for chromosomal imbalance in patients with ASD. Confirma   tory FISH studies with BAC clones are planned for accurate confirma   tion of CytoChip result.",2010.0,,"D. Avdjieva Tzavella1, S. Hadjidekova2, B. Rukova2, D. Nesheva2, E.  Simeonov3, R. Tincheva1, D. Toncheva2","1Department of Clinical Genetics, University Pediatrics Hospital, Medical  University, Sofia, Bulgaria, Sofia, Bulgaria, 2Department of Medical Genetics,  Medical Faculty, Medical University, Sofia, Bulgaria, 3Clinic of Pediatrics,  University Hospital Alexandrovska, Sofia, Bulgaria","We report two children with autistic behavior, mental retardation and  dysmorphic features.",,autistic behavior,[],"['autistic', 'behavior']"
214,245,Detection of genomic imbalances by arraycGH in two  children with syndromic autism.,P02.024,,"Autism is a complex behaviorally defined disorder of the immature  brain. It is not a disease but a syndrome with multiple non genetic  and/or genetic causes. Autism spectrum disorders (ASD) are condi   tions which can be either isolated or syndromic, that is associated  with other clinical features such as facial dysmorphism, limb or vis   ceral malformations, and growth abnormalities. Currently, diagnosable  medical conditions, cytogenetic abnormalities, environmental factors,  and single gene defects associated with autism, together account for  10 20% of cases. We report two children with autistic behavior, mental retardation and  dysmorphic features. We have used genomic array CytoChip (BlueG   nome, Cambridge, UK), covering the entire genome at a median 565  kb, a resolution optimised to detect pathogenic imbalances while mini  Clinical genetics and Dysmorphology mizing polymorphisms. Array CGH  analysis revealed cryptic ampli   fication of 16p11.2 region spanning 1,362 Mb in first patient and an  amplification spanning 1,274Mb of 7p12.3 region in second patient.  The microdeletion and a reciprocal microduplication of 16p11.2 region  carry substantial susceptibility to autism and appear to account for ap   proximately 1% of cases. 7p12.3 is a region of shared genetic associa   tion between ASD and attention deficit hyperactivity disorder (ADHD). These data strongly support the idea that only a whole genome high  resolution analysis such as array CGH is able to provide an accurate  diagnosis for chromosomal imbalance in patients with ASD. Confirma   tory FISH studies with BAC clones are planned for accurate confirma   tion of CytoChip result.",2010.0,,"D. Avdjieva Tzavella1, S. Hadjidekova2, B. Rukova2, D. Nesheva2, E.  Simeonov3, R. Tincheva1, D. Toncheva2","1Department of Clinical Genetics, University Pediatrics Hospital, Medical  University, Sofia, Bulgaria, Sofia, Bulgaria, 2Department of Medical Genetics,  Medical Faculty, Medical University, Sofia, Bulgaria, 3Clinic of Pediatrics,  University Hospital Alexandrovska, Sofia, Bulgaria",These data strongly support the idea that only a whole genome high  resolution analysis such as array CGH is able to provide an accurate  diagnosis for chromosomal imbalance in patients with ASD.,patients with ASD,,"['patient', 'with', 'ASD']",[]
216,296,congenital heart defects in Ellis van creveld syndrome,P02.076,,"Ellis van Creveld syndrome (EVCS) is an autosomal recessive skeletal  dysplasia characterized by short ribs, short limbs, postaxial polydac   tyly, dysplastic nails and teeth, frequently associated with congenital  heart defects. We present four cases in order to illustrate this rare  entity and to discuss the variability of heart defects. H.B.I. (5,8 y old female): disproportionate dwarfism, dysmorphic cra   niofacies (sparse, fine hair; proeminent metopic suture, accessory gin   gival frenulae, conical teeth), narrow thorax, pectus carinatum, distal  limb shortening symmetrically affecting the forearms and lower legs,  brachydactyly and bilateral postaxial polydactyly, hypoplastic nails,  fused proximal and medium falanges (finger II   V); ecocardiography:  ASD ostium secundum, pulmonary valvular stenosis, hypertrophic car   diomyopathy. T.L.A. (1,6 old male): disproportionate dwarfism, craniofacial dysmor   phy (sparse hair, accessory gingival frenulae), narrow thorax, distal limb shortening symmetrically affecting the forearms and lower legs,  brachydactyly and bilateral postaxial polydactyly, hypoplastic bilateral  fibulae; ecocardiography: large ASD ostium primum, cleft anterior mi   tral valve, hypoplastic tricuspid valve. P.G.M. (6 days   deceased): disproportionate dwarfism, dysmorphic  craniofacies (accessory gingival frenulae, neonatal teeth), narrow tho   rax, distal limb shortening symmetrically affecting the forearms and  lower legs, bilateral postaxial polydactyly (feet); echocardiography:  ASD, enlarged right ventricle. T.M. (5y old, female): disproportionate dwarfism, craniofacial dysmor   phy (accessory gingival frenulae, conical teeth), distal limb shorten   ing symmetrically affecting the forearms and lower legs, brachydactyly  and bilateral postaxial polydactyly, hypoplastic nails. In conclusion, we present four cases of EVCS in order to illustrate this  rare genetic disorder but also to discuss the variable expression of  heart defects, long term follow up, management and genetic counsel   ing.",2010.0,,"M. C. Panzaru1, M. Volosciuc2, E. Braha1, L. Caba1, C. Rusu1","1Gr.T. Popa University of Medicine and Pharmacy, Iasi, Romania, 2Medical  Genetics Centre, Iasi, Romania. ","(1,6 old male): disproportionate dwarfism, craniofacial dysmor   phy (sparse hair, accessory gingival frenulae), narrow thorax, distal limb shortening symmetrically affecting the forearms and lower legs,  brachydactyly and bilateral postaxial polydactyly, hypoplastic bilateral  fibulae; ecocardiography: large ASD ostium primum, cleft anterior mi   tral valve, hypoplastic tricuspid valve.",,ASD ostium,[],"['ASD', 'ostium']"
218,343,"Duplications of 17q12 q21 in patients with mental  retardation, growth disturbances and facial dysmorphism",P02.123,,"Purpose: In recent years, small genomic rearrangements of 17q12 and  17q21.31 have been described in patients with autism, cognitive im   pairment/ mental retardation, renal disease, epilepsy, and/or growth  retardation. We present three unrelated patients with partially overlap   ping duplications in the 17q12 q21.32 region. Methods: Microarray analysis (Affymetrix SNP_6.0, BAC array, or oligo  array) was performed on purified DNA from peripheral lymphocytes.  FISH analysis was done on cultured lymphocytes according to stan   dard protocols. Results: We identified three unrelated patients with partially overlap   ping de novo  duplications in the 17q12 q21.32 region. All patients were  investigated with genome wide array platforms, showing sizes of the  duplications of 1.5 Mb, 6.6 Mb, and 7.7 Mb respectively. Though the  patients had diverse clinical features as well, all presented with mental  retardation, facial dysmorphism and growth disturbances. Conclusion: We report three patients with mental retardation, growth  disturbances and facial dysmorphism carrying partially overlapping du   plications of the gene rich locus on chromosome 17q12 q21.32. We  add new clinical features to the variable phenotype of 17q12 q21.32  duplications.",2010.0,,"L. L. Klitten1,2, R. S. Mller1,2, B. Dallapiccola3, M. C. Digilio3, H. C. Mefford4, R.  C. M. Hennekam5, N. Tommerup1, H. Hjalgrim2","1Wilhelm Johannsen Centre for Functional Genome Research, University of  Copenhagen, Copenhagen, Denmark, 2Danish Epilepsy Centre, Dianalund,  Denmark, 3Bambino Ges Children Hospital, IRCCS Rome, Italy, 4Department  of Pediatrics, Division of Genetic Medicine, University of Washington, Seattle,  WA, United States, 5Department of Pediatrics, Academic Medical Centre,  University of Amsterdam, Amsterdam, Netherlands","Purpose: In recent years, small genomic rearrangements of 17q12 and  17q21.31 have been described in patients with autism, cognitive im   pairment/ mental retardation, renal disease, epilepsy, and/or growth  retardation.",patients with autism,,"['patient', 'with', 'autism']",[]
222,392,"Autistic features and unusual behavior in a girl with  ring chromosome 11: clinical, psychological and molecular  cytogenetic characterization",P02.172,,"We report an 8 year old Caucasian girl with a ring 11 chromosome pre   senting with microcephaly, short stature, intellectual disabilities, spas   tic ataxic syndrome and autistic features. The majority of phenotypic  features resemble those previously reported for r(11), whereas spas   tic ataxic syndrome and autistic features are not. The proposita is a  girl delivered at term to non consanguineous parents. She has severe  growth and psychomotor retardation, bicuspid aortic valve, congenital  strabismus, hipoplastic thymus gland, pancreas dysfunction, cafe  au lait pigmentary skin changes, partial ptosis, abnormal ear shape,  high arched palate, broad nasal bridge, shortening of III metatarsal  bone. MRI has showed slight frontal lobe atrophy, hydrocephalus and  myelination deficit. She has inconsistent eye contact, increased anxi   ety/fears and ritualistic, stereotyped, self injurious behavior, and is ner   vous, depressive and tearfulness. Total CARS score is 36 (moderate  autism). Repetitive Behavior Scale Revised score is 37 (high scores  for self injurious, restricted and ritualistic/sameness behavior; median  scores for stereotyped behavior; low score for compulsive behavior).  Speech difficulties refer to rhinolalia and poor vocabulary. The girl has  good concentration span and long term verbal memory, being ex   tremely good in gestalt recognition with occasional difficulties of com   mon things recognition. Molecular cytogenetic characterization was  performed by FISH with site specific DNA probes for subtelomeric and  interstitial chromosome 11 regions as well as by whole genome BAC  array 1Mb CGH. We found ring chromosome to be associated with  loss of 11q24.1 >11qter (121,411,392 134,916,587 or ~13.5Mb) with   out chromosomal DNA loss within 11pter. To the best our knowledge,  this is the first case of r(11) characterized by array CGH.",2010.0,,"E. A. Saprina1,2, S. G. Vorsanova1,3, Y. B. Yurov1,3, V. Y. Voinova3,2, O. S.  Kurinnaia1,3, A. D. Kolotii1,3, I. Y. Iourov1,3","1National Research Center of Mental Health, RAMS, Moscow, Russian  Federation, 2Moscow City University of Psychology and Education,  Moscow, Russian Federation, 3Institute of Pediatrics and Children Surgery,  Rosmedtechnologii, Moscow, Russian Federation","We report an 8 year old Caucasian girl with a ring 11 chromosome pre   senting with microcephaly, short stature, intellectual disabilities, spas   tic ataxic syndrome and autistic features.",,autistic features,[],"['autistic', 'feature']"
222,392,"Autistic features and unusual behavior in a girl with  ring chromosome 11: clinical, psychological and molecular  cytogenetic characterization",P02.172,,"We report an 8 year old Caucasian girl with a ring 11 chromosome pre   senting with microcephaly, short stature, intellectual disabilities, spas   tic ataxic syndrome and autistic features. The majority of phenotypic  features resemble those previously reported for r(11), whereas spas   tic ataxic syndrome and autistic features are not. The proposita is a  girl delivered at term to non consanguineous parents. She has severe  growth and psychomotor retardation, bicuspid aortic valve, congenital  strabismus, hipoplastic thymus gland, pancreas dysfunction, cafe  au lait pigmentary skin changes, partial ptosis, abnormal ear shape,  high arched palate, broad nasal bridge, shortening of III metatarsal  bone. MRI has showed slight frontal lobe atrophy, hydrocephalus and  myelination deficit. She has inconsistent eye contact, increased anxi   ety/fears and ritualistic, stereotyped, self injurious behavior, and is ner   vous, depressive and tearfulness. Total CARS score is 36 (moderate  autism). Repetitive Behavior Scale Revised score is 37 (high scores  for self injurious, restricted and ritualistic/sameness behavior; median  scores for stereotyped behavior; low score for compulsive behavior).  Speech difficulties refer to rhinolalia and poor vocabulary. The girl has  good concentration span and long term verbal memory, being ex   tremely good in gestalt recognition with occasional difficulties of com   mon things recognition. Molecular cytogenetic characterization was  performed by FISH with site specific DNA probes for subtelomeric and  interstitial chromosome 11 regions as well as by whole genome BAC  array 1Mb CGH. We found ring chromosome to be associated with  loss of 11q24.1 >11qter (121,411,392 134,916,587 or ~13.5Mb) with   out chromosomal DNA loss within 11pter. To the best our knowledge,  this is the first case of r(11) characterized by array CGH.",2010.0,,"E. A. Saprina1,2, S. G. Vorsanova1,3, Y. B. Yurov1,3, V. Y. Voinova3,2, O. S.  Kurinnaia1,3, A. D. Kolotii1,3, I. Y. Iourov1,3","1National Research Center of Mental Health, RAMS, Moscow, Russian  Federation, 2Moscow City University of Psychology and Education,  Moscow, Russian Federation, 3Institute of Pediatrics and Children Surgery,  Rosmedtechnologii, Moscow, Russian Federation","The majority of phenotypic  features resemble those previously reported for r(11), whereas spas   tic ataxic syndrome and autistic features are not.",,autistic features,[],"['autistic', 'feature']"
223,418,High frequency of autistic traits in Williams Beuren  patients.,P02.198,,"Williams Beuren syndrome (WBS) is characterized by elfin facies,  congenital heart disease (supravalvar aortic stenosis), mental retarda   tion and peculiar hyper sociable behavior. It is caused by microdeletion  of 1.5 to 1.8Mb in 7q.11.23 region. We studied 31 WBS patients (20 M and 12 F) and their age ranged  from 9 to 26 years (median 14y). The diagnosis of WBS was confirmed  by FISH, MLPA or micro satellite markers analysis in all patients. The objectives were to evaluate cognitive ability, the execution IQ,  verbal and total, the frequency of visual spatial deficits and autistic  traits. The tests used were: WISC III, WAIS III, Rey Complex Figure  and scale of autistic traits (ATA). All patients had cognitive impairment in all tests, the total IQ ranged  from 51 to 86 (median 63): 22 with mild mental retardation, 4 moder  Clinical genetics and Dysmorphology102 ate, 4 borderline and 1 on average lower. All patients had marked vi   sual spatial deficit. The frequency of autistic traits were found in 13/31  patients (41.94%) with predominance in males (10M: 3F). No correla   tion was found between the size of the deletion and the presence or  absence of autism. Our study reinforces the importance of the systematic assessment of  the cognitive function in WBS patients and alert for the presence of a  high frequency of autistic traits, opposite of overfriendliness personal   ity typically found in WBS patients. These latter data are preliminary  and further studies are necessary to confirm this specific finding in  WBS. (FAPESP)",2010.0,,"C. A. Kim1, F. B. Assumpo Junior2, R. S. Honjo1, R. L. Dutra1, V. A. S.  Amaral1, H. K. Oh3, D. R. Bertola1, L. M. J. Albano1, M. M. Nunes1","1Unidade de Gentica, ICr/FMUSP, So Paulo, Brazil, 2Departamento de  Psicologia,USP, So Paulo, Brazil, 3College of Alternative Medicine, Jeonju,  Korea, Republic of","The tests used were: WISC III, WAIS III, Rey Complex Figure  and scale of autistic traits (ATA).",,autistic traits,[],"['autistic', 'trait']"
223,418,High frequency of autistic traits in Williams Beuren  patients.,P02.198,,"Williams Beuren syndrome (WBS) is characterized by elfin facies,  congenital heart disease (supravalvar aortic stenosis), mental retarda   tion and peculiar hyper sociable behavior. It is caused by microdeletion  of 1.5 to 1.8Mb in 7q.11.23 region. We studied 31 WBS patients (20 M and 12 F) and their age ranged  from 9 to 26 years (median 14y). The diagnosis of WBS was confirmed  by FISH, MLPA or micro satellite markers analysis in all patients. The objectives were to evaluate cognitive ability, the execution IQ,  verbal and total, the frequency of visual spatial deficits and autistic  traits. The tests used were: WISC III, WAIS III, Rey Complex Figure  and scale of autistic traits (ATA). All patients had cognitive impairment in all tests, the total IQ ranged  from 51 to 86 (median 63): 22 with mild mental retardation, 4 moder  Clinical genetics and Dysmorphology102 ate, 4 borderline and 1 on average lower. All patients had marked vi   sual spatial deficit. The frequency of autistic traits were found in 13/31  patients (41.94%) with predominance in males (10M: 3F). No correla   tion was found between the size of the deletion and the presence or  absence of autism. Our study reinforces the importance of the systematic assessment of  the cognitive function in WBS patients and alert for the presence of a  high frequency of autistic traits, opposite of overfriendliness personal   ity typically found in WBS patients. These latter data are preliminary  and further studies are necessary to confirm this specific finding in  WBS. (FAPESP)",2010.0,,"C. A. Kim1, F. B. Assumpo Junior2, R. S. Honjo1, R. L. Dutra1, V. A. S.  Amaral1, H. K. Oh3, D. R. Bertola1, L. M. J. Albano1, M. M. Nunes1","1Unidade de Gentica, ICr/FMUSP, So Paulo, Brazil, 2Departamento de  Psicologia,USP, So Paulo, Brazil, 3College of Alternative Medicine, Jeonju,  Korea, Republic of",The frequency of autistic traits were found in 13/31  patients (41.94%) with predominance in males (10M: 3F).,,autistic traits,[],"['autistic', 'trait']"
223,418,High frequency of autistic traits in Williams Beuren  patients.,P02.198,,"Williams Beuren syndrome (WBS) is characterized by elfin facies,  congenital heart disease (supravalvar aortic stenosis), mental retarda   tion and peculiar hyper sociable behavior. It is caused by microdeletion  of 1.5 to 1.8Mb in 7q.11.23 region. We studied 31 WBS patients (20 M and 12 F) and their age ranged  from 9 to 26 years (median 14y). The diagnosis of WBS was confirmed  by FISH, MLPA or micro satellite markers analysis in all patients. The objectives were to evaluate cognitive ability, the execution IQ,  verbal and total, the frequency of visual spatial deficits and autistic  traits. The tests used were: WISC III, WAIS III, Rey Complex Figure  and scale of autistic traits (ATA). All patients had cognitive impairment in all tests, the total IQ ranged  from 51 to 86 (median 63): 22 with mild mental retardation, 4 moder  Clinical genetics and Dysmorphology102 ate, 4 borderline and 1 on average lower. All patients had marked vi   sual spatial deficit. The frequency of autistic traits were found in 13/31  patients (41.94%) with predominance in males (10M: 3F). No correla   tion was found between the size of the deletion and the presence or  absence of autism. Our study reinforces the importance of the systematic assessment of  the cognitive function in WBS patients and alert for the presence of a  high frequency of autistic traits, opposite of overfriendliness personal   ity typically found in WBS patients. These latter data are preliminary  and further studies are necessary to confirm this specific finding in  WBS. (FAPESP)",2010.0,,"C. A. Kim1, F. B. Assumpo Junior2, R. S. Honjo1, R. L. Dutra1, V. A. S.  Amaral1, H. K. Oh3, D. R. Bertola1, L. M. J. Albano1, M. M. Nunes1","1Unidade de Gentica, ICr/FMUSP, So Paulo, Brazil, 2Departamento de  Psicologia,USP, So Paulo, Brazil, 3College of Alternative Medicine, Jeonju,  Korea, Republic of","Our study reinforces the importance of the systematic assessment of  the cognitive function in WBS patients and alert for the presence of a  high frequency of autistic traits, opposite of overfriendliness personal   ity typically found in WBS patients.",,autistic traits,[],"['autistic', 'trait']"
227,449,"Balanced and unbalanced forms of transmission of a  complex chromosomal rearrangement involving chromosomes  3, 8 and 10 in two generations",P03.025,,"We report a familial apparently balanced complex chromosomal re   arrangement (BCCR) involving chromosomes 3, 8 and 10. The pro   band is the fourth child from the eighth pregnancy of an unaffected  mother whose karyotype was determined as 46,XX,t(8;10)(q13;q24),i ns(3;8)(q26.2;q22q23). Standard chromosome analysis of amniocytes  revealed apparently the same balanced karyotype in the proband.  However, at the age of three years the boy was referred for genetic  analysis because of psychomotor delay, speech problems, autistic fea   tures, teeth irregularity and dysplastic ears. Array CGH and SNP array  analysis were performed but yielded no clues, including no evidence  for uniparental disomy. Probands elder brother was born prematurely  and died perinatally due to multiple severe malformations including  bilateral cleft lip and palate, protruding premaxilla, right microtia with  the absence of ear canal, deformation of legs, hypospadia and hypo   genitalism. Chromosome analysis showed an unbalanced transloca   tion t(8;10)(q13;q24) which led to partial monosomy of 8q. Probands  unaffected stepbrother has normal karyotype. Probands unaffected  stepsister has karyotype 46,XX,t(8;10)(q13;q24). In her case a recom   bination replaced the deletion in the translocated part of chromosome  8 with a segment of the normal chromosome 8. This, in combination  with chromosome 3 lacking the insertion, led to a balanced karyotype  with a simple reciprocal translocation. All findings were validated using  FISH with chromosome paints. BCCRs are very rare in population.  Our case illustrates multiple complex scenarios how the chromosomes  affected by the rearrangements can be distributed to gametes and de  Cytogenetics10 scendants of BBCR carriers. Supported by INCORE (EC FP6 043318), CHERISH (EC FP7 223692)  and MZOFNM2005.",2010.0,,"Z. Zmitkova1, M. Simandlova1, A. Baxova2, M. Vlckova1, J. Drabova1, D.  Novotna1, Z. Vlckova1, Z. Zemanova3, E. Kocarek1, Z. Sedlacek1","1Department of Biology and Medical genetics,Charles University, 2nd  Faculty of Medicine and University Hospital Motol, Prague, Czech Republic,  2Department of Biology and Medical genetics,Charles University, 1st Faculty  of Medicine and General University Hospital, Prague, Czech Republic,  3Center of Oncocytogenetics, Institute of Clinical Biochemistry and Laboratory  Diagnostics, Charles University 1st Faculty of Medicine and General University  Hospital, Prague, Czech Republic","However, at the age of three years the boy was referred for genetic  analysis because of psychomotor delay, speech problems, autistic fea   tures, teeth irregularity and dysplastic ears.",,autistic fea,[],"['autistic', 'fea']"
228,461,Duplications 20p and 3q as a consequence of familial  complex chromosomal rearrangement,P03.037,,"Balanced complex chromosome rearrangements (CCRs) are extreme   ly rare. Their carriers have a high risk of primary infertility, spontane   ous abortions or children with unbalanced karyotypes. We report an  unusual case of a familial CCR involving three chromosomes. An 8 year old girl was referred for chromosome analysis because of  heart defect, dysmorphic facial features, mild mental retardation and  autistic features including a delay of speech development. Karyotyping  revealed derivative chromosomes 20 and 22. For further clarification of  the rearrangement, FISH was performed using 20p and 20q subtelo   meric probes. It showed that material from 20p was translocated onto  22p. Array CGH was essential for the identification of the suspected  third partner in this CCR: It showed a 3q duplication of about 16.5 Mb,  and the CCR thus involved chromosomes 3, 20 and 22. Karyotyping and FISH analysis of other relatives indicated that four  members of this family are carriers of a balanced form of this CCR.  These individuals are asymptomatic. Four of their descendants have  two types of unbalanced CCRs. The proband and her maternal aunt  have partial duplications of chromosome 3. Both have similar dysmor   phic facial features and mental retardation, but the aunt is lacking the  heart defect and autism. Two other individuals have partial duplica   tions of chromosome 20. These children are currently very young.  Their mental functioning seems to be normal, but the motor develop   ment is delayed and macrosomia is present in both cases. This work was supported by grants INCORE (EC FP6 043318), CHER   ISH (EC FP7 223692) and MZOFNM2005.",2010.0,,"J. Drabova , A. Puchmajerova, D. Novotna, Z. Vlckova, Z. Zmitkova, Z.  Sedlacek","Department of Biology and Medical Genetics, Charles University 2nd Faculty of  Medicine and Universit, Prague, Czech Republic","An 8 year old girl was referred for chromosome analysis because of  heart defect, dysmorphic facial features, mild mental retardation and  autistic features including a delay of speech development.",,autistic features,[],"['autistic', 'feature']"
230,489,t wo girls with mental retardation and behavioural  abnormalities: is the deletion of the A tXN1 gene on 6p22.3 a  major factor in causing the phenotype?,P03.065,,"6p22 interstitial deletions are relatively rare, with only eight patients  described so far. The clinical phenotype in these patients includes  developmental delay/mental retardation, defects of brain, heart and  kidney, craniofacial malformations and dysmorphic features. The com   mon deleted region, 2.2 Mb, harbouring 12 genes, has been defined  as critical for this syndrome. ATXN1 , located within this interval, has  been suggested as a candidate gene for the mental retardation based  on its expression in CNS and the cognitive impairments manifested in  knock out mice. We report on two patients carrying partly overlapping  de novo deletions within 6p22.3, which are smaller than the ones pre   viously reported. Patient 1 displays mild mental retardation and behav   ioural problems; her 115 kb deletion (chr6:16215803 16332297, hg19)  encompasses only GMPR  and ATXN1 . Patient 2 has severe mental  retardation, autistic features and hyperactivity. Her deletion spans 2.3  Mb (chr6:14545576 16846846, hg19) and includes JARID2 , DTNBP1   and MYLIP , in addition to GMPR  and ATXN1 . Because the GMP re   ductases encoded by GMPR and GMPR2  have redundant functions,  haploinsufficiency of GMPR  is not likely causing the cognitive impair   ments in our patients. We therefore suggest that ATXN1 hemizygosity  is sufficient to cause the mental retardation in patient 1. Furthermore,  additional genes such as MYLIP , which is expressed in brain and has  been shown to have a role in regulating neurite outgrowth, is expected  to contribute to the significantly more severe phenotype of patient 2.Cytogenetics11",2010.0,,"T. Bary1,2, D. Misceo1,2, M. Fannemel2, A. Stormyr2, O. K. Rdningen2,  J. R. Helle2, . Braaten2, C. F. Rustad2, B. E. Kristiansen2, H. S. Sorte2, P.  Strmme3,4, E. Frengen1,2","1Institute of Medical Genetics, Faculty of Medicine, University of Oslo, Norway,  2Department of Medical Genetics, Oslo University Hospital, Ullevl, Norway,  3Department of Pediatrics, Oslo University Hospital, Ullevl, Norway, 4Faculty  Division Ullevl University Hospital, Faculty of Medicine, Norway","Patient 2 has severe mental  retardation, autistic features and hyperactivity.",,autistic features,[],"['autistic', 'feature']"
232,524,"Developmental delay and autistic features in a girl with  45,X/46,X,r(X)",P03.102,,"We report here a case of a 2 years old female with developmental  delay (sit unsupported at 11 months, walking indepently at 18 months,  no 2 words phrases by 25 months) and autistic features (limited com   munication, obsessive behaviour and social difficulties ). No lymph   edema, neck webbing, congenital heart defcts, dysplastic nails, nor  facial dysmorphism were present. Cytogenetics analysis of 48 GTG band metaphases (400 550 band)  from peripheral blood lymphocytes prepared according to standard  procedures revealed a 45,X karyotype in 24 cells and 46 chromo   somes with absence of one X chromosome and the presence of a  small ring chromosome in 24 cells. Fluorescence in situ hybridization  (FISH) studies were also performed. Metaphase arm specific chromo   some painting probes, XCAPX long (Texas Red) and XCAPX short  (FITC), revealed the presence of two red and two green signals, which  is consistent with the fact that the ring is completely derived from X   chromosome material. With the XCyteX probe we confirmed that the  r(X) had more than pericentromeric material (p11.1 q11.1). The pres   ence of XIST (Xq13.2) was confirmed on both, ring and normal X chro   mosome. Individuals with 45,X/46,X,r(X) cytogenetic constitution comprises  about 6 7% of cases with a diagnosis of Turner syndrome. It has been  noted that there is an increased prevalence in mental retardation and  another atypical physical abnormalities in this group, in comparison  with 45,X cases. The etiology of mental retardation and congenital  malformation remains uncertain. Even in the presence of XIST expres   sion, cases with abnormal phenotypes have been described. X inacti   vation may be incomplete despite XIST expression.",2010.0,,"B. Barrea1, M. L. Onaindia1, J. Garca1, M. Fiao1, M. A. Tapia1, M. J. Angulo1,  M. A. Fernndez Cuesta2, C. Ruiz Espinosa2, M. J. Garca Barcina1","1Unidad de Gentica del Hospital Universitario de Basurto (OSAKIDETZA  /Servicio Vasco de Salud), Bilbao, Spain, 2Servicio de Pediatra del Hospital  Universitario de Basurto (OSAKIDETZA /Servicio Vasco de Salud), Bilbao,  Spain","We report here a case of a 2 years old female with developmental  delay (sit unsupported at 11 months, walking indepently at 18 months,  no 2 words phrases by 25 months) and autistic features (limited com   munication, obsessive behaviour and social difficulties ).",,autistic features,[],"['autistic', 'feature']"
236,826,Molecular characterisation of SH2D1A and ODZ1 gene  deletions in three patients with variable phenotype of X linked  lymphoproliferative syndrome,P06.148,,"The SH2D1A  gene encodes an adaptor protein interacting with the  cytoplasmic tail of SLAM family members. Mutations of SH2D1A  are  responsible for the X linked lymphoproliferative syndrome. We present 3 patients from 2 families with complete deletions of the  SH2D1A  gene. The first patient was an 18 year old man with Burkitt Cancer genetics1 lymphoma treated by intensive chemotherapy at the age of 16 followed  by severe aplastic anaemia treated by stem cell transplantation from  his brother. Molecular analysis showed a deletion of all SH2D1A  exons.  His maternal cousin, a 25 year old man with mild learning difficulties,  mild autistic features and severe epidermolysis bullosa like dermatitis  that manifested at the age of 8 years, carried the same deletion. Due  to this atypical phenotype, array CGH was performed to specify the  extent of the deletion. It was about 65 kb long and removed also the 3  terminal part of the ODZ1  gene. The molecular defect was identical in  both cousins. The third patient was a 20 year old man who developed  EBV driven lymphoproliferation at the age of 3. He recovered after  chemotherapy and now, at the age of 21, he is well, suffering only from  hypogammaglobulinaemia. His brother died of lymphoproliferation in  infancy. The deletion in this patient spanned over 200 kb, affecting the  entire SH2D1A  and a part of ODZ1 . FISH analysis was used to identify  female carriers in this family. Our study can help to decipher the phe   notype contribution of genes deleted together with SH2D1A  in carriers  of large Xq25 deletions. Supported by INCORE, IGA NS10480 3 and MZOFNM2005.",2010.0,,"M. Vlckova1, A. Janda2, E. Mejstrikova2, T. Freiberger3, B. Ravcukova3,  Z. Zmitkova1, J. Drabova1, M. Koudova1,4, M. Hancarova1, P. Keslova2, D.  Sumerauer2, O. Hrusak2, R. Zachova5, Z. Sedlacek1","1Department of Biology and Medical Genetics, Charles University 2nd  Faculty of Medicine and University Hospital Motol, Prague, Czech Republic,  2Department of Paediatric Haematology and Oncology, Charles University 2nd  Faculty of Medicine and University Hospital Motol, Prague, Czech Republic,  3Molecular Genetics Laboratory, Centre for Cardiovascular Surgery and  Transplantation, Brno, Czech Republic, 4Present adress: GHC, Prague, Czech  Republic, 5Department of Immunology, Charles University 2nd Faculty of  Medicine and University Hospital Motol, Prague, Czech Republic","His maternal cousin, a 25 year old man with mild learning difficulties,  mild autistic features and severe epidermolysis bullosa like dermatitis  that manifested at the age of 8 years, carried the same deletion.",,autistic features,[],"['autistic', 'feature']"
237,873,rs4307059 and rs4141463 study in an Italian cohort with  Autism spectrum disorder.,P08.10,,"The genetic component of Autism spectrum disorders (ASD) is com   plex including known chomosomal anomalies, rare genetic variants  and copy number variants. More recently, a set of common polymor   phisms on 5p14.1 have been associated with ASD in two independent  studies (Wang et al, Nature 2009 and Ma et al, Annals Human Genet   ics 2009) and another SNP on the gene MACROD2 showed asso   ciation at the genome wide level (IMFAR, International Meeting For  Autism Research 2009). Thanks to Fondazione SmithKline (FSK), a large multicentric study  has been funded with the aim of collecting biological material (DNA,  RNA, plasma and lymphoblastoid cell lines) from extremely well char   acterized patients, parents and relatives and studying ASD pathology.  Till now we have collected 533 individuals for 162 familial units, and it  is planned to recruit a total of 350 families within year 2010. At the moment we have genotyped 486 individuals (144 families) for  the two SNPs (rs 4307059, located at 5p14.1 and rs4141463 located  in the MACROD2 gene) with allelic discrimination TaqMan Assays. We  performed TDT test (UNPHASED software) and we did not find any  significant association for any of the two SNPs. Increasing the number of individuals will allow us to test more complex  models of transmission (such as parent of origin effect, preferential  transmission to males or females, gene gene interactions) and inves   tigate the correlation of affection status with the numerous available  quantitative phenotypes.",2010.0,,"P. Prandini1, E. Trabetti1, A. Pasquali1, P. Muglia2, L. Da Ros2, M. G.  Romanelli1, G. Malerba1, B. Dalla Bernardina3, L. Zoccante3, F. Boscaini3, G.  Masi3, F. Nardocci3, R. Scifo3, A. Zuddas3, A. Pascotto3, A. Tiberti3, M. Molteni3,  P. Curatolo3, L. Margari3, M. Elia3, P. A. Battistella3, A. Parmeggiani3, P. F.  Pignatti1","1University of Verona, Verona, Italy, 2Fondazione Smith Kline, Roma, Italy, 3The  Italian Collaborative Study of Autism, Italy","Thanks to Fondazione SmithKline (FSK), a large multicentric study  has been funded with the aim of collecting biological material (DNA,  RNA, plasma and lymphoblastoid cell lines) from extremely well char   acterized patients, parents and relatives and studying ASD pathology.",,ASD pathology,[],"['ASD', 'pathology']"
238,947,Identification and characterization of copy number  variations in 50 children with autism,P09.021,,"Autism is a neurodevelopmental disorder that manifests in the first  three years of life. The group of pervasive developmental disorders  (PDDs), also termed autism spectrum disorders (ASDs), includes the  prototypical autism as well as PDD not otherwise specified (PDD), Complex traits and polygenic disorders220 Rett syndrome and Aspergers disorder. Autism is characterized by  difficulties in managing social interaction and communication, and a  limited, repetitive and stereotyped patterns of reactions and behavior.  ASDs are etiologically heterogenous, and only 10% of the cases are  due to known medical conditions (chromosomal imbalances, genetic  disorders like Fragile X, Rett syndrome or Tuberous sclerosis). The emerge of new high resolution screening methods allows for de   tection of submicroscopic genomic aberrations. One of these methods;  microarray based comparative genomic hybridization (aCGH) offers  the possibility of detecting copy number variations (CNVs, deletions or  duplications) associated with autism. We present the results of applying aCGH for identification of causal  CNVs in 50 children diagnosed with autism. Genomic DNA was ex   tracted from buccal cells and aCGH was performed using 44k and  105k human genome CGH oligo microarrays (Agilent Technologies  Inc.). Causal CNVs were identified in 9 (18%) of the patients. Two pa   tients had large aberrations (unbalanced translocation between chro   mosome 8 and chromosome 12, idic(15)). Five patients had smaller  CNVs in or close to genes previously associated with autism, and  two patients had CNVs not previously reported. Further analyses are  needed to determine the significance of these aberrations. Our data  demonstrates the utility of aCGH as a powerful diagnostic tool for de   tection of genomic imbalances in ASD.",2010.0,,"H. Sorte1, E. Sponheim2, K. Eiklid1, E. Gjevik2, O. Rodningen1","1Department of Medical Genetics, Ullevaal, Oslo University Hospital, Oslo,  Norway, 2KPH BU, Oslo University Hospital, Oslo, Norway","The group of pervasive developmental disorders  (PDDs), also termed autism spectrum disorders (ASDs), includes the  prototypical autism as well as PDD not otherwise specified (PDD), Complex traits and polygenic disorders220 Rett syndrome and Aspergers disorder.",,Aspergers disorder,[],"['Asperger\x80\x99s', 'disorder']"
239,948,common variants in cadherin 10 gene show  association with autism spectrum disorders in Finnish  population,P09.022,,"Autism spectrum disorders (ASDs) are severe neurodevelopmental  disorders that are highly heritable, but phenotypic and genetic het   erogeneity have made it challenging to identify predisposing variants  across populations. Although 10 20% of ASD cases are known to be  caused by rare high penetrance mutations, cytogenetic abnormalities,  and de novo DNA copy number variation, genome wide association  studies (GWAS) with large sample sizes have also revealed common  genetic variants associated with ASDs. Recently, several candidate  genes have been shown in independent studies to be associated with  ASDs in different populations. To test for association between ASDs  and genetic variants in these genes in the Finnish founder popula   tion, we have genotyped 79 single nucleotide polymorphisms (SNPs)  in eight candidate genes in families with autism (n,142) or Asperger  syndrome (AS; n,121) and performed association analyses. In the au   tism study sample, the most significant association was observed with  an intronic SNP in CDH10 , rs1505874 ( P,0.000066). In the AS study  sample, the most significant association was also observed in CDH10,  but with intronic rs6867043 ( P,0.000774). In a recent GWAS (Wang  et al.  2009), signals with a strong genome wide significance were ob   served in six SNPs located between CDH10  and CDH9 . Results from  our study support the role of CDH10  in ASDs using an independent  sample. To our knowledge, this is the first replicated association be   tween ASDs and CDH10  reported. CDH10 is involved in neuronal cell  adhesion and in the development of synaptic complexes so our results  further support the hypothesis that neuronal cell adhesion are impli   cated in the etiology of ASDs.",2010.0,,"M. Muona1, K. Rehnstrm1,2, H. Kilpinen1,2, P. J. Wagner1, L. Peltonen1,2","1Institute for Molecular Medicine Finland FIMM, Helsinki, Finland, 2Wellcome  Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge  CB10 1SA, UK, United Kingdom","Although 10 20% of ASD cases are known to be  caused by rare high penetrance mutations, cytogenetic abnormalities,  and de novo DNA copy number variation, genome wide association  studies (GWAS) with large sample sizes have also revealed common  genetic variants associated with ASDs.",,ASD cases,[],"['ASD', 'case']"
239,948,common variants in cadherin 10 gene show  association with autism spectrum disorders in Finnish  population,P09.022,,"Autism spectrum disorders (ASDs) are severe neurodevelopmental  disorders that are highly heritable, but phenotypic and genetic het   erogeneity have made it challenging to identify predisposing variants  across populations. Although 10 20% of ASD cases are known to be  caused by rare high penetrance mutations, cytogenetic abnormalities,  and de novo DNA copy number variation, genome wide association  studies (GWAS) with large sample sizes have also revealed common  genetic variants associated with ASDs. Recently, several candidate  genes have been shown in independent studies to be associated with  ASDs in different populations. To test for association between ASDs  and genetic variants in these genes in the Finnish founder popula   tion, we have genotyped 79 single nucleotide polymorphisms (SNPs)  in eight candidate genes in families with autism (n,142) or Asperger  syndrome (AS; n,121) and performed association analyses. In the au   tism study sample, the most significant association was observed with  an intronic SNP in CDH10 , rs1505874 ( P,0.000066). In the AS study  sample, the most significant association was also observed in CDH10,  but with intronic rs6867043 ( P,0.000774). In a recent GWAS (Wang  et al.  2009), signals with a strong genome wide significance were ob   served in six SNPs located between CDH10  and CDH9 . Results from  our study support the role of CDH10  in ASDs using an independent  sample. To our knowledge, this is the first replicated association be   tween ASDs and CDH10  reported. CDH10 is involved in neuronal cell  adhesion and in the development of synaptic complexes so our results  further support the hypothesis that neuronal cell adhesion are impli   cated in the etiology of ASDs.",2010.0,,"M. Muona1, K. Rehnstrm1,2, H. Kilpinen1,2, P. J. Wagner1, L. Peltonen1,2","1Institute for Molecular Medicine Finland FIMM, Helsinki, Finland, 2Wellcome  Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge  CB10 1SA, UK, United Kingdom","To test for association between ASDs  and genetic variants in these genes in the Finnish founder popula   tion, we have genotyped 79 single nucleotide polymorphisms (SNPs)  in eight candidate genes in families with autism (n,142) or Asperger  syndrome (AS; n,121) and performed association analyses.",families with autism,,"['family', 'with', 'autism']",[]
240,959,Systematic evaluation of the clinical significance of  inherited and de novo copy Number Variations in families with  Autism spectrum Disorders,P09.033,,"Array based studies have detected a wealth of copy number variations  (CNVs) in patients with autism spectrum disorders (ASD). Since some  CNVs also occur in healthy individuals their contributions to the patients  phenotype remain largely unclear. We systematically evaluated the clini   cal significance of de novo  and inherited CNVs containing genes being  transcribed in the brain, by taking into account the Social Responsive   ness Scale (SRS) scores of patients and both parents. Thus, CNVs were  grouped into four categories. First, de novo  CNVs in families with both  parents having normal SRS scores, and second, CNVs inherited from  a carrier parent with an elevated SRS score. These are the most likely  to be causally related to ASD. The genes in these two categories par   ticipate in pathways probably associated with ASD, such as contactin  based cell communication ( CNTN5 , CNTN6 ), phosphoinositol signaling  (PIK3CA ), and regulation of neurotransmitter levels ( KCNMB4 , TPH2 ).  The de novo  CNVs found in patients with at least one parent scoring  higher than 1 SD above the mean on the SRS, and the CNVs inher   ited from an unaffected parent, while the other parent has an elevated  SRS score, are likely to exert a minor contribution to the phenotype.  Our analysis also indicates that in 6 out of 48 ASD patients two or more  genetic etiologies may be involved. This study extends the scope of  genome wide CNV profiling beyond de novo  CNVs in sporadic patients,  and may constitute a first step toward uncovering the missing heritability  in genome wide screening studies of complex psychiatric disorders .Complex traits and polygenic disorders22",2010.0,,"M. Poot1, E. van Daalen2,3, C. Kemner2,4, N. E. Verbeek1, M. V. de Jonge2,3,  T. Dijkhuizen5, P. Rump5, R. Houben2, R. van t Slot1, B. van der Zwaag1,  W. G. Staal2,3, F. A. Beemer1, J. P. Burbach3, H. K. Ploos van Amstel1, R.  Hochstenbach1, E. H. Brilstra1","1Department of Medical Genetics, Utrecht, Netherlands, 2Department of Child  and Adolescent Psychiatry, Utrecht, Netherlands, 3Department of Neuroscience  and Pharmacology, Rudolf Magnus Institute of Neuroscience, Utrecht,  Netherlands, 4Developmental Psychology, Utrecht, Netherlands, 5Department of  Genetics, Groningen, Netherlands",Array based studies have detected a wealth of copy number variations  (CNVs) in patients with autism spectrum disorders (ASD).,patients with autism,,"['patient', 'with', 'autism']",[]
240,959,Systematic evaluation of the clinical significance of  inherited and de novo copy Number Variations in families with  Autism spectrum Disorders,P09.033,,"Array based studies have detected a wealth of copy number variations  (CNVs) in patients with autism spectrum disorders (ASD). Since some  CNVs also occur in healthy individuals their contributions to the patients  phenotype remain largely unclear. We systematically evaluated the clini   cal significance of de novo  and inherited CNVs containing genes being  transcribed in the brain, by taking into account the Social Responsive   ness Scale (SRS) scores of patients and both parents. Thus, CNVs were  grouped into four categories. First, de novo  CNVs in families with both  parents having normal SRS scores, and second, CNVs inherited from  a carrier parent with an elevated SRS score. These are the most likely  to be causally related to ASD. The genes in these two categories par   ticipate in pathways probably associated with ASD, such as contactin  based cell communication ( CNTN5 , CNTN6 ), phosphoinositol signaling  (PIK3CA ), and regulation of neurotransmitter levels ( KCNMB4 , TPH2 ).  The de novo  CNVs found in patients with at least one parent scoring  higher than 1 SD above the mean on the SRS, and the CNVs inher   ited from an unaffected parent, while the other parent has an elevated  SRS score, are likely to exert a minor contribution to the phenotype.  Our analysis also indicates that in 6 out of 48 ASD patients two or more  genetic etiologies may be involved. This study extends the scope of  genome wide CNV profiling beyond de novo  CNVs in sporadic patients,  and may constitute a first step toward uncovering the missing heritability  in genome wide screening studies of complex psychiatric disorders .Complex traits and polygenic disorders22",2010.0,,"M. Poot1, E. van Daalen2,3, C. Kemner2,4, N. E. Verbeek1, M. V. de Jonge2,3,  T. Dijkhuizen5, P. Rump5, R. Houben2, R. van t Slot1, B. van der Zwaag1,  W. G. Staal2,3, F. A. Beemer1, J. P. Burbach3, H. K. Ploos van Amstel1, R.  Hochstenbach1, E. H. Brilstra1","1Department of Medical Genetics, Utrecht, Netherlands, 2Department of Child  and Adolescent Psychiatry, Utrecht, Netherlands, 3Department of Neuroscience  and Pharmacology, Rudolf Magnus Institute of Neuroscience, Utrecht,  Netherlands, 4Developmental Psychology, Utrecht, Netherlands, 5Department of  Genetics, Groningen, Netherlands",Our analysis also indicates that in 6 out of 48 ASD patients two or more  genetic etiologies may be involved.,,ASD patients,[],"['ASD', 'patient']"
244,1317,molecular investigation of TBX1  gene in individuals  with Asperger syndrome,P12.013,," Asperger syndrome (AS) is a neurodevelopmental disorder from the  Autism Spectrum Disorders. It is characterized by impairments in so   cialization and ritualistic and stereotypic behaviors. Despite of the de   scription of mutations in several genes, the etiology remains unknown.  Genetic and early developmental factors are considered important for  its occurrence. Behavioral and psychiatric disorders are a prominent  part of the 22q11 deletion syndrome. Furthermore, there is a description  of one individual with AS and mutation in TBX1  gene that is mapped in  22q11.2 region. Therefore, the objective of this study was to perform  a mutation screening of TBX1  gene in individuals with AS. We ana   lyzed 14 subjects. Mutation screening of TBX1  by direct sequencing  detected several synonymous single nucleotide polymorphism (SNP),  already reported in NCBI database. The sequence variant 1189A  C  was identified in one patient. This Asn397His transversion was geno   typed in a sample of 100 control individuals and it was found in 20% of  them. This kind of mutation in TBX1 gene may be more common than  expected, however its relevance in pathogenesis of AS still remains to  be determined considering the clinical and genetic heterogeneity of the  disease and the restricted number of individuals studied.",2010.0,,"M. Simioni1, C. E. Steiner1, A. C. Fett Conte2, A. Barbosa Gonalves3, V. L.  Gil da Silva Lopes1","1Department of Medical Genetics, University of Campinas (Unicamp),  Campinas, Brazil, 2Faculdade de Medicina de S.J. do Rio Preto, So Jos  do Rio Preto, Brazil, 3Universidade Estadual Paulista Jlio de Mesquita Filho  (UNESP), So Jos do Rio Preto, Brazil.", Asperger syndrome (AS) is a neurodevelopmental disorder from the  Autism Spectrum Disorders.,,Asperger syndrome,[],"['Asperger', 'syndrome']"
245,1432,Molecular genetic testing of mental retardation in  Bulgaria,P12.128,,"Mental retardation is highly heterogeneous in clinical and genetic point  of view. Here we discuss on: Fragile X syndrome (FXS), Rett syn   drome (RTT), Prader Willi/Angelman syndromes (PWS/AS) and mi   crodeletion syndromes (MDS). The genes studied are: FMR1, MECP2,  CDKL5, ARX, and methylation analysis of exon 1 of the SNRPN. Multi   plex ligation dependent probe amplification (MLPA) analysis was used  to look for large deletions/duplications, to screen for microdeletion syn   dromes, and to clarify methylation status of FMR1 and SNRPN genes.  Our results in the group of FXS revealed about 12% mutations in the  FMR1 gene. A mosaic case full mutation/normal allele was detected.  The genetic tests in the group of RTT girls revealed about 26% muta   tions along the MECP2 gene. No CDKL5 gene mutations were detect   ed. The genetic tests in the group of PWS/AS revealed 64% mutations  along the 15q11 q13 region. The MLPA analysis in the group of MDS  revealed genetically confirmed cases with diagnosis Williams Beuren  and Wolf Hirschhorn syndromes. Altogether, we manage to clarify the  molecular basis in about 30% of our mentally retarded patients. The  percentage of genetically proved diagnosis among our RTT patients,  PWS/AS and MDS cases is relatively high, which represents a good  clinical recognition of these pathological entities. On the contrary, the  percentage of the genetically confirmed FXS cases is relatively low.  Most probably this is due to the characteristics of this group, being  clinically mixed and containing some definite autistic cases. Acknowledgements: The study was supported by the grant No 27/2009,  Sofia Medical University, BulgariaP12.129  The Arg468His mutation in MFN2 is the most frequent cause of cmt2A in spanish Patients C. Casasnovas1, I. Banchs2, J. Cassereau3, N. Gueguen4, A. Chevrollier4, J.  Martnez Matos1, D. Bonneau4, V. Volpini2;   1Unitat de Neuromuscular. Neurology Department. Hospital Universitari de  Bellvitge   IDIBELL,, LHospitalet de Llobregat. Barcelona, Spain, 2Center for  Molecular Genetic Diagnosis (CDGM)  IDIBELL, LHospitalet de Llobregat,  Spain, 3INSERM, U771, Dpartement de Neurologie, Centre hospitalier  universitaire., Angers, France, 4INSERM U694, Dpartement de Biochimie et  Gntique, Centre Hospitalier., Angers, France. Introduction: The most common form of axonal Charcot Marie Tooth  disease (CMT) is type 2A, caused by mutations in mitochondrial GT   Pase mitofusin 2 (MFN2).  Objective: To establish the incidence of MFN2 mutations in a cohort of  Spanish patients with axonal CMT neuropathy.  Material and Methods: We studied 85 families with suspected axo   nal CMT. All MFN2 exons were studied through direct sequencing. A  bioenergetics study in fibroblasts was conducted using a skin biopsy  taken from a patient with an Arg468His mutation.  Results: Twenty four patients from 14 different families were identified  with nine different MFN2 mutations. MFN2 mutations were responsible  for CMT2 in 16%  7.7% of the families studied and in 30.8%  14.2%  (12/39) of families with known dominant inheritance. The Arg468His  mutation was the most prevalent (6/14 families). A bioenergetics study  in fibroblasts was conducted using a skin biopsy taken from a patient  with this mutation. These bioenergetic studies showed the typical re   sults of MFN2 patients.  Conclusion: The Arg468His mutation is the most prevalent (6/14 fami   lies) mutation in MFN2 causing CMT2A in Spanish patients and our  study confirmed that it is actually pathological, presenting as a neu   ropathy in a mild to moderate degree.",2010.0,,"T. Todorov1,2, A. Todorova1,2, D. Avdjieva3, P. Dimova4, R. Tincheva3, V. Mitev1","1Department of Medical Chemistry and Biochemistry, Medical University Sofia,  Sofia, Bulgaria, 2Genetic Madico Diagnostic Laboratory Genica, Sofia, Bulgaria,  3Department of Pediatrics, Medical University Sofia, Sofia, Bulgaria, 4St","Most probably this is due to the characteristics of this group, being  clinically mixed and containing some definite autistic cases.",,autistic cases,[],"['autistic', 'case']"
246,1501,A 134 kb duplication 0.5 mb upstream of sOX9  associated with hermaphroditism in an XX male and autism in  his XY brother,P12.200,,"In a sibship of six a 46,XX male hermaphrodite with ovotestes and no  detectable SRY sequence had a brother with infantile autism without  mental retardation. Both brothers had inherited an identical 134 Kb  duplication of the regulatory genomic region 0.5 Mb upstream of SOX9  from their mother. In another brother who had inherited the same ma   ternal SOX9 haplotype, no upstream duplication was found, proving  that the mother was a gonadal mosaic for the duplication. We hypoth   esize that the duplication caused sufficient SRY independent SOX9  expression in the undifferentiated fetal gonads to promote testicular  development. Apparently, this effect was tissue  and/or fetal specific as  no SOX9 expression was detectable in leukocytes and skin fibroblasts  from any of the siblings. The observations in the family also suggest  that such a SOX9 regulatory region duplication may predispose for  autism in the presence of a Y chromosome, i.e. a SRY gene. This hy   pothesis is supported by the SOX9 segregation pattern which as a less  than 8,2 % probability of being a random event, and the unexplained  general excess of autistic features in males. We therefore propose that  an additional role of SOX9, directly linked to testicular differentiation,  could be the promotion of male specific brain development. Molecular basis of Mendelian disorders ",2010.0,,"A. Brendehaug1, O. Bruland1, A. Molven2, G. Houge1","1Haukeland University Hospital, Bergen, Norway, 2The Gade Insttitute, UiB,  Bergen, Norway","In a sibship of six a 46,XX male hermaphrodite with ovotestes and no  detectable SRY sequence had a brother with infantile autism without  mental retardation.",brother with infantile autism,,"['brother', 'with', 'infantile', 'autism']",[]
246,1501,A 134 kb duplication 0.5 mb upstream of sOX9  associated with hermaphroditism in an XX male and autism in  his XY brother,P12.200,,"In a sibship of six a 46,XX male hermaphrodite with ovotestes and no  detectable SRY sequence had a brother with infantile autism without  mental retardation. Both brothers had inherited an identical 134 Kb  duplication of the regulatory genomic region 0.5 Mb upstream of SOX9  from their mother. In another brother who had inherited the same ma   ternal SOX9 haplotype, no upstream duplication was found, proving  that the mother was a gonadal mosaic for the duplication. We hypoth   esize that the duplication caused sufficient SRY independent SOX9  expression in the undifferentiated fetal gonads to promote testicular  development. Apparently, this effect was tissue  and/or fetal specific as  no SOX9 expression was detectable in leukocytes and skin fibroblasts  from any of the siblings. The observations in the family also suggest  that such a SOX9 regulatory region duplication may predispose for  autism in the presence of a Y chromosome, i.e. a SRY gene. This hy   pothesis is supported by the SOX9 segregation pattern which as a less  than 8,2 % probability of being a random event, and the unexplained  general excess of autistic features in males. We therefore propose that  an additional role of SOX9, directly linked to testicular differentiation,  could be the promotion of male specific brain development. Molecular basis of Mendelian disorders ",2010.0,,"A. Brendehaug1, O. Bruland1, A. Molven2, G. Houge1","1Haukeland University Hospital, Bergen, Norway, 2The Gade Insttitute, UiB,  Bergen, Norway","This hy   pothesis is supported by the SOX9 segregation pattern which as a less  than 8,2 % probability of being a random event, and the unexplained  general excess of autistic features in males.",,autistic features,[],"['autistic', 'feature']"
250,178, Genetic causes of pervasive developmental disorders,P01.02,,"The pervasive developmental disorders (PDDs), or autism spectrum  disorders (ASD), range from a severe form, called autistic disorder, to a milder form, Asperger syndrome.This paper will focus on classic autism and Asperger syndrome, intending to review the current understanding of the etiologies and the  multiple pathogenetic pathways that are likely to lead to the autistic phenotype. Like mental retardation, autism is likely to be caused by many different genetic mechanisms and genes rather than a single, or few, major genes or environmental effects. Applying routine genetic testing in clinical (CLIA certified) diagnostic laboratories its possible to identify the specific etiology and recurrence risk in 10% to 15% of autism cases and is clinically indicated for any child with autism.In this study we report 5 cases with different genetic syndromes in which ASD has been described as one of the possible manifestations:  Down syndrome, 22q13 deletion, ,,cri du chat syndrome   5p15 deletion, Cornelia de Lange syndrome, Sotos syndrome. c onclusions : The etiologies of ASD are complex and presence of a  wide variety cytogenetic abnormalities are providing us with extremely  valuable information about the role played by genetics in autism and collaboration with psychiatrists. Such recognition  and understanding  will help clinicians implement syndrome specific treatments of patients  identified with a genetic cause of autism spectrum disorder. Early  identification of this genetic disorder is critical not only to the individual  patient but for the entire family.",2011.0,,"G. C. Cozaru , A. C. Papari","Andrei aguna University, Constanta, Romania","The pervasive developmental disorders (PDDs), or autism spectrum  disorders (ASD), range from a severe form, called autistic disorder, to a milder form, Asperger syndrome.This paper will focus on classic autism and Asperger syndrome, intending to review the current understanding of the etiologies and the  multiple pathogenetic pathways that are likely to lead to the autistic phenotype.",,autistic disorder,[],"['autistic', 'disorder']"
250,178, Genetic causes of pervasive developmental disorders,P01.02,,"The pervasive developmental disorders (PDDs), or autism spectrum  disorders (ASD), range from a severe form, called autistic disorder, to a milder form, Asperger syndrome.This paper will focus on classic autism and Asperger syndrome, intending to review the current understanding of the etiologies and the  multiple pathogenetic pathways that are likely to lead to the autistic phenotype. Like mental retardation, autism is likely to be caused by many different genetic mechanisms and genes rather than a single, or few, major genes or environmental effects. Applying routine genetic testing in clinical (CLIA certified) diagnostic laboratories its possible to identify the specific etiology and recurrence risk in 10% to 15% of autism cases and is clinically indicated for any child with autism.In this study we report 5 cases with different genetic syndromes in which ASD has been described as one of the possible manifestations:  Down syndrome, 22q13 deletion, ,,cri du chat syndrome   5p15 deletion, Cornelia de Lange syndrome, Sotos syndrome. c onclusions : The etiologies of ASD are complex and presence of a  wide variety cytogenetic abnormalities are providing us with extremely  valuable information about the role played by genetics in autism and collaboration with psychiatrists. Such recognition  and understanding  will help clinicians implement syndrome specific treatments of patients  identified with a genetic cause of autism spectrum disorder. Early  identification of this genetic disorder is critical not only to the individual  patient but for the entire family.",2011.0,,"G. C. Cozaru , A. C. Papari","Andrei aguna University, Constanta, Romania","The pervasive developmental disorders (PDDs), or autism spectrum  disorders (ASD), range from a severe form, called autistic disorder, to a milder form, Asperger syndrome.This paper will focus on classic autism and Asperger syndrome, intending to review the current understanding of the etiologies and the  multiple pathogenetic pathways that are likely to lead to the autistic phenotype.",,Asperger syndrome,[],"['Asperger', 'syndrome']"
250,178, Genetic causes of pervasive developmental disorders,P01.02,,"The pervasive developmental disorders (PDDs), or autism spectrum  disorders (ASD), range from a severe form, called autistic disorder, to a milder form, Asperger syndrome.This paper will focus on classic autism and Asperger syndrome, intending to review the current understanding of the etiologies and the  multiple pathogenetic pathways that are likely to lead to the autistic phenotype. Like mental retardation, autism is likely to be caused by many different genetic mechanisms and genes rather than a single, or few, major genes or environmental effects. Applying routine genetic testing in clinical (CLIA certified) diagnostic laboratories its possible to identify the specific etiology and recurrence risk in 10% to 15% of autism cases and is clinically indicated for any child with autism.In this study we report 5 cases with different genetic syndromes in which ASD has been described as one of the possible manifestations:  Down syndrome, 22q13 deletion, ,,cri du chat syndrome   5p15 deletion, Cornelia de Lange syndrome, Sotos syndrome. c onclusions : The etiologies of ASD are complex and presence of a  wide variety cytogenetic abnormalities are providing us with extremely  valuable information about the role played by genetics in autism and collaboration with psychiatrists. Such recognition  and understanding  will help clinicians implement syndrome specific treatments of patients  identified with a genetic cause of autism spectrum disorder. Early  identification of this genetic disorder is critical not only to the individual  patient but for the entire family.",2011.0,,"G. C. Cozaru , A. C. Papari","Andrei aguna University, Constanta, Romania","The pervasive developmental disorders (PDDs), or autism spectrum  disorders (ASD), range from a severe form, called autistic disorder, to a milder form, Asperger syndrome.This paper will focus on classic autism and Asperger syndrome, intending to review the current understanding of the etiologies and the  multiple pathogenetic pathways that are likely to lead to the autistic phenotype.",,Asperger syndrome,[],"['Asperger', 'syndrome']"
250,178, Genetic causes of pervasive developmental disorders,P01.02,,"The pervasive developmental disorders (PDDs), or autism spectrum  disorders (ASD), range from a severe form, called autistic disorder, to a milder form, Asperger syndrome.This paper will focus on classic autism and Asperger syndrome, intending to review the current understanding of the etiologies and the  multiple pathogenetic pathways that are likely to lead to the autistic phenotype. Like mental retardation, autism is likely to be caused by many different genetic mechanisms and genes rather than a single, or few, major genes or environmental effects. Applying routine genetic testing in clinical (CLIA certified) diagnostic laboratories its possible to identify the specific etiology and recurrence risk in 10% to 15% of autism cases and is clinically indicated for any child with autism.In this study we report 5 cases with different genetic syndromes in which ASD has been described as one of the possible manifestations:  Down syndrome, 22q13 deletion, ,,cri du chat syndrome   5p15 deletion, Cornelia de Lange syndrome, Sotos syndrome. c onclusions : The etiologies of ASD are complex and presence of a  wide variety cytogenetic abnormalities are providing us with extremely  valuable information about the role played by genetics in autism and collaboration with psychiatrists. Such recognition  and understanding  will help clinicians implement syndrome specific treatments of patients  identified with a genetic cause of autism spectrum disorder. Early  identification of this genetic disorder is critical not only to the individual  patient but for the entire family.",2011.0,,"G. C. Cozaru , A. C. Papari","Andrei aguna University, Constanta, Romania","The pervasive developmental disorders (PDDs), or autism spectrum  disorders (ASD), range from a severe form, called autistic disorder, to a milder form, Asperger syndrome.This paper will focus on classic autism and Asperger syndrome, intending to review the current understanding of the etiologies and the  multiple pathogenetic pathways that are likely to lead to the autistic phenotype.",,autistic phenotype,[],"['autistic', 'phenotype']"
250,178, Genetic causes of pervasive developmental disorders,P01.02,,"The pervasive developmental disorders (PDDs), or autism spectrum  disorders (ASD), range from a severe form, called autistic disorder, to a milder form, Asperger syndrome.This paper will focus on classic autism and Asperger syndrome, intending to review the current understanding of the etiologies and the  multiple pathogenetic pathways that are likely to lead to the autistic phenotype. Like mental retardation, autism is likely to be caused by many different genetic mechanisms and genes rather than a single, or few, major genes or environmental effects. Applying routine genetic testing in clinical (CLIA certified) diagnostic laboratories its possible to identify the specific etiology and recurrence risk in 10% to 15% of autism cases and is clinically indicated for any child with autism.In this study we report 5 cases with different genetic syndromes in which ASD has been described as one of the possible manifestations:  Down syndrome, 22q13 deletion, ,,cri du chat syndrome   5p15 deletion, Cornelia de Lange syndrome, Sotos syndrome. c onclusions : The etiologies of ASD are complex and presence of a  wide variety cytogenetic abnormalities are providing us with extremely  valuable information about the role played by genetics in autism and collaboration with psychiatrists. Such recognition  and understanding  will help clinicians implement syndrome specific treatments of patients  identified with a genetic cause of autism spectrum disorder. Early  identification of this genetic disorder is critical not only to the individual  patient but for the entire family.",2011.0,,"G. C. Cozaru , A. C. Papari","Andrei aguna University, Constanta, Romania","Applying routine genetic testing in clinical (CLIA certified) diagnostic laboratories its possible to identify the specific etiology and recurrence risk in 10% to 15% of autism cases and is clinically indicated for any child with autism.In this study we report 5 cases with different genetic syndromes in which ASD has been described as one of the possible manifestations:  Down syndrome, 22q13 deletion, ,,cri du chat syndrome   5p15 deletion, Cornelia de Lange syndrome, Sotos syndrome.",child with autism,,"['child', 'with', 'autism']",[]
251,179, Assessment of Assisted Reproductive t echnology and its associated risk with Autism s pectral Disorder in i ndian population,P01.03,,"Autism Spectral Disorders are hypothesized to be on a rise across  the globe and developing countries like India are no exceptions. According to unconfirmed estimates there are about 1.7 million affected individuals in India. Increased globalisation and changing socio  economical development seen in last two decades have led to  changing lifestyles and increased exposure to various risk factors of Autism Spectral Disorder. In India, metropolitan cities like Chennai, Hyderabad etc. are showing an increased incidence of stress related disorders like Thyroid malfunction, Polycystic Ovarian Disease, infertility etc., and hence assisted reproduction is on the rise among the young urban population. Though similar indications are available in other countries, the suspected association between increased rate of Assisted Reproduction and Autism Spectral Disorder in India needs to be established.To explore this link, a questionnaire based case control cohort study was conducted in Indian Autistic population and preliminary results indicate that ART cases represented 8 10% of the autistic subjects analysed. This is the first report from Indian population indicating the link between Assisted Reproduction and Autism Spectral Disorder.",2011.0,,"M. P. Mamidala, C. Rahul, N. Rajesh, V. Rajesh","Birla Institute of Science and Technology, Pilani Hyderabad Campus, Hyderabad, India","Though similar indications are available in other countries, the suspected association between increased rate of Assisted Reproduction and Autism Spectral Disorder in India needs to be established.To explore this link, a questionnaire based case control cohort study was conducted in Indian Autistic population and preliminary results indicate that ART cases represented 8 10% of the autistic subjects analysed.",,Autistic population,[],"['Autistic', 'population']"
251,179, Assessment of Assisted Reproductive t echnology and its associated risk with Autism s pectral Disorder in i ndian population,P01.03,,"Autism Spectral Disorders are hypothesized to be on a rise across  the globe and developing countries like India are no exceptions. According to unconfirmed estimates there are about 1.7 million affected individuals in India. Increased globalisation and changing socio  economical development seen in last two decades have led to  changing lifestyles and increased exposure to various risk factors of Autism Spectral Disorder. In India, metropolitan cities like Chennai, Hyderabad etc. are showing an increased incidence of stress related disorders like Thyroid malfunction, Polycystic Ovarian Disease, infertility etc., and hence assisted reproduction is on the rise among the young urban population. Though similar indications are available in other countries, the suspected association between increased rate of Assisted Reproduction and Autism Spectral Disorder in India needs to be established.To explore this link, a questionnaire based case control cohort study was conducted in Indian Autistic population and preliminary results indicate that ART cases represented 8 10% of the autistic subjects analysed. This is the first report from Indian population indicating the link between Assisted Reproduction and Autism Spectral Disorder.",2011.0,,"M. P. Mamidala, C. Rahul, N. Rajesh, V. Rajesh","Birla Institute of Science and Technology, Pilani Hyderabad Campus, Hyderabad, India","Though similar indications are available in other countries, the suspected association between increased rate of Assisted Reproduction and Autism Spectral Disorder in India needs to be established.To explore this link, a questionnaire based case control cohort study was conducted in Indian Autistic population and preliminary results indicate that ART cases represented 8 10% of the autistic subjects analysed.",,autistic subjects,[],"['autistic', 'subject']"
252,265,"3.7 m b tandem microduplication in chromosome 5p13.1 p13.2 associated with developmental delay, macrocephaly, obesity, and lymphedema. Further characterization of the dup(5p13) syndrome.",P02.005,,"In a male patient with developmental delay, autistic behaviour, obesity,  lymphedema, hypertension, macrocephaly, and facial features (dolichocephaly, short neck, low set posterior hairline, dysplastic ears, broad nasal root, short nose, microretrognathia) of chromosome 5p duplication (trisomy 5p) a 3.7 Mb de novo tandem microduplication  of 5p13.1 13.2 (rs4703415 rs261752, i.e., chr5:35.62 39.36Mb) was identified. This observation contributes to the characterization and dissection of the 5p13 duplication syndrome. A comparison with previous case reports is provided. Similar to the patients with duplication of the entire NIPBL gene reported by Yan et al (2009) but different from several case reports on 5p13 duplication, there was, for instance, no heart defect in our patient. The possible role of genes within the duplicated region, especially of NIPBL, is discussed.",2011.0,,"K. Oexle1, M. Hempel1, A. Jauch2, T. Meitinger1, S. Stengel Rutkowski3, T.  Strom4","1MRI, Mnchen, Germany, 2University Hospital, Heidelberg, Germany, 3LMU,  Mnchen, Germany, 4Helmholtz Center, Mnchen, Germany","In a male patient with developmental delay, autistic behaviour, obesity,  lymphedema, hypertension, macrocephaly, and facial features (dolichocephaly, short neck, low set posterior hairline, dysplastic ears, broad nasal root, short nose, microretrognathia) of chromosome 5p duplication (trisomy 5p) a 3.7 Mb de novo tandem microduplication  of 5p13.1 13.2 (rs4703415 rs261752, i.e., chr5:35.62 39.36Mb) was identified.",,autistic behaviour,[],"['autistic', 'behaviour']"
255,294, Autism s pectrum Disorders and s eizure s yndrome,P02.036,,"iNtRODU cti ON: Autism and autism spectrum disorders (ASD) are  serious early childhood neurodevelopment disorders with a genetic  aetiology and increasing prevalence. Patients often have co morbid disorders. 11 39% may have seizure syndrome. According to the literature, 42% of patients with autism, ASD and mental retardation  have seizure syndrome. The aim of the study was to obtain information about patients with autism, ASD and seizure syndrome. m E t HOD s : 158 patients with autism and ASD were ascertained who  had been treated in the Childrens University Hospital, Child Psychiatry  Clinic and Medical Genetics Clinic from 2006   2010. We recorded the patients clinical symptoms (ICD 10), ADOS, electroencephalography (EEG) and IQ. SPSS 13 was used for statistical analysis. The frequency of seizure syndrome in both patient groups was calculated. RE s UL ts : Seizure syndrome was identified in four patients with  autism and 11 patients with ASD. Two patients in the autism group had their IQ within normal limits, four patients were moderately mentally retarded. In the ASD group, one patient had IQ within normal limits, four patients were mildly mentally retarded, four patients had severe mental retardation. c ON c LU si ON: The incidence of seizure syndrome was 9.5% in both  patient groups. Seizure syndrome is more frequent in patients with  some degree of mental retardation than in patients with normal IQ.",2011.0,,"D. Bauze1,2, L. Kevere1, Z. Kronberga1, A. Rizevs1, S. Jelisejevs1, R.  Andrezina3, B. Lace4","1Childrens University Hospital, Child Psychiatry Clinic, Riga, Latvia, 2Childrens  University Hospital, Medical Genetics Clinic, Riga, Latvia, 3Riga Stradins  University, Riga, Latvia, 4Childrens University Hospital, Medical Genetics Clinic,  Riga, Latvia","According to the literature, 42% of patients with autism, ASD and mental retardation  have seizure syndrome.",patients with autism,,"['patient', 'with', 'autism']",[]
255,294, Autism s pectrum Disorders and s eizure s yndrome,P02.036,,"iNtRODU cti ON: Autism and autism spectrum disorders (ASD) are  serious early childhood neurodevelopment disorders with a genetic  aetiology and increasing prevalence. Patients often have co morbid disorders. 11 39% may have seizure syndrome. According to the literature, 42% of patients with autism, ASD and mental retardation  have seizure syndrome. The aim of the study was to obtain information about patients with autism, ASD and seizure syndrome. m E t HOD s : 158 patients with autism and ASD were ascertained who  had been treated in the Childrens University Hospital, Child Psychiatry  Clinic and Medical Genetics Clinic from 2006   2010. We recorded the patients clinical symptoms (ICD 10), ADOS, electroencephalography (EEG) and IQ. SPSS 13 was used for statistical analysis. The frequency of seizure syndrome in both patient groups was calculated. RE s UL ts : Seizure syndrome was identified in four patients with  autism and 11 patients with ASD. Two patients in the autism group had their IQ within normal limits, four patients were moderately mentally retarded. In the ASD group, one patient had IQ within normal limits, four patients were mildly mentally retarded, four patients had severe mental retardation. c ON c LU si ON: The incidence of seizure syndrome was 9.5% in both  patient groups. Seizure syndrome is more frequent in patients with  some degree of mental retardation than in patients with normal IQ.",2011.0,,"D. Bauze1,2, L. Kevere1, Z. Kronberga1, A. Rizevs1, S. Jelisejevs1, R.  Andrezina3, B. Lace4","1Childrens University Hospital, Child Psychiatry Clinic, Riga, Latvia, 2Childrens  University Hospital, Medical Genetics Clinic, Riga, Latvia, 3Riga Stradins  University, Riga, Latvia, 4Childrens University Hospital, Medical Genetics Clinic,  Riga, Latvia","The aim of the study was to obtain information about patients with autism, ASD and seizure syndrome.",patients with autism,,"['patient', 'with', 'autism']",[]
255,294, Autism s pectrum Disorders and s eizure s yndrome,P02.036,,"iNtRODU cti ON: Autism and autism spectrum disorders (ASD) are  serious early childhood neurodevelopment disorders with a genetic  aetiology and increasing prevalence. Patients often have co morbid disorders. 11 39% may have seizure syndrome. According to the literature, 42% of patients with autism, ASD and mental retardation  have seizure syndrome. The aim of the study was to obtain information about patients with autism, ASD and seizure syndrome. m E t HOD s : 158 patients with autism and ASD were ascertained who  had been treated in the Childrens University Hospital, Child Psychiatry  Clinic and Medical Genetics Clinic from 2006   2010. We recorded the patients clinical symptoms (ICD 10), ADOS, electroencephalography (EEG) and IQ. SPSS 13 was used for statistical analysis. The frequency of seizure syndrome in both patient groups was calculated. RE s UL ts : Seizure syndrome was identified in four patients with  autism and 11 patients with ASD. Two patients in the autism group had their IQ within normal limits, four patients were moderately mentally retarded. In the ASD group, one patient had IQ within normal limits, four patients were mildly mentally retarded, four patients had severe mental retardation. c ON c LU si ON: The incidence of seizure syndrome was 9.5% in both  patient groups. Seizure syndrome is more frequent in patients with  some degree of mental retardation than in patients with normal IQ.",2011.0,,"D. Bauze1,2, L. Kevere1, Z. Kronberga1, A. Rizevs1, S. Jelisejevs1, R.  Andrezina3, B. Lace4","1Childrens University Hospital, Child Psychiatry Clinic, Riga, Latvia, 2Childrens  University Hospital, Medical Genetics Clinic, Riga, Latvia, 3Riga Stradins  University, Riga, Latvia, 4Childrens University Hospital, Medical Genetics Clinic,  Riga, Latvia","m E t HOD s : 158 patients with autism and ASD were ascertained who  had been treated in the Childrens University Hospital, Child Psychiatry  Clinic and Medical Genetics Clinic from 2006   2010.",patients with autism,,"['patient', 'with', 'autism']",[]
255,294, Autism s pectrum Disorders and s eizure s yndrome,P02.036,,"iNtRODU cti ON: Autism and autism spectrum disorders (ASD) are  serious early childhood neurodevelopment disorders with a genetic  aetiology and increasing prevalence. Patients often have co morbid disorders. 11 39% may have seizure syndrome. According to the literature, 42% of patients with autism, ASD and mental retardation  have seizure syndrome. The aim of the study was to obtain information about patients with autism, ASD and seizure syndrome. m E t HOD s : 158 patients with autism and ASD were ascertained who  had been treated in the Childrens University Hospital, Child Psychiatry  Clinic and Medical Genetics Clinic from 2006   2010. We recorded the patients clinical symptoms (ICD 10), ADOS, electroencephalography (EEG) and IQ. SPSS 13 was used for statistical analysis. The frequency of seizure syndrome in both patient groups was calculated. RE s UL ts : Seizure syndrome was identified in four patients with  autism and 11 patients with ASD. Two patients in the autism group had their IQ within normal limits, four patients were moderately mentally retarded. In the ASD group, one patient had IQ within normal limits, four patients were mildly mentally retarded, four patients had severe mental retardation. c ON c LU si ON: The incidence of seizure syndrome was 9.5% in both  patient groups. Seizure syndrome is more frequent in patients with  some degree of mental retardation than in patients with normal IQ.",2011.0,,"D. Bauze1,2, L. Kevere1, Z. Kronberga1, A. Rizevs1, S. Jelisejevs1, R.  Andrezina3, B. Lace4","1Childrens University Hospital, Child Psychiatry Clinic, Riga, Latvia, 2Childrens  University Hospital, Medical Genetics Clinic, Riga, Latvia, 3Riga Stradins  University, Riga, Latvia, 4Childrens University Hospital, Medical Genetics Clinic,  Riga, Latvia",RE s UL ts : Seizure syndrome was identified in four patients with  autism and 11 patients with ASD.,patients with ASD,,"['patient', 'with', 'ASD']",[]
255,294, Autism s pectrum Disorders and s eizure s yndrome,P02.036,,"iNtRODU cti ON: Autism and autism spectrum disorders (ASD) are  serious early childhood neurodevelopment disorders with a genetic  aetiology and increasing prevalence. Patients often have co morbid disorders. 11 39% may have seizure syndrome. According to the literature, 42% of patients with autism, ASD and mental retardation  have seizure syndrome. The aim of the study was to obtain information about patients with autism, ASD and seizure syndrome. m E t HOD s : 158 patients with autism and ASD were ascertained who  had been treated in the Childrens University Hospital, Child Psychiatry  Clinic and Medical Genetics Clinic from 2006   2010. We recorded the patients clinical symptoms (ICD 10), ADOS, electroencephalography (EEG) and IQ. SPSS 13 was used for statistical analysis. The frequency of seizure syndrome in both patient groups was calculated. RE s UL ts : Seizure syndrome was identified in four patients with  autism and 11 patients with ASD. Two patients in the autism group had their IQ within normal limits, four patients were moderately mentally retarded. In the ASD group, one patient had IQ within normal limits, four patients were mildly mentally retarded, four patients had severe mental retardation. c ON c LU si ON: The incidence of seizure syndrome was 9.5% in both  patient groups. Seizure syndrome is more frequent in patients with  some degree of mental retardation than in patients with normal IQ.",2011.0,,"D. Bauze1,2, L. Kevere1, Z. Kronberga1, A. Rizevs1, S. Jelisejevs1, R.  Andrezina3, B. Lace4","1Childrens University Hospital, Child Psychiatry Clinic, Riga, Latvia, 2Childrens  University Hospital, Medical Genetics Clinic, Riga, Latvia, 3Riga Stradins  University, Riga, Latvia, 4Childrens University Hospital, Medical Genetics Clinic,  Riga, Latvia","In the ASD group, one patient had IQ within normal limits, four patients were mildly mentally retarded, four patients had severe mental retardation.",,ASD group,[],"['ASD', 'group']"
256,295, s ub microscopic chromosomal imbalances in two children with idiopathic autism spectrum disorder,P02.037,,"Autism is a childhood neurodevelopmental disorder apparent by 3  years of age and characterized by qualitative impairments in reciprocal social interaction, deficits in verbal communication, restricted interests and repetitive behaviors. The exact aetiology of autism remains unknown, although it is likely to result from a complex combination  of genetic, neurological, and environmental factors. Recent high resolution microarray based studies in autism have identified a number of novel submicroscopic copy number variants (CNVs) including both deletions and duplications.We report two children with autistic behavior and mental retardation. We have used genomic array CytoChip Oligo (BlueGnome, Cambridge, UK), format 2x105K, version 1.1. and BlueFuse Multi software, version 2.2. The 2x105K array detects 35 Kb imbalances on the backbone and has tiling of 20 probes over 137 OMIM disease loci. Array CGH  Clinical genetics and Dysmorphology77 analysis revealed cryptic deletion of 16p11.2 region spanning 513 kb  in first patient and an amplification spanning 1,624 Mb of Xp22.31 region in second patient. Deletions and duplications at chromosome 16p11.2 appear to be associated with ~1% of unexplained, idiopathic and nonsyndromic autism. Several of the genes that reside within  the 16p11.2 microdeletion represent promising candidates for autism based on known expression and functional data. Submicroscopic duplication of Xp22.31 has been reported as either a possible cause of intellectual disability and/or autistic behavior or a benign variant. . The Xp22.31 duplication included the steroid sulfatase (STS) gene.Our results indicate that array CGH is a powerful tool to detect sub microscopic pathogenic imbalances in patients with idiopathic autism and/or mental retardation.",2011.0,,"D. Avdjieva Tzavella1, S. Hadjidekova2, B. Rukova2, D. Nesheva2, E.  Simeonov3, T. Todorov4, A. Todorova5, I. Dimova2, R. Tincheva1, D. Toncheva2","1Department of Clinical Genetics, University Pediatrics Hospital, Medical  University, Sofia, Bulgaria, Sofia, Bulgaria, 2Department of Medical Genetics,  Medical Faculty, Medical University, Sofia, Bulgaria, 3Clinic of Pediatrics,  University Hospital Alexandrovska, Sofia, Bulgaria, 4Department of Medical  Chemistry and Biochemistry, Sofia Medical University, Sofia, Bulgaria,  5Department of Medical Chemistry and Biochemistry, Sofia, Bulgaria",Recent high resolution microarray based studies in autism have identified a number of novel submicroscopic copy number variants (CNVs) including both deletions and duplications.We report two children with autistic behavior and mental retardation.,,autistic behavior,[],"['autistic', 'behavior']"
256,295, s ub microscopic chromosomal imbalances in two children with idiopathic autism spectrum disorder,P02.037,,"Autism is a childhood neurodevelopmental disorder apparent by 3  years of age and characterized by qualitative impairments in reciprocal social interaction, deficits in verbal communication, restricted interests and repetitive behaviors. The exact aetiology of autism remains unknown, although it is likely to result from a complex combination  of genetic, neurological, and environmental factors. Recent high resolution microarray based studies in autism have identified a number of novel submicroscopic copy number variants (CNVs) including both deletions and duplications.We report two children with autistic behavior and mental retardation. We have used genomic array CytoChip Oligo (BlueGnome, Cambridge, UK), format 2x105K, version 1.1. and BlueFuse Multi software, version 2.2. The 2x105K array detects 35 Kb imbalances on the backbone and has tiling of 20 probes over 137 OMIM disease loci. Array CGH  Clinical genetics and Dysmorphology77 analysis revealed cryptic deletion of 16p11.2 region spanning 513 kb  in first patient and an amplification spanning 1,624 Mb of Xp22.31 region in second patient. Deletions and duplications at chromosome 16p11.2 appear to be associated with ~1% of unexplained, idiopathic and nonsyndromic autism. Several of the genes that reside within  the 16p11.2 microdeletion represent promising candidates for autism based on known expression and functional data. Submicroscopic duplication of Xp22.31 has been reported as either a possible cause of intellectual disability and/or autistic behavior or a benign variant. . The Xp22.31 duplication included the steroid sulfatase (STS) gene.Our results indicate that array CGH is a powerful tool to detect sub microscopic pathogenic imbalances in patients with idiopathic autism and/or mental retardation.",2011.0,,"D. Avdjieva Tzavella1, S. Hadjidekova2, B. Rukova2, D. Nesheva2, E.  Simeonov3, T. Todorov4, A. Todorova5, I. Dimova2, R. Tincheva1, D. Toncheva2","1Department of Clinical Genetics, University Pediatrics Hospital, Medical  University, Sofia, Bulgaria, Sofia, Bulgaria, 2Department of Medical Genetics,  Medical Faculty, Medical University, Sofia, Bulgaria, 3Clinic of Pediatrics,  University Hospital Alexandrovska, Sofia, Bulgaria, 4Department of Medical  Chemistry and Biochemistry, Sofia Medical University, Sofia, Bulgaria,  5Department of Medical Chemistry and Biochemistry, Sofia, Bulgaria",Submicroscopic duplication of Xp22.31 has been reported as either a possible cause of intellectual disability and/or autistic behavior or a benign variant.,,autistic behavior,[],"['autistic', 'behavior']"
256,295, s ub microscopic chromosomal imbalances in two children with idiopathic autism spectrum disorder,P02.037,,"Autism is a childhood neurodevelopmental disorder apparent by 3  years of age and characterized by qualitative impairments in reciprocal social interaction, deficits in verbal communication, restricted interests and repetitive behaviors. The exact aetiology of autism remains unknown, although it is likely to result from a complex combination  of genetic, neurological, and environmental factors. Recent high resolution microarray based studies in autism have identified a number of novel submicroscopic copy number variants (CNVs) including both deletions and duplications.We report two children with autistic behavior and mental retardation. We have used genomic array CytoChip Oligo (BlueGnome, Cambridge, UK), format 2x105K, version 1.1. and BlueFuse Multi software, version 2.2. The 2x105K array detects 35 Kb imbalances on the backbone and has tiling of 20 probes over 137 OMIM disease loci. Array CGH  Clinical genetics and Dysmorphology77 analysis revealed cryptic deletion of 16p11.2 region spanning 513 kb  in first patient and an amplification spanning 1,624 Mb of Xp22.31 region in second patient. Deletions and duplications at chromosome 16p11.2 appear to be associated with ~1% of unexplained, idiopathic and nonsyndromic autism. Several of the genes that reside within  the 16p11.2 microdeletion represent promising candidates for autism based on known expression and functional data. Submicroscopic duplication of Xp22.31 has been reported as either a possible cause of intellectual disability and/or autistic behavior or a benign variant. . The Xp22.31 duplication included the steroid sulfatase (STS) gene.Our results indicate that array CGH is a powerful tool to detect sub microscopic pathogenic imbalances in patients with idiopathic autism and/or mental retardation.",2011.0,,"D. Avdjieva Tzavella1, S. Hadjidekova2, B. Rukova2, D. Nesheva2, E.  Simeonov3, T. Todorov4, A. Todorova5, I. Dimova2, R. Tincheva1, D. Toncheva2","1Department of Clinical Genetics, University Pediatrics Hospital, Medical  University, Sofia, Bulgaria, Sofia, Bulgaria, 2Department of Medical Genetics,  Medical Faculty, Medical University, Sofia, Bulgaria, 3Clinic of Pediatrics,  University Hospital Alexandrovska, Sofia, Bulgaria, 4Department of Medical  Chemistry and Biochemistry, Sofia Medical University, Sofia, Bulgaria,  5Department of Medical Chemistry and Biochemistry, Sofia, Bulgaria",The Xp22.31 duplication included the steroid sulfatase (STS) gene.Our results indicate that array CGH is a powerful tool to detect sub microscopic pathogenic imbalances in patients with idiopathic autism and/or mental retardation.,patients with idiopathic autism,,"['patient', 'with', 'idiopathic', 'autism']",[]
257,296, c hildren autism and mitochondrial DNA mutations,P02.038,,"In the data of the WHO (World Health Organization) the prevalence of  autism in childrenis reported as 1 6 per 1000. The number in Bulgaria is currently unknown. But the hospitalizationof patients with speech, hearing and communication problems has  increased in the past 10 years. Our experience in clinical genetics proved that childhood autism is a heterogeneous syndrome. The aim of our work was to analyze children with autism for mitochondrial DNA mutations and discuss the possibility of their treatment. We made clinical and laboratory investigations and sequenced mt DNA regions in peripheral blood by the PCR SBT method in 4 of our patients with autism.We found different mt DNA mutations and polymorphisms. In a girl suspected for Rett syndrome we found G6852A in mt CO1,which  changed Gly>Ser. In the 3 boys with autism we found the polymorphism T4216C (connected with predisposition to LHON or insulin resistance) in the first,the polymorphism G9055A (protective of Parkinson disease) in the second, and a polymorphism connected with predisposition to LHON in the third. The children with mt DNA changes improved on treatment with a casein  and gluten free diet and high dose vitamin Q10. We propose that children with autism should be investigated for mtDNA mutations and treated as mitochondrial disorders.",2011.0,,B. I. Radeva,"Medical Center Childens Health, Sofia, Bulgaria",The aim of our work was to analyze children with autism for mitochondrial DNA mutations and discuss the possibility of their treatment.,children with autism,,"['child', 'with', 'autism']",[]
257,296, c hildren autism and mitochondrial DNA mutations,P02.038,,"In the data of the WHO (World Health Organization) the prevalence of  autism in childrenis reported as 1 6 per 1000. The number in Bulgaria is currently unknown. But the hospitalizationof patients with speech, hearing and communication problems has  increased in the past 10 years. Our experience in clinical genetics proved that childhood autism is a heterogeneous syndrome. The aim of our work was to analyze children with autism for mitochondrial DNA mutations and discuss the possibility of their treatment. We made clinical and laboratory investigations and sequenced mt DNA regions in peripheral blood by the PCR SBT method in 4 of our patients with autism.We found different mt DNA mutations and polymorphisms. In a girl suspected for Rett syndrome we found G6852A in mt CO1,which  changed Gly>Ser. In the 3 boys with autism we found the polymorphism T4216C (connected with predisposition to LHON or insulin resistance) in the first,the polymorphism G9055A (protective of Parkinson disease) in the second, and a polymorphism connected with predisposition to LHON in the third. The children with mt DNA changes improved on treatment with a casein  and gluten free diet and high dose vitamin Q10. We propose that children with autism should be investigated for mtDNA mutations and treated as mitochondrial disorders.",2011.0,,B. I. Radeva,"Medical Center Childens Health, Sofia, Bulgaria",We made clinical and laboratory investigations and sequenced mt DNA regions in peripheral blood by the PCR SBT method in 4 of our patients with autism.We found different mt DNA mutations and polymorphisms.,patients with autism,,"['patient', 'with', 'autism']",[]
257,296, c hildren autism and mitochondrial DNA mutations,P02.038,,"In the data of the WHO (World Health Organization) the prevalence of  autism in childrenis reported as 1 6 per 1000. The number in Bulgaria is currently unknown. But the hospitalizationof patients with speech, hearing and communication problems has  increased in the past 10 years. Our experience in clinical genetics proved that childhood autism is a heterogeneous syndrome. The aim of our work was to analyze children with autism for mitochondrial DNA mutations and discuss the possibility of their treatment. We made clinical and laboratory investigations and sequenced mt DNA regions in peripheral blood by the PCR SBT method in 4 of our patients with autism.We found different mt DNA mutations and polymorphisms. In a girl suspected for Rett syndrome we found G6852A in mt CO1,which  changed Gly>Ser. In the 3 boys with autism we found the polymorphism T4216C (connected with predisposition to LHON or insulin resistance) in the first,the polymorphism G9055A (protective of Parkinson disease) in the second, and a polymorphism connected with predisposition to LHON in the third. The children with mt DNA changes improved on treatment with a casein  and gluten free diet and high dose vitamin Q10. We propose that children with autism should be investigated for mtDNA mutations and treated as mitochondrial disorders.",2011.0,,B. I. Radeva,"Medical Center Childens Health, Sofia, Bulgaria","In the 3 boys with autism we found the polymorphism T4216C (connected with predisposition to LHON or insulin resistance) in the first,the polymorphism G9055A (protective of Parkinson disease) in the second, and a polymorphism connected with predisposition to LHON in the third.",boys with autism,,"['boy', 'with', 'autism']",[]
257,296, c hildren autism and mitochondrial DNA mutations,P02.038,,"In the data of the WHO (World Health Organization) the prevalence of  autism in childrenis reported as 1 6 per 1000. The number in Bulgaria is currently unknown. But the hospitalizationof patients with speech, hearing and communication problems has  increased in the past 10 years. Our experience in clinical genetics proved that childhood autism is a heterogeneous syndrome. The aim of our work was to analyze children with autism for mitochondrial DNA mutations and discuss the possibility of their treatment. We made clinical and laboratory investigations and sequenced mt DNA regions in peripheral blood by the PCR SBT method in 4 of our patients with autism.We found different mt DNA mutations and polymorphisms. In a girl suspected for Rett syndrome we found G6852A in mt CO1,which  changed Gly>Ser. In the 3 boys with autism we found the polymorphism T4216C (connected with predisposition to LHON or insulin resistance) in the first,the polymorphism G9055A (protective of Parkinson disease) in the second, and a polymorphism connected with predisposition to LHON in the third. The children with mt DNA changes improved on treatment with a casein  and gluten free diet and high dose vitamin Q10. We propose that children with autism should be investigated for mtDNA mutations and treated as mitochondrial disorders.",2011.0,,B. I. Radeva,"Medical Center Childens Health, Sofia, Bulgaria",We propose that children with autism should be investigated for mtDNA mutations and treated as mitochondrial disorders.,children with autism,,"['child', 'with', 'autism']",[]
258,317, A c GH Array study in non syndromic (primary) autism disorder,P02.059,,"iNtRODU cti ON: Autism is a neurodevelopmental disorder with a strong genetic basis  in its etiology. Cytogenetic abnormalities have been detected in 5 10% of the patients with autism. Conventional karyotype analysis has revealed that chromosomal structural aberrations such as  translocation, inversion, deletion, and duplication play a role in causing autism spectrum disorders (ASD). Unfortunately, there is not a single specific biological marker clearly responsible from autism. Array CGH is a molecular karyotyping method remarkable with fast analysis and highly sensitive diagnostic value.We aimed to use this technology to screen autistic patients whole genome in order to investigate new dchromosomal abberations. m A t ER i AL AND  m E t HOD: We isolated DNA samples of 35 primary autism patients between 0 18  years(median age:8.5).DNA samples which labelled according to the protocol, were hybridized with CytoSure Syndrome Plus(v2) 4x44K (Oxford Gene Technology, Oxford, UK) microchips and scanned with Agilent Microarray Scanner( Agilent Technologies, Palo Alto, CA ). Obtained data were analyzed using Cytosure Analysis Software v.2.0.8 software(Oxford Gene Technology, Oxford, UK).RE s UL ts : We found 16p13.11 deletion in thirteen patients, 16p11.2 deletion in twelve patients, 1q21 deletion in ten patients, 2q21.1 deletion in eight patients, 2p21 deletion in seven patients, 8p23.1 deletions in seven patients. c ON c LU si ON: Accordig to these data, we can postulate that 16p13.11 region  and related genes also represent a predisposition to autism in our patients. Verification of the data belonging to these regions, may provide important clues for gene expression and proteomics studies responsible from the pathogenesis of the disease and treatment strategies.",2011.0,,"E. Gumuslu1, N. Cine1, B. Kara2, H. Savli1","1Kocaeli University Medical Genetics Department, Kocaeli, Turkey, 2Kocaeli  University Department Of Pediatrics, Kocaeli, Turkey",Cytogenetic abnormalities have been detected in 5 10% of the patients with autism.,patients with autism,,"['patient', 'with', 'autism']",[]
258,317, A c GH Array study in non syndromic (primary) autism disorder,P02.059,,"iNtRODU cti ON: Autism is a neurodevelopmental disorder with a strong genetic basis  in its etiology. Cytogenetic abnormalities have been detected in 5 10% of the patients with autism. Conventional karyotype analysis has revealed that chromosomal structural aberrations such as  translocation, inversion, deletion, and duplication play a role in causing autism spectrum disorders (ASD). Unfortunately, there is not a single specific biological marker clearly responsible from autism. Array CGH is a molecular karyotyping method remarkable with fast analysis and highly sensitive diagnostic value.We aimed to use this technology to screen autistic patients whole genome in order to investigate new dchromosomal abberations. m A t ER i AL AND  m E t HOD: We isolated DNA samples of 35 primary autism patients between 0 18  years(median age:8.5).DNA samples which labelled according to the protocol, were hybridized with CytoSure Syndrome Plus(v2) 4x44K (Oxford Gene Technology, Oxford, UK) microchips and scanned with Agilent Microarray Scanner( Agilent Technologies, Palo Alto, CA ). Obtained data were analyzed using Cytosure Analysis Software v.2.0.8 software(Oxford Gene Technology, Oxford, UK).RE s UL ts : We found 16p13.11 deletion in thirteen patients, 16p11.2 deletion in twelve patients, 1q21 deletion in ten patients, 2q21.1 deletion in eight patients, 2p21 deletion in seven patients, 8p23.1 deletions in seven patients. c ON c LU si ON: Accordig to these data, we can postulate that 16p13.11 region  and related genes also represent a predisposition to autism in our patients. Verification of the data belonging to these regions, may provide important clues for gene expression and proteomics studies responsible from the pathogenesis of the disease and treatment strategies.",2011.0,,"E. Gumuslu1, N. Cine1, B. Kara2, H. Savli1","1Kocaeli University Medical Genetics Department, Kocaeli, Turkey, 2Kocaeli  University Department Of Pediatrics, Kocaeli, Turkey",Array CGH is a molecular karyotyping method remarkable with fast analysis and highly sensitive diagnostic value.We aimed to use this technology to screen autistic patients whole genome in order to investigate new dchromosomal abberations.,,autistic patients whole genome,[],"['autistic', 'patient\x80\x99s', 'whole', 'genome']"
270,541, 12p13.33 microdeletion syndrome: redefining the associated clinical phenotype,P03.022,,"Subtelomeric rearrangement associated with developemental  disabilities detection rate represents 5% of the etiologies. Sub telomeric or interstitial deletions of less than 5 Mb involving chromosome 12p13.33 is one the least frequently deleted region. Only 5 patients diagnosed with FISH telomere analysis or array CGH have been  reported. The most phenotypic manifestation of this microdeletion seems to be speech delay associated with autism spectrum disorders (ASD) phenotype. Two of them were inherited from an apparently healthy parent, suggesting variable expressivity and incomplete penetrance.A French collaboration together with a search in the Decipher database permitted to gather 6 novel patients (4 probands) with a 12p13.33 subtelomeric or interstitial rearrangement identified by high resolution array CGH to further delineate this rare microdeletional syndrome.  Speech delay was found in 5/6 patients, with dysarthry in 3/6, mental retardation in 4/6 patients, ASD phenotype in 3/6 patients, mild non specific dysmorphism (3/6) with prominent ear lobes in 2/6 patients, normal growth parameters with macrocephaly in 1/6 patient and microcephaly in 1/6. Variable expressivity or incomplete penetrance was found in both familial cases. The clinical and molecular data of this group of patients were compared to the other observations of the literature. The ELKS/ERC1 gene is found in the commonly deleted  region, and appears as a good candidate for speech delay.These results reinforce the hypothesis that the 12p13.33 subtelomeric or interstitial deletions can be responsible of a variable phenotyope ranging from normal developpement, speech delay, to mental retardation and ASD.",2011.0,,"J. THEVENON1, F. Mugneret2, P. Callier3, A. David4, J. Andrieux5, B. Delobel5,  S. Sukno5, A. Mosca3, N. Marle3, D. Sanlaville6, D. Minot1, A. Masurel Paulet1,  L. Gaunt7, C. Thauvin Robinet1, J. Clayton Smith7, L. Faivre1","1Centre de rfrence maladies rares, Dijon, France, 2cytogntique, Dijon,  France, 3Cytogntique, Dijon, France, 4Centre de gntique, Nantes, France,  5Hopital Jeanne de Flandres, Lille, France, 6Laboratoire de Cytogntique,  Lyon, France, 7Genetic Medicine, Manchester, United Kingdom","Speech delay was found in 5/6 patients, with dysarthry in 3/6, mental retardation in 4/6 patients, ASD phenotype in 3/6 patients, mild non specific dysmorphism (3/6) with prominent ear lobes in 2/6 patients, normal growth parameters with macrocephaly in 1/6 patient and microcephaly in 1/6.",,ASD phenotype,[],"['ASD', 'phenotype']"
274,577, t etrasomy 15q in a girl with epilepsy and hypomelanosis,P03.059,,"Servicio de Anlisis Clnicos. Complejo  Hospitalario Universitario de Albacete., Albacete, Spain, 2Neurologa Peditrica.  Complejo Hospitalario Universitario de Albacete, Albacete, Spain. The inv dup (15) or idic (15) is the most common of the heterogeneous  group of the extra structurally abnormal chromosomes (ESAC). Two cytogenetics types have been identified. One is a metacentric or submetacentric and heterochromatic chromosome, not containing the Prader Willi Syndrome/ Angelman Syndrome Critical Region  (PWS/ASCR) [dic(15)(q11).dic(15)(q11)], can be familial or de novo  and most children show a normal phenotype. The second type has 15q euchromatin including PWS/ASCR [dic(15)(q12 or q13)], that frequently derives from the two homologous maternal chromosomes at meiosis. This condition is associated with an abnormal phenotype, which constitutes the idic(15) syndrome, and is nearly always sporadic.The inv dup (15) displays distinctive clinical findings represented by early central hypotonia and intellectual disability, epilepsy and autistic behaviour. Expressive language is absent or very poor and  often echolalic. Epilepsy with a wide variety of seizures, as a typical Lennox Gastaut Syndrome (LGS), can occur in these individuals. Areas of increased and reduced skin pigmentation can be occasionally observed.We report on a 6 years old girl, patient of Neuropediatrics, with language delay, LGS and hypopigmented streaks on the trunk. Cytogenetic studies and FISH analysis showed that she had a de novo 46,XX,+idic(15)(q13) karyotype. Cytogenetic analysis confirm the diagnosis of idic(15) syndrome in our patient.",2011.0,,"A. Gmez1, M. Quintanilla1, P. Martn Tamayo2, G. M. Varo1, L. Navarro1",1Unidad de Gentica Clnica,"This condition is associated with an abnormal phenotype, which constitutes the idic(15) syndrome, and is nearly always sporadic.The inv dup (15) displays distinctive clinical findings represented by early central hypotonia and intellectual disability, epilepsy and autistic behaviour.",,autistic behaviour,[],"['autistic', 'behaviour']"
277,592," A new variant of Potocky Lupsky syndrome in two unrelated patients affected by severe epileptic encephalopathy, detected by Genome Array c GH",P03.074,,", Cagliari, Italy, 3Dipartimento di Scienze e Tecnologie Biomediche,  sez. Biologia e Genetica, Universit di Cagliari, Italy., Monserrato( Cagliari),  Italy, 4Dipartimento di Biologia Sperimentale, Universit di Cagliari, Italy.,  Monserrato( Cagliari), Italy, 5Neuropsichiatria Infantile, Azienda Ospedaliero   Universitaria, Cagliari, Italy., Cagliari, Italy. The duplication 17p11.2 syndrome, associated with dup(17) (p11.2p11.2), is a recently recognized syndrome of multiple congenital anomalies and mental retardation. It is the first predicted reciprocal microduplication syndrome described_the homologous recombination reciprocal of the Smith Magenis syndrome (SMS) microdeletion  (del(17)(p11.2p11.2)(Potocky et al, 2007).Herein, we report a novel pathologic variant of this syndrome detected by Genome Array CGH in two non consanguineous subjects with dup(17)(p11.2p11.2),Array analysis was performed using the BAC Cyto chips Blue Gnome platform, at 0.5 Mb median resolution, and revealed the presence of the same BAC duplication in both patients.The duplicated BAC (RP11 78O7), of about 140 Kb, maps in 17p11.2 and contains an interesting gene, presumably involved in the pathology. The parents did not show the duplication, suggesting that it was a de novo rearrangement.Cytogenetic and clinical features of subjects with partial trisomy of proximal 17p have been described, mostly in isolated case reports or literature reviews, and non specific and non characterizing findings include developmental delay, mental retardation, and dysmorphicfeatures.Our patients present a peculiar form of epileptic encephalopathy associated with severe mental retardation and autistic behaviour. Molecular and genetic studies are in progress to define and characterize the rearrangement and for better genotype/phenotype correlation.",2011.0,,"A. Nucaro1, C. Montaldo2, S. Zorco2, N. Santini2, T. Dettori3, P. Caria3, A. Milia4,  C. Cianchetti5, D. Pruna5","1Istituto di Neurogenetica e Neurofarmacologia, Monserrato( Cagliari), Italy,  2Dipartimento di Scienze Chirurgiche, Laboratorio OBL , Universit di Cagliari,  Italy","The parents did not show the duplication, suggesting that it was a de novo rearrangement.Cytogenetic and clinical features of subjects with partial trisomy of proximal 17p have been described, mostly in isolated case reports or literature reviews, and non specific and non characterizing findings include developmental delay, mental retardation, and dysmorphicfeatures.Our patients present a peculiar form of epileptic encephalopathy associated with severe mental retardation and autistic behaviour.",,autistic behaviour,[],"['autistic', 'behaviour']"
278,612,Report of a patient with distal Williams Beuren deletion.,P03.095,,"A 7 years old boy was referred to the genetic consultation given  psychomotor delay, learning difficulties and dysmorphism. He presents behavioral disorders as depression, impulsivity, hyperactivity and relationships difficulties with other children. EEG shows epilepsy. He uses short sentences but with pronunciations difficulties.  Developmental quotient was evaluated at 63 (Terman Merrill). Minor dysmorphic features were observed with upslanting palpebral fissures, strabismus, mild retrognathia and protruding upper lip with long philtrum. Growth parameters at 7 years are in the normal range.CGH analysis showed a 2.015 Mb deletion distal to the Williams Beuren deletion. The deletion is maternally inherited. The family belongs to underprivileged socio cultural environment with relatives presenting learning difficulties and intellectual disabilities. Given this blurring familial situation, this deletion was initially considered as being  of unknown clinical significance. Furthermore polymorphic CNV were reported in this region.Two publications (Edelmann et al., 2007 ; J Med Genet 44:136 143 and Ramocki et al., 2010 ; Am J Hum Genet 87:857 865) reported  deletions or duplications distal to the Williams Beuren deletion. These patients exhibit variable expression of epilepsy, learning difficulties, intellectual disabilities (mild to severe developmental delay or intellectual disability with autistic features in some patients) and/or neurobehavioral abnormalities (inattention, hyperactivity, impulsivity and aggression including self abusive behavior and depression). The majority of the patients have a deletion inherited from a normal or less affected parent. HIP1 and YWHAG genes are also deleted in our patient. However the inheritance from normal relatives, strongly  suggests an incomplete penetrance of this deletion which preclude a unambiguous genetic counseling.",2011.0,,"B. Grisart, S. Vidrequin, K. Rack, C. Verellen Dumoulin, A. Destre","Centre de Gntique Humaine, Institut de Pathologie et de Gntique, Charleroi (Gosselies), Belgium","These patients exhibit variable expression of epilepsy, learning difficulties, intellectual disabilities (mild to severe developmental delay or intellectual disability with autistic features in some patients) and/or neurobehavioral abnormalities (inattention, hyperactivity, impulsivity and aggression including self abusive behavior and depression).",,autistic features,[],"['autistic', 'feature']"
282,1064, Next generation sequencing of known and putative susceptibility genes for schizophrenia and autism spectrum disorders to detect rare high penetrant risk variants,P08.64,,"Schizophrenia (SZ) and autism spectrum disorders (ASD) are  complex neurodevelopmental disorders that share certain phenotypes including cognitive deficits and some behavioural characteristics. Such similarities suggest that these disorders may share an underlying pathology and thus may share some genetic risk variants. This study  involves next generation sequencing of the exonic regions of 215 potential susceptibility genes in an Irish sample of 150 cases of ASD, 300 cases of SZ and 300 controls, in order to identify single nucleotide polymorphisms, indels and structural variants contributing to one or both disorders. A multiplex target enrichment method is used whereby DNA samples are multiplexed together using DNA indexes/barcodes and enriched for the exonic regions of these genes using the Agilent SureSelect target enrichment method. This is followed by 80bp paired end sequencing in a single lane of an Illumina GAII. Gene selection  comprised of five categories: 1) Interactors of NRXN1, 2) Interactors of DISC1, 3) Genes within the Glutamate Receptor Complexes; NMDA, mGluR5 and AMPA, 4) Cell adhesion molecules and 5) Functional and Positional Candidates. Analysis of the pilot set of samples indicates that the approach undertaken is successful with an even spread of sequence information for 24 indexed samples per lane, >8X coverage for 84% of target regions and overall SNP concordance with previous GWAS data (Affymetrix 6.0) of 99.3%. In addition to description of this novel sequencing method, data will be presented on the rare variant analysis in the SZ and ASD samples.",2011.0,,"D. W. Morris, S. Furlong, E. Kenny, P. Cormican, C. Fahey, R. Anney, G.  Donohoe, A. Corvin, L. Gallagher, M. Gill","Trinity College Dublin, Dublin, Ireland","In addition to description of this novel sequencing method, data will be presented on the rare variant analysis in the SZ and ASD samples.",,ASD samples,[],"['ASD', 'sample']"
284,1113, Association of the ciliary gene AHI1 with autism,P09.032,,"of Medical Genetics, Utrecht, Netherlands. Joubert syndrome (JBTS) is an autosomaal recessive disorder  characterized by hypoplasia of the cerebellar vermis, the characteristic neuroradiologic molar tooth sign, and neurologic symptoms, including dysregulation of breathing and developmental delay. JBTS also includes variable features such as retinal dystrophy and renal  anomalies. Up to 27% of JBTS patients show features of autism. Thus far, 10 genes for JBTS have been identified. The ciliary gene AHI1  has been found mutated in 7 to 16% of cases with JBTS. On the other hand, of the 39 genes associated with autism, 29 (74%) encode ciliary genes. This association of ciliary genes with autism is highly significant (P < 0.001; two sided Fischer exact test). Therefore, we tested the hypothesis that ciliary genes may be involved in autism, by performing a candidate gene association study with a cohort of 84 patients with autism vs. 145 healthy controls for the 10 known JBTS genes (AHI1,  NPHP1, CEP290, ARL13B, RPGRIP1L, MKS3, CC2D2A, OFD1, TMEM216, and INPP5E). For AHI1 we found nominal association  with odds ratios from 3.077 to 9.174 and p values for association < 0.0001 for SNPs rs12179084, rs2327587 and rs7766656. Our data suggest that dysfunction of primary cilia may constitute an important neuropathological pathway in autism.",2011.0,,"H. Y. Kroes, S. Kevelam, R. van t Slot, C. G. De Kovel, M. Poot",Dept,This association of ciliary genes with autism is highly significant (P < 0.001; two sided Fischer exact test).,genes with autism,,"['gene', 'with', 'autism']",[]
284,1113, Association of the ciliary gene AHI1 with autism,P09.032,,"of Medical Genetics, Utrecht, Netherlands. Joubert syndrome (JBTS) is an autosomaal recessive disorder  characterized by hypoplasia of the cerebellar vermis, the characteristic neuroradiologic molar tooth sign, and neurologic symptoms, including dysregulation of breathing and developmental delay. JBTS also includes variable features such as retinal dystrophy and renal  anomalies. Up to 27% of JBTS patients show features of autism. Thus far, 10 genes for JBTS have been identified. The ciliary gene AHI1  has been found mutated in 7 to 16% of cases with JBTS. On the other hand, of the 39 genes associated with autism, 29 (74%) encode ciliary genes. This association of ciliary genes with autism is highly significant (P < 0.001; two sided Fischer exact test). Therefore, we tested the hypothesis that ciliary genes may be involved in autism, by performing a candidate gene association study with a cohort of 84 patients with autism vs. 145 healthy controls for the 10 known JBTS genes (AHI1,  NPHP1, CEP290, ARL13B, RPGRIP1L, MKS3, CC2D2A, OFD1, TMEM216, and INPP5E). For AHI1 we found nominal association  with odds ratios from 3.077 to 9.174 and p values for association < 0.0001 for SNPs rs12179084, rs2327587 and rs7766656. Our data suggest that dysfunction of primary cilia may constitute an important neuropathological pathway in autism.",2011.0,,"H. Y. Kroes, S. Kevelam, R. van t Slot, C. G. De Kovel, M. Poot",Dept,"Therefore, we tested the hypothesis that ciliary genes may be involved in autism, by performing a candidate gene association study with a cohort of 84 patients with autism vs. 145 healthy controls for the 10 known JBTS genes (AHI1,  NPHP1, CEP290, ARL13B, RPGRIP1L, MKS3, CC2D2A, OFD1, TMEM216, and INPP5E).",patients with autism,,"['patient', 'with', 'autism']",[]
285,1114, a c GH analysis of two families showing both autism and epilepsy,P09.033,,"Autism is a genetic disorder, with an estimated heritability greater than  90%. Over the past years, the convergence of genomic technologies has led to the identification of several susceptibility loci by means of linkage studies. Autism is associated with epilepsy in early childhood and epilepsy occurs in 10 30% of autism patients. We analysed two families showing both autism and epilepsy. The first one is the family of a woman, showing a severe and progressive epileptic disorder, who is married with an healthy man and has six children: two girls are healthy, a girl and two boys are affected by autism, while a boy showed partial seizures only twice. The three children with autism show a moderate mental retardation and an EEG with no epileptic alterations. The second family is composed by an epileptic woman married with a healthy man and their child affected by autism.The genetic basis of autism and epilepsy were studied in these  families. In particular, we performed an array CGH analysis to search for pathological CNVs which are common to all affected members of the two families.The study detected a single common region on chromosome 15q11.2, which has already been reported to be either deleted or duplicated in about 1% of epileptic patients. Moreover, the same region was associated with ASDs (autism spectrum disorders). We found a loss of 15q11.2 in all individuals belonging to the first family, while a gain of the region in the two affected members of the second family.Complex traits and polygenic disorders274",2011.0,,"R. Combi1, S. Redaelli2, V. Sansoni1, C. M. Cornaggia3, L. Dalpr2","1Dept of Biotechnology and Biosciences, University of Milano Bicocca, Milano,  Italy, 2Dept of Neurosciences and Biomedical Technologies, University of  Milano Bicocca, Monza, Italy, 3Clinical Psychiatry, University of Milano Bicocca,  Monza, Italy",The three children with autism show a moderate mental retardation and an EEG with no epileptic alterations.,children with autism,,"['child', 'with', 'autism']",[]
286,1115, Prevalence of fragile X syndrome in non syndromic autistic children in western saudi arabia,P09.034,,"Prevalence of Fragile X Syndrome (FXS) in the general population is around 1 in 1000 males and 1 in 2500 females. It is widely reported in the literature that FXS in the autistic populati5%, and that 30% of the FXS cases have full Autism. Among the remaining patients with FXS, of those who do not meet the criteria for an autism spectrum disorder  (ASD) diagnosis, the majority have one or more autistic features, such as hand flapping, poor eye contact and tactile defensiveness. Also it is reported that FXS is the most common single gene cause of autism, responsible for 2% to 6% of all cases of autism.We studied 41 patients with non syndromic Autism in Western Saudi Arabia, we determined the trinucleotide repeat number (TRN) of CGG in 5 end for the untranslated region of the gene FMR1 using PCR technique as described by Chong et al, (AJMG 51:522 526, 1994).After performing gel electrophoresis for the PCR products using 2%  agarose gel, the results analysis demonstrated that all samples have a CGG trinucleotide repeat number less than 50 repeats.In conclusion even though our sample number is small, with the percentage reported FMR1 gene mutation seems to not play a major role in the etiology of Autism in Western Saudi Arabia. There is a much lower prevalence of FXS. We may attribute this to a larger role of recessive causes, especially if considering parental consanguinity, though there may be other reasons as well.",2011.0,,"M. M. Alwasiyah1, C. Trujillo2","1Aziziah Maternity & Children Hospital, Jeddah, Saudi Arabia, 2Dr Erfan &  Bagedo Hospital, Jeddah, Saudi Arabia","It is widely reported in the literature that FXS in the autistic populati5%, and that 30% of the FXS cases have full Autism.",,autistic populati5,[],"['autistic', 'populati5']"
286,1115, Prevalence of fragile X syndrome in non syndromic autistic children in western saudi arabia,P09.034,,"Prevalence of Fragile X Syndrome (FXS) in the general population is around 1 in 1000 males and 1 in 2500 females. It is widely reported in the literature that FXS in the autistic populati5%, and that 30% of the FXS cases have full Autism. Among the remaining patients with FXS, of those who do not meet the criteria for an autism spectrum disorder  (ASD) diagnosis, the majority have one or more autistic features, such as hand flapping, poor eye contact and tactile defensiveness. Also it is reported that FXS is the most common single gene cause of autism, responsible for 2% to 6% of all cases of autism.We studied 41 patients with non syndromic Autism in Western Saudi Arabia, we determined the trinucleotide repeat number (TRN) of CGG in 5 end for the untranslated region of the gene FMR1 using PCR technique as described by Chong et al, (AJMG 51:522 526, 1994).After performing gel electrophoresis for the PCR products using 2%  agarose gel, the results analysis demonstrated that all samples have a CGG trinucleotide repeat number less than 50 repeats.In conclusion even though our sample number is small, with the percentage reported FMR1 gene mutation seems to not play a major role in the etiology of Autism in Western Saudi Arabia. There is a much lower prevalence of FXS. We may attribute this to a larger role of recessive causes, especially if considering parental consanguinity, though there may be other reasons as well.",2011.0,,"M. M. Alwasiyah1, C. Trujillo2","1Aziziah Maternity & Children Hospital, Jeddah, Saudi Arabia, 2Dr Erfan &  Bagedo Hospital, Jeddah, Saudi Arabia","Among the remaining patients with FXS, of those who do not meet the criteria for an autism spectrum disorder  (ASD) diagnosis, the majority have one or more autistic features, such as hand flapping, poor eye contact and tactile defensiveness.",,autistic features,[],"['autistic', 'feature']"
286,1115, Prevalence of fragile X syndrome in non syndromic autistic children in western saudi arabia,P09.034,,"Prevalence of Fragile X Syndrome (FXS) in the general population is around 1 in 1000 males and 1 in 2500 females. It is widely reported in the literature that FXS in the autistic populati5%, and that 30% of the FXS cases have full Autism. Among the remaining patients with FXS, of those who do not meet the criteria for an autism spectrum disorder  (ASD) diagnosis, the majority have one or more autistic features, such as hand flapping, poor eye contact and tactile defensiveness. Also it is reported that FXS is the most common single gene cause of autism, responsible for 2% to 6% of all cases of autism.We studied 41 patients with non syndromic Autism in Western Saudi Arabia, we determined the trinucleotide repeat number (TRN) of CGG in 5 end for the untranslated region of the gene FMR1 using PCR technique as described by Chong et al, (AJMG 51:522 526, 1994).After performing gel electrophoresis for the PCR products using 2%  agarose gel, the results analysis demonstrated that all samples have a CGG trinucleotide repeat number less than 50 repeats.In conclusion even though our sample number is small, with the percentage reported FMR1 gene mutation seems to not play a major role in the etiology of Autism in Western Saudi Arabia. There is a much lower prevalence of FXS. We may attribute this to a larger role of recessive causes, especially if considering parental consanguinity, though there may be other reasons as well.",2011.0,,"M. M. Alwasiyah1, C. Trujillo2","1Aziziah Maternity & Children Hospital, Jeddah, Saudi Arabia, 2Dr Erfan &  Bagedo Hospital, Jeddah, Saudi Arabia","Also it is reported that FXS is the most common single gene cause of autism, responsible for 2% to 6% of all cases of autism.We studied 41 patients with non syndromic Autism in Western Saudi Arabia, we determined the trinucleotide repeat number (TRN) of CGG in 5 end for the untranslated region of the gene FMR1 using PCR technique as described by Chong et al, (AJMG 51:522 526, 1994).After performing gel electrophoresis for the PCR products using 2%  agarose gel, the results analysis demonstrated that all samples have a CGG trinucleotide repeat number less than 50 repeats.In conclusion even though our sample number is small, with the percentage reported FMR1 gene mutation seems to not play a major role in the etiology of Autism in Western Saudi Arabia.",patients with non syndromic Autism,,"['patient', 'with', 'non', 'syndromic', 'Autism']",[]
288,1117, Large scale genetic pathway analysis of copy number variants highlights important rare genetic causes and gene networks for autism spectrum disorders,P09.036,,"The ability to quantify individuals genomic risk for disease can  facilitate the development of new interventions and improve medical practice. Many rare Copy Number Variants (CNVs) that harbor  small genomic deletions and insertions have been described in the autism spectrum disorders (ASD). To identify these likely functional elements, we combined three previously published large cohorts of autistic patients with a large number of controls to analyze over 25K unrelated individuals. After stringent quality control measures, we compared 3K cases to over 19K ethnically matched controls in a two stage genome wide association design. In all, we uncovered 275 statistically significant distinct copy number variable regions. The 60 genes nearest these robust CNVRs are most enriched in gene networks impacting neurological disease, behavior and developmental disorder. A more focused analysis of a subset of 87 CNVRs that are predicted to disrupt 26 genes highlights GABA receptor signaling, and methionine/glutathione trans sulfuration as the most significant canonical pathways disrupted in ASD. Furthermore, we used available family members to characterize CNVRs into inherited vs de novo and used ethnicity information to characterize their effects in different ethnic populations. Taken together, the CNVRs we have identified impact multiple novel genes and signaling pathways, including genes involved in GABA receptor signaling, that may be important for new  personalized therapeutic development.",2011.0,,"D. Hadley1, J. Glessner1, K. Wang2, F. Mentch1, D. Abrams1, C. Kim1, E.  Frackelton1, C. Hou1, R. Chiavacci1, J. Connolly1, G. Lyon1, H. Hakonarson1","1The Childrens Hospital of Philadelphia, Philadelphia, PA, United States,  2University of Southern Califormia, Los Angeles, CA, United States","To identify these likely functional elements, we combined three previously published large cohorts of autistic patients with a large number of controls to analyze over 25K unrelated individuals.",,autistic patients,[],"['autistic', 'patient']"
290,1119, Gene ontology enrichment analysis in two independent family based samples of over 2100 families highlights biologically plausible processes for autism spectrum disorders,P09.038,,"There is growing evidence to support the role of rare structural and  sequence variation in the aetiology of autism spectrum disorders (ASDs). However, genome wide association studies (GWAS) of ASDs have yielded only modest evidence to support common variation in the aetiology of disorder. GWAS rely upon statistically robust genome  wide significant associations to identify genes and loci of risk. There are considerable modest association signals that do not meet stringent genome wide significance thresholds. These signals may conceal underlying patterns that are important to understanding the aetiology Complex traits and polygenic disorders275 of disease. We have developed a robust method, pedSNP ratio test  (pedSRT) to examine association enrichment in biologically linked gene sets for family based association studies. Using a two stage approach we explore association enrichment in GWA data from more than 2100 families from the Autism Genome Project. Based on estimates  from study sensitive simulation we identify excess of observed and replicated association enrichment. We highlight enrichment for sets of genes involved in diverse biological processes including pyruvate metabolism, transcription factor activation and cell signalling. Many of the genes and processes that show enrichment have previously been examined in autistic disorders and offer biologically plausibility to these findings. Moreover, our data supports the hypothesis, that in part, common variation is important in the aetiology of ASDs. This work is presented on behalf of the Autism Genome Project Consortium.",2011.0,,"R. J. L. Anney1, E. A. Heron1, R. Segurado1, M. Gill1, L. Gallagher1, A. G. P.  Consortium2","1Trinity College Dublin, Dublin, Ireland, 2Autism Genome Project, Consortium,  United Kingdom",Many of the genes and processes that show enrichment have previously been examined in autistic disorders and offer biologically plausibility to these findings.,,autistic disorders,[],"['autistic', 'disorder']"
291,1120," AKAPs integrate genome wide association findings for autism spectrum disorders into signalling networks regulating steroidogenesis, neurite outgrowth and synaptic function",P09.039,,"Background: Autism spectrum disorders (ASD) are highly heritable.  In recent years, several genome wide association studies (GWAS) of ASD were published. Methods: We have carried out a bioinformatics analysis using Ingenuity and a systematic literature analysis of 200 genes from five  published GWAS that yielded association with ASD through single nucleotide polymorphisms at P < 0.0001, and we used the results from a sixth published GWAS to validate our findings. We also searched for overlap between the identified candidate genes and genes located in copy number variations (CNVs) in people with ASD and we identified microRNAs that downregulate gene expression of ASD candidate genes and are deregulated in ASD.Results: A total of 120 of the 200 ASD candidate genes encode proteins that fit into three signalling networks regulating steroidogenesis,  neurite outgrowth and synaptic function, and we were able to place 50 other ASD candidate genes in the identified networks. The proteins encoded by 11 ASD linked AKAP (A kinase anchor protein) genes functionally integrate signalling cascades within and between these networks. Lastly, we found that 70 of the 200 ASD candidate genes were found in CNVs in people with ASD and 100 of these genes were downregulated by ASD implicated microRNAs.ConclusionsWe have identified three signalling networks for ASD that contribute to our understanding of the molecular basis of the disorder and that are functionally integrated by the AKAPs, druggable proteins that need to be further investigated as possible targets for psychopharmacological treatments of ASD.",2011.0,,"G. Poelmans1, B. Franke2, D. L. Pauls3, J. K. Buitelaar1","1Department of Cognitive Neuroscience, Donders Institute for Brain, Cognition  and Behaviour, Radboud University Nijmegen Medical Centre, Nijmegen,  Netherlands, 2Departments of Human Genetics and Psychiatry, Donders  Institute for Brain, Cognition and Behaviour, Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands,  3Psychiatric and Neurodevelopmental  Genetics Unit, Center for Human Genetic Research, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States","Methods: We have carried out a bioinformatics analysis using Ingenuity and a systematic literature analysis of 200 genes from five  published GWAS that yielded association with ASD through single nucleotide polymorphisms at P < 0.0001, and we used the results from a sixth published GWAS to validate our findings.",association with ASD,,"['association', 'with', 'ASD']",[]
291,1120," AKAPs integrate genome wide association findings for autism spectrum disorders into signalling networks regulating steroidogenesis, neurite outgrowth and synaptic function",P09.039,,"Background: Autism spectrum disorders (ASD) are highly heritable.  In recent years, several genome wide association studies (GWAS) of ASD were published. Methods: We have carried out a bioinformatics analysis using Ingenuity and a systematic literature analysis of 200 genes from five  published GWAS that yielded association with ASD through single nucleotide polymorphisms at P < 0.0001, and we used the results from a sixth published GWAS to validate our findings. We also searched for overlap between the identified candidate genes and genes located in copy number variations (CNVs) in people with ASD and we identified microRNAs that downregulate gene expression of ASD candidate genes and are deregulated in ASD.Results: A total of 120 of the 200 ASD candidate genes encode proteins that fit into three signalling networks regulating steroidogenesis,  neurite outgrowth and synaptic function, and we were able to place 50 other ASD candidate genes in the identified networks. The proteins encoded by 11 ASD linked AKAP (A kinase anchor protein) genes functionally integrate signalling cascades within and between these networks. Lastly, we found that 70 of the 200 ASD candidate genes were found in CNVs in people with ASD and 100 of these genes were downregulated by ASD implicated microRNAs.ConclusionsWe have identified three signalling networks for ASD that contribute to our understanding of the molecular basis of the disorder and that are functionally integrated by the AKAPs, druggable proteins that need to be further investigated as possible targets for psychopharmacological treatments of ASD.",2011.0,,"G. Poelmans1, B. Franke2, D. L. Pauls3, J. K. Buitelaar1","1Department of Cognitive Neuroscience, Donders Institute for Brain, Cognition  and Behaviour, Radboud University Nijmegen Medical Centre, Nijmegen,  Netherlands, 2Departments of Human Genetics and Psychiatry, Donders  Institute for Brain, Cognition and Behaviour, Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands,  3Psychiatric and Neurodevelopmental  Genetics Unit, Center for Human Genetic Research, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States","We also searched for overlap between the identified candidate genes and genes located in copy number variations (CNVs) in people with ASD and we identified microRNAs that downregulate gene expression of ASD candidate genes and are deregulated in ASD.Results: A total of 120 of the 200 ASD candidate genes encode proteins that fit into three signalling networks regulating steroidogenesis,  neurite outgrowth and synaptic function, and we were able to place 50 other ASD candidate genes in the identified networks.",people with ASD,ASD candidate,"['people', 'with', 'ASD']","['ASD', 'candidate']"
291,1120," AKAPs integrate genome wide association findings for autism spectrum disorders into signalling networks regulating steroidogenesis, neurite outgrowth and synaptic function",P09.039,,"Background: Autism spectrum disorders (ASD) are highly heritable.  In recent years, several genome wide association studies (GWAS) of ASD were published. Methods: We have carried out a bioinformatics analysis using Ingenuity and a systematic literature analysis of 200 genes from five  published GWAS that yielded association with ASD through single nucleotide polymorphisms at P < 0.0001, and we used the results from a sixth published GWAS to validate our findings. We also searched for overlap between the identified candidate genes and genes located in copy number variations (CNVs) in people with ASD and we identified microRNAs that downregulate gene expression of ASD candidate genes and are deregulated in ASD.Results: A total of 120 of the 200 ASD candidate genes encode proteins that fit into three signalling networks regulating steroidogenesis,  neurite outgrowth and synaptic function, and we were able to place 50 other ASD candidate genes in the identified networks. The proteins encoded by 11 ASD linked AKAP (A kinase anchor protein) genes functionally integrate signalling cascades within and between these networks. Lastly, we found that 70 of the 200 ASD candidate genes were found in CNVs in people with ASD and 100 of these genes were downregulated by ASD implicated microRNAs.ConclusionsWe have identified three signalling networks for ASD that contribute to our understanding of the molecular basis of the disorder and that are functionally integrated by the AKAPs, druggable proteins that need to be further investigated as possible targets for psychopharmacological treatments of ASD.",2011.0,,"G. Poelmans1, B. Franke2, D. L. Pauls3, J. K. Buitelaar1","1Department of Cognitive Neuroscience, Donders Institute for Brain, Cognition  and Behaviour, Radboud University Nijmegen Medical Centre, Nijmegen,  Netherlands, 2Departments of Human Genetics and Psychiatry, Donders  Institute for Brain, Cognition and Behaviour, Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands,  3Psychiatric and Neurodevelopmental  Genetics Unit, Center for Human Genetic Research, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States","We also searched for overlap between the identified candidate genes and genes located in copy number variations (CNVs) in people with ASD and we identified microRNAs that downregulate gene expression of ASD candidate genes and are deregulated in ASD.Results: A total of 120 of the 200 ASD candidate genes encode proteins that fit into three signalling networks regulating steroidogenesis,  neurite outgrowth and synaptic function, and we were able to place 50 other ASD candidate genes in the identified networks.",people with ASD,ASD candidate,"['people', 'with', 'ASD']","['ASD', 'candidate']"
291,1120," AKAPs integrate genome wide association findings for autism spectrum disorders into signalling networks regulating steroidogenesis, neurite outgrowth and synaptic function",P09.039,,"Background: Autism spectrum disorders (ASD) are highly heritable.  In recent years, several genome wide association studies (GWAS) of ASD were published. Methods: We have carried out a bioinformatics analysis using Ingenuity and a systematic literature analysis of 200 genes from five  published GWAS that yielded association with ASD through single nucleotide polymorphisms at P < 0.0001, and we used the results from a sixth published GWAS to validate our findings. We also searched for overlap between the identified candidate genes and genes located in copy number variations (CNVs) in people with ASD and we identified microRNAs that downregulate gene expression of ASD candidate genes and are deregulated in ASD.Results: A total of 120 of the 200 ASD candidate genes encode proteins that fit into three signalling networks regulating steroidogenesis,  neurite outgrowth and synaptic function, and we were able to place 50 other ASD candidate genes in the identified networks. The proteins encoded by 11 ASD linked AKAP (A kinase anchor protein) genes functionally integrate signalling cascades within and between these networks. Lastly, we found that 70 of the 200 ASD candidate genes were found in CNVs in people with ASD and 100 of these genes were downregulated by ASD implicated microRNAs.ConclusionsWe have identified three signalling networks for ASD that contribute to our understanding of the molecular basis of the disorder and that are functionally integrated by the AKAPs, druggable proteins that need to be further investigated as possible targets for psychopharmacological treatments of ASD.",2011.0,,"G. Poelmans1, B. Franke2, D. L. Pauls3, J. K. Buitelaar1","1Department of Cognitive Neuroscience, Donders Institute for Brain, Cognition  and Behaviour, Radboud University Nijmegen Medical Centre, Nijmegen,  Netherlands, 2Departments of Human Genetics and Psychiatry, Donders  Institute for Brain, Cognition and Behaviour, Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands,  3Psychiatric and Neurodevelopmental  Genetics Unit, Center for Human Genetic Research, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States","We also searched for overlap between the identified candidate genes and genes located in copy number variations (CNVs) in people with ASD and we identified microRNAs that downregulate gene expression of ASD candidate genes and are deregulated in ASD.Results: A total of 120 of the 200 ASD candidate genes encode proteins that fit into three signalling networks regulating steroidogenesis,  neurite outgrowth and synaptic function, and we were able to place 50 other ASD candidate genes in the identified networks.",people with ASD,ASD candidate,"['people', 'with', 'ASD']","['ASD', 'candidate']"
291,1120," AKAPs integrate genome wide association findings for autism spectrum disorders into signalling networks regulating steroidogenesis, neurite outgrowth and synaptic function",P09.039,,"Background: Autism spectrum disorders (ASD) are highly heritable.  In recent years, several genome wide association studies (GWAS) of ASD were published. Methods: We have carried out a bioinformatics analysis using Ingenuity and a systematic literature analysis of 200 genes from five  published GWAS that yielded association with ASD through single nucleotide polymorphisms at P < 0.0001, and we used the results from a sixth published GWAS to validate our findings. We also searched for overlap between the identified candidate genes and genes located in copy number variations (CNVs) in people with ASD and we identified microRNAs that downregulate gene expression of ASD candidate genes and are deregulated in ASD.Results: A total of 120 of the 200 ASD candidate genes encode proteins that fit into three signalling networks regulating steroidogenesis,  neurite outgrowth and synaptic function, and we were able to place 50 other ASD candidate genes in the identified networks. The proteins encoded by 11 ASD linked AKAP (A kinase anchor protein) genes functionally integrate signalling cascades within and between these networks. Lastly, we found that 70 of the 200 ASD candidate genes were found in CNVs in people with ASD and 100 of these genes were downregulated by ASD implicated microRNAs.ConclusionsWe have identified three signalling networks for ASD that contribute to our understanding of the molecular basis of the disorder and that are functionally integrated by the AKAPs, druggable proteins that need to be further investigated as possible targets for psychopharmacological treatments of ASD.",2011.0,,"G. Poelmans1, B. Franke2, D. L. Pauls3, J. K. Buitelaar1","1Department of Cognitive Neuroscience, Donders Institute for Brain, Cognition  and Behaviour, Radboud University Nijmegen Medical Centre, Nijmegen,  Netherlands, 2Departments of Human Genetics and Psychiatry, Donders  Institute for Brain, Cognition and Behaviour, Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands,  3Psychiatric and Neurodevelopmental  Genetics Unit, Center for Human Genetic Research, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States","Lastly, we found that 70 of the 200 ASD candidate genes were found in CNVs in people with ASD and 100 of these genes were downregulated by ASD implicated microRNAs.ConclusionsWe have identified three signalling networks for ASD that contribute to our understanding of the molecular basis of the disorder and that are functionally integrated by the AKAPs, druggable proteins that need to be further investigated as possible targets for psychopharmacological treatments of ASD.",people with ASD,ASD candidate,"['people', 'with', 'ASD']","['ASD', 'candidate']"
291,1120," AKAPs integrate genome wide association findings for autism spectrum disorders into signalling networks regulating steroidogenesis, neurite outgrowth and synaptic function",P09.039,,"Background: Autism spectrum disorders (ASD) are highly heritable.  In recent years, several genome wide association studies (GWAS) of ASD were published. Methods: We have carried out a bioinformatics analysis using Ingenuity and a systematic literature analysis of 200 genes from five  published GWAS that yielded association with ASD through single nucleotide polymorphisms at P < 0.0001, and we used the results from a sixth published GWAS to validate our findings. We also searched for overlap between the identified candidate genes and genes located in copy number variations (CNVs) in people with ASD and we identified microRNAs that downregulate gene expression of ASD candidate genes and are deregulated in ASD.Results: A total of 120 of the 200 ASD candidate genes encode proteins that fit into three signalling networks regulating steroidogenesis,  neurite outgrowth and synaptic function, and we were able to place 50 other ASD candidate genes in the identified networks. The proteins encoded by 11 ASD linked AKAP (A kinase anchor protein) genes functionally integrate signalling cascades within and between these networks. Lastly, we found that 70 of the 200 ASD candidate genes were found in CNVs in people with ASD and 100 of these genes were downregulated by ASD implicated microRNAs.ConclusionsWe have identified three signalling networks for ASD that contribute to our understanding of the molecular basis of the disorder and that are functionally integrated by the AKAPs, druggable proteins that need to be further investigated as possible targets for psychopharmacological treatments of ASD.",2011.0,,"G. Poelmans1, B. Franke2, D. L. Pauls3, J. K. Buitelaar1","1Department of Cognitive Neuroscience, Donders Institute for Brain, Cognition  and Behaviour, Radboud University Nijmegen Medical Centre, Nijmegen,  Netherlands, 2Departments of Human Genetics and Psychiatry, Donders  Institute for Brain, Cognition and Behaviour, Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands,  3Psychiatric and Neurodevelopmental  Genetics Unit, Center for Human Genetic Research, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States","Lastly, we found that 70 of the 200 ASD candidate genes were found in CNVs in people with ASD and 100 of these genes were downregulated by ASD implicated microRNAs.ConclusionsWe have identified three signalling networks for ASD that contribute to our understanding of the molecular basis of the disorder and that are functionally integrated by the AKAPs, druggable proteins that need to be further investigated as possible targets for psychopharmacological treatments of ASD.",people with ASD,ASD implicated microRNAs,"['people', 'with', 'ASD']","['ASD', 'implicated', 'microRNAs']"
292,1127, i s c ADP s 2 involved in autism and intellectual disability?,P09.046,,"O. Genetica Medica, Policlinico S.Orsola Malpighi, Universit di Bologna,  Bologna, Italy, 2Dipartimento di Biologia Evoluzionistica Sperimentale,  Universit di Bologna, Bologna, Italy, 3Stella Maris Istituto Scientifico per la  Neuropsichiatria dellInfanzia e dellAdolescenza, Calambrone (Pisa), Italy,  4U.O. Neuropsichiatria Infantile, Dipartimento di Pediatria, Universit di Catania,  Catania, Italy. We describe a family where brother and sister show mild intellectual disability, behavior abnormalities and epilepsy, with normal brain imaging and no major dysmorphic features. Karyotype is normal, as well FMR1 analysis in the male patient. Their mother, who died of cancer at 48 years of age, and a maternal aunt are both reported  to have behavioral abnormalities, mild intellectual disability, but no seizures. Two maternal uncles are healthy.In both patients, array CGH analysis revealed a 250 kb deletion of chromosome 7q31.32 encompassing one single gene, CADPS2. The father does not carry the deletion, indicating likely maternal inheritance. The deletion was excluded in one of the maternal uncles.CADPS2 is a calcium binding protein that regulates the exocytosis of synaptic and dense core vesicles in neurons and neuroendocrine cells. CADPS2 is a candidate gene for autistic disorders, since it maps in the  autism susceptibility region AUTS1 on chromosome 7q31.32, which alsocorresponds to a candidate region for mood disorders. Knock out mice show an autistic like phenotype and some ASD (Autism Spectrum Disorders) patients show a possible defect in CADPS2 splicing. We performed, therefore, a mutation screening in 46 individuals with ASD and in 34 patients with intellectual disability who did not carry any genomic rearrangement as far as array CGH analysis could detect. Two novel variants were identified in two unrelated ASD individuals, in exon 6 and exon 13 respectively. None of these changes was detected in 140 healthy individuals and functional analysis of these variants is currently ongoing. Detailed results will be presented.",2011.0,,"G. Tortora1, C. Graziano1, S. Miccoli1, E. Bacchelli2, F. Minopoli1, A. Battaglia3,  L. Mazzone4, G. Romeo1, E. Maestrini2, E. Bonora1",1U,"CADPS2 is a candidate gene for autistic disorders, since it maps in the  autism susceptibility region AUTS1 on chromosome 7q31.32, which alsocorresponds to a candidate region for mood disorders.",,autistic disorders,[],"['autistic', 'disorder']"
292,1127, i s c ADP s 2 involved in autism and intellectual disability?,P09.046,,"O. Genetica Medica, Policlinico S.Orsola Malpighi, Universit di Bologna,  Bologna, Italy, 2Dipartimento di Biologia Evoluzionistica Sperimentale,  Universit di Bologna, Bologna, Italy, 3Stella Maris Istituto Scientifico per la  Neuropsichiatria dellInfanzia e dellAdolescenza, Calambrone (Pisa), Italy,  4U.O. Neuropsichiatria Infantile, Dipartimento di Pediatria, Universit di Catania,  Catania, Italy. We describe a family where brother and sister show mild intellectual disability, behavior abnormalities and epilepsy, with normal brain imaging and no major dysmorphic features. Karyotype is normal, as well FMR1 analysis in the male patient. Their mother, who died of cancer at 48 years of age, and a maternal aunt are both reported  to have behavioral abnormalities, mild intellectual disability, but no seizures. Two maternal uncles are healthy.In both patients, array CGH analysis revealed a 250 kb deletion of chromosome 7q31.32 encompassing one single gene, CADPS2. The father does not carry the deletion, indicating likely maternal inheritance. The deletion was excluded in one of the maternal uncles.CADPS2 is a calcium binding protein that regulates the exocytosis of synaptic and dense core vesicles in neurons and neuroendocrine cells. CADPS2 is a candidate gene for autistic disorders, since it maps in the  autism susceptibility region AUTS1 on chromosome 7q31.32, which alsocorresponds to a candidate region for mood disorders. Knock out mice show an autistic like phenotype and some ASD (Autism Spectrum Disorders) patients show a possible defect in CADPS2 splicing. We performed, therefore, a mutation screening in 46 individuals with ASD and in 34 patients with intellectual disability who did not carry any genomic rearrangement as far as array CGH analysis could detect. Two novel variants were identified in two unrelated ASD individuals, in exon 6 and exon 13 respectively. None of these changes was detected in 140 healthy individuals and functional analysis of these variants is currently ongoing. Detailed results will be presented.",2011.0,,"G. Tortora1, C. Graziano1, S. Miccoli1, E. Bacchelli2, F. Minopoli1, A. Battaglia3,  L. Mazzone4, G. Romeo1, E. Maestrini2, E. Bonora1",1U,"We performed, therefore, a mutation screening in 46 individuals with ASD and in 34 patients with intellectual disability who did not carry any genomic rearrangement as far as array CGH analysis could detect.",individuals with ASD,,"['individual', 'with', 'ASD']",[]
292,1127, i s c ADP s 2 involved in autism and intellectual disability?,P09.046,,"O. Genetica Medica, Policlinico S.Orsola Malpighi, Universit di Bologna,  Bologna, Italy, 2Dipartimento di Biologia Evoluzionistica Sperimentale,  Universit di Bologna, Bologna, Italy, 3Stella Maris Istituto Scientifico per la  Neuropsichiatria dellInfanzia e dellAdolescenza, Calambrone (Pisa), Italy,  4U.O. Neuropsichiatria Infantile, Dipartimento di Pediatria, Universit di Catania,  Catania, Italy. We describe a family where brother and sister show mild intellectual disability, behavior abnormalities and epilepsy, with normal brain imaging and no major dysmorphic features. Karyotype is normal, as well FMR1 analysis in the male patient. Their mother, who died of cancer at 48 years of age, and a maternal aunt are both reported  to have behavioral abnormalities, mild intellectual disability, but no seizures. Two maternal uncles are healthy.In both patients, array CGH analysis revealed a 250 kb deletion of chromosome 7q31.32 encompassing one single gene, CADPS2. The father does not carry the deletion, indicating likely maternal inheritance. The deletion was excluded in one of the maternal uncles.CADPS2 is a calcium binding protein that regulates the exocytosis of synaptic and dense core vesicles in neurons and neuroendocrine cells. CADPS2 is a candidate gene for autistic disorders, since it maps in the  autism susceptibility region AUTS1 on chromosome 7q31.32, which alsocorresponds to a candidate region for mood disorders. Knock out mice show an autistic like phenotype and some ASD (Autism Spectrum Disorders) patients show a possible defect in CADPS2 splicing. We performed, therefore, a mutation screening in 46 individuals with ASD and in 34 patients with intellectual disability who did not carry any genomic rearrangement as far as array CGH analysis could detect. Two novel variants were identified in two unrelated ASD individuals, in exon 6 and exon 13 respectively. None of these changes was detected in 140 healthy individuals and functional analysis of these variants is currently ongoing. Detailed results will be presented.",2011.0,,"G. Tortora1, C. Graziano1, S. Miccoli1, E. Bacchelli2, F. Minopoli1, A. Battaglia3,  L. Mazzone4, G. Romeo1, E. Maestrini2, E. Bonora1",1U,"Two novel variants were identified in two unrelated ASD individuals, in exon 6 and exon 13 respectively.",,ASD individuals,[],"['ASD', 'individual']"
294,1315,PON1 phenotype and gene polymorphisms in children with autism,J09.01,,"Autism is a neurodevelopmental disorder of unknown etiology.  Many genetic and environmental factors are incriminated in its pathogenesis. Subacute exposure to organophosphates (OPs) during critical periods of prenatal neurodevelopment is one of the factors that may trigger autism. Human serum paraoxonase (PON1)  is a HDL associated hydrolase, which in addition to hydrolyzing the OPs, plays a physiological role in reducing LDL oxidation. The PON1 gene shows two functional polymorphisms: M55L and Q192R. These polymorphisms influence the concentration and activity of PON1 towards different substrates, including OPs.The gene environment interaction is tested in the present study by assessing the distribution and frequency of M55L and Q192R polymorphisms in 58 autistic children and 43 controls.No significant difference (p>0.05) in genotypes distribution was found  between autistic patients and controls (QQ 51.72%, QR 43.1%, RR 5.17% / MM 12.1%, ML 60.3%, LL 27.6% for autistic group and QQ 51.16%, QR 44.18%, RR 4.65% / MM 9.3%, ML 53.5%, LL 37.2% for control group).Although, the paraoxonase activity did not present a significant difference between the patients and controls (p>0.05), there was a significant activity increase in the autistic groups with R allele number and both in autistic and control groups with L allele number (p<0.05). The arylesterase activity was significantly decreased (p<0.05) in autistic patients, with no relation to the number of R alleles, but increased in relation with L allele number (p<0.05).These results provide support for the hypothesis that PON1 arylesterase activity could represent a biochemical/genetic test in  estimating autism risk.",2011.0,,"E. Dronca1, M. Dronca2, T. Mocanu3, I. V. Pop1","1Department of Medical Genetics, University of Medicine and Pharmacy Iuliu  Hatieganu, Cluj Napoca, Romania, 2Department of Medical Biochemistry,  University of Medicine and Pharmacy Iuliu Hatieganu, Cluj Napoca, Romania,  3Department of Physiology, University of Medicine and Pharmacy Iuliu  Hatieganu, Cluj Napoca, Romania","These polymorphisms influence the concentration and activity of PON1 towards different substrates, including OPs.The gene environment interaction is tested in the present study by assessing the distribution and frequency of M55L and Q192R polymorphisms in 58 autistic children and 43 controls.No significant difference (p>0.05) in genotypes distribution was found  between autistic patients and controls (QQ 51.72%, QR 43.1%, RR 5.17% / MM 12.1%, ML 60.3%, LL 27.6% for autistic group and QQ 51.16%, QR 44.18%, RR 4.65% / MM 9.3%, ML 53.5%, LL 37.2% for control group).Although, the paraoxonase activity did not present a significant difference between the patients and controls (p>0.05), there was a significant activity increase in the autistic groups with R allele number and both in autistic and control groups with L allele number (p<0.05).",,autistic children,[],"['autistic', 'child']"
294,1315,PON1 phenotype and gene polymorphisms in children with autism,J09.01,,"Autism is a neurodevelopmental disorder of unknown etiology.  Many genetic and environmental factors are incriminated in its pathogenesis. Subacute exposure to organophosphates (OPs) during critical periods of prenatal neurodevelopment is one of the factors that may trigger autism. Human serum paraoxonase (PON1)  is a HDL associated hydrolase, which in addition to hydrolyzing the OPs, plays a physiological role in reducing LDL oxidation. The PON1 gene shows two functional polymorphisms: M55L and Q192R. These polymorphisms influence the concentration and activity of PON1 towards different substrates, including OPs.The gene environment interaction is tested in the present study by assessing the distribution and frequency of M55L and Q192R polymorphisms in 58 autistic children and 43 controls.No significant difference (p>0.05) in genotypes distribution was found  between autistic patients and controls (QQ 51.72%, QR 43.1%, RR 5.17% / MM 12.1%, ML 60.3%, LL 27.6% for autistic group and QQ 51.16%, QR 44.18%, RR 4.65% / MM 9.3%, ML 53.5%, LL 37.2% for control group).Although, the paraoxonase activity did not present a significant difference between the patients and controls (p>0.05), there was a significant activity increase in the autistic groups with R allele number and both in autistic and control groups with L allele number (p<0.05). The arylesterase activity was significantly decreased (p<0.05) in autistic patients, with no relation to the number of R alleles, but increased in relation with L allele number (p<0.05).These results provide support for the hypothesis that PON1 arylesterase activity could represent a biochemical/genetic test in  estimating autism risk.",2011.0,,"E. Dronca1, M. Dronca2, T. Mocanu3, I. V. Pop1","1Department of Medical Genetics, University of Medicine and Pharmacy Iuliu  Hatieganu, Cluj Napoca, Romania, 2Department of Medical Biochemistry,  University of Medicine and Pharmacy Iuliu Hatieganu, Cluj Napoca, Romania,  3Department of Physiology, University of Medicine and Pharmacy Iuliu  Hatieganu, Cluj Napoca, Romania","These polymorphisms influence the concentration and activity of PON1 towards different substrates, including OPs.The gene environment interaction is tested in the present study by assessing the distribution and frequency of M55L and Q192R polymorphisms in 58 autistic children and 43 controls.No significant difference (p>0.05) in genotypes distribution was found  between autistic patients and controls (QQ 51.72%, QR 43.1%, RR 5.17% / MM 12.1%, ML 60.3%, LL 27.6% for autistic group and QQ 51.16%, QR 44.18%, RR 4.65% / MM 9.3%, ML 53.5%, LL 37.2% for control group).Although, the paraoxonase activity did not present a significant difference between the patients and controls (p>0.05), there was a significant activity increase in the autistic groups with R allele number and both in autistic and control groups with L allele number (p<0.05).",,autistic patients,[],"['autistic', 'patient']"
294,1315,PON1 phenotype and gene polymorphisms in children with autism,J09.01,,"Autism is a neurodevelopmental disorder of unknown etiology.  Many genetic and environmental factors are incriminated in its pathogenesis. Subacute exposure to organophosphates (OPs) during critical periods of prenatal neurodevelopment is one of the factors that may trigger autism. Human serum paraoxonase (PON1)  is a HDL associated hydrolase, which in addition to hydrolyzing the OPs, plays a physiological role in reducing LDL oxidation. The PON1 gene shows two functional polymorphisms: M55L and Q192R. These polymorphisms influence the concentration and activity of PON1 towards different substrates, including OPs.The gene environment interaction is tested in the present study by assessing the distribution and frequency of M55L and Q192R polymorphisms in 58 autistic children and 43 controls.No significant difference (p>0.05) in genotypes distribution was found  between autistic patients and controls (QQ 51.72%, QR 43.1%, RR 5.17% / MM 12.1%, ML 60.3%, LL 27.6% for autistic group and QQ 51.16%, QR 44.18%, RR 4.65% / MM 9.3%, ML 53.5%, LL 37.2% for control group).Although, the paraoxonase activity did not present a significant difference between the patients and controls (p>0.05), there was a significant activity increase in the autistic groups with R allele number and both in autistic and control groups with L allele number (p<0.05). The arylesterase activity was significantly decreased (p<0.05) in autistic patients, with no relation to the number of R alleles, but increased in relation with L allele number (p<0.05).These results provide support for the hypothesis that PON1 arylesterase activity could represent a biochemical/genetic test in  estimating autism risk.",2011.0,,"E. Dronca1, M. Dronca2, T. Mocanu3, I. V. Pop1","1Department of Medical Genetics, University of Medicine and Pharmacy Iuliu  Hatieganu, Cluj Napoca, Romania, 2Department of Medical Biochemistry,  University of Medicine and Pharmacy Iuliu Hatieganu, Cluj Napoca, Romania,  3Department of Physiology, University of Medicine and Pharmacy Iuliu  Hatieganu, Cluj Napoca, Romania","These polymorphisms influence the concentration and activity of PON1 towards different substrates, including OPs.The gene environment interaction is tested in the present study by assessing the distribution and frequency of M55L and Q192R polymorphisms in 58 autistic children and 43 controls.No significant difference (p>0.05) in genotypes distribution was found  between autistic patients and controls (QQ 51.72%, QR 43.1%, RR 5.17% / MM 12.1%, ML 60.3%, LL 27.6% for autistic group and QQ 51.16%, QR 44.18%, RR 4.65% / MM 9.3%, ML 53.5%, LL 37.2% for control group).Although, the paraoxonase activity did not present a significant difference between the patients and controls (p>0.05), there was a significant activity increase in the autistic groups with R allele number and both in autistic and control groups with L allele number (p<0.05).",,autistic group,[],"['autistic', 'group']"
294,1315,PON1 phenotype and gene polymorphisms in children with autism,J09.01,,"Autism is a neurodevelopmental disorder of unknown etiology.  Many genetic and environmental factors are incriminated in its pathogenesis. Subacute exposure to organophosphates (OPs) during critical periods of prenatal neurodevelopment is one of the factors that may trigger autism. Human serum paraoxonase (PON1)  is a HDL associated hydrolase, which in addition to hydrolyzing the OPs, plays a physiological role in reducing LDL oxidation. The PON1 gene shows two functional polymorphisms: M55L and Q192R. These polymorphisms influence the concentration and activity of PON1 towards different substrates, including OPs.The gene environment interaction is tested in the present study by assessing the distribution and frequency of M55L and Q192R polymorphisms in 58 autistic children and 43 controls.No significant difference (p>0.05) in genotypes distribution was found  between autistic patients and controls (QQ 51.72%, QR 43.1%, RR 5.17% / MM 12.1%, ML 60.3%, LL 27.6% for autistic group and QQ 51.16%, QR 44.18%, RR 4.65% / MM 9.3%, ML 53.5%, LL 37.2% for control group).Although, the paraoxonase activity did not present a significant difference between the patients and controls (p>0.05), there was a significant activity increase in the autistic groups with R allele number and both in autistic and control groups with L allele number (p<0.05). The arylesterase activity was significantly decreased (p<0.05) in autistic patients, with no relation to the number of R alleles, but increased in relation with L allele number (p<0.05).These results provide support for the hypothesis that PON1 arylesterase activity could represent a biochemical/genetic test in  estimating autism risk.",2011.0,,"E. Dronca1, M. Dronca2, T. Mocanu3, I. V. Pop1","1Department of Medical Genetics, University of Medicine and Pharmacy Iuliu  Hatieganu, Cluj Napoca, Romania, 2Department of Medical Biochemistry,  University of Medicine and Pharmacy Iuliu Hatieganu, Cluj Napoca, Romania,  3Department of Physiology, University of Medicine and Pharmacy Iuliu  Hatieganu, Cluj Napoca, Romania","These polymorphisms influence the concentration and activity of PON1 towards different substrates, including OPs.The gene environment interaction is tested in the present study by assessing the distribution and frequency of M55L and Q192R polymorphisms in 58 autistic children and 43 controls.No significant difference (p>0.05) in genotypes distribution was found  between autistic patients and controls (QQ 51.72%, QR 43.1%, RR 5.17% / MM 12.1%, ML 60.3%, LL 27.6% for autistic group and QQ 51.16%, QR 44.18%, RR 4.65% / MM 9.3%, ML 53.5%, LL 37.2% for control group).Although, the paraoxonase activity did not present a significant difference between the patients and controls (p>0.05), there was a significant activity increase in the autistic groups with R allele number and both in autistic and control groups with L allele number (p<0.05).",,autistic groups,[],"['autistic', 'group']"
294,1315,PON1 phenotype and gene polymorphisms in children with autism,J09.01,,"Autism is a neurodevelopmental disorder of unknown etiology.  Many genetic and environmental factors are incriminated in its pathogenesis. Subacute exposure to organophosphates (OPs) during critical periods of prenatal neurodevelopment is one of the factors that may trigger autism. Human serum paraoxonase (PON1)  is a HDL associated hydrolase, which in addition to hydrolyzing the OPs, plays a physiological role in reducing LDL oxidation. The PON1 gene shows two functional polymorphisms: M55L and Q192R. These polymorphisms influence the concentration and activity of PON1 towards different substrates, including OPs.The gene environment interaction is tested in the present study by assessing the distribution and frequency of M55L and Q192R polymorphisms in 58 autistic children and 43 controls.No significant difference (p>0.05) in genotypes distribution was found  between autistic patients and controls (QQ 51.72%, QR 43.1%, RR 5.17% / MM 12.1%, ML 60.3%, LL 27.6% for autistic group and QQ 51.16%, QR 44.18%, RR 4.65% / MM 9.3%, ML 53.5%, LL 37.2% for control group).Although, the paraoxonase activity did not present a significant difference between the patients and controls (p>0.05), there was a significant activity increase in the autistic groups with R allele number and both in autistic and control groups with L allele number (p<0.05). The arylesterase activity was significantly decreased (p<0.05) in autistic patients, with no relation to the number of R alleles, but increased in relation with L allele number (p<0.05).These results provide support for the hypothesis that PON1 arylesterase activity could represent a biochemical/genetic test in  estimating autism risk.",2011.0,,"E. Dronca1, M. Dronca2, T. Mocanu3, I. V. Pop1","1Department of Medical Genetics, University of Medicine and Pharmacy Iuliu  Hatieganu, Cluj Napoca, Romania, 2Department of Medical Biochemistry,  University of Medicine and Pharmacy Iuliu Hatieganu, Cluj Napoca, Romania,  3Department of Physiology, University of Medicine and Pharmacy Iuliu  Hatieganu, Cluj Napoca, Romania","The arylesterase activity was significantly decreased (p<0.05) in autistic patients, with no relation to the number of R alleles, but increased in relation with L allele number (p<0.05).These results provide support for the hypothesis that PON1 arylesterase activity could represent a biochemical/genetic test in  estimating autism risk.",,autistic patients,[],"['autistic', 'patient']"
296,1419, Diagnostic use of targeted array c GH platforms: 2009 2010 Kocaeli University Experience,P11.009,,"iNtRODU cti ON: Array CGH technology is a new method for  screening human genetic disorders that cause changes in DNA copy  number. This molecular karyotyping technology is remarkable with fast analysis and highly sensitive diagnostic value. We aimed to use this technology as a diagnostic tool in Kocaeli University Hospital. We  performed analysis for nine groups of patients, using different targeted array CGH platforms. m A t ER i AL s  and  m E t HOD: Following patient groups were accepted  to Kocaeli University Medical Genetics Department; Microdeletion  Syndrome(35 patients) Primary Autism(35 patients), 18q21.31 Deletion Syndrome(2 patients), Mental Retardation(52 patients),  Prenatal Diagnosis(10 patients), Implantation Failure(50 patients), Primary Amenorrhea(1 patients), IVF improvement(7 patients) and Hematological Malignacy(4 patients). We isolated DNA samples of 514 patients. DNA samples labelled according to the protocols.Samples were hybridized with CytoSure Syndrome Plus(v2) 4x44K microchips and with 24Sure platforms.Hybridised platformes were scanned with Agilent Microarray Scanner.Scanned results were analysed by Cytosure Analysis Software v.2.0.8 and BlueFuse Multi v2.1.RE s UL ts : We found 7 aberrations in 35 autistic patients, 35  microdeletions in 35 patients, 6 aberrations in 10 prenatal diagnosis investigations, 38 aberrations in 52 mental retardation patients, 4  aberrations in 50 implantation failure patients, and 5 aberrations in 4 hematological malignancy patients.All aberrations were confirmed with FISH analysis.All analysis have been completed less then 72 hours. Starting DNA amounts were between 10ng to 500ng. c ON c LU si ON: We conclude that, targeted aCGH platforms have  a precious contribution to solve our diagnostic problems in clinical use. This technology is an efficient tool for delineating chromosomal aberrations. It is an indispensable attachment to conventional cytogenetics.",2011.0,,"H. Savli, D. Sunnetci, N. Uzulmez, E. Gumuslu, S. Eren, B. Enguzel, R.  Akkoyunlu, D. Yavuz, Z. Ilkay, N. Cine","Medical Genetics Department, Medicine Faculty of Kocaeli University, Kocaeli,  Turkey","DNA samples labelled according to the protocols.Samples were hybridized with CytoSure Syndrome Plus(v2) 4x44K microchips and with 24Sure platforms.Hybridised platformes were scanned with Agilent Microarray Scanner.Scanned results were analysed by Cytosure Analysis Software v.2.0.8 and BlueFuse Multi v2.1.RE s UL ts : We found 7 aberrations in 35 autistic patients, 35  microdeletions in 35 patients, 6 aberrations in 10 prenatal diagnosis investigations, 38 aberrations in 52 mental retardation patients, 4  aberrations in 50 implantation failure patients, and 5 aberrations in 4 hematological malignancy patients.All aberrations were confirmed with FISH analysis.All analysis have been completed less then 72 hours.",,autistic patients,[],"['autistic', 'patient']"
300,1712, Non syndromic XL m R due to a novel frameshift mutation in MED12,P12.143,,"X linked mental retardation (XLMR) is a common disease arising from  many mutations along the X chromosome. They have been divided into syndromic and non syndromic according to the association of 422 Molecular basis of Mendelian disorders additional features. Identification of genes causing non syndromic  XLMR has long been challenging but large scale systematic resequencing has been shown to be promising for the discovery of rare, disease causing sequence variants.We report on a family including 10 affected males with severe MR  and several females with variable cognitive impairment consistent with X linked recessive inheritance. Male patients all had severe mental retardation and behavior problems. Dysmorphic features included long narrow face, malar hypoplasia, large forehead, full nasal root, thin nose, small philtrum. Head circumference was normal. They had no marfanoid habitus or visceral malformations. Brain MRI, in two patients, showed isolated moderate cerebral atrophy. Most affected females were moderately mentally affected but one of them had severe MR with autistic features. The initial linkage study revealed a localization region from Xp11.21 (AlaS2) to Xq22.3 (COL4A5) in 6 of 7 affected males. A novel, unreported frameshift mutation was identified in the MED12 gene  by exome sequencing performed within the EuroMRX consortium. The mutation segregated with disease in all affected males. MED12  encodes a subunit of the mediator complex, which serves as an interface between transcription factors and RNA polymerase II. Two recurrent missense mutations in MED12 have been previously reported in Lujan Fryns syndrome and in FG syndrome type 1 (Opitz Kaveggia). The present data extends the phenotypic spectrum associated with MED12 mutations.",2011.0,,"G. Lesca1,2, D. Boggio1, M. Moizard3,4, W. Chen5, H. Hu5, S. Haas5, H. Ropers5,  V. Kalscheuer5, G. Bussy6, P. Edery1,2, M. Reynaud3,4, J. Lespinasse7","1Service de Gntique, Hpital Femme Mre Enfant, Hospices Civils de Lyon,  Lyon, France, 2INSERM U1028 and CNRS UMR5292, Lyon Neuroscience  Research Center, TIGER team, University Lyon 1, Lyon, France, 3INSERM,  U930, Tours, France, 4Service de Gntique, CHU de Tours, Tours, France,  5Max Planck Institute for Molecular Genetics, Berlin, Germany, 6Service de  Neuropdiatrie, Hopital Femme Mre Enfant, Hospices Civils de Lyon, Lyon,  France, 7Laboratoire de Gntique Chromosomique, Hpital de Chambery,  Chambry, France",Most affected females were moderately mentally affected but one of them had severe MR with autistic features.,,autistic features,[],"['autistic', 'feature']"
301,1789, m utation analysis of m e c P2 Gene in Egyptian Patients with Rett s yndrome,P12.221,,"This presentation describes molecular analysis of the MeCP2 gene  in 15 Egyptian Patients with provetional diagnosis of having Rett Syndrome. The clinical presentations of postnatal microcephaly, regression of milestones, and autistic behaviour with the constant finding of abnormal hand movements (hand washing, flapping, and  fingers into mouth) were the main criteria for the clinical geneticist and the neurologist to refere female patients suspected to have Rett syndrome for molecular diagnosis. Direct sequencing analysis of the coding region of MeCP2 gene revield pathogenic mutations in 6 patients out of the 15 ones (40%). Re examination of mutation negative cases confirming the picture of classical Rett. Conclusion , Large genomic rearrangements or other genes involvement may contribute, to a larger extent than that previously described in other ethnic populations, to the etiology of Rett in Egyptian patients. This is  still under further investigations.",2011.0,,"A. K. Abdel Aleem1,2, W. Al saeed1, I. Kamal3, M. Zaki4, L. Mansour5, G. Rady3","1Medical Molecular Genetics Department National Research Centre, Giza,  Egypt, 2Weil Cornell Medical College  Qatar, Doha, Qatar, 3Faculty of Science  Cairo university, Cairo, Egypt, 4Clinical Genetics Department National Research  Centre, Giza, Egypt, 5Pediatric Neurology Faculty of Medicine Cairo University,  Cairo, Egypt","The clinical presentations of postnatal microcephaly, regression of milestones, and autistic behaviour with the constant finding of abnormal hand movements (hand washing, flapping, and  fingers into mouth) were the main criteria for the clinical geneticist and the neurologist to refere female patients suspected to have Rett syndrome for molecular diagnosis.",,autistic behaviour,[],"['autistic', 'behaviour']"
303,36, De Novo Mutations in Neurodevelopmental disorders,S10.3,,"INTRODUCTION: Schizophrenia (SCZ), autism spectrum disorders (ASD) and intellectual deficiency (ID) are common, devastating and poorly treated neurodevelopmental brain disorders. The wide spectrum of symptoms and clinical variability in these disorders suggest a complex genetic etiology, which is consistent with the numerous loci thus far identified by linkage, copy number variation and association studies. Although heritability in all three disorders may be as high as ~80%, the genes responsible for much ESHG Concurrent Symposia  Abstracts   European Human Genetics Conference 2012 www.eshg.org12 www.eshg.orgof this heritability remain to be identified. Based on the observed redu  ced reproductive fitness, the relatively uniform world wide incidence, the  increased risk of disease with increasing paternal age and the phenotypic  complexity of each disease, we, and others, hypothesized that a fraction of this missing heritability may be the result of the occurrence of de novo mu  tations affecting any of a large number of genes. In order to test this hypo thesis we first sequenced over 400 synaptic genes in 148 subjects with SCZ, 148 subjects with ASD and 96 subjects with ID. Many likely de novo mutati   ons were identified   these plus relevant functional studies will be presen   ted. Next we sequenced the exomes of SCZ, ASD and ID probands, plus their parents, identifying numerous additional de novo mutations (DNMs). In ad  dition, 1/4 of identified DNMs are nonsense mutations, which is more than  what is expected by chance. Interestingly, some of the identified genes, such  as SHANK3, show deleterious de novo mutations in patients from the three  disease cohorts, suggesting close biological overlap in these disorders. Our  study supports the notion that DNMs may account for some of the missing  heritability SCZ, ASD and ID while providing a list of genes possibly involved in disease pathogenesis.",2012.0,,"G. A. Rouleau, J. Michaud","Centre of Excellence in Neurosciences of Universit de Montral, Centre Hospitalier de lUniversit de Montral, Faculty of Medicine, Universit of Montral, Montreal, QC, Canada","In order to test this hypo thesis we first sequenced over 400 synaptic genes in 148 subjects with SCZ, 148 subjects with ASD and 96 subjects with ID.",subjects with ASD,,"['subject', 'with', 'ASD']",[]
305,201," A familial case of developmental delay/intellectual disability, variable psychiatric disorders and optic atrophy due to a novel 1.5 Mb deletion on 3q29",P02.010,,"We report on a family segregating a 3q29 deletion centromeric to the classic  Chromosome 3q29 deletion syndrome (OMIM #609424). The proband, a  4 yr. old girl, presented with severe global developmental delay and autism.  Family history was positive for psychiatric/ophthalmologic disorders.Array CGH analysis (Agilent, 44K) revealed a 1.5 Mb deletion on chromoso   me 3q29 (194,529,547 195,888,674 bp, hg18). The deletion, confirmed by a real time PCR assay, was inherited from the mother, affected by mild depres   sion, and was also present in the maternal uncle (anxiety/depression), two maternal aunts (schizophrenia), the maternal grandmother (microcephaly, depression and visual deficit), and her brother (schizoaffective disorder).The deletion encompasses 14 genes, including the OPA1 gene, who se haploinsufficiency causes autosomal dominant optic atrophy type 1 (OMIM#165500). Complete ophthalmologic evaluation performed in three deleted subjects of the family (mother, uncle, grandmother) confirmed the presence of a variable degree of optic atrophy. Among the deleted genes, HES1, which encodes for a basic helix loop helix transcription factor, is es   sential for neurogenesis. This gene has been suggested to have a role in the determination of autistic spectrum disorders and could be related with the psychiatric diseases observed in the family.In conclusion, we detected a novel 3q29 deletion associated with optic atro phy and variable neuropsychiatric manifestations, ranging from mild de   pression to schizophrenia.",2012.0,,"E. Biamino1, E. F. Belligni1, C. Molinatto1, E. Di Gregorio2, A. Calcia2, A. M. Fea3, P .  Cannizzo3, A. Brusco2, G. B. Ferrero1, M. Silengo1","1Department of Pediatrics, University of Turin, Turin, Italy, 2Department of Genetics,  Biology and Biochemistry, University of Turin, and Medical Genetics Unit, San Giovanni  Battista Hospital, Turin, Italy, 3Istituto di Fisiopatologia Clinica, Clinica Oculistica,  University of Turin, Turin, Italy","This gene has been suggested to have a role in the determination of autistic spectrum disorders and could be related with the psychiatric diseases observed in the family.In conclusion, we detected a novel 3q29 deletion associated with optic atro phy and variable neuropsychiatric manifestations, ranging from mild de   pression to schizophrenia.",,autistic spectrum,[],"['autistic', 'spectrum']"
306,219, Array CGH with normal karyotype. Utility in pediatrics diagnosis.,P02.030,,"Hospital Virgen de las Nieves., Granada, Spain, 2Servicio de  Pediatra. Hospital Virgen de las Nieves., Granada, Spain, 3FIBAO. Hospital Clnico San  Cecilio., Granada, Spain. Microarray based comparative genomic hybridization (array CGH) has pro vides a relatively quick method to scan the genome for gains and loses of chromosomal material. This new methodologies have led to identification of novel genomic disorder in patients with developmental delay/mental retardation and/or multiple congenital anomalies (DD/MR/MCA), with a significant increase in diagnostic yield .In this study we present the result of array CGH obtained in 150 children with normal karyotype but DD/MR/MCA. The array CGH 60K from agilent platform was performed.In 34 patients (22,66%) was detected a chromosomal deletion or duplicati   on previously described like pathogenic copy number variants (CNVs),. In 15 cases (10%) was necessary the analysis of parental samples, showing that 6 anomalies (40%) had occurred de novo and was classified as pathogenic and in 9 cases (60%) appeared to be inherited from an unaffected parent. In a total of 40 patients (26,66%) was possible to detect a pathogenic CNVs .Recent studies suggest that when aCGH is performed with an apparently normal karyotype, the diagnostic yield increases by an additional 8 17%. In our study we have obtained a 26,66% of children with pathogenic CNVs that is higher than the results obtained by other authors. This increase at the detection rate probably is due to the array type utilized.www.eshg.org Abstracts   European Human Genetics Conference 201257 www.eshg.orgESHG Posters As a conclusion, array CGH can be implemented routinely after a normal  chromosome result when a phenotype of DD/MR/MCA is present, but is  also appropriate for patients with autism and apparently balanced trans  locations.",2012.0,,"M. Perez Sanchez1, A. Mora Guijosa1, S. Roldn2, J. Barrionuevo Porras2, A. Gonzlez  Ramrez3",1Servicio de Anlisis Clnicos,"This increase at the detection rate probably is due to the array type utilized.www.eshg.org Abstracts   European Human Genetics Conference 201257 www.eshg.orgESHG Posters As a conclusion, array CGH can be implemented routinely after a normal  chromosome result when a phenotype of DD/MR/MCA is present, but is  also appropriate for patients with autism and apparently balanced trans  locations.",patients with autism,,"['patient', 'with', 'autism']",[]
307,223, Two cases with different microaberrations of the long arm of chromosome 15 and autism,P02.034,,"Autism is a complex neurodevelopmental disorder of the immature brain  with unknown origin that manifests in early childhood. The exact aetiology of autism remains speculative, although it is likely to result from a complex combination of multiple non genetic and/or genetic factors. Advances in high resolution comparative genomic hybridization (CGH) microarray tech   nology have revealed sub microscopic aberrations that lead to identification of many disease causing genomic copy number variants (CNVs) in autism. Numerous reports have implicated duplications or deletions of proximal chromosome 15q as significant risk factors for autism and autism related disorders.We report two autistic children with 15q11 13 rearrangements. We have used genomic array CytoChip Oligo (BlueGnome, Cambridge, UK), format 2x105K, version 1.1. and BlueFuse Multi software, version 2.2. The 2x105K array detects 35 kbp imbalances on the backbone and has tiling of 20 probes over 137 OMIM disease loci. In the first case a de novo cryptic deletion of 2q36.3 region spanning 1,456 Mb and amplification of (15)(q12q13.1) re gion spanning 3,473 Mb were found in 12 years old girl with autism, severe mental retardation and dysmorphic features. The second case showed dele tion of 15q11.2 region spanning 494, 905 bp in a boy with idiopathic autism. FISH experiments with BAC clone confirm the CytoChip results.These data strongly support the implication of 15q11 13 rearrangements as a predisposing factor for autism.",2012.0,,"D. Avdjieva Tzavella1, S. Hadjidekova2, B. Rukova2, D. Nesheva2, R. Tincheva1, D.  Toncheva2","1Department of Clinical Genetics, University Pediatrics Hospital, Medical University,  Sofia, Bulgaria, Sofia, Bulgaria, 2Department of Medical Genetics, Medical Faculty,  Medical University, Sofia, Bulgaria",Numerous reports have implicated duplications or deletions of proximal chromosome 15q as significant risk factors for autism and autism related disorders.We report two autistic children with 15q11 13 rearrangements.,,autistic children,[],"['autistic', 'child']"
307,223, Two cases with different microaberrations of the long arm of chromosome 15 and autism,P02.034,,"Autism is a complex neurodevelopmental disorder of the immature brain  with unknown origin that manifests in early childhood. The exact aetiology of autism remains speculative, although it is likely to result from a complex combination of multiple non genetic and/or genetic factors. Advances in high resolution comparative genomic hybridization (CGH) microarray tech   nology have revealed sub microscopic aberrations that lead to identification of many disease causing genomic copy number variants (CNVs) in autism. Numerous reports have implicated duplications or deletions of proximal chromosome 15q as significant risk factors for autism and autism related disorders.We report two autistic children with 15q11 13 rearrangements. We have used genomic array CytoChip Oligo (BlueGnome, Cambridge, UK), format 2x105K, version 1.1. and BlueFuse Multi software, version 2.2. The 2x105K array detects 35 kbp imbalances on the backbone and has tiling of 20 probes over 137 OMIM disease loci. In the first case a de novo cryptic deletion of 2q36.3 region spanning 1,456 Mb and amplification of (15)(q12q13.1) re gion spanning 3,473 Mb were found in 12 years old girl with autism, severe mental retardation and dysmorphic features. The second case showed dele tion of 15q11.2 region spanning 494, 905 bp in a boy with idiopathic autism. FISH experiments with BAC clone confirm the CytoChip results.These data strongly support the implication of 15q11 13 rearrangements as a predisposing factor for autism.",2012.0,,"D. Avdjieva Tzavella1, S. Hadjidekova2, B. Rukova2, D. Nesheva2, R. Tincheva1, D.  Toncheva2","1Department of Clinical Genetics, University Pediatrics Hospital, Medical University,  Sofia, Bulgaria, Sofia, Bulgaria, 2Department of Medical Genetics, Medical Faculty,  Medical University, Sofia, Bulgaria","In the first case a de novo cryptic deletion of 2q36.3 region spanning 1,456 Mb and amplification of (15)(q12q13.1) re gion spanning 3,473 Mb were found in 12 years old girl with autism, severe mental retardation and dysmorphic features.",girl with autism,,"['girl', 'with', 'autism']",[]
307,223, Two cases with different microaberrations of the long arm of chromosome 15 and autism,P02.034,,"Autism is a complex neurodevelopmental disorder of the immature brain  with unknown origin that manifests in early childhood. The exact aetiology of autism remains speculative, although it is likely to result from a complex combination of multiple non genetic and/or genetic factors. Advances in high resolution comparative genomic hybridization (CGH) microarray tech   nology have revealed sub microscopic aberrations that lead to identification of many disease causing genomic copy number variants (CNVs) in autism. Numerous reports have implicated duplications or deletions of proximal chromosome 15q as significant risk factors for autism and autism related disorders.We report two autistic children with 15q11 13 rearrangements. We have used genomic array CytoChip Oligo (BlueGnome, Cambridge, UK), format 2x105K, version 1.1. and BlueFuse Multi software, version 2.2. The 2x105K array detects 35 kbp imbalances on the backbone and has tiling of 20 probes over 137 OMIM disease loci. In the first case a de novo cryptic deletion of 2q36.3 region spanning 1,456 Mb and amplification of (15)(q12q13.1) re gion spanning 3,473 Mb were found in 12 years old girl with autism, severe mental retardation and dysmorphic features. The second case showed dele tion of 15q11.2 region spanning 494, 905 bp in a boy with idiopathic autism. FISH experiments with BAC clone confirm the CytoChip results.These data strongly support the implication of 15q11 13 rearrangements as a predisposing factor for autism.",2012.0,,"D. Avdjieva Tzavella1, S. Hadjidekova2, B. Rukova2, D. Nesheva2, R. Tincheva1, D.  Toncheva2","1Department of Clinical Genetics, University Pediatrics Hospital, Medical University,  Sofia, Bulgaria, Sofia, Bulgaria, 2Department of Medical Genetics, Medical Faculty,  Medical University, Sofia, Bulgaria","The second case showed dele tion of 15q11.2 region spanning 494, 905 bp in a boy with idiopathic autism.",boy with idiopathic autism,,"['boy', 'with', 'idiopathic', 'autism']",[]
309,269, Diencephalic mesencephalic junction dysplasia: A novel recessive brain malformation,P02.082,,", Seattle, WA, United States, 4Department of Radiology and Biomedical  Imaging, University of California, San Francisco, 94143, USA, San Francisco, CA, United  States, 5Multimodal Imaging Laboratory (MMIL), Department of Radiology and  Neurosciences, University of California, San Diego, 92093 USA, San Diego, CA, United States,  6Diffusion Tensor Image Analyses and Brain Morphometry Center, Childrens  Hospital of Philadelphia, Department of Radiology, Childrens Hospital of Philadelphia, Philadelphia PA 19104 USA, Philadelphia, PA, United States,  7Neurogenetics Laboratory,  Howard Hughes Medical Institute, Department of Neurosciences and Pediatrics, Rady Childrens Hospital, University of California, San Diego, 92093 USA, San Diego, CA,  United States. We describe six patients from three unrelated consanguineous Egyptian families with a novel characteristic brain malformation at the level of the  diencephalic mesencephalic junction (DMJ). Diagnostic testing including  high resolution karyotyping and extended metabolic screening were nor   mal. Brain MRI demonstrated a dysplasia of the DMJ with a characteristic  butterfly like contour of the midbrain on axial sections. Additional ima ging features included variable degrees of supratentorial ventricular dilata   tion and hypoplasia to complete agenesis of the corpus callosum. Diffusion tensor imaging showed diffuse hypomyelination and lack of an identifiable corticospinal tract. All patients displayed severe cognitive impairment, post natal progressive microcephaly, axial hypotonia, spastic quadriparesis and seizures. Autistic features were noted in older cases. Talipes equinovarus, non obstructive cardiomyopathy and persistent hyperplastic primary vi treous were additional findings in two families. One of the patients required shunting for hydrocephalus, however, this yielded no change in ventricular size suggestive of dysplasia rather than obstruction. We propose the term diencephalic mesencephalic junction dysplasia (DMJD) to characterize this autosomal recessive malformation.",2012.0,,"M. S. Zaki1, S. N. Saleem2, W. B. Dobyns3, J. Barkovich4, H. Bartsch5, A. Dales5, M. Asharti6,  A. Grijalvo Perez7, J. G. Gleeson7","1National Research Centre, Dokki,, Egypt, 2Radiology Department, Cairo University,  Cairo, Egypt, 3Department of Pediatrics, Seattle Childrens Research Institute, Seattle,  WA 98195 6320",Autistic features were noted in older cases.,,Autistic features,[],"['Autistic', 'feature']"
310,286, De novo FMR2 (AFF2) deletion encompassing exons 2 and 3 in a boy with a mild intellectual disability,P02.102,,"Alterations of the Fragile Mental Retardation 2 gene (FMR2, synonym AFF2)  can result in a mild to moderate intellectual disability (ID), speech delay, hyperactivity, and autistic behaviour. The well known underlying molecular mechanism of this condition, also referred to as FRAXE, is a (CCG)n trinu cleotide repeat expansion which leads to silencing of the FMR2 gene. Addi   tionally, deletions within the FMR2 gene were described in handful number individuals with ID.Here we report on a de novo 131 kb deletion of FMR2 gene in a 2 years old boy with a mild developmental delay, behaviour changes, hypotonia, and discrete facial dysmorphism. The deletion, detected by SNP array ana   lysis (Affymetrix 250 K Nsp I), spans between the base pairs 147454718 147586323 (NCBI36). The aberration and its de novo origin were confirmed by MLPA. RNA analysis on the patient showed a 994 bp deletion of AFF2 transcript, resulting in the complete loss of exons 2 and 3.In conclusion, this case report further confirms the role of FMR2 gene dele tions as a FRAXE phenotype underlying mechanism. RNA analyses demon   strate that the deletion within the FMR2 gene ceases the transcript produc tion.",2012.0,,"A. Behboudi1,2, T . Zagoras3, L. Samuelsson3, C. Jiang1, E. Kaerrstedt3, M. Stefanova3,2","1Systems Biology Research Centre  Tumor biology, School of Life Sciences, University  of Skvde, Skvde, Sweden, 2Department of Medical and Clinical Genetics, Institute of  Biomedicine, University of Gothenburg, Gothenburg, Sweden, 3Department of Clinical  Gentics, Sahlgrenska University Hospital, Gothenburg, Sweden","Alterations of the Fragile Mental Retardation 2 gene (FMR2, synonym AFF2)  can result in a mild to moderate intellectual disability (ID), speech delay, hyperactivity, and autistic behaviour.",,autistic behaviour,[],"['autistic', 'behaviour']"
311,287, Detection of serum anti neuronal antibodies in patients with Fragile X syndrome,P02.103,,"Fragile X syndrome (FXS) is the most common form of familial mental retar dation and known cause of autism. The mutation responsible for FRAXA is a large expansion of the trinucleotide CGG repeats at 5 end of the FMR1 gene  resulting in the transcriptional silencing of the gene. There are close simila rities between autism profiles in idiopathic and comorbid autism (FXS).Aim: The aim of the study was to investigate the frequency of serum anti neural antibodies in a group of 23 Fragile X males.Material and methods: Serum anti neuronal antibodies were measured by Western blot technique (Anti neuronal Antigens EUROLINE WB EUROIM   MUN) in 23 patients with FXS (full mutation in the FMR1 gene), aged bet  ween 10 and 32 years, in comparison to 19 healthy matched malesResults: We detected the presence of antibodies in the serum of 10 FXS ma les and in 1 from the reference group. FXS males had significantly higher percent of elevated levels of serum anti neuronal antibodies (43,48%) than healthy controls (5,26%).Conclusion: Serum anti neuronal antibodies were found in a subgroup of FXS patients. Autistic symptoms in FXS may be, in part, caused by autoim mune factors. Further wide scale studies are necessary to shed light on the role of anti neuronal antibodies in autistic syndromesThe work was in part financed from Institutional grant KNW 2 021/10 awarded to MZL  Abstracts   European Human Genetics Conference 2012 www.eshg.org72ESHG Posters www.eshg.orgP02.104 Offspring of a fully mutated fragile X male patient: a premutated  female baby L. Van Maldergem1,2, B. Haddad3, D. Amram2, C. Touboul3, E. Flori4, V. Biancalana5;   1Centre de Gntique Humaine, Besanon, France, 2UF Gntique Clinique, Centre  Hospitalier Intercommunal, Crteil, France, 3Dept Gyn Obst, Centre Hospitalier  Intercommunal, Crteil, France, 4Dept Cytogenetics, University Regional Hospital,  Strasbourg, France, 5Laboratory of Genetic Diagnosis, University Regional Hospital,  Strasbourg, France. A 28 y old male originating from eastern Algeria with a diagnosis of Fragi  le X mental retardation established at the age of 12 y during evaluation of  severe learning disabilities married his second cousin. He required special  education in France and is currently working in a shelter. After an arrange ment has been decided by his family, his second cousin who was educated in  Algeria was married to him. Although he suffers moderate mental retarda  tion, his wife is of normal intelligence. A pregnancy developed soon thereaf ter. A male with the full mutation is expected to transmit alleles of premuta   tion size to his daughters, based on an experience of less than ten reported  cases. This is why prenatal testing is still recommended for a female fetus  of a fully mutated genitor. Fetal DNA was extracted from cultured amnio cytes and submitted to Southern blotting and (CGG)n PCR analysis. While  the father is mosaic for a methylated full mutation in lymphocytes (around  20% of the cells are not methylated), his wife has two normal alleles. The female fetus harbored a normal allele and a 105 CGG repeats premutation.  She was therefore predicted to be unaffected with Fragile X syndrome and  the pregnancy was pursued. Repeat ultrasound examination of the fetus was normal. After an uneventful pregnancy, the woman gave birth to a healthy female baby. Reproduction in Fragile X males is exceptional. This case re port gives further support to this unusual reverse instability mechanism as a common one.",2012.0,,"M. Lisik , A. Pyrkosz, E. Gutmajster, A. L. Sieron","Department of General, Molecular Biology and Genetics, Katowice, Poland","Autistic symptoms in FXS may be, in part, caused by autoim mune factors.",,Autistic symptoms,[],"['Autistic', 'symptom']"
311,287, Detection of serum anti neuronal antibodies in patients with Fragile X syndrome,P02.103,,"Fragile X syndrome (FXS) is the most common form of familial mental retar dation and known cause of autism. The mutation responsible for FRAXA is a large expansion of the trinucleotide CGG repeats at 5 end of the FMR1 gene  resulting in the transcriptional silencing of the gene. There are close simila rities between autism profiles in idiopathic and comorbid autism (FXS).Aim: The aim of the study was to investigate the frequency of serum anti neural antibodies in a group of 23 Fragile X males.Material and methods: Serum anti neuronal antibodies were measured by Western blot technique (Anti neuronal Antigens EUROLINE WB EUROIM   MUN) in 23 patients with FXS (full mutation in the FMR1 gene), aged bet  ween 10 and 32 years, in comparison to 19 healthy matched malesResults: We detected the presence of antibodies in the serum of 10 FXS ma les and in 1 from the reference group. FXS males had significantly higher percent of elevated levels of serum anti neuronal antibodies (43,48%) than healthy controls (5,26%).Conclusion: Serum anti neuronal antibodies were found in a subgroup of FXS patients. Autistic symptoms in FXS may be, in part, caused by autoim mune factors. Further wide scale studies are necessary to shed light on the role of anti neuronal antibodies in autistic syndromesThe work was in part financed from Institutional grant KNW 2 021/10 awarded to MZL  Abstracts   European Human Genetics Conference 2012 www.eshg.org72ESHG Posters www.eshg.orgP02.104 Offspring of a fully mutated fragile X male patient: a premutated  female baby L. Van Maldergem1,2, B. Haddad3, D. Amram2, C. Touboul3, E. Flori4, V. Biancalana5;   1Centre de Gntique Humaine, Besanon, France, 2UF Gntique Clinique, Centre  Hospitalier Intercommunal, Crteil, France, 3Dept Gyn Obst, Centre Hospitalier  Intercommunal, Crteil, France, 4Dept Cytogenetics, University Regional Hospital,  Strasbourg, France, 5Laboratory of Genetic Diagnosis, University Regional Hospital,  Strasbourg, France. A 28 y old male originating from eastern Algeria with a diagnosis of Fragi  le X mental retardation established at the age of 12 y during evaluation of  severe learning disabilities married his second cousin. He required special  education in France and is currently working in a shelter. After an arrange ment has been decided by his family, his second cousin who was educated in  Algeria was married to him. Although he suffers moderate mental retarda  tion, his wife is of normal intelligence. A pregnancy developed soon thereaf ter. A male with the full mutation is expected to transmit alleles of premuta   tion size to his daughters, based on an experience of less than ten reported  cases. This is why prenatal testing is still recommended for a female fetus  of a fully mutated genitor. Fetal DNA was extracted from cultured amnio cytes and submitted to Southern blotting and (CGG)n PCR analysis. While  the father is mosaic for a methylated full mutation in lymphocytes (around  20% of the cells are not methylated), his wife has two normal alleles. The female fetus harbored a normal allele and a 105 CGG repeats premutation.  She was therefore predicted to be unaffected with Fragile X syndrome and  the pregnancy was pursued. Repeat ultrasound examination of the fetus was normal. After an uneventful pregnancy, the woman gave birth to a healthy female baby. Reproduction in Fragile X males is exceptional. This case re port gives further support to this unusual reverse instability mechanism as a common one.",2012.0,,"M. Lisik , A. Pyrkosz, E. Gutmajster, A. L. Sieron","Department of General, Molecular Biology and Genetics, Katowice, Poland","Further wide scale studies are necessary to shed light on the role of anti neuronal antibodies in autistic syndromesThe work was in part financed from Institutional grant KNW 2 021/10 awarded to MZL  Abstracts   European Human Genetics Conference 2012 www.eshg.org72ESHG Posters www.eshg.orgP02.104 Offspring of a fully mutated fragile X male patient: a premutated  female baby L. Van Maldergem1,2, B. Haddad3, D. Amram2, C. Touboul3, E. Flori4, V. Biancalana5;   1Centre de Gntique Humaine, Besanon, France, 2UF Gntique Clinique, Centre  Hospitalier Intercommunal, Crteil, France, 3Dept Gyn Obst, Centre Hospitalier  Intercommunal, Crteil, France, 4Dept Cytogenetics, University Regional Hospital,  Strasbourg, France, 5Laboratory of Genetic Diagnosis, University Regional Hospital,  Strasbourg, France.",,autistic syndromesThe,[],"['autistic', 'syndromesThe']"
312,303," A Microdeletion at the 7q11.23 Locus including HIP1 in a Girl with Developmental Delay, Behavioural Problems, Gait Abnormalities and Facial Dysmorphism",P02.121,,"Recurrent deletions in the proximal region 7q11.23 are common in pati   ents with Williams Beuren syndrome (WBS). However, only a few patients  with a microdeletion including the HIP1 gene, located in the distal region  of 7q11.23, have been reported. These patients show a neurodevelopmen tal and epilepsy syndrome. HIP1 encodes huntingtin interacting protein 1  which is normally expressed in the brain. HIP1 knockout mice develop a  progressive neurologic phenotype with tremor and gait ataxia. Therefore, HIP1 haploinsufficiency has been proposed to lead to cognitive and beha vioural dysfunction in these patients. We present a 4 year old girl with mo  tor and speech delay, mild ataxia, and behavioral problems including im  pulsivity, aggression and mild autistic features. She showed facial dysmor   phism, including a short nose with anteverted nares, downturned corners  of the mouth, and a full lower lip, reminiscent of patients with WBS. Array  CGH analysis revealed an intragenic 14 23kb deletion in the distal region 7q11.23, which leads to loss of exons 5 to 8 of HIP1. The deletion detected  in this patient overlaps with a recurrent distal deletion in 7q11.23 in the  patients reported by Ramocki et al. (2010). Those patients had similar cli nical features, including intellectual disabilities, neurobehavioral problems and in addition epilepsy. However, no information about facial dysmorphism  was reported. Our patient appears to be the first with HIP1 haploinsuffici   ency. Further, our observation supports HIP1 to be a good candidate gene in  patients with developmental delay, behavioral and gait abnormalities and  the facial dysmorphism described.",2012.0,,"F. Kieling1, K. Hackmann2, C. Heine1, S. Syrbe3, D. Mitter1","1Institut fr Humangenetik, Universittsklinikum Leipzig, Leipzig, Germany, 2Institut  fr Klinische Genetik, TU Dresden, Dresden, Germany, 3Klinik und Poliklinik fr  Gastroenterologie und Rheumatologie, Universittsklinikum Leipzig, Leipzig, Germany","We present a 4 year old girl with mo  tor and speech delay, mild ataxia, and behavioral problems including im  pulsivity, aggression and mild autistic features.",,autistic features,[],"['autistic', 'feature']"
316,392, Genetic study of PTEN mutations among individuals with ASDs / MR and macrocephaly,P02.213,,"Autism spectrum disorders (ASDs) are a group of severe neurodevelopmen tal conditions among which pervasive developmental disorder (not other   wise specified) and autistic disorder are the most common. The prevalence of ASDs is currently estimated at 60 and 13 per 10,000 for ASDs and autism, respectively. Autistic disorder is often associated with macrocephaly; 24%  of patients have head circumference (HC) at >98th centile. Mutations in the  PTEN gene have been reported in patients with ASDs and significant ma  crocephaly (HC ranging from +2.5 SD to +8 SD). Germline PTEN mutations also cause a variety of inherited cancer predispositions like the Cowden, Bannayan Riley Ruvalcalba, Proteus and Proteus like syndromes. These  conditions may also have neurobehavioural features resembling autism as  well as overgrowth and macrocephaly. On the contrary, most macrocephalic  autistic patients with confirmed PTEN mutations were lacking the typical signs of these syndromes, at least at the time of testing. We have selected 53 autistic individuals with HC ranging from +2 SD to +4.8 SD (including  their relatives) for PTEN mutation analysis. Three novel (p.Asp331Thrfs*11,  p.Thr321Glnfs*23, p.Glu242*) and two known germline mutations  (p.Pro246Leu, p.Arg130*) have been found in 8 of the 53 probands (15%). We discuss possible genotype/phenotype correlation in our group of pati   ents. Our data support former findings that PTEN mutations are frequent  in patients with ASDs and macrocephaly. Therefore PTEN testing should  be considered in such patients. The findings may impact the assessment of  the recurrence risk and medical management of the families including early cancer prevention. Supported by CZ.2.16/3.1.00/24022 and MZ0FNM2012.",2012.0,,"M. Havlovicova, P . Vasovcak, A. Krepelova, M. Simandlova, T . Marikova, A. Holubova, Z. Sedlacek","Department of Biology and Medical Genetics, Charles University 2nd Faculty of Medicine  and University Hospital Motol, Prague, Czech Republic",Autism spectrum disorders (ASDs) are a group of severe neurodevelopmen tal conditions among which pervasive developmental disorder (not other   wise specified) and autistic disorder are the most common.,,autistic disorder,[],"['autistic', 'disorder']"
316,392, Genetic study of PTEN mutations among individuals with ASDs / MR and macrocephaly,P02.213,,"Autism spectrum disorders (ASDs) are a group of severe neurodevelopmen tal conditions among which pervasive developmental disorder (not other   wise specified) and autistic disorder are the most common. The prevalence of ASDs is currently estimated at 60 and 13 per 10,000 for ASDs and autism, respectively. Autistic disorder is often associated with macrocephaly; 24%  of patients have head circumference (HC) at >98th centile. Mutations in the  PTEN gene have been reported in patients with ASDs and significant ma  crocephaly (HC ranging from +2.5 SD to +8 SD). Germline PTEN mutations also cause a variety of inherited cancer predispositions like the Cowden, Bannayan Riley Ruvalcalba, Proteus and Proteus like syndromes. These  conditions may also have neurobehavioural features resembling autism as  well as overgrowth and macrocephaly. On the contrary, most macrocephalic  autistic patients with confirmed PTEN mutations were lacking the typical signs of these syndromes, at least at the time of testing. We have selected 53 autistic individuals with HC ranging from +2 SD to +4.8 SD (including  their relatives) for PTEN mutation analysis. Three novel (p.Asp331Thrfs*11,  p.Thr321Glnfs*23, p.Glu242*) and two known germline mutations  (p.Pro246Leu, p.Arg130*) have been found in 8 of the 53 probands (15%). We discuss possible genotype/phenotype correlation in our group of pati   ents. Our data support former findings that PTEN mutations are frequent  in patients with ASDs and macrocephaly. Therefore PTEN testing should  be considered in such patients. The findings may impact the assessment of  the recurrence risk and medical management of the families including early cancer prevention. Supported by CZ.2.16/3.1.00/24022 and MZ0FNM2012.",2012.0,,"M. Havlovicova, P . Vasovcak, A. Krepelova, M. Simandlova, T . Marikova, A. Holubova, Z. Sedlacek","Department of Biology and Medical Genetics, Charles University 2nd Faculty of Medicine  and University Hospital Motol, Prague, Czech Republic",Autistic disorder is often associated with macrocephaly; 24%  of patients have head circumference (HC) at >98th centile.,,Autistic disorder,[],"['Autistic', 'disorder']"
316,392, Genetic study of PTEN mutations among individuals with ASDs / MR and macrocephaly,P02.213,,"Autism spectrum disorders (ASDs) are a group of severe neurodevelopmen tal conditions among which pervasive developmental disorder (not other   wise specified) and autistic disorder are the most common. The prevalence of ASDs is currently estimated at 60 and 13 per 10,000 for ASDs and autism, respectively. Autistic disorder is often associated with macrocephaly; 24%  of patients have head circumference (HC) at >98th centile. Mutations in the  PTEN gene have been reported in patients with ASDs and significant ma  crocephaly (HC ranging from +2.5 SD to +8 SD). Germline PTEN mutations also cause a variety of inherited cancer predispositions like the Cowden, Bannayan Riley Ruvalcalba, Proteus and Proteus like syndromes. These  conditions may also have neurobehavioural features resembling autism as  well as overgrowth and macrocephaly. On the contrary, most macrocephalic  autistic patients with confirmed PTEN mutations were lacking the typical signs of these syndromes, at least at the time of testing. We have selected 53 autistic individuals with HC ranging from +2 SD to +4.8 SD (including  their relatives) for PTEN mutation analysis. Three novel (p.Asp331Thrfs*11,  p.Thr321Glnfs*23, p.Glu242*) and two known germline mutations  (p.Pro246Leu, p.Arg130*) have been found in 8 of the 53 probands (15%). We discuss possible genotype/phenotype correlation in our group of pati   ents. Our data support former findings that PTEN mutations are frequent  in patients with ASDs and macrocephaly. Therefore PTEN testing should  be considered in such patients. The findings may impact the assessment of  the recurrence risk and medical management of the families including early cancer prevention. Supported by CZ.2.16/3.1.00/24022 and MZ0FNM2012.",2012.0,,"M. Havlovicova, P . Vasovcak, A. Krepelova, M. Simandlova, T . Marikova, A. Holubova, Z. Sedlacek","Department of Biology and Medical Genetics, Charles University 2nd Faculty of Medicine  and University Hospital Motol, Prague, Czech Republic","On the contrary, most macrocephalic  autistic patients with confirmed PTEN mutations were lacking the typical signs of these syndromes, at least at the time of testing.",,autistic patients,[],"['autistic', 'patient']"
316,392, Genetic study of PTEN mutations among individuals with ASDs / MR and macrocephaly,P02.213,,"Autism spectrum disorders (ASDs) are a group of severe neurodevelopmen tal conditions among which pervasive developmental disorder (not other   wise specified) and autistic disorder are the most common. The prevalence of ASDs is currently estimated at 60 and 13 per 10,000 for ASDs and autism, respectively. Autistic disorder is often associated with macrocephaly; 24%  of patients have head circumference (HC) at >98th centile. Mutations in the  PTEN gene have been reported in patients with ASDs and significant ma  crocephaly (HC ranging from +2.5 SD to +8 SD). Germline PTEN mutations also cause a variety of inherited cancer predispositions like the Cowden, Bannayan Riley Ruvalcalba, Proteus and Proteus like syndromes. These  conditions may also have neurobehavioural features resembling autism as  well as overgrowth and macrocephaly. On the contrary, most macrocephalic  autistic patients with confirmed PTEN mutations were lacking the typical signs of these syndromes, at least at the time of testing. We have selected 53 autistic individuals with HC ranging from +2 SD to +4.8 SD (including  their relatives) for PTEN mutation analysis. Three novel (p.Asp331Thrfs*11,  p.Thr321Glnfs*23, p.Glu242*) and two known germline mutations  (p.Pro246Leu, p.Arg130*) have been found in 8 of the 53 probands (15%). We discuss possible genotype/phenotype correlation in our group of pati   ents. Our data support former findings that PTEN mutations are frequent  in patients with ASDs and macrocephaly. Therefore PTEN testing should  be considered in such patients. The findings may impact the assessment of  the recurrence risk and medical management of the families including early cancer prevention. Supported by CZ.2.16/3.1.00/24022 and MZ0FNM2012.",2012.0,,"M. Havlovicova, P . Vasovcak, A. Krepelova, M. Simandlova, T . Marikova, A. Holubova, Z. Sedlacek","Department of Biology and Medical Genetics, Charles University 2nd Faculty of Medicine  and University Hospital Motol, Prague, Czech Republic",We have selected 53 autistic individuals with HC ranging from +2 SD to +4.8 SD (including  their relatives) for PTEN mutation analysis.,,autistic individuals,[],"['autistic', 'individual']"
320,442, A clinical study of patients with pericentromeric deletion and duplication within 16p11.2 p12.2,P03.002,,"The pericentromeric region on 16p is susceptible to chromosomal rearran  gements. There are many reports that deletions of 16p11.2 are observed  about 1% among patients with autism. The 16p11.2 p12.2 deletion syndro  me is characterized by developmental disabilities and dysmorphic features. We have identified pericetromeric deletion and duplication, within 16p11.2 p12.2 in three patients by Cytogenetics 2.7M array. Patient 1 was a 10 year old girl with autism and obesity. She had a heterozygous 593kb deletion in 16p11.2. Her mother with the same deletion was not autistic, but was obese. Patient 2 was a 2 year old boy with VSD, hypotonia, developmental delay and frequent ear infections. He had.dysmorphic features including flat face, down slanting palpebral fissures, low set posteriorly rotated ears and thin upper lip. Autistic features were not seen. Microarray analysis revealed a 7.7Mb deletion at 16p11.2 p12.2. He showed common clinical features to the 16p11.2 p12.2 deletion syndrome. Patient 3 was an 8 year old girl with developmental delay, autism and dysmophic features including hypertri   chosis, wide mouth and macrocephaly. She showed poor communication skills and ritualized patterns of interests and behavior. Microarray analysis revealed a 6.7Mb duplication at 16p11.2 p12.2. The duplicated region of pa tient 3 was very similar with the deleted region of the patient 2. We suggest that 16p11.2 p12.2 duplication may be a new syndrome with autism.",2012.0,,"N. Okamoto1, K. Saito2, T . Matsui2, N. Harada2, N. Miyake3, N. Matsumoto3","1Department of Medical Genetics, Osaka Medical Center & Research Institute for  Maternal and Child Health, Osaka, Japan, 2Department of Molecular Genetics, Advanced  Medical Science Research Center, Mitsubishi Chemical Medience Corporation, Tokyo,  Japan, 3Department of Human Genetics, Yokohama City University Graduate School of  Medicine, Yokohama, Japan",There are many reports that deletions of 16p11.2 are observed  about 1% among patients with autism.,patients with autism,,"['patient', 'with', 'autism']",[]
320,442, A clinical study of patients with pericentromeric deletion and duplication within 16p11.2 p12.2,P03.002,,"The pericentromeric region on 16p is susceptible to chromosomal rearran  gements. There are many reports that deletions of 16p11.2 are observed  about 1% among patients with autism. The 16p11.2 p12.2 deletion syndro  me is characterized by developmental disabilities and dysmorphic features. We have identified pericetromeric deletion and duplication, within 16p11.2 p12.2 in three patients by Cytogenetics 2.7M array. Patient 1 was a 10 year old girl with autism and obesity. She had a heterozygous 593kb deletion in 16p11.2. Her mother with the same deletion was not autistic, but was obese. Patient 2 was a 2 year old boy with VSD, hypotonia, developmental delay and frequent ear infections. He had.dysmorphic features including flat face, down slanting palpebral fissures, low set posteriorly rotated ears and thin upper lip. Autistic features were not seen. Microarray analysis revealed a 7.7Mb deletion at 16p11.2 p12.2. He showed common clinical features to the 16p11.2 p12.2 deletion syndrome. Patient 3 was an 8 year old girl with developmental delay, autism and dysmophic features including hypertri   chosis, wide mouth and macrocephaly. She showed poor communication skills and ritualized patterns of interests and behavior. Microarray analysis revealed a 6.7Mb duplication at 16p11.2 p12.2. The duplicated region of pa tient 3 was very similar with the deleted region of the patient 2. We suggest that 16p11.2 p12.2 duplication may be a new syndrome with autism.",2012.0,,"N. Okamoto1, K. Saito2, T . Matsui2, N. Harada2, N. Miyake3, N. Matsumoto3","1Department of Medical Genetics, Osaka Medical Center & Research Institute for  Maternal and Child Health, Osaka, Japan, 2Department of Molecular Genetics, Advanced  Medical Science Research Center, Mitsubishi Chemical Medience Corporation, Tokyo,  Japan, 3Department of Human Genetics, Yokohama City University Graduate School of  Medicine, Yokohama, Japan",Patient 1 was a 10 year old girl with autism and obesity.,girl with autism,,"['girl', 'with', 'autism']",[]
320,442, A clinical study of patients with pericentromeric deletion and duplication within 16p11.2 p12.2,P03.002,,"The pericentromeric region on 16p is susceptible to chromosomal rearran  gements. There are many reports that deletions of 16p11.2 are observed  about 1% among patients with autism. The 16p11.2 p12.2 deletion syndro  me is characterized by developmental disabilities and dysmorphic features. We have identified pericetromeric deletion and duplication, within 16p11.2 p12.2 in three patients by Cytogenetics 2.7M array. Patient 1 was a 10 year old girl with autism and obesity. She had a heterozygous 593kb deletion in 16p11.2. Her mother with the same deletion was not autistic, but was obese. Patient 2 was a 2 year old boy with VSD, hypotonia, developmental delay and frequent ear infections. He had.dysmorphic features including flat face, down slanting palpebral fissures, low set posteriorly rotated ears and thin upper lip. Autistic features were not seen. Microarray analysis revealed a 7.7Mb deletion at 16p11.2 p12.2. He showed common clinical features to the 16p11.2 p12.2 deletion syndrome. Patient 3 was an 8 year old girl with developmental delay, autism and dysmophic features including hypertri   chosis, wide mouth and macrocephaly. She showed poor communication skills and ritualized patterns of interests and behavior. Microarray analysis revealed a 6.7Mb duplication at 16p11.2 p12.2. The duplicated region of pa tient 3 was very similar with the deleted region of the patient 2. We suggest that 16p11.2 p12.2 duplication may be a new syndrome with autism.",2012.0,,"N. Okamoto1, K. Saito2, T . Matsui2, N. Harada2, N. Miyake3, N. Matsumoto3","1Department of Medical Genetics, Osaka Medical Center & Research Institute for  Maternal and Child Health, Osaka, Japan, 2Department of Molecular Genetics, Advanced  Medical Science Research Center, Mitsubishi Chemical Medience Corporation, Tokyo,  Japan, 3Department of Human Genetics, Yokohama City University Graduate School of  Medicine, Yokohama, Japan",Autistic features were not seen.,,Autistic features,[],"['Autistic', 'feature']"
320,442, A clinical study of patients with pericentromeric deletion and duplication within 16p11.2 p12.2,P03.002,,"The pericentromeric region on 16p is susceptible to chromosomal rearran  gements. There are many reports that deletions of 16p11.2 are observed  about 1% among patients with autism. The 16p11.2 p12.2 deletion syndro  me is characterized by developmental disabilities and dysmorphic features. We have identified pericetromeric deletion and duplication, within 16p11.2 p12.2 in three patients by Cytogenetics 2.7M array. Patient 1 was a 10 year old girl with autism and obesity. She had a heterozygous 593kb deletion in 16p11.2. Her mother with the same deletion was not autistic, but was obese. Patient 2 was a 2 year old boy with VSD, hypotonia, developmental delay and frequent ear infections. He had.dysmorphic features including flat face, down slanting palpebral fissures, low set posteriorly rotated ears and thin upper lip. Autistic features were not seen. Microarray analysis revealed a 7.7Mb deletion at 16p11.2 p12.2. He showed common clinical features to the 16p11.2 p12.2 deletion syndrome. Patient 3 was an 8 year old girl with developmental delay, autism and dysmophic features including hypertri   chosis, wide mouth and macrocephaly. She showed poor communication skills and ritualized patterns of interests and behavior. Microarray analysis revealed a 6.7Mb duplication at 16p11.2 p12.2. The duplicated region of pa tient 3 was very similar with the deleted region of the patient 2. We suggest that 16p11.2 p12.2 duplication may be a new syndrome with autism.",2012.0,,"N. Okamoto1, K. Saito2, T . Matsui2, N. Harada2, N. Miyake3, N. Matsumoto3","1Department of Medical Genetics, Osaka Medical Center & Research Institute for  Maternal and Child Health, Osaka, Japan, 2Department of Molecular Genetics, Advanced  Medical Science Research Center, Mitsubishi Chemical Medience Corporation, Tokyo,  Japan, 3Department of Human Genetics, Yokohama City University Graduate School of  Medicine, Yokohama, Japan",We suggest that 16p11.2 p12.2 duplication may be a new syndrome with autism.,syndrome with autism,,"['syndrome', 'with', 'autism']",[]
322,459, Additional evidence to support the role of the 20q13.33 region in susceptibility to autism,P03.020,,"Autism spectrum disorders (ASD) are a group of highly heritable complex neurodevelopmental disorders and identifying its genetic bases has been challenging. The susceptibility genes so far identified seem to be involved in the proper establishment of the synaptic cleft, the secretion of surface pro teins, the excitation/inhibition balance, or the overall cellular translation processes, suggesting that impacting translation dependent processes like synaptic plasticity or cell to cell connectivity may lead to an ASD phenotype. Chromosomal imbalances identified by conventional or molecular cytoge netic techniques account for 10 15% of patients with autism. Here, we re port a third case of pure de novo 20q13.33 deletion in a boy presenting with  autism. Metabolic evaluation and standard karyotype were reported as nor   mal, as was FMR1 molecular analysis. The Human Genome Microarray CGH  180K from Agilent used for array CGH analyses revealed an interstitial de   letion of at least 556 kb in the 20q13.33 region (arr20q13.33(61,229,038 61,785,825)x1, hg18). This deletion encompassed 21 genes including CHR   NA4  and KCNQ2 . These genes are interesting candidate genes in the autistic www.eshg.org Abstracts   European Human Genetics Conference 2012109 www.eshg.orgESHG Posters phenotype since they have been reported in association with entities with  exclusive neurological manifestations such as epilepsy. The frequent associa   tion between epileptic and autistic phenotypes suggests that these diseases may share common predisposing genes. Interestingly, a de novo 20q13.33  duplication encompassing CHRNA4  and KCNQ2  in a girl with autism has also  been reported. This study underlines that copy number variations of the 20q13.33 region can cause autism and emphasizes the importance of array CGH in the genetic work up of patients with autism.",2012.0,,"A. Mosca Boidron1, M. Valduga2, C. Thauvin3, N. Lagarde4, C. Henry4, M. Bri  Deixheimer2, N. Marle1, M. Payet1, C. Ragon1, L. Gueneau5, P . Callier1, F. Mugneret1, P .  Jonveaux2, L. Faivre6","1Laboratoire de Cytogntique CHU Dijon, Dijon, France, 2Laboratoire de Gntique, EA  4002, CHU, Nancy University, Nancy, France, 3Centre de Gntique et centre de rfrence  maladies rares anomalies du dveloppement et syndromes malformatifs, CHU Dijon,  Dijon, France, 4Centre de Ressources Autismes de Bourgogne, CHU Dijon, Dijon, France,  5Equipe Gntique et Anomalies du Dveloppement, Universit de Bourgogne, Facult  de Mdecine, Dijon, France, 6Centre de Gntique et centre de rfrence maladies rares  anomalies du dveloppement et syndromes malformatifs, Dijon, France","The susceptibility genes so far identified seem to be involved in the proper establishment of the synaptic cleft, the secretion of surface pro teins, the excitation/inhibition balance, or the overall cellular translation processes, suggesting that impacting translation dependent processes like synaptic plasticity or cell to cell connectivity may lead to an ASD phenotype.",,ASD phenotype,[],"['ASD', 'phenotype']"
322,459, Additional evidence to support the role of the 20q13.33 region in susceptibility to autism,P03.020,,"Autism spectrum disorders (ASD) are a group of highly heritable complex neurodevelopmental disorders and identifying its genetic bases has been challenging. The susceptibility genes so far identified seem to be involved in the proper establishment of the synaptic cleft, the secretion of surface pro teins, the excitation/inhibition balance, or the overall cellular translation processes, suggesting that impacting translation dependent processes like synaptic plasticity or cell to cell connectivity may lead to an ASD phenotype. Chromosomal imbalances identified by conventional or molecular cytoge netic techniques account for 10 15% of patients with autism. Here, we re port a third case of pure de novo 20q13.33 deletion in a boy presenting with  autism. Metabolic evaluation and standard karyotype were reported as nor   mal, as was FMR1 molecular analysis. The Human Genome Microarray CGH  180K from Agilent used for array CGH analyses revealed an interstitial de   letion of at least 556 kb in the 20q13.33 region (arr20q13.33(61,229,038 61,785,825)x1, hg18). This deletion encompassed 21 genes including CHR   NA4  and KCNQ2 . These genes are interesting candidate genes in the autistic www.eshg.org Abstracts   European Human Genetics Conference 2012109 www.eshg.orgESHG Posters phenotype since they have been reported in association with entities with  exclusive neurological manifestations such as epilepsy. The frequent associa   tion between epileptic and autistic phenotypes suggests that these diseases may share common predisposing genes. Interestingly, a de novo 20q13.33  duplication encompassing CHRNA4  and KCNQ2  in a girl with autism has also  been reported. This study underlines that copy number variations of the 20q13.33 region can cause autism and emphasizes the importance of array CGH in the genetic work up of patients with autism.",2012.0,,"A. Mosca Boidron1, M. Valduga2, C. Thauvin3, N. Lagarde4, C. Henry4, M. Bri  Deixheimer2, N. Marle1, M. Payet1, C. Ragon1, L. Gueneau5, P . Callier1, F. Mugneret1, P .  Jonveaux2, L. Faivre6","1Laboratoire de Cytogntique CHU Dijon, Dijon, France, 2Laboratoire de Gntique, EA  4002, CHU, Nancy University, Nancy, France, 3Centre de Gntique et centre de rfrence  maladies rares anomalies du dveloppement et syndromes malformatifs, CHU Dijon,  Dijon, France, 4Centre de Ressources Autismes de Bourgogne, CHU Dijon, Dijon, France,  5Equipe Gntique et Anomalies du Dveloppement, Universit de Bourgogne, Facult  de Mdecine, Dijon, France, 6Centre de Gntique et centre de rfrence maladies rares  anomalies du dveloppement et syndromes malformatifs, Dijon, France",Chromosomal imbalances identified by conventional or molecular cytoge netic techniques account for 10 15% of patients with autism.,patients with autism,,"['patient', 'with', 'autism']",[]
322,459, Additional evidence to support the role of the 20q13.33 region in susceptibility to autism,P03.020,,"Autism spectrum disorders (ASD) are a group of highly heritable complex neurodevelopmental disorders and identifying its genetic bases has been challenging. The susceptibility genes so far identified seem to be involved in the proper establishment of the synaptic cleft, the secretion of surface pro teins, the excitation/inhibition balance, or the overall cellular translation processes, suggesting that impacting translation dependent processes like synaptic plasticity or cell to cell connectivity may lead to an ASD phenotype. Chromosomal imbalances identified by conventional or molecular cytoge netic techniques account for 10 15% of patients with autism. Here, we re port a third case of pure de novo 20q13.33 deletion in a boy presenting with  autism. Metabolic evaluation and standard karyotype were reported as nor   mal, as was FMR1 molecular analysis. The Human Genome Microarray CGH  180K from Agilent used for array CGH analyses revealed an interstitial de   letion of at least 556 kb in the 20q13.33 region (arr20q13.33(61,229,038 61,785,825)x1, hg18). This deletion encompassed 21 genes including CHR   NA4  and KCNQ2 . These genes are interesting candidate genes in the autistic www.eshg.org Abstracts   European Human Genetics Conference 2012109 www.eshg.orgESHG Posters phenotype since they have been reported in association with entities with  exclusive neurological manifestations such as epilepsy. The frequent associa   tion between epileptic and autistic phenotypes suggests that these diseases may share common predisposing genes. Interestingly, a de novo 20q13.33  duplication encompassing CHRNA4  and KCNQ2  in a girl with autism has also  been reported. This study underlines that copy number variations of the 20q13.33 region can cause autism and emphasizes the importance of array CGH in the genetic work up of patients with autism.",2012.0,,"A. Mosca Boidron1, M. Valduga2, C. Thauvin3, N. Lagarde4, C. Henry4, M. Bri  Deixheimer2, N. Marle1, M. Payet1, C. Ragon1, L. Gueneau5, P . Callier1, F. Mugneret1, P .  Jonveaux2, L. Faivre6","1Laboratoire de Cytogntique CHU Dijon, Dijon, France, 2Laboratoire de Gntique, EA  4002, CHU, Nancy University, Nancy, France, 3Centre de Gntique et centre de rfrence  maladies rares anomalies du dveloppement et syndromes malformatifs, CHU Dijon,  Dijon, France, 4Centre de Ressources Autismes de Bourgogne, CHU Dijon, Dijon, France,  5Equipe Gntique et Anomalies du Dveloppement, Universit de Bourgogne, Facult  de Mdecine, Dijon, France, 6Centre de Gntique et centre de rfrence maladies rares  anomalies du dveloppement et syndromes malformatifs, Dijon, France",The frequent associa   tion between epileptic and autistic phenotypes suggests that these diseases may share common predisposing genes.,,autistic phenotypes,[],"['autistic', 'phenotype']"
322,459, Additional evidence to support the role of the 20q13.33 region in susceptibility to autism,P03.020,,"Autism spectrum disorders (ASD) are a group of highly heritable complex neurodevelopmental disorders and identifying its genetic bases has been challenging. The susceptibility genes so far identified seem to be involved in the proper establishment of the synaptic cleft, the secretion of surface pro teins, the excitation/inhibition balance, or the overall cellular translation processes, suggesting that impacting translation dependent processes like synaptic plasticity or cell to cell connectivity may lead to an ASD phenotype. Chromosomal imbalances identified by conventional or molecular cytoge netic techniques account for 10 15% of patients with autism. Here, we re port a third case of pure de novo 20q13.33 deletion in a boy presenting with  autism. Metabolic evaluation and standard karyotype were reported as nor   mal, as was FMR1 molecular analysis. The Human Genome Microarray CGH  180K from Agilent used for array CGH analyses revealed an interstitial de   letion of at least 556 kb in the 20q13.33 region (arr20q13.33(61,229,038 61,785,825)x1, hg18). This deletion encompassed 21 genes including CHR   NA4  and KCNQ2 . These genes are interesting candidate genes in the autistic www.eshg.org Abstracts   European Human Genetics Conference 2012109 www.eshg.orgESHG Posters phenotype since they have been reported in association with entities with  exclusive neurological manifestations such as epilepsy. The frequent associa   tion between epileptic and autistic phenotypes suggests that these diseases may share common predisposing genes. Interestingly, a de novo 20q13.33  duplication encompassing CHRNA4  and KCNQ2  in a girl with autism has also  been reported. This study underlines that copy number variations of the 20q13.33 region can cause autism and emphasizes the importance of array CGH in the genetic work up of patients with autism.",2012.0,,"A. Mosca Boidron1, M. Valduga2, C. Thauvin3, N. Lagarde4, C. Henry4, M. Bri  Deixheimer2, N. Marle1, M. Payet1, C. Ragon1, L. Gueneau5, P . Callier1, F. Mugneret1, P .  Jonveaux2, L. Faivre6","1Laboratoire de Cytogntique CHU Dijon, Dijon, France, 2Laboratoire de Gntique, EA  4002, CHU, Nancy University, Nancy, France, 3Centre de Gntique et centre de rfrence  maladies rares anomalies du dveloppement et syndromes malformatifs, CHU Dijon,  Dijon, France, 4Centre de Ressources Autismes de Bourgogne, CHU Dijon, Dijon, France,  5Equipe Gntique et Anomalies du Dveloppement, Universit de Bourgogne, Facult  de Mdecine, Dijon, France, 6Centre de Gntique et centre de rfrence maladies rares  anomalies du dveloppement et syndromes malformatifs, Dijon, France","Interestingly, a de novo 20q13.33  duplication encompassing CHRNA4  and KCNQ2  in a girl with autism has also  been reported.",girl with autism,,"['girl', 'with', 'autism']",[]
322,459, Additional evidence to support the role of the 20q13.33 region in susceptibility to autism,P03.020,,"Autism spectrum disorders (ASD) are a group of highly heritable complex neurodevelopmental disorders and identifying its genetic bases has been challenging. The susceptibility genes so far identified seem to be involved in the proper establishment of the synaptic cleft, the secretion of surface pro teins, the excitation/inhibition balance, or the overall cellular translation processes, suggesting that impacting translation dependent processes like synaptic plasticity or cell to cell connectivity may lead to an ASD phenotype. Chromosomal imbalances identified by conventional or molecular cytoge netic techniques account for 10 15% of patients with autism. Here, we re port a third case of pure de novo 20q13.33 deletion in a boy presenting with  autism. Metabolic evaluation and standard karyotype were reported as nor   mal, as was FMR1 molecular analysis. The Human Genome Microarray CGH  180K from Agilent used for array CGH analyses revealed an interstitial de   letion of at least 556 kb in the 20q13.33 region (arr20q13.33(61,229,038 61,785,825)x1, hg18). This deletion encompassed 21 genes including CHR   NA4  and KCNQ2 . These genes are interesting candidate genes in the autistic www.eshg.org Abstracts   European Human Genetics Conference 2012109 www.eshg.orgESHG Posters phenotype since they have been reported in association with entities with  exclusive neurological manifestations such as epilepsy. The frequent associa   tion between epileptic and autistic phenotypes suggests that these diseases may share common predisposing genes. Interestingly, a de novo 20q13.33  duplication encompassing CHRNA4  and KCNQ2  in a girl with autism has also  been reported. This study underlines that copy number variations of the 20q13.33 region can cause autism and emphasizes the importance of array CGH in the genetic work up of patients with autism.",2012.0,,"A. Mosca Boidron1, M. Valduga2, C. Thauvin3, N. Lagarde4, C. Henry4, M. Bri  Deixheimer2, N. Marle1, M. Payet1, C. Ragon1, L. Gueneau5, P . Callier1, F. Mugneret1, P .  Jonveaux2, L. Faivre6","1Laboratoire de Cytogntique CHU Dijon, Dijon, France, 2Laboratoire de Gntique, EA  4002, CHU, Nancy University, Nancy, France, 3Centre de Gntique et centre de rfrence  maladies rares anomalies du dveloppement et syndromes malformatifs, CHU Dijon,  Dijon, France, 4Centre de Ressources Autismes de Bourgogne, CHU Dijon, Dijon, France,  5Equipe Gntique et Anomalies du Dveloppement, Universit de Bourgogne, Facult  de Mdecine, Dijon, France, 6Centre de Gntique et centre de rfrence maladies rares  anomalies du dveloppement et syndromes malformatifs, Dijon, France",This study underlines that copy number variations of the 20q13.33 region can cause autism and emphasizes the importance of array CGH in the genetic work up of patients with autism.,patients with autism,,"['patient', 'with', 'autism']",[]
323,460, Brain specific X chromosome aneuploidy is likely to contribute to the pathogenesis of autism and can explain the unsolved paradox of male susceptibility,P03.022,,"Autism is a common childhood psychiatric disorder characterized by impai red social interaction and communication, repetitive/stereotypic behavior. Numerous studies indicate that chromosomal and genomic imbalances play a role in the etiology and pathogenesis of autism. However, the incidence and role of genomic imbalances in the autistic brain   the prime target of the disease   have not been addressed. Here, we report on the first evaluation of mosaic aneuplody in the autistic brain. Postmortem brain tissue samples (cerebral cortex and cerebellum) of 12 autistic patients and 12 age /sex  matched controls were provided by the Brain and Tissue Bank for Develop mental disorders, University of Maryland. In the male autistic brain, we ob served statistically significant increase of chromosome X aneuploidy rates in the cerebral cortex and cerebellum (p,0.0166) as compared to control samples. Autistic spectrum disorders currently affect four times as many males as females. Mosaic chromosome X aneuploidy in the brain may help to explain the preponderance of autism among males in addition to specific alterations of the X chromosome genes. We conclude that intercellular geno mic variation manifesting as brain specific low level mosaic aneuploidy is one of the possible genetic factors likely contributing to autism neuropatho logy. Our findings support the hypothesis that somatic genome instability could affect as homeostasis of aneuploid neurons as functioning of the neu ronal network in the whole autistic brain, playing, therefore, an important role in the pathogenesis. Supported by BMBF/DLR (RUS 09/006).",2012.0,,"Y. B. Yurov1,2,3, S. G. Vorsanova2,1,3, A. D. Kolotii2, T . Liehr4, I. Y. Iourov1,2","1Mental Health Research Center, RAMS, Moscow, Russian Federation, 2Institute of  Paediatrics and Paediatric Surgery, Ministry of Health, Moscow, Russian Federation,  3Moscow City University of Psychology and Education, Moscow, Russian Federation,  4Institute of Human Genetics and Anthropology, Jena, Germany","However, the incidence and role of genomic imbalances in the autistic brain   the prime target of the disease   have not been addressed.",,autistic brain,[],"['autistic', 'brain']"
323,460, Brain specific X chromosome aneuploidy is likely to contribute to the pathogenesis of autism and can explain the unsolved paradox of male susceptibility,P03.022,,"Autism is a common childhood psychiatric disorder characterized by impai red social interaction and communication, repetitive/stereotypic behavior. Numerous studies indicate that chromosomal and genomic imbalances play a role in the etiology and pathogenesis of autism. However, the incidence and role of genomic imbalances in the autistic brain   the prime target of the disease   have not been addressed. Here, we report on the first evaluation of mosaic aneuplody in the autistic brain. Postmortem brain tissue samples (cerebral cortex and cerebellum) of 12 autistic patients and 12 age /sex  matched controls were provided by the Brain and Tissue Bank for Develop mental disorders, University of Maryland. In the male autistic brain, we ob served statistically significant increase of chromosome X aneuploidy rates in the cerebral cortex and cerebellum (p,0.0166) as compared to control samples. Autistic spectrum disorders currently affect four times as many males as females. Mosaic chromosome X aneuploidy in the brain may help to explain the preponderance of autism among males in addition to specific alterations of the X chromosome genes. We conclude that intercellular geno mic variation manifesting as brain specific low level mosaic aneuploidy is one of the possible genetic factors likely contributing to autism neuropatho logy. Our findings support the hypothesis that somatic genome instability could affect as homeostasis of aneuploid neurons as functioning of the neu ronal network in the whole autistic brain, playing, therefore, an important role in the pathogenesis. Supported by BMBF/DLR (RUS 09/006).",2012.0,,"Y. B. Yurov1,2,3, S. G. Vorsanova2,1,3, A. D. Kolotii2, T . Liehr4, I. Y. Iourov1,2","1Mental Health Research Center, RAMS, Moscow, Russian Federation, 2Institute of  Paediatrics and Paediatric Surgery, Ministry of Health, Moscow, Russian Federation,  3Moscow City University of Psychology and Education, Moscow, Russian Federation,  4Institute of Human Genetics and Anthropology, Jena, Germany","Here, we report on the first evaluation of mosaic aneuplody in the autistic brain.",,autistic brain,[],"['autistic', 'brain']"
323,460, Brain specific X chromosome aneuploidy is likely to contribute to the pathogenesis of autism and can explain the unsolved paradox of male susceptibility,P03.022,,"Autism is a common childhood psychiatric disorder characterized by impai red social interaction and communication, repetitive/stereotypic behavior. Numerous studies indicate that chromosomal and genomic imbalances play a role in the etiology and pathogenesis of autism. However, the incidence and role of genomic imbalances in the autistic brain   the prime target of the disease   have not been addressed. Here, we report on the first evaluation of mosaic aneuplody in the autistic brain. Postmortem brain tissue samples (cerebral cortex and cerebellum) of 12 autistic patients and 12 age /sex  matched controls were provided by the Brain and Tissue Bank for Develop mental disorders, University of Maryland. In the male autistic brain, we ob served statistically significant increase of chromosome X aneuploidy rates in the cerebral cortex and cerebellum (p,0.0166) as compared to control samples. Autistic spectrum disorders currently affect four times as many males as females. Mosaic chromosome X aneuploidy in the brain may help to explain the preponderance of autism among males in addition to specific alterations of the X chromosome genes. We conclude that intercellular geno mic variation manifesting as brain specific low level mosaic aneuploidy is one of the possible genetic factors likely contributing to autism neuropatho logy. Our findings support the hypothesis that somatic genome instability could affect as homeostasis of aneuploid neurons as functioning of the neu ronal network in the whole autistic brain, playing, therefore, an important role in the pathogenesis. Supported by BMBF/DLR (RUS 09/006).",2012.0,,"Y. B. Yurov1,2,3, S. G. Vorsanova2,1,3, A. D. Kolotii2, T . Liehr4, I. Y. Iourov1,2","1Mental Health Research Center, RAMS, Moscow, Russian Federation, 2Institute of  Paediatrics and Paediatric Surgery, Ministry of Health, Moscow, Russian Federation,  3Moscow City University of Psychology and Education, Moscow, Russian Federation,  4Institute of Human Genetics and Anthropology, Jena, Germany","Postmortem brain tissue samples (cerebral cortex and cerebellum) of 12 autistic patients and 12 age /sex  matched controls were provided by the Brain and Tissue Bank for Develop mental disorders, University of Maryland.",,autistic patients,[],"['autistic', 'patient']"
323,460, Brain specific X chromosome aneuploidy is likely to contribute to the pathogenesis of autism and can explain the unsolved paradox of male susceptibility,P03.022,,"Autism is a common childhood psychiatric disorder characterized by impai red social interaction and communication, repetitive/stereotypic behavior. Numerous studies indicate that chromosomal and genomic imbalances play a role in the etiology and pathogenesis of autism. However, the incidence and role of genomic imbalances in the autistic brain   the prime target of the disease   have not been addressed. Here, we report on the first evaluation of mosaic aneuplody in the autistic brain. Postmortem brain tissue samples (cerebral cortex and cerebellum) of 12 autistic patients and 12 age /sex  matched controls were provided by the Brain and Tissue Bank for Develop mental disorders, University of Maryland. In the male autistic brain, we ob served statistically significant increase of chromosome X aneuploidy rates in the cerebral cortex and cerebellum (p,0.0166) as compared to control samples. Autistic spectrum disorders currently affect four times as many males as females. Mosaic chromosome X aneuploidy in the brain may help to explain the preponderance of autism among males in addition to specific alterations of the X chromosome genes. We conclude that intercellular geno mic variation manifesting as brain specific low level mosaic aneuploidy is one of the possible genetic factors likely contributing to autism neuropatho logy. Our findings support the hypothesis that somatic genome instability could affect as homeostasis of aneuploid neurons as functioning of the neu ronal network in the whole autistic brain, playing, therefore, an important role in the pathogenesis. Supported by BMBF/DLR (RUS 09/006).",2012.0,,"Y. B. Yurov1,2,3, S. G. Vorsanova2,1,3, A. D. Kolotii2, T . Liehr4, I. Y. Iourov1,2","1Mental Health Research Center, RAMS, Moscow, Russian Federation, 2Institute of  Paediatrics and Paediatric Surgery, Ministry of Health, Moscow, Russian Federation,  3Moscow City University of Psychology and Education, Moscow, Russian Federation,  4Institute of Human Genetics and Anthropology, Jena, Germany","In the male autistic brain, we ob served statistically significant increase of chromosome X aneuploidy rates in the cerebral cortex and cerebellum (p,0.0166) as compared to control samples.",,autistic brain,[],"['autistic', 'brain']"
323,460, Brain specific X chromosome aneuploidy is likely to contribute to the pathogenesis of autism and can explain the unsolved paradox of male susceptibility,P03.022,,"Autism is a common childhood psychiatric disorder characterized by impai red social interaction and communication, repetitive/stereotypic behavior. Numerous studies indicate that chromosomal and genomic imbalances play a role in the etiology and pathogenesis of autism. However, the incidence and role of genomic imbalances in the autistic brain   the prime target of the disease   have not been addressed. Here, we report on the first evaluation of mosaic aneuplody in the autistic brain. Postmortem brain tissue samples (cerebral cortex and cerebellum) of 12 autistic patients and 12 age /sex  matched controls were provided by the Brain and Tissue Bank for Develop mental disorders, University of Maryland. In the male autistic brain, we ob served statistically significant increase of chromosome X aneuploidy rates in the cerebral cortex and cerebellum (p,0.0166) as compared to control samples. Autistic spectrum disorders currently affect four times as many males as females. Mosaic chromosome X aneuploidy in the brain may help to explain the preponderance of autism among males in addition to specific alterations of the X chromosome genes. We conclude that intercellular geno mic variation manifesting as brain specific low level mosaic aneuploidy is one of the possible genetic factors likely contributing to autism neuropatho logy. Our findings support the hypothesis that somatic genome instability could affect as homeostasis of aneuploid neurons as functioning of the neu ronal network in the whole autistic brain, playing, therefore, an important role in the pathogenesis. Supported by BMBF/DLR (RUS 09/006).",2012.0,,"Y. B. Yurov1,2,3, S. G. Vorsanova2,1,3, A. D. Kolotii2, T . Liehr4, I. Y. Iourov1,2","1Mental Health Research Center, RAMS, Moscow, Russian Federation, 2Institute of  Paediatrics and Paediatric Surgery, Ministry of Health, Moscow, Russian Federation,  3Moscow City University of Psychology and Education, Moscow, Russian Federation,  4Institute of Human Genetics and Anthropology, Jena, Germany",Autistic spectrum disorders currently affect four times as many males as females.,,Autistic spectrum,[],"['Autistic', 'spectrum']"
323,460, Brain specific X chromosome aneuploidy is likely to contribute to the pathogenesis of autism and can explain the unsolved paradox of male susceptibility,P03.022,,"Autism is a common childhood psychiatric disorder characterized by impai red social interaction and communication, repetitive/stereotypic behavior. Numerous studies indicate that chromosomal and genomic imbalances play a role in the etiology and pathogenesis of autism. However, the incidence and role of genomic imbalances in the autistic brain   the prime target of the disease   have not been addressed. Here, we report on the first evaluation of mosaic aneuplody in the autistic brain. Postmortem brain tissue samples (cerebral cortex and cerebellum) of 12 autistic patients and 12 age /sex  matched controls were provided by the Brain and Tissue Bank for Develop mental disorders, University of Maryland. In the male autistic brain, we ob served statistically significant increase of chromosome X aneuploidy rates in the cerebral cortex and cerebellum (p,0.0166) as compared to control samples. Autistic spectrum disorders currently affect four times as many males as females. Mosaic chromosome X aneuploidy in the brain may help to explain the preponderance of autism among males in addition to specific alterations of the X chromosome genes. We conclude that intercellular geno mic variation manifesting as brain specific low level mosaic aneuploidy is one of the possible genetic factors likely contributing to autism neuropatho logy. Our findings support the hypothesis that somatic genome instability could affect as homeostasis of aneuploid neurons as functioning of the neu ronal network in the whole autistic brain, playing, therefore, an important role in the pathogenesis. Supported by BMBF/DLR (RUS 09/006).",2012.0,,"Y. B. Yurov1,2,3, S. G. Vorsanova2,1,3, A. D. Kolotii2, T . Liehr4, I. Y. Iourov1,2","1Mental Health Research Center, RAMS, Moscow, Russian Federation, 2Institute of  Paediatrics and Paediatric Surgery, Ministry of Health, Moscow, Russian Federation,  3Moscow City University of Psychology and Education, Moscow, Russian Federation,  4Institute of Human Genetics and Anthropology, Jena, Germany","Our findings support the hypothesis that somatic genome instability could affect as homeostasis of aneuploid neurons as functioning of the neu ronal network in the whole autistic brain, playing, therefore, an important role in the pathogenesis.",,autistic brain,[],"['autistic', 'brain']"
324,470,Chromosome kissing in association with the ATR X syndrome,P03.036,,"ATR X (X linked  thalassemia / mental retardation) syndrome is one of the syndromes associated with abnormal epigenetic gene regulation, which  appears males with X linked mental retardation, HbH disease, skeletal ab   normalities, and autistic behavior. ATR X syndrome is caused by a mutation  in the ATRX gene localized on the X chromosome (Xq21.1), which encodes  ATRX protein, one of the chromatin remodeling proteins. However, the  details of molecular mechanism with symptoms of this syndrome are still unknown. Here to learn more about the relationships between nuclear ar chitecture and failure of epigenetic regulation in the ATR X syndrome, we ex   amined characteristics of spatial positioning of following three chromosome arm specific regions by 3D FISH technique; 1) Xq (ATRX gene has mapped on), 2) 16p (HBA has mapped on), and 3) 11p (HBB has mapped on). After  image acquisition by confocal laser scaning microscope, analysis of relative  spatial positioning of three painted regions was performed. The results sho   wed that neighborhood association of particular two chromosome territory  regions called as chromosome kissing was observed with high frequency  between Xq and 16p and between 11p and 16p in cell nuclei from the ATR X syndrome patients, respectively. The frequency of the same combination from the normal individual is approximately halves of them, respectively.  Thus we considered that the spatial arrangement of nuclear architecture  has been affected after one has been attacked with the ATR X syndrome.",2012.0,,"H. Tanabe1, T . Wada2","1The Graduate University for Advanced Studies (Sokendai), Kanagawa, Japan,  2Kanagawa Childrens Medical Center, Kanagawa, Japan","ATR X (X linked  thalassemia / mental retardation) syndrome is one of the syndromes associated with abnormal epigenetic gene regulation, which  appears males with X linked mental retardation, HbH disease, skeletal ab   normalities, and autistic behavior.",,autistic behavior,[],"['autistic', 'behavior']"
326,476," Detection of cryptic chromosome rearrangements by BAC Genome Array CGH in five patients, with normal and/or abnormal karyotypes, associated with Mental Retardation, Autism and/or Epilepsy: new insights for genotype/phenotype correlation",P03.042,,", Cagliari, Italy,  2Experimental Biology Department, Cagliari, Italy., Cagliari, Italy, 3Surgical Sciences  Department, University, Cagliari, Italy., Cagliari, Italy, 4Genetic and Biomedical Research  Institute CNR, Cittadella Universitaria. Monserrato,Cagliari, Italy., Monserrato( Cagliari), Italy. We re examined ten patients with normal and/or abnormal karyotypes and dysmorphic features, associated with Mental Retardation, Autism and/or Epilepsy. We applied a fast BAC Genome Array  CGH platform (Cytochips Blue gnome, Techno genetics   Bouty). Cyto Chips are high quality BAC microarrays (4898 BAC Clones spotted in quadruplicate 0.6 Mb). This ap proach led us to discover further cryptic chromosomal rearrangements, pre viously undetected by conventional cytogenetic procedures. We identified two genes: SLC8A3 (human gene for member 3 of solute carrier family 8), a  sodium calcium exchanger electively expressed in the brain, and a possible candidate gene for Epilepsy (Nucaro et al 2010) and the CSMD1 gene (Cub  and sushi multiple domains 1) a candidate gene for Autism associated with Mental Retardation (MR) and Epilepsy (Nucaro et al 2011). This approach allows us to better delineate the genotype/phenotype correlation in our pa tients. Our experience shows the validity of the BAC platform as a reliable method for genome wide screening of chromosomal aberrations, as well as oligonucleotide based Array CGH, in patients with idiopathic Mental Retar dation and/or in association with Autism and Epilepsy.",2012.0,,"V. Cabras1, A. Milia2, C. Montaldo3, A. Nucaro4","1Experimental Medical Pathology Departement, Cagliari, Italy","Our experience shows the validity of the BAC platform as a reliable method for genome wide screening of chromosomal aberrations, as well as oligonucleotide based Array CGH, in patients with idiopathic Mental Retar dation and/or in association with Autism and Epilepsy.",association with Autism,,"['association', 'with', 'Autism']",[]
332,530, Clinical and molecular characterization of a patient with de novo 0.45 Mb deletion of 2p16.1,P03.102,,"The widespread use of microarray methods has contributed to the identi fication of several new rare microdeletion syndromes including that asso   ciated with deletions of 2p15 p16.1. The 2p15 p16.1 microdeletion syndro me is characterized by developmental delay, intellectual disability, autism, microcephaly, growth retardation, facial abnormalities, disturbed vision and other symptoms. We report here an 11 year old autistic girl showing clinical features consistent with the syndrome. Conventional cytogenetic analysis of the patient showed a normal female karyotype. Illumina HumanCytoSNP 12 BeadChip analysis revealed a 0.45 Mb long deletion of the paternal allele of  2p16.1. FISH analysis confirmed the deletion in the patient but not in any of  her parents. The deleted region contains only 3 protein coding RefSeq ge  nes, BCLA11, PAPOLG and REL, and 1 long non coding RNA gene FLJ16341. Based on high phenotype similarity of our patient with 6 reported patients  showing the typical phenotype of the 2p15 p16.1 microdeletion syndrome  we propose that the critical region of the syndrome can be narrowed down and that these brain expressed genes can be considered candidates for the clinical symptoms. However, multiple deletions of variable length within  the interval between 2p14 and 2p16.1 have been described in patients with  intellectual disability but not necessarily the other typical symptoms of the syndrome and some of these deletions do not overlap. This observati  on indicates that also other genes located in this broader unstable region  are associated with cognitive functioning. Supported by CHERISH 223692, SF0180027s10, CZ.2.16/3.1.00/24022 and MZ0FNM2012.",2012.0,,"M. Hanrov1, M. Simandlov1, J. Drbov1, K. Mnnik2, A. Kurg2, Z. Sedlek1","1Department Of Biology And Medical Genetics, Prague, Czech Republic, 2Institute of  Molecular and Cell Biology, Tartu, Estonia",We report here an 11 year old autistic girl showing clinical features consistent with the syndrome.,,autistic girl,[],"['autistic', 'girl']"
334,552, Molecular screening for subtelomeric aberrations in Thai patients with idiopathic mental retardation and autism by multiplex ligation dependent probe amplification (MLPA),P03.127,,"Chromosomal rearrangements involving telomeres have been identified to account for approximately 5 10% causes of mental retardation (MR). This  finding leads to the suggestion that all cases of undiagnosed MR should be  screened for subtelomeric aberration. Nevertheless, resolution of standard karyotyping using G banding is limited and cannot detect this anomaly.  Therefore, in this study, multiplex ligation dependent probe amplification  (MLPA) technique, was used to screen 129 patients with idiopathic MR.  Twelve of them were also diagnosed with autistic disorder. We identified 5 patients (3.87%) with subtelomeric aberration. All have MR with normal ka ryotypes. One patient has a submicroscopic deletion at 1p36.33 which was  confirmed by real time PCR. There are two patients with subtelomeric du  plication at 15q11.2 and 11p15.5 subsequently. Two patients have the same  duplication at Xp22.33. Results were confirmed by using additional MLPA probes. Parental samples were also examined when available. Interestingly the deletion at 1p36.33 and duplication at Xp22.33 fall into the regions whe  re copy number variation (CNV) have been reported. However the patholo   gic effect of these aberrations is still inconclusive. Further characterization  of these aberration boundaries and screening in normal population should be performed. Nonetheless this study shows that MLPA technique is able to detect subtelomeric aberration in patients with idiopathic MR and may  increase diagnostic yield especially where array facility is unavailable.",2012.0,,"S. Rujirabanjerd, O. Plong on, T . Sripo, P . Limprasert","Faculty of Medicine, Prince of Songkla University, Hat Yai, Songkhla, Thailand","Therefore, in this study, multiplex ligation dependent probe amplification  (MLPA) technique, was used to screen 129 patients with idiopathic MR.  Twelve of them were also diagnosed with autistic disorder.",,autistic disorder,[],"['autistic', 'disorder']"
342,957, Identifying phenotypes and exploring genetic aetiology of autism spectrum disorders : a 87 patient study.,P09.026,,"Autism is characterized by limited verbal communication, lack of recipro cal social interaction, and stereotypical behaviour affecting preferentially Boys. Mental retardation and or seizures coexists in two thirds of patients. Autistic spectrum disorders are complex multifactorial disorders involving various genes, and many aetiologic diagnosis remain unravelled.We report a collaborative study between our Genetic Department and the Autism Center (CRA). A population of 87 children with autism was selec ted. We identified 5 different phenotypic groups (8 32 children per group), using the behaviour and the intellectual efficiency evaluation criteria from the following tests PER R, CARST , and ADIR.Among them 45 patients (6  14 per group) were negative for FMR1 ampli   fication and then tested by array CGH (180K) to search for deleterious chro mosomal rearrangements. The Array CGH analysis showed the presence of 49 copy number variants (CNV) not referred as polymorphisms in 28 child ren with an average of 2 CNV per patient. A deleterious CNV was found in 5 children from 4 different groups. A parental study was done in 10 families for 14 aberrations : 12 rearrangements were inherited and 2 were de novo with a 6q26 deletion (gene PACRG) and an isochromosome Yp (deletion of NLGN4Y) both considered of uncertain clinical significance (VOUS). Five CNVs were previously reported in autism: 1q21.1,3p26.3q26.2 (CNTN4), 15q13.3 (CHRNA7), 16p11.2 and Xp22.31. Three aberrations in 3p26 (dup) and Xp22 (del/dup) seemed more specific to autism as not present in our cohort of 400 patients with intellectual disability.In conclusion, the aetiologic diagnosis was found in 11% of autistic child ren.",2012.0,,"E. Landais1, N. Golovkine2, R. Dard1, F. Lempp1, N. Bednarek1, S. Godet2, R. Senezuk2, A.  Lannoy1, P . Jonveaux3, M. Beri3, C. Bonnet3, M. Valduga3, J. Motte1, G. Schmit2, D. Gaillard1,  M. Doco.Fenzy1","1CHU Reims, Reims, France, 2Centre de Ressource Autisme, Reims, France, 3CHU Nancy,  Nancy, France","Autistic spectrum disorders are complex multifactorial disorders involving various genes, and many aetiologic diagnosis remain unravelled.We report a collaborative study between our Genetic Department and the Autism Center (CRA).",,Autistic spectrum,[],"['Autistic', 'spectrum']"
342,957, Identifying phenotypes and exploring genetic aetiology of autism spectrum disorders : a 87 patient study.,P09.026,,"Autism is characterized by limited verbal communication, lack of recipro cal social interaction, and stereotypical behaviour affecting preferentially Boys. Mental retardation and or seizures coexists in two thirds of patients. Autistic spectrum disorders are complex multifactorial disorders involving various genes, and many aetiologic diagnosis remain unravelled.We report a collaborative study between our Genetic Department and the Autism Center (CRA). A population of 87 children with autism was selec ted. We identified 5 different phenotypic groups (8 32 children per group), using the behaviour and the intellectual efficiency evaluation criteria from the following tests PER R, CARST , and ADIR.Among them 45 patients (6  14 per group) were negative for FMR1 ampli   fication and then tested by array CGH (180K) to search for deleterious chro mosomal rearrangements. The Array CGH analysis showed the presence of 49 copy number variants (CNV) not referred as polymorphisms in 28 child ren with an average of 2 CNV per patient. A deleterious CNV was found in 5 children from 4 different groups. A parental study was done in 10 families for 14 aberrations : 12 rearrangements were inherited and 2 were de novo with a 6q26 deletion (gene PACRG) and an isochromosome Yp (deletion of NLGN4Y) both considered of uncertain clinical significance (VOUS). Five CNVs were previously reported in autism: 1q21.1,3p26.3q26.2 (CNTN4), 15q13.3 (CHRNA7), 16p11.2 and Xp22.31. Three aberrations in 3p26 (dup) and Xp22 (del/dup) seemed more specific to autism as not present in our cohort of 400 patients with intellectual disability.In conclusion, the aetiologic diagnosis was found in 11% of autistic child ren.",2012.0,,"E. Landais1, N. Golovkine2, R. Dard1, F. Lempp1, N. Bednarek1, S. Godet2, R. Senezuk2, A.  Lannoy1, P . Jonveaux3, M. Beri3, C. Bonnet3, M. Valduga3, J. Motte1, G. Schmit2, D. Gaillard1,  M. Doco.Fenzy1","1CHU Reims, Reims, France, 2Centre de Ressource Autisme, Reims, France, 3CHU Nancy,  Nancy, France",A population of 87 children with autism was selec ted.,children with autism,,"['child', 'with', 'autism']",[]
342,957, Identifying phenotypes and exploring genetic aetiology of autism spectrum disorders : a 87 patient study.,P09.026,,"Autism is characterized by limited verbal communication, lack of recipro cal social interaction, and stereotypical behaviour affecting preferentially Boys. Mental retardation and or seizures coexists in two thirds of patients. Autistic spectrum disorders are complex multifactorial disorders involving various genes, and many aetiologic diagnosis remain unravelled.We report a collaborative study between our Genetic Department and the Autism Center (CRA). A population of 87 children with autism was selec ted. We identified 5 different phenotypic groups (8 32 children per group), using the behaviour and the intellectual efficiency evaluation criteria from the following tests PER R, CARST , and ADIR.Among them 45 patients (6  14 per group) were negative for FMR1 ampli   fication and then tested by array CGH (180K) to search for deleterious chro mosomal rearrangements. The Array CGH analysis showed the presence of 49 copy number variants (CNV) not referred as polymorphisms in 28 child ren with an average of 2 CNV per patient. A deleterious CNV was found in 5 children from 4 different groups. A parental study was done in 10 families for 14 aberrations : 12 rearrangements were inherited and 2 were de novo with a 6q26 deletion (gene PACRG) and an isochromosome Yp (deletion of NLGN4Y) both considered of uncertain clinical significance (VOUS). Five CNVs were previously reported in autism: 1q21.1,3p26.3q26.2 (CNTN4), 15q13.3 (CHRNA7), 16p11.2 and Xp22.31. Three aberrations in 3p26 (dup) and Xp22 (del/dup) seemed more specific to autism as not present in our cohort of 400 patients with intellectual disability.In conclusion, the aetiologic diagnosis was found in 11% of autistic child ren.",2012.0,,"E. Landais1, N. Golovkine2, R. Dard1, F. Lempp1, N. Bednarek1, S. Godet2, R. Senezuk2, A.  Lannoy1, P . Jonveaux3, M. Beri3, C. Bonnet3, M. Valduga3, J. Motte1, G. Schmit2, D. Gaillard1,  M. Doco.Fenzy1","1CHU Reims, Reims, France, 2Centre de Ressource Autisme, Reims, France, 3CHU Nancy,  Nancy, France","Three aberrations in 3p26 (dup) and Xp22 (del/dup) seemed more specific to autism as not present in our cohort of 400 patients with intellectual disability.In conclusion, the aetiologic diagnosis was found in 11% of autistic child ren.",,autistic child,[],"['autistic', 'child']"
343,958, A 3 year old patient with autism and microdeletion in the KIAA0442 (AUTS2 ) gene,P09.027,,"A 2 10/12  year  old boy with bilateral cleft lip and cleft palate as well as de   velopmental delay was presented to our genetics clinic. He is the first child of non consanguineous healthy parents. He shows behavioural patterns of   Abstracts   European Human Genetics Conference 2012 www.eshg.org224 ESHG Posters www.eshg.orgthe autism spectrum which include avoiding eye contact, no response to his  name, playing alone and stereotyped movements when listening to music.  His postnatal chromosomal analysis revealed a normal male karyotype  46,XY.Array CGH analysis showed a microdeletion of 170 kb: arr (7q11.22) (70,077,607 70,247,036)x1 dn. This part of the chromosome contains exons  6 15 of the 19 exons spanning the AUTS2   gene. His parents do not carry this  microdeletion, indicating that it was a de novo event.Autism spectrum disorder (ASD, OMIM 209850) encompasses different  forms of autism with a broader phenotype. Two thirds of all patients with  ASD suffer from mental retardation. Among the genes involved, AUTS2  dis  ruption has been described in 7 patients with ASD and mental retardation.  In all of these seven patients translocations with different breakpoints bet   ween exon 1 and 7 and different translocation partners were the underlying  mechanism of the disruption. Additionally other genes were disrupted ac  cording to the breakpoint of the partner chromosome. Our patient shares  the same symptoms as the 7 patients with translocation, indicating that disturbed function of AUTS2  and not the truncated translocation partner  causes the clinical presentation of the patients.",2012.0,,"C. Huebner1, D. Steinemann2, J. Schmidtke1, M. Arslan Kirchner1","1Institute of Human Genetics, Hannover Medical School, Hannover, Germany, 2Institute  for Cellular and Molecular Pathology, Hannover Medical School, Hannover, Germany","Among the genes involved, AUTS2  dis  ruption has been described in 7 patients with ASD and mental retardation.",patients with ASD,,"['patient', 'with', 'ASD']",[]
344,959, Contribution of rare and common variants of the PTCHD1 gene to Autism Spectrum Disorder and Intellectual Disability,P09.028,,"Autism is a severe neurodevelopmental disorder, characterized by impaired verbal communication, limited reciprocal social interaction, restricted inte rests and repetitive behavior, often accompanied by intellectual disability (ID). Although it is one of the most heritable neuropsychiatric disorders, the underlying genetic factors remain largely unknown.A recent study reported rare mutations in the X linked gene PTCHD1 (pat   ched domain containing protein 1)in patients with autism spectrum disor   der (ASD) and ID (Noor et al. 2010), suggesting a possible role of this gene  in cognitive development. PTCHD1 is highly expressed in brain regions and  encodes a transmembrane protein containing a patched related domain. It has been suggested that PTCHD1 plays a role in the hedgehog signaling pa  thway.In this study we aimed to investigate the possible contribution of common variants in PTCHD1 to ASD through a case control association study. The  study sample consisted of 595 Caucasian autistic patients (270 Spanish, 247 Dutch and 78 German) and 680 gender matched controls (320 Spanish, 269 Dutch and 82 German). Twenty eight tagSNPs were selected on the basis of linkage disequilibrium (LD) patterns. A significant association, that over   came the Bonferroni correction for multiple testing and permutations was obtained with the marker rs7052177 (p, 6.13e 4). Furthermore, in order to evaluate the possible participation of PTCHD1 rare variants in ASD and  ID, we are currently performing a mutation screening in the Spanish ASD cohort, and in an additional sample of 200 individuals with ID. The prelimi nary results of this study support the involvement of this gene in autism and cognitive impairments.",2012.0,,"B. Torrico1,2, A. Hervs3, B. Franke4, J. Buitelaar5, C. Freitag6, A. Reif7, M. Maristany8, M.  Mil9, C. Toma1,2, B. Cormand1,2","1Department of Genetics, University of Barcelona, Barcelona, Spain, 2Biomedical  Network Research Centre on Rare Diseases (CIBERER), Barcelona, Spain, 3Child and  Adolescent Mental Health Unit, Hospital Universitari Mtua de Terrassa, Terrassa, Spain,  4Departments of Human Genetics and Psychiatry, Donders Institute for Brain, Cognition  and Behaviour, Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands,  5Department of Cognitive Neuroscience, Donders Institute for Brain, Cognition and  Behaviour, Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands,  6Department of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy,  JW Goethe University Frankfurt am Main, Frankfurt am Main, Germany, 7Department of  Psychiatry, Psychosomatics, and Psychotherapy, University of Wuerzburg, Wuerzburg, Germany,  8Developmental Disorders Unit (UETD), Hospital Sant Joan de Du, Esplugues  de Llobregat,, Barcelona, Spain, 9Biochemistry and Molecular Genetics Department,  Biochemical Diagnosis Centre, Hospital Clinic, Barcelona, Spain","Although it is one of the most heritable neuropsychiatric disorders, the underlying genetic factors remain largely unknown.A recent study reported rare mutations in the X linked gene PTCHD1 (pat   ched domain containing protein 1)in patients with autism spectrum disor   der (ASD) and ID (Noor et al.",patients with autism,,"['patient', 'with', 'autism']",[]
344,959, Contribution of rare and common variants of the PTCHD1 gene to Autism Spectrum Disorder and Intellectual Disability,P09.028,,"Autism is a severe neurodevelopmental disorder, characterized by impaired verbal communication, limited reciprocal social interaction, restricted inte rests and repetitive behavior, often accompanied by intellectual disability (ID). Although it is one of the most heritable neuropsychiatric disorders, the underlying genetic factors remain largely unknown.A recent study reported rare mutations in the X linked gene PTCHD1 (pat   ched domain containing protein 1)in patients with autism spectrum disor   der (ASD) and ID (Noor et al. 2010), suggesting a possible role of this gene  in cognitive development. PTCHD1 is highly expressed in brain regions and  encodes a transmembrane protein containing a patched related domain. It has been suggested that PTCHD1 plays a role in the hedgehog signaling pa  thway.In this study we aimed to investigate the possible contribution of common variants in PTCHD1 to ASD through a case control association study. The  study sample consisted of 595 Caucasian autistic patients (270 Spanish, 247 Dutch and 78 German) and 680 gender matched controls (320 Spanish, 269 Dutch and 82 German). Twenty eight tagSNPs were selected on the basis of linkage disequilibrium (LD) patterns. A significant association, that over   came the Bonferroni correction for multiple testing and permutations was obtained with the marker rs7052177 (p, 6.13e 4). Furthermore, in order to evaluate the possible participation of PTCHD1 rare variants in ASD and  ID, we are currently performing a mutation screening in the Spanish ASD cohort, and in an additional sample of 200 individuals with ID. The prelimi nary results of this study support the involvement of this gene in autism and cognitive impairments.",2012.0,,"B. Torrico1,2, A. Hervs3, B. Franke4, J. Buitelaar5, C. Freitag6, A. Reif7, M. Maristany8, M.  Mil9, C. Toma1,2, B. Cormand1,2","1Department of Genetics, University of Barcelona, Barcelona, Spain, 2Biomedical  Network Research Centre on Rare Diseases (CIBERER), Barcelona, Spain, 3Child and  Adolescent Mental Health Unit, Hospital Universitari Mtua de Terrassa, Terrassa, Spain,  4Departments of Human Genetics and Psychiatry, Donders Institute for Brain, Cognition  and Behaviour, Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands,  5Department of Cognitive Neuroscience, Donders Institute for Brain, Cognition and  Behaviour, Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands,  6Department of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy,  JW Goethe University Frankfurt am Main, Frankfurt am Main, Germany, 7Department of  Psychiatry, Psychosomatics, and Psychotherapy, University of Wuerzburg, Wuerzburg, Germany,  8Developmental Disorders Unit (UETD), Hospital Sant Joan de Du, Esplugues  de Llobregat,, Barcelona, Spain, 9Biochemistry and Molecular Genetics Department,  Biochemical Diagnosis Centre, Hospital Clinic, Barcelona, Spain","The  study sample consisted of 595 Caucasian autistic patients (270 Spanish, 247 Dutch and 78 German) and 680 gender matched controls (320 Spanish, 269 Dutch and 82 German).",,autistic patients,[],"['autistic', 'patient']"
344,959, Contribution of rare and common variants of the PTCHD1 gene to Autism Spectrum Disorder and Intellectual Disability,P09.028,,"Autism is a severe neurodevelopmental disorder, characterized by impaired verbal communication, limited reciprocal social interaction, restricted inte rests and repetitive behavior, often accompanied by intellectual disability (ID). Although it is one of the most heritable neuropsychiatric disorders, the underlying genetic factors remain largely unknown.A recent study reported rare mutations in the X linked gene PTCHD1 (pat   ched domain containing protein 1)in patients with autism spectrum disor   der (ASD) and ID (Noor et al. 2010), suggesting a possible role of this gene  in cognitive development. PTCHD1 is highly expressed in brain regions and  encodes a transmembrane protein containing a patched related domain. It has been suggested that PTCHD1 plays a role in the hedgehog signaling pa  thway.In this study we aimed to investigate the possible contribution of common variants in PTCHD1 to ASD through a case control association study. The  study sample consisted of 595 Caucasian autistic patients (270 Spanish, 247 Dutch and 78 German) and 680 gender matched controls (320 Spanish, 269 Dutch and 82 German). Twenty eight tagSNPs were selected on the basis of linkage disequilibrium (LD) patterns. A significant association, that over   came the Bonferroni correction for multiple testing and permutations was obtained with the marker rs7052177 (p, 6.13e 4). Furthermore, in order to evaluate the possible participation of PTCHD1 rare variants in ASD and  ID, we are currently performing a mutation screening in the Spanish ASD cohort, and in an additional sample of 200 individuals with ID. The prelimi nary results of this study support the involvement of this gene in autism and cognitive impairments.",2012.0,,"B. Torrico1,2, A. Hervs3, B. Franke4, J. Buitelaar5, C. Freitag6, A. Reif7, M. Maristany8, M.  Mil9, C. Toma1,2, B. Cormand1,2","1Department of Genetics, University of Barcelona, Barcelona, Spain, 2Biomedical  Network Research Centre on Rare Diseases (CIBERER), Barcelona, Spain, 3Child and  Adolescent Mental Health Unit, Hospital Universitari Mtua de Terrassa, Terrassa, Spain,  4Departments of Human Genetics and Psychiatry, Donders Institute for Brain, Cognition  and Behaviour, Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands,  5Department of Cognitive Neuroscience, Donders Institute for Brain, Cognition and  Behaviour, Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands,  6Department of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy,  JW Goethe University Frankfurt am Main, Frankfurt am Main, Germany, 7Department of  Psychiatry, Psychosomatics, and Psychotherapy, University of Wuerzburg, Wuerzburg, Germany,  8Developmental Disorders Unit (UETD), Hospital Sant Joan de Du, Esplugues  de Llobregat,, Barcelona, Spain, 9Biochemistry and Molecular Genetics Department,  Biochemical Diagnosis Centre, Hospital Clinic, Barcelona, Spain","Furthermore, in order to evaluate the possible participation of PTCHD1 rare variants in ASD and  ID, we are currently performing a mutation screening in the Spanish ASD cohort, and in an additional sample of 200 individuals with ID.",,ASD cohort,[],"['ASD', 'cohort']"
345,960," Mirror effects for Autism Spectrum Disorder due to gene dosage at 10q11.22 affecting GPRIN2 gene, a regulator of neurite outgrowth and PPYR1 gene involved in energy homeostasis.",P09.030,,", Madrid, Spain. We recently reported that a small duplication on 10q11.22 including  GPRIN2 gene, a regulator of neurite outgrowth, and PPYR1, a gene involved in energy homeostasis is a candidate modifier for Rett syndrome. Specifi   cally, duplications were found in the Zappella variant, the Rett variant with recovery of speech, and lacking the typical growth delay, underweighting and autistic features. Since PPYR1 knockout mice display underweight and reduced white adipose tissue an overexpression of PPYR1 due to gene du plication may be responsible for the higher body weight characterizing Zap pella variant. We concluded that duplication at 10q11.22 may play a role in protecting from both underweighting and autistic features in Rett patients. We now report more convincing evidences that dosage balance at GPRIN2 locus plays a role in autism spectrum disorders (ASD). We observed 6 pati   ents affected by ASD with an overlapping small deletion including the two genes (and extending to MAPK8 in one patient). We then compared a group of 164 ASD patients with a group of 180 syndromic and non syndromic intel lectual deficit (SID/NSID) patients and 160 controls. Seven deletions were identified in the ASD group. On the contrary, no deletion has were found in SID/NSID nor in control group (p,0,005 and p,0,008). We are currently extending this study to a second cohort including about 100 ASD patients and 135 SID/NSID. Overall, these data suggest that gene dosage at 10q11.22 affecting GPRIN2 gene may have mirror effects being duplication protective and deletion prone to ASD.",2012.0,,"V. Disciglio1, M. Fichera2,3, R. Ciccone4, M. Mucciolo1, E. Ndoni1, A. Fernndez Jan5,  O. Galesi2, M. Vinci2, P . Failla2, M. A. Mencarelli1, C. Lo Rizzo1, F. Mari1, O. Zuffardi4, C.  Romano2, A. Renieri1","1Medical Genetics Unit, Biotechnology Department, University of Siena, Siena, Italy,  2Laboratory of Genetics Diagnosis, IRCCS Oasi SS Maria,, Troina, Italy, 3Medical Genetics,  University of Catania, Catania, Italy, 4Biologia Generale e Genetica Medica, Universita  degli Studi di Pavia, Pavia, Italy, 5Unidad de Neurologa Infanto juvenil Hospital  Universitario Quirn Centro CADE","Specifi   cally, duplications were found in the Zappella variant, the Rett variant with recovery of speech, and lacking the typical growth delay, underweighting and autistic features.",,autistic features,[],"['autistic', 'feature']"
345,960," Mirror effects for Autism Spectrum Disorder due to gene dosage at 10q11.22 affecting GPRIN2 gene, a regulator of neurite outgrowth and PPYR1 gene involved in energy homeostasis.",P09.030,,", Madrid, Spain. We recently reported that a small duplication on 10q11.22 including  GPRIN2 gene, a regulator of neurite outgrowth, and PPYR1, a gene involved in energy homeostasis is a candidate modifier for Rett syndrome. Specifi   cally, duplications were found in the Zappella variant, the Rett variant with recovery of speech, and lacking the typical growth delay, underweighting and autistic features. Since PPYR1 knockout mice display underweight and reduced white adipose tissue an overexpression of PPYR1 due to gene du plication may be responsible for the higher body weight characterizing Zap pella variant. We concluded that duplication at 10q11.22 may play a role in protecting from both underweighting and autistic features in Rett patients. We now report more convincing evidences that dosage balance at GPRIN2 locus plays a role in autism spectrum disorders (ASD). We observed 6 pati   ents affected by ASD with an overlapping small deletion including the two genes (and extending to MAPK8 in one patient). We then compared a group of 164 ASD patients with a group of 180 syndromic and non syndromic intel lectual deficit (SID/NSID) patients and 160 controls. Seven deletions were identified in the ASD group. On the contrary, no deletion has were found in SID/NSID nor in control group (p,0,005 and p,0,008). We are currently extending this study to a second cohort including about 100 ASD patients and 135 SID/NSID. Overall, these data suggest that gene dosage at 10q11.22 affecting GPRIN2 gene may have mirror effects being duplication protective and deletion prone to ASD.",2012.0,,"V. Disciglio1, M. Fichera2,3, R. Ciccone4, M. Mucciolo1, E. Ndoni1, A. Fernndez Jan5,  O. Galesi2, M. Vinci2, P . Failla2, M. A. Mencarelli1, C. Lo Rizzo1, F. Mari1, O. Zuffardi4, C.  Romano2, A. Renieri1","1Medical Genetics Unit, Biotechnology Department, University of Siena, Siena, Italy,  2Laboratory of Genetics Diagnosis, IRCCS Oasi SS Maria,, Troina, Italy, 3Medical Genetics,  University of Catania, Catania, Italy, 4Biologia Generale e Genetica Medica, Universita  degli Studi di Pavia, Pavia, Italy, 5Unidad de Neurologa Infanto juvenil Hospital  Universitario Quirn Centro CADE",We concluded that duplication at 10q11.22 may play a role in protecting from both underweighting and autistic features in Rett patients.,,autistic features,[],"['autistic', 'feature']"
345,960," Mirror effects for Autism Spectrum Disorder due to gene dosage at 10q11.22 affecting GPRIN2 gene, a regulator of neurite outgrowth and PPYR1 gene involved in energy homeostasis.",P09.030,,", Madrid, Spain. We recently reported that a small duplication on 10q11.22 including  GPRIN2 gene, a regulator of neurite outgrowth, and PPYR1, a gene involved in energy homeostasis is a candidate modifier for Rett syndrome. Specifi   cally, duplications were found in the Zappella variant, the Rett variant with recovery of speech, and lacking the typical growth delay, underweighting and autistic features. Since PPYR1 knockout mice display underweight and reduced white adipose tissue an overexpression of PPYR1 due to gene du plication may be responsible for the higher body weight characterizing Zap pella variant. We concluded that duplication at 10q11.22 may play a role in protecting from both underweighting and autistic features in Rett patients. We now report more convincing evidences that dosage balance at GPRIN2 locus plays a role in autism spectrum disorders (ASD). We observed 6 pati   ents affected by ASD with an overlapping small deletion including the two genes (and extending to MAPK8 in one patient). We then compared a group of 164 ASD patients with a group of 180 syndromic and non syndromic intel lectual deficit (SID/NSID) patients and 160 controls. Seven deletions were identified in the ASD group. On the contrary, no deletion has were found in SID/NSID nor in control group (p,0,005 and p,0,008). We are currently extending this study to a second cohort including about 100 ASD patients and 135 SID/NSID. Overall, these data suggest that gene dosage at 10q11.22 affecting GPRIN2 gene may have mirror effects being duplication protective and deletion prone to ASD.",2012.0,,"V. Disciglio1, M. Fichera2,3, R. Ciccone4, M. Mucciolo1, E. Ndoni1, A. Fernndez Jan5,  O. Galesi2, M. Vinci2, P . Failla2, M. A. Mencarelli1, C. Lo Rizzo1, F. Mari1, O. Zuffardi4, C.  Romano2, A. Renieri1","1Medical Genetics Unit, Biotechnology Department, University of Siena, Siena, Italy,  2Laboratory of Genetics Diagnosis, IRCCS Oasi SS Maria,, Troina, Italy, 3Medical Genetics,  University of Catania, Catania, Italy, 4Biologia Generale e Genetica Medica, Universita  degli Studi di Pavia, Pavia, Italy, 5Unidad de Neurologa Infanto juvenil Hospital  Universitario Quirn Centro CADE",We then compared a group of 164 ASD patients with a group of 180 syndromic and non syndromic intel lectual deficit (SID/NSID) patients and 160 controls.,,ASD patients,[],"['ASD', 'patient']"
345,960," Mirror effects for Autism Spectrum Disorder due to gene dosage at 10q11.22 affecting GPRIN2 gene, a regulator of neurite outgrowth and PPYR1 gene involved in energy homeostasis.",P09.030,,", Madrid, Spain. We recently reported that a small duplication on 10q11.22 including  GPRIN2 gene, a regulator of neurite outgrowth, and PPYR1, a gene involved in energy homeostasis is a candidate modifier for Rett syndrome. Specifi   cally, duplications were found in the Zappella variant, the Rett variant with recovery of speech, and lacking the typical growth delay, underweighting and autistic features. Since PPYR1 knockout mice display underweight and reduced white adipose tissue an overexpression of PPYR1 due to gene du plication may be responsible for the higher body weight characterizing Zap pella variant. We concluded that duplication at 10q11.22 may play a role in protecting from both underweighting and autistic features in Rett patients. We now report more convincing evidences that dosage balance at GPRIN2 locus plays a role in autism spectrum disorders (ASD). We observed 6 pati   ents affected by ASD with an overlapping small deletion including the two genes (and extending to MAPK8 in one patient). We then compared a group of 164 ASD patients with a group of 180 syndromic and non syndromic intel lectual deficit (SID/NSID) patients and 160 controls. Seven deletions were identified in the ASD group. On the contrary, no deletion has were found in SID/NSID nor in control group (p,0,005 and p,0,008). We are currently extending this study to a second cohort including about 100 ASD patients and 135 SID/NSID. Overall, these data suggest that gene dosage at 10q11.22 affecting GPRIN2 gene may have mirror effects being duplication protective and deletion prone to ASD.",2012.0,,"V. Disciglio1, M. Fichera2,3, R. Ciccone4, M. Mucciolo1, E. Ndoni1, A. Fernndez Jan5,  O. Galesi2, M. Vinci2, P . Failla2, M. A. Mencarelli1, C. Lo Rizzo1, F. Mari1, O. Zuffardi4, C.  Romano2, A. Renieri1","1Medical Genetics Unit, Biotechnology Department, University of Siena, Siena, Italy,  2Laboratory of Genetics Diagnosis, IRCCS Oasi SS Maria,, Troina, Italy, 3Medical Genetics,  University of Catania, Catania, Italy, 4Biologia Generale e Genetica Medica, Universita  degli Studi di Pavia, Pavia, Italy, 5Unidad de Neurologa Infanto juvenil Hospital  Universitario Quirn Centro CADE",Seven deletions were identified in the ASD group.,,ASD group,[],"['ASD', 'group']"
345,960," Mirror effects for Autism Spectrum Disorder due to gene dosage at 10q11.22 affecting GPRIN2 gene, a regulator of neurite outgrowth and PPYR1 gene involved in energy homeostasis.",P09.030,,", Madrid, Spain. We recently reported that a small duplication on 10q11.22 including  GPRIN2 gene, a regulator of neurite outgrowth, and PPYR1, a gene involved in energy homeostasis is a candidate modifier for Rett syndrome. Specifi   cally, duplications were found in the Zappella variant, the Rett variant with recovery of speech, and lacking the typical growth delay, underweighting and autistic features. Since PPYR1 knockout mice display underweight and reduced white adipose tissue an overexpression of PPYR1 due to gene du plication may be responsible for the higher body weight characterizing Zap pella variant. We concluded that duplication at 10q11.22 may play a role in protecting from both underweighting and autistic features in Rett patients. We now report more convincing evidences that dosage balance at GPRIN2 locus plays a role in autism spectrum disorders (ASD). We observed 6 pati   ents affected by ASD with an overlapping small deletion including the two genes (and extending to MAPK8 in one patient). We then compared a group of 164 ASD patients with a group of 180 syndromic and non syndromic intel lectual deficit (SID/NSID) patients and 160 controls. Seven deletions were identified in the ASD group. On the contrary, no deletion has were found in SID/NSID nor in control group (p,0,005 and p,0,008). We are currently extending this study to a second cohort including about 100 ASD patients and 135 SID/NSID. Overall, these data suggest that gene dosage at 10q11.22 affecting GPRIN2 gene may have mirror effects being duplication protective and deletion prone to ASD.",2012.0,,"V. Disciglio1, M. Fichera2,3, R. Ciccone4, M. Mucciolo1, E. Ndoni1, A. Fernndez Jan5,  O. Galesi2, M. Vinci2, P . Failla2, M. A. Mencarelli1, C. Lo Rizzo1, F. Mari1, O. Zuffardi4, C.  Romano2, A. Renieri1","1Medical Genetics Unit, Biotechnology Department, University of Siena, Siena, Italy,  2Laboratory of Genetics Diagnosis, IRCCS Oasi SS Maria,, Troina, Italy, 3Medical Genetics,  University of Catania, Catania, Italy, 4Biologia Generale e Genetica Medica, Universita  degli Studi di Pavia, Pavia, Italy, 5Unidad de Neurologa Infanto juvenil Hospital  Universitario Quirn Centro CADE",We are currently extending this study to a second cohort including about 100 ASD patients and 135 SID/NSID.,,ASD patients,[],"['ASD', 'patient']"
347,973," SNP association of CNTN4, CNTN5, CNTN6, CHL1 and GRIN2B corroborates and extends copy number variation data in autism",P09.044,,"Research into the genetics of neurobehavioral disorders such as autism spectrum disorder (ASD) is caught within the dichotomy of rare variants with a high phenotypic impact, such as copy number variations (CNVs), vs. common variants with a low effect size. To overcome this (false) dichoto my and to find missed heritability we performed an association study on candidate genes, which we had previously identified by SNP array based CNV analyses in ASD patients (Neurogenetics (2011) 12, 315). Within these CNVs, genes with clear expression in the brain were selected. In total we examined 2,042 SNPs, spanning 16 Mb of genomic DNA, which were located   Abstracts   European Human Genetics Conference 2012 www.eshg.org228 ESHG Posters www.eshg.orgwithin or immediately bordering these genes. We compared a cohort of 74  ASD patients without relevant CNVs with a population based cohort of 132  healthy individuals that were not related to the ASD families. After Bonfer   roni correction for multiple testing we found significant association for one  SNP within intron 11 of CNTN4  (rs1420021), two SNPs within intron 7 and  9 of CNTN5 (rs6590473 and rs11222599), one SNP within intron 1 of CHL1  (rs17329247), one SNP within intron 1 of CNTN6  (rs9878022), and 5 SNPs  flanking exon 4 of GRIN2B . Our data corroborate involvement of contactins  in ASD as indicated by our previous CNV study and indicate that certain  genes may harbour variants with both high penetrance and with a smaller  degree of effect for the same phenotype.",2012.0,,"M. Poot, C. G. de Kovel","Department of Medical Genetics, Utrecht, Netherlands","To overcome this (false) dichoto my and to find missed heritability we performed an association study on candidate genes, which we had previously identified by SNP array based CNV analyses in ASD patients (Neurogenetics (2011) 12, 315).",,ASD patients,[],"['ASD', 'patient']"
347,973," SNP association of CNTN4, CNTN5, CNTN6, CHL1 and GRIN2B corroborates and extends copy number variation data in autism",P09.044,,"Research into the genetics of neurobehavioral disorders such as autism spectrum disorder (ASD) is caught within the dichotomy of rare variants with a high phenotypic impact, such as copy number variations (CNVs), vs. common variants with a low effect size. To overcome this (false) dichoto my and to find missed heritability we performed an association study on candidate genes, which we had previously identified by SNP array based CNV analyses in ASD patients (Neurogenetics (2011) 12, 315). Within these CNVs, genes with clear expression in the brain were selected. In total we examined 2,042 SNPs, spanning 16 Mb of genomic DNA, which were located   Abstracts   European Human Genetics Conference 2012 www.eshg.org228 ESHG Posters www.eshg.orgwithin or immediately bordering these genes. We compared a cohort of 74  ASD patients without relevant CNVs with a population based cohort of 132  healthy individuals that were not related to the ASD families. After Bonfer   roni correction for multiple testing we found significant association for one  SNP within intron 11 of CNTN4  (rs1420021), two SNPs within intron 7 and  9 of CNTN5 (rs6590473 and rs11222599), one SNP within intron 1 of CHL1  (rs17329247), one SNP within intron 1 of CNTN6  (rs9878022), and 5 SNPs  flanking exon 4 of GRIN2B . Our data corroborate involvement of contactins  in ASD as indicated by our previous CNV study and indicate that certain  genes may harbour variants with both high penetrance and with a smaller  degree of effect for the same phenotype.",2012.0,,"M. Poot, C. G. de Kovel","Department of Medical Genetics, Utrecht, Netherlands",We compared a cohort of 74  ASD patients without relevant CNVs with a population based cohort of 132  healthy individuals that were not related to the ASD families.,,ASD patients,[],"['ASD', 'patient']"
347,973," SNP association of CNTN4, CNTN5, CNTN6, CHL1 and GRIN2B corroborates and extends copy number variation data in autism",P09.044,,"Research into the genetics of neurobehavioral disorders such as autism spectrum disorder (ASD) is caught within the dichotomy of rare variants with a high phenotypic impact, such as copy number variations (CNVs), vs. common variants with a low effect size. To overcome this (false) dichoto my and to find missed heritability we performed an association study on candidate genes, which we had previously identified by SNP array based CNV analyses in ASD patients (Neurogenetics (2011) 12, 315). Within these CNVs, genes with clear expression in the brain were selected. In total we examined 2,042 SNPs, spanning 16 Mb of genomic DNA, which were located   Abstracts   European Human Genetics Conference 2012 www.eshg.org228 ESHG Posters www.eshg.orgwithin or immediately bordering these genes. We compared a cohort of 74  ASD patients without relevant CNVs with a population based cohort of 132  healthy individuals that were not related to the ASD families. After Bonfer   roni correction for multiple testing we found significant association for one  SNP within intron 11 of CNTN4  (rs1420021), two SNPs within intron 7 and  9 of CNTN5 (rs6590473 and rs11222599), one SNP within intron 1 of CHL1  (rs17329247), one SNP within intron 1 of CNTN6  (rs9878022), and 5 SNPs  flanking exon 4 of GRIN2B . Our data corroborate involvement of contactins  in ASD as indicated by our previous CNV study and indicate that certain  genes may harbour variants with both high penetrance and with a smaller  degree of effect for the same phenotype.",2012.0,,"M. Poot, C. G. de Kovel","Department of Medical Genetics, Utrecht, Netherlands",We compared a cohort of 74  ASD patients without relevant CNVs with a population based cohort of 132  healthy individuals that were not related to the ASD families.,,ASD families,[],"['ASD', 'family']"
353,1217, Excess of novel nonsense mutations identified in putative susceptibility genes for schizophrenia and autism spectrum disorders,P11.117,,"Schizophrenia (SZ) and autism spectrum disorders (ASD) are complex ge  netic neurodevelopmental disorders that share certain phenotypes (e.g.  cognitive deficits), and may share an underlying pathology due to shared  genetic risk variants (e.g. already identified NRXN1). This study involves next generation sequencing of the exonic regions of 215 putative suscep   tibility genes in an Irish sample of 151 cases of ASD, 274 cases of SZ and 287 controls, to identify rare mutations contributing to one or both disor   ders. A multiplex target enrichment method combined DNA samples using indexes/barcodes followed by enrichment of exonic regions using Agilent  SureSelect and paired end sequencing on an Illumina GAII. Selected genes  were categorised as: 1) NRXN1 and interactors, 2) Postsynaptic Glutamate Receptor Complexes (NMDA, mGluR5 and AMPA), 3) Neural cell adhesion molecules, 4) DISC1 and interactors, and 5) Functional and Positional Can didates. Analysis of 2,170 rare variants revealed an excess of nonsense mu tations in cases (n,12) compared to controls (n,1; p,0.019). All nonsense mutations were novel and 3 were in DST (2xSZ, 1xControl). The other SZ mutations were in DLG5, FAT1, FYN, INADL, MACF1 and MYO16. Five of 7 SZ nonsense genes have NRXN1 related function. ASD mutations were in CNT   NAP1, GRIP1, GRIN2B and NRG1. Rare ASD mutations have previously been reported for GRIP1 and GRIN2B. Analysis of all rare variants in the 11 non sense genes identified an excess of cases carrying one or more mutations compared to controls (p,0.019). These results supply new supportive data for known ASD risk genes and identify putative new susceptibility genes for both disorders.",2012.0,,"S. Furlong, E. M. Kenny, P . Cormican, C. Fahey, R. Anney, G. Donohoe, A. P . Corvin, L.  Gallagher, M. Gill, D. W. Morris","Trinity College Dublin, Dublin, Ireland","ASD mutations were in CNT   NAP1, GRIP1, GRIN2B and NRG1.",,ASD mutations,[],"['ASD', 'mutation']"
353,1217, Excess of novel nonsense mutations identified in putative susceptibility genes for schizophrenia and autism spectrum disorders,P11.117,,"Schizophrenia (SZ) and autism spectrum disorders (ASD) are complex ge  netic neurodevelopmental disorders that share certain phenotypes (e.g.  cognitive deficits), and may share an underlying pathology due to shared  genetic risk variants (e.g. already identified NRXN1). This study involves next generation sequencing of the exonic regions of 215 putative suscep   tibility genes in an Irish sample of 151 cases of ASD, 274 cases of SZ and 287 controls, to identify rare mutations contributing to one or both disor   ders. A multiplex target enrichment method combined DNA samples using indexes/barcodes followed by enrichment of exonic regions using Agilent  SureSelect and paired end sequencing on an Illumina GAII. Selected genes  were categorised as: 1) NRXN1 and interactors, 2) Postsynaptic Glutamate Receptor Complexes (NMDA, mGluR5 and AMPA), 3) Neural cell adhesion molecules, 4) DISC1 and interactors, and 5) Functional and Positional Can didates. Analysis of 2,170 rare variants revealed an excess of nonsense mu tations in cases (n,12) compared to controls (n,1; p,0.019). All nonsense mutations were novel and 3 were in DST (2xSZ, 1xControl). The other SZ mutations were in DLG5, FAT1, FYN, INADL, MACF1 and MYO16. Five of 7 SZ nonsense genes have NRXN1 related function. ASD mutations were in CNT   NAP1, GRIP1, GRIN2B and NRG1. Rare ASD mutations have previously been reported for GRIP1 and GRIN2B. Analysis of all rare variants in the 11 non sense genes identified an excess of cases carrying one or more mutations compared to controls (p,0.019). These results supply new supportive data for known ASD risk genes and identify putative new susceptibility genes for both disorders.",2012.0,,"S. Furlong, E. M. Kenny, P . Cormican, C. Fahey, R. Anney, G. Donohoe, A. P . Corvin, L.  Gallagher, M. Gill, D. W. Morris","Trinity College Dublin, Dublin, Ireland",Rare ASD mutations have previously been reported for GRIP1 and GRIN2B.,,ASD mutations,[],"['ASD', 'mutation']"
353,1217, Excess of novel nonsense mutations identified in putative susceptibility genes for schizophrenia and autism spectrum disorders,P11.117,,"Schizophrenia (SZ) and autism spectrum disorders (ASD) are complex ge  netic neurodevelopmental disorders that share certain phenotypes (e.g.  cognitive deficits), and may share an underlying pathology due to shared  genetic risk variants (e.g. already identified NRXN1). This study involves next generation sequencing of the exonic regions of 215 putative suscep   tibility genes in an Irish sample of 151 cases of ASD, 274 cases of SZ and 287 controls, to identify rare mutations contributing to one or both disor   ders. A multiplex target enrichment method combined DNA samples using indexes/barcodes followed by enrichment of exonic regions using Agilent  SureSelect and paired end sequencing on an Illumina GAII. Selected genes  were categorised as: 1) NRXN1 and interactors, 2) Postsynaptic Glutamate Receptor Complexes (NMDA, mGluR5 and AMPA), 3) Neural cell adhesion molecules, 4) DISC1 and interactors, and 5) Functional and Positional Can didates. Analysis of 2,170 rare variants revealed an excess of nonsense mu tations in cases (n,12) compared to controls (n,1; p,0.019). All nonsense mutations were novel and 3 were in DST (2xSZ, 1xControl). The other SZ mutations were in DLG5, FAT1, FYN, INADL, MACF1 and MYO16. Five of 7 SZ nonsense genes have NRXN1 related function. ASD mutations were in CNT   NAP1, GRIP1, GRIN2B and NRG1. Rare ASD mutations have previously been reported for GRIP1 and GRIN2B. Analysis of all rare variants in the 11 non sense genes identified an excess of cases carrying one or more mutations compared to controls (p,0.019). These results supply new supportive data for known ASD risk genes and identify putative new susceptibility genes for both disorders.",2012.0,,"S. Furlong, E. M. Kenny, P . Cormican, C. Fahey, R. Anney, G. Donohoe, A. P . Corvin, L.  Gallagher, M. Gill, D. W. Morris","Trinity College Dublin, Dublin, Ireland",These results supply new supportive data for known ASD risk genes and identify putative new susceptibility genes for both disorders.,,ASD risk,[],"['ASD', 'risk']"
354,1256, Inherited and de novo SHANK2 variants associated with autism spectrum disorder impair neuronal morphogenesis and physiology,P12.021,,"Mutations in the postsynaptic scaffolding gene SHANK2  have recently been  identified in individuals with autism spectrum disorder (ASD) and intellec tual disability (ID). However, the cellular and physiological consequences of these mutations in neurons remain unknown. We have analyzed the func tional impact caused by two inherited and one de novo SHANK2  mutations  from ASD individuals (L1008_P1009dup, T1127M, R462X). Although all three variants affect spine volume and have smaller SHANK2 cluster sizes, T1127M additionally fails to rescue spine volume in Shank2 knock down neurons. R462X is not able to rescue spine volume and dendritic branching and lacks postsynaptic clustering, indicating the most severe dysfunction. To demonstrate that R462X when expressed in mouse can be linked to phy   siological effects, we analyzed synaptic transmission and behavior. Princi   pal neurons of mice expressing rAAV transduced SHANK2 R462X present a specific, long lasting reduction in miniature postsynaptic AMPA receptor currents. This dominant negative effect translates into dose dependent alte red cognitive behavior of SHANK2 R462X expressing mice, with an impact on the penetrance of ASD.",2012.0,,"S. Berkel1, W. Tang2, M. Trevino2, M. Vogt3, H. A. Obenhaus2, P . Gass3, S. W. Scherer4, R.  Sprengel2, G. Schratt5, G. A. Rappold1","1Institute of Human Genetics, Heidelberg, Germany, 2Max Planck Institute for Medical  Research, Heidelberg, Germany, 3Central Institute of Mental Health, Mannheim,  Germany, 4University of Toronto, Toronto, ON, Canada, 5Institute of physiological  chemistry, Marburg, Germany",Mutations in the postsynaptic scaffolding gene SHANK2  have recently been  identified in individuals with autism spectrum disorder (ASD) and intellec tual disability (ID).,individuals with autism,,"['individual', 'with', 'autism']",[]
354,1256, Inherited and de novo SHANK2 variants associated with autism spectrum disorder impair neuronal morphogenesis and physiology,P12.021,,"Mutations in the postsynaptic scaffolding gene SHANK2  have recently been  identified in individuals with autism spectrum disorder (ASD) and intellec tual disability (ID). However, the cellular and physiological consequences of these mutations in neurons remain unknown. We have analyzed the func tional impact caused by two inherited and one de novo SHANK2  mutations  from ASD individuals (L1008_P1009dup, T1127M, R462X). Although all three variants affect spine volume and have smaller SHANK2 cluster sizes, T1127M additionally fails to rescue spine volume in Shank2 knock down neurons. R462X is not able to rescue spine volume and dendritic branching and lacks postsynaptic clustering, indicating the most severe dysfunction. To demonstrate that R462X when expressed in mouse can be linked to phy   siological effects, we analyzed synaptic transmission and behavior. Princi   pal neurons of mice expressing rAAV transduced SHANK2 R462X present a specific, long lasting reduction in miniature postsynaptic AMPA receptor currents. This dominant negative effect translates into dose dependent alte red cognitive behavior of SHANK2 R462X expressing mice, with an impact on the penetrance of ASD.",2012.0,,"S. Berkel1, W. Tang2, M. Trevino2, M. Vogt3, H. A. Obenhaus2, P . Gass3, S. W. Scherer4, R.  Sprengel2, G. Schratt5, G. A. Rappold1","1Institute of Human Genetics, Heidelberg, Germany, 2Max Planck Institute for Medical  Research, Heidelberg, Germany, 3Central Institute of Mental Health, Mannheim,  Germany, 4University of Toronto, Toronto, ON, Canada, 5Institute of physiological  chemistry, Marburg, Germany","We have analyzed the func tional impact caused by two inherited and one de novo SHANK2  mutations  from ASD individuals (L1008_P1009dup, T1127M, R462X).",,ASD individuals,[],"['ASD', 'individual']"
358,1546, Deletion of SHANK3 gene detected by MLPA in a patient with autistic features and hyperactivity,J02.03,,"Autism is a severe neurodevelopmental disorder and one of the most heri   table neuropsychiatric syndromes, with a male to female ratio of 4:1. The diagnosis of autism is based on impairments in reciprocal social interaction  and communication, and restricted and stereotyped patterns of interests  and activities, with abnormal development apparent within the first 3 years of life. Autistic spectrum disorders (ASDs) include: autistic disorder, child  hood disintegrative disorder, pervasive developmental disorder not other   wise specified, Asperger syndrome and Rett syndrome. There is substantial  evidence from twin and family studies to support the involvement of genetic factors in ASDs. We report a case of 3 years old boy with echolalia, irrelevant talk, not com  prehensible. Muttered to himself occasionally, poor social interaction and avoided eye contact. He was unable to follow commands and responded to  his name very rarely. The child was born after 8 yrs of a non consanguineous  marriage, gestation was controlled and it was a full term caesarean delivery. The provisional clinical diagnosis was autistic features with hyperactivity.  Karyotype was normal, X fragile syndrome analysis was normal too and  was performed a genetic analysis using MLPA (SALSA MLPA Subtelome  ric Screening P070, X linked mental retardation P106 and Microdeletion  Syndromes P245). Analysis results showed a deletion in SHANK3 gene in  22q13.3. Parents were not carrier of this deletion.Several studies have described similar results and these findings have led to  the hypothesis that haploinsufficiency of SHANK3 may cause the behaviou  ral phenotypic consequences of severe expressive language delay, severe/profound mental retardation and at times autism.",2012.0,,"F. Gonzalo, A. Zuniga, L. Pedrola, Y. Bello","Hospital de la Ribera, Alzira (Valencia), Spain","Autistic spectrum disorders (ASDs) include: autistic disorder, child  hood disintegrative disorder, pervasive developmental disorder not other   wise specified, Asperger syndrome and Rett syndrome.",,Autistic spectrum,[],"['Autistic', 'spectrum']"
358,1546, Deletion of SHANK3 gene detected by MLPA in a patient with autistic features and hyperactivity,J02.03,,"Autism is a severe neurodevelopmental disorder and one of the most heri   table neuropsychiatric syndromes, with a male to female ratio of 4:1. The diagnosis of autism is based on impairments in reciprocal social interaction  and communication, and restricted and stereotyped patterns of interests  and activities, with abnormal development apparent within the first 3 years of life. Autistic spectrum disorders (ASDs) include: autistic disorder, child  hood disintegrative disorder, pervasive developmental disorder not other   wise specified, Asperger syndrome and Rett syndrome. There is substantial  evidence from twin and family studies to support the involvement of genetic factors in ASDs. We report a case of 3 years old boy with echolalia, irrelevant talk, not com  prehensible. Muttered to himself occasionally, poor social interaction and avoided eye contact. He was unable to follow commands and responded to  his name very rarely. The child was born after 8 yrs of a non consanguineous  marriage, gestation was controlled and it was a full term caesarean delivery. The provisional clinical diagnosis was autistic features with hyperactivity.  Karyotype was normal, X fragile syndrome analysis was normal too and  was performed a genetic analysis using MLPA (SALSA MLPA Subtelome  ric Screening P070, X linked mental retardation P106 and Microdeletion  Syndromes P245). Analysis results showed a deletion in SHANK3 gene in  22q13.3. Parents were not carrier of this deletion.Several studies have described similar results and these findings have led to  the hypothesis that haploinsufficiency of SHANK3 may cause the behaviou  ral phenotypic consequences of severe expressive language delay, severe/profound mental retardation and at times autism.",2012.0,,"F. Gonzalo, A. Zuniga, L. Pedrola, Y. Bello","Hospital de la Ribera, Alzira (Valencia), Spain","Autistic spectrum disorders (ASDs) include: autistic disorder, child  hood disintegrative disorder, pervasive developmental disorder not other   wise specified, Asperger syndrome and Rett syndrome.",,autistic disorder,[],"['autistic', 'disorder']"
358,1546, Deletion of SHANK3 gene detected by MLPA in a patient with autistic features and hyperactivity,J02.03,,"Autism is a severe neurodevelopmental disorder and one of the most heri   table neuropsychiatric syndromes, with a male to female ratio of 4:1. The diagnosis of autism is based on impairments in reciprocal social interaction  and communication, and restricted and stereotyped patterns of interests  and activities, with abnormal development apparent within the first 3 years of life. Autistic spectrum disorders (ASDs) include: autistic disorder, child  hood disintegrative disorder, pervasive developmental disorder not other   wise specified, Asperger syndrome and Rett syndrome. There is substantial  evidence from twin and family studies to support the involvement of genetic factors in ASDs. We report a case of 3 years old boy with echolalia, irrelevant talk, not com  prehensible. Muttered to himself occasionally, poor social interaction and avoided eye contact. He was unable to follow commands and responded to  his name very rarely. The child was born after 8 yrs of a non consanguineous  marriage, gestation was controlled and it was a full term caesarean delivery. The provisional clinical diagnosis was autistic features with hyperactivity.  Karyotype was normal, X fragile syndrome analysis was normal too and  was performed a genetic analysis using MLPA (SALSA MLPA Subtelome  ric Screening P070, X linked mental retardation P106 and Microdeletion  Syndromes P245). Analysis results showed a deletion in SHANK3 gene in  22q13.3. Parents were not carrier of this deletion.Several studies have described similar results and these findings have led to  the hypothesis that haploinsufficiency of SHANK3 may cause the behaviou  ral phenotypic consequences of severe expressive language delay, severe/profound mental retardation and at times autism.",2012.0,,"F. Gonzalo, A. Zuniga, L. Pedrola, Y. Bello","Hospital de la Ribera, Alzira (Valencia), Spain","Autistic spectrum disorders (ASDs) include: autistic disorder, child  hood disintegrative disorder, pervasive developmental disorder not other   wise specified, Asperger syndrome and Rett syndrome.",,Asperger syndrome,[],"['Asperger', 'syndrome']"
358,1546, Deletion of SHANK3 gene detected by MLPA in a patient with autistic features and hyperactivity,J02.03,,"Autism is a severe neurodevelopmental disorder and one of the most heri   table neuropsychiatric syndromes, with a male to female ratio of 4:1. The diagnosis of autism is based on impairments in reciprocal social interaction  and communication, and restricted and stereotyped patterns of interests  and activities, with abnormal development apparent within the first 3 years of life. Autistic spectrum disorders (ASDs) include: autistic disorder, child  hood disintegrative disorder, pervasive developmental disorder not other   wise specified, Asperger syndrome and Rett syndrome. There is substantial  evidence from twin and family studies to support the involvement of genetic factors in ASDs. We report a case of 3 years old boy with echolalia, irrelevant talk, not com  prehensible. Muttered to himself occasionally, poor social interaction and avoided eye contact. He was unable to follow commands and responded to  his name very rarely. The child was born after 8 yrs of a non consanguineous  marriage, gestation was controlled and it was a full term caesarean delivery. The provisional clinical diagnosis was autistic features with hyperactivity.  Karyotype was normal, X fragile syndrome analysis was normal too and  was performed a genetic analysis using MLPA (SALSA MLPA Subtelome  ric Screening P070, X linked mental retardation P106 and Microdeletion  Syndromes P245). Analysis results showed a deletion in SHANK3 gene in  22q13.3. Parents were not carrier of this deletion.Several studies have described similar results and these findings have led to  the hypothesis that haploinsufficiency of SHANK3 may cause the behaviou  ral phenotypic consequences of severe expressive language delay, severe/profound mental retardation and at times autism.",2012.0,,"F. Gonzalo, A. Zuniga, L. Pedrola, Y. Bello","Hospital de la Ribera, Alzira (Valencia), Spain",The provisional clinical diagnosis was autistic features with hyperactivity.,,autistic features,[],"['autistic', 'feature']"
361,1709, Investigation of mitochondrial tRNA Thr and tRNAPro genes mutations in autism,J09.38,,"Objectives: Autism as one of three recognized condition in the autism spec trum disorders (ASDs) is a neurodevelopmental, multifactorial disorder. Autism is noticeably reported to be affected by mitochondrial dysfunction which impairs energy metabolism. mtDNA encodes 22 tRNAs working as amino acid transporters for synthesis of the respiratory chain enzymes. In volvement of mutations within tRNA genes have been well documented in mitochondrial disorders. In this study, tRNA Pro and tRNAThr were investigated  to find mutations which are related to autism pathogenesis, as these two genes mutations have been reported to be involved in some neurological disorders.Methods: In this study, a cohort of 24 unrelated idiopathic patients and 100 ethnically matched Persian control individuals were obtained. PCR sequen   cing of mtDNA fragments was employed to investigate the involvement of mitochondrial variations in autism.Results: A substitution , G15928A, was identified in two groups without a significant difference (P , 0.179, P> 0.05). A new homoplasmic substitusion, A15973G, was identified within the T loop of tRNA Pro gene in 1 patient as  it had not been reported before. This variation is moderatelyly conserved (75 %) among species and also, was not detected in blood sample from the patients mother.Conclusion: Investigation on mitochondrial varations may strengthen the role of genetics in association with autism. To reveal the relation of A15973G   Abstracts   European Human Genetics Conference 2012 www.eshg.org398 ESHG Published Abstracts www.eshg.organd autism, more delicate molecular methods could be done for determining  the percentage of heteroplasmic mtDNA in mothers sample of the patient.",2012.0,,"F. Piryaei, M. Houshmand, Z. Piryaei","National Institute of Genetics Engineering and Biotechnology, Tehran, Islamic Republic of Iran","This variation is moderatelyly conserved (75 %) among species and also, was not detected in blood sample from the patients mother.Conclusion: Investigation on mitochondrial varations may strengthen the role of genetics in association with autism.",association with autism,,"['association', 'with', 'autism']",[]
368,178,Genome wide assocation study identifies common variation associated with congenital heart disease,C18.5,,"We tested the hypothesis that common variants contribute to congenital heart disease by conducting a genome wide association study for Tetralogy of Fallot (TOF) using a northern European discovery set of 835 cases and 5159 controls. A large region on chromosome 12q24 which includes PT  PN11  was associated (P , 1.4  10  7) and replicated in 798 cases and 2931  controls (replication P , 3.9  10 5; combined P , 7.7  10 11). SNPs in GPC5  on chromosome 13q32 were also associated (P , 1.7  10 7) and replica  ted convincingly in 789 cases and 2927 controls (replication P , 1.2  10 5;  combined P , 3.03  10 11). We extended the GWAS to a discovery cohort of  1,995 cases with various CHD phenotypes. A region on chromosome 4p16, between MSX1 and STX18, was associated (P,9.5x10  7) with the risk of atrial  septal defect (ASD; N,340 cases), and this was replicated in a further 445 ASD cases and 2520 controls (replication P,1.1x10  4; combined P,6.9x10  10). The association between SNPs at 12q24 and TOF was not apparent in  any other CHD subgroup; similarly, the association between SNPs at 4p16 and ASD was not apparent for CHD phenotypes other than ASD. We con clude that there is phenotypic specificity for common variants associated with CHD.  J. Goodship:  None. H. Cordell: None. J. Bentham: None. A. Topf: None. D.  Zelenika: None. S. Heath: None. C. Mamasoula: None. D. Brook: None. S. Bhattacharya:  None. D. Winlaw:  None. K. Devriendt: None. S. Mital:  None. A.  Postma: None. M. Lathrop:  None. M. Farrall: None. B. Keavney:  None.ABSTRACTS CONCURRENT SESSIONS ESHG 2013 | PARIS, FRANCE | WWW.ESHG.ORG 49Back to index",2013.0,,"J. Goodship1, H. Cordell1, J. Bentham2, A. Topf1, D. Zelenika3, S. Heath3, C. Mamasoula1, D.  Brook4, S. Bhattacharya2, D. Winlaw5, K. Devriendt6, S. Mital7, A. Postma8, M. Lathrop3, M.  Farrall2, B. Keavney1","1Institute of Genetic Medicine, Newcastle upon Tyne, United Kingdom, 2Department of  Cardiovascular Medicine, Oxford, United Kingdom, 3Centre National de Genotypage,  Evry, France, 4Institute of Genetics, Nottingham, United Kingdom, 5The Childrens  Hospital, Westmead, Australia, 6Centre for Human Genetics, Leuven, Belgium, 7Hospital  for Sick Children, Toronto, ON, Canada, 8Academic Medical Centre, Amsterdam,  Netherlands","A region on chromosome 4p16, between MSX1 and STX18, was associated (P,9.5x10  7) with the risk of atrial  septal defect (ASD; N,340 cases), and this was replicated in a further 445 ASD cases and 2520 controls (replication P,1.1x10  4; combined P,6.9x10  10).",,ASD cases,[],"['ASD', 'case']"
374,446,"Smaller and larger deletions of the Williams Beuren syndrome region implicate genes involved in mild facial phenotype, epilepsy and autistic traits",P02.135,,"Williams Beuren syndrome is a multisystemic disorder caused by a hemizy   gous deletion of 1.5Mb on chromosome 7q11.23 spanning 28 genes. A few patients with larger and smaller WBS deletion have been reported. They  show clinical features that vary between isolated SVAS to the full spectrum  of WBS phenotype, associated with epilepsy or autism spectrum behavior.We describe four patients with atypical 7q11.23 deletions identified by mul   tiple ligation probe amplification analysis and fine mapping by quantitative real time PCR. Two carry an approximately 3.5 Mb larger deletion towards the telomere that includes HIP1  and YWHAG genes. Other two carry a shor   ter deletion of approximately 1.2 Mb at centromeric side that excludes the  distal WBS genes BAZ1B  and FZD9 , respectively. Along with previously reported cases, genotype phenotype correlation in  the patients described here further suggests that haploinsufficiency of HIP1   and YWHAG might cause the severe neurological and neuropsychological  deficits including epilepsy and autistic traits and that the preservation of BAZ1B  and FZD9  genes may be related to mild facial features and moderate  neuropsychological deficits. This report highlights the importance to cha racterize additional patients with 7q11.23 atypical deletions and to com pare neuropsychological and clinical features between individuals with lar  ger and smaller WBS deletion to shed light on the pathogenic role of genes  within and flanking the Williams Beuren syndrome region.  C. Fusco: None. L. Micale: None. B. Augello:  None. M. Pellico:  None. D.  Menghini:  None. P. Alfieri: None. M. Digilio:  None. B. Mandriani:  None. S.  Vicari: None. G. merla: None.",2013.0,,"C. Fusco1, L. Micale1, B. Augello1, M. Pellico1, D. Menghini2, P . Alfieri2, M. Digilio3, B.  Mandriani1,4, S. Vicari2, g. merla1,5","1IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy, 2IRCCS Children  Hospital Bambino Ges, Rome, Italy, 3IRCCS Children Hospital Bambino Ges, San  Giovanni Rotondo, Italy, 4University of Brescia, Brescia, Italy, 5University of Trieste,  Trieste, Italy","Along with previously reported cases, genotype phenotype correlation in  the patients described here further suggests that haploinsufficiency of HIP1   and YWHAG might cause the severe neurological and neuropsychological  deficits including epilepsy and autistic traits and that the preservation of BAZ1B  and FZD9  genes may be related to mild facial features and moderate  neuropsychological deficits.",,autistic traits,[],"['autistic', 'trait']"
375,449,Translocation of X;autosome and pattern of X inactivation,P02.138,,"The aim of this study was to correlate genotype/phenotype in Xp terminal deletion and to reveal the pattern of X inactivation in X autosome transloca   tion. We report on a 4 years old girl and presented with developmental delay, seizures and obvious autistic behavior .She had dysmorphic facies and large hairy nevus in her forearm. Her Brain CT showed complete agenesis of the corpus callosum and EEG records showed bilateral epileptogenic focus. She has a karyotype of 45,X,t(X;14)(p22;p11), both parents had normal karyo type. FISH analysis using Xp subtelomere, Shox, XIST gene, and subtelomere 14 revealed Ish t(X;14)(Xpter ,Xp22 ). The active centromere belongs to the chromosome 14. Array CGH using Agilent detected a 2Mb loss in Xp22.33 and 4,5Mb gain in Xp22.2p22.12. The deleted region contains 12 genes of which CSFRA and Shox are known as OMIM Morbid Genes. The duplicated region contains 7 OMIM morbid Genes. We used late replicating chromatin technique to detect the pattern of X inactivation. we found that 70% of the translocated X is the inactive one, in the same time the translocated chro mosome 14 escape inactivation, while in 30% the normal X is the inactivate one leaving the abnormal X as the active one. The clinical picture may be affected by the haploinsufficiency of the genes that are known to escape X inactivation and lie within the deleted region (Xp22.33), or it is affected by duplicated genes (Xp22.2p22.12) on the abnormal X when it was the active one. We recommend study of gene expression of those genes.  A.M. Mohamed: None. M.S. Zaki:  None. A.K. Kamel: None. G. Gillesson:   None. A. Caliebe: None. M. Mekkawy: None. P. Safwat: None. R. Siebert: None. I. Mazen: None.",2013.0,,"A. M. Mohamed1, M. S. Zaki1, A. K. Kamel1, G. Gillesson2, A. Caliebe3, M. Mekkawy1, P .  Safwat1, R. Siebert3, I. Mazen1","1National Research cetre, Cairo, Egypt, 2Institut fr Humangenetik Lbeck, Universitt  zu Luebeck, Luebeck, Luebeck, Germany, 3Institute of Human Genetics, Christian  Albrechts University Kiel & University Hospital Schleswig Holstein, Campus Kiel,, Kiel, Germany","We report on a 4 years old girl and presented with developmental delay, seizures and obvious autistic behavior .She had dysmorphic facies and large hairy nevus in her forearm.",,autistic behavior,[],"['autistic', 'behavior']"
381,599,Fulminant Hepatic Failure associated with Phelan McDermid syndrome,P05.014,,"Phelan McDermid syndrome is caused by 22q13.3 deletion and its typical features are severe intellectual disability, absent or poor speech develop ment, decreased pain sensitivity, hypotonia and mild facial dysmorphism. The syndrome could also comprise autistic features, seizures or thermore gulation problems. Rare symtoms are hearing loss, genitourinary anomalies and congenital heart defect. Extremely rare is association of Phelan McDer   mid syndrome and hepatic failure in early childhood. There have been de  scribed only 2 patients with this condition so far. In these cases PIM3 gene  (localized in 22q13.33) was considered to be responsible. We present 7 patients (2 males and 5 females) with Phelan McDermid syn drome. Age at diagnosis ranges from 10 month to 55 years and deletion ex   tent varies from 0.4 Mb to 7.6 Mb. All patients present common features  of the syndrome, but they differ in inconstant sypmtoms. Any correlations  between phenotype and deletion range havent been observed.Patients have been diagnosed using FISH and MLPA, deletion extents were  proven by oligonucleotide arrayCGH. There are 6 patients with deleted PIM3 gene in our group, including two adult patients, but only one of these patients (10 year old boy with 1.9 Mb  long deletion) has developed hepatic failure recently. Therefore simple PIM3  deletion doesnt seem to be the cause of hepatic failure.The possible mechanism is an alteration of the gene on the other allele, epi genetic factors or mutation in some modifier genes. We discuss potential  benefit of whole exome sequencing to further elucidate mechanism in these  patients.Support: Czech Ministry of Health project 00064203.  R. Pourov: None. P. Hedvikov: None. J. Drbov: None. M. Simandlov:   None. . Vejvalkov: None. M. Malkov: None. D. Novotn: None.",2013.0,,"R. Pourov, P . Hedvikov, J. Drbov, M. Simandlov, . Vejvalkov, M. Malkov, D. Novotn","University Hospital Motol, Prague, Czech Republic","The syndrome could also comprise autistic features, seizures or thermore gulation problems.",,autistic features,[],"['autistic', 'feature']"
383,614,Custom designed CGH array in autism spectrum disorders,P05.030,,"Introduction: Autism spectrum disorders (ASD) have a complex multifac torial etilogy. Recently, copy number variants (CNVs) have been shown to contribute to over 10% of ASD cases. Many of the known genes whose mutations cause ASD, have functions related to epigenetic regulation. We have applied a custom designed oligo array CGH with an exonic overlapping coverage of 450 genes known to cause autism or intellectual disability and autism candidate genes related to epigenetic machinery.Material and methods: Custom oligonucleotide arrays (formats 4x44 and 8x60) were designed with e Array Agilent technology. The final array design contains: 36,000 exonic probes for 450 genes considered of high priority (mean distance between probes 25bp), 2,000 probes for regulatory ele ments and microRNAs and 22,000 whole genome probes (backbone).Results: We have studied a series of 139 patients including syndromic au   tism and/or familial cases of idiopathic autism. We have found 24 cases with pathological CNVs. Most are non recurrent CNV, what allow us to propose new candidate genes involved in autism.Discussion: Our results confirm the importance of three regions in autism: Xq28 (MECP2), 22q13 (SHANK3) and 16q13, while all others regions are extremely heterogeneous. Most pathological CNV were found in cases with syndromic autism.  C. Orellana: None. M. Rosell:  None. S. Monfort:  None. S. Mayo: None. S.  Oltra: None. F. Martinez: None.",2013.0,,"C. Orellana, M. Rosell, S. Monfort, S. Mayo, S. Oltra, F. Martinez","Hospital Universitario La Fe, Valencia, Spain","Recently, copy number variants (CNVs) have been shown to contribute to over 10% of ASD cases.",,ASD cases,[],"['ASD', 'case']"
383,614,Custom designed CGH array in autism spectrum disorders,P05.030,,"Introduction: Autism spectrum disorders (ASD) have a complex multifac torial etilogy. Recently, copy number variants (CNVs) have been shown to contribute to over 10% of ASD cases. Many of the known genes whose mutations cause ASD, have functions related to epigenetic regulation. We have applied a custom designed oligo array CGH with an exonic overlapping coverage of 450 genes known to cause autism or intellectual disability and autism candidate genes related to epigenetic machinery.Material and methods: Custom oligonucleotide arrays (formats 4x44 and 8x60) were designed with e Array Agilent technology. The final array design contains: 36,000 exonic probes for 450 genes considered of high priority (mean distance between probes 25bp), 2,000 probes for regulatory ele ments and microRNAs and 22,000 whole genome probes (backbone).Results: We have studied a series of 139 patients including syndromic au   tism and/or familial cases of idiopathic autism. We have found 24 cases with pathological CNVs. Most are non recurrent CNV, what allow us to propose new candidate genes involved in autism.Discussion: Our results confirm the importance of three regions in autism: Xq28 (MECP2), 22q13 (SHANK3) and 16q13, while all others regions are extremely heterogeneous. Most pathological CNV were found in cases with syndromic autism.  C. Orellana: None. M. Rosell:  None. S. Monfort:  None. S. Mayo: None. S.  Oltra: None. F. Martinez: None.",2013.0,,"C. Orellana, M. Rosell, S. Monfort, S. Mayo, S. Oltra, F. Martinez","Hospital Universitario La Fe, Valencia, Spain",Most pathological CNV were found in cases with syndromic autism.,cases with syndromic autism,,"['case', 'with', 'syndromic', 'autism']",[]
384,615,The 15q11.2 deletion and autism spectrum disorders,P05.031,,"Autism Spectrum Disorders (ASDs) are frequent genetic neurodevelopmen tal disorders. Several studies have shown the association of Copy Number Variations, both de novo and rare inherited, with ASD. Deletions of chromo   some 15q11.2 (BP1 BP2 region) including CYFIP1, NIPA1, NIPA2  and TUBG  CP5, are associated with intellectual disability, epilepsy, schizophrenia and autism. CYFIP1  is an important binding partner of FMRP and FMR1 muta   tions cause Fragile X syndrome, often associated with autism (30%). Also, patients with the Prader Willi phenotype caused by paternal deletions of the 15q11 13 BP1 BP3 region present a more severe behavioral phenotype ABSTRACTS POSTERS ESHG 2013 | PARIS, FRANCE | WWW.ESHG.ORG 163Back to index (ADHD, autism and OCD) compared to those having the BP2 BP3 deletion.  Together, this pinpoints the 15q11.2 deleted region as a risk variant for  ASD. Quantitative Real Time Polymerase Chain Reaction is used to test the oc currence of deletions of CYFIP1 in ASD patients with intellectual disability  (IQ<70), ASD patients with normal intelligence (IQ>70) and controls. We also performed exome sequencing on two ASD families with the proband carrying the del15q11.2, inherited from a normal parent.We present the results of an association study of CYFIP1 deletions in ASD  patients. Given the variability of the phenotype of del15q11.2, we hypothe size that additional variants in the other allele, genes of the FMRP network or known ASD genes can contribute to the phenotype (multi hit model). We  present the results of exome sequencing of two ASD families, searching for  additional hits.The 15q11.2 deletion is likely to be a risk factor for ASD with/without men  tal retardation. A multi hit model could explain the phenotypic variability.  V. De Wolf: None. H. Peeters:  None. K. Devriendt: None.",2013.0,,"V. De Wolf, H. Peeters, K. Devriendt","KU Leuven, Leuven, Belgium","Quantitative Real Time Polymerase Chain Reaction is used to test the oc currence of deletions of CYFIP1 in ASD patients with intellectual disability  (IQ<70), ASD patients with normal intelligence (IQ>70) and controls.",,ASD patients,[],"['ASD', 'patient']"
384,615,The 15q11.2 deletion and autism spectrum disorders,P05.031,,"Autism Spectrum Disorders (ASDs) are frequent genetic neurodevelopmen tal disorders. Several studies have shown the association of Copy Number Variations, both de novo and rare inherited, with ASD. Deletions of chromo   some 15q11.2 (BP1 BP2 region) including CYFIP1, NIPA1, NIPA2  and TUBG  CP5, are associated with intellectual disability, epilepsy, schizophrenia and autism. CYFIP1  is an important binding partner of FMRP and FMR1 muta   tions cause Fragile X syndrome, often associated with autism (30%). Also, patients with the Prader Willi phenotype caused by paternal deletions of the 15q11 13 BP1 BP3 region present a more severe behavioral phenotype ABSTRACTS POSTERS ESHG 2013 | PARIS, FRANCE | WWW.ESHG.ORG 163Back to index (ADHD, autism and OCD) compared to those having the BP2 BP3 deletion.  Together, this pinpoints the 15q11.2 deleted region as a risk variant for  ASD. Quantitative Real Time Polymerase Chain Reaction is used to test the oc currence of deletions of CYFIP1 in ASD patients with intellectual disability  (IQ<70), ASD patients with normal intelligence (IQ>70) and controls. We also performed exome sequencing on two ASD families with the proband carrying the del15q11.2, inherited from a normal parent.We present the results of an association study of CYFIP1 deletions in ASD  patients. Given the variability of the phenotype of del15q11.2, we hypothe size that additional variants in the other allele, genes of the FMRP network or known ASD genes can contribute to the phenotype (multi hit model). We  present the results of exome sequencing of two ASD families, searching for  additional hits.The 15q11.2 deletion is likely to be a risk factor for ASD with/without men  tal retardation. A multi hit model could explain the phenotypic variability.  V. De Wolf: None. H. Peeters:  None. K. Devriendt: None.",2013.0,,"V. De Wolf, H. Peeters, K. Devriendt","KU Leuven, Leuven, Belgium","Quantitative Real Time Polymerase Chain Reaction is used to test the oc currence of deletions of CYFIP1 in ASD patients with intellectual disability  (IQ<70), ASD patients with normal intelligence (IQ>70) and controls.",,ASD patients,[],"['ASD', 'patient']"
384,615,The 15q11.2 deletion and autism spectrum disorders,P05.031,,"Autism Spectrum Disorders (ASDs) are frequent genetic neurodevelopmen tal disorders. Several studies have shown the association of Copy Number Variations, both de novo and rare inherited, with ASD. Deletions of chromo   some 15q11.2 (BP1 BP2 region) including CYFIP1, NIPA1, NIPA2  and TUBG  CP5, are associated with intellectual disability, epilepsy, schizophrenia and autism. CYFIP1  is an important binding partner of FMRP and FMR1 muta   tions cause Fragile X syndrome, often associated with autism (30%). Also, patients with the Prader Willi phenotype caused by paternal deletions of the 15q11 13 BP1 BP3 region present a more severe behavioral phenotype ABSTRACTS POSTERS ESHG 2013 | PARIS, FRANCE | WWW.ESHG.ORG 163Back to index (ADHD, autism and OCD) compared to those having the BP2 BP3 deletion.  Together, this pinpoints the 15q11.2 deleted region as a risk variant for  ASD. Quantitative Real Time Polymerase Chain Reaction is used to test the oc currence of deletions of CYFIP1 in ASD patients with intellectual disability  (IQ<70), ASD patients with normal intelligence (IQ>70) and controls. We also performed exome sequencing on two ASD families with the proband carrying the del15q11.2, inherited from a normal parent.We present the results of an association study of CYFIP1 deletions in ASD  patients. Given the variability of the phenotype of del15q11.2, we hypothe size that additional variants in the other allele, genes of the FMRP network or known ASD genes can contribute to the phenotype (multi hit model). We  present the results of exome sequencing of two ASD families, searching for  additional hits.The 15q11.2 deletion is likely to be a risk factor for ASD with/without men  tal retardation. A multi hit model could explain the phenotypic variability.  V. De Wolf: None. H. Peeters:  None. K. Devriendt: None.",2013.0,,"V. De Wolf, H. Peeters, K. Devriendt","KU Leuven, Leuven, Belgium","We also performed exome sequencing on two ASD families with the proband carrying the del15q11.2, inherited from a normal parent.We present the results of an association study of CYFIP1 deletions in ASD  patients.",,ASD families,[],"['ASD', 'family']"
384,615,The 15q11.2 deletion and autism spectrum disorders,P05.031,,"Autism Spectrum Disorders (ASDs) are frequent genetic neurodevelopmen tal disorders. Several studies have shown the association of Copy Number Variations, both de novo and rare inherited, with ASD. Deletions of chromo   some 15q11.2 (BP1 BP2 region) including CYFIP1, NIPA1, NIPA2  and TUBG  CP5, are associated with intellectual disability, epilepsy, schizophrenia and autism. CYFIP1  is an important binding partner of FMRP and FMR1 muta   tions cause Fragile X syndrome, often associated with autism (30%). Also, patients with the Prader Willi phenotype caused by paternal deletions of the 15q11 13 BP1 BP3 region present a more severe behavioral phenotype ABSTRACTS POSTERS ESHG 2013 | PARIS, FRANCE | WWW.ESHG.ORG 163Back to index (ADHD, autism and OCD) compared to those having the BP2 BP3 deletion.  Together, this pinpoints the 15q11.2 deleted region as a risk variant for  ASD. Quantitative Real Time Polymerase Chain Reaction is used to test the oc currence of deletions of CYFIP1 in ASD patients with intellectual disability  (IQ<70), ASD patients with normal intelligence (IQ>70) and controls. We also performed exome sequencing on two ASD families with the proband carrying the del15q11.2, inherited from a normal parent.We present the results of an association study of CYFIP1 deletions in ASD  patients. Given the variability of the phenotype of del15q11.2, we hypothe size that additional variants in the other allele, genes of the FMRP network or known ASD genes can contribute to the phenotype (multi hit model). We  present the results of exome sequencing of two ASD families, searching for  additional hits.The 15q11.2 deletion is likely to be a risk factor for ASD with/without men  tal retardation. A multi hit model could explain the phenotypic variability.  V. De Wolf: None. H. Peeters:  None. K. Devriendt: None.",2013.0,,"V. De Wolf, H. Peeters, K. Devriendt","KU Leuven, Leuven, Belgium","Given the variability of the phenotype of del15q11.2, we hypothe size that additional variants in the other allele, genes of the FMRP network or known ASD genes can contribute to the phenotype (multi hit model).",,ASD genes,[],"['ASD', 'gene']"
384,615,The 15q11.2 deletion and autism spectrum disorders,P05.031,,"Autism Spectrum Disorders (ASDs) are frequent genetic neurodevelopmen tal disorders. Several studies have shown the association of Copy Number Variations, both de novo and rare inherited, with ASD. Deletions of chromo   some 15q11.2 (BP1 BP2 region) including CYFIP1, NIPA1, NIPA2  and TUBG  CP5, are associated with intellectual disability, epilepsy, schizophrenia and autism. CYFIP1  is an important binding partner of FMRP and FMR1 muta   tions cause Fragile X syndrome, often associated with autism (30%). Also, patients with the Prader Willi phenotype caused by paternal deletions of the 15q11 13 BP1 BP3 region present a more severe behavioral phenotype ABSTRACTS POSTERS ESHG 2013 | PARIS, FRANCE | WWW.ESHG.ORG 163Back to index (ADHD, autism and OCD) compared to those having the BP2 BP3 deletion.  Together, this pinpoints the 15q11.2 deleted region as a risk variant for  ASD. Quantitative Real Time Polymerase Chain Reaction is used to test the oc currence of deletions of CYFIP1 in ASD patients with intellectual disability  (IQ<70), ASD patients with normal intelligence (IQ>70) and controls. We also performed exome sequencing on two ASD families with the proband carrying the del15q11.2, inherited from a normal parent.We present the results of an association study of CYFIP1 deletions in ASD  patients. Given the variability of the phenotype of del15q11.2, we hypothe size that additional variants in the other allele, genes of the FMRP network or known ASD genes can contribute to the phenotype (multi hit model). We  present the results of exome sequencing of two ASD families, searching for  additional hits.The 15q11.2 deletion is likely to be a risk factor for ASD with/without men  tal retardation. A multi hit model could explain the phenotypic variability.  V. De Wolf: None. H. Peeters:  None. K. Devriendt: None.",2013.0,,"V. De Wolf, H. Peeters, K. Devriendt","KU Leuven, Leuven, Belgium","We  present the results of exome sequencing of two ASD families, searching for  additional hits.The 15q11.2 deletion is likely to be a risk factor for ASD with/without men  tal retardation.",,ASD families,[],"['ASD', 'family']"
385,616, The genetic basis of autism spectrum disorders: identification and analysis of structural variants,P05.032,,"U.Leuven, Leuven, Belgium, 2Department of  Adolescent and Child Psychiatry, K.U.Leuven, Leuven, Belgium, 3Department of Parenting  and Special Education, K.U.Leuven, K.U.Leuven, Leuven, Belgium. Background: The genetic causes of autism spectrum disorders (ASDs) are heterogeneous and still unknown in the majority of cases. Structural copy number variants (CNVs) were found in sufficiently high frequency to suggest that cytogenetic and microarray analyses are considered in routine clinical workup. An inte resting paradigm for clinical practice is that each rare CNV may account for only a small proportion of variance in ASD at the population level but may have a large effect in a few families in which it segregates.Material and methods: CNV association studies are performed in a family based cohort. The sample contains 161 families ascertained through one or more autistic probands with normal intelligence or mild intellectual disability. The study cohort contains 648 individuals: 227 probands, 324 parents, 97 unaffected siblings belonging to 161 families. All probands, unaffected siblings and parents are genotyped with high resolution Illumina OMNI 2.5 8v1 microarrays. For all individuals, an extensive list of phenotypic information is collected inclu   ding IQ, SRS scores, 3DI, clinical genetic examination and family history.Results:We present the results of a family based study on the validity of CNV de   tection in ASD using a high resolution platform. We study the segregation of known and novel rare CNVs with qualitative and quantitative autism phenotypes. Additionally association studies are performed with respect to amongst others gene content and parental origin.Conclusion:With this study we aim to contribute to the clinical validation of the current knowledge of ASD risk variants and to the identification of novel variants.  N. Brison: None. S. Iqbal:  None. W. De la Marche: None. J. Steyaert:  None. I.  Noens: None. K. Devriendt: None. H. Peeters:  None.",2013.0,,"N. Brison1, S. Iqbal1, W. De la Marche2, J. Steyaert2, I. Noens3, K. Devriendt1, H. Peeters1","1Department of Human Genetics, K",The sample contains 161 families ascertained through one or more autistic probands with normal intelligence or mild intellectual disability.,,autistic probands,[],"['autistic', 'probands']"
385,616, The genetic basis of autism spectrum disorders: identification and analysis of structural variants,P05.032,,"U.Leuven, Leuven, Belgium, 2Department of  Adolescent and Child Psychiatry, K.U.Leuven, Leuven, Belgium, 3Department of Parenting  and Special Education, K.U.Leuven, K.U.Leuven, Leuven, Belgium. Background: The genetic causes of autism spectrum disorders (ASDs) are heterogeneous and still unknown in the majority of cases. Structural copy number variants (CNVs) were found in sufficiently high frequency to suggest that cytogenetic and microarray analyses are considered in routine clinical workup. An inte resting paradigm for clinical practice is that each rare CNV may account for only a small proportion of variance in ASD at the population level but may have a large effect in a few families in which it segregates.Material and methods: CNV association studies are performed in a family based cohort. The sample contains 161 families ascertained through one or more autistic probands with normal intelligence or mild intellectual disability. The study cohort contains 648 individuals: 227 probands, 324 parents, 97 unaffected siblings belonging to 161 families. All probands, unaffected siblings and parents are genotyped with high resolution Illumina OMNI 2.5 8v1 microarrays. For all individuals, an extensive list of phenotypic information is collected inclu   ding IQ, SRS scores, 3DI, clinical genetic examination and family history.Results:We present the results of a family based study on the validity of CNV de   tection in ASD using a high resolution platform. We study the segregation of known and novel rare CNVs with qualitative and quantitative autism phenotypes. Additionally association studies are performed with respect to amongst others gene content and parental origin.Conclusion:With this study we aim to contribute to the clinical validation of the current knowledge of ASD risk variants and to the identification of novel variants.  N. Brison: None. S. Iqbal:  None. W. De la Marche: None. J. Steyaert:  None. I.  Noens: None. K. Devriendt: None. H. Peeters:  None.",2013.0,,"N. Brison1, S. Iqbal1, W. De la Marche2, J. Steyaert2, I. Noens3, K. Devriendt1, H. Peeters1","1Department of Human Genetics, K",Additionally association studies are performed with respect to amongst others gene content and parental origin.Conclusion:With this study we aim to contribute to the clinical validation of the current knowledge of ASD risk variants and to the identification of novel variants.,,ASD risk,[],"['ASD', 'risk']"
388,648, BKCa channels: a new therapeutic target in Fragile X Syndrome treatment,P05.067,,"The most common cause of inherited mental deficiency (MD) associated  with autistic features, Fragile X Syndrome (FXS), results from the FMR1 gene  silencing and loss of Fragile X Mental Retardation Protein (FMRP). Among synaptic proteins deregulated by the absence of Fmrp in fmr1  knock out  (KO) mice (murine model for FXS), Kcnma1 ( subunit of large conductance Ca 2+ activated potassium channels, BKCa) seems to be the most significant  deregulated one. Since several papers showed an involvement of BKCa chan nels in MD, this channel could be a new therapeutic target for FXS. The objectives of this study were: 1) to characterize the molecular BKCa channel anomaly in fmr1  KO mouse model and 2) to evaluate the thera  peutic effect of a BKCa channel opener molecule (BCOM), BMS 204352, on dendritic spines maturation of fmr1  KO neurons and on social behavior of  fmr1  KO mice. In fmr1  KO mice, Kcnma1 protein quantity was lower in ce  rebral structures and neurons, and associated with a reduced BKCa whole cell current. In vitro addition of BMS 204352 induced dendrite spines ma  turation of fmr1  KO neurons. In vivo, using a behavioral test of direct social  interaction, a single injection of BMS 204352 rescued affiliative behaviors to wild type level. In conclusion, we demonstrated 1) a Kcnma1 protein anomaly in fmr1  KO  mice inducing a decrease in BKCa whole cell current, and 2) that a BCOM, BMS 204352, restored a regular phenotype of dendrite spines and social interaction in fmr1  KO mice. Therefore, BKCa channel could be a new thera  peutic target in FXS treatment.  B. Hebert: None. O. Perche: None. A. Menuet: None. N. Doisne: None. J. Pichon:  None. B. Laudier: None. S. Briault: None.",2013.0,,"B. Hebert1, O. Perche2, A. Menuet1, N. Doisne1, J. Pichon1, B. Laudier1, S. Briault2","1CNRS   UMR7355   UNIVERSITY OF ORLEANS, Orleans, France, 2CHRO   CNRS    UMR7355   UNIVERSITY OF ORLEANS, Orleans, France","The most common cause of inherited mental deficiency (MD) associated  with autistic features, Fragile X Syndrome (FXS), results from the FMR1 gene  silencing and loss of Fragile X Mental Retardation Protein (FMRP).",,autistic features,[],"['autistic', 'feature']"
390,651,Study of a large Spanish cohort of 22q13 deletion syndromes patients. A genotype phenotype correlation?,P05.070,,"Phelan McDermid Syndrome (PMS) is a neurodevelopmental disorder caused by the deletion or disruption of a 22q13 region containing the post synaptic protein gene SHANK3 . The clinical features of PMS (also known  as 22q13 deletion syndrome) are highly variable and include hypotonia, speech and otherdevelopmental delays, autistic traits and mildly dysmor   phic features. Other less frequent features include seizures, brain, renal and cardiac malformations, motor deficits, and lymphedema Patient deletion sizes are also highly variable, Clinical expression also varies widely, even among patients with small deletions, and no correlation between deletion size and phenotype has been found. A role for additional genetic factors, in addition to SHANK3 haploinsufficiency, is likely. Because PMS is considered  to be underdiagnosed, the true prevalence is unknown. Aims. We aim to define a possible genotype phenotype comparison to use  high resolution deletion breakpoint mapping on a large cohort of patients, addressed the hypothesis that additional genes or regions of chromosome  22q13 besides SHANK3 may contribute to the PMS phenotype. Results. Terminal deletion breakpoints were identified for more than 50  individuals in a patient cohort using a custom designed high resolution oli  gonucleotide array comparative genomic hybridisation platform, prompting  this genotype phenotype association study. Most of them have been studied by FISH, MLPA and array CGH and their clinical features have been defined.  Interestingly, a great genetic variability, with deletion sizes between 10 Kb  and as much as 9 MB was found.Conclusions. Preliminary data from this large cohort (first, with Spanish patients) were presented and may it provide additional data on genotype  phenotype hypothesis.  J. Nevado: None. M. Palomares:  None. F. Santos: None. E. Vallespin: None. A.  Delicado: None. S. Garca Miar: None. M.L. de Torres: None. M.A. Mori:   None. M. Mil:  None. M. Del Campo: None. L. Armengol: None. E. Guilln:   None. J. Rosell: None. E. Galn:  None. L.D. Pablo:  None.",2013.0,,"J. Nevado1,2, M. Palomares1,2, F. Santos1,2, E. Vallespin1,2, A. Delicado1,2, S. Garca Miar1,2,  M. L. de Torres1,2, M. A. Mori1,2, M. Mil3,4, M. Del Campo5, L. Armengol6, E. Guilln7, J.  Rosell8, E. Galn9, L. D. Pablo1,2","1INGEMM IdiPaz, Madrid, Spain, 2CIBERER, Madrid, Spain, 3Hospital Clinic, Barcelona,  Spain, 4CIBERER, Barcelona, Spain, 5Hospital Vall dHebron, Barcelona, Spain, 6Q  Genomics, Barcelona, Spain, 7Hospital Virgen de la Arrixaca, Murcia, Spain, 8Hospital  Son Espases, Palma de Mallorca, Spain, 9Hospital Materno Infantil Infanta Cristina,  Badajoz, Spain","The clinical features of PMS (also known  as 22q13 deletion syndrome) are highly variable and include hypotonia, speech and otherdevelopmental delays, autistic traits and mildly dysmor   phic features.",,autistic traits,[],"['autistic', 'trait']"
391,653,"HDAC1: a novel cause of autism, developmental delay and epilepsy",P05.072,,"Autism and epilepsy are clinically and genetically heterogeneous disorders. Epilepsy occurs in 25% of patients with autism. Chromosomal Microarray Analysis (CMA) and massively parallel sequencing have identified a large number of genomic regions as well as specific genes which confer suscep   tibility to autism. Six pathogenic copy number variants (4 deletions and 2 duplications) which ranged from 1.3  17.2 Mb and overlapping the HDAC1 gene had been reported. HDAC1, a histone deacetylase, directly interacts with MeCP2 through the transcription co repressor Sin3A/HDAC complex. Mutations in MECP2 cause Rett syndrome; however, no mutations have been described in HDAC1 so far. In a 10 year old boy with non syndromic autism, developmental delay and epilepsy, routine karyotype, CMA, meta bolic, and neuroimaging studies were normal. Whole exome sequencing of ABSTRACTS POSTERS ESHG 2013 | PARIS, FRANCE | WWW.ESHG.ORG 173Back to index gDNA from the boy and his parents identified a de novo, novel variant in  HDAC1 (c.154N>S) which was not detected in public or 1100 private exome  databases. Expression of HDAC1 was reduced by 40% while expression of  HDAC4, RAI1 and MBD5 in the probands peripheral blood lymphocytes was normal. Taken together, these data suggest that this novel HDAC1 mutation prevents  transcription repression leading to autism, developmental delay and epi lepsy in this patient. Direct DNA sequencing of gDNA from additional pa tients with autism +/  epilepsy and normal copy number state of HDAC1 is  underway.  M.J. Dasouki: None. J. Roberts: None. W. Zeng:  A. Employment (full or  part time); Significant; Ambry Genetics. S. Mullegama: None. K. Gonzales: A.  Employment (full or part time); Significant; Ambry Genetics. S. Elsea: None.",2013.0,,"M. J. DASOUKI1, J. Roberts1, W. Zeng2, S. Mullegama3, K. Gonzales2, S. Elsea3","1University of Kansas Medical Center, Kansas City, KS, United States, 2Ambry Genetics,  Aliso Viejo, CA, United States, 3Virginia Commonwealth University, Richmond, VA, United  States",Epilepsy occurs in 25% of patients with autism.,patients with autism,,"['patient', 'with', 'autism']",[]
391,653,"HDAC1: a novel cause of autism, developmental delay and epilepsy",P05.072,,"Autism and epilepsy are clinically and genetically heterogeneous disorders. Epilepsy occurs in 25% of patients with autism. Chromosomal Microarray Analysis (CMA) and massively parallel sequencing have identified a large number of genomic regions as well as specific genes which confer suscep   tibility to autism. Six pathogenic copy number variants (4 deletions and 2 duplications) which ranged from 1.3  17.2 Mb and overlapping the HDAC1 gene had been reported. HDAC1, a histone deacetylase, directly interacts with MeCP2 through the transcription co repressor Sin3A/HDAC complex. Mutations in MECP2 cause Rett syndrome; however, no mutations have been described in HDAC1 so far. In a 10 year old boy with non syndromic autism, developmental delay and epilepsy, routine karyotype, CMA, meta bolic, and neuroimaging studies were normal. Whole exome sequencing of ABSTRACTS POSTERS ESHG 2013 | PARIS, FRANCE | WWW.ESHG.ORG 173Back to index gDNA from the boy and his parents identified a de novo, novel variant in  HDAC1 (c.154N>S) which was not detected in public or 1100 private exome  databases. Expression of HDAC1 was reduced by 40% while expression of  HDAC4, RAI1 and MBD5 in the probands peripheral blood lymphocytes was normal. Taken together, these data suggest that this novel HDAC1 mutation prevents  transcription repression leading to autism, developmental delay and epi lepsy in this patient. Direct DNA sequencing of gDNA from additional pa tients with autism +/  epilepsy and normal copy number state of HDAC1 is  underway.  M.J. Dasouki: None. J. Roberts: None. W. Zeng:  A. Employment (full or  part time); Significant; Ambry Genetics. S. Mullegama: None. K. Gonzales: A.  Employment (full or part time); Significant; Ambry Genetics. S. Elsea: None.",2013.0,,"M. J. DASOUKI1, J. Roberts1, W. Zeng2, S. Mullegama3, K. Gonzales2, S. Elsea3","1University of Kansas Medical Center, Kansas City, KS, United States, 2Ambry Genetics,  Aliso Viejo, CA, United States, 3Virginia Commonwealth University, Richmond, VA, United  States","In a 10 year old boy with non syndromic autism, developmental delay and epilepsy, routine karyotype, CMA, meta bolic, and neuroimaging studies were normal.",boy with non syndromic autism,,"['boy', 'with', 'non', 'syndromic', 'autism']",[]
392,654," Identification of a novel missense mutation in HUWE1 (Xp11.2) segregating with intellectual disability in a large family, by Targeted High Throughput Sequencing.",P05.073,,"Genetic diagnosis in Intellectual Disability (ID) remains difficult because of the extreme genetic heterogeneity of this frequent condition. We report the case of a large 4 generation family with suggestive X linked inheritance of ID (XLID), in which 20 members are affected, with moderate to severe ID and mild dysmorphic features in males, and behavioral phenotype in females. Standard cytogenetic and molecular investigations did not provide a diagno sis. A young patient of this family was included in a strategy of targeted high throughput sequencing of 220 ID genes. It led to the identification of a novel missense mutation (c.6437C>G; p.Thr2146Arg) affecting a highly conserved residue in the HUWE1  gene. We then showed its co segregation with ID in  3 affected males and 3 obligate carrier females while it was absent in 3 un affected males. Analysis of available DNA for others family members is on going. This missense predicted to be damaging (SIFT , Polyphen2), is absent from 10,563 chromosomes in the EVS database. Overlapping duplications including HUWE1  have been found to segregate with ID in 12 families (Froy   en et al.2012). Three missense mutations were also shown to segregate with ID in 3 families with probable or possible XLID, while a de novo missense  was recently observed in a boy with autism spectrum disorder but not in his more mildly affected brother. It is therefore probable that the p.Thr2146Arg missense is causative of ID in this large family. A functional test of HUWE1   activity on DNA repair is currently performed on patients cells to confirm its pathogenicity.  Y. Alembik: None. J. Lauer Zillhardt:  None. B. Gerard: None. C. Redin:  None. B. Van Loon:  None. L. Castelnau: None. J. Chelly: None. J. Mandel:  None. A. Piton:  None.",2013.0,,"Y. Alembik1, J. Lauer Zillhardt2, B. Gerard2, C. Redin3,4, B. Van Loon5, L. Castelnau6, J.  Chelly6,7, J. Mandel2,3,4, A. Piton3,4","1Service de gntique mdicale des Hpitaux Universitaires de Strasbourg, Strasbourg,  France, 2Laboratoire de diagnostic gntique des Hpitaux Universitaires de Strasbourg,  Strasbourg, France, 3Department of Translational Medicine and Neurogenetics, IGBMC  (CNRS, INSERM and Universit de Strasbourg), Illkirch, France, 4Chaire de Gntique  Humaine, Collge de France, Paris, France, 5Institute of Veterinary Biochemistry and  Molecular Biology, University of Zurich, Zurich, Switzerland, 6Inserm U1016, Genetics  and pathophysiology of neurodevelopmental and neuromuscular diseases, Paris, France,  7APHP , Cochin Saint Vincent de Paul Hospital, Biochimistry and molecular genetics  laboratory, Paris, France","Three missense mutations were also shown to segregate with ID in 3 families with probable or possible XLID, while a de novo missense  was recently observed in a boy with autism spectrum disorder but not in his more mildly affected brother.",boy with autism,,"['boy', 'with', 'autism']",[]
393,657,A patient with cryptic interstitial 0.72 Mb deletion in the 22q13.2 region,P05.076,,"The 22q13 deletion syndrome is characterized by intellectual disability (ID), developmental delay, speech deficit and hypotonia. Almost all of the published 22q13 deletions have been described as terminal. It is estimated that SHANK3  gene, which maps to 22q13 region, is the major candidate gene  for the neurologic features of the syndrome. Four cases with interstitial de   letions of 22q13 are reported previously.We report on a 7 year old boy with ID, autistic behavior; abnormal EEG, spa sticity and mild dysmorphic features included ptosis, facial asymmetry, pro minent ears, clinodactyly of F5, T2 3 syndactyly. Patient also suffers from persistent urticaria with eosinophilia and elevated IgE level (2140 KU/L, normal<90). Chromosomal microarray analysis (HumanCytoSNP 12 Bead Chip; Illumina Inc.) revealed a small interstitional de novo 0.72 Mb deletion  in chromosomal region 22q13.2. This region harbors several known genes with different functions (SREBF2, CYP2D6, NFAM1, TNFRSF13C), but not SHANK3  gene.Our patient has the smallest deletion among reported 22q13  region deletions and two copies of SHANK3 gene. Our patient phenotype  showed some differences in comparison with other patients with 22q13 de  ABSTRACTS POSTERS ESHG 2013 | PARIS, FRANCE | WWW.ESHG.ORG 174Back to index letion. Although he has ID and early childhood speech delay, he has normal  growth parameters. In addition he has immune system dysfunction, which  may be caused by a deletion of TNFRSF13C gene (related to immune system  dysfunction) or NFAM1  gene (cause atopic dermatitis and high IgE levels).  It has been previously supposed that 22q13 deletion syndrome may be as sociated with immune system dysfunction in addition to neuropsychiatric  disorders.  R. Teek: None. K. Simenson: None. K. Kuuse: None. E. iglane  lik: None. K.  unap:  None.",2013.0,,"R. Teek1,2, K. Simenson3, K. Kuuse1, E. iglane  lik2,4, K. unap1,2","1Department of Genetics, United Laboratories, Tartu University Hospital, Tartu, Estonia,  2Department of Pediatrics, University of Tartu, Tartu, Estonia, 3Medical Faculty,  University of Tartu, Tartu, Estonia, 4Children s Clinic, Tartu University Hospital, Tartu,  Estonia","Four cases with interstitial de   letions of 22q13 are reported previously.We report on a 7 year old boy with ID, autistic behavior; abnormal EEG, spa sticity and mild dysmorphic features included ptosis, facial asymmetry, pro minent ears, clinodactyly of F5, T2 3 syndactyly.",,autistic behavior,[],"['autistic', 'behavior']"
395,669,A wide spectrum of intellectual disability in two siblings with a 6p22.3 p23 microdeletion encompassing JARID2,P05.089,,"Interstitial deletions of 6p22 6p24 are associated with a variable phenotype including intellectual disability, autistic spectrum disorder, hypotonia and congenital abnormalities. There are many potential disease causing genes in this region, including JARID2, DTNBP1, ATXN1, and MYLIP , and delinea ting genotype phenotype correlations has been a challenge. It has been sug gested that deletions of JARID2, a DNA binding transcriptional repressor expressed in embryonic and adult neurones, are associated with a characte ristic facial appearance as well as intellectual disability.Our first patient presented with mild to moderate learning disability and some Marfanoid systemic features, scoring 6/20 on the revised Ghent cri   teria. Cardiac and ophthalmic investigations were normal. CGH microarray identified a 1.2Mb microdeletion on chromosome 6p22.3 p23 involving JARID2 and DTNBP1 only; targeted microarray and FISH studies did not identify this deletion or a predisposing rearrangement in either parent. The patients younger brother presented with much more severe learning disabilities and autistic spectrum disorder. He had no similar skeletal fea tures but both boys had similar prominent supraorbital ridges. Investigation with CGH microarray found the same microdeletion, suggesting low level somatic gonadal mosaicism or true gonadal mosaicism as a cause for the two affected siblings.This case illustrates the wide spectrum of learning difficulties and behaviou ral difficulties that may be seen even in siblings with identical small micro deletions in this region. This may represent a challenge to the establishment of a clinically recognisable phenotype for JARID2 deletions and highlights the complexity of the genetic aetiology of intellectual disability.  A.C. Foster: None. G.K. Hall:  None. F.S. Togneri: None. D. McMullan:  None. T.  Cole: None.ABSTRACTS POSTERS ESHG 2013 | PARIS, FRANCE | WWW.ESHG.ORG 177Back to index",2013.0,,"A. C. Foster, G. K. Hall, F. S. Togneri, D. McMullan, T . Cole","Birmingham Womens Hospital, Birmingham, United Kingdom","Interstitial deletions of 6p22 6p24 are associated with a variable phenotype including intellectual disability, autistic spectrum disorder, hypotonia and congenital abnormalities.",,autistic spectrum,[],"['autistic', 'spectrum']"
395,669,A wide spectrum of intellectual disability in two siblings with a 6p22.3 p23 microdeletion encompassing JARID2,P05.089,,"Interstitial deletions of 6p22 6p24 are associated with a variable phenotype including intellectual disability, autistic spectrum disorder, hypotonia and congenital abnormalities. There are many potential disease causing genes in this region, including JARID2, DTNBP1, ATXN1, and MYLIP , and delinea ting genotype phenotype correlations has been a challenge. It has been sug gested that deletions of JARID2, a DNA binding transcriptional repressor expressed in embryonic and adult neurones, are associated with a characte ristic facial appearance as well as intellectual disability.Our first patient presented with mild to moderate learning disability and some Marfanoid systemic features, scoring 6/20 on the revised Ghent cri   teria. Cardiac and ophthalmic investigations were normal. CGH microarray identified a 1.2Mb microdeletion on chromosome 6p22.3 p23 involving JARID2 and DTNBP1 only; targeted microarray and FISH studies did not identify this deletion or a predisposing rearrangement in either parent. The patients younger brother presented with much more severe learning disabilities and autistic spectrum disorder. He had no similar skeletal fea tures but both boys had similar prominent supraorbital ridges. Investigation with CGH microarray found the same microdeletion, suggesting low level somatic gonadal mosaicism or true gonadal mosaicism as a cause for the two affected siblings.This case illustrates the wide spectrum of learning difficulties and behaviou ral difficulties that may be seen even in siblings with identical small micro deletions in this region. This may represent a challenge to the establishment of a clinically recognisable phenotype for JARID2 deletions and highlights the complexity of the genetic aetiology of intellectual disability.  A.C. Foster: None. G.K. Hall:  None. F.S. Togneri: None. D. McMullan:  None. T.  Cole: None.ABSTRACTS POSTERS ESHG 2013 | PARIS, FRANCE | WWW.ESHG.ORG 177Back to index",2013.0,,"A. C. Foster, G. K. Hall, F. S. Togneri, D. McMullan, T . Cole","Birmingham Womens Hospital, Birmingham, United Kingdom",The patients younger brother presented with much more severe learning disabilities and autistic spectrum disorder.,,autistic spectrum,[],"['autistic', 'spectrum']"
398,681,GABA and Glutamate metabolisms are affected in the brain of Mecp2 deficient mouse.,P05.101,,"Rett syndrome (RTT) is a severe neurological disorder that affects female patients. RTT is caused by mutations in the X linked methyl CpG binding protein 2 (MECP2) with an incidence of 1/15000. RTT patients develop nor   mally until 6 18 months of age, before the onset of deficits in autonomic, cognitive, motor functions (stereotypic hand movements, impaired loco motion) and autistic features. Studies on Mecp2 mouse models revealed a severe deregulation in the neurotransmission. In particular, bioamine de  ABSTRACTS POSTERS ESHG 2013 | PARIS, FRANCE | WWW.ESHG.ORG 180Back to index ficits have been primarily and extensively studied in Mecp2 deficient mice.  Dysfunction of the gabaergic and glutamatergic systems has been also poin  ted out since the balance between brain excitation and inhibition appears  affected in the brain of the Mecp2 deficient mouse. However, the results are divergent due to the differences in the age and tissues studied. To date few  projects have been dedicated to the follow GABA and Glutamate metabolism  in eight different brain areas of the Mecp2 deficient mice. In the present stu dy we used real time PCR, western blotting and HPLC to compare the GABA and Glutamate metabolism in several key areas of the Mecp2 mutant mice  brain at different developmental stages (early and late symptomatic). Key  enzymes (Kcc2, Nkcc1, Vglut1/2, Gad1/2) will be considered. In conclusion, our results revealed a spatial and temporal deregulation of the glutamater   gic and gabaergic systems for all levels of regulations studied. Moreover, we found that pharmacological stimulation of the gabaergic system is efficient to improve the lifespan of Mecp2 deficient mice.  R. El Khoury:  None. N. Panayotis: None. A. Ghata: None. V. Matagne:  None. G. Alcaraz:  None. L. Villard: None. J. Roux: None.",2013.0,,"R. El Khoury, N. Panayotis, A. Ghata, V. Matagne, G. Alcaraz, L. Villard, J. ROUX","INSERM UMR_S910, Marseille, France","RTT patients develop nor   mally until 6 18 months of age, before the onset of deficits in autonomic, cognitive, motor functions (stereotypic hand movements, impaired loco motion) and autistic features.",,autistic features,[],"['autistic', 'feature']"
400,684,Plasma levels of leptin and adiponectin in Fragile X syndrome,P05.104,,"Medykw 18,, Katowice, Poland,  3Department of Pathophysiology Medical University of Silesia, ul. Medykw 18,,  Katowice, Poland. Fragile X syndrome (FXS) is the most common form of familial mental retar dation and one of the leading known causes of autism. The mutation respon   sible for FXS is a large expansion of the CGG repeats in the promoter region of the FMR1  gene resulting in its transcriptional silencing. Leptin may be  considered a cytokine like hormone with pleiotropic actions since it may be involved in the regulation of neuroendocrine functions, immune system, in addition to its role in development. Leptin and adiponectin may act in parallel as opposing metabolic counterparts. Thus, we hypothesized on in volvement of adiponectin in the pathophysiology of autism.Material and methods23 male patients, mean age 19,3  6,6, affected by Fragile X syndrome (full mutation in the FMR1  gene), were enrolled into the study. Controls were 24  healthy males, mean age 21,8  5,8. Plasma leptin and adiponectin levels were determined by ELISA method.ResultsPlasma leptin levels in Fragile X syndrome patients were similar as in con trol group (11,53  10,24 ng/ml) vs (5,73  4,52) were not significantly dif   ferent from those found in controls (p , 0,5).While plasma adiponectin levels in Fragile X syndrome patients (6,68  3,44 ng/ml) were significantly lower in controls (8,95  4,24) (p< 0,04).ConclusionAdiponectin may be involved in autistic features observed in FXS patients in light of its anti inflammatory properties. Further investigations are necessa   ry to evaluate the role of adipokines in FXS.The work was in part financed from Institutional grant KNW 2 021/10 awarded to MZLABSTRACTS POSTERS ESHG 2013 | PARIS, FRANCE | WWW.ESHG.ORG 181Back to index  M.Z. Lisik:  None. A. Pyrkosz: None. E. Gutmajster: None. J.E. Zejda:  None. M.  Olszanecka Glinianowicz:  None. A.L. Sieron:  None.",2013.0,,"M. Z. Lisik1, A. Pyrkosz1, E. Gutmajster1, J. E. Zejda2, M. Olszanecka Glinianowicz3, A. L.  Sieron1","1Department of General, Molecular Biology and Genetics, Katowice, Poland, 2Department  of Epidemiology Medical University of Silesia, ul","Plasma leptin and adiponectin levels were determined by ELISA method.ResultsPlasma leptin levels in Fragile X syndrome patients were similar as in con trol group (11,53  10,24 ng/ml) vs (5,73  4,52) were not significantly dif   ferent from those found in controls (p , 0,5).While plasma adiponectin levels in Fragile X syndrome patients (6,68  3,44 ng/ml) were significantly lower in controls (8,95  4,24) (p< 0,04).ConclusionAdiponectin may be involved in autistic features observed in FXS patients in light of its anti inflammatory properties.",,autistic features,[],"['autistic', 'feature']"
401,689, 20 ans aprs: a second family with mutation in X linked monoamine oxidase A gene affecting cognition and behavior,P05.109,,"Intellectual disability (ID) is characterized by an extraordinary genetic he terogeneity, with more than 200 genes implicated in monogenic forms. This complexity precluded systematic testing for mutations and because clini cal features are often non specific, for some of these genes only few cases or families have been unambiguously documented. It is the case of the the X linked gene encoding monoamine oxidase A (MAOA), for which only one nonsense mutation has been identified in Brunner syndrome, characterized in one unique family by borderline ID and impulsive and aggressive behavi ors. We have developed targeted NGS sequencing of 220 ID genes in patients with undiagnosed ID. We identified a p.C266F missense mutation in MAOA in a boy with autistic features and behavioral disturbances. He has good ver   bal comprehension but IQ could not be measured due to attention deficit and heterogeneous results in WISC IV test. Two maternal uncles carry the mutation and have severe ID, with a history of maltreatment in early child hood. The phenotype overlaps with Brunner syndrome. This novel missense mutation decreases MAOA activity, as shown by abnormal levels of urinary monoamines and by measurement of enzymatic activity. The identification of this point mutation confirms, for the first time since 1993, the monogenic implication of the MAOA gene in ID, autistic features and behavioral abnor malities. Variable expressivity might be due to environmental factors. We will discuss possible therapeutic options and hypotheses that could account for the very long time lag between the initial and highly publicized report and the finding of a second family.  A. Piton:  None. H. Poquet:  None. R. Claire: None. A. Masurel: None. J. Lauer:  None. J. Muller: None. J. Thevenon: None. Y. Herenger:  None. S. Chancenotte:  None. M. Bonnet:  None. J. Pinoit:  None. F. Huet: None. C. Thauvin Robinet:   None. S. LeGras: None. B. Jost: None. B. Grard: None. K. Poch: None. J. Launay: None. L. Faivre: None. J. Mandel: None.",2013.0,,"A. Piton1,2, H. Poquet3,4, R. Claire1,2, A. Masurel3, J. Lauer5, J. Muller1,5, J. Thevenon3,6, Y.  Herenger5, S. Chancenotte7,8, M. Bonnet8, J. Pinoit9, F. Huet3, C. Thauvin Robinet3,6, S.  LeGras1, B. Jost1, B. Grard5, K. Poch10, J. Launay10, L. Faivre3,6, J. Mandel1,5,2","1IGBMC, Strasbourg, France, 2Chaire de Gntique Humaine, Collge de France, Paris,  France, 3Centre de gntique et Centre de Rfrence Anomalies du dveloppement  et Syndromes malformatifs, Hpital dEnfants, CHU Dijon, Dijon, France, 4Service de  Pdopsychiatrie, Hpital dEnfants, CHU Dijon, France, Dijon, France, 5Laboratoire  de Diagnostic Gntique, Hpitaux Universitaires de Strasbourg, Strasbourg, France,  6EA 4271 GAD, Facult de Mdecine, Universit de Bourgogne, Dijon, France, 7Centre  de gntique et Centre de Rfrence Anomalies du dveloppement et Syndromes  malformatifs, Hpital dEnfants, CHU Dijon, France, Dijon, France, 8Centre Rfrent des  Troubles du Langage et des Apprentissages, Hpital dEnfants, CHU Dijon, Dijon, France,  94 Service de Pdopsychiatrie, Hpital dEnfants, CHU Dijon, Dijon, France, 109 Service  de Biochimie et de Biologie Molculaire, Groupe Hospitalier Universitaire Saint Louis Lariboisire Fernand Widal, AP HP , Paris, France",We identified a p.C266F missense mutation in MAOA in a boy with autistic features and behavioral disturbances.,,autistic features,[],"['autistic', 'feature']"
401,689, 20 ans aprs: a second family with mutation in X linked monoamine oxidase A gene affecting cognition and behavior,P05.109,,"Intellectual disability (ID) is characterized by an extraordinary genetic he terogeneity, with more than 200 genes implicated in monogenic forms. This complexity precluded systematic testing for mutations and because clini cal features are often non specific, for some of these genes only few cases or families have been unambiguously documented. It is the case of the the X linked gene encoding monoamine oxidase A (MAOA), for which only one nonsense mutation has been identified in Brunner syndrome, characterized in one unique family by borderline ID and impulsive and aggressive behavi ors. We have developed targeted NGS sequencing of 220 ID genes in patients with undiagnosed ID. We identified a p.C266F missense mutation in MAOA in a boy with autistic features and behavioral disturbances. He has good ver   bal comprehension but IQ could not be measured due to attention deficit and heterogeneous results in WISC IV test. Two maternal uncles carry the mutation and have severe ID, with a history of maltreatment in early child hood. The phenotype overlaps with Brunner syndrome. This novel missense mutation decreases MAOA activity, as shown by abnormal levels of urinary monoamines and by measurement of enzymatic activity. The identification of this point mutation confirms, for the first time since 1993, the monogenic implication of the MAOA gene in ID, autistic features and behavioral abnor malities. Variable expressivity might be due to environmental factors. We will discuss possible therapeutic options and hypotheses that could account for the very long time lag between the initial and highly publicized report and the finding of a second family.  A. Piton:  None. H. Poquet:  None. R. Claire: None. A. Masurel: None. J. Lauer:  None. J. Muller: None. J. Thevenon: None. Y. Herenger:  None. S. Chancenotte:  None. M. Bonnet:  None. J. Pinoit:  None. F. Huet: None. C. Thauvin Robinet:   None. S. LeGras: None. B. Jost: None. B. Grard: None. K. Poch: None. J. Launay: None. L. Faivre: None. J. Mandel: None.",2013.0,,"A. Piton1,2, H. Poquet3,4, R. Claire1,2, A. Masurel3, J. Lauer5, J. Muller1,5, J. Thevenon3,6, Y.  Herenger5, S. Chancenotte7,8, M. Bonnet8, J. Pinoit9, F. Huet3, C. Thauvin Robinet3,6, S.  LeGras1, B. Jost1, B. Grard5, K. Poch10, J. Launay10, L. Faivre3,6, J. Mandel1,5,2","1IGBMC, Strasbourg, France, 2Chaire de Gntique Humaine, Collge de France, Paris,  France, 3Centre de gntique et Centre de Rfrence Anomalies du dveloppement  et Syndromes malformatifs, Hpital dEnfants, CHU Dijon, Dijon, France, 4Service de  Pdopsychiatrie, Hpital dEnfants, CHU Dijon, France, Dijon, France, 5Laboratoire  de Diagnostic Gntique, Hpitaux Universitaires de Strasbourg, Strasbourg, France,  6EA 4271 GAD, Facult de Mdecine, Universit de Bourgogne, Dijon, France, 7Centre  de gntique et Centre de Rfrence Anomalies du dveloppement et Syndromes  malformatifs, Hpital dEnfants, CHU Dijon, France, Dijon, France, 8Centre Rfrent des  Troubles du Langage et des Apprentissages, Hpital dEnfants, CHU Dijon, Dijon, France,  94 Service de Pdopsychiatrie, Hpital dEnfants, CHU Dijon, Dijon, France, 109 Service  de Biochimie et de Biologie Molculaire, Groupe Hospitalier Universitaire Saint Louis Lariboisire Fernand Widal, AP HP , Paris, France","The identification of this point mutation confirms, for the first time since 1993, the monogenic implication of the MAOA gene in ID, autistic features and behavioral abnor malities.",,autistic features,[],"['autistic', 'feature']"
402,690,"Microduplication disrupting the MYT1L gene in a familial case of intellectual disability, and neuropsychiatric disorder.",P05.110,,"MYT1L is a member of the myelin transcription factor 1 gene family and is highly expressed in mouse embryonic brain. MYT1L interacts directly with  DISC1, which is involved in schizophrenia. We describe a family in which  the father, his son and his daughter have a 549 kb interstitial duplication in the 2p25.3 region detected by array comparative genomic hybridization and  confirmed by quantitative PCR. This duplication encompasses the five first  exons and is predicted to disrupt the MYT1L gene. The phenotype includes:  slight facial features including bulbous nasal tip, wide mouth, overfolded helix, strabismus, moderate intellectual disability (ID) with speech impedi   ment, hypotonia, hyperactivity, mood disorder with aggressive behaviour, neonatal feeding difficulties followed by a tendency to hyperphagia with overweight and a prominent abdomen with thick panniculus adiposus. Par  tial deletions of chromosome band 2p25.3 encompassing the MYT1L gene  have been reported in patients presenting with ID and overweight whereas  duplications disrupting the MYT1L gene have been reported in patients pre  senting with autism and schizophrenia. Moreover, single nucleotide poly   morphisms (SNPs) of MYT1L contribute to major depressive disorder and  schizophrenia. Recently, de Ligt et al. reported a de novo splice site mu tation of the MYT1L gene identified by exome sequencing in a patient with  severe ID, autistic features, neonatal hypotonia and feeding difficulties, as well as mild facial features.This report and previous publications strongly suggest that alterations of  the MYT1L gene are responsible for diverse neuropsychiatric disorders with  intellectual disability and a tendency to overweight.  M. Willems: None. A. Schneider: None. M. Girard: None. M. Tournaire:  None. N. Ruiz Palares: None. M. Barat: None. I. Touitou:  None. B. Echenne:  None. G. Lefort:  None. D. Genevive: None. L. Pinson:  None. J. Puechberty:  None.",2013.0,,"M. Willems1, A. Schneider2, M. Girard2, M. Tournaire2, N. Ruiz Palares2, M. Barat3, I.  Touitou3, B. Echenne4, G. Lefort2, D. Genevive1, L. Pinson1, J. Puechberty1","1Dpartement de Gntique Mdicale, Hpital Arnaud de Villeneuve, Montpellier, France,  2Dpartement de Cytogntique, Hpital Arnaud de Villeneuve, Montpellier, France,  3Laboratoire de Biologie Molculaire, Hpital Arnaud de Villeneuve, Montpellier, France,  4Dpartement de Neuropdiatrie, Hpital Gui de Chauliac, Montpellier, France","reported a de novo splice site mu tation of the MYT1L gene identified by exome sequencing in a patient with  severe ID, autistic features, neonatal hypotonia and feeding difficulties, as well as mild facial features.This report and previous publications strongly suggest that alterations of  the MYT1L gene are responsible for diverse neuropsychiatric disorders with  intellectual disability and a tendency to overweight.",,autistic features,[],"['autistic', 'feature']"
403,692,Two brothers with mental retardation and microduplication Xp22.32 p22.31,P05.112,,"Neuroligins (NL) are synaptic cell adhesion molecules that bind specifically ABSTRACTS POSTERS ESHG 2013 | PARIS, FRANCE | WWW.ESHG.ORG 183Back to index to a set of synaptic membrane proteins called neurexins. In humans, this  protein family is encoded by five genes, NLGN1,  2,  3,  4 and  4Y. Several  recent studies have implicated NL in autistic disorders and mental retar  dation. The functional role predicts that mutations and/or polymorphisms in NLGN genes may be implicated in the development of neuropsychiatric  disorders. We describe two brothers born to non consanguineous parents, with a fa mily history of mental retardation (elder brother 16 years old). Both had showed delayed psychomotor development and language disorders; phe  notypic examination were negative except for long and asymmetric face;  clinodactyly of the 5th finger of hands were present only in the second brot her. Brain MRI were normal. The karyotype analysis and genetic analysis for  X fragile syndrome were negative. Both have performed array CGH which  showed a microduplication Xp22.32 p22.31 (5,842,988 6,106,308)x2 mat. The mother was heterozygous unaffected. Our observation helps to con  firm the pathogenic role of this microriarrangements. The microduplication  highlighted our patients is in the short arm of the X chromosome that inclu   des NLGN4 gene. Our cases and the data in literature suggest that neurode   velopmental defects in autism spectrum disorders and mental retardation  (MR) could be related to a reduced function of this protein.  M. Pizzino:  None. S. Meduri:  None. C. Pidone:  None. I. Loddo:  None. E.  German: None. A. Gagliano:  None. S. Briuglia:  None.",2013.0,,"M. Pizzino , S. Meduri, C. Pidone, I. Loddo, E. German, A. Gagliano, S. Briuglia","Genetics and Pediatric Immunology, Messina, Italy",Several  recent studies have implicated NL in autistic disorders and mental retar  dation.,,autistic disorders,[],"['autistic', 'disorder']"
404,693, Alteration in synaptic genes NRXN1 and NLGN4 may predispose to neurological syndromes,P05.113,,"Neurexins and neuroligins are proteins functionally connected by interac tion in synaptic network formation and maitenance. According to recent studies alteration in NRXN1 (2p16.3) and NLGN4 (Xp22.3) genes can pre  dispose to the wide spectrum of neurodevelopmental disorders including autistic spectrum disorders, intellectual disability, speech and language de   lay, hypotonia and schizophrenia. NRXN1 as one of the largest known human  genes (1,1 Mb) tends to frequent intragenic alterations. Whole genome ge notyping was performed using the Illumina HumanCytoSNP 12v2.1.We present 3 children of comparable age (5 6 year old), having different size of microdeletion in isoform alpha1 NRXN1 gene (40   360 kb ) and slightly  different phenotype. All children had mild to moderate mental retardation, two of them had speech delay and anxiosity, hypotonia and facial dysmor   phism. Two of detected deletions were intronic, the third deletion covered exones 1 to 11 of NRXN1. As the deletion in the NRXN1 may not be fully  penetrant, we examine also parental DNA.Microduplication (300 kb) spanning the exones 1,2 and 3 of NLGN4 gene  was found in 22 year old patient with hyperkinetic syndrome, attention failure, but without mental retardation. The same duplication was detected in clinically normal mother and maternal cousin with Asperger syndrome. Thanks to this family examination prenatal array diagnosis in a new preg nancy could be provided. Consequently probands brother without duplica   tion in NLGN4 was born.  V. Becvarova:  None. L. Hnykova: None. H. Machkova: None. E. Hlavova:  None. G. Kreckova: None. J. Horacek:  None. I. Soldatova:  None. M. Putzova:  None. D. Stejskal: None. M. Godava: None. E. Zemankova: None. M. Trkova: None.",2013.0,,"V. Becvarova1, L. Hnykova1, H. Machkova1, E. Hlavova1, G. Kreckova1, J. Horacek1, I.  Soldatova1, M. Putzova1, D. Stejskal1, M. Godava2, E. Zemankova3, M. Trkova1","1GENNET , Prague, Czech Republic, 2Department of medical genetics, University Hospital,  Olomouc, Czech Republic, 3E med, Benesov, Czech Republic","According to recent studies alteration in NRXN1 (2p16.3) and NLGN4 (Xp22.3) genes can pre  dispose to the wide spectrum of neurodevelopmental disorders including autistic spectrum disorders, intellectual disability, speech and language de   lay, hypotonia and schizophrenia.",,autistic spectrum,[],"['autistic', 'spectrum']"
404,693, Alteration in synaptic genes NRXN1 and NLGN4 may predispose to neurological syndromes,P05.113,,"Neurexins and neuroligins are proteins functionally connected by interac tion in synaptic network formation and maitenance. According to recent studies alteration in NRXN1 (2p16.3) and NLGN4 (Xp22.3) genes can pre  dispose to the wide spectrum of neurodevelopmental disorders including autistic spectrum disorders, intellectual disability, speech and language de   lay, hypotonia and schizophrenia. NRXN1 as one of the largest known human  genes (1,1 Mb) tends to frequent intragenic alterations. Whole genome ge notyping was performed using the Illumina HumanCytoSNP 12v2.1.We present 3 children of comparable age (5 6 year old), having different size of microdeletion in isoform alpha1 NRXN1 gene (40   360 kb ) and slightly  different phenotype. All children had mild to moderate mental retardation, two of them had speech delay and anxiosity, hypotonia and facial dysmor   phism. Two of detected deletions were intronic, the third deletion covered exones 1 to 11 of NRXN1. As the deletion in the NRXN1 may not be fully  penetrant, we examine also parental DNA.Microduplication (300 kb) spanning the exones 1,2 and 3 of NLGN4 gene  was found in 22 year old patient with hyperkinetic syndrome, attention failure, but without mental retardation. The same duplication was detected in clinically normal mother and maternal cousin with Asperger syndrome. Thanks to this family examination prenatal array diagnosis in a new preg nancy could be provided. Consequently probands brother without duplica   tion in NLGN4 was born.  V. Becvarova:  None. L. Hnykova: None. H. Machkova: None. E. Hlavova:  None. G. Kreckova: None. J. Horacek:  None. I. Soldatova:  None. M. Putzova:  None. D. Stejskal: None. M. Godava: None. E. Zemankova: None. M. Trkova: None.",2013.0,,"V. Becvarova1, L. Hnykova1, H. Machkova1, E. Hlavova1, G. Kreckova1, J. Horacek1, I.  Soldatova1, M. Putzova1, D. Stejskal1, M. Godava2, E. Zemankova3, M. Trkova1","1GENNET , Prague, Czech Republic, 2Department of medical genetics, University Hospital,  Olomouc, Czech Republic, 3E med, Benesov, Czech Republic",The same duplication was detected in clinically normal mother and maternal cousin with Asperger syndrome.,cousin with Asperger,Asperger syndrome,"['cousin', 'with', 'Asperger']","['Asperger', 'syndrome']"
407,703,"Mutation analysis of MECP2, CDKL5, and FOXG1 genes in Czech patients with Rett syndrome and Rett like phenotype",P05.124,,"Rett syndrome is a severe X linked dominant neurodevelopmental disorder affecting mostly females and primarily caused by de novo mutations in the MECP2 gene. It is characterized by developmental regression, acquired mi crocephaly, loss of purposeful hand use and speech, stereotypic hand mo vements, autistic features, gait apraxia, breathing anomalies, and seizures. Mutations in other genes have been identified in early onset seizure variant (CDKL5) and congenital variant (FOXG1) of Rett syndrome. We report the results of molecular analysis of MECP2, CDKL5, and FOXG1 genes in patients with Rett syndrome and mental retardation with Rett like features from Czech Republic.MECP2 and CDKL5 were analyzed by high resolution melting analysis and DNA sequencing of coding regions and exon/intron boundaries. FOXG1 was analyzed by DNA sequencing. Large deletions in all three genes were analy   zed by multiplex ligation dependent probe amplification.We identified MECP2 mutations in 65 out of 86 patients with classic Rett syndrome (76%). 20 patients with Rett syndrome variants were initially screened for MECP2 mutations and 6 MECP2 mutations were identified (30%). The subsequent analysis of CDKL5 gene in patients with early onset seizure variant revealed mutations in 2 cases (6,7%). No mutation has been identified in FOXG1 gene in the patients with congenital variant of Rett syn drome.We confirmed the high frequency of MECP2 mutations in classic Rett syn ABSTRACTS POSTERS ESHG 2013 | PARIS, FRANCE | WWW.ESHG.ORG 186Back to index drome. On the other hand, MECP2 mutations are not a frequent cause of  early onset seizure and congenital variant of Rett syndrome or mental re  tardation with Rett like phenotype. Supported by grants NT 13120 4/2012, MZCR RVO VFN64165/2012, P24/LF1/3, and UNCE 204011/2012.  D. Zahorakova: None. A. Puchmajerova: None. A. Baxova: None. P. Martasek:   None.",2013.0,,"D. Zahorakova1, A. Puchmajerova1, A. Baxova2, P . Martasek1","1Department of Pediatrics, 1st Faculty of Medicine, Charles University in Prague and  General Teaching Hospital, Prague, Czech Republic, 2Institute of Biology and Clinical  Genetics, 1st Faculty of Medicine, Charles University in Prague and General Teaching Hospital, Prague, Czech Republic","It is characterized by developmental regression, acquired mi crocephaly, loss of purposeful hand use and speech, stereotypic hand mo vements, autistic features, gait apraxia, breathing anomalies, and seizures.",,autistic features,[],"['autistic', 'feature']"
408,706, Characterization of novel de novo mutation in the SLC6A8 gene,P05.127,,"Introduction: Cerebral creatine deficiency is an X linked disorder caused by mutations in the SLC6A8  gene (Xq28). It consists of 13 exons and encodes a  protein of 635 amino acids. This disorder causes an increase of creatine le vels in urine and plasma, and urinary creatine/creatinine ratio. The clinical presentation of males affected is mental retardation, expressive speech and language delay, epilepsy, developmental delay and autistic behaviour.Subjects and Methods: An 8 year old male patient presents learning diffi   culties, behaviour disorder and epilepsy. An increase of creatine/creatinine ratio, guanidineacetate and glycine levels (plasma and urine) was detected. The 13 exons of the SLC6A8 gene, including the intron exon junctions, were  analyzed by PCR and direct sequencing reaction.Results: We detected a 34 pb deletion (c.1016+11_1017 52del34) in intron 6, that was predicted to cause an aberrant splicing into acceptor splice site. At the cDNA level, this mutation produces a 30 pb deletion in exon 7 and a single amino acid insertion (p. K339_S349delinsN). This variant was not detected in the mother and is therefore considered de novo.Discussion: DNA and RNA analysis were necessary to characterize this novel pathogenic mutation. The detected change in the creatine transporter could be responsible for a lower and/or no activity of the protein. Functional stu dies in cultured skin fibroblasts will be necessary to show  a deficiency of the  creatine transporter function.   J. Aguirre Lamban: None. C. Cervera Acedo:  None. E. Sarasola: None. L.  Calvo Perez:  None. A. Garcia Oguiza: None. J. Garcia Peas: None. M.  Garcia Barcina:  None. M. Poch Olive:  None. E. Dominguez Garrido:  None.",2013.0,,"J. Aguirre Lamban1, C. Cervera Acedo1, E. Sarasola2, L. Calvo Perez3, A. Garcia Oguiza3,  J. Garcia Peas4, M. Garcia Barcina2, M. Poch Olive3, E. Dominguez Garrido1","1Fundacion RiojaSalud CIBIR, Logroo, Spain, 2Hospital de Basurto, Bilbao, Spain,  3Hospital San Pedro, Logroo, Spain, 4Hospital Nio Jesus, Madrid, Spain","The clinical presentation of males affected is mental retardation, expressive speech and language delay, epilepsy, developmental delay and autistic behaviour.Subjects and Methods: An 8 year old male patient presents learning diffi   culties, behaviour disorder and epilepsy.",,autistic behaviour,[],"['autistic', 'behaviour']"
410,728,The association analysis of ABHD11 gene (rs2293484 and rs10279013 with autism in a South African population.,P06.05,,"Background : Autism is genetically inherited neurodevelopmental disorder characterized by significant impairments of social interaction, difficulties in communication and displays of restrictive or repetitive behaviors activi ties and interests. Genome scan data have pointed towards the long arm of chromosome 7 as a strong candidate region. Various association and linkage studies are being undertaken in order to screen candidate genes mapping to the long arm of chromosome 7 as susceptibility loci. The anhydrolase do   main containing 11 gene (ABHD11) is located on 7q11.23 which is a hotspot region for autism. This gene has not been investigated for its association to autism. Aims : The aim of this study was to investigate the association of two SNPs from genes ABHD11 (rs2293484 and rs10279013) in South African autistic population.Methods : A total of 435 individuals were recruited in cluding 217 autistic and 218 control subjects. The Taqman Real Time PCR and geno typing assay was utilized to determine the genotypes. Results: A significant association of SNP rs10279013 but not for SNP rs229348 with autism in the South African (SA) population is observed. Conclusion: There might be a possible role of ABHD11 in autism especially for SA populations. The present study represents the first report on genetic association studies on ABHD11 gene in SA population  Z. Arieff: None. J.R. Sharma: None. M. Davids: None. M. Kaur: None.",2013.0,,"Z. Arieff1, J. R. Sharma1, M. Davids1, M. Kaur2","1Department of Biotechnogy,University of Western Cape, Private Bag X17, Bellville 7535,  South Africa, South Africa, 2Computational Bioscience Research Center, King Abdullah  University of Science and Technology, Thuwal 2355 6900, Kingdom of Saudi Arabia, Saudi Arabia",Aims : The aim of this study was to investigate the association of two SNPs from genes ABHD11 (rs2293484 and rs10279013) in South African autistic population.Methods : A total of 435 individuals were recruited in cluding 217 autistic and 218 control subjects.,,autistic population,[],"['autistic', 'population']"
410,728,The association analysis of ABHD11 gene (rs2293484 and rs10279013 with autism in a South African population.,P06.05,,"Background : Autism is genetically inherited neurodevelopmental disorder characterized by significant impairments of social interaction, difficulties in communication and displays of restrictive or repetitive behaviors activi ties and interests. Genome scan data have pointed towards the long arm of chromosome 7 as a strong candidate region. Various association and linkage studies are being undertaken in order to screen candidate genes mapping to the long arm of chromosome 7 as susceptibility loci. The anhydrolase do   main containing 11 gene (ABHD11) is located on 7q11.23 which is a hotspot region for autism. This gene has not been investigated for its association to autism. Aims : The aim of this study was to investigate the association of two SNPs from genes ABHD11 (rs2293484 and rs10279013) in South African autistic population.Methods : A total of 435 individuals were recruited in cluding 217 autistic and 218 control subjects. The Taqman Real Time PCR and geno typing assay was utilized to determine the genotypes. Results: A significant association of SNP rs10279013 but not for SNP rs229348 with autism in the South African (SA) population is observed. Conclusion: There might be a possible role of ABHD11 in autism especially for SA populations. The present study represents the first report on genetic association studies on ABHD11 gene in SA population  Z. Arieff: None. J.R. Sharma: None. M. Davids: None. M. Kaur: None.",2013.0,,"Z. Arieff1, J. R. Sharma1, M. Davids1, M. Kaur2","1Department of Biotechnogy,University of Western Cape, Private Bag X17, Bellville 7535,  South Africa, South Africa, 2Computational Bioscience Research Center, King Abdullah  University of Science and Technology, Thuwal 2355 6900, Kingdom of Saudi Arabia, Saudi Arabia",Results: A significant association of SNP rs10279013 but not for SNP rs229348 with autism in the South African (SA) population is observed.,rs229348 with autism,,"['rs229348', 'with', 'autism']",[]
411,729,"CNV characterization, inheritance and phenotypic correlations in families with autism",P06.06,,"In this study, we characterized potentially pathogenic CNVs in a sample of 342 Portuguese children with Autism Spectrum Disorders (ASDs), geno typed by the Autism Genome Project whole genome CNV analysis. We selec ted high confidence CNVs (detected by 3 algorithms) not overlapping more than 20% with CNVs in 8000 controls.We identified 165 CNVs in 132 individuals, 78% with only one CNV. CNVs ranged from 5 kb to 3 Mb, and 67% were deletions. However, genic CNVs, which represented 53% of all CNVs, were more frequently duplications (65%). Genic CNVs integrated between 1 and 17 genes, and included genes implicated in ASD etiology like NRXN1 and CHD2, as well as novel genes.  CNVs were mainly inherited, with only 10% de novo. We further evaluated the presence of autistic traits in parents, using appro priate questionnaires, and the type of inheritance of the CNV (inherited vs  de novo). We observed a significant excess of autistic traits in the fathers  that transmitted CNVs, mainly for the aloof personality, defined as lak   king interest in social interaction. Analysis of familial correlation data from  parents and probands showed a significant correlation between parents. We  therefore show evidence for an excess of subthreshold autistic traits in CNV transmitting parents of children with ASD, particularly for paternal trans mission. We also observed a tendency for assortative mating in families of  affected individuals, in particular for inherited CNVs. We conclude that a large fraction of CNVs are inherited and correlate with autistic traits in parents in the studied sample.  I.C. Conceio: None. C. Correia: None. B. Oliveira: None. M.M. Rama: None. C. Caf: None. J. Almeida: None. S. Mouga:  None. F. Duque:  None. G.  Oliveira: None. A.M. Vicente: None.",2013.0,,"I. C. Conceio1,2,3, C. Correia1,2,3, B. Oliveira1,2,3, M. M. Rama1, C. Caf4, J. Almeida4, S.  Mouga4,5, F. Duque4,6, G. Oliveira4,5,7, A. M. Vicente1,2,3","1Instituto Nacional de Sade Doutor Ricardo Jorge, Lisbon, Portugal, 2Center for  Biodiversity, Functional & Integrative Genomics, Lisbon, Portugal, 3Instituto Gulbenkian  de Cincia, Oeiras, Portugal, 4Unidade Neurodesenvolvimento e Autismo, Centro de  Desenvolvimento, Hospital Peditrico (HP), Centro Hospitalar e Universitrio de Coimbra (CHUC), Coimbra, Portugal,  5Instituto Biomdico de Investigao em Luz  e Imagem, Faculdade de Medicina da Universidade de Coimbra, Coimbra, Portugal,  6Faculdade de Medicina da Universidade de Coimbra, Coimbra, Portugal, 7Centro de  Investigao e Formao Clinica do HP CHUC, Coimbra, Portugal","In this study, we characterized potentially pathogenic CNVs in a sample of 342 Portuguese children with Autism Spectrum Disorders (ASDs), geno typed by the Autism Genome Project whole genome CNV analysis.",children with Autism,,"['child', 'with', 'Autism']",[]
411,729,"CNV characterization, inheritance and phenotypic correlations in families with autism",P06.06,,"In this study, we characterized potentially pathogenic CNVs in a sample of 342 Portuguese children with Autism Spectrum Disorders (ASDs), geno typed by the Autism Genome Project whole genome CNV analysis. We selec ted high confidence CNVs (detected by 3 algorithms) not overlapping more than 20% with CNVs in 8000 controls.We identified 165 CNVs in 132 individuals, 78% with only one CNV. CNVs ranged from 5 kb to 3 Mb, and 67% were deletions. However, genic CNVs, which represented 53% of all CNVs, were more frequently duplications (65%). Genic CNVs integrated between 1 and 17 genes, and included genes implicated in ASD etiology like NRXN1 and CHD2, as well as novel genes.  CNVs were mainly inherited, with only 10% de novo. We further evaluated the presence of autistic traits in parents, using appro priate questionnaires, and the type of inheritance of the CNV (inherited vs  de novo). We observed a significant excess of autistic traits in the fathers  that transmitted CNVs, mainly for the aloof personality, defined as lak   king interest in social interaction. Analysis of familial correlation data from  parents and probands showed a significant correlation between parents. We  therefore show evidence for an excess of subthreshold autistic traits in CNV transmitting parents of children with ASD, particularly for paternal trans mission. We also observed a tendency for assortative mating in families of  affected individuals, in particular for inherited CNVs. We conclude that a large fraction of CNVs are inherited and correlate with autistic traits in parents in the studied sample.  I.C. Conceio: None. C. Correia: None. B. Oliveira: None. M.M. Rama: None. C. Caf: None. J. Almeida: None. S. Mouga:  None. F. Duque:  None. G.  Oliveira: None. A.M. Vicente: None.",2013.0,,"I. C. Conceio1,2,3, C. Correia1,2,3, B. Oliveira1,2,3, M. M. Rama1, C. Caf4, J. Almeida4, S.  Mouga4,5, F. Duque4,6, G. Oliveira4,5,7, A. M. Vicente1,2,3","1Instituto Nacional de Sade Doutor Ricardo Jorge, Lisbon, Portugal, 2Center for  Biodiversity, Functional & Integrative Genomics, Lisbon, Portugal, 3Instituto Gulbenkian  de Cincia, Oeiras, Portugal, 4Unidade Neurodesenvolvimento e Autismo, Centro de  Desenvolvimento, Hospital Peditrico (HP), Centro Hospitalar e Universitrio de Coimbra (CHUC), Coimbra, Portugal,  5Instituto Biomdico de Investigao em Luz  e Imagem, Faculdade de Medicina da Universidade de Coimbra, Coimbra, Portugal,  6Faculdade de Medicina da Universidade de Coimbra, Coimbra, Portugal, 7Centro de  Investigao e Formao Clinica do HP CHUC, Coimbra, Portugal","Genic CNVs integrated between 1 and 17 genes, and included genes implicated in ASD etiology like NRXN1 and CHD2, as well as novel genes.",,ASD etiology,[],"['ASD', 'etiology']"
411,729,"CNV characterization, inheritance and phenotypic correlations in families with autism",P06.06,,"In this study, we characterized potentially pathogenic CNVs in a sample of 342 Portuguese children with Autism Spectrum Disorders (ASDs), geno typed by the Autism Genome Project whole genome CNV analysis. We selec ted high confidence CNVs (detected by 3 algorithms) not overlapping more than 20% with CNVs in 8000 controls.We identified 165 CNVs in 132 individuals, 78% with only one CNV. CNVs ranged from 5 kb to 3 Mb, and 67% were deletions. However, genic CNVs, which represented 53% of all CNVs, were more frequently duplications (65%). Genic CNVs integrated between 1 and 17 genes, and included genes implicated in ASD etiology like NRXN1 and CHD2, as well as novel genes.  CNVs were mainly inherited, with only 10% de novo. We further evaluated the presence of autistic traits in parents, using appro priate questionnaires, and the type of inheritance of the CNV (inherited vs  de novo). We observed a significant excess of autistic traits in the fathers  that transmitted CNVs, mainly for the aloof personality, defined as lak   king interest in social interaction. Analysis of familial correlation data from  parents and probands showed a significant correlation between parents. We  therefore show evidence for an excess of subthreshold autistic traits in CNV transmitting parents of children with ASD, particularly for paternal trans mission. We also observed a tendency for assortative mating in families of  affected individuals, in particular for inherited CNVs. We conclude that a large fraction of CNVs are inherited and correlate with autistic traits in parents in the studied sample.  I.C. Conceio: None. C. Correia: None. B. Oliveira: None. M.M. Rama: None. C. Caf: None. J. Almeida: None. S. Mouga:  None. F. Duque:  None. G.  Oliveira: None. A.M. Vicente: None.",2013.0,,"I. C. Conceio1,2,3, C. Correia1,2,3, B. Oliveira1,2,3, M. M. Rama1, C. Caf4, J. Almeida4, S.  Mouga4,5, F. Duque4,6, G. Oliveira4,5,7, A. M. Vicente1,2,3","1Instituto Nacional de Sade Doutor Ricardo Jorge, Lisbon, Portugal, 2Center for  Biodiversity, Functional & Integrative Genomics, Lisbon, Portugal, 3Instituto Gulbenkian  de Cincia, Oeiras, Portugal, 4Unidade Neurodesenvolvimento e Autismo, Centro de  Desenvolvimento, Hospital Peditrico (HP), Centro Hospitalar e Universitrio de Coimbra (CHUC), Coimbra, Portugal,  5Instituto Biomdico de Investigao em Luz  e Imagem, Faculdade de Medicina da Universidade de Coimbra, Coimbra, Portugal,  6Faculdade de Medicina da Universidade de Coimbra, Coimbra, Portugal, 7Centro de  Investigao e Formao Clinica do HP CHUC, Coimbra, Portugal","We further evaluated the presence of autistic traits in parents, using appro priate questionnaires, and the type of inheritance of the CNV (inherited vs  de novo).",,autistic traits,[],"['autistic', 'trait']"
411,729,"CNV characterization, inheritance and phenotypic correlations in families with autism",P06.06,,"In this study, we characterized potentially pathogenic CNVs in a sample of 342 Portuguese children with Autism Spectrum Disorders (ASDs), geno typed by the Autism Genome Project whole genome CNV analysis. We selec ted high confidence CNVs (detected by 3 algorithms) not overlapping more than 20% with CNVs in 8000 controls.We identified 165 CNVs in 132 individuals, 78% with only one CNV. CNVs ranged from 5 kb to 3 Mb, and 67% were deletions. However, genic CNVs, which represented 53% of all CNVs, were more frequently duplications (65%). Genic CNVs integrated between 1 and 17 genes, and included genes implicated in ASD etiology like NRXN1 and CHD2, as well as novel genes.  CNVs were mainly inherited, with only 10% de novo. We further evaluated the presence of autistic traits in parents, using appro priate questionnaires, and the type of inheritance of the CNV (inherited vs  de novo). We observed a significant excess of autistic traits in the fathers  that transmitted CNVs, mainly for the aloof personality, defined as lak   king interest in social interaction. Analysis of familial correlation data from  parents and probands showed a significant correlation between parents. We  therefore show evidence for an excess of subthreshold autistic traits in CNV transmitting parents of children with ASD, particularly for paternal trans mission. We also observed a tendency for assortative mating in families of  affected individuals, in particular for inherited CNVs. We conclude that a large fraction of CNVs are inherited and correlate with autistic traits in parents in the studied sample.  I.C. Conceio: None. C. Correia: None. B. Oliveira: None. M.M. Rama: None. C. Caf: None. J. Almeida: None. S. Mouga:  None. F. Duque:  None. G.  Oliveira: None. A.M. Vicente: None.",2013.0,,"I. C. Conceio1,2,3, C. Correia1,2,3, B. Oliveira1,2,3, M. M. Rama1, C. Caf4, J. Almeida4, S.  Mouga4,5, F. Duque4,6, G. Oliveira4,5,7, A. M. Vicente1,2,3","1Instituto Nacional de Sade Doutor Ricardo Jorge, Lisbon, Portugal, 2Center for  Biodiversity, Functional & Integrative Genomics, Lisbon, Portugal, 3Instituto Gulbenkian  de Cincia, Oeiras, Portugal, 4Unidade Neurodesenvolvimento e Autismo, Centro de  Desenvolvimento, Hospital Peditrico (HP), Centro Hospitalar e Universitrio de Coimbra (CHUC), Coimbra, Portugal,  5Instituto Biomdico de Investigao em Luz  e Imagem, Faculdade de Medicina da Universidade de Coimbra, Coimbra, Portugal,  6Faculdade de Medicina da Universidade de Coimbra, Coimbra, Portugal, 7Centro de  Investigao e Formao Clinica do HP CHUC, Coimbra, Portugal","We observed a significant excess of autistic traits in the fathers  that transmitted CNVs, mainly for the aloof personality, defined as lak   king interest in social interaction.",,autistic traits,[],"['autistic', 'trait']"
411,729,"CNV characterization, inheritance and phenotypic correlations in families with autism",P06.06,,"In this study, we characterized potentially pathogenic CNVs in a sample of 342 Portuguese children with Autism Spectrum Disorders (ASDs), geno typed by the Autism Genome Project whole genome CNV analysis. We selec ted high confidence CNVs (detected by 3 algorithms) not overlapping more than 20% with CNVs in 8000 controls.We identified 165 CNVs in 132 individuals, 78% with only one CNV. CNVs ranged from 5 kb to 3 Mb, and 67% were deletions. However, genic CNVs, which represented 53% of all CNVs, were more frequently duplications (65%). Genic CNVs integrated between 1 and 17 genes, and included genes implicated in ASD etiology like NRXN1 and CHD2, as well as novel genes.  CNVs were mainly inherited, with only 10% de novo. We further evaluated the presence of autistic traits in parents, using appro priate questionnaires, and the type of inheritance of the CNV (inherited vs  de novo). We observed a significant excess of autistic traits in the fathers  that transmitted CNVs, mainly for the aloof personality, defined as lak   king interest in social interaction. Analysis of familial correlation data from  parents and probands showed a significant correlation between parents. We  therefore show evidence for an excess of subthreshold autistic traits in CNV transmitting parents of children with ASD, particularly for paternal trans mission. We also observed a tendency for assortative mating in families of  affected individuals, in particular for inherited CNVs. We conclude that a large fraction of CNVs are inherited and correlate with autistic traits in parents in the studied sample.  I.C. Conceio: None. C. Correia: None. B. Oliveira: None. M.M. Rama: None. C. Caf: None. J. Almeida: None. S. Mouga:  None. F. Duque:  None. G.  Oliveira: None. A.M. Vicente: None.",2013.0,,"I. C. Conceio1,2,3, C. Correia1,2,3, B. Oliveira1,2,3, M. M. Rama1, C. Caf4, J. Almeida4, S.  Mouga4,5, F. Duque4,6, G. Oliveira4,5,7, A. M. Vicente1,2,3","1Instituto Nacional de Sade Doutor Ricardo Jorge, Lisbon, Portugal, 2Center for  Biodiversity, Functional & Integrative Genomics, Lisbon, Portugal, 3Instituto Gulbenkian  de Cincia, Oeiras, Portugal, 4Unidade Neurodesenvolvimento e Autismo, Centro de  Desenvolvimento, Hospital Peditrico (HP), Centro Hospitalar e Universitrio de Coimbra (CHUC), Coimbra, Portugal,  5Instituto Biomdico de Investigao em Luz  e Imagem, Faculdade de Medicina da Universidade de Coimbra, Coimbra, Portugal,  6Faculdade de Medicina da Universidade de Coimbra, Coimbra, Portugal, 7Centro de  Investigao e Formao Clinica do HP CHUC, Coimbra, Portugal","We  therefore show evidence for an excess of subthreshold autistic traits in CNV transmitting parents of children with ASD, particularly for paternal trans mission.",children with ASD,autistic traits,"['child', 'with', 'ASD']","['autistic', 'trait']"
411,729,"CNV characterization, inheritance and phenotypic correlations in families with autism",P06.06,,"In this study, we characterized potentially pathogenic CNVs in a sample of 342 Portuguese children with Autism Spectrum Disorders (ASDs), geno typed by the Autism Genome Project whole genome CNV analysis. We selec ted high confidence CNVs (detected by 3 algorithms) not overlapping more than 20% with CNVs in 8000 controls.We identified 165 CNVs in 132 individuals, 78% with only one CNV. CNVs ranged from 5 kb to 3 Mb, and 67% were deletions. However, genic CNVs, which represented 53% of all CNVs, were more frequently duplications (65%). Genic CNVs integrated between 1 and 17 genes, and included genes implicated in ASD etiology like NRXN1 and CHD2, as well as novel genes.  CNVs were mainly inherited, with only 10% de novo. We further evaluated the presence of autistic traits in parents, using appro priate questionnaires, and the type of inheritance of the CNV (inherited vs  de novo). We observed a significant excess of autistic traits in the fathers  that transmitted CNVs, mainly for the aloof personality, defined as lak   king interest in social interaction. Analysis of familial correlation data from  parents and probands showed a significant correlation between parents. We  therefore show evidence for an excess of subthreshold autistic traits in CNV transmitting parents of children with ASD, particularly for paternal trans mission. We also observed a tendency for assortative mating in families of  affected individuals, in particular for inherited CNVs. We conclude that a large fraction of CNVs are inherited and correlate with autistic traits in parents in the studied sample.  I.C. Conceio: None. C. Correia: None. B. Oliveira: None. M.M. Rama: None. C. Caf: None. J. Almeida: None. S. Mouga:  None. F. Duque:  None. G.  Oliveira: None. A.M. Vicente: None.",2013.0,,"I. C. Conceio1,2,3, C. Correia1,2,3, B. Oliveira1,2,3, M. M. Rama1, C. Caf4, J. Almeida4, S.  Mouga4,5, F. Duque4,6, G. Oliveira4,5,7, A. M. Vicente1,2,3","1Instituto Nacional de Sade Doutor Ricardo Jorge, Lisbon, Portugal, 2Center for  Biodiversity, Functional & Integrative Genomics, Lisbon, Portugal, 3Instituto Gulbenkian  de Cincia, Oeiras, Portugal, 4Unidade Neurodesenvolvimento e Autismo, Centro de  Desenvolvimento, Hospital Peditrico (HP), Centro Hospitalar e Universitrio de Coimbra (CHUC), Coimbra, Portugal,  5Instituto Biomdico de Investigao em Luz  e Imagem, Faculdade de Medicina da Universidade de Coimbra, Coimbra, Portugal,  6Faculdade de Medicina da Universidade de Coimbra, Coimbra, Portugal, 7Centro de  Investigao e Formao Clinica do HP CHUC, Coimbra, Portugal",We conclude that a large fraction of CNVs are inherited and correlate with autistic traits in parents in the studied sample.,,autistic traits,[],"['autistic', 'trait']"
412,730,Missing heritability of Korean patient with autism spectrum disorder(ASD),P06.07,,"Genome wide association studies (GWAS) have been identified SNPs asso   ciated with complex traits. However, a great deal of the heritable variation associated with common traits remains unaccounted for within the geno me. The objective of this study is to discover large parts of additive gene tic variance not typically associated with autism spectrum disorder (ASD) through GWAS in Korean population and estimates of ASD heritability.Subjects with ASD were recruited through the Korean Autism Genetic Study Consortium. Each child was diagnosed as ASD by using the Korean versions of ADOS and ADI R (Lord et al. 1994; Lord et al. 1997).Total 146 patients were genotyped on the Affymetrix 5.0 platform. Geno   type data for n,858 sex matched controls were drawn from the Korea As sociation Resource database. Genotype data were filtered for <5% missing   ness/sample or /SNP; MAF >0.01; HWE p>0.0001. Cases were verified as unrelated using identity by descent estimation in PLINK v1.07. In order to examine the missing heritability in ASD, we applied genome wide complex trait analysis (GCTA) to 142 case and 842 controls after data filtering.The results identified phenotypic variants of 84.5% (0.313 SE) with affec ted status of ASD, 7.0% (0.027 SE) with topGWAS SNPs ( 1mb region) and 81.0%( 0.313 SE) with nonGWAS SNPs. Increase from the genetic variance identified by top GWAS hits region indicates there might be more risk loci to be identified. Our results suggest that many common variants of small effect remain to be discovered, although GWAS is useful in identifying the most common variants associated with ASD.  J.E. Park: None. S.A. Kim: None. M. Park: None. I.H. Cho:  None. H.J. Yoo:  None.",2013.0,,"J. E. Park1, S. A. Kim2, M. Park3, I. H. Cho4, H. J. Yoo5","1Department of Psychiatry, Seoul National University Bundang Hospital and  Department of Agricultural Biotechnology , College of Agricaltural Life Science, Seoul  National University, Seoungnam si, Korea, Republic of, 2Department of Pharmacology,  College of Medicine, Eulji University, Daejeon, Korea, Republic of, 3Department of  Preventive Medicine, College of Medicine, Eulji University, Seoungnam si, Korea,  Republic of, 4Department of Psychiatry, Gacheon University School of Medical Science,  Incheon, Korea, Republic of, 5Department of Psychiatry, College of Medicine, Seoul  National University Seoul National University Bundang Hospital, Seoungnam si, Korea, Republic of",The objective of this study is to discover large parts of additive gene tic variance not typically associated with autism spectrum disorder (ASD) through GWAS in Korean population and estimates of ASD heritability.Subjects with ASD were recruited through the Korean Autism Genetic Study Consortium.,Subjects with ASD,ASD heritability,"['Subjects', 'with', 'ASD']","['ASD', 'heritability']"
413,731,A rare microdeletion disrupting KLHL23 may influence the autism phenotype,P06.08,,"Autism spectrum disorder (ASD) is a severe neurodevelopmental disorder with highly complex genetic predisposition.Rare copy number variants (CNVs) are known to play a role in the genetic etiology of ASD. The follow up of these rare events, by targeted gene sequen   cing and functional studies, has proven to be a powerful tool for the identi ABSTRACTS POSTERS ESHG 2013 | PARIS, FRANCE | WWW.ESHG.ORG 193Back to index fication of novel candidate genetic loci. In a genome wide CNVs screening performed by the AGP , a rare inherited  microdeletion, disrupting two genes transcribed in the same direction,  KLHL23 and SSB, was identified in an Italian ASD individual. This deletion, potentially resulting in a gene fusion transcript, causes a frameshift with the  introduction of a premature stop codon. No fusion transcript was detected  by RT PCR, suggesting that it is subject to nonsense mediated mRNA decay. KLHL23 encodes for a brain expressed Kelch repeat protein of unknown function. While several CNVs affecting SSB are reported in controls making  it an unikely dosege sensitive gene, no CNVs have been previously described  in KLHL23. KLHL23 expression analysis in peripheral blood of the CNV car riers did not show reduction of RNA levels, although we cant exclude that  the deletion could have an effect on the brain. In a mutation screening of KLHL23 in 85 multiplex familis with ASD we identified a damaging variant (M65V), absent in controls, and segregating  with the ASD in an affected sibling pair. Taken together our results suggest that rare variants altering KLHL23 func tion in the brain, could contribute to ASD risk in a small number of cases.  S. Lomartire: None. E. Bacchelli: None. F. Ceroni: None. F. Minopoli:  None. C.  Cameli: None. R. Tancredi: None. I. M.g.s.a.c.:  None. A.P. Monaco:  None. A.  Battaglia: None. E. Maestrini: None. A. G.p.:  None.",2013.0,,"S. Lomartire1, E. Bacchelli1, F. Ceroni1, F. Minopoli1, C. Cameli1, R. Tancredi2, I. M.G.S.A.C.3,  A. P . Monaco4,5, A. Battaglia2, E. Maestrini1, A. G.P .6","1FaBiT  Dipartimento di Farmacia e BioTecnologie, Bologna, Italy, 2Stella Maris Istituto  Scientifico per la Neuropsichiatria dellInfanzia e dellAdolescenza, Calambrone, Pisa, Italy,  3International Molecular Genetic Study of Autism Consortium, Newcastle upon  Tyne, United Kingdom, 4Wellcome Trust Centre for Human Genetics, University of  Oxford,, Oxford OX3 7BN, United Kingdom, 5Office of the President, Tufts University,  Boston, MA, United States, 6Autism Genome Project, USA, CA, United States","In a genome wide CNVs screening performed by the AGP , a rare inherited  microdeletion, disrupting two genes transcribed in the same direction,  KLHL23 and SSB, was identified in an Italian ASD individual.",,ASD individual,[],"['ASD', 'individual']"
413,731,A rare microdeletion disrupting KLHL23 may influence the autism phenotype,P06.08,,"Autism spectrum disorder (ASD) is a severe neurodevelopmental disorder with highly complex genetic predisposition.Rare copy number variants (CNVs) are known to play a role in the genetic etiology of ASD. The follow up of these rare events, by targeted gene sequen   cing and functional studies, has proven to be a powerful tool for the identi ABSTRACTS POSTERS ESHG 2013 | PARIS, FRANCE | WWW.ESHG.ORG 193Back to index fication of novel candidate genetic loci. In a genome wide CNVs screening performed by the AGP , a rare inherited  microdeletion, disrupting two genes transcribed in the same direction,  KLHL23 and SSB, was identified in an Italian ASD individual. This deletion, potentially resulting in a gene fusion transcript, causes a frameshift with the  introduction of a premature stop codon. No fusion transcript was detected  by RT PCR, suggesting that it is subject to nonsense mediated mRNA decay. KLHL23 encodes for a brain expressed Kelch repeat protein of unknown function. While several CNVs affecting SSB are reported in controls making  it an unikely dosege sensitive gene, no CNVs have been previously described  in KLHL23. KLHL23 expression analysis in peripheral blood of the CNV car riers did not show reduction of RNA levels, although we cant exclude that  the deletion could have an effect on the brain. In a mutation screening of KLHL23 in 85 multiplex familis with ASD we identified a damaging variant (M65V), absent in controls, and segregating  with the ASD in an affected sibling pair. Taken together our results suggest that rare variants altering KLHL23 func tion in the brain, could contribute to ASD risk in a small number of cases.  S. Lomartire: None. E. Bacchelli: None. F. Ceroni: None. F. Minopoli:  None. C.  Cameli: None. R. Tancredi: None. I. M.g.s.a.c.:  None. A.P. Monaco:  None. A.  Battaglia: None. E. Maestrini: None. A. G.p.:  None.",2013.0,,"S. Lomartire1, E. Bacchelli1, F. Ceroni1, F. Minopoli1, C. Cameli1, R. Tancredi2, I. M.G.S.A.C.3,  A. P . Monaco4,5, A. Battaglia2, E. Maestrini1, A. G.P .6","1FaBiT  Dipartimento di Farmacia e BioTecnologie, Bologna, Italy, 2Stella Maris Istituto  Scientifico per la Neuropsichiatria dellInfanzia e dellAdolescenza, Calambrone, Pisa, Italy,  3International Molecular Genetic Study of Autism Consortium, Newcastle upon  Tyne, United Kingdom, 4Wellcome Trust Centre for Human Genetics, University of  Oxford,, Oxford OX3 7BN, United Kingdom, 5Office of the President, Tufts University,  Boston, MA, United States, 6Autism Genome Project, USA, CA, United States","In a mutation screening of KLHL23 in 85 multiplex familis with ASD we identified a damaging variant (M65V), absent in controls, and segregating  with the ASD in an affected sibling pair.",familis with ASD,,"['familis', 'with', 'ASD']",[]
413,731,A rare microdeletion disrupting KLHL23 may influence the autism phenotype,P06.08,,"Autism spectrum disorder (ASD) is a severe neurodevelopmental disorder with highly complex genetic predisposition.Rare copy number variants (CNVs) are known to play a role in the genetic etiology of ASD. The follow up of these rare events, by targeted gene sequen   cing and functional studies, has proven to be a powerful tool for the identi ABSTRACTS POSTERS ESHG 2013 | PARIS, FRANCE | WWW.ESHG.ORG 193Back to index fication of novel candidate genetic loci. In a genome wide CNVs screening performed by the AGP , a rare inherited  microdeletion, disrupting two genes transcribed in the same direction,  KLHL23 and SSB, was identified in an Italian ASD individual. This deletion, potentially resulting in a gene fusion transcript, causes a frameshift with the  introduction of a premature stop codon. No fusion transcript was detected  by RT PCR, suggesting that it is subject to nonsense mediated mRNA decay. KLHL23 encodes for a brain expressed Kelch repeat protein of unknown function. While several CNVs affecting SSB are reported in controls making  it an unikely dosege sensitive gene, no CNVs have been previously described  in KLHL23. KLHL23 expression analysis in peripheral blood of the CNV car riers did not show reduction of RNA levels, although we cant exclude that  the deletion could have an effect on the brain. In a mutation screening of KLHL23 in 85 multiplex familis with ASD we identified a damaging variant (M65V), absent in controls, and segregating  with the ASD in an affected sibling pair. Taken together our results suggest that rare variants altering KLHL23 func tion in the brain, could contribute to ASD risk in a small number of cases.  S. Lomartire: None. E. Bacchelli: None. F. Ceroni: None. F. Minopoli:  None. C.  Cameli: None. R. Tancredi: None. I. M.g.s.a.c.:  None. A.P. Monaco:  None. A.  Battaglia: None. E. Maestrini: None. A. G.p.:  None.",2013.0,,"S. Lomartire1, E. Bacchelli1, F. Ceroni1, F. Minopoli1, C. Cameli1, R. Tancredi2, I. M.G.S.A.C.3,  A. P . Monaco4,5, A. Battaglia2, E. Maestrini1, A. G.P .6","1FaBiT  Dipartimento di Farmacia e BioTecnologie, Bologna, Italy, 2Stella Maris Istituto  Scientifico per la Neuropsichiatria dellInfanzia e dellAdolescenza, Calambrone, Pisa, Italy,  3International Molecular Genetic Study of Autism Consortium, Newcastle upon  Tyne, United Kingdom, 4Wellcome Trust Centre for Human Genetics, University of  Oxford,, Oxford OX3 7BN, United Kingdom, 5Office of the President, Tufts University,  Boston, MA, United States, 6Autism Genome Project, USA, CA, United States","Taken together our results suggest that rare variants altering KLHL23 func tion in the brain, could contribute to ASD risk in a small number of cases.",,ASD risk,[],"['ASD', 'risk']"
414,732,Identification of MicroRNA 486 3p and miR 361 5p molecular signatures associated with autism in whole blood samples as a promising candidate biomarkers,P06.09,,"For molecular diagnostic purposes, it would be desirable to develop peri   pheral blood based biomarkers which effectively identify disease state. As autism is one of the most debilitating neurocognitive disorders and only cli nical criteria are available, some more effective and not so subjective signs are needed. To verify that pooled miRNA expression, reproduce the average of single subject values, we chose 3 micro RNAs (mir 766 3p, mir 486 3p and mir 361 5p), that were found to be dysregulated in autism patients whole blood in previous our work. Concordance between pooled and single subject results were demonstrated for 2 of the selected miRNAs by qRT PCR analyses, identifying significant difference only for down regulated mir 361 5p (p<0,0001; mean RQ:   0,38) and up regulated mir 486 3p (p<0,0001; mean RQ: 8,003), but not for miR 766 3p (p,0,995) in autistic group. The expression changes of the miRNA signature were then evaluated for their correlation with the patients clinical symptoms measured by Gilliam Au tism Rating Scale (GARS) which reveals correlation of the communication and stereotype subscales with mir 361 5p (p,0,028/ p,0,043). The results indicated that the whole blood based miRNA profiling is a promising way to identify candidate biomarkers for autism, and the identified miRNA signa ture warrants further investigation. Further molecular analysis on miRNA gene expression changes will give a more detailed picture about the miRNA associated mechanism in autism.  N. Popov:  None. T. Vachev: None. V. Krasteva:  None.",2013.0,,"N. Popov1, T . Vachev2,1, V. Krasteva1","1Medical University of Plovdiv, Plovdiv, Bulgaria, 2University of Plovdiv Paisii  Hilendarski, Plovdiv, Bulgaria","Concordance between pooled and single subject results were demonstrated for 2 of the selected miRNAs by qRT PCR analyses, identifying significant difference only for down regulated mir 361 5p (p<0,0001; mean RQ:   0,38) and up regulated mir 486 3p (p<0,0001; mean RQ: 8,003), but not for miR 766 3p (p,0,995) in autistic group.",,autistic group,[],"['autistic', 'group']"
415,733,Large deletion 11q13.3 encompassing SHANK2 in a patient with autism,P06.12,,"Autism Spectrum Disorders (ASD) are characterized by deficits in social interaction, communication, and repetitive behaviour. Recent studies have highlighted the involvement of rare copy number variations in the genetic etiology of ASD particularly those affecting genes involved in the neuronal synaptic complex. Among them, the SHANK gene family consists of three members: SHANK1, SHANK2 and SHANK3, which encode scaffolding pro teins required for formation and function of neuronal synapses. SHANK2 mutations have been associated with ASD and mild intellectual disability. Recently, three patients with autism carrying a de novo deletion of SHANK2 associated with a duplication of the alpha 7 nicotinic receptor CHRNA7 were reported. Based on these observations, a multiple hit model for ASD has been proposed for SHANK2.Here we reported a patient with autism, minor dysmorphic features, hypo tony, and multiple ear infections. The whole genome SNP array (Human CytoSNP 12, Illumina) analysis revealed a de novo 11q13.3q13.4 deletion (69,789,180 71,783,240) of 1.9 Mb encompassing 6 referenced OMIM genes including SHANK2. In addition, the patient carried an intermediate CGG re ABSTRACTS POSTERS ESHG 2013 | PARIS, FRANCE | WWW.ESHG.ORG 194Back to index peat length at the Fragile X mental retardation (FMR1) locus inherited from  his mother. We discuss the genotype phenotype correlation of the 11q13.3 deletion and  the co occurrence of the 11q13.3 deletion and the FRAXA intermediate al   lele.  A.C. Tabet: None. R. Delorme: None. L. Perrin: None. S. Drunat: None. A. Thaly: None. C. Dupont:  None. B. Benzacken: None. A. Verloes: None. T.  Bourgeron: None.",2013.0,,"A. C. Tabet1, R. Delorme2, L. Perrin3, S. Drunat4, A. Thaly1, C. Dupont1, B. Benzacken1,5, A.  Verloes3, T . Bourgeron6","1Cytogenetic Unit, Robert Debre Hospital APHP , Paris, France, 2Department of child  and adolescent psychiatry, Robert Debre Hospital APHP , Paris, France, 3Clinical genetic  Unit, Robert Debre Hospital APHP , Paris, France, 4Molecular genetic Unit, Robert Debre  Hospital APHP , Paris, France, 5Cytogenetic Unit, Jean Verdier Hospital, Bondy, France,  6Pasteur Institut, Paris, France","Recently, three patients with autism carrying a de novo deletion of SHANK2 associated with a duplication of the alpha 7 nicotinic receptor CHRNA7 were reported.",patients with autism,,"['patient', 'with', 'autism']",[]
415,733,Large deletion 11q13.3 encompassing SHANK2 in a patient with autism,P06.12,,"Autism Spectrum Disorders (ASD) are characterized by deficits in social interaction, communication, and repetitive behaviour. Recent studies have highlighted the involvement of rare copy number variations in the genetic etiology of ASD particularly those affecting genes involved in the neuronal synaptic complex. Among them, the SHANK gene family consists of three members: SHANK1, SHANK2 and SHANK3, which encode scaffolding pro teins required for formation and function of neuronal synapses. SHANK2 mutations have been associated with ASD and mild intellectual disability. Recently, three patients with autism carrying a de novo deletion of SHANK2 associated with a duplication of the alpha 7 nicotinic receptor CHRNA7 were reported. Based on these observations, a multiple hit model for ASD has been proposed for SHANK2.Here we reported a patient with autism, minor dysmorphic features, hypo tony, and multiple ear infections. The whole genome SNP array (Human CytoSNP 12, Illumina) analysis revealed a de novo 11q13.3q13.4 deletion (69,789,180 71,783,240) of 1.9 Mb encompassing 6 referenced OMIM genes including SHANK2. In addition, the patient carried an intermediate CGG re ABSTRACTS POSTERS ESHG 2013 | PARIS, FRANCE | WWW.ESHG.ORG 194Back to index peat length at the Fragile X mental retardation (FMR1) locus inherited from  his mother. We discuss the genotype phenotype correlation of the 11q13.3 deletion and  the co occurrence of the 11q13.3 deletion and the FRAXA intermediate al   lele.  A.C. Tabet: None. R. Delorme: None. L. Perrin: None. S. Drunat: None. A. Thaly: None. C. Dupont:  None. B. Benzacken: None. A. Verloes: None. T.  Bourgeron: None.",2013.0,,"A. C. Tabet1, R. Delorme2, L. Perrin3, S. Drunat4, A. Thaly1, C. Dupont1, B. Benzacken1,5, A.  Verloes3, T . Bourgeron6","1Cytogenetic Unit, Robert Debre Hospital APHP , Paris, France, 2Department of child  and adolescent psychiatry, Robert Debre Hospital APHP , Paris, France, 3Clinical genetic  Unit, Robert Debre Hospital APHP , Paris, France, 4Molecular genetic Unit, Robert Debre  Hospital APHP , Paris, France, 5Cytogenetic Unit, Jean Verdier Hospital, Bondy, France,  6Pasteur Institut, Paris, France","Based on these observations, a multiple hit model for ASD has been proposed for SHANK2.Here we reported a patient with autism, minor dysmorphic features, hypo tony, and multiple ear infections.",patient with autism,,"['patient', 'with', 'autism']",[]
416,734,Mosaic copy number variation in the autism and schizophrenia brain: providing a basis for a new (mitotic) theory of neuropsychiatric diseases,P06.13,,"A plethora of data on germ line genomic rearrangements in brain disorders including autism and schizophrenia does exist. On the other hand, the con  tribution of non heritable genomic alterations to the pathogenesis is hardly  appreciated. Here, we have assessed post zygotic autosomal aneuploidy in prefrontal cortex of the diseased and normal brain by molecular cytogenetic  techniques (FISH and interphase chromosome specific multicolor banding  with DNA probes for chromosomes 1, 7, 8, 9, 10, 11, 16, 17 and 18). Twel  ve autistic, 19 schizophrenic and 27 control samples provided by the Brain and Tissue Bank for Developmental disorders, University of Maryland and bank of our institute were analyzed. Aneuploidy rate per autosome was 0.3  0.8% in all three cohorts analyzed (0.46%, 0.62% and 0.59%). However, we  observed statistically significant increase of chromosome 9 aneuploidy in  the autistic brain. In schizophrenia, chromosome 1 and 18 aneuploidy rates were significantly increased. Additionally, we performed array CGH and in silico analysis of our data on genomic rearrangements in childhood neuro  developmental diseases (124 individuals) and found that CNV burdens in  these individuals typically affect two pathways specific for brain cells: cell  cycle regulation and programmed cell death. We concluded that somatic genome variation (chromosome specific mosaic aneuploidy) is a non heri   table genetic factor contributing to pathogenesis of brain disorders, that is,  however, a result of specific CNV burdens. Our data provide a basis for a new  (mitotic) theory of neuropsychiatric diseases. Supported by the President of  the Russian Federation Grant MD 4401.2013.7 and RFBR 12 04 00215 .  I.Y. Iourov:  None. S.G. Vorsanova: None. I.A. Demidova: None. O.S.  Kurinnaia: None. A.D. Kolotii:  None. V.S. Kravets: None. M.A. Zelenova:  None. T. Liehr:  None. Y.B. Yurov: None.",2013.0,,"I. Y. Iourov1,2, S. G. Vorsanova1,2,3, I. A. Demidova1,2,3, O. S. Kurinnaia1,2,3, A. D. Kolotii1,2, V. S.  Kravets1,2,3, M. A. Zelenova1,3, T . Liehr4, Y. B. Yurov1,2,3","1Mental Health Research Center, Russian Academy of Medical Sciences, Moscow, Russian  Federation, 2Institute of Paediatrics and Children Surgery, Ministry of Health, Moscow,  Russian Federation, 3Moscow State University of Psychology and Education, Moscow,  Russian Federation, 4Institute of Human Genetics, Jena, Germany","However, we  observed statistically significant increase of chromosome 9 aneuploidy in  the autistic brain.",,autistic brain,[],"['autistic', 'brain']"
417,735,Synaptic transmission: looking for clues to Autism Spectrum Disorders (ASD) etiology in Copy Number Variants containing synaptic genes,P06.15,,"Copy Number Variants (CNVs) play an important role in susceptibility to  ASD, often mediated by the deletion or duplication of genes involved in  synaptic structure and function. In this study we tested the hypothesis that  there is an enrichment in CNVs encompassing synaptic transmission genes in ASD.To obtain a list of genes involved in synaptic structure and function, we que ry pathway databases for synaptic pathways (KEGG and GO). By intersecting this list with the results of a large CNV genomic screening in ASD patients (performed by the Autism Genome Project), and CNV information on the Database of Genomic Variants (DGV), we found a significantly increased bur den of CNVs encompassing synaptic genes in ASD subjects compared to DGV controls (Fisher exact test P,2.2X10  16, OR,1.47). Detailed analysis of the frequencies of each synaptic gene duplicated or de   leted by CNVs in ASD and control subjects identified 39 genes that were si gnificantly more frequent in ASD (P<0.05). Closer inspection of CNV overlap between the ASD sample and additional control databases (eg SAGE, Pop Gene) highlighted synaptic structure or function genes (eg NF1, GABRG1,  CHRNA7 ) that warrant further investigation. Additionally, 5 synaptic genes,  PLA2G1B, PPP2R3C, KCNK7, ADCY7 and RAPSN , were disrupted by CNVs ex   clusively in the ASD dataset, and were also absent from the additional con trol CNV databases queried.The present results show an excess of structural alterations encompassing synaptic genes in ASD and highlight candidate genes for sequencing and functional studies.  B.A. Oliveira: None. C.A. Correia: None. I.C. Conceio: None. C. Caf: None. J. Almeida: None. S. Mouga:  None. F. Duque:  None. G. Oliveira:   None. A.M. Vicente: None.",2013.0,,"B. A. Oliveira1,2,3, C. A. Correia1,2,3, I. C. Conceio1,2,3, C. Caf4, J. Almeida4, S. Mouga4,5, F.  Duque5,6, G. Oliveira7,5,6, A. M. Vicente1,2,3","1Instituto Nacional de Sade Doutor Ricardo Jorge, Lisbon, Portugal, 2Centre for  Biodiversity, Functional & Integrative Genomics, Lisbon, Portugal, 3Instituto Gulbenkian  de Cincia, Oeiras, Portugal, 4Unidade Neurodesenvolvimento e Autismo, Centro de  Desenvolvimento, Hospital Peditrico (HP), Centro Hospitalar e Universitrio de  Coimbra (CHUC);, Coimbra, Portugal, 5Instituto Biomdico de Investigao em Luz  e Imagem, Faculdade de Medicina da Universidade de Coimbra, Coimbra, Portugal,  6Faculdade de Medicina da Universidade de Coimbra, Coimbra, Portugal, 7Unidade  Neurodesenvolvimento e Autismo, Centro de Desenvolvimento, Hospital Peditrico (HP), Centro Hospitalar e Universitrio de Coimbra (CHUC), Coimbra, Portugal","By intersecting this list with the results of a large CNV genomic screening in ASD patients (performed by the Autism Genome Project), and CNV information on the Database of Genomic Variants (DGV), we found a significantly increased bur den of CNVs encompassing synaptic genes in ASD subjects compared to DGV controls (Fisher exact test P,2.2X10  16, OR,1.47).",,ASD patients,[],"['ASD', 'patient']"
417,735,Synaptic transmission: looking for clues to Autism Spectrum Disorders (ASD) etiology in Copy Number Variants containing synaptic genes,P06.15,,"Copy Number Variants (CNVs) play an important role in susceptibility to  ASD, often mediated by the deletion or duplication of genes involved in  synaptic structure and function. In this study we tested the hypothesis that  there is an enrichment in CNVs encompassing synaptic transmission genes in ASD.To obtain a list of genes involved in synaptic structure and function, we que ry pathway databases for synaptic pathways (KEGG and GO). By intersecting this list with the results of a large CNV genomic screening in ASD patients (performed by the Autism Genome Project), and CNV information on the Database of Genomic Variants (DGV), we found a significantly increased bur den of CNVs encompassing synaptic genes in ASD subjects compared to DGV controls (Fisher exact test P,2.2X10  16, OR,1.47). Detailed analysis of the frequencies of each synaptic gene duplicated or de   leted by CNVs in ASD and control subjects identified 39 genes that were si gnificantly more frequent in ASD (P<0.05). Closer inspection of CNV overlap between the ASD sample and additional control databases (eg SAGE, Pop Gene) highlighted synaptic structure or function genes (eg NF1, GABRG1,  CHRNA7 ) that warrant further investigation. Additionally, 5 synaptic genes,  PLA2G1B, PPP2R3C, KCNK7, ADCY7 and RAPSN , were disrupted by CNVs ex   clusively in the ASD dataset, and were also absent from the additional con trol CNV databases queried.The present results show an excess of structural alterations encompassing synaptic genes in ASD and highlight candidate genes for sequencing and functional studies.  B.A. Oliveira: None. C.A. Correia: None. I.C. Conceio: None. C. Caf: None. J. Almeida: None. S. Mouga:  None. F. Duque:  None. G. Oliveira:   None. A.M. Vicente: None.",2013.0,,"B. A. Oliveira1,2,3, C. A. Correia1,2,3, I. C. Conceio1,2,3, C. Caf4, J. Almeida4, S. Mouga4,5, F.  Duque5,6, G. Oliveira7,5,6, A. M. Vicente1,2,3","1Instituto Nacional de Sade Doutor Ricardo Jorge, Lisbon, Portugal, 2Centre for  Biodiversity, Functional & Integrative Genomics, Lisbon, Portugal, 3Instituto Gulbenkian  de Cincia, Oeiras, Portugal, 4Unidade Neurodesenvolvimento e Autismo, Centro de  Desenvolvimento, Hospital Peditrico (HP), Centro Hospitalar e Universitrio de  Coimbra (CHUC);, Coimbra, Portugal, 5Instituto Biomdico de Investigao em Luz  e Imagem, Faculdade de Medicina da Universidade de Coimbra, Coimbra, Portugal,  6Faculdade de Medicina da Universidade de Coimbra, Coimbra, Portugal, 7Unidade  Neurodesenvolvimento e Autismo, Centro de Desenvolvimento, Hospital Peditrico (HP), Centro Hospitalar e Universitrio de Coimbra (CHUC), Coimbra, Portugal","By intersecting this list with the results of a large CNV genomic screening in ASD patients (performed by the Autism Genome Project), and CNV information on the Database of Genomic Variants (DGV), we found a significantly increased bur den of CNVs encompassing synaptic genes in ASD subjects compared to DGV controls (Fisher exact test P,2.2X10  16, OR,1.47).",,ASD subjects,[],"['ASD', 'subject']"
417,735,Synaptic transmission: looking for clues to Autism Spectrum Disorders (ASD) etiology in Copy Number Variants containing synaptic genes,P06.15,,"Copy Number Variants (CNVs) play an important role in susceptibility to  ASD, often mediated by the deletion or duplication of genes involved in  synaptic structure and function. In this study we tested the hypothesis that  there is an enrichment in CNVs encompassing synaptic transmission genes in ASD.To obtain a list of genes involved in synaptic structure and function, we que ry pathway databases for synaptic pathways (KEGG and GO). By intersecting this list with the results of a large CNV genomic screening in ASD patients (performed by the Autism Genome Project), and CNV information on the Database of Genomic Variants (DGV), we found a significantly increased bur den of CNVs encompassing synaptic genes in ASD subjects compared to DGV controls (Fisher exact test P,2.2X10  16, OR,1.47). Detailed analysis of the frequencies of each synaptic gene duplicated or de   leted by CNVs in ASD and control subjects identified 39 genes that were si gnificantly more frequent in ASD (P<0.05). Closer inspection of CNV overlap between the ASD sample and additional control databases (eg SAGE, Pop Gene) highlighted synaptic structure or function genes (eg NF1, GABRG1,  CHRNA7 ) that warrant further investigation. Additionally, 5 synaptic genes,  PLA2G1B, PPP2R3C, KCNK7, ADCY7 and RAPSN , were disrupted by CNVs ex   clusively in the ASD dataset, and were also absent from the additional con trol CNV databases queried.The present results show an excess of structural alterations encompassing synaptic genes in ASD and highlight candidate genes for sequencing and functional studies.  B.A. Oliveira: None. C.A. Correia: None. I.C. Conceio: None. C. Caf: None. J. Almeida: None. S. Mouga:  None. F. Duque:  None. G. Oliveira:   None. A.M. Vicente: None.",2013.0,,"B. A. Oliveira1,2,3, C. A. Correia1,2,3, I. C. Conceio1,2,3, C. Caf4, J. Almeida4, S. Mouga4,5, F.  Duque5,6, G. Oliveira7,5,6, A. M. Vicente1,2,3","1Instituto Nacional de Sade Doutor Ricardo Jorge, Lisbon, Portugal, 2Centre for  Biodiversity, Functional & Integrative Genomics, Lisbon, Portugal, 3Instituto Gulbenkian  de Cincia, Oeiras, Portugal, 4Unidade Neurodesenvolvimento e Autismo, Centro de  Desenvolvimento, Hospital Peditrico (HP), Centro Hospitalar e Universitrio de  Coimbra (CHUC);, Coimbra, Portugal, 5Instituto Biomdico de Investigao em Luz  e Imagem, Faculdade de Medicina da Universidade de Coimbra, Coimbra, Portugal,  6Faculdade de Medicina da Universidade de Coimbra, Coimbra, Portugal, 7Unidade  Neurodesenvolvimento e Autismo, Centro de Desenvolvimento, Hospital Peditrico (HP), Centro Hospitalar e Universitrio de Coimbra (CHUC), Coimbra, Portugal","Closer inspection of CNV overlap between the ASD sample and additional control databases (eg SAGE, Pop Gene) highlighted synaptic structure or function genes (eg NF1, GABRG1,  CHRNA7 ) that warrant further investigation.",,ASD sample,[],"['ASD', 'sample']"
417,735,Synaptic transmission: looking for clues to Autism Spectrum Disorders (ASD) etiology in Copy Number Variants containing synaptic genes,P06.15,,"Copy Number Variants (CNVs) play an important role in susceptibility to  ASD, often mediated by the deletion or duplication of genes involved in  synaptic structure and function. In this study we tested the hypothesis that  there is an enrichment in CNVs encompassing synaptic transmission genes in ASD.To obtain a list of genes involved in synaptic structure and function, we que ry pathway databases for synaptic pathways (KEGG and GO). By intersecting this list with the results of a large CNV genomic screening in ASD patients (performed by the Autism Genome Project), and CNV information on the Database of Genomic Variants (DGV), we found a significantly increased bur den of CNVs encompassing synaptic genes in ASD subjects compared to DGV controls (Fisher exact test P,2.2X10  16, OR,1.47). Detailed analysis of the frequencies of each synaptic gene duplicated or de   leted by CNVs in ASD and control subjects identified 39 genes that were si gnificantly more frequent in ASD (P<0.05). Closer inspection of CNV overlap between the ASD sample and additional control databases (eg SAGE, Pop Gene) highlighted synaptic structure or function genes (eg NF1, GABRG1,  CHRNA7 ) that warrant further investigation. Additionally, 5 synaptic genes,  PLA2G1B, PPP2R3C, KCNK7, ADCY7 and RAPSN , were disrupted by CNVs ex   clusively in the ASD dataset, and were also absent from the additional con trol CNV databases queried.The present results show an excess of structural alterations encompassing synaptic genes in ASD and highlight candidate genes for sequencing and functional studies.  B.A. Oliveira: None. C.A. Correia: None. I.C. Conceio: None. C. Caf: None. J. Almeida: None. S. Mouga:  None. F. Duque:  None. G. Oliveira:   None. A.M. Vicente: None.",2013.0,,"B. A. Oliveira1,2,3, C. A. Correia1,2,3, I. C. Conceio1,2,3, C. Caf4, J. Almeida4, S. Mouga4,5, F.  Duque5,6, G. Oliveira7,5,6, A. M. Vicente1,2,3","1Instituto Nacional de Sade Doutor Ricardo Jorge, Lisbon, Portugal, 2Centre for  Biodiversity, Functional & Integrative Genomics, Lisbon, Portugal, 3Instituto Gulbenkian  de Cincia, Oeiras, Portugal, 4Unidade Neurodesenvolvimento e Autismo, Centro de  Desenvolvimento, Hospital Peditrico (HP), Centro Hospitalar e Universitrio de  Coimbra (CHUC);, Coimbra, Portugal, 5Instituto Biomdico de Investigao em Luz  e Imagem, Faculdade de Medicina da Universidade de Coimbra, Coimbra, Portugal,  6Faculdade de Medicina da Universidade de Coimbra, Coimbra, Portugal, 7Unidade  Neurodesenvolvimento e Autismo, Centro de Desenvolvimento, Hospital Peditrico (HP), Centro Hospitalar e Universitrio de Coimbra (CHUC), Coimbra, Portugal","Additionally, 5 synaptic genes,  PLA2G1B, PPP2R3C, KCNK7, ADCY7 and RAPSN , were disrupted by CNVs ex   clusively in the ASD dataset, and were also absent from the additional con trol CNV databases queried.The present results show an excess of structural alterations encompassing synaptic genes in ASD and highlight candidate genes for sequencing and functional studies.",,ASD dataset,[],"['ASD', 'dataset']"
418,736,A NCAM2 deletion in a patient with autism,P06.16,,"An 8 year old boy with autism spectrum disorder, speech delay, behavioural problems, disturbed sleep and macrocephaly presented in our genetics cli nic. He is the first child of non consanguineous parents. Chromosomal ana   lysis had revealed a normal male karyotype 46,XY, and testing for fragile X syndrome and PTEN sequencing was inconspicuous.Array CGH analysis showed a microdeletion of 1.6Mb: arr 21q21.1 q21.2(22444986 24047363)x1. This part of the chromosome contains the entire NCAM2 gene and no other functional genes. His mother also carries  this microdeletion. She has no obvious behavioural features of autism, but also is macrocephalic. Three maternal blood relatives are reported to have speech problems. Results of psychological assessments of the mother and the other affected individuals are pending.Autism spectrum disorder (ASD, OMIM 209850) encompasses different forms of autism with a broader phenotype. Two thirds of all patients with ASD suffer from mental retardation. Among the genes involved, NCAM2 has  been assumed to play a role in the development of ASD because of its func tion in neurites (outgrowth, bundling). In the literature, there is one report of an autistic boy with an 8.8 MB microdeletion involving 19 genes inclu   ding NCAM2 and another autism related candidate gene, GRIK1 . Our case  supports the assumption that NCAM2 deficiency, as other cell adhesion pro ABSTRACTS POSTERS ESHG 2013 | PARIS, FRANCE | WWW.ESHG.ORG 195Back to index tein defects, plays a role in the development of autism, speech development  and macrocephaly, perhaps with variable expressivity.  C. Scholz:  None. D. Steinemann: None. M. Arslan Kirchner:  None. M.  Stuhrmann: None. M. Roy: None. J. Schmidtke: None.",2013.0,,"C. Scholz1, D. Steinemann2, M. Arslan Kirchner1, M. Stuhrmann1, M. Roy3, J. Schmidtke1","1Institute of Human Genetics, Hannover Medical School, Hannover, Germany, 2Institute  for Cellular and Molecular Pathology, Hannover Medical School, Hannover, Germany,  3Psychiatric Clinic, Hannover Medical School, Hannover, Germany","An 8 year old boy with autism spectrum disorder, speech delay, behavioural problems, disturbed sleep and macrocephaly presented in our genetics cli nic.",boy with autism,,"['boy', 'with', 'autism']",[]
418,736,A NCAM2 deletion in a patient with autism,P06.16,,"An 8 year old boy with autism spectrum disorder, speech delay, behavioural problems, disturbed sleep and macrocephaly presented in our genetics cli nic. He is the first child of non consanguineous parents. Chromosomal ana   lysis had revealed a normal male karyotype 46,XY, and testing for fragile X syndrome and PTEN sequencing was inconspicuous.Array CGH analysis showed a microdeletion of 1.6Mb: arr 21q21.1 q21.2(22444986 24047363)x1. This part of the chromosome contains the entire NCAM2 gene and no other functional genes. His mother also carries  this microdeletion. She has no obvious behavioural features of autism, but also is macrocephalic. Three maternal blood relatives are reported to have speech problems. Results of psychological assessments of the mother and the other affected individuals are pending.Autism spectrum disorder (ASD, OMIM 209850) encompasses different forms of autism with a broader phenotype. Two thirds of all patients with ASD suffer from mental retardation. Among the genes involved, NCAM2 has  been assumed to play a role in the development of ASD because of its func tion in neurites (outgrowth, bundling). In the literature, there is one report of an autistic boy with an 8.8 MB microdeletion involving 19 genes inclu   ding NCAM2 and another autism related candidate gene, GRIK1 . Our case  supports the assumption that NCAM2 deficiency, as other cell adhesion pro ABSTRACTS POSTERS ESHG 2013 | PARIS, FRANCE | WWW.ESHG.ORG 195Back to index tein defects, plays a role in the development of autism, speech development  and macrocephaly, perhaps with variable expressivity.  C. Scholz:  None. D. Steinemann: None. M. Arslan Kirchner:  None. M.  Stuhrmann: None. M. Roy: None. J. Schmidtke: None.",2013.0,,"C. Scholz1, D. Steinemann2, M. Arslan Kirchner1, M. Stuhrmann1, M. Roy3, J. Schmidtke1","1Institute of Human Genetics, Hannover Medical School, Hannover, Germany, 2Institute  for Cellular and Molecular Pathology, Hannover Medical School, Hannover, Germany,  3Psychiatric Clinic, Hannover Medical School, Hannover, Germany",Two thirds of all patients with ASD suffer from mental retardation.,patients with ASD,,"['patient', 'with', 'ASD']",[]
418,736,A NCAM2 deletion in a patient with autism,P06.16,,"An 8 year old boy with autism spectrum disorder, speech delay, behavioural problems, disturbed sleep and macrocephaly presented in our genetics cli nic. He is the first child of non consanguineous parents. Chromosomal ana   lysis had revealed a normal male karyotype 46,XY, and testing for fragile X syndrome and PTEN sequencing was inconspicuous.Array CGH analysis showed a microdeletion of 1.6Mb: arr 21q21.1 q21.2(22444986 24047363)x1. This part of the chromosome contains the entire NCAM2 gene and no other functional genes. His mother also carries  this microdeletion. She has no obvious behavioural features of autism, but also is macrocephalic. Three maternal blood relatives are reported to have speech problems. Results of psychological assessments of the mother and the other affected individuals are pending.Autism spectrum disorder (ASD, OMIM 209850) encompasses different forms of autism with a broader phenotype. Two thirds of all patients with ASD suffer from mental retardation. Among the genes involved, NCAM2 has  been assumed to play a role in the development of ASD because of its func tion in neurites (outgrowth, bundling). In the literature, there is one report of an autistic boy with an 8.8 MB microdeletion involving 19 genes inclu   ding NCAM2 and another autism related candidate gene, GRIK1 . Our case  supports the assumption that NCAM2 deficiency, as other cell adhesion pro ABSTRACTS POSTERS ESHG 2013 | PARIS, FRANCE | WWW.ESHG.ORG 195Back to index tein defects, plays a role in the development of autism, speech development  and macrocephaly, perhaps with variable expressivity.  C. Scholz:  None. D. Steinemann: None. M. Arslan Kirchner:  None. M.  Stuhrmann: None. M. Roy: None. J. Schmidtke: None.",2013.0,,"C. Scholz1, D. Steinemann2, M. Arslan Kirchner1, M. Stuhrmann1, M. Roy3, J. Schmidtke1","1Institute of Human Genetics, Hannover Medical School, Hannover, Germany, 2Institute  for Cellular and Molecular Pathology, Hannover Medical School, Hannover, Germany,  3Psychiatric Clinic, Hannover Medical School, Hannover, Germany","In the literature, there is one report of an autistic boy with an 8.8 MB microdeletion involving 19 genes inclu   ding NCAM2 and another autism related candidate gene, GRIK1 .",,autistic boy,[],"['autistic', 'boy']"
419,737,Targeted high throughput gene sequencing of the NMDA receptor multi protein complex and high resolution genomic study of 100 families with autism spectrum disorder,P06.17,,"Autism spectrum disorder (ASD) is an early childhood neurodevelopmental disorder characterized by a significant genetic aetiology and a prevalence  currently estimated at 1/100. Epidemiological studies described that ASDs  are heterogeneous at both clinical and genetic levels, which has been further illustrated by the large number of loci and genes that have been identified to  date (>100). Several biological pathways have been highlighted, particularly  the NMDA receptor multiprotein (NRC) complex, affected by copy number variations (CNV) and mutations enriched in NRC proteins encoding genes.We performed a global genetic study of 100 French families including at least 1 individual with ASD, which was included in the research project Neurophysiological Molecular and Developmental Analysis of the Glutama   te Synapse in Autism (NMDA Autism) (ClinicalTrials.gov NCT01770548).For each family, we firstly performed a high resolution pangenomic compa rative genomic hybridization (CGH) analysis with 1M CGH Agilent Array for   mat to identify rare or de novo CNVs; Secondly, a high throughput targeted sequencing of 216 genes mostly belonging to the NRC complex was carried out with the SureSelect Agilent strategy in order to assess the contribution of gene mutations in our cohort.Preliminary results on CGH experiments led us to identify small rare CNVs in several known regions (20p12.1 MACROD2; 18q21.1 KATNAL2; 11p13.11) or novel potential candidates such as FRMPD4, GUCY2F and NXPH3. We have also observed several large genomics variations previously described (1,2Mb amplification at 16p13.11 and 5,6 Mb deletion at 11q14.2 q14.3). The results from the high throughput sequencing analysis, which is current ly being performed, will be also presented.  S. Alirol: None. S. Marouillat:  None. A. Paubel: None. P. Vourch: None. C.  Andres: None. C. Barthelemy:  None. D. Campion: None. N. Juteau: None. A.  Toutain:  None. E. Lemonnier:  None. P. Goupille:  None. F. Bonnet Brilhault:   None. F. Laumonnier:  None.",2013.0,,"S. Alirol1,2, S. Marouillat1,2, A. Paubel1,2,3, P . Vourch1,2,3, C. Andres1,2,3, C. Barthelemy1,2,3, D.  Campion4, N. Juteau3,5, A. Toutain1,2,3, E. Lemonnier6, P . Goupille3,5, F. Bonnet Brilhault1,2,3,  F. Laumonnier1,2","1INSERM UMR930, Tours, France, 2University Franois Rabelais, Tours, France, 3Centre  Hospitalier Rgional Universitaire, Tours, France, 4INSERM UMR1079, Rouen, France,  5INSERM CIC 0202, Tours, France, 6Centre Hospitalier Rgional Universitaire, Brest,  France","Several biological pathways have been highlighted, particularly  the NMDA receptor multiprotein (NRC) complex, affected by copy number variations (CNV) and mutations enriched in NRC proteins encoding genes.We performed a global genetic study of 100 French families including at least 1 individual with ASD, which was included in the research project Neurophysiological Molecular and Developmental Analysis of the Glutama   te Synapse in Autism (NMDA Autism) (ClinicalTrials.gov NCT01770548).For each family, we firstly performed a high resolution pangenomic compa rative genomic hybridization (CGH) analysis with 1M CGH Agilent Array for   mat to identify rare or de novo CNVs; Secondly, a high throughput targeted sequencing of 216 genes mostly belonging to the NRC complex was carried out with the SureSelect Agilent strategy in order to assess the contribution of gene mutations in our cohort.Preliminary results on CGH experiments led us to identify small rare CNVs in several known regions (20p12.1 MACROD2; 18q21.1 KATNAL2; 11p13.11) or novel potential candidates such as FRMPD4, GUCY2F and NXPH3.",individual with ASD,,"['individual', 'with', 'ASD']",[]
420,738,Homozygous exonic deletion in CTNNA3 suggests a role for alfaT catenin in susceptibility to Autism Spectrum Disorders (ASDs),P06.18,,"Autism spectrum disorders (ASDs) are highly heritable, neurodevelopmen tal conditions, showing extreme genetic heterogeneity. While it is well esta blished that de novo genetic variation plays an important role in ASD risk, recent studies have demonstrated a convincing evidence of a rare recessive contribution to the heritability of ASDs.In the genome wide CNV study carried out by the Autism Genetic Consorti   um (AGP), we identified one homozygous deletion intersecting the CTNNA3 gene in an Italian proband with ASD and moderate intellectual disability (PIQ,50). This deletion includes a coding exon, leading to a putative frames hift and premature stop codon, inherited from both parents, each heterozy   gote for a deletion of slightly different length. The unaffected sister is also heterozygote for the deletion.CTNNA3 encodes for the alfaT catenin protein that has a crucial role in cel lular adherence showing suggestive association in GWAS and a de novo de   letion.Even if the frequency of exonic deletions of CTNNA3 is not significantly dif   ferent between ASDs cases and controls (17/2446 cases and 35/5097 con trols, P,.88), no homozygous exonic deletions were found in a sample of  5097 controls, suggesting that only the complete knockout of CTNNA3 could  cause or confer susceptibility for ASDs. Expression analysis of alfaT catenin and alfaN catenin proteins in mouse cortex and hippocampus (P0 P90), provided further support of a role of CTNNA3 in early mid fetal develop  ment of the brain. While the exact biological significance of CTNNA3 homozygous deletion is yet to be determined, we hypothesize that it could have clinical relevance to  the ASDs phenotype in this Italian patient.  E. Bacchelli: None. F. Ceroni: None. D. Pinto:  None. M. Giannandrea:  None. S.  Lomartire: None. P. DAdamo: None. R. Tancredi: None. I. M.g.s.a.c.:  None. A.P.  Monaco: None. A. Battaglia: None. E. Maestrini: None. A.G. P.: None.",2013.0,,"E. Bacchelli1, F. Ceroni1, D. Pinto2, M. Giannandrea3, S. Lomartire1, P . D Adamo3, R.  Tancredi4, I. M.G.S.A.C.5, A. P . Monaco6,7, A. Battaglia4, E. Maestrini1, A. G. P .8","1FaBiT  Dipartimento di Farmacia e BioTecnologie, Bologna, Italy, 2Departments of  Psychiatry, and Genetics and Genomic Sciences, Seaver Autism Center, The Mindich Child Health & Development Institute, Mount Sinai School of Medicine, New York, NY, United States,  3Dulbecco Telethon Institute, San Raffaele Scientific Institute, Milan, Italy,  4Stella Maris Istituto Scientifico per la Neuropsichiatria dellInfanzia e dellAdolescenza,  Calambrone, Pisa, Italy, 5International Molecular Genetic Study of Autism Consortium,  Newcastle upon Tyne, United Kingdom, 6Wellcome Trust Centre for Human Genetics,  University of Oxford,, Oxford OX3 7BN, United Kingdom, 7Office of the President, Tufts  University, Boston, MA, United States, 8Autism Genome Project, USA, CA, United States","While it is well esta blished that de novo genetic variation plays an important role in ASD risk, recent studies have demonstrated a convincing evidence of a rare recessive contribution to the heritability of ASDs.In the genome wide CNV study carried out by the Autism Genetic Consorti   um (AGP), we identified one homozygous deletion intersecting the CTNNA3 gene in an Italian proband with ASD and moderate intellectual disability (PIQ,50).",proband with ASD,ASD risk,"['proband', 'with', 'ASD']","['ASD', 'risk']"
420,738,Homozygous exonic deletion in CTNNA3 suggests a role for alfaT catenin in susceptibility to Autism Spectrum Disorders (ASDs),P06.18,,"Autism spectrum disorders (ASDs) are highly heritable, neurodevelopmen tal conditions, showing extreme genetic heterogeneity. While it is well esta blished that de novo genetic variation plays an important role in ASD risk, recent studies have demonstrated a convincing evidence of a rare recessive contribution to the heritability of ASDs.In the genome wide CNV study carried out by the Autism Genetic Consorti   um (AGP), we identified one homozygous deletion intersecting the CTNNA3 gene in an Italian proband with ASD and moderate intellectual disability (PIQ,50). This deletion includes a coding exon, leading to a putative frames hift and premature stop codon, inherited from both parents, each heterozy   gote for a deletion of slightly different length. The unaffected sister is also heterozygote for the deletion.CTNNA3 encodes for the alfaT catenin protein that has a crucial role in cel lular adherence showing suggestive association in GWAS and a de novo de   letion.Even if the frequency of exonic deletions of CTNNA3 is not significantly dif   ferent between ASDs cases and controls (17/2446 cases and 35/5097 con trols, P,.88), no homozygous exonic deletions were found in a sample of  5097 controls, suggesting that only the complete knockout of CTNNA3 could  cause or confer susceptibility for ASDs. Expression analysis of alfaT catenin and alfaN catenin proteins in mouse cortex and hippocampus (P0 P90), provided further support of a role of CTNNA3 in early mid fetal develop  ment of the brain. While the exact biological significance of CTNNA3 homozygous deletion is yet to be determined, we hypothesize that it could have clinical relevance to  the ASDs phenotype in this Italian patient.  E. Bacchelli: None. F. Ceroni: None. D. Pinto:  None. M. Giannandrea:  None. S.  Lomartire: None. P. DAdamo: None. R. Tancredi: None. I. M.g.s.a.c.:  None. A.P.  Monaco: None. A. Battaglia: None. E. Maestrini: None. A.G. P.: None.",2013.0,,"E. Bacchelli1, F. Ceroni1, D. Pinto2, M. Giannandrea3, S. Lomartire1, P . D Adamo3, R.  Tancredi4, I. M.G.S.A.C.5, A. P . Monaco6,7, A. Battaglia4, E. Maestrini1, A. G. P .8","1FaBiT  Dipartimento di Farmacia e BioTecnologie, Bologna, Italy, 2Departments of  Psychiatry, and Genetics and Genomic Sciences, Seaver Autism Center, The Mindich Child Health & Development Institute, Mount Sinai School of Medicine, New York, NY, United States,  3Dulbecco Telethon Institute, San Raffaele Scientific Institute, Milan, Italy,  4Stella Maris Istituto Scientifico per la Neuropsichiatria dellInfanzia e dellAdolescenza,  Calambrone, Pisa, Italy, 5International Molecular Genetic Study of Autism Consortium,  Newcastle upon Tyne, United Kingdom, 6Wellcome Trust Centre for Human Genetics,  University of Oxford,, Oxford OX3 7BN, United Kingdom, 7Office of the President, Tufts  University, Boston, MA, United States, 8Autism Genome Project, USA, CA, United States","The unaffected sister is also heterozygote for the deletion.CTNNA3 encodes for the alfaT catenin protein that has a crucial role in cel lular adherence showing suggestive association in GWAS and a de novo de   letion.Even if the frequency of exonic deletions of CTNNA3 is not significantly dif   ferent between ASDs cases and controls (17/2446 cases and 35/5097 con trols, P,.88), no homozygous exonic deletions were found in a sample of  5097 controls, suggesting that only the complete knockout of CTNNA3 could  cause or confer susceptibility for ASDs.",,ASDs cases,[],"['ASDs', 'case']"
420,738,Homozygous exonic deletion in CTNNA3 suggests a role for alfaT catenin in susceptibility to Autism Spectrum Disorders (ASDs),P06.18,,"Autism spectrum disorders (ASDs) are highly heritable, neurodevelopmen tal conditions, showing extreme genetic heterogeneity. While it is well esta blished that de novo genetic variation plays an important role in ASD risk, recent studies have demonstrated a convincing evidence of a rare recessive contribution to the heritability of ASDs.In the genome wide CNV study carried out by the Autism Genetic Consorti   um (AGP), we identified one homozygous deletion intersecting the CTNNA3 gene in an Italian proband with ASD and moderate intellectual disability (PIQ,50). This deletion includes a coding exon, leading to a putative frames hift and premature stop codon, inherited from both parents, each heterozy   gote for a deletion of slightly different length. The unaffected sister is also heterozygote for the deletion.CTNNA3 encodes for the alfaT catenin protein that has a crucial role in cel lular adherence showing suggestive association in GWAS and a de novo de   letion.Even if the frequency of exonic deletions of CTNNA3 is not significantly dif   ferent between ASDs cases and controls (17/2446 cases and 35/5097 con trols, P,.88), no homozygous exonic deletions were found in a sample of  5097 controls, suggesting that only the complete knockout of CTNNA3 could  cause or confer susceptibility for ASDs. Expression analysis of alfaT catenin and alfaN catenin proteins in mouse cortex and hippocampus (P0 P90), provided further support of a role of CTNNA3 in early mid fetal develop  ment of the brain. While the exact biological significance of CTNNA3 homozygous deletion is yet to be determined, we hypothesize that it could have clinical relevance to  the ASDs phenotype in this Italian patient.  E. Bacchelli: None. F. Ceroni: None. D. Pinto:  None. M. Giannandrea:  None. S.  Lomartire: None. P. DAdamo: None. R. Tancredi: None. I. M.g.s.a.c.:  None. A.P.  Monaco: None. A. Battaglia: None. E. Maestrini: None. A.G. P.: None.",2013.0,,"E. Bacchelli1, F. Ceroni1, D. Pinto2, M. Giannandrea3, S. Lomartire1, P . D Adamo3, R.  Tancredi4, I. M.G.S.A.C.5, A. P . Monaco6,7, A. Battaglia4, E. Maestrini1, A. G. P .8","1FaBiT  Dipartimento di Farmacia e BioTecnologie, Bologna, Italy, 2Departments of  Psychiatry, and Genetics and Genomic Sciences, Seaver Autism Center, The Mindich Child Health & Development Institute, Mount Sinai School of Medicine, New York, NY, United States,  3Dulbecco Telethon Institute, San Raffaele Scientific Institute, Milan, Italy,  4Stella Maris Istituto Scientifico per la Neuropsichiatria dellInfanzia e dellAdolescenza,  Calambrone, Pisa, Italy, 5International Molecular Genetic Study of Autism Consortium,  Newcastle upon Tyne, United Kingdom, 6Wellcome Trust Centre for Human Genetics,  University of Oxford,, Oxford OX3 7BN, United Kingdom, 7Office of the President, Tufts  University, Boston, MA, United States, 8Autism Genome Project, USA, CA, United States","While the exact biological significance of CTNNA3 homozygous deletion is yet to be determined, we hypothesize that it could have clinical relevance to  the ASDs phenotype in this Italian patient.",,ASDs phenotype,[],"['ASDs', 'phenotype']"
422,740,.12Mb microdeletion at 19p13.2 including NFIX in an individual with autism spectrum disorder.,P06.200,,"Marshall Smith syndrome (MSS) is the overgrowth syndrome, characterized by tall stature, macrocephaly, distinctive facial appearance, and intellectual disability. Recently, Sotos like and MSS were found to be caused by muta   tions of Nuclear factor I X (NFIX). We describe an additional male patient with microdeletion at 19p13.2 encompassing NFIX. He was born to noncon sanguineous parents at 40 weeks of gestation. His birth weight was 2570 g, and height 46 cm. At the age of 2 years and 8 months, he was referred to our clinic for a diagnostic evaluation because of developmental delay and grow   th retardation. His weight was 10.6 kg ( 1.8 S.D.), height 86.7 cm ( 1.2 S.D.), and OFC 48.0 cm ( 0.7 S.D.). He could crawl, but could not walk alone and speak a significant word. He had some autistic traits and stereotypes.He was ABSTRACTS POSTERS ESHG 2013 | PARIS, FRANCE | WWW.ESHG.ORG 196Back to index medicated with antiepileptics for recurrent febrile convulsions. Array CGH  revealed 0.12 Mb deletion at 19p13.2 encompassing NFIX. Further analysis  with quantitative PCR confirmed the deletion of NFIX as a de novo event. Our patient had a relative macrocephaly, but did not present overgrowth and characteristic facial features as MSS. The autistic traits are the most pro  minent clinical feature in our patient. Haploinsufficiency and mutations in  the DNA binding /dimerization domain of NFIX causes Sotos like syndrome, whereas the truncated mutations of NFIX represent MSS [Malon et al., 2010; Yoneda et al., 2012; Priolo et al., 2012]. The present report provides insight  into consideration of genotype phenotype correlation in NFIX mutations.  I. Ohashi:  None. Y. Kuroda: None. T. Naruto: None. K. Ida: None. K. Enomoto:   None. K. Tanoue: None. K. Kurosawa: None.",2013.0,,"I. Ohashi1, Y. Kuroda1, T . Naruto1, K. Ida1, K. Enomoto1, K. Tanoue2, K. Kurosawa1","1Division of Medical Genetics, Kanagawa Childrens Medical Center, Yokohama, Japan,  2Division of Integrated Pediatrics, Kanagawa Childrens Medical Center, Yokohama,  Japan","He had some autistic traits and stereotypes.He was ABSTRACTS POSTERS ESHG 2013 | PARIS, FRANCE | WWW.ESHG.ORG 196Back to index medicated with antiepileptics for recurrent febrile convulsions.",,autistic traits,[],"['autistic', 'trait']"
422,740,.12Mb microdeletion at 19p13.2 including NFIX in an individual with autism spectrum disorder.,P06.200,,"Marshall Smith syndrome (MSS) is the overgrowth syndrome, characterized by tall stature, macrocephaly, distinctive facial appearance, and intellectual disability. Recently, Sotos like and MSS were found to be caused by muta   tions of Nuclear factor I X (NFIX). We describe an additional male patient with microdeletion at 19p13.2 encompassing NFIX. He was born to noncon sanguineous parents at 40 weeks of gestation. His birth weight was 2570 g, and height 46 cm. At the age of 2 years and 8 months, he was referred to our clinic for a diagnostic evaluation because of developmental delay and grow   th retardation. His weight was 10.6 kg ( 1.8 S.D.), height 86.7 cm ( 1.2 S.D.), and OFC 48.0 cm ( 0.7 S.D.). He could crawl, but could not walk alone and speak a significant word. He had some autistic traits and stereotypes.He was ABSTRACTS POSTERS ESHG 2013 | PARIS, FRANCE | WWW.ESHG.ORG 196Back to index medicated with antiepileptics for recurrent febrile convulsions. Array CGH  revealed 0.12 Mb deletion at 19p13.2 encompassing NFIX. Further analysis  with quantitative PCR confirmed the deletion of NFIX as a de novo event. Our patient had a relative macrocephaly, but did not present overgrowth and characteristic facial features as MSS. The autistic traits are the most pro  minent clinical feature in our patient. Haploinsufficiency and mutations in  the DNA binding /dimerization domain of NFIX causes Sotos like syndrome, whereas the truncated mutations of NFIX represent MSS [Malon et al., 2010; Yoneda et al., 2012; Priolo et al., 2012]. The present report provides insight  into consideration of genotype phenotype correlation in NFIX mutations.  I. Ohashi:  None. Y. Kuroda: None. T. Naruto: None. K. Ida: None. K. Enomoto:   None. K. Tanoue: None. K. Kurosawa: None.",2013.0,,"I. Ohashi1, Y. Kuroda1, T . Naruto1, K. Ida1, K. Enomoto1, K. Tanoue2, K. Kurosawa1","1Division of Medical Genetics, Kanagawa Childrens Medical Center, Yokohama, Japan,  2Division of Integrated Pediatrics, Kanagawa Childrens Medical Center, Yokohama,  Japan",The autistic traits are the most pro  minent clinical feature in our patient.,,autistic traits,[],"['autistic', 'trait']"
426,765,Identification of a genomic homozygous deletion of ZNF277 in a child with SLI,P06.48,,"Specific language impairment (SLI) is a common neurodevelopmental dis   order in which language abilities are below age expectations, in the absence  of explanatory environmental or medical conditions, such as hearing loss,  intellectual disability or autism. SLI affects 3 7% of English speaking pre  school children. During a genome wide CNV scan using a multi algorithm approach, we identified a homozygous deletion of 21,379bp in the ZNF277   gene, overlapping exon 5, in an individual with severe receptive and ex   pressive SLI. This deletion was of particular interest as it falls within the AUTS1 region of linkage to autism. ZNF277 flanks the DOCK4 and IMMP2L   genes, which have been suggested to play a role in autistic spectrum dis   orders (ASD). We therefore screened cohorts of children with SLI or ASD and control subjects for the presence of ZNF277  deletions. We observed  an increased frequency of ZNF277  deletions in probands with SLI (6/318,  1.9%) compared to both probands with ASD (1/253, 0.4%) and indepen   dent controls (2/224, 0.8%). We performed quantitative PCR analyses of the expression of IMMP2L, DOCK4 and ZNF277  in lymphoblastoid cell lines car  rying either a DOCK4 microdeletion or a ZNF277 microdeletion. We found  that, while ZNF277  microdeletions affect the expression of ZNF277 , they do  not alter the levels of DOCK4 or IMMP2L transcripts. Similarly, DOCK4 mi  crodeletions do not affect the expression levels of ZNF277 . Given these fin  dings, we postulate that ZNF277  microdeletions may contribute to the risk  of speech and language impairments in a manner that is independent of the autism risks previously described in this region.  F. Ceroni: None. N.H. Simpson:  None. C. Francks: None. G. Baird: None. G.  Conti Ramsden: None. A.E. OHare: None. E. Maestrini: None. E. Bacchelli: None. S.E. Fisher:  None. D.F. Newbury: None. I. M.g.s.a.c:  None. S.L.I.  Consortium: None.",2013.0,,"F. Ceroni1, N. H. Simpson2, C. Francks3,4, G. Baird5, G. Conti Ramsden6, A. E. OHare7, E.  Maestrini1, E. Bacchelli1, S. E. Fisher3,4, D. F. Newbury2, I. M.G.S.A.C1,2, S. L. I. Consortium2","1Dipartimento di Farmacia e Biotecnologie, University of Bologna, Bologna, Italy,  2Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, United  Kingdom, 3Max Planck Institute for Psycholinguistics, Nijmegen, Netherlands, 4Donders  Institute for Brain, Cognition & Behaviour, Nijmegen, Netherlands, 5Guys & St Thomas  NHS Foundation Trust, Newcomen Childrens Neurosciences Centre, St Thomas  Hospital, London, United Kingdom, 6School of Psychological Sciences, The University  of Manchester, Manchester, United Kingdom, 7Child Life and Health, University of  Edinburgh, Edinburgh, United Kingdom","ZNF277 flanks the DOCK4 and IMMP2L   genes, which have been suggested to play a role in autistic spectrum dis   orders (ASD).",,autistic spectrum,[],"['autistic', 'spectrum']"
426,765,Identification of a genomic homozygous deletion of ZNF277 in a child with SLI,P06.48,,"Specific language impairment (SLI) is a common neurodevelopmental dis   order in which language abilities are below age expectations, in the absence  of explanatory environmental or medical conditions, such as hearing loss,  intellectual disability or autism. SLI affects 3 7% of English speaking pre  school children. During a genome wide CNV scan using a multi algorithm approach, we identified a homozygous deletion of 21,379bp in the ZNF277   gene, overlapping exon 5, in an individual with severe receptive and ex   pressive SLI. This deletion was of particular interest as it falls within the AUTS1 region of linkage to autism. ZNF277 flanks the DOCK4 and IMMP2L   genes, which have been suggested to play a role in autistic spectrum dis   orders (ASD). We therefore screened cohorts of children with SLI or ASD and control subjects for the presence of ZNF277  deletions. We observed  an increased frequency of ZNF277  deletions in probands with SLI (6/318,  1.9%) compared to both probands with ASD (1/253, 0.4%) and indepen   dent controls (2/224, 0.8%). We performed quantitative PCR analyses of the expression of IMMP2L, DOCK4 and ZNF277  in lymphoblastoid cell lines car  rying either a DOCK4 microdeletion or a ZNF277 microdeletion. We found  that, while ZNF277  microdeletions affect the expression of ZNF277 , they do  not alter the levels of DOCK4 or IMMP2L transcripts. Similarly, DOCK4 mi  crodeletions do not affect the expression levels of ZNF277 . Given these fin  dings, we postulate that ZNF277  microdeletions may contribute to the risk  of speech and language impairments in a manner that is independent of the autism risks previously described in this region.  F. Ceroni: None. N.H. Simpson:  None. C. Francks: None. G. Baird: None. G.  Conti Ramsden: None. A.E. OHare: None. E. Maestrini: None. E. Bacchelli: None. S.E. Fisher:  None. D.F. Newbury: None. I. M.g.s.a.c:  None. S.L.I.  Consortium: None.",2013.0,,"F. Ceroni1, N. H. Simpson2, C. Francks3,4, G. Baird5, G. Conti Ramsden6, A. E. OHare7, E.  Maestrini1, E. Bacchelli1, S. E. Fisher3,4, D. F. Newbury2, I. M.G.S.A.C1,2, S. L. I. Consortium2","1Dipartimento di Farmacia e Biotecnologie, University of Bologna, Bologna, Italy,  2Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, United  Kingdom, 3Max Planck Institute for Psycholinguistics, Nijmegen, Netherlands, 4Donders  Institute for Brain, Cognition & Behaviour, Nijmegen, Netherlands, 5Guys & St Thomas  NHS Foundation Trust, Newcomen Childrens Neurosciences Centre, St Thomas  Hospital, London, United Kingdom, 6School of Psychological Sciences, The University  of Manchester, Manchester, United Kingdom, 7Child Life and Health, University of  Edinburgh, Edinburgh, United Kingdom","We observed  an increased frequency of ZNF277  deletions in probands with SLI (6/318,  1.9%) compared to both probands with ASD (1/253, 0.4%) and indepen   dent controls (2/224, 0.8%).",probands with ASD,,"['probands', 'with', 'ASD']",[]
427,843,Genomics of FXT AS (Fragile X associated Tremor Ataxia) mouse brains reveals hallmarks of altered neurodevelopmement and neurodegeneration.,P08.43,,"While FMR1 is silenced in Fragile X syndrome (FXS) patients carrying the full mutation, its expression is elevated (2 8 fold) in premutated individuals. The se subjects may develop the Fragile X associated Tremor/Ataxia syndrome (FXTAS), a late onset neurodegenerative disorder characterized by ataxia and parkinsonism. In addition, people carrying the premutation can be affected by a set of neurological and behavioural disorders during young age. Memory problems have been detected in these patients as well as in the mouse mo del for FXTAS. In those animals, by transcriptome analysis we have shown a profound deregulation of the expression levels of genes involved in learning, memory and autistic behavior, Parkinson disease and neurodegeneration. These findings suggest the presence of a synapthopathy (Zongaro et al., HMG, 2013). Furthermore, we studied gene expression profiles of whole brain ob tained from both young and old FXTAS mice. We observed that in this context different neurodegenerative pathways are involved at different ages. In FXTAS mice, we also studied the expression level of several microRNAs that target FMR1 mRNA and we observed that one them, miR 221, is down regulated  at the synapse of young FXTAS mice and in the full brain of the older ones.  Interestingly, many of those deregulated mRNAs at the synapse, as well as in whole brain, are target of miR 221. These findings suggest a network regula  tion   including miRNAs and mRNAs  for FMR1 mRNA.  S. Zongaro: None. R. Hukema: None. R. Willemsen: None. B. Mari: None. B.  Bardoni: None.",2013.0,,"S. Zongaro1, R. Hukema2, R. Willemsen2, B. Mari3, B. Bardoni1","1Institut de Pharmacologie Molculaire et Cellulaire, Valbonne, France, 2Erasmus  University, Rotterdam, Netherlands, 3Instutut de Pharmacologie Molculaire et Cellulaire,  Valbonne, France","In those animals, by transcriptome analysis we have shown a profound deregulation of the expression levels of genes involved in learning, memory and autistic behavior, Parkinson disease and neurodegeneration.",,autistic behavior,[],"['autistic', 'behavior']"
428,897,Serious neurologic entity in two unrelated patients with Xq13.1 duplication,P08.99,,"Onassis Public Benefit Foundation, Athens, Greece, 31st Department of  Pediatrics, Medical School, University of Athens, Athens, Greece, 43rd Department of  Pediatrics, Medical School, University of Athens, Athens, Greece, 51 st Department of  Pediatrics, Medical School, University of Athens, Athens, Greece. The use of array CGH substantially improves the diagnosis of chromosomal  abnormalities that are not evident by conventional karyotype. Recently in an extended family with global developmental delay and autistic features,  a novel Xq12 q13.3 duplication was identified which contained amongst  others TAF1, GJB1 genes .(Kaya et al.2012).The GJB1 gene is associated with  morphology of myelin sheath and peripheral neuropathy, while TAF1  has  been linked with torsion dystonia  3. We present the clinical and molecular findings in two unrelated patients  with Xq13.1 duplication. The first one is a 5 year old boy with truncal hy   potonia, low deep tendon reflexes and proximal weakness. The other pati   ent is a 16 year old boy with progressive difficulties in walking, tremor and  learning disorder, while his mother has an identical positive family history in three deceased males. High resolution 4X180K Agilent arrays used in the  study (> 236.000 probes, average resolution of 8.9 Kb) revealed a duplicati   on on Xq13.1 (0.423 Mb) containing the TAF1 and GJB1 genes in both pati   ents, while the second patient had an additional deletion on 17q21.31 (0.63  Mb) containing KANSL1  gene. To our knowledge this is the second report  of the Xq13.1 duplication extending the previously described phenotypic  spectrum in that a more serious neurologic entity could be attributed to the  TAF1 and GJB1 genes.  K. Kosma: None. M. Tzetis: None. K. Giannikou:  None. V. Oikonomakis:   None. A. Xaidara: None. A. Dinopoulos:  None. S. Youroukos: None. A.  Syrmou: None. S. Ktsiou Tzeli:  None. E. Kanavakis: None.",2013.0,,"K. Kosma1, M. Tzetis1, K. Giannikou1,2, V. Oikonomakis1, A. Xaidara3, A. Dinopoulos4, S.  Youroukos5, A. Syrmou1, S. Ktsiou Tzeli1, E. Kanavakis1","1Department of Medical Genetics, Medical School, University of Athens, Athens, Greece,  2Alexander S","Recently in an extended family with global developmental delay and autistic features,  a novel Xq12 q13.3 duplication was identified which contained amongst  others TAF1, GJB1 genes .",,autistic features,[],"['autistic', 'feature']"
429,1369,Detection of allele specific gene expression on next generation sequencing data,P15.06,,"of Life and Reproduction Sciences,University of Verona, Verona, Italy, 2Dept. of  Biotechnology, University of Verona, Verona, Italy, 3Dept. of Pathology and Diagnostics,  University of Verona, Verona, Italy. Some studies observed that variation of gene expression between alleles is  common, and this variation may contribute to human variability of several  traits. The goal of our study is to develop a statistical framework aiming to  measure and detect allele specific gene expression (GE) differences from global GE experiments conducted using next generation sequencing (NGS)  technology. Our method for identification of allele specific differential ex   pression (ASDE) is based on the likelihood estimation of the observed data  depending on the parameter  (the relative amount of the reference allele with respect to the alternative allele). ASDE was estimated by a Likelihood  Ratio Test (LRT). Only genes with at least two heterozygous sites were selec  ted. Currently we tested the method on a total of 7 mantle cell lymphoma samples (MCL), 12 muscle cell samples (MC) and 15 lymphoblastoid cell li  nes samples (LCL). Using an arbitrary threshold of LRT > 250 we observed  15, 22 and 33 ASDE genes for MCL, MC and LCL, respectively, on a total of 10910, 8357 and 13328 expressed genes. For MCL samples we observed 3  and 1 ASDE genes in common with MC and LCL, respectively. No common  ASDE genes were observed between MC and LCL. We plan to improve the method to identify haplotypes underlying ASDE, and to investigate the cor   relation between ASDE genes and their chromosomal location or specific classes of functionality. These bioinformatic results should be confirmed by wet lab experiments. In conclusion we developed a simple method to detect ASDE genes from NGS data.  V. Mijatovic:  None. L. Xumerle: None. E. Trabetti: None. P. Prandini:   None. C. Zusi:  None. G. Buson:  None. A. Ferrarini: None. A. Zam: None. M.  Delledonne: None. P.F. Pignatti:  None. G. Malerba: None.",2013.0,,"V. Mijatovic1, L. Xumerle1, E. Trabetti1, P . Prandini1, C. Zusi1, G. Buson2, A. Ferrarini2, A.  Zam3, M. Delledonne2, P . F. Pignatti1, G. Malerba1",1Dept,"Using an arbitrary threshold of LRT > 250 we observed  15, 22 and 33 ASDE genes for MCL, MC and LCL, respectively, on a total of 10910, 8357 and 13328 expressed genes.",,ASDE genes,[],"['ASDE', 'gene']"
429,1369,Detection of allele specific gene expression on next generation sequencing data,P15.06,,"of Life and Reproduction Sciences,University of Verona, Verona, Italy, 2Dept. of  Biotechnology, University of Verona, Verona, Italy, 3Dept. of Pathology and Diagnostics,  University of Verona, Verona, Italy. Some studies observed that variation of gene expression between alleles is  common, and this variation may contribute to human variability of several  traits. The goal of our study is to develop a statistical framework aiming to  measure and detect allele specific gene expression (GE) differences from global GE experiments conducted using next generation sequencing (NGS)  technology. Our method for identification of allele specific differential ex   pression (ASDE) is based on the likelihood estimation of the observed data  depending on the parameter  (the relative amount of the reference allele with respect to the alternative allele). ASDE was estimated by a Likelihood  Ratio Test (LRT). Only genes with at least two heterozygous sites were selec  ted. Currently we tested the method on a total of 7 mantle cell lymphoma samples (MCL), 12 muscle cell samples (MC) and 15 lymphoblastoid cell li  nes samples (LCL). Using an arbitrary threshold of LRT > 250 we observed  15, 22 and 33 ASDE genes for MCL, MC and LCL, respectively, on a total of 10910, 8357 and 13328 expressed genes. For MCL samples we observed 3  and 1 ASDE genes in common with MC and LCL, respectively. No common  ASDE genes were observed between MC and LCL. We plan to improve the method to identify haplotypes underlying ASDE, and to investigate the cor   relation between ASDE genes and their chromosomal location or specific classes of functionality. These bioinformatic results should be confirmed by wet lab experiments. In conclusion we developed a simple method to detect ASDE genes from NGS data.  V. Mijatovic:  None. L. Xumerle: None. E. Trabetti: None. P. Prandini:   None. C. Zusi:  None. G. Buson:  None. A. Ferrarini: None. A. Zam: None. M.  Delledonne: None. P.F. Pignatti:  None. G. Malerba: None.",2013.0,,"V. Mijatovic1, L. Xumerle1, E. Trabetti1, P . Prandini1, C. Zusi1, G. Buson2, A. Ferrarini2, A.  Zam3, M. Delledonne2, P . F. Pignatti1, G. Malerba1",1Dept,"For MCL samples we observed 3  and 1 ASDE genes in common with MC and LCL, respectively.",,ASDE genes,[],"['ASDE', 'gene']"
429,1369,Detection of allele specific gene expression on next generation sequencing data,P15.06,,"of Life and Reproduction Sciences,University of Verona, Verona, Italy, 2Dept. of  Biotechnology, University of Verona, Verona, Italy, 3Dept. of Pathology and Diagnostics,  University of Verona, Verona, Italy. Some studies observed that variation of gene expression between alleles is  common, and this variation may contribute to human variability of several  traits. The goal of our study is to develop a statistical framework aiming to  measure and detect allele specific gene expression (GE) differences from global GE experiments conducted using next generation sequencing (NGS)  technology. Our method for identification of allele specific differential ex   pression (ASDE) is based on the likelihood estimation of the observed data  depending on the parameter  (the relative amount of the reference allele with respect to the alternative allele). ASDE was estimated by a Likelihood  Ratio Test (LRT). Only genes with at least two heterozygous sites were selec  ted. Currently we tested the method on a total of 7 mantle cell lymphoma samples (MCL), 12 muscle cell samples (MC) and 15 lymphoblastoid cell li  nes samples (LCL). Using an arbitrary threshold of LRT > 250 we observed  15, 22 and 33 ASDE genes for MCL, MC and LCL, respectively, on a total of 10910, 8357 and 13328 expressed genes. For MCL samples we observed 3  and 1 ASDE genes in common with MC and LCL, respectively. No common  ASDE genes were observed between MC and LCL. We plan to improve the method to identify haplotypes underlying ASDE, and to investigate the cor   relation between ASDE genes and their chromosomal location or specific classes of functionality. These bioinformatic results should be confirmed by wet lab experiments. In conclusion we developed a simple method to detect ASDE genes from NGS data.  V. Mijatovic:  None. L. Xumerle: None. E. Trabetti: None. P. Prandini:   None. C. Zusi:  None. G. Buson:  None. A. Ferrarini: None. A. Zam: None. M.  Delledonne: None. P.F. Pignatti:  None. G. Malerba: None.",2013.0,,"V. Mijatovic1, L. Xumerle1, E. Trabetti1, P . Prandini1, C. Zusi1, G. Buson2, A. Ferrarini2, A.  Zam3, M. Delledonne2, P . F. Pignatti1, G. Malerba1",1Dept,No common  ASDE genes were observed between MC and LCL.,,ASDE genes,[],"['ASDE', 'gene']"
429,1369,Detection of allele specific gene expression on next generation sequencing data,P15.06,,"of Life and Reproduction Sciences,University of Verona, Verona, Italy, 2Dept. of  Biotechnology, University of Verona, Verona, Italy, 3Dept. of Pathology and Diagnostics,  University of Verona, Verona, Italy. Some studies observed that variation of gene expression between alleles is  common, and this variation may contribute to human variability of several  traits. The goal of our study is to develop a statistical framework aiming to  measure and detect allele specific gene expression (GE) differences from global GE experiments conducted using next generation sequencing (NGS)  technology. Our method for identification of allele specific differential ex   pression (ASDE) is based on the likelihood estimation of the observed data  depending on the parameter  (the relative amount of the reference allele with respect to the alternative allele). ASDE was estimated by a Likelihood  Ratio Test (LRT). Only genes with at least two heterozygous sites were selec  ted. Currently we tested the method on a total of 7 mantle cell lymphoma samples (MCL), 12 muscle cell samples (MC) and 15 lymphoblastoid cell li  nes samples (LCL). Using an arbitrary threshold of LRT > 250 we observed  15, 22 and 33 ASDE genes for MCL, MC and LCL, respectively, on a total of 10910, 8357 and 13328 expressed genes. For MCL samples we observed 3  and 1 ASDE genes in common with MC and LCL, respectively. No common  ASDE genes were observed between MC and LCL. We plan to improve the method to identify haplotypes underlying ASDE, and to investigate the cor   relation between ASDE genes and their chromosomal location or specific classes of functionality. These bioinformatic results should be confirmed by wet lab experiments. In conclusion we developed a simple method to detect ASDE genes from NGS data.  V. Mijatovic:  None. L. Xumerle: None. E. Trabetti: None. P. Prandini:   None. C. Zusi:  None. G. Buson:  None. A. Ferrarini: None. A. Zam: None. M.  Delledonne: None. P.F. Pignatti:  None. G. Malerba: None.",2013.0,,"V. Mijatovic1, L. Xumerle1, E. Trabetti1, P . Prandini1, C. Zusi1, G. Buson2, A. Ferrarini2, A.  Zam3, M. Delledonne2, P . F. Pignatti1, G. Malerba1",1Dept,"We plan to improve the method to identify haplotypes underlying ASDE, and to investigate the cor   relation between ASDE genes and their chromosomal location or specific classes of functionality.",,ASDE genes,[],"['ASDE', 'gene']"
429,1369,Detection of allele specific gene expression on next generation sequencing data,P15.06,,"of Life and Reproduction Sciences,University of Verona, Verona, Italy, 2Dept. of  Biotechnology, University of Verona, Verona, Italy, 3Dept. of Pathology and Diagnostics,  University of Verona, Verona, Italy. Some studies observed that variation of gene expression between alleles is  common, and this variation may contribute to human variability of several  traits. The goal of our study is to develop a statistical framework aiming to  measure and detect allele specific gene expression (GE) differences from global GE experiments conducted using next generation sequencing (NGS)  technology. Our method for identification of allele specific differential ex   pression (ASDE) is based on the likelihood estimation of the observed data  depending on the parameter  (the relative amount of the reference allele with respect to the alternative allele). ASDE was estimated by a Likelihood  Ratio Test (LRT). Only genes with at least two heterozygous sites were selec  ted. Currently we tested the method on a total of 7 mantle cell lymphoma samples (MCL), 12 muscle cell samples (MC) and 15 lymphoblastoid cell li  nes samples (LCL). Using an arbitrary threshold of LRT > 250 we observed  15, 22 and 33 ASDE genes for MCL, MC and LCL, respectively, on a total of 10910, 8357 and 13328 expressed genes. For MCL samples we observed 3  and 1 ASDE genes in common with MC and LCL, respectively. No common  ASDE genes were observed between MC and LCL. We plan to improve the method to identify haplotypes underlying ASDE, and to investigate the cor   relation between ASDE genes and their chromosomal location or specific classes of functionality. These bioinformatic results should be confirmed by wet lab experiments. In conclusion we developed a simple method to detect ASDE genes from NGS data.  V. Mijatovic:  None. L. Xumerle: None. E. Trabetti: None. P. Prandini:   None. C. Zusi:  None. G. Buson:  None. A. Ferrarini: None. A. Zam: None. M.  Delledonne: None. P.F. Pignatti:  None. G. Malerba: None.",2013.0,,"V. Mijatovic1, L. Xumerle1, E. Trabetti1, P . Prandini1, C. Zusi1, G. Buson2, A. Ferrarini2, A.  Zam3, M. Delledonne2, P . F. Pignatti1, G. Malerba1",1Dept,In conclusion we developed a simple method to detect ASDE genes from NGS data.,,ASDE genes,[],"['ASDE', 'gene']"
432,1678, Developmental neuropsychological assessment of 4 5 years old children born following Preimplantation Genetic Diagnosis,P19.57,,"Introduction:  Preimplantation genetic diagnosis (PGD) is a technique that  enables the prevention of affected embryo transfer for couples at risk of transmitting a genetic disorder to offspring. Due to its relative invasiveness it is essential to identify any adverse effects on the long term development of children born as a result of PGD.Aim: The aim of this study was to measure and evaluate developmental neu  ropsychological profiles of 4 5 year old children born after PGD relative to norms representing the general population.Materials and methods: Twenty seven, 4 5 year old, PGD children were recruited. Participants were subjected to a battery of neuropsychological assessments including: WPPSI III(cognitive development), PLS 4(language development), WRAVMA(visual motor abilities), CARS2(screening test for autistic spectrum disorders) and the Miles ABC Test(ocular dominance). Pa rental questionnaires regarding executive function and demographics were performed as well. Each subjects tests results were compared to each tests norms as provided by the test authors. When available, Israeli norms were used for comparison.Results: Children born after PGD showed scores within the normal or above normal ranges for all developmental outcomes. The mean WPPSI Full Scale Intelligence Quotient and Verbal Intelligence Quotient were signi ficantly higher than the general population(P,0.013), although not clinically significant(10015). All other tests performed within normal test ranges.Conclusions: This pilot study shows that children conceived after PGD dis   play normal developmental neuropsychological outcomes at age 4 5 years when compared to age matched normal children in the general population. A larger controlled study is needed to confirm the validity of this conclusi on.  G. Altarescu:  None. G.C. Sacks: None. J. Guedalia:  None. T. Gilboa:   None. E.J. Margalioth:  None. E. Levy Lahad: None. T. Eldar Geva: None.",2013.0,,"G. Altarescu1, G. C. Sacks2, J. Guedalia3, T . Gilboa4, E. J. Margalioth5, E. Levy Lahad6, T .  Eldar Geva5","1Preimplantation Genetic Unit, Medical Genetics Institute, Shaare Zedek Medical  Center, Jerusalem, Israel, 2Preimplantation Genetic Unit, Shaare Zedek Medical Center,  Jerusalem, Israel, 3Neuropsychology Unit, Shaare Zedek Medical Center, Jerusalem,  Israel, 4Pediatric Neurology Unit, Shaare Zedek Medical Center, Jerusalem, Israel, 5IVF  Unit, Shaare Zedek Medical Center, Jerusalem, Israel, 6Medical Genetics Institute, Shaare  Zedek Medical Center, Jerusalem, Israel","Participants were subjected to a battery of neuropsychological assessments including: WPPSI III(cognitive development), PLS 4(language development), WRAVMA(visual motor abilities), CARS2(screening test for autistic spectrum disorders) and the Miles ABC Test(ocular dominance).",,autistic spectrum,[],"['autistic', 'spectrum']"
435,1811,A rare case of a complete 9p trisomy without autistic features and resulting from a de novo unbalanced t(9;15) translocation,J02.03,,"Trisomy 9p is one of the most frequent autosomal anomalies compatible with long survival rate. The phenotype of the 9 p duplication syndrome is clinically recognizable, and phenotype/genotype correlations suggested that the critical region is located on 9p22. We report on a rare case of a tri somy for the whole short arm of chromosome 9 resulting from a de novo unbalanced t(9;15) translocation. A 3 year old girl was referred to genetic counselling because of facial dysmorphism, seizures, and moderate mental retardation. MRI (Magnetic resonance imaging) was interpreted as normal. Chromosome analysis revealed a 46,XX,der(15)add(15)(p11) karyotype. Parental karyotypes were normal. Thus, we conclude that this chromosomal rearrangement occurred de novo. In order to identify this additional materi   al on chromosome 15, we performed array CGH (Nimbelgen Whole genome tiling135K HG18) that showed a duplication of the whole short arm of chro mosome 9. No other imbalances were found elsewhere in the genome. FISH studies performed with whole chromosome 15 and chromosome 9 painting probes confirmed that the chromosomal material added on chromosome 15 derived from 9p. Our observation is unique because the duplication of the whole short arm of chromosome 9 without monosomy of another chromo some and resulting from a de novo unbalanced translocation was never re ported. Our patient had the most common clinical findings of the trisomy 9p syndrome but neither visceral anomalies, nor autistic features. Our report doesnt strengthen the hypothesis that a critical region for autism or autism spectrum disorders (ASD) may be located on the area of 9p23 24.3.  F. Abdelhedi:  None. A. Lebbar: None. I. Ben Ayed: None. H. Ben Othmen:  None. L. Dardour: None. B. Ben Rhouma: None. C. Triki: None. N. Belguith:   None. H. Kamoun: None. J.M. Dupont:  None.",2013.0,,"F. Abdelhedi1, A. Lebbar2, I. Ben Ayed2, H. Ben Othmen3, L. Dardour4, B. Ben Rhouma1, C.  Triki3, N. Belguith4, H. Kamoun4, J. M. Dupont2","1Facult de Mdecine, Sfax, Tunisia, 2Laboratoire de Cytogntique, APHP , Hpitaux  universitaires Paris Centre, Paris, France, 3Service de Neuro Pdiatrie, CHU Hedi Chaker,  Sfax, Tunisia, 4Service de Gntique, CHU Hedi Chaker, Sfax, Tunisia","Our patient had the most common clinical findings of the trisomy 9p syndrome but neither visceral anomalies, nor autistic features.",,autistic features,[],"['autistic', 'feature']"
441,1935, Pharmacogenetic Study of Second Generation Antipsychotic Therapy in Autism Spectrum Disorders,J06.05,,"Background: Autism spectrum disorders (ASD) are among the most  common children neurodevelopment disorders. ASD patients often have co morbid conditions, such us obsessive compulsive, sleep disorders, self  destructive behavior, increased irritability, aggression and self injury. One third of ASD patients take an antipsychotic medication. One of the most  popular second generation antipsychotic is risperidone. Two cytochrome  P450 genes, CYP2D6 and CYP2C19, are involved in metabolization of psy   chotropic medications.The aim of the study was to determine the incidence of CYP2D6*4, CYP2D6*41, CYP2C19*2 alleles in the case and control groups, and progno stic assessment of risperidone therapy in association with defined alleles.Methods: Ninety five patients with ASD participated in the study. The con  trol group consisted of 190 healthy, non related individuals without ASD. CYP2C19*2, CYP2D6*4, CYP2D6*41 were genotyped by the TaqMan method. Alleles and haplotype frequency differences in case and control groups were compared by chi square ( 2) test. Frequency of adverse reactions and  therapy corrections were evaluated in the patient group.Results: Association with ASD pharmacotherapy was not found for the ha  plotypes CYP2D6*41C/T  CYP2D6*4C/T (p,0.4), therefore these cannot be safely used in the drug therapy prognostics. In the case group CYP2D6*41 allele T was observed more frequently than in the control group (p,0.01).The most common adverse drug reaction was hyperprolactinemia, the cau se of which may be associated with ASD neurotransmitter defects, and not with the primary phase of xenobiotic metabolism.  D. Bauze: None. L. Kevere: None. Z. Kronberga: None. A. Rizevs: None. K. Viksna: None. R. Andrezina: None. B. Lace: None.",2013.0,,"D. Bauze1, L. Kevere1, Z. Kronberga1, A. Rizevs1, K. Viksna2, R. Andrezina3, B. Lace2","1Children s University Hospital, Riga, Latvia,  2Latvian Biomedical Research and Study  Centre, Riga, Latvia, 3Riga Stradins University, Riga, Latvia","ASD patients often have co morbid conditions, such us obsessive compulsive, sleep disorders, self  destructive behavior, increased irritability, aggression and self injury.",,ASD patients,[],"['ASD', 'patient']"
441,1935, Pharmacogenetic Study of Second Generation Antipsychotic Therapy in Autism Spectrum Disorders,J06.05,,"Background: Autism spectrum disorders (ASD) are among the most  common children neurodevelopment disorders. ASD patients often have co morbid conditions, such us obsessive compulsive, sleep disorders, self  destructive behavior, increased irritability, aggression and self injury. One third of ASD patients take an antipsychotic medication. One of the most  popular second generation antipsychotic is risperidone. Two cytochrome  P450 genes, CYP2D6 and CYP2C19, are involved in metabolization of psy   chotropic medications.The aim of the study was to determine the incidence of CYP2D6*4, CYP2D6*41, CYP2C19*2 alleles in the case and control groups, and progno stic assessment of risperidone therapy in association with defined alleles.Methods: Ninety five patients with ASD participated in the study. The con  trol group consisted of 190 healthy, non related individuals without ASD. CYP2C19*2, CYP2D6*4, CYP2D6*41 were genotyped by the TaqMan method. Alleles and haplotype frequency differences in case and control groups were compared by chi square ( 2) test. Frequency of adverse reactions and  therapy corrections were evaluated in the patient group.Results: Association with ASD pharmacotherapy was not found for the ha  plotypes CYP2D6*41C/T  CYP2D6*4C/T (p,0.4), therefore these cannot be safely used in the drug therapy prognostics. In the case group CYP2D6*41 allele T was observed more frequently than in the control group (p,0.01).The most common adverse drug reaction was hyperprolactinemia, the cau se of which may be associated with ASD neurotransmitter defects, and not with the primary phase of xenobiotic metabolism.  D. Bauze: None. L. Kevere: None. Z. Kronberga: None. A. Rizevs: None. K. Viksna: None. R. Andrezina: None. B. Lace: None.",2013.0,,"D. Bauze1, L. Kevere1, Z. Kronberga1, A. Rizevs1, K. Viksna2, R. Andrezina3, B. Lace2","1Children s University Hospital, Riga, Latvia,  2Latvian Biomedical Research and Study  Centre, Riga, Latvia, 3Riga Stradins University, Riga, Latvia",One third of ASD patients take an antipsychotic medication.,,ASD patients,[],"['ASD', 'patient']"
441,1935, Pharmacogenetic Study of Second Generation Antipsychotic Therapy in Autism Spectrum Disorders,J06.05,,"Background: Autism spectrum disorders (ASD) are among the most  common children neurodevelopment disorders. ASD patients often have co morbid conditions, such us obsessive compulsive, sleep disorders, self  destructive behavior, increased irritability, aggression and self injury. One third of ASD patients take an antipsychotic medication. One of the most  popular second generation antipsychotic is risperidone. Two cytochrome  P450 genes, CYP2D6 and CYP2C19, are involved in metabolization of psy   chotropic medications.The aim of the study was to determine the incidence of CYP2D6*4, CYP2D6*41, CYP2C19*2 alleles in the case and control groups, and progno stic assessment of risperidone therapy in association with defined alleles.Methods: Ninety five patients with ASD participated in the study. The con  trol group consisted of 190 healthy, non related individuals without ASD. CYP2C19*2, CYP2D6*4, CYP2D6*41 were genotyped by the TaqMan method. Alleles and haplotype frequency differences in case and control groups were compared by chi square ( 2) test. Frequency of adverse reactions and  therapy corrections were evaluated in the patient group.Results: Association with ASD pharmacotherapy was not found for the ha  plotypes CYP2D6*41C/T  CYP2D6*4C/T (p,0.4), therefore these cannot be safely used in the drug therapy prognostics. In the case group CYP2D6*41 allele T was observed more frequently than in the control group (p,0.01).The most common adverse drug reaction was hyperprolactinemia, the cau se of which may be associated with ASD neurotransmitter defects, and not with the primary phase of xenobiotic metabolism.  D. Bauze: None. L. Kevere: None. Z. Kronberga: None. A. Rizevs: None. K. Viksna: None. R. Andrezina: None. B. Lace: None.",2013.0,,"D. Bauze1, L. Kevere1, Z. Kronberga1, A. Rizevs1, K. Viksna2, R. Andrezina3, B. Lace2","1Children s University Hospital, Riga, Latvia,  2Latvian Biomedical Research and Study  Centre, Riga, Latvia, 3Riga Stradins University, Riga, Latvia","Two cytochrome  P450 genes, CYP2D6 and CYP2C19, are involved in metabolization of psy   chotropic medications.The aim of the study was to determine the incidence of CYP2D6*4, CYP2D6*41, CYP2C19*2 alleles in the case and control groups, and progno stic assessment of risperidone therapy in association with defined alleles.Methods: Ninety five patients with ASD participated in the study.",patients with ASD,,"['patient', 'with', 'ASD']",[]
441,1935, Pharmacogenetic Study of Second Generation Antipsychotic Therapy in Autism Spectrum Disorders,J06.05,,"Background: Autism spectrum disorders (ASD) are among the most  common children neurodevelopment disorders. ASD patients often have co morbid conditions, such us obsessive compulsive, sleep disorders, self  destructive behavior, increased irritability, aggression and self injury. One third of ASD patients take an antipsychotic medication. One of the most  popular second generation antipsychotic is risperidone. Two cytochrome  P450 genes, CYP2D6 and CYP2C19, are involved in metabolization of psy   chotropic medications.The aim of the study was to determine the incidence of CYP2D6*4, CYP2D6*41, CYP2C19*2 alleles in the case and control groups, and progno stic assessment of risperidone therapy in association with defined alleles.Methods: Ninety five patients with ASD participated in the study. The con  trol group consisted of 190 healthy, non related individuals without ASD. CYP2C19*2, CYP2D6*4, CYP2D6*41 were genotyped by the TaqMan method. Alleles and haplotype frequency differences in case and control groups were compared by chi square ( 2) test. Frequency of adverse reactions and  therapy corrections were evaluated in the patient group.Results: Association with ASD pharmacotherapy was not found for the ha  plotypes CYP2D6*41C/T  CYP2D6*4C/T (p,0.4), therefore these cannot be safely used in the drug therapy prognostics. In the case group CYP2D6*41 allele T was observed more frequently than in the control group (p,0.01).The most common adverse drug reaction was hyperprolactinemia, the cau se of which may be associated with ASD neurotransmitter defects, and not with the primary phase of xenobiotic metabolism.  D. Bauze: None. L. Kevere: None. Z. Kronberga: None. A. Rizevs: None. K. Viksna: None. R. Andrezina: None. B. Lace: None.",2013.0,,"D. Bauze1, L. Kevere1, Z. Kronberga1, A. Rizevs1, K. Viksna2, R. Andrezina3, B. Lace2","1Children s University Hospital, Riga, Latvia,  2Latvian Biomedical Research and Study  Centre, Riga, Latvia, 3Riga Stradins University, Riga, Latvia","Frequency of adverse reactions and  therapy corrections were evaluated in the patient group.Results: Association with ASD pharmacotherapy was not found for the ha  plotypes CYP2D6*41C/T  CYP2D6*4C/T (p,0.4), therefore these cannot be safely used in the drug therapy prognostics.",,ASD pharmacotherapy,[],"['ASD', 'pharmacotherapy']"
441,1935, Pharmacogenetic Study of Second Generation Antipsychotic Therapy in Autism Spectrum Disorders,J06.05,,"Background: Autism spectrum disorders (ASD) are among the most  common children neurodevelopment disorders. ASD patients often have co morbid conditions, such us obsessive compulsive, sleep disorders, self  destructive behavior, increased irritability, aggression and self injury. One third of ASD patients take an antipsychotic medication. One of the most  popular second generation antipsychotic is risperidone. Two cytochrome  P450 genes, CYP2D6 and CYP2C19, are involved in metabolization of psy   chotropic medications.The aim of the study was to determine the incidence of CYP2D6*4, CYP2D6*41, CYP2C19*2 alleles in the case and control groups, and progno stic assessment of risperidone therapy in association with defined alleles.Methods: Ninety five patients with ASD participated in the study. The con  trol group consisted of 190 healthy, non related individuals without ASD. CYP2C19*2, CYP2D6*4, CYP2D6*41 were genotyped by the TaqMan method. Alleles and haplotype frequency differences in case and control groups were compared by chi square ( 2) test. Frequency of adverse reactions and  therapy corrections were evaluated in the patient group.Results: Association with ASD pharmacotherapy was not found for the ha  plotypes CYP2D6*41C/T  CYP2D6*4C/T (p,0.4), therefore these cannot be safely used in the drug therapy prognostics. In the case group CYP2D6*41 allele T was observed more frequently than in the control group (p,0.01).The most common adverse drug reaction was hyperprolactinemia, the cau se of which may be associated with ASD neurotransmitter defects, and not with the primary phase of xenobiotic metabolism.  D. Bauze: None. L. Kevere: None. Z. Kronberga: None. A. Rizevs: None. K. Viksna: None. R. Andrezina: None. B. Lace: None.",2013.0,,"D. Bauze1, L. Kevere1, Z. Kronberga1, A. Rizevs1, K. Viksna2, R. Andrezina3, B. Lace2","1Children s University Hospital, Riga, Latvia,  2Latvian Biomedical Research and Study  Centre, Riga, Latvia, 3Riga Stradins University, Riga, Latvia","In the case group CYP2D6*41 allele T was observed more frequently than in the control group (p,0.01).The most common adverse drug reaction was hyperprolactinemia, the cau se of which may be associated with ASD neurotransmitter defects, and not with the primary phase of xenobiotic metabolism.",,ASD neurotransmitter,[],"['ASD', 'neurotransmitter']"
442,1936,Abnormal growth and dysmorphic features in children with autism spectrum disorders,J06.06,,"Autism spectrum disorders (ASDs) are very heterogeneous neurodevelop mental disorders of children diagnosed solely on the basis of the triad of per   sistent social and language deficits and stereotypic behaviors. Several lines of evidence have indicated the strong role of genetics in the etiology of ASDs. Progress in understanding the genetic and biological basis of autism has been impeded by the variability among individuals with autism. Clinical morpho logy might be used as a biomarker for ASDs to clarify the complexity of the disorder. In an effort to delineate more homogeneous autism subgroups for genetic study, we evaluated 83 autistic individuals. The clinical examination consi sted of standard morphological measurements and comprised a broad range of qualitative and quantitative physical measurements. Our findings show that morphological features are associated with autism and a comprehensi ve clinical morphology examination that classifies autistic children as either phenotypically normal or abnormal is the first step needed for separating autism into causally distinct subgroups. Exploring potential underlying ge netic mechanisms of this association might lead to a better understanding of autism. Identifiable endophenotypes and reliable biomarkers within ASDs would help to focus molecular research and uncover genetic causes and deve lopmental mechanisms.  D. Avdjieva Tzavella: None. S. Hadjidekova: None. B. Rukova: None. H. Kathom: None. R. Tincheva: None. D. Toncheva: None.ABSTRACTS PUBLISHED ABSTRACTS ESHG 2013 | PARIS, FRANCE | WWW.ESHG.ORG 504Back to index",2013.0,,"D. Avdjieva Tzavella1, S. Hadjidekova2, B. Rukova2, H. Kathom3, R. Tincheva3, D. Toncheva2","1Department of Clinical Genetics, University Pediatrics Hospital, Medical University, Sofia,  Bulgaria, Sofia, Bulgaria, 2Department of Medical Genetics, Medical Faculty, Medical  University, Sofia, Bulgaria, 3Department of Clinical Genetics, University Pediatrics  Hospital, Medical University,, Sofia, Bulgaria",Progress in understanding the genetic and biological basis of autism has been impeded by the variability among individuals with autism.,individuals with autism,,"['individual', 'with', 'autism']",[]
442,1936,Abnormal growth and dysmorphic features in children with autism spectrum disorders,J06.06,,"Autism spectrum disorders (ASDs) are very heterogeneous neurodevelop mental disorders of children diagnosed solely on the basis of the triad of per   sistent social and language deficits and stereotypic behaviors. Several lines of evidence have indicated the strong role of genetics in the etiology of ASDs. Progress in understanding the genetic and biological basis of autism has been impeded by the variability among individuals with autism. Clinical morpho logy might be used as a biomarker for ASDs to clarify the complexity of the disorder. In an effort to delineate more homogeneous autism subgroups for genetic study, we evaluated 83 autistic individuals. The clinical examination consi sted of standard morphological measurements and comprised a broad range of qualitative and quantitative physical measurements. Our findings show that morphological features are associated with autism and a comprehensi ve clinical morphology examination that classifies autistic children as either phenotypically normal or abnormal is the first step needed for separating autism into causally distinct subgroups. Exploring potential underlying ge netic mechanisms of this association might lead to a better understanding of autism. Identifiable endophenotypes and reliable biomarkers within ASDs would help to focus molecular research and uncover genetic causes and deve lopmental mechanisms.  D. Avdjieva Tzavella: None. S. Hadjidekova: None. B. Rukova: None. H. Kathom: None. R. Tincheva: None. D. Toncheva: None.ABSTRACTS PUBLISHED ABSTRACTS ESHG 2013 | PARIS, FRANCE | WWW.ESHG.ORG 504Back to index",2013.0,,"D. Avdjieva Tzavella1, S. Hadjidekova2, B. Rukova2, H. Kathom3, R. Tincheva3, D. Toncheva2","1Department of Clinical Genetics, University Pediatrics Hospital, Medical University, Sofia,  Bulgaria, Sofia, Bulgaria, 2Department of Medical Genetics, Medical Faculty, Medical  University, Sofia, Bulgaria, 3Department of Clinical Genetics, University Pediatrics  Hospital, Medical University,, Sofia, Bulgaria","In an effort to delineate more homogeneous autism subgroups for genetic study, we evaluated 83 autistic individuals.",,autistic individuals,[],"['autistic', 'individual']"
442,1936,Abnormal growth and dysmorphic features in children with autism spectrum disorders,J06.06,,"Autism spectrum disorders (ASDs) are very heterogeneous neurodevelop mental disorders of children diagnosed solely on the basis of the triad of per   sistent social and language deficits and stereotypic behaviors. Several lines of evidence have indicated the strong role of genetics in the etiology of ASDs. Progress in understanding the genetic and biological basis of autism has been impeded by the variability among individuals with autism. Clinical morpho logy might be used as a biomarker for ASDs to clarify the complexity of the disorder. In an effort to delineate more homogeneous autism subgroups for genetic study, we evaluated 83 autistic individuals. The clinical examination consi sted of standard morphological measurements and comprised a broad range of qualitative and quantitative physical measurements. Our findings show that morphological features are associated with autism and a comprehensi ve clinical morphology examination that classifies autistic children as either phenotypically normal or abnormal is the first step needed for separating autism into causally distinct subgroups. Exploring potential underlying ge netic mechanisms of this association might lead to a better understanding of autism. Identifiable endophenotypes and reliable biomarkers within ASDs would help to focus molecular research and uncover genetic causes and deve lopmental mechanisms.  D. Avdjieva Tzavella: None. S. Hadjidekova: None. B. Rukova: None. H. Kathom: None. R. Tincheva: None. D. Toncheva: None.ABSTRACTS PUBLISHED ABSTRACTS ESHG 2013 | PARIS, FRANCE | WWW.ESHG.ORG 504Back to index",2013.0,,"D. Avdjieva Tzavella1, S. Hadjidekova2, B. Rukova2, H. Kathom3, R. Tincheva3, D. Toncheva2","1Department of Clinical Genetics, University Pediatrics Hospital, Medical University, Sofia,  Bulgaria, Sofia, Bulgaria, 2Department of Medical Genetics, Medical Faculty, Medical  University, Sofia, Bulgaria, 3Department of Clinical Genetics, University Pediatrics  Hospital, Medical University,, Sofia, Bulgaria",Our findings show that morphological features are associated with autism and a comprehensi ve clinical morphology examination that classifies autistic children as either phenotypically normal or abnormal is the first step needed for separating autism into causally distinct subgroups.,,autistic children,[],"['autistic', 'child']"
443,1937, Cytogenetic analysis in autistic disorder,J06.07,,"Autistic disorder (AD) is a very complex and severe neuropsychiatric con dition, increasingly frequent among children, with intricate and yet uncer  tain etiology, defined by impairments in communication and social skills,  with onset prior to age 3 years. Genetic and cytogenetic studies revealed that most of the chromosomes are associated with autism, abnormalities of  chromosomes 15 and X being most frequently documented. AIM OF THE STUDY: Cytogenetic analysis on peripheral blood samples from children with autism was performed to identify possible structural or nume rical chromosomal abnormalities by GTG banding. RESULTS: The study revealed normal karyotypes in most cases (47 out of  50 individuals). Two of the male patients had modified karyotypes (2% mo saicism): chromosome 9qh+ polymorphism and terminal deletion on chro  mosome 15q, respectively. One of the female patients had an extra chromo  some 8 (2% mosaicism).CONCLUSION: This is the first cytogenetic testing performed specifically on  autistic children in Romania. Our results show that karyotyping analysis is not conclusive in most cases with autism. Nevertheless, the test should be proposed and performed for every autistic patient, in order to eliminate possible numerical or structural  chromosomal abnormalities as the cause for AD.  E. Dronca: None. M.S. Militaru:  None. O. Popescu:  None.",2013.0,,"E. Dronca1, M. S. Militaru1, O. Popescu2","1Department of Medical Genetics, Iuliu Hatieganu University of Medicine and Pharmacy,  Cluj Napoca, Romania, 2Babes Bolyai University, Cluj Napoca, Romania","Autistic disorder (AD) is a very complex and severe neuropsychiatric con dition, increasingly frequent among children, with intricate and yet uncer  tain etiology, defined by impairments in communication and social skills,  with onset prior to age 3 years.",,Autistic disorder,[],"['Autistic', 'disorder']"
443,1937, Cytogenetic analysis in autistic disorder,J06.07,,"Autistic disorder (AD) is a very complex and severe neuropsychiatric con dition, increasingly frequent among children, with intricate and yet uncer  tain etiology, defined by impairments in communication and social skills,  with onset prior to age 3 years. Genetic and cytogenetic studies revealed that most of the chromosomes are associated with autism, abnormalities of  chromosomes 15 and X being most frequently documented. AIM OF THE STUDY: Cytogenetic analysis on peripheral blood samples from children with autism was performed to identify possible structural or nume rical chromosomal abnormalities by GTG banding. RESULTS: The study revealed normal karyotypes in most cases (47 out of  50 individuals). Two of the male patients had modified karyotypes (2% mo saicism): chromosome 9qh+ polymorphism and terminal deletion on chro  mosome 15q, respectively. One of the female patients had an extra chromo  some 8 (2% mosaicism).CONCLUSION: This is the first cytogenetic testing performed specifically on  autistic children in Romania. Our results show that karyotyping analysis is not conclusive in most cases with autism. Nevertheless, the test should be proposed and performed for every autistic patient, in order to eliminate possible numerical or structural  chromosomal abnormalities as the cause for AD.  E. Dronca: None. M.S. Militaru:  None. O. Popescu:  None.",2013.0,,"E. Dronca1, M. S. Militaru1, O. Popescu2","1Department of Medical Genetics, Iuliu Hatieganu University of Medicine and Pharmacy,  Cluj Napoca, Romania, 2Babes Bolyai University, Cluj Napoca, Romania",AIM OF THE STUDY: Cytogenetic analysis on peripheral blood samples from children with autism was performed to identify possible structural or nume rical chromosomal abnormalities by GTG banding.,children with autism,,"['child', 'with', 'autism']",[]
443,1937, Cytogenetic analysis in autistic disorder,J06.07,,"Autistic disorder (AD) is a very complex and severe neuropsychiatric con dition, increasingly frequent among children, with intricate and yet uncer  tain etiology, defined by impairments in communication and social skills,  with onset prior to age 3 years. Genetic and cytogenetic studies revealed that most of the chromosomes are associated with autism, abnormalities of  chromosomes 15 and X being most frequently documented. AIM OF THE STUDY: Cytogenetic analysis on peripheral blood samples from children with autism was performed to identify possible structural or nume rical chromosomal abnormalities by GTG banding. RESULTS: The study revealed normal karyotypes in most cases (47 out of  50 individuals). Two of the male patients had modified karyotypes (2% mo saicism): chromosome 9qh+ polymorphism and terminal deletion on chro  mosome 15q, respectively. One of the female patients had an extra chromo  some 8 (2% mosaicism).CONCLUSION: This is the first cytogenetic testing performed specifically on  autistic children in Romania. Our results show that karyotyping analysis is not conclusive in most cases with autism. Nevertheless, the test should be proposed and performed for every autistic patient, in order to eliminate possible numerical or structural  chromosomal abnormalities as the cause for AD.  E. Dronca: None. M.S. Militaru:  None. O. Popescu:  None.",2013.0,,"E. Dronca1, M. S. Militaru1, O. Popescu2","1Department of Medical Genetics, Iuliu Hatieganu University of Medicine and Pharmacy,  Cluj Napoca, Romania, 2Babes Bolyai University, Cluj Napoca, Romania",One of the female patients had an extra chromo  some 8 (2% mosaicism).CONCLUSION: This is the first cytogenetic testing performed specifically on  autistic children in Romania.,,autistic children,[],"['autistic', 'child']"
443,1937, Cytogenetic analysis in autistic disorder,J06.07,,"Autistic disorder (AD) is a very complex and severe neuropsychiatric con dition, increasingly frequent among children, with intricate and yet uncer  tain etiology, defined by impairments in communication and social skills,  with onset prior to age 3 years. Genetic and cytogenetic studies revealed that most of the chromosomes are associated with autism, abnormalities of  chromosomes 15 and X being most frequently documented. AIM OF THE STUDY: Cytogenetic analysis on peripheral blood samples from children with autism was performed to identify possible structural or nume rical chromosomal abnormalities by GTG banding. RESULTS: The study revealed normal karyotypes in most cases (47 out of  50 individuals). Two of the male patients had modified karyotypes (2% mo saicism): chromosome 9qh+ polymorphism and terminal deletion on chro  mosome 15q, respectively. One of the female patients had an extra chromo  some 8 (2% mosaicism).CONCLUSION: This is the first cytogenetic testing performed specifically on  autistic children in Romania. Our results show that karyotyping analysis is not conclusive in most cases with autism. Nevertheless, the test should be proposed and performed for every autistic patient, in order to eliminate possible numerical or structural  chromosomal abnormalities as the cause for AD.  E. Dronca: None. M.S. Militaru:  None. O. Popescu:  None.",2013.0,,"E. Dronca1, M. S. Militaru1, O. Popescu2","1Department of Medical Genetics, Iuliu Hatieganu University of Medicine and Pharmacy,  Cluj Napoca, Romania, 2Babes Bolyai University, Cluj Napoca, Romania",Our results show that karyotyping analysis is not conclusive in most cases with autism.,cases with autism,,"['case', 'with', 'autism']",[]
443,1937, Cytogenetic analysis in autistic disorder,J06.07,,"Autistic disorder (AD) is a very complex and severe neuropsychiatric con dition, increasingly frequent among children, with intricate and yet uncer  tain etiology, defined by impairments in communication and social skills,  with onset prior to age 3 years. Genetic and cytogenetic studies revealed that most of the chromosomes are associated with autism, abnormalities of  chromosomes 15 and X being most frequently documented. AIM OF THE STUDY: Cytogenetic analysis on peripheral blood samples from children with autism was performed to identify possible structural or nume rical chromosomal abnormalities by GTG banding. RESULTS: The study revealed normal karyotypes in most cases (47 out of  50 individuals). Two of the male patients had modified karyotypes (2% mo saicism): chromosome 9qh+ polymorphism and terminal deletion on chro  mosome 15q, respectively. One of the female patients had an extra chromo  some 8 (2% mosaicism).CONCLUSION: This is the first cytogenetic testing performed specifically on  autistic children in Romania. Our results show that karyotyping analysis is not conclusive in most cases with autism. Nevertheless, the test should be proposed and performed for every autistic patient, in order to eliminate possible numerical or structural  chromosomal abnormalities as the cause for AD.  E. Dronca: None. M.S. Militaru:  None. O. Popescu:  None.",2013.0,,"E. Dronca1, M. S. Militaru1, O. Popescu2","1Department of Medical Genetics, Iuliu Hatieganu University of Medicine and Pharmacy,  Cluj Napoca, Romania, 2Babes Bolyai University, Cluj Napoca, Romania","Nevertheless, the test should be proposed and performed for every autistic patient, in order to eliminate possible numerical or structural  chromosomal abnormalities as the cause for AD.",,autistic patient,[],"['autistic', 'patient']"
444,1938, Marfan syndrome with Asperger disorder and schizophrenia in an adolescent boy,J06.08,,"Aim: To present the rare association of 2 psychiatric disorders in an ado lescent with Marfan syndrome. Methods: A 17 years old boy was evaluated in our neuropsychiatry department for a psychotic episode. Results: The adolescent was in a state of extreme agitation and presented auditory and visual hallucinations. Furthermore, he had persecution delirium, was highly suspicious and anxious and feared for his life. The symptoms appeared gra dually during the 3 weeks prior to admission. His medical history revealed he was previously diagnosed with Marfan syndrome and Asperger disorder. The physical examination was suggestive for the connective tissue disorder and otherwise unremarkable. The EEG didnt show abnormal electrical ac tivity, while a heart ultrasound confirmed a mildly dilated aortic bulb. He received antipsychotic and sedative treatment with a favorable outcome and remains in psychiatric follow up. Conclusions: Although, several cases with Marfan syndrome and different psychiatric disorders are reported in the li terature, to our knowledge this is the first time both schizophrenia and As perger disorder are found in such a young patient with Marfan syndrome  C. Pienar: None. S. Dumitriu:  None. M. Puiu:  None.",2013.0,,"C. Pienar, S. Dumitriu, M. Puiu","University of Medicine &Pharmacy Victor Babes, Timisoara, Romania",His medical history revealed he was previously diagnosed with Marfan syndrome and Asperger disorder.,,Asperger disorder,[],"['Asperger', 'disorder']"
446,2229,Microarray Comparative Genomic Hybridization analysis (array CGH) as a diagnostic tool for the investigation of patients with autism or autistic spectrum disorders,J18.03,,"Onassis Public Benefit Foundation, Athens, Greece. Aim: Autism or autistic spectrum disorders (ASD) are a lifelong neurode   velopmental disorder and  few cases of chromosomal abnormalities are  found by conventional cytogenetic techniques, while the microarray Compa  rative Genomic Hybridization analysis (array CGH) allows the identification of submicroscopic genomic rearrangements. This study describes the ap  plication of array CGH, as a diagnostic tool for the investigation of patients  with autism or ASD. Materials  Methods: During the last 4 years, 88/480 patients were studied with autism or ASD of unknown aetiology but with normal previous con ventional karyotype and other genetic tests. High resolution 4X180K and  1x244K Agilent arrays were used in the study (>170.000 and > 236.000 pro  bes respectively, average resolution of 8.9 Kb). Results: Submicroscopic genomic rearrangements (CNVs), ranging in size from 0.08 to19.01 Mb were detected in 51/88 (58%), some of which also presented: seizures (8/51), hypotonia (1/51), obesity (2/51), mental retar  dation (9/51), hearing loss (1/51) and dysmorphic features (2 / 51). CNVs  detected were in loci at high risk for autism: 2q37.2, 2p16.3, 5p15.32p14.3,  7p22.3, 10q26.3, 12q24.22q24.3, 15q11.2q11.3, 16p11.2, 18q22.3q23, 21q22.3, q21.31. Genes associated with autism or ASD which were identi fied included: NRXN1, SHANK3, DOCK8, ZNF92, ASMT , HSFX1, KCNH7, CHR   FAM7A, CHRNA7, KCND2, CNTNAP3, , MAOB, STS, VCX. Conclusions: In patients with autism or ASD and non syndromic phenotype,  array CGH analysis is mandatory to detect possible submicroscopic chromo somal abnormalities. For the family, positive results of array CGH, provides comprehensive genetic counseling, which includes determining the patients  prognosis and planning antenatal diagnosis in subsequent pregnancies.  V. Oikonomakis:  None. M. Tzetis: None. K. Kosma: None. A. Syrmou:  None. K. Giannikou:  None. H. Fryssira: None. E. Kanavakis: None. S. Kitsiou  Tzeli: None.",2013.0,,"V. Oikonomakis1, M. Tzetis1, K. Kosma1, A. Syrmou1, K. Giannikou1,2, H. Fryssira1, E.  Kanavakis1, S. Kitsiou Tzeli1","1Department of Medical Genetics, Medical School, University of Athens, Athens, Greece,  2Alexander S","Aim: Autism or autistic spectrum disorders (ASD) are a lifelong neurode   velopmental disorder and  few cases of chromosomal abnormalities are  found by conventional cytogenetic techniques, while the microarray Compa  rative Genomic Hybridization analysis (array CGH) allows the identification of submicroscopic genomic rearrangements.",,autistic spectrum,[],"['autistic', 'spectrum']"
446,2229,Microarray Comparative Genomic Hybridization analysis (array CGH) as a diagnostic tool for the investigation of patients with autism or autistic spectrum disorders,J18.03,,"Onassis Public Benefit Foundation, Athens, Greece. Aim: Autism or autistic spectrum disorders (ASD) are a lifelong neurode   velopmental disorder and  few cases of chromosomal abnormalities are  found by conventional cytogenetic techniques, while the microarray Compa  rative Genomic Hybridization analysis (array CGH) allows the identification of submicroscopic genomic rearrangements. This study describes the ap  plication of array CGH, as a diagnostic tool for the investigation of patients  with autism or ASD. Materials  Methods: During the last 4 years, 88/480 patients were studied with autism or ASD of unknown aetiology but with normal previous con ventional karyotype and other genetic tests. High resolution 4X180K and  1x244K Agilent arrays were used in the study (>170.000 and > 236.000 pro  bes respectively, average resolution of 8.9 Kb). Results: Submicroscopic genomic rearrangements (CNVs), ranging in size from 0.08 to19.01 Mb were detected in 51/88 (58%), some of which also presented: seizures (8/51), hypotonia (1/51), obesity (2/51), mental retar  dation (9/51), hearing loss (1/51) and dysmorphic features (2 / 51). CNVs  detected were in loci at high risk for autism: 2q37.2, 2p16.3, 5p15.32p14.3,  7p22.3, 10q26.3, 12q24.22q24.3, 15q11.2q11.3, 16p11.2, 18q22.3q23, 21q22.3, q21.31. Genes associated with autism or ASD which were identi fied included: NRXN1, SHANK3, DOCK8, ZNF92, ASMT , HSFX1, KCNH7, CHR   FAM7A, CHRNA7, KCND2, CNTNAP3, , MAOB, STS, VCX. Conclusions: In patients with autism or ASD and non syndromic phenotype,  array CGH analysis is mandatory to detect possible submicroscopic chromo somal abnormalities. For the family, positive results of array CGH, provides comprehensive genetic counseling, which includes determining the patients  prognosis and planning antenatal diagnosis in subsequent pregnancies.  V. Oikonomakis:  None. M. Tzetis: None. K. Kosma: None. A. Syrmou:  None. K. Giannikou:  None. H. Fryssira: None. E. Kanavakis: None. S. Kitsiou  Tzeli: None.",2013.0,,"V. Oikonomakis1, M. Tzetis1, K. Kosma1, A. Syrmou1, K. Giannikou1,2, H. Fryssira1, E.  Kanavakis1, S. Kitsiou Tzeli1","1Department of Medical Genetics, Medical School, University of Athens, Athens, Greece,  2Alexander S","Conclusions: In patients with autism or ASD and non syndromic phenotype,  array CGH analysis is mandatory to detect possible submicroscopic chromo somal abnormalities.",patients with autism,,"['patient', 'with', 'autism']",[]
455,192, Efficient molecular diagnosis of Intellectual Disability: targeted High throughput exon sequencing of 217 ID genes detects causative mutations in at least 26 of 106 tested patients,C18.2,,"Intellectual disability is a major public health problem, characterized by an extreme genetic heterogeneity, with several hundred genes implicated in monogenic forms with or without autism, complicating molecular dia gnosis. In patients without evocative syndromic forms the offer is limited to Fragile X testing and array CGH, leaving most cases undiagnosed. Trio Exome sequencing was recently proposed as a diagnostic approach, but re mains costly for general implementation. We thus tested targeted exon se   quencing of 217 genes previously implicated in X linked ID, or in autosomal dominant or recessive forms in which ID is the major clinical concern. We analyzed 106 patients (mostly males and sporadic cases) with molecularly undiagnosed ID. One third of them harbored autistic features.We identified causative mutations in 26 patients: sixteen in X linked ge nes (ATRX, CUL4B, DMD , FMR1, HCFC1, IL1RAPL1 , IQSEC2, KDM5C, MAOA,  MECP2, SLC9A6 , SLC16A2, PHF8), 10 de novo in autosomal genes (DYRK1A ,  GRIN1 , MED13L , TCF4, RAI1 , SHANK3, SLC2A1, SYNGAP1 ). We detected likely  causative mutations requiring additional validation in 5 patients (in NLGN3  for instance). Our findings confirm MED13L as an ID gene, but raise doubts on SHROOM4 or SRPX2. We identified causative mutations in syndromic ge  nes in patients deviating from the classic phenotype. Some genes were hit  more than once suggesting they correspond to more frequent conditions.  The identification of mutations in 25 29% of patients proves the diagnostic efficiency of this strategy, higher than CGH and comparable to trio exome sequencing at lesser cost. We have now updated our captured gene list to  270 genes, and will report on its use.",2014.0,,"J. Mandel1,2,3, C. Redin1,3, J. Muller1,2, B. Grard2, B. Jost1, M. Dumas1, S. Le Gras1, the  French clinical genetics of ID consortium, D. Bonneau4, H. Dollfus5, Y. Alembik5, E. Flori6,  V. Drouin Garraud7, D. Lacombe8, M. Doco Fenzy9, P . Sarda10, D. Genevive10, P . Edery11, B.  Isidor12, L. Olivier Faivre13, A. Piton1,3","1IGBMC, Illkirch, CU Strasbourg, France, 2Laboratoire diagnostic genetique CHU  Strasbourg, Strasbourg, France, 3Collge de France, Paris, France, 4Department of  Biochemistry and Genetics, Angers University Hospital, Angers, France, 5Service de  Gntique mdicale, CHU Strasbourg, Strasbourg, France, 6Service de cytogntique,  CHU Strasbourg, Strasbourg, France, 7Department of Medical Genetics, CHU Rouen,  Rouen, France, 8Service de gntique mdicale,CHU Pellegrin, Bordeaux, Bordeaux,  France, 9Service de cytogntique, CHU Reims, Reims, France, 10Dpartement de  gntique mdicale, CHU Montpellier, Montpellier, France, 11Dpartement de gntique  mdicale, CHU Lyon Bron, Lyon, France, 12Service de gntique mdicale, CHU Nantes,  Nantes, France, 13Dpartement de gntique mdicale, CHU Dijon, Dijon, France","One third of them harbored autistic features.We identified causative mutations in 26 patients: sixteen in X linked ge nes (ATRX, CUL4B, DMD , FMR1, HCFC1, IL1RAPL1 , IQSEC2, KDM5C, MAOA,  MECP2, SLC9A6 , SLC16A2, PHF8), 10 de novo in autosomal genes (DYRK1A ,  GRIN1 , MED13L , TCF4, RAI1 , SHANK3, SLC2A1, SYNGAP1 ).",,autistic features,[],"['autistic', 'feature']"
457,343, M Exome sequencing in 32 patients with anophthalmia/microphthalmia and other developmental eye defects,P02.04,,", Menlo Park, CA, United States, 3Division of Medical  Genetics, Einstein Medical Center, Philadelphia, PA, United States, 4Cardiovascular  Research Institute, University of California, San Francisco, San Francisco, CA, United  States, 5Department of Neurology, University of California, San Francisco, San Francisco,  CA, United States. Anophthalmia/microphthalmia (A/M) is a genetically heterogeneous birth defect for which the etiology remains unknown in more than 50% patients. A/M can occur without other structural eye defects (simplex A/M), or can be present with other ocular findings (complex A/M), such as anterior segment dysgenesis (ASD). We used exome sequencing (ACE ExomeTM, Personalis, Inc., 18 exomes; UCSF Genomics Core, 20 exomes; 6 were run twice) to se   quence DNA from 32 children with A/M or other developmental eye defects for pathogenic mutations. In 19 patients with simplex A/M, we identified mutations in STRA6 (1 patient), RARB (1 patient; p.Arg387Cys), GDF6 (1 pa tient; p.Ala249Glu) and OTX2 (1 patient; p.Gln91His) and in 9 patients with complex A/M, we found mutations in STRA6 in 2 patients. Putative causative variants were identified in 3 out of 4 patients with other developmental eye defects   a homozygous mutation in GCNT2, p.Tyr347Cys, in a female with cataracts and microtia and a de novo mutation in COL4A1, p.Gly773Arg, in a female with cataracts and cardiomyopathy. In a male with a chorioretinal defect, microcephaly, seizures and sensorineural deafness, we identified a maternally inherited splice site mutation and a paternally inherited mis sense mutation, p.Ala507Ser, in PNPT1 which is critical for mRNA import into mitochondria and has not been associated with eye defects. In one child with ASD, no mutation was identified. Our overall detection rate for A/M was 6/28 (21%), illustrating high genetic heterogeneity and the need for further gene discovery.",2014.0,,"A. Slavotinek1, S. T . Garcia2, G. Chandratillake2, T . Bardakjian3, R. Lao4, P . Tang4, E.  Wan4, D. Wu1, K. Umeda1, J. Tirch2, R. Tischler2, J. Harris2, M. J. Clark2, S. Chervitz2, A.  Patwardhan2, J. M. West2, A. Schneider3, P . Kwok4, S. Baranzini5, R. M. Chen2","1Department of Pediatrics, University of California, San Francisco, San Francisco, CA,  United States, 2Personalis, Inc","In one child with ASD, no mutation was identified.",child with ASD,,"['child', 'with', 'ASD']",[]
458,598, S Two New Cases of Myopathy with Cataracts and Combined Respiratory Chain Deficiency caused by Mutations in GFER gene,P06.21,,"Myopathy with cataracts and combined respiratory chain deficiency (MPMCHD, OMIM#613076) is caused by mutations in GFER gene and has been described in a single consanguineous family (Di Fonzo et al, AJHG 2009, 84:594). We report two additional cases of MPMCHD in a non con sanguineous Caucasian family: one patient presented at 6 months with ca taracts, mild developmental delays (DD) and hypotonia and at 16 months suffered severe episodes of hypoglycemia and lactic acidosis. Despite inter   mittent periods of relative metabolic stability, the condition is progressing. At 13 years he is wheel chair bound, has failure to thrive (requiring tube feeding), global DD, autistic features, central hypotonia, and dystonia. Urine organic acid analyses reveal persistent 3 methylglutaconic aciduria. Muscle biopsy showed ragged red fibers and decreased staining for cytochrom C oxidase. Muscle analysis demonstrated reduced respiratory chain complex IV activity and increased mtDNA content in the absence of mutations or de   letions. This patients sister has clinical presentation characterized by later onset and milder, but similar clinical course which includes congenital ca taracts, global DD and autistic features. Bouts of lethargy associated with lactic acidosis are frequent and require hospital admissions. Whole exome sequencing [done at Baylor College of Medicine] revealed two mutations in GFER gene: c.581G>A (p.R194H, previously reported) and c.215delG (p.A73Pfs*73).These cases further describe the phenotype associated with GFER gene mu tations. Although both patients have features similar to the other 3 reported patients with MPMCHD, the clinical course in our patients is more severe and includes prominent lactic acidosis and 3 methylglutaconic aciduria but not deafness.",2014.0,,"D. Gavrilov, A. Studinski","Departments of Medical Genetics, and Laboratory Medicine and Pathology, Biochemical Genetics Laboratory, Mayo Clinic School of Medicine, Rochester, MN, United States","At 13 years he is wheel chair bound, has failure to thrive (requiring tube feeding), global DD, autistic features, central hypotonia, and dystonia.",,autistic features,[],"['autistic', 'feature']"
458,598, S Two New Cases of Myopathy with Cataracts and Combined Respiratory Chain Deficiency caused by Mutations in GFER gene,P06.21,,"Myopathy with cataracts and combined respiratory chain deficiency (MPMCHD, OMIM#613076) is caused by mutations in GFER gene and has been described in a single consanguineous family (Di Fonzo et al, AJHG 2009, 84:594). We report two additional cases of MPMCHD in a non con sanguineous Caucasian family: one patient presented at 6 months with ca taracts, mild developmental delays (DD) and hypotonia and at 16 months suffered severe episodes of hypoglycemia and lactic acidosis. Despite inter   mittent periods of relative metabolic stability, the condition is progressing. At 13 years he is wheel chair bound, has failure to thrive (requiring tube feeding), global DD, autistic features, central hypotonia, and dystonia. Urine organic acid analyses reveal persistent 3 methylglutaconic aciduria. Muscle biopsy showed ragged red fibers and decreased staining for cytochrom C oxidase. Muscle analysis demonstrated reduced respiratory chain complex IV activity and increased mtDNA content in the absence of mutations or de   letions. This patients sister has clinical presentation characterized by later onset and milder, but similar clinical course which includes congenital ca taracts, global DD and autistic features. Bouts of lethargy associated with lactic acidosis are frequent and require hospital admissions. Whole exome sequencing [done at Baylor College of Medicine] revealed two mutations in GFER gene: c.581G>A (p.R194H, previously reported) and c.215delG (p.A73Pfs*73).These cases further describe the phenotype associated with GFER gene mu tations. Although both patients have features similar to the other 3 reported patients with MPMCHD, the clinical course in our patients is more severe and includes prominent lactic acidosis and 3 methylglutaconic aciduria but not deafness.",2014.0,,"D. Gavrilov, A. Studinski","Departments of Medical Genetics, and Laboratory Medicine and Pathology, Biochemical Genetics Laboratory, Mayo Clinic School of Medicine, Rochester, MN, United States","This patients sister has clinical presentation characterized by later onset and milder, but similar clinical course which includes congenital ca taracts, global DD and autistic features.",,autistic features,[],"['autistic', 'feature']"
462,688, M Array Comparative Genome Hybridization (aCGH) in children with autistic spectrum phenotype,P08.12,,"Aim: Autism or autistic spectrum disorders ( ASD), are a group of complex  neurodevelopmental disabilities, affecting social interaction and communi cation skills (Rosti R O et al 2013). Only  few cases of chromosomal abnor malities are identified by conventional cytogenetic techniques while mole cular karyotype allows for the detection of submicroscopic genomic rear rangements providing a diagnostic yield ranging from 10% to 18% (Shen Y 2010). Material  Methods:. A total of 629 patients were studied by the De   partment of Medical Genetics, from which 114 fulfilled the the autism/ ASD clinical criteria The arrays used were high definition1244K and 4X180K with the additional ability of SNP identification for the detection of unipa   rental disomy UPD and /or copy neutral loss of homozygosity (LOH).. All patients were referred by Clinical Geneticists after detailed evaluation and normal conventional karyotype. Results: Submicroscopic genomic rearran gements (CNVs), 0.08 19.01 Mb in size were detected in 55/114 subjects with autism or ASD, with the following most important genes previously implicated in the etiology of autism or ASD: NRXN1, SHANK3, DOCK8, ZNF92,  ASMT , HSFX1, KCNH7, CHRFAM7A, CHRNA7,  KCND2, CNTNAP3, , MAOB,  STS, VCX  Conlusions The identification of genetic alterations (CNVs) in a af  fected child with autism/ ASD allows more specific consultaion to the family about diagnosis, prognosis and recurrent risks, while genetic reevaluation with aCGH is also warranted in adult autism patients.",2014.0,,"V. Oikonomakis, K. Kosma, M. Tzetis, E. Fryssira, N. Pervanidou, A. Xaidara, A. Syrmou, S.  Rigoglou, S. Kitsiou Tzeli, E. Kanavakis","Department of Medical Genetics, Medical School, University of Athens, Athens, Greece","Aim: Autism or autistic spectrum disorders ( ASD), are a group of complex  neurodevelopmental disabilities, affecting social interaction and communi cation skills (Rosti R O et al 2013).",,autistic spectrum,[],"['autistic', 'spectrum']"
462,688, M Array Comparative Genome Hybridization (aCGH) in children with autistic spectrum phenotype,P08.12,,"Aim: Autism or autistic spectrum disorders ( ASD), are a group of complex  neurodevelopmental disabilities, affecting social interaction and communi cation skills (Rosti R O et al 2013). Only  few cases of chromosomal abnor malities are identified by conventional cytogenetic techniques while mole cular karyotype allows for the detection of submicroscopic genomic rear rangements providing a diagnostic yield ranging from 10% to 18% (Shen Y 2010). Material  Methods:. A total of 629 patients were studied by the De   partment of Medical Genetics, from which 114 fulfilled the the autism/ ASD clinical criteria The arrays used were high definition1244K and 4X180K with the additional ability of SNP identification for the detection of unipa   rental disomy UPD and /or copy neutral loss of homozygosity (LOH).. All patients were referred by Clinical Geneticists after detailed evaluation and normal conventional karyotype. Results: Submicroscopic genomic rearran gements (CNVs), 0.08 19.01 Mb in size were detected in 55/114 subjects with autism or ASD, with the following most important genes previously implicated in the etiology of autism or ASD: NRXN1, SHANK3, DOCK8, ZNF92,  ASMT , HSFX1, KCNH7, CHRFAM7A, CHRNA7,  KCND2, CNTNAP3, , MAOB,  STS, VCX  Conlusions The identification of genetic alterations (CNVs) in a af  fected child with autism/ ASD allows more specific consultaion to the family about diagnosis, prognosis and recurrent risks, while genetic reevaluation with aCGH is also warranted in adult autism patients.",2014.0,,"V. Oikonomakis, K. Kosma, M. Tzetis, E. Fryssira, N. Pervanidou, A. Xaidara, A. Syrmou, S.  Rigoglou, S. Kitsiou Tzeli, E. Kanavakis","Department of Medical Genetics, Medical School, University of Athens, Athens, Greece","A total of 629 patients were studied by the De   partment of Medical Genetics, from which 114 fulfilled the the autism/ ASD clinical criteria The arrays used were high definition1244K and 4X180K with the additional ability of SNP identification for the detection of unipa   rental disomy UPD and /or copy neutral loss of homozygosity (LOH).. All patients were referred by Clinical Geneticists after detailed evaluation and normal conventional karyotype.",,ASD clinical criteria,[],"['ASD', 'clinical', 'criterion']"
462,688, M Array Comparative Genome Hybridization (aCGH) in children with autistic spectrum phenotype,P08.12,,"Aim: Autism or autistic spectrum disorders ( ASD), are a group of complex  neurodevelopmental disabilities, affecting social interaction and communi cation skills (Rosti R O et al 2013). Only  few cases of chromosomal abnor malities are identified by conventional cytogenetic techniques while mole cular karyotype allows for the detection of submicroscopic genomic rear rangements providing a diagnostic yield ranging from 10% to 18% (Shen Y 2010). Material  Methods:. A total of 629 patients were studied by the De   partment of Medical Genetics, from which 114 fulfilled the the autism/ ASD clinical criteria The arrays used were high definition1244K and 4X180K with the additional ability of SNP identification for the detection of unipa   rental disomy UPD and /or copy neutral loss of homozygosity (LOH).. All patients were referred by Clinical Geneticists after detailed evaluation and normal conventional karyotype. Results: Submicroscopic genomic rearran gements (CNVs), 0.08 19.01 Mb in size were detected in 55/114 subjects with autism or ASD, with the following most important genes previously implicated in the etiology of autism or ASD: NRXN1, SHANK3, DOCK8, ZNF92,  ASMT , HSFX1, KCNH7, CHRFAM7A, CHRNA7,  KCND2, CNTNAP3, , MAOB,  STS, VCX  Conlusions The identification of genetic alterations (CNVs) in a af  fected child with autism/ ASD allows more specific consultaion to the family about diagnosis, prognosis and recurrent risks, while genetic reevaluation with aCGH is also warranted in adult autism patients.",2014.0,,"V. Oikonomakis, K. Kosma, M. Tzetis, E. Fryssira, N. Pervanidou, A. Xaidara, A. Syrmou, S.  Rigoglou, S. Kitsiou Tzeli, E. Kanavakis","Department of Medical Genetics, Medical School, University of Athens, Athens, Greece","Results: Submicroscopic genomic rearran gements (CNVs), 0.08 19.01 Mb in size were detected in 55/114 subjects with autism or ASD, with the following most important genes previously implicated in the etiology of autism or ASD: NRXN1, SHANK3, DOCK8, ZNF92,  ASMT , HSFX1, KCNH7, CHRFAM7A, CHRNA7,  KCND2, CNTNAP3, , MAOB,  STS, VCX  Conlusions The identification of genetic alterations (CNVs) in a af  fected child with autism/ ASD allows more specific consultaion to the family about diagnosis, prognosis and recurrent risks, while genetic reevaluation with aCGH is also warranted in adult autism patients.",subjects with autism,,"['subject', 'with', 'autism']",[]
463,691, S De novo single exon deletion of AUTS2 in a patient with profound intellectual disability,P08.15,,"The autism susceptibility candidate 2 (AUTS2) gene has a critical role in early brain development with its strong expression in fetal and adult brain. Association of AUTS2 with intellectual disability (ID), autism spectrum dis   orders, and other neurodevelopmental disorders has recently gained more attention. Genomic rearrangements and copy number variations (CNVs) in volving AUTS2 have been implicated in a range of neurodevelopmental dis   orders with or without congenital malformations and dysmorphic features. Here we report a 127kb de novo deletion encompassing exon 5 of AUTS2 at 7q11.22 which result in inframe deletion of 10 amino acids. The deletion was detected by SNP array analysis applying InfiniumHD whole genome genoty   ping assay with the HumanCytoSNP 12 BeadChip (Illumina Inc.). Obtained data were analyzed with Illumina GenomeStudio and QuantiSNP software. The single exon deletion was detected in a 10 year old female patient with severe speech disorder, intention tremor, fine motor activity deficit, beha vior disturbance, residual lesion in the CNS, and intracranial hypertension. This is one of the smallest de novo intragenic deletions of AUTS2 described in patients with neurodevelopmental disorders. Along with the review of previously reported 20 cases with small pathogenic CNVs and 4 cases with different de novo balanced translocations of 7q11.2 interrupting the AUTS2 gene with severe profound to borderline ID without autistic features or de   layed psychomotor development with mild to moderate autism, this report provides additional insight into the clinical spectrum of AUTS2 disruptions.",2014.0,,"D. Babikyan, S. Midyan, A. Hovhannisyan, A. Gasparyan, T . Sarkisian","Center of Medical Genetics and Primary Health Care, Yerevan, Armenia","Along with the review of previously reported 20 cases with small pathogenic CNVs and 4 cases with different de novo balanced translocations of 7q11.2 interrupting the AUTS2 gene with severe profound to borderline ID without autistic features or de   layed psychomotor development with mild to moderate autism, this report provides additional insight into the clinical spectrum of AUTS2 disruptions.",,autistic features,[],"['autistic', 'feature']"
464,695," S Chromosomal microarray analysis of patients with intellectual disability, autism or multiple congenital anomalies presenting for genetic services",P08.19,,"Copy number variations (CNVs) are the most common identifiable causes  of intellectual disability/developmental delay (ID/DD), autism spectrum  disorders (ASDs), or multiple congenital anomalies (MCAs). Chromoso   mal microarray analysis (CMA), with a 10 20% diagnostic yield, can iden   tify CNVs1 Mb. We report our experience with the use of the Affymetrix  SNP Arrays in 1600 Italian patients during the past 6 years (2008 2013). We identified CNVs with a high score of pathogenicity in 415 (27%) pati   ents. Among them 143 (34.4%) showed a CNV overlapping with a known syndrome, 272 (65.6%) a likely pathogenic rearrangement. Of particular interest, we found some CNVs useful to further delineate the clinical fea tures associated with deletions in 8q12.1q12.3, in 15q25.2, in 17q21.31, in 2q24.1q24.2, in 22q11.2, and duplications in 16p13.3 and in 11p13. Some CNVs were useful to describe new syndromes such as a 1.7 Mb deletion in 3q13.2q13.31. Also, we have identified a large group of small CNVs (< 1.0 Mb) encompassing, either in whole or in part, functionally related genes to the phenotypes such as CASK, CNTN6, SNTG2, HIP1, DLG2, NRXN1, MCPH1  and CHL1 genes. Among these small CNVs, we have reported a FOXP1 gene  microdeletion in a boy with autism and speech delay, and a de novo intersti   tial deletion of 0.122 Mb at 2q24.2 region harboring only TBR1 gene in a boy with moderate to severe intellectual disability. Variants of uncertain signi ficance (VOUS) because unreported, containing genes of uncertain clinical significance or non genic but potentially regulating nearby gene expression, were identify in 128 individuals (8%).",2014.0,,"O. Palumbo , P . Palumbo, R. Stallone, T . Palladino, L. Zelante, M. Carella","IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy","Among these small CNVs, we have reported a FOXP1 gene  microdeletion in a boy with autism and speech delay, and a de novo intersti   tial deletion of 0.122 Mb at 2q24.2 region harboring only TBR1 gene in a boy with moderate to severe intellectual disability.",boy with autism,,"['boy', 'with', 'autism']",[]
466,706, M A Novel HCFC1 mutation associated with X Linked Intellectual Disability,P08.30,,"X Linked Intellectual Disability is a heterogeneous disorder with a variable phenotypic spectrum. Currently over 90 XLID genes have been found to be implicated in XLID. The host cell factor C1 (HCFC1) gene is located on chro mosome Xq28 and is a member of the host cell factor family. A mutation in HCFC1 has been previously found to be associated with XLID in a non syndromic XLID family namely MRX3. Currently very few studies exist that further confirm HCFC1 as an XLID gene.We present an XLID family with two affected sons having mild intellectual disability epilepsy and no congenital abnormalities. Fragile X analysis and array CGH using a chromosome X exon specific array were performed and revealed normal results. Subsequently, next generation whole exome se   quencing analysis for both brothers was performed on Illumina HiSeq 2000 following Agilent SureSelect sample preparation (20x coverage). Reads were aligned using the Burrows Wheeler Aligner and the Genome Analysis Tool Kit. Autosome variants and variants present in dbSNP 135 were filtered out. Analysis of rare X chromosome variants present in both brothers revealed a non synonymous mutation in exon 4 of HCFC1 (p.Ala897Val). This mutation is located within GABP2 and ZBTB17 binding domains. Previous screening studies of patients have reported variants within the GABP2 binding domain p.Gly876Ser in an individual with autism spectrum disorder (Piton et al.,  2011) and p.Ala864Thr in a patient with mental retardation (Tarpey et al.,  2010). The mutation was confirmed by Sanger sequencing in both patients and their mother. Extended family studies are ongoing.",2014.0,,"C. Sismani , C. Koufaris, A. Alexandrou, L. Kokkinou, C. Ioannidou, P . Evangelidou, V.  Anastasiadou, P . C. Patsalis","The Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus","Previous screening studies of patients have reported variants within the GABP2 binding domain p.Gly876Ser in an individual with autism spectrum disorder (Piton et al.,  2011) and p.Ala864Thr in a patient with mental retardation (Tarpey et al.,  2010).",individual with autism,,"['individual', 'with', 'autism']",[]
467,713," M Recurrent CNVs in 15q11.2 q12 in Bulgarian patients with generalized epilepsy and intellectual disability V . Peycheva1, K. Kamenarova1, N. Ivanova1, P . Dimova2, S. Jhelyazkova3, D. Avdjieva4, E. Slavkova2, G. Maximov2, V. Stoyanova2, I. Litvinenko4, I. Tournev3, V. Bozhinova2, V. Mitev1,",P08.36,,"Naum, Department of Neurology, Medical University of Sofia, Sofia, Bulgaria,  3Clinic of Neurology, University Hospital  Alexandrovska, Department of Neurology, Medical University of Sofia, Sofia, Bulgaria,  4University Pediatrics Hospital, Department of Pediatrics, Medical University of Sofia,  Sofia, Bulgaria, 5Neurogenetics Group, VIB Department of Molecular Genetics, University  of Antwerp, Antwerpen, Belgium. Copy number variants are frequent in autism spectrum disorders and gene ralized epilepsy. In this study, we performed comparative genomic hybridi   zation assay (aCGH) using Agilent Microarray Kit, 4x180K in a preselected sample of 36 Bulgarian patients with epilepsy and intellectual disability (ID). The region most often engaged in copy number changes included 15q11.2 15q12. In 7 patients (19.4%) CNVs were located in 15q12. Five of them har bored microduplications in GABRG3 gene, 1 patient showed microduplica tion in GABRB3 gene and in 1 patient both rearrangements were present. Aberrations in 15q11.2 region were observed in 2 patients. One of them was a 0.161 Mb deletion, including SNURF/SNRPN upstream reading frame. In the other patient, a 2.608 Mb duplication covering 36 genes was revealed. Genomic region on 15q11 13 is involved in many clinically important re arrangements. These include aberrations of various sizes which can affect the neuronal differentiation by disrupting normal epigenetic control and gene expression. All Bulgarian patients with CNVs harboring 15q12 shared a common clinical phenotype of severe ID, speech impairment or complete lack of speech, different types of seizures, facial dysmorphisms, microcepha ly and behavior abnormalities of the autistic spectrum. In contrast, the two patients with 15q11.2 rearrangements displayed different clinical characte ristics and milder forms of mental retardation. Our results are in line with the central role of GABAergic systems in ID and epilepsy. Further studies are needed to investigate the parental origin and elucidate the effect of the CNVs and the phenotype genotype correlations. Acknowledgement: the study was supported by DTK02/67/2009, DUNK01 2/2009 funded by NSF.",2014.0,,"R. Kaneva1, A. Jordanova1,5","1Molecular Medicine Center, Department of Medical Chemistry and Biochemistry,  Medical University of Sofia, Sofia, Bulgaria, 2Clinic of Child Neurology, University  Hospital of Neurology and Psychiatry St","All Bulgarian patients with CNVs harboring 15q12 shared a common clinical phenotype of severe ID, speech impairment or complete lack of speech, different types of seizures, facial dysmorphisms, microcepha ly and behavior abnormalities of the autistic spectrum.",,autistic spectrum,[],"['autistic', 'spectrum']"
470,733, M NPAS3 related copy number variants: a role in developmental delay?,P08.56,,"Neuronal PAS domain containing protein 3 (NPAS3) is a transcription factor expressed primarily in developing and adult brain tissues. Current evidence  suggests it is involved in neuronal development and maturation, and it has  recently been highlighted as potentially playing a key role in the evolution of the human brain. Clinically, NPAS3 has been identified as a candidate gene for schizophrenia, and numerous studies have supported this association. In addition, several cases of learning disabilities in patients with disruptions of this gene are reported, but this association remains relatively unexplored. Here, we present four unrelated individuals with small copy number vari ants (CNVs) within NPAS3: two intragenic duplications and two intragenic deletions. These CNVs range between 111 460kb in length and encompass  exonic sequences within the NPAS3 gene. All four patients had variable de   grees of developmental delay, and three had subtle distinctive facial features.  Two patients also had macrosomia and macrocephaly, while the other two had autistic features and behaviour issues, including psychosis in one indivi dual. In contrast, CNVs involving exonic sequences in NPAS3 have only been seen in one of over 19,000 controls. In summary, these four cases support an association between NPAS3 and developmental delay. This association is compatible with this genes postulated effects on neuronal development, and suggests that abnormal function of NPAS3 may be implicated in other cases of non specific cognitive impairment.",2014.0,,"L. Badalato1, S. M. Nikkel1, I. J. Anderson2, M. P . Dinulos3, S. E. Vallee4, E. Baxter5, J.  McGowan Jordan1, J. A. Rosenfeld6, C. M. Armour1","1Childrens Hospital of Eastern Ontario, Ottawa, ON, Canada, 2University of Tennessee  Genetics Center, Knoxville, TN, United States, 3The Geisel School of Medicine at  Dartmouth, Hanover, NH, United States, 4Dartmouth Hitchcock Medical Center, Lebanon,  NH, United States, 5British Columbia Cancer Agency, Vancouver, BC, Canada, 6Signature  Genomic Laboratories, PerkinElmer, Inc, Spokane, WA, United States","Two patients also had macrosomia and macrocephaly, while the other two had autistic features and behaviour issues, including psychosis in one indivi dual.",,autistic features,[],"['autistic', 'feature']"
472,739," M Analysis of MECP2, CDKL5, and FOXG1 genes in Czech patients with Rett syndrome and Rett like features",P08.62,,"Background: Rett syndrome is a severe X linked dominant neurodevelop mental disorder primarily caused by de novo MECP2 mutations. Clinical features include developmental regression at the age of 6 18 months, ac quired microcephaly, autistic behavior, loss or severe impairment of speech and purposeful hand use, stereotypic hand movements, gait apraxia, and seizures. CDKL5 mutations have been identified in early onset seizure vari ant and FOXG1 mutations in congenital variant of Rett syndrome. We report the results of mutation analysis of these genes in Czech patients with Rett syndrome and mental retardation with Rett like features. Materials and  methods: MECP2 was analyzed in 416 patients, CDKL5 was analyzed in 59 patients, and FOXG1 was analyzed in 20 patients. MECP2 and CDKL5 were analyzed by high resolution melting analysis and DNA sequencing. FOXG1 was analyzed by DNA sequencing. Large deletions and duplications were analyzed by MLPA analysis (MRC Holland). Results: Pathogenic mutations  in the MECP2 gene in were identified in 45 patients with classic Rett syn drome, 7 patients with atypical Rett syndrome, 11 patients with Rett like features, and 1 patient with autism. CDKL5 mutations were found in 2 pati   ents with early onset seizures and Rett like phenotype. No FOXG1 mutation was detected in this study. Conclusions:  MECP2 mutations are common in  classic Rett syndrome patients, but they are less frequent in atypical or Rett like phenotypes. However, analysis of MECP2 in these patients should not be discouraged. More patients should be examined to determine frequencies of CDKL5 and FOXG1 mutations in Czech Republic. Supported by grants NT 13120 4/2012, UNCE 204011/2012, MZCR RVO VFN64165/2012.",2014.0,,"D. Zahorakova1, A. Puchmajerova1, A. Baxova2, P . Martasek1","1Department of Pediatrics, 1st Faculty of Medicine and General Teaching Hospital,  Charles University in Prague, Prague, Czech Republic, 2Institute of Biology and Clinical  Genetics, 1st Faculty of Medicine and General Teaching Hospital, Charles University in Prague, Prague, Czech Republic","Clinical features include developmental regression at the age of 6 18 months, ac quired microcephaly, autistic behavior, loss or severe impairment of speech and purposeful hand use, stereotypic hand movements, gait apraxia, and seizures.",,autistic behavior,[],"['autistic', 'behavior']"
472,739," M Analysis of MECP2, CDKL5, and FOXG1 genes in Czech patients with Rett syndrome and Rett like features",P08.62,,"Background: Rett syndrome is a severe X linked dominant neurodevelop mental disorder primarily caused by de novo MECP2 mutations. Clinical features include developmental regression at the age of 6 18 months, ac quired microcephaly, autistic behavior, loss or severe impairment of speech and purposeful hand use, stereotypic hand movements, gait apraxia, and seizures. CDKL5 mutations have been identified in early onset seizure vari ant and FOXG1 mutations in congenital variant of Rett syndrome. We report the results of mutation analysis of these genes in Czech patients with Rett syndrome and mental retardation with Rett like features. Materials and  methods: MECP2 was analyzed in 416 patients, CDKL5 was analyzed in 59 patients, and FOXG1 was analyzed in 20 patients. MECP2 and CDKL5 were analyzed by high resolution melting analysis and DNA sequencing. FOXG1 was analyzed by DNA sequencing. Large deletions and duplications were analyzed by MLPA analysis (MRC Holland). Results: Pathogenic mutations  in the MECP2 gene in were identified in 45 patients with classic Rett syn drome, 7 patients with atypical Rett syndrome, 11 patients with Rett like features, and 1 patient with autism. CDKL5 mutations were found in 2 pati   ents with early onset seizures and Rett like phenotype. No FOXG1 mutation was detected in this study. Conclusions:  MECP2 mutations are common in  classic Rett syndrome patients, but they are less frequent in atypical or Rett like phenotypes. However, analysis of MECP2 in these patients should not be discouraged. More patients should be examined to determine frequencies of CDKL5 and FOXG1 mutations in Czech Republic. Supported by grants NT 13120 4/2012, UNCE 204011/2012, MZCR RVO VFN64165/2012.",2014.0,,"D. Zahorakova1, A. Puchmajerova1, A. Baxova2, P . Martasek1","1Department of Pediatrics, 1st Faculty of Medicine and General Teaching Hospital,  Charles University in Prague, Prague, Czech Republic, 2Institute of Biology and Clinical  Genetics, 1st Faculty of Medicine and General Teaching Hospital, Charles University in Prague, Prague, Czech Republic","Results: Pathogenic mutations  in the MECP2 gene in were identified in 45 patients with classic Rett syn drome, 7 patients with atypical Rett syndrome, 11 patients with Rett like features, and 1 patient with autism.",patient with autism,,"['patient', 'with', 'autism']",[]
473,743, M The power of Next Generation Sequencing in identifying mutations in non specific ASD ID phenotypes: the example of SHANK3,P08.66,,"Autism Spectrum Disorders (ASDs) comprise a range of early onset neuro  developmental conditions of varying severity, with or without Intellectual Disability (ID), characterized by impairments in relatedness and communi cation, accompanied by restricted interests and repetitive stereotyped be haviors. SHANK3 haploinsufficiency implicated in Phelan McDermid 22q13 microdeletion is one of the more prevalent monogenic causes of ASD, ex   plaining at least 0,5% of cases, but the indication of SHANK3  sequencing in  patients with ASD and ID remain difficult. Here we report on two patients with de novo SHANK3 mutations identified by next generation sequencing  (NGS). Patient 1, aged 15, was part of a cohort of 40 patients screened by exome sequencing for undiagnosed severe ID, and a truncating mutation  was identified in SHANK3  (c.4381C>T ; p.Gln1461*). Patient 2, aged 10, was  part of a cohort of 106 patients with ID screened by targeted NGS of 220 ID  genes, and a causative heterozygous truncating mutation of SHANK3  was  identified (c.2955_2970dup;p.Pro992Argfs*325). They both had normal measurements, severe ID, developmental and speech delay with acquisition  of a few words and secondary regression with absence of speech, attention  deficit and behavioral disorders necessitating treatment, autistic traits, in  somnia and tantrum. Patient 1 had eating and digestive difficulties, patient 2 had distal spasticity, epilepsy from age 5, and facial dysmorphic features. These two clinical presentations appear nonspecific within the ASD ID spec  trum. After reviewed the other patients with SHANK3 mutations, we argue  that NGS will be helpful to determine patients with SHANK3  mutations in  the absence of clear distinctive clinical features.",2014.0,,"H. Poquet1, M. Willems2, J. Thevenon1, C. Redin3, M. Lefebvre1, C. Redin1, A. Mosca  Boidron1, C. Thauvin Robinet1, Y. Duffourd1, S. Lumbroso2, B. Gerard3, J. Mandel3, J.  Rivire1, A. Piton3, L. Olivier Faivre1","1CHU, Dijon, France, 2CHU, Montpellier, France, 3IGBMC, Strasbourg, France","SHANK3 haploinsufficiency implicated in Phelan McDermid 22q13 microdeletion is one of the more prevalent monogenic causes of ASD, ex   plaining at least 0,5% of cases, but the indication of SHANK3  sequencing in  patients with ASD and ID remain difficult.",patients with ASD,,"['patient', 'with', 'ASD']",[]
473,743, M The power of Next Generation Sequencing in identifying mutations in non specific ASD ID phenotypes: the example of SHANK3,P08.66,,"Autism Spectrum Disorders (ASDs) comprise a range of early onset neuro  developmental conditions of varying severity, with or without Intellectual Disability (ID), characterized by impairments in relatedness and communi cation, accompanied by restricted interests and repetitive stereotyped be haviors. SHANK3 haploinsufficiency implicated in Phelan McDermid 22q13 microdeletion is one of the more prevalent monogenic causes of ASD, ex   plaining at least 0,5% of cases, but the indication of SHANK3  sequencing in  patients with ASD and ID remain difficult. Here we report on two patients with de novo SHANK3 mutations identified by next generation sequencing  (NGS). Patient 1, aged 15, was part of a cohort of 40 patients screened by exome sequencing for undiagnosed severe ID, and a truncating mutation  was identified in SHANK3  (c.4381C>T ; p.Gln1461*). Patient 2, aged 10, was  part of a cohort of 106 patients with ID screened by targeted NGS of 220 ID  genes, and a causative heterozygous truncating mutation of SHANK3  was  identified (c.2955_2970dup;p.Pro992Argfs*325). They both had normal measurements, severe ID, developmental and speech delay with acquisition  of a few words and secondary regression with absence of speech, attention  deficit and behavioral disorders necessitating treatment, autistic traits, in  somnia and tantrum. Patient 1 had eating and digestive difficulties, patient 2 had distal spasticity, epilepsy from age 5, and facial dysmorphic features. These two clinical presentations appear nonspecific within the ASD ID spec  trum. After reviewed the other patients with SHANK3 mutations, we argue  that NGS will be helpful to determine patients with SHANK3  mutations in  the absence of clear distinctive clinical features.",2014.0,,"H. Poquet1, M. Willems2, J. Thevenon1, C. Redin3, M. Lefebvre1, C. Redin1, A. Mosca  Boidron1, C. Thauvin Robinet1, Y. Duffourd1, S. Lumbroso2, B. Gerard3, J. Mandel3, J.  Rivire1, A. Piton3, L. Olivier Faivre1","1CHU, Dijon, France, 2CHU, Montpellier, France, 3IGBMC, Strasbourg, France","They both had normal measurements, severe ID, developmental and speech delay with acquisition  of a few words and secondary regression with absence of speech, attention  deficit and behavioral disorders necessitating treatment, autistic traits, in  somnia and tantrum.",,autistic traits,[],"['autistic', 'trait']"
474,746, M An hiPSCs based in vitro model of Angelman Syndrome and dup15 Autism,P08.70,,"UBE3A gene maps on 15q11q13 chromosome and encodes for the pro tein E6AP , an Ubiquitine ligase involved in protein degradation process. The gene is maternally imprinted in central nervous system and different studies show that loss of expressed copy causes Angelman Sydrome (AS) while the duplication of 15q11q13 represents the genetic cause in 1 3% of autistic patients (dup15 Autism). Using 2 cohorts of AS and dup15 autism patients, we applied induced Pluripotent Stem cells (iPSCs) technology and neuronal differentiation to identify molecular targets of a dys regulated dosage of UBE3A. To generate iPSCs we used 4 canonical factors identified by Yamanaka (c Myc, Klf 4, Oct3/4 e Sox2) through retroviral or lentiviral vectors. We performed 14 attempts and in 13 we generated cells that we defined as partially reprogrammed because they lost their typical fibro blasts morphology, but died after passaging. In the last experiment we used a commercial lentiviral vector with the same 4 pluripotency factors making a dup15 hiPSCs cell line positive to pluripotent expression markers; further characterizations are still ongoing. Once we have hiPSCs we will proceed with neuronal differentiantion. With our experiments we confirm that the hiPSCs genesis is a stochastic process with a successful rate of 0.1 2% and that no standard protocol exists. In the other hand this new challenging and arduous technology give to the scientists the possibility to understand the pathogenetic mechanisms in tissues that for obviously reasons are difficult to study.",2014.0,,"F. La Carpia1, M. Gentile2, C. Schwartz3, G. Neri1, F. Gurrieri1, E. Sangiorgi1","1universit cattolica del sacro cuore, roma, Italy, 2Dipartimento Materno Infantile ASL,  Bari, Italy, 3Greenwood Genetic Centre, Greenwood, SC, United States",The gene is maternally imprinted in central nervous system and different studies show that loss of expressed copy causes Angelman Sydrome (AS) while the duplication of 15q11q13 represents the genetic cause in 1 3% of autistic patients (dup15 Autism).,,autistic patients,[],"['autistic', 'patient']"
476,753, S Xq12 and Xq13 submicroscopic duplications in a single patient: confirming the existence of a new X linked disorder and narrowing the critical region.,P08.77,,"R.C.C.S.  Foundation, Milano, Italy, 2Medical Genetics, University of Pavia, Pavia, Italy, 3Medical  Genetics Unit, CaGranda Ospedale Maggiore Policlinico, I.R.C.C.S. Foundation, Milano, Italy. In 2012 Kaya et al. reported three related patients with a recurrent dupli cation Xq12 q13.3 with mental retardation, autism, seizures and dysmor   phic features. The duplicated region (9.4 Mb) contains numerous genes and the authors pointed out the possible role of an increased dosage of specific genes focusing on their presumed role in developmental delay and autism. Subsequent reports (Prontera et al. 2012; Wentz et al. 2013) described 4 more patients with a variable association of severe global developmental delay, microcephaly, dysmorphism and autism spectrum disorder, all car rying a duplication in the Xq12 q13.3 region, supporting the existence of a clinically recognizable X linked recessive disorder. We describe a further patient affected by global developmental delay, epilepsy, autistic traits and carrying two non contiguous duplications detected by array CGH, involving Xq12 and Xq13 regions. Detailed clinical description is provided and com pared to previous reported cases. Due to the narrowed size of the duplicated regions (123 Kb and 509 Kb, respectively), this case helps to redefine the region of interest for this condition. The two duplications in our patients involve 13 genes, and 7 of them are mainly expressed in the nervous sy   stem (OPHN1, SNX12, MED12, NLGN3, GJB1, ZMYM3, TAF1) and all, except for SNX12, are involved in the pathogenesis of a known human disease. Our  observation provides further evidence of the existence of a new genomic condition, helping to define the corresponding clinical phenotype, and to identify a more definite critical region.",2014.0,,"E. Alfei1, S. DArrigo1, C. Pantaleoni1, F. Novara2, R. Ciccone2, O. Zuffardi2, F. Natacci3","1Developmental Neurology Division, Carlo Besta Neurological Institute, I","We describe a further patient affected by global developmental delay, epilepsy, autistic traits and carrying two non contiguous duplications detected by array CGH, involving Xq12 and Xq13 regions.",,autistic traits,[],"['autistic', 'trait']"
479,778, S Three SNP haplotypes in Neuroligins may correlate to autism susceptibility,P09.021,,"Chemistry  and Biology, University of Salerno, Fisciano (SA), Italy. Autism is a neurodevelopmental disorder showing a striking sex bias with  a male:female ratio of 4:1. Despite some genetic variants are causative for autism in about 17% of cases, its etiology is still largely unknown. Increa sing evidences highlight the possible role of environmental factors, such as infections, xenobiotics and drugs in enhancing autism genetic susceptibili ty. Among genetic variants, we focused on the X linked neuroligins that are involved in synaptic plasticity, are mutated in a few number of autistic pa tients, and are hemizygous in males. Hence we analyzed NLGN 3 and NLGN 4X in 52 Italian autistic cases (male:female,4,6:1) and in 31 healthy siblings (male:female,1:1,1) by Sanger sequencing. Among the other variants, in NLGN 4X, we found 2 de novo SNPs and 3 SNPs in non coding regions (1 intronic and 2 in the 3UTR), giving 2 different haplotypes: one was new and one was already described in a non specific mental retardation Chinese pa tients. In NLGN 3, we found 3 already described intronic SNPs in haplotype block. The 3 haplotypes have statistical significance in autistics comparing to the minor allele frequencies (MAF) from the 1000 Genomes Project CEU. Interestingly, healthy siblings, half of which were female, have a middle sta tistical significance between autistics and MAF CEU. As these SNPs map to non coding regions, they could be involved in the genetic susceptibility to trigging environmental factors (probably lacking in siblings), and, being lo cated on X chromosome, could explain the male prevalence of autism. ACK   NOWLEDGEMENTS: Italian Ministry of Health GR 2009 1570296 project, Italian Ministry of Education, University and Research InterOmics Flag   ship project.",2014.0,,"M. Landini1, A. Mezzelani1, I. Merelli1, M. Raggi2, F. Ciceri2, L. Villa2, M. Molteni2, A.  Marabotti3,1, L. Milanesi1","1Institute of Biomedical Technologies, National Research Council, Segrate (Milano), Italy,  2Scientific Institute, IRCSS Eugenio Medea, Bosisio Parini, Lecco, Italy, 3Dept","Hence we analyzed NLGN 3 and NLGN 4X in 52 Italian autistic cases (male:female,4,6:1) and in 31 healthy siblings (male:female,1:1,1) by Sanger sequencing.",,autistic cases,[],"['autistic', 'case']"
480,779, M Diagnostic utility of microarray analysis to detect rare CNVs in autism spectrum disorders,P09.022,,"Background: The genetic causes of Autism Spectrum Disorders (ASDs) are heterogeneous and still unknown in the majority of cases. Copy number va riant (CNV) detection is part of routine clinical workup. An interesting para digm for clinical practice is that each rare CNV may account for only a small proportion of variance in ASD at population level but may have large effects in particular families. We aim to evaluate family and patient specific charac teristics that may alter the clinical utility of autism risk variants. Material  and methods: The study contains 466 clinically well characterized patients with ASD from 392 families. Individuals were genotyped by either Affyme   trix SNP 6.0 array, OGT Oligo array or Illumina Omni2.5 8v1 SNP array. Ge notype data of each platform were preprocessed and normalized by limiting the resolution to 200 Kb and developing customized analysis protocols per platform to detect smaller variants in targeted regions. A filtering pipeline specific for ASD was developed using standard and customized Cartagenia ABSTRACTS POSTERS ESHG 2014 | MILAN, ITALY | WWW.ESHG.ORG 170Back to inde x Bench software applications. Results: We present a family based study on  the validity of CNV detection in ASD using microarray analysis. The clinical  utility of this screening is evaluated for different parameters (e.g. sporadic  versus familial ASD, IQ, comorbidity). In some cases, we found a better dia gnostic performance of the higher resolution platforms. Conclusion: We  contribute to the diagnostic utility and indication of rare CNV detection in ASD families with respect to clinical presentation and family history.",2014.0,,"N. Brison1,2, S. Iqbal1, W. De la Marche3,2, J. Steyaert3,2, I. Noens4,2, S. Van Vooren5, G. Thijs5,  K. Devriendt1,2, H. Peeters1,2","1Center for Human Genetics, UZ Leuven, Leuven, Belgium, 2Leuven Autism Research  Consortium (LAuRes) , University of Leuven, Leuven, Belgium, 3Department of Adolescent  and Child Psychiatry, University of Leuven, Leuven, Belgium, 4Department of Parenting  and Special Education, University of Leuven, Leuven, Belgium, 5Cartagenia, Leuven,  Belgium",Material  and methods: The study contains 466 clinically well characterized patients with ASD from 392 families.,patients with ASD,,"['patient', 'with', 'ASD']",[]
480,779, M Diagnostic utility of microarray analysis to detect rare CNVs in autism spectrum disorders,P09.022,,"Background: The genetic causes of Autism Spectrum Disorders (ASDs) are heterogeneous and still unknown in the majority of cases. Copy number va riant (CNV) detection is part of routine clinical workup. An interesting para digm for clinical practice is that each rare CNV may account for only a small proportion of variance in ASD at population level but may have large effects in particular families. We aim to evaluate family and patient specific charac teristics that may alter the clinical utility of autism risk variants. Material  and methods: The study contains 466 clinically well characterized patients with ASD from 392 families. Individuals were genotyped by either Affyme   trix SNP 6.0 array, OGT Oligo array or Illumina Omni2.5 8v1 SNP array. Ge notype data of each platform were preprocessed and normalized by limiting the resolution to 200 Kb and developing customized analysis protocols per platform to detect smaller variants in targeted regions. A filtering pipeline specific for ASD was developed using standard and customized Cartagenia ABSTRACTS POSTERS ESHG 2014 | MILAN, ITALY | WWW.ESHG.ORG 170Back to inde x Bench software applications. Results: We present a family based study on  the validity of CNV detection in ASD using microarray analysis. The clinical  utility of this screening is evaluated for different parameters (e.g. sporadic  versus familial ASD, IQ, comorbidity). In some cases, we found a better dia gnostic performance of the higher resolution platforms. Conclusion: We  contribute to the diagnostic utility and indication of rare CNV detection in ASD families with respect to clinical presentation and family history.",2014.0,,"N. Brison1,2, S. Iqbal1, W. De la Marche3,2, J. Steyaert3,2, I. Noens4,2, S. Van Vooren5, G. Thijs5,  K. Devriendt1,2, H. Peeters1,2","1Center for Human Genetics, UZ Leuven, Leuven, Belgium, 2Leuven Autism Research  Consortium (LAuRes) , University of Leuven, Leuven, Belgium, 3Department of Adolescent  and Child Psychiatry, University of Leuven, Leuven, Belgium, 4Department of Parenting  and Special Education, University of Leuven, Leuven, Belgium, 5Cartagenia, Leuven,  Belgium",Conclusion: We  contribute to the diagnostic utility and indication of rare CNV detection in ASD families with respect to clinical presentation and family history.,,ASD families,[],"['ASD', 'family']"
481,780, S Genetic evidence that hyperactive Th2 and NK immune pathways contribute to the pathogenesis of Autism Spectrum Disorder,P09.023,,"Converging evidence suggests that abnormal immunity is involved in the pathophysiology of Autism Spectrum Disorder (ASD) both in children and  adults. Altered immune processes include ongoing neuroinflammation in  post mortem brains, elevated pro inflammatory cytokines in cerebrospinal  fluid and blood, altered immune cell function, presence of brain specific  auto antibodies, and dysregulated immune transcriptome. One strategy to  assess whether dysimmunity contributes to ASD pathogenesis or represents  a collateral by standing effect is to investigate whether functional SNPs  known to influence immune gene expression or function are associated with  ASD. We genotyped 484 simplex and 18 multiplex families with an ASD pro  band at 34 known functional SNPs located in 26 immune genes involved in  all major immune pathways. Statistically significant opposite transmission  patterns between ASD and unaffected siblings were evident for rs2243250 (IL4 ) and rs231775 (CTLA4), with the combination of high IL4 expression  and low CTLA4 function alleles associated with autism and the opposite  alleles overtransmitted to unaffected siblings. Similarly, at rs361525 and rs2430561 , functional SNPs located in the TNFA and IFNG genes, the combi  nation of high expression alleles was associated with autism, while the op posite alleles were protective. These results indicate that common variants conferring hyper responsive Th2 (IL4 and CTLA4) and NK (TNFA and IFNG)  activation also confer autism vulnerability. Hence previously reported in creases in plasma Th2 cytokine levels and NK cell activation are not mere by standing effects, but are instead part of the pathophysiological cascade resulting in autistic disorder in a sizable subgroup of patients.",2014.0,,"I. S. Piras1,2, S. Gabriele1, V. Napolioni1, R. Sacco1, A. M. Persico1,2","1Unit of Child and Adolescent NeuroPsychiatry & Laboratory of Molecular Psychiatry  and Neurogenetics, University Campus Bio Medico, Rome, Italy, 2Mafalda Luce Center  for Pervasive Developmental Disorders, Milan, Italy",One strategy to  assess whether dysimmunity contributes to ASD pathogenesis or represents  a collateral by standing effect is to investigate whether functional SNPs  known to influence immune gene expression or function are associated with  ASD.,,ASD pathogenesis,[],"['ASD', 'pathogenesis']"
481,780, S Genetic evidence that hyperactive Th2 and NK immune pathways contribute to the pathogenesis of Autism Spectrum Disorder,P09.023,,"Converging evidence suggests that abnormal immunity is involved in the pathophysiology of Autism Spectrum Disorder (ASD) both in children and  adults. Altered immune processes include ongoing neuroinflammation in  post mortem brains, elevated pro inflammatory cytokines in cerebrospinal  fluid and blood, altered immune cell function, presence of brain specific  auto antibodies, and dysregulated immune transcriptome. One strategy to  assess whether dysimmunity contributes to ASD pathogenesis or represents  a collateral by standing effect is to investigate whether functional SNPs  known to influence immune gene expression or function are associated with  ASD. We genotyped 484 simplex and 18 multiplex families with an ASD pro  band at 34 known functional SNPs located in 26 immune genes involved in  all major immune pathways. Statistically significant opposite transmission  patterns between ASD and unaffected siblings were evident for rs2243250 (IL4 ) and rs231775 (CTLA4), with the combination of high IL4 expression  and low CTLA4 function alleles associated with autism and the opposite  alleles overtransmitted to unaffected siblings. Similarly, at rs361525 and rs2430561 , functional SNPs located in the TNFA and IFNG genes, the combi  nation of high expression alleles was associated with autism, while the op posite alleles were protective. These results indicate that common variants conferring hyper responsive Th2 (IL4 and CTLA4) and NK (TNFA and IFNG)  activation also confer autism vulnerability. Hence previously reported in creases in plasma Th2 cytokine levels and NK cell activation are not mere by standing effects, but are instead part of the pathophysiological cascade resulting in autistic disorder in a sizable subgroup of patients.",2014.0,,"I. S. Piras1,2, S. Gabriele1, V. Napolioni1, R. Sacco1, A. M. Persico1,2","1Unit of Child and Adolescent NeuroPsychiatry & Laboratory of Molecular Psychiatry  and Neurogenetics, University Campus Bio Medico, Rome, Italy, 2Mafalda Luce Center  for Pervasive Developmental Disorders, Milan, Italy","Hence previously reported in creases in plasma Th2 cytokine levels and NK cell activation are not mere by standing effects, but are instead part of the pathophysiological cascade resulting in autistic disorder in a sizable subgroup of patients.",,autistic disorder,[],"['autistic', 'disorder']"
483,787," M aCGH reevaluation reveals clinically relevant CNVs, in patients with previously unexplained developmental delay / ASD, candidate for exome sequencing. Presentation of selected cases.",P09.030,,"Array comparative genomic hybridization (aCGH) constitutes a first tier  diagnostic test for individuals with unexplained developmental delay (DD)  or autism spectrum disorder (ASD) with an estimated diagnostic yield of  about 15% to 20%. The advent of exome sequencing has revolutionized the  diagnostic process in the remainder of undiagnosed patients, allowing the  identification of causal mutations in an additional 25% to 55% of such pati   ents, depending on the different studies criteria.Over the last few years, copy number variation databases have accumulated significant amounts of data, often facilitating the task of distinguishing bet   ween benign and pathogenic copy number variants and the delineation of novel, recurrent, microdeletion/microduplication syndromes.We present selected cases of patients, candidate for exome sequencing analysis. Reevaluation of aCGH data allowed re classification of variants of previous unknown clinical significance, to the category of clinically relevant CNVs overlapping newly recognized DD/ASD genes such as CAMTA1 , RB1   CC1, CNTNAP2  and others. Our examples demonstrate that aCGH remains a valuable diagnostic tool for the investigation of such patients, and underscore the need to reassess the pathogenicity of previously detected aCGH variants before consideration of exome sequencing.",2014.0,,"K. Varvagiannis1,2, E. Ranza2, E. Stathaki2, S. Gimelli2, F. Sloan Bna2, S. E. Antonarakis1,2,  A. Bottani2","1University of Geneva Medical School, Geneva, Switzerland, 2Geneva University Hospitals    HUG, Geneva, Switzerland","Reevaluation of aCGH data allowed re classification of variants of previous unknown clinical significance, to the category of clinically relevant CNVs overlapping newly recognized DD/ASD genes such as CAMTA1 , RB1   CC1, CNTNAP2  and others.",,ASD genes,[],"['ASD', 'gene']"
484,792, S No evidence for a contribution of CHRNA7 rare variants in autism susceptibility,P09.035,,"Recurrent microdeletions of chromosome 15q13.3 are causally associated with a wide range of phenotypic features, including autism spectrum disor   der (ASD), seizures, intellectual disability, and other psychiatric conditions. The pathogenicity of the reciprocal microduplications is more uncertain.Even if the recurrent deletion contains several genes, CHRNA7, encoding for the alpha7 subunit of the neuronal nicotinic acetylcholine receptor, is consi   dered the culprit gene in mediating the neurological phenotypes in patients with the 15q13.3 deletion.In order to evaluate the role of CHRNA7 rare variants in ASD susceptibility, we have performed copy number variant (CNV) analysis and mutation scree ning of the coding sequence of CHRNA7 in a sample of 135 ASD individuals from Italy. Rare sequence variation in this gene remains largely unexplored, given the existence of a fusion gene, CHRFAM7A, which includes a partial duplication of exons 5 10 of CHRNA7. Hence, any attempts at sequencing to detect mutations must distinguish between CHRNA7 and CHRFAM7A, ma king next generation sequencing approaches unreliable for this purpose.CNV analysis led to the identification of a CHRNA7 microduplication in a subject with autism and moderate cognitive impaiment. No pathogenic mutations were identified in CHRNA7 coding regions. However, we detec ted rare variants in the proximal promoter region, previously described to functionally reduce transcription. In conclusion, rare sequence variants in CHRNA7 do not significantly contribute to ASD susceptibility, at least in our clinical sample characterized by low frequency of associated medical comorbidity. This study represents the first sequence variant analysis of the CHRNA7 gene in a sample of idiopathic autism.",2014.0,,"E. Bacchelli1, A. Battaglia2, C. Cameli1, S. Lomartire1, S. Thomson3, J. S. Sutcliffe3, R.  Tancredi2, E. Maestrini1","1FaBiT  Dipartimento di Farmacia e BioTecnologie, Bologna, Italy, 2Stella Maris Clinical  Research Institute for Child and Adolescent Neuropsychiatry, Calambrone (Pisa), Italy,  3Molecular Physiology and Biophysics, Centers for Molecular Neuroscience and Human  Genetics Research, Vanderbilt University, Nashville, TN, United States","The pathogenicity of the reciprocal microduplications is more uncertain.Even if the recurrent deletion contains several genes, CHRNA7, encoding for the alpha7 subunit of the neuronal nicotinic acetylcholine receptor, is consi   dered the culprit gene in mediating the neurological phenotypes in patients with the 15q13.3 deletion.In order to evaluate the role of CHRNA7 rare variants in ASD susceptibility, we have performed copy number variant (CNV) analysis and mutation scree ning of the coding sequence of CHRNA7 in a sample of 135 ASD individuals from Italy.",,ASD susceptibility,[],"['ASD', 'susceptibility']"
484,792, S No evidence for a contribution of CHRNA7 rare variants in autism susceptibility,P09.035,,"Recurrent microdeletions of chromosome 15q13.3 are causally associated with a wide range of phenotypic features, including autism spectrum disor   der (ASD), seizures, intellectual disability, and other psychiatric conditions. The pathogenicity of the reciprocal microduplications is more uncertain.Even if the recurrent deletion contains several genes, CHRNA7, encoding for the alpha7 subunit of the neuronal nicotinic acetylcholine receptor, is consi   dered the culprit gene in mediating the neurological phenotypes in patients with the 15q13.3 deletion.In order to evaluate the role of CHRNA7 rare variants in ASD susceptibility, we have performed copy number variant (CNV) analysis and mutation scree ning of the coding sequence of CHRNA7 in a sample of 135 ASD individuals from Italy. Rare sequence variation in this gene remains largely unexplored, given the existence of a fusion gene, CHRFAM7A, which includes a partial duplication of exons 5 10 of CHRNA7. Hence, any attempts at sequencing to detect mutations must distinguish between CHRNA7 and CHRFAM7A, ma king next generation sequencing approaches unreliable for this purpose.CNV analysis led to the identification of a CHRNA7 microduplication in a subject with autism and moderate cognitive impaiment. No pathogenic mutations were identified in CHRNA7 coding regions. However, we detec ted rare variants in the proximal promoter region, previously described to functionally reduce transcription. In conclusion, rare sequence variants in CHRNA7 do not significantly contribute to ASD susceptibility, at least in our clinical sample characterized by low frequency of associated medical comorbidity. This study represents the first sequence variant analysis of the CHRNA7 gene in a sample of idiopathic autism.",2014.0,,"E. Bacchelli1, A. Battaglia2, C. Cameli1, S. Lomartire1, S. Thomson3, J. S. Sutcliffe3, R.  Tancredi2, E. Maestrini1","1FaBiT  Dipartimento di Farmacia e BioTecnologie, Bologna, Italy, 2Stella Maris Clinical  Research Institute for Child and Adolescent Neuropsychiatry, Calambrone (Pisa), Italy,  3Molecular Physiology and Biophysics, Centers for Molecular Neuroscience and Human  Genetics Research, Vanderbilt University, Nashville, TN, United States","The pathogenicity of the reciprocal microduplications is more uncertain.Even if the recurrent deletion contains several genes, CHRNA7, encoding for the alpha7 subunit of the neuronal nicotinic acetylcholine receptor, is consi   dered the culprit gene in mediating the neurological phenotypes in patients with the 15q13.3 deletion.In order to evaluate the role of CHRNA7 rare variants in ASD susceptibility, we have performed copy number variant (CNV) analysis and mutation scree ning of the coding sequence of CHRNA7 in a sample of 135 ASD individuals from Italy.",,ASD individuals,[],"['ASD', 'individual']"
484,792, S No evidence for a contribution of CHRNA7 rare variants in autism susceptibility,P09.035,,"Recurrent microdeletions of chromosome 15q13.3 are causally associated with a wide range of phenotypic features, including autism spectrum disor   der (ASD), seizures, intellectual disability, and other psychiatric conditions. The pathogenicity of the reciprocal microduplications is more uncertain.Even if the recurrent deletion contains several genes, CHRNA7, encoding for the alpha7 subunit of the neuronal nicotinic acetylcholine receptor, is consi   dered the culprit gene in mediating the neurological phenotypes in patients with the 15q13.3 deletion.In order to evaluate the role of CHRNA7 rare variants in ASD susceptibility, we have performed copy number variant (CNV) analysis and mutation scree ning of the coding sequence of CHRNA7 in a sample of 135 ASD individuals from Italy. Rare sequence variation in this gene remains largely unexplored, given the existence of a fusion gene, CHRFAM7A, which includes a partial duplication of exons 5 10 of CHRNA7. Hence, any attempts at sequencing to detect mutations must distinguish between CHRNA7 and CHRFAM7A, ma king next generation sequencing approaches unreliable for this purpose.CNV analysis led to the identification of a CHRNA7 microduplication in a subject with autism and moderate cognitive impaiment. No pathogenic mutations were identified in CHRNA7 coding regions. However, we detec ted rare variants in the proximal promoter region, previously described to functionally reduce transcription. In conclusion, rare sequence variants in CHRNA7 do not significantly contribute to ASD susceptibility, at least in our clinical sample characterized by low frequency of associated medical comorbidity. This study represents the first sequence variant analysis of the CHRNA7 gene in a sample of idiopathic autism.",2014.0,,"E. Bacchelli1, A. Battaglia2, C. Cameli1, S. Lomartire1, S. Thomson3, J. S. Sutcliffe3, R.  Tancredi2, E. Maestrini1","1FaBiT  Dipartimento di Farmacia e BioTecnologie, Bologna, Italy, 2Stella Maris Clinical  Research Institute for Child and Adolescent Neuropsychiatry, Calambrone (Pisa), Italy,  3Molecular Physiology and Biophysics, Centers for Molecular Neuroscience and Human  Genetics Research, Vanderbilt University, Nashville, TN, United States","Hence, any attempts at sequencing to detect mutations must distinguish between CHRNA7 and CHRFAM7A, ma king next generation sequencing approaches unreliable for this purpose.CNV analysis led to the identification of a CHRNA7 microduplication in a subject with autism and moderate cognitive impaiment.",subject with autism,,"['subject', 'with', 'autism']",[]
484,792, S No evidence for a contribution of CHRNA7 rare variants in autism susceptibility,P09.035,,"Recurrent microdeletions of chromosome 15q13.3 are causally associated with a wide range of phenotypic features, including autism spectrum disor   der (ASD), seizures, intellectual disability, and other psychiatric conditions. The pathogenicity of the reciprocal microduplications is more uncertain.Even if the recurrent deletion contains several genes, CHRNA7, encoding for the alpha7 subunit of the neuronal nicotinic acetylcholine receptor, is consi   dered the culprit gene in mediating the neurological phenotypes in patients with the 15q13.3 deletion.In order to evaluate the role of CHRNA7 rare variants in ASD susceptibility, we have performed copy number variant (CNV) analysis and mutation scree ning of the coding sequence of CHRNA7 in a sample of 135 ASD individuals from Italy. Rare sequence variation in this gene remains largely unexplored, given the existence of a fusion gene, CHRFAM7A, which includes a partial duplication of exons 5 10 of CHRNA7. Hence, any attempts at sequencing to detect mutations must distinguish between CHRNA7 and CHRFAM7A, ma king next generation sequencing approaches unreliable for this purpose.CNV analysis led to the identification of a CHRNA7 microduplication in a subject with autism and moderate cognitive impaiment. No pathogenic mutations were identified in CHRNA7 coding regions. However, we detec ted rare variants in the proximal promoter region, previously described to functionally reduce transcription. In conclusion, rare sequence variants in CHRNA7 do not significantly contribute to ASD susceptibility, at least in our clinical sample characterized by low frequency of associated medical comorbidity. This study represents the first sequence variant analysis of the CHRNA7 gene in a sample of idiopathic autism.",2014.0,,"E. Bacchelli1, A. Battaglia2, C. Cameli1, S. Lomartire1, S. Thomson3, J. S. Sutcliffe3, R.  Tancredi2, E. Maestrini1","1FaBiT  Dipartimento di Farmacia e BioTecnologie, Bologna, Italy, 2Stella Maris Clinical  Research Institute for Child and Adolescent Neuropsychiatry, Calambrone (Pisa), Italy,  3Molecular Physiology and Biophysics, Centers for Molecular Neuroscience and Human  Genetics Research, Vanderbilt University, Nashville, TN, United States","In conclusion, rare sequence variants in CHRNA7 do not significantly contribute to ASD susceptibility, at least in our clinical sample characterized by low frequency of associated medical comorbidity.",,ASD susceptibility,[],"['ASD', 'susceptibility']"
485,834, M MEF2C haploinsufficiency is a recurrent finding in patients with autism spectrum disorders,P09.078,,"Since the first description of MEF2C haploinsufficiency syndrome in 2009, 42 patients have been reported either with deletion or point mutation of this gene. Intellectual disability (ID) is the core disorder of this syndrome but autistic features such as stereotypic movements and lack of social com munications are commonly reported. To further assess the role of MEF2C in autism spectrum disorder (ASD), we looked for MEF2C point mutations by Sanger sequencing and for MEF2C copy number variations by SNP array in a cohort of 195 patients with ASD and mild to severe ID.We identified a de novo frameshift mutation leading to a premature stop codon in 2 siblings with ASD and severe ID. A maternal germinal mosaicism was confirmed based on the haplotype. A de novo MEF2C deletion was also found in a patient with ASD and a mild ID. In this study, we observed MEF2C haploinsufficiency in 1,5% (95% confidence interval: 0 3.2%) of patients with ASD. This is the first study to look specifically at MEF2C in ASD. Of note, a mutation in MEF2C was also found once by whole exome sequencing in another cohort of 175 trios with ASD. According to this notable MEF2C ha ploinsufficiency frequency in ASD, we strongly recommend to pay specific attention to this gene when performing non targeted genetic screening in ASD with a comorbid ID even for patients without severe ID.",2014.0,,"A. Ziegler1,2, R. Delorme3,2,4, P . Amati Bonneau1,5, A. Guilmatre2,4, T . Bourgeron2,4,6, D.  Bonneau1,5","1Department of Biochemistry and Genetics, CHU Angers, Angers, France, 2Human  Genetics and Cognitive Functions, Institut Pasteur, Paris, France, 3Assistance Publique  Hpitaux de Paris, Robert Debr Hospital, Department of Child and Adolescent  Psychiatry, Paris, France, 4CNRS URA 2182 Genes, synapses and cognition, Institut  Pasteur, Paris, France, 5UMR CNRS 6214 INSERM 1083, Angers, France, 6University Denis  Diderot Paris 7, Paris, France",Intellectual disability (ID) is the core disorder of this syndrome but autistic features such as stereotypic movements and lack of social com munications are commonly reported.,,autistic features,[],"['autistic', 'feature']"
485,834, M MEF2C haploinsufficiency is a recurrent finding in patients with autism spectrum disorders,P09.078,,"Since the first description of MEF2C haploinsufficiency syndrome in 2009, 42 patients have been reported either with deletion or point mutation of this gene. Intellectual disability (ID) is the core disorder of this syndrome but autistic features such as stereotypic movements and lack of social com munications are commonly reported. To further assess the role of MEF2C in autism spectrum disorder (ASD), we looked for MEF2C point mutations by Sanger sequencing and for MEF2C copy number variations by SNP array in a cohort of 195 patients with ASD and mild to severe ID.We identified a de novo frameshift mutation leading to a premature stop codon in 2 siblings with ASD and severe ID. A maternal germinal mosaicism was confirmed based on the haplotype. A de novo MEF2C deletion was also found in a patient with ASD and a mild ID. In this study, we observed MEF2C haploinsufficiency in 1,5% (95% confidence interval: 0 3.2%) of patients with ASD. This is the first study to look specifically at MEF2C in ASD. Of note, a mutation in MEF2C was also found once by whole exome sequencing in another cohort of 175 trios with ASD. According to this notable MEF2C ha ploinsufficiency frequency in ASD, we strongly recommend to pay specific attention to this gene when performing non targeted genetic screening in ASD with a comorbid ID even for patients without severe ID.",2014.0,,"A. Ziegler1,2, R. Delorme3,2,4, P . Amati Bonneau1,5, A. Guilmatre2,4, T . Bourgeron2,4,6, D.  Bonneau1,5","1Department of Biochemistry and Genetics, CHU Angers, Angers, France, 2Human  Genetics and Cognitive Functions, Institut Pasteur, Paris, France, 3Assistance Publique  Hpitaux de Paris, Robert Debr Hospital, Department of Child and Adolescent  Psychiatry, Paris, France, 4CNRS URA 2182 Genes, synapses and cognition, Institut  Pasteur, Paris, France, 5UMR CNRS 6214 INSERM 1083, Angers, France, 6University Denis  Diderot Paris 7, Paris, France","To further assess the role of MEF2C in autism spectrum disorder (ASD), we looked for MEF2C point mutations by Sanger sequencing and for MEF2C copy number variations by SNP array in a cohort of 195 patients with ASD and mild to severe ID.We identified a de novo frameshift mutation leading to a premature stop codon in 2 siblings with ASD and severe ID.",patients with ASD,,"['patient', 'with', 'ASD']",[]
485,834, M MEF2C haploinsufficiency is a recurrent finding in patients with autism spectrum disorders,P09.078,,"Since the first description of MEF2C haploinsufficiency syndrome in 2009, 42 patients have been reported either with deletion or point mutation of this gene. Intellectual disability (ID) is the core disorder of this syndrome but autistic features such as stereotypic movements and lack of social com munications are commonly reported. To further assess the role of MEF2C in autism spectrum disorder (ASD), we looked for MEF2C point mutations by Sanger sequencing and for MEF2C copy number variations by SNP array in a cohort of 195 patients with ASD and mild to severe ID.We identified a de novo frameshift mutation leading to a premature stop codon in 2 siblings with ASD and severe ID. A maternal germinal mosaicism was confirmed based on the haplotype. A de novo MEF2C deletion was also found in a patient with ASD and a mild ID. In this study, we observed MEF2C haploinsufficiency in 1,5% (95% confidence interval: 0 3.2%) of patients with ASD. This is the first study to look specifically at MEF2C in ASD. Of note, a mutation in MEF2C was also found once by whole exome sequencing in another cohort of 175 trios with ASD. According to this notable MEF2C ha ploinsufficiency frequency in ASD, we strongly recommend to pay specific attention to this gene when performing non targeted genetic screening in ASD with a comorbid ID even for patients without severe ID.",2014.0,,"A. Ziegler1,2, R. Delorme3,2,4, P . Amati Bonneau1,5, A. Guilmatre2,4, T . Bourgeron2,4,6, D.  Bonneau1,5","1Department of Biochemistry and Genetics, CHU Angers, Angers, France, 2Human  Genetics and Cognitive Functions, Institut Pasteur, Paris, France, 3Assistance Publique  Hpitaux de Paris, Robert Debr Hospital, Department of Child and Adolescent  Psychiatry, Paris, France, 4CNRS URA 2182 Genes, synapses and cognition, Institut  Pasteur, Paris, France, 5UMR CNRS 6214 INSERM 1083, Angers, France, 6University Denis  Diderot Paris 7, Paris, France","To further assess the role of MEF2C in autism spectrum disorder (ASD), we looked for MEF2C point mutations by Sanger sequencing and for MEF2C copy number variations by SNP array in a cohort of 195 patients with ASD and mild to severe ID.We identified a de novo frameshift mutation leading to a premature stop codon in 2 siblings with ASD and severe ID.",siblings with ASD,,"['sibling', 'with', 'ASD']",[]
485,834, M MEF2C haploinsufficiency is a recurrent finding in patients with autism spectrum disorders,P09.078,,"Since the first description of MEF2C haploinsufficiency syndrome in 2009, 42 patients have been reported either with deletion or point mutation of this gene. Intellectual disability (ID) is the core disorder of this syndrome but autistic features such as stereotypic movements and lack of social com munications are commonly reported. To further assess the role of MEF2C in autism spectrum disorder (ASD), we looked for MEF2C point mutations by Sanger sequencing and for MEF2C copy number variations by SNP array in a cohort of 195 patients with ASD and mild to severe ID.We identified a de novo frameshift mutation leading to a premature stop codon in 2 siblings with ASD and severe ID. A maternal germinal mosaicism was confirmed based on the haplotype. A de novo MEF2C deletion was also found in a patient with ASD and a mild ID. In this study, we observed MEF2C haploinsufficiency in 1,5% (95% confidence interval: 0 3.2%) of patients with ASD. This is the first study to look specifically at MEF2C in ASD. Of note, a mutation in MEF2C was also found once by whole exome sequencing in another cohort of 175 trios with ASD. According to this notable MEF2C ha ploinsufficiency frequency in ASD, we strongly recommend to pay specific attention to this gene when performing non targeted genetic screening in ASD with a comorbid ID even for patients without severe ID.",2014.0,,"A. Ziegler1,2, R. Delorme3,2,4, P . Amati Bonneau1,5, A. Guilmatre2,4, T . Bourgeron2,4,6, D.  Bonneau1,5","1Department of Biochemistry and Genetics, CHU Angers, Angers, France, 2Human  Genetics and Cognitive Functions, Institut Pasteur, Paris, France, 3Assistance Publique  Hpitaux de Paris, Robert Debr Hospital, Department of Child and Adolescent  Psychiatry, Paris, France, 4CNRS URA 2182 Genes, synapses and cognition, Institut  Pasteur, Paris, France, 5UMR CNRS 6214 INSERM 1083, Angers, France, 6University Denis  Diderot Paris 7, Paris, France",A de novo MEF2C deletion was also found in a patient with ASD and a mild ID.,patient with ASD,,"['patient', 'with', 'ASD']",[]
485,834, M MEF2C haploinsufficiency is a recurrent finding in patients with autism spectrum disorders,P09.078,,"Since the first description of MEF2C haploinsufficiency syndrome in 2009, 42 patients have been reported either with deletion or point mutation of this gene. Intellectual disability (ID) is the core disorder of this syndrome but autistic features such as stereotypic movements and lack of social com munications are commonly reported. To further assess the role of MEF2C in autism spectrum disorder (ASD), we looked for MEF2C point mutations by Sanger sequencing and for MEF2C copy number variations by SNP array in a cohort of 195 patients with ASD and mild to severe ID.We identified a de novo frameshift mutation leading to a premature stop codon in 2 siblings with ASD and severe ID. A maternal germinal mosaicism was confirmed based on the haplotype. A de novo MEF2C deletion was also found in a patient with ASD and a mild ID. In this study, we observed MEF2C haploinsufficiency in 1,5% (95% confidence interval: 0 3.2%) of patients with ASD. This is the first study to look specifically at MEF2C in ASD. Of note, a mutation in MEF2C was also found once by whole exome sequencing in another cohort of 175 trios with ASD. According to this notable MEF2C ha ploinsufficiency frequency in ASD, we strongly recommend to pay specific attention to this gene when performing non targeted genetic screening in ASD with a comorbid ID even for patients without severe ID.",2014.0,,"A. Ziegler1,2, R. Delorme3,2,4, P . Amati Bonneau1,5, A. Guilmatre2,4, T . Bourgeron2,4,6, D.  Bonneau1,5","1Department of Biochemistry and Genetics, CHU Angers, Angers, France, 2Human  Genetics and Cognitive Functions, Institut Pasteur, Paris, France, 3Assistance Publique  Hpitaux de Paris, Robert Debr Hospital, Department of Child and Adolescent  Psychiatry, Paris, France, 4CNRS URA 2182 Genes, synapses and cognition, Institut  Pasteur, Paris, France, 5UMR CNRS 6214 INSERM 1083, Angers, France, 6University Denis  Diderot Paris 7, Paris, France","In this study, we observed MEF2C haploinsufficiency in 1,5% (95% confidence interval: 0 3.2%) of patients with ASD.",patients with ASD,,"['patient', 'with', 'ASD']",[]
485,834, M MEF2C haploinsufficiency is a recurrent finding in patients with autism spectrum disorders,P09.078,,"Since the first description of MEF2C haploinsufficiency syndrome in 2009, 42 patients have been reported either with deletion or point mutation of this gene. Intellectual disability (ID) is the core disorder of this syndrome but autistic features such as stereotypic movements and lack of social com munications are commonly reported. To further assess the role of MEF2C in autism spectrum disorder (ASD), we looked for MEF2C point mutations by Sanger sequencing and for MEF2C copy number variations by SNP array in a cohort of 195 patients with ASD and mild to severe ID.We identified a de novo frameshift mutation leading to a premature stop codon in 2 siblings with ASD and severe ID. A maternal germinal mosaicism was confirmed based on the haplotype. A de novo MEF2C deletion was also found in a patient with ASD and a mild ID. In this study, we observed MEF2C haploinsufficiency in 1,5% (95% confidence interval: 0 3.2%) of patients with ASD. This is the first study to look specifically at MEF2C in ASD. Of note, a mutation in MEF2C was also found once by whole exome sequencing in another cohort of 175 trios with ASD. According to this notable MEF2C ha ploinsufficiency frequency in ASD, we strongly recommend to pay specific attention to this gene when performing non targeted genetic screening in ASD with a comorbid ID even for patients without severe ID.",2014.0,,"A. Ziegler1,2, R. Delorme3,2,4, P . Amati Bonneau1,5, A. Guilmatre2,4, T . Bourgeron2,4,6, D.  Bonneau1,5","1Department of Biochemistry and Genetics, CHU Angers, Angers, France, 2Human  Genetics and Cognitive Functions, Institut Pasteur, Paris, France, 3Assistance Publique  Hpitaux de Paris, Robert Debr Hospital, Department of Child and Adolescent  Psychiatry, Paris, France, 4CNRS URA 2182 Genes, synapses and cognition, Institut  Pasteur, Paris, France, 5UMR CNRS 6214 INSERM 1083, Angers, France, 6University Denis  Diderot Paris 7, Paris, France","Of note, a mutation in MEF2C was also found once by whole exome sequencing in another cohort of 175 trios with ASD.",trios with ASD,,"['trio', 'with', 'ASD']",[]
486,848, M A cell reprogramming based approach to study 7q11.23 gene dosage imbalances in Williams Beuren syndrome and autism spectrum disorder,P09.094,,"Symmetrical gene dosage imbalances at 7q11.23 cause two neurodeve lopmental diseases, Williams Beuren Syndrome (WBS) and the 7q11.23 microduplication associated to autistic spectrum disorder (7dup ASD). Be sides intellectual disability and craniofacial dysmorphisms, WBS patients display hypersociality and comparatively well preserved language skills while 7dup ASD is associated with impairments of varying severity across the autistic spectrum. The striking symmetry in genotype and phenotype between the two conditions points to the 7q11.23 cluster as a surprisingly small subset of dosage sensitive genes affecting social behavior and cogniti on. The molecular phenotypes of these syndromes in disease relevant cell types remain to be elucidated however, due to scarce availability of primary diseased tissues. Convergent evidence both from human studies and mouse models, points to transcriptional dysregulation as a critical aspect of both conditions, consistent with the presence of several transcription factors in the 7q11.23 interval.Here we present the first analysis of transcriptional dysregulation in human physiopathologically relevant cell types carrying 7q11.23 dosage imbalan   ces. We selected a large and unique panel of WBS and 7dup ASD patients and derived induced pluripotent stem cells (iPSC) with the most advanced reprogramming technology based on synthetic mRNAs. These were then differentiated into relevant lineages to establish experimentally tractable models of these conditions. Next, we integrated high throughput sequen   cing for transcriptional and chromatin analysis and present here a functio nal dissection of these symmetric conditions that uncovers the principles of dosage dependent transcriptional dysregulation in disease relevant human cells types.",2014.0,,"S. Atashpaz1, A. Adamo1, P . Germain1, J. Chenoweth2, G. DAgostino1, M. Zanella1, P .  Prontera3, C. Unger4, P . W. Andrews4, G. Pruneri1, B. Hamilton5, G. Merla6, R. D. McKay2, G.  Testa1","1European Institute of Oncology, Milan, Italy, 2Lieber Institute for Brain Development,  Baltimore, MD, United States, 3Department of Experimental Medicine and Biochemical  Sciences, University of Perugia, Perugia, Italy, 4Centre for Stem Cell Biology, Department  of Biomedical Science, University of Sheffield, Sheffield, United Kingdom, 5Stemgent,  Cambridge, MA, United States, 6Medical Genetics Unit, Casa Sollievo della Sofferenza  Hospital, San Giovanni Rotondo, Italy","Symmetrical gene dosage imbalances at 7q11.23 cause two neurodeve lopmental diseases, Williams Beuren Syndrome (WBS) and the 7q11.23 microduplication associated to autistic spectrum disorder (7dup ASD).",,autistic spectrum,[],"['autistic', 'spectrum']"
486,848, M A cell reprogramming based approach to study 7q11.23 gene dosage imbalances in Williams Beuren syndrome and autism spectrum disorder,P09.094,,"Symmetrical gene dosage imbalances at 7q11.23 cause two neurodeve lopmental diseases, Williams Beuren Syndrome (WBS) and the 7q11.23 microduplication associated to autistic spectrum disorder (7dup ASD). Be sides intellectual disability and craniofacial dysmorphisms, WBS patients display hypersociality and comparatively well preserved language skills while 7dup ASD is associated with impairments of varying severity across the autistic spectrum. The striking symmetry in genotype and phenotype between the two conditions points to the 7q11.23 cluster as a surprisingly small subset of dosage sensitive genes affecting social behavior and cogniti on. The molecular phenotypes of these syndromes in disease relevant cell types remain to be elucidated however, due to scarce availability of primary diseased tissues. Convergent evidence both from human studies and mouse models, points to transcriptional dysregulation as a critical aspect of both conditions, consistent with the presence of several transcription factors in the 7q11.23 interval.Here we present the first analysis of transcriptional dysregulation in human physiopathologically relevant cell types carrying 7q11.23 dosage imbalan   ces. We selected a large and unique panel of WBS and 7dup ASD patients and derived induced pluripotent stem cells (iPSC) with the most advanced reprogramming technology based on synthetic mRNAs. These were then differentiated into relevant lineages to establish experimentally tractable models of these conditions. Next, we integrated high throughput sequen   cing for transcriptional and chromatin analysis and present here a functio nal dissection of these symmetric conditions that uncovers the principles of dosage dependent transcriptional dysregulation in disease relevant human cells types.",2014.0,,"S. Atashpaz1, A. Adamo1, P . Germain1, J. Chenoweth2, G. DAgostino1, M. Zanella1, P .  Prontera3, C. Unger4, P . W. Andrews4, G. Pruneri1, B. Hamilton5, G. Merla6, R. D. McKay2, G.  Testa1","1European Institute of Oncology, Milan, Italy, 2Lieber Institute for Brain Development,  Baltimore, MD, United States, 3Department of Experimental Medicine and Biochemical  Sciences, University of Perugia, Perugia, Italy, 4Centre for Stem Cell Biology, Department  of Biomedical Science, University of Sheffield, Sheffield, United Kingdom, 5Stemgent,  Cambridge, MA, United States, 6Medical Genetics Unit, Casa Sollievo della Sofferenza  Hospital, San Giovanni Rotondo, Italy","Be sides intellectual disability and craniofacial dysmorphisms, WBS patients display hypersociality and comparatively well preserved language skills while 7dup ASD is associated with impairments of varying severity across the autistic spectrum.",,autistic spectrum,[],"['autistic', 'spectrum']"
486,848, M A cell reprogramming based approach to study 7q11.23 gene dosage imbalances in Williams Beuren syndrome and autism spectrum disorder,P09.094,,"Symmetrical gene dosage imbalances at 7q11.23 cause two neurodeve lopmental diseases, Williams Beuren Syndrome (WBS) and the 7q11.23 microduplication associated to autistic spectrum disorder (7dup ASD). Be sides intellectual disability and craniofacial dysmorphisms, WBS patients display hypersociality and comparatively well preserved language skills while 7dup ASD is associated with impairments of varying severity across the autistic spectrum. The striking symmetry in genotype and phenotype between the two conditions points to the 7q11.23 cluster as a surprisingly small subset of dosage sensitive genes affecting social behavior and cogniti on. The molecular phenotypes of these syndromes in disease relevant cell types remain to be elucidated however, due to scarce availability of primary diseased tissues. Convergent evidence both from human studies and mouse models, points to transcriptional dysregulation as a critical aspect of both conditions, consistent with the presence of several transcription factors in the 7q11.23 interval.Here we present the first analysis of transcriptional dysregulation in human physiopathologically relevant cell types carrying 7q11.23 dosage imbalan   ces. We selected a large and unique panel of WBS and 7dup ASD patients and derived induced pluripotent stem cells (iPSC) with the most advanced reprogramming technology based on synthetic mRNAs. These were then differentiated into relevant lineages to establish experimentally tractable models of these conditions. Next, we integrated high throughput sequen   cing for transcriptional and chromatin analysis and present here a functio nal dissection of these symmetric conditions that uncovers the principles of dosage dependent transcriptional dysregulation in disease relevant human cells types.",2014.0,,"S. Atashpaz1, A. Adamo1, P . Germain1, J. Chenoweth2, G. DAgostino1, M. Zanella1, P .  Prontera3, C. Unger4, P . W. Andrews4, G. Pruneri1, B. Hamilton5, G. Merla6, R. D. McKay2, G.  Testa1","1European Institute of Oncology, Milan, Italy, 2Lieber Institute for Brain Development,  Baltimore, MD, United States, 3Department of Experimental Medicine and Biochemical  Sciences, University of Perugia, Perugia, Italy, 4Centre for Stem Cell Biology, Department  of Biomedical Science, University of Sheffield, Sheffield, United Kingdom, 5Stemgent,  Cambridge, MA, United States, 6Medical Genetics Unit, Casa Sollievo della Sofferenza  Hospital, San Giovanni Rotondo, Italy",We selected a large and unique panel of WBS and 7dup ASD patients and derived induced pluripotent stem cells (iPSC) with the most advanced reprogramming technology based on synthetic mRNAs.,,ASD patients,[],"['ASD', 'patient']"
487,858, S The role of the NR2A and NR2B subunits of the NMDA receptor in epileptogenesis,P09.105,,"NMDA receptors are tetrameric ligand gated ion channels composed of two glycine binding NR1 subunits and two glutamate binding NR2 subunits (NR2A, NR2B, NR2C, NR2D) regulating synaptic plasticity. Mutations in the NR2A and NR2B subunits encoded by the genes GRIN2A  and GRIN2B  have  been associated with different phenotypes of intellectual disability (ID). Mutations in GRIN2A  were known to cause unspecific ID and epilepsy as  well as other neurodevelopmental disorders, whereas mutations in GRIN2B have mainly been associated with autism spectrum disorders (ASD) but not seizures. We show for the first time that mutations of NR2 subunits of the NMDA receptor cause different and specific epilepsy phenotypes. NR2 muta   tions are involved in benign Rolandic epilepsy, the most frequent childhood epilepsy as well as in a variety of rare infantile epileptic encephalopathi es, such as Landau Kleffner and West syndrome. Furthermore, we demon   strate distinct genotype phenotype correlations. Severe encephalopathic phenotypes are significantly more often caused by truncating mutations in GRIN2A , whereas missense mutations are by far more common in benign  Rolandic epilepsy patients. For GRIN2B , the majority of ASD individuals pre  sent with truncating mutations, whereas all epilepsy cases appear to have gain of function mutations. The severity of phenotypes depends on the af fected domain and the extent of receptor activation. Our observations high light the so far underestimated role of dysregulated NMDA signalling in both frequent and rare epilepsy disorders and reveal promising pharmacologic targets for novel therapeutic approaches.",2014.0,,"J. Lemke1, K. Geider2, B. Laube2, D. Lal3, E. M. Reinthaler4, S. Weckhuysen5, S. Biskup6,  EuroEPINOMICS RES Consortium, S. von Spiczak7","1Institute of Human Genetics, University of Leipzig, Leipzig, Germany, 2Department  of Neurophysiology and Neurosensory Systems, Technical University Darmstadt, Darmstadt, Germany,  3Cologne Center for Genomics, University of Cologne, Cologne,  Germany, 4Department of Neurology, Medical University of Vienna, Vienna, Austria,  5Neurogenetics Group, Department of Molecular Genetics, VIB, Antwerp, Belgium,  6CeGaT GmbH, Tbingen, Germany, 7Department of Neuropediatrics, University Medical  Center Schleswig Holstein and Christian Albrecht University Kiel, Kiel, Germany","For GRIN2B , the majority of ASD individuals pre  sent with truncating mutations, whereas all epilepsy cases appear to have gain of function mutations.",,ASD individuals,[],"['ASD', 'individual']"
488,862, S PARK2 deletions in patients with Autism Spectrum Disorder (ASD) and other neurodevelopmental pathologies,P09.109,,"The PARK2 gene encodes Parkin, a component of a multiprotein E3 ubiquitin ligase complex that targets misfolded proteins for proteasomal degradation, such as dopamine transporters, synaptotagmin and ? synuclein. PARK2 ge netic mutations are associated with Parkinson Disease, while Copy Number Variants (CNV) have been found in patients with developmental delay (DD), Attention Deficit Hyperactivity Disorder (ADHD) and ASD.We identified 5 male patients with inherited PARK2 deletions in 342 ASD indi   viduals, screened for CNVs using Illumina 1M SNP arrays (frequency,1.5%). Three patients had a 45Kb deletion of intron 9, and two patients had a deleti on of either 29Kb in intron 6 or 266Kb encompassing exons 5 and 6. Clinical presentation was heterogeneous in these ASD patients. A literature search showed recurrent deletions of introns 2 and 3 (N,15 ADHD, N,7 ASD), as  well as exons 1 (N,1 ASD) and 2 (N,2 ASD and DD), while DECIPHER re  ported one ASD individual with an exon 5 6 deletion. In available control databases, deletions of segments from exons 1 to intron 4 as well as intron 9 were recurrent, but only 1/4139 controls had a CNV overlapping exon 6,  suggesting a pathogenic role of deletions in this region. The smaller exon  6 CNVs deleted a functional domain SYT11 binding site, compromising the  attachment of synaptotagmin and ubiquitination.These results support a role of PARK2 structural variants in ASD. However, certain PARK2 regions are also frequently deleted in control subjects, and  therefore rigorous analysis is mandatory before assuming a pathogenic role  for identified CNVs.",2014.0,,"I. C. Conceio1,2,3, M. M. Rama1, B. Oliveira1,2,3, C. Caf4, J. Almeida4, S. Mouga4, G.  Oliveira4,5,6, A. M. Vicente1,2,3","1Instituto Nacional de Sade Doutor Ricardo Jorge, Lisbon, Portugal, 2Center for  Biodiversity, Functional & Integrative Genomics, Lisbon, Portugal, 3Instituto Gulbenkian  de Cincia, Oeiras, Portugal, 4Unidade Neurodesenvolvimento e Autismo, Centro de  Desenvolvimento, Hospital Peditrico (HP), Centro Hospitalar e Universitrio de  Coimbra (CHUC), Coimbra, Portugal, 5Faculdade de Medicina da Universidade de  Coimbra, Coimbra, Portugal, 6Centro de Investigao e Formao Clinica do HP CHUC,  Coimbra, Portugal",Clinical presentation was heterogeneous in these ASD patients.,,ASD patients,[],"['ASD', 'patient']"
488,862, S PARK2 deletions in patients with Autism Spectrum Disorder (ASD) and other neurodevelopmental pathologies,P09.109,,"The PARK2 gene encodes Parkin, a component of a multiprotein E3 ubiquitin ligase complex that targets misfolded proteins for proteasomal degradation, such as dopamine transporters, synaptotagmin and ? synuclein. PARK2 ge netic mutations are associated with Parkinson Disease, while Copy Number Variants (CNV) have been found in patients with developmental delay (DD), Attention Deficit Hyperactivity Disorder (ADHD) and ASD.We identified 5 male patients with inherited PARK2 deletions in 342 ASD indi   viduals, screened for CNVs using Illumina 1M SNP arrays (frequency,1.5%). Three patients had a 45Kb deletion of intron 9, and two patients had a deleti on of either 29Kb in intron 6 or 266Kb encompassing exons 5 and 6. Clinical presentation was heterogeneous in these ASD patients. A literature search showed recurrent deletions of introns 2 and 3 (N,15 ADHD, N,7 ASD), as  well as exons 1 (N,1 ASD) and 2 (N,2 ASD and DD), while DECIPHER re  ported one ASD individual with an exon 5 6 deletion. In available control databases, deletions of segments from exons 1 to intron 4 as well as intron 9 were recurrent, but only 1/4139 controls had a CNV overlapping exon 6,  suggesting a pathogenic role of deletions in this region. The smaller exon  6 CNVs deleted a functional domain SYT11 binding site, compromising the  attachment of synaptotagmin and ubiquitination.These results support a role of PARK2 structural variants in ASD. However, certain PARK2 regions are also frequently deleted in control subjects, and  therefore rigorous analysis is mandatory before assuming a pathogenic role  for identified CNVs.",2014.0,,"I. C. Conceio1,2,3, M. M. Rama1, B. Oliveira1,2,3, C. Caf4, J. Almeida4, S. Mouga4, G.  Oliveira4,5,6, A. M. Vicente1,2,3","1Instituto Nacional de Sade Doutor Ricardo Jorge, Lisbon, Portugal, 2Center for  Biodiversity, Functional & Integrative Genomics, Lisbon, Portugal, 3Instituto Gulbenkian  de Cincia, Oeiras, Portugal, 4Unidade Neurodesenvolvimento e Autismo, Centro de  Desenvolvimento, Hospital Peditrico (HP), Centro Hospitalar e Universitrio de  Coimbra (CHUC), Coimbra, Portugal, 5Faculdade de Medicina da Universidade de  Coimbra, Coimbra, Portugal, 6Centro de Investigao e Formao Clinica do HP CHUC,  Coimbra, Portugal","A literature search showed recurrent deletions of introns 2 and 3 (N,15 ADHD, N,7 ASD), as  well as exons 1 (N,1 ASD) and 2 (N,2 ASD and DD), while DECIPHER re  ported one ASD individual with an exon 5 6 deletion.",,ASD individual,[],"['ASD', 'individual']"
493,904, S The association analysis of CDH10 gene (rs4307059 and rs4327572) with autism in a South African population,P09.151,,"Autism spectrum disorders encompass a group of childhood neurodevelop mental and neuropsychiatric disorders characterized by deficits in verbal communication and impairment of social interaction. Numerous researches have pointed out that strong genetics components are involved in suscepti bility to autism. Genome wide association studies have revealed out strong association signal for CDH10  gene with SNP rs4307059 and rs4327572.  This gene had not been investigated for its association with Autism in South African population. Aim: In this study we aimed to investigate the associa   tion of two SNPs (rs4307059 and rs4327572) of CDH10  gene of autism in  the South African (SA) population. For SNPS rs4307059, the present study group was comprised of typed cases (188, unrelated autistic children) and typed controls (212, unrelated healthy children) where the respective figu res for rs4327572 were 72 and 209 respectively. The Taqman Real Time PCR and genotyping assay was utilized to determine the genotypes. Results: There was no significant association of SNP rs4307059 and4327572 with autism in the South African (SA) population. Conclusion: There might be a possible role of CDH10 in autism but we need to validate it with a larger sample number. The present study represents the first report on study of genetic association of CDH10  gene in SA population.",2014.0,,"J. R. Sharma, Z. Arieff, F. October","Department of Biotechnology, University of Western Cape, Bellville, South Africa",This gene had not been investigated for its association with Autism in South African population.,association with Autism,,"['association', 'with', 'Autism']",[]
493,904, S The association analysis of CDH10 gene (rs4307059 and rs4327572) with autism in a South African population,P09.151,,"Autism spectrum disorders encompass a group of childhood neurodevelop mental and neuropsychiatric disorders characterized by deficits in verbal communication and impairment of social interaction. Numerous researches have pointed out that strong genetics components are involved in suscepti bility to autism. Genome wide association studies have revealed out strong association signal for CDH10  gene with SNP rs4307059 and rs4327572.  This gene had not been investigated for its association with Autism in South African population. Aim: In this study we aimed to investigate the associa   tion of two SNPs (rs4307059 and rs4327572) of CDH10  gene of autism in  the South African (SA) population. For SNPS rs4307059, the present study group was comprised of typed cases (188, unrelated autistic children) and typed controls (212, unrelated healthy children) where the respective figu res for rs4327572 were 72 and 209 respectively. The Taqman Real Time PCR and genotyping assay was utilized to determine the genotypes. Results: There was no significant association of SNP rs4307059 and4327572 with autism in the South African (SA) population. Conclusion: There might be a possible role of CDH10 in autism but we need to validate it with a larger sample number. The present study represents the first report on study of genetic association of CDH10  gene in SA population.",2014.0,,"J. R. Sharma, Z. Arieff, F. October","Department of Biotechnology, University of Western Cape, Bellville, South Africa","For SNPS rs4307059, the present study group was comprised of typed cases (188, unrelated autistic children) and typed controls (212, unrelated healthy children) where the respective figu res for rs4327572 were 72 and 209 respectively.",,autistic children,[],"['autistic', 'child']"
494,905, MThe Haplotype analysis to test for the association of three SNPs with autism in a South African Population,P09.152,,"Autism spectrum disorder is a neuropsychiatric developmental disorder characterized by communication difficulties and impaired social interac tion. The anhydrolase domain containing 11 gene (ABHD11 ) is located on  7q11.23 which is a hotspot region for autism and ABCA13  maps to chromo  some 7p12.3 in which multiple rare coding variants are observed. The aim of this study was to investigate the association of SNPs from genes ABHD11   (rs2293484 and rs10279013) and ABHD13  (rs17060) with haplotype ana   lysis in South African autistic population. A total of 435 individuals were recruited including 197 autistic and 213 control subjects. The Taqman Re  al Time PCR and genotyping assay was used to determine the genotypes. A  significant association of SNP rs10279013 with autism in the South African population is observed. Haplotype analysis with three SNPs revealed that  the frequency of CGC, TGT and TCT haplotypes is significantly higher in con  trols than cases (p<0.05). The haplotypes TGC and TCC presented a signi ficantly higher frequency in cases and the odds documented nearly 3 3.47  fold higher risk to the disease in carriers of the haplotypes [OR,3.0 (1.16  7.79), OR,3.47 (0.95 12.63), respectively]. In conclusion there is a role of various haplotypes of these SNPs in increasing susceptibility to autism for South African populations. The present study represents the first report on  haplotype analysis on these SNPs in a SA population.",2014.0,,"Z. Arieff1, J. R. Sharma1, M. Davids1, M. Kaur2","1Department of Biotechnology, University of Western Cape, Bellville, South Africa,  2Computational Bioscience Research Center, King Abdullah University of Science and  Technology, Thuwal, Saudi Arabia",The aim of this study was to investigate the association of SNPs from genes ABHD11   (rs2293484 and rs10279013) and ABHD13  (rs17060) with haplotype ana   lysis in South African autistic population.,,autistic population,[],"['autistic', 'population']"
502,1048, S Mosaic deletion of 18q in lymphocytes represents a diagnostic challenge for clinicians and underlines the importance of CMA testing in children with ID,P11.099,,"We report on a 2 year old boy with mental retardation, muscular hypoto  nia, deafness with atresia of the external auditory canal and a preauricular tag on the right side. The boy was referred for global intellectual disabili ty with very limited speech capabilities and autistic traits. The pregnancy had been uneventful except for an emergency Cesarean section because of breech position. Birth measurements were normal, however, the baby was hypotonic and exhibited difficulties in feeding. At physical examination at the age of 2 years measurements were still normal but we noted discrete dysmorphic features: long eye lashes, broad mouth with cupid bow lips, small fingers with broad short endphalanges, clinodactyly of toes V on both sides, tender translucent skin, fine hair and cryptorchidism on the right side. On the MRI at the age of 2 years delayed myelinisation was visible. As the atresia of the external auditory canal is typical for a deletion 18q we performed a karyotype on lymphocytes which was first reported with no pathological findings.The array (2.7 Affymetrix SNP oligo array platform) analysis revealed a de   letion in mosaic form of 20.7 Mb of the long arm of chromosome 18, encom passing 69 genes in total. The mosaic was confirmed with FISH, which also revealed that the mosaic ratio in this case was 13% in cultivated blood and 81% in buccal swab. Reevaluating the karyotype the deletion was visible.This case demonstrates the higher sensitivity of SNParrayCMA testing for mosaic aberrations.ABSTRACTS POSTERS ESHG 2014 | MILAN, ITALY | WWW.ESHG.ORG 226Back to inde x",2014.0,,"D. Niedrist , B. Oneda, R. Baldinger, A. Rauch","Institute of Medical Genetics, University of Zurich, Schlieren Zurich, Switzerland",The boy was referred for global intellectual disabili ty with very limited speech capabilities and autistic traits.,,autistic traits,[],"['autistic', 'trait']"
504,1255, M Somatic mosaicism for deletion at 8p21.3p23.1: some new twists on generation of terminal 8p rearrangements,P13.18,,"Somatic mosaicism for terminal 8p deletions is rare. Here, we report on a case of a deletion at 8p21.3p23.1 affecting about 50% of cells addressed by SNP/oligonucleotide CGH. An 8 year old girl presented with intellec tual disability, autistic features, microcephaly, large upper incisors, small lower jaw, hypertrichosis, and pectus excavatum. Cytogenetic analysis has indicated the presence of a deletion at the short arm of chromosome 8 in  about 60% of cells. SNP/oligonucleotide CGH has confirmed the presence  of mosaic terminal deletion at 8p21.3p23.1 spanning about 11.152 Mb af fecting 178 genes. Molecular cytogenetic analysis showed that 48% of cells are affected by this deletion. Clinically, the index case resembles non mo  saic deletions of 8p23. Nevertheless, milder manifestations of intellectual  disability, microcephaly and facial dismorphisms were noticed, whereas autistic features were found to be more prominent. Interestingly, genomic  loci flanking the breakpoint of mosaic deletion were regularly deleted. The  regular deletion spanned three olfactory receptor (OR) genes (OR7E158P , OR7E161P , OR7E160P) and three beta defensin (DEFB) genes (DEFB137,  DEFB136, DEFB134). Since OR gene clusters are known to be involved in  generation of 8p chromosome rearrangements, we have hypothesized that at least in the present case DEFB gene cluster is also involved in chromoso   me abnormality formation. Finally, to our knowledge this is the first case of  a mosaic 8p deletion addressed by SNP/oligonucleotide CGH and mediated  by OR gene recombination. Supported by the Russian Federation President Grant (MD 4401.2013.7).",2014.0,,"A. D. Kolotii1,2, S. G. Vorsanova1,2,3, Y. B. Yurov1,2,3, V. Y. Voinova1,2,3, I. Y. Iourov1,2,4","1National Research Center of Mental Health, RAMS, Moscow, Russian Federation,  2Institute of Paediatrics and Paediatric Surgery, Ministry of Health, Moscow, Russian  Federation, 3Moscow City University of Psychology and Education, Moscow, Russian  Federation, 4Department of Medical Genetics, Russian Medical Academy of Postgraduate  Education, Ministry of Health, Moscow, Russian Federation","An 8 year old girl presented with intellec tual disability, autistic features, microcephaly, large upper incisors, small lower jaw, hypertrichosis, and pectus excavatum.",,autistic features,[],"['autistic', 'feature']"
504,1255, M Somatic mosaicism for deletion at 8p21.3p23.1: some new twists on generation of terminal 8p rearrangements,P13.18,,"Somatic mosaicism for terminal 8p deletions is rare. Here, we report on a case of a deletion at 8p21.3p23.1 affecting about 50% of cells addressed by SNP/oligonucleotide CGH. An 8 year old girl presented with intellec tual disability, autistic features, microcephaly, large upper incisors, small lower jaw, hypertrichosis, and pectus excavatum. Cytogenetic analysis has indicated the presence of a deletion at the short arm of chromosome 8 in  about 60% of cells. SNP/oligonucleotide CGH has confirmed the presence  of mosaic terminal deletion at 8p21.3p23.1 spanning about 11.152 Mb af fecting 178 genes. Molecular cytogenetic analysis showed that 48% of cells are affected by this deletion. Clinically, the index case resembles non mo  saic deletions of 8p23. Nevertheless, milder manifestations of intellectual  disability, microcephaly and facial dismorphisms were noticed, whereas autistic features were found to be more prominent. Interestingly, genomic  loci flanking the breakpoint of mosaic deletion were regularly deleted. The  regular deletion spanned three olfactory receptor (OR) genes (OR7E158P , OR7E161P , OR7E160P) and three beta defensin (DEFB) genes (DEFB137,  DEFB136, DEFB134). Since OR gene clusters are known to be involved in  generation of 8p chromosome rearrangements, we have hypothesized that at least in the present case DEFB gene cluster is also involved in chromoso   me abnormality formation. Finally, to our knowledge this is the first case of  a mosaic 8p deletion addressed by SNP/oligonucleotide CGH and mediated  by OR gene recombination. Supported by the Russian Federation President Grant (MD 4401.2013.7).",2014.0,,"A. D. Kolotii1,2, S. G. Vorsanova1,2,3, Y. B. Yurov1,2,3, V. Y. Voinova1,2,3, I. Y. Iourov1,2,4","1National Research Center of Mental Health, RAMS, Moscow, Russian Federation,  2Institute of Paediatrics and Paediatric Surgery, Ministry of Health, Moscow, Russian  Federation, 3Moscow City University of Psychology and Education, Moscow, Russian  Federation, 4Department of Medical Genetics, Russian Medical Academy of Postgraduate  Education, Ministry of Health, Moscow, Russian Federation","Nevertheless, milder manifestations of intellectual  disability, microcephaly and facial dismorphisms were noticed, whereas autistic features were found to be more prominent.",,autistic features,[],"['autistic', 'feature']"
513,1962, 9q34.11 q34.12 deletion associated with autism and dysmorphic features: a case report,J08.07,,"Obregia  Clinical Hospital of Psychiatry, Bucharest, Romania. The use of high resolution array based comparative genomic hybridiza   tion (array CGH) in whole genome investigation led to an unprecedented rate of discovery of clinically relevant microdeletions/microduplications in neurodevelopmental disorders. We report on a 12 year old boy with facial dysmorphic features, autism (Asperger syndrome), motor and vocal tics, speech disorder in early childhood presenting a 9q34.11   q34.12 deletion. Cytogenetic investigations included array CGH investigation (105K plat   form, Agilent Technologies) and FISH (BAC probes). Array CGH revealed a de novo 2.4 Mb deletion spanning cytogenetic bands 9q34.11 q34.12 (geno mic coordinates, hg19: 131485878 133931680). Approximately 50 genes are located within the deleted region, some of these being disease causing OMIM genes: AGM5, CDG1M, TOR1A, ASS1, ABL1. Deletions of genomic re gion 9q34.11 q34.13, proximal to EHMT1, are rarely described. Few pati   ents with deletions similar to our case have been reported in the literature and centralized in databases (e.g. DECIPHER). Haploinsufficiency of genes located in this region might be responsible for the clinical findings in the reported patients (such as autism, intellectual disability, epilepsy, move ment disorders etc). Thus our case adds to the body of knowledge and will help in establishing genotype phenotype correlations. Acknowledgments: Professor Jean Michel Dupont from Cochin Hospital, Paris, France for kindly providing the BAC FISH probe; Project PN 09.33.02.03.",2014.0,,"A. Arghir1, M. Budisteanu1,2, S. Papuc1, B. Budisteanu2, I. Borcan1, M. Cristea1, A. Tutulan  Cunita1","1Victor Babes National Institute of Pathology, Bucharest, Romania, 2Alex","We report on a 12 year old boy with facial dysmorphic features, autism (Asperger syndrome), motor and vocal tics, speech disorder in early childhood presenting a 9q34.11   q34.12 deletion.",,Asperger syndrome,[],"['Asperger', 'syndrome']"
514,1963, A clinical case with autism and 22q13.3 deletion or Phelan McDermid syndrome,J08.08,,"Naum, Sofia, Bulgaria, 3Medical Center  Children`s Health, Sofia, Bulgaria, 4Chair of Medical genetics, Medical University, Sofia,  Bulgaria. The 22q13.3 deletion is a contiguous gene deletion syndrome (MIM 606232) with gene locus SHANK3/ProSAP2 on the terminal end of chromosome 22. The syndrome is characterized by neonatal hypotonia, mental retardation, speech delay, autistic behaviour, normal to accelerated growth, minor facial dysmorphism.The authors present a boy who was successfully treated for VSD at 6 months of age with cardiosurgical operation. After the procedure the child started ABSTRACTS PUBLISHED ABSTRACTS ESHG 2014 | MILAN, ITALY | WWW.ESHG.ORG 425Back to inde x losing interest for toys and relatives. At age of 11 years, he was consulted  for autistic behaviour. He presented with facial and cranial dysmorphysm  (hypertelorism, epicanthic folds, ptosis, dolichocephaly, fleshy hands, severe  mental retardation, severe speech delay. The diagnosis of DiGeorge syndro me was suspected at the base of history for VSD, mental retardation and  facial dysmorphysm. Heparine blood of the child was investigated with Fluo  rescent in situ Hybridization (FISH). Test VYSIS   locus specific for 22q11.2 and test ARSA   control of locus 22q13 were applied. In all 30 investigated interphase nucleus and metaphases were found one green signal for ARSA  and two red for TUPLE 1. The result showed nuc ish (22)q11.2 (TUPLE  1x2), 22q13 (ARSAx1) which confirmed the diagnosis Phelan McDermid syndrome. The recommended treatment included a free of milk and gluten  diet, special education and logopedic thrapy. The family attended genetic  conseling.The presented clinical case confirmed the association of 22q13.3 deletion  with autism (Itsara et al., 2009. The authors proposed for a first time a new  symptom   congenital heart malformation in Phelan McDermid syndrome.",2014.0,,"B. Radeva1, M. Stancheva Ivanova2, P . Mitev3, R. Staneva4","1Medical Center Childens health, Sofia, Bulgaria, 2University Hospital for Active  Treatment in Neurology and Psychiatry St","The syndrome is characterized by neonatal hypotonia, mental retardation, speech delay, autistic behaviour, normal to accelerated growth, minor facial dysmorphism.The authors present a boy who was successfully treated for VSD at 6 months of age with cardiosurgical operation.",,autistic behaviour,[],"['autistic', 'behaviour']"
514,1963, A clinical case with autism and 22q13.3 deletion or Phelan McDermid syndrome,J08.08,,"Naum, Sofia, Bulgaria, 3Medical Center  Children`s Health, Sofia, Bulgaria, 4Chair of Medical genetics, Medical University, Sofia,  Bulgaria. The 22q13.3 deletion is a contiguous gene deletion syndrome (MIM 606232) with gene locus SHANK3/ProSAP2 on the terminal end of chromosome 22. The syndrome is characterized by neonatal hypotonia, mental retardation, speech delay, autistic behaviour, normal to accelerated growth, minor facial dysmorphism.The authors present a boy who was successfully treated for VSD at 6 months of age with cardiosurgical operation. After the procedure the child started ABSTRACTS PUBLISHED ABSTRACTS ESHG 2014 | MILAN, ITALY | WWW.ESHG.ORG 425Back to inde x losing interest for toys and relatives. At age of 11 years, he was consulted  for autistic behaviour. He presented with facial and cranial dysmorphysm  (hypertelorism, epicanthic folds, ptosis, dolichocephaly, fleshy hands, severe  mental retardation, severe speech delay. The diagnosis of DiGeorge syndro me was suspected at the base of history for VSD, mental retardation and  facial dysmorphysm. Heparine blood of the child was investigated with Fluo  rescent in situ Hybridization (FISH). Test VYSIS   locus specific for 22q11.2 and test ARSA   control of locus 22q13 were applied. In all 30 investigated interphase nucleus and metaphases were found one green signal for ARSA  and two red for TUPLE 1. The result showed nuc ish (22)q11.2 (TUPLE  1x2), 22q13 (ARSAx1) which confirmed the diagnosis Phelan McDermid syndrome. The recommended treatment included a free of milk and gluten  diet, special education and logopedic thrapy. The family attended genetic  conseling.The presented clinical case confirmed the association of 22q13.3 deletion  with autism (Itsara et al., 2009. The authors proposed for a first time a new  symptom   congenital heart malformation in Phelan McDermid syndrome.",2014.0,,"B. Radeva1, M. Stancheva Ivanova2, P . Mitev3, R. Staneva4","1Medical Center Childens health, Sofia, Bulgaria, 2University Hospital for Active  Treatment in Neurology and Psychiatry St","At age of 11 years, he was consulted  for autistic behaviour.",,autistic behaviour,[],"['autistic', 'behaviour']"
518,1980, A novel mutation in the endosomal Na+/H+ exchanger NHE6(SLC9A6)causes Christianson syndrome with electrical status epilepticus during slow wave sleep (ESES).,J08.24,,"Mutations in the solute carrier family 9, subfamily A member 6(SLC9A6 )  gene, encoding the endosomal Na+/H+ exchanger 6 (NHE6) are associated with Christianson syndrome, a syndromic form of X linked intel  lectual disability characterized by microcephaly, severe global developmen  tal delay, autistic behavior,early onset seizures and ataxia. In a 7 year old boy with characteristic clinical and neuroimaging features of Christianson syndrome and epileptic encephalopathy with continuous spikes and waves during sleep, we identified a novel splice site mutation (IVS10 1G>A) in SLC9A6 . These findings expand the clinical spectrum of the  syndrome and indicate NHE6 dysfunction as a new cause of electrical status epilepticus during slow wave sleep (ESES).",2014.0,,"G. Zanni1, S. Barresi1, R. Cohen2, N. Specchio3, L. Basel Vanagaite4, E. Valente5, A. Shuper2,  F. Vigevano6, E. Bertini1","1Department of Neurosciences, Unit of Molecular Medicine for Neuromuscular and  Neurodegenerative disorders, Bambino Ges Childrens IRRCS, ROMA, Italy, 2Schneiders  Children Medical Center of Israel And Sackler School of Medicine, Tel Aviv, Israel,  3Division of Neurology, Department of Neurosciences, Bambino Ges Childrens Hospital,  ROMA, Italy, 4Schneiders Children Medical Center of Israel And Sackler School of  Medicine, Tel Aviv, Tel Aviv, Israel, 5Unit of Neurogenetics, Mendel Laboratory, IRCCS  Casa Sollievo della Sofferenza Institute, San, ROMA, Italy, 6Division of Neurology,  Department of Neurosciences, Bambino Ges Childrens Hospital,, ROMA, Italy","Mutations in the solute carrier family 9, subfamily A member 6(SLC9A6 )  gene, encoding the endosomal Na+/H+ exchanger 6 (NHE6) are associated with Christianson syndrome, a syndromic form of X linked intel  lectual disability characterized by microcephaly, severe global developmen  tal delay, autistic behavior,early onset seizures and ataxia.",,autistic behavior,[],"['autistic', 'behavior']"
519,2041, Genetic alterations of postsynaptic NMDA receptor related complex are associated with autism spectrum disorder,J09.59,,"Autism spectrum disorder (ASD) is an early childhood neurodevelopmen tal disorder characterized by a significant genetic aetiology and prevalence currently estimated at 1/100. Several biological pathways have been high lighted, particularly the excitatory synapse, affected by copy number varia tions (CNV) and enrichment in mutations in genes belonging to the NMDA  receptor complex (NRC). We performed a global genetic study of 100 French  families including at least 1 individual with autism, who were included in the research project (ClinicalTrials.gov NCT01770548).Our project aimed to evaluate both the contribution of CNV in ASD, and  secondly the presence of mutations in the NRC complex. For each family,  we firstly performed a high resolution pangenomic comparative genomic hybridization (CGH) analysis with 1M CGH Agilent Array format to identify  rare or de novo CNVs. In parallel, a high throughput targeted sequencing of  216 genes mostly belonging to the NRC complex (179) was carried out with the SureSelect Agilent strategy in order to assess the contribution of gene  mutations in our cohort. The first results of our study allowed us to characterize candidates and li kely pathogens genetic alterations in at least 10% of patient. We have found mutations or CNV in genes encoding receptors (NLGN4X, GRM5 ), and in cy   tosolic (UPF3B), nuclear (MACROD2), and synaptic (NXPH3) proteins. They also emphasized that the NRC is targeted both by mutations and CNV, inhe   rited or de novo. These results underscore the fundamental role of this multiprotein network in the process of neuronal communication and learning and its pathophysio   logical impact in autism.",2014.0,,"S. Alirol1, S. Marouillat1, P . Vourch1,2, C. Andres1,2, C. Barthlmy1,3, D. Campion4, C.  Foulon5,6, N. Juteau5,6, M. Raynaud1,7, A. Toutain1,7, L. Eric8, P . Goupille5,6, F. Bonnet  Brilhault1,3, F. Laumonnier1,7","1UMR Imagerie et Cerveau, Inserm U930, Universit Franois Rabelais, Tours,  France, 2Service de Biochimie et de Biologie Molculaire, CHRU, Tours, France, 3Centre  Universitaire dexplorations fonctionnelles et de neurophysiologie en pdopsychiatrie, CHRU, Tours, France,  4INSERM UMR1079, Universit de Rouen, Rouen, France, 5Cellule  Promotion et Contrle Qualit, DRCi, CHRU, Tours, France, 6CIC Inserm 0202, CHRU,  Tours, France, 7Service de Gntique, CHRU, Tours, France, 8Ple Organe des sens et  Laboratoire de neurobiologie EA 4685, CHRU, Brest, France","We performed a global genetic study of 100 French  families including at least 1 individual with autism, who were included in the research project (ClinicalTrials.gov NCT01770548).Our project aimed to evaluate both the contribution of CNV in ASD, and  secondly the presence of mutations in the NRC complex.",individual with autism,,"['individual', 'with', 'autism']",[]
524,2409, Epidemiology of consanguineous families in Autism,J17.71,,"Analyses of large autism datasets have provided statistical and functio nal evidence for the role of rare point mutations (ORoak, 2012, Sanders, 2012; Yu, 2013) and transmitted and de novo copy number variants (CNVs)(Morrow, 2008; Pinto, 2010; Levy, 2011; Sanders, 2011), and offer crucial insights into the diverse genetic mechanisms that can lead to Autism Spec trum Disorders (ASDs). Here we present CNV analysis for a cohort of 183 consanguineous families with one or more children affected with ASD. We provide new insights into the genetic architecture of ASDs as our cohort is uniquely enriched for recessive loss of function variants. We follow up fin dings and draw comparisons with additional large ASD and control data   sets: the Simons Simplex and the Autism Genetic Resource Exchange (AGRE) collections (2,670 affected individuals; 9681 total individuals). Comparing across these cohorts, we demonstrate that ascertainment can lead to selec tion of different underlying genetic mechanisms causing ASDs. These diffe rences are reflected in metrics such as the affected male:female ratio and the relative contribution of de novo CNVs versus inherited homozygous de   letions. Specifically, we find that de novo CNVs play a significant role in non consanguineous families with a single affected child (p,0.04), but a lesser role in multiplex families, and they are no more common in ASD cases than  controls in multiplex consanguineous families. In contrast, we present the  strongest statistical evidence (p,0.013) to date that homozygous deletions, are a major contributor to ASD disease burden in consanguineous families,  contributing to as much as 5 10% of cases.",2014.0,,"K. Schmitz Abe1,2,3, T . Yu2, C. Walsh2, K. Markianos2","1Harvard Medical School, Boston, MA, United States, 2Division of Genetics and Genomics  Boston Childrens Hospital, Boston, MA, United States, 3The Manton Center for Orphan  Disease Research Boston Childrens Hospital, Boston, MA, United States","We follow up fin dings and draw comparisons with additional large ASD and control data   sets: the Simons Simplex and the Autism Genetic Resource Exchange (AGRE) collections (2,670 affected individuals; 9681 total individuals).",comparisons with additional large ASD,,"['comparison', 'with', 'additional', 'large', 'ASD']",[]
524,2409, Epidemiology of consanguineous families in Autism,J17.71,,"Analyses of large autism datasets have provided statistical and functio nal evidence for the role of rare point mutations (ORoak, 2012, Sanders, 2012; Yu, 2013) and transmitted and de novo copy number variants (CNVs)(Morrow, 2008; Pinto, 2010; Levy, 2011; Sanders, 2011), and offer crucial insights into the diverse genetic mechanisms that can lead to Autism Spec trum Disorders (ASDs). Here we present CNV analysis for a cohort of 183 consanguineous families with one or more children affected with ASD. We provide new insights into the genetic architecture of ASDs as our cohort is uniquely enriched for recessive loss of function variants. We follow up fin dings and draw comparisons with additional large ASD and control data   sets: the Simons Simplex and the Autism Genetic Resource Exchange (AGRE) collections (2,670 affected individuals; 9681 total individuals). Comparing across these cohorts, we demonstrate that ascertainment can lead to selec tion of different underlying genetic mechanisms causing ASDs. These diffe rences are reflected in metrics such as the affected male:female ratio and the relative contribution of de novo CNVs versus inherited homozygous de   letions. Specifically, we find that de novo CNVs play a significant role in non consanguineous families with a single affected child (p,0.04), but a lesser role in multiplex families, and they are no more common in ASD cases than  controls in multiplex consanguineous families. In contrast, we present the  strongest statistical evidence (p,0.013) to date that homozygous deletions, are a major contributor to ASD disease burden in consanguineous families,  contributing to as much as 5 10% of cases.",2014.0,,"K. Schmitz Abe1,2,3, T . Yu2, C. Walsh2, K. Markianos2","1Harvard Medical School, Boston, MA, United States, 2Division of Genetics and Genomics  Boston Childrens Hospital, Boston, MA, United States, 3The Manton Center for Orphan  Disease Research Boston Childrens Hospital, Boston, MA, United States","Specifically, we find that de novo CNVs play a significant role in non consanguineous families with a single affected child (p,0.04), but a lesser role in multiplex families, and they are no more common in ASD cases than  controls in multiplex consanguineous families.",,ASD cases,[],"['ASD', 'case']"
524,2409, Epidemiology of consanguineous families in Autism,J17.71,,"Analyses of large autism datasets have provided statistical and functio nal evidence for the role of rare point mutations (ORoak, 2012, Sanders, 2012; Yu, 2013) and transmitted and de novo copy number variants (CNVs)(Morrow, 2008; Pinto, 2010; Levy, 2011; Sanders, 2011), and offer crucial insights into the diverse genetic mechanisms that can lead to Autism Spec trum Disorders (ASDs). Here we present CNV analysis for a cohort of 183 consanguineous families with one or more children affected with ASD. We provide new insights into the genetic architecture of ASDs as our cohort is uniquely enriched for recessive loss of function variants. We follow up fin dings and draw comparisons with additional large ASD and control data   sets: the Simons Simplex and the Autism Genetic Resource Exchange (AGRE) collections (2,670 affected individuals; 9681 total individuals). Comparing across these cohorts, we demonstrate that ascertainment can lead to selec tion of different underlying genetic mechanisms causing ASDs. These diffe rences are reflected in metrics such as the affected male:female ratio and the relative contribution of de novo CNVs versus inherited homozygous de   letions. Specifically, we find that de novo CNVs play a significant role in non consanguineous families with a single affected child (p,0.04), but a lesser role in multiplex families, and they are no more common in ASD cases than  controls in multiplex consanguineous families. In contrast, we present the  strongest statistical evidence (p,0.013) to date that homozygous deletions, are a major contributor to ASD disease burden in consanguineous families,  contributing to as much as 5 10% of cases.",2014.0,,"K. Schmitz Abe1,2,3, T . Yu2, C. Walsh2, K. Markianos2","1Harvard Medical School, Boston, MA, United States, 2Division of Genetics and Genomics  Boston Childrens Hospital, Boston, MA, United States, 3The Manton Center for Orphan  Disease Research Boston Childrens Hospital, Boston, MA, United States","In contrast, we present the  strongest statistical evidence (p,0.013) to date that homozygous deletions, are a major contributor to ASD disease burden in consanguineous families,  contributing to as much as 5 10% of cases.",,ASD disease,[],"['ASD', 'disease']"
527,134, Whole genome sequencing reveals the mutation characteristics in Autism Spectrum Disorder,C10.1,,"Johns, NL, Canada. Autism spectrum disorder (ASD) is genetically heterogeneous, with evi  dence for hundreds of susceptibility loci. Previous microarray and exome  sequencing studies have examined portions of the genome in simplex fami  lies (parents and one ASD affected child) having presumed sporadic forms of the disorder. We used whole genome sequencing (WGS) of 85 quartet  families (parents and two ASD affected siblings), consisting of 170 indivi  duals with ASD, to generate a comprehensive data resource encompassing all classes of genetic variation (including noncoding variants) and accom panying phenotypes, in apparently familial forms of ASD. By examining de  novo and rare inherited single nucleotide and structural variations in genes  previously reported to be associated with ASD or other neurodevelopmental disorders, we found that more than two thirds of the affected siblings car  ried different ASD relevant mutations. These siblings with discordant muta   tions tended to demonstrate more clinical variability than those who shared  a risk variant. Our study emphasizes that substantial genetic heterogeneity exists in ASD, necessitating the use of WGS to delineate all genic and non genic susceptibility variants in research and in clinical diagnostics. We have now sequenced 200 additional ASD families using WGS. We will present our complete data analysis as well as additional progress from this study.",2015.0,,"R. K. Yuen1, B. Thiruvahindrapuram1, D. Merico1, S. Walker1, K. Tammimies1,2, N. Hoang1,  C. Chrysler3, T . Nalpathamkalam1, G. Pellecchia1, Y. Liu1,4, M. J. Gazzellone1, L. D Abate1, E.  Deneault1, J. L. Howe1, R. S. Liu1, A. Thompson3, M. Zarrei1, M. Uddin1, C. R. Marshall1, R. H.  Ring5, L. Zwaigenbaum6, P . N. Ray1, R. Weksberg1, M. Carter1, B. Fernandez7, W. Roberts1,  P . Szatmari1, S. W. Scherer1","1The Hospital for Sick Children, Toronto, ON, Canada, 2Karolinska Institutet, Stockholm,  Sweden, 3McMaster University, Hamilton, ON, Canada, 4Qilu Childrens Hospital of  Shandong University, Shandong, China, 5The Hospital for Sick Children, Autism Speaks,  NJ, United States, 6University of Alberta, Edmonton, AB, Canada, 7Memorial University of  Newfoundland, St",Previous microarray and exome  sequencing studies have examined portions of the genome in simplex fami  lies (parents and one ASD affected child) having presumed sporadic forms of the disorder.,,ASD affected child,[],"['ASD', 'affected', 'child']"
527,134, Whole genome sequencing reveals the mutation characteristics in Autism Spectrum Disorder,C10.1,,"Johns, NL, Canada. Autism spectrum disorder (ASD) is genetically heterogeneous, with evi  dence for hundreds of susceptibility loci. Previous microarray and exome  sequencing studies have examined portions of the genome in simplex fami  lies (parents and one ASD affected child) having presumed sporadic forms of the disorder. We used whole genome sequencing (WGS) of 85 quartet  families (parents and two ASD affected siblings), consisting of 170 indivi  duals with ASD, to generate a comprehensive data resource encompassing all classes of genetic variation (including noncoding variants) and accom panying phenotypes, in apparently familial forms of ASD. By examining de  novo and rare inherited single nucleotide and structural variations in genes  previously reported to be associated with ASD or other neurodevelopmental disorders, we found that more than two thirds of the affected siblings car  ried different ASD relevant mutations. These siblings with discordant muta   tions tended to demonstrate more clinical variability than those who shared  a risk variant. Our study emphasizes that substantial genetic heterogeneity exists in ASD, necessitating the use of WGS to delineate all genic and non genic susceptibility variants in research and in clinical diagnostics. We have now sequenced 200 additional ASD families using WGS. We will present our complete data analysis as well as additional progress from this study.",2015.0,,"R. K. Yuen1, B. Thiruvahindrapuram1, D. Merico1, S. Walker1, K. Tammimies1,2, N. Hoang1,  C. Chrysler3, T . Nalpathamkalam1, G. Pellecchia1, Y. Liu1,4, M. J. Gazzellone1, L. D Abate1, E.  Deneault1, J. L. Howe1, R. S. Liu1, A. Thompson3, M. Zarrei1, M. Uddin1, C. R. Marshall1, R. H.  Ring5, L. Zwaigenbaum6, P . N. Ray1, R. Weksberg1, M. Carter1, B. Fernandez7, W. Roberts1,  P . Szatmari1, S. W. Scherer1","1The Hospital for Sick Children, Toronto, ON, Canada, 2Karolinska Institutet, Stockholm,  Sweden, 3McMaster University, Hamilton, ON, Canada, 4Qilu Childrens Hospital of  Shandong University, Shandong, China, 5The Hospital for Sick Children, Autism Speaks,  NJ, United States, 6University of Alberta, Edmonton, AB, Canada, 7Memorial University of  Newfoundland, St","We used whole genome sequencing (WGS) of 85 quartet  families (parents and two ASD affected siblings), consisting of 170 indivi  duals with ASD, to generate a comprehensive data resource encompassing all classes of genetic variation (including noncoding variants) and accom panying phenotypes, in apparently familial forms of ASD.",duals with ASD,ASD affected siblings,"['duals', 'with', 'ASD']","['ASD', 'affected', 'sibling']"
527,134, Whole genome sequencing reveals the mutation characteristics in Autism Spectrum Disorder,C10.1,,"Johns, NL, Canada. Autism spectrum disorder (ASD) is genetically heterogeneous, with evi  dence for hundreds of susceptibility loci. Previous microarray and exome  sequencing studies have examined portions of the genome in simplex fami  lies (parents and one ASD affected child) having presumed sporadic forms of the disorder. We used whole genome sequencing (WGS) of 85 quartet  families (parents and two ASD affected siblings), consisting of 170 indivi  duals with ASD, to generate a comprehensive data resource encompassing all classes of genetic variation (including noncoding variants) and accom panying phenotypes, in apparently familial forms of ASD. By examining de  novo and rare inherited single nucleotide and structural variations in genes  previously reported to be associated with ASD or other neurodevelopmental disorders, we found that more than two thirds of the affected siblings car  ried different ASD relevant mutations. These siblings with discordant muta   tions tended to demonstrate more clinical variability than those who shared  a risk variant. Our study emphasizes that substantial genetic heterogeneity exists in ASD, necessitating the use of WGS to delineate all genic and non genic susceptibility variants in research and in clinical diagnostics. We have now sequenced 200 additional ASD families using WGS. We will present our complete data analysis as well as additional progress from this study.",2015.0,,"R. K. Yuen1, B. Thiruvahindrapuram1, D. Merico1, S. Walker1, K. Tammimies1,2, N. Hoang1,  C. Chrysler3, T . Nalpathamkalam1, G. Pellecchia1, Y. Liu1,4, M. J. Gazzellone1, L. D Abate1, E.  Deneault1, J. L. Howe1, R. S. Liu1, A. Thompson3, M. Zarrei1, M. Uddin1, C. R. Marshall1, R. H.  Ring5, L. Zwaigenbaum6, P . N. Ray1, R. Weksberg1, M. Carter1, B. Fernandez7, W. Roberts1,  P . Szatmari1, S. W. Scherer1","1The Hospital for Sick Children, Toronto, ON, Canada, 2Karolinska Institutet, Stockholm,  Sweden, 3McMaster University, Hamilton, ON, Canada, 4Qilu Childrens Hospital of  Shandong University, Shandong, China, 5The Hospital for Sick Children, Autism Speaks,  NJ, United States, 6University of Alberta, Edmonton, AB, Canada, 7Memorial University of  Newfoundland, St","By examining de  novo and rare inherited single nucleotide and structural variations in genes  previously reported to be associated with ASD or other neurodevelopmental disorders, we found that more than two thirds of the affected siblings car  ried different ASD relevant mutations.",,ASD relevant mutations,[],"['ASD', 'relevant', 'mutation']"
527,134, Whole genome sequencing reveals the mutation characteristics in Autism Spectrum Disorder,C10.1,,"Johns, NL, Canada. Autism spectrum disorder (ASD) is genetically heterogeneous, with evi  dence for hundreds of susceptibility loci. Previous microarray and exome  sequencing studies have examined portions of the genome in simplex fami  lies (parents and one ASD affected child) having presumed sporadic forms of the disorder. We used whole genome sequencing (WGS) of 85 quartet  families (parents and two ASD affected siblings), consisting of 170 indivi  duals with ASD, to generate a comprehensive data resource encompassing all classes of genetic variation (including noncoding variants) and accom panying phenotypes, in apparently familial forms of ASD. By examining de  novo and rare inherited single nucleotide and structural variations in genes  previously reported to be associated with ASD or other neurodevelopmental disorders, we found that more than two thirds of the affected siblings car  ried different ASD relevant mutations. These siblings with discordant muta   tions tended to demonstrate more clinical variability than those who shared  a risk variant. Our study emphasizes that substantial genetic heterogeneity exists in ASD, necessitating the use of WGS to delineate all genic and non genic susceptibility variants in research and in clinical diagnostics. We have now sequenced 200 additional ASD families using WGS. We will present our complete data analysis as well as additional progress from this study.",2015.0,,"R. K. Yuen1, B. Thiruvahindrapuram1, D. Merico1, S. Walker1, K. Tammimies1,2, N. Hoang1,  C. Chrysler3, T . Nalpathamkalam1, G. Pellecchia1, Y. Liu1,4, M. J. Gazzellone1, L. D Abate1, E.  Deneault1, J. L. Howe1, R. S. Liu1, A. Thompson3, M. Zarrei1, M. Uddin1, C. R. Marshall1, R. H.  Ring5, L. Zwaigenbaum6, P . N. Ray1, R. Weksberg1, M. Carter1, B. Fernandez7, W. Roberts1,  P . Szatmari1, S. W. Scherer1","1The Hospital for Sick Children, Toronto, ON, Canada, 2Karolinska Institutet, Stockholm,  Sweden, 3McMaster University, Hamilton, ON, Canada, 4Qilu Childrens Hospital of  Shandong University, Shandong, China, 5The Hospital for Sick Children, Autism Speaks,  NJ, United States, 6University of Alberta, Edmonton, AB, Canada, 7Memorial University of  Newfoundland, St",We have now sequenced 200 additional ASD families using WGS.,,ASD families,[],"['ASD', 'family']"
530,156," Chromosomal contacts connect loci associated with autism, BMI and head circumference phenotypes",C13.3,,"We identified the cis  and trans acting long range chromosomal contacts of five genes located within the 16p11.2 600kb BP4 BP5 copy number variants (CNVs). Its deletion is one of the most frequent known etiologies of autism spectrum disorder (ASD), while this deletion and reciprocal duplication are associated with mirror phenotypes on BMI, head circumference and brain volume. We observed complex chromatin looping between genes located in the proximal 600kb BP4 BP5 and those mapping to the distal 16p11.2 220kb BP2 BP3 region, two loci separated by 650kb, successfully confir   med by reciprocal 4C, FISH, Hi C and associations between active regula   tory regions. Phenotyping of 137 unrelated carriers of distal 16p11.2 220 kb BP2 BP3 deletion and duplication showed that these CNVs are similarly associated with ASD and reciprocal impacts on BMI and HC.Our results indicate that chromosomal contacts maps could uncover func tionally and clinically related genes. Consistent with this hypothesis, loci chromatin contacted by our selected viewpoints are enriched for ASD genes (OR,2.15, P,1.65e 08). Furthermore, we uncovered 16p11.2 600kb BP4 BP5 chromatin loops with (i) the 1q21.1 cytoband, whose deletions and du plications were previously linked to micro  and macrocephaly, respectively; (ii) PTEN, mutations of which are associated with a macrocephalic form of ASD; and (iii) the 2p15 cytoband. We enrolled 35 carriers of 2p15 16.1 de   letion and duplication and showed that they similarly display mirror pheno types on HC and weight.Finally, we observe that genes differentially expressed in 16p11.2 BP4 BP5 CNV carriers are concomitantly modified in their chromatin interactions, suggesting that disruption of chromatin interplays participates in the ob   served phenotypes. ABSTRACTS CONCURRENT SESSIONS ESHG 2015 | GLASGOW, SCOTLAND, UK | WWW.ESHG.ORG 36Back to inde x",2015.0,,"M. Loviglio1, M. Leleu2, G. Giannuzzi1, K. Mannik1, E. Migliavacca1, I. Roberts Caldeira3,  I. van der Werf1, 16p11.2 European Consortium, J. S. Beckmann4, S. Jacquemont1, J.  Rougemont2, A. Reymond1","1Center for Integrative Genomics, Lausanne, Switzerland, 2EPFL, Lausanne, Switzerland,  3Service de Gntique Mdicale, Centre Hospitalier Universitaire Vaudois, Lausanne,  Switzerland, 4Swiss Institute of Bioinformatics, Lausanne, Switzerland","Consistent with this hypothesis, loci chromatin contacted by our selected viewpoints are enriched for ASD genes (OR,2.15, P,1.65e 08).",,ASD genes,[],"['ASD', 'gene']"
531,204, ST AG1 haploinsufficiency is responsible for a new cohesinopathy with intellectual disability and characteristic facial features in four unrelated individuals,C21.2,,"Cohesinopathies are rare disorders arising from a dysfunction in the cohesin  pathway, which enables chromosome segregation and proper cell division.  So far, seven genes from this pathway have been reported in human disease.  Five of them are involved in autosomal dominant (NIPBL, SMC3, RAD21) or X linked (SMC1A and HDAC8) Cornelia de Lange syndrome, and two of them  in autosomal recessive Roberts (ESCO2) and Warsaw Breakage syndromes  (DDX11). All are severe neurodevelopmental conditions characterized by intellectual disability, growth retardation, microcephaly, limb defects and facial dysmorphism. STAG1 belongs to the STAG subunit of the core cohesin complex, which,  along with three other subunits, mediates cohesion between sister chroma tids. Here, we report an international series of four unrelated individuals, 3  males and 1 female, aged 8 to 33 years, referred for moderate to severe intel  lectual disability that could be attributed to STAG1 haploinsufficiency. Three had history of intrauterine growth retardation, two with prenatal onset  microcephaly, one with post natal growth retardation. One individual had  epilepsy, two had autistic features. The four patients shared common facial features, with widely spaced incisors, thin eyebrows, and high nasal bridge. The mechanism for haploinsufficiency was a small deletion encompassing  STAG1 diagnosed by array CGH in two individuals, an intragenic deletion in  STAG1 found by whole genome analysis in one individual, and a missense heterozygous mutation (c.641A>G) revealed by exome analysis in the last patient. All the variants were shown to be de novo. This series provides evi dence that STAG1 haploinsufficiency leads to a new cohesinopathy with a clinically recognizable phenotype.",2015.0,,"D. Lehalle1,2, A. Masurel Paulet1,2, A. Mosca Boidron3,4, M. Deardorff5, H. Olivie6, J.  Thevenon1,2,4, M. Willemsen7, C. Zweier8, A. Rauch9, C. Gilissen10, P . Callier1,3,4, C. Thauvin  Robinet1,2,4, L. Faivre1,2,4","1Fdration Hospitalo Universitaire Mdecine Translationnelle et Anomalies du  Dveloppement (TRANSLAD), Centre Hospitalier Universitaire Dijon, 21079, Dijon, France,  2Centre de Gntique et Centre de Rfrence Anomalies du Dveloppement et  Syndromes Malformatifs de lInterrgion Est, Centre Hospitalier Universitaire Dijon, 21079, Dijon, France,  3Laboratoire de Cytogntique, Centre Hospitalier Universitaire  Dijon, F 21079, Dijon, France, 4Equipe GAD, EA4271, Facult de Mdecine, Universit  de Bourgogne, Dijon, France, 5Division of Human Genetics, The Childrens Hospital  of Philadelphia, Clinical Genetics Center, and the Perelman School of Medicine of the University of Pennsylvania, Philadelphia, Philadelphia, PA, United States,  6KU Leuven,  Department of Human Genetics, Leuven, Belgium, 7Department of Human Genetics, Radboud Institute for Molecular Life Sciences and Donders Centre for Neuroscience,  Radboud University Medical Center, Geert Grooteplein 10, 6525 GA, Nijmegen,  Netherlands, 8Institute of Human Genetics, Friedrich Alexander Universitat Erlangen  Nurnberg, 91054, Erlangen, Germany, 9Institute of Medical Genetics, University of  Zurich, 8603, Schwerzenbach Zurich, Switzerland, 10Department of Human Genetics,  Radboud Institute for Molecular Life Sciences and Donders Centre for Neuroscience,  Radboud University Medical Center, Geert Grooteplein 10, 6525 GA, Nijmegen, Germany","One individual had  epilepsy, two had autistic features.",,autistic features,[],"['autistic', 'feature']"
533,228, CDKN1C mutations in familial and prenatally diagnosed Beckwith Wiedemann syndrome cases.,PM01.08,,"CDKN1C (cyclin dependent kinase inhibitor 1) gene mapping within the 11p15.5 cluster of imprinted genes, encodes an inhibitor of several cyclin  dependent kinases (Cdk) acting in the cell cycle G1   S transition. The mo  noallelic maternal expression of CDKN1C is under the control of the IC2  imprinting centre through the antisense non coding KCNQ1OT1 transcript. The protein comprises three functional domains including from the N  to the C terminus a CDK binding, a PAPA and a PCNA domain. CDKN1C mutations underlie the Beckwith Wiedemann syndrome (BWS) ac  counting for 10% of sporadic cases and up to 40% of familial cases. Here we report on the clinical and molecular characterization of ten BWS  families, negative for the known 11p15 (epi)genetic alterations and 2 prena tal cases diagnosed because of omphalocele. Twelve distinct mutations were  detected, including 6 stop, 3 frameshift, two missense mutations and one  complex mutation, seven of which yet unreported. Most important 11/12  mutations were maternally transmitted allowing to provide the family with  genetic counseling and to assess the recurrence in two subsequent prenatal diagnoses. The clinical presentation of the investigated cases was heteroge  neous although severe in all the carriers of inactivating mutations, including  one case born prematurely at 28th week also displaying psychomotor delay  and another with autistic traits, not associated with de novo or inherited  CNVs as shown by array CGH.Conversely the two patients with a missense mutations, predicted to be da  maging by several bionformatic tools, exhibited a mild phenotype",2015.0,,"L. Calzari1, A. De Crescenzo2, A. Mussa3, M. Divizia4, M. Police5, S. Di Presa6, S. Di Candia7,  L. Memo8, C. Izzi9, D. Melis10, G. Ferrero3, A. Riccio10, L. Larizza1, S. Russo1","1Istituto Auxologico Italiano, Milano, Italy, 2, Universit Federico II, Napoli, Italy,  3Universit di Torino, Torino, Italy, 4Istituto Neuroligo Gaslini, Genova, Italy, 5Osp  Moscati, Avellino, Italy, 6IRCCS Burlo garofalo, Trieste, Italy, 7Ospedale San Raffaele,  Milano, Italy, 8Ospedale San Martino, Belluno, Italy, 9Spedali Civili, Brescia, Italy,  10Universit Federico II, Napoli, Italy","The clinical presentation of the investigated cases was heteroge  neous although severe in all the carriers of inactivating mutations, including  one case born prematurely at 28th week also displaying psychomotor delay  and another with autistic traits, not associated with de novo or inherited  CNVs as shown by array CGH.Conversely the two patients with a missense mutations, predicted to be da  maging by several bionformatic tools, exhibited a mild phenotype",,autistic traits,[],"['autistic', 'trait']"
540,573, A very common inborn error of carnitine biosynthesis about which little is known,PS06.05,,"Introduction: TMLHE deficiency is a very common inborn error of carnitine  biosynthesis. The gene is X linked, and about 1 in 350 healthy males of Eu ropean descent have a deletion of exon 2 resulting in inability to synthesize carnitine. TMLHE deficiency likely is a risk factor for autism, but the pene  trance for autism is less than 5%, and replication studies are needed.Materials and Methods: The frequency of exon 2 deletion was determined in 10,678 male samples undergoing array CGH for evaluation of heteroge neous disabilities and in 2124 male samples from the Baylor Mendelian Ge nome Center exome project. A case evaluation was performed on a TMLHE  deficient male with autism and two episodes of regression.Results: Deletion of exon 2 of TMLHE was found in 50 of 10,678 males  undergoing array CGH (0.46%) compared to 7 in 2245 males undergoing exome sequencing in the Mendelian studies (0.31%). The phenotypic data for the deficient males are being tabulated. Carnitine deficiency in a TMLHE  case suggests that deficits in carnitine biosynthesis may be responsible for some cases of regression in individuals with autism.Conclusions: Deletion of exon 2 is confirmed to be very common in various clinical samples. A case study suggests that carnitine supplementation may be useful in treating regressive autism episodes in patients with TMLHE  deficiency. It is unknown if infant males with TMLHE deficiency should re  ceive any dietary modification. It is unknown if there are genetic, dietary, or microbiome factors that influence the development of autism in TMLHE  deficient males.ABSTRACTS POSTERS ESHG 2015 | GLASGOW, SCOTLAND, UK | WWW.ESHG.ORG 131Back to inde x",2015.0,,"A. L. Beaudet , R. Kochel, M. Ziats, Y. Yang, S. Elsea, Q. Sun, J. Lupski, A. Patel, T . Gambin,  C. Shaw, C. Schaaf, P . Stankiewicz","Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, United States","A case evaluation was performed on a TMLHE  deficient male with autism and two episodes of regression.Results: Deletion of exon 2 of TMLHE was found in 50 of 10,678 males  undergoing array CGH (0.46%) compared to 7 in 2245 males undergoing exome sequencing in the Mendelian studies (0.31%).",male with autism,,"['male', 'with', 'autism']",[]
540,573, A very common inborn error of carnitine biosynthesis about which little is known,PS06.05,,"Introduction: TMLHE deficiency is a very common inborn error of carnitine  biosynthesis. The gene is X linked, and about 1 in 350 healthy males of Eu ropean descent have a deletion of exon 2 resulting in inability to synthesize carnitine. TMLHE deficiency likely is a risk factor for autism, but the pene  trance for autism is less than 5%, and replication studies are needed.Materials and Methods: The frequency of exon 2 deletion was determined in 10,678 male samples undergoing array CGH for evaluation of heteroge neous disabilities and in 2124 male samples from the Baylor Mendelian Ge nome Center exome project. A case evaluation was performed on a TMLHE  deficient male with autism and two episodes of regression.Results: Deletion of exon 2 of TMLHE was found in 50 of 10,678 males  undergoing array CGH (0.46%) compared to 7 in 2245 males undergoing exome sequencing in the Mendelian studies (0.31%). The phenotypic data for the deficient males are being tabulated. Carnitine deficiency in a TMLHE  case suggests that deficits in carnitine biosynthesis may be responsible for some cases of regression in individuals with autism.Conclusions: Deletion of exon 2 is confirmed to be very common in various clinical samples. A case study suggests that carnitine supplementation may be useful in treating regressive autism episodes in patients with TMLHE  deficiency. It is unknown if infant males with TMLHE deficiency should re  ceive any dietary modification. It is unknown if there are genetic, dietary, or microbiome factors that influence the development of autism in TMLHE  deficient males.ABSTRACTS POSTERS ESHG 2015 | GLASGOW, SCOTLAND, UK | WWW.ESHG.ORG 131Back to inde x",2015.0,,"A. L. Beaudet , R. Kochel, M. Ziats, Y. Yang, S. Elsea, Q. Sun, J. Lupski, A. Patel, T . Gambin,  C. Shaw, C. Schaaf, P . Stankiewicz","Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, United States",Carnitine deficiency in a TMLHE  case suggests that deficits in carnitine biosynthesis may be responsible for some cases of regression in individuals with autism.Conclusions: Deletion of exon 2 is confirmed to be very common in various clinical samples.,individuals with autism,,"['individual', 'with', 'autism']",[]
541,687, De novo 19p13.2 microdeletion encompassing the part of NFIX gene in a girl with Sotos like phenotype,PM08.02,,"19p13.2 microdeletion is a rare genomic disorder. To date, less than ten cases was described so far in the literature. This chromosomal syndrome manifests in developmental delay/intellectual impairment, postnatal over   growth, macrocephaly, craniofacial dysmorphy, slender habitus, advanced bone age, and scoliosis. Hypotonia, unusual behavior with autistic traits, ophthalmologic, gastrointestinal, and hand/foot abnormalities are also fre quent. Very similar phenotype is observed in the Sotos syndrome 2 (MIM #614753) that is caused by heterozygous mutations/deletions of the NFIX gene located on chromosome 19p13.2.Here, we report on the case of a 7 year old girl referred to genetic counse   ling because of psychomotor retardation, speech delay and dysmorphic fea tures (macrocephaly, long/narrow and triangular face, high forehead, fron tal bossing, downslanting palpebral fissures, dysplastic low set ears, small nose, flat philtrum, micrognathia). At the examination, behavioral problems (anxiety, tantrums, autoaggression), seizures, and poor coordination were noted. Skeletal anomalies (advanced bone age, joint laxity, slender hands with long fingers, abnormal setting of the lower limbs), strabismus, hypero pia as well as constipations and abdominal pain were also diagnosed.Whole genome oligonucleotide microarray analysis revealed a de novo 158.18 kb (the smallest so far) deletion of 19p13.2 region (chr19:13,020,206 13,178,390; hg19) encompassing seven genes; three of them (NFIX, DAND5 and CALR) could be the candidate genes for the genotype phenotype rela   tionship.This study contributes additional information for the newly identified 19p13.2 microdeletion syndrome and clarifies the clinical roles of genes in the involved region. Our results also confirm that haploinsufficiency of NFIX leads to Sotos like phenotype.This study was supported by the MNiSW Grant No. 0193/IP1/2013/72.",2015.0,,"M. Kucharczyk1, M. Mynek1, M. Kugaudo1,2, A. Cielikowska1, A. Jezela Stanek1, A.  Gutkowska1, M. Biaecka1, A. Marczak1, D. Sielska Rotblum1, M. Krajewska Walasek1","1Department of Medical Genetics, Childrens Memorial Health Institute, Warsaw, Poland,  2Department of Child and Adolescent Psychiatry, Medical University of Warsaw, Warsaw,  Poland","Hypotonia, unusual behavior with autistic traits, ophthalmologic, gastrointestinal, and hand/foot abnormalities are also fre quent.",,autistic traits,[],"['autistic', 'trait']"
545,708, A novel HCN1 mutation not associated with epileptic encephalopathy,PS08.23,,"B. Rossi Hospital, University of Verona, Verona, Italy. The hyperpolarization activated cyclic nucleotide gated channel (HCN1 4) family has important roles in the control of heart rate and neuronal excita  bility. HCN channels selectively conduct K+/Na+ inward current after hy   perpolarized potential. In neurons, HCN channels participate in a variety  of functions among which excitabily, dendritic integration and plasticity.  Animal models have indicated that dysregulation of these channels is as  sociated with several forms of epilepsy including febrile seizures, absence and temporal lobe epilepsy as well as other neurological disorders. Recently HCN1 point mutations have been found in individuals with early onset epi  leptic encephalopathy with features resembling Dravet syndrome but with  different progression over time. All of them developed intellectual disability and autistic traits. Here we report the case of a 9 year old girl with a Rett like phenotype, cha  racterized by intellectual disability, hand stereotypies, absent speech, nega tive brain MRI and EEG data and no history of epilepsy. By NGS approach,  with the use of a targeted intellectual disability/epilepsy gene panel, we  found the girl to carry a novel de novo heterozygous missense mutation in exon 4 of the HCN1 gene. This mutation is located in the glycine tyrosine glycine (GYG) motif, which constitutes the ion selectivity filter typical of K+  permeable channels. This motif is highly conserved structurally and functio  nally during evolution.This is the first report of a HCN1 mutation involved in a neurodevelopmen  tal phenotype without epilepsy.",2015.0,,"E. Bettella1, R. Polli1, E. Leonardi1, L. Zoccante2, A. Murgia1","1Laboratory of Molecular Genetics of Neurodevelopment, Department of Womens and  Childrens Health, University of Padova, Padua, Italy, 2Neuropsychiatry Unit, Department  of Life Science and Reproduction G",All of them developed intellectual disability and autistic traits.,,autistic traits,[],"['autistic', 'trait']"
547,713, GenIDA: a social network and database to inform on natural history of monogenic forms of intellectual disability and autism,PM08.28,,", Institut de gntique et de biologie  molculaire et cellulaire (IGBMC)  INSERM U964  CNRS UMR7104  University of Strasbourg, Illkirch, France,  2Engineering, informatics and imaging sciences laboratory  (ICube)  CNRS UMR 7357  ENGEES  INSA of Strasbourg, Illkirch, France, 3ECAM,  Strasbourg Europe, Schiltigheim, France, 4Genetic diagnostic laboratory, CHU,  Strasbourg, France, 5Collge de France, Chaire de gntique humaine, Paris, France. Intellectual disability (ID) has an incidence of 2% and overlaps with autism. It is characterized by a striking genetic heterogeneity that underlies a phe notypic heterogeneity in severity and in associated medical problems. Pro gress in genome analysis has allowed the identification of many recurrent CNVs and of more than 400 genes implicated in monogenic forms of ID/autism. An increasing number of genetic diagnoses are made in individuals with ID/autism but the genetic heterogeneity renders extremely difficult the determination of genotype phenotype correlations and natural history. Symptomatic treatments for comorbidities are proposed with limited op portunities to assess their efficacies or potential adverse effects.We have initiated the development of an alternative database model for specific genetic causes of ID/autism, organized in a social network format whereby most clinical information is entered by the family of the patient based on wide range questionnaires translated in different languages. Con   tacts between families affected by the same genetic cause is possible in an anonymous way, creating gene or CNV specific social networks to which in terested professionals could be associated, akin to disease specific patients associations. Anonymized summary data will be accessible to families and to professionals. We will present the structure and features of the GenIDA social network that is currently in its beta testing phase.This innovative strategy to collect information on natural history and co morbidities of rare monogenic forms of ID/autism will promote families empowerment and hopefully impact patients care. The setting up of patient e cohorts should favor international clinical studies.Supported by USIAS and RaDiCo.",2015.0,,"F. Colin1, T . Mazzucotelli2, P . Parrend2,3, A. Deruyver2, J. L. Mandel1,4,5",1Translational medicine and neurogenetics dept,Intellectual disability (ID) has an incidence of 2% and overlaps with autism.,overlaps with autism,,"['overlap', 'with', 'autism']",[]
548,744, RBFOX1 intragenic deletions detected by array CGH 6 new cases with neurological phenotype,PS08.59,,"Introduction: In the last couple of years, it has become evident the impor   tance of whole genome array CGH in the screening of de novo microdele tions or duplications in patients with phenotypic features of mental retar dation (MR) and autistic spectral disorders (ASD). Copy number variations (CNV) in RBFOX1, also known as A2BP1, have been associated with human neurodevelopmental disease, including autism spectrum disease.This gene, spanning 1.7 MB on chromosome 16p13.3, is one of the largest genes in the human genome, responsible for encoding splicing regulatory factors, specifically expressed in neurons and muscles, and having a regula  tory action in alternative splicing of a large tissue specific gene networks. Materials and methods: Oligonucleotide array CGH analysis, using an Agi  lent 4x180K platform, was performed in 1200 patients with mental retarda tion, autism spectrum disorders and congenital anomalies. Results: In our cohort, we identified 6 cases with intragenic deletions in RB  FOX1, 4 of them with additional CNV in other chromosomes. These CNVs are located at 16p13.3, extended in a 1,2Mb region between 6,087,983 7   ,207,012 (GRCh37/hg19), which corresponds to intronic regions in 5 out of  6 patients. Five of these patients have an inherited deletion, from an unaffec  ted progenitor, and one has an unknown inheritance pattern.Conclusions: The phenotypes of all these children have in common, as wide  ly described, neurological alterations. The rearrangements identified lead to  a reduction in RBFOX1 expression, corroborating the importance of RBFOX1 haploinsufficiency in this phenotypes. The continuing follow up of these  patients and similar cases can help our understanding on the phenotypic  diversity of these patients.",2015.0,,"N. Lavoura1, J. B. Melo1, S. I. Ferreira1, M. C. Pinto1, C. Pais1, A. Mascarenhas1, L. Ramos2,  I. M. Carreira1","1Laboratrio de Citogentica e Genmica, Faculdade de Medicina da Universidade de  Coimbra, Coimbra, Portugal, 2Servio de Gentica Mdica, Hospital Peditrico, Centro  Hospital e Universitrio de Coimbra, Coimbra, Portugal","Introduction: In the last couple of years, it has become evident the impor   tance of whole genome array CGH in the screening of de novo microdele tions or duplications in patients with phenotypic features of mental retar dation (MR) and autistic spectral disorders (ASD).",,autistic spectral disorders,[],"['autistic', 'spectral', 'disorder']"
551,751," Compound heterozygous mutation in SZT2 gene in a patient with macrocephaly, epilepsy and severe intellectual disability",PS08.67,,"We report on a family included in a trio exome sequencing study performed  on 250 patients with intellectual disability. The 15 year old boy is the first and only child of healthy, non consanguineous  German parents, born at term after a pregnancy complicated by uterus myomatosus and gestosis. Birth measurements were normal but green am niotic fluid was noted. The boy walked independently with 2  years and never learned to speak and he is not toilet trained. Seizures started with 4 years of age and could be treated effectively. Agitated behavior and autistic features needed medication. Brain MRI revealed reduced temporal gyri on the left. The patient attends a special school and behaves like a toddler. Body measurements were normal throughout life, but head circumference was above the 97th centile. The patient has a high and broad forehead, promi nent lips and small hands and feet.Trio exome sequencing revealed a maternally inherited frame shift muta   tion (c.841delC, p.(Gly281Ser fs*33)) and a paternally inherited missense  mutation in SZT2  gene (c.9787G>A, p.(Asp3263Asn)). The possibly dama  ging missense mutation may lead to a residual protein function and cause a milder phenotype resembling the three brothers described by Falcone et al (2013) who are homozygous for a 3 bp in frame deletion. Patients with  homozygous or compound heterozygous truncating mutations as described  by Basel Vanagaite et al (2013) show severe infantile encephalopathy with epilepsy. This sixth patient broadens the phenotypic spectrum caused by mutations in SZT2  gene showing an intermediate clinical course compared  to the patients published to date.",2015.0,,"B. Albrecht1, H. Ldecke1, T . Strom2, H. Engels3, D. Wieczorek1","1Institut fuer Humangenetik, Essen, Germany, 2Institut fuer Humangenetik, Helmholtz  Zentrum, Mnchen, Germany, 3Institut fuer Humangenetik, Biomedizinisches Zentrum,  Bonn, Germany",Agitated behavior and autistic features needed medication.,,autistic features,[],"['autistic', 'feature']"
552,755, A new ILRAPL1 point mutation: clinical report of a X linked mental retardation family.,PS08.71,,"IL1RAPL1 (interleukin 1 receptor accessory protein like 1) located at Xp21.3 21.2 has been shown to be deleted in X linked mental retardation patients with contiguous gene syndrome. Rarely, intragenic deletions or mu tations have been identified. Non specific intellectual disability, behaviour impairment with autistic spectrum disorder (ASD) and mild dysmorphism are actually recognized to be associated with IL1RAPL1 mutations.IL1RAPL1gene comprises 11 exons and harbors 3 extra cellular Ig like do   mains (NM_014271.3). IL1RAPL1 protein does not bind interleukin 1 but is regulating the formation of synapses of the cortical neurons. IL1RAPL1 forms with the protein tyrosine phosphatase rho (PTPrho) a complex indu cing pre and postsynaptic differentiation (Hayashi et al., 2013).So far, very few papers reported family with XLMR caused by point mutati   ons in IL1RAPL1 gene (Ramos Brossier et al., 2014). We report here a family  ABSTRACTS POSTERS ESHG 2015 | GLASGOW, SCOTLAND, UK | WWW.ESHG.ORG 166Back to inde x with XLMR with two brothers as probands, their mother and sister carrying  a new point IL1RAPL1 mutation c.1054C>T (p.Arg352*). The mutation was  identified after X chromosome analysis by next generation sequencing tech   nique. This new mutation lying in exon 8 induces a premature stop codon.  The resulting truncated protein is predicted to lack part of extracellular do   main, transmembrane domain and the entire cytoplasmic domain. To our knowledge, this substitution is not yet described in the literature but its pa thogenic character is highly likely.Interestingly, in contradiction with the so far published data, all the fema  le carriers were found with mild learning disabilities, and some behaviour  impairments without any X skewed inactivation detected at the level of lym phocytes DNA.",2015.0,,"U. Ullmann, S. Boulanger, P . Hilbert, V. Benoit","IPG, Gosselies, Belgium","Non specific intellectual disability, behaviour impairment with autistic spectrum disorder (ASD) and mild dysmorphism are actually recognized to be associated with IL1RAPL1 mutations.IL1RAPL1gene comprises 11 exons and harbors 3 extra cellular Ig like do   mains (NM_014271.3).",,autistic spectrum,[],"['autistic', 'spectrum']"
554,762," Severe psychiatric phenotype in a child with 47, XYY and multiple rearrangements detected in array CGH",PS09.005,,"Sophias  Childrens Hospital, Athens, Greece, 3Psychiatric Department, Aghia Sophia Childrens  Hospital, Athens, Greece. Co occurrence of 47,XYY syndrome and other molecular rearrangements in the same individual is extremely rare. We report a boy referred for genetic evaluation at the age of 9 years old when he was admitted to the psychiatric unit of the Childrens Hospital due to extended aggressive behaviour, which attributed to a severe psychiatric phenotype. He had no peculiar phenotypic findings, except for a unilateral iris coloboma. The probands family and me dical history were not indicative of any abnormality.Cytogenetic analysis revealed a 47,XXY karyotype*, while the high resolu tion array based comparative genomic hybridization (aCGH) identified im  portant rearrangements shown below: Chromosomal  region/ sizePosition of  1st aberrant  probePosition  of last  aberrant  probeImportant Genes in  aberrant regioncomments DUP 7q11.23;  882.9Kb74,144,422 75,027,348GTF2I, NCF1, GTF2IRD2,  STAG3L2, PMS2P5, GATSL1,  WBSCR16, GTF2IRD2B,  NCF1C, LOC100093631,  GTF2IP1, GATSL2, SPDYE8P ,  PMS2L2, STAG3L1, TRIM74,  TRIM73Microduplication  in the Williams  syndrome region DEL 11p15.5;  1.6Mb383,89 2,014,937 DRD4 ADHD** DEL 20q13.33;  907.3Kb61,632,196 62,539,530HAR1B, HAR1A, CHRNA4,  KCNQ2Psychotic  behavior, ASD**,  epilepsy *Aberrations detected with aCGH due to 47XXY karyotype: DUP Xp22.33,  2.7Mb; DUP Xq21.31   q21.32, 3.9Mb; DUP Yp11.32   p11.2, 9.96Mb; DUP  Yq11.21   q12, 15.1Mb ADHD ** Autism Deficit Hyperactivity Disorder; ASD: Autism Spectrum Dis order This case underlines the utility of aCGH in addition to the routine cytogenetic  analysis in cases with severe psychiatric phenotype for accurate diagnosis and complete genetic counselling.",2015.0,,"M. Tzetis1, K. Kosma1, A. Syrmou1, A. Xaidara2, L. Maragoudaki1, T . Korpa3, G. Kolaitis3, E.  Kanavakis1, S. Kitsiou Tzeli1","1Dept of Medical Genetics, Athens, Greece, 21st Department of Pediatrics, St","The probands family and me dical history were not indicative of any abnormality.Cytogenetic analysis revealed a 47,XXY karyotype*, while the high resolu tion array based comparative genomic hybridization (aCGH) identified im  portant rearrangements shown below: Chromosomal  region/ sizePosition of  1st aberrant  probePosition  of last  aberrant  probeImportant Genes in  aberrant regioncomments DUP 7q11.23;  882.9Kb74,144,422 75,027,348GTF2I, NCF1, GTF2IRD2,  STAG3L2, PMS2P5, GATSL1,  WBSCR16, GTF2IRD2B,  NCF1C, LOC100093631,  GTF2IP1, GATSL2, SPDYE8P ,  PMS2L2, STAG3L1, TRIM74,  TRIM73Microduplication  in the Williams  syndrome region DEL 11p15.5;  1.6Mb383,89 2,014,937 DRD4 ADHD** DEL 20q13.33;  907.3Kb61,632,196 62,539,530HAR1B, HAR1A, CHRNA4,  KCNQ2Psychotic  behavior, ASD**,  epilepsy *Aberrations detected with aCGH due to 47XXY karyotype: DUP Xp22.33,  2.7Mb; DUP Xq21.31   q21.32, 3.9Mb; DUP Yp11.32   p11.2, 9.96Mb; DUP  Yq11.21   q12, 15.1Mb ADHD ** Autism Deficit Hyperactivity Disorder; ASD: Autism Spectrum Dis order This case underlines the utility of aCGH in addition to the routine cytogenetic  analysis in cases with severe psychiatric phenotype for accurate diagnosis and complete genetic counselling.",,ASD*,[],['ASD*']
556,773, The autism associated long noncoding RNA MSNP1AS regulates a network of genes involved in neuronal process stability.,PM09.016,,"From genome wide association studies (GWAS), a novel gene was discove  red that has a highly significant association with autism spectrum disorder  (ASD). The gene is a long noncoding RNA (lncRNA) designated MSNP1AS  (moesin pseudogene 1, antisense). Expression of MSNP1AS was increased  in the cerebral cortex of individuals with ASD and individuals with the ASD associated genetic marker. Overexpression of MSNP1AS in human neuronal  cells caused decreased expression of moesin (MSN) mRNA and moesin pro  tein, which is involved in neuronal process stability and immune response. These data indicate one aspect of the potential contribution of increased  MSNP1AS expression in ASD. However, there are likely to be additional  transcriptomic impacts of this lncRNA. To determine the effects of altered MSNP1AS expression on the neuronal transcriptome, we transfected human  neuronal progenitor cells with constructs that overexpressed MSNP1AS or  transcriptionally silenced MSNP1AS. RNA Seq analysis indicated altered  expression of multiple genes that contribute to altered neuronal process stability and immune response, including MSN. However, our data indica  te several genes that are impacted by MSNP1AS dysregulation more signi  ficantly than MSN, suggesting a network of genes that contribute to ASD risk.  Ongoing experiments seek to define the role of the MSNP1AS gene network  in neuronal process stability.",2015.0,,"J. DeWitt , N. Grepo, D. B. Campbell","University of Southern California, Los Angeles, CA, United States","From genome wide association studies (GWAS), a novel gene was discove  red that has a highly significant association with autism spectrum disorder  (ASD).",association with autism,,"['association', 'with', 'autism']",[]
556,773, The autism associated long noncoding RNA MSNP1AS regulates a network of genes involved in neuronal process stability.,PM09.016,,"From genome wide association studies (GWAS), a novel gene was discove  red that has a highly significant association with autism spectrum disorder  (ASD). The gene is a long noncoding RNA (lncRNA) designated MSNP1AS  (moesin pseudogene 1, antisense). Expression of MSNP1AS was increased  in the cerebral cortex of individuals with ASD and individuals with the ASD associated genetic marker. Overexpression of MSNP1AS in human neuronal  cells caused decreased expression of moesin (MSN) mRNA and moesin pro  tein, which is involved in neuronal process stability and immune response. These data indicate one aspect of the potential contribution of increased  MSNP1AS expression in ASD. However, there are likely to be additional  transcriptomic impacts of this lncRNA. To determine the effects of altered MSNP1AS expression on the neuronal transcriptome, we transfected human  neuronal progenitor cells with constructs that overexpressed MSNP1AS or  transcriptionally silenced MSNP1AS. RNA Seq analysis indicated altered  expression of multiple genes that contribute to altered neuronal process stability and immune response, including MSN. However, our data indica  te several genes that are impacted by MSNP1AS dysregulation more signi  ficantly than MSN, suggesting a network of genes that contribute to ASD risk.  Ongoing experiments seek to define the role of the MSNP1AS gene network  in neuronal process stability.",2015.0,,"J. DeWitt , N. Grepo, D. B. Campbell","University of Southern California, Los Angeles, CA, United States",Expression of MSNP1AS was increased  in the cerebral cortex of individuals with ASD and individuals with the ASD associated genetic marker.,individuals with ASD,ASD associated genetic marker,"['individual', 'with', 'ASD']","['ASD', 'associated', 'genetic', 'marker']"
556,773, The autism associated long noncoding RNA MSNP1AS regulates a network of genes involved in neuronal process stability.,PM09.016,,"From genome wide association studies (GWAS), a novel gene was discove  red that has a highly significant association with autism spectrum disorder  (ASD). The gene is a long noncoding RNA (lncRNA) designated MSNP1AS  (moesin pseudogene 1, antisense). Expression of MSNP1AS was increased  in the cerebral cortex of individuals with ASD and individuals with the ASD associated genetic marker. Overexpression of MSNP1AS in human neuronal  cells caused decreased expression of moesin (MSN) mRNA and moesin pro  tein, which is involved in neuronal process stability and immune response. These data indicate one aspect of the potential contribution of increased  MSNP1AS expression in ASD. However, there are likely to be additional  transcriptomic impacts of this lncRNA. To determine the effects of altered MSNP1AS expression on the neuronal transcriptome, we transfected human  neuronal progenitor cells with constructs that overexpressed MSNP1AS or  transcriptionally silenced MSNP1AS. RNA Seq analysis indicated altered  expression of multiple genes that contribute to altered neuronal process stability and immune response, including MSN. However, our data indica  te several genes that are impacted by MSNP1AS dysregulation more signi  ficantly than MSN, suggesting a network of genes that contribute to ASD risk.  Ongoing experiments seek to define the role of the MSNP1AS gene network  in neuronal process stability.",2015.0,,"J. DeWitt , N. Grepo, D. B. Campbell","University of Southern California, Los Angeles, CA, United States","However, our data indica  te several genes that are impacted by MSNP1AS dysregulation more signi  ficantly than MSN, suggesting a network of genes that contribute to ASD risk.",,ASD risk,[],"['ASD', 'risk']"
557,774, Expression profile of circulating miRNAs in Autism Spectrum Disorder (ASD),PS09.017,,"Introduction: ASD is a genetically complex disorder, highly heterogeneous and with unclear etiology. In this study we addressed the possible contri bution of epigenetic factors to ASD etiology, focusing on deregulated Mi croRNAs (miRNAs) expression. miRNAs are small noncoding RNA molecules that negatively regulate gene expression. miRNAs are thought to be released from pathological tissues to plasma in illness situations, and the strong correlation between circulating and tissue miRNAs indicates that plasma miRNAs may be useful disease biomarkers.Methods: miRNA plasma profiles were obtained for patients with ASD and other neurodevelopmental disabilities (NDD), essentially disruptive beha vior, language delay and psychomotor delay. Patients were all male, with a mean developmental coefficient of 9218, and no obvious dysmorphisms. Exiqon human miRNome PCR panels (testing 752 miRNAs) were used for miRNA profiling.Results: We identified 50 miRNAs differentially expressed in ASD vs NDD. Notably, of the 10 miRNAs with higher fold change (increased 2.5 3.3X), 8 miRNAs had a target gene in common, MMP16. This gene is expressed at high levels in the brain, and a balanced de novo translocation in a ASD pati   ent involving MMP16 has previously been described.Conclusions: This is the first study of circulating miRNA profiles comparing patients with ASD and other NDDs. The preliminary results suggest that miRNA profilling may eventually improve differential diagnosis. The results also implicate novel pathological pathways in ASD, namely involving metal   oproteinases. These are crucial molecules for the integrity of the extracellu   lar matrix and consequently for cell migration and regeneration, processes thought to be involved in ASD.",2015.0,,"I. C. Conceio1,2,3, A. C. Rodrigues1, K. Kwiatkowska1, I. Picano1, C. Caf4, J. Almeida4, S.  Mouga4, F. Duque4,5,6, F. J. Enguita7,8, G. Oliveira4,5,6, A. M. Vicente1,2,3","1Instituto Nacional de Sade Doutor Ricardo Jorge, Lisbon, Portugal, 2Biosystems  and Integrative Sciences Institute (BioISI), Faculdade de Cincias, Universidade de Lisboa, Lisbon, Portugal,  3Instituto Gulbenkian de Cincia, Oeiras, Portugal, 4Unidade  Neurodesenvolvimento e Autismo, Centro de Desenvolvimento, Hospital Peditrico, Centro Hospitalar e Universitrio de Coimbra (CHUC), Coimbra, Portugal,  5Instituto  Biomdico de Investigao em Luz e Imagem, Faculdade de Medicina da Universidade de Coimbra, Coimbra, Portugal,  6Centro de Investigao e Formao Clinica do HP CHUC,  Coimbra, Portugal, 7Instituto de Medicina Molecular, Lisbon, Portugal, 8Faculdade de  Medicina, Universidade de Lisboa, Lisbon, Portugal","In this study we addressed the possible contri bution of epigenetic factors to ASD etiology, focusing on deregulated Mi croRNAs (miRNAs) expression.",,ASD etiology,[],"['ASD', 'etiology']"
557,774, Expression profile of circulating miRNAs in Autism Spectrum Disorder (ASD),PS09.017,,"Introduction: ASD is a genetically complex disorder, highly heterogeneous and with unclear etiology. In this study we addressed the possible contri bution of epigenetic factors to ASD etiology, focusing on deregulated Mi croRNAs (miRNAs) expression. miRNAs are small noncoding RNA molecules that negatively regulate gene expression. miRNAs are thought to be released from pathological tissues to plasma in illness situations, and the strong correlation between circulating and tissue miRNAs indicates that plasma miRNAs may be useful disease biomarkers.Methods: miRNA plasma profiles were obtained for patients with ASD and other neurodevelopmental disabilities (NDD), essentially disruptive beha vior, language delay and psychomotor delay. Patients were all male, with a mean developmental coefficient of 9218, and no obvious dysmorphisms. Exiqon human miRNome PCR panels (testing 752 miRNAs) were used for miRNA profiling.Results: We identified 50 miRNAs differentially expressed in ASD vs NDD. Notably, of the 10 miRNAs with higher fold change (increased 2.5 3.3X), 8 miRNAs had a target gene in common, MMP16. This gene is expressed at high levels in the brain, and a balanced de novo translocation in a ASD pati   ent involving MMP16 has previously been described.Conclusions: This is the first study of circulating miRNA profiles comparing patients with ASD and other NDDs. The preliminary results suggest that miRNA profilling may eventually improve differential diagnosis. The results also implicate novel pathological pathways in ASD, namely involving metal   oproteinases. These are crucial molecules for the integrity of the extracellu   lar matrix and consequently for cell migration and regeneration, processes thought to be involved in ASD.",2015.0,,"I. C. Conceio1,2,3, A. C. Rodrigues1, K. Kwiatkowska1, I. Picano1, C. Caf4, J. Almeida4, S.  Mouga4, F. Duque4,5,6, F. J. Enguita7,8, G. Oliveira4,5,6, A. M. Vicente1,2,3","1Instituto Nacional de Sade Doutor Ricardo Jorge, Lisbon, Portugal, 2Biosystems  and Integrative Sciences Institute (BioISI), Faculdade de Cincias, Universidade de Lisboa, Lisbon, Portugal,  3Instituto Gulbenkian de Cincia, Oeiras, Portugal, 4Unidade  Neurodesenvolvimento e Autismo, Centro de Desenvolvimento, Hospital Peditrico, Centro Hospitalar e Universitrio de Coimbra (CHUC), Coimbra, Portugal,  5Instituto  Biomdico de Investigao em Luz e Imagem, Faculdade de Medicina da Universidade de Coimbra, Coimbra, Portugal,  6Centro de Investigao e Formao Clinica do HP CHUC,  Coimbra, Portugal, 7Instituto de Medicina Molecular, Lisbon, Portugal, 8Faculdade de  Medicina, Universidade de Lisboa, Lisbon, Portugal","miRNAs are thought to be released from pathological tissues to plasma in illness situations, and the strong correlation between circulating and tissue miRNAs indicates that plasma miRNAs may be useful disease biomarkers.Methods: miRNA plasma profiles were obtained for patients with ASD and other neurodevelopmental disabilities (NDD), essentially disruptive beha vior, language delay and psychomotor delay.",patients with ASD,,"['patient', 'with', 'ASD']",[]
557,774, Expression profile of circulating miRNAs in Autism Spectrum Disorder (ASD),PS09.017,,"Introduction: ASD is a genetically complex disorder, highly heterogeneous and with unclear etiology. In this study we addressed the possible contri bution of epigenetic factors to ASD etiology, focusing on deregulated Mi croRNAs (miRNAs) expression. miRNAs are small noncoding RNA molecules that negatively regulate gene expression. miRNAs are thought to be released from pathological tissues to plasma in illness situations, and the strong correlation between circulating and tissue miRNAs indicates that plasma miRNAs may be useful disease biomarkers.Methods: miRNA plasma profiles were obtained for patients with ASD and other neurodevelopmental disabilities (NDD), essentially disruptive beha vior, language delay and psychomotor delay. Patients were all male, with a mean developmental coefficient of 9218, and no obvious dysmorphisms. Exiqon human miRNome PCR panels (testing 752 miRNAs) were used for miRNA profiling.Results: We identified 50 miRNAs differentially expressed in ASD vs NDD. Notably, of the 10 miRNAs with higher fold change (increased 2.5 3.3X), 8 miRNAs had a target gene in common, MMP16. This gene is expressed at high levels in the brain, and a balanced de novo translocation in a ASD pati   ent involving MMP16 has previously been described.Conclusions: This is the first study of circulating miRNA profiles comparing patients with ASD and other NDDs. The preliminary results suggest that miRNA profilling may eventually improve differential diagnosis. The results also implicate novel pathological pathways in ASD, namely involving metal   oproteinases. These are crucial molecules for the integrity of the extracellu   lar matrix and consequently for cell migration and regeneration, processes thought to be involved in ASD.",2015.0,,"I. C. Conceio1,2,3, A. C. Rodrigues1, K. Kwiatkowska1, I. Picano1, C. Caf4, J. Almeida4, S.  Mouga4, F. Duque4,5,6, F. J. Enguita7,8, G. Oliveira4,5,6, A. M. Vicente1,2,3","1Instituto Nacional de Sade Doutor Ricardo Jorge, Lisbon, Portugal, 2Biosystems  and Integrative Sciences Institute (BioISI), Faculdade de Cincias, Universidade de Lisboa, Lisbon, Portugal,  3Instituto Gulbenkian de Cincia, Oeiras, Portugal, 4Unidade  Neurodesenvolvimento e Autismo, Centro de Desenvolvimento, Hospital Peditrico, Centro Hospitalar e Universitrio de Coimbra (CHUC), Coimbra, Portugal,  5Instituto  Biomdico de Investigao em Luz e Imagem, Faculdade de Medicina da Universidade de Coimbra, Coimbra, Portugal,  6Centro de Investigao e Formao Clinica do HP CHUC,  Coimbra, Portugal, 7Instituto de Medicina Molecular, Lisbon, Portugal, 8Faculdade de  Medicina, Universidade de Lisboa, Lisbon, Portugal","This gene is expressed at high levels in the brain, and a balanced de novo translocation in a ASD pati   ent involving MMP16 has previously been described.Conclusions: This is the first study of circulating miRNA profiles comparing patients with ASD and other NDDs.",patients with ASD,,"['patient', 'with', 'ASD']",[]
558,775, Autistic variome: gene hunting through SNP microarray genome analysis and bioinformatics,PM09.018,,"I. Pirogov, Separated Structural Unit Clinical Research Institute of Pediatrics, Ministry of Health of Russia, Moscow, Russian Federation,  3Moscow City University of Psychology and Education, Moscow, Russian Federation, 4Department of Medical Genetics, Russian Medical Academy of Postgraduate  Education, Ministry of Health, Moscow, Russian Federation, 5The State Educational  Institution of Professional Training under the Federal Agency of Health Care and Social  Development, Moscow, Russian Federation. Despite of significant advances in bioinformatics and genomics, analyses of  generalized data on copy number variation (CNV) or variome aimed at gene  hunting still represent a major challenge. Here, we have used an approach  towards identifying genes implicated in autism pathogenesis through eva luation of autistic variome addressed by microarray genome analysis with  an original bioinformatic technology. To identify the spectrum of CNV, a high  resolution SNP array genome scan (Affymetrix platform) was used. Bioinfor   matics analysis has represented a complex evaluation of CNV by simulations of transcriptional, interactomic and metabolomic activity of candidate genes  using available genome, transcriptome and proteome databases (Iourov et  al., 2014). Pathogenic CNV were found in 38 children with autism from the Russian cohort (n,212). Six chromosomal rearrangements were detected:  deletions at 6p11.2 (PRISM2), 9q21.13 (GDA, ZFAND5, TMC1), 8p23.3p23.1  (46 genes), Xp22.12 (RPS6KA3, CNKSR2) and Yq11.223q11.23 duplications. Furthermore, bioinformatic analysis of CNV and single gene deletions/du  plications has defined following autism candidate genes: CBARA1, KRT83,  RBFOX1, NDP , ATP6V1E1, CNKSR2, ATP1A2, FBXO21, ACSL3, ATP2B3, IM   PA1, CNTNAP4. The latter allowed speculations on potential autistic mole cular pathways involving genome instability, programmed cell death and  axon guidance. Successful delineation of a panel of candidate genes suggests  generalized variome analyses as a valuable source for gene hunting. These data supports the idea that additional bioinformatic technologies are able  to give further insights into disease pathogenesis. Thus, a disease variome  determined by SNP array genome scan and addressed an original bioinfor   matic technology appears to be an issue for genomic studies. Supported by  Russian Scientific Fund (Grant #14 35 00060).",2015.0,,"S. G. Vorsanova1,2,3, I. Y. Iourov1,2,4, S. A. Korostelev5, M. A. Zelenova1,2,3, K. S. Vasin1,2,3, A. P .  Silvanovich1, Y. B. Yurov1,2,3","1Mental Health Research Center, RAMS, Moscow, Russian Federation, 2Russian National  Research Medical University named after N","Here, we have used an approach  towards identifying genes implicated in autism pathogenesis through eva luation of autistic variome addressed by microarray genome analysis with  an original bioinformatic technology.",,autistic variome,[],"['autistic', 'variome']"
558,775, Autistic variome: gene hunting through SNP microarray genome analysis and bioinformatics,PM09.018,,"I. Pirogov, Separated Structural Unit Clinical Research Institute of Pediatrics, Ministry of Health of Russia, Moscow, Russian Federation,  3Moscow City University of Psychology and Education, Moscow, Russian Federation, 4Department of Medical Genetics, Russian Medical Academy of Postgraduate  Education, Ministry of Health, Moscow, Russian Federation, 5The State Educational  Institution of Professional Training under the Federal Agency of Health Care and Social  Development, Moscow, Russian Federation. Despite of significant advances in bioinformatics and genomics, analyses of  generalized data on copy number variation (CNV) or variome aimed at gene  hunting still represent a major challenge. Here, we have used an approach  towards identifying genes implicated in autism pathogenesis through eva luation of autistic variome addressed by microarray genome analysis with  an original bioinformatic technology. To identify the spectrum of CNV, a high  resolution SNP array genome scan (Affymetrix platform) was used. Bioinfor   matics analysis has represented a complex evaluation of CNV by simulations of transcriptional, interactomic and metabolomic activity of candidate genes  using available genome, transcriptome and proteome databases (Iourov et  al., 2014). Pathogenic CNV were found in 38 children with autism from the Russian cohort (n,212). Six chromosomal rearrangements were detected:  deletions at 6p11.2 (PRISM2), 9q21.13 (GDA, ZFAND5, TMC1), 8p23.3p23.1  (46 genes), Xp22.12 (RPS6KA3, CNKSR2) and Yq11.223q11.23 duplications. Furthermore, bioinformatic analysis of CNV and single gene deletions/du  plications has defined following autism candidate genes: CBARA1, KRT83,  RBFOX1, NDP , ATP6V1E1, CNKSR2, ATP1A2, FBXO21, ACSL3, ATP2B3, IM   PA1, CNTNAP4. The latter allowed speculations on potential autistic mole cular pathways involving genome instability, programmed cell death and  axon guidance. Successful delineation of a panel of candidate genes suggests  generalized variome analyses as a valuable source for gene hunting. These data supports the idea that additional bioinformatic technologies are able  to give further insights into disease pathogenesis. Thus, a disease variome  determined by SNP array genome scan and addressed an original bioinfor   matic technology appears to be an issue for genomic studies. Supported by  Russian Scientific Fund (Grant #14 35 00060).",2015.0,,"S. G. Vorsanova1,2,3, I. Y. Iourov1,2,4, S. A. Korostelev5, M. A. Zelenova1,2,3, K. S. Vasin1,2,3, A. P .  Silvanovich1, Y. B. Yurov1,2,3","1Mental Health Research Center, RAMS, Moscow, Russian Federation, 2Russian National  Research Medical University named after N","Pathogenic CNV were found in 38 children with autism from the Russian cohort (n,212).",children with autism,,"['child', 'with', 'autism']",[]
558,775, Autistic variome: gene hunting through SNP microarray genome analysis and bioinformatics,PM09.018,,"I. Pirogov, Separated Structural Unit Clinical Research Institute of Pediatrics, Ministry of Health of Russia, Moscow, Russian Federation,  3Moscow City University of Psychology and Education, Moscow, Russian Federation, 4Department of Medical Genetics, Russian Medical Academy of Postgraduate  Education, Ministry of Health, Moscow, Russian Federation, 5The State Educational  Institution of Professional Training under the Federal Agency of Health Care and Social  Development, Moscow, Russian Federation. Despite of significant advances in bioinformatics and genomics, analyses of  generalized data on copy number variation (CNV) or variome aimed at gene  hunting still represent a major challenge. Here, we have used an approach  towards identifying genes implicated in autism pathogenesis through eva luation of autistic variome addressed by microarray genome analysis with  an original bioinformatic technology. To identify the spectrum of CNV, a high  resolution SNP array genome scan (Affymetrix platform) was used. Bioinfor   matics analysis has represented a complex evaluation of CNV by simulations of transcriptional, interactomic and metabolomic activity of candidate genes  using available genome, transcriptome and proteome databases (Iourov et  al., 2014). Pathogenic CNV were found in 38 children with autism from the Russian cohort (n,212). Six chromosomal rearrangements were detected:  deletions at 6p11.2 (PRISM2), 9q21.13 (GDA, ZFAND5, TMC1), 8p23.3p23.1  (46 genes), Xp22.12 (RPS6KA3, CNKSR2) and Yq11.223q11.23 duplications. Furthermore, bioinformatic analysis of CNV and single gene deletions/du  plications has defined following autism candidate genes: CBARA1, KRT83,  RBFOX1, NDP , ATP6V1E1, CNKSR2, ATP1A2, FBXO21, ACSL3, ATP2B3, IM   PA1, CNTNAP4. The latter allowed speculations on potential autistic mole cular pathways involving genome instability, programmed cell death and  axon guidance. Successful delineation of a panel of candidate genes suggests  generalized variome analyses as a valuable source for gene hunting. These data supports the idea that additional bioinformatic technologies are able  to give further insights into disease pathogenesis. Thus, a disease variome  determined by SNP array genome scan and addressed an original bioinfor   matic technology appears to be an issue for genomic studies. Supported by  Russian Scientific Fund (Grant #14 35 00060).",2015.0,,"S. G. Vorsanova1,2,3, I. Y. Iourov1,2,4, S. A. Korostelev5, M. A. Zelenova1,2,3, K. S. Vasin1,2,3, A. P .  Silvanovich1, Y. B. Yurov1,2,3","1Mental Health Research Center, RAMS, Moscow, Russian Federation, 2Russian National  Research Medical University named after N","The latter allowed speculations on potential autistic mole cular pathways involving genome instability, programmed cell death and  axon guidance.",,autistic mole,[],"['autistic', 'mole']"
559,776, Identification of a rare deletion encompassing ELMOD3 and CAPG in two siblings with Autism Spectrum Disorder,PS09.019,,"Pharmacy and Biotechnology, University of Bologna, Bologna, Italy, 2Dept.  Biomedical Sciences, University of Cagliari, Cagliari, Italy, 3Dept. Pedagogy,  Psychology and Philosophy, University of Cagliari, Cagliari, Italy, 4Center for Pervasive  Developmental Disorders, Azienda Ospedaliera Brotzu, Cagliari, Italy. Autism Spectrum Disorder (ASD) is a severe neurodevelopmental condi   tion with highly complex genetic predisposition. Recent discoveries have highlighted the importance of both sequence and structural rare variations in ASD susceptibility. In particular, focusing on rare copy number variants (CNVs) has already been highly productive in uncovering an increasing num ber of specific genes and chromosomal intervals conferring risk to ASD.During a genome wide CNV scan using a multi algorithm approach on 9 multiplex ASD families from Sardinia, we identified a rare genic deletion of ~37 Kb, transmitted from the unaffected mother to both affected siblings. This deletion includes the entire CAPG gene and the last coding exons of  ELMOD3 . CAPG encodes a member of the gelsolin/villin family of actin re  gulatory proteins, that might be involved in control of dendritic spine shape. ELMOD3 belongs to the engulfment and cell motility (ELMO) family, with recently proposed functional links to sound perception and actin cytoske leton.No deletions involving this genomic region were found in 4768 controls from published high resolution SNP array data, while other two deletions encompassing CAPG and ELMOD3 have been reported in two subjects with  ASD, suggesting that CAPG and/or ELMOD3 haploinsufficiency may have  clinical relevance to ASD. In order to test this hypothesis together with a recessive model of inheritance, we first excluded that this deletion is a com mon polymorphism in Sardinia, then we performed expression and muta   tion analysis of both genes in the discovery pedigree, and a further clinical evaluation of all family members.Grant references: Fondazione Banco di Sardegna, Kyulan Family Foundati o",2015.0,,"E. Bacchelli1, L. Moi2, A. Fadda2, J. Pinna2, C. Cameli1, R. Fadda2, A. Salvago3, L. Delitala3,  E. Maestrini1, G. Doneddu4, P . Zavattari2",1Dept,Recent discoveries have highlighted the importance of both sequence and structural rare variations in ASD susceptibility.,,ASD susceptibility,[],"['ASD', 'susceptibility']"
559,776, Identification of a rare deletion encompassing ELMOD3 and CAPG in two siblings with Autism Spectrum Disorder,PS09.019,,"Pharmacy and Biotechnology, University of Bologna, Bologna, Italy, 2Dept.  Biomedical Sciences, University of Cagliari, Cagliari, Italy, 3Dept. Pedagogy,  Psychology and Philosophy, University of Cagliari, Cagliari, Italy, 4Center for Pervasive  Developmental Disorders, Azienda Ospedaliera Brotzu, Cagliari, Italy. Autism Spectrum Disorder (ASD) is a severe neurodevelopmental condi   tion with highly complex genetic predisposition. Recent discoveries have highlighted the importance of both sequence and structural rare variations in ASD susceptibility. In particular, focusing on rare copy number variants (CNVs) has already been highly productive in uncovering an increasing num ber of specific genes and chromosomal intervals conferring risk to ASD.During a genome wide CNV scan using a multi algorithm approach on 9 multiplex ASD families from Sardinia, we identified a rare genic deletion of ~37 Kb, transmitted from the unaffected mother to both affected siblings. This deletion includes the entire CAPG gene and the last coding exons of  ELMOD3 . CAPG encodes a member of the gelsolin/villin family of actin re  gulatory proteins, that might be involved in control of dendritic spine shape. ELMOD3 belongs to the engulfment and cell motility (ELMO) family, with recently proposed functional links to sound perception and actin cytoske leton.No deletions involving this genomic region were found in 4768 controls from published high resolution SNP array data, while other two deletions encompassing CAPG and ELMOD3 have been reported in two subjects with  ASD, suggesting that CAPG and/or ELMOD3 haploinsufficiency may have  clinical relevance to ASD. In order to test this hypothesis together with a recessive model of inheritance, we first excluded that this deletion is a com mon polymorphism in Sardinia, then we performed expression and muta   tion analysis of both genes in the discovery pedigree, and a further clinical evaluation of all family members.Grant references: Fondazione Banco di Sardegna, Kyulan Family Foundati o",2015.0,,"E. Bacchelli1, L. Moi2, A. Fadda2, J. Pinna2, C. Cameli1, R. Fadda2, A. Salvago3, L. Delitala3,  E. Maestrini1, G. Doneddu4, P . Zavattari2",1Dept,"In particular, focusing on rare copy number variants (CNVs) has already been highly productive in uncovering an increasing num ber of specific genes and chromosomal intervals conferring risk to ASD.During a genome wide CNV scan using a multi algorithm approach on 9 multiplex ASD families from Sardinia, we identified a rare genic deletion of ~37 Kb, transmitted from the unaffected mother to both affected siblings.",,ASD families,[],"['ASD', 'family']"
568,947, Delineating a new interstitial genomic rearrangement by array CGH at 19p13.3 band,PS11.011,,"Introduction: High resolution microarray comparative genomic hybridiza   tion (aCGH) is a powerful genetic tool implemented as a first tier test for  diagnosis of genomic imbalances in individuals with intellectual disability, autistic disorders and congenital malformations.it also has been proven to be successful in characterizing the growing list of microdeletion/duplicati   on syndromes. Using this experimental approach, we and others recently described new microdeletion/microduplication syndromes.Methods: A genotype first approach, using aCGH, in which patients are characterized by a similar genomic rearrangement before a common clinical presentation has been used.Results: We report 13 new patients with proximal 19p13.3 submicroscopic rearrangements and review patients from the literature and public genomic databases such as DECIPHER and ISCA Consortium for a total of 37 cases. We describe the phenotypic findings and suggest these patients represent a new microdeletion/duplication syndrome at 19p13.3 band, with a 113.5 Kb critical region as Small Region of Overlapping harboring three genes. Common features consist of abnormal head circumference in most patients (macrocephaly with the deletions and microcephaly with the duplications), intellectual disability (ID) with developmental delay, hypotonia, speech de   lay and common dysmorphic features.Discussion: This study provides detailed clinical information for geneticists to assist in the evaluation, diagnosis and management of individuals with similar genomic interstitial rearrangements at 19p13.3 band.",2015.0,,"J. NEVADO1,2, J. A. Rosenfeld3, M. Rocio1, M. Palomares Bralo1,2, E. Vallespin1,2, M. A.  Mori1,2, K. W. Gripp4, 19p13.3 microdeletion/microduplication syndrome study group, J.  A. Tenorio1,2, R. Martn Arenas1, F. Santos Simarro1,2, M. L. De Torres1, S. Garcia Miaur1,2,  B. Fernandez1, M. V. Fernandez Montao1, I. Rueda Arenas1, P . D. Lapunzina1,2","1INGEMM, HOSPITAL UNIVERSITARIO LA PAZ, MADRID, Spain, 2CIBERER, Madrid, Spain,  3Signature Genomics, Perkin Elmer, USA, WA, United States, 4AI DuPont Hospital for  Children, WILMINGTON, DE, United States","Introduction: High resolution microarray comparative genomic hybridiza   tion (aCGH) is a powerful genetic tool implemented as a first tier test for  diagnosis of genomic imbalances in individuals with intellectual disability, autistic disorders and congenital malformations.it also has been proven to be successful in characterizing the growing list of microdeletion/duplicati   on syndromes.",,autistic disorders,[],"['autistic', 'disorder']"
570,950," A 60Kb deletion in the AUTS2 gene in a patient with cardiopathy, facial dysmorphism and autistic traits",PM11.014,,"We present the case of a child referred to the Dismorphology consultati   on at the age of 3 months. Born after normal pregnancy and instrumental delivery at 36+5 w. Birth weight: 2690g and Apgar 7/9. At 4 hours of life he presented an episode of choking while sucking that needs stimulation for recovery. Progressively acquires suck swallow coordination and no si gnificant symptoms associated were observed. An atrial septal defect (ASD) (ostium secundum) was diagnosed by echocardiography and the patient was discharged for control in external consultations.On the exploration at 3m slightly decreased axial, lower limbs on flexion (without arthrogryposis), increased tendon reflexes, and peculiar phenoty   pic traits (hypertelorism and almond shaped palpebral fissures, short phil trum, thin upper lip and microstomia) were observed.At 15 months, the ASD was repared. He presented a convergent not paretic  strabismus, the muscle tone was improved in general but the lower limb  tone was increased when excited, the reflexes were symmetrical but exal   ted and the CPR was extensor bilateral. We observed a limitation of joints  extension which improved in subsequent controls. Now, at 41momths, he  presented a global developmental delay with autistic traits.The aCGH (Nimblegen, 720K) performed defined a 60Kb deletion on  7q11.22, not seen in the aCGH (qChip  R, 60K), and confirmed by MLPA in  the AUTS2 gene.Balanced genomic rearrangements disrupting AUTS2 gene have been iden   tified implicating AUTS2 in neurodevelopmental disorders. More recent de   scriptions suggest that the AUTS2 syndrome could be a single gene disorder and our case support this hypothesis.",2015.0,,"M. J. Garca Barcina, E. Santamara, E. Sarasola, M. A. Fernndez Cuesta, C. Ruiz Espinoza, B. Barrea","Hospital Universitario de Basurto, Bilbao, Spain","Now, at 41momths, he  presented a global developmental delay with autistic traits.The aCGH (Nimblegen, 720K) performed defined a 60Kb deletion on  7q11.22, not seen in the aCGH (qChip  R, 60K), and confirmed by MLPA in  the AUTS2 gene.Balanced genomic rearrangements disrupting AUTS2 gene have been iden   tified implicating AUTS2 in neurodevelopmental disorders.",,autistic traits,[],"['autistic', 'trait']"
571,1001, A case of developmental delay and dysmorphic features with duplication 15q11q13 inherited from the mother,PM11.056,,"Childrens Hospital Ljubljana, Department of Endocrinology, Diabates and Metabolic Diseases, 1000 Ljubljana, Slovenia. A 10 year old boy with speech delay, dysmorphic features, short stature, joint hyperlaxity, muscular hypotony and conductive deafness is presented. His father was diagnosed with X linked spondilopehyseal dysplasia tarda.Birth parameters were normal. In the first months he developed motor de   velopmental delay with muscular hypotony. At one year short stature was diagnosed. Repeatedly he has been treated for mild middle ear infections and a conductive hearing loss was diagnosed at 10 years. At this age (height 130,67 cm ( 1.793 SDS); weight 28,25 kg ( 1.194 SDS); head circumference 55,5 cm (0.478 SDS)) he presented with two cafe au lait spots. Several dys morphic features were observed: long face, high vaulted palate, wide, retro verted nostrils, low set ears, tag on the lobule, deep philtrum, tented upper lip, joint hyperlaxity, proximal placed thumbs, wide spaced nipples and 2 3 toe syndactily of the both feet. The boy had difficulties in fine motor skills, concentration, attention and social skills. At the age of 11,5 years suspect of autism spectrum disorder was made.aCGH detected interstitial duplication of approximately 6.1Mb at 15q11.2q13.1 (arr[hg19] 15q11.2q13.1(22,765,628 28,940,098)3 mat), subsequently confirmed by FISH. Parental analyses identified the mother as a carrier of the same duplication.Several reports have suggested that maternally transmitted 15q duplicati   ons were associated with autistic features with variable degrees of deve lopmental delay, while paternally derived cases presented with no major medical problems. Genetic counseling is vital to discuss the recurrence risks and options for prenatal and preimplantation genetic diagnosis in familial cases of 15q11q13 duplication.",2015.0,,S. Bertok,Univ,"Parental analyses identified the mother as a carrier of the same duplication.Several reports have suggested that maternally transmitted 15q duplicati   ons were associated with autistic features with variable degrees of deve lopmental delay, while paternally derived cases presented with no major medical problems.",,autistic features,[],"['autistic', 'feature']"
573,1077, Genotype phenotype correlation in three patients with Wolf Hirschhorn syndrome,PM11.136,,"Wolf Hirschhorn syndrome (WHS) (OMIM 194190) is a multiple congenital anomalies/mental retardation (MCA/MR) syndrome caused by partial 4p deletion that was first described independently by Wolf et al. and by Hirsch   horn et al. in 1965.Clinical signs and symptpms include typical facial appearance, resembling the Greek warrior helmet profile, mental retardation, severe growth delay, hypotonia, congenital heart malformations, midline defects, such as cleft pa late and hypospadias, ocular colobomas, renal abnormalities and seizures. Different phenotypes and clinical findings are caused by the number of ge nes deleted on the 4p16.3 locus.Here we represent the clinical findings of three patients who have deletion on 4p16.3 chromosomal locus. Size of the deletions were different from each other.The first patient is a 3,5  year old female who has afebrile convulsion, hea ring loss and speech delay. Submicroscobic heterozygous deletion including PIGG, GAK, FGFRL1, SPON2 genes on 4p16.3 was determined by MLPA me thod performed with P373 A1 MLPA probemix.The second patient is a 2 day old female patient. She has a dysmorphic face appearence, preauricular pit, PDA? and sacral dimple. She has a 46,XX,del(4)(p15.?3) karyotype. A 19 Mb heterozygous deletion between 4p16.3 4p15.3 regions was determined by arrayCGH [CytoScan750K_Array, Affymetrix] method. Deleted region includes 88 genes described in OMIM.Third patient is a 9 year old male who has microcephaly, dysmorphic face appearence, iris coloboma, exophtalmus, ASD+PDA+ pulmonary steno sis, gastroesophageal reflux, scoliosis and seizures. He has a 46,XY, der(4)t(4;18)(p16.3;p11.2) karyotype.Differential expressivity and incomplete penetrance in WHS cause difficul   ties in clinical diagnosis and problems in understanding the genotype/phe notype correlations.",2015.0,,"H. Gurkan1, U. Vatansever2, E. I. Atl1, D. Eker1, S. Ulusal1, N. A. iftdemir2, H. Tozkr1","1Trakya University, Medical Faculty, Department of Medical Genetics, Edirne, Turkey,  2Trakya University, Medical Faculty, Department of Pediatrics, Edirne, Turkey","Deleted region includes 88 genes described in OMIM.Third patient is a 9 year old male who has microcephaly, dysmorphic face appearence, iris coloboma, exophtalmus, ASD+PDA+ pulmonary steno sis, gastroesophageal reflux, scoliosis and seizures.",,ASD+PDA+ pulmonary steno,[],"['ASD+PDA+', 'pulmonary', 'steno']"
577,1250, Duplication of SHANK3 gene in a case of schizophrenia associated with autism,PM13.32,,"The autistic spectrum is comprised of the Asperger syndrome, Heller syn drome, Rett syndrome, atypical autism, disorganized schizophrenia, as well  as, although somewhere marginally placed, schizoid personality disorder  and obsessive compulsive disorder.We present a case of a 21 years old female with a psychopathological pic  ture that consisted of: psychomotor agitation, a suicide attempt by defene  stration, which was secondary to delusional ideation, auditory and visual hallucinations, anxiety, lack of insight, mixed insomnia. Our case, diagnosed with schizophrenia, also presents manifestations that are characteristic for  autistic spectrum disorders. Based on her academic performances, our pati   ent might have a superior than average intellect. The result of the arrayCGH analysis showed genomic imbalances including  several genes. From the list of deleted/duplicated genes, one that was pre  viously reported in patients with psychotic disorders is the SHANK3 gene. ArrayCGH analysis for our case identified an 82.3 Kb duplication of chro  mosome 22q from 51.055.575 51.137.968 bp; this region encompassed the  SHANK3. The patients mother did not carry the duplication. The genetic analysis for father was not possible because he is deceased. Several papers have reported SHANK3 gene variants in autistic spectrum consisting of both  copy number variants and point mutations. The presence of three copies of the SHANK3 gene was reported in associa   tion with autistic spectrum disorders in other papers. These findings led to  the idea that both haploinsufficiency, as well as an over expression of the  SHANK3 gene are associated with manifestations of autistic spectrum dis   orders and other neurobehavioral abnormalities.",2015.0,,"A. Belengeanu1, C. Giurgi Oncu1, S. Farcas1, D. Misceo2","1University of Medicine and Pharmacy Victor Babes, Timisoara, Romania, 2Department of Medical Genetics, Oslo University Hospital, University of Oslo, Oslo, Norway","The autistic spectrum is comprised of the Asperger syndrome, Heller syn drome, Rett syndrome, atypical autism, disorganized schizophrenia, as well  as, although somewhere marginally placed, schizoid personality disorder  and obsessive compulsive disorder.We present a case of a 21 years old female with a psychopathological pic  ture that consisted of: psychomotor agitation, a suicide attempt by defene  stration, which was secondary to delusional ideation, auditory and visual hallucinations, anxiety, lack of insight, mixed insomnia.",,autistic spectrum,[],"['autistic', 'spectrum']"
577,1250, Duplication of SHANK3 gene in a case of schizophrenia associated with autism,PM13.32,,"The autistic spectrum is comprised of the Asperger syndrome, Heller syn drome, Rett syndrome, atypical autism, disorganized schizophrenia, as well  as, although somewhere marginally placed, schizoid personality disorder  and obsessive compulsive disorder.We present a case of a 21 years old female with a psychopathological pic  ture that consisted of: psychomotor agitation, a suicide attempt by defene  stration, which was secondary to delusional ideation, auditory and visual hallucinations, anxiety, lack of insight, mixed insomnia. Our case, diagnosed with schizophrenia, also presents manifestations that are characteristic for  autistic spectrum disorders. Based on her academic performances, our pati   ent might have a superior than average intellect. The result of the arrayCGH analysis showed genomic imbalances including  several genes. From the list of deleted/duplicated genes, one that was pre  viously reported in patients with psychotic disorders is the SHANK3 gene. ArrayCGH analysis for our case identified an 82.3 Kb duplication of chro  mosome 22q from 51.055.575 51.137.968 bp; this region encompassed the  SHANK3. The patients mother did not carry the duplication. The genetic analysis for father was not possible because he is deceased. Several papers have reported SHANK3 gene variants in autistic spectrum consisting of both  copy number variants and point mutations. The presence of three copies of the SHANK3 gene was reported in associa   tion with autistic spectrum disorders in other papers. These findings led to  the idea that both haploinsufficiency, as well as an over expression of the  SHANK3 gene are associated with manifestations of autistic spectrum dis   orders and other neurobehavioral abnormalities.",2015.0,,"A. Belengeanu1, C. Giurgi Oncu1, S. Farcas1, D. Misceo2","1University of Medicine and Pharmacy Victor Babes, Timisoara, Romania, 2Department of Medical Genetics, Oslo University Hospital, University of Oslo, Oslo, Norway","The autistic spectrum is comprised of the Asperger syndrome, Heller syn drome, Rett syndrome, atypical autism, disorganized schizophrenia, as well  as, although somewhere marginally placed, schizoid personality disorder  and obsessive compulsive disorder.We present a case of a 21 years old female with a psychopathological pic  ture that consisted of: psychomotor agitation, a suicide attempt by defene  stration, which was secondary to delusional ideation, auditory and visual hallucinations, anxiety, lack of insight, mixed insomnia.",,Asperger syndrome,[],"['Asperger', 'syndrome']"
577,1250, Duplication of SHANK3 gene in a case of schizophrenia associated with autism,PM13.32,,"The autistic spectrum is comprised of the Asperger syndrome, Heller syn drome, Rett syndrome, atypical autism, disorganized schizophrenia, as well  as, although somewhere marginally placed, schizoid personality disorder  and obsessive compulsive disorder.We present a case of a 21 years old female with a psychopathological pic  ture that consisted of: psychomotor agitation, a suicide attempt by defene  stration, which was secondary to delusional ideation, auditory and visual hallucinations, anxiety, lack of insight, mixed insomnia. Our case, diagnosed with schizophrenia, also presents manifestations that are characteristic for  autistic spectrum disorders. Based on her academic performances, our pati   ent might have a superior than average intellect. The result of the arrayCGH analysis showed genomic imbalances including  several genes. From the list of deleted/duplicated genes, one that was pre  viously reported in patients with psychotic disorders is the SHANK3 gene. ArrayCGH analysis for our case identified an 82.3 Kb duplication of chro  mosome 22q from 51.055.575 51.137.968 bp; this region encompassed the  SHANK3. The patients mother did not carry the duplication. The genetic analysis for father was not possible because he is deceased. Several papers have reported SHANK3 gene variants in autistic spectrum consisting of both  copy number variants and point mutations. The presence of three copies of the SHANK3 gene was reported in associa   tion with autistic spectrum disorders in other papers. These findings led to  the idea that both haploinsufficiency, as well as an over expression of the  SHANK3 gene are associated with manifestations of autistic spectrum dis   orders and other neurobehavioral abnormalities.",2015.0,,"A. Belengeanu1, C. Giurgi Oncu1, S. Farcas1, D. Misceo2","1University of Medicine and Pharmacy Victor Babes, Timisoara, Romania, 2Department of Medical Genetics, Oslo University Hospital, University of Oslo, Oslo, Norway","Our case, diagnosed with schizophrenia, also presents manifestations that are characteristic for  autistic spectrum disorders.",,autistic spectrum,[],"['autistic', 'spectrum']"
577,1250, Duplication of SHANK3 gene in a case of schizophrenia associated with autism,PM13.32,,"The autistic spectrum is comprised of the Asperger syndrome, Heller syn drome, Rett syndrome, atypical autism, disorganized schizophrenia, as well  as, although somewhere marginally placed, schizoid personality disorder  and obsessive compulsive disorder.We present a case of a 21 years old female with a psychopathological pic  ture that consisted of: psychomotor agitation, a suicide attempt by defene  stration, which was secondary to delusional ideation, auditory and visual hallucinations, anxiety, lack of insight, mixed insomnia. Our case, diagnosed with schizophrenia, also presents manifestations that are characteristic for  autistic spectrum disorders. Based on her academic performances, our pati   ent might have a superior than average intellect. The result of the arrayCGH analysis showed genomic imbalances including  several genes. From the list of deleted/duplicated genes, one that was pre  viously reported in patients with psychotic disorders is the SHANK3 gene. ArrayCGH analysis for our case identified an 82.3 Kb duplication of chro  mosome 22q from 51.055.575 51.137.968 bp; this region encompassed the  SHANK3. The patients mother did not carry the duplication. The genetic analysis for father was not possible because he is deceased. Several papers have reported SHANK3 gene variants in autistic spectrum consisting of both  copy number variants and point mutations. The presence of three copies of the SHANK3 gene was reported in associa   tion with autistic spectrum disorders in other papers. These findings led to  the idea that both haploinsufficiency, as well as an over expression of the  SHANK3 gene are associated with manifestations of autistic spectrum dis   orders and other neurobehavioral abnormalities.",2015.0,,"A. Belengeanu1, C. Giurgi Oncu1, S. Farcas1, D. Misceo2","1University of Medicine and Pharmacy Victor Babes, Timisoara, Romania, 2Department of Medical Genetics, Oslo University Hospital, University of Oslo, Oslo, Norway",Several papers have reported SHANK3 gene variants in autistic spectrum consisting of both  copy number variants and point mutations.,,autistic spectrum,[],"['autistic', 'spectrum']"
577,1250, Duplication of SHANK3 gene in a case of schizophrenia associated with autism,PM13.32,,"The autistic spectrum is comprised of the Asperger syndrome, Heller syn drome, Rett syndrome, atypical autism, disorganized schizophrenia, as well  as, although somewhere marginally placed, schizoid personality disorder  and obsessive compulsive disorder.We present a case of a 21 years old female with a psychopathological pic  ture that consisted of: psychomotor agitation, a suicide attempt by defene  stration, which was secondary to delusional ideation, auditory and visual hallucinations, anxiety, lack of insight, mixed insomnia. Our case, diagnosed with schizophrenia, also presents manifestations that are characteristic for  autistic spectrum disorders. Based on her academic performances, our pati   ent might have a superior than average intellect. The result of the arrayCGH analysis showed genomic imbalances including  several genes. From the list of deleted/duplicated genes, one that was pre  viously reported in patients with psychotic disorders is the SHANK3 gene. ArrayCGH analysis for our case identified an 82.3 Kb duplication of chro  mosome 22q from 51.055.575 51.137.968 bp; this region encompassed the  SHANK3. The patients mother did not carry the duplication. The genetic analysis for father was not possible because he is deceased. Several papers have reported SHANK3 gene variants in autistic spectrum consisting of both  copy number variants and point mutations. The presence of three copies of the SHANK3 gene was reported in associa   tion with autistic spectrum disorders in other papers. These findings led to  the idea that both haploinsufficiency, as well as an over expression of the  SHANK3 gene are associated with manifestations of autistic spectrum dis   orders and other neurobehavioral abnormalities.",2015.0,,"A. Belengeanu1, C. Giurgi Oncu1, S. Farcas1, D. Misceo2","1University of Medicine and Pharmacy Victor Babes, Timisoara, Romania, 2Department of Medical Genetics, Oslo University Hospital, University of Oslo, Oslo, Norway",The presence of three copies of the SHANK3 gene was reported in associa   tion with autistic spectrum disorders in other papers.,,autistic spectrum,[],"['autistic', 'spectrum']"
577,1250, Duplication of SHANK3 gene in a case of schizophrenia associated with autism,PM13.32,,"The autistic spectrum is comprised of the Asperger syndrome, Heller syn drome, Rett syndrome, atypical autism, disorganized schizophrenia, as well  as, although somewhere marginally placed, schizoid personality disorder  and obsessive compulsive disorder.We present a case of a 21 years old female with a psychopathological pic  ture that consisted of: psychomotor agitation, a suicide attempt by defene  stration, which was secondary to delusional ideation, auditory and visual hallucinations, anxiety, lack of insight, mixed insomnia. Our case, diagnosed with schizophrenia, also presents manifestations that are characteristic for  autistic spectrum disorders. Based on her academic performances, our pati   ent might have a superior than average intellect. The result of the arrayCGH analysis showed genomic imbalances including  several genes. From the list of deleted/duplicated genes, one that was pre  viously reported in patients with psychotic disorders is the SHANK3 gene. ArrayCGH analysis for our case identified an 82.3 Kb duplication of chro  mosome 22q from 51.055.575 51.137.968 bp; this region encompassed the  SHANK3. The patients mother did not carry the duplication. The genetic analysis for father was not possible because he is deceased. Several papers have reported SHANK3 gene variants in autistic spectrum consisting of both  copy number variants and point mutations. The presence of three copies of the SHANK3 gene was reported in associa   tion with autistic spectrum disorders in other papers. These findings led to  the idea that both haploinsufficiency, as well as an over expression of the  SHANK3 gene are associated with manifestations of autistic spectrum dis   orders and other neurobehavioral abnormalities.",2015.0,,"A. Belengeanu1, C. Giurgi Oncu1, S. Farcas1, D. Misceo2","1University of Medicine and Pharmacy Victor Babes, Timisoara, Romania, 2Department of Medical Genetics, Oslo University Hospital, University of Oslo, Oslo, Norway","These findings led to  the idea that both haploinsufficiency, as well as an over expression of the  SHANK3 gene are associated with manifestations of autistic spectrum dis   orders and other neurobehavioral abnormalities.",,autistic spectrum,[],"['autistic', 'spectrum']"
582,1507, The unique evolutionary signature of autism genes,PS18.07,,"Autism spectrum disorder (ASD) is a prevalent heritable neurodevelopmen tal disorder, characterized by social, and communication disabilities that greatly reduce reproductive fitness. The maintenance of such heritable and low reproductive trait in the human population is an evolutionary enigma that likely left a signature in ASD genes. To test this hypothesis, we studied the allelic characteristics of 441 ASD genes and 15,144 non ASD genes in a whole exome sequencing dataset, which included data on 503,481 single nucleotide variants (SNVs) in 1351 European Americans, and 1088 African Americans individuals. We discovered that ASD genes were significantly lon ger, and less variable than non ASD genes (2684 vs. 1632 bp, and nucleoti   de diversity  , 0.036 vs.  , 0.046 respectively; P<0.001). The mutational dearth in ASD genes was particularly eminent when considering only SNVs with functional consequences, a possible effect of negative selection. Inte restingly, ASD genes also showed signs of positive selection, but these were less evident (P<0.09). We used these genomic characteristics to generate a multivariate model that classified ASD from non ASD genes with 72% ac curacy. These finding suggest that ASD genes have a unique evolutionary signature that could be used to identify new candidate genes for this con dition.",2015.0,,"E. Tsur, M. Friger, I. Menashe","Ben Gurion University of the Negev, Beer Sheva, Israel",The maintenance of such heritable and low reproductive trait in the human population is an evolutionary enigma that likely left a signature in ASD genes.,,ASD genes,[],"['ASD', 'gene']"
582,1507, The unique evolutionary signature of autism genes,PS18.07,,"Autism spectrum disorder (ASD) is a prevalent heritable neurodevelopmen tal disorder, characterized by social, and communication disabilities that greatly reduce reproductive fitness. The maintenance of such heritable and low reproductive trait in the human population is an evolutionary enigma that likely left a signature in ASD genes. To test this hypothesis, we studied the allelic characteristics of 441 ASD genes and 15,144 non ASD genes in a whole exome sequencing dataset, which included data on 503,481 single nucleotide variants (SNVs) in 1351 European Americans, and 1088 African Americans individuals. We discovered that ASD genes were significantly lon ger, and less variable than non ASD genes (2684 vs. 1632 bp, and nucleoti   de diversity  , 0.036 vs.  , 0.046 respectively; P<0.001). The mutational dearth in ASD genes was particularly eminent when considering only SNVs with functional consequences, a possible effect of negative selection. Inte restingly, ASD genes also showed signs of positive selection, but these were less evident (P<0.09). We used these genomic characteristics to generate a multivariate model that classified ASD from non ASD genes with 72% ac curacy. These finding suggest that ASD genes have a unique evolutionary signature that could be used to identify new candidate genes for this con dition.",2015.0,,"E. Tsur, M. Friger, I. Menashe","Ben Gurion University of the Negev, Beer Sheva, Israel","To test this hypothesis, we studied the allelic characteristics of 441 ASD genes and 15,144 non ASD genes in a whole exome sequencing dataset, which included data on 503,481 single nucleotide variants (SNVs) in 1351 European Americans, and 1088 African Americans individuals.",,ASD genes,[],"['ASD', 'gene']"
582,1507, The unique evolutionary signature of autism genes,PS18.07,,"Autism spectrum disorder (ASD) is a prevalent heritable neurodevelopmen tal disorder, characterized by social, and communication disabilities that greatly reduce reproductive fitness. The maintenance of such heritable and low reproductive trait in the human population is an evolutionary enigma that likely left a signature in ASD genes. To test this hypothesis, we studied the allelic characteristics of 441 ASD genes and 15,144 non ASD genes in a whole exome sequencing dataset, which included data on 503,481 single nucleotide variants (SNVs) in 1351 European Americans, and 1088 African Americans individuals. We discovered that ASD genes were significantly lon ger, and less variable than non ASD genes (2684 vs. 1632 bp, and nucleoti   de diversity  , 0.036 vs.  , 0.046 respectively; P<0.001). The mutational dearth in ASD genes was particularly eminent when considering only SNVs with functional consequences, a possible effect of negative selection. Inte restingly, ASD genes also showed signs of positive selection, but these were less evident (P<0.09). We used these genomic characteristics to generate a multivariate model that classified ASD from non ASD genes with 72% ac curacy. These finding suggest that ASD genes have a unique evolutionary signature that could be used to identify new candidate genes for this con dition.",2015.0,,"E. Tsur, M. Friger, I. Menashe","Ben Gurion University of the Negev, Beer Sheva, Israel","To test this hypothesis, we studied the allelic characteristics of 441 ASD genes and 15,144 non ASD genes in a whole exome sequencing dataset, which included data on 503,481 single nucleotide variants (SNVs) in 1351 European Americans, and 1088 African Americans individuals.",,ASD genes,[],"['ASD', 'gene']"
582,1507, The unique evolutionary signature of autism genes,PS18.07,,"Autism spectrum disorder (ASD) is a prevalent heritable neurodevelopmen tal disorder, characterized by social, and communication disabilities that greatly reduce reproductive fitness. The maintenance of such heritable and low reproductive trait in the human population is an evolutionary enigma that likely left a signature in ASD genes. To test this hypothesis, we studied the allelic characteristics of 441 ASD genes and 15,144 non ASD genes in a whole exome sequencing dataset, which included data on 503,481 single nucleotide variants (SNVs) in 1351 European Americans, and 1088 African Americans individuals. We discovered that ASD genes were significantly lon ger, and less variable than non ASD genes (2684 vs. 1632 bp, and nucleoti   de diversity  , 0.036 vs.  , 0.046 respectively; P<0.001). The mutational dearth in ASD genes was particularly eminent when considering only SNVs with functional consequences, a possible effect of negative selection. Inte restingly, ASD genes also showed signs of positive selection, but these were less evident (P<0.09). We used these genomic characteristics to generate a multivariate model that classified ASD from non ASD genes with 72% ac curacy. These finding suggest that ASD genes have a unique evolutionary signature that could be used to identify new candidate genes for this con dition.",2015.0,,"E. Tsur, M. Friger, I. Menashe","Ben Gurion University of the Negev, Beer Sheva, Israel","We discovered that ASD genes were significantly lon ger, and less variable than non ASD genes (2684 vs. 1632 bp, and nucleoti   de diversity  , 0.036 vs.  , 0.046 respectively; P<0.001).",,ASD genes,[],"['ASD', 'gene']"
582,1507, The unique evolutionary signature of autism genes,PS18.07,,"Autism spectrum disorder (ASD) is a prevalent heritable neurodevelopmen tal disorder, characterized by social, and communication disabilities that greatly reduce reproductive fitness. The maintenance of such heritable and low reproductive trait in the human population is an evolutionary enigma that likely left a signature in ASD genes. To test this hypothesis, we studied the allelic characteristics of 441 ASD genes and 15,144 non ASD genes in a whole exome sequencing dataset, which included data on 503,481 single nucleotide variants (SNVs) in 1351 European Americans, and 1088 African Americans individuals. We discovered that ASD genes were significantly lon ger, and less variable than non ASD genes (2684 vs. 1632 bp, and nucleoti   de diversity  , 0.036 vs.  , 0.046 respectively; P<0.001). The mutational dearth in ASD genes was particularly eminent when considering only SNVs with functional consequences, a possible effect of negative selection. Inte restingly, ASD genes also showed signs of positive selection, but these were less evident (P<0.09). We used these genomic characteristics to generate a multivariate model that classified ASD from non ASD genes with 72% ac curacy. These finding suggest that ASD genes have a unique evolutionary signature that could be used to identify new candidate genes for this con dition.",2015.0,,"E. Tsur, M. Friger, I. Menashe","Ben Gurion University of the Negev, Beer Sheva, Israel","We discovered that ASD genes were significantly lon ger, and less variable than non ASD genes (2684 vs. 1632 bp, and nucleoti   de diversity  , 0.036 vs.  , 0.046 respectively; P<0.001).",,ASD genes,[],"['ASD', 'gene']"
582,1507, The unique evolutionary signature of autism genes,PS18.07,,"Autism spectrum disorder (ASD) is a prevalent heritable neurodevelopmen tal disorder, characterized by social, and communication disabilities that greatly reduce reproductive fitness. The maintenance of such heritable and low reproductive trait in the human population is an evolutionary enigma that likely left a signature in ASD genes. To test this hypothesis, we studied the allelic characteristics of 441 ASD genes and 15,144 non ASD genes in a whole exome sequencing dataset, which included data on 503,481 single nucleotide variants (SNVs) in 1351 European Americans, and 1088 African Americans individuals. We discovered that ASD genes were significantly lon ger, and less variable than non ASD genes (2684 vs. 1632 bp, and nucleoti   de diversity  , 0.036 vs.  , 0.046 respectively; P<0.001). The mutational dearth in ASD genes was particularly eminent when considering only SNVs with functional consequences, a possible effect of negative selection. Inte restingly, ASD genes also showed signs of positive selection, but these were less evident (P<0.09). We used these genomic characteristics to generate a multivariate model that classified ASD from non ASD genes with 72% ac curacy. These finding suggest that ASD genes have a unique evolutionary signature that could be used to identify new candidate genes for this con dition.",2015.0,,"E. Tsur, M. Friger, I. Menashe","Ben Gurion University of the Negev, Beer Sheva, Israel","The mutational dearth in ASD genes was particularly eminent when considering only SNVs with functional consequences, a possible effect of negative selection.",,ASD genes,[],"['ASD', 'gene']"
582,1507, The unique evolutionary signature of autism genes,PS18.07,,"Autism spectrum disorder (ASD) is a prevalent heritable neurodevelopmen tal disorder, characterized by social, and communication disabilities that greatly reduce reproductive fitness. The maintenance of such heritable and low reproductive trait in the human population is an evolutionary enigma that likely left a signature in ASD genes. To test this hypothesis, we studied the allelic characteristics of 441 ASD genes and 15,144 non ASD genes in a whole exome sequencing dataset, which included data on 503,481 single nucleotide variants (SNVs) in 1351 European Americans, and 1088 African Americans individuals. We discovered that ASD genes were significantly lon ger, and less variable than non ASD genes (2684 vs. 1632 bp, and nucleoti   de diversity  , 0.036 vs.  , 0.046 respectively; P<0.001). The mutational dearth in ASD genes was particularly eminent when considering only SNVs with functional consequences, a possible effect of negative selection. Inte restingly, ASD genes also showed signs of positive selection, but these were less evident (P<0.09). We used these genomic characteristics to generate a multivariate model that classified ASD from non ASD genes with 72% ac curacy. These finding suggest that ASD genes have a unique evolutionary signature that could be used to identify new candidate genes for this con dition.",2015.0,,"E. Tsur, M. Friger, I. Menashe","Ben Gurion University of the Negev, Beer Sheva, Israel","Inte restingly, ASD genes also showed signs of positive selection, but these were less evident (P<0.09).",,ASD genes,[],"['ASD', 'gene']"
582,1507, The unique evolutionary signature of autism genes,PS18.07,,"Autism spectrum disorder (ASD) is a prevalent heritable neurodevelopmen tal disorder, characterized by social, and communication disabilities that greatly reduce reproductive fitness. The maintenance of such heritable and low reproductive trait in the human population is an evolutionary enigma that likely left a signature in ASD genes. To test this hypothesis, we studied the allelic characteristics of 441 ASD genes and 15,144 non ASD genes in a whole exome sequencing dataset, which included data on 503,481 single nucleotide variants (SNVs) in 1351 European Americans, and 1088 African Americans individuals. We discovered that ASD genes were significantly lon ger, and less variable than non ASD genes (2684 vs. 1632 bp, and nucleoti   de diversity  , 0.036 vs.  , 0.046 respectively; P<0.001). The mutational dearth in ASD genes was particularly eminent when considering only SNVs with functional consequences, a possible effect of negative selection. Inte restingly, ASD genes also showed signs of positive selection, but these were less evident (P<0.09). We used these genomic characteristics to generate a multivariate model that classified ASD from non ASD genes with 72% ac curacy. These finding suggest that ASD genes have a unique evolutionary signature that could be used to identify new candidate genes for this con dition.",2015.0,,"E. Tsur, M. Friger, I. Menashe","Ben Gurion University of the Negev, Beer Sheva, Israel",We used these genomic characteristics to generate a multivariate model that classified ASD from non ASD genes with 72% ac curacy.,,ASD genes,[],"['ASD', 'gene']"
582,1507, The unique evolutionary signature of autism genes,PS18.07,,"Autism spectrum disorder (ASD) is a prevalent heritable neurodevelopmen tal disorder, characterized by social, and communication disabilities that greatly reduce reproductive fitness. The maintenance of such heritable and low reproductive trait in the human population is an evolutionary enigma that likely left a signature in ASD genes. To test this hypothesis, we studied the allelic characteristics of 441 ASD genes and 15,144 non ASD genes in a whole exome sequencing dataset, which included data on 503,481 single nucleotide variants (SNVs) in 1351 European Americans, and 1088 African Americans individuals. We discovered that ASD genes were significantly lon ger, and less variable than non ASD genes (2684 vs. 1632 bp, and nucleoti   de diversity  , 0.036 vs.  , 0.046 respectively; P<0.001). The mutational dearth in ASD genes was particularly eminent when considering only SNVs with functional consequences, a possible effect of negative selection. Inte restingly, ASD genes also showed signs of positive selection, but these were less evident (P<0.09). We used these genomic characteristics to generate a multivariate model that classified ASD from non ASD genes with 72% ac curacy. These finding suggest that ASD genes have a unique evolutionary signature that could be used to identify new candidate genes for this con dition.",2015.0,,"E. Tsur, M. Friger, I. Menashe","Ben Gurion University of the Negev, Beer Sheva, Israel",These finding suggest that ASD genes have a unique evolutionary signature that could be used to identify new candidate genes for this con dition.,,ASD genes,[],"['ASD', 'gene']"
583,1723, Prenatal and postnatal correlations in velo cardio facial syndrome,J01.46,,"DiGeorge syndrome (velo cardio facial) is the most common microdeletion  syndrome(22q11.2) in humans, having the incidence about 1/4000 new   borns. It is diagnosed in about 1/68 cases of heart malformations( Wilson et al.,1994). It is characterised by a broad phenotypic variability, having impor   tant variability even among the same family affected members and between identical tweens.Frequent could be associated heart,kidney malformations, palatal anomalies, immune deficits. Comportamental problems and mental retardation are resent in about 46% of cases, with different severity , in cluding delay of motor and verbal aquisition, autistic features , psichiatric disorers as depresion, bipolar affection and schisofrenia.In our prenatal cases diagnostic suspicion was ultrasound diagnosis of heart malformations as truncus arteriosus and tetralogy of Fallot. In a newborn case, medical history of polyhydramnios, typical facies and heart malforma tion, in this case interrupted Aortic arch, rised suspicion of this syndrome. All cases were confirmed using arrayCGH and FISH technique.In conclusion, presence of heart malformations in prenatal diagnosis its an important marker of a possible genetic syndrome. Additional, using of microarray analysis would allow as an increased number of microdeletion or microduplication syndromes to be diagnosed. Apart from prognosis of the heart malformation, clinical variability and variable association of in tellectual disability, represents a challenging step in prenatal counselling of families.",2015.0,,"F. M. NEDELEA1,2, A. Vayna1, A. Veduta1, M. Bari1, D. Stambouli2, G. Peltecu1","1Clinical Hospital Filantropia, Bucharest, Romania, 2Cytogenomic Medical Laboratory,  Bucharest, Romania","Comportamental problems and mental retardation are resent in about 46% of cases, with different severity , in cluding delay of motor and verbal aquisition, autistic features , psichiatric disorers as depresion, bipolar affection and schisofrenia.In our prenatal cases diagnostic suspicion was ultrasound diagnosis of heart malformations as truncus arteriosus and tetralogy of Fallot.",,autistic features,[],"['autistic', 'feature']"
589,21,Using next generation sequencing to understand the genetics of autism,S06.1,,"Autism is a devastating neurodevelopmental disorder that afflicts approxi mately 1% of live births. It is characterized by deficits in language, social in teraction and repetitive behaviors. I will summarize our findings regarding the discovery of genetic mutations and their contribution to autism spec trum disorder (ASD) and developmental delay (DD). I will present evidence from exome and molecular inversion probe sequencing of more than 10,000 children with simplex autism and show how these data may be used to pin point specific genes. The emerging data strongly argue that the develop ment of the human brain is particularly sensitive to the timing and expres   sion of many different genes; multiple genetic perturbations within specific neurodevelopmental pathways related to long term potentiation, chromatin remodeling, synaptic function and Wnt signaling appear particularly impor   tant; and that the maternal and paternal contributions differ significantly. I will present data on how grouping patients based on a specific gene can be used to predict clinical subtypes of autism. Next generation exome and ge nome sequencing data provide a powerful path forward for understanding the genetic architecture of these diseases but the heterogeneity demands an unprecedented level of global cooperation and networking.",2016.0,,"E. Eichler,","Seattle, WA, United States, University of Washington & HHMI, Seattle, WA, United  States","I will present evidence from exome and molecular inversion probe sequencing of more than 10,000 children with simplex autism and show how these data may be used to pin point specific genes.",children with simplex autism,,"['child', 'with', 'simplex', 'autism']",[]
590,22, A highly conserved program of neuronal microexons is misregulated in autistic brains,S06.2,,"A key challenge in understanding autism is to establish whether this gene tically heterogeneous disorder is caused by common mechanisms. Tran scriptomic profiling has revealed consistently altered signatures in autistic brains. These include a program of 3 27 nucleotide microexons, which is misregulated in the brains of individuals with autism spectrum disorder. Relative to all other types of alternative splicing, microexons display the most striking evolutionary conservation and switch like regulation during neuronal differentiation. These microexons modulate the function of inter   action domains of proteins involved in neurogenesis and are modulated by neuronal activity. Most neural microexons are regulated by the neuronal  specific splicing factor nSR100/SRRM4 through its binding to adjacent in  tronic enhancer motifs, and reduced levels of this protein are also observed in autistic brains. Collectively, these results provide evidence that misregu  lation of a splicing network affected by neuronal activity is associated with  associated with autism spectrum disorder.",2016.0,,"M. Irimia, M. Quesnel Vallieres, N. Parikshak, D. H. Geschwind, S. P . Cordes, B. J.  Blencowe","Centre for Genomic Regulation (CRG), Barcelona, Spain, University of Toronto, Toronto,  ON, Canada, University of California Los Angeles, Los Angeles, CA, United States,  Lunenfeld Tanenbaum Research Institute, Toronto, ON, Canada",Tran scriptomic profiling has revealed consistently altered signatures in autistic brains.,,autistic brains,[],"['autistic', 'brain']"
590,22, A highly conserved program of neuronal microexons is misregulated in autistic brains,S06.2,,"A key challenge in understanding autism is to establish whether this gene tically heterogeneous disorder is caused by common mechanisms. Tran scriptomic profiling has revealed consistently altered signatures in autistic brains. These include a program of 3 27 nucleotide microexons, which is misregulated in the brains of individuals with autism spectrum disorder. Relative to all other types of alternative splicing, microexons display the most striking evolutionary conservation and switch like regulation during neuronal differentiation. These microexons modulate the function of inter   action domains of proteins involved in neurogenesis and are modulated by neuronal activity. Most neural microexons are regulated by the neuronal  specific splicing factor nSR100/SRRM4 through its binding to adjacent in  tronic enhancer motifs, and reduced levels of this protein are also observed in autistic brains. Collectively, these results provide evidence that misregu  lation of a splicing network affected by neuronal activity is associated with  associated with autism spectrum disorder.",2016.0,,"M. Irimia, M. Quesnel Vallieres, N. Parikshak, D. H. Geschwind, S. P . Cordes, B. J.  Blencowe","Centre for Genomic Regulation (CRG), Barcelona, Spain, University of Toronto, Toronto,  ON, Canada, University of California Los Angeles, Los Angeles, CA, United States,  Lunenfeld Tanenbaum Research Institute, Toronto, ON, Canada","These include a program of 3 27 nucleotide microexons, which is misregulated in the brains of individuals with autism spectrum disorder.",individuals with autism,,"['individual', 'with', 'autism']",[]
590,22, A highly conserved program of neuronal microexons is misregulated in autistic brains,S06.2,,"A key challenge in understanding autism is to establish whether this gene tically heterogeneous disorder is caused by common mechanisms. Tran scriptomic profiling has revealed consistently altered signatures in autistic brains. These include a program of 3 27 nucleotide microexons, which is misregulated in the brains of individuals with autism spectrum disorder. Relative to all other types of alternative splicing, microexons display the most striking evolutionary conservation and switch like regulation during neuronal differentiation. These microexons modulate the function of inter   action domains of proteins involved in neurogenesis and are modulated by neuronal activity. Most neural microexons are regulated by the neuronal  specific splicing factor nSR100/SRRM4 through its binding to adjacent in  tronic enhancer motifs, and reduced levels of this protein are also observed in autistic brains. Collectively, these results provide evidence that misregu  lation of a splicing network affected by neuronal activity is associated with  associated with autism spectrum disorder.",2016.0,,"M. Irimia, M. Quesnel Vallieres, N. Parikshak, D. H. Geschwind, S. P . Cordes, B. J.  Blencowe","Centre for Genomic Regulation (CRG), Barcelona, Spain, University of Toronto, Toronto,  ON, Canada, University of California Los Angeles, Los Angeles, CA, United States,  Lunenfeld Tanenbaum Research Institute, Toronto, ON, Canada","Most neural microexons are regulated by the neuronal  specific splicing factor nSR100/SRRM4 through its binding to adjacent in  tronic enhancer motifs, and reduced levels of this protein are also observed in autistic brains.",,autistic brains,[],"['autistic', 'brain']"
591,141,A Complex Mutational Spectrum of Structural Variation Contributing to Autism,C15.1,,"Recent genomic studies of autism spectrum disorder (ASD) have relied upon genome wide characterization of coding mutations using whole exome sequencing (WES) and copy number variants (CNV) using chromosomal microarray (CMA). In ASD, these efforts have revealed a strong associati on with de novo loss of function (LoF) mutations and CNVs segments that alter the dosage of genes under evolutionary constraint. Unfortunately, the impact of balanced and complex structural variation (SV), which also repre sent LoF variation, remains uncharacterized in ASD and other human disea   se studies. Here, we explored the full mutational spectrum of SV contribu ting to ASD by integrating large insert, short insert and synthetic long read whole genome sequencing (WGS) technologies with CMA in 307 idiopathic ASD probands and 120 family members from the Simons Simplex Collec tion. Analyses revealed a diverse landscape of SVs beyond canonical CNVs, including inversions, insertions, and translocations. We also categorized 13 distinct subclasses of recurrent complex SVs and demonstrate that each ge nome sequenced harbored at least one such large complex rearrangement (~5 kb resolution). We identified 26 de novo SVs likely contributing to ASD, 50% of which were cryptic to detection by previous technologies on the se same samples. These data confirmed 13 previously proposed ASD risk factors and discovered 12 novel candidates. We estimate that the overall contribution of de novo SVs in ASD at this resolution to be at least 8.2%, or a two fold increase over previous analyses restricted to CNVs. These data suggest that cryptic and complex SV represent an important and presently underappreciated component of ASD etiology. ABSTRACTS CONCURRENT SESSIONS ESHG 2016 | BARCELONA, SPAIN | WWW.ESHG.ORG  38Back to index",2016.0,,"M. E. Talkowski, R. Collins, C. Redin, M. Stone, J. Glessner, S. Sanders, H. Brand,","Massachusetts General Hospital, Boston, MA, United States, Harvard Medical School,  Boston, MA, United States, Broad Institute, Cambridge, MA, United States, University of  California San Francisco, San Francisco, CA, United States","Here, we explored the full mutational spectrum of SV contribu ting to ASD by integrating large insert, short insert and synthetic long read whole genome sequencing (WGS) technologies with CMA in 307 idiopathic ASD probands and 120 family members from the Simons Simplex Collec tion.",,ASD probands,[],"['ASD', 'probands']"
591,141,A Complex Mutational Spectrum of Structural Variation Contributing to Autism,C15.1,,"Recent genomic studies of autism spectrum disorder (ASD) have relied upon genome wide characterization of coding mutations using whole exome sequencing (WES) and copy number variants (CNV) using chromosomal microarray (CMA). In ASD, these efforts have revealed a strong associati on with de novo loss of function (LoF) mutations and CNVs segments that alter the dosage of genes under evolutionary constraint. Unfortunately, the impact of balanced and complex structural variation (SV), which also repre sent LoF variation, remains uncharacterized in ASD and other human disea   se studies. Here, we explored the full mutational spectrum of SV contribu ting to ASD by integrating large insert, short insert and synthetic long read whole genome sequencing (WGS) technologies with CMA in 307 idiopathic ASD probands and 120 family members from the Simons Simplex Collec tion. Analyses revealed a diverse landscape of SVs beyond canonical CNVs, including inversions, insertions, and translocations. We also categorized 13 distinct subclasses of recurrent complex SVs and demonstrate that each ge nome sequenced harbored at least one such large complex rearrangement (~5 kb resolution). We identified 26 de novo SVs likely contributing to ASD, 50% of which were cryptic to detection by previous technologies on the se same samples. These data confirmed 13 previously proposed ASD risk factors and discovered 12 novel candidates. We estimate that the overall contribution of de novo SVs in ASD at this resolution to be at least 8.2%, or a two fold increase over previous analyses restricted to CNVs. These data suggest that cryptic and complex SV represent an important and presently underappreciated component of ASD etiology. ABSTRACTS CONCURRENT SESSIONS ESHG 2016 | BARCELONA, SPAIN | WWW.ESHG.ORG  38Back to index",2016.0,,"M. E. Talkowski, R. Collins, C. Redin, M. Stone, J. Glessner, S. Sanders, H. Brand,","Massachusetts General Hospital, Boston, MA, United States, Harvard Medical School,  Boston, MA, United States, Broad Institute, Cambridge, MA, United States, University of  California San Francisco, San Francisco, CA, United States",These data confirmed 13 previously proposed ASD risk factors and discovered 12 novel candidates.,,ASD risk,[],"['ASD', 'risk']"
591,141,A Complex Mutational Spectrum of Structural Variation Contributing to Autism,C15.1,,"Recent genomic studies of autism spectrum disorder (ASD) have relied upon genome wide characterization of coding mutations using whole exome sequencing (WES) and copy number variants (CNV) using chromosomal microarray (CMA). In ASD, these efforts have revealed a strong associati on with de novo loss of function (LoF) mutations and CNVs segments that alter the dosage of genes under evolutionary constraint. Unfortunately, the impact of balanced and complex structural variation (SV), which also repre sent LoF variation, remains uncharacterized in ASD and other human disea   se studies. Here, we explored the full mutational spectrum of SV contribu ting to ASD by integrating large insert, short insert and synthetic long read whole genome sequencing (WGS) technologies with CMA in 307 idiopathic ASD probands and 120 family members from the Simons Simplex Collec tion. Analyses revealed a diverse landscape of SVs beyond canonical CNVs, including inversions, insertions, and translocations. We also categorized 13 distinct subclasses of recurrent complex SVs and demonstrate that each ge nome sequenced harbored at least one such large complex rearrangement (~5 kb resolution). We identified 26 de novo SVs likely contributing to ASD, 50% of which were cryptic to detection by previous technologies on the se same samples. These data confirmed 13 previously proposed ASD risk factors and discovered 12 novel candidates. We estimate that the overall contribution of de novo SVs in ASD at this resolution to be at least 8.2%, or a two fold increase over previous analyses restricted to CNVs. These data suggest that cryptic and complex SV represent an important and presently underappreciated component of ASD etiology. ABSTRACTS CONCURRENT SESSIONS ESHG 2016 | BARCELONA, SPAIN | WWW.ESHG.ORG  38Back to index",2016.0,,"M. E. Talkowski, R. Collins, C. Redin, M. Stone, J. Glessner, S. Sanders, H. Brand,","Massachusetts General Hospital, Boston, MA, United States, Harvard Medical School,  Boston, MA, United States, Broad Institute, Cambridge, MA, United States, University of  California San Francisco, San Francisco, CA, United States",These data suggest that cryptic and complex SV represent an important and presently underappreciated component of ASD etiology.,,ASD etiology,[],"['ASD', 'etiology']"
592,142, A potential role for the linker for activation of T cells (LAT) in the neuroanatomical phenotype of the 220kb 16p11,C15.2,,"Copy number variants (CNVs) of the distal 16p11.2 220kb BP2 BP3 regi  on show mirror effect on BMI and head size, and association with autism  spectrum disorders (ASD) and schizophrenia, as previously reported for  the proximal 16p11.2 600kb BP4 BP5 deletion and duplication. These two CNVs prone regions at 16p11.2 are also reciprocally engaged in complex  chromatin looping, successfully confirmed by 4C, FISH, Hi C and concomi   tant expression changes. We assessed the 220kb BP2 BP3 duplication by  overexpressing each of the 9 encompassed human transcripts, CD19, NFAT   C2IP , ATXN2L, TUFM, ATP2A1, RABEP2, SPNS1, LAT and SH2B1, in zebrafish  embryos. Overexpression of the linker for activation of T cells (LAT) induced  a reduction in dividing cells in the brain and number of post mitotic neurons in the anterior forebrain at 2dpf, and of intertectal axonal tracts at 3dpf, re  sulting in microcephaly at later stages. We showed similar results upon ove  rexpression of CD247 and ZAP70, two genes belonging to the LATs immune system signaling pathway. Co injections experiments showed that KCTD13,  MVP , and MAPK3, three genes mapping within the 600kb BP4 BP5 locus and  major driver and modifiers, respectively, of the head circumference pheno type linked to that region, and LAT acted in an additive manner to increase the severity of the microcephaly phenotype, suggesting the presence of ge netic interaction. Chromatin conformation capture further showed that LAT cis  and trans interacting chromatin partners were enriched for ASD genes (p,5.6E 03, OR,1.9). Our results suggest that LAT , besides its well recogni zed function in T cells development, is a major contributor in the 16p11.2 (BP2 BP3) 220kb CNVs neurodevelopmental phenotypes.",2016.0,,"M. Loviglio, T . Arbogast, M. Leleu, G. Giannuzzi, K. Mnnik, p. Consortium, J. S.  Beckmann, S. Jacquemont, N. Katsanis, C. Golzio, A. Reymond","Center for Integrative Genomics, Lausanne, Switzerland, Center for Human Disease  Modeling   Duke University, Durham, NC, United States, EPFL, Lausanne, Switzerland,  Swiss Institute of Bioinformatics (SIB), Lausanne, Switzerland, CHUSJ   Universit de  Montral, Montral, QC, Canada","Copy number variants (CNVs) of the distal 16p11.2 220kb BP2 BP3 regi  on show mirror effect on BMI and head size, and association with autism  spectrum disorders (ASD) and schizophrenia, as previously reported for  the proximal 16p11.2 600kb BP4 BP5 deletion and duplication.",association with autism,,"['association', 'with', 'autism']",[]
592,142, A potential role for the linker for activation of T cells (LAT) in the neuroanatomical phenotype of the 220kb 16p11,C15.2,,"Copy number variants (CNVs) of the distal 16p11.2 220kb BP2 BP3 regi  on show mirror effect on BMI and head size, and association with autism  spectrum disorders (ASD) and schizophrenia, as previously reported for  the proximal 16p11.2 600kb BP4 BP5 deletion and duplication. These two CNVs prone regions at 16p11.2 are also reciprocally engaged in complex  chromatin looping, successfully confirmed by 4C, FISH, Hi C and concomi   tant expression changes. We assessed the 220kb BP2 BP3 duplication by  overexpressing each of the 9 encompassed human transcripts, CD19, NFAT   C2IP , ATXN2L, TUFM, ATP2A1, RABEP2, SPNS1, LAT and SH2B1, in zebrafish  embryos. Overexpression of the linker for activation of T cells (LAT) induced  a reduction in dividing cells in the brain and number of post mitotic neurons in the anterior forebrain at 2dpf, and of intertectal axonal tracts at 3dpf, re  sulting in microcephaly at later stages. We showed similar results upon ove  rexpression of CD247 and ZAP70, two genes belonging to the LATs immune system signaling pathway. Co injections experiments showed that KCTD13,  MVP , and MAPK3, three genes mapping within the 600kb BP4 BP5 locus and  major driver and modifiers, respectively, of the head circumference pheno type linked to that region, and LAT acted in an additive manner to increase the severity of the microcephaly phenotype, suggesting the presence of ge netic interaction. Chromatin conformation capture further showed that LAT cis  and trans interacting chromatin partners were enriched for ASD genes (p,5.6E 03, OR,1.9). Our results suggest that LAT , besides its well recogni zed function in T cells development, is a major contributor in the 16p11.2 (BP2 BP3) 220kb CNVs neurodevelopmental phenotypes.",2016.0,,"M. Loviglio, T . Arbogast, M. Leleu, G. Giannuzzi, K. Mnnik, p. Consortium, J. S.  Beckmann, S. Jacquemont, N. Katsanis, C. Golzio, A. Reymond","Center for Integrative Genomics, Lausanne, Switzerland, Center for Human Disease  Modeling   Duke University, Durham, NC, United States, EPFL, Lausanne, Switzerland,  Swiss Institute of Bioinformatics (SIB), Lausanne, Switzerland, CHUSJ   Universit de  Montral, Montral, QC, Canada","Chromatin conformation capture further showed that LAT cis  and trans interacting chromatin partners were enriched for ASD genes (p,5.6E 03, OR,1.9).",,ASD genes,[],"['ASD', 'gene']"
593,143, Disruption of POGZ is associated with intellectual disability and autism spectrum disorders,C15.3,,"Introduction: Intellectual disability (ID) and autism spectrum disorders (ASD) are genetically heterogeneous, and associated genes for both condi   tions overlap substantially. Few mutations in POGZ were reported in recent exome studies. However, these studies did not provide detailed clinical in formation, leaving the pathogenicity and a clear phenotypic definition of the POGZ patient unknown.Patients and Methods: We collected the clinical and molecular data of 25 individuals with disruptive mutations in POGZ identified by diagnostic who le exome, whole genome, or targeted sequencing of 5,223 individuals with neurodevelopmental disorders (ID primarily) or by targeted resequencing of this locus in 12,041 individuals with ASD and/or ID. In parallel, we utili   zed a Drosophila knockdown model of the POGZ orthologue row to provide further support for the importance of POGZ in cognitive function.Results: We defined common phenotypic features of POGZ patients, inclu   ding variable levels of developmental delay and more severe speech and language delay compared to motor delay and coordination issues. We also identified significant associations with vision problems, microcephaly, hy   peractivity, a tendency to obesity and feeding difficulties. In addition, we found that downregulation of row expression, specifically in neurons, leads to deficits in habituation, a form of non associative learning that is highly relevant for both ID and ASD. Conclusion: Combined, these data underscore the pathogenicity of loss of  function mutations in POGZ and define a novel POGZ related syndrome. Some features may be explained by the high expression of POGZ early in fetal brain development, particularly in the cerebellum and pituitary.",2016.0,,"H. A. F. Stessman, M. H. Willemsen, M. Fenckova, O. Penn, A. Hoischen, B. Xiong, T .  Wang, K. Hoekzema, L. Vives, I. Vogel, H. G. Brunner, I. van der Burgt, C. Ockeloen,  J. Schuurs Hoeijmakers, J. Klein Wassink Ruiter, C. Stumpel, J. Vles, C. Marcelis, H.  van Bokhoven, V. Cantagrel, S. Lyonnet, L. Colleaux, R. Bernier, J. Gerdts, B. P . Coe,  C. Romano, L. Grillo, A. Alberti, C. Scuderi, M. Nordenskjld, M. Kvarnung, H. Guo,  K. Xia, A. Piton, B. Gerard, D. Genevieve, B. Delobel, D. Lehalle, L. Perrin,  F. Prieur, J. Thevenon, J. Gecz, M. Shaw, R. Pfundt, B. Keren, A. Jacquette, A.  Schenck, E. Eichler, T . Kleefstra","University of Washington, Seattle, WA, United States, Radboud University Medical  Centre, Nijmegen, Netherlands, School of Life Sciences, Changsha, China, Aarhus  University Hospital, Aarhus, Denmark, University Medical Center Groningen, Groningen,  Netherlands, Maastricht UMC+, Maastricht, Netherlands, Institut Imagine, INSERM,  Paris, France, IRCCS Associazione Oasi Maria Santissima, Troina, Italy, IRCCS  Associazione Oasi Maria Santissima, Toina, Italy, Center for Molecular Medicine,  Karolinska Institutet, Stockholm, Sweden, School of Life Sciences, Central South  University, Changsha, China, Institut Gntique Biologie Molculaire Cellulaire,  Illkirch, France, Hpitaux Universitaires de Strasbourg, Strasbourg, France, Hpital  Arnaud de Villeneuve, Montpellier, France, Hopital Saint Vincent de Paul, Lille, France,  Fdration Hospitalo Universitaire TRANSLAD, Dijon, France, Hpital Robert Debr,  Paris, France, CHU de Saint tienne, Saint Etienne, France, Robinson Research  Institute and the University of Adelaide at the Womens and Childrens Hospital, North Adelaide, Australia,  Hpital de la Piti Salptrire, Paris, France, Howard Hughes  Medical Institute, Seattle, WA, United States","However, these studies did not provide detailed clinical in formation, leaving the pathogenicity and a clear phenotypic definition of the POGZ patient unknown.Patients and Methods: We collected the clinical and molecular data of 25 individuals with disruptive mutations in POGZ identified by diagnostic who le exome, whole genome, or targeted sequencing of 5,223 individuals with neurodevelopmental disorders (ID primarily) or by targeted resequencing of this locus in 12,041 individuals with ASD and/or ID.",individuals with ASD,,"['individual', 'with', 'ASD']",[]
595,441, Myhre syndrome with a full spectrum of cardiovascular and gastrointestinal complications,P04.065,,"Introduction. Myhre syndrome/LAPS is a rare cause of syndromic limitation of the range of joint motion, generally presenting with variable degrees of intellectual disability and short stature. Fifty six molecularly proven cases have been reported in the medical literature to date.Clinical report. The patient was born SGA at term as the only child of healthy Italian parents. Paternal and maternal ages at conception were 39 and 31 years respectively. We evaluated the girl at 14 years. Cardinal history fin dings were delayed motor milestones with normal speech development and a full scale IQ of 74; mild autistic traits; stiffness gradually involving small and large joints and resulting in pronounced functional impairment of the shoulder girdle and tibiotarsal joints in her early teens; GH defici   ency; thelarche variant; bilateral chronic otitis media with effusion lea   ding to tympanosclerosis; marked retinal vessel tortuosity; astigmatism; laryngospasm during procedural sedation. Congenital heart disease (CHD) requiring surgery (tetralogy of Fallot and peripheral pulmonary stenosis) was identified at 2 weeks of age. Her long standing hepatomegaly, alrea dy present at 6 months, and mild protein losing enteropathy might be pa thogenetically related to perturbed extracellular matrix homoeostasis, as both of them were not significantly modified either by cardiac therapies or, more recently, by constrictive pericarditis. On physical examination stocky build, short palpebral fissures and skin thickening were noted. Direct se   quencing of SMAD4 identified the recurrent de novo mutation p.Ile500Val  (NM_005359.5:c.1498A>G).ABSTRACTS POSTERS ESHG 2016 | BARCELONA, SPAIN | WWW.ESHG.ORG  109Back to index Conclusions. We report a new case of Myhre syndrome whose gastrointe  stinal features and unusually severe CHD broaden the clinical spectrum of  the disease.",2016.0,,"A. M. Spinelli, A. Morgan, E. Rubinato, M. C. Pellegrin, A. Delise, V. Guastalla, A.  Benettoni, I. Bruno, F. Faletra","University of Trieste and University of Padova, Trieste, Italy, Institute for Maternal and  Child Health   IRCCS Burlo Garofolo, Trieste, Italy, University of Trieste, Trieste, Italy",Cardinal history fin dings were delayed motor milestones with normal speech development and a full scale IQ of 74; mild autistic traits; stiffness gradually involving small and large joints and resulting in pronounced functional impairment of the shoulder girdle and tibiotarsal joints in her early teens; GH defici   ency; thelarche variant; bilateral chronic otitis media with effusion lea   ding to tympanosclerosis; marked retinal vessel tortuosity; astigmatism; laryngospasm during procedural sedation.,,autistic traits,[],"['autistic', 'trait']"
601,643, 2q37,P08.06,,"E Veltishev at the Pirogov  Russian National Research Medical University, Ministry of Health, Moscow, Russian Federation,  2Mental Health Research Center, Moscow, Russian Federation, 3Moscow State  University of Psychology and Education, Moscow, Russian Federation. Introduction. 2q37.3 deletion syndrome is considered to be a rare chro mosomal disorder associated with variable clinical features, among which are intellectual disability (ID), autistic features, brachydactyly, short stat   ure, hypotonia and obesity. Some facial features are characteristic for the syndrome (i.e. round face, frontal bossing, arched eyebrows, deep set eyes, upslanted palpebral fissures, epicanthal folds, thin upper lip, minor ear anomalies). Haploinsufficiency of HDAC4 seems to be the most critical for the phenotypic spectrum. Here, we have attempted to assess chromosome ABSTRACTS POSTERS ESHG 2016 | BARCELONA, SPAIN | WWW.ESHG.ORG  157Back to index 2q37.3 deletions and HDAC4 haploinsufficiency per se in children with in  tellectual disability, autism and/or congenital malformation. Materials and Methods. Molecular karyotyping by SNP/oligonucleotide mi  croarray (resolution: >1kbp) was used to analyze 300 children with ID, au   tism spectrum disorders and congenital malformations. Results. Cytogenetically visible 2q37 deletions were detected in 2 cases.  Molecular karyotyping confirmed the presence of these deletions (5Mb and 8.5Mb). Furthermore, a CNV within 2q37.3 (44kbp) leading to HDAC4 loss was detected in a patient. All affected female patients had ID, autism and  minor ear anomalies. One had widely set nipples and hypotonia. Another  one had a short statue. Two patients presented with ocular hypertelorism. HDAC4 haploinsufficiency was observed in all three cases. Conclusions. We show that 2q37 deletions can be common in children with  ID, autism, congenital malformations tending to a frequency as high as 1%. Therefore, one can suggest that 2q37.3 deletions are likely to be more com  mon among these children than previously recognized. Supported by the  Russian Science Foundation (Grant #14 35 00060).",2016.0,,"I. A. Demidova, S. G. Vorsanova, K. Vasin, M. A. Zelenova, N. S. Shmitova, N. S.  Shmitova, O. S. Kurinnaia, Y. B. Yurov, I. Y. Iourov,",Research and Clinical Institute for Pediatrics named after Y,"2q37.3 deletion syndrome is considered to be a rare chro mosomal disorder associated with variable clinical features, among which are intellectual disability (ID), autistic features, brachydactyly, short stat   ure, hypotonia and obesity.",,autistic features,[],"['autistic', 'feature']"
606,650, Clinical utility of whole exome sequencing; case report of a child with global neurodevelopmental delay focused on autism spectrum disorder,P08.13,," Introduction: Autism Spectrum Disorders (ASD, OMIM#209850) are a group of heterogeneous neurobehavioral syndromes without an accurate  molecular genetics protocol after a non conclusive karyotype, fragile X and  CGH array tests results. Here we report the case of a two years old child, born at 41 weeks gestation after induced labor for oligohydramnios, with a  global neurodevelopmental delay focused on ASD, a suggestive hereditary  family history and normal karyotype, fragile X and CGH array tests. Who le exome sequencing was performed to depict the complex genetics autism spectrum disorder. Material and methods: Exome sequencing and selective analysis of ASD  known genes was applied at first. Then a second analysis extended to re maining OMIM genes was carried out (qGenomics Laboratory) Results: ASD related genes analysis did not reveal any significant finding,  but the extended study to other OMIM genes identified a likely pathogenic mutation in GDI1 gene (c.389 1G> C; hemizygous splicing variant). This  gene has been strongly associated with intellectual disabilities (ID) although  there is only evidence from 3 published families with X linked ID and GDI1 mutations (one nonsense, two missense) (Strobl Wildemann G, et al. Am J Med Genet A. 2011). Conclusions: The mutation found in the studied family provides more evi  dence about the GDI1 role in X linked ID. Furthermore, GDI1 seems to be related also to another clinical feature, ASD. Our findings suggest including GDI1 in ASD panels as well as in X linked intellectual disabilities. Finally, our  work underlines the utility of whole exome sequencing instead of specific  gene panels for an accurate diagnosis and complete genetic counselling.",2016.0,,"A. Vallmaj, D. Casellas, A. Castan, M. Garca, B. Rodrguez Santiago, M. Obn","Hospital U de Girona Dr Josep Trueta, Girona, Spain, qGenomics Laboratory,  Barcelona, Spain.","Then a second analysis extended to re maining OMIM genes was carried out (qGenomics Laboratory) Results: ASD related genes analysis did not reveal any significant finding,  but the extended study to other OMIM genes identified a likely pathogenic mutation in GDI1 gene (c.389 1G> C; hemizygous splicing variant).",,ASD related genes,[],"['ASD', 'related', 'gene']"
606,650, Clinical utility of whole exome sequencing; case report of a child with global neurodevelopmental delay focused on autism spectrum disorder,P08.13,," Introduction: Autism Spectrum Disorders (ASD, OMIM#209850) are a group of heterogeneous neurobehavioral syndromes without an accurate  molecular genetics protocol after a non conclusive karyotype, fragile X and  CGH array tests results. Here we report the case of a two years old child, born at 41 weeks gestation after induced labor for oligohydramnios, with a  global neurodevelopmental delay focused on ASD, a suggestive hereditary  family history and normal karyotype, fragile X and CGH array tests. Who le exome sequencing was performed to depict the complex genetics autism spectrum disorder. Material and methods: Exome sequencing and selective analysis of ASD  known genes was applied at first. Then a second analysis extended to re maining OMIM genes was carried out (qGenomics Laboratory) Results: ASD related genes analysis did not reveal any significant finding,  but the extended study to other OMIM genes identified a likely pathogenic mutation in GDI1 gene (c.389 1G> C; hemizygous splicing variant). This  gene has been strongly associated with intellectual disabilities (ID) although  there is only evidence from 3 published families with X linked ID and GDI1 mutations (one nonsense, two missense) (Strobl Wildemann G, et al. Am J Med Genet A. 2011). Conclusions: The mutation found in the studied family provides more evi  dence about the GDI1 role in X linked ID. Furthermore, GDI1 seems to be related also to another clinical feature, ASD. Our findings suggest including GDI1 in ASD panels as well as in X linked intellectual disabilities. Finally, our  work underlines the utility of whole exome sequencing instead of specific  gene panels for an accurate diagnosis and complete genetic counselling.",2016.0,,"A. Vallmaj, D. Casellas, A. Castan, M. Garca, B. Rodrguez Santiago, M. Obn","Hospital U de Girona Dr Josep Trueta, Girona, Spain, qGenomics Laboratory,  Barcelona, Spain.",Our findings suggest including GDI1 in ASD panels as well as in X linked intellectual disabilities.,,ASD panels,[],"['ASD', 'panel']"
607,651, Targeted gene panel to investigate intellectual disability and autism spectrum disorders comorbidity,P08.14,,"Intellectual disability (ID) and autism spectrum disorder (ASD) are clinical   ly and genetically heterogeneous diseases. Recent whole exome sequencing studies indicated that genes associated with different neurologic disorders are shared among these disorders or converge on common functional pa thways.The aim of this study was to design a customized multiplex PCR based gene panel to investigate the genetic bases of ID and ASD comorbidity. The gene panel covers 74 genes, including a subset of genes that are found recurrently mutated in ID or ASD conditions, genes shared among ID and ASD disease network and ID/ASD genes that are directly connected to these. We analy   zed 18 clinically selected patients with ID and ASD without syndromic fea tures, negative for Fragile X test and array CGH. For all 18 patients, 85 97% of the targeted regions achieved read depths of at least 20x, with average read depths ranging from 91x to 612x. 22 rare single nucleotide variants (SNV) were found in the exonic sequences of 16 out of the 18 patients: most of them are predicted to be deleterious and have very low frequency or are no present in public databases. Although familial segregation analysis will be helpful to determine the pathogenic nature of the variants, likely causa tive variants have been assigned for 8 (44%) of the patients. These results confirm the diagnostic value of the targeted gene panel for investigating children with ID and ASD.Funding: Italian Ministry of health Young Investigator Grant GR 2011 02347754 to E.L.",2016.0,,"E. Leonardi, A. Gasparini, M. Carraro, E. Bettella, R. Polli, F. Cesca, S. Sartori, S. C. E. Tosatto, A. Murgia","University of Padua, Padova, Italy",Recent whole exome sequencing studies indicated that genes associated with different neurologic disorders are shared among these disorders or converge on common functional pa thways.The aim of this study was to design a customized multiplex PCR based gene panel to investigate the genetic bases of ID and ASD comorbidity.,,ASD comorbidity,[],"['ASD', 'comorbidity']"
607,651, Targeted gene panel to investigate intellectual disability and autism spectrum disorders comorbidity,P08.14,,"Intellectual disability (ID) and autism spectrum disorder (ASD) are clinical   ly and genetically heterogeneous diseases. Recent whole exome sequencing studies indicated that genes associated with different neurologic disorders are shared among these disorders or converge on common functional pa thways.The aim of this study was to design a customized multiplex PCR based gene panel to investigate the genetic bases of ID and ASD comorbidity. The gene panel covers 74 genes, including a subset of genes that are found recurrently mutated in ID or ASD conditions, genes shared among ID and ASD disease network and ID/ASD genes that are directly connected to these. We analy   zed 18 clinically selected patients with ID and ASD without syndromic fea tures, negative for Fragile X test and array CGH. For all 18 patients, 85 97% of the targeted regions achieved read depths of at least 20x, with average read depths ranging from 91x to 612x. 22 rare single nucleotide variants (SNV) were found in the exonic sequences of 16 out of the 18 patients: most of them are predicted to be deleterious and have very low frequency or are no present in public databases. Although familial segregation analysis will be helpful to determine the pathogenic nature of the variants, likely causa tive variants have been assigned for 8 (44%) of the patients. These results confirm the diagnostic value of the targeted gene panel for investigating children with ID and ASD.Funding: Italian Ministry of health Young Investigator Grant GR 2011 02347754 to E.L.",2016.0,,"E. Leonardi, A. Gasparini, M. Carraro, E. Bettella, R. Polli, F. Cesca, S. Sartori, S. C. E. Tosatto, A. Murgia","University of Padua, Padova, Italy","The gene panel covers 74 genes, including a subset of genes that are found recurrently mutated in ID or ASD conditions, genes shared among ID and ASD disease network and ID/ASD genes that are directly connected to these.",,ASD conditions,[],"['ASD', 'condition']"
607,651, Targeted gene panel to investigate intellectual disability and autism spectrum disorders comorbidity,P08.14,,"Intellectual disability (ID) and autism spectrum disorder (ASD) are clinical   ly and genetically heterogeneous diseases. Recent whole exome sequencing studies indicated that genes associated with different neurologic disorders are shared among these disorders or converge on common functional pa thways.The aim of this study was to design a customized multiplex PCR based gene panel to investigate the genetic bases of ID and ASD comorbidity. The gene panel covers 74 genes, including a subset of genes that are found recurrently mutated in ID or ASD conditions, genes shared among ID and ASD disease network and ID/ASD genes that are directly connected to these. We analy   zed 18 clinically selected patients with ID and ASD without syndromic fea tures, negative for Fragile X test and array CGH. For all 18 patients, 85 97% of the targeted regions achieved read depths of at least 20x, with average read depths ranging from 91x to 612x. 22 rare single nucleotide variants (SNV) were found in the exonic sequences of 16 out of the 18 patients: most of them are predicted to be deleterious and have very low frequency or are no present in public databases. Although familial segregation analysis will be helpful to determine the pathogenic nature of the variants, likely causa tive variants have been assigned for 8 (44%) of the patients. These results confirm the diagnostic value of the targeted gene panel for investigating children with ID and ASD.Funding: Italian Ministry of health Young Investigator Grant GR 2011 02347754 to E.L.",2016.0,,"E. Leonardi, A. Gasparini, M. Carraro, E. Bettella, R. Polli, F. Cesca, S. Sartori, S. C. E. Tosatto, A. Murgia","University of Padua, Padova, Italy","The gene panel covers 74 genes, including a subset of genes that are found recurrently mutated in ID or ASD conditions, genes shared among ID and ASD disease network and ID/ASD genes that are directly connected to these.",,ASD disease,[],"['ASD', 'disease']"
607,651, Targeted gene panel to investigate intellectual disability and autism spectrum disorders comorbidity,P08.14,,"Intellectual disability (ID) and autism spectrum disorder (ASD) are clinical   ly and genetically heterogeneous diseases. Recent whole exome sequencing studies indicated that genes associated with different neurologic disorders are shared among these disorders or converge on common functional pa thways.The aim of this study was to design a customized multiplex PCR based gene panel to investigate the genetic bases of ID and ASD comorbidity. The gene panel covers 74 genes, including a subset of genes that are found recurrently mutated in ID or ASD conditions, genes shared among ID and ASD disease network and ID/ASD genes that are directly connected to these. We analy   zed 18 clinically selected patients with ID and ASD without syndromic fea tures, negative for Fragile X test and array CGH. For all 18 patients, 85 97% of the targeted regions achieved read depths of at least 20x, with average read depths ranging from 91x to 612x. 22 rare single nucleotide variants (SNV) were found in the exonic sequences of 16 out of the 18 patients: most of them are predicted to be deleterious and have very low frequency or are no present in public databases. Although familial segregation analysis will be helpful to determine the pathogenic nature of the variants, likely causa tive variants have been assigned for 8 (44%) of the patients. These results confirm the diagnostic value of the targeted gene panel for investigating children with ID and ASD.Funding: Italian Ministry of health Young Investigator Grant GR 2011 02347754 to E.L.",2016.0,,"E. Leonardi, A. Gasparini, M. Carraro, E. Bettella, R. Polli, F. Cesca, S. Sartori, S. C. E. Tosatto, A. Murgia","University of Padua, Padova, Italy","The gene panel covers 74 genes, including a subset of genes that are found recurrently mutated in ID or ASD conditions, genes shared among ID and ASD disease network and ID/ASD genes that are directly connected to these.",,ASD genes,[],"['ASD', 'gene']"
608,663,Foxp1 related intellectual disability syndrome: a recognizable entity,P08.27,,"Introduction: Intellectual disability (ID) and specific language impairment (SLI) cover a wide range of conditions with heterogeneous phenotypes and  etiologies, making them challenging for clinical geneticists. Mutations in  forkhead box protein P1 (FOXP1), a transcription regulator, are associated with ID and SLI, with or without autistic features (MIM: 613670). Multiple  FOXP1 patients have been described, though so far, no specific phenotype  emerged. Materials and Methods: We report on the clinical and molecular data of 21 novel and well characterized patients with FOXP1 mutations and review the  25 previously reported FOXP1 patients to delineate the condition. Results: Phenotypic analysis shows a combination of neuromotor delay, ID,  SLI, and typical facial features including a high broad forehead, bent downs  lanting palpebral fissures, ptosis, blepharophimosis, and a short nose with bulbous tip. Relative macrocephaly, strabismus, a wide mouth with down turned corners, and pronounced nasolabial folds appear more variable.  Behavioural problems and autistic features are common. Brain, cardiac and  urogenital malformations seem associated. Molecular data show de novo  mutations in all cases, either monogenic or part of a more extended intersti   tial 3p deletions. Subgroup analysis reveals sensorineural hearing loss and  more severe ID in patients with interstitial 3p deletions. Conclusions: FOXP1 related ID syndrome is a recognizable entity that seems  more frequent than expected. We expand the phenotypic description with  typical facial features and associated organ system involvements. This will enable clinicians to make a gestalt diagnosis and will be helpful to evaluate genotype phenotype correlations when interpreting large NGS data obtai   ned in patients with ID and/or SLI.",2016.0,,"I. Meerschaut, J. Ptre, N. Revencu, N. Bockaert, A. Oostra, O. Vanakker, M.  Vilenov, T . J. L. de Ravel, D. Mekahli, K. K. Vaux, J. Sebat, F. F. Hamdan, J. L. Michaud,  P . Lapunzina, N. Di Donato, L. Hudgins, A. K. Hanson Kahn, B. Dallapiccola, A.  Novelli, J. Andrieux, J. Morton, N. Ragge, J. Radley, M. J. Parker, K. Neas, A.  Dheedene, B. Menten, D. Lederer, B. Callewaert,","Center for Medical Genetics Ghent, Ghent University Hospital, Ghent, Belgium,  Department of Pediatrics, Ghent University Hospital, Ghent, Belgium, Centre Gntique,  Cliniques Universitaires Saint Luc, Brussels, Belgium, NYS Institute for Basic Research  in Developmental Disabilities, Staten Island, NY, United States, Centre for Human  Genetics, University Hospital Leuven, Leuven, Belgium, Gleeson Laboratory for  Neurodevelopmental Genetics, University of California, San Diego, CA, United States,  Beyster Center for Genomics of Psychiatric Diseases, University of California, San Diego,  CA, United States, CHU Saint Justine Research Center, Montral, QC, Canada, Instituto  de Gentica Mdica Y Molecular, Hospital Universitario La Paz, Madrid, Spain, Institut  fr Klinische Genetik, Technische Universitt Dresden, Dresden, Germany, Department  of Genetics, Stanford University School of Medicine, Stanford, CA, United States,  Laboratorio Di Genetica Medica, Ospedale Pediatrico del Bambino Gesu, Rome, Italy,  Institut de Gntique Mdicale, Hospital Jeanne de Flandre, Lille, France, Clinical  Genetics Unit, Birmingham Womens Hospital, Birmingham, United Kingdom, Sheffield  Clinical Genetics Service, Sheffield Childrens Hospital, Sheffield, United Kingdom,  Genetic Health Service NZ, Wellington, New Zealand, Centre de Gntique Humaine,  Institut de Pathologie et de Gntique asbl, Gosselies, Belgium","Mutations in  forkhead box protein P1 (FOXP1), a transcription regulator, are associated with ID and SLI, with or without autistic features (MIM: 613670).",,autistic features,[],"['autistic', 'feature']"
608,663,Foxp1 related intellectual disability syndrome: a recognizable entity,P08.27,,"Introduction: Intellectual disability (ID) and specific language impairment (SLI) cover a wide range of conditions with heterogeneous phenotypes and  etiologies, making them challenging for clinical geneticists. Mutations in  forkhead box protein P1 (FOXP1), a transcription regulator, are associated with ID and SLI, with or without autistic features (MIM: 613670). Multiple  FOXP1 patients have been described, though so far, no specific phenotype  emerged. Materials and Methods: We report on the clinical and molecular data of 21 novel and well characterized patients with FOXP1 mutations and review the  25 previously reported FOXP1 patients to delineate the condition. Results: Phenotypic analysis shows a combination of neuromotor delay, ID,  SLI, and typical facial features including a high broad forehead, bent downs  lanting palpebral fissures, ptosis, blepharophimosis, and a short nose with bulbous tip. Relative macrocephaly, strabismus, a wide mouth with down turned corners, and pronounced nasolabial folds appear more variable.  Behavioural problems and autistic features are common. Brain, cardiac and  urogenital malformations seem associated. Molecular data show de novo  mutations in all cases, either monogenic or part of a more extended intersti   tial 3p deletions. Subgroup analysis reveals sensorineural hearing loss and  more severe ID in patients with interstitial 3p deletions. Conclusions: FOXP1 related ID syndrome is a recognizable entity that seems  more frequent than expected. We expand the phenotypic description with  typical facial features and associated organ system involvements. This will enable clinicians to make a gestalt diagnosis and will be helpful to evaluate genotype phenotype correlations when interpreting large NGS data obtai   ned in patients with ID and/or SLI.",2016.0,,"I. Meerschaut, J. Ptre, N. Revencu, N. Bockaert, A. Oostra, O. Vanakker, M.  Vilenov, T . J. L. de Ravel, D. Mekahli, K. K. Vaux, J. Sebat, F. F. Hamdan, J. L. Michaud,  P . Lapunzina, N. Di Donato, L. Hudgins, A. K. Hanson Kahn, B. Dallapiccola, A.  Novelli, J. Andrieux, J. Morton, N. Ragge, J. Radley, M. J. Parker, K. Neas, A.  Dheedene, B. Menten, D. Lederer, B. Callewaert,","Center for Medical Genetics Ghent, Ghent University Hospital, Ghent, Belgium,  Department of Pediatrics, Ghent University Hospital, Ghent, Belgium, Centre Gntique,  Cliniques Universitaires Saint Luc, Brussels, Belgium, NYS Institute for Basic Research  in Developmental Disabilities, Staten Island, NY, United States, Centre for Human  Genetics, University Hospital Leuven, Leuven, Belgium, Gleeson Laboratory for  Neurodevelopmental Genetics, University of California, San Diego, CA, United States,  Beyster Center for Genomics of Psychiatric Diseases, University of California, San Diego,  CA, United States, CHU Saint Justine Research Center, Montral, QC, Canada, Instituto  de Gentica Mdica Y Molecular, Hospital Universitario La Paz, Madrid, Spain, Institut  fr Klinische Genetik, Technische Universitt Dresden, Dresden, Germany, Department  of Genetics, Stanford University School of Medicine, Stanford, CA, United States,  Laboratorio Di Genetica Medica, Ospedale Pediatrico del Bambino Gesu, Rome, Italy,  Institut de Gntique Mdicale, Hospital Jeanne de Flandre, Lille, France, Clinical  Genetics Unit, Birmingham Womens Hospital, Birmingham, United Kingdom, Sheffield  Clinical Genetics Service, Sheffield Childrens Hospital, Sheffield, United Kingdom,  Genetic Health Service NZ, Wellington, New Zealand, Centre de Gntique Humaine,  Institut de Pathologie et de Gntique asbl, Gosselies, Belgium",Behavioural problems and autistic features are common.,,autistic features,[],"['autistic', 'feature']"
610,676, Diagnosis of intellectual disability by sequencing all genes known in pathology,P08.42,,"The etiologies of intellectual disability (ID) are very heterogeneous. For this reason, exome sequencing is increasingly used in the diagnosis of ID.We sequenced 151 index cases with the Illumina TruSight One panel which targets the coding sequences of 4813 genes involved in human pathology. Our aim was a diagnostic yield close to exome sequencing but less expensi ve. All patients had a negative diagnostic work up before sequencing inclu   ding chromosome microarray analysis.A definitive or likely diagnosis was found for 42 index cases (28%) in 39 different genes: 30 were autosomal dominant (de novo or with a low mo saicism in one parent), 6 were autosomal recessive, 6 were X linked. We also made 4 partial diagnoses which do not explain the whole phenotype. Besi  des, 10 variants were classified as variants of unknown significance. Finally, we identified 7 incidental findings irrelevant with the indication.In our series, 56 patients had autism and ID with normal motor develop ment and autistic regression. In these patients, we achieved a unique dia gnosis (1.7%); therefore our diagnostic yield was 42% among our 95 pati   ents with ID and no autism. We had also 35% diagnoses in our 40 patients with ID and epilepsy.Overall, this technique provides a significant advance in the diagnostic strat   egy of patients with ID. However, it highlights the need to better characterize its clinical indications. Mostly, our experience suggests that ID as part of an autistic syndrome is currently not a good indication due to the supposed multifactorial nature of this pathology.ABSTRACTS POSTERS ESHG 2016 | BARCELONA, SPAIN | WWW.ESHG.ORG  165Back to index",2016.0,,"B. Keren, C. Mignot, C. Nava, E. Lejeune, C. Mach, C. Estrade, V. Olin, A. Lafitte, S.  Karagic, A. Jacquette, P . Charles, S. Whalen, I. Marey, S. Heide, F. Mochel, A. Afenjar,  D. Doummar, T . Billette de Villemeur, A. Guet, D. Rodriguez, M. Marie Laure, Y.  Marie, S. Chantot Bastaraud, R. Touraine, F. Lesne, A. Faudet, F. Soubrier, D. Hron,  C. Depienne","Dpartement de Gntique, ICM UPMC, Inserm UMR_S/CNRS UMR , GH  Piti Salptrire, APHP , Paris, France, Dpartement de Gntique, centre de rfrence  dficience intellectuelle de causes rares, filire Dfiscience, GH Piti Salptrire, APHP , Paris, France,  Dpartement de Gntique, GH Piti Salptrire, APHP , Paris,  France, Dpartement de Gntique, centre de rfrence dficience intellectuelle de  causes rares, filire Dfiscience, GH Armand Trousseau, APHP , Paris, France, Service  de Neuropdiatrie, GH Armand Trousseau, APHP , Paris, France, ICM, plateforme  de gnotypage et squenage, GH Piti Salptrire, Paris, France, Paris, France,  Laboratoire de Cytogntique, GH Armand Trousseau, APHP , Paris, France, Service de  Gntique, CHU Nord, Saint Etienne, France","Finally, we identified 7 incidental findings irrelevant with the indication.In our series, 56 patients had autism and ID with normal motor develop ment and autistic regression.",,autistic regression,[],"['autistic', 'regression']"
610,676, Diagnosis of intellectual disability by sequencing all genes known in pathology,P08.42,,"The etiologies of intellectual disability (ID) are very heterogeneous. For this reason, exome sequencing is increasingly used in the diagnosis of ID.We sequenced 151 index cases with the Illumina TruSight One panel which targets the coding sequences of 4813 genes involved in human pathology. Our aim was a diagnostic yield close to exome sequencing but less expensi ve. All patients had a negative diagnostic work up before sequencing inclu   ding chromosome microarray analysis.A definitive or likely diagnosis was found for 42 index cases (28%) in 39 different genes: 30 were autosomal dominant (de novo or with a low mo saicism in one parent), 6 were autosomal recessive, 6 were X linked. We also made 4 partial diagnoses which do not explain the whole phenotype. Besi  des, 10 variants were classified as variants of unknown significance. Finally, we identified 7 incidental findings irrelevant with the indication.In our series, 56 patients had autism and ID with normal motor develop ment and autistic regression. In these patients, we achieved a unique dia gnosis (1.7%); therefore our diagnostic yield was 42% among our 95 pati   ents with ID and no autism. We had also 35% diagnoses in our 40 patients with ID and epilepsy.Overall, this technique provides a significant advance in the diagnostic strat   egy of patients with ID. However, it highlights the need to better characterize its clinical indications. Mostly, our experience suggests that ID as part of an autistic syndrome is currently not a good indication due to the supposed multifactorial nature of this pathology.ABSTRACTS POSTERS ESHG 2016 | BARCELONA, SPAIN | WWW.ESHG.ORG  165Back to index",2016.0,,"B. Keren, C. Mignot, C. Nava, E. Lejeune, C. Mach, C. Estrade, V. Olin, A. Lafitte, S.  Karagic, A. Jacquette, P . Charles, S. Whalen, I. Marey, S. Heide, F. Mochel, A. Afenjar,  D. Doummar, T . Billette de Villemeur, A. Guet, D. Rodriguez, M. Marie Laure, Y.  Marie, S. Chantot Bastaraud, R. Touraine, F. Lesne, A. Faudet, F. Soubrier, D. Hron,  C. Depienne","Dpartement de Gntique, ICM UPMC, Inserm UMR_S/CNRS UMR , GH  Piti Salptrire, APHP , Paris, France, Dpartement de Gntique, centre de rfrence  dficience intellectuelle de causes rares, filire Dfiscience, GH Piti Salptrire, APHP , Paris, France,  Dpartement de Gntique, GH Piti Salptrire, APHP , Paris,  France, Dpartement de Gntique, centre de rfrence dficience intellectuelle de  causes rares, filire Dfiscience, GH Armand Trousseau, APHP , Paris, France, Service  de Neuropdiatrie, GH Armand Trousseau, APHP , Paris, France, ICM, plateforme  de gnotypage et squenage, GH Piti Salptrire, Paris, France, Paris, France,  Laboratoire de Cytogntique, GH Armand Trousseau, APHP , Paris, France, Service de  Gntique, CHU Nord, Saint Etienne, France","Mostly, our experience suggests that ID as part of an autistic syndrome is currently not a good indication due to the supposed multifactorial nature of this pathology.ABSTRACTS POSTERS ESHG 2016 | BARCELONA, SPAIN | WWW.ESHG.ORG  165Back to index",,autistic syndrome,[],"['autistic', 'syndrome']"
611,686,"Efficacy of GenIDA, a family oriented international online registry and clinical database for genetic forms of intellectual disability and/or autism, to collect medically relevant information on the Koolen de Vries Syndrome",P08.52,,"Intellectual disability (ID) and autism spectrum disorders (ASD) are over   lapping disorders that constitute a major public health problem with a cu  mulated frequency of about 2.5%. Progress in genome analysis has allowed the identification of many recurrent CNVs and more than 600 genes impli cated in monogenic forms of ID/ASD. However, information on the clinical spectrum and natural history is often lacking behind. These data are essen   tial for improved clinical management of patients and genetic counselling of family members.Therefore, we initiated a unique database model for specific genetic causes of ID/ASD, called GenIDA (genida.unistra.fr), whereby clinical information is entered and updated by the family of the affected individual based on a structured clinical questionnaire that is available in multiple languages. We have used Koolen   de Vries syndrome (KdVS) as a test case for the GenIDA approach. KdVS is a multi system condition characterized by (neonatal) hy   potonia, moderate ID, epilepsy, congenital abnormalities and characteristic facial dysmorphism. We transferred a large existing family based KdVS clini cal dataset (>70 cases) and asked parents to update the data on the GenIDA website.This project shows the willingness of parents to participate in studies dealing with rare diseases affecting their child. Direct comparison with data collected by clinicians allowed us to evaluate the quality of the data entered by families, search for novel and/or more penetrant comorbidities (i e. be havioral problems like hyperactivity were significantly more reported) and generate a first natural history analysis.  University of Strasbourg Institute of Advanced Study  Fondation University of StrasbourgP08.53Unreported mutation found by whole exome sequencing in the KPTN gene is causative for Macrocephaly in an Iranian infant H. Galehdari1, G. Shariati2, A. Saberi3, M. Hamid4, E. Jahangiri1, F. Seifi1, N. Mazaheri1, M.  Zamani1, J. Zeighami1, M. Sarvari1;  1Genetics, Ahwaz, Iran, Islamic Republic of, 2Narges Genetic Diagnostic Lab, Ahwaz, Iran,  Islamic Republic of, 3Jondishapur University, Ahwaz, Iran, Islamic Republic of, 4Pasteur  Institute, Tehran, Iran, Islamic Republic of. Mutation in KPTN gene have been identified as causative for autosomal re cessive mental retardation and clinically characterized by significantly be low average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. Most consistent features are global developmental delay, macrocephaly with frontal bossing, high levels of anxiety, repetitive speech, and mild to severe speech deficits. Recent repots suggest that KPTN mutations are associated with a broader phenotypic spectrum. We used next generation sequencing to find out disease causing gene confirmed by Sanger sequencing. We iden   tified a novel nonsense mutation(c.609 G>A) in 14 years old Iranian patient with autistic behavior, macrocephaly, skull deformity, speech impairment and symptoms included hydrocephaly have been showed by MRI at birth. This mutation was neither found in ExAC nor 1000G and ClinVar.",2016.0,,"F. P . Colin, K. P . J. Schellekens, T . Mazzucotelli, T . Kleefstra, D. A. Koolen, J. L.  Mandel,","Translational medicine and neurogenetics dept , Institut de gntique et de biologie  molculaire et cellulaire (IGBMC)  INSERM U  CNRS UMR  University of  Strasbourg, Illkirch, France, Department of Human Genetics, Radboud University  Medical Centre, Nijmegen, Netherlands, Genetic diagnostic laboratory, CHU, Strasbourg,  France, Collge de France, Chaire de gntique humaine, Paris, France. ","We iden   tified a novel nonsense mutation(c.609 G>A) in 14 years old Iranian patient with autistic behavior, macrocephaly, skull deformity, speech impairment and symptoms included hydrocephaly have been showed by MRI at birth.",,autistic behavior,[],"['autistic', 'behavior']"
612,690, Novel PGAP1 gene mutation in patients with mental retardation in a Turkish family,P08.57,,"Introduction: Pathogenic variants in the PGAP1 gene were reported as cau sative for autosomal recessive mental retardation type 42 and hereditary  spastic paraplegia type 67. Materials and Methods: Here we represent a  Turkish family with two affected children who were born as the first (14  years old male) and second child(11 years old male) of consanguineous fa mily. Growth and motor delay, delayed language development, short stature, intellectual disability, stereotypic movements, autistic features, large ears, abnormality of the pinna, flattened nasal bridge, shortening of all distal pha langes, clinodactyly of 5th finger were noted in two patients. The second child had epileptic seizures which were not seen in first child. Cranial MRI of first child revealed bilateral myelinisation delay at temporal lobes, thin ning of corpus callosum.Whole exome sequencing (WES) was performed for patients and their parents. Results : WES analysis revealed homozygous pre viously unreported variant in exon 25 of the PGAP1 gene, c.2349delins14 (p.His783Glnfs*2) in patients. Both parents are heterozygous carrier of the detected variant. Conclusions: We present a novel PGAP1variant in a Tur kish family. Few cases were reported about PGAP1 mutations in patients with intellectual disability. Our case presentation will be helpful to define the phenotype of the patients with PGAP1 mutations and to confirm the cli nical findings of previous studies and also to shed light on the further stu dies. Table 1. Reported Cases with PGAP1  Mutations: PATIENT AGE SEX ORIGIN CLINICAL FEATURES MUTATION REFERENCES 1,2 4 ,2 F,M Syrian developmental delay, hypotonia,seizures ,stereotypic  movements, large ears, flattenend nasal bridgec.589_591del Murakami et al., 2014 3,4 6, 9  monthsM,M ? spastisity, developmental delay c.1952+1G4T Novarino et al, 2014 5 7 M ? cerebral visual impairment ,strabismus, nystagmus, intellectual disability, hypotonia, upward slanting palpebral fissures, deep set eyes, large ear lobes, prominent helices and antihelices, teeth showed extra mamelons with diminished enamelc.274_276del andc.921_925delBosch et al , 2015 6,7 9,5 F,M Turkish severe psychomotor retardation, hypotonia, nystagmus,  retinal dystrophy, comprised mild synophris, low  frontal and posterior hair line, hypertelorism, bifid  uvula, mild pectus excavatum and broad 1st toes.(c.1090 2A>G; IVS9  2A>G; p.?)Granzow et al, 2015 8,9 11,14 M,M Turkish developmental delay, seizures ,stereotypic movements,  autistic features ,large ears,clinodactyly ,flattened nasal bridge, strabismusc.2349delins14 PRESENT CASEABSTRACTS POSTERS ESHG 2016 | BARCELONA, SPAIN | WWW.ESHG.ORG  169Back to index",2016.0,,"L. zer, D. Trujillano, E. nsal, S. Aktuna, F. Akyiit, P . elikkol, A. Rolfs, V. Baltac","Mikrogen Genetic Diagnosis Center, Ankara, Turkey, Centogene, Rostock, Germany,  stanbul Yeni Yzyl University School of Medicine ,Department of Medical Biology and  Genetics, stanbul, Turkey, Centogene, Rostock, Turkey, stanbul Yeni Yzyl University  School of Medicine ,Department of Medical Biology and Genetics, iSTANBUL, Turkey","Growth and motor delay, delayed language development, short stature, intellectual disability, stereotypic movements, autistic features, large ears, abnormality of the pinna, flattened nasal bridge, shortening of all distal pha langes, clinodactyly of 5th finger were noted in two patients.",,autistic features,[],"['autistic', 'feature']"
612,690, Novel PGAP1 gene mutation in patients with mental retardation in a Turkish family,P08.57,,"Introduction: Pathogenic variants in the PGAP1 gene were reported as cau sative for autosomal recessive mental retardation type 42 and hereditary  spastic paraplegia type 67. Materials and Methods: Here we represent a  Turkish family with two affected children who were born as the first (14  years old male) and second child(11 years old male) of consanguineous fa mily. Growth and motor delay, delayed language development, short stature, intellectual disability, stereotypic movements, autistic features, large ears, abnormality of the pinna, flattened nasal bridge, shortening of all distal pha langes, clinodactyly of 5th finger were noted in two patients. The second child had epileptic seizures which were not seen in first child. Cranial MRI of first child revealed bilateral myelinisation delay at temporal lobes, thin ning of corpus callosum.Whole exome sequencing (WES) was performed for patients and their parents. Results : WES analysis revealed homozygous pre viously unreported variant in exon 25 of the PGAP1 gene, c.2349delins14 (p.His783Glnfs*2) in patients. Both parents are heterozygous carrier of the detected variant. Conclusions: We present a novel PGAP1variant in a Tur kish family. Few cases were reported about PGAP1 mutations in patients with intellectual disability. Our case presentation will be helpful to define the phenotype of the patients with PGAP1 mutations and to confirm the cli nical findings of previous studies and also to shed light on the further stu dies. Table 1. Reported Cases with PGAP1  Mutations: PATIENT AGE SEX ORIGIN CLINICAL FEATURES MUTATION REFERENCES 1,2 4 ,2 F,M Syrian developmental delay, hypotonia,seizures ,stereotypic  movements, large ears, flattenend nasal bridgec.589_591del Murakami et al., 2014 3,4 6, 9  monthsM,M ? spastisity, developmental delay c.1952+1G4T Novarino et al, 2014 5 7 M ? cerebral visual impairment ,strabismus, nystagmus, intellectual disability, hypotonia, upward slanting palpebral fissures, deep set eyes, large ear lobes, prominent helices and antihelices, teeth showed extra mamelons with diminished enamelc.274_276del andc.921_925delBosch et al , 2015 6,7 9,5 F,M Turkish severe psychomotor retardation, hypotonia, nystagmus,  retinal dystrophy, comprised mild synophris, low  frontal and posterior hair line, hypertelorism, bifid  uvula, mild pectus excavatum and broad 1st toes.(c.1090 2A>G; IVS9  2A>G; p.?)Granzow et al, 2015 8,9 11,14 M,M Turkish developmental delay, seizures ,stereotypic movements,  autistic features ,large ears,clinodactyly ,flattened nasal bridge, strabismusc.2349delins14 PRESENT CASEABSTRACTS POSTERS ESHG 2016 | BARCELONA, SPAIN | WWW.ESHG.ORG  169Back to index",2016.0,,"L. zer, D. Trujillano, E. nsal, S. Aktuna, F. Akyiit, P . elikkol, A. Rolfs, V. Baltac","Mikrogen Genetic Diagnosis Center, Ankara, Turkey, Centogene, Rostock, Germany,  stanbul Yeni Yzyl University School of Medicine ,Department of Medical Biology and  Genetics, stanbul, Turkey, Centogene, Rostock, Turkey, stanbul Yeni Yzyl University  School of Medicine ,Department of Medical Biology and Genetics, iSTANBUL, Turkey",")Granzow et al, 2015 8,9 11,14 M,M Turkish developmental delay, seizures ,stereotypic movements,  autistic features ,large ears,clinodactyly ,flattened nasal bridge, strabismusc.2349delins14 PRESENT CASEABSTRACTS POSTERS ESHG 2016 | BARCELONA, SPAIN | WWW.ESHG.ORG  169Back to index",,autistic features,[],"['autistic', 'feature']"
613,696, Mosaic Xq26,P08.64,,"Introduction. Recurrent mosaic duplications are exclusive in the available literature. This is especially the case in terms of clinically relevant X chro mosome duplications in females. However, a growing amount of reports on somatic genome variations causing intellectual disability and congenital malformations allows speculations that mosaic (sub)chromosomal rear rangements might be more common and clinically relevant than previously recognized.Materials and Methods. Molecular karyotyping using SNP/oligonucleotide microarray (resolution: >1 kbp) was performed in a cohort of 402 children with intellectual disability, autism, epilepsy and/or congenital malformati ons.Results. Four girls (~1%) have exhibited mosaic duplications spanning Xq26.2q26.3.The age varied from 1 year 1 month to 6 years. Shared features included intellectual disability/developmental delay, microcephaly, broad phyltrum and wide nasal bridge, long lashes, ptosis; one patient demonstrated autistic features. The overlapping region for all duplications included 8 genes: GPC3,  MIR19B2 , MIR106A, PHF6, HPRT1, MIR503, MIR424, PLAC1. Although non  mosaic duplication in this region involving genes PHF6 and HPRT1 has been  described in the literature previously, the lack of phenotypic resemblance to the detected cases and an original bioinformatics analysis allow the specu lation that mosaic duplications Xq26.2q26.3 might be a new chromosomal syndrome associated with intellectual disability and congenital malforma tions.Conclusions. Our study demonstrates that mosaic duplications Xq26.2q26.3 are relatively common in children with intellectual disability, autism, epi lepsy and/or congenital malformations. Furthermore, our findings demon   strate the possibility that mosaic chromosomal rearrangements can be a cause for a new chromosomal syndrome. Supported by the Russian Science Foundation (grant: 14 15 00411).",2016.0,,"S. G. Vorsanova, Y. B. Yurov, M. A. Zelenova, O. S. Kurinnaia, K. Vasin, V. S.  Kravets, M. Gordeeva, I. Y. Iourov,","Research and Clinical Institute for Pediatrics named after Y.E Veltishev at the Pirogov  Russian National Research Medical University, Ministry of Health, Moscow, Russian  Federation, 2Mental Health Research Center, Moscow, Russian Federation, 3Moscow State  University of Psychology and Education, Moscow, Russian Federation, 4Department of  Medical Genetics, Russian Medical Academy of Postgraduate Education, Ministry of  Health, Moscow, Russian Federation. ","Shared features included intellectual disability/developmental delay, microcephaly, broad phyltrum and wide nasal bridge, long lashes, ptosis; one patient demonstrated autistic features.",,autistic features,[],"['autistic', 'feature']"
615,704, Characterization of patient with de novo frameshift PUF60 mutation suggests that disruption of this gene is sufficient for most symptoms of Verheij syndrome,P08.72,,"Verheij syndrome (OMIM 615583) is associated with rare de novo 8q24.3  microdeletions. Patients show developmental delay, short stature, microce   phaly, coloboma, and craniofacial, skeletal, cardiac and renal defects. Initial   ly two patients were described with deletions of 15 24 Mb, later followed by five patients with much shorter deletions, the smallest encompassing only three genes, SCRIB , PUF60  and NRBP2 . A de novo loss of function missense  PUF60  mutation was also found in a similar patient who however lacked  coloboma and renal abnormalities. These observations and knockdown of PUF60  and/or SCRIB in zebrafish suggested that the two genes influenced  different symptoms, together exacerbating the phenotype of the syndrome.We report a 16 year old boy with autism, moderate intellectual disability, speech delay, growth retardation, short stature, microcephaly, cardiac and renal defects, skeletal anomalies and a facies with bitemporal narrowing, thick eyebrows, long philtrum, broad nasal root and thin upper lip. Karyoty   ping and microarray analysis yielded no findings. Whole exome sequencing of the family trio identified a private heterozygous de novo deletion of four  nucleotides in PUF60  (NM_078480.2:c.407_410delTCTA,p.I136Tfs*31). The  patient showed no eye symptoms but no focused ophthalmological exami nation has been performed yet. The presence of severe renal hypoplasia in the patient and his overall similarity to the typical picture of the Verheij syndrome suggest that also the renal symptoms can be attributed solely to defects of PUF60  which may be of key importance for the syndrome. The  case illustrates the strength of exome sequencing in deciphering the genetic basis of diseases.Supported by NT/14200, 00064203, CZ.2.16/3.1.00/24022 and NF CZ11 PDP 3 003 2014.",2016.0,,"M. Hanrov, M. Havlovicov, D. Prchalov, V. Strneck, Z. Sedlek","Department of Biology and Medical Genetics, Charles University nd Faculty of  Medicine and University Hospital Motol, Prague, Czech Republic, Institute of Inherited  Metabolic Disorders, Charles University st Faculty of Medicine and General University Hospital, Prague, Czech Republic","These observations and knockdown of PUF60  and/or SCRIB in zebrafish suggested that the two genes influenced  different symptoms, together exacerbating the phenotype of the syndrome.We report a 16 year old boy with autism, moderate intellectual disability, speech delay, growth retardation, short stature, microcephaly, cardiac and renal defects, skeletal anomalies and a facies with bitemporal narrowing, thick eyebrows, long philtrum, broad nasal root and thin upper lip.",boy with autism,,"['boy', 'with', 'autism']",[]
618,709,Rubinstein Taybi syndrome type 2: Report of 9 new cases that extend the phenotypic and genotypic spectrum,P08.77,,"BACKGROUND: Rubinstein Taybi syndrome is an autosomal dominant  neurodevelopmental disorder characterised by growth deficiency, broad  thumbs and great toes, intellectual disability and characteristic craniofacial  appearance. Mutations in CREBBP account for around 55% of cases, with a further 8% attributed to the paralogous gene EP300. Comparatively few  reports exist describing the phenotype of Rubinstein Taybi due to EP300  mutations. METHODS: Clinical and genetic data were gathered from 9 pa tients from the UK and Ireland with pathogenic EP300 mutations, identified either by targeted testing or exome sequencing. RESULTS: All patients had  mild or moderate intellectual impairment. Behavioural or social difficul   ties were noted in eight, including three with autistic spectrum disorders.  Typical dysmorphic features of Rubinstein Taybi were only variably present.  Additional observations include maternal pre eclampsia (2/9), syndactyly  (3/9), delayed bone age (2/9), feeding or swallowing issues (2/9), scolio   sis (2/9) and hypermobility of the elbow (2/9). Six patients had truncating mutations in EP300, with pathogenic missense mutations identified in the remaining three. DISCUSSION: The findings support previous observations that microcephaly, maternal pre eclampsia, mild growth restriction and a mild to moderate intellectual disability are key pointers to the diagnosis of EP300 related Rubinstein Taybi syndrome. Variability in the presence of typical facial features of Rubinstein Taybi further highlights clinical hetero geneity, particularly among patients identified by exome sequencing. Fea tures that overlap with Floating Harbor syndrome including craniofacial dysmorphism and delayed osseous maturation were observed in 3 patients. Previous reports have only described mutations predicted to cause haplo insufficiency of EP300. This cohort includes the first described pathogenic missense mutations in EP300.",2016.0,,"M. J. Hamilton, R. Newbury Ecob, M. Holder Espinasse, J. A. Hurst, E. Clement, W.  Reardon, S. Joss, E. Hobson, M. Blyth, M. Al Shehhi, S. Lynch, M. Suri","University of Glasgow, Glasgow, United Kingdom, West of Scotland Cinical Genetics  Service, Glasgow, United Kingdom, Department of Clinical Genetics, Nottingham City  Hospital, Nottingham, United Kingdom, Department of Clinical Genetics, University  Hospitals Bristol, Bristol, United Kingdom, Clinical Genetics Service, Guys and St  Thomas Hospital, London, United Kingdom, Clinical Genetics Unit, Great Ormond Street  Hospital for Children, London, United Kingdom, Department of Clinical Genetics, Our  Ladys Childrens Hospital, Dublin, Ireland, Yorkshire Regional Genetics Service, Chapel  Allerton Hospital, Leeds, United Kingdom, ACoRD, University College Dublin, Dublin,  Ireland","Behavioural or social difficul   ties were noted in eight, including three with autistic spectrum disorders.",,autistic spectrum,[],"['autistic', 'spectrum']"
620,741,Contribution of chromosomal aberrations in mosaicism to Autism Spectrum Disorders,P09.017,,"Introduction: Autism Spectrum Disorder (ASD) is one of the most frequent  neurodevelopmental disorders. ASD has a strong genetic component in its  etiology, including de novo germ line mutations and copy number variants.  Detectable mosaicism for chromosomal rearrangements in blood has been reported in >1% of the aging population (>65y), but is very rare in young  people. Chromosomal mosaicism due to early developmental events could  be causative of ASD.Methods: We have studied molecular karyotypes (SNP array) of blood DNA of two large ASD datasets, the Autism Genome Project and the Simons Sim  plex Collection (4427 patients, 9268 parents, 2433 unaffected siblings) for  mosaic chromosomal alterations >0.4Mb, using the MAD and Tripod soft wares. As age matched controls, we also used reported data of 5094 child  ren with no developmental abnormalities. We independently analyzed data  from cell line DNA of 564 patients and 806 parents.Results: Mosaic alterations (0.4 155Mb) were detected in blood DNA of  21 out of 4427 patients (0,47%). A total of 34 events were also detected  in parental samples (0,37%) and 5/7517 unaffected children (0,07%). The frequency of detectable mosaicism is significantly higher in ASD patients. In cell line DNA, the frequency was similar in cases and parents although 6 unbalanced chromosomal translocations were detected in patients and just 1 in parents.Conclusion: Chromosomal aberrations present in mosaicism are detected in blood samples of a small but significant proportion of children with ASD (0,47%). This finding at early ages suggests that mosaicism may be present in other cell types affecting brain development and causing ASD.",2016.0,,"M. Lopez Sanchez, I. Cusc, A. Cceres, J. R. Gonzalez, L. A. Prez Jurado,","Genetics Unit, Universitat Pompeu Fabra, Barcelona, Spain, Hospital del Mar Research  Institute (IMIM), Barcelona, Spain, Centre de Recerca en Epidemiologia Ambiental  (CREAL), Barcelona, Spain, Centro de Investigacin Biomdica en Red de Enfermedades  Raras (CIBERER), Madrid, Spain, Centro de Investigacin Biomdica en Red de  Epidemiologa y Salud Pblica (CIBERESP), Madrid, Spain","Chromosomal mosaicism due to early developmental events could  be causative of ASD.Methods: We have studied molecular karyotypes (SNP array) of blood DNA of two large ASD datasets, the Autism Genome Project and the Simons Sim  plex Collection (4427 patients, 9268 parents, 2433 unaffected siblings) for  mosaic chromosomal alterations >0.4Mb, using the MAD and Tripod soft wares.",,ASD datasets,[],"['ASD', 'datasets']"
620,741,Contribution of chromosomal aberrations in mosaicism to Autism Spectrum Disorders,P09.017,,"Introduction: Autism Spectrum Disorder (ASD) is one of the most frequent  neurodevelopmental disorders. ASD has a strong genetic component in its  etiology, including de novo germ line mutations and copy number variants.  Detectable mosaicism for chromosomal rearrangements in blood has been reported in >1% of the aging population (>65y), but is very rare in young  people. Chromosomal mosaicism due to early developmental events could  be causative of ASD.Methods: We have studied molecular karyotypes (SNP array) of blood DNA of two large ASD datasets, the Autism Genome Project and the Simons Sim  plex Collection (4427 patients, 9268 parents, 2433 unaffected siblings) for  mosaic chromosomal alterations >0.4Mb, using the MAD and Tripod soft wares. As age matched controls, we also used reported data of 5094 child  ren with no developmental abnormalities. We independently analyzed data  from cell line DNA of 564 patients and 806 parents.Results: Mosaic alterations (0.4 155Mb) were detected in blood DNA of  21 out of 4427 patients (0,47%). A total of 34 events were also detected  in parental samples (0,37%) and 5/7517 unaffected children (0,07%). The frequency of detectable mosaicism is significantly higher in ASD patients. In cell line DNA, the frequency was similar in cases and parents although 6 unbalanced chromosomal translocations were detected in patients and just 1 in parents.Conclusion: Chromosomal aberrations present in mosaicism are detected in blood samples of a small but significant proportion of children with ASD (0,47%). This finding at early ages suggests that mosaicism may be present in other cell types affecting brain development and causing ASD.",2016.0,,"M. Lopez Sanchez, I. Cusc, A. Cceres, J. R. Gonzalez, L. A. Prez Jurado,","Genetics Unit, Universitat Pompeu Fabra, Barcelona, Spain, Hospital del Mar Research  Institute (IMIM), Barcelona, Spain, Centre de Recerca en Epidemiologia Ambiental  (CREAL), Barcelona, Spain, Centro de Investigacin Biomdica en Red de Enfermedades  Raras (CIBERER), Madrid, Spain, Centro de Investigacin Biomdica en Red de  Epidemiologa y Salud Pblica (CIBERESP), Madrid, Spain",The frequency of detectable mosaicism is significantly higher in ASD patients.,,ASD patients,[],"['ASD', 'patient']"
620,741,Contribution of chromosomal aberrations in mosaicism to Autism Spectrum Disorders,P09.017,,"Introduction: Autism Spectrum Disorder (ASD) is one of the most frequent  neurodevelopmental disorders. ASD has a strong genetic component in its  etiology, including de novo germ line mutations and copy number variants.  Detectable mosaicism for chromosomal rearrangements in blood has been reported in >1% of the aging population (>65y), but is very rare in young  people. Chromosomal mosaicism due to early developmental events could  be causative of ASD.Methods: We have studied molecular karyotypes (SNP array) of blood DNA of two large ASD datasets, the Autism Genome Project and the Simons Sim  plex Collection (4427 patients, 9268 parents, 2433 unaffected siblings) for  mosaic chromosomal alterations >0.4Mb, using the MAD and Tripod soft wares. As age matched controls, we also used reported data of 5094 child  ren with no developmental abnormalities. We independently analyzed data  from cell line DNA of 564 patients and 806 parents.Results: Mosaic alterations (0.4 155Mb) were detected in blood DNA of  21 out of 4427 patients (0,47%). A total of 34 events were also detected  in parental samples (0,37%) and 5/7517 unaffected children (0,07%). The frequency of detectable mosaicism is significantly higher in ASD patients. In cell line DNA, the frequency was similar in cases and parents although 6 unbalanced chromosomal translocations were detected in patients and just 1 in parents.Conclusion: Chromosomal aberrations present in mosaicism are detected in blood samples of a small but significant proportion of children with ASD (0,47%). This finding at early ages suggests that mosaicism may be present in other cell types affecting brain development and causing ASD.",2016.0,,"M. Lopez Sanchez, I. Cusc, A. Cceres, J. R. Gonzalez, L. A. Prez Jurado,","Genetics Unit, Universitat Pompeu Fabra, Barcelona, Spain, Hospital del Mar Research  Institute (IMIM), Barcelona, Spain, Centre de Recerca en Epidemiologia Ambiental  (CREAL), Barcelona, Spain, Centro de Investigacin Biomdica en Red de Enfermedades  Raras (CIBERER), Madrid, Spain, Centro de Investigacin Biomdica en Red de  Epidemiologa y Salud Pblica (CIBERESP), Madrid, Spain","In cell line DNA, the frequency was similar in cases and parents although 6 unbalanced chromosomal translocations were detected in patients and just 1 in parents.Conclusion: Chromosomal aberrations present in mosaicism are detected in blood samples of a small but significant proportion of children with ASD (0,47%).",children with ASD,,"['child', 'with', 'ASD']",[]
621,742, Genomic and genetic variation at complex segmental duplications in Autism Spectrum disorders,P09.018,,"Introduction: Autism Spectrum Disorders (ASD) are among the most heri   table neurodevelopmental conditions but the aetiology remains elusive in a high proportion of cases. Complex rearrangements and gene conversion events in segmental duplications (SDs) could contribute to the phenotype, but are largely unstudied. To determine their variation and role in ASD, we have studied two candidate hot spot regions: the Williams Beuren syndro me locus at 7q11.23 and the chr9 pericentromeric region.Methods: We performed targeted sequencing of the multi copy genes in SDs (GTF2I, GTF2IRD2 and CNTNAP3) and single copy genes in 279 ASD patients  and 105 controls. To identify CNVs, SNVs and gene conversions, we mapped the sequences to a single paralogous copy and integrated read depth and relative paralogous sequence quantification. All results were experimentally validated by other methods in an extended case and control population.Results: Copy gains of a 7q11.23 block containing truncated GTF2I and func  tional GTF2IRD2  genes were identified in 1.8% ASD cases vs 0.45% controls.  We also identified a disruptive mutation (p.M1?) in a GTF2IRD2  copy in two  affected brothers, inherited from their father. In the chr9 pericentromeric region, a de novo deletion was identified in a patient but the global distribu  tion of rearrangements and rare SNVs did not differ significantly between controls and patients.Conclusions: Despite their complex genetic architecture, our method suc cessfully identifies rearrangements and SNVs in SDs, such as copy gains and mutations at GTF2IRD2 or deletions of CNTNAP3 that could represent sus  ceptibility factors for ASD.Grant support: FISPI1302481/PI1300823/FEDER, 2014SGR1468 and FI DGR/2013.ABSTRACTS POSTERS ESHG 2016 | BARCELONA, SPAIN | WWW.ESHG.ORG  182Back to index",2016.0,,"M. Codina Sol, R. Flores, A. Homs, C. Aguado, L. Prez Jurado, I. Cusc,","Departament de Cincies Experimentals i de la Salut, Universitat Pompeu Fabra,  Barcelona, Spain, Neurosciences Program, Institut Hospital del Mar dInvestigacions  Mdiques (IMIM), Barcelona, Spain, Centro de Investigacin Biomdica en Red de  Enfermedades Raras (CIBERER), ISCIII, Barcelona, Spain","To determine their variation and role in ASD, we have studied two candidate hot spot regions: the Williams Beuren syndro me locus at 7q11.23 and the chr9 pericentromeric region.Methods: We performed targeted sequencing of the multi copy genes in SDs (GTF2I, GTF2IRD2 and CNTNAP3) and single copy genes in 279 ASD patients  and 105 controls.",,ASD patients,[],"['ASD', 'patient']"
621,742, Genomic and genetic variation at complex segmental duplications in Autism Spectrum disorders,P09.018,,"Introduction: Autism Spectrum Disorders (ASD) are among the most heri   table neurodevelopmental conditions but the aetiology remains elusive in a high proportion of cases. Complex rearrangements and gene conversion events in segmental duplications (SDs) could contribute to the phenotype, but are largely unstudied. To determine their variation and role in ASD, we have studied two candidate hot spot regions: the Williams Beuren syndro me locus at 7q11.23 and the chr9 pericentromeric region.Methods: We performed targeted sequencing of the multi copy genes in SDs (GTF2I, GTF2IRD2 and CNTNAP3) and single copy genes in 279 ASD patients  and 105 controls. To identify CNVs, SNVs and gene conversions, we mapped the sequences to a single paralogous copy and integrated read depth and relative paralogous sequence quantification. All results were experimentally validated by other methods in an extended case and control population.Results: Copy gains of a 7q11.23 block containing truncated GTF2I and func  tional GTF2IRD2  genes were identified in 1.8% ASD cases vs 0.45% controls.  We also identified a disruptive mutation (p.M1?) in a GTF2IRD2  copy in two  affected brothers, inherited from their father. In the chr9 pericentromeric region, a de novo deletion was identified in a patient but the global distribu  tion of rearrangements and rare SNVs did not differ significantly between controls and patients.Conclusions: Despite their complex genetic architecture, our method suc cessfully identifies rearrangements and SNVs in SDs, such as copy gains and mutations at GTF2IRD2 or deletions of CNTNAP3 that could represent sus  ceptibility factors for ASD.Grant support: FISPI1302481/PI1300823/FEDER, 2014SGR1468 and FI DGR/2013.ABSTRACTS POSTERS ESHG 2016 | BARCELONA, SPAIN | WWW.ESHG.ORG  182Back to index",2016.0,,"M. Codina Sol, R. Flores, A. Homs, C. Aguado, L. Prez Jurado, I. Cusc,","Departament de Cincies Experimentals i de la Salut, Universitat Pompeu Fabra,  Barcelona, Spain, Neurosciences Program, Institut Hospital del Mar dInvestigacions  Mdiques (IMIM), Barcelona, Spain, Centro de Investigacin Biomdica en Red de  Enfermedades Raras (CIBERER), ISCIII, Barcelona, Spain",All results were experimentally validated by other methods in an extended case and control population.Results: Copy gains of a 7q11.23 block containing truncated GTF2I and func  tional GTF2IRD2  genes were identified in 1.8% ASD cases vs 0.45% controls.,,ASD cases,[],"['ASD', 'case']"
621,742, Genomic and genetic variation at complex segmental duplications in Autism Spectrum disorders,P09.018,,"Introduction: Autism Spectrum Disorders (ASD) are among the most heri   table neurodevelopmental conditions but the aetiology remains elusive in a high proportion of cases. Complex rearrangements and gene conversion events in segmental duplications (SDs) could contribute to the phenotype, but are largely unstudied. To determine their variation and role in ASD, we have studied two candidate hot spot regions: the Williams Beuren syndro me locus at 7q11.23 and the chr9 pericentromeric region.Methods: We performed targeted sequencing of the multi copy genes in SDs (GTF2I, GTF2IRD2 and CNTNAP3) and single copy genes in 279 ASD patients  and 105 controls. To identify CNVs, SNVs and gene conversions, we mapped the sequences to a single paralogous copy and integrated read depth and relative paralogous sequence quantification. All results were experimentally validated by other methods in an extended case and control population.Results: Copy gains of a 7q11.23 block containing truncated GTF2I and func  tional GTF2IRD2  genes were identified in 1.8% ASD cases vs 0.45% controls.  We also identified a disruptive mutation (p.M1?) in a GTF2IRD2  copy in two  affected brothers, inherited from their father. In the chr9 pericentromeric region, a de novo deletion was identified in a patient but the global distribu  tion of rearrangements and rare SNVs did not differ significantly between controls and patients.Conclusions: Despite their complex genetic architecture, our method suc cessfully identifies rearrangements and SNVs in SDs, such as copy gains and mutations at GTF2IRD2 or deletions of CNTNAP3 that could represent sus  ceptibility factors for ASD.Grant support: FISPI1302481/PI1300823/FEDER, 2014SGR1468 and FI DGR/2013.ABSTRACTS POSTERS ESHG 2016 | BARCELONA, SPAIN | WWW.ESHG.ORG  182Back to index",2016.0,,"M. Codina Sol, R. Flores, A. Homs, C. Aguado, L. Prez Jurado, I. Cusc,","Departament de Cincies Experimentals i de la Salut, Universitat Pompeu Fabra,  Barcelona, Spain, Neurosciences Program, Institut Hospital del Mar dInvestigacions  Mdiques (IMIM), Barcelona, Spain, Centro de Investigacin Biomdica en Red de  Enfermedades Raras (CIBERER), ISCIII, Barcelona, Spain","In the chr9 pericentromeric region, a de novo deletion was identified in a patient but the global distribu  tion of rearrangements and rare SNVs did not differ significantly between controls and patients.Conclusions: Despite their complex genetic architecture, our method suc cessfully identifies rearrangements and SNVs in SDs, such as copy gains and mutations at GTF2IRD2 or deletions of CNTNAP3 that could represent sus  ceptibility factors for ASD.Grant support: FISPI1302481/PI1300823/FEDER, 2014SGR1468 and FI DGR/2013.ABSTRACTS POSTERS ESHG 2016 | BARCELONA, SPAIN | WWW.ESHG.ORG  182Back to index",,ASD.Grant support,[],"['ASD.Grant', 'support']"
622,743, The power of New Generation Sequencing in identifying mutations in non specific ASD ID phenotypes: the example of SHANK3,P09.019,,"Introduction: Autism spectrum disorders (ASDs) are characterized by im  pairments in reciprocal social communication and stereotyped behaviors.  Intellectual Disability (ID) frequently coexists with these two core sym  ptoms. Monogenic causes are rare, among them, de novo or truncating mu tations in SHANK3  concern almost one in 50 children with autism and mo  derate to profound ID. SHANK3  haploinsufficiency is frequently associated  with neonatal hypotonia, moderate to severe ID, absent to severely delayed speech, ASD and moderate dysmorphic features (Phelan McDermid syndro me). Thus, the question arises to look for the presence of distinctive signs  to identify a subgroup of individuals who could benefit from the sequencing  of this gene.Materials and Methods: Here we report on 2 boys with ASD and ID and a girl  with severe ID associated with a SHANK3  mutation found by next generation  sequencing (NGS) study (Illumina). Results: Two of these mutations are truncated and de novo involving the  exon 21 in the prolin rich domain (NM_001080420.1:c.2955_2970dup  (p.(Pro992Arg*325) and NM_001080420.1:c.4381C>T (p.(Gln1461*)). The  third is a 3 bases deletion variant NM_001080420.1:c.5090_5092delACC (p.(His1697del)) involving the exon 22 in the SAM (Sterile Alpha Motif) do   main involved in multimerization of SHANK3 protein. Conclusion: The retrospective clinical examination of these patients did not  permit to distinct specific signs, which highlights the phenotypic hetero  geneity of these patients. Given the scarcity of variants involving SHANK3 ,  the unsystematic presence of the distinctive clinical features of Phelan Mc  Dermid Syndrome, a NGS approach by panel or exome seems more justified  than a targeted sequencing approach of SHANK3  in this phenotype.",2016.0,,"A. Mosca Boidron, H. Poquet, M. Willems, J. Thevenon, C. Redin, C. Thauvin, Y.  Duffourd, S. Lumbroso, B. Grard, J. Mandel, F. Amsellem, A. Beggiato, R. Delorme, N.  Marle, P . Callier, J. Rivire, P . Kuentz, A. Piton, L. Faivre,","Cytogenetics, Dijon, France, Equipe Gntique et Anomalies du Dveloppement, Dijon,  France, Dpartement de Gntique mdicale, Montpellier, France, Dpartement  de Gntique mdicale, Dijon, France, IGBMC, Strasbourg, France, Laboratoire de  Biochimie, Nimes, France, Psychiatrie de l enfance et de ladolescence, Hpital Robert  Debr, Paris, France","Monogenic causes are rare, among them, de novo or truncating mu tations in SHANK3  concern almost one in 50 children with autism and mo  derate to profound ID.",children with autism,,"['child', 'with', 'autism']",[]
622,743, The power of New Generation Sequencing in identifying mutations in non specific ASD ID phenotypes: the example of SHANK3,P09.019,,"Introduction: Autism spectrum disorders (ASDs) are characterized by im  pairments in reciprocal social communication and stereotyped behaviors.  Intellectual Disability (ID) frequently coexists with these two core sym  ptoms. Monogenic causes are rare, among them, de novo or truncating mu tations in SHANK3  concern almost one in 50 children with autism and mo  derate to profound ID. SHANK3  haploinsufficiency is frequently associated  with neonatal hypotonia, moderate to severe ID, absent to severely delayed speech, ASD and moderate dysmorphic features (Phelan McDermid syndro me). Thus, the question arises to look for the presence of distinctive signs  to identify a subgroup of individuals who could benefit from the sequencing  of this gene.Materials and Methods: Here we report on 2 boys with ASD and ID and a girl  with severe ID associated with a SHANK3  mutation found by next generation  sequencing (NGS) study (Illumina). Results: Two of these mutations are truncated and de novo involving the  exon 21 in the prolin rich domain (NM_001080420.1:c.2955_2970dup  (p.(Pro992Arg*325) and NM_001080420.1:c.4381C>T (p.(Gln1461*)). The  third is a 3 bases deletion variant NM_001080420.1:c.5090_5092delACC (p.(His1697del)) involving the exon 22 in the SAM (Sterile Alpha Motif) do   main involved in multimerization of SHANK3 protein. Conclusion: The retrospective clinical examination of these patients did not  permit to distinct specific signs, which highlights the phenotypic hetero  geneity of these patients. Given the scarcity of variants involving SHANK3 ,  the unsystematic presence of the distinctive clinical features of Phelan Mc  Dermid Syndrome, a NGS approach by panel or exome seems more justified  than a targeted sequencing approach of SHANK3  in this phenotype.",2016.0,,"A. Mosca Boidron, H. Poquet, M. Willems, J. Thevenon, C. Redin, C. Thauvin, Y.  Duffourd, S. Lumbroso, B. Grard, J. Mandel, F. Amsellem, A. Beggiato, R. Delorme, N.  Marle, P . Callier, J. Rivire, P . Kuentz, A. Piton, L. Faivre,","Cytogenetics, Dijon, France, Equipe Gntique et Anomalies du Dveloppement, Dijon,  France, Dpartement de Gntique mdicale, Montpellier, France, Dpartement  de Gntique mdicale, Dijon, France, IGBMC, Strasbourg, France, Laboratoire de  Biochimie, Nimes, France, Psychiatrie de l enfance et de ladolescence, Hpital Robert  Debr, Paris, France","Thus, the question arises to look for the presence of distinctive signs  to identify a subgroup of individuals who could benefit from the sequencing  of this gene.Materials and Methods: Here we report on 2 boys with ASD and ID and a girl  with severe ID associated with a SHANK3  mutation found by next generation  sequencing (NGS) study (Illumina).",boys with ASD,,"['boy', 'with', 'ASD']",[]
623,746, Rare copy number variations are associated with specific clinical manifestations in children with autism spectrum disorder,P09.022,,"Introduction: Autism spectrum disorder (ASD) is a complex heritable neu  rodevelopmental condition characterized by social, and communication disabilities. However, children with ASD manifest additional symptoms that further complicate the clinical picture of this disorder. Rare copy number va riations (CNVs) play a significant role in ASD susceptibility. Here, we ask wh ether rare CNVs are associated with specific clinical manifestations among children with ASD.Methods: We studied seventy clinical characteristics in 1115 children that are diagnosed with ASD and have CNV data from the Simons Simplex Coll ection (SSC). Associations between these characteristics and total burden of CNVs as well as specific CNVs, were determined at P<0.01.Results: Rare CNVs were more prevalent among African American females. Interestingly, core ASD traits (i.e. communication and social difficulties) were associated with genomic burden of duplications whereas severity of clinical comorbidities (e.g. IQ, irritability, and pregnancy optimality scores) were associated with genomic burden of deletions. Further, we found asso   ciations between several clinical characteristics and specific ASD suscepti   bility CNV loci. Specifically, duplications in 15q11.2 q13.1, and in 16p11.2 were associated with a higher irritability, duplications in 22q11.21 were associated with a worse neonatal optimally score, and CNVs in 9p24.3 were associated with worse verbal ability.Conclusions: Our results suggests that rare CNVs contributes to the severity of ASD across several clinical and behavioral aspects.ABSTRACTS POSTERS ESHG 2016 | BARCELONA, SPAIN | WWW.ESHG.ORG  183Back to index",2016.0,,"I. Shtein, I. Menashe","Ben Gurion University of the Negev, Beer Sheva, Israel","However, children with ASD manifest additional symptoms that further complicate the clinical picture of this disorder.",children with ASD,,"['child', 'with', 'ASD']",[]
623,746, Rare copy number variations are associated with specific clinical manifestations in children with autism spectrum disorder,P09.022,,"Introduction: Autism spectrum disorder (ASD) is a complex heritable neu  rodevelopmental condition characterized by social, and communication disabilities. However, children with ASD manifest additional symptoms that further complicate the clinical picture of this disorder. Rare copy number va riations (CNVs) play a significant role in ASD susceptibility. Here, we ask wh ether rare CNVs are associated with specific clinical manifestations among children with ASD.Methods: We studied seventy clinical characteristics in 1115 children that are diagnosed with ASD and have CNV data from the Simons Simplex Coll ection (SSC). Associations between these characteristics and total burden of CNVs as well as specific CNVs, were determined at P<0.01.Results: Rare CNVs were more prevalent among African American females. Interestingly, core ASD traits (i.e. communication and social difficulties) were associated with genomic burden of duplications whereas severity of clinical comorbidities (e.g. IQ, irritability, and pregnancy optimality scores) were associated with genomic burden of deletions. Further, we found asso   ciations between several clinical characteristics and specific ASD suscepti   bility CNV loci. Specifically, duplications in 15q11.2 q13.1, and in 16p11.2 were associated with a higher irritability, duplications in 22q11.21 were associated with a worse neonatal optimally score, and CNVs in 9p24.3 were associated with worse verbal ability.Conclusions: Our results suggests that rare CNVs contributes to the severity of ASD across several clinical and behavioral aspects.ABSTRACTS POSTERS ESHG 2016 | BARCELONA, SPAIN | WWW.ESHG.ORG  183Back to index",2016.0,,"I. Shtein, I. Menashe","Ben Gurion University of the Negev, Beer Sheva, Israel",Rare copy number va riations (CNVs) play a significant role in ASD susceptibility.,,ASD susceptibility,[],"['ASD', 'susceptibility']"
623,746, Rare copy number variations are associated with specific clinical manifestations in children with autism spectrum disorder,P09.022,,"Introduction: Autism spectrum disorder (ASD) is a complex heritable neu  rodevelopmental condition characterized by social, and communication disabilities. However, children with ASD manifest additional symptoms that further complicate the clinical picture of this disorder. Rare copy number va riations (CNVs) play a significant role in ASD susceptibility. Here, we ask wh ether rare CNVs are associated with specific clinical manifestations among children with ASD.Methods: We studied seventy clinical characteristics in 1115 children that are diagnosed with ASD and have CNV data from the Simons Simplex Coll ection (SSC). Associations between these characteristics and total burden of CNVs as well as specific CNVs, were determined at P<0.01.Results: Rare CNVs were more prevalent among African American females. Interestingly, core ASD traits (i.e. communication and social difficulties) were associated with genomic burden of duplications whereas severity of clinical comorbidities (e.g. IQ, irritability, and pregnancy optimality scores) were associated with genomic burden of deletions. Further, we found asso   ciations between several clinical characteristics and specific ASD suscepti   bility CNV loci. Specifically, duplications in 15q11.2 q13.1, and in 16p11.2 were associated with a higher irritability, duplications in 22q11.21 were associated with a worse neonatal optimally score, and CNVs in 9p24.3 were associated with worse verbal ability.Conclusions: Our results suggests that rare CNVs contributes to the severity of ASD across several clinical and behavioral aspects.ABSTRACTS POSTERS ESHG 2016 | BARCELONA, SPAIN | WWW.ESHG.ORG  183Back to index",2016.0,,"I. Shtein, I. Menashe","Ben Gurion University of the Negev, Beer Sheva, Israel","Interestingly, core ASD traits (i.e.",,ASD traits,[],"['ASD', 'trait']"
625,748, Resilience formation against chronic stress: the Tsc2KO mouse model to study the involvement of the mTOR pathway,P09.024,,"Characteristic for autistic children is their reliability on well structured days and predictable procedures. Deviations of these cause stress in them and result in behavioural abnormalities. We therefore hypothesize that autistic children have reduced resilience for chronic stress. In order to analyse me chanism of stress resilience in autism we are using a Tsc2KO mouse model for tuberous sclerosis. TSC2 (together with TSC1) is part of a complex that inhibits the mechanistic target of rapamycin (mTOR) kinase. Mutations in either of the two genes result in increased mTOR activity and upregulated downstream signalling. mTOR signalling plays an important role in memory formation. It also is supposed to be a key player in stress resilience.According to these studies we have established a behaviour battery to ana   lyse the consequences of chronic social defeat in Tsc2KO animals. After a 14 days period of chronic stress exposure mice are being analysed in this battery, which consists of an object recognition test, an elevated plus maze test, a test of nest building, an evaluation of social interaction, sucrose pre ference, spontaneous alternation in a Y  maze test, a tail suspension test and the analysis of prepulse inhibition of startle response.First results show that non stressed Tsc2KO animals have alterations in social behaviour and in nest building when compared to wildtype mice. Of note, they also show an altered response to stress and changes in stress re silience. These data will give us closer insight into specific problems in au   tism and will also gain our understanding of mechanisms underlying stress resilience.",2016.0,,"A. Arlt, J. Winter, S. Schweiger","Institute of Human Genetics, University Medical Center, Johannes Gutenberg University, Mainz, Germany",Characteristic for autistic children is their reliability on well structured days and predictable procedures.,,autistic children,[],"['autistic', 'child']"
625,748, Resilience formation against chronic stress: the Tsc2KO mouse model to study the involvement of the mTOR pathway,P09.024,,"Characteristic for autistic children is their reliability on well structured days and predictable procedures. Deviations of these cause stress in them and result in behavioural abnormalities. We therefore hypothesize that autistic children have reduced resilience for chronic stress. In order to analyse me chanism of stress resilience in autism we are using a Tsc2KO mouse model for tuberous sclerosis. TSC2 (together with TSC1) is part of a complex that inhibits the mechanistic target of rapamycin (mTOR) kinase. Mutations in either of the two genes result in increased mTOR activity and upregulated downstream signalling. mTOR signalling plays an important role in memory formation. It also is supposed to be a key player in stress resilience.According to these studies we have established a behaviour battery to ana   lyse the consequences of chronic social defeat in Tsc2KO animals. After a 14 days period of chronic stress exposure mice are being analysed in this battery, which consists of an object recognition test, an elevated plus maze test, a test of nest building, an evaluation of social interaction, sucrose pre ference, spontaneous alternation in a Y  maze test, a tail suspension test and the analysis of prepulse inhibition of startle response.First results show that non stressed Tsc2KO animals have alterations in social behaviour and in nest building when compared to wildtype mice. Of note, they also show an altered response to stress and changes in stress re silience. These data will give us closer insight into specific problems in au   tism and will also gain our understanding of mechanisms underlying stress resilience.",2016.0,,"A. Arlt, J. Winter, S. Schweiger","Institute of Human Genetics, University Medical Center, Johannes Gutenberg University, Mainz, Germany",We therefore hypothesize that autistic children have reduced resilience for chronic stress.,,autistic children,[],"['autistic', 'child']"
626,749, Association between copy number variations and savant skills among people with autism spectrum disorder,P09.025,,"Background: Savant skills, are reported in 10% 30% of people with autism spectrum disorder (ASD). The co existence of these two traits suggests com mon underlying mechanisms that require further exploration. Copy number variations (CNVs) are excellent candidate to mutually underlie these two di stinct conditions. Methods: We studied the association between CNVs and savant skills among  1108 children diagnosed with ASD from the Simons Simplex Collection (SSC) database. Savant skills were determined based on five designated questions from the autism diagnostic interview revised (ADI R) questionnaire. CNVs  data were retrieved from a genome wide analysis of CNVs in these children. Results: Savant skills were significantly more prevalent in our sample than in other children with ASD in the SSC cohort (42% vs. 29%; P<0.001). Child   ren with savant skills had, on average, a higher IQ (93.024.2 vs. 79.125.5; P<0.001), and a larger head circumference (HC) (54.32.55 vs. 53.82.60; P , 0.003). Interestingly, savant skills were associated with a lower count  of rare CNVs among children with ASD (14.05.54 vs. 14.86.2 for children  with and without savant skills respectively; P , 0.03). In addition, children with exceptional computational ability had lower burden of rare deletions compared to other children (203.46164.25kb vs. 333.67715.56kb; P ,  6.8x10 5) even after accounting for IQ and socioeconomic status. We also  examined whether certain talents are predisposed by specific ASD suscepti bility CNV loci, but no such associations were found. Conclusions: Our findings suggest that CNVs contribute to the presentation  of exceptional talents among children with ASD.",2016.0,,"H. Rosenthal , I. Menashe","Ben Gurion University of the Negev, Beer Sheva, Israel","Background: Savant skills, are reported in 10% 30% of people with autism spectrum disorder (ASD).",people with autism,,"['people', 'with', 'autism']",[]
626,749, Association between copy number variations and savant skills among people with autism spectrum disorder,P09.025,,"Background: Savant skills, are reported in 10% 30% of people with autism spectrum disorder (ASD). The co existence of these two traits suggests com mon underlying mechanisms that require further exploration. Copy number variations (CNVs) are excellent candidate to mutually underlie these two di stinct conditions. Methods: We studied the association between CNVs and savant skills among  1108 children diagnosed with ASD from the Simons Simplex Collection (SSC) database. Savant skills were determined based on five designated questions from the autism diagnostic interview revised (ADI R) questionnaire. CNVs  data were retrieved from a genome wide analysis of CNVs in these children. Results: Savant skills were significantly more prevalent in our sample than in other children with ASD in the SSC cohort (42% vs. 29%; P<0.001). Child   ren with savant skills had, on average, a higher IQ (93.024.2 vs. 79.125.5; P<0.001), and a larger head circumference (HC) (54.32.55 vs. 53.82.60; P , 0.003). Interestingly, savant skills were associated with a lower count  of rare CNVs among children with ASD (14.05.54 vs. 14.86.2 for children  with and without savant skills respectively; P , 0.03). In addition, children with exceptional computational ability had lower burden of rare deletions compared to other children (203.46164.25kb vs. 333.67715.56kb; P ,  6.8x10 5) even after accounting for IQ and socioeconomic status. We also  examined whether certain talents are predisposed by specific ASD suscepti bility CNV loci, but no such associations were found. Conclusions: Our findings suggest that CNVs contribute to the presentation  of exceptional talents among children with ASD.",2016.0,,"H. Rosenthal , I. Menashe","Ben Gurion University of the Negev, Beer Sheva, Israel",Results: Savant skills were significantly more prevalent in our sample than in other children with ASD in the SSC cohort (42% vs. 29%; P<0.001).,children with ASD,,"['child', 'with', 'ASD']",[]
626,749, Association between copy number variations and savant skills among people with autism spectrum disorder,P09.025,,"Background: Savant skills, are reported in 10% 30% of people with autism spectrum disorder (ASD). The co existence of these two traits suggests com mon underlying mechanisms that require further exploration. Copy number variations (CNVs) are excellent candidate to mutually underlie these two di stinct conditions. Methods: We studied the association between CNVs and savant skills among  1108 children diagnosed with ASD from the Simons Simplex Collection (SSC) database. Savant skills were determined based on five designated questions from the autism diagnostic interview revised (ADI R) questionnaire. CNVs  data were retrieved from a genome wide analysis of CNVs in these children. Results: Savant skills were significantly more prevalent in our sample than in other children with ASD in the SSC cohort (42% vs. 29%; P<0.001). Child   ren with savant skills had, on average, a higher IQ (93.024.2 vs. 79.125.5; P<0.001), and a larger head circumference (HC) (54.32.55 vs. 53.82.60; P , 0.003). Interestingly, savant skills were associated with a lower count  of rare CNVs among children with ASD (14.05.54 vs. 14.86.2 for children  with and without savant skills respectively; P , 0.03). In addition, children with exceptional computational ability had lower burden of rare deletions compared to other children (203.46164.25kb vs. 333.67715.56kb; P ,  6.8x10 5) even after accounting for IQ and socioeconomic status. We also  examined whether certain talents are predisposed by specific ASD suscepti bility CNV loci, but no such associations were found. Conclusions: Our findings suggest that CNVs contribute to the presentation  of exceptional talents among children with ASD.",2016.0,,"H. Rosenthal , I. Menashe","Ben Gurion University of the Negev, Beer Sheva, Israel","Interestingly, savant skills were associated with a lower count  of rare CNVs among children with ASD (14.05.54 vs. 14.86.2 for children  with and without savant skills respectively; P , 0.03).",children with ASD,,"['child', 'with', 'ASD']",[]
626,749, Association between copy number variations and savant skills among people with autism spectrum disorder,P09.025,,"Background: Savant skills, are reported in 10% 30% of people with autism spectrum disorder (ASD). The co existence of these two traits suggests com mon underlying mechanisms that require further exploration. Copy number variations (CNVs) are excellent candidate to mutually underlie these two di stinct conditions. Methods: We studied the association between CNVs and savant skills among  1108 children diagnosed with ASD from the Simons Simplex Collection (SSC) database. Savant skills were determined based on five designated questions from the autism diagnostic interview revised (ADI R) questionnaire. CNVs  data were retrieved from a genome wide analysis of CNVs in these children. Results: Savant skills were significantly more prevalent in our sample than in other children with ASD in the SSC cohort (42% vs. 29%; P<0.001). Child   ren with savant skills had, on average, a higher IQ (93.024.2 vs. 79.125.5; P<0.001), and a larger head circumference (HC) (54.32.55 vs. 53.82.60; P , 0.003). Interestingly, savant skills were associated with a lower count  of rare CNVs among children with ASD (14.05.54 vs. 14.86.2 for children  with and without savant skills respectively; P , 0.03). In addition, children with exceptional computational ability had lower burden of rare deletions compared to other children (203.46164.25kb vs. 333.67715.56kb; P ,  6.8x10 5) even after accounting for IQ and socioeconomic status. We also  examined whether certain talents are predisposed by specific ASD suscepti bility CNV loci, but no such associations were found. Conclusions: Our findings suggest that CNVs contribute to the presentation  of exceptional talents among children with ASD.",2016.0,,"H. Rosenthal , I. Menashe","Ben Gurion University of the Negev, Beer Sheva, Israel","We also  examined whether certain talents are predisposed by specific ASD suscepti bility CNV loci, but no such associations were found.",,ASD suscepti bility,[],"['ASD', 'suscepti', 'bility']"
626,749, Association between copy number variations and savant skills among people with autism spectrum disorder,P09.025,,"Background: Savant skills, are reported in 10% 30% of people with autism spectrum disorder (ASD). The co existence of these two traits suggests com mon underlying mechanisms that require further exploration. Copy number variations (CNVs) are excellent candidate to mutually underlie these two di stinct conditions. Methods: We studied the association between CNVs and savant skills among  1108 children diagnosed with ASD from the Simons Simplex Collection (SSC) database. Savant skills were determined based on five designated questions from the autism diagnostic interview revised (ADI R) questionnaire. CNVs  data were retrieved from a genome wide analysis of CNVs in these children. Results: Savant skills were significantly more prevalent in our sample than in other children with ASD in the SSC cohort (42% vs. 29%; P<0.001). Child   ren with savant skills had, on average, a higher IQ (93.024.2 vs. 79.125.5; P<0.001), and a larger head circumference (HC) (54.32.55 vs. 53.82.60; P , 0.003). Interestingly, savant skills were associated with a lower count  of rare CNVs among children with ASD (14.05.54 vs. 14.86.2 for children  with and without savant skills respectively; P , 0.03). In addition, children with exceptional computational ability had lower burden of rare deletions compared to other children (203.46164.25kb vs. 333.67715.56kb; P ,  6.8x10 5) even after accounting for IQ and socioeconomic status. We also  examined whether certain talents are predisposed by specific ASD suscepti bility CNV loci, but no such associations were found. Conclusions: Our findings suggest that CNVs contribute to the presentation  of exceptional talents among children with ASD.",2016.0,,"H. Rosenthal , I. Menashe","Ben Gurion University of the Negev, Beer Sheva, Israel",Conclusions: Our findings suggest that CNVs contribute to the presentation  of exceptional talents among children with ASD.,children with ASD,,"['child', 'with', 'ASD']",[]
627,750, Peculiar brain activity in autism spectrum disease due to 11p15,P09.026,,"Introduction: ASD is a neurodevelopmental disorder with multiple genetic  and non genetic causes. The 11p15.4 15.5 duplication can be associated with intellectual disability and dysmorphic features. The aim was to assess the neural networks involved in visual and verbal memory encoding and retrieval in ASD due to 11p15.4 15.5 duplication.Materials and methods: A woman with autistic features, macrocephaly and body asymmetry due to 11p15.4 15.5 duplication and 7 healthy controls were investigated. Six runs of BOLD fMRI data were collected to assess the networks of the visual and verbal memory encoding and retrieval; a single run of encoding task was followed by 10 minute retention period, then 2 runs of the retrieval tasks both for visual and verbal domain respectively. During encoding participants were instructed to memorize the task stimu li, whilst during retrieval they were instructed to decide whether the given image or word was presented during the encoding period. Data analysis was performed using the SPM8 toolbox under Matlab, with standard processing steps.Results: In patient fMRI for visual memory encoding/retrieval showed hig her activation in the posterior insulae, and anterior and posterior cingulate cortices compared to the controls where visual areas were predominant in these tasks. Verbal memory activation was higher in the hippocampi, parahippocampal cortices, precuneus; and lower in the anterior insulae; higher visual areas in our patient compared to the controls.Conclusion: The 11p15.4 15.5 duplication resulted in peculiar activity pat   tern of the brain responsible for visual and verbal memory in ASD. This ob servation may help to understand the pathogenesis of ASD.",2016.0,,"M. Szegedi, G. Inczdy Farkas, . Szab, I. Haltrich, G. Fekete, G. Rudas, L. R. Kozk,  M. J. Molnr","Semmelweis University, Institute of Genomic Medicine and Rare Disorders, Budapest,  Hungary, MR Research Centre   Szentgothai Knowledge Center, Semmelweis University,  Budapest, Hungary, nd Department of Paediatrics, Semmelweis University, Budapest,  Hungary","The aim was to assess the neural networks involved in visual and verbal memory encoding and retrieval in ASD due to 11p15.4 15.5 duplication.Materials and methods: A woman with autistic features, macrocephaly and body asymmetry due to 11p15.4 15.5 duplication and 7 healthy controls were investigated.",,autistic features,[],"['autistic', 'feature']"
628,751, Association and functional significance of SNPs in the AVPR1A gene in autism spectrum disorder in Korean population,P09.027,,"Objectives: The arginine vasopressin receptor 1A gene (AVPR1A) is related to social reciprocity in humans and animals. The objective of this study is to evaluate the association of AVPR1A with autism spectrum disorder (ASD) and the functional significance of the markers.Methods: 1) The probands with ASD and their biological parents were re cruited. Diagnosis was ascertained using ADI R and ADOS. 2) Two micro satellites (RS3, RS1) in the 5 flanking region and 2 SNPs in the promoter region of AVPR1A were genotyped. Transmission disequilibrium test and quantitative association test with behavior measures were performed using the FBAT package (v.2.0.2c). 4) For evaluation of the functional significance of the associated marker, luciferase assay was performed.ABSTRACTS POSTERS ESHG 2016 | BARCELONA, SPAIN | WWW.ESHG.ORG  184Back to index Results: Total 212 family trios (9 multiplex families, 644 persons) partici  pated. 1) One SNP (rs10877969) was strongly associated with ASD (addi   tive p value,1.62x10 6; dominant p value,4.81x10 6). Haplotypes with rs10877969 and rs72945336 revealed statistical significances at the mul   tiallelic mode (additive p value,2.2x10 5; dominant p value,1.43x10 5). 2)  The rs10877969 was quantitatively associated with Social Responsiveness  Scale and all subdomain scores of ADI R (p<0.01). 3) In the luciferase as say with T98G cell line, the luciferase activity of rs7294536A promoter was higher than that of rs7294536G, while rs10877969 allelic variants didnt  influence to promoter activity. Conclusion: We observed significant association of an SNP of AVPR1A with affection status and social phenotypes of ASD, accompanied with functional  activity of the marker. Grant support: 1) Healthcare Technology R&D project (A120029), Ministry of Health and Welfare, 2) National Research Foundation of Korea (NRF  2014R1A2A1A11053289), Republic of Kore",2016.0,,"H. Yoo, S. Kim, S. Yang, J. Park, M. Park","Seoul National University Bundang Hospital, Seongnam, Korea, Republic of, Seoul  National University College of Medicine, Seoul, Korea, Republic of, Eulji University, Daejon,  Korea, Republic of, National Institute of Animal Science, Wanju, Korea, Republic of",The objective of this study is to evaluate the association of AVPR1A with autism spectrum disorder (ASD) and the functional significance of the markers.Methods: 1) The probands with ASD and their biological parents were re cruited.,probands with ASD,,"['probands', 'with', 'ASD']",[]
629,752, Copy number variation in 19 Italian multiplex families with autism spectrum disorder: importance of synaptic and neurite elongation genes,P09.028,,"Autism Spectrum Disorder is endowed with impressive heritability estima tes and high recurrence rates. Its genetic underpinnings are very heteroge neous and include many common and rare variants located in hundreds of different loci, each characterized by variable levels of penetrance. Multiplex families from single ethnic groups represent a useful means to reduce hete rogeneity and enhance genetic load. We screened 19 Italian ASD multiplex families (3 triplets and 16 duplets, total N,41 ASD subjects), using array CGH (Agilent 180K). Certainly or probably causal CNVs, defined clinical   ly relevant CNVs, were detected in 17/41 (41%) of ASD probands, corre sponding to 9/19 (47%) multiplex families with at least one affected sibling genetically positive. However only in 3/9 (33%) of these families, siblings share the same causal or highly causal CNV. Additional potentially relevant CNVs not shared by affected sib pairs were detected also in these three fa milies. 45 genes are located on the clinically relevant CNVs. Through an enrichment analysis, we found that 9/45 (20%) of these genes appear pri marily involved in neurite outgrowth and synapse formation/management. Our results highlight the importance of synaptic and neurite elongation ge nes in the pathogenesis of autism, despite genetic heterogeneity in ASD even within multiplex families belonging to a single ethnic group. Differences in CNV burden may likely contribute to the substantial clinical heterogeneity observed between affected sibs. The genetic and epigenetic mechanisms un derlying genomic instability in these families deserve further scrutiny.",2016.0,,"C. Picinelli, C. Lintas, I. Piras, R. Sacco, C. Brogna, A. M. Persico,","Mafalda Luce Center for Pervasive Developmental Disorders, Milan, Italy, Unit of  Child and Adolescent NeuroPsychiatry & Laboratory of Molecular Psychiatry and  Neurogenetics, University Campus Bio Medico, Rome, Italy, Unit of Child and  Adolescent Neuropsychiatry, Gaetano Martino University Hospital, University of  Messina, Messina, Italy","We screened 19 Italian ASD multiplex families (3 triplets and 16 duplets, total N,41 ASD subjects), using array CGH (Agilent 180K).",,ASD multiplex families,[],"['ASD', 'multiplex', 'family']"
629,752, Copy number variation in 19 Italian multiplex families with autism spectrum disorder: importance of synaptic and neurite elongation genes,P09.028,,"Autism Spectrum Disorder is endowed with impressive heritability estima tes and high recurrence rates. Its genetic underpinnings are very heteroge neous and include many common and rare variants located in hundreds of different loci, each characterized by variable levels of penetrance. Multiplex families from single ethnic groups represent a useful means to reduce hete rogeneity and enhance genetic load. We screened 19 Italian ASD multiplex families (3 triplets and 16 duplets, total N,41 ASD subjects), using array CGH (Agilent 180K). Certainly or probably causal CNVs, defined clinical   ly relevant CNVs, were detected in 17/41 (41%) of ASD probands, corre sponding to 9/19 (47%) multiplex families with at least one affected sibling genetically positive. However only in 3/9 (33%) of these families, siblings share the same causal or highly causal CNV. Additional potentially relevant CNVs not shared by affected sib pairs were detected also in these three fa milies. 45 genes are located on the clinically relevant CNVs. Through an enrichment analysis, we found that 9/45 (20%) of these genes appear pri marily involved in neurite outgrowth and synapse formation/management. Our results highlight the importance of synaptic and neurite elongation ge nes in the pathogenesis of autism, despite genetic heterogeneity in ASD even within multiplex families belonging to a single ethnic group. Differences in CNV burden may likely contribute to the substantial clinical heterogeneity observed between affected sibs. The genetic and epigenetic mechanisms un derlying genomic instability in these families deserve further scrutiny.",2016.0,,"C. Picinelli, C. Lintas, I. Piras, R. Sacco, C. Brogna, A. M. Persico,","Mafalda Luce Center for Pervasive Developmental Disorders, Milan, Italy, Unit of  Child and Adolescent NeuroPsychiatry & Laboratory of Molecular Psychiatry and  Neurogenetics, University Campus Bio Medico, Rome, Italy, Unit of Child and  Adolescent Neuropsychiatry, Gaetano Martino University Hospital, University of  Messina, Messina, Italy","We screened 19 Italian ASD multiplex families (3 triplets and 16 duplets, total N,41 ASD subjects), using array CGH (Agilent 180K).",,ASD subjects,[],"['ASD', 'subject']"
629,752, Copy number variation in 19 Italian multiplex families with autism spectrum disorder: importance of synaptic and neurite elongation genes,P09.028,,"Autism Spectrum Disorder is endowed with impressive heritability estima tes and high recurrence rates. Its genetic underpinnings are very heteroge neous and include many common and rare variants located in hundreds of different loci, each characterized by variable levels of penetrance. Multiplex families from single ethnic groups represent a useful means to reduce hete rogeneity and enhance genetic load. We screened 19 Italian ASD multiplex families (3 triplets and 16 duplets, total N,41 ASD subjects), using array CGH (Agilent 180K). Certainly or probably causal CNVs, defined clinical   ly relevant CNVs, were detected in 17/41 (41%) of ASD probands, corre sponding to 9/19 (47%) multiplex families with at least one affected sibling genetically positive. However only in 3/9 (33%) of these families, siblings share the same causal or highly causal CNV. Additional potentially relevant CNVs not shared by affected sib pairs were detected also in these three fa milies. 45 genes are located on the clinically relevant CNVs. Through an enrichment analysis, we found that 9/45 (20%) of these genes appear pri marily involved in neurite outgrowth and synapse formation/management. Our results highlight the importance of synaptic and neurite elongation ge nes in the pathogenesis of autism, despite genetic heterogeneity in ASD even within multiplex families belonging to a single ethnic group. Differences in CNV burden may likely contribute to the substantial clinical heterogeneity observed between affected sibs. The genetic and epigenetic mechanisms un derlying genomic instability in these families deserve further scrutiny.",2016.0,,"C. Picinelli, C. Lintas, I. Piras, R. Sacco, C. Brogna, A. M. Persico,","Mafalda Luce Center for Pervasive Developmental Disorders, Milan, Italy, Unit of  Child and Adolescent NeuroPsychiatry & Laboratory of Molecular Psychiatry and  Neurogenetics, University Campus Bio Medico, Rome, Italy, Unit of Child and  Adolescent Neuropsychiatry, Gaetano Martino University Hospital, University of  Messina, Messina, Italy","Certainly or probably causal CNVs, defined clinical   ly relevant CNVs, were detected in 17/41 (41%) of ASD probands, corre sponding to 9/19 (47%) multiplex families with at least one affected sibling genetically positive.",,ASD probands,[],"['ASD', 'probands']"
630,753, Increased frequency of the autism broader phenotype in mothers transmitting etiological CNVs to sons affected by Autism Spectrum Disorder (ASD),P09.029,,"Autism Spectrum Disorder is a frequent neurodevelopmental disorder with a high male to female ratio. An increased prevalence of autism like perso   nality traits is found in unaffected relatives of ASD children, suggesting a genetic liability of a broader autism phenotype. We therefore hypothesized that the parents of ASD children who transmit etiological CNVs might exhi bit ASD traits more frequently than non transmitting parents. To test this hypothesis, we analysed CNV inheritance and parental behavioral traits in families from the Autism Genome Project, assessed using the Broad Autism Phenotype Questionnaire (BAPQ) (N,341) and the Social Responsiveness Scale (SRS) (N,456). We selected CNVs spanning well established candidate genes for ASD, and compared transmitting and non transmitting parental test scores using a t test corrected for multiple testing by the Group Benja   mini Hochberg Procedure. Overall, CNV transmitting parents did not differ significantly in BAPQ and  SRS scores from non transmitting parents. However, independent analyses of relative pairs revealed a significant difference in BAPQ global (t, 2.18; ad  justed P,.032), BAPQ aloofness domain (t, 2.61; adjusted P,.032) and SRS  scores (t, 2.03; adjusted P,.047) between mothers transmitting and mo thers not transmitting etiological CNVs to their affected sons. Our findings  indicate that mothers presenting personality traits in the broader autism  phenotype are frequently carriers of pathogenic CNVs that they transmit to their ASD sons. The results from the analyses of maternal phenotype and CNV transmission patterns to sons support previous reports of maternal  transmission bias to male offspring, and the prevalent hypothesis of a high  er genetic risk tolerance in females due to putative protective factors. (FCT PD/BD/52485/2014)",2016.0,,"M. Asif, I. Conceio, K. Kwiatkowska, C. Rasga, C. Caf, L. Sousa, G. Oliveira, F.  M. Couto, A. M. Vicente,","Faculdade de Cincias da Universidade de Lisboa, Lisbon, Portugal, Biosystems and  Integrative Sciences Institute, Lisbon, Portugal, Instituto Nacional de Sade Doutor  Ricardo Jorge, Lisbon, Portugal, Unidade de Neurodesenvolvimento e Autismo do  Servio do Centro de Desenvolvimento da Criana and Centro de Investigao e Formao Clinica, Pediatric Hospital, Centro Hospitalar e Universitrio de Coimbra, Coimbra, Portugal,  University of Lisboa, Faculty of Sciences, DEIO and CEAUL, Lisbon,  Portugal, University Clinic of Pediatrics and Institute for Biomedical Imaging and Life  Science, Faculty of Medicine, University of Coimbra, Coimbra, Portugal, Department  of Informatics, Faculty of Sciences, University of Lisbon, Lisbon, Portugal, Instituto  Gulbenkian de Cincia, Oeiras, Lisbon, Portugal","An increased prevalence of autism like perso   nality traits is found in unaffected relatives of ASD children, suggesting a genetic liability of a broader autism phenotype.",,ASD children,[],"['ASD', 'child']"
630,753, Increased frequency of the autism broader phenotype in mothers transmitting etiological CNVs to sons affected by Autism Spectrum Disorder (ASD),P09.029,,"Autism Spectrum Disorder is a frequent neurodevelopmental disorder with a high male to female ratio. An increased prevalence of autism like perso   nality traits is found in unaffected relatives of ASD children, suggesting a genetic liability of a broader autism phenotype. We therefore hypothesized that the parents of ASD children who transmit etiological CNVs might exhi bit ASD traits more frequently than non transmitting parents. To test this hypothesis, we analysed CNV inheritance and parental behavioral traits in families from the Autism Genome Project, assessed using the Broad Autism Phenotype Questionnaire (BAPQ) (N,341) and the Social Responsiveness Scale (SRS) (N,456). We selected CNVs spanning well established candidate genes for ASD, and compared transmitting and non transmitting parental test scores using a t test corrected for multiple testing by the Group Benja   mini Hochberg Procedure. Overall, CNV transmitting parents did not differ significantly in BAPQ and  SRS scores from non transmitting parents. However, independent analyses of relative pairs revealed a significant difference in BAPQ global (t, 2.18; ad  justed P,.032), BAPQ aloofness domain (t, 2.61; adjusted P,.032) and SRS  scores (t, 2.03; adjusted P,.047) between mothers transmitting and mo thers not transmitting etiological CNVs to their affected sons. Our findings  indicate that mothers presenting personality traits in the broader autism  phenotype are frequently carriers of pathogenic CNVs that they transmit to their ASD sons. The results from the analyses of maternal phenotype and CNV transmission patterns to sons support previous reports of maternal  transmission bias to male offspring, and the prevalent hypothesis of a high  er genetic risk tolerance in females due to putative protective factors. (FCT PD/BD/52485/2014)",2016.0,,"M. Asif, I. Conceio, K. Kwiatkowska, C. Rasga, C. Caf, L. Sousa, G. Oliveira, F.  M. Couto, A. M. Vicente,","Faculdade de Cincias da Universidade de Lisboa, Lisbon, Portugal, Biosystems and  Integrative Sciences Institute, Lisbon, Portugal, Instituto Nacional de Sade Doutor  Ricardo Jorge, Lisbon, Portugal, Unidade de Neurodesenvolvimento e Autismo do  Servio do Centro de Desenvolvimento da Criana and Centro de Investigao e Formao Clinica, Pediatric Hospital, Centro Hospitalar e Universitrio de Coimbra, Coimbra, Portugal,  University of Lisboa, Faculty of Sciences, DEIO and CEAUL, Lisbon,  Portugal, University Clinic of Pediatrics and Institute for Biomedical Imaging and Life  Science, Faculty of Medicine, University of Coimbra, Coimbra, Portugal, Department  of Informatics, Faculty of Sciences, University of Lisbon, Lisbon, Portugal, Instituto  Gulbenkian de Cincia, Oeiras, Lisbon, Portugal",We therefore hypothesized that the parents of ASD children who transmit etiological CNVs might exhi bit ASD traits more frequently than non transmitting parents.,,ASD children,[],"['ASD', 'child']"
630,753, Increased frequency of the autism broader phenotype in mothers transmitting etiological CNVs to sons affected by Autism Spectrum Disorder (ASD),P09.029,,"Autism Spectrum Disorder is a frequent neurodevelopmental disorder with a high male to female ratio. An increased prevalence of autism like perso   nality traits is found in unaffected relatives of ASD children, suggesting a genetic liability of a broader autism phenotype. We therefore hypothesized that the parents of ASD children who transmit etiological CNVs might exhi bit ASD traits more frequently than non transmitting parents. To test this hypothesis, we analysed CNV inheritance and parental behavioral traits in families from the Autism Genome Project, assessed using the Broad Autism Phenotype Questionnaire (BAPQ) (N,341) and the Social Responsiveness Scale (SRS) (N,456). We selected CNVs spanning well established candidate genes for ASD, and compared transmitting and non transmitting parental test scores using a t test corrected for multiple testing by the Group Benja   mini Hochberg Procedure. Overall, CNV transmitting parents did not differ significantly in BAPQ and  SRS scores from non transmitting parents. However, independent analyses of relative pairs revealed a significant difference in BAPQ global (t, 2.18; ad  justed P,.032), BAPQ aloofness domain (t, 2.61; adjusted P,.032) and SRS  scores (t, 2.03; adjusted P,.047) between mothers transmitting and mo thers not transmitting etiological CNVs to their affected sons. Our findings  indicate that mothers presenting personality traits in the broader autism  phenotype are frequently carriers of pathogenic CNVs that they transmit to their ASD sons. The results from the analyses of maternal phenotype and CNV transmission patterns to sons support previous reports of maternal  transmission bias to male offspring, and the prevalent hypothesis of a high  er genetic risk tolerance in females due to putative protective factors. (FCT PD/BD/52485/2014)",2016.0,,"M. Asif, I. Conceio, K. Kwiatkowska, C. Rasga, C. Caf, L. Sousa, G. Oliveira, F.  M. Couto, A. M. Vicente,","Faculdade de Cincias da Universidade de Lisboa, Lisbon, Portugal, Biosystems and  Integrative Sciences Institute, Lisbon, Portugal, Instituto Nacional de Sade Doutor  Ricardo Jorge, Lisbon, Portugal, Unidade de Neurodesenvolvimento e Autismo do  Servio do Centro de Desenvolvimento da Criana and Centro de Investigao e Formao Clinica, Pediatric Hospital, Centro Hospitalar e Universitrio de Coimbra, Coimbra, Portugal,  University of Lisboa, Faculty of Sciences, DEIO and CEAUL, Lisbon,  Portugal, University Clinic of Pediatrics and Institute for Biomedical Imaging and Life  Science, Faculty of Medicine, University of Coimbra, Coimbra, Portugal, Department  of Informatics, Faculty of Sciences, University of Lisbon, Lisbon, Portugal, Instituto  Gulbenkian de Cincia, Oeiras, Lisbon, Portugal",We therefore hypothesized that the parents of ASD children who transmit etiological CNVs might exhi bit ASD traits more frequently than non transmitting parents.,,ASD traits,[],"['ASD', 'trait']"
630,753, Increased frequency of the autism broader phenotype in mothers transmitting etiological CNVs to sons affected by Autism Spectrum Disorder (ASD),P09.029,,"Autism Spectrum Disorder is a frequent neurodevelopmental disorder with a high male to female ratio. An increased prevalence of autism like perso   nality traits is found in unaffected relatives of ASD children, suggesting a genetic liability of a broader autism phenotype. We therefore hypothesized that the parents of ASD children who transmit etiological CNVs might exhi bit ASD traits more frequently than non transmitting parents. To test this hypothesis, we analysed CNV inheritance and parental behavioral traits in families from the Autism Genome Project, assessed using the Broad Autism Phenotype Questionnaire (BAPQ) (N,341) and the Social Responsiveness Scale (SRS) (N,456). We selected CNVs spanning well established candidate genes for ASD, and compared transmitting and non transmitting parental test scores using a t test corrected for multiple testing by the Group Benja   mini Hochberg Procedure. Overall, CNV transmitting parents did not differ significantly in BAPQ and  SRS scores from non transmitting parents. However, independent analyses of relative pairs revealed a significant difference in BAPQ global (t, 2.18; ad  justed P,.032), BAPQ aloofness domain (t, 2.61; adjusted P,.032) and SRS  scores (t, 2.03; adjusted P,.047) between mothers transmitting and mo thers not transmitting etiological CNVs to their affected sons. Our findings  indicate that mothers presenting personality traits in the broader autism  phenotype are frequently carriers of pathogenic CNVs that they transmit to their ASD sons. The results from the analyses of maternal phenotype and CNV transmission patterns to sons support previous reports of maternal  transmission bias to male offspring, and the prevalent hypothesis of a high  er genetic risk tolerance in females due to putative protective factors. (FCT PD/BD/52485/2014)",2016.0,,"M. Asif, I. Conceio, K. Kwiatkowska, C. Rasga, C. Caf, L. Sousa, G. Oliveira, F.  M. Couto, A. M. Vicente,","Faculdade de Cincias da Universidade de Lisboa, Lisbon, Portugal, Biosystems and  Integrative Sciences Institute, Lisbon, Portugal, Instituto Nacional de Sade Doutor  Ricardo Jorge, Lisbon, Portugal, Unidade de Neurodesenvolvimento e Autismo do  Servio do Centro de Desenvolvimento da Criana and Centro de Investigao e Formao Clinica, Pediatric Hospital, Centro Hospitalar e Universitrio de Coimbra, Coimbra, Portugal,  University of Lisboa, Faculty of Sciences, DEIO and CEAUL, Lisbon,  Portugal, University Clinic of Pediatrics and Institute for Biomedical Imaging and Life  Science, Faculty of Medicine, University of Coimbra, Coimbra, Portugal, Department  of Informatics, Faculty of Sciences, University of Lisbon, Lisbon, Portugal, Instituto  Gulbenkian de Cincia, Oeiras, Lisbon, Portugal",Our findings  indicate that mothers presenting personality traits in the broader autism  phenotype are frequently carriers of pathogenic CNVs that they transmit to their ASD sons.,,ASD sons,[],"['ASD', 'son']"
633,765, Autism related gene expression is spatially restricted in mid gestation human fetal cerebellum,P09.042,,"Introduction: Cerebellar dysfunction has a large impact on both cognitive and motor behavior and mounting evidence implicates the cerebellum in  autism spectrum disorders (ASD). However, the impact of ASD genes on ce  rebellar development and function is largely unknown. Here, we defined the 15 post conception week (pcw) human fetal cerebellar transcriptome and  hypothesized that ASD genes have neuron type specific expression. Materials and Methods: Laser capture microdissection (LCM) of intact cerebella from two 15 pcw fetuses enabled isolation of Purkinje cell (PC) and granule cell (GC) progenitor neurons. High quality RNA was isolated  (RIN>8), sequencing libraries using TruSeq RNA Access kit were construc  ted, barcoded, and sequenced using the Illumina HiSeq 2000. Paired end reads were aligned to the human genome HG19 using Tophat2, genes and  counts were summarized using HTSeq. Gene level differential expression  was analyzed using DESeq2.Results: On average, RNA seq generated 18 million high quality reads per  sample, 96% of which mapped uniquely. Hierarchical clustering using the  most variable genes within the dataset distinguished LCM isolated PC and GC samples, including several known PC  or GC specific genes. ASD genes generated from exome sequencing studies were expressed either throug  hout the cerebellum or restricted to PC neurons. Conclusions: LCM is an effective method to enrich for developing PC and GC neurons in human fetal cerebellum. ASD genes are expressed throughout  mid gestation cerebellum or restricted to PC neurons, further substantia   ting cerebellar neuroimaging and neuropathological findings in ASD, and  providing a potential neuronal therapeutic target. Grant references NICHD; R24HD000836 47R24HD000836 NINDS; 2RO1NS050375",2016.0,,"I. A. Glass, K. Aldinger, A. Timms, M. Deng, T . Naluai Cecchini, D. ODay, M. Weaver,  M. O. Dorschner, W. B. Dobyns, K. J. Millen","Department of Pediatrics, University of Washington; Center for Integrative Brain  Research, Seattle Childrens Research Institute, Seattle, WA, United States, Center for  Integrative Brain Research, Seattle Childrens Research Institute, Seattle, Seattle, WA, United States,  Center for Developmental Biology and Regenerative Medicine, Seattle  Childrens Research Institute,, Seattle, WA, United States, Department of Pediatrics, University of Washington, Seattle, WA, United States, Department of Pathology,  University of Washington, Seattle, WA, United States","However, the impact of ASD genes on ce  rebellar development and function is largely unknown.",,ASD genes,[],"['ASD', 'gene']"
633,765, Autism related gene expression is spatially restricted in mid gestation human fetal cerebellum,P09.042,,"Introduction: Cerebellar dysfunction has a large impact on both cognitive and motor behavior and mounting evidence implicates the cerebellum in  autism spectrum disorders (ASD). However, the impact of ASD genes on ce  rebellar development and function is largely unknown. Here, we defined the 15 post conception week (pcw) human fetal cerebellar transcriptome and  hypothesized that ASD genes have neuron type specific expression. Materials and Methods: Laser capture microdissection (LCM) of intact cerebella from two 15 pcw fetuses enabled isolation of Purkinje cell (PC) and granule cell (GC) progenitor neurons. High quality RNA was isolated  (RIN>8), sequencing libraries using TruSeq RNA Access kit were construc  ted, barcoded, and sequenced using the Illumina HiSeq 2000. Paired end reads were aligned to the human genome HG19 using Tophat2, genes and  counts were summarized using HTSeq. Gene level differential expression  was analyzed using DESeq2.Results: On average, RNA seq generated 18 million high quality reads per  sample, 96% of which mapped uniquely. Hierarchical clustering using the  most variable genes within the dataset distinguished LCM isolated PC and GC samples, including several known PC  or GC specific genes. ASD genes generated from exome sequencing studies were expressed either throug  hout the cerebellum or restricted to PC neurons. Conclusions: LCM is an effective method to enrich for developing PC and GC neurons in human fetal cerebellum. ASD genes are expressed throughout  mid gestation cerebellum or restricted to PC neurons, further substantia   ting cerebellar neuroimaging and neuropathological findings in ASD, and  providing a potential neuronal therapeutic target. Grant references NICHD; R24HD000836 47R24HD000836 NINDS; 2RO1NS050375",2016.0,,"I. A. Glass, K. Aldinger, A. Timms, M. Deng, T . Naluai Cecchini, D. ODay, M. Weaver,  M. O. Dorschner, W. B. Dobyns, K. J. Millen","Department of Pediatrics, University of Washington; Center for Integrative Brain  Research, Seattle Childrens Research Institute, Seattle, WA, United States, Center for  Integrative Brain Research, Seattle Childrens Research Institute, Seattle, Seattle, WA, United States,  Center for Developmental Biology and Regenerative Medicine, Seattle  Childrens Research Institute,, Seattle, WA, United States, Department of Pediatrics, University of Washington, Seattle, WA, United States, Department of Pathology,  University of Washington, Seattle, WA, United States","Here, we defined the 15 post conception week (pcw) human fetal cerebellar transcriptome and  hypothesized that ASD genes have neuron type specific expression.",,ASD genes,[],"['ASD', 'gene']"
633,765, Autism related gene expression is spatially restricted in mid gestation human fetal cerebellum,P09.042,,"Introduction: Cerebellar dysfunction has a large impact on both cognitive and motor behavior and mounting evidence implicates the cerebellum in  autism spectrum disorders (ASD). However, the impact of ASD genes on ce  rebellar development and function is largely unknown. Here, we defined the 15 post conception week (pcw) human fetal cerebellar transcriptome and  hypothesized that ASD genes have neuron type specific expression. Materials and Methods: Laser capture microdissection (LCM) of intact cerebella from two 15 pcw fetuses enabled isolation of Purkinje cell (PC) and granule cell (GC) progenitor neurons. High quality RNA was isolated  (RIN>8), sequencing libraries using TruSeq RNA Access kit were construc  ted, barcoded, and sequenced using the Illumina HiSeq 2000. Paired end reads were aligned to the human genome HG19 using Tophat2, genes and  counts were summarized using HTSeq. Gene level differential expression  was analyzed using DESeq2.Results: On average, RNA seq generated 18 million high quality reads per  sample, 96% of which mapped uniquely. Hierarchical clustering using the  most variable genes within the dataset distinguished LCM isolated PC and GC samples, including several known PC  or GC specific genes. ASD genes generated from exome sequencing studies were expressed either throug  hout the cerebellum or restricted to PC neurons. Conclusions: LCM is an effective method to enrich for developing PC and GC neurons in human fetal cerebellum. ASD genes are expressed throughout  mid gestation cerebellum or restricted to PC neurons, further substantia   ting cerebellar neuroimaging and neuropathological findings in ASD, and  providing a potential neuronal therapeutic target. Grant references NICHD; R24HD000836 47R24HD000836 NINDS; 2RO1NS050375",2016.0,,"I. A. Glass, K. Aldinger, A. Timms, M. Deng, T . Naluai Cecchini, D. ODay, M. Weaver,  M. O. Dorschner, W. B. Dobyns, K. J. Millen","Department of Pediatrics, University of Washington; Center for Integrative Brain  Research, Seattle Childrens Research Institute, Seattle, WA, United States, Center for  Integrative Brain Research, Seattle Childrens Research Institute, Seattle, Seattle, WA, United States,  Center for Developmental Biology and Regenerative Medicine, Seattle  Childrens Research Institute,, Seattle, WA, United States, Department of Pediatrics, University of Washington, Seattle, WA, United States, Department of Pathology,  University of Washington, Seattle, WA, United States",ASD genes generated from exome sequencing studies were expressed either throug  hout the cerebellum or restricted to PC neurons.,,ASD genes,[],"['ASD', 'gene']"
633,765, Autism related gene expression is spatially restricted in mid gestation human fetal cerebellum,P09.042,,"Introduction: Cerebellar dysfunction has a large impact on both cognitive and motor behavior and mounting evidence implicates the cerebellum in  autism spectrum disorders (ASD). However, the impact of ASD genes on ce  rebellar development and function is largely unknown. Here, we defined the 15 post conception week (pcw) human fetal cerebellar transcriptome and  hypothesized that ASD genes have neuron type specific expression. Materials and Methods: Laser capture microdissection (LCM) of intact cerebella from two 15 pcw fetuses enabled isolation of Purkinje cell (PC) and granule cell (GC) progenitor neurons. High quality RNA was isolated  (RIN>8), sequencing libraries using TruSeq RNA Access kit were construc  ted, barcoded, and sequenced using the Illumina HiSeq 2000. Paired end reads were aligned to the human genome HG19 using Tophat2, genes and  counts were summarized using HTSeq. Gene level differential expression  was analyzed using DESeq2.Results: On average, RNA seq generated 18 million high quality reads per  sample, 96% of which mapped uniquely. Hierarchical clustering using the  most variable genes within the dataset distinguished LCM isolated PC and GC samples, including several known PC  or GC specific genes. ASD genes generated from exome sequencing studies were expressed either throug  hout the cerebellum or restricted to PC neurons. Conclusions: LCM is an effective method to enrich for developing PC and GC neurons in human fetal cerebellum. ASD genes are expressed throughout  mid gestation cerebellum or restricted to PC neurons, further substantia   ting cerebellar neuroimaging and neuropathological findings in ASD, and  providing a potential neuronal therapeutic target. Grant references NICHD; R24HD000836 47R24HD000836 NINDS; 2RO1NS050375",2016.0,,"I. A. Glass, K. Aldinger, A. Timms, M. Deng, T . Naluai Cecchini, D. ODay, M. Weaver,  M. O. Dorschner, W. B. Dobyns, K. J. Millen","Department of Pediatrics, University of Washington; Center for Integrative Brain  Research, Seattle Childrens Research Institute, Seattle, WA, United States, Center for  Integrative Brain Research, Seattle Childrens Research Institute, Seattle, Seattle, WA, United States,  Center for Developmental Biology and Regenerative Medicine, Seattle  Childrens Research Institute,, Seattle, WA, United States, Department of Pediatrics, University of Washington, Seattle, WA, United States, Department of Pathology,  University of Washington, Seattle, WA, United States","ASD genes are expressed throughout  mid gestation cerebellum or restricted to PC neurons, further substantia   ting cerebellar neuroimaging and neuropathological findings in ASD, and  providing a potential neuronal therapeutic target.",,ASD genes,[],"['ASD', 'gene']"
637,795, Social anxiety and autism spectrum traits among adult FMR1 premutation carriers,P09.076,," Introduction: Behavioral symptoms and traits have been proposed as early markers in neurodegenerative diseases. The aim was of this study was to evaluate social anxiety and autism in FMR1 premutation carriers and con trols using the Social Phobia Inventory and the Autism Spectrum Quotient.Material and Methods: Fifty nine premutation carriers (40 females; 19 ma les) (7 females and 9 males with FXTAS) were compared to 50 controls (32 females; 18 males).Results: Our results show that FMR1 premutation carriers have higher so   cial anxiety scores and autistic traits compared to controls. Indeed, the SPIN scores were higher increased in women FMR1 premutation carriers compa red to men whereas the AQ scores were similar between the two genders. Finally, SPIN scores were correlated with the repeat size when the CGG num ber was greater than 100.Conclusions: Overall, these results indicate that social anxiety is greater in FMR1 premutation carrier women than in controls but not in men. In addi   tion, both men and women with the FMR1 premutation have an increased risk of autism traits. Our results suggest that a wide range of behavioral/psychiatric traits should be included within the Fragile X Spectrum disorder and that the penetrance of these traits depends on the genetic background (CGG repeat number, gene modifiers, epigenetic, among others) as well as on gender.Acknowledgments: This work was supported by the Instituto de Salud Car   los III (ISCIII; PI12/00879), cofinanced by the Fondo Europeo de Desarrollo Regional una manera de hacer Europa and AGAUR from the Autonomous Catalan Government (2014 SGR603).ABSTRACTS POSTERS ESHG 2016 | BARCELONA, SPAIN | WWW.ESHG.ORG  195Back to index",2016.0,,"M. Mil, O. Lopez Mourel, E. Mur, I. Madrigal, M. Alvarez Mora, L. Rodriguez  Revenga","Hospital Clinic, Barcelona, Spain, PIC, Parc de Recerca Universitat Autnoma de  Barcelona, Barcelona, Spain, CSM Mart i Juli Instituto de Neuropsiquiatra y  Adicciones (INAD). Parc de Salut Mar, Barcelona, Spain.",The aim was of this study was to evaluate social anxiety and autism in FMR1 premutation carriers and con trols using the Social Phobia Inventory and the Autism Spectrum Quotient.Material and Methods: Fifty nine premutation carriers (40 females; 19 ma les) (7 females and 9 males with FXTAS) were compared to 50 controls (32 females; 18 males).Results: Our results show that FMR1 premutation carriers have higher so   cial anxiety scores and autistic traits compared to controls.,,autistic traits,[],"['autistic', 'trait']"
640,815, MECP2 duplication: genetic and clinical study in Spanish patients,P09.097,,"Introduction: The MECP2 duplication syndrome (OMIM_300260) is a neu  rodevelopmental disorder X linked characterized by severe to profound intellectual disability, early infantile hypotonia, autistic traits, seizures and recurrent respiratory infections. It usually affects boys, but also there are girls affected. Duplication could be de novo or inherited from asymptomatic carrier mother. It has been reported about 120 cases all over the world, wi thout a known incidence.The aim of the study is to characterize a Spanish cohort with MECP2 dupli cation syndrome to improve our knowledge of the disease and perform a genotype phenotype correlation.Material and Method: The cohort consists in 13 patients of both sexes dia gnosed in different Spanish hospitals. The duplications were detected by MLPA and/or CGH array. The clinical characterization was carried out using a checklist designed for the project. The molecular characterization is di vided into several steps: 1) Checking the duplication by qPCR doses, stu dy XCI and FISH; 2) If FISH shows tandem duplication, we narrowed the breakpoints through qPCR, PCR long and Sanger sequencing; 3) Analyze the expression of the two MeCP2 isoforms by RT qPCR.Results: In this collaborative study has been characterized a heterogeneous cohort, with both sexes, with different phenotypes (Rett like and duplicati   on patients) and inherited or de novo duplication located in different regi ons (tandem, other region of ChrX or ChrY). However, this information is not enough to create a clear genotype phenotype correlation.Conclusions: We suppose MECP2 duplication syndrome is an underdia gnosed disease that needs further characterization studies in order to give a better genetic and clinical diagnosis.",2016.0,,"L. Blasco Prez, S. Vidal Falc, E. Gean Molins, N. Brandi Tarrau, P . Pacheco  Fernandez, M. del Campo, V. Catal, E. Guilln, P . Lapunzina, E. Lloveras, H.  Maortua, F. Martinez, A. Mesas, J. Nevado, M. Obn, C. Orellana, A. Plaja, M.  Rosello, M. I. Tejada, E. Tizzano, J. Armstrong Morn","Fundaci sant joan de deu, Barcelona, Spain, Hospital Universitario San Juan de Dios,  Barcelona, Spain, Hospital Valle Hebrn, Barcelona, Spain, Universidad Autnoma de  Barcelona, Barcelona, Spain, Hospital Virgen de la Arrixaca, Murcia, Spain, Instituto  de Investigacin Sanitaria del Hospital Universitario La Paz, Madrid, Spain, LABCO  Iberia, Barcelona, Spain, Hospital Universitario de Cruces, Bilbao, Spain, Hospital  Universitario y Politcnico La Fe, Valencia, Spain, Hospital Xanit, Mlaga, Spain,  Laboratoris ICS, Girona, Spain, Hospital Universitari Vall dHebron, Barcelona, Spain,  Hospital sant joan de deu, Barcelona, Spain","Introduction: The MECP2 duplication syndrome (OMIM_300260) is a neu  rodevelopmental disorder X linked characterized by severe to profound intellectual disability, early infantile hypotonia, autistic traits, seizures and recurrent respiratory infections.",,autistic traits,[],"['autistic', 'trait']"
642,855, A French collaborative study of genotype phenotype relationships in 78 patients carried a 22q13,P09.140,,"Patients with Phelan McDermid Syndrome, (or 22q13.3 deletion syndrome)  often have intellectual disability (ID), language impairment and autism. SHANK3 is one of the genes that contribute to the phenotype. There is a high clinical heterogeneity and the genotype phenotype correlation is still unclear. Our French collaborative study aims to precise it and look for poten  tial modifying genetic factors. We reported genetic and phenotypic data from 78 patients, 73 carried a 22q13.3 deletion and 5 had a duplication ranging in size from 45.8 kb to 9.10 Mb. The neonatal period revealed mild motor developmental delay in deleted  carriers. All patients exhibited language disorder and 50% had no verbal  communication. Autistic traits were reported in 50% of cases, unfortunate ly, objective tests were available only for three patients. Most patients had intellectual deficiency and medical comorbidity were also noted. Long term  follow up of two patients showed motor regression and acute psychiatric  disorder episode at adulthood.Patients with duplication had language di  sturbance and three presented with autistic traits.We studied the correlation between the size of the deleted segments and the main clinical features. We also analyzed the presence of other CNVs affecting  gene coding sequences to detect potential second hit implicated in the cli  nical heterogeneity of the syndrome. Interestingly, 2 patients with deletion had also a CNV at 16p11.2 involved in ASD, ID and obesity.Based on the results of this pilot study, we aim to extend this research to  other European and International centers to identify factors that modulate  the severity of the disorder.",2016.0,,"A. Tabet, M. Ducloy, J. Buratti, A. Mathieu, B. Keren, E. Pipiras, S. Chantot  Bastaraud, C. Le Caignec, J. Dupont, S. Kemeny, A. Mosca Boidron, C. Missirian, D.  Sanlaville, G. Vieville, M. Vuillaume, R. Delorme, T . Bourgeron","Robert Debre Hospital APHP , paris, France, GHFC unit, Pasteur institute, Paris, France,  GHFC unit, Pasteur institute, paris, France, Genetic unit, Piti Salpetrire hospital,  paris, France, Cytogenetic unit, Jean Verdier Hospital, Bondy, France, Cytogenetic  Unit, Trousseau Hospital, paris, France, Genetic Unit, Nantes Hospital, Nantes, France,  Cochin Hospital APHP , paris, France, Genetic Unit, CHU Estaing, Clermont Ferrand,  France, Cytogenetic Unit, Dijon Hospital, Dijon, France, Genetic Unit, La Timone  Hospital, Marseille, France, Lyon Civil Hospital, Lyon, France, Cytogenetic Unit,  Grenoble Hospital, Grenoble, France, Genetic unit, Bordeaux hospital, Bordeaux,  France, Psychopathologic Unit, Robert Debre Hospital, Paris, France","Autistic traits were reported in 50% of cases, unfortunate ly, objective tests were available only for three patients.",,Autistic traits,[],"['Autistic', 'trait']"
642,855, A French collaborative study of genotype phenotype relationships in 78 patients carried a 22q13,P09.140,,"Patients with Phelan McDermid Syndrome, (or 22q13.3 deletion syndrome)  often have intellectual disability (ID), language impairment and autism. SHANK3 is one of the genes that contribute to the phenotype. There is a high clinical heterogeneity and the genotype phenotype correlation is still unclear. Our French collaborative study aims to precise it and look for poten  tial modifying genetic factors. We reported genetic and phenotypic data from 78 patients, 73 carried a 22q13.3 deletion and 5 had a duplication ranging in size from 45.8 kb to 9.10 Mb. The neonatal period revealed mild motor developmental delay in deleted  carriers. All patients exhibited language disorder and 50% had no verbal  communication. Autistic traits were reported in 50% of cases, unfortunate ly, objective tests were available only for three patients. Most patients had intellectual deficiency and medical comorbidity were also noted. Long term  follow up of two patients showed motor regression and acute psychiatric  disorder episode at adulthood.Patients with duplication had language di  sturbance and three presented with autistic traits.We studied the correlation between the size of the deleted segments and the main clinical features. We also analyzed the presence of other CNVs affecting  gene coding sequences to detect potential second hit implicated in the cli  nical heterogeneity of the syndrome. Interestingly, 2 patients with deletion had also a CNV at 16p11.2 involved in ASD, ID and obesity.Based on the results of this pilot study, we aim to extend this research to  other European and International centers to identify factors that modulate  the severity of the disorder.",2016.0,,"A. Tabet, M. Ducloy, J. Buratti, A. Mathieu, B. Keren, E. Pipiras, S. Chantot  Bastaraud, C. Le Caignec, J. Dupont, S. Kemeny, A. Mosca Boidron, C. Missirian, D.  Sanlaville, G. Vieville, M. Vuillaume, R. Delorme, T . Bourgeron","Robert Debre Hospital APHP , paris, France, GHFC unit, Pasteur institute, Paris, France,  GHFC unit, Pasteur institute, paris, France, Genetic unit, Piti Salpetrire hospital,  paris, France, Cytogenetic unit, Jean Verdier Hospital, Bondy, France, Cytogenetic  Unit, Trousseau Hospital, paris, France, Genetic Unit, Nantes Hospital, Nantes, France,  Cochin Hospital APHP , paris, France, Genetic Unit, CHU Estaing, Clermont Ferrand,  France, Cytogenetic Unit, Dijon Hospital, Dijon, France, Genetic Unit, La Timone  Hospital, Marseille, France, Lyon Civil Hospital, Lyon, France, Cytogenetic Unit,  Grenoble Hospital, Grenoble, France, Genetic unit, Bordeaux hospital, Bordeaux,  France, Psychopathologic Unit, Robert Debre Hospital, Paris, France",Long term  follow up of two patients showed motor regression and acute psychiatric  disorder episode at adulthood.Patients with duplication had language di  sturbance and three presented with autistic traits.We studied the correlation between the size of the deleted segments and the main clinical features.,,autistic traits,[],"['autistic', 'trait']"
647,1002, Lacrimo auriculo dento digital syndrome: Description of two families reveals great phenotypic variability,P11.090,,"Lacrimo auriculo dento digital syndrome (LADD) is an autosomal domi   nant condition characterised by abnormalities of the lacrimal and salivary glands, teeth and hands. Only about 60 cases have been described in the literature. Mutations in the FGFR2, FGFR3 and FGF10 genes cause LADD syndrome. We report two familial FGF10 related cases and provide litera ture review.ABSTRACTS POSTERS ESHG 2016 | BARCELONA, SPAIN | WWW.ESHG.ORG  243Back to index Case 1 is a 12 year old girl presenting with dry mouth secondary to salivary  glands hypoplasia. She also had absent lacrimal ducts, small ears and dental  anomalies. Molecular analysis revealed an exon 3 deletion in FGFR10. Her  father, who carried the mutation, had blocked tear ducts as a child. His mo ther and brother have teeth abnormalities. Her cousin through her paternal  uncle was independently diagnosed with LADD syndrome. Case 2 is an 11 year old girl with complete absence of salivary glands, wi despread dental decay, obstructed tear ducts, and cognitive and behavioral difficulties on the autistic spectrum. She developed focal seizures secondary  to focal cortical dysplasia identified on brain MRI. Her father underwent se   veral surgical procedures to improve the patency of his nasolacrimal ducts  in childhood. He was found to have agenesis of the parotid and right sub  mandibular glands, although he was asymptomatic. Both were found to have  the p.Arg78Leu mutation in FGFR10.This report underlines the phenotypical variability that may be present as a  result of FGFR10 mutations, ranging from LADD syndrome to aplasia of the  lacrimal and salivary glands (ALSG). ALSG and LADD may represent variab le presentations of the same clinical spectrum caused by FGF10 mutations.",2016.0,,"A. Beleza Meireles, E. Hughes, M. Harrison, D. Josifova","Guys Hospital, London, United Kingdom","Case 2 is an 11 year old girl with complete absence of salivary glands, wi despread dental decay, obstructed tear ducts, and cognitive and behavioral difficulties on the autistic spectrum.",,autistic spectrum,[],"['autistic', 'spectrum']"
648,1059, Genetic and neurodevelopmental spectrum of SYNGAP1 associated intellectual disability and epilepsy,P11.150,,"angeborene Stoffwechselerkrankungen, Oldenburg,  Germany,  12Department of Pediatric Neurology and Developmental Medicine and  Epilepsy Center, University of Munich, Munich, Germany, 13Department of Medical  Genetics, Institute of Mother and Child, Warsaw, Poland, 14Clinic of Neurology of Child  and Adolescents; Institute of Mother and Child, Warsaw, Poland, 15Department of  Pediatrics, Division of Child Neurology, School of Medicine, Dokuz Eyll University, Izmir,  Turkey, 16Boazii University, Department of Molecular Biology and Genetics, Istanbul,  Turkey, 17AP H Objective: We aimed to delineate the neurodevelopmental spectrum asso   ciated with SYNGAP1 mutations and to investigate genotype phenotype  correlations.Methods: We sequenced the exome or screened the exons of SYNGAP1 in a total of 251 patients with neurodevelopmental disorders. Molecular and clinical data from patients with SYNGAP1 mutations from other centers were also collected, focusing on developmental aspects and the associated epilepsy phenotype. A review of SYNGAP1 mutations published in the lite rature was also performed.Results: We describe 17 unrelated affected individuals carrying 13 diffe rent novel loss of function SYNGAP1 mutations. Developmental delay was the first manifestation of SYNGAP1 related encephalopathy; intellectual disability became progressively obvious and was associated with autistic behaviors in eight patients. Hypotonia and unstable gait were frequent as sociated neurological features. With the exception of one patient who ex   perienced a single seizure, all patients had epilepsy, characterized by falls or head drops due to atonic or myoclonic seizures, (myoclonic) absences, and/or eyelid myoclonia. Triggers of seizures were frequent (n,7). Seizures were pharmacoresistant in half of the patients. The severity of the epilepsy did not correlate with the presence of autistic features or with the severity of cognitive impairment. Mutations were distributed throughout the gene, but spared spliced 3 and 5 exons. Seizures in patients with mutations in exons 4 5 were more pharmacoresponsive than in patients with mutations in exons 8 15.Conclusion: SYNGAP1 encephalopathy is characterized by early neurodeve lopmental delay typically preceding the onset of a relatively recognizable epilepsy comprising generalized seizures (absences, myoclonic jerks) and frequent triggers.",2016.0,,"C. Mignot, C. von Stlpnagel, C. Nava, D. Ville, D. Sanlaville, G. Lesca, A.  Rastetter, B. Gachet, Y. Marie, C. Korenke, I. Borggraefe, D. Hoffmann Zacharska,  E. Szczepanik, M. Rudzka Dybaa, U. Yi, H. alayan, A. Isapof, I. Marey, E.  Panagiotakaki, C. Korff, E. Rossier, A. Riess, S. Beck Woedl, A. Rauch, C. Zweier,  J. Hoyer, A. Reis, M. Mironov, M. Bobylova, k. Mukhin, L. Hernandez Hernandez,  B. Maher, S. Sisodiya, S. Wechuysen, C. Myers, H. Mefford, K. Hrtnagel, S.  Biskup, EuroEPINOMICS RES MAE working group, J. Lemke, D. Heron, G. Kluger,  C. Depienne,","APHP , Groupe hospitalier Piti Salptrire Paris, Paris, France, Centre de Rfrence  Dficiences Intellectuelles de Causes Rares, Paris, France, Groupe de Recherche  Clinique (GRC) Dficience Intellectuelle et Autisme UPMC, Paris, France, Hospital  for Neuropediatrics and Neurological Rehabilitation, Epilepsy Center for Children and  Adolescents, Vogtareuth, Germany, Paracelsus Medical University Salzburg, Salzburg,  Austria, Sorbonne Universits, UPMC Univ Paris , INSERM UMR S , CNRS UMR  , ICM, Paris, France, Service de Neurologie Pdiatrique, Hpital Femme Mre  Enfant, CHU de Lyon, Bron, France, Service de Gntique, Groupement Hospitalier Est,  Hospices Civils de Lyon, Bron, France, Universit Claude Bernard Lyon , Villeurbanne,  France, CRNL, CNRS UMR , INSERM U, Villeurbanne, France, Klinikum  Oldenburg, Zentrum fr Kinder  und Jugendmedizin (Elisabeth Kinderkrankenhaus), Klinik fr Neuropdiatrie u",Developmental delay was the first manifestation of SYNGAP1 related encephalopathy; intellectual disability became progressively obvious and was associated with autistic behaviors in eight patients.,,autistic behaviors,[],"['autistic', 'behavior']"
648,1059, Genetic and neurodevelopmental spectrum of SYNGAP1 associated intellectual disability and epilepsy,P11.150,,"angeborene Stoffwechselerkrankungen, Oldenburg,  Germany,  12Department of Pediatric Neurology and Developmental Medicine and  Epilepsy Center, University of Munich, Munich, Germany, 13Department of Medical  Genetics, Institute of Mother and Child, Warsaw, Poland, 14Clinic of Neurology of Child  and Adolescents; Institute of Mother and Child, Warsaw, Poland, 15Department of  Pediatrics, Division of Child Neurology, School of Medicine, Dokuz Eyll University, Izmir,  Turkey, 16Boazii University, Department of Molecular Biology and Genetics, Istanbul,  Turkey, 17AP H Objective: We aimed to delineate the neurodevelopmental spectrum asso   ciated with SYNGAP1 mutations and to investigate genotype phenotype  correlations.Methods: We sequenced the exome or screened the exons of SYNGAP1 in a total of 251 patients with neurodevelopmental disorders. Molecular and clinical data from patients with SYNGAP1 mutations from other centers were also collected, focusing on developmental aspects and the associated epilepsy phenotype. A review of SYNGAP1 mutations published in the lite rature was also performed.Results: We describe 17 unrelated affected individuals carrying 13 diffe rent novel loss of function SYNGAP1 mutations. Developmental delay was the first manifestation of SYNGAP1 related encephalopathy; intellectual disability became progressively obvious and was associated with autistic behaviors in eight patients. Hypotonia and unstable gait were frequent as sociated neurological features. With the exception of one patient who ex   perienced a single seizure, all patients had epilepsy, characterized by falls or head drops due to atonic or myoclonic seizures, (myoclonic) absences, and/or eyelid myoclonia. Triggers of seizures were frequent (n,7). Seizures were pharmacoresistant in half of the patients. The severity of the epilepsy did not correlate with the presence of autistic features or with the severity of cognitive impairment. Mutations were distributed throughout the gene, but spared spliced 3 and 5 exons. Seizures in patients with mutations in exons 4 5 were more pharmacoresponsive than in patients with mutations in exons 8 15.Conclusion: SYNGAP1 encephalopathy is characterized by early neurodeve lopmental delay typically preceding the onset of a relatively recognizable epilepsy comprising generalized seizures (absences, myoclonic jerks) and frequent triggers.",2016.0,,"C. Mignot, C. von Stlpnagel, C. Nava, D. Ville, D. Sanlaville, G. Lesca, A.  Rastetter, B. Gachet, Y. Marie, C. Korenke, I. Borggraefe, D. Hoffmann Zacharska,  E. Szczepanik, M. Rudzka Dybaa, U. Yi, H. alayan, A. Isapof, I. Marey, E.  Panagiotakaki, C. Korff, E. Rossier, A. Riess, S. Beck Woedl, A. Rauch, C. Zweier,  J. Hoyer, A. Reis, M. Mironov, M. Bobylova, k. Mukhin, L. Hernandez Hernandez,  B. Maher, S. Sisodiya, S. Wechuysen, C. Myers, H. Mefford, K. Hrtnagel, S.  Biskup, EuroEPINOMICS RES MAE working group, J. Lemke, D. Heron, G. Kluger,  C. Depienne,","APHP , Groupe hospitalier Piti Salptrire Paris, Paris, France, Centre de Rfrence  Dficiences Intellectuelles de Causes Rares, Paris, France, Groupe de Recherche  Clinique (GRC) Dficience Intellectuelle et Autisme UPMC, Paris, France, Hospital  for Neuropediatrics and Neurological Rehabilitation, Epilepsy Center for Children and  Adolescents, Vogtareuth, Germany, Paracelsus Medical University Salzburg, Salzburg,  Austria, Sorbonne Universits, UPMC Univ Paris , INSERM UMR S , CNRS UMR  , ICM, Paris, France, Service de Neurologie Pdiatrique, Hpital Femme Mre  Enfant, CHU de Lyon, Bron, France, Service de Gntique, Groupement Hospitalier Est,  Hospices Civils de Lyon, Bron, France, Universit Claude Bernard Lyon , Villeurbanne,  France, CRNL, CNRS UMR , INSERM U, Villeurbanne, France, Klinikum  Oldenburg, Zentrum fr Kinder  und Jugendmedizin (Elisabeth Kinderkrankenhaus), Klinik fr Neuropdiatrie u",The severity of the epilepsy did not correlate with the presence of autistic features or with the severity of cognitive impairment.,,autistic features,[],"['autistic', 'feature']"
651,1295, The use of automated facial analysis in the clinical diagnostic of autism spectrum disorders (ASD),P14.005,,"Introduction: Autism can be part of a genetic syndrome associating with dysmorphic features. While there are many studies that described genetic alterations associated with ASD, none have identified facial phenotypes as sociating to ASD with computer aided facial analysis. Here we evaluate the geno/phenotype relation in a limited number of autistic individuals.Methods: An image set of affected individuals divided into two cohorts: pre senting facial dysmorphologies (AFD) (n,20) and without dysmorphology  (ANFD) by human experts. These cohorts were compared to unaffected con  trols (n,50) using variables and rankings produced by the Facial Dysmor   phology Novel Analysis (FDNA) technology. In both ASD cohorts mutations of 103 genes associated to autism, repeat expansions of FMR1 gene, and in  some AFD cases chromosomal abnormalities have been identified. Results: Clear trends were recognizable in the three groups along facial dys morphology variables and rankings. Although labeled as not showing facial  dysmorphology, the ANFD cohort was automatically ranked separately from  the unaffected controls. In addition, two possible clusters of ANFD were re cognized by the technology. The AFD cohort was clearly recognized as sepa  rate from the other two cohorts. In the AFD group Fragile X, CHARGE, Silver  Russell, Cohen, 2q37.3 microdeletion syndrome, and Speech Language Dis   order 1 were identified. Conclusion: The preliminary results show that deep phenotyping provided  by a computer aided facial analysis could be instrumental in the early clini cal diagnostic of the syndromic ASD forms and could help in the selection of diagnostic molecular tests. Larger study is needed to assess these trends  and to allow cross validation.",2016.0,,"N. A. Varga, P . Balicza, K. Pentelenyi, H. Piko, M. Szegedi, V. Karcagi, M. Molnar","Institute of Genomic Medicine and Rare Disorders, Budapest, Hungary","Here we evaluate the geno/phenotype relation in a limited number of autistic individuals.Methods: An image set of affected individuals divided into two cohorts: pre senting facial dysmorphologies (AFD) (n,20) and without dysmorphology  (ANFD) by human experts.",,autistic individuals,[],"['autistic', 'individual']"
651,1295, The use of automated facial analysis in the clinical diagnostic of autism spectrum disorders (ASD),P14.005,,"Introduction: Autism can be part of a genetic syndrome associating with dysmorphic features. While there are many studies that described genetic alterations associated with ASD, none have identified facial phenotypes as sociating to ASD with computer aided facial analysis. Here we evaluate the geno/phenotype relation in a limited number of autistic individuals.Methods: An image set of affected individuals divided into two cohorts: pre senting facial dysmorphologies (AFD) (n,20) and without dysmorphology  (ANFD) by human experts. These cohorts were compared to unaffected con  trols (n,50) using variables and rankings produced by the Facial Dysmor   phology Novel Analysis (FDNA) technology. In both ASD cohorts mutations of 103 genes associated to autism, repeat expansions of FMR1 gene, and in  some AFD cases chromosomal abnormalities have been identified. Results: Clear trends were recognizable in the three groups along facial dys morphology variables and rankings. Although labeled as not showing facial  dysmorphology, the ANFD cohort was automatically ranked separately from  the unaffected controls. In addition, two possible clusters of ANFD were re cognized by the technology. The AFD cohort was clearly recognized as sepa  rate from the other two cohorts. In the AFD group Fragile X, CHARGE, Silver  Russell, Cohen, 2q37.3 microdeletion syndrome, and Speech Language Dis   order 1 were identified. Conclusion: The preliminary results show that deep phenotyping provided  by a computer aided facial analysis could be instrumental in the early clini cal diagnostic of the syndromic ASD forms and could help in the selection of diagnostic molecular tests. Larger study is needed to assess these trends  and to allow cross validation.",2016.0,,"N. A. Varga, P . Balicza, K. Pentelenyi, H. Piko, M. Szegedi, V. Karcagi, M. Molnar","Institute of Genomic Medicine and Rare Disorders, Budapest, Hungary","In both ASD cohorts mutations of 103 genes associated to autism, repeat expansions of FMR1 gene, and in  some AFD cases chromosomal abnormalities have been identified.",,ASD cohorts,[],"['ASD', 'cohort']"
651,1295, The use of automated facial analysis in the clinical diagnostic of autism spectrum disorders (ASD),P14.005,,"Introduction: Autism can be part of a genetic syndrome associating with dysmorphic features. While there are many studies that described genetic alterations associated with ASD, none have identified facial phenotypes as sociating to ASD with computer aided facial analysis. Here we evaluate the geno/phenotype relation in a limited number of autistic individuals.Methods: An image set of affected individuals divided into two cohorts: pre senting facial dysmorphologies (AFD) (n,20) and without dysmorphology  (ANFD) by human experts. These cohorts were compared to unaffected con  trols (n,50) using variables and rankings produced by the Facial Dysmor   phology Novel Analysis (FDNA) technology. In both ASD cohorts mutations of 103 genes associated to autism, repeat expansions of FMR1 gene, and in  some AFD cases chromosomal abnormalities have been identified. Results: Clear trends were recognizable in the three groups along facial dys morphology variables and rankings. Although labeled as not showing facial  dysmorphology, the ANFD cohort was automatically ranked separately from  the unaffected controls. In addition, two possible clusters of ANFD were re cognized by the technology. The AFD cohort was clearly recognized as sepa  rate from the other two cohorts. In the AFD group Fragile X, CHARGE, Silver  Russell, Cohen, 2q37.3 microdeletion syndrome, and Speech Language Dis   order 1 were identified. Conclusion: The preliminary results show that deep phenotyping provided  by a computer aided facial analysis could be instrumental in the early clini cal diagnostic of the syndromic ASD forms and could help in the selection of diagnostic molecular tests. Larger study is needed to assess these trends  and to allow cross validation.",2016.0,,"N. A. Varga, P . Balicza, K. Pentelenyi, H. Piko, M. Szegedi, V. Karcagi, M. Molnar","Institute of Genomic Medicine and Rare Disorders, Budapest, Hungary",Conclusion: The preliminary results show that deep phenotyping provided  by a computer aided facial analysis could be instrumental in the early clini cal diagnostic of the syndromic ASD forms and could help in the selection of diagnostic molecular tests.,,ASD forms,[],"['ASD', 'form']"
653,1426, An integrative analysis of genomic studies for the identification of the molecular network regions associated with autism spectrum disorders,P16.03,,"Introduction: Molecular interaction networks are crucial for the interpreta  tion of genome wide data of pathologies characterized by a marked genetic heterogeneity like Autism Spectrum Disorders (ASDs). Indeed biological functions involved in a specific pathology are likely to be more conserved than individual genetic variations. We define the network regions enriched  in genetic variations associated with ASDs. Compared with previous studies,  we consider several reported evidences and the whole network topology to predict relevant interacting partners of ASDs genes.Materials and Methods: Lists of genes associated with ASDs were collected  from a manually curated database and genomic studies. A diffusion based  method was used to identify genes in network proximity to those from the  lists. Direct and indirect protein protein interactions were collected from five different databases. The Italian cohort (195 cases and 87 controls) was genotyped with a high density platform. Results: We defined genome wide scores summarizing the proximity of  each gene to the gene lists associated to ASDs. We highlighted the network  regions, with corresponding biological functions, differently represented in the considered genomic studies. We found significant number of genes in network proximity to genes associated with ASDs among the genes reported  in the literature as having a minimal evidence of association with ASDs and  the genes containing alleles associated with ASDs in our Italian cohort. Conclusions: We summarise the network regions densely populated by ASDs associated genes providing a network based tool to quantify the func tional relation of novel genes with those already associated with ASDs. Italian Health Ministry (GR 2009 1570296), Flagship project InterOmics  (PB05), MIMOMICS EU(305280)",2016.0,,"E. Mosca, M. Bersanelli, R. Alfieri, M. Landini, N. Galluccio, M. E. Raggi, L. Villa,  M. Moleteni, A. Bonfanti, S. Camposeo, A. Massagli, G. Castellani, F. Ciceri, A.  Marabotti, L. Milanesi, A. Mezzelani","Institute of Biomedical Technologies, National Research Council, Segrate, Italy,  Department of Physics and Astronomy, University of Bologna, Bologna, Italy, INGM,  National Institute of Molecular Genetics Romeo ed Enrica Invernizzi, Milan, Italy,  Scientific Institute, IRCSS Eugenio Medea, Bosisio Parini (LC), Italy, Scientific Institute,  IRCSS Eugenio Medea, Brindisi, Italy, Department of Chemistry and Biology, University  of Salerno, Fisciano (SA), Italy","Compared with previous studies,  we consider several reported evidences and the whole network topology to predict relevant interacting partners of ASDs genes.Materials and Methods: Lists of genes associated with ASDs were collected  from a manually curated database and genomic studies.",,ASDs genes,[],"['ASDs', 'gene']"
653,1426, An integrative analysis of genomic studies for the identification of the molecular network regions associated with autism spectrum disorders,P16.03,,"Introduction: Molecular interaction networks are crucial for the interpreta  tion of genome wide data of pathologies characterized by a marked genetic heterogeneity like Autism Spectrum Disorders (ASDs). Indeed biological functions involved in a specific pathology are likely to be more conserved than individual genetic variations. We define the network regions enriched  in genetic variations associated with ASDs. Compared with previous studies,  we consider several reported evidences and the whole network topology to predict relevant interacting partners of ASDs genes.Materials and Methods: Lists of genes associated with ASDs were collected  from a manually curated database and genomic studies. A diffusion based  method was used to identify genes in network proximity to those from the  lists. Direct and indirect protein protein interactions were collected from five different databases. The Italian cohort (195 cases and 87 controls) was genotyped with a high density platform. Results: We defined genome wide scores summarizing the proximity of  each gene to the gene lists associated to ASDs. We highlighted the network  regions, with corresponding biological functions, differently represented in the considered genomic studies. We found significant number of genes in network proximity to genes associated with ASDs among the genes reported  in the literature as having a minimal evidence of association with ASDs and  the genes containing alleles associated with ASDs in our Italian cohort. Conclusions: We summarise the network regions densely populated by ASDs associated genes providing a network based tool to quantify the func tional relation of novel genes with those already associated with ASDs. Italian Health Ministry (GR 2009 1570296), Flagship project InterOmics  (PB05), MIMOMICS EU(305280)",2016.0,,"E. Mosca, M. Bersanelli, R. Alfieri, M. Landini, N. Galluccio, M. E. Raggi, L. Villa,  M. Moleteni, A. Bonfanti, S. Camposeo, A. Massagli, G. Castellani, F. Ciceri, A.  Marabotti, L. Milanesi, A. Mezzelani","Institute of Biomedical Technologies, National Research Council, Segrate, Italy,  Department of Physics and Astronomy, University of Bologna, Bologna, Italy, INGM,  National Institute of Molecular Genetics Romeo ed Enrica Invernizzi, Milan, Italy,  Scientific Institute, IRCSS Eugenio Medea, Bosisio Parini (LC), Italy, Scientific Institute,  IRCSS Eugenio Medea, Brindisi, Italy, Department of Chemistry and Biology, University  of Salerno, Fisciano (SA), Italy",Conclusions: We summarise the network regions densely populated by ASDs associated genes providing a network based tool to quantify the func tional relation of novel genes with those already associated with ASDs.,,ASDs associated genes,[],"['ASDs', 'associated', 'gene']"
655,1718, Parent Perspectives on Whole Genome Sequencing for Autism Spectrum Disorder,P20.25,,"Autism spectrum disorder (ASD) is a group of neurodevelopmental conditi   ons that have a complex genetic etiology. Whole genome sequencing (WGS) is a powerful ASD research tool since it can assay many types of genetic va riation in a single test. In recent years, there has been a lot of debate around return of results following genetic testing; however, there is a paucity of em pirical data on research subjects experience with WGS, in particular. To eli cit and analyze participants experiences with WGS, we invited parents (and capable children) who were enrolled in an ASD genomic study to participate in semi structured interviews at two times during the WGS testing cycle: 1) following informed consent, and 2) following return of results. To date, we have interviewed 19 parents at time 1 and 8 parents at time 2. Emerging themes from time 1 interviews include, hope for a genetic diagnosis, hope for treatment, and altruism. Parents also hoped for findings that they could use for planning and prevention purposes, although they expressed con cerns over inflicted insight and insurance discrimination. Following return of results at time 2, emerging themes include, the value of learning genetic information, the resolution of blame between biological parents, and dis   appointment at not receiving treatment guiding information. Our findings suggest that participants may have different motivations/concerns before and after testing; whereas many begin with altruistic motivations, their desire for actionable results weighs heavily post testing. Though our ana   lysis is provisional, these results suggest that novel strategies for education and informed consent are necessary. ELECTRONIC POSTERS E P01 Reproductive Genetics/Prenatal  Genetics E",2016.0,,"M. J. Szego, J. A. Anderson, N. Hoang, P . Szatmari, S. W. Scherer,","University of Toronto, Toronto, ON, Canada, The Hospital for Sick Children, Toronto,  ON, Canada",Whole genome sequencing (WGS) is a powerful ASD research tool since it can assay many types of genetic va riation in a single test.,,ASD research,[],"['ASD', 'research']"
655,1718, Parent Perspectives on Whole Genome Sequencing for Autism Spectrum Disorder,P20.25,,"Autism spectrum disorder (ASD) is a group of neurodevelopmental conditi   ons that have a complex genetic etiology. Whole genome sequencing (WGS) is a powerful ASD research tool since it can assay many types of genetic va riation in a single test. In recent years, there has been a lot of debate around return of results following genetic testing; however, there is a paucity of em pirical data on research subjects experience with WGS, in particular. To eli cit and analyze participants experiences with WGS, we invited parents (and capable children) who were enrolled in an ASD genomic study to participate in semi structured interviews at two times during the WGS testing cycle: 1) following informed consent, and 2) following return of results. To date, we have interviewed 19 parents at time 1 and 8 parents at time 2. Emerging themes from time 1 interviews include, hope for a genetic diagnosis, hope for treatment, and altruism. Parents also hoped for findings that they could use for planning and prevention purposes, although they expressed con cerns over inflicted insight and insurance discrimination. Following return of results at time 2, emerging themes include, the value of learning genetic information, the resolution of blame between biological parents, and dis   appointment at not receiving treatment guiding information. Our findings suggest that participants may have different motivations/concerns before and after testing; whereas many begin with altruistic motivations, their desire for actionable results weighs heavily post testing. Though our ana   lysis is provisional, these results suggest that novel strategies for education and informed consent are necessary. ELECTRONIC POSTERS E P01 Reproductive Genetics/Prenatal  Genetics E",2016.0,,"M. J. Szego, J. A. Anderson, N. Hoang, P . Szatmari, S. W. Scherer,","University of Toronto, Toronto, ON, Canada, The Hospital for Sick Children, Toronto,  ON, Canada","To eli cit and analyze participants experiences with WGS, we invited parents (and capable children) who were enrolled in an ASD genomic study to participate in semi structured interviews at two times during the WGS testing cycle: 1) following informed consent, and 2) following return of results.",,ASD genomic study,[],"['ASD', 'genomic', 'study']"
659,1858, Interstitial deletion of 5q35,P08.13,,"We report on a 15 years old boy, first child of healthy, non consanguineous  parents. During pregnancy, a ventricular septal defect (VSD), atrial septal  defect (ASD) and an omphalocele were diagnosed. At the time of presen   tation, he demonstrated global developmental delay and unspecific facial  dysmorphism. Conventional cytogenetic analysis revealed an apparently normal male karyotype (46,XY; GTG banding at 550 band level). Array CGH analysis (Agilent 400k microarray set) uncovered a de novo deletion of 1.6  Mb in the chromosomal region 5q35.1 q35.2. This deletion was confirmed  by FISH analysis. The deletion comprises 11 genes including the NKX2 5 gene (OMIM 600584). Mutations in the NKX2 5 gene were identified in patients with ASD, VSD, tetralogy of Fallot, and other congenital cardiac defects. The de   letion does not overlap with the minimal Sotos syndrome deletion region.To the best of our knowledge, there are only two reports on patients with small deletions in 5q35.1 q35.2 including the NKX2 5 gene. One patient was described with severe heart defect, microcephaly, minor facial dys morphic features, scoliosis, cryptorchidism, learning difficulties associated with ADHD and an IQ of 83. He carried a 2.2 Mb deletion in 5q35.1 q35.2 (Baekvad Hansen et al., 2006). The other patient (Decipher database, pa tient 257414) with ASD, cryptorchidism, hypothyroidism and intellectual disability showed a 2.1 Mb deletion in 5q35.1 q35.2. E",2016.0,,"A. Rpke , C. Mller Hofstede, S. Ledig, P . Wieacker, F. Tttelmann","Institut fr Humangenetik, Mnster, Germany","Mutations in the NKX2 5 gene were identified in patients with ASD, VSD, tetralogy of Fallot, and other congenital cardiac defects.",patients with ASD,,"['patient', 'with', 'ASD']",[]
660,1861," Patient with language impairment, intellectual disability, autism and de novo truncating FOXP1 variant helps to define emerging somatic phenotype associated with FOXP1 defects",P08.16,,"FOXP1 (forkhead box protein P1) is a transcription factor important in neu rodevelopment. Thirteen patients with de novo protein disrupting intrage  nic FOXP1 variants have been reported. They have language impairment,  developmental delay/intellectual disability (ID) and autistic features. We report an 8 year old boy with severe language impairment, moderate ID and atypical autism. His speech regressed at 18 months of age and started to improve again since 5 years of age. However, expressive speech is severely affected and shows no progress. The boy is hyperactive and anxious. Other features include hypotonia, mild facial dysmorphism, hypermetropia and strabismus.Karyotyping and microarray analysis yielded no findings. Targeted next ge   neration sequencing using the TruSight Autism panel (Illumina) identified a private heterozygous nonsense FOXP1 mutation (NM_032682.5:c.1319C>G,p. S440*), which was confirmed using Sanger sequencing in the patient but in neither of his parents indicating its de novo nature. The aberrant transcript is likely removed by nonsense mediated decay (NMD), and FOXP1 haploin  sufficiency was proposed as the main pathogenic mechanism. If the tran script escaped NMD, the p.S440* mutation would truncate FOXP1 between the leucine zipper dimerization domain and the FOX DNA binding domain. A recently functionally characterized neighbouring FOXP1 variant p.Y439* showed aberrant protein localization.Our patient supports the role of FOXP1 in language, cognition and behaviour,  and helps to define the emerging characteristic somatic phenotype of FOXP1  mutation carriers which may include prominent forehead, frontal hair ups weep, arched eyebrows, hypertelorism, downslanting palpebral fissures, ptosis, low set ears, short nose with a broad tip and smooth philtrum.Supported by NT/14200, 00064203, CZ.2.16/3.1.00/24022 and NF CZ11 PDP 3 003 2014. E",2016.0,,"D. Prchalov, M. Havlovicov, M. Hanrov, V. Strneck, Z. Sedlek","Department of Biology and Medical Genetics, Charles University nd Faculty of  Medicine and University Hospital Motol, Prague, Czech Republic, Institute of Inherited  Metabolic Disorders, Charles University st Faculty of Medicine and General University Hospital, Prague, Czech Republic","They have language impairment,  developmental delay/intellectual disability (ID) and autistic features.",,autistic features,[],"['autistic', 'feature']"
662,1864, Primary immunodeficiency disorder associated with severe intellectual disability and abnormal brain MRI findings in a patient with 3q29 microduplication syndrome A case report,P08.20,,"Introduction: Chromosome interstitial 3q29 microduplication syndrome (OMIM 611936) has been associated with a recognizable pattern of ab   normalities such as mild to moderate cognitive impairment, cerebral palsy, speech delay, autistic traits, seizures, obesity, musculoskeletal anomalies (chest wall and fingers deformities) and common craniofacial dysmorphic features.Materials and method: We have investigated a 34 year old woman with severe intellectual disability, abnormal brain MRI findings suggestive for fronto temporal dementia and primary immunodeficiency characterized through persistent mucosal infections with Candida albicans. Results of EEG, karyotype, cerebral fluid analyses, abdominal ultrasound and urine/plasma metabolic screens were normal.DNA isolated and purified from peripheral venous blood was further as sessed by array CGH platform (Roche NimbleGen, Madison, WI, USA) using  an Array CHX 3x720k slide. Copy number data was analyzed with Nexus 6.1  software (Nexus BioDiscovery, El Segundo, CA).Results:   Assessment through Array CGH identified 1.65 Mb duplication at  3q29. The duplicated region encompasses 29 genes including several prote  in coding genes such as RNF168, WDR53, TFRC, PIGX, PAK2, NCBP2, PIGZ, MFI2, BDH1, FBXO45 or DLG1 and a non coding mRNA: mir4797 Conclusions: We described a case with typical 3q29 microduplication syn  drome with severe phenotype. To our knowledge, thus is the first case with primary immunodeficiency features and expands the heterogeneous clini cal spectrum of this syndrome. Consideration should be given to the above  mentioned locus (3q29) in patients with recurrent fungal infections, intel  lectual disability and/or abnormal brain MRI findings.Acknowledgement: This study was supported within the frame of European  Social Found, Human Resources Development Operational Program 2007  2013, project no. POSDRU/159/1.5/S/136893 E",2016.0,,"I. Streata, S. Sosoi, A. L. Riza, F. Burada, M. G. Netea, F. Mixich, M. Ioana","University of Medicine and Pharmacy of Craiova, Human Genomics Laboratory,  Craiova, Romania, Department of Medicine and Nijmegen Institute for Infection,  Inflammation and Immunity (Ni), Radboud University Nijmegen Medical Center, Nijmegen, Netherlands","Introduction: Chromosome interstitial 3q29 microduplication syndrome (OMIM 611936) has been associated with a recognizable pattern of ab   normalities such as mild to moderate cognitive impairment, cerebral palsy, speech delay, autistic traits, seizures, obesity, musculoskeletal anomalies (chest wall and fingers deformities) and common craniofacial dysmorphic features.Materials and method: We have investigated a 34 year old woman with severe intellectual disability, abnormal brain MRI findings suggestive for fronto temporal dementia and primary immunodeficiency characterized through persistent mucosal infections with Candida albicans.",,autistic traits,[],"['autistic', 'trait']"
663,1867, Autosomal recessive primary microcephaly caused by deletion 8p23,P08.25,,"Case report: We present a case where a mentally retarded female, whose previous diagnosis was referred to as autistic spectrum disorder, has pri  mary microcephaly inherited as an autosomal recessive. Her birth weight  was 2500g at 38 weak of gestation. Diagnosis of microcephaly was confir   med early after birth. Head circumference was on 3rd percentile. She has not  suffered epilepsy, but she has had mild dysmorphic features and moderate  cognitive impairment. She was referred to geneticist to specify the diagnosis  at the age of 8. Methods: We have used SNP array (Illumina) analysis. The homozygous  deletion of approximately 46 kb, encompassing the first three exons of the  MCPH1 gene (microcephalin 1), was found in child. The phenotype in the  heterozygous carrier mother was normal. The phenotype and genotype of  her biological father was unknown.Conclusion: Microcephaly may be part of many genetic malformation syn dromes or may result from a variety of intrauterine factors. More specific and accurate diagnosis with molecular confirmation may provide a possibi   lity of more focused health supervision, which could be essential for patient and genetic counselling in prenatal diagnosis of parents. E",2016.0,,"M. Hejtmankova, V. Becvarova, L. Hnykova, J. Horacek, M. Trkova, D. Stejskal","GENNET , Praha , Czech Republic","Case report: We present a case where a mentally retarded female, whose previous diagnosis was referred to as autistic spectrum disorder, has pri  mary microcephaly inherited as an autosomal recessive.",,autistic spectrum,[],"['autistic', 'spectrum']"
667,1881, Autism and seizure in a patient with maternal derived 15q11,P09.07,," Proximal 15q duplications that include the critical region for Prader Willi syndrome (PWS) and angelman syndrome (AS) have been reported in pati   ents with autism. Of the cases of autism reported to have duplications of the PWS/AS critical region, all have been maternal in origin.We describe here a female patient in wich autism segregates with maternal inherance of a proximal 15q duplication. The patient was born at 37 gesta tion weeks with a weigh of 3150 gr. and no incidences in neonatal period. In posterior pediatric revission was detected language and cognitive delayed, supected due to autistic disorder (AD), at 3 years age preseted epilepsy epi sodies. The familiar history include fater and maternal grandmother with epilepsy, maternal uncle with autism and a sister healty.Comparative Genomic Hybridization (CGH Array) with the Nimblegen CGX Cytogenetic Microarrays platform, suplied by PerkinElmer, was performed for the patient and parentsThe CGH  Array was normal in the father and both mother and patient presented a duplication of 5,56 Mb in 15q11.2 q13.1 PWS/AS region (arr(hg19)15q11.2 q13.1(22,822,019 28,379,369)x3). The Array CGH from grandmother, maternal uncle and sister were no done. This results are according with previous studies that show the correlation between this duplication and autistic disorder when have been maternal in origin. The family history with the maternal uncle diagnosed of autistic dis   order also agree this posibility. The epilepsy, presented in some members  of both families, can be originated for another unknow genetics alteration,  without any correlation with the PSW/AS region. E",2016.0,,"M. Martinez Atienza, S. Garcia Linares, A. Rubio Lopez de la Oliva, A. Gonzalez  Ramirez., A. Mora Guijosa, M. Perez Sanchez.,","Complejo Hospitalario de Granada SAS., Granada., Spain, Instituto biosanitario de  Granada., Granada., Spain, FIBAO. Complejo Hospitalario de Granada. SAS., Granada.,  Spain.", Proximal 15q duplications that include the critical region for Prader Willi syndrome (PWS) and angelman syndrome (AS) have been reported in pati   ents with autism.,ents with autism,,"['ents', 'with', 'autism']",[]
667,1881, Autism and seizure in a patient with maternal derived 15q11,P09.07,," Proximal 15q duplications that include the critical region for Prader Willi syndrome (PWS) and angelman syndrome (AS) have been reported in pati   ents with autism. Of the cases of autism reported to have duplications of the PWS/AS critical region, all have been maternal in origin.We describe here a female patient in wich autism segregates with maternal inherance of a proximal 15q duplication. The patient was born at 37 gesta tion weeks with a weigh of 3150 gr. and no incidences in neonatal period. In posterior pediatric revission was detected language and cognitive delayed, supected due to autistic disorder (AD), at 3 years age preseted epilepsy epi sodies. The familiar history include fater and maternal grandmother with epilepsy, maternal uncle with autism and a sister healty.Comparative Genomic Hybridization (CGH Array) with the Nimblegen CGX Cytogenetic Microarrays platform, suplied by PerkinElmer, was performed for the patient and parentsThe CGH  Array was normal in the father and both mother and patient presented a duplication of 5,56 Mb in 15q11.2 q13.1 PWS/AS region (arr(hg19)15q11.2 q13.1(22,822,019 28,379,369)x3). The Array CGH from grandmother, maternal uncle and sister were no done. This results are according with previous studies that show the correlation between this duplication and autistic disorder when have been maternal in origin. The family history with the maternal uncle diagnosed of autistic dis   order also agree this posibility. The epilepsy, presented in some members  of both families, can be originated for another unknow genetics alteration,  without any correlation with the PSW/AS region. E",2016.0,,"M. Martinez Atienza, S. Garcia Linares, A. Rubio Lopez de la Oliva, A. Gonzalez  Ramirez., A. Mora Guijosa, M. Perez Sanchez.,","Complejo Hospitalario de Granada SAS., Granada., Spain, Instituto biosanitario de  Granada., Granada., Spain, FIBAO. Complejo Hospitalario de Granada. SAS., Granada.,  Spain.","In posterior pediatric revission was detected language and cognitive delayed, supected due to autistic disorder (AD), at 3 years age preseted epilepsy epi sodies.",,autistic disorder,[],"['autistic', 'disorder']"
667,1881, Autism and seizure in a patient with maternal derived 15q11,P09.07,," Proximal 15q duplications that include the critical region for Prader Willi syndrome (PWS) and angelman syndrome (AS) have been reported in pati   ents with autism. Of the cases of autism reported to have duplications of the PWS/AS critical region, all have been maternal in origin.We describe here a female patient in wich autism segregates with maternal inherance of a proximal 15q duplication. The patient was born at 37 gesta tion weeks with a weigh of 3150 gr. and no incidences in neonatal period. In posterior pediatric revission was detected language and cognitive delayed, supected due to autistic disorder (AD), at 3 years age preseted epilepsy epi sodies. The familiar history include fater and maternal grandmother with epilepsy, maternal uncle with autism and a sister healty.Comparative Genomic Hybridization (CGH Array) with the Nimblegen CGX Cytogenetic Microarrays platform, suplied by PerkinElmer, was performed for the patient and parentsThe CGH  Array was normal in the father and both mother and patient presented a duplication of 5,56 Mb in 15q11.2 q13.1 PWS/AS region (arr(hg19)15q11.2 q13.1(22,822,019 28,379,369)x3). The Array CGH from grandmother, maternal uncle and sister were no done. This results are according with previous studies that show the correlation between this duplication and autistic disorder when have been maternal in origin. The family history with the maternal uncle diagnosed of autistic dis   order also agree this posibility. The epilepsy, presented in some members  of both families, can be originated for another unknow genetics alteration,  without any correlation with the PSW/AS region. E",2016.0,,"M. Martinez Atienza, S. Garcia Linares, A. Rubio Lopez de la Oliva, A. Gonzalez  Ramirez., A. Mora Guijosa, M. Perez Sanchez.,","Complejo Hospitalario de Granada SAS., Granada., Spain, Instituto biosanitario de  Granada., Granada., Spain, FIBAO. Complejo Hospitalario de Granada. SAS., Granada.,  Spain.","The familiar history include fater and maternal grandmother with epilepsy, maternal uncle with autism and a sister healty.Comparative Genomic Hybridization (CGH Array) with the Nimblegen CGX Cytogenetic Microarrays platform, suplied by PerkinElmer, was performed for the patient and parentsThe CGH  Array was normal in the father and both mother and patient presented a duplication of 5,56 Mb in 15q11.2 q13.1 PWS/AS region (arr(hg19)15q11.2 q13.1(22,822,019 28,379,369)x3).",uncle with autism,,"['uncle', 'with', 'autism']",[]
667,1881, Autism and seizure in a patient with maternal derived 15q11,P09.07,," Proximal 15q duplications that include the critical region for Prader Willi syndrome (PWS) and angelman syndrome (AS) have been reported in pati   ents with autism. Of the cases of autism reported to have duplications of the PWS/AS critical region, all have been maternal in origin.We describe here a female patient in wich autism segregates with maternal inherance of a proximal 15q duplication. The patient was born at 37 gesta tion weeks with a weigh of 3150 gr. and no incidences in neonatal period. In posterior pediatric revission was detected language and cognitive delayed, supected due to autistic disorder (AD), at 3 years age preseted epilepsy epi sodies. The familiar history include fater and maternal grandmother with epilepsy, maternal uncle with autism and a sister healty.Comparative Genomic Hybridization (CGH Array) with the Nimblegen CGX Cytogenetic Microarrays platform, suplied by PerkinElmer, was performed for the patient and parentsThe CGH  Array was normal in the father and both mother and patient presented a duplication of 5,56 Mb in 15q11.2 q13.1 PWS/AS region (arr(hg19)15q11.2 q13.1(22,822,019 28,379,369)x3). The Array CGH from grandmother, maternal uncle and sister were no done. This results are according with previous studies that show the correlation between this duplication and autistic disorder when have been maternal in origin. The family history with the maternal uncle diagnosed of autistic dis   order also agree this posibility. The epilepsy, presented in some members  of both families, can be originated for another unknow genetics alteration,  without any correlation with the PSW/AS region. E",2016.0,,"M. Martinez Atienza, S. Garcia Linares, A. Rubio Lopez de la Oliva, A. Gonzalez  Ramirez., A. Mora Guijosa, M. Perez Sanchez.,","Complejo Hospitalario de Granada SAS., Granada., Spain, Instituto biosanitario de  Granada., Granada., Spain, FIBAO. Complejo Hospitalario de Granada. SAS., Granada.,  Spain.",This results are according with previous studies that show the correlation between this duplication and autistic disorder when have been maternal in origin.,,autistic disorder,[],"['autistic', 'disorder']"
668,1883, Polymorphism of a potassium/chloride transporter gene SLC12A5 is associated with autistic like traits in healthy individuals,P09.09,,"Previous studies have indicated autistic like traits to lie on a continuum with autism spectrum disorders in the general population. In a recent stu dy, a K Cl cotransporter protein, KCC2 gene SLC12A5 on chromosome 20,  which previously was linked to idiopathic generalized epilepsy, familial fe  brile seizures and schizophrenia, was reported to be associated with func tionally impairing variants in autism spectrum disorders. Here, we report a  novel association of a polymorhism, rs9074, located in the 3UTR region of  SLC12A5 with autistic like traits in a healthy population.A total of 75 healthy volunteers aged between 18 30 participated to the study. Autistic like traits were quantitized on the autism spectrum quotient  (AQ) scale. AQ scores measured for each individual were comprised of five  subscales of social skills, attention switching, communication, attention to details and imagination categories utilizing a previously validated version  of the AQ in Turkish. SNP genotyping assays were performed with specific  primers and probes in an RT PCR platform.rs9074 genotypes were distributed as GG:48%, GA:41.3%, AA:10.7% with  allele frequencies in HWE. Total AQ (p,0.008), social skills (p,0.002) and at   tention switching (p,0.038) subscale scores were significantly higher in AA  bearers compared to GG+GA genotypes (Mann Whitney U test). AQ scores  were normally distributed. A significant association between AA genotype  and social skills scores (p,0.014) in subjects +0.5 SD above average for total AQ (normally distributed) were also noted (Fishers exact test).These results suggest a possible role of KCC2 in neurodevelopmental stages  in liaison with autism spectrum disorders. Ankara University Scientific Research Projects Funds (No.I3 L333 033). E",2016.0,,"S. A. Zergeroglu, T . Tuncali, H. D. Ozguven, C. Kalaycioglu","Ankara University Institute of Health Sciences, Department of Interdisciplinary  Neuroscience, Ankara, Turkey, Ankara University School of Medicine, Medical Genetics  Department, Ankara, Turkey, Ankara University School of Medicine, Department of  Psychiatry, Ankara, Turkey",Previous studies have indicated autistic like traits to lie on a continuum with autism spectrum disorders in the general population.,continuum with autism,,"['continuum', 'with', 'autism']",[]
668,1883, Polymorphism of a potassium/chloride transporter gene SLC12A5 is associated with autistic like traits in healthy individuals,P09.09,,"Previous studies have indicated autistic like traits to lie on a continuum with autism spectrum disorders in the general population. In a recent stu dy, a K Cl cotransporter protein, KCC2 gene SLC12A5 on chromosome 20,  which previously was linked to idiopathic generalized epilepsy, familial fe  brile seizures and schizophrenia, was reported to be associated with func tionally impairing variants in autism spectrum disorders. Here, we report a  novel association of a polymorhism, rs9074, located in the 3UTR region of  SLC12A5 with autistic like traits in a healthy population.A total of 75 healthy volunteers aged between 18 30 participated to the study. Autistic like traits were quantitized on the autism spectrum quotient  (AQ) scale. AQ scores measured for each individual were comprised of five  subscales of social skills, attention switching, communication, attention to details and imagination categories utilizing a previously validated version  of the AQ in Turkish. SNP genotyping assays were performed with specific  primers and probes in an RT PCR platform.rs9074 genotypes were distributed as GG:48%, GA:41.3%, AA:10.7% with  allele frequencies in HWE. Total AQ (p,0.008), social skills (p,0.002) and at   tention switching (p,0.038) subscale scores were significantly higher in AA  bearers compared to GG+GA genotypes (Mann Whitney U test). AQ scores  were normally distributed. A significant association between AA genotype  and social skills scores (p,0.014) in subjects +0.5 SD above average for total AQ (normally distributed) were also noted (Fishers exact test).These results suggest a possible role of KCC2 in neurodevelopmental stages  in liaison with autism spectrum disorders. Ankara University Scientific Research Projects Funds (No.I3 L333 033). E",2016.0,,"S. A. Zergeroglu, T . Tuncali, H. D. Ozguven, C. Kalaycioglu","Ankara University Institute of Health Sciences, Department of Interdisciplinary  Neuroscience, Ankara, Turkey, Ankara University School of Medicine, Medical Genetics  Department, Ankara, Turkey, Ankara University School of Medicine, Department of  Psychiatry, Ankara, Turkey","A significant association between AA genotype  and social skills scores (p,0.014) in subjects +0.5 SD above average for total AQ (normally distributed) were also noted (Fishers exact test).These results suggest a possible role of KCC2 in neurodevelopmental stages  in liaison with autism spectrum disorders.",liaison with autism,,"['liaison', 'with', 'autism']",[]
670,1887, CGH arrays analysis in a series of pediatric patients suffering from neurological diseases and/or congenital malformations of unknown etiology,P09.14,,"Background and aims:CGH arrays (Comparative Genomic Hybridization Arrays) are powerful and innovative technologies whose implementation is allowing an extraordinary change in the diagnosis of various diseases, es   pecially in the diagnostic and research of intellectual disability, autism and malformation syndromes. Our aim was to analyze, by CGH arrays, a series of patients affected by several neurological diseases and/or malformations to try to determine the etiology of the disease in these patients.Methods: A total of 66 pediatric index patients with normal karyotype were analyzed for Copy Number Variations by CGH arrays using CGX 8 plex (Agilent Technologies). Proband patients were clinically classified as: au   tism spectrum disorders (ASD) (n,30), intellectual disability (n,17), mal   formation syndromes (n,9), psychomotor delay (n,8), hypotonia (n,1) and early puberty (n,1).Results: 10 pathogenic (or probably pathogenic) variants and 21 variants of unknown significance were detected. Pathogenic or probably pathogenic variants were identified in 3 patients with psychomotor delay (and other features), 3 patients with intellectual disability, 3 patients with ASD and in one patient with hypotonia and malformations. 6 of the 10 variants were previously described and associated to known syndromes (Prader Willi syndrome (n,1), 1q21.1 microdeletion syndrome (n,1), 16p11.2 microde   letion syndrome (n,1), 22q11 deletion syndrome (n,2), and a tetrasomy of 15q11.2 region (n,1)).Discussion and conclusions: Array CGH is a rapid and cost effective techni   que for postnatal screening of unknown syndromes, intellectual disability and autism sprectrum disorders. Our experience shows that a 15% of ped iatric patients derived for the analysis of Copy Number Variations present a  pathogenic or probably pathogenic variant. E",2016.0,,"M. Gamundi, B. Ma, E. Borrs, I. Hernan, B. Pascual, R. Vidal, V. Delgadillo, R.  Martorell, M. Carballo","Unitat de Gentica Molecular, Hospital de Terrassa, Terrassa, Spain, Neurologia  Peditrica, Hospital de Terrassa, Terrassa, Spain, Neonatologia, Hospital de Terrassa,  Terrassa, Spain","Pathogenic or probably pathogenic variants were identified in 3 patients with psychomotor delay (and other features), 3 patients with intellectual disability, 3 patients with ASD and in one patient with hypotonia and malformations.",patients with ASD,,"['patient', 'with', 'ASD']",[]
672,1891, DNA Repair Gene Variants and The Risk of Autism Spectrum Disorder,P09.19,,"Introduction: Autism spectrum disorder (ASD) is a complex disorder, and its extreme heterogeneity further complicates our understanding of its biology. Epidemiological evidence from family and twin studies supports a strong genetic component in ASD etiology. Oxidative stress and abnormal DNA me thylation have been implicated in the pathophysiology of ASD. Brain tissues from ASD cases showed higher levels of oxidative stress biomarkers than healthy controls in postmortem analysis. Association between oxidative stress and DNA damage has been well known. Thus, we sought to investiga te a potential link between DNA repair genes and ASD and analyze the role of XPD Asp312Asn and XRCC4 G 1394T gene polymorphisms for ASD in the Turkish population.Material and Methods: Genotyping was conducted by PCR RFLP based on 100 patients and 96 unrelated healthy controls.Results: We, for the first time, demonstrated a positive association between XRCC4 gene variants and ASD risk. Frequencies of XRCC4 1394 T/G+G/G genotypes were higher in patients (%34) than the controls (%18.7). The statistical analysis revealed that the individuals who had XRCC4 1394 T/G+G/G genotype had an increased risk for ASD (OR , 2.23, 95% CI , 1.10 4.55). However, no significant association was found for XPD Asp312Asn polymorphism with the risk of ASD.Conclusion: Our findings suggest that XRCC4 G 1394T polymorphism might be associated with ASD pathogenesis. E",2016.0,,"S. Dasdemir, M. Guven, K. C. Pekkoc, H. Ulucan, B. Dogangun, E. Kirtas, M. T . Kadak,  M. Kucur, M. Seven","Istanbul University, Cerrahpasa Faculty of Medicine, Department of Medical Genetics,  Istanbul, Turkey, Istanbul University, Cerrahpasa Faculty of Medicine, Department of  Medical Biology, Istanbul, Turkey, Istanbul University, Cerrahpasa Faculty of Medicine,  Department of Child and Adolescent Pyschiatry, Istanbul, Turkey, Istanbul University,  Cerrahpasa Faculty of Medicine, Department of Biochemistry, Istanbul, Turkey",Epidemiological evidence from family and twin studies supports a strong genetic component in ASD etiology.,,ASD etiology,[],"['ASD', 'etiology']"
672,1891, DNA Repair Gene Variants and The Risk of Autism Spectrum Disorder,P09.19,,"Introduction: Autism spectrum disorder (ASD) is a complex disorder, and its extreme heterogeneity further complicates our understanding of its biology. Epidemiological evidence from family and twin studies supports a strong genetic component in ASD etiology. Oxidative stress and abnormal DNA me thylation have been implicated in the pathophysiology of ASD. Brain tissues from ASD cases showed higher levels of oxidative stress biomarkers than healthy controls in postmortem analysis. Association between oxidative stress and DNA damage has been well known. Thus, we sought to investiga te a potential link between DNA repair genes and ASD and analyze the role of XPD Asp312Asn and XRCC4 G 1394T gene polymorphisms for ASD in the Turkish population.Material and Methods: Genotyping was conducted by PCR RFLP based on 100 patients and 96 unrelated healthy controls.Results: We, for the first time, demonstrated a positive association between XRCC4 gene variants and ASD risk. Frequencies of XRCC4 1394 T/G+G/G genotypes were higher in patients (%34) than the controls (%18.7). The statistical analysis revealed that the individuals who had XRCC4 1394 T/G+G/G genotype had an increased risk for ASD (OR , 2.23, 95% CI , 1.10 4.55). However, no significant association was found for XPD Asp312Asn polymorphism with the risk of ASD.Conclusion: Our findings suggest that XRCC4 G 1394T polymorphism might be associated with ASD pathogenesis. E",2016.0,,"S. Dasdemir, M. Guven, K. C. Pekkoc, H. Ulucan, B. Dogangun, E. Kirtas, M. T . Kadak,  M. Kucur, M. Seven","Istanbul University, Cerrahpasa Faculty of Medicine, Department of Medical Genetics,  Istanbul, Turkey, Istanbul University, Cerrahpasa Faculty of Medicine, Department of  Medical Biology, Istanbul, Turkey, Istanbul University, Cerrahpasa Faculty of Medicine,  Department of Child and Adolescent Pyschiatry, Istanbul, Turkey, Istanbul University,  Cerrahpasa Faculty of Medicine, Department of Biochemistry, Istanbul, Turkey",Brain tissues from ASD cases showed higher levels of oxidative stress biomarkers than healthy controls in postmortem analysis.,,ASD cases,[],"['ASD', 'case']"
672,1891, DNA Repair Gene Variants and The Risk of Autism Spectrum Disorder,P09.19,,"Introduction: Autism spectrum disorder (ASD) is a complex disorder, and its extreme heterogeneity further complicates our understanding of its biology. Epidemiological evidence from family and twin studies supports a strong genetic component in ASD etiology. Oxidative stress and abnormal DNA me thylation have been implicated in the pathophysiology of ASD. Brain tissues from ASD cases showed higher levels of oxidative stress biomarkers than healthy controls in postmortem analysis. Association between oxidative stress and DNA damage has been well known. Thus, we sought to investiga te a potential link between DNA repair genes and ASD and analyze the role of XPD Asp312Asn and XRCC4 G 1394T gene polymorphisms for ASD in the Turkish population.Material and Methods: Genotyping was conducted by PCR RFLP based on 100 patients and 96 unrelated healthy controls.Results: We, for the first time, demonstrated a positive association between XRCC4 gene variants and ASD risk. Frequencies of XRCC4 1394 T/G+G/G genotypes were higher in patients (%34) than the controls (%18.7). The statistical analysis revealed that the individuals who had XRCC4 1394 T/G+G/G genotype had an increased risk for ASD (OR , 2.23, 95% CI , 1.10 4.55). However, no significant association was found for XPD Asp312Asn polymorphism with the risk of ASD.Conclusion: Our findings suggest that XRCC4 G 1394T polymorphism might be associated with ASD pathogenesis. E",2016.0,,"S. Dasdemir, M. Guven, K. C. Pekkoc, H. Ulucan, B. Dogangun, E. Kirtas, M. T . Kadak,  M. Kucur, M. Seven","Istanbul University, Cerrahpasa Faculty of Medicine, Department of Medical Genetics,  Istanbul, Turkey, Istanbul University, Cerrahpasa Faculty of Medicine, Department of  Medical Biology, Istanbul, Turkey, Istanbul University, Cerrahpasa Faculty of Medicine,  Department of Child and Adolescent Pyschiatry, Istanbul, Turkey, Istanbul University,  Cerrahpasa Faculty of Medicine, Department of Biochemistry, Istanbul, Turkey","Thus, we sought to investiga te a potential link between DNA repair genes and ASD and analyze the role of XPD Asp312Asn and XRCC4 G 1394T gene polymorphisms for ASD in the Turkish population.Material and Methods: Genotyping was conducted by PCR RFLP based on 100 patients and 96 unrelated healthy controls.Results: We, for the first time, demonstrated a positive association between XRCC4 gene variants and ASD risk.",,ASD risk,[],"['ASD', 'risk']"
672,1891, DNA Repair Gene Variants and The Risk of Autism Spectrum Disorder,P09.19,,"Introduction: Autism spectrum disorder (ASD) is a complex disorder, and its extreme heterogeneity further complicates our understanding of its biology. Epidemiological evidence from family and twin studies supports a strong genetic component in ASD etiology. Oxidative stress and abnormal DNA me thylation have been implicated in the pathophysiology of ASD. Brain tissues from ASD cases showed higher levels of oxidative stress biomarkers than healthy controls in postmortem analysis. Association between oxidative stress and DNA damage has been well known. Thus, we sought to investiga te a potential link between DNA repair genes and ASD and analyze the role of XPD Asp312Asn and XRCC4 G 1394T gene polymorphisms for ASD in the Turkish population.Material and Methods: Genotyping was conducted by PCR RFLP based on 100 patients and 96 unrelated healthy controls.Results: We, for the first time, demonstrated a positive association between XRCC4 gene variants and ASD risk. Frequencies of XRCC4 1394 T/G+G/G genotypes were higher in patients (%34) than the controls (%18.7). The statistical analysis revealed that the individuals who had XRCC4 1394 T/G+G/G genotype had an increased risk for ASD (OR , 2.23, 95% CI , 1.10 4.55). However, no significant association was found for XPD Asp312Asn polymorphism with the risk of ASD.Conclusion: Our findings suggest that XRCC4 G 1394T polymorphism might be associated with ASD pathogenesis. E",2016.0,,"S. Dasdemir, M. Guven, K. C. Pekkoc, H. Ulucan, B. Dogangun, E. Kirtas, M. T . Kadak,  M. Kucur, M. Seven","Istanbul University, Cerrahpasa Faculty of Medicine, Department of Medical Genetics,  Istanbul, Turkey, Istanbul University, Cerrahpasa Faculty of Medicine, Department of  Medical Biology, Istanbul, Turkey, Istanbul University, Cerrahpasa Faculty of Medicine,  Department of Child and Adolescent Pyschiatry, Istanbul, Turkey, Istanbul University,  Cerrahpasa Faculty of Medicine, Department of Biochemistry, Istanbul, Turkey","However, no significant association was found for XPD Asp312Asn polymorphism with the risk of ASD.Conclusion: Our findings suggest that XRCC4 G 1394T polymorphism might be associated with ASD pathogenesis.",,ASD pathogenesis,[],"['ASD', 'pathogenesis']"
673,1902, Genetics of language deficits in schizophrenia and autism: an evolutionary approach,P09.38,,"Both autism spectrum disorders (ASD) and schizophrenia (SZ) are highly prevalent cognitive disorders, entailing language deficits. Recent advances in genome wide technologies have provided with a long list of candidate genes for SZ and ASD, but the gap between genes, the pathophysiology of SZ and ASD, and their distinctive cognitive and linguistic profiles still remains open. Our study aims to bridge this gap through an evo devo approach that focuses on how language evolved in the species and that construes both con ditions as poles of a continuum of modes of cognition, also encompassing typically developing cognition. To this aim, we have performed literature mining and network analysis of known candidate genes for SZ and ASD and found that they are overrepresented among the gene believed to be impor   tant for the evolution of the human faculty of language. Many of these genes are common risk factors for both conditions. Additionally, we performed in silico data mining of previously published SZ and ASD microarray data   sets and found that many of these genes important for language evolution (like CNTNAP2, DLX5, FOXP1, or ROBO2) are differentially expressed in the brains of schizophrenics and autists. We will conclude that the (substanti   ally opposite) linguistic (dys)abilities seen in SZ and ASD patients may re present abnormal (but still related) ontogenetic itineraries for the human faculty of language and that the same factors that prompted the transition from an ape like cognition to a human specific cognition may explain the high prevalence of SZ and ASD, but also their related cognitive profiles.Grant: FFI2014 61888 EXP E",2016.0,,"A. Bentez Burraco, E. Murphy, W. Lattanzi","University of Huelva, Huelva, Spain, University College London, London, United  Kingdom, Universit Cattolica del Sacro Cuore, Rome, Italy","Additionally, we performed in silico data mining of previously published SZ and ASD microarray data   sets and found that many of these genes important for language evolution (like CNTNAP2, DLX5, FOXP1, or ROBO2) are differentially expressed in the brains of schizophrenics and autists.",,ASD microarray,[],"['ASD', 'microarray']"
673,1902, Genetics of language deficits in schizophrenia and autism: an evolutionary approach,P09.38,,"Both autism spectrum disorders (ASD) and schizophrenia (SZ) are highly prevalent cognitive disorders, entailing language deficits. Recent advances in genome wide technologies have provided with a long list of candidate genes for SZ and ASD, but the gap between genes, the pathophysiology of SZ and ASD, and their distinctive cognitive and linguistic profiles still remains open. Our study aims to bridge this gap through an evo devo approach that focuses on how language evolved in the species and that construes both con ditions as poles of a continuum of modes of cognition, also encompassing typically developing cognition. To this aim, we have performed literature mining and network analysis of known candidate genes for SZ and ASD and found that they are overrepresented among the gene believed to be impor   tant for the evolution of the human faculty of language. Many of these genes are common risk factors for both conditions. Additionally, we performed in silico data mining of previously published SZ and ASD microarray data   sets and found that many of these genes important for language evolution (like CNTNAP2, DLX5, FOXP1, or ROBO2) are differentially expressed in the brains of schizophrenics and autists. We will conclude that the (substanti   ally opposite) linguistic (dys)abilities seen in SZ and ASD patients may re present abnormal (but still related) ontogenetic itineraries for the human faculty of language and that the same factors that prompted the transition from an ape like cognition to a human specific cognition may explain the high prevalence of SZ and ASD, but also their related cognitive profiles.Grant: FFI2014 61888 EXP E",2016.0,,"A. Bentez Burraco, E. Murphy, W. Lattanzi","University of Huelva, Huelva, Spain, University College London, London, United  Kingdom, Universit Cattolica del Sacro Cuore, Rome, Italy","We will conclude that the (substanti   ally opposite) linguistic (dys)abilities seen in SZ and ASD patients may re present abnormal (but still related) ontogenetic itineraries for the human faculty of language and that the same factors that prompted the transition from an ape like cognition to a human specific cognition may explain the high prevalence of SZ and ASD, but also their related cognitive profiles.Grant: FFI2014 61888 EXP E",,ASD patients,[],"['ASD', 'patient']"
675,1925, Monosomy 2q37,P11.14,,"Monosomy 2q37 qter (AHO like syndrome, OMIM 600430) shows variable  manifestations depending from various deletions size and different genes lost. Combination of moderate mental delay, overweight, brachydactyly type E (BDE) noted as recognizable pattern.Case report. Patients karyotype was confirmed by FISH: 46,X,del(2)(q37.1~q37.2)dn; loss started distally from D2S2633/D2S206 (investiga tion was carried out by A.Polytiko, T .Liehr, Jena, Germany). Proposita (G1, P1, BW,3100g, BL,51cm, OFC,34cm) had normal neonatal history and metabolic data. In infancy girl showed hypotonia, umbilical hernia, sitting at 7 months, walked since 1 year 2 months. Toddlers period: speech delay (normal hearing), muscle weakness, wide based gait, seizures, mild thorax deformation, hypermethrophia, astigmatism. Childhood: mental retardati on, poor speech, impulsive/agressive behaviour, reduced attention, autistic signs, cognitive deficit, overweight, vertebrae degenerative changes, short 3,4 th fingers/toes. At 18 years old: height,156cm (<10th centile), obesity (weight,80kg; >97th centile), intellectual disability, low capacity of com munication, facial dysmorphisms (narrow palpebral fissures, deep set eyes, broad nasal tip, thin upper lip), nevuses, skeletal abnormalities: short neck, Schmorls hernias (Th11 L2), kyphosis (corset), BDE hands/feet, pes pla   nus, hallux valgus. Normal menarche, mammary hypoplasia. US, MRI stu dies: normal brain, heart, hepar; abnormal gallbladder shape, retroperito neal renal ectopia.Conclusion. Accoding to deletions breakpoint the patient had haploinsuf ficiency of numbers genes located distally ARL4C, including candidate genes for mental/ behavior disturbances, overweight, BDE (HDAC4, PER2, GPC1, TWIST2, etc), and displayed a wide spectrum of clinical features both typical and uncommon. Patients with subtelomeric unbalance presented a longer lifespan but suffered from mental impairment/social disability and need for medical care corrected individually at each lifes stage. E",2016.0,,"N. Rumiantsava, O. Khurs","Republican Scientific and Practical Center, Minsk, Belarus, Republican Scientific and  Practical Center Mother&Child, Minsk, Belarus","Childhood: mental retardati on, poor speech, impulsive/agressive behaviour, reduced attention, autistic signs, cognitive deficit, overweight, vertebrae degenerative changes, short 3,4 th fingers/toes.",,autistic signs,[],"['autistic', 'sign']"
676,1931, Kleefstra syndrome in a girl of 4 months,P11.22,,"Introduction: Kleefstra syndrome (OMIM: 610253) is a rare genetic condi   tion caused by a heterozygous microdeletion in about 75%, and by EHMT1 pathogenic variant in the remaining 25%. This syndrome comprises ID, childhood hypotonia and distinctive facial features. In the reviewed literatu   re, to our knowledge only 114 cases were published so far, so the incidence is unknown in general population. The array CGH is a very powerful tool that can help us to diagnose patients with a deletion of EHMT1.Case report: We report a case of a blood study for arrayCGH study with a wide clinical history. The clinical features of this girl of about 4 months were,  psychomotor retardation with pathological motor development, axial hypo  tonia, lack of head control, heart disease (ASD + VSD + pulmonary steno sis), microcephaly, upper lip V inverted shaped, and clear skin. Consangui  nity (parents cousins brothers). Normal studies for: cytogenetic analysis,  CATCH 22, cerebral ultrasound and ophthalmologic evaluation.Results: After the processed arrayCGH by Agilent platform of 60K, we found a deletion of the genome region of the chromosome (9)(q34.4): arr[hg18] 9q34.3(138.395.514 140.138.805)x1 Conclusions: The increasing use of array CGH in clinical cytogenetic labora tories provide an efficient method to find out the causes of the pathology of  the patients underdiagnosed. In familiar cases it could be a powerful tool for  a good genetic counselling for future pregnancies. This must be the first test in patients with clinical features susceptible of study. E",2016.0,,"C. Garrido, D. Escu, M.A. Caamao, A. Morales, A. Torrents, M.M. Snchez, E.  Gen","Reference Laboratory, L Hospitalet de Llobregat (Barcelona), Spain, Hospital de Len,  Len, Spain","The clinical features of this girl of about 4 months were,  psychomotor retardation with pathological motor development, axial hypo  tonia, lack of head control, heart disease (ASD + VSD + pulmonary steno sis), microcephaly, upper lip V inverted shaped, and clear skin.",,ASD +,[],"['ASD', '+']"
679,2140, Genetic counselling in idiopathic autism: parental knowledge and perspectivesM,EMP1.22,," Introduction: Autism Spectrum Disorders (ASD) are among the most inheritable neurodevelopmental disorders, but the aetiology remains unknown in 
the majority of cases. Therefore, most parents must base their reproductive 
decisions on empiric recurrence risk (RR) estimates. To determine factors 
influencing family planning and benefits of genetic counselling (GC), we studied knowledge and perceptions in parents with children with idiopathic 
ASD.
Materials and Methods: Parents with at least one child with ASD (n=39) answered a basal questionnaire addressing different topics, such as knowledge, 
perceived causes and RR or attitude towards genetics. A subset whose child had obtained negative results in molecular karyotype and exome sequencing (n=15) received GC and a following-up questionnaire afterwards and 
fifteen days later.
Results: Although most parents had received information about ASD, few 
had seen a medical geneticist or a genetic counsellor. Genetics was the most 
frequent perceived cause, especially among those with affected relatives. RR 
was overestimated by most parents and qualitative and quantitative estimates correlated. About half of parents believed that RR affected their family planning and their risk perception was higher compared to those who 
did not. After GC, quantitative but not qualitative RR estimates lowered and 
knowledge and favorable opinion towards genetics increased.
Conclusions: Although most parents perceived genetic factors as the most 
common cause of ASD, few had visited a genetics service. Perception of RR 
affects family planning and is overestimated by most parents. GC can improve knowledge and RR estimates and is key to take informed choices.
Grant support: FI-DGR/2013.",2016.0,,"M. Codina-Sol1,2,3, M. del Campo4,5, L. Prez-Jurado1,2,3, C. Serra-Juh1,2,3","1
Departament de Cincies Experimentals i de la Salut, Universitat Pompeu 
Fabra, Barcelona, Spain, 2
Neurosciences Program, Institut Hospital del Mar 
dInvestigacions Mdiques (IMIM), Barcelona, Spain, 3
Centro de Investigacin 
Biomdica en Red de Enfermedades Raras (CIBERER), ISCIII, Barcelona, 
Spain, 4
Servicio de Gentica, Hospital Universitari Vall dHebron, Barcelona, 
Spain, 5
Division of Dysmorphology and teratology, Department of Pediatrics, 
University of California, San Diego, CA, United States","Materials and Methods: Parents with at least one child with ASD (n=39) answered a basal questionnaire addressing different topics, such as knowledge, 
perceived causes and RR or attitude towards genetics.",child with ASD,,"['child', 'with', 'ASD']",[]
680,17, Gonadal mosaicism: its contribution for de novo events,P01.25,,"1Laboratrio de Citogentica e Genmica da Faculdade de Medicina da Universidade de Coimbra, Coimbra, Por  tugal,2CIMAGO   Centro de Investigao em Ambiente, Gentica e Oncobiologia, Faculdade de Medicina da Uni versidade de Coimbra, Coimbra, Portugal, 3CNC IBILI, Universidade de Coimbra, Coimbra, Portugal,4Servio de Obstetrcia A, Centro Hospitalar e Universitrio de Coim bra, Coimbra, Portugal, 5Centro do Desenvolvimento da828Criana, Centro Hospitalar e Universitrio de Coimbra, Coimbra, Portugal. A genetic abnormality in a child with healthy noncarrier parents is usually attributed to a de novo event during cell division (mitosis/meiosis). The recurrence of de novo chromosomal abnormalities can occur because of: (1)chance alone, (2) parental gonadal/ somatic gonadal mosaicism, or (3) factors associated with an increased risk of meiotic error (in recurrent aneuploidies). When unex pected recurrences happen from apparently non carrier parents, germ line mosaicism should be suspected. We report two cases that strongly suggest parental gonadal/somatic gonadal mosaicism. Case 1 refers to a healthy woman with recurrent trisomy 21 pregnancies (three). Par  ental karyotypes were normal but FISH analysis of oralmucosa cells and peripheral lymphocytes revealed, in the mother, low level somatic mosaicism for trisomy 21. Case 2 involves two brothers, one presenting autistic spectrumdisorder and intellectual disability (ID) and the other with ID and some autistic features. aCGH analysis revealed in both siblings a de novo 50 kb (93,428,335 93,478,653) microdeletion in 15q26.1. Molecular testing of the parents strongly suggested a parental gonadal mosaicism. Having a previous pregnancy/ child with a chromosome abnormalityis associated with an increased risk of a future chromosome alteration. In case of recurrent trisomies this risk is in u  enced by maternal age, that can mask other mechanisms. Inrecurrent structural rearrangements the more likely cause is occult parental mosaicism. Gonadal mosaicism remains an important pitfall that should be considered even during thecounseling of families with de novo alterations, as it can seriously in uence genetic risk. I.M. Carreira: None. M.C. Pinto: None. A. Jardim: None. L. Simoes: None. P. Paiva: None. S. Franco: None. F. Coelho: None. G. Oliveira: None. J.B. Melo: None. E",2017.0,,"I. M. Carreira1,2,3, M. C. Pinto1, A. Jardim1, L. Simoes1,P .","Paiva1, S. Franco4, F. Coelho4, G. Oliveira5, J. B. Melo1,2,3","Case 2 involves two brothers, one presenting autistic spectrumdisorder and intellectual disability (ID) and the other with ID and some autistic features.",,autistic spectrumdisorder,[],"['autistic', 'spectrumdisorder']"
680,17, Gonadal mosaicism: its contribution for de novo events,P01.25,,"1Laboratrio de Citogentica e Genmica da Faculdade de Medicina da Universidade de Coimbra, Coimbra, Por  tugal,2CIMAGO   Centro de Investigao em Ambiente, Gentica e Oncobiologia, Faculdade de Medicina da Uni versidade de Coimbra, Coimbra, Portugal, 3CNC IBILI, Universidade de Coimbra, Coimbra, Portugal,4Servio de Obstetrcia A, Centro Hospitalar e Universitrio de Coim bra, Coimbra, Portugal, 5Centro do Desenvolvimento da828Criana, Centro Hospitalar e Universitrio de Coimbra, Coimbra, Portugal. A genetic abnormality in a child with healthy noncarrier parents is usually attributed to a de novo event during cell division (mitosis/meiosis). The recurrence of de novo chromosomal abnormalities can occur because of: (1)chance alone, (2) parental gonadal/ somatic gonadal mosaicism, or (3) factors associated with an increased risk of meiotic error (in recurrent aneuploidies). When unex pected recurrences happen from apparently non carrier parents, germ line mosaicism should be suspected. We report two cases that strongly suggest parental gonadal/somatic gonadal mosaicism. Case 1 refers to a healthy woman with recurrent trisomy 21 pregnancies (three). Par  ental karyotypes were normal but FISH analysis of oralmucosa cells and peripheral lymphocytes revealed, in the mother, low level somatic mosaicism for trisomy 21. Case 2 involves two brothers, one presenting autistic spectrumdisorder and intellectual disability (ID) and the other with ID and some autistic features. aCGH analysis revealed in both siblings a de novo 50 kb (93,428,335 93,478,653) microdeletion in 15q26.1. Molecular testing of the parents strongly suggested a parental gonadal mosaicism. Having a previous pregnancy/ child with a chromosome abnormalityis associated with an increased risk of a future chromosome alteration. In case of recurrent trisomies this risk is in u  enced by maternal age, that can mask other mechanisms. Inrecurrent structural rearrangements the more likely cause is occult parental mosaicism. Gonadal mosaicism remains an important pitfall that should be considered even during thecounseling of families with de novo alterations, as it can seriously in uence genetic risk. I.M. Carreira: None. M.C. Pinto: None. A. Jardim: None. L. Simoes: None. P. Paiva: None. S. Franco: None. F. Coelho: None. G. Oliveira: None. J.B. Melo: None. E",2017.0,,"I. M. Carreira1,2,3, M. C. Pinto1, A. Jardim1, L. Simoes1,P .","Paiva1, S. Franco4, F. Coelho4, G. Oliveira5, J. B. Melo1,2,3","Case 2 involves two brothers, one presenting autistic spectrumdisorder and intellectual disability (ID) and the other with ID and some autistic features.",,autistic features,[],"['autistic', 'feature']"
683,221," TBL1XR1 de novo deletion at 3(q26.32) in a boy with developmental delay, growth retardation and dysmorphisms",P08.11,,"1Cytogenetics and Genomics Laboratory, Faculty of Medi  cine, University of Coimbra, Coimbra, Portugal,2CNC, IBILI, Group of Aging and Brain Diseases: AdvancedDiagnosis and Biomarkers, Coimbra, Portugal, 3CIMAGO  Centro de Investigao em Meio Ambiente, Gentica e Oncobiologia, Coimbra, Portugal,4Medical Genetics Unit, Hospital Peditrico, Centro Hospitalar e Universitrio de Coimbra, Coimbra, Portugal,5Faculty of Medicine   Uni  versity of Coimbra, Coimbra, Portugal Array Comparative Genomic Hybridization(array CGH) has the power to study the whole genome with a higherresolution, detecting imbalances that can range from single gene or exon imbalances to chromosome segments or entire aneuploidies. In patients with a speci c phenotype, the identi cation of a single gene imbalance, namely a deletion, allows the identi cation of disease related genes and genotype phenotype correlations. TBL1XR1 mutations have been reported to be associated with autism, autosomal dominant mental retardation(OMIM: 616944) and Pierpont syndrome(OMIM: 602342). Only two cases with genedeletions have been reported: a single case with mild developmental delay(DD) and a 1.6 Mb de novo deletion at 3q26.31q26.32; and a familial case (mother/daughter) withmoderate intellectual disability(ID) and facial dysmorph  isms with a 708 kb deletion at 3q26.32. We report a 5 year old male with global DD, growth retardation and dys morphisms with a 3q26.32 de novo deletion, being TBL1XR1 the only known coding gene within the deletion. TBL1XR1 encodes a ubiquitously expressed protein that localizes to the nucleus and plays a role in transcription mediated by nuclear receptors. TBL1XR1 mutations have also been described in autistic patients with ID. In DecipherDatabase, deletions encompassing TBL1XR1 are reported in two patients: one with a de novo deletion and autism, hearing impairment and spotty hyperpigmentation, and theother with a partial de novo deletion of the gene but other genomic imbalances. The fact that the gene presents a highAbstracts from the 50thEuropean Society of Human Genetics Conference:. . . 923haploinsuf ciency score, together with the report of patients with ID and de novo TBL1XR1 deletions, supports its involvement in human disease. J.B. Melo: None. S.I. Ferreira: None. S.I. Ferreira Val: None. S. Maia: None. I.M. Carreira: None. E",2017.0,,"J. B. Melo1,2,3, S. I. Ferreira1,3, Val1, S. Maia4,5,I .M .","Carreira1,2,3",TBL1XR1 mutations have also been described in autistic patients with ID.,,autistic patients,[],"['autistic', 'patient']"
684,224, Maternally inherited deletions in 7q31 encompassing CADPS2 in two unrelated patients with intellectual impairment suggesting a parent of origin effect,P08.14,,"Germany CADPS2 plays an important role in the release of neutrophin 3 and brain derived neutrophic factor (BDNF). BDNF is indispensable for brain development. CADPS2 is maternally expressed in human blood and amygdala.Maternally inherited genetic variants of CADPS2 were suggested to contribute to intellectual disability (ID) and autism spectrum disorders (ASD), whereas paternallyinherited missense variants were not shown to have speci c phenotype. We report on two unrelated girls, in whom array CGH was performed due to ID and behavioral pro blems. Patient 1, a 13 year old girl showed a microdeletion of 79 kb in 7q31.32(12212618_122291639) (GRCh37/ hg19) encompassing four exons of CADPS2 . Her beha  vioral phenotype was characterized by anxiety. She showed mild dysmorphic features in terms of arched eyebrows and a prominent columella, the body measurements were normal.Patient 2, a 4 year old girl, had a microdeletion of 4.15 Mb in 7q31.31q31.32(118243718_122394183) (GRCh37/hg19) encompassing the whole CADPS2 gene. This patient showed behavioral problems consisting of impulsive dis  turbance with a tendency of self destruction. She had no distinctive dysmorphic features but shows a secondarymicrocephaly ( 4,5 SD). Both deletions were of maternal origin. Until now only three patients with ID and ASD oftwo families were reported to have deletions of CADPS2 , onede novo and one maternally inherited. We report on two new unrelated patients with maternally inherited CADPS2 deletions. Our ndings support the hypothesis that the phenotype underlies a parent of origin effect. B. Hoffmann: None. I. Hning: None. G. Gillessen  Kaesbach: None. E",2017.0,,"B. Hoffmann, I. Hu ning, G. Gillessen Kaesbach","Institut fr Humangenetik, Universitt zu Lbeck, Lbeck,","Until now only three patients with ID and ASD oftwo families were reported to have deletions of CADPS2 , onede novo and one maternally inherited.",,ASD oftwo,[],"['ASD', 'oftwo']"
689,237, A novel KDM6B gene de novo mutation in two siblings with a variable neurocognitive phenotype,P08.29,,"Department of Biology and Medical Genetics, Praha 5   Motol, Czech Republic Introduction: The clinical  and genetic heterogeneity of neurocognitive disorders (NCD) poses a signi cant diagnostic challenge. Targeted NGS comprising exonic regions with disease causing variation (hence clinical exome sequencing; CES) has become a rst line diag  nostic  and research tool in such instances. Material and Methods: Two siblings (male 22  and female 10 years) with NCD were analyzed. Both suffered from speechdelay, intellectual disability, dysmorphic features and some autistic traits. The girl is severely affected and has unsteady gait. Following aCGH CES was used in order toelucidate the underlying genetic causes of their unclear and clinically variable NCD . Results: A novel nonsense mutation in KDM6B gene (17p13.1) was found in both of the siblings by CES. In addition, family analysis con  rmed that this pathogenic variant occurred de novo in both siblings, indicating likely germline mosaicism in oneof their parents. Conclusions: KDM6B is H3K27 deme  thylase involved in transcription of HOX genes during embryonic development, similarly to KDM6A associated with Kabuki syndrome 2. Due to the close function of both genes, variable expressivity of phenotypes associated with pathogenic variation in KDM6B could be expected. According to the published l iterature we have identi ed a thirdmutation inKDM6B linked to the development of NCD. Our ndings suggest that KDM6B could be another candidate gene in intellectual disability and thus should warrant further studies in this regard. Supported by 00064203, OPPK CZ.2.16/3.1.00/24022 and NF CZ11 PDP 3 003 2014.M. Havlovicov: None. J. Pad rov: None. M. Mal  kov: None. J. Drbov: None. D. Novotn: None. V. Pajko ov: None. J. Geryk: None. M. Macek jr.: None. E",2017.0,,"M. Havlovicova , J. Pade rova, M. Mal kova, J. Dra bova,","D. Novotna , V. Pajkoova , J. Geryk, M. Macek jr.","Both suffered from speechdelay, intellectual disability, dysmorphic features and some autistic traits.",,autistic traits,[],"['autistic', 'trait']"
690,238, Elevated expression and ampli cation of rRNA genes in a mentally retarded child with 13p + abnormal chromosome: a familial case study,P08.30,,"Graphodatsky1, D. V. Yudkin1 1Institute of Molecular and Cellular Biology SB RAS, Novosibirsk, Russian Federation,2Novosibirsk State Med  ical University, Novosibirsk, Russian Federation,3Novosi  birsk State Regional Clinical Diagnostic Center, Novosibirsk, Russian Federation,4Novosibirsk State Uni  versity, Novosibirsk, Russian Federation Introduction: A cytogenetic and molecular genetic study of the family with a male child who had mental retardation and autistic features revealed an abnormal chromosome 13 bearing an enlarged p arm with ampli ed ribosomal DNA (rDNA) in a boy and his father. Study and results: Cytogenetic analysis using standard G banding and FISH with labeled rDNA probes revealed an abnormalchromosome 13 with an enlarged p arm due to rDNA ampli cation in a male child, who had clinically con rmed mental retardation and an autistic behavior. This chromo some is evidently inherited from the father, who has mor  phologically the same chromosome, but is healthy. The karyotype of the mother was normal. Ag NOR stainingshowed brightly stained large whole p arm nucleolus organizer regions (NORs) in a child and normal sized NORs in his father with 13p + NOR amount mosaicism. qRT PCR with speci c primers showed highly increased levels of 18 S, 28 S and 5,8 S ribosomal RNA (rRNA) in the patient s blood samples compared to a normal healthy control donor. Both patient s father and mother had no elevated levels of rRNAs expression. Conclusions: In this case rRNA level seems to correlate with mental retardationin familial individuals with 13p +. Our ndings of rRNA overexpression in a patient with mental retardation and his parents may show a possible link between the karyotype (p arm enlargement due to rDNA ampli cation), rDNA func  tionality (rRNA overexpression), functional changes in the brain and mental retardation. The study is supported byRussian Science Foundation Grant 15 15 10001. I.S. Kolesnikova: None. A.A. Dolskiy: None. N.A. Lemskaya: None. Y.V. Maksimova: None. A.R. Shorina:Abstracts from the 50thEuropean Society of Human Genetics Conference:. . . 931None. A.S. Telepova: None. A.S. Graphodatsky: None. D.V. Yudkin: None. E",2017.0,,"I. S. Kolesnikova1, A. A. Dolskiy1, N. A. Lemskaya1,Y .V .","Maksimova2, A. R. Shorina3, A. S. Telepova4,A .S .","Graphodatsky1, D. V. Yudkin1 1Institute of Molecular and Cellular Biology SB RAS, Novosibirsk, Russian Federation,2Novosibirsk State Med  ical University, Novosibirsk, Russian Federation,3Novosi  birsk State Regional Clinical Diagnostic Center, Novosibirsk, Russian Federation,4Novosibirsk State Uni  versity, Novosibirsk, Russian Federation Introduction: A cytogenetic and molecular genetic study of the family with a male child who had mental retardation and autistic features revealed an abnormal chromosome 13 bearing an enlarged p arm with ampli ed ribosomal DNA (rDNA) in a boy and his father.",,autistic features,[],"['autistic', 'feature']"
690,238, Elevated expression and ampli cation of rRNA genes in a mentally retarded child with 13p + abnormal chromosome: a familial case study,P08.30,,"Graphodatsky1, D. V. Yudkin1 1Institute of Molecular and Cellular Biology SB RAS, Novosibirsk, Russian Federation,2Novosibirsk State Med  ical University, Novosibirsk, Russian Federation,3Novosi  birsk State Regional Clinical Diagnostic Center, Novosibirsk, Russian Federation,4Novosibirsk State Uni  versity, Novosibirsk, Russian Federation Introduction: A cytogenetic and molecular genetic study of the family with a male child who had mental retardation and autistic features revealed an abnormal chromosome 13 bearing an enlarged p arm with ampli ed ribosomal DNA (rDNA) in a boy and his father. Study and results: Cytogenetic analysis using standard G banding and FISH with labeled rDNA probes revealed an abnormalchromosome 13 with an enlarged p arm due to rDNA ampli cation in a male child, who had clinically con rmed mental retardation and an autistic behavior. This chromo some is evidently inherited from the father, who has mor  phologically the same chromosome, but is healthy. The karyotype of the mother was normal. Ag NOR stainingshowed brightly stained large whole p arm nucleolus organizer regions (NORs) in a child and normal sized NORs in his father with 13p + NOR amount mosaicism. qRT PCR with speci c primers showed highly increased levels of 18 S, 28 S and 5,8 S ribosomal RNA (rRNA) in the patient s blood samples compared to a normal healthy control donor. Both patient s father and mother had no elevated levels of rRNAs expression. Conclusions: In this case rRNA level seems to correlate with mental retardationin familial individuals with 13p +. Our ndings of rRNA overexpression in a patient with mental retardation and his parents may show a possible link between the karyotype (p arm enlargement due to rDNA ampli cation), rDNA func  tionality (rRNA overexpression), functional changes in the brain and mental retardation. The study is supported byRussian Science Foundation Grant 15 15 10001. I.S. Kolesnikova: None. A.A. Dolskiy: None. N.A. Lemskaya: None. Y.V. Maksimova: None. A.R. Shorina:Abstracts from the 50thEuropean Society of Human Genetics Conference:. . . 931None. A.S. Telepova: None. A.S. Graphodatsky: None. D.V. Yudkin: None. E",2017.0,,"I. S. Kolesnikova1, A. A. Dolskiy1, N. A. Lemskaya1,Y .V .","Maksimova2, A. R. Shorina3, A. S. Telepova4,A .S .","Study and results: Cytogenetic analysis using standard G banding and FISH with labeled rDNA probes revealed an abnormalchromosome 13 with an enlarged p arm due to rDNA ampli cation in a male child, who had clinically con rmed mental retardation and an autistic behavior.",,autistic behavior,[],"['autistic', 'behavior']"
697,258, Usefulness of oligonucleotide array CGH in clinicaldiagnostics of autism spectrum disorders,P09.11,,"Kazmierczak1, E. Bocian1, P. Stankiewicz2,3,B . Nowakowska1 1Department of Medical Genetics, Institute of Mother and Child, Warsaw, Poland,22) Department of Molecular & Human Genetics, Baylor College of Medicine, Houston, TX, United States,3Institute of Mother and Child, Warsaw, Poland Autism spectrum disorders (ASDs) are one of the most common groups of neurodevelopmental disorders with theprevalence of 1 2%. Genetic factors play an important role in the etiology of ASDs; it has been estimated that sub  microscopic copy number variants (CNVs) are the cause ofASDs in ~ 5 13% of patients. We elected to use aCGH to evaluate its ef cacy for identi cation and characterization of CNVs in a cohort of 178 patients with ASDs and toidentify novel ASDs genes. The analyses of the patients  genomes were performed using genome wide oligonucleo  tide microarrays (180k; Agilent Technology, OGT) with anaverage resolution of 30 kpz. We identi ed 25 CNVs in 21 out of 178 (11.8%) patients. Pathogenic or likely pathogenic CNVs were detected in 12 (6.7%) patients, whereas CNVsof unknown clinical signi cance were found in 6.2% of patients with ASDs. All of the identi ed CNVs were sub  microscopic in size (between 75 kb and 4.54 Mb) and thuscould not have been detected by standard karyotype ana  lysis. Our study further con rmed the potential of aCGH in elucidating the etiology of ASDs, demonstrated by theidenti cation of two novel genes: ARHGAP24 and SLC16A7 as pathogenic for ASDs and three genes: SNX19 , PIGN andHCN1 as candidate for ASDs. The work was supported by grant R13 0005 04/2008 and project 3942/E  215/S/2016 from the Polish Ministry of Science and Higher Education B. Wisniowiecka Kowalnik: None. M. K dzior: None. E. Obersztyn: None. N. Bezniakow: None. J. Castaneda: None. A. Kutkowska Ka mierczak: None. E. Bocian: None. P. Stankiewicz: None. B. Nowakowska: None.940E",2017.0,,"B. Wisniowiecka Kowalnik1,M .K e dzior1, E. Obersztyn1,","N. Bezniakow1, J. Castaneda1, A. Kutkowska",We elected to use aCGH to evaluate its ef cacy for identi cation and characterization of CNVs in a cohort of 178 patients with ASDs and toidentify novel ASDs genes.,,ASDs genes,[],"['ASDs', 'gene']"
698,259," Synaptosome Associated Protein 25 (SNAP25) Gene AssociationAnalysis Revealed Risk Variants for ASD, in Iranian Population",P09.12,,"Islamic Republic of,2Shahid Beheshti University of Med  ical sciences, Tehran, Iran, Islamic Republic of Autism spectrum disorder (ASD) is a common,complex neurological condition, affecting approximately 1%of peo  ple worldwide. Monogenic neurodevelopmental disorders which showed autistic behavior patterns have sugges tedsynaptic dysfunction, as a key mechanism in the patho  physiology of ASD. Subsequently, genes involved in synaptic signaling have been investigated with a priority forcandidategene studies. A synaptosomal associated protein 25(SNAP25) gene plays a crucial role in the central ner  voussystem, contributing to exocytosis by targeting andfusion ofvesicles to the cell membrane. Studies have shown a correlation between aberrant expression of theSNA  P25and a varietyof brain diseases. Single nucleotide poly morphisms (SNPs) inthis gene are associated with several psychiatric diseases, suchas bipolar, schizophrenia, and attention de cit/hyperactivitydisorder. The aim of the pre  sent study was to investigatewhether polymorphisms (rs3746544 and rs1051312) in theregulatory 3  untranslated region (3 UTR) of theSNAP25gene have an association with ASD in unrelated Iranian case(N ,524) control (N , 472) samples. We observed robustassociation of the rs3746544 SNP and ASD patients, in bothallele andhaplotype based analyses. Our results supported thepre  vious observations and indicated a possible role for  SNAP25polymorphisms as susceptibility genetic factorsinvolved in developing ASD. M. Safari: None. M. Taheri: None. E",2017.0,,"M. Safari1, M. Taheri2","1Hamadan University of Medical Sciences, Hamadan, Iran,","Monogenic neurodevelopmental disorders which showed autistic behavior patterns have sugges tedsynaptic dysfunction, as a key mechanism in the patho  physiology of ASD.",,autistic behavior,[],"['autistic', 'behavior']"
698,259," Synaptosome Associated Protein 25 (SNAP25) Gene AssociationAnalysis Revealed Risk Variants for ASD, in Iranian Population",P09.12,,"Islamic Republic of,2Shahid Beheshti University of Med  ical sciences, Tehran, Iran, Islamic Republic of Autism spectrum disorder (ASD) is a common,complex neurological condition, affecting approximately 1%of peo  ple worldwide. Monogenic neurodevelopmental disorders which showed autistic behavior patterns have sugges tedsynaptic dysfunction, as a key mechanism in the patho  physiology of ASD. Subsequently, genes involved in synaptic signaling have been investigated with a priority forcandidategene studies. A synaptosomal associated protein 25(SNAP25) gene plays a crucial role in the central ner  voussystem, contributing to exocytosis by targeting andfusion ofvesicles to the cell membrane. Studies have shown a correlation between aberrant expression of theSNA  P25and a varietyof brain diseases. Single nucleotide poly morphisms (SNPs) inthis gene are associated with several psychiatric diseases, suchas bipolar, schizophrenia, and attention de cit/hyperactivitydisorder. The aim of the pre  sent study was to investigatewhether polymorphisms (rs3746544 and rs1051312) in theregulatory 3  untranslated region (3 UTR) of theSNAP25gene have an association with ASD in unrelated Iranian case(N ,524) control (N , 472) samples. We observed robustassociation of the rs3746544 SNP and ASD patients, in bothallele andhaplotype based analyses. Our results supported thepre  vious observations and indicated a possible role for  SNAP25polymorphisms as susceptibility genetic factorsinvolved in developing ASD. M. Safari: None. M. Taheri: None. E",2017.0,,"M. Safari1, M. Taheri2","1Hamadan University of Medical Sciences, Hamadan, Iran,","The aim of the pre  sent study was to investigatewhether polymorphisms (rs3746544 and rs1051312) in theregulatory 3  untranslated region (3 UTR) of theSNAP25gene have an association with ASD in unrelated Iranian case(N ,524) control (N , 472) samples.",association with ASD,,"['association', 'with', 'ASD']",[]
698,259," Synaptosome Associated Protein 25 (SNAP25) Gene AssociationAnalysis Revealed Risk Variants for ASD, in Iranian Population",P09.12,,"Islamic Republic of,2Shahid Beheshti University of Med  ical sciences, Tehran, Iran, Islamic Republic of Autism spectrum disorder (ASD) is a common,complex neurological condition, affecting approximately 1%of peo  ple worldwide. Monogenic neurodevelopmental disorders which showed autistic behavior patterns have sugges tedsynaptic dysfunction, as a key mechanism in the patho  physiology of ASD. Subsequently, genes involved in synaptic signaling have been investigated with a priority forcandidategene studies. A synaptosomal associated protein 25(SNAP25) gene plays a crucial role in the central ner  voussystem, contributing to exocytosis by targeting andfusion ofvesicles to the cell membrane. Studies have shown a correlation between aberrant expression of theSNA  P25and a varietyof brain diseases. Single nucleotide poly morphisms (SNPs) inthis gene are associated with several psychiatric diseases, suchas bipolar, schizophrenia, and attention de cit/hyperactivitydisorder. The aim of the pre  sent study was to investigatewhether polymorphisms (rs3746544 and rs1051312) in theregulatory 3  untranslated region (3 UTR) of theSNAP25gene have an association with ASD in unrelated Iranian case(N ,524) control (N , 472) samples. We observed robustassociation of the rs3746544 SNP and ASD patients, in bothallele andhaplotype based analyses. Our results supported thepre  vious observations and indicated a possible role for  SNAP25polymorphisms as susceptibility genetic factorsinvolved in developing ASD. M. Safari: None. M. Taheri: None. E",2017.0,,"M. Safari1, M. Taheri2","1Hamadan University of Medical Sciences, Hamadan, Iran,","We observed robustassociation of the rs3746544 SNP and ASD patients, in bothallele andhaplotype based analyses.",,ASD patients,[],"['ASD', 'patient']"
699,262, Copy number variations (CNVs) of Alzheimer s disease susceptibility genes in a pediatric clinical cohort,P09.17,,"1Mental Health Research Center, Moscow, Russian Fed  eration,2Academician Yu.E. Veltishchev Research Clinical Institute of Pediatrics, N.I. Pirogov Russian NationalResearch Medical University, Ministry of Health of the Russian Federation, Moscow, Russian Federation, 3Mos  cow State University of Psychology and Education, Mos cow, Russian Federation, 4Russian Medical Academy of Postgraduate Education, Moscow, Russian Federation Introduction Alzheimer s disease (AD) is the leading cause of neurodegeneration. Complex AD etiology suggests the contribution of both genetic and environmental factors.Nowadays, there are about 150 AD susceptibility genes. However, their role in AD pathogenesis is generally unclear. Materials/methods We evaluated 150 AD susceptibility genes in a clinical cohort of 450 children with autism and intellectual disability, which were studied using SNP array molecular karyotyping and an original bioinformaticstechnology (Iourov et al., 2014). Results Unique CNVs of APP, PSEN1, NOS3, HFE were found in 5 patients (1%). These CNVs possiblyincrease AD risk in adulthood. CNVs of CR1 andCLU had a higher frequency (4.8%). Partial duplication of CR1 and partial triplication of CLU were found in 12 and 10 indi  viduals, respectively. Partial CLU loss was found in a patient. CR1 andCLU CNVs were de ned as benign. Conclusions Studying AD susceptibility gene CNVs shows that at least two types of candidate genes for this disease exist. The rst type encompasses genes affected by rare CNVs, which are likely to be involved in AD patho genesis, whereas the second type encompasses genes affected by common CNVs, which are likely to be benign. Furthermore, the second type is probably considered asrelated to AD because of the common involvement in genomic variations producing false positive results in genome wide association studies. Supported by the RussianScience Foundation (project #14 15 00411) (clinical cohort analysis) and ERA.Net RUS Plus Programme (AD studies). K.S. Vasin: None. Y.B. Yurov: None. S.G. Vorsanova: None. N.S. Shmitova: None. I.Y. Iourov: None. E",2017.0,,"K. S. Vasin1,2,3, Y. B. Yurov1,2,3, S. G. Vorsanova1,2,3,N .","S. Shmitova1, I. Y. Iourov1,2,4","Materials/methods We evaluated 150 AD susceptibility genes in a clinical cohort of 450 children with autism and intellectual disability, which were studied using SNP array molecular karyotyping and an original bioinformaticstechnology (Iourov et al., 2014).",children with autism,,"['child', 'with', 'autism']",[]
702,280, 16p11.2 microdeletion and microduplication in two Lithuanian patients with speech delay,P11.01,,"Utkus1,2 1Department of Human and Medical Genetics, Faculty of Medicine, Vilnius, Lithuania,2Center for Medical Genetics, Vilnius University Hospital Santariskiu Clinics, Vilnius, Lithuania Introduction: Recurrent 16p11.2 microdeletion and microduplication syndrome is a well described condition with various expression of neurocognitive features and congenital malformations. Incomplete penetrance of theaffected genes and variable expressivity usually is indicated as cause of clinical features. Here we present two unrelated patients from Lithuania with opposite CNVs in the 16p11.2region. Methods and results: SNP CGH analysis using Illumina HumanCytoSNP 12v2.1 BeadChips has been performed. 571 kb microdeletion at 16p11.2(29628020_30199805 hg19) has been detected in the rst male patient who has expressive and receptive language delay with minor facial and behavioral abnormalities.Smaller 366 kb microduplication of almost the same chro  mosome 16 region (29833488_30199805 hg19) has been detected in the second female patient with severely delayedspeech development, global psychomotor retardation, hypernasal speech, muscular hypotonia and dysmorphic features. Discussion: 16p11.2 region is a variable site withmany clinically insigni cant small CNVs detected. Larger CNVs, encompassing disease related genes, are subject for interpretation on clinical signi cance when neurological features are manifested. 16p11.2 CNVs are often detected in ASD patients but our patients do not manifest any similar features. Delayed speech is the only common clinical fea ture in both of our patients and it is one of most frequent features indicated in patients with 16p11.2 CNVs. Invol  vement of this genomic region in speech development hasbeen con rmed by several studies although candidate genes have not been determined yet. Five disease related genes arelocated in affected region and only haploinsuf ciency sen  sitive TBX6 has indirect effect on neural development. V. liuas: None. B. Aleksiuniene: None. E. Dagyte: None. L. Ambrozaityte: None. B. Tumiene: None. B. Burnyte: None. A. Utkus: None. E",2017.0,,"V. Sliuas1,2, B. Aleksiuniene1,2, E. Dagyte1,2,L .","Ambrozaityte1,2, B. Tumiene1,2, B. Burnyte1,2,A .",16p11.2 CNVs are often detected in ASD patients but our patients do not manifest any similar features.,,ASD patients,[],"['ASD', 'patient']"
717,156, Different phenotype with 22q13.3 deletion syndrome in two patients,P08.01,,"1Trakya University, Medical Faculty, Department of Medical Genetics, Edirne, Turkey,2Trakya University, Medical Faculty, Department of Pediatric Neurology, Edirne, Turkey,3Trakya University, Medical Faculty, Department of Child and Adolescent Mental Health and Diseases, Edirne, Turkey The 22q13.3 deletion syndrome, also known as Phelan  McDermid syndrome (PHMDS) (OMIM #606232), is acontiguous gene disorder resulting from deletion of the distal long arm of chromosome 22. The deletion occurs near the end of the chromosome at a location designated q13.3.In addition to normal growth and a constellation of minor dysmorphic features, this syndrome is characterized by neurological de cits which include global developmental delay, moderate to severe intellectual impairment, absent or severely delayed speech, and decreased muscle tone (hypotonia). Some people with this condition have autismor autistic like behavior that affects communication and social interaction, such as poor eye contact, sensitivity to touch, and aggressive behaviors. They may also chew onnon food items such as clothing. Less frequently, people with this condition have seizures. Patient 1: 9 year old girl patient Genetic Diseases Diagnosis referred to our center with autism like behaviors. The chromosome structure was determined as 46,XX. In the constructed arrayCGH analysis, 4315 kb deletion wasdetected in 22q13.31 q13.33 and 5057 kb duplication was detected in 8p23.3 p22.2 (Agilent 4x180K ISCA CGH +SNP). Patient 2: A 16 month old girl was admitted to our Genetic Diagnosis Diagnosis Center with ndings ofAbstracts from the 51stEuropean Society of Human Genetics Conference:  941hypotonia. The chromosome structure was determined as 46,XX. 5205 kb deletion was detected in the arrayCGH analysis 22q13.31 q13.33. In 22q13.3 deletion syndrome, changes in the phenotype of the patient can be seen according to the size of the deletion. Both patients underwent SHANK3 deletion. However, patient 1 included4315 kb deletions 45 genes, while patient 2 included 5205 kb deletions 63 genes. H. Gurkan: None. E. Atl :None. E. Atl :None. S. Demir: None. Y. zen: None. H. Tozk r:None. D. Eker: None. C. Akurut: None. Y. Karal: None. I. Gorker: None. E",2018.0,,"H. Gurkan1, E. Atl 1, E. Atl 1, S. Demir1, Y. zen1, H. Tozk r1,D .","Eker1, C. Akurut1, Y. Karal2, I. Gorker3",Patient 1: 9 year old girl patient Genetic Diseases Diagnosis referred to our center with autism like behaviors.,center with autism,,"['center', 'with', 'autism']",[]
721,182, Novel WAC frameshift variant in a boy with DeSanto Shinawi syndrome revealed using whole exome sequencing,P08.33,,"1Department of Biology and Medical Genetics, Charles University 2nd Faculty of Medicine and University Hospital Motol, Prague, Czech Republic,2Department of Pediatrics and Adolescent Medicine, Diagnostic and Research Unit for RareDiseases, Charles University 1st Faculty of Medicine and General University Hospital, Prague, Czech Republic DeSanto Shinawi syndrome is a rare autosomal dominant neurodevelopmental disorder caused by mutations in the WAC gene. It is characterized by global developmental delay, hypotonia, behavioral, sleep and feeding problems, eye abnormalities, constipation and seizures. Facial features can be mildly dysmorphic but are nonspeci c. In total, 18 patients have been reported. We describe an 18 year old boy who has been examined since preschool age because of hypotonia, speech disorder and strabism. His facial pheno type was not remarkable, but with advancing age features such as broad, prominent forehead, bushy eyebrows, deep  set eyes, depressed nasal bridge, bulbous nasal tip, low setposteriorly rotated ears, wide mouth with thin upper lip and broad chin became more pronounced. He had abnormalities of extremities, abnormal CNS MRI ndings and recurrent respiratory infections. He suffered from underweight affecting fat and muscular components, and showed anxietyand autistic traits. Previous specialized investigations failed to explain the etiology of his affection. Exome sequencing revealed a de novo heterozygous WAC frameshift variant NM_016628.4:c.383del, p.(Pro128Leufs*64) which was absent from all databases. All other patients with WAC mutations also carried truncating variants spread across thegene. The long follow up of our patient allowed delineating of the WAC  related phenotype and its developmental tra  jectory. The facial phenotype was consistent with previouscases, but we show that the main features become more pronounced with age. Nevertheless, the guidance from phenotype is rather limited and it is likely that additionalcases of this syndrome will continue to be identi ed via the genotype  rst approach. Supported by 17 29423A and 00064203. S. Bendova: None. M. Havlovicova: None. M. Hancar  ova: None. D. Prchalova: None. V. Stranecky: None. Z. Sedlacek: None. E",2018.0,,"S. Bendova1, M. Havlovicova1, M. Hancarova1, D. Prchalova1,","V. Stranecky2, Z. Sedlacek1","He suffered from underweight affecting fat and muscular components, and showed anxietyand autistic traits.",,autistic traits,[],"['autistic', 'trait']"
724,187," A microdeletion including the gene NUS1 demonstrating interpretation problems, expansion of the phenotype andtreatment modi cation",P09.01,,"Medical Center, Be'er Ya'akov, Israel Chromosomal microarray (CMA) is nowadays recognized as essential in the evaluation of autism and developmentaldelay. CMA interpretation depends on databases as ClinGen, DECIPHER and others, which lack information, and original papers are still essential in deciphering thesignicance of microdeletions/microduplications. We pre  sent an 8.5 years old boy, with intractable epilepsy, autistic spectrum disorder (ASD), hypotonia during infancy, stra bismus and behavioral problems. Multiple EEG examina  tions revealed frequent generalized interictal and ictal slow spike & wave discharges. He has various seizure types, andis treated with a combination of valproic acid, clobazam and ethusuximide with a relative improvement but partial con  trol. The child exhibited behavioral problems includingaggression and violence, with recurrent rage attacks. Levetiractam administration escalated the frequency of these behaviors signi cantly, and therefore was dis  continued. Metabolic workup was normal including: lactic, ammonia, blood amino acids, Carnitine, Acylcarnitine. A chromosomal microarray performed demonstrated a dele tion on chromosome 6: arr[hg19]6q22.1(117,431,000  118,040,939)x1. This 609kb deletion including the NUS1 gene is located within the minimal essential critical regionon chromosome 6q22. The region is known for autism, seizures, tremor and mild dysmorphic features, but less known for behavioural problems as in the case presented.The databases mentioned had only scarce information on the microdeletion, and we found only one paper interpreting it. This work further delineates this rare genetic disorder.We suggest that behavioral problems are part of this microdeletion, and suggest caution using Levetiractam in these patients. We emphasize the importance of earlygenetic evaluation in children with ASD and epilepsy. E. Banne: None. S. Josefsberg: None. J. Rosensaft: None. H. Bassan: None.E",2018.0,,"E. Banne1, S. Josefsberg1, J. Rosensaft1, H. Bassan2","1Kaplan Medical Center, Rehovot, Israel,2Assaf Harofe","We pre  sent an 8.5 years old boy, with intractable epilepsy, autistic spectrum disorder (ASD), hypotonia during infancy, stra bismus and behavioral problems.",,autistic spectrum,[],"['autistic', 'spectrum']"
724,187," A microdeletion including the gene NUS1 demonstrating interpretation problems, expansion of the phenotype andtreatment modi cation",P09.01,,"Medical Center, Be'er Ya'akov, Israel Chromosomal microarray (CMA) is nowadays recognized as essential in the evaluation of autism and developmentaldelay. CMA interpretation depends on databases as ClinGen, DECIPHER and others, which lack information, and original papers are still essential in deciphering thesignicance of microdeletions/microduplications. We pre  sent an 8.5 years old boy, with intractable epilepsy, autistic spectrum disorder (ASD), hypotonia during infancy, stra bismus and behavioral problems. Multiple EEG examina  tions revealed frequent generalized interictal and ictal slow spike & wave discharges. He has various seizure types, andis treated with a combination of valproic acid, clobazam and ethusuximide with a relative improvement but partial con  trol. The child exhibited behavioral problems includingaggression and violence, with recurrent rage attacks. Levetiractam administration escalated the frequency of these behaviors signi cantly, and therefore was dis  continued. Metabolic workup was normal including: lactic, ammonia, blood amino acids, Carnitine, Acylcarnitine. A chromosomal microarray performed demonstrated a dele tion on chromosome 6: arr[hg19]6q22.1(117,431,000  118,040,939)x1. This 609kb deletion including the NUS1 gene is located within the minimal essential critical regionon chromosome 6q22. The region is known for autism, seizures, tremor and mild dysmorphic features, but less known for behavioural problems as in the case presented.The databases mentioned had only scarce information on the microdeletion, and we found only one paper interpreting it. This work further delineates this rare genetic disorder.We suggest that behavioral problems are part of this microdeletion, and suggest caution using Levetiractam in these patients. We emphasize the importance of earlygenetic evaluation in children with ASD and epilepsy. E. Banne: None. S. Josefsberg: None. J. Rosensaft: None. H. Bassan: None.E",2018.0,,"E. Banne1, S. Josefsberg1, J. Rosensaft1, H. Bassan2","1Kaplan Medical Center, Rehovot, Israel,2Assaf Harofe",We emphasize the importance of earlygenetic evaluation in children with ASD and epilepsy.,children with ASD,,"['child', 'with', 'ASD']",[]
725,192," A new case involving 2q13 microduplication associated with autism spectrum disorder, intellectual disability anddysmorphic features",P09.08,,"Romania,2University of Medicine and Pharmacy, Craiova, Romania,3Prof. Dr. Alex. Obregia Clinical Hospital of Psychiatry, Bucharest, Romania,4Victor Babes National Institute of Pathology, Bucharest, Romania,5Titu Maiorescu University, Bucharest, Romania Autism spectrum disorder (ASD) is a neurodevelopmental condition characterized by impairment of social interaction,reduced communication skills and stereotyped patterns of behavior. The etiology of ASD is complex including genetic, epigenetic and environmental factors. 2q13 dupli cation have been associated with developmental delay, intellectual disability, ASD and dysmorphism. Several previous studies have linked the NPHP1 gene, located inthis genomic region, to ASD. In this paper we report a new case of 2q13 duplication in association with ASD and intellectual disability. The patient is a 5 years old boy bornat term from health, non consanguineous parents who was referred to the department of Child Psychiatry for speech delay and behavioral problems. Clinical evaluation revealeddysmorphic features (high forehead, large protruding ears, open held mouth), severe speech delay (he says only 6 simple words), moderate intellectual disability, autisticbehavior (no visual contact, dif cult social interaction, stereotypic movements). The genomic pro le obtained by array CGH (Agilent platforms) unveiled a 645 Kb dupli cation at 2q13 (110457697 111103309, hg18) encompass  ingRGPD6 ,MALL andNPHP1 genes. To date, 11 cases with 2q13 microduplication, including NPHP1 andMALL genes, have been reported. All patients presented behavior problems including ASD, attention de cit hyperactivity disorder (ADHD), obsessive compulsive disorder. Intellec tual disability was also noted in 8 patients. Other features described in some cases were speech delay and dysmorphic traits. All these ndings were found in our case, further contributing to the delineating of the 2q13 microduplication. I.O. Focsa: None. I. Streata: None. S. Sosoi: None. M. Ioana: None. R. Grozavescu: None. M. Budisteanu: None. E",2018.0,,"I. O. Focsa1, I. Streata2, S. Sosoi2, M. Ioana2, R. Grozavescu3,","M. Budisteanu3,4,51""C. Davila"" University of Medicine and Pharmacy, Bucharest,",In this paper we report a new case of 2q13 duplication in association with ASD and intellectual disability.,association with ASD,,"['association', 'with', 'ASD']",[]
726,193, Duplication of 15q11.2 BP1 BP2 region in Bulgarian autistic patient,P09.09,,"1Genetic Medico Diagnostic Laboratory Genica, So a, Bulgaria,2IMDL Genome Centre Bulgaria, So a, Bulgaria, 3Department of Pediatrics and Medical Genetics, Medical University, Plovdiv, Bulgaria,4University Hospital St.Abstracts from the 51stEuropean Society of Human Genetics Conference:  959George , Plovdiv, Bulgaria,5Pediatric Clinic, Aleksandrovska University Hospital, So a, Bulgaria It is well known that copy number variants (CNVs) with different frequency and inheritance patterns contribute to neurodevelopmental disorders etiology and could be con sidered as signi cant risk factors. Here we report autistic behaviour patient with lack of speech and developmental delay that was referred for genetic testing. Both father andbrother of the proban are heterozygous carriers of beta  talasemia mutations. The patient was previously tested for Fragile X syndrome and X linked mental retardation relatedgenes were sequenced as well as whole exome sequencing was performed without detecting any relevant variants correlating with the clinical features. The only positiveresult was for HLA DQ2 and HLA DQ8 genes predisposing to celiac disease. At the end aCGH array (180K) was per  formed and it detected 278kb duplicated region (11p14.3 /chr11: 22102205 22361578) that included the ANO5 and SLC17A6 genes. This duplication was interpreted as uncertain clinical signi cance based on the international recommendations. Second aCGH analysis with higher resolution (2,7M) was perform so we can gain additional information and eventually to clarify the previous nding. An additional duplication of 312 kb was detected in chro  mosome 15 (15q11.2), which included 4 genes: TUBGCP5 , CYFIP1 ,NIPA2 and NIPA1 (PMIDs: 28588435, 27566550). Duplication was inherited by the father who is without clinical manifestation. The 15q11.2 BP1 BP2 region is found duplicated or deleted in people with cog nitive, language, and behavioral impairmen and a variable phenotype so probably this nding is the leading cause for the clinical features in the affected child. A. Mandadzhieva: None. A. Kirov: None. I. Pacheva: None. E. Simeonov: None. T. Todorov: None. A. Todorova: None. E",2018.0,,"A. Mandadzhieva1,2, A. Kirov2, I. Pacheva3,4, E. Simeonov5,T .","Todorov1,2, A. Todorova1,2",Here we report autistic behaviour patient with lack of speech and developmental delay that was referred for genetic testing.,,autistic behaviour,[],"['autistic', 'behaviour']"
727,194, Metabolism of vitamin D system in children with autismspectrum disorders,P09.10,,"Introduction: The frequency of autistic spectrum disorders (ASD) over the past 5 years has increased from 1:110 to1:68 and continues to grow. An important role in etio  pathogenesis of ASD is given to metabolic disorders, in particular, to the disorder of metabolism of vitamin D sys tem, which plays one of the leading roles in maintaining the epigenetic health of the organism.Purpose: To study the state of vitamin D metabolism in children with ASD for the development of the examination and treatment algorithms. Results: We examined 130 children: 86 with ASD and 44 neurotypical. The polymorphism Bsml of the VDR gene was studied: bb (pathological homozygote)   13 (15.20%)and 0 (0%), respectively, Bb   43 (50.00%) and 26 (59.09%), BB   29 (33.72%) and 18 (40.90%). 95% of children with ASD showed a decrease of 25 OH D level inthe blood, whereas in the control group in only 9% cases. Polymorphic variants of the genes methylation cycle were studied: an increase in the frequency of MTHFR 677 C/Tpolymorphisms (47.67% and 36.36%, respectively), MTHFR 677 T/T (9.30% and 6.82%), MTRR 66 G/G (31.40% and 25.00%), MTR 2756 A/G (44.19% and34.09%). Conclusions: The speci c weight of vitamin D de ciency in children with ASD occupies one of the leading places andfrequent combination with a disorder of the methylation cycle allows to carry out effective complex therapy. S. Lisniak: None. Y. Grechanina: None. E",2018.0,,"S. Lisniak, Y. Grechanina","Kharkov interregional specialized medical genetic center,Kharkiv, Ukraine",Introduction: The frequency of autistic spectrum disorders (ASD) over the past 5 years has increased from 1:110 to1:68 and continues to grow.,,autistic spectrum,[],"['autistic', 'spectrum']"
727,194, Metabolism of vitamin D system in children with autismspectrum disorders,P09.10,,"Introduction: The frequency of autistic spectrum disorders (ASD) over the past 5 years has increased from 1:110 to1:68 and continues to grow. An important role in etio  pathogenesis of ASD is given to metabolic disorders, in particular, to the disorder of metabolism of vitamin D sys tem, which plays one of the leading roles in maintaining the epigenetic health of the organism.Purpose: To study the state of vitamin D metabolism in children with ASD for the development of the examination and treatment algorithms. Results: We examined 130 children: 86 with ASD and 44 neurotypical. The polymorphism Bsml of the VDR gene was studied: bb (pathological homozygote)   13 (15.20%)and 0 (0%), respectively, Bb   43 (50.00%) and 26 (59.09%), BB   29 (33.72%) and 18 (40.90%). 95% of children with ASD showed a decrease of 25 OH D level inthe blood, whereas in the control group in only 9% cases. Polymorphic variants of the genes methylation cycle were studied: an increase in the frequency of MTHFR 677 C/Tpolymorphisms (47.67% and 36.36%, respectively), MTHFR 677 T/T (9.30% and 6.82%), MTRR 66 G/G (31.40% and 25.00%), MTR 2756 A/G (44.19% and34.09%). Conclusions: The speci c weight of vitamin D de ciency in children with ASD occupies one of the leading places andfrequent combination with a disorder of the methylation cycle allows to carry out effective complex therapy. S. Lisniak: None. Y. Grechanina: None. E",2018.0,,"S. Lisniak, Y. Grechanina","Kharkov interregional specialized medical genetic center,Kharkiv, Ukraine","An important role in etio  pathogenesis of ASD is given to metabolic disorders, in particular, to the disorder of metabolism of vitamin D sys tem, which plays one of the leading roles in maintaining the epigenetic health of the organism.Purpose: To study the state of vitamin D metabolism in children with ASD for the development of the examination and treatment algorithms.",children with ASD,,"['child', 'with', 'ASD']",[]
727,194, Metabolism of vitamin D system in children with autismspectrum disorders,P09.10,,"Introduction: The frequency of autistic spectrum disorders (ASD) over the past 5 years has increased from 1:110 to1:68 and continues to grow. An important role in etio  pathogenesis of ASD is given to metabolic disorders, in particular, to the disorder of metabolism of vitamin D sys tem, which plays one of the leading roles in maintaining the epigenetic health of the organism.Purpose: To study the state of vitamin D metabolism in children with ASD for the development of the examination and treatment algorithms. Results: We examined 130 children: 86 with ASD and 44 neurotypical. The polymorphism Bsml of the VDR gene was studied: bb (pathological homozygote)   13 (15.20%)and 0 (0%), respectively, Bb   43 (50.00%) and 26 (59.09%), BB   29 (33.72%) and 18 (40.90%). 95% of children with ASD showed a decrease of 25 OH D level inthe blood, whereas in the control group in only 9% cases. Polymorphic variants of the genes methylation cycle were studied: an increase in the frequency of MTHFR 677 C/Tpolymorphisms (47.67% and 36.36%, respectively), MTHFR 677 T/T (9.30% and 6.82%), MTRR 66 G/G (31.40% and 25.00%), MTR 2756 A/G (44.19% and34.09%). Conclusions: The speci c weight of vitamin D de ciency in children with ASD occupies one of the leading places andfrequent combination with a disorder of the methylation cycle allows to carry out effective complex therapy. S. Lisniak: None. Y. Grechanina: None. E",2018.0,,"S. Lisniak, Y. Grechanina","Kharkov interregional specialized medical genetic center,Kharkiv, Ukraine","95% of children with ASD showed a decrease of 25 OH D level inthe blood, whereas in the control group in only 9% cases.",children with ASD,,"['child', 'with', 'ASD']",[]
727,194, Metabolism of vitamin D system in children with autismspectrum disorders,P09.10,,"Introduction: The frequency of autistic spectrum disorders (ASD) over the past 5 years has increased from 1:110 to1:68 and continues to grow. An important role in etio  pathogenesis of ASD is given to metabolic disorders, in particular, to the disorder of metabolism of vitamin D sys tem, which plays one of the leading roles in maintaining the epigenetic health of the organism.Purpose: To study the state of vitamin D metabolism in children with ASD for the development of the examination and treatment algorithms. Results: We examined 130 children: 86 with ASD and 44 neurotypical. The polymorphism Bsml of the VDR gene was studied: bb (pathological homozygote)   13 (15.20%)and 0 (0%), respectively, Bb   43 (50.00%) and 26 (59.09%), BB   29 (33.72%) and 18 (40.90%). 95% of children with ASD showed a decrease of 25 OH D level inthe blood, whereas in the control group in only 9% cases. Polymorphic variants of the genes methylation cycle were studied: an increase in the frequency of MTHFR 677 C/Tpolymorphisms (47.67% and 36.36%, respectively), MTHFR 677 T/T (9.30% and 6.82%), MTRR 66 G/G (31.40% and 25.00%), MTR 2756 A/G (44.19% and34.09%). Conclusions: The speci c weight of vitamin D de ciency in children with ASD occupies one of the leading places andfrequent combination with a disorder of the methylation cycle allows to carry out effective complex therapy. S. Lisniak: None. Y. Grechanina: None. E",2018.0,,"S. Lisniak, Y. Grechanina","Kharkov interregional specialized medical genetic center,Kharkiv, Ukraine",Conclusions: The speci c weight of vitamin D de ciency in children with ASD occupies one of the leading places andfrequent combination with a disorder of the methylation cycle allows to carry out effective complex therapy.,children with ASD,,"['child', 'with', 'ASD']",[]
729,210, CNVs associated with autism spectrum disorder in a cohort of children from Gois (Brazil),P09.31,,"Ribeiro1,2, C. C. da Silva1,2,3, L. B. Minasi1 1Ponti cal Catholic University of Gois, School of Agricultural and Biological Sciences, Genetics Master s Program, Replicon Research Group, Goinia, Brazil,2Federal University of Gois, Biotechnology and Biodiversity PhD Program, Goinia, Brazil,3Human Cytogenetics and Molecular Genetics Laboratory, Secretary of Goias State for Public Health, Goinia, Brazil Introduction: Autism spectrum disorder (ASD) is a neu  rodevelopmental disorder with a complex genetic archi  tecture. The worldwide prevalence of autism is increasing.However, autism prevalence is low (0.27%) in Brazil due to misdiagnosis of the disorder. Material and Methods: We report on 16 probands with ASD referred by the public health system of Gois. ASD assessment using Autism Diagnostic Interview Revised (ADI R), G band karyotyping, and PCR of FMR1 using Amplidex kit were carried out for all patients. Chromoso  mal Microarray Analysis (CMA) using GeneChipCytoScanHDTMarray was done for patients who had normal results in karyotype and PCR. Results: The behavioral phenotypes for all participants were classi ed in the ASD according to ADI R results whose karyotypes showed neither visible numerical nor structural chromosomal aberrations. FMR1 analysis revealed two children affected by Fragile X Syndrome. CMA showed a total of 21 CNVs identi ed in 12/14 (86%) patients. A total of 13/21 pathogenic CNVs were observedin 8 patients, all located at genetic ASD hotspots, including 22q11.23, Xp22.33 (2/13), 16p11.2 (3/13), harboring no OMIM genes. However, the hotspots at 15q13.3, 15q11.2(2/13), and Xp11.23 (2/13) harbored CHRNA7 ,PWRN2 and ZNF630 genes, respectively, associated with ASD. The remaining CNVs were classi ed as having unknown clinical signi cance, distributed at loci: 2q12.2, 3p22.1, 9p21.1 (3/8), Xp22.32, Xq21.1, and Xq24. Two patients showed no alterations in CMA. Conclusions: Identify CNVs and genes using CMA in our patients was very important to understand the hetero  geneous spectrum of ASD. The results helped the clinicalmanagement of all patients. A.D. da Cruz: None. I.P. Pinto: None. G.R. Nasci  mento: None. M.A. Gigonzac: None. A.S. da Cruz: None. T.C. Vieira: None. D.M. Cunha: None. C.L. Ribeiro: None. C.C. da Silva: None. L.B. Minasi: None. E",2018.0,,"A. D. da Cruz1,2,3, I. P. Pinto1,2, G. R. Nascimento1,M .A .","Gigonzac1,3, A. S. da Cruz1, T. C. Vieira1,3, D. M. Cunha1,C .L .",Material and Methods: We report on 16 probands with ASD referred by the public health system of Gois.,probands with ASD,,"['probands', 'with', 'ASD']",[]
729,210, CNVs associated with autism spectrum disorder in a cohort of children from Gois (Brazil),P09.31,,"Ribeiro1,2, C. C. da Silva1,2,3, L. B. Minasi1 1Ponti cal Catholic University of Gois, School of Agricultural and Biological Sciences, Genetics Master s Program, Replicon Research Group, Goinia, Brazil,2Federal University of Gois, Biotechnology and Biodiversity PhD Program, Goinia, Brazil,3Human Cytogenetics and Molecular Genetics Laboratory, Secretary of Goias State for Public Health, Goinia, Brazil Introduction: Autism spectrum disorder (ASD) is a neu  rodevelopmental disorder with a complex genetic archi  tecture. The worldwide prevalence of autism is increasing.However, autism prevalence is low (0.27%) in Brazil due to misdiagnosis of the disorder. Material and Methods: We report on 16 probands with ASD referred by the public health system of Gois. ASD assessment using Autism Diagnostic Interview Revised (ADI R), G band karyotyping, and PCR of FMR1 using Amplidex kit were carried out for all patients. Chromoso  mal Microarray Analysis (CMA) using GeneChipCytoScanHDTMarray was done for patients who had normal results in karyotype and PCR. Results: The behavioral phenotypes for all participants were classi ed in the ASD according to ADI R results whose karyotypes showed neither visible numerical nor structural chromosomal aberrations. FMR1 analysis revealed two children affected by Fragile X Syndrome. CMA showed a total of 21 CNVs identi ed in 12/14 (86%) patients. A total of 13/21 pathogenic CNVs were observedin 8 patients, all located at genetic ASD hotspots, including 22q11.23, Xp22.33 (2/13), 16p11.2 (3/13), harboring no OMIM genes. However, the hotspots at 15q13.3, 15q11.2(2/13), and Xp11.23 (2/13) harbored CHRNA7 ,PWRN2 and ZNF630 genes, respectively, associated with ASD. The remaining CNVs were classi ed as having unknown clinical signi cance, distributed at loci: 2q12.2, 3p22.1, 9p21.1 (3/8), Xp22.32, Xq21.1, and Xq24. Two patients showed no alterations in CMA. Conclusions: Identify CNVs and genes using CMA in our patients was very important to understand the hetero  geneous spectrum of ASD. The results helped the clinicalmanagement of all patients. A.D. da Cruz: None. I.P. Pinto: None. G.R. Nasci  mento: None. M.A. Gigonzac: None. A.S. da Cruz: None. T.C. Vieira: None. D.M. Cunha: None. C.L. Ribeiro: None. C.C. da Silva: None. L.B. Minasi: None. E",2018.0,,"A. D. da Cruz1,2,3, I. P. Pinto1,2, G. R. Nascimento1,M .A .","Gigonzac1,3, A. S. da Cruz1, T. C. Vieira1,3, D. M. Cunha1,C .L .","ASD assessment using Autism Diagnostic Interview Revised (ADI R), G band karyotyping, and PCR of FMR1 using Amplidex kit were carried out for all patients.",,ASD assessment,[],"['ASD', 'assessment']"
729,210, CNVs associated with autism spectrum disorder in a cohort of children from Gois (Brazil),P09.31,,"Ribeiro1,2, C. C. da Silva1,2,3, L. B. Minasi1 1Ponti cal Catholic University of Gois, School of Agricultural and Biological Sciences, Genetics Master s Program, Replicon Research Group, Goinia, Brazil,2Federal University of Gois, Biotechnology and Biodiversity PhD Program, Goinia, Brazil,3Human Cytogenetics and Molecular Genetics Laboratory, Secretary of Goias State for Public Health, Goinia, Brazil Introduction: Autism spectrum disorder (ASD) is a neu  rodevelopmental disorder with a complex genetic archi  tecture. The worldwide prevalence of autism is increasing.However, autism prevalence is low (0.27%) in Brazil due to misdiagnosis of the disorder. Material and Methods: We report on 16 probands with ASD referred by the public health system of Gois. ASD assessment using Autism Diagnostic Interview Revised (ADI R), G band karyotyping, and PCR of FMR1 using Amplidex kit were carried out for all patients. Chromoso  mal Microarray Analysis (CMA) using GeneChipCytoScanHDTMarray was done for patients who had normal results in karyotype and PCR. Results: The behavioral phenotypes for all participants were classi ed in the ASD according to ADI R results whose karyotypes showed neither visible numerical nor structural chromosomal aberrations. FMR1 analysis revealed two children affected by Fragile X Syndrome. CMA showed a total of 21 CNVs identi ed in 12/14 (86%) patients. A total of 13/21 pathogenic CNVs were observedin 8 patients, all located at genetic ASD hotspots, including 22q11.23, Xp22.33 (2/13), 16p11.2 (3/13), harboring no OMIM genes. However, the hotspots at 15q13.3, 15q11.2(2/13), and Xp11.23 (2/13) harbored CHRNA7 ,PWRN2 and ZNF630 genes, respectively, associated with ASD. The remaining CNVs were classi ed as having unknown clinical signi cance, distributed at loci: 2q12.2, 3p22.1, 9p21.1 (3/8), Xp22.32, Xq21.1, and Xq24. Two patients showed no alterations in CMA. Conclusions: Identify CNVs and genes using CMA in our patients was very important to understand the hetero  geneous spectrum of ASD. The results helped the clinicalmanagement of all patients. A.D. da Cruz: None. I.P. Pinto: None. G.R. Nasci  mento: None. M.A. Gigonzac: None. A.S. da Cruz: None. T.C. Vieira: None. D.M. Cunha: None. C.L. Ribeiro: None. C.C. da Silva: None. L.B. Minasi: None. E",2018.0,,"A. D. da Cruz1,2,3, I. P. Pinto1,2, G. R. Nascimento1,M .A .","Gigonzac1,3, A. S. da Cruz1, T. C. Vieira1,3, D. M. Cunha1,C .L .","A total of 13/21 pathogenic CNVs were observedin 8 patients, all located at genetic ASD hotspots, including 22q11.23, Xp22.33 (2/13), 16p11.2 (3/13), harboring no OMIM genes.",,ASD hotspots,[],"['ASD', 'hotspot']"
732,246, Cytogenetically pseudobalanced chromosome 2 structuralrearrangements associated with 2q23.1 microdeletion syndrome,P11.23,,"Iourov1,2,4 1Academician Yu.E. Veltishchev Research Clinical Institute of Pediatrics, N.I. Pirogov Russian National Research MedicalUniversity, Ministry of Health of the Russian Federation, Moscow, Russian Federation, 2FSBSI Mental Health Research Center, Moscow, Russian Federation,3Stem cell bank Pokrovsky , Saint Petersburg, Russian Federation, 4FSBEI FPE Russian Medical Academy of PostgraduateEducation of the Ministry of Healthcare of the Russian Federation, Moscow, Russian Federation Introduction: 2q23.1 microdeletion syndrome (""pseudo  Angelman"" syndrome) is characterized by speech delay and intellectual disability, autistic features, inappropriatelaughter and short stature. The disease is mainly associated with MBD5 loss. Over 100 cases of the syndrome are described in the available literature. Here, we report on twocases of cytogenetically pseudobalanced chromosome 2 structural rearrangements associated with 2q23.1 micro  deletion syndrome. Materials and Methods: Using karyotyping and SNP array (Affymetrix Cytoscan HD), we detected two cases of 2q23.1 microdeletion resulted from a paracentric inversionand reciprocal translocation in a cohort of 466 patients with intellectual disability, autistic features and congenital malformations. Results: The patients were a 2 year old girl and a 6 year  old boy, exhibiting 2q22.3q24.1(148,513,845  155,196,310)1, 46,XX,der(2)inv(q21.1q22.3)del(q22q24)and 2q23.1q23.3(148,851,963 151,316,465)1, 2q22.2q24.1(143,753,727 155,408,790)1~2, 46,XY,t (2;11)(q31.1;q21), respectively. Common clinical featureswere motor, speech and developmental delay, gait dis  turbance, myopia. Additionally, the girl exhibited micro  cephaly, cleft palate, muscle hypotonia, hearing loss,congenital heart disease. The boy presented with seizures, protruding ears, micrognathia, joints hypermobility. Beside MBD5 deletion, both cases demonstrated a loss of ACVR2A, ORC4, EPC2, KIF5C, LYPD6, MMADHC, RND3, NMI, TNFAIP6, RIF1, NEB, ARL5A, CACNB4, STAM2, PRPF40A, RPRM, GALNT13, FMNL2 andARL6IP6 . Conclusions: Rare cases of pseudobalanced chromoso  mal rearrangements exemplify the intrinsic need for genome wide CNV scan in molecular cytogenetic diag nosis. Furthermore, these cases demonstrate the complexity of pseudobalanced chromosomal abnormalities that can be easily overlooked. Supported by RSF (14 15 00411). A.D. Kolotii: None. S.G. Vorsanova: None. Y.B. Yurov: None. O.S. Kurinnaia: None. M.A. Zelenova: None. M.A. Bulatnikova: None. I.Y. Iourov: None. E",2018.0,,"A. D. Kolotii1,2, S. G. Vorsanova1,2, Y. B. Yurov1,2,O .S .","Kurinnaia1,2, M. A. Zelenova1,2, M. A. Bulatnikova3,I .Y .","Pirogov Russian National Research MedicalUniversity, Ministry of Health of the Russian Federation, Moscow, Russian Federation, 2FSBSI Mental Health Research Center, Moscow, Russian Federation,3Stem cell bank Pokrovsky , Saint Petersburg, Russian Federation, 4FSBEI FPE Russian Medical Academy of PostgraduateEducation of the Ministry of Healthcare of the Russian Federation, Moscow, Russian Federation Introduction: 2q23.1 microdeletion syndrome (""pseudo  Angelman"" syndrome) is characterized by speech delay and intellectual disability, autistic features, inappropriatelaughter and short stature.",,autistic features,[],"['autistic', 'feature']"
732,246, Cytogenetically pseudobalanced chromosome 2 structuralrearrangements associated with 2q23.1 microdeletion syndrome,P11.23,,"Iourov1,2,4 1Academician Yu.E. Veltishchev Research Clinical Institute of Pediatrics, N.I. Pirogov Russian National Research MedicalUniversity, Ministry of Health of the Russian Federation, Moscow, Russian Federation, 2FSBSI Mental Health Research Center, Moscow, Russian Federation,3Stem cell bank Pokrovsky , Saint Petersburg, Russian Federation, 4FSBEI FPE Russian Medical Academy of PostgraduateEducation of the Ministry of Healthcare of the Russian Federation, Moscow, Russian Federation Introduction: 2q23.1 microdeletion syndrome (""pseudo  Angelman"" syndrome) is characterized by speech delay and intellectual disability, autistic features, inappropriatelaughter and short stature. The disease is mainly associated with MBD5 loss. Over 100 cases of the syndrome are described in the available literature. Here, we report on twocases of cytogenetically pseudobalanced chromosome 2 structural rearrangements associated with 2q23.1 micro  deletion syndrome. Materials and Methods: Using karyotyping and SNP array (Affymetrix Cytoscan HD), we detected two cases of 2q23.1 microdeletion resulted from a paracentric inversionand reciprocal translocation in a cohort of 466 patients with intellectual disability, autistic features and congenital malformations. Results: The patients were a 2 year old girl and a 6 year  old boy, exhibiting 2q22.3q24.1(148,513,845  155,196,310)1, 46,XX,der(2)inv(q21.1q22.3)del(q22q24)and 2q23.1q23.3(148,851,963 151,316,465)1, 2q22.2q24.1(143,753,727 155,408,790)1~2, 46,XY,t (2;11)(q31.1;q21), respectively. Common clinical featureswere motor, speech and developmental delay, gait dis  turbance, myopia. Additionally, the girl exhibited micro  cephaly, cleft palate, muscle hypotonia, hearing loss,congenital heart disease. The boy presented with seizures, protruding ears, micrognathia, joints hypermobility. Beside MBD5 deletion, both cases demonstrated a loss of ACVR2A, ORC4, EPC2, KIF5C, LYPD6, MMADHC, RND3, NMI, TNFAIP6, RIF1, NEB, ARL5A, CACNB4, STAM2, PRPF40A, RPRM, GALNT13, FMNL2 andARL6IP6 . Conclusions: Rare cases of pseudobalanced chromoso  mal rearrangements exemplify the intrinsic need for genome wide CNV scan in molecular cytogenetic diag nosis. Furthermore, these cases demonstrate the complexity of pseudobalanced chromosomal abnormalities that can be easily overlooked. Supported by RSF (14 15 00411). A.D. Kolotii: None. S.G. Vorsanova: None. Y.B. Yurov: None. O.S. Kurinnaia: None. M.A. Zelenova: None. M.A. Bulatnikova: None. I.Y. Iourov: None. E",2018.0,,"A. D. Kolotii1,2, S. G. Vorsanova1,2, Y. B. Yurov1,2,O .S .","Kurinnaia1,2, M. A. Zelenova1,2, M. A. Bulatnikova3,I .Y .","Materials and Methods: Using karyotyping and SNP array (Affymetrix Cytoscan HD), we detected two cases of 2q23.1 microdeletion resulted from a paracentric inversionand reciprocal translocation in a cohort of 466 patients with intellectual disability, autistic features and congenital malformations.",,autistic features,[],"['autistic', 'feature']"
733,258, Patient with de novo 18q22.1 q22.3 delection. A case report,P11.35,,"Poyatos Andjar., M. Perez Sanchez Servicio Andaluz de Salud (SAS)., Granada, Spain988 J. del PicchiaLaboratory evaluation of patients with developmental delay/ intellectual disability, congenital anomalies, dismorphic features and autistic disorders has changed signi cantly in the last years with the introduction of microarray technol  ogies. Structural aberrations of chromosomes are associates with various syndromes, although there are a lot of cho mosomal gains and losses that are not yet associated with a specic syndrome. Most of the cases are the novo, few cases are due to unbalanced rearraments and others areinherents. We present a three years old boy derived from neuropediatric for genetics studies due to global develop  mental delay. He was born at 38 gestation week from noconsanguineous healthy parents. Karyotype in leucocites was normal (46;XY). Comparative Genomic Hybridization (CGH Array) with the Nimblegen CGX CytogeneticMicroarrays platform, suplied by PerkinElmer, was per  formed for the patient and parents. The CGH  Array was normal en both parents, but the patient presented a delecc tion of 2,40 Mb in 18q22.1 q22.3 chromosomical region (arr[hg19] 18q22.1 q22.3 (66,375,444 68,773,023)x1 Abnormal Male). The duplication is de novo and no previously described. These delection have 11 genes included (5 OMIM) and then with a high pathologic prob  ability. . Chromosomic aberrations detected de novo and no previously described can be di cult to determine his pathologic potential, and it is necesary to have in mind the patient pathology and genes involved in the delecction/duplication . In our case we believe that the chromosomal alteration detected, alone or in conjuntion with another chromosomal or enviromental cause will be responsible ofthe patient pathology. M. Molina Zayas: None. M. Martinez Atienza: None. M. Del Aguila Garca: None. A. Gonzlez Ramirez: None. S. Garca Linares: None. A. Mora Guijosa: None. A. Poyatos Andjar.: None. M. Perez Sanchez: None. E",2018.0,,"M. Molina Zayas, m. Martinez Atienza, M. Del Aguila Garca, A.","Gonzlez Ramirez, S. Garca Linares, A. Mora Guijosa, A.","Poyatos Andjar., M. Perez Sanchez Servicio Andaluz de Salud (SAS)., Granada, Spain988 J. del PicchiaLaboratory evaluation of patients with developmental delay/ intellectual disability, congenital anomalies, dismorphic features and autistic disorders has changed signi cantly in the last years with the introduction of microarray technol  ogies.",,autistic disorders,[],"['autistic', 'disorder']"
739,173, Dual molecular effects of dominant RORA mutations cause two variants of syndromic intellectual disability with either autistic features or cerebellar ataxia,C17.3,,"Schema14, A. G. Chiocchetti15, M. McDonald16,J .d e Bellescize17, M. Vincent1,3, H. Van Esch18, S. Sattler19,I . Forghani20, I. Thiffault21,22,23, C. M. Freitag15, D. Barbouth20, M. Cadieux Dion21, N. P. Saf na23,24,25, L. Grote23,24,25,W . Carr26, C. Saunders21,22,23, S. Pajusalu13, A. Boland27, D. Hays Karlowicz16, J. Deleuze27, M. H. Wojcik28, R. Pressman20,B . Isidor1,3, A. Vogels18, W. Van Paesschen29, F. Rivier30,N . Leboucq31, B. Cogn1,3, S. Sasorith4, D. Sanlaville11,12,K . Retterer9, S. Odent5,32, N. Katsanis2, S. Bzieau1,3, M. Koenig4,L . Pasquier33, E. E. Davis2, S. Kry1,3; 1Service de Gntique Mdicale, CHU Nantes, Nantes, France,2Center for Human Disease Modeling, Durham, NC, United States,3l'institut du thorax, INSERM, CNRS, UNIV Nantes, Nantes, France,4EA7402 Institut Uni  versitaire de Recherche Clinique, and Laboratoire de Gntique Molculaire, CHU and Universit de Mon tpellier, Montpellier, France, 5Service de Gntique Clin  ique, Centre Rfrence Dciences Intellectuelles de causes rares (CRDI), Centre de rfrence anomalies du dveloppement CLAD Ouest, CHU Rennes, Rennes, France,6Division of Neurology, University Hospital Antwerp, Antwerp, Belgium,7Neurogenetics Group, Center for Molecular Neurology, VIB, Antwerp, Belgium, 8Laboratory of Neurogenetics, Institute Born Bunge, Uni  versity of Antwerp, Antwerp, Belgium,9GeneDx, 207 Perry Parkway, Gaithersburg, MD, United States,10Chromosome Laboratory, Department of Clinical Genetics, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark, 11Service de gntique, Groupement Hospitalier Est, Hos  pices Civils de Lyon, Lyon, France,12INSERM U1028, CNRS UMR5292, Centre de Recherche en Neurosciencesde Lyon, Universit Claude Bernard Lyon 1, Lyon, France, 13Department of Clinical Genetics, United Laboratories, Tartu University Hospital and Institute of Clinical Medi cine, University of Tartu, Tartu, Estonia, 14University of Minnesota  Fairview Minneapolis, Minneapolis, MN, Uni  ted States,15Department of Child and Adolescent Psy  chiatry, Psychosomatics and Psychotherapy, JW Goethe University Frankfurt, Deutschordenstrae 50, Frankfurt, Germany,16Division of Medical Genetics, Department of Pediatrics, Duke University, Durham, NC, United States, 17Epilepsy, Sleep and Pediatric Neurophysiology Depart  ment, Hospices Civils, Lyon, Bron, France,18Center for Human Genetics, University Hospitals Leuven, Leuven, Belgium,19Carle Physician Group, Urbana, IL, United States,20Dr. John T. Macdonald Foundation Department of Human Genetics, University of Miami, Miller School of Medicine, Miami, FL, United States,21Center for Pediatric Genomic Medicine, Children s Mercy Hospital, Kansas City, MO, United States,22Department of Pathology and Laboratory Medicine, Children's Mercy Hospitals, KansasCity, MO, United States,23University of Missouri Kansas City, School of Medicine, Kansas City, MO, United States, 24Division of Clinical Genetics, Children s Mercy Hospital, Kansas City, MO, United States,25Department of Pedia  trics, Children's Mercy Hospital, Kansas City, MO, United States,26Laboratoire de Gntique Molculaire & Gno  mique, CHU de Rennes, Rennes, France,27Centre National de Recherche en Gnomique Humaine (CNRGH), Institut de Biologie Franois Jacob, DRF, CEA, Evry, France, 28The Broad Institute of MIT and Harvard, Cambridge, MA, United States,29Department of Neurology, University Hospitals Leuven, Leuven, Belgium,30Department of Neuropdiatrie and CR Maladies Neuromusculaires, CHU de Montpellier, Montpellier, France,31Neuroradiologie, CHU de Montpellier, Montpellier, France,32CNRS UMR 6290, Universite de Rennes, Rennes, France,33Service de Gntique Clinique, Centre Rfrence D ciences Intel  lectuelles de causes rares (CRDI), Centre de rfrenceanomalies du dveloppement CLAD Ouest, Rennes, France. Introduction: Through a multi center international col  laboration, we identi ed 16 individuals with de novo or dominant variants in RORA , encoding the retinoic acid receptor (RAR) related orphan nuclear receptor alpha, bywhole exome sequencing or chromosomal microarray. The mutational spectrum included four copy number variations (two de novo deletions, one dominant deletion and one de novo duplication) and nine de novo single nucleotide var  iants. Intellectual disability (ID) was the predominant clinical feature (15/16), accompanied by seizures (11/16), autisticfeatures (5/16) and cerebellar hypoplasia or atrophy (3/16). Materials and methods: To investigate the relevance of RORA disruption to neurodevelopmental phenotypes in humans, we abrogated the D. rerio ortholog, roraa , through either transient suppression or CRISPR/Cas9 genome editing. Results: Disruption of roraa causes a signi cant reduction of cerebellar size in developing larvae. Moreover, wild type human RORA mRNA could rescue cerebellar defects caused by roraa morpholino knockdown. Through in vivo complementation and titration of variant mRNA, we observed that missense variants had two distinct pathogenicmechanisms of either haploinsuf ciency or dominant toxic effects, according to their localization in the ligand  or DNA binding domains. Notably, ID and autism were hall mark features in individuals with loss of function variants, whereas ID and cerebellar features were the main pheno  types in individuals with variants harboring a dominanttoxic effect. Conclusions: Our combined genetic and functional data point to dual mutational effects that likely determine phe notypic outcome. In sum, our results show that RORA variants lead to a neurodevelopmental disorderAbstracts from the 51stEuropean Society of Human Genetics Conference: Oral. . . 839characterized by intellectual disability, seizures, autistic features and cerebellar defects. X. Latypova: None. C. Guissart: None. T.N. Khan: None. P. Rollier: None. H. Stamberger: None. K. McWalter: A. Employment (full or part time); Signi cant; Gene Dx. M.T. Cho: A. Employment (full or part time); Signi cant; Gene Dx. S. Kjaergaard: None. S. Wec  khuysen: None. G. Lesca: None. T. Besnard: None. K. unap: None. L. Schema: None. A.G. Chiocchetti: None. M. McDonald: None. J. de Bellescize: None. M. Vincent: None. H. Van Esch: None. S. Sattler: None. I. Forghani: None. I. Thiffault: None. C.M. Freitag: None. D. Bar  bouth: None. M. Cadieux Dion: None. N.P. Saf na: None. L. Grote: None. W. Carr: None. C. Saunders: None. S. Pajusalu: None. A. Boland: None. D. Hays Karlowicz: None. J. Deleuze: None. M.H. Wojcik: None. R. Pressman: None. B. Isidor: None. A. Vogels: None. W. Van Paesschen: None. F. Rivier: None. N. Leboucq: None. B. Cogn: None. S. Sasorith: None. D. Sanlaville: None. K. Retterer: A. Employment (full or part time); Signi cant; Gene Dx. S. Odent: None. N. Katsanis: E. Ownership Interest (stock, stock options, patent or other intellectual property); Signi cant; Rescindo Therapeutics, Inc. F. Consultant/Advisory Board; Signi cant; Rescindo Therapeutics, Inc. S. Bzieau: None. M. Koenig: None. L. Pasquier: None. E.E. Davis: None. S. Kry: None.",2018.0,,"X. Latypova1,2,3, C. Guissart4, T. N. Khan2, P. Rollier5,H .","Stamberger6,7,8, K. McWalter9, M. T. Cho9, S. Kjaergaard10,S .838 J. del PicchiaWeckhuysen6,7,8, G. Lesca11,12, T. Besnard1,3, K. unap13,L .","839characterized by intellectual disability, seizures, autistic features and cerebellar defects.",,autistic features,[],"['autistic', 'feature']"
741,176, Abnormal Social and Cognitive Behavior is associated with Inherited Noncoding Mutations in Human AcceleratedRegions (HARs),C17.6,,"Saffar1, S. Balkhy7, G. G. Gascon8, M. Nieto9, C. A. Walsh1 1Boston Children's Hospital, Boston, MA, United States,2Yale University, New Haven, CT, United States,3Centro de Biologa Molecular Severo Ochoa , Madrid, Spain,4Kuwait Center for Autism, Kuwait City, Kuwait,5Istanbul Institute of Child and Adolescent Psychiatry, Istanbul, Turkey,6Bahcesehir University School of Medicine, Istanbul, Turkey,7King Faisal Specialist Hospital and Research Center, Jeddah, Saudi Arabia,8Massachusetts General Hospital, Boston, MA, United States,9Centro Nacional de Biotecnologa, Madrid, Spain Comparative analyses have identi ed genomic regions potentially involved in human evolution, but do not directlyassess function. Human accelerated regions (HARs) repre  sent conserved genomic loci with elevated divergence in humans compared to other primate and non primate species.At least some HARs are thought to contribute to neurode  velopmental functions underlying the unique social and behavioral traits of humans. If some HARs regulate human specic social and behavioral traits, then mutations would likely impact cognitive and social disorders. Recent studies support the role of HARs in complex neurodevelopmentalfunctions and associated disorders including Autism Spec  trum Disorder (ASD) and Schizophrenia. Strikingly, through large scale whole genome and targeted HAR omesequencing we nd, for the rst time, that rare noncoding mutations in neurally active HARs contribute to simplex, multiplex, and consanguineous ASD cases. These mutationshighlight more than 20 HARs with putative essential roles in neural development. Functional validation of candidate HARs and underlying mutations using chromatin interac tion sequencing, high throughput reporter assays, and transgenic mice allowed for further functional character  ization of inherited HAR mutations in active regulatoryelements for RBFOX1 ,CUX1, PTBP2, GPC4, CDKL5 , and other genes implicated in neural function, autism spectrum disorder, or both. Our data expand the previous associationof HARs in consanguineous families with ASD to include both simplex and multiplex families, providing strongAbstracts from the 51stEuropean Society of Human Genetics Conference: Oral. . . 841genetic evidence that speci c HARs are essential for normal development, consistent with suggestions that their evolu  tionary changes may have altered social and/or cognitive behavior. R.N. Doan: None. T. Shin: None. B. Bae: None. B. Cubelos: None. C. Chang: None. A.A. Hossain: None. S. Al Saad: None. N.M. Mukaddes: None. O. Oner: None. M. Al Saffar: None. S. Balkhy: None. G.G. Gascon: None. M. Nieto: None. C.A. Walsh: None. C18 Cardiovascular disorder",2018.0,,"R. N. Doan1, T. Shin1, B. Bae2, B. Cubelos3, C. Chang1,A .A .","Hossain1, S. Al Saad4, N. M. Mukaddes5, O. Oner6, M. Al","Strikingly, through large scale whole genome and targeted HAR omesequencing we nd, for the rst time, that rare noncoding mutations in neurally active HARs contribute to simplex, multiplex, and consanguineous ASD cases.",,ASD cases,[],"['ASD', 'case']"
741,176, Abnormal Social and Cognitive Behavior is associated with Inherited Noncoding Mutations in Human AcceleratedRegions (HARs),C17.6,,"Saffar1, S. Balkhy7, G. G. Gascon8, M. Nieto9, C. A. Walsh1 1Boston Children's Hospital, Boston, MA, United States,2Yale University, New Haven, CT, United States,3Centro de Biologa Molecular Severo Ochoa , Madrid, Spain,4Kuwait Center for Autism, Kuwait City, Kuwait,5Istanbul Institute of Child and Adolescent Psychiatry, Istanbul, Turkey,6Bahcesehir University School of Medicine, Istanbul, Turkey,7King Faisal Specialist Hospital and Research Center, Jeddah, Saudi Arabia,8Massachusetts General Hospital, Boston, MA, United States,9Centro Nacional de Biotecnologa, Madrid, Spain Comparative analyses have identi ed genomic regions potentially involved in human evolution, but do not directlyassess function. Human accelerated regions (HARs) repre  sent conserved genomic loci with elevated divergence in humans compared to other primate and non primate species.At least some HARs are thought to contribute to neurode  velopmental functions underlying the unique social and behavioral traits of humans. If some HARs regulate human specic social and behavioral traits, then mutations would likely impact cognitive and social disorders. Recent studies support the role of HARs in complex neurodevelopmentalfunctions and associated disorders including Autism Spec  trum Disorder (ASD) and Schizophrenia. Strikingly, through large scale whole genome and targeted HAR omesequencing we nd, for the rst time, that rare noncoding mutations in neurally active HARs contribute to simplex, multiplex, and consanguineous ASD cases. These mutationshighlight more than 20 HARs with putative essential roles in neural development. Functional validation of candidate HARs and underlying mutations using chromatin interac tion sequencing, high throughput reporter assays, and transgenic mice allowed for further functional character  ization of inherited HAR mutations in active regulatoryelements for RBFOX1 ,CUX1, PTBP2, GPC4, CDKL5 , and other genes implicated in neural function, autism spectrum disorder, or both. Our data expand the previous associationof HARs in consanguineous families with ASD to include both simplex and multiplex families, providing strongAbstracts from the 51stEuropean Society of Human Genetics Conference: Oral. . . 841genetic evidence that speci c HARs are essential for normal development, consistent with suggestions that their evolu  tionary changes may have altered social and/or cognitive behavior. R.N. Doan: None. T. Shin: None. B. Bae: None. B. Cubelos: None. C. Chang: None. A.A. Hossain: None. S. Al Saad: None. N.M. Mukaddes: None. O. Oner: None. M. Al Saffar: None. S. Balkhy: None. G.G. Gascon: None. M. Nieto: None. C.A. Walsh: None. C18 Cardiovascular disorder",2018.0,,"R. N. Doan1, T. Shin1, B. Bae2, B. Cubelos3, C. Chang1,A .A .","Hossain1, S. Al Saad4, N. M. Mukaddes5, O. Oner6, M. Al","Our data expand the previous associationof HARs in consanguineous families with ASD to include both simplex and multiplex families, providing strongAbstracts from the 51stEuropean Society of Human Genetics Conference: Oral.",families with ASD,,"['family', 'with', 'ASD']",[]
747,132,A Gastrointestinal dysfunction in autism spectrum disorder: New insights from the Foxp1 +/ mouse with altered gut motility and achalasia,P03.05,,"D. Groneberg2, A. Reigl2, E. Zizer3, A. Friebe2, B. Niesler1, G. Rappold1 1Department of Human Molecular Genetics, Institute of Human Genetics, University of Heidelberg, Heidelberg, Germany,2Institute of Physiology, University of Wrzburg, Wrzburg, Germany,3Department of Internal Medicine I, University of Ulm, Ulm, Germany Gastrointestinal (GI) dysfunction is common in individuals with autism spectrum disorder (ASD), but these symptoms are often overlooked and it is still not clear how GI dysfunction relates to the core features of ASD.FOXP1 syndrome is characterized by autistic traits, such as social de cits, language impairment, and intellectualdisability. But feeding dif culties, constipation, and other GI problems were also reported. Whether these symptoms are due to primary impairment or a secondary effect of altered behaviour or side effects of psychotropic medication remains unclear. We investigated the GI tract of patient relevant Foxp1 +/ mice. These mice have a lower body weight than wild type animals and show altered feeding behaviour. Foxp1 was expressed in all GI sections and was reduced in Foxp1+/ mice compared with WT. A pronounced atrophy of the tunica muscularis was detected in the oesophagus and colon, caused by reduced muscle cell proliferation. Nitricoxide induced relaxation of the lower oesophagus sphincter was impaired and achalasia con rmed in vivo by mano  metry. Several Foxp1 targets previously identi ed by microarray analysis in the brain were signi cantly deregu  lated in the oesophagus of Foxp1 +/  mice. The total gut transit was signi cantly prolonged. Spatiotemporal maps depicting the colonic contraction patterns revealed strongly disturbed contractility and peristalsis. Overall, our ndings provide the rst evidence that GI disturbances in patients with FOXP1 autism spectrum disorder may be caused by impaired gut motility and achalasia, driven by FOXP1  dependent deregulation of genes. Furthermore, this is therst report of achalasia being caused by a heterozygous gene deletion. H. Frhlich: None. M. Kollmeyer: None. M. Stuhlin  ger: None. V. Linz: None. D. Groneberg: None. A. Reigl: None. E. Zizer: None. A. Friebe: None. B. Niesler: None. G. Rappold: None.",2019.0,,H. Frhlich,"1, M. Kollmeyer1, M. Stuhlinger1, V. Linz1,","D. Groneberg2, A. Reigl2, E. Zizer3, A. Friebe2, B. Niesler1, G. Rappold1 1Department of Human Molecular Genetics, Institute of Human Genetics, University of Heidelberg, Heidelberg, Germany,2Institute of Physiology, University of Wrzburg, Wrzburg, Germany,3Department of Internal Medicine I, University of Ulm, Ulm, Germany Gastrointestinal (GI) dysfunction is common in individuals with autism spectrum disorder (ASD), but these symptoms are often overlooked and it is still not clear how GI dysfunction relates to the core features of ASD.FOXP1 syndrome is characterized by autistic traits, such as social de cits, language impairment, and intellectualdisability.",individuals with autism,ASD.FOXP1 syndrome,"['individual', 'with', 'autism']","['ASD.FOXP1', 'syndrome']"
747,132,A Gastrointestinal dysfunction in autism spectrum disorder: New insights from the Foxp1 +/ mouse with altered gut motility and achalasia,P03.05,,"D. Groneberg2, A. Reigl2, E. Zizer3, A. Friebe2, B. Niesler1, G. Rappold1 1Department of Human Molecular Genetics, Institute of Human Genetics, University of Heidelberg, Heidelberg, Germany,2Institute of Physiology, University of Wrzburg, Wrzburg, Germany,3Department of Internal Medicine I, University of Ulm, Ulm, Germany Gastrointestinal (GI) dysfunction is common in individuals with autism spectrum disorder (ASD), but these symptoms are often overlooked and it is still not clear how GI dysfunction relates to the core features of ASD.FOXP1 syndrome is characterized by autistic traits, such as social de cits, language impairment, and intellectualdisability. But feeding dif culties, constipation, and other GI problems were also reported. Whether these symptoms are due to primary impairment or a secondary effect of altered behaviour or side effects of psychotropic medication remains unclear. We investigated the GI tract of patient relevant Foxp1 +/ mice. These mice have a lower body weight than wild type animals and show altered feeding behaviour. Foxp1 was expressed in all GI sections and was reduced in Foxp1+/ mice compared with WT. A pronounced atrophy of the tunica muscularis was detected in the oesophagus and colon, caused by reduced muscle cell proliferation. Nitricoxide induced relaxation of the lower oesophagus sphincter was impaired and achalasia con rmed in vivo by mano  metry. Several Foxp1 targets previously identi ed by microarray analysis in the brain were signi cantly deregu  lated in the oesophagus of Foxp1 +/  mice. The total gut transit was signi cantly prolonged. Spatiotemporal maps depicting the colonic contraction patterns revealed strongly disturbed contractility and peristalsis. Overall, our ndings provide the rst evidence that GI disturbances in patients with FOXP1 autism spectrum disorder may be caused by impaired gut motility and achalasia, driven by FOXP1  dependent deregulation of genes. Furthermore, this is therst report of achalasia being caused by a heterozygous gene deletion. H. Frhlich: None. M. Kollmeyer: None. M. Stuhlin  ger: None. V. Linz: None. D. Groneberg: None. A. Reigl: None. E. Zizer: None. A. Friebe: None. B. Niesler: None. G. Rappold: None.",2019.0,,H. Frhlich,"1, M. Kollmeyer1, M. Stuhlinger1, V. Linz1,","D. Groneberg2, A. Reigl2, E. Zizer3, A. Friebe2, B. Niesler1, G. Rappold1 1Department of Human Molecular Genetics, Institute of Human Genetics, University of Heidelberg, Heidelberg, Germany,2Institute of Physiology, University of Wrzburg, Wrzburg, Germany,3Department of Internal Medicine I, University of Ulm, Ulm, Germany Gastrointestinal (GI) dysfunction is common in individuals with autism spectrum disorder (ASD), but these symptoms are often overlooked and it is still not clear how GI dysfunction relates to the core features of ASD.FOXP1 syndrome is characterized by autistic traits, such as social de cits, language impairment, and intellectualdisability.",individuals with autism,autistic traits,"['individual', 'with', 'autism']","['autistic', 'trait']"
749,297,"A A case of dihydropyrimidine dehydrogenase de ciency and homozygous mutation DPYD:c.1905 +1G>A in Bulgarian patient with severe autistic disorderAbstracts from the 52ndEuropean Society of Human Genetics (ESHG). . . 1335M. B. Ivanova1,2, V. Jordanova1, T. Todorov3,",P06.10,,"Obstetrics and Gynecology Maichin dom , Medical University, So a, Bulgaria,2Faculty of Chemistry and Pharmacy, Department of Analytical Chemistry, So a University ""St. Kl. Ohridski"", So a, Bulgaria,3Genetic Medico Diagnostic Laboratory Genica ,S oa, Bulgaria, 4Department of Medical Chemistry and Biochemistry, Medical University, So a, Bulgaria,5Department of Medical genetics, Medical University So a, So a, Bulgaria Background: Dihydropyrimidine dehydrogenase (DPD) deciency is an autosomal recessive disorder of the pyrimidine metabolism characterised by thymine uraciluria with variable expressivity and different phenotypes. It varies from asymptomatic to severe neurological manifesta tions and an increased risk of toxicity from 5  uorouracil treatment. Materials and Methods: A child with severe autistic behavior, intellectual disability (no speech at 6 years old) and family history   aunt with mental retardation, was referred for genetic counseling. Metabolic screening wasperformed in urine sample by dipstick   glucose, ketone, pH, and reducing sugars, followed by LC MS/MS blood aminoacids and acylcarnitines and GC/MS urine organicacids analysis. Mutations in DPYD gene are reported in DPD de ciency patients. The gene was investigated by direct Sanger sequencing in proband and his parents. Results: Elevated levels of thymine and uracil were detected by GC/MS urine test which was suggestive of DPD deciency. Molecular analysis of DPYD gene showed a homozygous splice site mutation c.1905 +1G>A in the proband, inherited from heterozygous parents. Subse  quently, prenatal testing in the family was performed. Thefetus was healthy non carrier. Conclusion: Here we report the rst Bulgarian patient with severe autistic disorder caused by DPD de ciency and subsequent prenatal diagnostics performed in the family. As patients with this de ciency could be easily detected by determination of the thymine uraciluria, screening for thesedefects are indicative for all patients with any autistic behavior and intellectual disability. It also could be useful for those patients who are going to be treated with 5 uorouracil to prevent lethal toxicities and personalise treatments. M.B. Ivanova: None. V. Jordanova: None. T. Todorov: None. A. Todorova: None. D. Dimitrov: None. I. Dimova: None. A. Savov: None.",2019.0,,"A. Todorova3,4, D. Dimitrov1, I. Dimova5, A. Savov1","1National Genetic Laboratory, University Hospital of","Materials and Methods: A child with severe autistic behavior, intellectual disability (no speech at 6 years old) and family history   aunt with mental retardation, was referred for genetic counseling.",,autistic behavior,[],"['autistic', 'behavior']"
749,297,"A A case of dihydropyrimidine dehydrogenase de ciency and homozygous mutation DPYD:c.1905 +1G>A in Bulgarian patient with severe autistic disorderAbstracts from the 52ndEuropean Society of Human Genetics (ESHG). . . 1335M. B. Ivanova1,2, V. Jordanova1, T. Todorov3,",P06.10,,"Obstetrics and Gynecology Maichin dom , Medical University, So a, Bulgaria,2Faculty of Chemistry and Pharmacy, Department of Analytical Chemistry, So a University ""St. Kl. Ohridski"", So a, Bulgaria,3Genetic Medico Diagnostic Laboratory Genica ,S oa, Bulgaria, 4Department of Medical Chemistry and Biochemistry, Medical University, So a, Bulgaria,5Department of Medical genetics, Medical University So a, So a, Bulgaria Background: Dihydropyrimidine dehydrogenase (DPD) deciency is an autosomal recessive disorder of the pyrimidine metabolism characterised by thymine uraciluria with variable expressivity and different phenotypes. It varies from asymptomatic to severe neurological manifesta tions and an increased risk of toxicity from 5  uorouracil treatment. Materials and Methods: A child with severe autistic behavior, intellectual disability (no speech at 6 years old) and family history   aunt with mental retardation, was referred for genetic counseling. Metabolic screening wasperformed in urine sample by dipstick   glucose, ketone, pH, and reducing sugars, followed by LC MS/MS blood aminoacids and acylcarnitines and GC/MS urine organicacids analysis. Mutations in DPYD gene are reported in DPD de ciency patients. The gene was investigated by direct Sanger sequencing in proband and his parents. Results: Elevated levels of thymine and uracil were detected by GC/MS urine test which was suggestive of DPD deciency. Molecular analysis of DPYD gene showed a homozygous splice site mutation c.1905 +1G>A in the proband, inherited from heterozygous parents. Subse  quently, prenatal testing in the family was performed. Thefetus was healthy non carrier. Conclusion: Here we report the rst Bulgarian patient with severe autistic disorder caused by DPD de ciency and subsequent prenatal diagnostics performed in the family. As patients with this de ciency could be easily detected by determination of the thymine uraciluria, screening for thesedefects are indicative for all patients with any autistic behavior and intellectual disability. It also could be useful for those patients who are going to be treated with 5 uorouracil to prevent lethal toxicities and personalise treatments. M.B. Ivanova: None. V. Jordanova: None. T. Todorov: None. A. Todorova: None. D. Dimitrov: None. I. Dimova: None. A. Savov: None.",2019.0,,"A. Todorova3,4, D. Dimitrov1, I. Dimova5, A. Savov1","1National Genetic Laboratory, University Hospital of",Conclusion: Here we report the rst Bulgarian patient with severe autistic disorder caused by DPD de ciency and subsequent prenatal diagnostics performed in the family.,,autistic disorder,[],"['autistic', 'disorder']"
749,297,"A A case of dihydropyrimidine dehydrogenase de ciency and homozygous mutation DPYD:c.1905 +1G>A in Bulgarian patient with severe autistic disorderAbstracts from the 52ndEuropean Society of Human Genetics (ESHG). . . 1335M. B. Ivanova1,2, V. Jordanova1, T. Todorov3,",P06.10,,"Obstetrics and Gynecology Maichin dom , Medical University, So a, Bulgaria,2Faculty of Chemistry and Pharmacy, Department of Analytical Chemistry, So a University ""St. Kl. Ohridski"", So a, Bulgaria,3Genetic Medico Diagnostic Laboratory Genica ,S oa, Bulgaria, 4Department of Medical Chemistry and Biochemistry, Medical University, So a, Bulgaria,5Department of Medical genetics, Medical University So a, So a, Bulgaria Background: Dihydropyrimidine dehydrogenase (DPD) deciency is an autosomal recessive disorder of the pyrimidine metabolism characterised by thymine uraciluria with variable expressivity and different phenotypes. It varies from asymptomatic to severe neurological manifesta tions and an increased risk of toxicity from 5  uorouracil treatment. Materials and Methods: A child with severe autistic behavior, intellectual disability (no speech at 6 years old) and family history   aunt with mental retardation, was referred for genetic counseling. Metabolic screening wasperformed in urine sample by dipstick   glucose, ketone, pH, and reducing sugars, followed by LC MS/MS blood aminoacids and acylcarnitines and GC/MS urine organicacids analysis. Mutations in DPYD gene are reported in DPD de ciency patients. The gene was investigated by direct Sanger sequencing in proband and his parents. Results: Elevated levels of thymine and uracil were detected by GC/MS urine test which was suggestive of DPD deciency. Molecular analysis of DPYD gene showed a homozygous splice site mutation c.1905 +1G>A in the proband, inherited from heterozygous parents. Subse  quently, prenatal testing in the family was performed. Thefetus was healthy non carrier. Conclusion: Here we report the rst Bulgarian patient with severe autistic disorder caused by DPD de ciency and subsequent prenatal diagnostics performed in the family. As patients with this de ciency could be easily detected by determination of the thymine uraciluria, screening for thesedefects are indicative for all patients with any autistic behavior and intellectual disability. It also could be useful for those patients who are going to be treated with 5 uorouracil to prevent lethal toxicities and personalise treatments. M.B. Ivanova: None. V. Jordanova: None. T. Todorov: None. A. Todorova: None. D. Dimitrov: None. I. Dimova: None. A. Savov: None.",2019.0,,"A. Todorova3,4, D. Dimitrov1, I. Dimova5, A. Savov1","1National Genetic Laboratory, University Hospital of","As patients with this de ciency could be easily detected by determination of the thymine uraciluria, screening for thesedefects are indicative for all patients with any autistic behavior and intellectual disability.",,autistic behavior,[],"['autistic', 'behavior']"
753,381,C New candidate genes in autism spectrum disorder,P08.06,,"E. Benetti2, A. Giliberti1, M. Cannone1, F. Valentino1, F. Ariani1, A. Pinto3, S. Furini2, R. Canitano4, J. D. Buxbaum5, S. De Rubeis5, A. Renieri1 1Medical Genetics, University of Siena, Siena, Italy, 2Department of Medical Biotechnologies, University of Siena, Siena, Italy,3Genetica Medica, Azienda Ospedaliera Universitaria Senese, Siena, Italy,4Child Neuropsychiatry, Azienda Ospedaliera Universitaria Senese, Siena, Italy, 5Department of Psychiatry, Ichan School of Medicine, at Mount Sinai, New York, NY, United States Introduction: Autism spectrum disorder (ASD) is a well  known highly genetic heterogeneous entity. Materials and Methods: In the context of an Interna  tional project aiming at identifying the genetic causes of ASD (Autism Sequencing Consortium, Mount Sinai), weperformed a whole exome sequencing (WES) analysis in a cohort of 100 ASD patients, not harboring CNVs, attending the Medical Genetics Unit of Siena. Results: Mutations in already known ASD related genes were detected in 11% of cases, while either de novo or inherited mutations in novel genes were identi ed in 21% of cases. The novel identi ed genes can be pooled in three categories: i genes for which causative mutations have not1378been previously reported (eight genes), ii genes for which a likely association with ASD has been previously reported in a single case (eg DRP2 etc) and iii genes whose mutations have been previously associated with intellectual disability (ID) in only one (eg BCORL1 etc) or a few families (eg BRD4 recently associated with a Cornelia De Lange likephenotype etc). Conclusions: Overall, our extensive approach goes beyond safely con rming the pathogenic role of ASD/ID candidate genes and allows establishing the novel role of ID related genes in ASD. It delineates the impact of new genes across neurodevelopmental dimensions, providingimportant new insights into functional pathways involved in heterogeneous ASD phenotypes. F. Mari: None. C. Fallerini: None. A. Curr: None. D. Lopergolo: None. E. Benetti: None. A. Giliberti: None. M. Cannone: None. F. Valentino: None. F. Ariani: None. A. Pinto: None. S. Furini: None. R. Canitano: None. J.D. Buxbaum: None. S. De Rubeis: None. A. Renieri: None.",2019.0,,F. Mari,"1, C. Fallerini1, A. Curr1, D. Lopergolo1,","Materials and Methods: In the context of an Interna  tional project aiming at identifying the genetic causes of ASD (Autism Sequencing Consortium, Mount Sinai), weperformed a whole exome sequencing (WES) analysis in a cohort of 100 ASD patients, not harboring CNVs, attending the Medical Genetics Unit of Siena.",,ASD patients,[],"['ASD', 'patient']"
753,381,C New candidate genes in autism spectrum disorder,P08.06,,"E. Benetti2, A. Giliberti1, M. Cannone1, F. Valentino1, F. Ariani1, A. Pinto3, S. Furini2, R. Canitano4, J. D. Buxbaum5, S. De Rubeis5, A. Renieri1 1Medical Genetics, University of Siena, Siena, Italy, 2Department of Medical Biotechnologies, University of Siena, Siena, Italy,3Genetica Medica, Azienda Ospedaliera Universitaria Senese, Siena, Italy,4Child Neuropsychiatry, Azienda Ospedaliera Universitaria Senese, Siena, Italy, 5Department of Psychiatry, Ichan School of Medicine, at Mount Sinai, New York, NY, United States Introduction: Autism spectrum disorder (ASD) is a well  known highly genetic heterogeneous entity. Materials and Methods: In the context of an Interna  tional project aiming at identifying the genetic causes of ASD (Autism Sequencing Consortium, Mount Sinai), weperformed a whole exome sequencing (WES) analysis in a cohort of 100 ASD patients, not harboring CNVs, attending the Medical Genetics Unit of Siena. Results: Mutations in already known ASD related genes were detected in 11% of cases, while either de novo or inherited mutations in novel genes were identi ed in 21% of cases. The novel identi ed genes can be pooled in three categories: i genes for which causative mutations have not1378been previously reported (eight genes), ii genes for which a likely association with ASD has been previously reported in a single case (eg DRP2 etc) and iii genes whose mutations have been previously associated with intellectual disability (ID) in only one (eg BCORL1 etc) or a few families (eg BRD4 recently associated with a Cornelia De Lange likephenotype etc). Conclusions: Overall, our extensive approach goes beyond safely con rming the pathogenic role of ASD/ID candidate genes and allows establishing the novel role of ID related genes in ASD. It delineates the impact of new genes across neurodevelopmental dimensions, providingimportant new insights into functional pathways involved in heterogeneous ASD phenotypes. F. Mari: None. C. Fallerini: None. A. Curr: None. D. Lopergolo: None. E. Benetti: None. A. Giliberti: None. M. Cannone: None. F. Valentino: None. F. Ariani: None. A. Pinto: None. S. Furini: None. R. Canitano: None. J.D. Buxbaum: None. S. De Rubeis: None. A. Renieri: None.",2019.0,,F. Mari,"1, C. Fallerini1, A. Curr1, D. Lopergolo1,","Results: Mutations in already known ASD related genes were detected in 11% of cases, while either de novo or inherited mutations in novel genes were identi ed in 21% of cases.",,ASD related genes,[],"['ASD', 'related', 'gene']"
753,381,C New candidate genes in autism spectrum disorder,P08.06,,"E. Benetti2, A. Giliberti1, M. Cannone1, F. Valentino1, F. Ariani1, A. Pinto3, S. Furini2, R. Canitano4, J. D. Buxbaum5, S. De Rubeis5, A. Renieri1 1Medical Genetics, University of Siena, Siena, Italy, 2Department of Medical Biotechnologies, University of Siena, Siena, Italy,3Genetica Medica, Azienda Ospedaliera Universitaria Senese, Siena, Italy,4Child Neuropsychiatry, Azienda Ospedaliera Universitaria Senese, Siena, Italy, 5Department of Psychiatry, Ichan School of Medicine, at Mount Sinai, New York, NY, United States Introduction: Autism spectrum disorder (ASD) is a well  known highly genetic heterogeneous entity. Materials and Methods: In the context of an Interna  tional project aiming at identifying the genetic causes of ASD (Autism Sequencing Consortium, Mount Sinai), weperformed a whole exome sequencing (WES) analysis in a cohort of 100 ASD patients, not harboring CNVs, attending the Medical Genetics Unit of Siena. Results: Mutations in already known ASD related genes were detected in 11% of cases, while either de novo or inherited mutations in novel genes were identi ed in 21% of cases. The novel identi ed genes can be pooled in three categories: i genes for which causative mutations have not1378been previously reported (eight genes), ii genes for which a likely association with ASD has been previously reported in a single case (eg DRP2 etc) and iii genes whose mutations have been previously associated with intellectual disability (ID) in only one (eg BCORL1 etc) or a few families (eg BRD4 recently associated with a Cornelia De Lange likephenotype etc). Conclusions: Overall, our extensive approach goes beyond safely con rming the pathogenic role of ASD/ID candidate genes and allows establishing the novel role of ID related genes in ASD. It delineates the impact of new genes across neurodevelopmental dimensions, providingimportant new insights into functional pathways involved in heterogeneous ASD phenotypes. F. Mari: None. C. Fallerini: None. A. Curr: None. D. Lopergolo: None. E. Benetti: None. A. Giliberti: None. M. Cannone: None. F. Valentino: None. F. Ariani: None. A. Pinto: None. S. Furini: None. R. Canitano: None. J.D. Buxbaum: None. S. De Rubeis: None. A. Renieri: None.",2019.0,,F. Mari,"1, C. Fallerini1, A. Curr1, D. Lopergolo1,","The novel identi ed genes can be pooled in three categories: i genes for which causative mutations have not1378been previously reported (eight genes), ii genes for which a likely association with ASD has been previously reported in a single case (eg DRP2 etc) and iii genes whose mutations have been previously associated with intellectual disability (ID) in only one (eg BCORL1 etc) or a few families (eg BRD4 recently associated with a Cornelia De Lange likephenotype etc).",association with ASD,,"['association', 'with', 'ASD']",[]
753,381,C New candidate genes in autism spectrum disorder,P08.06,,"E. Benetti2, A. Giliberti1, M. Cannone1, F. Valentino1, F. Ariani1, A. Pinto3, S. Furini2, R. Canitano4, J. D. Buxbaum5, S. De Rubeis5, A. Renieri1 1Medical Genetics, University of Siena, Siena, Italy, 2Department of Medical Biotechnologies, University of Siena, Siena, Italy,3Genetica Medica, Azienda Ospedaliera Universitaria Senese, Siena, Italy,4Child Neuropsychiatry, Azienda Ospedaliera Universitaria Senese, Siena, Italy, 5Department of Psychiatry, Ichan School of Medicine, at Mount Sinai, New York, NY, United States Introduction: Autism spectrum disorder (ASD) is a well  known highly genetic heterogeneous entity. Materials and Methods: In the context of an Interna  tional project aiming at identifying the genetic causes of ASD (Autism Sequencing Consortium, Mount Sinai), weperformed a whole exome sequencing (WES) analysis in a cohort of 100 ASD patients, not harboring CNVs, attending the Medical Genetics Unit of Siena. Results: Mutations in already known ASD related genes were detected in 11% of cases, while either de novo or inherited mutations in novel genes were identi ed in 21% of cases. The novel identi ed genes can be pooled in three categories: i genes for which causative mutations have not1378been previously reported (eight genes), ii genes for which a likely association with ASD has been previously reported in a single case (eg DRP2 etc) and iii genes whose mutations have been previously associated with intellectual disability (ID) in only one (eg BCORL1 etc) or a few families (eg BRD4 recently associated with a Cornelia De Lange likephenotype etc). Conclusions: Overall, our extensive approach goes beyond safely con rming the pathogenic role of ASD/ID candidate genes and allows establishing the novel role of ID related genes in ASD. It delineates the impact of new genes across neurodevelopmental dimensions, providingimportant new insights into functional pathways involved in heterogeneous ASD phenotypes. F. Mari: None. C. Fallerini: None. A. Curr: None. D. Lopergolo: None. E. Benetti: None. A. Giliberti: None. M. Cannone: None. F. Valentino: None. F. Ariani: None. A. Pinto: None. S. Furini: None. R. Canitano: None. J.D. Buxbaum: None. S. De Rubeis: None. A. Renieri: None.",2019.0,,F. Mari,"1, C. Fallerini1, A. Curr1, D. Lopergolo1,","It delineates the impact of new genes across neurodevelopmental dimensions, providingimportant new insights into functional pathways involved in heterogeneous ASD phenotypes.",,ASD phenotypes,[],"['ASD', 'phenotype']"
755,384,B Truncating CHD8 variants cause a Sotos like syndrome with autism,P08.09,,"M. Tischkowitz3, W. Mohamed4, U. Kini4, S. McKee5, L. Yates6,7, M. Bertoli6, S. Lynch8, S. Holder9,  . the Deciphering Developmental Disorders study10, S. Banka1 1Manchester Centre for Genomic Medicine, St Mary s Hospital, Manchester University Hospitals NHSFoundation Trust, Manchester Academic Health Sciences Centre, Manchester, United Kingdom, 2Division of Evolution and Genomic Sciences, School of BiologicalSciences, University of Manchester, Manchester, United Kingdom, 3Academic Department of Medical Genetics, University of Cambridge, Cambridge University HospitalsNHS foundation Trust, Cambridge Biomedical Campus, Cambridge, United Kingdom, 4Oxford Centre for Genomic Medicine, Oxford University Hospitals NHS FoundationTrust, Oxford, United Kingdom, 55Northern Ireland Regional Genetics Centre, Belfast Health and Social Care Trust, Belfast City Hospital, Belfast, United Kingdom, 6West of Scotland Regional Genetics Service, NHS Greater Glasgow and Clyde, Institute of Medical Genetics, Yorkhill Hospital, Glasgow, United Kingdom,7KwaZulu Natal Research and Innovation Sequencing Platform (KRISP), University of KwaZulu Natal, Durban, South Africa, 8Temple Street Children s Hospital, Dublin, Ireland,9North West Thames Regional Genetics Service, Harrow, London, United Kingdom,10Department of Medical Genetics, Cambridge University Hospitals Foundation Trust,Cambridge, United Kingdom Variants in the chromodomain helicase DNA binding protein 8 (CHD8) have been associated with intellectual disability (ID), autism spectrum disorders (ASD) and overgrowth and CHD8 is one of the causative genes for OGID (overgrowth and ID). However, the phenotypic spectrum of individuals heterozygous for CHD8 truncating variants has not been clearly de ned. We investigated 26 individuals with CHD8 protein truncating variants (PTVs), including 10 previously unreported patients, and found a1380pattern of common features: macrocephaly (76%), tall stature (65%), developmental delay and/or intellectual disability (DD/ID, 81%), autism spectrum disorders (ASD, 81%), sleep dif culties (48%), gastrointestinal problems (42%), and distinct facial features. The gestalt is reminiscent of Sotos and Weaver syndromes. Most of the individuals inour cohort had moderate to severe intellectual disability, and some had regression of speech (37%), seizures (27%) and hypotonia (27%), and two individuals were also non ambulant. Most individuals had ASD (81%), similarly to previous studies, but we found a higher incidence of comorbid neurodevelopmental delay/impairment. Our studyshows that haploinsuf ciency of CHD8 is associated with a Sotos like syndrome with pronounced autistic traits. S. Douzgou: None. H. Liang: None. K. Metcalfe: None. S. Somarathi: None. M. Tischkowitz: None. W. Mohamed: None. U. Kini: None. S. McKee: None. L. Yates: None. M. Bertoli: None. S. Lynch: None. S. Holder: None.  . the Deciphering Developmental Dis  orders study: None. S. Banka: None.",2019.0,,S. Douzgou,"1, H. Liang2, K. Metcalfe1, S. Somarathi1,",Our studyshows that haploinsuf ciency of CHD8 is associated with a Sotos like syndrome with pronounced autistic traits.,,autistic traits,[],"['autistic', 'trait']"
757,397,"D GATAD2B Associated Neurodevelopmental Disorder (GAND), further delineation of the phenotype in a series of 10 patients",P08.23,,"F. Petit3, T. Smol3, A. Ziegler4, D. Bonneau4, S. Mercier5, P. Edery6, G. Lesca7, N. Chatron7, B. Duban Bedu8, C. Colson9, B. Gerard10, B. Durand10, Y. Capri11, T. Frebourg1, A. Lebre12, G. Nicolas1, P. Saugier Veber1, A. Guerrot1 1Normandie Univ, UNIROUEN, Inserm U1245 and Rouen University Hospital, Department of Genetics, F 76000,Normandy Center for Genomic and Personalized Medicine, Reference Center for Developmental Disorders, Rouen, France, 2Centre de Gntique, CHU Dijon Bourgogne, Unit Fonctionnelle Innovation en Diagnostic gnomique des maladies rares, FHU TRANSLAD, INSERM 1231, Gntique des Anomalies du Dveloppement, UniversitBourgogne Franche Comt, Dijon, France, 3CHU Lille, Clinique de Gntique, Hopital Jeanne de Flandre, F  59000 and EA7364 RADEME, Universit de Lille, F 59000,Lille, France, 4Department of Biochemistry and Genetics, University Hospital, 49933 Angers Cedex 9 ; UMR CNRS 60154 INSERM 1083 and Mitovasc Institute, University ofAngers, 49933, Angers, France, 5Service de gntique mdicale, CHU Nantes, Nantes, France,6Service de gntique clinique, Centre de Rfrence Anomalies duDveloppement et Syndromes Malformatifs Sud Est  HCL ; Centre de Recherche en Neurosciences de Lyon, GENDEV, Inserm U1028, UMR CNRS 5292, UCBL1, Lyon, France, 7Hospices Civils de Lyon, Genetic Department and Molecular Biology Laboratory, Centre de Biologie Est, Bron, F 69677, France; Universit Claude Bernard Lyon 1,F 69100, Villeurbanne, Lyon, France, 8Cytogenetics Service, Saint Vincent de Paul Catholic Hospitals1388Association of Lille, Free Faculty of Medicine, Lille, France,9Service de Gntique, CHU de Caen   Hpital Clmenceau, Caen, France,10Laboratoire de Diagnostic Gntique, Hpitaux Universitaires de Strasbourg, Strasbourg, France,11Department of Genetics, APHP  Robert DEBRE University Hospital, Denis Diderot Schoolof Medicine, Paris University, Paris, France, 12Department of Genetics, Reims University Hospital, Reims, France Introduction: Pathogenic variants in the GATAD2B gene have recently been associated with a syndromic neurode  velopmental disorder (GAND) characterized by severeintellectual disability (ID), impaired speech, childhood hypotonia, and dysmorphic features. The majority of reported patients harbored de novo loss of function (LoF) variants. To date, the phenotype of only four patients has been precisely described in the literature, contrasting with the relative frequency of detection of such LoF GATAD2B variants. Here, we describe 10 patients with con rmed LoF GATAD2B variants and further delineate the clinical phenotype. Methods: Patients were included by contacting referent clinicians from several French genetics departments. Results: Developmental delay was severe with a median age of 2.4 years (range [2 5]) for independent walking and of 2.75 years (range [1 4]) for rst spoken words. They showed very little subsequent progress, one patientremaining non verbal at age 30 years. ID was mostly moderate, with only one severe and one mild case, which differs from the original description of severe ID. Mostcommon dysmorphic features included broad forehead, deeply set eyes, hypertelorism, downturned mouth and, anomalies of the extremities. Conversely, prenatal compli cations, non cerebral organ malformations, epilepsy and autistic behaviour were very rare. One patient presented asthma and recurrent respiratory infections, another onepresented severe feeding dif culties and developed acute lymphoblastic leukemia and IgG de ciency. Conclusions: NGS based approaches for sequencing will improve the detection of GATAD2B variations. Better knowledge of the clinical phenotype is essential for a cor  rect interpretation of the molecular results and for anaccurate management of these patients. G. Vera: None. A. Sorlin: None. G. Delplancq: None. F. Lecoquierre: None. F. Petit: None. T. Smol: None. A. Ziegler: None. D. Bonneau: None. S. Mercier: None. P. Edery: None. G. Lesca: None. N. Chatron: None. B. Duban Bedu: None. C. Colson: None. B. Gerard: None. B. Durand: None. Y. Capri: None. T. Frebourg: None. A. Lebre: None. G. Nicolas: None. P. Saugier Veber: None. A. Guerrot: None.",2019.0,,G. Vera,"1, A. Sorlin2, G. Delplancq2, F. Lecoquierre1,","Conversely, prenatal compli cations, non cerebral organ malformations, epilepsy and autistic behaviour were very rare.",,autistic behaviour,[],"['autistic', 'behaviour']"
759,415,D Genotype Phenotype correlation of 11 new Spanishpatients with Bainbridge Ropers syndrome,P08.43,,"J. Moreno Ruiz3, P. Tirado Requero4, F. Santos  Simarro5,6, S. Garca Miaur5,6, M. Palomares Bralo5,6, M. Serrano7, A. Cueto1, T. Vendrell1, A. Cordero1, M. Carcas1, I. Paramonov1, URDCAT consortium, E. Tizzano1, I. Cusco1,6 1Department of Clinical and Molecular Genetics. Hospital Vall d Hebron, Barcelona, Spain,2Clinical Genetics, Pediatrics Department, Parc Taul Hospital Universitari,Institut d'Investigaci i Innovaci Parc Taul., Sabadell, Spain, 3Department of Pediatrics. Hospital Costa del Sol, Marbella (Mlaga), Spain,4Neurologa Infantil Hospital La Paz, Madrid, Spain,5Instituto de Gentica Mdica y Molecular (INGEMM) IdiPAZ, Hospital Universitario LaPaz, Madrid, Spain,6CIBERER, Centro de Investigacin Biomdica en Red de Enfermedades Raras, ISCIII, Madrid, Spain,7Neurologa Peditrica y Medicina Gentica. Instituto Peditrico de Enfermedades Raras. Hospital Sant Joan de Deu, Barcelona, Spain Introduction: Bainbridge ropers syndrome (BRPS) is a neurodevelopmental disorder caused by mutations in ASXL3 . Patients with BRPS show delayed psychomotor development, intellectual disability, speech alterations, hypotonia, poor growth and dysmorphic features. It is categorized as a syndromic cause of Autism spectrumdisorder (ASD). Nowadays, 33 patients with BRPS have been reported. Our work expands the mutational spectrum of the ASXL3 with the genotype phenotype characterizing 11 new patients. Material and Methods: In a collaborative initiative we have identi ed 11 patients with neurodevelopmental dis  orders and ASD phenotype with loss of function(LoF) mutations in the ASXL3 gene. Exome sequencing was used as a diagnostic tool and Sanger sequencing was used forfamilial segregation. The mutational spectrum of ASXL3 was revised in public_data (PubMed, Clinvar, SFARI). Results: We identi ed 10 new ASXL3 LoF variants and one recurrent mutation (c.3106C>T;p.Arg1036Ter). The main clinical characteristics of our patients included moderate severe intellectual disability with ASD traits andneuroconductual disorder including aggressively behavior in adolescence. Dysmorphic features highly suggestive of ASXL3 were delineated eyebrows and the skeletal pheno  type. So far, 77 different LoF mutations (48 frameshifts, 28 Stop Gain, 1 splicing) have been identi ed including our present results. There are 3 recurrent mutations and 73unique variants. Conclusions: The inclusion of new patients with BRPS increases the knowledge of mutational spectrum of ASXL3 and is essential to further delineate the phenotype of this syndrome. The recognition of this syndrome in the context of a neurodevelopmental disorder is indispensable for theorientation of molecular diagnosis. Grant: FIS_FEDER_PI16/00369; PERIS SLT002/16/ 00174 I. Valenzuela: None. E. Gabau: None. C. Pardo  Domnguez: None. J. Moreno Ruiz: None. P. Tirado  Requero: None. F. Santos Simarro: None. S. Garca  Miaur: None. M. Palomares Bralo: None. M. Serrano: None. A. Cueto: None. T. Vendrell: None. A. Cordero: None. M. Carcas: None. I. Paramonov: None. E. Tiz  zano: None. I. Cusco: None.",2019.0,,I. Valenzuela,"1, E. Gabau2, C. Pardo Domnguez3,",Material and Methods: In a collaborative initiative we have identi ed 11 patients with neurodevelopmental dis  orders and ASD phenotype with loss of function(LoF) mutations in the ASXL3 gene.,,ASD phenotype,[],"['ASD', 'phenotype']"
759,415,D Genotype Phenotype correlation of 11 new Spanishpatients with Bainbridge Ropers syndrome,P08.43,,"J. Moreno Ruiz3, P. Tirado Requero4, F. Santos  Simarro5,6, S. Garca Miaur5,6, M. Palomares Bralo5,6, M. Serrano7, A. Cueto1, T. Vendrell1, A. Cordero1, M. Carcas1, I. Paramonov1, URDCAT consortium, E. Tizzano1, I. Cusco1,6 1Department of Clinical and Molecular Genetics. Hospital Vall d Hebron, Barcelona, Spain,2Clinical Genetics, Pediatrics Department, Parc Taul Hospital Universitari,Institut d'Investigaci i Innovaci Parc Taul., Sabadell, Spain, 3Department of Pediatrics. Hospital Costa del Sol, Marbella (Mlaga), Spain,4Neurologa Infantil Hospital La Paz, Madrid, Spain,5Instituto de Gentica Mdica y Molecular (INGEMM) IdiPAZ, Hospital Universitario LaPaz, Madrid, Spain,6CIBERER, Centro de Investigacin Biomdica en Red de Enfermedades Raras, ISCIII, Madrid, Spain,7Neurologa Peditrica y Medicina Gentica. Instituto Peditrico de Enfermedades Raras. Hospital Sant Joan de Deu, Barcelona, Spain Introduction: Bainbridge ropers syndrome (BRPS) is a neurodevelopmental disorder caused by mutations in ASXL3 . Patients with BRPS show delayed psychomotor development, intellectual disability, speech alterations, hypotonia, poor growth and dysmorphic features. It is categorized as a syndromic cause of Autism spectrumdisorder (ASD). Nowadays, 33 patients with BRPS have been reported. Our work expands the mutational spectrum of the ASXL3 with the genotype phenotype characterizing 11 new patients. Material and Methods: In a collaborative initiative we have identi ed 11 patients with neurodevelopmental dis  orders and ASD phenotype with loss of function(LoF) mutations in the ASXL3 gene. Exome sequencing was used as a diagnostic tool and Sanger sequencing was used forfamilial segregation. The mutational spectrum of ASXL3 was revised in public_data (PubMed, Clinvar, SFARI). Results: We identi ed 10 new ASXL3 LoF variants and one recurrent mutation (c.3106C>T;p.Arg1036Ter). The main clinical characteristics of our patients included moderate severe intellectual disability with ASD traits andneuroconductual disorder including aggressively behavior in adolescence. Dysmorphic features highly suggestive of ASXL3 were delineated eyebrows and the skeletal pheno  type. So far, 77 different LoF mutations (48 frameshifts, 28 Stop Gain, 1 splicing) have been identi ed including our present results. There are 3 recurrent mutations and 73unique variants. Conclusions: The inclusion of new patients with BRPS increases the knowledge of mutational spectrum of ASXL3 and is essential to further delineate the phenotype of this syndrome. The recognition of this syndrome in the context of a neurodevelopmental disorder is indispensable for theorientation of molecular diagnosis. Grant: FIS_FEDER_PI16/00369; PERIS SLT002/16/ 00174 I. Valenzuela: None. E. Gabau: None. C. Pardo  Domnguez: None. J. Moreno Ruiz: None. P. Tirado  Requero: None. F. Santos Simarro: None. S. Garca  Miaur: None. M. Palomares Bralo: None. M. Serrano: None. A. Cueto: None. T. Vendrell: None. A. Cordero: None. M. Carcas: None. I. Paramonov: None. E. Tiz  zano: None. I. Cusco: None.",2019.0,,I. Valenzuela,"1, E. Gabau2, C. Pardo Domnguez3,",The main clinical characteristics of our patients included moderate severe intellectual disability with ASD traits andneuroconductual disorder including aggressively behavior in adolescence.,disability with ASD,ASD traits,"['disability', 'with', 'ASD']","['ASD', 'trait']"
764,451,A Autism monozygotic twins with APBA2 gene duplication vary for tick development,P09.018,,"Sarajevo, Bosnia and Herzegovina Introduction: Autism, or autism spectrum disorder (ASD) is neurological and developmental disorder that begins earlyin childhood and lasts throughout a person's life, character  ized by challenges with social skills, repetitive behaviors, speech and non verbal communication. Large genome rearrangements are being identi ed in ASD as an under  lying cause for development of this syndrome. These rearrangements are mostly deletions, but duplications canbe found. We present case of twin boys with APBA2 gene duplication. Materials and Methods: Twin boys, age 9 were referred to genetic counseling and testing with diagnosed ASD (DSM IV). DNA was isolated from buccal swabs of the boys, and 3 ml of whole blood from parents. Parents pro vided completed questionnaires for tick disorders in chil  dren as well as Coordination Disorder Questionnaire (DCDQ). Identi cation of mutations was made with MLPA (multiplex ligase dependent probe ampli cation) technique, with MLPA kits P343 and P339 (Mrc Holland). Results: All samples were typed successfully. We iden  tied de novo APBA2 gene duplication in both twins. This gene, located on 15q13.1 locus is already associated with autism features. DCDQ scores are similar in twins withindication of DCD. Assessment of the Questionnaires for tick disorders in children revealed that one sibling is com  pletely absent for ticks while other has high score for sec tion related to vocal and involuntary ticks. Conclusions: This nding require further investigation and follow up on spatial and temporal differences in autismassociated traits in APBA2 gene duplication associated autism. N. Lojo Kadric: None. L. Pojskic: None.",2019.0,,"N. Lojo Kadric, L. Pojskic","Institute for genetic engineering and biotechnology,","Materials and Methods: Twin boys, age 9 were referred to genetic counseling and testing with diagnosed ASD (DSM IV).",testing with diagnosed ASD,,"['testing', 'with', 'diagnosed', 'ASD']",[]
765,452,B MLPA analysis as a diagnostic test in patients withautism spectrum disorders,P09.019,,"S. Bichev2 1Department of Clinical Genetics, University Pediatrics Hospital, Medical University, So a, Bulgaria, So a, Bulgaria,2National Genetic Laboratory, University Hospital Majcin Dom""Medical University, So a, Bulgaria, So a, Bulgaria Introduction: Autism spectrum disorders (ASDs) are a heterogeneous group of conditions characterized by impaired reciprocal social interaction, lack of communica  tion, isolated interests and repetitive or stereotypedbehaviors. Most cases are idiopathic, although there is increasing evidence that ASDs have an important genetic component with aetiological heterogeneity. The aim of ourstudy was to evaluate the role of multiplex ligation Abstracts from the 52ndEuropean Society of Human Genetics (ESHG). . . 1419dependent probe ampli cation (MLPA) as a screening test in patients with autism spectrum disorders. Materials and Methods: For this study we used MLPA P245 Microdeletion Syndromes for screening of the most common microdeletion syndromes and MLPA P036 Sub  telomeres Mix 1 for screening of subtelomeric deletions/duplications in 198 patients with autism spectrum disorders. To con rm alternations discovered with MLPA P036 Subtelomeres Mix 1 we used MLPA P070 SubtelomeresMix 2B. Results: We identi ed 12 autistic patients with sub  microscopic aberrations. There were 2 patients with sub telomeric deletion at the 14q and 2q regions respectively. Two patients had the same deletion at the 1p36.33 region. One patient had a submicroscopic deletion at the 6q regionand duplication at the 13q region simultaneously. Two patients had the submicroscopic deletions at the 4q region. Three duplications were detected at 3p, 9p, and 17p11.2regions. Two patients were with deletion at the 8p and 22q11.21 regions respectively. Conclusions: The present study shows that the incidence of a submicroscopic aberrations detected by MLPA in autistic patients is approximately 6 %. MLPA is a rapid and cost effective method for detection of genomic imbalancesin patients with autism spectrum disorders. D. Avdjieva Tzavella: None. H. Kathom: None. T. Delchev: None. S. Bichev: None.",2019.0,,D. Avdjieva Tzavella,"1, H. Kathom1, T. Delchev1,",1419dependent probe ampli cation (MLPA) as a screening test in patients with autism spectrum disorders.,patients with autism,,"['patient', 'with', 'autism']",[]
765,452,B MLPA analysis as a diagnostic test in patients withautism spectrum disorders,P09.019,,"S. Bichev2 1Department of Clinical Genetics, University Pediatrics Hospital, Medical University, So a, Bulgaria, So a, Bulgaria,2National Genetic Laboratory, University Hospital Majcin Dom""Medical University, So a, Bulgaria, So a, Bulgaria Introduction: Autism spectrum disorders (ASDs) are a heterogeneous group of conditions characterized by impaired reciprocal social interaction, lack of communica  tion, isolated interests and repetitive or stereotypedbehaviors. Most cases are idiopathic, although there is increasing evidence that ASDs have an important genetic component with aetiological heterogeneity. The aim of ourstudy was to evaluate the role of multiplex ligation Abstracts from the 52ndEuropean Society of Human Genetics (ESHG). . . 1419dependent probe ampli cation (MLPA) as a screening test in patients with autism spectrum disorders. Materials and Methods: For this study we used MLPA P245 Microdeletion Syndromes for screening of the most common microdeletion syndromes and MLPA P036 Sub  telomeres Mix 1 for screening of subtelomeric deletions/duplications in 198 patients with autism spectrum disorders. To con rm alternations discovered with MLPA P036 Subtelomeres Mix 1 we used MLPA P070 SubtelomeresMix 2B. Results: We identi ed 12 autistic patients with sub  microscopic aberrations. There were 2 patients with sub telomeric deletion at the 14q and 2q regions respectively. Two patients had the same deletion at the 1p36.33 region. One patient had a submicroscopic deletion at the 6q regionand duplication at the 13q region simultaneously. Two patients had the submicroscopic deletions at the 4q region. Three duplications were detected at 3p, 9p, and 17p11.2regions. Two patients were with deletion at the 8p and 22q11.21 regions respectively. Conclusions: The present study shows that the incidence of a submicroscopic aberrations detected by MLPA in autistic patients is approximately 6 %. MLPA is a rapid and cost effective method for detection of genomic imbalancesin patients with autism spectrum disorders. D. Avdjieva Tzavella: None. H. Kathom: None. T. Delchev: None. S. Bichev: None.",2019.0,,D. Avdjieva Tzavella,"1, H. Kathom1, T. Delchev1,",Materials and Methods: For this study we used MLPA P245 Microdeletion Syndromes for screening of the most common microdeletion syndromes and MLPA P036 Sub  telomeres Mix 1 for screening of subtelomeric deletions/duplications in 198 patients with autism spectrum disorders.,patients with autism,,"['patient', 'with', 'autism']",[]
765,452,B MLPA analysis as a diagnostic test in patients withautism spectrum disorders,P09.019,,"S. Bichev2 1Department of Clinical Genetics, University Pediatrics Hospital, Medical University, So a, Bulgaria, So a, Bulgaria,2National Genetic Laboratory, University Hospital Majcin Dom""Medical University, So a, Bulgaria, So a, Bulgaria Introduction: Autism spectrum disorders (ASDs) are a heterogeneous group of conditions characterized by impaired reciprocal social interaction, lack of communica  tion, isolated interests and repetitive or stereotypedbehaviors. Most cases are idiopathic, although there is increasing evidence that ASDs have an important genetic component with aetiological heterogeneity. The aim of ourstudy was to evaluate the role of multiplex ligation Abstracts from the 52ndEuropean Society of Human Genetics (ESHG). . . 1419dependent probe ampli cation (MLPA) as a screening test in patients with autism spectrum disorders. Materials and Methods: For this study we used MLPA P245 Microdeletion Syndromes for screening of the most common microdeletion syndromes and MLPA P036 Sub  telomeres Mix 1 for screening of subtelomeric deletions/duplications in 198 patients with autism spectrum disorders. To con rm alternations discovered with MLPA P036 Subtelomeres Mix 1 we used MLPA P070 SubtelomeresMix 2B. Results: We identi ed 12 autistic patients with sub  microscopic aberrations. There were 2 patients with sub telomeric deletion at the 14q and 2q regions respectively. Two patients had the same deletion at the 1p36.33 region. One patient had a submicroscopic deletion at the 6q regionand duplication at the 13q region simultaneously. Two patients had the submicroscopic deletions at the 4q region. Three duplications were detected at 3p, 9p, and 17p11.2regions. Two patients were with deletion at the 8p and 22q11.21 regions respectively. Conclusions: The present study shows that the incidence of a submicroscopic aberrations detected by MLPA in autistic patients is approximately 6 %. MLPA is a rapid and cost effective method for detection of genomic imbalancesin patients with autism spectrum disorders. D. Avdjieva Tzavella: None. H. Kathom: None. T. Delchev: None. S. Bichev: None.",2019.0,,D. Avdjieva Tzavella,"1, H. Kathom1, T. Delchev1,",Results: We identi ed 12 autistic patients with sub  microscopic aberrations.,,autistic patients,[],"['autistic', 'patient']"
765,452,B MLPA analysis as a diagnostic test in patients withautism spectrum disorders,P09.019,,"S. Bichev2 1Department of Clinical Genetics, University Pediatrics Hospital, Medical University, So a, Bulgaria, So a, Bulgaria,2National Genetic Laboratory, University Hospital Majcin Dom""Medical University, So a, Bulgaria, So a, Bulgaria Introduction: Autism spectrum disorders (ASDs) are a heterogeneous group of conditions characterized by impaired reciprocal social interaction, lack of communica  tion, isolated interests and repetitive or stereotypedbehaviors. Most cases are idiopathic, although there is increasing evidence that ASDs have an important genetic component with aetiological heterogeneity. The aim of ourstudy was to evaluate the role of multiplex ligation Abstracts from the 52ndEuropean Society of Human Genetics (ESHG). . . 1419dependent probe ampli cation (MLPA) as a screening test in patients with autism spectrum disorders. Materials and Methods: For this study we used MLPA P245 Microdeletion Syndromes for screening of the most common microdeletion syndromes and MLPA P036 Sub  telomeres Mix 1 for screening of subtelomeric deletions/duplications in 198 patients with autism spectrum disorders. To con rm alternations discovered with MLPA P036 Subtelomeres Mix 1 we used MLPA P070 SubtelomeresMix 2B. Results: We identi ed 12 autistic patients with sub  microscopic aberrations. There were 2 patients with sub telomeric deletion at the 14q and 2q regions respectively. Two patients had the same deletion at the 1p36.33 region. One patient had a submicroscopic deletion at the 6q regionand duplication at the 13q region simultaneously. Two patients had the submicroscopic deletions at the 4q region. Three duplications were detected at 3p, 9p, and 17p11.2regions. Two patients were with deletion at the 8p and 22q11.21 regions respectively. Conclusions: The present study shows that the incidence of a submicroscopic aberrations detected by MLPA in autistic patients is approximately 6 %. MLPA is a rapid and cost effective method for detection of genomic imbalancesin patients with autism spectrum disorders. D. Avdjieva Tzavella: None. H. Kathom: None. T. Delchev: None. S. Bichev: None.",2019.0,,D. Avdjieva Tzavella,"1, H. Kathom1, T. Delchev1,",Conclusions: The present study shows that the incidence of a submicroscopic aberrations detected by MLPA in autistic patients is approximately 6 %.,,autistic patients,[],"['autistic', 'patient']"
765,452,B MLPA analysis as a diagnostic test in patients withautism spectrum disorders,P09.019,,"S. Bichev2 1Department of Clinical Genetics, University Pediatrics Hospital, Medical University, So a, Bulgaria, So a, Bulgaria,2National Genetic Laboratory, University Hospital Majcin Dom""Medical University, So a, Bulgaria, So a, Bulgaria Introduction: Autism spectrum disorders (ASDs) are a heterogeneous group of conditions characterized by impaired reciprocal social interaction, lack of communica  tion, isolated interests and repetitive or stereotypedbehaviors. Most cases are idiopathic, although there is increasing evidence that ASDs have an important genetic component with aetiological heterogeneity. The aim of ourstudy was to evaluate the role of multiplex ligation Abstracts from the 52ndEuropean Society of Human Genetics (ESHG). . . 1419dependent probe ampli cation (MLPA) as a screening test in patients with autism spectrum disorders. Materials and Methods: For this study we used MLPA P245 Microdeletion Syndromes for screening of the most common microdeletion syndromes and MLPA P036 Sub  telomeres Mix 1 for screening of subtelomeric deletions/duplications in 198 patients with autism spectrum disorders. To con rm alternations discovered with MLPA P036 Subtelomeres Mix 1 we used MLPA P070 SubtelomeresMix 2B. Results: We identi ed 12 autistic patients with sub  microscopic aberrations. There were 2 patients with sub telomeric deletion at the 14q and 2q regions respectively. Two patients had the same deletion at the 1p36.33 region. One patient had a submicroscopic deletion at the 6q regionand duplication at the 13q region simultaneously. Two patients had the submicroscopic deletions at the 4q region. Three duplications were detected at 3p, 9p, and 17p11.2regions. Two patients were with deletion at the 8p and 22q11.21 regions respectively. Conclusions: The present study shows that the incidence of a submicroscopic aberrations detected by MLPA in autistic patients is approximately 6 %. MLPA is a rapid and cost effective method for detection of genomic imbalancesin patients with autism spectrum disorders. D. Avdjieva Tzavella: None. H. Kathom: None. T. Delchev: None. S. Bichev: None.",2019.0,,D. Avdjieva Tzavella,"1, H. Kathom1, T. Delchev1,",MLPA is a rapid and cost effective method for detection of genomic imbalancesin patients with autism spectrum disorders.,patients with autism,,"['patient', 'with', 'autism']",[]
766,453,C Rare variants targeting genes that encode forcytochrome P450 enzymes in Autism Spectrum Disorder,P09.020,,"J. Vilela1,2, C. Rasga1,2, G. Oliveira3,4,5, A. M. Vicente1,2 1National Health Institute Doutor Ricardo Jorge, Lisbon, Portugal,2BioISI   Biosystems & Integrative Sciences Institute, Faculty of Sciences, University of Lisbon, Lisbon, Portugal,3Unidade de Neurodesenvolvimento e Autismo (UNDA), Servio do Centro de Desenvolvimento da Criana, Centro de Investiga o e Forma o Clnica, Hospital Peditrico, Centro Hospitalar e Universitrio deCoimbra, Coimbra, Portugal, 4Institute for Biomedical Imaging and Life Sciences, Faculty of Medicine, Universidade de Coimbra, Coimbra, Portugal,5University Clinic of Pediatrics, Faculty of Medicine, University of Coimbra, Coimbra, Portugal Autism Spectrum Disorder (ASD) heritability estimates of 50 80% support the hypothesis that gene environment interactions play a role in this pathology. ASD risk hasbeen associated with early exposure to various xenobiotics that are cleared in the liver by Cytochrome P450 enzymes.We therefore explored the hypothesis that variants in CYP450 genes, which de ne the rapid or slow metabolizer status of their carriers, may render individuals exposed to certain toxicants more susceptible to brain disruption during early development. To identify rare variants in 57 CYP450 genes we inspected exome sequence data, from publiclyavailable ASD datasets, for loss of function (LoF) and missense Single Nucleotide Variants (SNVs) predicted to be detrimental by in silico tools (MAF<5%), as well as rare (<1%) Copy Number Variants (CNVs). In 2674 ASD subjects, we found 516 LoF and missense SNVs, targeting 54CYP450 genes, most frequently in CYP2A13 ,CYP1A1 , CYP2D6 and CYP4B1 . Additionally, we identi ed 135 CNVs targeting 24 CYP450 genes in 3030 ASD indivi  duals. CYP2D6 was exclusively targeted by CNVs in 13 out of 3030 ASD subjects, while CYP4X1 was signi cantly more frequently targeted by CNVs in ASD cases (22/3030; 0.72%) than controls (2/9649; 0.02%). CYP2D6 metabo  lizes most psychoactive drugs, while CYP1A1 acts on polycyclic aromatic hydrocarbons (PAHs) and CYP4X1 is involved in the metabolism of endocrine disrupting chemi cals (e.g. phthalates and bisphenol A). Early exposure to neurotoxic phthalates, bisphenol A and PAHs has been previously associated with ASD risk, and here we provideevidence for an effect of gene environmental exposure interaction mediated by CYP450 gene variants. J.X. Santos: None. A.R. Marques: None. H. Marti  niano: None. J. Vilela: None. C. Rasga: None. G. Oli  veira: None. A.M. Vicente: None.",2019.0,,J. X. Santos,"1,2, A. R. Marques1,2, H. Martiniano2,","ASD risk hasbeen associated with early exposure to various xenobiotics that are cleared in the liver by Cytochrome P450 enzymes.We therefore explored the hypothesis that variants in CYP450 genes, which de ne the rapid or slow metabolizer status of their carriers, may render individuals exposed to certain toxicants more susceptible to brain disruption during early development.",,ASD risk,[],"['ASD', 'risk']"
766,453,C Rare variants targeting genes that encode forcytochrome P450 enzymes in Autism Spectrum Disorder,P09.020,,"J. Vilela1,2, C. Rasga1,2, G. Oliveira3,4,5, A. M. Vicente1,2 1National Health Institute Doutor Ricardo Jorge, Lisbon, Portugal,2BioISI   Biosystems & Integrative Sciences Institute, Faculty of Sciences, University of Lisbon, Lisbon, Portugal,3Unidade de Neurodesenvolvimento e Autismo (UNDA), Servio do Centro de Desenvolvimento da Criana, Centro de Investiga o e Forma o Clnica, Hospital Peditrico, Centro Hospitalar e Universitrio deCoimbra, Coimbra, Portugal, 4Institute for Biomedical Imaging and Life Sciences, Faculty of Medicine, Universidade de Coimbra, Coimbra, Portugal,5University Clinic of Pediatrics, Faculty of Medicine, University of Coimbra, Coimbra, Portugal Autism Spectrum Disorder (ASD) heritability estimates of 50 80% support the hypothesis that gene environment interactions play a role in this pathology. ASD risk hasbeen associated with early exposure to various xenobiotics that are cleared in the liver by Cytochrome P450 enzymes.We therefore explored the hypothesis that variants in CYP450 genes, which de ne the rapid or slow metabolizer status of their carriers, may render individuals exposed to certain toxicants more susceptible to brain disruption during early development. To identify rare variants in 57 CYP450 genes we inspected exome sequence data, from publiclyavailable ASD datasets, for loss of function (LoF) and missense Single Nucleotide Variants (SNVs) predicted to be detrimental by in silico tools (MAF<5%), as well as rare (<1%) Copy Number Variants (CNVs). In 2674 ASD subjects, we found 516 LoF and missense SNVs, targeting 54CYP450 genes, most frequently in CYP2A13 ,CYP1A1 , CYP2D6 and CYP4B1 . Additionally, we identi ed 135 CNVs targeting 24 CYP450 genes in 3030 ASD indivi  duals. CYP2D6 was exclusively targeted by CNVs in 13 out of 3030 ASD subjects, while CYP4X1 was signi cantly more frequently targeted by CNVs in ASD cases (22/3030; 0.72%) than controls (2/9649; 0.02%). CYP2D6 metabo  lizes most psychoactive drugs, while CYP1A1 acts on polycyclic aromatic hydrocarbons (PAHs) and CYP4X1 is involved in the metabolism of endocrine disrupting chemi cals (e.g. phthalates and bisphenol A). Early exposure to neurotoxic phthalates, bisphenol A and PAHs has been previously associated with ASD risk, and here we provideevidence for an effect of gene environmental exposure interaction mediated by CYP450 gene variants. J.X. Santos: None. A.R. Marques: None. H. Marti  niano: None. J. Vilela: None. C. Rasga: None. G. Oli  veira: None. A.M. Vicente: None.",2019.0,,J. X. Santos,"1,2, A. R. Marques1,2, H. Martiniano2,","To identify rare variants in 57 CYP450 genes we inspected exome sequence data, from publiclyavailable ASD datasets, for loss of function (LoF) and missense Single Nucleotide Variants (SNVs) predicted to be detrimental by in silico tools (MAF<5%), as well as rare (<1%) Copy Number Variants (CNVs).",,ASD datasets,[],"['ASD', 'datasets']"
766,453,C Rare variants targeting genes that encode forcytochrome P450 enzymes in Autism Spectrum Disorder,P09.020,,"J. Vilela1,2, C. Rasga1,2, G. Oliveira3,4,5, A. M. Vicente1,2 1National Health Institute Doutor Ricardo Jorge, Lisbon, Portugal,2BioISI   Biosystems & Integrative Sciences Institute, Faculty of Sciences, University of Lisbon, Lisbon, Portugal,3Unidade de Neurodesenvolvimento e Autismo (UNDA), Servio do Centro de Desenvolvimento da Criana, Centro de Investiga o e Forma o Clnica, Hospital Peditrico, Centro Hospitalar e Universitrio deCoimbra, Coimbra, Portugal, 4Institute for Biomedical Imaging and Life Sciences, Faculty of Medicine, Universidade de Coimbra, Coimbra, Portugal,5University Clinic of Pediatrics, Faculty of Medicine, University of Coimbra, Coimbra, Portugal Autism Spectrum Disorder (ASD) heritability estimates of 50 80% support the hypothesis that gene environment interactions play a role in this pathology. ASD risk hasbeen associated with early exposure to various xenobiotics that are cleared in the liver by Cytochrome P450 enzymes.We therefore explored the hypothesis that variants in CYP450 genes, which de ne the rapid or slow metabolizer status of their carriers, may render individuals exposed to certain toxicants more susceptible to brain disruption during early development. To identify rare variants in 57 CYP450 genes we inspected exome sequence data, from publiclyavailable ASD datasets, for loss of function (LoF) and missense Single Nucleotide Variants (SNVs) predicted to be detrimental by in silico tools (MAF<5%), as well as rare (<1%) Copy Number Variants (CNVs). In 2674 ASD subjects, we found 516 LoF and missense SNVs, targeting 54CYP450 genes, most frequently in CYP2A13 ,CYP1A1 , CYP2D6 and CYP4B1 . Additionally, we identi ed 135 CNVs targeting 24 CYP450 genes in 3030 ASD indivi  duals. CYP2D6 was exclusively targeted by CNVs in 13 out of 3030 ASD subjects, while CYP4X1 was signi cantly more frequently targeted by CNVs in ASD cases (22/3030; 0.72%) than controls (2/9649; 0.02%). CYP2D6 metabo  lizes most psychoactive drugs, while CYP1A1 acts on polycyclic aromatic hydrocarbons (PAHs) and CYP4X1 is involved in the metabolism of endocrine disrupting chemi cals (e.g. phthalates and bisphenol A). Early exposure to neurotoxic phthalates, bisphenol A and PAHs has been previously associated with ASD risk, and here we provideevidence for an effect of gene environmental exposure interaction mediated by CYP450 gene variants. J.X. Santos: None. A.R. Marques: None. H. Marti  niano: None. J. Vilela: None. C. Rasga: None. G. Oli  veira: None. A.M. Vicente: None.",2019.0,,J. X. Santos,"1,2, A. R. Marques1,2, H. Martiniano2,","In 2674 ASD subjects, we found 516 LoF and missense SNVs, targeting 54CYP450 genes, most frequently in CYP2A13 ,CYP1A1 , CYP2D6 and CYP4B1 .",,ASD subjects,[],"['ASD', 'subject']"
766,453,C Rare variants targeting genes that encode forcytochrome P450 enzymes in Autism Spectrum Disorder,P09.020,,"J. Vilela1,2, C. Rasga1,2, G. Oliveira3,4,5, A. M. Vicente1,2 1National Health Institute Doutor Ricardo Jorge, Lisbon, Portugal,2BioISI   Biosystems & Integrative Sciences Institute, Faculty of Sciences, University of Lisbon, Lisbon, Portugal,3Unidade de Neurodesenvolvimento e Autismo (UNDA), Servio do Centro de Desenvolvimento da Criana, Centro de Investiga o e Forma o Clnica, Hospital Peditrico, Centro Hospitalar e Universitrio deCoimbra, Coimbra, Portugal, 4Institute for Biomedical Imaging and Life Sciences, Faculty of Medicine, Universidade de Coimbra, Coimbra, Portugal,5University Clinic of Pediatrics, Faculty of Medicine, University of Coimbra, Coimbra, Portugal Autism Spectrum Disorder (ASD) heritability estimates of 50 80% support the hypothesis that gene environment interactions play a role in this pathology. ASD risk hasbeen associated with early exposure to various xenobiotics that are cleared in the liver by Cytochrome P450 enzymes.We therefore explored the hypothesis that variants in CYP450 genes, which de ne the rapid or slow metabolizer status of their carriers, may render individuals exposed to certain toxicants more susceptible to brain disruption during early development. To identify rare variants in 57 CYP450 genes we inspected exome sequence data, from publiclyavailable ASD datasets, for loss of function (LoF) and missense Single Nucleotide Variants (SNVs) predicted to be detrimental by in silico tools (MAF<5%), as well as rare (<1%) Copy Number Variants (CNVs). In 2674 ASD subjects, we found 516 LoF and missense SNVs, targeting 54CYP450 genes, most frequently in CYP2A13 ,CYP1A1 , CYP2D6 and CYP4B1 . Additionally, we identi ed 135 CNVs targeting 24 CYP450 genes in 3030 ASD indivi  duals. CYP2D6 was exclusively targeted by CNVs in 13 out of 3030 ASD subjects, while CYP4X1 was signi cantly more frequently targeted by CNVs in ASD cases (22/3030; 0.72%) than controls (2/9649; 0.02%). CYP2D6 metabo  lizes most psychoactive drugs, while CYP1A1 acts on polycyclic aromatic hydrocarbons (PAHs) and CYP4X1 is involved in the metabolism of endocrine disrupting chemi cals (e.g. phthalates and bisphenol A). Early exposure to neurotoxic phthalates, bisphenol A and PAHs has been previously associated with ASD risk, and here we provideevidence for an effect of gene environmental exposure interaction mediated by CYP450 gene variants. J.X. Santos: None. A.R. Marques: None. H. Marti  niano: None. J. Vilela: None. C. Rasga: None. G. Oli  veira: None. A.M. Vicente: None.",2019.0,,J. X. Santos,"1,2, A. R. Marques1,2, H. Martiniano2,","Additionally, we identi ed 135 CNVs targeting 24 CYP450 genes in 3030 ASD indivi  duals.",,ASD indivi,[],"['ASD', 'indivi']"
766,453,C Rare variants targeting genes that encode forcytochrome P450 enzymes in Autism Spectrum Disorder,P09.020,,"J. Vilela1,2, C. Rasga1,2, G. Oliveira3,4,5, A. M. Vicente1,2 1National Health Institute Doutor Ricardo Jorge, Lisbon, Portugal,2BioISI   Biosystems & Integrative Sciences Institute, Faculty of Sciences, University of Lisbon, Lisbon, Portugal,3Unidade de Neurodesenvolvimento e Autismo (UNDA), Servio do Centro de Desenvolvimento da Criana, Centro de Investiga o e Forma o Clnica, Hospital Peditrico, Centro Hospitalar e Universitrio deCoimbra, Coimbra, Portugal, 4Institute for Biomedical Imaging and Life Sciences, Faculty of Medicine, Universidade de Coimbra, Coimbra, Portugal,5University Clinic of Pediatrics, Faculty of Medicine, University of Coimbra, Coimbra, Portugal Autism Spectrum Disorder (ASD) heritability estimates of 50 80% support the hypothesis that gene environment interactions play a role in this pathology. ASD risk hasbeen associated with early exposure to various xenobiotics that are cleared in the liver by Cytochrome P450 enzymes.We therefore explored the hypothesis that variants in CYP450 genes, which de ne the rapid or slow metabolizer status of their carriers, may render individuals exposed to certain toxicants more susceptible to brain disruption during early development. To identify rare variants in 57 CYP450 genes we inspected exome sequence data, from publiclyavailable ASD datasets, for loss of function (LoF) and missense Single Nucleotide Variants (SNVs) predicted to be detrimental by in silico tools (MAF<5%), as well as rare (<1%) Copy Number Variants (CNVs). In 2674 ASD subjects, we found 516 LoF and missense SNVs, targeting 54CYP450 genes, most frequently in CYP2A13 ,CYP1A1 , CYP2D6 and CYP4B1 . Additionally, we identi ed 135 CNVs targeting 24 CYP450 genes in 3030 ASD indivi  duals. CYP2D6 was exclusively targeted by CNVs in 13 out of 3030 ASD subjects, while CYP4X1 was signi cantly more frequently targeted by CNVs in ASD cases (22/3030; 0.72%) than controls (2/9649; 0.02%). CYP2D6 metabo  lizes most psychoactive drugs, while CYP1A1 acts on polycyclic aromatic hydrocarbons (PAHs) and CYP4X1 is involved in the metabolism of endocrine disrupting chemi cals (e.g. phthalates and bisphenol A). Early exposure to neurotoxic phthalates, bisphenol A and PAHs has been previously associated with ASD risk, and here we provideevidence for an effect of gene environmental exposure interaction mediated by CYP450 gene variants. J.X. Santos: None. A.R. Marques: None. H. Marti  niano: None. J. Vilela: None. C. Rasga: None. G. Oli  veira: None. A.M. Vicente: None.",2019.0,,J. X. Santos,"1,2, A. R. Marques1,2, H. Martiniano2,","CYP2D6 was exclusively targeted by CNVs in 13 out of 3030 ASD subjects, while CYP4X1 was signi cantly more frequently targeted by CNVs in ASD cases (22/3030; 0.72%) than controls (2/9649; 0.02%).",,ASD subjects,[],"['ASD', 'subject']"
766,453,C Rare variants targeting genes that encode forcytochrome P450 enzymes in Autism Spectrum Disorder,P09.020,,"J. Vilela1,2, C. Rasga1,2, G. Oliveira3,4,5, A. M. Vicente1,2 1National Health Institute Doutor Ricardo Jorge, Lisbon, Portugal,2BioISI   Biosystems & Integrative Sciences Institute, Faculty of Sciences, University of Lisbon, Lisbon, Portugal,3Unidade de Neurodesenvolvimento e Autismo (UNDA), Servio do Centro de Desenvolvimento da Criana, Centro de Investiga o e Forma o Clnica, Hospital Peditrico, Centro Hospitalar e Universitrio deCoimbra, Coimbra, Portugal, 4Institute for Biomedical Imaging and Life Sciences, Faculty of Medicine, Universidade de Coimbra, Coimbra, Portugal,5University Clinic of Pediatrics, Faculty of Medicine, University of Coimbra, Coimbra, Portugal Autism Spectrum Disorder (ASD) heritability estimates of 50 80% support the hypothesis that gene environment interactions play a role in this pathology. ASD risk hasbeen associated with early exposure to various xenobiotics that are cleared in the liver by Cytochrome P450 enzymes.We therefore explored the hypothesis that variants in CYP450 genes, which de ne the rapid or slow metabolizer status of their carriers, may render individuals exposed to certain toxicants more susceptible to brain disruption during early development. To identify rare variants in 57 CYP450 genes we inspected exome sequence data, from publiclyavailable ASD datasets, for loss of function (LoF) and missense Single Nucleotide Variants (SNVs) predicted to be detrimental by in silico tools (MAF<5%), as well as rare (<1%) Copy Number Variants (CNVs). In 2674 ASD subjects, we found 516 LoF and missense SNVs, targeting 54CYP450 genes, most frequently in CYP2A13 ,CYP1A1 , CYP2D6 and CYP4B1 . Additionally, we identi ed 135 CNVs targeting 24 CYP450 genes in 3030 ASD indivi  duals. CYP2D6 was exclusively targeted by CNVs in 13 out of 3030 ASD subjects, while CYP4X1 was signi cantly more frequently targeted by CNVs in ASD cases (22/3030; 0.72%) than controls (2/9649; 0.02%). CYP2D6 metabo  lizes most psychoactive drugs, while CYP1A1 acts on polycyclic aromatic hydrocarbons (PAHs) and CYP4X1 is involved in the metabolism of endocrine disrupting chemi cals (e.g. phthalates and bisphenol A). Early exposure to neurotoxic phthalates, bisphenol A and PAHs has been previously associated with ASD risk, and here we provideevidence for an effect of gene environmental exposure interaction mediated by CYP450 gene variants. J.X. Santos: None. A.R. Marques: None. H. Marti  niano: None. J. Vilela: None. C. Rasga: None. G. Oli  veira: None. A.M. Vicente: None.",2019.0,,J. X. Santos,"1,2, A. R. Marques1,2, H. Martiniano2,","CYP2D6 was exclusively targeted by CNVs in 13 out of 3030 ASD subjects, while CYP4X1 was signi cantly more frequently targeted by CNVs in ASD cases (22/3030; 0.72%) than controls (2/9649; 0.02%).",,ASD cases,[],"['ASD', 'case']"
766,453,C Rare variants targeting genes that encode forcytochrome P450 enzymes in Autism Spectrum Disorder,P09.020,,"J. Vilela1,2, C. Rasga1,2, G. Oliveira3,4,5, A. M. Vicente1,2 1National Health Institute Doutor Ricardo Jorge, Lisbon, Portugal,2BioISI   Biosystems & Integrative Sciences Institute, Faculty of Sciences, University of Lisbon, Lisbon, Portugal,3Unidade de Neurodesenvolvimento e Autismo (UNDA), Servio do Centro de Desenvolvimento da Criana, Centro de Investiga o e Forma o Clnica, Hospital Peditrico, Centro Hospitalar e Universitrio deCoimbra, Coimbra, Portugal, 4Institute for Biomedical Imaging and Life Sciences, Faculty of Medicine, Universidade de Coimbra, Coimbra, Portugal,5University Clinic of Pediatrics, Faculty of Medicine, University of Coimbra, Coimbra, Portugal Autism Spectrum Disorder (ASD) heritability estimates of 50 80% support the hypothesis that gene environment interactions play a role in this pathology. ASD risk hasbeen associated with early exposure to various xenobiotics that are cleared in the liver by Cytochrome P450 enzymes.We therefore explored the hypothesis that variants in CYP450 genes, which de ne the rapid or slow metabolizer status of their carriers, may render individuals exposed to certain toxicants more susceptible to brain disruption during early development. To identify rare variants in 57 CYP450 genes we inspected exome sequence data, from publiclyavailable ASD datasets, for loss of function (LoF) and missense Single Nucleotide Variants (SNVs) predicted to be detrimental by in silico tools (MAF<5%), as well as rare (<1%) Copy Number Variants (CNVs). In 2674 ASD subjects, we found 516 LoF and missense SNVs, targeting 54CYP450 genes, most frequently in CYP2A13 ,CYP1A1 , CYP2D6 and CYP4B1 . Additionally, we identi ed 135 CNVs targeting 24 CYP450 genes in 3030 ASD indivi  duals. CYP2D6 was exclusively targeted by CNVs in 13 out of 3030 ASD subjects, while CYP4X1 was signi cantly more frequently targeted by CNVs in ASD cases (22/3030; 0.72%) than controls (2/9649; 0.02%). CYP2D6 metabo  lizes most psychoactive drugs, while CYP1A1 acts on polycyclic aromatic hydrocarbons (PAHs) and CYP4X1 is involved in the metabolism of endocrine disrupting chemi cals (e.g. phthalates and bisphenol A). Early exposure to neurotoxic phthalates, bisphenol A and PAHs has been previously associated with ASD risk, and here we provideevidence for an effect of gene environmental exposure interaction mediated by CYP450 gene variants. J.X. Santos: None. A.R. Marques: None. H. Marti  niano: None. J. Vilela: None. C. Rasga: None. G. Oli  veira: None. A.M. Vicente: None.",2019.0,,J. X. Santos,"1,2, A. R. Marques1,2, H. Martiniano2,","Early exposure to neurotoxic phthalates, bisphenol A and PAHs has been previously associated with ASD risk, and here we provideevidence for an effect of gene environmental exposure interaction mediated by CYP450 gene variants.",,ASD risk,[],"['ASD', 'risk']"
767,454,D Autism Spectrum Disorder: gene variants involved in the nonsense mediated mRNA decay pathway,P09.021,,"J. Vilela1,2, C. Rasga1,2, G. Oliveira4,5, L. Romo6,2, A. M. Vicente1,2,7 1Departamento de Promo o da Sade e Doenas n o Transmissveis, Instituto Nacional de Sade Doutor Ricardo Jorge, Lisboa, Portugal,2BioISI   Biosystems & Integrative Sciences Institute, Faculdade de Cincias,Universidade de Lisboa, Lisboa, Portugal, 3Departamento de Informtica, Faculdade de Cincias, Universidade de Lisboa, Lisboa, Portugal,4Unidade de Neurodesenvolvimento e Autismo (UNDA), Servio do Centro de Desenvolvimento da Criana, Centro de Investiga o e Forma o Clnica, Hospital Peditrico, Centro Hospitalar e Universitrio de Coimbra, Lisboa, Portugal,5Institute for Biomedical Imaging and Life Sciences, Faculty of Medicine, Universidade de Coimbra,Lisboa, Portugal, 6Departamento de Gentica Humana, Instituto Nacional de Sade Doutor Ricardo Jorge, Lisboa,1420Portugal,7Instituto Gulbenkian de Cincia, Oeiras, Portugal Genetic factors account for 50 80% of the familial risk of Autism Spectrum Disorder (ASD), but most of the genetic determinants are still unknown and a role for otherregulatory mechanisms is likely. The nonsense mediated decay (NMD) pathway is essential to control mRNA quality and has an important role in the regulation of thetranscriptome. Mutations in genes involved in the NMD pathway, such as the UPF3B gene, a core component of this pathway, were previously linked to ASD. In this study weexplored the potential role of other NMD factors in ASD. We generated a list of 153 genes involved in the NMD pathway using AmiGO, Reactome and a systematic litera ture review. To identify potentially pathogenic variants in the NMD genes, we analyzed whole exome sequencing data (WES) data from 1338 ASD subjects. We also searched forCopy Number Variants (CNVs) targeting NMD genes in ASD patients (n ,3570) and checked their frequency in controls (n ,9649). We identi ed 43 high impact variants in 28 NMD genes, including the UPF3B and ACE, two genes previously implicated in ASD. Importantly, 11 were novel candidategenes that carry loss of function and missense (deleterious and damaging) variants with a frequency of 1 to 5% in this ASD dataset. Additionally, 5 NMD genes were found to betargeted by CNVs in 12 ASD subjects but none of the controls. The discovery of 33 NMD genes that are intriguing candidates for ASD in large patient genomic datasets sup  ports the involvement of the NMD pathway in ASD pathophysiology. A.R. Marques: None. H. Martiniano: None. J.X. Santos: None. J. Vilela: None. C. Rasga: None. G. Oli  veira: None. L. Romo: None. A.M. Vicente: None.",2019.0,,A. R. Marques,"1,2, H. Martiniano2,3, J. X. Santos1,2,","To identify potentially pathogenic variants in the NMD genes, we analyzed whole exome sequencing data (WES) data from 1338 ASD subjects.",,ASD subjects,[],"['ASD', 'subject']"
767,454,D Autism Spectrum Disorder: gene variants involved in the nonsense mediated mRNA decay pathway,P09.021,,"J. Vilela1,2, C. Rasga1,2, G. Oliveira4,5, L. Romo6,2, A. M. Vicente1,2,7 1Departamento de Promo o da Sade e Doenas n o Transmissveis, Instituto Nacional de Sade Doutor Ricardo Jorge, Lisboa, Portugal,2BioISI   Biosystems & Integrative Sciences Institute, Faculdade de Cincias,Universidade de Lisboa, Lisboa, Portugal, 3Departamento de Informtica, Faculdade de Cincias, Universidade de Lisboa, Lisboa, Portugal,4Unidade de Neurodesenvolvimento e Autismo (UNDA), Servio do Centro de Desenvolvimento da Criana, Centro de Investiga o e Forma o Clnica, Hospital Peditrico, Centro Hospitalar e Universitrio de Coimbra, Lisboa, Portugal,5Institute for Biomedical Imaging and Life Sciences, Faculty of Medicine, Universidade de Coimbra,Lisboa, Portugal, 6Departamento de Gentica Humana, Instituto Nacional de Sade Doutor Ricardo Jorge, Lisboa,1420Portugal,7Instituto Gulbenkian de Cincia, Oeiras, Portugal Genetic factors account for 50 80% of the familial risk of Autism Spectrum Disorder (ASD), but most of the genetic determinants are still unknown and a role for otherregulatory mechanisms is likely. The nonsense mediated decay (NMD) pathway is essential to control mRNA quality and has an important role in the regulation of thetranscriptome. Mutations in genes involved in the NMD pathway, such as the UPF3B gene, a core component of this pathway, were previously linked to ASD. In this study weexplored the potential role of other NMD factors in ASD. We generated a list of 153 genes involved in the NMD pathway using AmiGO, Reactome and a systematic litera ture review. To identify potentially pathogenic variants in the NMD genes, we analyzed whole exome sequencing data (WES) data from 1338 ASD subjects. We also searched forCopy Number Variants (CNVs) targeting NMD genes in ASD patients (n ,3570) and checked their frequency in controls (n ,9649). We identi ed 43 high impact variants in 28 NMD genes, including the UPF3B and ACE, two genes previously implicated in ASD. Importantly, 11 were novel candidategenes that carry loss of function and missense (deleterious and damaging) variants with a frequency of 1 to 5% in this ASD dataset. Additionally, 5 NMD genes were found to betargeted by CNVs in 12 ASD subjects but none of the controls. The discovery of 33 NMD genes that are intriguing candidates for ASD in large patient genomic datasets sup  ports the involvement of the NMD pathway in ASD pathophysiology. A.R. Marques: None. H. Martiniano: None. J.X. Santos: None. J. Vilela: None. C. Rasga: None. G. Oli  veira: None. L. Romo: None. A.M. Vicente: None.",2019.0,,A. R. Marques,"1,2, H. Martiniano2,3, J. X. Santos1,2,","We also searched forCopy Number Variants (CNVs) targeting NMD genes in ASD patients (n ,3570) and checked their frequency in controls (n ,9649).",,ASD patients,[],"['ASD', 'patient']"
767,454,D Autism Spectrum Disorder: gene variants involved in the nonsense mediated mRNA decay pathway,P09.021,,"J. Vilela1,2, C. Rasga1,2, G. Oliveira4,5, L. Romo6,2, A. M. Vicente1,2,7 1Departamento de Promo o da Sade e Doenas n o Transmissveis, Instituto Nacional de Sade Doutor Ricardo Jorge, Lisboa, Portugal,2BioISI   Biosystems & Integrative Sciences Institute, Faculdade de Cincias,Universidade de Lisboa, Lisboa, Portugal, 3Departamento de Informtica, Faculdade de Cincias, Universidade de Lisboa, Lisboa, Portugal,4Unidade de Neurodesenvolvimento e Autismo (UNDA), Servio do Centro de Desenvolvimento da Criana, Centro de Investiga o e Forma o Clnica, Hospital Peditrico, Centro Hospitalar e Universitrio de Coimbra, Lisboa, Portugal,5Institute for Biomedical Imaging and Life Sciences, Faculty of Medicine, Universidade de Coimbra,Lisboa, Portugal, 6Departamento de Gentica Humana, Instituto Nacional de Sade Doutor Ricardo Jorge, Lisboa,1420Portugal,7Instituto Gulbenkian de Cincia, Oeiras, Portugal Genetic factors account for 50 80% of the familial risk of Autism Spectrum Disorder (ASD), but most of the genetic determinants are still unknown and a role for otherregulatory mechanisms is likely. The nonsense mediated decay (NMD) pathway is essential to control mRNA quality and has an important role in the regulation of thetranscriptome. Mutations in genes involved in the NMD pathway, such as the UPF3B gene, a core component of this pathway, were previously linked to ASD. In this study weexplored the potential role of other NMD factors in ASD. We generated a list of 153 genes involved in the NMD pathway using AmiGO, Reactome and a systematic litera ture review. To identify potentially pathogenic variants in the NMD genes, we analyzed whole exome sequencing data (WES) data from 1338 ASD subjects. We also searched forCopy Number Variants (CNVs) targeting NMD genes in ASD patients (n ,3570) and checked their frequency in controls (n ,9649). We identi ed 43 high impact variants in 28 NMD genes, including the UPF3B and ACE, two genes previously implicated in ASD. Importantly, 11 were novel candidategenes that carry loss of function and missense (deleterious and damaging) variants with a frequency of 1 to 5% in this ASD dataset. Additionally, 5 NMD genes were found to betargeted by CNVs in 12 ASD subjects but none of the controls. The discovery of 33 NMD genes that are intriguing candidates for ASD in large patient genomic datasets sup  ports the involvement of the NMD pathway in ASD pathophysiology. A.R. Marques: None. H. Martiniano: None. J.X. Santos: None. J. Vilela: None. C. Rasga: None. G. Oli  veira: None. L. Romo: None. A.M. Vicente: None.",2019.0,,A. R. Marques,"1,2, H. Martiniano2,3, J. X. Santos1,2,","Importantly, 11 were novel candidategenes that carry loss of function and missense (deleterious and damaging) variants with a frequency of 1 to 5% in this ASD dataset.",,ASD dataset,[],"['ASD', 'dataset']"
767,454,D Autism Spectrum Disorder: gene variants involved in the nonsense mediated mRNA decay pathway,P09.021,,"J. Vilela1,2, C. Rasga1,2, G. Oliveira4,5, L. Romo6,2, A. M. Vicente1,2,7 1Departamento de Promo o da Sade e Doenas n o Transmissveis, Instituto Nacional de Sade Doutor Ricardo Jorge, Lisboa, Portugal,2BioISI   Biosystems & Integrative Sciences Institute, Faculdade de Cincias,Universidade de Lisboa, Lisboa, Portugal, 3Departamento de Informtica, Faculdade de Cincias, Universidade de Lisboa, Lisboa, Portugal,4Unidade de Neurodesenvolvimento e Autismo (UNDA), Servio do Centro de Desenvolvimento da Criana, Centro de Investiga o e Forma o Clnica, Hospital Peditrico, Centro Hospitalar e Universitrio de Coimbra, Lisboa, Portugal,5Institute for Biomedical Imaging and Life Sciences, Faculty of Medicine, Universidade de Coimbra,Lisboa, Portugal, 6Departamento de Gentica Humana, Instituto Nacional de Sade Doutor Ricardo Jorge, Lisboa,1420Portugal,7Instituto Gulbenkian de Cincia, Oeiras, Portugal Genetic factors account for 50 80% of the familial risk of Autism Spectrum Disorder (ASD), but most of the genetic determinants are still unknown and a role for otherregulatory mechanisms is likely. The nonsense mediated decay (NMD) pathway is essential to control mRNA quality and has an important role in the regulation of thetranscriptome. Mutations in genes involved in the NMD pathway, such as the UPF3B gene, a core component of this pathway, were previously linked to ASD. In this study weexplored the potential role of other NMD factors in ASD. We generated a list of 153 genes involved in the NMD pathway using AmiGO, Reactome and a systematic litera ture review. To identify potentially pathogenic variants in the NMD genes, we analyzed whole exome sequencing data (WES) data from 1338 ASD subjects. We also searched forCopy Number Variants (CNVs) targeting NMD genes in ASD patients (n ,3570) and checked their frequency in controls (n ,9649). We identi ed 43 high impact variants in 28 NMD genes, including the UPF3B and ACE, two genes previously implicated in ASD. Importantly, 11 were novel candidategenes that carry loss of function and missense (deleterious and damaging) variants with a frequency of 1 to 5% in this ASD dataset. Additionally, 5 NMD genes were found to betargeted by CNVs in 12 ASD subjects but none of the controls. The discovery of 33 NMD genes that are intriguing candidates for ASD in large patient genomic datasets sup  ports the involvement of the NMD pathway in ASD pathophysiology. A.R. Marques: None. H. Martiniano: None. J.X. Santos: None. J. Vilela: None. C. Rasga: None. G. Oli  veira: None. L. Romo: None. A.M. Vicente: None.",2019.0,,A. R. Marques,"1,2, H. Martiniano2,3, J. X. Santos1,2,","Additionally, 5 NMD genes were found to betargeted by CNVs in 12 ASD subjects but none of the controls.",,ASD subjects,[],"['ASD', 'subject']"
767,454,D Autism Spectrum Disorder: gene variants involved in the nonsense mediated mRNA decay pathway,P09.021,,"J. Vilela1,2, C. Rasga1,2, G. Oliveira4,5, L. Romo6,2, A. M. Vicente1,2,7 1Departamento de Promo o da Sade e Doenas n o Transmissveis, Instituto Nacional de Sade Doutor Ricardo Jorge, Lisboa, Portugal,2BioISI   Biosystems & Integrative Sciences Institute, Faculdade de Cincias,Universidade de Lisboa, Lisboa, Portugal, 3Departamento de Informtica, Faculdade de Cincias, Universidade de Lisboa, Lisboa, Portugal,4Unidade de Neurodesenvolvimento e Autismo (UNDA), Servio do Centro de Desenvolvimento da Criana, Centro de Investiga o e Forma o Clnica, Hospital Peditrico, Centro Hospitalar e Universitrio de Coimbra, Lisboa, Portugal,5Institute for Biomedical Imaging and Life Sciences, Faculty of Medicine, Universidade de Coimbra,Lisboa, Portugal, 6Departamento de Gentica Humana, Instituto Nacional de Sade Doutor Ricardo Jorge, Lisboa,1420Portugal,7Instituto Gulbenkian de Cincia, Oeiras, Portugal Genetic factors account for 50 80% of the familial risk of Autism Spectrum Disorder (ASD), but most of the genetic determinants are still unknown and a role for otherregulatory mechanisms is likely. The nonsense mediated decay (NMD) pathway is essential to control mRNA quality and has an important role in the regulation of thetranscriptome. Mutations in genes involved in the NMD pathway, such as the UPF3B gene, a core component of this pathway, were previously linked to ASD. In this study weexplored the potential role of other NMD factors in ASD. We generated a list of 153 genes involved in the NMD pathway using AmiGO, Reactome and a systematic litera ture review. To identify potentially pathogenic variants in the NMD genes, we analyzed whole exome sequencing data (WES) data from 1338 ASD subjects. We also searched forCopy Number Variants (CNVs) targeting NMD genes in ASD patients (n ,3570) and checked their frequency in controls (n ,9649). We identi ed 43 high impact variants in 28 NMD genes, including the UPF3B and ACE, two genes previously implicated in ASD. Importantly, 11 were novel candidategenes that carry loss of function and missense (deleterious and damaging) variants with a frequency of 1 to 5% in this ASD dataset. Additionally, 5 NMD genes were found to betargeted by CNVs in 12 ASD subjects but none of the controls. The discovery of 33 NMD genes that are intriguing candidates for ASD in large patient genomic datasets sup  ports the involvement of the NMD pathway in ASD pathophysiology. A.R. Marques: None. H. Martiniano: None. J.X. Santos: None. J. Vilela: None. C. Rasga: None. G. Oli  veira: None. L. Romo: None. A.M. Vicente: None.",2019.0,,A. R. Marques,"1,2, H. Martiniano2,3, J. X. Santos1,2,",The discovery of 33 NMD genes that are intriguing candidates for ASD in large patient genomic datasets sup  ports the involvement of the NMD pathway in ASD pathophysiology.,,ASD pathophysiology,[],"['ASD', 'pathophysiology']"
768,455,A Application of oligonucleotide array CGH in 280patients with autism spectrum disorder,P09.022,,"E. Obersztyn1, A. Kutkowska Ka mierczak1, A. Pietrzyk1, N. Braun Walicka1, J. Castaeda1, A. Barczyk1, A. Sobczy ska Tomaszewska2, K. Czerska2, B. Nowakowska1 1Institute of Mother and Child, Warsaw, Poland, 2MEDGEN, Warsaw, Poland Autism Spectrum Disorders (ASD) is a heterogenous group of neurodevelopmental disorders characterized by problems in social interaction and communication as well as thepresence of repetitive and stereotyped behaviour. It is estimated that the prevalence of ASD is 1 2% in general population with the average male to female ratio 4 5:1. Research studies have shown that clinically relevant CNVs (copy number variants) invisible in karyotype analysis are detected in 7 14% of patients with idiopathic ASD. We elected to use oligonucleotide microarrays (OGT) with average resolution of 30 kpz to evaluate its ef cacy for identi cation and characterization of CNVs in a cohort of 275 patients with ASDs. The analyses of the patients  genomes were performed using exon focused, high  resolution (180k) array design covering relevant 227genes for autism research. Chromosomal microarray analysis revealed 71 non  polymorphic CNVs in 63 out of 280 (22.5%) patients withASD. Pathogenic or likely pathogenic CNVs were detected in 24 (8.6%) patients, whereas CNVs with unknown clinical signicance were identi ed in 41 (18.2 %) of cases. All of the identi ed CNVs were submicroscopic in size (between 15 kb and 3.1 Mb) and therefore could not have been detected by standard karyotype analysis. Due to highresolution of the selected microarray, it was possible to identify 24 CNVs that could not have been detected using the clinical microarrays (OGT, 60k). Our study furtherconrmed the potential of aCGH in elucidating the etiology of ASDs, demonstrated by the identi cation of two novel genes: LRRTM4 and DOCK1 as candidate for ASDs. B. Winiowiecka Kowalnik: None. I. Plaskota: None. M. Kdzior: None. E. Obersztyn: None. A. Kutkowska  Kamierczak: None. A. Pietrzyk: None. N. Braun  Walicka: None. J. Castaeda: None. A. Barczyk: None. A. Sobczy ska Tomaszewska: None. K. Czerska: None. B. Nowakowska: None.",2019.0,,B. Wi niowiecka Kowalnik,"1, I. Plaskota1,M .K dzior1,",Research studies have shown that clinically relevant CNVs (copy number variants) invisible in karyotype analysis are detected in 7 14% of patients with idiopathic ASD.,patients with idiopathic ASD,,"['patient', 'with', 'idiopathic', 'ASD']",[]
769,456,C Genetic determinants for social skill training outcomesin autism spectrum disorder,P09.024,,"M. Becker1,2, U. Jonsson1,2,4, N. Choque Olsson1,2,5, S. Blte1,2, K. Tammimies1,2 1Center of Neurodevelopmental Disorders (KIND), Division of Neuropsychiatry, Department of Women and Children's Health, Karolinska Institutet, Stockholm, Sweden,2Child and Adolescent Psychiatry, Center for Psychiatry Research, Stockholm County Council, Stockholm, Sweden, 3Department of Biosciences and Nutrition, Karolinska Institutet, Huddinge, Stockholm, Sweden,4Department of Neuroscience, Child and Adolescent Psychiatry, Uppsala University, Uppsala, Sweden,5Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, SwedenAbstracts from the 52ndEuropean Society of Human Genetics (ESHG). . . 1421Introduction: Social skill group training (SSGT) is one of the most common interventions for children and adolescents with autism spectrum disorder (ASD). Individual responses to SSGT vary and limited clinical predictors exist for the treatment. Material and Methods: Therefore, we performed a detailed genetic characterization using genotyping, CNV calling and exome sequencing of autistic individuals from one of the largest randomized clinical trial for SSGT andanalyzed the association between genetic factors and SSGT treatment outcome. Identi ed rare copy number variations (CNVs) were prioritized and polygenic risk score (PRS)was calculated from ASD, education attainment (EA) and attention de cit hyperactivity disorder (ADHD) based on different p value thresholds (Pt < 0.01, 0.05, 0.1, 0.5, 1). Results: Individuals who carried large CNVs (> 500kb) showed signi cant worse outcome at 12 weeks post  treatment ( ,15.4, p ,0.017) and 3 months follow up (,14.2, p ,0.028). In addition, inferior outcomes were implicated for individuals with higher PRS for ASD (Pt , 0.5:,6.5, p,0.018) and ADHD (Pt 1.0: ,6.7, p, 0.015) at follow up treatment. Currently, we are analyzing exome sequencing data from the same 205 individuals and then combining different rare and common genetic variantdata carriers together. Conclusion: Autistic individuals with higher genetic burden for the disorder, including large rare CNVs andhigher load of PRS, have different bene ts of SSGT com  pared with individuals with lower genetic risk. Our results can aid in personalized intervention modi cations for ASD in the future. D. Li: None. I. Rabkina: None. S. Stamouli: None. H. Jiao: None. M. Becker: None. U. Jonsson: None. N. Choque Olsson: None. S. Blte: Other; Modest; Huber/ Hogrefe. K. Tammimies: None.",2019.0,,D. Li,"1,2, I. Rabkina1,2, S. Stamouli1,2, H. Jiao3,",1421Introduction: Social skill group training (SSGT) is one of the most common interventions for children and adolescents with autism spectrum disorder (ASD).,adolescents with autism,,"['adolescent', 'with', 'autism']",[]
769,456,C Genetic determinants for social skill training outcomesin autism spectrum disorder,P09.024,,"M. Becker1,2, U. Jonsson1,2,4, N. Choque Olsson1,2,5, S. Blte1,2, K. Tammimies1,2 1Center of Neurodevelopmental Disorders (KIND), Division of Neuropsychiatry, Department of Women and Children's Health, Karolinska Institutet, Stockholm, Sweden,2Child and Adolescent Psychiatry, Center for Psychiatry Research, Stockholm County Council, Stockholm, Sweden, 3Department of Biosciences and Nutrition, Karolinska Institutet, Huddinge, Stockholm, Sweden,4Department of Neuroscience, Child and Adolescent Psychiatry, Uppsala University, Uppsala, Sweden,5Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, SwedenAbstracts from the 52ndEuropean Society of Human Genetics (ESHG). . . 1421Introduction: Social skill group training (SSGT) is one of the most common interventions for children and adolescents with autism spectrum disorder (ASD). Individual responses to SSGT vary and limited clinical predictors exist for the treatment. Material and Methods: Therefore, we performed a detailed genetic characterization using genotyping, CNV calling and exome sequencing of autistic individuals from one of the largest randomized clinical trial for SSGT andanalyzed the association between genetic factors and SSGT treatment outcome. Identi ed rare copy number variations (CNVs) were prioritized and polygenic risk score (PRS)was calculated from ASD, education attainment (EA) and attention de cit hyperactivity disorder (ADHD) based on different p value thresholds (Pt < 0.01, 0.05, 0.1, 0.5, 1). Results: Individuals who carried large CNVs (> 500kb) showed signi cant worse outcome at 12 weeks post  treatment ( ,15.4, p ,0.017) and 3 months follow up (,14.2, p ,0.028). In addition, inferior outcomes were implicated for individuals with higher PRS for ASD (Pt , 0.5:,6.5, p,0.018) and ADHD (Pt 1.0: ,6.7, p, 0.015) at follow up treatment. Currently, we are analyzing exome sequencing data from the same 205 individuals and then combining different rare and common genetic variantdata carriers together. Conclusion: Autistic individuals with higher genetic burden for the disorder, including large rare CNVs andhigher load of PRS, have different bene ts of SSGT com  pared with individuals with lower genetic risk. Our results can aid in personalized intervention modi cations for ASD in the future. D. Li: None. I. Rabkina: None. S. Stamouli: None. H. Jiao: None. M. Becker: None. U. Jonsson: None. N. Choque Olsson: None. S. Blte: Other; Modest; Huber/ Hogrefe. K. Tammimies: None.",2019.0,,D. Li,"1,2, I. Rabkina1,2, S. Stamouli1,2, H. Jiao3,","Material and Methods: Therefore, we performed a detailed genetic characterization using genotyping, CNV calling and exome sequencing of autistic individuals from one of the largest randomized clinical trial for SSGT andanalyzed the association between genetic factors and SSGT treatment outcome.",,autistic individuals,[],"['autistic', 'individual']"
769,456,C Genetic determinants for social skill training outcomesin autism spectrum disorder,P09.024,,"M. Becker1,2, U. Jonsson1,2,4, N. Choque Olsson1,2,5, S. Blte1,2, K. Tammimies1,2 1Center of Neurodevelopmental Disorders (KIND), Division of Neuropsychiatry, Department of Women and Children's Health, Karolinska Institutet, Stockholm, Sweden,2Child and Adolescent Psychiatry, Center for Psychiatry Research, Stockholm County Council, Stockholm, Sweden, 3Department of Biosciences and Nutrition, Karolinska Institutet, Huddinge, Stockholm, Sweden,4Department of Neuroscience, Child and Adolescent Psychiatry, Uppsala University, Uppsala, Sweden,5Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, SwedenAbstracts from the 52ndEuropean Society of Human Genetics (ESHG). . . 1421Introduction: Social skill group training (SSGT) is one of the most common interventions for children and adolescents with autism spectrum disorder (ASD). Individual responses to SSGT vary and limited clinical predictors exist for the treatment. Material and Methods: Therefore, we performed a detailed genetic characterization using genotyping, CNV calling and exome sequencing of autistic individuals from one of the largest randomized clinical trial for SSGT andanalyzed the association between genetic factors and SSGT treatment outcome. Identi ed rare copy number variations (CNVs) were prioritized and polygenic risk score (PRS)was calculated from ASD, education attainment (EA) and attention de cit hyperactivity disorder (ADHD) based on different p value thresholds (Pt < 0.01, 0.05, 0.1, 0.5, 1). Results: Individuals who carried large CNVs (> 500kb) showed signi cant worse outcome at 12 weeks post  treatment ( ,15.4, p ,0.017) and 3 months follow up (,14.2, p ,0.028). In addition, inferior outcomes were implicated for individuals with higher PRS for ASD (Pt , 0.5:,6.5, p,0.018) and ADHD (Pt 1.0: ,6.7, p, 0.015) at follow up treatment. Currently, we are analyzing exome sequencing data from the same 205 individuals and then combining different rare and common genetic variantdata carriers together. Conclusion: Autistic individuals with higher genetic burden for the disorder, including large rare CNVs andhigher load of PRS, have different bene ts of SSGT com  pared with individuals with lower genetic risk. Our results can aid in personalized intervention modi cations for ASD in the future. D. Li: None. I. Rabkina: None. S. Stamouli: None. H. Jiao: None. M. Becker: None. U. Jonsson: None. N. Choque Olsson: None. S. Blte: Other; Modest; Huber/ Hogrefe. K. Tammimies: None.",2019.0,,D. Li,"1,2, I. Rabkina1,2, S. Stamouli1,2, H. Jiao3,","Conclusion: Autistic individuals with higher genetic burden for the disorder, including large rare CNVs andhigher load of PRS, have different bene ts of SSGT com  pared with individuals with lower genetic risk.",,Autistic individuals,[],"['Autistic', 'individual']"
770,457,B Evidence for altered calcium signaling and altered mitochondrial function in an autism case study,P09.025,,"Autism spectrum disorder (ASD) is a group of neurodeve  lopmental disorders characterized by de cits in social interaction, communication, and stereotypic behaviors. While its etiology is unknown, the large assemblage ofrisk variants impacting calcium ion channels and signaling proteins suggest that a functional disruption of this signaling hub may be involved in ASD pathogenesis. Inthis study, we evaluate how such risk variants exert their deleterious effects in a unique ASD case.We identi ed this subject in a previous study where we observed signi  cant changes in the single channel inositol triphosphate (IP3) receptor kinetics of ASD broblasts via optical patch clamp and found that this feature could be visualized with a high throughput Fluorometric Imaging Plate Reader (FLIPR) screening assay as a decrease incalcium release from the ER. This release was below the lower limit of controls in >75% of ASD subjects, but uniquely high in an 18 year old autistic female at a level farexceeding the upper limit of controls, nearing levels obtained with ionomycin, an ionophore. To assess the molecular basis of this nding, we com  pleted a transcription analysis to compare expression levels of calcium signaling related genes in broblast derived RNA from this subject to those of two controls and twotypical autism cases. The subject s transcriptome showed increased expression (>5sd) of genes including the ATP2A3 calcium pump and purinergic receptors, and extremely lowexpression (>24sd) of VDAC2, a mitochondrial calcium uptake channel. These ndings corroborate suggestions of mitochondrial dysfunction in her clinical biochemicalassays and are extended with Seahorse XFp assays. R.L. Nguyen: None. P. Flodman: None. M. Smith: None. J.J. Gargus: None.",2019.0,,"R. L. Nguyen, P. Flodman, M. Smith, J. J. Gargus","University of California, Irvine, Irvine, CA, United States","While its etiology is unknown, the large assemblage ofrisk variants impacting calcium ion channels and signaling proteins suggest that a functional disruption of this signaling hub may be involved in ASD pathogenesis.",,ASD pathogenesis,[],"['ASD', 'pathogenesis']"
770,457,B Evidence for altered calcium signaling and altered mitochondrial function in an autism case study,P09.025,,"Autism spectrum disorder (ASD) is a group of neurodeve  lopmental disorders characterized by de cits in social interaction, communication, and stereotypic behaviors. While its etiology is unknown, the large assemblage ofrisk variants impacting calcium ion channels and signaling proteins suggest that a functional disruption of this signaling hub may be involved in ASD pathogenesis. Inthis study, we evaluate how such risk variants exert their deleterious effects in a unique ASD case.We identi ed this subject in a previous study where we observed signi  cant changes in the single channel inositol triphosphate (IP3) receptor kinetics of ASD broblasts via optical patch clamp and found that this feature could be visualized with a high throughput Fluorometric Imaging Plate Reader (FLIPR) screening assay as a decrease incalcium release from the ER. This release was below the lower limit of controls in >75% of ASD subjects, but uniquely high in an 18 year old autistic female at a level farexceeding the upper limit of controls, nearing levels obtained with ionomycin, an ionophore. To assess the molecular basis of this nding, we com  pleted a transcription analysis to compare expression levels of calcium signaling related genes in broblast derived RNA from this subject to those of two controls and twotypical autism cases. The subject s transcriptome showed increased expression (>5sd) of genes including the ATP2A3 calcium pump and purinergic receptors, and extremely lowexpression (>24sd) of VDAC2, a mitochondrial calcium uptake channel. These ndings corroborate suggestions of mitochondrial dysfunction in her clinical biochemicalassays and are extended with Seahorse XFp assays. R.L. Nguyen: None. P. Flodman: None. M. Smith: None. J.J. Gargus: None.",2019.0,,"R. L. Nguyen, P. Flodman, M. Smith, J. J. Gargus","University of California, Irvine, Irvine, CA, United States","Inthis study, we evaluate how such risk variants exert their deleterious effects in a unique ASD case.We identi ed this subject in a previous study where we observed signi  cant changes in the single channel inositol triphosphate (IP3) receptor kinetics of ASD broblasts via optical patch clamp and found that this feature could be visualized with a high throughput Fluorometric Imaging Plate Reader (FLIPR) screening assay as a decrease incalcium release from the ER.",,ASD case,[],"['ASD', 'case']"
770,457,B Evidence for altered calcium signaling and altered mitochondrial function in an autism case study,P09.025,,"Autism spectrum disorder (ASD) is a group of neurodeve  lopmental disorders characterized by de cits in social interaction, communication, and stereotypic behaviors. While its etiology is unknown, the large assemblage ofrisk variants impacting calcium ion channels and signaling proteins suggest that a functional disruption of this signaling hub may be involved in ASD pathogenesis. Inthis study, we evaluate how such risk variants exert their deleterious effects in a unique ASD case.We identi ed this subject in a previous study where we observed signi  cant changes in the single channel inositol triphosphate (IP3) receptor kinetics of ASD broblasts via optical patch clamp and found that this feature could be visualized with a high throughput Fluorometric Imaging Plate Reader (FLIPR) screening assay as a decrease incalcium release from the ER. This release was below the lower limit of controls in >75% of ASD subjects, but uniquely high in an 18 year old autistic female at a level farexceeding the upper limit of controls, nearing levels obtained with ionomycin, an ionophore. To assess the molecular basis of this nding, we com  pleted a transcription analysis to compare expression levels of calcium signaling related genes in broblast derived RNA from this subject to those of two controls and twotypical autism cases. The subject s transcriptome showed increased expression (>5sd) of genes including the ATP2A3 calcium pump and purinergic receptors, and extremely lowexpression (>24sd) of VDAC2, a mitochondrial calcium uptake channel. These ndings corroborate suggestions of mitochondrial dysfunction in her clinical biochemicalassays and are extended with Seahorse XFp assays. R.L. Nguyen: None. P. Flodman: None. M. Smith: None. J.J. Gargus: None.",2019.0,,"R. L. Nguyen, P. Flodman, M. Smith, J. J. Gargus","University of California, Irvine, Irvine, CA, United States","Inthis study, we evaluate how such risk variants exert their deleterious effects in a unique ASD case.We identi ed this subject in a previous study where we observed signi  cant changes in the single channel inositol triphosphate (IP3) receptor kinetics of ASD broblasts via optical patch clamp and found that this feature could be visualized with a high throughput Fluorometric Imaging Plate Reader (FLIPR) screening assay as a decrease incalcium release from the ER.",,ASD broblasts,[],"['ASD', '\x81broblasts']"
770,457,B Evidence for altered calcium signaling and altered mitochondrial function in an autism case study,P09.025,,"Autism spectrum disorder (ASD) is a group of neurodeve  lopmental disorders characterized by de cits in social interaction, communication, and stereotypic behaviors. While its etiology is unknown, the large assemblage ofrisk variants impacting calcium ion channels and signaling proteins suggest that a functional disruption of this signaling hub may be involved in ASD pathogenesis. Inthis study, we evaluate how such risk variants exert their deleterious effects in a unique ASD case.We identi ed this subject in a previous study where we observed signi  cant changes in the single channel inositol triphosphate (IP3) receptor kinetics of ASD broblasts via optical patch clamp and found that this feature could be visualized with a high throughput Fluorometric Imaging Plate Reader (FLIPR) screening assay as a decrease incalcium release from the ER. This release was below the lower limit of controls in >75% of ASD subjects, but uniquely high in an 18 year old autistic female at a level farexceeding the upper limit of controls, nearing levels obtained with ionomycin, an ionophore. To assess the molecular basis of this nding, we com  pleted a transcription analysis to compare expression levels of calcium signaling related genes in broblast derived RNA from this subject to those of two controls and twotypical autism cases. The subject s transcriptome showed increased expression (>5sd) of genes including the ATP2A3 calcium pump and purinergic receptors, and extremely lowexpression (>24sd) of VDAC2, a mitochondrial calcium uptake channel. These ndings corroborate suggestions of mitochondrial dysfunction in her clinical biochemicalassays and are extended with Seahorse XFp assays. R.L. Nguyen: None. P. Flodman: None. M. Smith: None. J.J. Gargus: None.",2019.0,,"R. L. Nguyen, P. Flodman, M. Smith, J. J. Gargus","University of California, Irvine, Irvine, CA, United States","This release was below the lower limit of controls in >75% of ASD subjects, but uniquely high in an 18 year old autistic female at a level farexceeding the upper limit of controls, nearing levels obtained with ionomycin, an ionophore.",,ASD subjects,[],"['ASD', 'subject']"
770,457,B Evidence for altered calcium signaling and altered mitochondrial function in an autism case study,P09.025,,"Autism spectrum disorder (ASD) is a group of neurodeve  lopmental disorders characterized by de cits in social interaction, communication, and stereotypic behaviors. While its etiology is unknown, the large assemblage ofrisk variants impacting calcium ion channels and signaling proteins suggest that a functional disruption of this signaling hub may be involved in ASD pathogenesis. Inthis study, we evaluate how such risk variants exert their deleterious effects in a unique ASD case.We identi ed this subject in a previous study where we observed signi  cant changes in the single channel inositol triphosphate (IP3) receptor kinetics of ASD broblasts via optical patch clamp and found that this feature could be visualized with a high throughput Fluorometric Imaging Plate Reader (FLIPR) screening assay as a decrease incalcium release from the ER. This release was below the lower limit of controls in >75% of ASD subjects, but uniquely high in an 18 year old autistic female at a level farexceeding the upper limit of controls, nearing levels obtained with ionomycin, an ionophore. To assess the molecular basis of this nding, we com  pleted a transcription analysis to compare expression levels of calcium signaling related genes in broblast derived RNA from this subject to those of two controls and twotypical autism cases. The subject s transcriptome showed increased expression (>5sd) of genes including the ATP2A3 calcium pump and purinergic receptors, and extremely lowexpression (>24sd) of VDAC2, a mitochondrial calcium uptake channel. These ndings corroborate suggestions of mitochondrial dysfunction in her clinical biochemicalassays and are extended with Seahorse XFp assays. R.L. Nguyen: None. P. Flodman: None. M. Smith: None. J.J. Gargus: None.",2019.0,,"R. L. Nguyen, P. Flodman, M. Smith, J. J. Gargus","University of California, Irvine, Irvine, CA, United States","This release was below the lower limit of controls in >75% of ASD subjects, but uniquely high in an 18 year old autistic female at a level farexceeding the upper limit of controls, nearing levels obtained with ionomycin, an ionophore.",,autistic female,[],"['autistic', 'female']"
771,458,A Establishing genotype phenotype associations for ASD,P09.026,,"Genotypic and phenotypic heterogeneity of Autism Spec  trum Disorder (ASD) has hindered the establishment of genotype phenotype associations. Herein, we presented a novel approach that integrates semantic similarity andunsupervised machine learning methods to dissect the ASD genotypic heterogeneity and to identify phenotypic mani  festations of ASD genetic variants. This approach wasapplied to copy number variants (N ,6650), disrupting 3998 genes from 1119 ASD patients. Functional similarities among genes were computed using Resnik semanticsimilarity measure. Semantic similarity score, ranging from 0 to 1 represents the functional similarity between two genes, where 1 represents identical genes while score 0reects functionally dissimilar genes. Agglomerative hier  archical clustering of the computed gene similarity matrix identi ed four different clusters of functionally related genes. Silhouette analysis indicated that clusters were compact and consistent (average Silhouette value ,0.31). The genes (N ,519) of cluster 1 was more relevant to ASD as they were enriched for Cell adhesion molecules (CAMs) (adjusted p value ,0.00001) and Axon guidance (adjusted1422p value ,0.02) pathways, which are known to be strongly associated with ASD. Cluster 1 genes were also most signicantly enriched for Schizophrenia Human Phenotype Ontology (HPO) term, which is a co occurring condition with ASD. The other three clusters were not enriched for ASD related HPO terms. The results indicated thatphenotypic genotypic associations can established for ASD by reducing its genotypic heterogeneity i.e. clustering of functionally similar genes. However, to associate theseclusters with phenotype, further efforts are required to enrich HPO resource. (Grant reference: PTDC/CCI BIO/ 28685/2017) A.C.G. Ilhu: None. M. Asif: None. F.M. Couto: None.",2019.0,,"A. C. G. Ilhu, M. Asif, F. M. Couto","LASIGE, Lisbon, Portugal","Herein, we presented a novel approach that integrates semantic similarity andunsupervised machine learning methods to dissect the ASD genotypic heterogeneity and to identify phenotypic mani  festations of ASD genetic variants.",,ASD genotypic heterogeneity,[],"['ASD', 'genotypic', 'heterogeneity']"
771,458,A Establishing genotype phenotype associations for ASD,P09.026,,"Genotypic and phenotypic heterogeneity of Autism Spec  trum Disorder (ASD) has hindered the establishment of genotype phenotype associations. Herein, we presented a novel approach that integrates semantic similarity andunsupervised machine learning methods to dissect the ASD genotypic heterogeneity and to identify phenotypic mani  festations of ASD genetic variants. This approach wasapplied to copy number variants (N ,6650), disrupting 3998 genes from 1119 ASD patients. Functional similarities among genes were computed using Resnik semanticsimilarity measure. Semantic similarity score, ranging from 0 to 1 represents the functional similarity between two genes, where 1 represents identical genes while score 0reects functionally dissimilar genes. Agglomerative hier  archical clustering of the computed gene similarity matrix identi ed four different clusters of functionally related genes. Silhouette analysis indicated that clusters were compact and consistent (average Silhouette value ,0.31). The genes (N ,519) of cluster 1 was more relevant to ASD as they were enriched for Cell adhesion molecules (CAMs) (adjusted p value ,0.00001) and Axon guidance (adjusted1422p value ,0.02) pathways, which are known to be strongly associated with ASD. Cluster 1 genes were also most signicantly enriched for Schizophrenia Human Phenotype Ontology (HPO) term, which is a co occurring condition with ASD. The other three clusters were not enriched for ASD related HPO terms. The results indicated thatphenotypic genotypic associations can established for ASD by reducing its genotypic heterogeneity i.e. clustering of functionally similar genes. However, to associate theseclusters with phenotype, further efforts are required to enrich HPO resource. (Grant reference: PTDC/CCI BIO/ 28685/2017) A.C.G. Ilhu: None. M. Asif: None. F.M. Couto: None.",2019.0,,"A. C. G. Ilhu, M. Asif, F. M. Couto","LASIGE, Lisbon, Portugal","Herein, we presented a novel approach that integrates semantic similarity andunsupervised machine learning methods to dissect the ASD genotypic heterogeneity and to identify phenotypic mani  festations of ASD genetic variants.",,ASD genetic variants,[],"['ASD', 'genetic', 'variant']"
771,458,A Establishing genotype phenotype associations for ASD,P09.026,,"Genotypic and phenotypic heterogeneity of Autism Spec  trum Disorder (ASD) has hindered the establishment of genotype phenotype associations. Herein, we presented a novel approach that integrates semantic similarity andunsupervised machine learning methods to dissect the ASD genotypic heterogeneity and to identify phenotypic mani  festations of ASD genetic variants. This approach wasapplied to copy number variants (N ,6650), disrupting 3998 genes from 1119 ASD patients. Functional similarities among genes were computed using Resnik semanticsimilarity measure. Semantic similarity score, ranging from 0 to 1 represents the functional similarity between two genes, where 1 represents identical genes while score 0reects functionally dissimilar genes. Agglomerative hier  archical clustering of the computed gene similarity matrix identi ed four different clusters of functionally related genes. Silhouette analysis indicated that clusters were compact and consistent (average Silhouette value ,0.31). The genes (N ,519) of cluster 1 was more relevant to ASD as they were enriched for Cell adhesion molecules (CAMs) (adjusted p value ,0.00001) and Axon guidance (adjusted1422p value ,0.02) pathways, which are known to be strongly associated with ASD. Cluster 1 genes were also most signicantly enriched for Schizophrenia Human Phenotype Ontology (HPO) term, which is a co occurring condition with ASD. The other three clusters were not enriched for ASD related HPO terms. The results indicated thatphenotypic genotypic associations can established for ASD by reducing its genotypic heterogeneity i.e. clustering of functionally similar genes. However, to associate theseclusters with phenotype, further efforts are required to enrich HPO resource. (Grant reference: PTDC/CCI BIO/ 28685/2017) A.C.G. Ilhu: None. M. Asif: None. F.M. Couto: None.",2019.0,,"A. C. G. Ilhu, M. Asif, F. M. Couto","LASIGE, Lisbon, Portugal","This approach wasapplied to copy number variants (N ,6650), disrupting 3998 genes from 1119 ASD patients.",,ASD patients,[],"['ASD', 'patient']"
771,458,A Establishing genotype phenotype associations for ASD,P09.026,,"Genotypic and phenotypic heterogeneity of Autism Spec  trum Disorder (ASD) has hindered the establishment of genotype phenotype associations. Herein, we presented a novel approach that integrates semantic similarity andunsupervised machine learning methods to dissect the ASD genotypic heterogeneity and to identify phenotypic mani  festations of ASD genetic variants. This approach wasapplied to copy number variants (N ,6650), disrupting 3998 genes from 1119 ASD patients. Functional similarities among genes were computed using Resnik semanticsimilarity measure. Semantic similarity score, ranging from 0 to 1 represents the functional similarity between two genes, where 1 represents identical genes while score 0reects functionally dissimilar genes. Agglomerative hier  archical clustering of the computed gene similarity matrix identi ed four different clusters of functionally related genes. Silhouette analysis indicated that clusters were compact and consistent (average Silhouette value ,0.31). The genes (N ,519) of cluster 1 was more relevant to ASD as they were enriched for Cell adhesion molecules (CAMs) (adjusted p value ,0.00001) and Axon guidance (adjusted1422p value ,0.02) pathways, which are known to be strongly associated with ASD. Cluster 1 genes were also most signicantly enriched for Schizophrenia Human Phenotype Ontology (HPO) term, which is a co occurring condition with ASD. The other three clusters were not enriched for ASD related HPO terms. The results indicated thatphenotypic genotypic associations can established for ASD by reducing its genotypic heterogeneity i.e. clustering of functionally similar genes. However, to associate theseclusters with phenotype, further efforts are required to enrich HPO resource. (Grant reference: PTDC/CCI BIO/ 28685/2017) A.C.G. Ilhu: None. M. Asif: None. F.M. Couto: None.",2019.0,,"A. C. G. Ilhu, M. Asif, F. M. Couto","LASIGE, Lisbon, Portugal","Cluster 1 genes were also most signicantly enriched for Schizophrenia Human Phenotype Ontology (HPO) term, which is a co occurring condition with ASD.",condition with ASD,,"['condition', 'with', 'ASD']",[]
772,459,B Resolving effects of CASK mutations in children with neurodevelopmental disorders,P09.027,,"I. Rabkina1, L. Ballenberger1, M. Kele3, C. Willfors1, E. Herlenius2, S. Blte1, B. M. Anderlid4, A. Falk3, K. Tammimies1 1Center of Neurodevelopmental Disorders (KIND), Department of Women's and Children's Health, Karolinska Institutet, Solna, Sweden,2Department of Women s and Children s Health, Karolinska Institutet, Solna, Sweden, 3Department of Neuroscience, Karolinska Institutet, Solna, Sweden,4Department of Molecular Medicine and Surgery, Solna, Sweden Introduction: Mutations in the CASK gene cause a range of childhood neurodevelopmental disorders such as micro cephaly with pontine and cerebellar hypoplasia (MICPCH), epilepsy, developmental delay and autism. CASK , located on Xp11.4, plays a role in neuronal differentiation andsynapse function. The molecular consequences of CASK mutations have not been studied in human neurons. Our project aims to elucidate the downstream effects of differentCASK mutations using patient derived induced pluripotent stem cells (iPSCs). Materials and Methods: Skin cells from two patients, one female with severe MICPCH and one male with autism, with different CASK mutations were programmed to iPSCs and further differentiated to functional neurons. Bulk andsingle cell RNA sequencing was performed to identify molecular phenotypes and guide morphological and func  tional assessment of neuronal pathology in comparison withcontrol iPSCs. Results: A splice site mutation in the ASD patient decreases wild type CASK mRNA and a tandem duplica tion of two CASK exons is expressed in the MICPCH patient. The mutations reduce CASK protein levels indifferentiating neurons. Transcriptome analysis revealed dysregulation of genes involved in the synaptic vesicle cycle and single cell RNA sequencing indicated an imbal  ance in excitatory inhibitory neuronal populations. Conse  quently, we study synapse morphology and spontaneous ring rates of excitatory and inhibitory neurons. Moreover, we observed neuron subtype speci c upregulation of WNT signaling pathway components. Conclusions: We provide strong evidence that CASK mutations lead to perturbed neurotransmission through dysregulation of synapse vesicle traf cking and differential distribution of neuronal populations. Our results can guidedrug development and aid in understanding the pathological spectrum of CASK mutations. M. Becker: None. F. Mastropasqua: None. J.P. Reis  ing: None. I. Rabkina: None. L. Ballenberger: None. M. Kele: None. C. Willfors: None. E. Herlenius: None. S. Blte: None. B.M. Anderlid: None. A. Falk: None. K. Tammimies: None.",2019.0,,M. Becker,"1, F. Mastropasqua1, J. P. Reising2,","Materials and Methods: Skin cells from two patients, one female with severe MICPCH and one male with autism, with different CASK mutations were programmed to iPSCs and further differentiated to functional neurons.",male with autism,,"['male', 'with', 'autism']",[]
772,459,B Resolving effects of CASK mutations in children with neurodevelopmental disorders,P09.027,,"I. Rabkina1, L. Ballenberger1, M. Kele3, C. Willfors1, E. Herlenius2, S. Blte1, B. M. Anderlid4, A. Falk3, K. Tammimies1 1Center of Neurodevelopmental Disorders (KIND), Department of Women's and Children's Health, Karolinska Institutet, Solna, Sweden,2Department of Women s and Children s Health, Karolinska Institutet, Solna, Sweden, 3Department of Neuroscience, Karolinska Institutet, Solna, Sweden,4Department of Molecular Medicine and Surgery, Solna, Sweden Introduction: Mutations in the CASK gene cause a range of childhood neurodevelopmental disorders such as micro cephaly with pontine and cerebellar hypoplasia (MICPCH), epilepsy, developmental delay and autism. CASK , located on Xp11.4, plays a role in neuronal differentiation andsynapse function. The molecular consequences of CASK mutations have not been studied in human neurons. Our project aims to elucidate the downstream effects of differentCASK mutations using patient derived induced pluripotent stem cells (iPSCs). Materials and Methods: Skin cells from two patients, one female with severe MICPCH and one male with autism, with different CASK mutations were programmed to iPSCs and further differentiated to functional neurons. Bulk andsingle cell RNA sequencing was performed to identify molecular phenotypes and guide morphological and func  tional assessment of neuronal pathology in comparison withcontrol iPSCs. Results: A splice site mutation in the ASD patient decreases wild type CASK mRNA and a tandem duplica tion of two CASK exons is expressed in the MICPCH patient. The mutations reduce CASK protein levels indifferentiating neurons. Transcriptome analysis revealed dysregulation of genes involved in the synaptic vesicle cycle and single cell RNA sequencing indicated an imbal  ance in excitatory inhibitory neuronal populations. Conse  quently, we study synapse morphology and spontaneous ring rates of excitatory and inhibitory neurons. Moreover, we observed neuron subtype speci c upregulation of WNT signaling pathway components. Conclusions: We provide strong evidence that CASK mutations lead to perturbed neurotransmission through dysregulation of synapse vesicle traf cking and differential distribution of neuronal populations. Our results can guidedrug development and aid in understanding the pathological spectrum of CASK mutations. M. Becker: None. F. Mastropasqua: None. J.P. Reis  ing: None. I. Rabkina: None. L. Ballenberger: None. M. Kele: None. C. Willfors: None. E. Herlenius: None. S. Blte: None. B.M. Anderlid: None. A. Falk: None. K. Tammimies: None.",2019.0,,M. Becker,"1, F. Mastropasqua1, J. P. Reising2,",Results: A splice site mutation in the ASD patient decreases wild type CASK mRNA and a tandem duplica tion of two CASK exons is expressed in the MICPCH patient.,,ASD patient,[],"['ASD', 'patient']"
773,460,D Implicating genetic risk variants for circadian rhythm and sleep trait dif culties in individuals with autism spectrum disorder,P09.029,,"Laporte1, O. Diallo1, B. Chaumette2,5,6, S. Jacquemont3,4, M. Elsabbagh1,2,P .A .D i o n1,2, G. A. Rouleau1,2 1McGill University, Montreal, QC, Canada,2Montreal Neurological Institute and Hospital, Montreal, QC, Canada,3CHU Sainte Justine, Montreal, QC, Canada, 4Universit de Montral, Montreal, QC, Canada, 5Universit Paris Descartes; Bio Sorbonne Paris Cit; INSERM, Laboratoire de Physiopathologie des Maladies Psychiatriques, Centre de Psychiatrie et Neurosciences,UMR 894, GDR3557 Institut de Psychiatrie, Paris, France, 6Centre Hospitalier Sainte Anne, Service hospitalo  universitaire, GHU Paris Psychiatrie et Neurosciences,Paris, France Introduction: Autism spectrum disorder (ASD) is a largely hereditary neurodevelopmental disorder characterized by difculties in social interaction and communication, and restricted and repetitive behaviour. Sleep is disturbed in upto 80% of affected youths with ASD. Genes underlying the circadian rhythm are proposed to elucidate sleep and other timing problems in individuals with ASD. Our rst aim investigates whether copy number variants (CNVs) encom  passing core circadian clock genes, circadian pathway genes, and sleep trait candidate genes, detected fromprevious large genome wide association studies, areAbstracts from the 52ndEuropean Society of Human Genetics (ESHG). . . 1423signicantly overrepresented in ASD individuals compared to their unaffected siblings. Material and Methods: We used microarray data from probands with ASD (n ,2926) and their unaffected siblings (n,2434) from the Simons Simplex Collection (SSC). CNVs were called, validated, and subsequently ltered using established pipelines and detection algorithms (PennCNV, QuantiSNP, SnipPeep). Results: Fisher s exact test reveal that CNVs encom  passed in core circadian clock genes, circadian pathway genes, and sleep trait candidate genes are signi cantly overrepresented in probands with ASD in comparison totheir unaffected siblings (p ,0.003; Odds ratio 1.6; CI95% [1.2 ; 2.3]). Conclusions: These preliminary results are the rst to implicate a broad network of sleep related genes in the etiology of ASD. Using whole exome sequencing (WES) data from the SSC, future investigations will evaluate therepresentation of probands SNPs within sleep related genes in comparison to their unaffected siblings. Furthermore, SNP set Kernel Association Test (SKAT) using probands  WES and corresponding phenotypic sleep observations will identify candidate SNPs that associate signi cantly with disturbed sleep traits in individuals with ASD. Z. Schmilovich: None. R. Tesfaye: None. G. Huguet: None. A. Dionne Laporte: None. O. Diallo: None. B. Chaumette: None. S. Jacquemont: None. M. Elsabbagh: None. P.A. Dion: None. G.A. Rouleau: None.",2019.0,,Z. Schmilovich,"1,2, R. Tesfaye1,2, G. Huguet3,4, A. Dionne",Sleep is disturbed in upto 80% of affected youths with ASD.,youths with ASD,,"['youth', 'with', 'ASD']",[]
773,460,D Implicating genetic risk variants for circadian rhythm and sleep trait dif culties in individuals with autism spectrum disorder,P09.029,,"Laporte1, O. Diallo1, B. Chaumette2,5,6, S. Jacquemont3,4, M. Elsabbagh1,2,P .A .D i o n1,2, G. A. Rouleau1,2 1McGill University, Montreal, QC, Canada,2Montreal Neurological Institute and Hospital, Montreal, QC, Canada,3CHU Sainte Justine, Montreal, QC, Canada, 4Universit de Montral, Montreal, QC, Canada, 5Universit Paris Descartes; Bio Sorbonne Paris Cit; INSERM, Laboratoire de Physiopathologie des Maladies Psychiatriques, Centre de Psychiatrie et Neurosciences,UMR 894, GDR3557 Institut de Psychiatrie, Paris, France, 6Centre Hospitalier Sainte Anne, Service hospitalo  universitaire, GHU Paris Psychiatrie et Neurosciences,Paris, France Introduction: Autism spectrum disorder (ASD) is a largely hereditary neurodevelopmental disorder characterized by difculties in social interaction and communication, and restricted and repetitive behaviour. Sleep is disturbed in upto 80% of affected youths with ASD. Genes underlying the circadian rhythm are proposed to elucidate sleep and other timing problems in individuals with ASD. Our rst aim investigates whether copy number variants (CNVs) encom  passing core circadian clock genes, circadian pathway genes, and sleep trait candidate genes, detected fromprevious large genome wide association studies, areAbstracts from the 52ndEuropean Society of Human Genetics (ESHG). . . 1423signicantly overrepresented in ASD individuals compared to their unaffected siblings. Material and Methods: We used microarray data from probands with ASD (n ,2926) and their unaffected siblings (n,2434) from the Simons Simplex Collection (SSC). CNVs were called, validated, and subsequently ltered using established pipelines and detection algorithms (PennCNV, QuantiSNP, SnipPeep). Results: Fisher s exact test reveal that CNVs encom  passed in core circadian clock genes, circadian pathway genes, and sleep trait candidate genes are signi cantly overrepresented in probands with ASD in comparison totheir unaffected siblings (p ,0.003; Odds ratio 1.6; CI95% [1.2 ; 2.3]). Conclusions: These preliminary results are the rst to implicate a broad network of sleep related genes in the etiology of ASD. Using whole exome sequencing (WES) data from the SSC, future investigations will evaluate therepresentation of probands SNPs within sleep related genes in comparison to their unaffected siblings. Furthermore, SNP set Kernel Association Test (SKAT) using probands  WES and corresponding phenotypic sleep observations will identify candidate SNPs that associate signi cantly with disturbed sleep traits in individuals with ASD. Z. Schmilovich: None. R. Tesfaye: None. G. Huguet: None. A. Dionne Laporte: None. O. Diallo: None. B. Chaumette: None. S. Jacquemont: None. M. Elsabbagh: None. P.A. Dion: None. G.A. Rouleau: None.",2019.0,,Z. Schmilovich,"1,2, R. Tesfaye1,2, G. Huguet3,4, A. Dionne",Genes underlying the circadian rhythm are proposed to elucidate sleep and other timing problems in individuals with ASD.,individuals with ASD,,"['individual', 'with', 'ASD']",[]
773,460,D Implicating genetic risk variants for circadian rhythm and sleep trait dif culties in individuals with autism spectrum disorder,P09.029,,"Laporte1, O. Diallo1, B. Chaumette2,5,6, S. Jacquemont3,4, M. Elsabbagh1,2,P .A .D i o n1,2, G. A. Rouleau1,2 1McGill University, Montreal, QC, Canada,2Montreal Neurological Institute and Hospital, Montreal, QC, Canada,3CHU Sainte Justine, Montreal, QC, Canada, 4Universit de Montral, Montreal, QC, Canada, 5Universit Paris Descartes; Bio Sorbonne Paris Cit; INSERM, Laboratoire de Physiopathologie des Maladies Psychiatriques, Centre de Psychiatrie et Neurosciences,UMR 894, GDR3557 Institut de Psychiatrie, Paris, France, 6Centre Hospitalier Sainte Anne, Service hospitalo  universitaire, GHU Paris Psychiatrie et Neurosciences,Paris, France Introduction: Autism spectrum disorder (ASD) is a largely hereditary neurodevelopmental disorder characterized by difculties in social interaction and communication, and restricted and repetitive behaviour. Sleep is disturbed in upto 80% of affected youths with ASD. Genes underlying the circadian rhythm are proposed to elucidate sleep and other timing problems in individuals with ASD. Our rst aim investigates whether copy number variants (CNVs) encom  passing core circadian clock genes, circadian pathway genes, and sleep trait candidate genes, detected fromprevious large genome wide association studies, areAbstracts from the 52ndEuropean Society of Human Genetics (ESHG). . . 1423signicantly overrepresented in ASD individuals compared to their unaffected siblings. Material and Methods: We used microarray data from probands with ASD (n ,2926) and their unaffected siblings (n,2434) from the Simons Simplex Collection (SSC). CNVs were called, validated, and subsequently ltered using established pipelines and detection algorithms (PennCNV, QuantiSNP, SnipPeep). Results: Fisher s exact test reveal that CNVs encom  passed in core circadian clock genes, circadian pathway genes, and sleep trait candidate genes are signi cantly overrepresented in probands with ASD in comparison totheir unaffected siblings (p ,0.003; Odds ratio 1.6; CI95% [1.2 ; 2.3]). Conclusions: These preliminary results are the rst to implicate a broad network of sleep related genes in the etiology of ASD. Using whole exome sequencing (WES) data from the SSC, future investigations will evaluate therepresentation of probands SNPs within sleep related genes in comparison to their unaffected siblings. Furthermore, SNP set Kernel Association Test (SKAT) using probands  WES and corresponding phenotypic sleep observations will identify candidate SNPs that associate signi cantly with disturbed sleep traits in individuals with ASD. Z. Schmilovich: None. R. Tesfaye: None. G. Huguet: None. A. Dionne Laporte: None. O. Diallo: None. B. Chaumette: None. S. Jacquemont: None. M. Elsabbagh: None. P.A. Dion: None. G.A. Rouleau: None.",2019.0,,Z. Schmilovich,"1,2, R. Tesfaye1,2, G. Huguet3,4, A. Dionne",1423signicantly overrepresented in ASD individuals compared to their unaffected siblings.,,ASD individuals,[],"['ASD', 'individual']"
773,460,D Implicating genetic risk variants for circadian rhythm and sleep trait dif culties in individuals with autism spectrum disorder,P09.029,,"Laporte1, O. Diallo1, B. Chaumette2,5,6, S. Jacquemont3,4, M. Elsabbagh1,2,P .A .D i o n1,2, G. A. Rouleau1,2 1McGill University, Montreal, QC, Canada,2Montreal Neurological Institute and Hospital, Montreal, QC, Canada,3CHU Sainte Justine, Montreal, QC, Canada, 4Universit de Montral, Montreal, QC, Canada, 5Universit Paris Descartes; Bio Sorbonne Paris Cit; INSERM, Laboratoire de Physiopathologie des Maladies Psychiatriques, Centre de Psychiatrie et Neurosciences,UMR 894, GDR3557 Institut de Psychiatrie, Paris, France, 6Centre Hospitalier Sainte Anne, Service hospitalo  universitaire, GHU Paris Psychiatrie et Neurosciences,Paris, France Introduction: Autism spectrum disorder (ASD) is a largely hereditary neurodevelopmental disorder characterized by difculties in social interaction and communication, and restricted and repetitive behaviour. Sleep is disturbed in upto 80% of affected youths with ASD. Genes underlying the circadian rhythm are proposed to elucidate sleep and other timing problems in individuals with ASD. Our rst aim investigates whether copy number variants (CNVs) encom  passing core circadian clock genes, circadian pathway genes, and sleep trait candidate genes, detected fromprevious large genome wide association studies, areAbstracts from the 52ndEuropean Society of Human Genetics (ESHG). . . 1423signicantly overrepresented in ASD individuals compared to their unaffected siblings. Material and Methods: We used microarray data from probands with ASD (n ,2926) and their unaffected siblings (n,2434) from the Simons Simplex Collection (SSC). CNVs were called, validated, and subsequently ltered using established pipelines and detection algorithms (PennCNV, QuantiSNP, SnipPeep). Results: Fisher s exact test reveal that CNVs encom  passed in core circadian clock genes, circadian pathway genes, and sleep trait candidate genes are signi cantly overrepresented in probands with ASD in comparison totheir unaffected siblings (p ,0.003; Odds ratio 1.6; CI95% [1.2 ; 2.3]). Conclusions: These preliminary results are the rst to implicate a broad network of sleep related genes in the etiology of ASD. Using whole exome sequencing (WES) data from the SSC, future investigations will evaluate therepresentation of probands SNPs within sleep related genes in comparison to their unaffected siblings. Furthermore, SNP set Kernel Association Test (SKAT) using probands  WES and corresponding phenotypic sleep observations will identify candidate SNPs that associate signi cantly with disturbed sleep traits in individuals with ASD. Z. Schmilovich: None. R. Tesfaye: None. G. Huguet: None. A. Dionne Laporte: None. O. Diallo: None. B. Chaumette: None. S. Jacquemont: None. M. Elsabbagh: None. P.A. Dion: None. G.A. Rouleau: None.",2019.0,,Z. Schmilovich,"1,2, R. Tesfaye1,2, G. Huguet3,4, A. Dionne","Material and Methods: We used microarray data from probands with ASD (n ,2926) and their unaffected siblings (n,2434) from the Simons Simplex Collection (SSC).",probands with ASD,,"['probands', 'with', 'ASD']",[]
773,460,D Implicating genetic risk variants for circadian rhythm and sleep trait dif culties in individuals with autism spectrum disorder,P09.029,,"Laporte1, O. Diallo1, B. Chaumette2,5,6, S. Jacquemont3,4, M. Elsabbagh1,2,P .A .D i o n1,2, G. A. Rouleau1,2 1McGill University, Montreal, QC, Canada,2Montreal Neurological Institute and Hospital, Montreal, QC, Canada,3CHU Sainte Justine, Montreal, QC, Canada, 4Universit de Montral, Montreal, QC, Canada, 5Universit Paris Descartes; Bio Sorbonne Paris Cit; INSERM, Laboratoire de Physiopathologie des Maladies Psychiatriques, Centre de Psychiatrie et Neurosciences,UMR 894, GDR3557 Institut de Psychiatrie, Paris, France, 6Centre Hospitalier Sainte Anne, Service hospitalo  universitaire, GHU Paris Psychiatrie et Neurosciences,Paris, France Introduction: Autism spectrum disorder (ASD) is a largely hereditary neurodevelopmental disorder characterized by difculties in social interaction and communication, and restricted and repetitive behaviour. Sleep is disturbed in upto 80% of affected youths with ASD. Genes underlying the circadian rhythm are proposed to elucidate sleep and other timing problems in individuals with ASD. Our rst aim investigates whether copy number variants (CNVs) encom  passing core circadian clock genes, circadian pathway genes, and sleep trait candidate genes, detected fromprevious large genome wide association studies, areAbstracts from the 52ndEuropean Society of Human Genetics (ESHG). . . 1423signicantly overrepresented in ASD individuals compared to their unaffected siblings. Material and Methods: We used microarray data from probands with ASD (n ,2926) and their unaffected siblings (n,2434) from the Simons Simplex Collection (SSC). CNVs were called, validated, and subsequently ltered using established pipelines and detection algorithms (PennCNV, QuantiSNP, SnipPeep). Results: Fisher s exact test reveal that CNVs encom  passed in core circadian clock genes, circadian pathway genes, and sleep trait candidate genes are signi cantly overrepresented in probands with ASD in comparison totheir unaffected siblings (p ,0.003; Odds ratio 1.6; CI95% [1.2 ; 2.3]). Conclusions: These preliminary results are the rst to implicate a broad network of sleep related genes in the etiology of ASD. Using whole exome sequencing (WES) data from the SSC, future investigations will evaluate therepresentation of probands SNPs within sleep related genes in comparison to their unaffected siblings. Furthermore, SNP set Kernel Association Test (SKAT) using probands  WES and corresponding phenotypic sleep observations will identify candidate SNPs that associate signi cantly with disturbed sleep traits in individuals with ASD. Z. Schmilovich: None. R. Tesfaye: None. G. Huguet: None. A. Dionne Laporte: None. O. Diallo: None. B. Chaumette: None. S. Jacquemont: None. M. Elsabbagh: None. P.A. Dion: None. G.A. Rouleau: None.",2019.0,,Z. Schmilovich,"1,2, R. Tesfaye1,2, G. Huguet3,4, A. Dionne","Results: Fisher s exact test reveal that CNVs encom  passed in core circadian clock genes, circadian pathway genes, and sleep trait candidate genes are signi cantly overrepresented in probands with ASD in comparison totheir unaffected siblings (p ,0.003; Odds ratio 1.6; CI95% [1.2 ; 2.3]).",probands with ASD,,"['probands', 'with', 'ASD']",[]
773,460,D Implicating genetic risk variants for circadian rhythm and sleep trait dif culties in individuals with autism spectrum disorder,P09.029,,"Laporte1, O. Diallo1, B. Chaumette2,5,6, S. Jacquemont3,4, M. Elsabbagh1,2,P .A .D i o n1,2, G. A. Rouleau1,2 1McGill University, Montreal, QC, Canada,2Montreal Neurological Institute and Hospital, Montreal, QC, Canada,3CHU Sainte Justine, Montreal, QC, Canada, 4Universit de Montral, Montreal, QC, Canada, 5Universit Paris Descartes; Bio Sorbonne Paris Cit; INSERM, Laboratoire de Physiopathologie des Maladies Psychiatriques, Centre de Psychiatrie et Neurosciences,UMR 894, GDR3557 Institut de Psychiatrie, Paris, France, 6Centre Hospitalier Sainte Anne, Service hospitalo  universitaire, GHU Paris Psychiatrie et Neurosciences,Paris, France Introduction: Autism spectrum disorder (ASD) is a largely hereditary neurodevelopmental disorder characterized by difculties in social interaction and communication, and restricted and repetitive behaviour. Sleep is disturbed in upto 80% of affected youths with ASD. Genes underlying the circadian rhythm are proposed to elucidate sleep and other timing problems in individuals with ASD. Our rst aim investigates whether copy number variants (CNVs) encom  passing core circadian clock genes, circadian pathway genes, and sleep trait candidate genes, detected fromprevious large genome wide association studies, areAbstracts from the 52ndEuropean Society of Human Genetics (ESHG). . . 1423signicantly overrepresented in ASD individuals compared to their unaffected siblings. Material and Methods: We used microarray data from probands with ASD (n ,2926) and their unaffected siblings (n,2434) from the Simons Simplex Collection (SSC). CNVs were called, validated, and subsequently ltered using established pipelines and detection algorithms (PennCNV, QuantiSNP, SnipPeep). Results: Fisher s exact test reveal that CNVs encom  passed in core circadian clock genes, circadian pathway genes, and sleep trait candidate genes are signi cantly overrepresented in probands with ASD in comparison totheir unaffected siblings (p ,0.003; Odds ratio 1.6; CI95% [1.2 ; 2.3]). Conclusions: These preliminary results are the rst to implicate a broad network of sleep related genes in the etiology of ASD. Using whole exome sequencing (WES) data from the SSC, future investigations will evaluate therepresentation of probands SNPs within sleep related genes in comparison to their unaffected siblings. Furthermore, SNP set Kernel Association Test (SKAT) using probands  WES and corresponding phenotypic sleep observations will identify candidate SNPs that associate signi cantly with disturbed sleep traits in individuals with ASD. Z. Schmilovich: None. R. Tesfaye: None. G. Huguet: None. A. Dionne Laporte: None. O. Diallo: None. B. Chaumette: None. S. Jacquemont: None. M. Elsabbagh: None. P.A. Dion: None. G.A. Rouleau: None.",2019.0,,Z. Schmilovich,"1,2, R. Tesfaye1,2, G. Huguet3,4, A. Dionne","Furthermore, SNP set Kernel Association Test (SKAT) using probands  WES and corresponding phenotypic sleep observations will identify candidate SNPs that associate signi cantly with disturbed sleep traits in individuals with ASD.",individuals with ASD,,"['individual', 'with', 'ASD']",[]
778,491,D Evaluation of targeted sequencing as the rst tier genetic test for intellectual disability and autismspectrum disorders diagnosis,P09.065,,"E. Frriz, G. Cartagena, M. Bermejo, S. Santamara, C. Ruiz, J. Garca Planells, M. Garca Hoyos Instituto de Medicina Genmica (IMEGEN), Valencia, Spain Identi cation of the genetic aetiology of intellectual disability (ID) or autism spectrum disorders (ASDs)provides bene ts, like speci c genetic counselling, more accurate prognosis and specialized treatment. The world  wide average prevalence of ASDs is 1 in 160 children and1 3% of ID. Due to the genetic heterogeneity of these pathologies different genetic tests are available. Today,Abstracts from the 52ndEuropean Society of Human Genetics (ESHG). . . 1439chromosomal microarray is the rst tier recommended diagnostic test and provides a yield around 10 15% for ID patients and around 9% for ASDs patients, depending on the cohort. Our goal is to evaluate if the diagnostic yield estimated by targeted sequencing in our cohorts of ID or ASDs subjects is higher than that obtained by CGH array.We screened 701 in house selected ID related genes and 189 autism related genes in a cohort of more than 100 and 60 patients, respectively. Libraries were prepared withdifferent capture kits and the Illumina NextSeq500 platform was used to sequence targeted regions. Bioinformatic analysis was performed with an in house pipeline. Thediagnostic yield was 41% in the ID cohort and 20% in the ASDs cohort. Variants of uncertain signi cance were identi ed in 50% of the ID patients and 72% of the autism patients and negative results were obtained in 9% and 8% of the ID and autism individuals, respectively. ID or autism  related genes sequencing provide higher diagnostic yieldsthan CGH array. Furthermore, copy number variants evaluation could be performed simultaneously with our pipeline. For this reason, we proposed targeted sequencingas the rst tier genetic test for ID and autism diagnosis. M. Pea Vilabelda: A. Employment (full or part time); Signi cant; Instituto de Medicina Genmica (IMEGEN). L. Rausell: A. Employment (full or part time); Signi cant; Instituto de Medicina Genmica (IMEGEN). M. Lzaro: A. Employment (full or part time); Signi cant; Instituto de Medicina Genmica (IMEGEN). S. Vidal: A. Employment (full or part time); Signi cant; Instituto de Medicina Gen  mica (IMEGEN). M. Molero: A. Employment (full or part time); Signi cant; Instituto de Medicina Genmica (IMEGEN). L. Cabrera: A. Employment (full or part  time); Signi cant; Instituto de Medicina Genmica (IME  GEN). M.J. Garca: A. Employment (full or part time); Signi cant; Instituto de Medicina Genmica (IMEGEN). C. Prez: A. Employment (full or part time); Signi cant; Instituto de Medicina Genmica (IMEGEN). P. Cano: A. Employment (full or part time); Signi cant; Instituto de Medicina Genmica (IMEGEN). E. Frriz: A. Employ  ment (full or part time); Signi cant; Instituto de Medicina Genmica (IMEGEN). G. Cartagena: A. Employment (full or part time); Signi cant; Instituto de Medicina Genmica (IMEGEN). M. Bermejo: A. Employment (full or part  time); Signi cant; Instituto de Medicina Genmica (IME  GEN). S. Santamara: A. Employment (full or part time); Signi cant; Instituto de Medicina Genmica (IMEGEN). C. Ruiz: A. Employment (full or part time); Signi cant; Instituto de Medicina Genmica (IMEGEN). J. Garca  Planells: A. Employment (full or part time); Signi cant; Instituto de Medicina Genmica (IMEGEN). M. Garca  Hoyos: A. Employment (full or part time); Signi cant; Instituto de Medicina Genmica (IMEGEN).",2019.0,,"M. Pea Vilabelda, L. Rausell, M. Lzaro, S. Vidal,","M. Molero, L. Cabrera, M. J. Garca, C. Prez, P. Cano,","1439chromosomal microarray is the rst tier recommended diagnostic test and provides a yield around 10 15% for ID patients and around 9% for ASDs patients, depending on the cohort.",,ASDs patients,[],"['ASDs', 'patient']"
778,491,D Evaluation of targeted sequencing as the rst tier genetic test for intellectual disability and autismspectrum disorders diagnosis,P09.065,,"E. Frriz, G. Cartagena, M. Bermejo, S. Santamara, C. Ruiz, J. Garca Planells, M. Garca Hoyos Instituto de Medicina Genmica (IMEGEN), Valencia, Spain Identi cation of the genetic aetiology of intellectual disability (ID) or autism spectrum disorders (ASDs)provides bene ts, like speci c genetic counselling, more accurate prognosis and specialized treatment. The world  wide average prevalence of ASDs is 1 in 160 children and1 3% of ID. Due to the genetic heterogeneity of these pathologies different genetic tests are available. Today,Abstracts from the 52ndEuropean Society of Human Genetics (ESHG). . . 1439chromosomal microarray is the rst tier recommended diagnostic test and provides a yield around 10 15% for ID patients and around 9% for ASDs patients, depending on the cohort. Our goal is to evaluate if the diagnostic yield estimated by targeted sequencing in our cohorts of ID or ASDs subjects is higher than that obtained by CGH array.We screened 701 in house selected ID related genes and 189 autism related genes in a cohort of more than 100 and 60 patients, respectively. Libraries were prepared withdifferent capture kits and the Illumina NextSeq500 platform was used to sequence targeted regions. Bioinformatic analysis was performed with an in house pipeline. Thediagnostic yield was 41% in the ID cohort and 20% in the ASDs cohort. Variants of uncertain signi cance were identi ed in 50% of the ID patients and 72% of the autism patients and negative results were obtained in 9% and 8% of the ID and autism individuals, respectively. ID or autism  related genes sequencing provide higher diagnostic yieldsthan CGH array. Furthermore, copy number variants evaluation could be performed simultaneously with our pipeline. For this reason, we proposed targeted sequencingas the rst tier genetic test for ID and autism diagnosis. M. Pea Vilabelda: A. Employment (full or part time); Signi cant; Instituto de Medicina Genmica (IMEGEN). L. Rausell: A. Employment (full or part time); Signi cant; Instituto de Medicina Genmica (IMEGEN). M. Lzaro: A. Employment (full or part time); Signi cant; Instituto de Medicina Genmica (IMEGEN). S. Vidal: A. Employment (full or part time); Signi cant; Instituto de Medicina Gen  mica (IMEGEN). M. Molero: A. Employment (full or part time); Signi cant; Instituto de Medicina Genmica (IMEGEN). L. Cabrera: A. Employment (full or part  time); Signi cant; Instituto de Medicina Genmica (IME  GEN). M.J. Garca: A. Employment (full or part time); Signi cant; Instituto de Medicina Genmica (IMEGEN). C. Prez: A. Employment (full or part time); Signi cant; Instituto de Medicina Genmica (IMEGEN). P. Cano: A. Employment (full or part time); Signi cant; Instituto de Medicina Genmica (IMEGEN). E. Frriz: A. Employ  ment (full or part time); Signi cant; Instituto de Medicina Genmica (IMEGEN). G. Cartagena: A. Employment (full or part time); Signi cant; Instituto de Medicina Genmica (IMEGEN). M. Bermejo: A. Employment (full or part  time); Signi cant; Instituto de Medicina Genmica (IME  GEN). S. Santamara: A. Employment (full or part time); Signi cant; Instituto de Medicina Genmica (IMEGEN). C. Ruiz: A. Employment (full or part time); Signi cant; Instituto de Medicina Genmica (IMEGEN). J. Garca  Planells: A. Employment (full or part time); Signi cant; Instituto de Medicina Genmica (IMEGEN). M. Garca  Hoyos: A. Employment (full or part time); Signi cant; Instituto de Medicina Genmica (IMEGEN).",2019.0,,"M. Pea Vilabelda, L. Rausell, M. Lzaro, S. Vidal,","M. Molero, L. Cabrera, M. J. Garca, C. Prez, P. Cano,","Our goal is to evaluate if the diagnostic yield estimated by targeted sequencing in our cohorts of ID or ASDs subjects is higher than that obtained by CGH array.We screened 701 in house selected ID related genes and 189 autism related genes in a cohort of more than 100 and 60 patients, respectively.",,ASDs subjects,[],"['ASDs', 'subject']"
778,491,D Evaluation of targeted sequencing as the rst tier genetic test for intellectual disability and autismspectrum disorders diagnosis,P09.065,,"E. Frriz, G. Cartagena, M. Bermejo, S. Santamara, C. Ruiz, J. Garca Planells, M. Garca Hoyos Instituto de Medicina Genmica (IMEGEN), Valencia, Spain Identi cation of the genetic aetiology of intellectual disability (ID) or autism spectrum disorders (ASDs)provides bene ts, like speci c genetic counselling, more accurate prognosis and specialized treatment. The world  wide average prevalence of ASDs is 1 in 160 children and1 3% of ID. Due to the genetic heterogeneity of these pathologies different genetic tests are available. Today,Abstracts from the 52ndEuropean Society of Human Genetics (ESHG). . . 1439chromosomal microarray is the rst tier recommended diagnostic test and provides a yield around 10 15% for ID patients and around 9% for ASDs patients, depending on the cohort. Our goal is to evaluate if the diagnostic yield estimated by targeted sequencing in our cohorts of ID or ASDs subjects is higher than that obtained by CGH array.We screened 701 in house selected ID related genes and 189 autism related genes in a cohort of more than 100 and 60 patients, respectively. Libraries were prepared withdifferent capture kits and the Illumina NextSeq500 platform was used to sequence targeted regions. Bioinformatic analysis was performed with an in house pipeline. Thediagnostic yield was 41% in the ID cohort and 20% in the ASDs cohort. Variants of uncertain signi cance were identi ed in 50% of the ID patients and 72% of the autism patients and negative results were obtained in 9% and 8% of the ID and autism individuals, respectively. ID or autism  related genes sequencing provide higher diagnostic yieldsthan CGH array. Furthermore, copy number variants evaluation could be performed simultaneously with our pipeline. For this reason, we proposed targeted sequencingas the rst tier genetic test for ID and autism diagnosis. M. Pea Vilabelda: A. Employment (full or part time); Signi cant; Instituto de Medicina Genmica (IMEGEN). L. Rausell: A. Employment (full or part time); Signi cant; Instituto de Medicina Genmica (IMEGEN). M. Lzaro: A. Employment (full or part time); Signi cant; Instituto de Medicina Genmica (IMEGEN). S. Vidal: A. Employment (full or part time); Signi cant; Instituto de Medicina Gen  mica (IMEGEN). M. Molero: A. Employment (full or part time); Signi cant; Instituto de Medicina Genmica (IMEGEN). L. Cabrera: A. Employment (full or part  time); Signi cant; Instituto de Medicina Genmica (IME  GEN). M.J. Garca: A. Employment (full or part time); Signi cant; Instituto de Medicina Genmica (IMEGEN). C. Prez: A. Employment (full or part time); Signi cant; Instituto de Medicina Genmica (IMEGEN). P. Cano: A. Employment (full or part time); Signi cant; Instituto de Medicina Genmica (IMEGEN). E. Frriz: A. Employ  ment (full or part time); Signi cant; Instituto de Medicina Genmica (IMEGEN). G. Cartagena: A. Employment (full or part time); Signi cant; Instituto de Medicina Genmica (IMEGEN). M. Bermejo: A. Employment (full or part  time); Signi cant; Instituto de Medicina Genmica (IME  GEN). S. Santamara: A. Employment (full or part time); Signi cant; Instituto de Medicina Genmica (IMEGEN). C. Ruiz: A. Employment (full or part time); Signi cant; Instituto de Medicina Genmica (IMEGEN). J. Garca  Planells: A. Employment (full or part time); Signi cant; Instituto de Medicina Genmica (IMEGEN). M. Garca  Hoyos: A. Employment (full or part time); Signi cant; Instituto de Medicina Genmica (IMEGEN).",2019.0,,"M. Pea Vilabelda, L. Rausell, M. Lzaro, S. Vidal,","M. Molero, L. Cabrera, M. J. Garca, C. Prez, P. Cano,",Thediagnostic yield was 41% in the ID cohort and 20% in the ASDs cohort.,,ASDs cohort,[],"['ASDs', 'cohort']"
779,501,"B Molecular characterization of Spanish MECP2 duplication syndrome patients: more IRAK1 than we thought1444L. Blasco1, S. Vidal1, A. Pascual Alonso1, E. Gean2,",P09.075,,"E. Guilln7, P. Lapunzina8, E. Lloveras9, D. Ortigoza2, H. Maortua10, F. Martnez11, A. Mesas12, J. Nevado8, M. Obn13, C. Orellana11, A. Plaja14, M. Rosell11, M. Tejada10, F. Santos8, M. Snchez7, J. Fernndez15, E. Tizzano16, S. Alcntara3, J. Armstrong4 1Sant Joan de Du research foundation, Barcelona, Spain, 2Unidad de Consejo Gentico, Hospital Universitario San Juan de Dios, Barcelona, Spain,3Departament de Patologia i Teraputica Experimental, Campus de Bellvitge, Universitat de Barcelona, Barcelona, Spain, 4Servicio de Medicina Gentica i Molecular, Hospital Universitario San Juan de Dios, Barcelona, Spain,5Unitad de gentica mdica i biologia celular, Universidad Autnoma de Barcelona, Barcelona, Spain,6Pediatrics, Genetic Epidemiology, Hospital Vall d'Hebrn, Barcelona, Spain,7Unidad de Gentica, Hospital Virgen de la Arrixaca, Murcia, Spain,8Instituto de Gentica Mdica y Molecular, Instituto de Investigacin Sanitaria del Hospital Universitario La Paz, Madrid, Spain,9Departamento de gentica, LABCO Iberia, Barcelona, Spain,10Laboratorio de Gentica Molecular, Servicio de Gentica, Hospital Universitario de Cruces, Bilbao, Spain,11Unidad de gentica, Hospital Universitario y Politcnico La Fe,Valencia, Spain, 12Gastroenterologia, Hospital Xanit, Mlaga, Spain,13Area de Gentica clnica i Consell Gentic, Laboratoris ICS, Girona, Spain,14Institut de Recerca (VHIR), Universitat Autnoma de Barcelona, Hospital Universitari Vall d'Hebron, Barcelona, Spain, 15Hospital Universitario Reina Sofa, Crdoba, Spain, 16Area Gentica Clnica y Molecular, Hospital Universitari Vall d'Hebron, Barcelona, Spain Introduction: MECP2 duplication syndrome (OMIM#300260) is an X linked neurodevelopmental dis  order characterized by severe to profound intellectualdisability, early infantile hypotonia, autistic traits, seizures and recurrent respiratory infections. Duplication could be de novo or inherited from an asymptomatic carrier mother. We have molecularly characterized 22 Spanish children with MECP2 duplication syndrome and their carrier mothers. Materials and Methods: Clinical characterization was done using a checklist designed for the project. Duplications were detected by MLPA and/or CGH array and con rmed by Real Time qPCR. Localization of the duplication wasstudied by FISH. MECP2 expression was checked by RT  qPCR in blood cells and skin broblast cells when avail  able. We performed XCI assay to affected females andcarrier mothers.Results: We have noticed that in the minimum duplicated region (MDR) of all our patients there are MECP2 and IRAK1 genes and both are overexpressed. The cohort was classi ed according to different chromosomal localizations of the MDR: tandem in ChrXq28, ChrXp and ChrY. The clinical severity seems to be related to the position of theduplication, where the insertion in ChrY leads to the most severe phenotype. Conclusions: Due to the fact that IRAK1 is present in all the duplications we hypothesize that it must be implicated in the disorder. We encourage the study of the pathways in which IRAK1 participates. Besides, the point of insertion of the duplication seems to be crucial for the severity of the patient, as well as the genes involved in each rearrange  ment. Grants: Miradas que Hablan Duplicacin MECP2 parents' association. L. Blasco: None. S. Vidal: None. A. Pascual Alonso: None. E. Gean: None. M. O'Callaghan: None. A. Martnez: None. A. Castells: None. C. Xiol: None. N. Brandi: None. P. Pacheco: None. V. Catal: None. M. del Campo: None. E. Guilln: None. P. Lapunzina: None. E. Lloveras: None. D. Ortigoza: None. H. Maortua: None. F. Martnez: None. A. Mesas: None. J. Nevado: None. M. Obn: None. C. Orellana: None. A. Plaja: None. M. Rosell: None. M. Tejada: None. F. Santos: None. M. Snchez: None. J. Fernndez: None. E. Tizzano: None. S. Alcntara: None. J. Armstrong: None.",2019.0,,"M. O'Callaghan2, A. Martnez2, A. Castells3, C. Xiol1,","N. Brandi4, P. Pacheco4, V. Catal5, M. del Campo6,","E. Guilln7, P. Lapunzina8, E. Lloveras9, D. Ortigoza2, H. Maortua10, F. Martnez11, A. Mesas12, J. Nevado8, M. Obn13, C. Orellana11, A. Plaja14, M. Rosell11, M. Tejada10, F. Santos8, M. Snchez7, J. Fernndez15, E. Tizzano16, S. Alcntara3, J. Armstrong4 1Sant Joan de Du research foundation, Barcelona, Spain, 2Unidad de Consejo Gentico, Hospital Universitario San Juan de Dios, Barcelona, Spain,3Departament de Patologia i Teraputica Experimental, Campus de Bellvitge, Universitat de Barcelona, Barcelona, Spain, 4Servicio de Medicina Gentica i Molecular, Hospital Universitario San Juan de Dios, Barcelona, Spain,5Unitad de gentica mdica i biologia celular, Universidad Autnoma de Barcelona, Barcelona, Spain,6Pediatrics, Genetic Epidemiology, Hospital Vall d'Hebrn, Barcelona, Spain,7Unidad de Gentica, Hospital Virgen de la Arrixaca, Murcia, Spain,8Instituto de Gentica Mdica y Molecular, Instituto de Investigacin Sanitaria del Hospital Universitario La Paz, Madrid, Spain,9Departamento de gentica, LABCO Iberia, Barcelona, Spain,10Laboratorio de Gentica Molecular, Servicio de Gentica, Hospital Universitario de Cruces, Bilbao, Spain,11Unidad de gentica, Hospital Universitario y Politcnico La Fe,Valencia, Spain, 12Gastroenterologia, Hospital Xanit, Mlaga, Spain,13Area de Gentica clnica i Consell Gentic, Laboratoris ICS, Girona, Spain,14Institut de Recerca (VHIR), Universitat Autnoma de Barcelona, Hospital Universitari Vall d'Hebron, Barcelona, Spain, 15Hospital Universitario Reina Sofa, Crdoba, Spain, 16Area Gentica Clnica y Molecular, Hospital Universitari Vall d'Hebron, Barcelona, Spain Introduction: MECP2 duplication syndrome (OMIM#300260) is an X linked neurodevelopmental dis  order characterized by severe to profound intellectualdisability, early infantile hypotonia, autistic traits, seizures and recurrent respiratory infections.",,autistic traits,[],"['autistic', 'trait']"
795,117," Systematic evaluation of prenatal and pediatricdiagnostic yields from whole genome sequencing in 8,954 individuals",C08.4,,"J. L. Giordano3, V. S. Aggarwal4, H. Z. Whang1, X. Zhao1,2, D. Lucente1, L. Margolin2, D. M. Werling5, J. Y. An5, S. Dong5, S. J. Sanders5, B. Devlin6, K. Gilmore7, B. Powell8, A. Brandt9,A .H .O Donnell  Luria1,2,10, N. J. Lennon2, D. B. Goldstein11, H. L. Rehm1,2, N. L. Vora7, D. G. MacArthur1,2, B. Levy4, R. Wapner3, M. E. Talkowski1,2 1Center for Genomic Medicine, Boston, MA, United States, 2Program in Population and Medical Genetics and Genomics, The Broad Institute of M.I.T. and Harvard, Cambridge, MA, United States,3Department of Obstetrics & Gynecology, Columbia University Medical Center, NewYork, NY, United States, 4Department of Pathology and Cell Biology, Columbia University Medical Center, New York, NY, United States,5Department of Psychiatry, UCSF Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, United States,6Depart  ment of Psychiatry, University of Pittsburgh School ofMedicine, Pittsburgh, PA, United States, 7Department of Obstetrics and Gynecology, Division of Maternal Fetal Medicine, University of North Carolina at Chapel Hill,Chapel Hill, NC, United States, 8Center for Genomic Medicine Department of Genetics, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill,NC, United States, 9Department of Genetics, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States,10Division of Genetics and Genomics, Boston Children s Hospital, Boston, MA, UnitedStates,11Institute for Genomic Medicine, Columbia Uni  versity Medical Center, New York, NY, United States Clinical genetic screening in prenatal and pediatric cohorts have traditionally required a decision to test targeted genes or mutational classes, as evaluation of all variant classes hasbeen intractable. Whole genome sequencing (WGS) has the potential to transform diagnostic testing by capturing all classes variation with a single technology. Here, wecompared diagnostic yields from WGS to those from karyotype, CMA, and whole exome sequencing (WES) in a pediatric cohort of 2,100 quartet families with a probanddiagnosed with autism spectrum disorder (ASD; n ,8,400) and a prenatal cohort of 218 cases with a structural defect detected on ultrasound. We rst benchmarked our bioinfor  matic pipelines on 519 ASD quartets, discovering 3.4M SNVs, 0.3M indels, and 5,863 structural variants (SVs) per genome. WGS recapitulated 99.6% of all CMA predictedCNVs and >97% of all de novo coding variants from WES. Molecular validation of 171 de novo SVs revealed a 97% conrmation rate. The yield from WGS exceeded all other technologies, but provided only ~0.3% increased diagnostic yield over the combination of all conventional methods. We next evaluated WGS in the fetal structural anomaly samplesand discovered a diagnostic variant in 9.8% of cases that had negative karyotype and CMA results. This study suggests a modest overall increased diagnostic yield ofWGS compared to the combination of all conventional methods, and should temper enthusiasm regarding sub  stantial increases in interpretable pathogenic variants fromWGS. Nonetheless, WGS was superior to any individual method thus warranting evaluation as a rst tier screen in prenatal and pediatric diagnostic testing. C. Lowther: None. H. Brand: None. B.B. Currall: None. J.L. Giordano: None. V.S. Aggarwal: None. H.Z. Whang: None. X. Zhao: None. D. Lucente: None. L. Margolin: None. D.M. Werling: None. J.Y. An: None. S. Dong: None. S.J. Sanders: None. B. Devlin: None. K. Gilmore: None. B. Powell: None. A. Brandt: None. A.H. ODonnell Luria: None. N.J. Lennon: None. D.B. Goldstein: None. H.L. Rehm: None. N.L. Vora: None. D. G. MacArthur: None. B. Levy: None. R. Wapner: None. M.E. Talkowski: None.",2019.0,,C. Lowther,"1,2, H. Brand1,2, B. B. Currall1,","We rst benchmarked our bioinfor  matic pipelines on 519 ASD quartets, discovering 3.4M SNVs, 0.3M indels, and 5,863 structural variants (SVs) per genome.",,ASD quartets,[],"['ASD', 'quartet']"
798,147, Predicting Functional Effects of Missense Variants inVoltage Gated Sodium and Calcium Channels,C13.5,,"J. Lemke3, H. Lerche4, P. May5, R. S. Moeller2, E. Perez6, U. Scholl7, S. Syrbe8, A. J. Campbell1, D. Lal9, H. Wang1, M. J. Daly10 1Broad Institute of Harvard and MIT, Cambridge, MA, United States,2The Danish Epilepsy Center, Dianalund, Denmark,3University of Leipzig, Leipzig, Germany,4Uni  versity of Tbingen, Tbingen, Germany,5University of Luxemburg, Luxemburg, Luxembourg,6University of Cologne, Cologne, Germany,7Berlin Institute of Health, Charite Universitaetsmedizin Berlin, Berlin, Germany, 8University of Heidelberg, Heidelberg, Germany,9Cleve  land Clinic, Cleveland, OH, United States,10Institute for Molecular Medicine Finland (FIMM), Helsinki, Finland Malfunctions of multiple voltage gated sodium (Na vs encoded by SCNxA genes) and calcium channels (Ca vs encoded by CACNA1x genes) have been associated with severe neurological, psychiatric, cardiac and other diseases. In Na vs and Ca vs, altered channel activity is frequently grouped into gain or loss of ion channel function (GOF orLOF, respectively). This can lead to speci c diseases, e.g. SCN5A LOF variants to Brugada syndrome and SCN5A GOF variants to Long QT syndrome. Based on 19 knowngene disease mechanisms, we infer LOF (521 variants) and GOF (304 variants) of likely pathogenic variants from disease phenotypes of variant carriers. We show regional clustering of inferred GOF and LOF variants, respectively, across the alignment of the entiregene family, suggesting shared pathomechanisms in SCNxA/CACNA1x genes. We then use sequence  and structure based features (not including gene names or positions) to develop a machine learning method that can predict whether a missense variant results in a LOF or GOF associated disease phenotype (ROC ,0.85). We validate the GOF and LOF effect prediction on functionally tested variants in SCN1A, SCN2A andSCN8A (ROC,0.83) and in large exome wide datasets of individuals with diseaseslike autism and epilepsy. Our work also has implications for disease modeling and mechanisms of ion channels. Ulti  mately, functional prediction of missense variants in theseclinically relevant genes may enhance precision medicine in clinical practice. This work was supported by German Research Founda  tion stipends HE7987/1 1 and HE7987/1 2 awarded to HOH. H.O. Heyne: None. S. Iqbal: None. D. Palmer: None. K. Johannesen: None. J. Lemke: None. H. Lerche: None. P. May: None. R.S. Moeller: None. E. Perez: None. U. Scholl: None. S. Syrbe: None. A.J. Campbell: None. D. Lal: None. H. Wang: None. M.J. Daly: None.",2019.0,,H. O. Heyne,"1, S. Iqbal1, D. Palmer1, K. Johannesen2,","We validate the GOF and LOF effect prediction on functionally tested variants in SCN1A, SCN2A andSCN8A (ROC,0.83) and in large exome wide datasets of individuals with diseaseslike autism and epilepsy.",individuals with diseaseslike autism,,"['individual', 'with', 'diseaseslike', 'autism']",[]
801,138, New insights into the phenotype of COL4A3BP related intellectual disability: an emerging Golgipathy,P08.08,,"1Servio de Gentica Mdica, Hospital de Santa Maria, Centro Hospitalar e Universitrio Lisboa Norte, Lisboa, Portugal,2Servio de Pediatria, Hospital Garcia de Orta, Almada, Portugal Introduction: COL4A3BP encodes a protein implicated in intracellular ceramide transport to the Golgi complex. De novo missense variants in this gene have been linked to developmental disorders (DD) in a large scale study ofpatients with severe undiagnosed DD (Fitzgerald et al., 2015). Only ve patients have been reported to date and clinical data remains very scarce. We report a new patientwith COL4A3BP  related intellectual disability (ID) aiming to contribute to the recognition of this condition. Materials and methods: Clinical data was collected from the patient s medical records and compared with previous reports from scienti c literature and databases. Results: A 5 year old girl with unremarkable family history, pregnancy and delivery, presented with postnatal microcephaly, axial hypotonia, and severe global864 J. del Picchiadevelopmental delay. Short stature and facial dysmorphisms were noted and, at 24 months, she developed generalized seizures. Currently, she does not walk unaided, says only one word, and has poor visual contact and marked stereotypic behavior with bruxism. Whole exome sequencing identi ed a de novo pathogenic variant in COL4A3BP (S260L). Conclusions: This missense variant was previously found in 4 out of 5 known patients, suggesting a mutational hotspot in this gene. Former functional evidence indicates itresults in intracellular imbalances in ceramide, pivotal to the synthesis of sphingolipids. Our case has signi cant overlap with clinical data from previous patients. This report addsevidence to an emerging consistent phenotype associated with COL4A3BP mutations, characterized by severe ID, postnatal microcephaly, epilepsy, autistic behavior includ ing striking bruxism, and unspeci c dysmorphic features. J.R. Alves: None. J. Dupont: None. J.P. Monteiro: None. A.B. Sousa: None. E",2020.0,,J. R. Alves,"1, J. Dupont1, J. P. Monteiro2, A. B. Sousa1","This report addsevidence to an emerging consistent phenotype associated with COL4A3BP mutations, characterized by severe ID, postnatal microcephaly, epilepsy, autistic behavior includ ing striking bruxism, and unspeci c dysmorphic features.",,autistic behavior,[],"['autistic', 'behavior']"
802,141, Clinical signi cance of 2q37.1 duplication in patients with intellectual disability and facial dysmorphism,P08.11,,"M. Prochazka1,2 1Department of Medical Genetics, University Hospital Olomouc, Olomouc, Czech Republic,2Department of Medical Genetics, Faculty of Medicine and Dentistry, Palack University Olomouc, Olomouc, Czech Republic, 3Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palack University Olomouc, Olomouc, Czech Republic Background: 2q37 duplications including only ALPP, ALPPL2, DIS3L2 have been already described in patients with ID and facial dysmorphia. However, these duplications were concluded as benign variations based on inheritance from health parents. Aim: We report two unrelated patients with ASD, ID and facial dysmorphic features. Methods: Karyotyping, exclusion of CGG triplet repeats expansion in FMR1 and chromosomal microarray (CMA) were performed in both patients after informed consent collecting from their parents. Results: Chromosomal aberration and Fragile X syn  drome were excluded in both. 2q37 duplication including ALPP, ALPPL2, DIS3L2 was revealed by CMA. In patient 1 the duplication was inherited from father. Inheritance was unknown in patient 2. No other clinically relevant CNVs were observed. Clinical and genetics features of both patients Feature Patient 1 Patient 2 Height <3thpercentile 40thpercentile Head circumference <3thpercentile 34thpercentile Weight <3thpercentile 23thpercentile Body mass index (BMI)15.02 15.50 Add clinical features microcephaly noneClinical and genetics features of both patients Feature Patient 1 Patient 2 Coordinate (GRCh37) 233195538  233318065233195538  233311912 Length 123 kb 116 kb Overlapped coding genesALPP, ALPPL2, DIS3L2ALPP, ALPPL2, DIS3L2 Inheritance father unknown Discussion and conclusion: Duplication of 2q37 includ  ingDIS3L2 is assumed as benign (DECIPHER, ISCA, ClinVar). We described two unrelated patients with ASD,ID and facial dysmorphia who carried the duplication of 2q37 including DIS3L2 . We suggest that this CNV might cause of abnormal phenotype with variable penetrance. Ofcourse, we cannot exclude a nucleotide level changes which could explain a variable penetrance of 2q37 duplication. Acknowledgment :Supported by MH_CZ_DRO_F  NOL_00098892, IGA_LF_2020_007 Z. Capkova: B. Research Grant (principal investigator, collaborator or consultant and pending grants as well asgrants already received); Modest; University Hospital Olomouc, Palack University Olomouc. P. Capkova: B. Research Grant (principal investigator, collaborator orconsultant and pending grants as well as grants already received); Modest; University Hospital Olomouc, Palack University Olomouc. J. Srovnal: B. Research Grant(principal investigator, collaborator or consultant and pending grants as well as grants already received); Modest; University Hospital Olomouc, Palack University Olo  mouc. K. Staffova: B. Research Grant (principal investi  gator, collaborator or consultant and pending grants as wellas grants already received); Modest; University Hospital Olomouc, Palack University Olomouc. K. Adamova: B. Research Grant (principal investigator, collaborator orconsultant and pending grants as well as grants already received); Modest; University Hospital Olomouc, Palack University Olomouc. J. Pazderova: None. M. Hajduch:None. M. Prochazka: None. E",2020.0,,"Z. Capkova1,2, P. Capkova1,2, J. Srovnal1,3, K. Staffova1,3,","K. Adamova1,2, J. Pazderova1, M. Hajduch3,","Aim: We report two unrelated patients with ASD, ID and facial dysmorphic features.",patients with ASD,,"['patient', 'with', 'ASD']",[]
802,141, Clinical signi cance of 2q37.1 duplication in patients with intellectual disability and facial dysmorphism,P08.11,,"M. Prochazka1,2 1Department of Medical Genetics, University Hospital Olomouc, Olomouc, Czech Republic,2Department of Medical Genetics, Faculty of Medicine and Dentistry, Palack University Olomouc, Olomouc, Czech Republic, 3Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palack University Olomouc, Olomouc, Czech Republic Background: 2q37 duplications including only ALPP, ALPPL2, DIS3L2 have been already described in patients with ID and facial dysmorphia. However, these duplications were concluded as benign variations based on inheritance from health parents. Aim: We report two unrelated patients with ASD, ID and facial dysmorphic features. Methods: Karyotyping, exclusion of CGG triplet repeats expansion in FMR1 and chromosomal microarray (CMA) were performed in both patients after informed consent collecting from their parents. Results: Chromosomal aberration and Fragile X syn  drome were excluded in both. 2q37 duplication including ALPP, ALPPL2, DIS3L2 was revealed by CMA. In patient 1 the duplication was inherited from father. Inheritance was unknown in patient 2. No other clinically relevant CNVs were observed. Clinical and genetics features of both patients Feature Patient 1 Patient 2 Height <3thpercentile 40thpercentile Head circumference <3thpercentile 34thpercentile Weight <3thpercentile 23thpercentile Body mass index (BMI)15.02 15.50 Add clinical features microcephaly noneClinical and genetics features of both patients Feature Patient 1 Patient 2 Coordinate (GRCh37) 233195538  233318065233195538  233311912 Length 123 kb 116 kb Overlapped coding genesALPP, ALPPL2, DIS3L2ALPP, ALPPL2, DIS3L2 Inheritance father unknown Discussion and conclusion: Duplication of 2q37 includ  ingDIS3L2 is assumed as benign (DECIPHER, ISCA, ClinVar). We described two unrelated patients with ASD,ID and facial dysmorphia who carried the duplication of 2q37 including DIS3L2 . We suggest that this CNV might cause of abnormal phenotype with variable penetrance. Ofcourse, we cannot exclude a nucleotide level changes which could explain a variable penetrance of 2q37 duplication. Acknowledgment :Supported by MH_CZ_DRO_F  NOL_00098892, IGA_LF_2020_007 Z. Capkova: B. Research Grant (principal investigator, collaborator or consultant and pending grants as well asgrants already received); Modest; University Hospital Olomouc, Palack University Olomouc. P. Capkova: B. Research Grant (principal investigator, collaborator orconsultant and pending grants as well as grants already received); Modest; University Hospital Olomouc, Palack University Olomouc. J. Srovnal: B. Research Grant(principal investigator, collaborator or consultant and pending grants as well as grants already received); Modest; University Hospital Olomouc, Palack University Olo  mouc. K. Staffova: B. Research Grant (principal investi  gator, collaborator or consultant and pending grants as wellas grants already received); Modest; University Hospital Olomouc, Palack University Olomouc. K. Adamova: B. Research Grant (principal investigator, collaborator orconsultant and pending grants as well as grants already received); Modest; University Hospital Olomouc, Palack University Olomouc. J. Pazderova: None. M. Hajduch:None. M. Prochazka: None. E",2020.0,,"Z. Capkova1,2, P. Capkova1,2, J. Srovnal1,3, K. Staffova1,3,","K. Adamova1,2, J. Pazderova1, M. Hajduch3,","We described two unrelated patients with ASD,ID and facial dysmorphia who carried the duplication of 2q37 including DIS3L2 .",patients with ASD,,"['patient', 'with', 'ASD']",[]
803,148, Patient with the Tatton Brown Rahman syndrome &lt de novo constitutive DNMT3A variant,P08.23,,"M. Lejman5, A. Pietrzyk4, M. Kacprzak4 1University Children s Hospital, Department of Pediatric Hematology, Oncology and Transplantology, Lublin,Poland, 2Department of Cancer Genetics with Cytogenetic Laboratory, Medical University, Lublin, Poland,3StJohns Center Oncology, Lublin, Poland,4MedGen Medical Centre, Warsaw, Poland,5Genetic Diagnostics, Depart  ment of Pediatric Hematology, Oncology and Transplan  tology, Medical University, Lublin, Poland Introduction: Tatton Brown Rahman syndrome (TBRS; OMIM 615879) is an overgrowth and intellectual disabilitysyndrome, rst described in 2014. Additional clinical fea  tures include dysmorphic features, obesity, musculoskeletal disorders (hypotonia, hypermobility, kyphoscoliosis) andbehavioural problems (autistic spectrum disorders) and afebrile seizures. The underlying cause of the syndrome is constitutive variants in the DNMT3 gene. We present an 11  old boy with recognized Tatton Brown Rahman syndrome and con rmed variant in the DNMT3 gene. Materials and methods: During molecular diagnostic procedure analysis of FMR1 gene for FRAXA syndrome and panel of 264 genes correlated with autism and mental retardation (NGS) were performed. Results: ForFMR1 gene expansion of CGG repeats was not identi ed. NGS analysis allowed identi cation of known heterozygotic variant p.Pro904Leu (c.2711C>T) intheDNMT3A . This variant is reported in dbSNP database (rs149095705) and ClinVar Database as likely pathogenic. Molecular analysis of p.Pro904Leu was also performed forproband s mother and sister were mutation was not identi ed. Unfortunately the father s material was not available for genetic analysis. There is high probability ofde novo character of identi ed variant. Conclusions: In the case of patients with intellectual disability and obesity, Tatton Brown Rahman syndromeshould be considered in the differential diagnosis. Studies using the NGS technique facilitate the diagnosis of patients with intellectual disabilities. I. Jaszczuk: None. I. Winkler: None. A. Sobczy ska  Tomaszewska: None. M. Lejman: None. A. Pietrzyk: None. M. Kacprzak: None.Abstracts from the 53rd European Society of Human Genetics (ESHG) Conference: e Posters 869E",2020.0,,I. Jaszczuk,"1,2, I. Winkler3, A. Sobczy ska Tomaszewska4,","Additional clinical fea  tures include dysmorphic features, obesity, musculoskeletal disorders (hypotonia, hypermobility, kyphoscoliosis) andbehavioural problems (autistic spectrum disorders) and afebrile seizures.",,autistic spectrum,[],"['autistic', 'spectrum']"
807,164, Copy number variants in autism spectrum disorders patients,P09.07,,"Tutulan Cunita1,4, R. Grozavescu2,3, E. Andrei3, B. Budisteanu3, I. Focsa1,2, F. Linca3, D. Ioana3, G. Gaina1, L. Albulescu1, I. Dobrescu2,3, M. Budisteanu1,3,5, A. Arghir1 1Victor Babes National Institute of Pathology, Bucharest, Romania,2Carol Davila University of Medicine and Pharmacy, Bucharest, Romania,3Prof. Dr. Alex. Obregia Clinical Hospital of Psychiatry, Department of Pediatric Neurology, Bucharest, Romania,4Cytogenomic Medical Laboratory, Bucharest, Romania,5Titu Maiorescu Uni  versity, Faculty of Medicine, Bucharest, Romania Copy number variants (CNVs) have been shown to be involved in etiology of neurodevelopmental disorders like autism spectrum disorders (ASDs), intellectual disability(ID), and other psychiatric disorders. Chromosomal microarray analyses (CMA) has offered a high detection rate of small and large CNVs associated with ASD, and ledto discovery of new autism genes. We report on the results of chromosomal CMA investigation in a group of ASDs patients. Eighty patients were referred to our laboratory forgenetic testing with ASDs as part of a broad phenotype including ID or other clinical features. A complete clinical evaluation was performed with focus on psychiatric exam ination and psychological evaluation with speci c ASDs tests (ADOS, ADI R). Array CGH completed with kar  yotyping, FISH and qPCR tests were performed. A total of21 pathological CNVs (14 deletions and 7 duplications), with a median length of 3.7 Mb were detected in 17 patients. The involved genomic regions overlap 550 OMIMgenes. Besides well described syndromic regions associated with ASDs (e.g. deletions of 1q21.1, 22q13.3, 22q11.2, MBD5; Xq28 duplication), other genomic regions, rarelyreported in patients with ASDs were identi ed (deletion of 8p11.2p21.2, 9q34.1, 9p13, duplication of 7p22.2p22.1 , CHRNA7) ; thus having the potential to reveal new ASD genes. Our data illustrates the utility of array CGH in the investigation of patients with ASDs, speci cally in the context of complex phenotypes. Acknowledgment: Theresearch leading to these results has received funding from the EEA Grant 2014 2021, under the project contract No 6/ 2019, and MRI Projects PN 92.033.02.03 and",2020.0,,"S. M. Papuc1, A. Erbescu1, C. Iliescu2,3, M. Dobre1,","I. Minciu2,3, F. Rad2,3, I. Mihailescu3, L. Mateescu2,3,A .C .",We report on the results of chromosomal CMA investigation in a group of ASDs patients.,,ASDs patients,[],"['ASDs', 'patient']"
807,164, Copy number variants in autism spectrum disorders patients,P09.07,,"Tutulan Cunita1,4, R. Grozavescu2,3, E. Andrei3, B. Budisteanu3, I. Focsa1,2, F. Linca3, D. Ioana3, G. Gaina1, L. Albulescu1, I. Dobrescu2,3, M. Budisteanu1,3,5, A. Arghir1 1Victor Babes National Institute of Pathology, Bucharest, Romania,2Carol Davila University of Medicine and Pharmacy, Bucharest, Romania,3Prof. Dr. Alex. Obregia Clinical Hospital of Psychiatry, Department of Pediatric Neurology, Bucharest, Romania,4Cytogenomic Medical Laboratory, Bucharest, Romania,5Titu Maiorescu Uni  versity, Faculty of Medicine, Bucharest, Romania Copy number variants (CNVs) have been shown to be involved in etiology of neurodevelopmental disorders like autism spectrum disorders (ASDs), intellectual disability(ID), and other psychiatric disorders. Chromosomal microarray analyses (CMA) has offered a high detection rate of small and large CNVs associated with ASD, and ledto discovery of new autism genes. We report on the results of chromosomal CMA investigation in a group of ASDs patients. Eighty patients were referred to our laboratory forgenetic testing with ASDs as part of a broad phenotype including ID or other clinical features. A complete clinical evaluation was performed with focus on psychiatric exam ination and psychological evaluation with speci c ASDs tests (ADOS, ADI R). Array CGH completed with kar  yotyping, FISH and qPCR tests were performed. A total of21 pathological CNVs (14 deletions and 7 duplications), with a median length of 3.7 Mb were detected in 17 patients. The involved genomic regions overlap 550 OMIMgenes. Besides well described syndromic regions associated with ASDs (e.g. deletions of 1q21.1, 22q13.3, 22q11.2, MBD5; Xq28 duplication), other genomic regions, rarelyreported in patients with ASDs were identi ed (deletion of 8p11.2p21.2, 9q34.1, 9p13, duplication of 7p22.2p22.1 , CHRNA7) ; thus having the potential to reveal new ASD genes. Our data illustrates the utility of array CGH in the investigation of patients with ASDs, speci cally in the context of complex phenotypes. Acknowledgment: Theresearch leading to these results has received funding from the EEA Grant 2014 2021, under the project contract No 6/ 2019, and MRI Projects PN 92.033.02.03 and",2020.0,,"S. M. Papuc1, A. Erbescu1, C. Iliescu2,3, M. Dobre1,","I. Minciu2,3, F. Rad2,3, I. Mihailescu3, L. Mateescu2,3,A .C .","A complete clinical evaluation was performed with focus on psychiatric exam ination and psychological evaluation with speci c ASDs tests (ADOS, ADI R).",,ASDs tests,[],"['ASDs', 'test']"
807,164, Copy number variants in autism spectrum disorders patients,P09.07,,"Tutulan Cunita1,4, R. Grozavescu2,3, E. Andrei3, B. Budisteanu3, I. Focsa1,2, F. Linca3, D. Ioana3, G. Gaina1, L. Albulescu1, I. Dobrescu2,3, M. Budisteanu1,3,5, A. Arghir1 1Victor Babes National Institute of Pathology, Bucharest, Romania,2Carol Davila University of Medicine and Pharmacy, Bucharest, Romania,3Prof. Dr. Alex. Obregia Clinical Hospital of Psychiatry, Department of Pediatric Neurology, Bucharest, Romania,4Cytogenomic Medical Laboratory, Bucharest, Romania,5Titu Maiorescu Uni  versity, Faculty of Medicine, Bucharest, Romania Copy number variants (CNVs) have been shown to be involved in etiology of neurodevelopmental disorders like autism spectrum disorders (ASDs), intellectual disability(ID), and other psychiatric disorders. Chromosomal microarray analyses (CMA) has offered a high detection rate of small and large CNVs associated with ASD, and ledto discovery of new autism genes. We report on the results of chromosomal CMA investigation in a group of ASDs patients. Eighty patients were referred to our laboratory forgenetic testing with ASDs as part of a broad phenotype including ID or other clinical features. A complete clinical evaluation was performed with focus on psychiatric exam ination and psychological evaluation with speci c ASDs tests (ADOS, ADI R). Array CGH completed with kar  yotyping, FISH and qPCR tests were performed. A total of21 pathological CNVs (14 deletions and 7 duplications), with a median length of 3.7 Mb were detected in 17 patients. The involved genomic regions overlap 550 OMIMgenes. Besides well described syndromic regions associated with ASDs (e.g. deletions of 1q21.1, 22q13.3, 22q11.2, MBD5; Xq28 duplication), other genomic regions, rarelyreported in patients with ASDs were identi ed (deletion of 8p11.2p21.2, 9q34.1, 9p13, duplication of 7p22.2p22.1 , CHRNA7) ; thus having the potential to reveal new ASD genes. Our data illustrates the utility of array CGH in the investigation of patients with ASDs, speci cally in the context of complex phenotypes. Acknowledgment: Theresearch leading to these results has received funding from the EEA Grant 2014 2021, under the project contract No 6/ 2019, and MRI Projects PN 92.033.02.03 and",2020.0,,"S. M. Papuc1, A. Erbescu1, C. Iliescu2,3, M. Dobre1,","I. Minciu2,3, F. Rad2,3, I. Mihailescu3, L. Mateescu2,3,A .C .","deletions of 1q21.1, 22q13.3, 22q11.2, MBD5; Xq28 duplication), other genomic regions, rarelyreported in patients with ASDs were identi ed (deletion of 8p11.2p21.2, 9q34.1, 9p13, duplication of 7p22.2p22.1 , CHRNA7) ; thus having the potential to reveal new ASD genes.",,ASD genes,[],"['ASD', 'gene']"
809,176, NGS survey in neurological disorders focus on variants in HLA class II genes,P09.23,,"Molecular Medicine Center, MU So a, So a, Bulgaria Neuroin ammatory mechanisms may be involved in the genesis of epilepsies and autistic spectrum disorders. An NGS study with TrueSightOne gene panel was performed on 30 patients with neurological disorders (including sei zures as a main component). In 10 patients pathogenic/ probably pathogenic mutations were discovered. We haveperformed comprehensive study of HLA gene variants discovered by NGS after lack of pathogenic mutations in patients affected by epilepsy with or without autism/mental retardation and compared with patients with other pathol  ogies (referred as controls). We focused on variants anno  tated as Variants of Unknown Signi cance (VUS). We determined the frequency of such variants in DRB1 and DRB5, in cases and controls, as they were the most com  monly found in both groups. The frequency varied between11 15% in cases and 11 23% in controls. In addition, we reported variants found only in cases(5 variants in DRB5 and 1 in DRB1), only in controls (7 in DRB5 and 10 inDRB1) and both in cases and controls (5 in DRB5 and 6 in DRB1). We found 2 HLA DMB and 2 HLA G variants only in cases. This is a pilot study of the involvement ofHLA class II gene variants in neurological disorders and it will be followed by the analysis of these individual variants role. F. Shakola: None. I. Dimova: None. V. Peycheva: None. K. Mihova: None. K. Kamenarova: None. R. Kaneva: None. E",2020.0,,"F. Shakola , I. Dimova, V. Peycheva, K. Mihova,","K. Kamenarova, R. Kaneva","Molecular Medicine Center, MU So a, So a, Bulgaria Neuroin ammatory mechanisms may be involved in the genesis of epilepsies and autistic spectrum disorders.",,autistic spectrum,[],"['autistic', 'spectrum']"
811,194, Prevalence of PTEN mutations in Turkish children with autism spectrum disorders and macrocephaly,P09.58,,"M. Aksoy4, D. Celik4, S. Kose4, N. Majroh4, S. Duruk3 1Demiroglu Bilim University, Istanbul, Turkey,2Istanbul University, Istanbul, Turkey,3Behcet Uz Hospital, Izmir, Turkey,4Ege University, Izmir, Turkey,5Katip Celebi University, Izmir, Turkey,6Okmeydan Hospital, Istanbul, Turkey,7Yeditepe University, Istanbul, Turkey Prevalence of PTEN mutations in Turkish children with autism spectrum disorders and macrocephaly Introduction: Recently, people with autism spectrum disorders (ASD) and macrocephaly were found to carry mutations in PTEN gene. Mutations in this gene cause PTEN Hamartoma Tumour Syndrome (PHTS). However, PHTS often goes undetected especially in children since the manifestations of the diseaseare variable and subtle and guidelines for testing are few. Studies show 1 to 17% prevalence rates of PTEN mutations in children with ASD and macrocephaly. The varying resultson prevalence suggest the need for further studies. The aim of our study is to ndPTEN prevalence in Turkish children with ASD and macrocephaly and increase awareness of thissyndrome in Turkey. To the best of our knowledge this will be the rstPTEN prevalence study done in Turkey and South Eastern Europe. This is also the largest pediatriccohort for PTEN prevalence study in patients with ASD and macrocephaly. Materials and methods: PTEN sequencing were done for 128 patients with ASD and head cir cumference size more than 97% on growth charts between the ages of 3 to 18 recruited from ve different child and adolescent psychiatry clinics in Turkey. Result: We found 2known pathogenic, 1 new pathogenic and 2 variants of insigni cance (VUS) mutations out of 128 patients. The prevalence is 2,3% (VUS mutations are excluded). Con clusion: We recommend PTEN testing in patients with ASD and macrocephaly. Grant for this study is awarded by PTEN Research in London, UK. H. Kaymakcalan: None. I. Kaya: None. N. Cevher Binici: None. B. Ozbaran: None. G. Ozyurt: None. S. Erbilgin: None. E. Nikerel: None. M. Aksoy: None. D. Celik: None.S. Kose: None. N. Majroh: None. S. Duruk: None.E",2020.0,,"H. Kaymakcalan1, I. Kaya2, N. Cevher Binici3,","B. Ozbaran4, G. Ozyurt5, S. Erbilgin6, E. Nikerel7,","M. Aksoy4, D. Celik4, S. Kose4, N. Majroh4, S. Duruk3 1Demiroglu Bilim University, Istanbul, Turkey,2Istanbul University, Istanbul, Turkey,3Behcet Uz Hospital, Izmir, Turkey,4Ege University, Izmir, Turkey,5Katip Celebi University, Izmir, Turkey,6Okmeydan Hospital, Istanbul, Turkey,7Yeditepe University, Istanbul, Turkey Prevalence of PTEN mutations in Turkish children with autism spectrum disorders and macrocephaly Introduction: Recently, people with autism spectrum disorders (ASD) and macrocephaly were found to carry mutations in PTEN gene.",children with autism,,"['child', 'with', 'autism']",[]
811,194, Prevalence of PTEN mutations in Turkish children with autism spectrum disorders and macrocephaly,P09.58,,"M. Aksoy4, D. Celik4, S. Kose4, N. Majroh4, S. Duruk3 1Demiroglu Bilim University, Istanbul, Turkey,2Istanbul University, Istanbul, Turkey,3Behcet Uz Hospital, Izmir, Turkey,4Ege University, Izmir, Turkey,5Katip Celebi University, Izmir, Turkey,6Okmeydan Hospital, Istanbul, Turkey,7Yeditepe University, Istanbul, Turkey Prevalence of PTEN mutations in Turkish children with autism spectrum disorders and macrocephaly Introduction: Recently, people with autism spectrum disorders (ASD) and macrocephaly were found to carry mutations in PTEN gene. Mutations in this gene cause PTEN Hamartoma Tumour Syndrome (PHTS). However, PHTS often goes undetected especially in children since the manifestations of the diseaseare variable and subtle and guidelines for testing are few. Studies show 1 to 17% prevalence rates of PTEN mutations in children with ASD and macrocephaly. The varying resultson prevalence suggest the need for further studies. The aim of our study is to ndPTEN prevalence in Turkish children with ASD and macrocephaly and increase awareness of thissyndrome in Turkey. To the best of our knowledge this will be the rstPTEN prevalence study done in Turkey and South Eastern Europe. This is also the largest pediatriccohort for PTEN prevalence study in patients with ASD and macrocephaly. Materials and methods: PTEN sequencing were done for 128 patients with ASD and head cir cumference size more than 97% on growth charts between the ages of 3 to 18 recruited from ve different child and adolescent psychiatry clinics in Turkey. Result: We found 2known pathogenic, 1 new pathogenic and 2 variants of insigni cance (VUS) mutations out of 128 patients. The prevalence is 2,3% (VUS mutations are excluded). Con clusion: We recommend PTEN testing in patients with ASD and macrocephaly. Grant for this study is awarded by PTEN Research in London, UK. H. Kaymakcalan: None. I. Kaya: None. N. Cevher Binici: None. B. Ozbaran: None. G. Ozyurt: None. S. Erbilgin: None. E. Nikerel: None. M. Aksoy: None. D. Celik: None.S. Kose: None. N. Majroh: None. S. Duruk: None.E",2020.0,,"H. Kaymakcalan1, I. Kaya2, N. Cevher Binici3,","B. Ozbaran4, G. Ozyurt5, S. Erbilgin6, E. Nikerel7,","M. Aksoy4, D. Celik4, S. Kose4, N. Majroh4, S. Duruk3 1Demiroglu Bilim University, Istanbul, Turkey,2Istanbul University, Istanbul, Turkey,3Behcet Uz Hospital, Izmir, Turkey,4Ege University, Izmir, Turkey,5Katip Celebi University, Izmir, Turkey,6Okmeydan Hospital, Istanbul, Turkey,7Yeditepe University, Istanbul, Turkey Prevalence of PTEN mutations in Turkish children with autism spectrum disorders and macrocephaly Introduction: Recently, people with autism spectrum disorders (ASD) and macrocephaly were found to carry mutations in PTEN gene.",people with autism,,"['people', 'with', 'autism']",[]
811,194, Prevalence of PTEN mutations in Turkish children with autism spectrum disorders and macrocephaly,P09.58,,"M. Aksoy4, D. Celik4, S. Kose4, N. Majroh4, S. Duruk3 1Demiroglu Bilim University, Istanbul, Turkey,2Istanbul University, Istanbul, Turkey,3Behcet Uz Hospital, Izmir, Turkey,4Ege University, Izmir, Turkey,5Katip Celebi University, Izmir, Turkey,6Okmeydan Hospital, Istanbul, Turkey,7Yeditepe University, Istanbul, Turkey Prevalence of PTEN mutations in Turkish children with autism spectrum disorders and macrocephaly Introduction: Recently, people with autism spectrum disorders (ASD) and macrocephaly were found to carry mutations in PTEN gene. Mutations in this gene cause PTEN Hamartoma Tumour Syndrome (PHTS). However, PHTS often goes undetected especially in children since the manifestations of the diseaseare variable and subtle and guidelines for testing are few. Studies show 1 to 17% prevalence rates of PTEN mutations in children with ASD and macrocephaly. The varying resultson prevalence suggest the need for further studies. The aim of our study is to ndPTEN prevalence in Turkish children with ASD and macrocephaly and increase awareness of thissyndrome in Turkey. To the best of our knowledge this will be the rstPTEN prevalence study done in Turkey and South Eastern Europe. This is also the largest pediatriccohort for PTEN prevalence study in patients with ASD and macrocephaly. Materials and methods: PTEN sequencing were done for 128 patients with ASD and head cir cumference size more than 97% on growth charts between the ages of 3 to 18 recruited from ve different child and adolescent psychiatry clinics in Turkey. Result: We found 2known pathogenic, 1 new pathogenic and 2 variants of insigni cance (VUS) mutations out of 128 patients. The prevalence is 2,3% (VUS mutations are excluded). Con clusion: We recommend PTEN testing in patients with ASD and macrocephaly. Grant for this study is awarded by PTEN Research in London, UK. H. Kaymakcalan: None. I. Kaya: None. N. Cevher Binici: None. B. Ozbaran: None. G. Ozyurt: None. S. Erbilgin: None. E. Nikerel: None. M. Aksoy: None. D. Celik: None.S. Kose: None. N. Majroh: None. S. Duruk: None.E",2020.0,,"H. Kaymakcalan1, I. Kaya2, N. Cevher Binici3,","B. Ozbaran4, G. Ozyurt5, S. Erbilgin6, E. Nikerel7,",Studies show 1 to 17% prevalence rates of PTEN mutations in children with ASD and macrocephaly.,children with ASD,,"['child', 'with', 'ASD']",[]
811,194, Prevalence of PTEN mutations in Turkish children with autism spectrum disorders and macrocephaly,P09.58,,"M. Aksoy4, D. Celik4, S. Kose4, N. Majroh4, S. Duruk3 1Demiroglu Bilim University, Istanbul, Turkey,2Istanbul University, Istanbul, Turkey,3Behcet Uz Hospital, Izmir, Turkey,4Ege University, Izmir, Turkey,5Katip Celebi University, Izmir, Turkey,6Okmeydan Hospital, Istanbul, Turkey,7Yeditepe University, Istanbul, Turkey Prevalence of PTEN mutations in Turkish children with autism spectrum disorders and macrocephaly Introduction: Recently, people with autism spectrum disorders (ASD) and macrocephaly were found to carry mutations in PTEN gene. Mutations in this gene cause PTEN Hamartoma Tumour Syndrome (PHTS). However, PHTS often goes undetected especially in children since the manifestations of the diseaseare variable and subtle and guidelines for testing are few. Studies show 1 to 17% prevalence rates of PTEN mutations in children with ASD and macrocephaly. The varying resultson prevalence suggest the need for further studies. The aim of our study is to ndPTEN prevalence in Turkish children with ASD and macrocephaly and increase awareness of thissyndrome in Turkey. To the best of our knowledge this will be the rstPTEN prevalence study done in Turkey and South Eastern Europe. This is also the largest pediatriccohort for PTEN prevalence study in patients with ASD and macrocephaly. Materials and methods: PTEN sequencing were done for 128 patients with ASD and head cir cumference size more than 97% on growth charts between the ages of 3 to 18 recruited from ve different child and adolescent psychiatry clinics in Turkey. Result: We found 2known pathogenic, 1 new pathogenic and 2 variants of insigni cance (VUS) mutations out of 128 patients. The prevalence is 2,3% (VUS mutations are excluded). Con clusion: We recommend PTEN testing in patients with ASD and macrocephaly. Grant for this study is awarded by PTEN Research in London, UK. H. Kaymakcalan: None. I. Kaya: None. N. Cevher Binici: None. B. Ozbaran: None. G. Ozyurt: None. S. Erbilgin: None. E. Nikerel: None. M. Aksoy: None. D. Celik: None.S. Kose: None. N. Majroh: None. S. Duruk: None.E",2020.0,,"H. Kaymakcalan1, I. Kaya2, N. Cevher Binici3,","B. Ozbaran4, G. Ozyurt5, S. Erbilgin6, E. Nikerel7,",The aim of our study is to ndPTEN prevalence in Turkish children with ASD and macrocephaly and increase awareness of thissyndrome in Turkey.,children with ASD,,"['child', 'with', 'ASD']",[]
811,194, Prevalence of PTEN mutations in Turkish children with autism spectrum disorders and macrocephaly,P09.58,,"M. Aksoy4, D. Celik4, S. Kose4, N. Majroh4, S. Duruk3 1Demiroglu Bilim University, Istanbul, Turkey,2Istanbul University, Istanbul, Turkey,3Behcet Uz Hospital, Izmir, Turkey,4Ege University, Izmir, Turkey,5Katip Celebi University, Izmir, Turkey,6Okmeydan Hospital, Istanbul, Turkey,7Yeditepe University, Istanbul, Turkey Prevalence of PTEN mutations in Turkish children with autism spectrum disorders and macrocephaly Introduction: Recently, people with autism spectrum disorders (ASD) and macrocephaly were found to carry mutations in PTEN gene. Mutations in this gene cause PTEN Hamartoma Tumour Syndrome (PHTS). However, PHTS often goes undetected especially in children since the manifestations of the diseaseare variable and subtle and guidelines for testing are few. Studies show 1 to 17% prevalence rates of PTEN mutations in children with ASD and macrocephaly. The varying resultson prevalence suggest the need for further studies. The aim of our study is to ndPTEN prevalence in Turkish children with ASD and macrocephaly and increase awareness of thissyndrome in Turkey. To the best of our knowledge this will be the rstPTEN prevalence study done in Turkey and South Eastern Europe. This is also the largest pediatriccohort for PTEN prevalence study in patients with ASD and macrocephaly. Materials and methods: PTEN sequencing were done for 128 patients with ASD and head cir cumference size more than 97% on growth charts between the ages of 3 to 18 recruited from ve different child and adolescent psychiatry clinics in Turkey. Result: We found 2known pathogenic, 1 new pathogenic and 2 variants of insigni cance (VUS) mutations out of 128 patients. The prevalence is 2,3% (VUS mutations are excluded). Con clusion: We recommend PTEN testing in patients with ASD and macrocephaly. Grant for this study is awarded by PTEN Research in London, UK. H. Kaymakcalan: None. I. Kaya: None. N. Cevher Binici: None. B. Ozbaran: None. G. Ozyurt: None. S. Erbilgin: None. E. Nikerel: None. M. Aksoy: None. D. Celik: None.S. Kose: None. N. Majroh: None. S. Duruk: None.E",2020.0,,"H. Kaymakcalan1, I. Kaya2, N. Cevher Binici3,","B. Ozbaran4, G. Ozyurt5, S. Erbilgin6, E. Nikerel7,",This is also the largest pediatriccohort for PTEN prevalence study in patients with ASD and macrocephaly.,patients with ASD,,"['patient', 'with', 'ASD']",[]
811,194, Prevalence of PTEN mutations in Turkish children with autism spectrum disorders and macrocephaly,P09.58,,"M. Aksoy4, D. Celik4, S. Kose4, N. Majroh4, S. Duruk3 1Demiroglu Bilim University, Istanbul, Turkey,2Istanbul University, Istanbul, Turkey,3Behcet Uz Hospital, Izmir, Turkey,4Ege University, Izmir, Turkey,5Katip Celebi University, Izmir, Turkey,6Okmeydan Hospital, Istanbul, Turkey,7Yeditepe University, Istanbul, Turkey Prevalence of PTEN mutations in Turkish children with autism spectrum disorders and macrocephaly Introduction: Recently, people with autism spectrum disorders (ASD) and macrocephaly were found to carry mutations in PTEN gene. Mutations in this gene cause PTEN Hamartoma Tumour Syndrome (PHTS). However, PHTS often goes undetected especially in children since the manifestations of the diseaseare variable and subtle and guidelines for testing are few. Studies show 1 to 17% prevalence rates of PTEN mutations in children with ASD and macrocephaly. The varying resultson prevalence suggest the need for further studies. The aim of our study is to ndPTEN prevalence in Turkish children with ASD and macrocephaly and increase awareness of thissyndrome in Turkey. To the best of our knowledge this will be the rstPTEN prevalence study done in Turkey and South Eastern Europe. This is also the largest pediatriccohort for PTEN prevalence study in patients with ASD and macrocephaly. Materials and methods: PTEN sequencing were done for 128 patients with ASD and head cir cumference size more than 97% on growth charts between the ages of 3 to 18 recruited from ve different child and adolescent psychiatry clinics in Turkey. Result: We found 2known pathogenic, 1 new pathogenic and 2 variants of insigni cance (VUS) mutations out of 128 patients. The prevalence is 2,3% (VUS mutations are excluded). Con clusion: We recommend PTEN testing in patients with ASD and macrocephaly. Grant for this study is awarded by PTEN Research in London, UK. H. Kaymakcalan: None. I. Kaya: None. N. Cevher Binici: None. B. Ozbaran: None. G. Ozyurt: None. S. Erbilgin: None. E. Nikerel: None. M. Aksoy: None. D. Celik: None.S. Kose: None. N. Majroh: None. S. Duruk: None.E",2020.0,,"H. Kaymakcalan1, I. Kaya2, N. Cevher Binici3,","B. Ozbaran4, G. Ozyurt5, S. Erbilgin6, E. Nikerel7,",Materials and methods: PTEN sequencing were done for 128 patients with ASD and head cir cumference size more than 97% on growth charts between the ages of 3 to 18 recruited from ve different child and adolescent psychiatry clinics in Turkey.,patients with ASD,,"['patient', 'with', 'ASD']",[]
811,194, Prevalence of PTEN mutations in Turkish children with autism spectrum disorders and macrocephaly,P09.58,,"M. Aksoy4, D. Celik4, S. Kose4, N. Majroh4, S. Duruk3 1Demiroglu Bilim University, Istanbul, Turkey,2Istanbul University, Istanbul, Turkey,3Behcet Uz Hospital, Izmir, Turkey,4Ege University, Izmir, Turkey,5Katip Celebi University, Izmir, Turkey,6Okmeydan Hospital, Istanbul, Turkey,7Yeditepe University, Istanbul, Turkey Prevalence of PTEN mutations in Turkish children with autism spectrum disorders and macrocephaly Introduction: Recently, people with autism spectrum disorders (ASD) and macrocephaly were found to carry mutations in PTEN gene. Mutations in this gene cause PTEN Hamartoma Tumour Syndrome (PHTS). However, PHTS often goes undetected especially in children since the manifestations of the diseaseare variable and subtle and guidelines for testing are few. Studies show 1 to 17% prevalence rates of PTEN mutations in children with ASD and macrocephaly. The varying resultson prevalence suggest the need for further studies. The aim of our study is to ndPTEN prevalence in Turkish children with ASD and macrocephaly and increase awareness of thissyndrome in Turkey. To the best of our knowledge this will be the rstPTEN prevalence study done in Turkey and South Eastern Europe. This is also the largest pediatriccohort for PTEN prevalence study in patients with ASD and macrocephaly. Materials and methods: PTEN sequencing were done for 128 patients with ASD and head cir cumference size more than 97% on growth charts between the ages of 3 to 18 recruited from ve different child and adolescent psychiatry clinics in Turkey. Result: We found 2known pathogenic, 1 new pathogenic and 2 variants of insigni cance (VUS) mutations out of 128 patients. The prevalence is 2,3% (VUS mutations are excluded). Con clusion: We recommend PTEN testing in patients with ASD and macrocephaly. Grant for this study is awarded by PTEN Research in London, UK. H. Kaymakcalan: None. I. Kaya: None. N. Cevher Binici: None. B. Ozbaran: None. G. Ozyurt: None. S. Erbilgin: None. E. Nikerel: None. M. Aksoy: None. D. Celik: None.S. Kose: None. N. Majroh: None. S. Duruk: None.E",2020.0,,"H. Kaymakcalan1, I. Kaya2, N. Cevher Binici3,","B. Ozbaran4, G. Ozyurt5, S. Erbilgin6, E. Nikerel7,",Con clusion: We recommend PTEN testing in patients with ASD and macrocephaly.,patients with ASD,,"['patient', 'with', 'ASD']",[]
813,255, Neurodevelopmental disorders and chromatin remodel ing dysregulation: the lessons from Kabuki syndromespectrum and clinical presentation of Tunisian cases,P11.056,,"Kaabi, W. Ltaif, S. Aloulou, S. Mallek, S. Kammoun, UR17ES36 members Medical University, Sfax, Tunisia Objective: Kabuki syndrome (KS) [MIM: 147920] is linked to dysregulated lysine degradation and chromatin organization pathways. Here, we report four Tunisianpatients, who ful lled clinical criteria of KS, including neurodevelopmental de cits. Clinical Presentation: During our genetic couselling at the medical university of Sfax (Tunisia), we recorded fourpatients with KS distinct face, neurodevelopmental de cit, congenital heart disease, and skeletal/dental malformations. Our patients have respectively partial atrio ventricular septal defect, double outlet right ventricle, left ventricular hypertrophy and atrio ventricular septal defect with atrial isomerism. Neurodevelopmental de cits were constant but variable with respectively developmental delay, behavioural troubles with autistic traits, perceptive sensory deafness, mental retardation and delayed speech with abnormal voice;learning disabilities and behavioural troubles; developmen  tal delay, psycho motor retardation, delayed speech, and mental retardation; and nally learning disabilities and hypernasal speech. Conclusion: KS is a clinically recognizable syndrome and most patients have a pathogenic variant in the KMT2Dor KDM6A genes. The ve cardinal manifestations of KB dened in 1988 have been revisited recently (2018). The new consensus diagnostic criteria propose that a de nitive diagnosis can be made in an individual of any age with a history of infantile hypotonia, developmental delay and/or intellectual disability, and one or both of other major criterialike pathogenic molecular variant. In fact, either with or without molecular genetic con rmation, it seems to be possible to go on toward a correct clinical diagnosis. Thephenotypic variability is linked to the nature of the involved protein in the epigenetic machinery (readers, writers, erasers, or chromatin remodelers). N.B. Abdelmoula: B. Research Grant (principal inves  tigator, collaborator or consultant and pending grants as well as grants already received); Modest; Research UnitUR17ES36. B. Abdelmoula: B. Research Grant (principal investigator, collaborator or consultant and pending grants as well as grants already received); Modest; Research UnitUR17ES36. R. Louati: B. Research Grant (principal investigator, collaborator or consultant and pending grants as well as grants already received); Modest; Research UnitUR17ES36. F. Abid: B. Research Grant (principal investigator, collaborator or consultant and pending grants as well as grants already received); Modest; Research UnitUR17ES36. T. Sammouda: B. Research Grant (principal investigator, collaborator or consultant and pending grants as well as grants already received); Modest; Research UnitUR17ES36. W. Smaoui: B. Research Grant (principal investigator, collaborator or consultant and pending grants as well as grants already received); Modest; Research UnitUR17ES36. N. Abdellaoui: B. Research Grant (principal investigator, collaborator or consultant and pending grants as well as grants already received); Modest; Research UnitUR17ES36. K. Trigui: B. Research Grant (principal investigator, collaborator or consultant and pending grants as well as grants already received); Modest; Research UnitUR17ES36. O. Kaabi: B. Research Grant (principal918 J. del Picchiainvestigator, collaborator or consultant and pending grants as well as grants already received); Modest; Research Unit UR17ES36. W. Ltaif: B. Research Grant (principal investigator, collaborator or consultant and pending grants as well as grants already received); Modest; Research Unit UR17ES36. S. Aloulou: B. Research Grant (principal investigator, collaborator or consultant and pending grants as well as grants already received); Modest; Research Unit UR17ES36. S. Mallek: B. Research Grant (principal investigator, collaborator or consultant and pending grants as well as grants already received); Modest; Research Unit UR17ES36. S. Kammoun: B. Research Grant (principal investigator, collaborator or consultant and pending grants as well as grants already received); Modest; Research Unit UR17ES36. E",2020.0,,"N. B. ABDELMOULA , B. Abdelmoula, R. Louati, F. Abid,","T. Sammouda, W. Smaoui, N. Abdellaoui, K. Trigui, O.","Neurodevelopmental de cits were constant but variable with respectively developmental delay, behavioural troubles with autistic traits, perceptive sensory deafness, mental retardation and delayed speech with abnormal voice;learning disabilities and behavioural troubles; developmen  tal delay, psycho motor retardation, delayed speech, and mental retardation; and nally learning disabilities and hypernasal speech.",,autistic traits,[],"['autistic', 'trait']"
821,70, De novo frameshift variants in the neuronal splicing factor NOVA2 result in a common C terminal part and cause a severe form of neurodevelopmental disorder,C02.3,,"Courraud1, M. Hinckelmann1, F. Tran Mau Them3,4,C . Sellier1, A. Goldman5, A. Telegra 6, A. Boughton7,C . Gamble7, S. Moutton3,4, A. Quartier1, N. Jean3,4, P. Van Ness5, S. Grotto8, S. Nambot3,4, G. Douglas6,Y .S i6,J . Chelly1,9, Z. Shad10, E. Kaplan10, R. Dineen10, C. Golzio1, N. Charlet1, J. Mandel1, A. Piton1,9 1IGBMC, Illkirch, France,2CHU de Nantes, Nantes, France,3CHU de Dijon, Dijon, France,4Burgundy University, Dijon, France,5Baylor College of Medicine, Houston, TX, United States,6GeneDx, Gaithersburg, MD, United States,7Cook Children s Genetics, Fort Worth, TX, United States,8AP HP Robert Debr, Paris, France, 9Hpitaux Universitaires de Strasbourg, Strasbourg, France,10University of Illinois College of Medicine, Chicago, IL, United States Monogenic forms of intellectual disability (ID) are char  acterized by an extreme heterogeneity, with more than 700genes now implicated. The most frequent cause of mono  genic ID   the fragile X syndrome  is due to the absence of the RNA binding protein (RBP) FMRP. Many other IDgenes have been implicated in the RNA metabolism. NOVA2 is a RBP known to regulate neuron speci c alternative splicing (AS). We identi ed 6 individuals with de novo frameshift variants in NOVA2 affected with a neurodevelopmental disorder characterized by ID, motor and speech delay, autistic features, spasticity or ataxic gaitand abnormal brain MRI. All variants cluster in a small GC  repeat rich region, located in the last exon, indicating that the mutated transcript might escape to nonsense mediated decay. All 6 frameshift variants lead to the addition of a novel common C terminal part instead of the last KH RNA binding domain, suggesting a dominant negative mechan  ism. We detected 41 genes differentially spliced after downregulation of NOVA2 in human neuronal cells. TheNOVA2 variant protein shows decreased ability to bind target RNA sequences and to regulate target AS events. It also fails to complement the effect on neurite outgrowthinduced by NOVA2 downregulation in vitro and to rescue alterations of retinotectal axonal path nding induced by loss of NOVA2 ortholog in zebra sh. Our results showed that truncating mutations in NOVA2 cause a syndromic form of ID, suggesting a hypomorphic mechanism rather than a full heterozygous loss of function, although a speci c con  tribution of the novel C terminal extension cannot be excluded.Abstracts from the 53rd European Society of Human Genetics (ESHG) Conference: Oral Presentations 33F. Mattioli: None. G. Hayot: None. N. Drouot: None. B. Isidor: None. J. Courraud: None. M. Hinckelmann: None. F. Tran Mau Them: None. C. Sellier: None. A. Goldman: None. A. Telegra : A. Employment (full or part time); Signi cant; Genedx. A. Boughton: None. C. Gamble: None. S. Moutton: None. A. Quartier: None. N. Jean: None. P.Van Ness: None. S. Grotto: None. S. Nambot: None. G. Douglas: A. Employment (full or part time); Signi cant; GeneDx. Y. Si: A. Employment (full or part time);Signi cant; GeneDx. J. Chelly: None. Z. Shad: None. E. Kaplan: None. R. Dineen: None. C. Golzio: None. N. Charlet: None. J. Mandel: None. A. Piton: None.",2020.0,,F. Mattioli,"1*, G. Hayot1, N. Drouot1, B. Isidor2,J .","We identi ed 6 individuals with de novo frameshift variants in NOVA2 affected with a neurodevelopmental disorder characterized by ID, motor and speech delay, autistic features, spasticity or ataxic gaitand abnormal brain MRI.",,autistic features,[],"['autistic', 'feature']"
826,141," Loss of function of RIMS2, a synaptic membrane exocytosis gene, causes a new phenotype characterizedby congenital cone rod synaptic disease associated with neurodevelopmental and pancreatic involvement",C15.05,,"L. Jeddawi4, J. Van Dorpe5, C. Condroyer3, O. Pelle6,M . Polak7, N. Boddaert8, N. Bahi Buisson9, M. Cavallin10,J . Bacquet11, A. Mouallem Bzire11, O. Zambrowski11,12,J . Sahel3,13,14, I. Audo3,14,15, J. Kaplan1,11, J. Rozet1,E .D e Baere2, I. Perrault1 1Laboratory of Genetics in Ophthalmology (LGO), INSERM UMR1163, Institute of Genetic Diseases, Imagineand Paris University, Paris, France, 2Center for Medical Genetics, Ghent University and Ghent University Hospital, Ghent, Belgium,3Sorbonne Universit, INSERM, CNRS, Institut de la Vision, Paris, France,4Pediatric Ophthalmol  ogy Division, Dhahran Eye Specialist Hospital, Dharan, Saudi Arabia,5Department of Pathology, Ghent University and Ghent University Hospital, Ghent, Belgium,6Cell Sorting Facility, INSERM UMR1163, Institute of Genetic Diseases, Imagine and Paris University, Paris, France, 7Endocrinology, Gynecology and Pediatric Diabetology Department, University Hospital Necker Enfants Malades,Paris, France, 8Department of Pediatric Radiology, Hpital Necker Enfants Malades, Paris University, Paris, France, 9Pediatric Neurology Department, University Hospital Necker Enfants Malades, Paris, France,10Laboratory of Embryology and genetics of human malformation, INSERM UMR1163, Institute of Genetic Diseases, Imagine and ParisUniversity, Paris, France, 11Service d Ophtalmologie, Centre Hospitalier Intercommunal de Crteil (CHIC), Crteil, France,12Ophthalmology Department, University Hospital Necker Enfants Malades, Paris, France, 13Department of Ophthalmology, The University of Pitts  burgh School of Medicine, Pittsburgh, PA, United States, 14Centre Hospitalier National d Ophtalmologie des Quinze  Vingts, INSERM DHOS CIC 1423, Paris, France,Abstracts from the 53rd European Society of Human Genetics (ESHG) Conference: Oral Presentations 8115Institute of Ophthalmology, University College of London, London, United Kingdom Introduction : Anomalies in pre  and post synaptic trans  mission of visual information from photoreceptors to bipolar cells are responsible for stationary congenital night blindness (CSNB). Pre synaptic disorders, characterized bycongenital nystagmus and photophobia, night blindness, are known as cone rod synaptic disorder (CRSD) can be mis  taken for Leber congenital amaurosis (LCA). Full  eld electroretinogram is crucial for the differential diagnosis, but it can be dif cult to perform in young children. Here, we report (i) the identi cation of biallelic mutations in the RIMS2 gene encoding a pre synaptic protein not yet asso  ciated with human diseases in 3/4 families initially referred for LCA and (ii) the diagnostic adjustment to CRSD withvariable associated alteration including autistic behavior and insulinopathy. Methods : Exome sequencing combined with targeted RIMS2 testing were performed in 46 prescreened patients with CRSD and 94 with LCA. Biallelic RIMS2 mutated cases underwent ophthalmologic, neurologic and metabolicassessment. RIMS2 immunostaining was performed on human retina, brain and pancreas. Nonsense variants were functionally investigated in mammalian cells. Results.Biallelic RIMS2 sequence variants were found in four unrelated families. RIMS2, a protein regulating synaptic membrane exocytosis localizes in the human retinal outerplexiform layer, Purkinje cells and pancreatic islets. Apart from CRSD, neurodevelopmental disease was observed in all cases, and abnormal glucose homeostasis in the eldestpatient.?Nonsense variants lead to truncated RIMS2 and decreased insulin secretion in mammalian cells. Conclusion : This is the rst report of syndromic CRSD with neurodevelopmental or pancreatic involvement due to RIMS2 loss of function. The disease presentation is con  sistent with the localization and function of RIMS2. S. Mechaussier: None. B. Almoallem: None. C. Zeitz: None. K. Van Schil: None. L. Jeddawi: None. J. VanDorpe: None. C. Condroyer: None. O. Pelle: None. M. Polak: None. N. Boddaert: None. N. Bahi Buisson: None. M. Cavallin: None. J. Bacquet: None. A. Mouallem Bzire: None. O. Zambrowski: None. J. Sahel: None. I. Audo: None. J. Kaplan: None. J. Rozet: None. E. De Baere: None. I. Perrault: None.",2020.0,,S. Mechaussier,"1*, B. Almoallem2, C. Zeitz3, K. Van Schil2,","Here, we report (i) the identi cation of biallelic mutations in the RIMS2 gene encoding a pre synaptic protein not yet asso  ciated with human diseases in 3/4 families initially referred for LCA and (ii) the diagnostic adjustment to CRSD withvariable associated alteration including autistic behavior and insulinopathy.",,autistic behavior,[],"['autistic', 'behavior']"
830,85,"A Clinical and genetic analysis of new cases provides further characterisation of ALDH1A3 related anophthalmia/ microphthalmia Yesim Kesim 1, Fabiola Ceroni1,2, Alejandra Damin3,4, Fiona Blanco Kelly3,4, Carmen Ayuso3,4, Kathy Williamson5, Vronique Paquis6, Dorine Bax1, Claudine Rieubland7, Chamlal Mostafa8, Marta Cortn3,4, Nicolas Chassaing9,10, Patrick Calvas9,10, Nicola Ragge1,11 1Department of Biological and Medical Sciences, Faculty of Health and Life Sciences, Oxford Brookes University, Oxford, UnitedKingdom,2Department of Pharmacy and Biotechnology, University of Bologna, Bologna, Italy,3Department of Genetics & Genomics, Instituto de Investigacin Sanitaria Fundacin Jimnez Daz Uni versity Hospital, Universidad Autnoma de Madrid (IIS FJD, UAM),Madrid, Spain,4Centre for Biomedical Network Research on Rare Diseases (CIBERER), Madrid, Spain,5MRC Human Genetics Unit, MRC Institute of Genetics and Molecular Medicine, University of Edinburgh, Western General Hospital, Edinburgh, United Kingdom,6Department of Medical Genetics, Nice Teaching Hospital, Nice, France,7Depart ment of Human Genetics, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland,8Department of Pediatrics, Tangier Hospital, Tangier, Morocco,9UDEAR, Universit de Toulouse, Variants in genes associated with albinism were detected in all patients included in the study Patient code Gene Transcript Nucleotide change Amino acid change MAF Inheritance Rs code TG18 30 HPS1 NM_001322482 c",P02.004,,"612delC p.M205Wfs 5 0,0001 Homozygous rs281865082 TG18 31 OCA2 NM_001300984 c.2186T>C p.L729P N/A Homozygous Novel TG18 46 OCA2 NM_001300984 c.2186T>C p.L729P N/A Homozygous Novel TG19 01 SLC45A2 NM_001012509 c.400delC p.(Pro134Glnfs 9) N/A Homozygous Novel TG19 01 SLC45A2 NM_001012509 c.482G>T p.G161V N/A Homozygous Novel TG19 30 SLC45A2 NM_016180 c.386 1G>A N/A N/A Homozygous Novel TG19 36 OCA2 NM_000275 c.2037G>C p.(Gln319 ) 0,0000915 Homozygous rs121918169 TG19 46 OCA2 NM_000275 c.1648G>A p.(Glu550Lys) N/A Homozygous Novel TG19 48 SLC45A2 NM_001012509 c.328G>C p.G110R N/A Homozygous Novel TG19 54 SLC45A2 NM_016180 c.386 1G>A Splice variant N/A Homozygous NovelAbstracts from the 54thEuropean Society of Human Genetics (ESHG) Conference 118 European Journal of Human Genetics (2022) 30:88  608UMR 1056 Institut National de la Sant et de la Recherche Mdicale Universit Paul Sabatier, Toulouse, France,10Department of Medical Genetics, Purpan University Hospital, Toulouse, France,11Department of Clinical Genetics, West Midlands Regional Clinical Genetics Serviceand Birmingham Health Partners, Birmingham Women s and Children s Foundation Trust, Birmingham, United Kingdom. Introduction: Anophthalmia and microphthalmia (AM) are a genetically heterogeneous group of disorders that can be isolatedor syndromic. Biallelic ALDH1A3 variants are responsible for 11% of recessive AM cases, mostly described in consanguineous families, and present severe bilateral AM with variable neurodevelopmen tal anomalies. We present six families with biallelic ALDH1A3 variants, further characterising the associated phenotype. Material and Methods: AM individuals from UK, France and Spain were analysed by WES, targeted gene screening and arrays. Results: We identi ed 6 families: Family 1) with two brothers with bilateral anophthalmia, one present additional developmen tal delay, absent speech and autism with compound heterozygousALDH1A3 variants (c.874G>T:p.(D292Y);c.1393A>T:p.(I465F)); 2) a boy with bilateral anophthalmia, developmental and intellectual delay, seizures and autistic features with compound heterozygous variants (c.845G>C:p.(G282A);c.1459A>G:p.(R487G)); 3) a girl withbilateral microphthalmia and coloboma with compound hetero zygous variants (c.847_849del;p.(G283del);c.953C>A,:p.(S318Y)); 4) a girl with bilateral anophthalmia with a homozygous missense variant (c.1144G>A:p.(G382R)); 5) a boy with bilateral microphthal mia, unilateral coloboma and cataract, with a homozygous splice variant (c.1233 +2T>C) and 6) a boy with bilateral microphthalmia, iris and chorioretinal coloboma, facial dysmorphism with ahomozygous missense variant (c.434C>T:p.A145V). Conclusions: Three of the six families presented with com pound heterozygous variants, highlighting this mode of inheri tance in ALDH1A3 related disorders. Five of 6 families had a variant in the catalytic domain, supporting the importance of this domain,which is critical for substrate selectivity. Severe neurodevelop mental phenotypes were present in two individuals, and variably penetrant in family 1, supporting that this can be an importantfeature of the ALDH1A3 syndrome.",2021.0,,Y. Kesim: None. F. Ceroni: None. A. Damin: None. F. Blanco,Kelly: None. C. Ayuso: None. K. Williamson: None. V. Paquis:,"Results: We identi ed 6 families: Family 1) with two brothers with bilateral anophthalmia, one present additional developmen tal delay, absent speech and autism with compound heterozygousALDH1A3 variants (c.874G>T:p.(D292Y);c.1393A>T:p.(I465F)); 2) a boy with bilateral anophthalmia, developmental and intellectual delay, seizures and autistic features with compound heterozygous variants (c.845G>C:p.(G282A);c.1459A>G:p.(R487G)); 3) a girl withbilateral microphthalmia and coloboma with compound hetero zygous variants (c.847_849del;p.(G283del);c.953C>A,:p.(S318Y)); 4) a girl with bilateral anophthalmia with a homozygous missense variant (c.1144G>A:p.(G382R)); 5) a boy with bilateral microphthal mia, unilateral coloboma and cataract, with a homozygous splice variant (c.1233 +2T>C) and 6) a boy with bilateral microphthalmia, iris and chorioretinal coloboma, facial dysmorphism with ahomozygous missense variant (c.434C>T:p.A145V).",,autistic features,[],"['autistic', 'feature']"
832,271,"D Mutation burden in patients with small unrepaired atrial septal defects Anne Kathrine Mller Nielsen 1, Camilla Nyboe2, Anne Sif Lund Ovesen2, Sebastian Udholm2, Malthe Mlgrd Larsen3, Vibeke Hjprtdal1, Lars Allan Larsen3 1Rigshopitalet, Copenhagen, Denmark,2Aarhus University Hospital, Aarhus, Denmark,3University of Copenhagen, Copenhagen, Denmark",P05.018,," Introduction: In a recent nationwide cohort study, we have discovered that patients living with an atrial septal defect (ASD) have a shorter life expectancy, increased risk of atrial brillation, pneumonia, and psychiatric iss ues compared to the general population. The pathop hysiological mechanisms are still unknown. The objective of this study is to investigate if this group of patients is burdened by mutations in genes associated with ASD. Methods: We included 147 patients with an unrepaired ASD. We curated a list of ASD candidate genes, and patients wereanalyzed for genetic variants in these genes, using targeted next generation sequencing. We ltered for protein altering variants (PAVs) with minor allele frequency (MAF) <0.01 and predictedpathogenicity using the Combined Annotation Dependent Deple tion (CADD) method. The number of rare and pathogenic variants in cases were compared with variants identi ed in 33,370 controls of European ancestry. Results: We identi ed 384 rare (MAF < 0.01) PAVs in 59 genes. ASD patients were signi cantly enriched for very rare (MAF < 0.0001) PAVs compared to controls (P ,0.0001). The frequency of PAVs with CADD score 30 was signi cantly higher in ASD patients, compared to controls (P ,0.0042). Conclusions: Patients with a small, unrepaired ASD were enriched for rare PAVs within 59 ASD candidate disease genes. Our resultssuggest that recurrence risk may be increased for this group ofpatients and warrants further inve stigations. Funding: This work was supported by Novo Nordic Foundation (Grant no. NNFSA170030576), Brd. Hartmanns Fond, Kong Christian den Tiendes Fond, DagmarMarshalls Fond and Eva & Henry Frnkels Mindefond.",2021.0,,A.K.M. Nielsen: None. C. Nyboe: None. A.S.L. Ovesen: None. S.,Udholm: None. M.M. Larsen: None. V. Hjprtdal: None. L.A.,"We curated a list of ASD candidate genes, and patients wereanalyzed for genetic variants in these genes, using targeted next generation sequencing.",,ASD candidate,[],"['ASD', 'candidate']"
832,271,"D Mutation burden in patients with small unrepaired atrial septal defects Anne Kathrine Mller Nielsen 1, Camilla Nyboe2, Anne Sif Lund Ovesen2, Sebastian Udholm2, Malthe Mlgrd Larsen3, Vibeke Hjprtdal1, Lars Allan Larsen3 1Rigshopitalet, Copenhagen, Denmark,2Aarhus University Hospital, Aarhus, Denmark,3University of Copenhagen, Copenhagen, Denmark",P05.018,," Introduction: In a recent nationwide cohort study, we have discovered that patients living with an atrial septal defect (ASD) have a shorter life expectancy, increased risk of atrial brillation, pneumonia, and psychiatric iss ues compared to the general population. The pathop hysiological mechanisms are still unknown. The objective of this study is to investigate if this group of patients is burdened by mutations in genes associated with ASD. Methods: We included 147 patients with an unrepaired ASD. We curated a list of ASD candidate genes, and patients wereanalyzed for genetic variants in these genes, using targeted next generation sequencing. We ltered for protein altering variants (PAVs) with minor allele frequency (MAF) <0.01 and predictedpathogenicity using the Combined Annotation Dependent Deple tion (CADD) method. The number of rare and pathogenic variants in cases were compared with variants identi ed in 33,370 controls of European ancestry. Results: We identi ed 384 rare (MAF < 0.01) PAVs in 59 genes. ASD patients were signi cantly enriched for very rare (MAF < 0.0001) PAVs compared to controls (P ,0.0001). The frequency of PAVs with CADD score 30 was signi cantly higher in ASD patients, compared to controls (P ,0.0042). Conclusions: Patients with a small, unrepaired ASD were enriched for rare PAVs within 59 ASD candidate disease genes. Our resultssuggest that recurrence risk may be increased for this group ofpatients and warrants further inve stigations. Funding: This work was supported by Novo Nordic Foundation (Grant no. NNFSA170030576), Brd. Hartmanns Fond, Kong Christian den Tiendes Fond, DagmarMarshalls Fond and Eva & Henry Frnkels Mindefond.",2021.0,,A.K.M. Nielsen: None. C. Nyboe: None. A.S.L. Ovesen: None. S.,Udholm: None. M.M. Larsen: None. V. Hjprtdal: None. L.A.,"ASD patients were signi cantly enriched for very rare (MAF < 0.0001) PAVs compared to controls (P ,0.0001).",,ASD patients,[],"['ASD', 'patient']"
832,271,"D Mutation burden in patients with small unrepaired atrial septal defects Anne Kathrine Mller Nielsen 1, Camilla Nyboe2, Anne Sif Lund Ovesen2, Sebastian Udholm2, Malthe Mlgrd Larsen3, Vibeke Hjprtdal1, Lars Allan Larsen3 1Rigshopitalet, Copenhagen, Denmark,2Aarhus University Hospital, Aarhus, Denmark,3University of Copenhagen, Copenhagen, Denmark",P05.018,," Introduction: In a recent nationwide cohort study, we have discovered that patients living with an atrial septal defect (ASD) have a shorter life expectancy, increased risk of atrial brillation, pneumonia, and psychiatric iss ues compared to the general population. The pathop hysiological mechanisms are still unknown. The objective of this study is to investigate if this group of patients is burdened by mutations in genes associated with ASD. Methods: We included 147 patients with an unrepaired ASD. We curated a list of ASD candidate genes, and patients wereanalyzed for genetic variants in these genes, using targeted next generation sequencing. We ltered for protein altering variants (PAVs) with minor allele frequency (MAF) <0.01 and predictedpathogenicity using the Combined Annotation Dependent Deple tion (CADD) method. The number of rare and pathogenic variants in cases were compared with variants identi ed in 33,370 controls of European ancestry. Results: We identi ed 384 rare (MAF < 0.01) PAVs in 59 genes. ASD patients were signi cantly enriched for very rare (MAF < 0.0001) PAVs compared to controls (P ,0.0001). The frequency of PAVs with CADD score 30 was signi cantly higher in ASD patients, compared to controls (P ,0.0042). Conclusions: Patients with a small, unrepaired ASD were enriched for rare PAVs within 59 ASD candidate disease genes. Our resultssuggest that recurrence risk may be increased for this group ofpatients and warrants further inve stigations. Funding: This work was supported by Novo Nordic Foundation (Grant no. NNFSA170030576), Brd. Hartmanns Fond, Kong Christian den Tiendes Fond, DagmarMarshalls Fond and Eva & Henry Frnkels Mindefond.",2021.0,,A.K.M. Nielsen: None. C. Nyboe: None. A.S.L. Ovesen: None. S.,Udholm: None. M.M. Larsen: None. V. Hjprtdal: None. L.A.,"The frequency of PAVs with CADD score 30 was signi cantly higher in ASD patients, compared to controls (P ,0.0042).",,ASD patients,[],"['ASD', 'patient']"
832,271,"D Mutation burden in patients with small unrepaired atrial septal defects Anne Kathrine Mller Nielsen 1, Camilla Nyboe2, Anne Sif Lund Ovesen2, Sebastian Udholm2, Malthe Mlgrd Larsen3, Vibeke Hjprtdal1, Lars Allan Larsen3 1Rigshopitalet, Copenhagen, Denmark,2Aarhus University Hospital, Aarhus, Denmark,3University of Copenhagen, Copenhagen, Denmark",P05.018,," Introduction: In a recent nationwide cohort study, we have discovered that patients living with an atrial septal defect (ASD) have a shorter life expectancy, increased risk of atrial brillation, pneumonia, and psychiatric iss ues compared to the general population. The pathop hysiological mechanisms are still unknown. The objective of this study is to investigate if this group of patients is burdened by mutations in genes associated with ASD. Methods: We included 147 patients with an unrepaired ASD. We curated a list of ASD candidate genes, and patients wereanalyzed for genetic variants in these genes, using targeted next generation sequencing. We ltered for protein altering variants (PAVs) with minor allele frequency (MAF) <0.01 and predictedpathogenicity using the Combined Annotation Dependent Deple tion (CADD) method. The number of rare and pathogenic variants in cases were compared with variants identi ed in 33,370 controls of European ancestry. Results: We identi ed 384 rare (MAF < 0.01) PAVs in 59 genes. ASD patients were signi cantly enriched for very rare (MAF < 0.0001) PAVs compared to controls (P ,0.0001). The frequency of PAVs with CADD score 30 was signi cantly higher in ASD patients, compared to controls (P ,0.0042). Conclusions: Patients with a small, unrepaired ASD were enriched for rare PAVs within 59 ASD candidate disease genes. Our resultssuggest that recurrence risk may be increased for this group ofpatients and warrants further inve stigations. Funding: This work was supported by Novo Nordic Foundation (Grant no. NNFSA170030576), Brd. Hartmanns Fond, Kong Christian den Tiendes Fond, DagmarMarshalls Fond and Eva & Henry Frnkels Mindefond.",2021.0,,A.K.M. Nielsen: None. C. Nyboe: None. A.S.L. Ovesen: None. S.,Udholm: None. M.M. Larsen: None. V. Hjprtdal: None. L.A.,"Conclusions: Patients with a small, unrepaired ASD were enriched for rare PAVs within 59 ASD candidate disease genes.",,ASD candidate,[],"['ASD', 'candidate']"
835,394,"D <New heterozygous mutation in CDK13 gene in a child with developmental delay, dysmorphic facial features, and congenital heart defect",P08.014,,"> Ruya M. Bafaqih , Azhar Maghribi, Zohor Azher Medical genetics department, Faculty of Medicine, Umm al qura university, Makkah, Saudi Arabia. CDK13 is a protein coding gene for a member of the cyclin dependent kinases family 1. Heterozygous pathogenic mutations in CDK13 are inherited in an autosomal dominant mannercharacterized by congenital heart defects, dysmorphic facialAbstracts from the 54thEuropean Society of Human Genetics (ESHG) Conference 233 European Journal of Human Genetics (2022) 30:88  608features, and intellectual developmental disorder2. We present data relating to a child investigated for global developmental delay, intellectual disability, malformations of the heart and great vessels, autistic traits, and attention de cit hyperactivity disorder. The whole exome sequencing test identi ed in the CDK13 gene a heterozygous variant p. (Asp855Glu). To our knowledge, this variant is not reported before, and it is absent in the general population in the control databases. In silico analysis, predict adeleterious effect of this variant. Based on the ACMG guidelines,this variant is classi ed as a likely pathogenic variant. There are no variants identi ed in other genes in this child; this gene can most likely explain this child s phenotype. To our knowledge, there are a few cases reported with a mutation in cdk13 with the same clinicalfeature. References:1 Greifenberg, A. K., D. Hnig, K. Pilarova, R. Dster, K. Bartholomeeusen et al ., 2016 Structural and Functional Analysis of the Cdk13/Cyclin K Complex. Cell Rep 14 :320 331. 2 Bostwick, B., 1993 CDK13 Related Disorder in GeneReviews( ), edited by M. P. Adam, H. H. Ardinger, R. A. Pagon, S. E. Wallace, L. J.",2021.0,,"H. Bean et al . University of Washington, Seattle Copyright  1993","2020, University of Washington, Seattle. GeneReviews is aregistered trademark of the University of Washington, Seattle.","We present data relating to a child investigated for global developmental delay, intellectual disability, malformations of the heart and great vessels, autistic traits, and attention de cit hyperactivity disorder.",,autistic traits,[],"['autistic', 'trait']"
838,417,"C Deletions in MACROD2 gene and Autism Spectrum Disorders Fernando Macho Carballido , Javier Torres Hernndez, Maria Luisa Quintanilla Mata, Mara Esther Simarro Rueda, Laura Navarro Casado, Elia Lpez Ballesteros Hospital General Universitario de Albacete, Albacete, Spain",P08.045,," Introduction: Autism Spectrum Disorders (ASD),which are de ned as a chronic neurological disorder with a strong genetic basis,manifests at an early age with a variety of symptoms related to social interaction, communication and lack of exibility in reasoning and behavior. MACROD2 is a gene involved in DNA repair, cell signaling, gene transcription, and chromatin remodel ing. It is highly expressed in the ventricular zone of the brain during embryonic development. Deletions of 20p12.1 involvingMACROD2 have been associated with ASD according to several studies that preliminarily linked this gene to ASD. CASE REPORT First, in 2012, in a 12 year old patient diagnosed with ASD, a 400 K array CGH was made, resulting in a deletion of 86 Kb in 20p12.1(chr20: 14147320_14234229). This CNV was classi ed as of uncertain clinical signi cance and was not considered as the cause of the disorder. Recently, in another 3 year old patient with ASD, a genetic study was carried out using a 180K CGH array,nding a 0.265 Mb deletion in 20p12.1 (chr20: 14776880_15041538) in the MACROD2 gene. In both cases, the deletions were inherited from healthy mothers, so these altera tions could have incomplete penetrance and high phenotypicvariability. Discussion: Based on these cases and others previously reported [Lombardo et al., 2019; Frye et al., 2016], where deletionsin 20p12.1 are found in non syndromic boys with ASD, it would benecessary to review old cases in which no cause effect was found between the deletion and the disorder.",2021.0,,F. Macho Carballido: None. J. Torres Hernndez: None. M.,Quintanilla Mata: None. M. Simarro Rueda:,"Recently, in another 3 year old patient with ASD, a genetic study was carried out using a 180K CGH array,nding a 0.265 Mb deletion in 20p12.1 (chr20: 14776880_15041538) in the MACROD2 gene.",patient with ASD,,"['patient', 'with', 'ASD']",[]
838,417,"C Deletions in MACROD2 gene and Autism Spectrum Disorders Fernando Macho Carballido , Javier Torres Hernndez, Maria Luisa Quintanilla Mata, Mara Esther Simarro Rueda, Laura Navarro Casado, Elia Lpez Ballesteros Hospital General Universitario de Albacete, Albacete, Spain",P08.045,," Introduction: Autism Spectrum Disorders (ASD),which are de ned as a chronic neurological disorder with a strong genetic basis,manifests at an early age with a variety of symptoms related to social interaction, communication and lack of exibility in reasoning and behavior. MACROD2 is a gene involved in DNA repair, cell signaling, gene transcription, and chromatin remodel ing. It is highly expressed in the ventricular zone of the brain during embryonic development. Deletions of 20p12.1 involvingMACROD2 have been associated with ASD according to several studies that preliminarily linked this gene to ASD. CASE REPORT First, in 2012, in a 12 year old patient diagnosed with ASD, a 400 K array CGH was made, resulting in a deletion of 86 Kb in 20p12.1(chr20: 14147320_14234229). This CNV was classi ed as of uncertain clinical signi cance and was not considered as the cause of the disorder. Recently, in another 3 year old patient with ASD, a genetic study was carried out using a 180K CGH array,nding a 0.265 Mb deletion in 20p12.1 (chr20: 14776880_15041538) in the MACROD2 gene. In both cases, the deletions were inherited from healthy mothers, so these altera tions could have incomplete penetrance and high phenotypicvariability. Discussion: Based on these cases and others previously reported [Lombardo et al., 2019; Frye et al., 2016], where deletionsin 20p12.1 are found in non syndromic boys with ASD, it would benecessary to review old cases in which no cause effect was found between the deletion and the disorder.",2021.0,,F. Macho Carballido: None. J. Torres Hernndez: None. M.,Quintanilla Mata: None. M. Simarro Rueda:,"Discussion: Based on these cases and others previously reported [Lombardo et al., 2019; Frye et al., 2016], where deletionsin 20p12.1 are found in non syndromic boys with ASD, it would benecessary to review old cases in which no cause effect was found between the deletion and the disorder.",boys with ASD,,"['boy', 'with', 'ASD']",[]
842,429,"D Phelan McDermid syndrome: the use of modern methods of cytogenetic examination in the diagnosis ofautism spectrum disorders Larysa Sheiko 1, Iryna Lastivka2, Vita Antsupova3, Iana Ushko3, Ljudmila Brisevac1, Volodymyr Davydiuk4 1Shupyk National Medical Academy of Postgraduate Education, Kyiv, Ukraine,2Bukovinian State Medical University, Chernivtsi, Ukraine, 3Bohomolets National Medical University, Kyiv, Ukraine,4National Pirogov Memorial Medical University, Vinnitsa, Ukraine",P08.058,," Introduction: Phelan McDermid syndrome (PMD) is one of the autism spectrum disorder (ASD) syndromes caused by thedeletion of the terminal or interstitial parts chromosome 22q13.3. In the case of the formation of a circular chromosome without loss of material, the phenotype remains normal, but thereis a risk of microdeletion in the offspring. Patients with PMD areusually seen with a diagnosis of undifferentiated mental retarda tion or autism. Materials and Methods: a clinical case of Phelan McDermid syndrome in a child with undifferentiated mental retardation. Clinical genealogical, syndromic, cytogenetic, molecular genetic methods were used. Results: A six year old girl with undifferentiated mental retardation was referred for genetic counseling. Previously observed by a pediatrician, pediatric neurologist, psychiatrist for microcephaly, delayed statokinetic and psychoverbal develop ment. Girl phenotype: dolichocephaly, high forehead, attening of the middle part of the face, deep set eyes, full and puffy eyelids, long eyelashes, hypertelorism, full cheeks, enlarged ears. The child exhibits autistic behavior. Genetic testing included determinationof the karyotype of the proband and parents by several methods:GTG; FISH with DNA samples WCP1 22, X, Y and FISH with locus speci c samples 22SI LSI TUPLE1, 22q13 ARSA. Result: 46,XX,r(22) (p11.2q13), Phelan McDermid syndrome, recommendations forthe rehabilitation of the child were given. Maternal karyotype: 46, XX. Paternal karyotype: 46,XY,r(22), gene sequencing is recom mended SHANK3. Conclusions: The use of a complex of modern cytogenetic methods, FISH with DNA probes, or SHANK3 gene sequencing can signi cantly increase the number of diagnosed cases ofgenetically determined mental retardation and increase the effectiveness of preventive measures.",2021.0,,L. Sheiko: None. I. Lastivka: None. V. Antsupova: None. I.,Ushko: None. L. Brisevac: None. V. Davydiuk: None.,The child exhibits autistic behavior.,,autistic behavior,[],"['autistic', 'behavior']"
845,436,"D Compound heterozygous SPATA5 variants in siblings with intellectual disability, hypotonia and autistic features Daniela Avdjieva Tzavella 1, Slavena Atemin2, Tihomir Todorov3, Hadil Kathom1, Trayan Delchev1, Albena Todorova2Abstracts from the 54thEuropean Society of Human Genetics (ESHG) Conference 252 European Journal of Human Genetics (2022) 30:88  6081Department of Clinical Genetics, University Pediatrics Hospital, Medical University, So a, Bulgaria, So a, Bulgaria,2Genetic Medico Diagnostic Laboratory Genica , Department of Medical Chemistry and Biochemistry, Medical University, So a, Bulgaria,3Genetic Medico Diagnostic Laboratory Genica ,S oa, Bulgaria",P08.070,," Introduction: Variants in spermatogenesis associated protein 5 gene (SPATA5) are associated with Epilepsy, Hearing Loss and Mental Retardation Syndrome . SPATA5 protein localizes predo minantly in the mitochondria and is proposed to be involved in mitochondrial remodeling, ATP production and brain development. Materials and Methods: A boy aged 11 years (Patient 1) was born the rst child to non consanguineous parents at term. He was referred to genetic evaluation because of the mental retardation, hypotonia and autistic features. Patient 2 was a 1 year old girl and the younger sister of Patient 1.She was referred to genetic evaluation because of the developmental delay and low muscle tone. Metabolic and mitochondrial DNA testing resultswere normal in both patients. In an attempt to establish thediagnosis Whole exome sequencing was carried out. Results: Both patients underwent Whole Exome Sequencing. The two siblings carried compound heterozygous mutations in theSPATA5 gene: c.554G>A(p.Gly185Glu) and c.1831C>T(p.Pro611 Ser). The variants were con rmed by Sanger sequencing. Conclusions: Our results describe new, probably pathogenic variants in SPATA5 gene, and we con rm that bi allelic pathogenic variants in SPATA5 cause a syndromic form of intellectual disability. Our study expands the clinical spectrum of SPATA5 mutations.",2021.0,,D. Avdjieva Tzavella: None. S. Atemin: None. T. Todorov:,None. H. Kathom: None. T. Delchev: None. A. Todorova: None.,"He was referred to genetic evaluation because of the mental retardation, hypotonia and autistic features.",,autistic features,[],"['autistic', 'feature']"
846,446,"A A WES study in 200 intellectual disability/ autism patients Lucia Pia Bruno 1,2, Gabriella Doddato1,2, Floriana Valentino1,2, Annarita Giliberti1,2, Caterina Lo Rizzo3, Maria Antonietta Mencarelli3, Francesca Mari1,2,3, Anna Maria Pinto3, Francesca Fava1,2,3, Mar gherita Baldassarri1,2, Andrea Tommasi1,2,3, Alessandra Fabbiani1,2,3, Vittoria Lamacchia1,2,3, Elisa Benetti2, Simone Furini2, Francesca Ariani1,2,3, Alessandra Renieri1,2,3, Chiara Fallerini1,2 1Medical Genetics, University of Siena, Siena, Italy,2Med Biotech Hub and Competence Center, Department of Medical Biotechnologies, University of Siena, Siena, Italy,3Genetica Medica, Azienda Ospedaliera Universitaria Senese, Siena, Italy",P08.083,," Intellectual disability (ID) is a disorder characterized by an incomplete or arrested mental development and by IQ less than70. Autism spectrum disorder (ASD) is a neurodevelopmental condition characterized by social impairment, restricted interests and repetitive behaviors. ID and ASD symptoms are oftenoverlapping. In the present study, we investigated by Whole ExomeSequencing (WES) analysis a total of 200 ID/ASD patients. Our cohort included 40 patients with syndromic ID, 64 with non syndromic ID, 6 with autism and syndromic ID, 19 with autism and non syndromicID, and71 with isolated autism. We identi ed 39 patients with pathogenic variants (PVs) with a detection rate of 20%. In particular, 2 9P V sw e r ef o u n di nI Dp a t i e n t sa n d3i nA S Dp a t i e n t s .7P V sw e r e identi ed in patients with ID and ASD features. Regarding variant type, 13 variants were missense changes accounting for 33% of the total, 7 were frameshift, 14 were nonsense, 4 were splicing changes and 1 was inframe deletion. We report more de novo variants (37)than inherited ones (14). The majority of the mutated genes belongsto 4 biological pathways or regulate them: RAS/MAPK (e.g. FGFR3,PTPN11), Wnt/ catenin (e.g. DDX3X,GRIN2A, GRIN1), Sonic Hedge hog (e.g. B9D1,C2CD3) and GPCR signaling (e.g. DDX3X, MKS1). In conclusion, our results demonstrated the ef ciency of WES analysis on the identi cation of PVs in ID/ASD patients. Moreover this study allowed to subdivide the causing genes into four groups accordingto the biological pathways suggesting new molecular interactions.",2021.0,,L.P. Bruno: None. G. Doddato: None. F. Valentino: None. A.,Giliberti: None. C. Lo Rizzo: None. M. Mencarelli: None. F. Mari:,ID and ASD symptoms are oftenoverlapping.,,ASD symptoms,[],"['ASD', 'symptom']"
846,446,"A A WES study in 200 intellectual disability/ autism patients Lucia Pia Bruno 1,2, Gabriella Doddato1,2, Floriana Valentino1,2, Annarita Giliberti1,2, Caterina Lo Rizzo3, Maria Antonietta Mencarelli3, Francesca Mari1,2,3, Anna Maria Pinto3, Francesca Fava1,2,3, Mar gherita Baldassarri1,2, Andrea Tommasi1,2,3, Alessandra Fabbiani1,2,3, Vittoria Lamacchia1,2,3, Elisa Benetti2, Simone Furini2, Francesca Ariani1,2,3, Alessandra Renieri1,2,3, Chiara Fallerini1,2 1Medical Genetics, University of Siena, Siena, Italy,2Med Biotech Hub and Competence Center, Department of Medical Biotechnologies, University of Siena, Siena, Italy,3Genetica Medica, Azienda Ospedaliera Universitaria Senese, Siena, Italy",P08.083,," Intellectual disability (ID) is a disorder characterized by an incomplete or arrested mental development and by IQ less than70. Autism spectrum disorder (ASD) is a neurodevelopmental condition characterized by social impairment, restricted interests and repetitive behaviors. ID and ASD symptoms are oftenoverlapping. In the present study, we investigated by Whole ExomeSequencing (WES) analysis a total of 200 ID/ASD patients. Our cohort included 40 patients with syndromic ID, 64 with non syndromic ID, 6 with autism and syndromic ID, 19 with autism and non syndromicID, and71 with isolated autism. We identi ed 39 patients with pathogenic variants (PVs) with a detection rate of 20%. In particular, 2 9P V sw e r ef o u n di nI Dp a t i e n t sa n d3i nA S Dp a t i e n t s .7P V sw e r e identi ed in patients with ID and ASD features. Regarding variant type, 13 variants were missense changes accounting for 33% of the total, 7 were frameshift, 14 were nonsense, 4 were splicing changes and 1 was inframe deletion. We report more de novo variants (37)than inherited ones (14). The majority of the mutated genes belongsto 4 biological pathways or regulate them: RAS/MAPK (e.g. FGFR3,PTPN11), Wnt/ catenin (e.g. DDX3X,GRIN2A, GRIN1), Sonic Hedge hog (e.g. B9D1,C2CD3) and GPCR signaling (e.g. DDX3X, MKS1). In conclusion, our results demonstrated the ef ciency of WES analysis on the identi cation of PVs in ID/ASD patients. Moreover this study allowed to subdivide the causing genes into four groups accordingto the biological pathways suggesting new molecular interactions.",2021.0,,L.P. Bruno: None. G. Doddato: None. F. Valentino: None. A.,Giliberti: None. C. Lo Rizzo: None. M. Mencarelli: None. F. Mari:,"In the present study, we investigated by Whole ExomeSequencing (WES) analysis a total of 200 ID/ASD patients.",,ASD patients,[],"['ASD', 'patient']"
846,446,"A A WES study in 200 intellectual disability/ autism patients Lucia Pia Bruno 1,2, Gabriella Doddato1,2, Floriana Valentino1,2, Annarita Giliberti1,2, Caterina Lo Rizzo3, Maria Antonietta Mencarelli3, Francesca Mari1,2,3, Anna Maria Pinto3, Francesca Fava1,2,3, Mar gherita Baldassarri1,2, Andrea Tommasi1,2,3, Alessandra Fabbiani1,2,3, Vittoria Lamacchia1,2,3, Elisa Benetti2, Simone Furini2, Francesca Ariani1,2,3, Alessandra Renieri1,2,3, Chiara Fallerini1,2 1Medical Genetics, University of Siena, Siena, Italy,2Med Biotech Hub and Competence Center, Department of Medical Biotechnologies, University of Siena, Siena, Italy,3Genetica Medica, Azienda Ospedaliera Universitaria Senese, Siena, Italy",P08.083,," Intellectual disability (ID) is a disorder characterized by an incomplete or arrested mental development and by IQ less than70. Autism spectrum disorder (ASD) is a neurodevelopmental condition characterized by social impairment, restricted interests and repetitive behaviors. ID and ASD symptoms are oftenoverlapping. In the present study, we investigated by Whole ExomeSequencing (WES) analysis a total of 200 ID/ASD patients. Our cohort included 40 patients with syndromic ID, 64 with non syndromic ID, 6 with autism and syndromic ID, 19 with autism and non syndromicID, and71 with isolated autism. We identi ed 39 patients with pathogenic variants (PVs) with a detection rate of 20%. In particular, 2 9P V sw e r ef o u n di nI Dp a t i e n t sa n d3i nA S Dp a t i e n t s .7P V sw e r e identi ed in patients with ID and ASD features. Regarding variant type, 13 variants were missense changes accounting for 33% of the total, 7 were frameshift, 14 were nonsense, 4 were splicing changes and 1 was inframe deletion. We report more de novo variants (37)than inherited ones (14). The majority of the mutated genes belongsto 4 biological pathways or regulate them: RAS/MAPK (e.g. FGFR3,PTPN11), Wnt/ catenin (e.g. DDX3X,GRIN2A, GRIN1), Sonic Hedge hog (e.g. B9D1,C2CD3) and GPCR signaling (e.g. DDX3X, MKS1). In conclusion, our results demonstrated the ef ciency of WES analysis on the identi cation of PVs in ID/ASD patients. Moreover this study allowed to subdivide the causing genes into four groups accordingto the biological pathways suggesting new molecular interactions.",2021.0,,L.P. Bruno: None. G. Doddato: None. F. Valentino: None. A.,Giliberti: None. C. Lo Rizzo: None. M. Mencarelli: None. F. Mari:,"In particular, 2 9P V sw e r ef o u n di nI Dp a t i e n t sa n d3i nA S Dp a t i e n t s .7P V sw e r e identi ed in patients with ID and ASD features.",,ASD features,[],"['ASD', 'feature']"
846,446,"A A WES study in 200 intellectual disability/ autism patients Lucia Pia Bruno 1,2, Gabriella Doddato1,2, Floriana Valentino1,2, Annarita Giliberti1,2, Caterina Lo Rizzo3, Maria Antonietta Mencarelli3, Francesca Mari1,2,3, Anna Maria Pinto3, Francesca Fava1,2,3, Mar gherita Baldassarri1,2, Andrea Tommasi1,2,3, Alessandra Fabbiani1,2,3, Vittoria Lamacchia1,2,3, Elisa Benetti2, Simone Furini2, Francesca Ariani1,2,3, Alessandra Renieri1,2,3, Chiara Fallerini1,2 1Medical Genetics, University of Siena, Siena, Italy,2Med Biotech Hub and Competence Center, Department of Medical Biotechnologies, University of Siena, Siena, Italy,3Genetica Medica, Azienda Ospedaliera Universitaria Senese, Siena, Italy",P08.083,," Intellectual disability (ID) is a disorder characterized by an incomplete or arrested mental development and by IQ less than70. Autism spectrum disorder (ASD) is a neurodevelopmental condition characterized by social impairment, restricted interests and repetitive behaviors. ID and ASD symptoms are oftenoverlapping. In the present study, we investigated by Whole ExomeSequencing (WES) analysis a total of 200 ID/ASD patients. Our cohort included 40 patients with syndromic ID, 64 with non syndromic ID, 6 with autism and syndromic ID, 19 with autism and non syndromicID, and71 with isolated autism. We identi ed 39 patients with pathogenic variants (PVs) with a detection rate of 20%. In particular, 2 9P V sw e r ef o u n di nI Dp a t i e n t sa n d3i nA S Dp a t i e n t s .7P V sw e r e identi ed in patients with ID and ASD features. Regarding variant type, 13 variants were missense changes accounting for 33% of the total, 7 were frameshift, 14 were nonsense, 4 were splicing changes and 1 was inframe deletion. We report more de novo variants (37)than inherited ones (14). The majority of the mutated genes belongsto 4 biological pathways or regulate them: RAS/MAPK (e.g. FGFR3,PTPN11), Wnt/ catenin (e.g. DDX3X,GRIN2A, GRIN1), Sonic Hedge hog (e.g. B9D1,C2CD3) and GPCR signaling (e.g. DDX3X, MKS1). In conclusion, our results demonstrated the ef ciency of WES analysis on the identi cation of PVs in ID/ASD patients. Moreover this study allowed to subdivide the causing genes into four groups accordingto the biological pathways suggesting new molecular interactions.",2021.0,,L.P. Bruno: None. G. Doddato: None. F. Valentino: None. A.,Giliberti: None. C. Lo Rizzo: None. M. Mencarelli: None. F. Mari:,"In conclusion, our results demonstrated the ef ciency of WES analysis on the identi cation of PVs in ID/ASD patients.",,ASD patients,[],"['ASD', 'patient']"
849,471,"B Contribution of compound heterozygous CACNA1H mutations in autism spectrum disorder susceptibilityAbstracts from the 54thEuropean Society of Human Genetics (ESHG) Conference 266 European Journal of Human Genetics (2022) 30:88  608Marta Viggiano1, Cinzia Cameli1, Annio Posar2,3, Maria C",P09.025,," Scaduto2, Magal Rochat4, Paola Visconti2, Elena Bacchelli1, Elena Maestrini1 1Department of Pharmacy and Biotechnology, University of Bologna, Bologna, Italy,2IRCCS Istituto delle Scienze Neurologiche di Bologna, UOSI Disturbi dello Spettro Autistico, Bologna, Italy,3Department of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy,4IRCCS Istituto delle Scienze Neurologiche di Bologna, Diagnostica Funzionale Neuroradiologica, Bologna, Italy. Introduction: Autism Spectrum Disorder (ASD) is a complex neuropsychiatric disorder with a strong genetic component. Sofar, more than one hundred high con dence susceptibility genes have been identi ed and recent efforts have led to an ever growing list of ASD candidate genes. Among these, low voltage activated T type calcium channels (Ca v3) genes ( CACNA1G , CACNA1H ,CACNA1I ) have been consistently implicated, which nicely correlates with the role calcium signaling in neuronal function. Materials and Methods: We performed whole genome sequencing analysis in a cohort of 105 families, consisting of125 ASD individuals, 210 parents and 57 unaffected siblings, to explore the presence of rare damaging variants in Ca v3 genes. Results: We have identi ed inherited damaging variants in Ca v3 genes in 21 ASD families. Interestingly, compound heterozygous rare damaging missense variants were detected in the CACNA1H gene in 6 ASD subjects (2 sibs, 2 MZ twins and 2 independentcases), belonging to 4 different families. The identi ed biallelic damaging variants could affect the CACNA1H protein activity with a recessive model and contribute to the disease development in the context of a high risk genetic background. Thus, we areperforming functional analysis to clarify the role of the CACNA1H variants on the calcium channel activity. Conclusions: The identi cation of biallelic mutations in 4 different ASD families provides further support for a role ofCACNA1H in ASD susceptibility, and for the rst time highlights it as a candidate gene in ASD, acting in a recessive mode of inheritance.Supported by the Italian Ministry of Health (Grant GR 2013 02357561).",2021.0,,M. Viggiano: None. C. Cameli: None. A. Posar: None. M.C.,Scaduto: None. M. Rochat: None. P. Visconti: None. E. Bacchelli:,"Sofar, more than one hundred high con dence susceptibility genes have been identi ed and recent efforts have led to an ever growing list of ASD candidate genes.",,ASD candidate,[],"['ASD', 'candidate']"
849,471,"B Contribution of compound heterozygous CACNA1H mutations in autism spectrum disorder susceptibilityAbstracts from the 54thEuropean Society of Human Genetics (ESHG) Conference 266 European Journal of Human Genetics (2022) 30:88  608Marta Viggiano1, Cinzia Cameli1, Annio Posar2,3, Maria C",P09.025,," Scaduto2, Magal Rochat4, Paola Visconti2, Elena Bacchelli1, Elena Maestrini1 1Department of Pharmacy and Biotechnology, University of Bologna, Bologna, Italy,2IRCCS Istituto delle Scienze Neurologiche di Bologna, UOSI Disturbi dello Spettro Autistico, Bologna, Italy,3Department of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy,4IRCCS Istituto delle Scienze Neurologiche di Bologna, Diagnostica Funzionale Neuroradiologica, Bologna, Italy. Introduction: Autism Spectrum Disorder (ASD) is a complex neuropsychiatric disorder with a strong genetic component. Sofar, more than one hundred high con dence susceptibility genes have been identi ed and recent efforts have led to an ever growing list of ASD candidate genes. Among these, low voltage activated T type calcium channels (Ca v3) genes ( CACNA1G , CACNA1H ,CACNA1I ) have been consistently implicated, which nicely correlates with the role calcium signaling in neuronal function. Materials and Methods: We performed whole genome sequencing analysis in a cohort of 105 families, consisting of125 ASD individuals, 210 parents and 57 unaffected siblings, to explore the presence of rare damaging variants in Ca v3 genes. Results: We have identi ed inherited damaging variants in Ca v3 genes in 21 ASD families. Interestingly, compound heterozygous rare damaging missense variants were detected in the CACNA1H gene in 6 ASD subjects (2 sibs, 2 MZ twins and 2 independentcases), belonging to 4 different families. The identi ed biallelic damaging variants could affect the CACNA1H protein activity with a recessive model and contribute to the disease development in the context of a high risk genetic background. Thus, we areperforming functional analysis to clarify the role of the CACNA1H variants on the calcium channel activity. Conclusions: The identi cation of biallelic mutations in 4 different ASD families provides further support for a role ofCACNA1H in ASD susceptibility, and for the rst time highlights it as a candidate gene in ASD, acting in a recessive mode of inheritance.Supported by the Italian Ministry of Health (Grant GR 2013 02357561).",2021.0,,M. Viggiano: None. C. Cameli: None. A. Posar: None. M.C.,Scaduto: None. M. Rochat: None. P. Visconti: None. E. Bacchelli:,"Materials and Methods: We performed whole genome sequencing analysis in a cohort of 105 families, consisting of125 ASD individuals, 210 parents and 57 unaffected siblings, to explore the presence of rare damaging variants in Ca v3 genes.",,ASD individuals,[],"['ASD', 'individual']"
849,471,"B Contribution of compound heterozygous CACNA1H mutations in autism spectrum disorder susceptibilityAbstracts from the 54thEuropean Society of Human Genetics (ESHG) Conference 266 European Journal of Human Genetics (2022) 30:88  608Marta Viggiano1, Cinzia Cameli1, Annio Posar2,3, Maria C",P09.025,," Scaduto2, Magal Rochat4, Paola Visconti2, Elena Bacchelli1, Elena Maestrini1 1Department of Pharmacy and Biotechnology, University of Bologna, Bologna, Italy,2IRCCS Istituto delle Scienze Neurologiche di Bologna, UOSI Disturbi dello Spettro Autistico, Bologna, Italy,3Department of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy,4IRCCS Istituto delle Scienze Neurologiche di Bologna, Diagnostica Funzionale Neuroradiologica, Bologna, Italy. Introduction: Autism Spectrum Disorder (ASD) is a complex neuropsychiatric disorder with a strong genetic component. Sofar, more than one hundred high con dence susceptibility genes have been identi ed and recent efforts have led to an ever growing list of ASD candidate genes. Among these, low voltage activated T type calcium channels (Ca v3) genes ( CACNA1G , CACNA1H ,CACNA1I ) have been consistently implicated, which nicely correlates with the role calcium signaling in neuronal function. Materials and Methods: We performed whole genome sequencing analysis in a cohort of 105 families, consisting of125 ASD individuals, 210 parents and 57 unaffected siblings, to explore the presence of rare damaging variants in Ca v3 genes. Results: We have identi ed inherited damaging variants in Ca v3 genes in 21 ASD families. Interestingly, compound heterozygous rare damaging missense variants were detected in the CACNA1H gene in 6 ASD subjects (2 sibs, 2 MZ twins and 2 independentcases), belonging to 4 different families. The identi ed biallelic damaging variants could affect the CACNA1H protein activity with a recessive model and contribute to the disease development in the context of a high risk genetic background. Thus, we areperforming functional analysis to clarify the role of the CACNA1H variants on the calcium channel activity. Conclusions: The identi cation of biallelic mutations in 4 different ASD families provides further support for a role ofCACNA1H in ASD susceptibility, and for the rst time highlights it as a candidate gene in ASD, acting in a recessive mode of inheritance.Supported by the Italian Ministry of Health (Grant GR 2013 02357561).",2021.0,,M. Viggiano: None. C. Cameli: None. A. Posar: None. M.C.,Scaduto: None. M. Rochat: None. P. Visconti: None. E. Bacchelli:,Results: We have identi ed inherited damaging variants in Ca v3 genes in 21 ASD families.,,ASD families,[],"['ASD', 'family']"
849,471,"B Contribution of compound heterozygous CACNA1H mutations in autism spectrum disorder susceptibilityAbstracts from the 54thEuropean Society of Human Genetics (ESHG) Conference 266 European Journal of Human Genetics (2022) 30:88  608Marta Viggiano1, Cinzia Cameli1, Annio Posar2,3, Maria C",P09.025,," Scaduto2, Magal Rochat4, Paola Visconti2, Elena Bacchelli1, Elena Maestrini1 1Department of Pharmacy and Biotechnology, University of Bologna, Bologna, Italy,2IRCCS Istituto delle Scienze Neurologiche di Bologna, UOSI Disturbi dello Spettro Autistico, Bologna, Italy,3Department of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy,4IRCCS Istituto delle Scienze Neurologiche di Bologna, Diagnostica Funzionale Neuroradiologica, Bologna, Italy. Introduction: Autism Spectrum Disorder (ASD) is a complex neuropsychiatric disorder with a strong genetic component. Sofar, more than one hundred high con dence susceptibility genes have been identi ed and recent efforts have led to an ever growing list of ASD candidate genes. Among these, low voltage activated T type calcium channels (Ca v3) genes ( CACNA1G , CACNA1H ,CACNA1I ) have been consistently implicated, which nicely correlates with the role calcium signaling in neuronal function. Materials and Methods: We performed whole genome sequencing analysis in a cohort of 105 families, consisting of125 ASD individuals, 210 parents and 57 unaffected siblings, to explore the presence of rare damaging variants in Ca v3 genes. Results: We have identi ed inherited damaging variants in Ca v3 genes in 21 ASD families. Interestingly, compound heterozygous rare damaging missense variants were detected in the CACNA1H gene in 6 ASD subjects (2 sibs, 2 MZ twins and 2 independentcases), belonging to 4 different families. The identi ed biallelic damaging variants could affect the CACNA1H protein activity with a recessive model and contribute to the disease development in the context of a high risk genetic background. Thus, we areperforming functional analysis to clarify the role of the CACNA1H variants on the calcium channel activity. Conclusions: The identi cation of biallelic mutations in 4 different ASD families provides further support for a role ofCACNA1H in ASD susceptibility, and for the rst time highlights it as a candidate gene in ASD, acting in a recessive mode of inheritance.Supported by the Italian Ministry of Health (Grant GR 2013 02357561).",2021.0,,M. Viggiano: None. C. Cameli: None. A. Posar: None. M.C.,Scaduto: None. M. Rochat: None. P. Visconti: None. E. Bacchelli:,"Interestingly, compound heterozygous rare damaging missense variants were detected in the CACNA1H gene in 6 ASD subjects (2 sibs, 2 MZ twins and 2 independentcases), belonging to 4 different families.",,ASD subjects,[],"['ASD', 'subject']"
849,471,"B Contribution of compound heterozygous CACNA1H mutations in autism spectrum disorder susceptibilityAbstracts from the 54thEuropean Society of Human Genetics (ESHG) Conference 266 European Journal of Human Genetics (2022) 30:88  608Marta Viggiano1, Cinzia Cameli1, Annio Posar2,3, Maria C",P09.025,," Scaduto2, Magal Rochat4, Paola Visconti2, Elena Bacchelli1, Elena Maestrini1 1Department of Pharmacy and Biotechnology, University of Bologna, Bologna, Italy,2IRCCS Istituto delle Scienze Neurologiche di Bologna, UOSI Disturbi dello Spettro Autistico, Bologna, Italy,3Department of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy,4IRCCS Istituto delle Scienze Neurologiche di Bologna, Diagnostica Funzionale Neuroradiologica, Bologna, Italy. Introduction: Autism Spectrum Disorder (ASD) is a complex neuropsychiatric disorder with a strong genetic component. Sofar, more than one hundred high con dence susceptibility genes have been identi ed and recent efforts have led to an ever growing list of ASD candidate genes. Among these, low voltage activated T type calcium channels (Ca v3) genes ( CACNA1G , CACNA1H ,CACNA1I ) have been consistently implicated, which nicely correlates with the role calcium signaling in neuronal function. Materials and Methods: We performed whole genome sequencing analysis in a cohort of 105 families, consisting of125 ASD individuals, 210 parents and 57 unaffected siblings, to explore the presence of rare damaging variants in Ca v3 genes. Results: We have identi ed inherited damaging variants in Ca v3 genes in 21 ASD families. Interestingly, compound heterozygous rare damaging missense variants were detected in the CACNA1H gene in 6 ASD subjects (2 sibs, 2 MZ twins and 2 independentcases), belonging to 4 different families. The identi ed biallelic damaging variants could affect the CACNA1H protein activity with a recessive model and contribute to the disease development in the context of a high risk genetic background. Thus, we areperforming functional analysis to clarify the role of the CACNA1H variants on the calcium channel activity. Conclusions: The identi cation of biallelic mutations in 4 different ASD families provides further support for a role ofCACNA1H in ASD susceptibility, and for the rst time highlights it as a candidate gene in ASD, acting in a recessive mode of inheritance.Supported by the Italian Ministry of Health (Grant GR 2013 02357561).",2021.0,,M. Viggiano: None. C. Cameli: None. A. Posar: None. M.C.,Scaduto: None. M. Rochat: None. P. Visconti: None. E. Bacchelli:,"Conclusions: The identi cation of biallelic mutations in 4 different ASD families provides further support for a role ofCACNA1H in ASD susceptibility, and for the rst time highlights it as a candidate gene in ASD, acting in a recessive mode of inheritance.Supported by the Italian Ministry of Health (Grant GR 2013 02357561).",,ASD families,[],"['ASD', 'family']"
849,471,"B Contribution of compound heterozygous CACNA1H mutations in autism spectrum disorder susceptibilityAbstracts from the 54thEuropean Society of Human Genetics (ESHG) Conference 266 European Journal of Human Genetics (2022) 30:88  608Marta Viggiano1, Cinzia Cameli1, Annio Posar2,3, Maria C",P09.025,," Scaduto2, Magal Rochat4, Paola Visconti2, Elena Bacchelli1, Elena Maestrini1 1Department of Pharmacy and Biotechnology, University of Bologna, Bologna, Italy,2IRCCS Istituto delle Scienze Neurologiche di Bologna, UOSI Disturbi dello Spettro Autistico, Bologna, Italy,3Department of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy,4IRCCS Istituto delle Scienze Neurologiche di Bologna, Diagnostica Funzionale Neuroradiologica, Bologna, Italy. Introduction: Autism Spectrum Disorder (ASD) is a complex neuropsychiatric disorder with a strong genetic component. Sofar, more than one hundred high con dence susceptibility genes have been identi ed and recent efforts have led to an ever growing list of ASD candidate genes. Among these, low voltage activated T type calcium channels (Ca v3) genes ( CACNA1G , CACNA1H ,CACNA1I ) have been consistently implicated, which nicely correlates with the role calcium signaling in neuronal function. Materials and Methods: We performed whole genome sequencing analysis in a cohort of 105 families, consisting of125 ASD individuals, 210 parents and 57 unaffected siblings, to explore the presence of rare damaging variants in Ca v3 genes. Results: We have identi ed inherited damaging variants in Ca v3 genes in 21 ASD families. Interestingly, compound heterozygous rare damaging missense variants were detected in the CACNA1H gene in 6 ASD subjects (2 sibs, 2 MZ twins and 2 independentcases), belonging to 4 different families. The identi ed biallelic damaging variants could affect the CACNA1H protein activity with a recessive model and contribute to the disease development in the context of a high risk genetic background. Thus, we areperforming functional analysis to clarify the role of the CACNA1H variants on the calcium channel activity. Conclusions: The identi cation of biallelic mutations in 4 different ASD families provides further support for a role ofCACNA1H in ASD susceptibility, and for the rst time highlights it as a candidate gene in ASD, acting in a recessive mode of inheritance.Supported by the Italian Ministry of Health (Grant GR 2013 02357561).",2021.0,,M. Viggiano: None. C. Cameli: None. A. Posar: None. M.C.,Scaduto: None. M. Rochat: None. P. Visconti: None. E. Bacchelli:,"Conclusions: The identi cation of biallelic mutations in 4 different ASD families provides further support for a role ofCACNA1H in ASD susceptibility, and for the rst time highlights it as a candidate gene in ASD, acting in a recessive mode of inheritance.Supported by the Italian Ministry of Health (Grant GR 2013 02357561).",,ASD susceptibility,[],"['ASD', 'susceptibility']"
850,472,"D Mitochondrial DNA in uences the susceptibility to Autism Spectrum Disorders and the severity of the clinicalphenotype Leonardo Caporali 1, Claudio Fiorini1,2, Flavia Palombo1, Flavia Baccari3, Martina Romagnoli1, Paola Visconti4, Annio Posar4, Maria Cristina Scaduto4, Elena Maestrini5, Cinzia Cameli5, Marta Viggiano5, Anna Olivieri6, Antonio Torroni6, Elena Bacchelli5, Magali Rochat7, Valerio Carelli1,2,Alessandra Maresca1 1IRCCS Istituto delle Scienze Neurologiche di Bologna, Programma di Neurogenetica, Bologna, Italy,2Department of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy,3IRCCS Istituto delle Scienze Neurologiche di Bologna, UOSI Epidemiologia eStatistica, Bologna, Italy, Bologna, Italy,4IRCCS Istituto delle Scienze Neurologiche di Bologna, UOSI Disturbi dello Spettro Autistico, Bologna, Italy, Bologna, Italy,5Department of Pharmacy and Biotechnology, University of Bologna, Italy, Bologna, Italy,6Depart ment of Biology and Biotechnology ""L",P09.027,," Spallanzani"", University of Pavia, Pavia, Italy, Bologna, Italy,7IRCCS Istituto delle Scienze Neurologiche di Bologna, Programma Diagnostica FunzionaleNeuroradiologica, Bologna, Italy, Bologna, Italy.Introduction: Autism spectrum disorders (ASD) are complex and lifelong heterogeneous neurodevelopmental conditions. Different genetic models could explain ASD, ranging from monogenic disorder or copy number variation to polygenic disease. Mito chondrial DNA (mtDNA) may have a role in the pathogenesis ofASD. Materials and Methods: Our cohort consists of 98 families including 117 subjects with ASD, 193 parents and 59 unaffectedsiblings. We performed deep sequencing of mtDNA, de ning haplogroups and evaluating private variants, including those at low heteroplasmy. An independent cohort of 127 Italian families was used as a replica. Both these cohorts were compared to a controlgroup of 5088 healthy individuals. MtDNA content was assessed inblood cells. Multivariable regression was used to evaluate risk factors inuencing ASD severity classi ed by the calibrated severity score of Autism Diagnostic Observation Schedule. Results: Haplogroup H in probands resulted protective for ASD, counterbalanced by increased risk conferred by haplogroups L and I. Paternal haplogroups U5a and K increased the risk ofdeveloping ASD in offspring. Probands showed increased numberof missense mutations in MT ATP6 and MT ATP8 and reduced mtDNA content. Paternal super haplogroups H and JT are associated with mild phenotypes, whereas variants with 15% 5%heteroplasmy are associated with severe phenotypes. Conclusions: Our results indicate a contribution of mtDNA to ASD susceptibility and phenotypic expression. Paternal mtDNA inuences the ASD pathogenesis, possibly due to accumulation of nuclear de novo variants or epigenetic alterations in fathers  germinal cells that are transmitted to the offspring. Supported by the Italian Ministry of Health (GR 2013 02357561).",2021.0,,L. Caporali: None. C. Fiorini: None. F. Palombo: None. F.,Baccari: None. M. Romagnoli: None. P. Visconti: None. A. Posar:,"Materials and Methods: Our cohort consists of 98 families including 117 subjects with ASD, 193 parents and 59 unaffectedsiblings.",subjects with ASD,,"['subject', 'with', 'ASD']",[]
850,472,"D Mitochondrial DNA in uences the susceptibility to Autism Spectrum Disorders and the severity of the clinicalphenotype Leonardo Caporali 1, Claudio Fiorini1,2, Flavia Palombo1, Flavia Baccari3, Martina Romagnoli1, Paola Visconti4, Annio Posar4, Maria Cristina Scaduto4, Elena Maestrini5, Cinzia Cameli5, Marta Viggiano5, Anna Olivieri6, Antonio Torroni6, Elena Bacchelli5, Magali Rochat7, Valerio Carelli1,2,Alessandra Maresca1 1IRCCS Istituto delle Scienze Neurologiche di Bologna, Programma di Neurogenetica, Bologna, Italy,2Department of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy,3IRCCS Istituto delle Scienze Neurologiche di Bologna, UOSI Epidemiologia eStatistica, Bologna, Italy, Bologna, Italy,4IRCCS Istituto delle Scienze Neurologiche di Bologna, UOSI Disturbi dello Spettro Autistico, Bologna, Italy, Bologna, Italy,5Department of Pharmacy and Biotechnology, University of Bologna, Italy, Bologna, Italy,6Depart ment of Biology and Biotechnology ""L",P09.027,," Spallanzani"", University of Pavia, Pavia, Italy, Bologna, Italy,7IRCCS Istituto delle Scienze Neurologiche di Bologna, Programma Diagnostica FunzionaleNeuroradiologica, Bologna, Italy, Bologna, Italy.Introduction: Autism spectrum disorders (ASD) are complex and lifelong heterogeneous neurodevelopmental conditions. Different genetic models could explain ASD, ranging from monogenic disorder or copy number variation to polygenic disease. Mito chondrial DNA (mtDNA) may have a role in the pathogenesis ofASD. Materials and Methods: Our cohort consists of 98 families including 117 subjects with ASD, 193 parents and 59 unaffectedsiblings. We performed deep sequencing of mtDNA, de ning haplogroups and evaluating private variants, including those at low heteroplasmy. An independent cohort of 127 Italian families was used as a replica. Both these cohorts were compared to a controlgroup of 5088 healthy individuals. MtDNA content was assessed inblood cells. Multivariable regression was used to evaluate risk factors inuencing ASD severity classi ed by the calibrated severity score of Autism Diagnostic Observation Schedule. Results: Haplogroup H in probands resulted protective for ASD, counterbalanced by increased risk conferred by haplogroups L and I. Paternal haplogroups U5a and K increased the risk ofdeveloping ASD in offspring. Probands showed increased numberof missense mutations in MT ATP6 and MT ATP8 and reduced mtDNA content. Paternal super haplogroups H and JT are associated with mild phenotypes, whereas variants with 15% 5%heteroplasmy are associated with severe phenotypes. Conclusions: Our results indicate a contribution of mtDNA to ASD susceptibility and phenotypic expression. Paternal mtDNA inuences the ASD pathogenesis, possibly due to accumulation of nuclear de novo variants or epigenetic alterations in fathers  germinal cells that are transmitted to the offspring. Supported by the Italian Ministry of Health (GR 2013 02357561).",2021.0,,L. Caporali: None. C. Fiorini: None. F. Palombo: None. F.,Baccari: None. M. Romagnoli: None. P. Visconti: None. A. Posar:,Multivariable regression was used to evaluate risk factors inuencing ASD severity classi ed by the calibrated severity score of Autism Diagnostic Observation Schedule.,,ASD severity,[],"['ASD', 'severity']"
850,472,"D Mitochondrial DNA in uences the susceptibility to Autism Spectrum Disorders and the severity of the clinicalphenotype Leonardo Caporali 1, Claudio Fiorini1,2, Flavia Palombo1, Flavia Baccari3, Martina Romagnoli1, Paola Visconti4, Annio Posar4, Maria Cristina Scaduto4, Elena Maestrini5, Cinzia Cameli5, Marta Viggiano5, Anna Olivieri6, Antonio Torroni6, Elena Bacchelli5, Magali Rochat7, Valerio Carelli1,2,Alessandra Maresca1 1IRCCS Istituto delle Scienze Neurologiche di Bologna, Programma di Neurogenetica, Bologna, Italy,2Department of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy,3IRCCS Istituto delle Scienze Neurologiche di Bologna, UOSI Epidemiologia eStatistica, Bologna, Italy, Bologna, Italy,4IRCCS Istituto delle Scienze Neurologiche di Bologna, UOSI Disturbi dello Spettro Autistico, Bologna, Italy, Bologna, Italy,5Department of Pharmacy and Biotechnology, University of Bologna, Italy, Bologna, Italy,6Depart ment of Biology and Biotechnology ""L",P09.027,," Spallanzani"", University of Pavia, Pavia, Italy, Bologna, Italy,7IRCCS Istituto delle Scienze Neurologiche di Bologna, Programma Diagnostica FunzionaleNeuroradiologica, Bologna, Italy, Bologna, Italy.Introduction: Autism spectrum disorders (ASD) are complex and lifelong heterogeneous neurodevelopmental conditions. Different genetic models could explain ASD, ranging from monogenic disorder or copy number variation to polygenic disease. Mito chondrial DNA (mtDNA) may have a role in the pathogenesis ofASD. Materials and Methods: Our cohort consists of 98 families including 117 subjects with ASD, 193 parents and 59 unaffectedsiblings. We performed deep sequencing of mtDNA, de ning haplogroups and evaluating private variants, including those at low heteroplasmy. An independent cohort of 127 Italian families was used as a replica. Both these cohorts were compared to a controlgroup of 5088 healthy individuals. MtDNA content was assessed inblood cells. Multivariable regression was used to evaluate risk factors inuencing ASD severity classi ed by the calibrated severity score of Autism Diagnostic Observation Schedule. Results: Haplogroup H in probands resulted protective for ASD, counterbalanced by increased risk conferred by haplogroups L and I. Paternal haplogroups U5a and K increased the risk ofdeveloping ASD in offspring. Probands showed increased numberof missense mutations in MT ATP6 and MT ATP8 and reduced mtDNA content. Paternal super haplogroups H and JT are associated with mild phenotypes, whereas variants with 15% 5%heteroplasmy are associated with severe phenotypes. Conclusions: Our results indicate a contribution of mtDNA to ASD susceptibility and phenotypic expression. Paternal mtDNA inuences the ASD pathogenesis, possibly due to accumulation of nuclear de novo variants or epigenetic alterations in fathers  germinal cells that are transmitted to the offspring. Supported by the Italian Ministry of Health (GR 2013 02357561).",2021.0,,L. Caporali: None. C. Fiorini: None. F. Palombo: None. F.,Baccari: None. M. Romagnoli: None. P. Visconti: None. A. Posar:,Conclusions: Our results indicate a contribution of mtDNA to ASD susceptibility and phenotypic expression.,,ASD susceptibility,[],"['ASD', 'susceptibility']"
850,472,"D Mitochondrial DNA in uences the susceptibility to Autism Spectrum Disorders and the severity of the clinicalphenotype Leonardo Caporali 1, Claudio Fiorini1,2, Flavia Palombo1, Flavia Baccari3, Martina Romagnoli1, Paola Visconti4, Annio Posar4, Maria Cristina Scaduto4, Elena Maestrini5, Cinzia Cameli5, Marta Viggiano5, Anna Olivieri6, Antonio Torroni6, Elena Bacchelli5, Magali Rochat7, Valerio Carelli1,2,Alessandra Maresca1 1IRCCS Istituto delle Scienze Neurologiche di Bologna, Programma di Neurogenetica, Bologna, Italy,2Department of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy,3IRCCS Istituto delle Scienze Neurologiche di Bologna, UOSI Epidemiologia eStatistica, Bologna, Italy, Bologna, Italy,4IRCCS Istituto delle Scienze Neurologiche di Bologna, UOSI Disturbi dello Spettro Autistico, Bologna, Italy, Bologna, Italy,5Department of Pharmacy and Biotechnology, University of Bologna, Italy, Bologna, Italy,6Depart ment of Biology and Biotechnology ""L",P09.027,," Spallanzani"", University of Pavia, Pavia, Italy, Bologna, Italy,7IRCCS Istituto delle Scienze Neurologiche di Bologna, Programma Diagnostica FunzionaleNeuroradiologica, Bologna, Italy, Bologna, Italy.Introduction: Autism spectrum disorders (ASD) are complex and lifelong heterogeneous neurodevelopmental conditions. Different genetic models could explain ASD, ranging from monogenic disorder or copy number variation to polygenic disease. Mito chondrial DNA (mtDNA) may have a role in the pathogenesis ofASD. Materials and Methods: Our cohort consists of 98 families including 117 subjects with ASD, 193 parents and 59 unaffectedsiblings. We performed deep sequencing of mtDNA, de ning haplogroups and evaluating private variants, including those at low heteroplasmy. An independent cohort of 127 Italian families was used as a replica. Both these cohorts were compared to a controlgroup of 5088 healthy individuals. MtDNA content was assessed inblood cells. Multivariable regression was used to evaluate risk factors inuencing ASD severity classi ed by the calibrated severity score of Autism Diagnostic Observation Schedule. Results: Haplogroup H in probands resulted protective for ASD, counterbalanced by increased risk conferred by haplogroups L and I. Paternal haplogroups U5a and K increased the risk ofdeveloping ASD in offspring. Probands showed increased numberof missense mutations in MT ATP6 and MT ATP8 and reduced mtDNA content. Paternal super haplogroups H and JT are associated with mild phenotypes, whereas variants with 15% 5%heteroplasmy are associated with severe phenotypes. Conclusions: Our results indicate a contribution of mtDNA to ASD susceptibility and phenotypic expression. Paternal mtDNA inuences the ASD pathogenesis, possibly due to accumulation of nuclear de novo variants or epigenetic alterations in fathers  germinal cells that are transmitted to the offspring. Supported by the Italian Ministry of Health (GR 2013 02357561).",2021.0,,L. Caporali: None. C. Fiorini: None. F. Palombo: None. F.,Baccari: None. M. Romagnoli: None. P. Visconti: None. A. Posar:,"Paternal mtDNA inuences the ASD pathogenesis, possibly due to accumulation of nuclear de novo variants or epigenetic alterations in fathers  germinal cells that are transmitted to the offspring.",,ASD pathogenesis,[],"['ASD', 'pathogenesis']"
859,566,"A Complex cases with Autism Spectrum Disorder (ASD), developmental delay, hyperactivity and sleep distur bance explained by oligogenic mechanisms Maria Cerminara 1, Martina Servetti1,2, Margherita Squillario2, Livia Pisciotta1,3, Giovanni Spirito4,5, Maria Teresa Divizia2, Margherita Lerone2, Elisa De Grandis1,6, Silvia Boeri6, Lino Nobili1,6, Diego Vozzi5, Remo Sanges4,5, Federico Zara1,2, Stefano Gustincich5, Aldamaria Puliti1,2 1Department of Neurosciences, Rehabil itation, Ophthalmology, Genetics, Maternal and Child Health (DiNOGMI ), University of Genova, Genova, Italy,2Medical Genetics Unit, IRCCS Istituto Giannina Gaslini, Genova, Italy,3Child Neuropsychiatry Unit, ASST Fatebenefratelli Sacco, Milano, Italy,4Area of Neuroscience, Scuola Int ernazionale Superiore di Studi Avanzati (SISSA), Trieste, Italy,5Department of Neuroscience and Brain Technologies, Istituto Italiano di Tecnologia (IIT), Genova, Italy,6Child Neuropsychiatry Unit, IRCCS Istituto Giannina Gaslini, Genova, Italy",P09.140,," Introduction : Genetic diagnosis of complex ASD cases is often difcult. Emerging evidence suggest s that various genetic compo nents can account for these cases according to an oligogenic model. After the observation of a patient with deleterious variants inmultiple genes (FrontGenet, https://doi.org/10.3389/ fgene.2021.625564 ), we extended the search for possible oligogenic mechanisms to a cohort of 30 ASD trio families. Methods : Whole exome sequencing was performed and potentially deleterious variants prioritized by custom ltering strategies including the use of ORVAL (Oligogenic Resource for Variant Analysis Platform) and enrichment analysis of candidategenes with GeneCodis4. Results : Two cases showed possible deleterious rare variants, each in 3 different genes. A male patient was carrying 2 maternally inherited variants, one hemizygous in BCOR and one heterozygous inMYO9B , genes associated to cognitive and behaviour impair ment. A third heterozygous paternally inherited variant affected HTR1E , a serotonin receptor hypothesized to play a role in autism like behaviour and sleep disturbance. The second case, anothermale patient, had 2 maternally inherited variants, one hemizygousinZC4H2 , associated to developmental delay, and one hetero zygous in ALDH5A1 , associated to behaviour and sleep impair ment. A further paternally inherited variant affected CPLX3 , involved in neurotransmitter release, hypothesized to be impli cated in neurodevelopmental delay. Implicated genes revealed enrichment in ASD associated biological processes and pathways.As our previously described patient, these two patients presentedcomplex ASD phenotype.Conclusions : About 10% of patients from our ASD cohort showed rare deleterious variants in multiple genes that seem to fully explain their complex phenotype.",2021.0,,M. Cerminara: None. M. Servetti: None. M. Squillario: None. L.,Pisciotta: None. G. Spirito: None. M.T. Divizia: None. M. Lerone:, Introduction : Genetic diagnosis of complex ASD cases is often difcult.,,ASD cases,[],"['ASD', 'case']"
859,566,"A Complex cases with Autism Spectrum Disorder (ASD), developmental delay, hyperactivity and sleep distur bance explained by oligogenic mechanisms Maria Cerminara 1, Martina Servetti1,2, Margherita Squillario2, Livia Pisciotta1,3, Giovanni Spirito4,5, Maria Teresa Divizia2, Margherita Lerone2, Elisa De Grandis1,6, Silvia Boeri6, Lino Nobili1,6, Diego Vozzi5, Remo Sanges4,5, Federico Zara1,2, Stefano Gustincich5, Aldamaria Puliti1,2 1Department of Neurosciences, Rehabil itation, Ophthalmology, Genetics, Maternal and Child Health (DiNOGMI ), University of Genova, Genova, Italy,2Medical Genetics Unit, IRCCS Istituto Giannina Gaslini, Genova, Italy,3Child Neuropsychiatry Unit, ASST Fatebenefratelli Sacco, Milano, Italy,4Area of Neuroscience, Scuola Int ernazionale Superiore di Studi Avanzati (SISSA), Trieste, Italy,5Department of Neuroscience and Brain Technologies, Istituto Italiano di Tecnologia (IIT), Genova, Italy,6Child Neuropsychiatry Unit, IRCCS Istituto Giannina Gaslini, Genova, Italy",P09.140,," Introduction : Genetic diagnosis of complex ASD cases is often difcult. Emerging evidence suggest s that various genetic compo nents can account for these cases according to an oligogenic model. After the observation of a patient with deleterious variants inmultiple genes (FrontGenet, https://doi.org/10.3389/ fgene.2021.625564 ), we extended the search for possible oligogenic mechanisms to a cohort of 30 ASD trio families. Methods : Whole exome sequencing was performed and potentially deleterious variants prioritized by custom ltering strategies including the use of ORVAL (Oligogenic Resource for Variant Analysis Platform) and enrichment analysis of candidategenes with GeneCodis4. Results : Two cases showed possible deleterious rare variants, each in 3 different genes. A male patient was carrying 2 maternally inherited variants, one hemizygous in BCOR and one heterozygous inMYO9B , genes associated to cognitive and behaviour impair ment. A third heterozygous paternally inherited variant affected HTR1E , a serotonin receptor hypothesized to play a role in autism like behaviour and sleep disturbance. The second case, anothermale patient, had 2 maternally inherited variants, one hemizygousinZC4H2 , associated to developmental delay, and one hetero zygous in ALDH5A1 , associated to behaviour and sleep impair ment. A further paternally inherited variant affected CPLX3 , involved in neurotransmitter release, hypothesized to be impli cated in neurodevelopmental delay. Implicated genes revealed enrichment in ASD associated biological processes and pathways.As our previously described patient, these two patients presentedcomplex ASD phenotype.Conclusions : About 10% of patients from our ASD cohort showed rare deleterious variants in multiple genes that seem to fully explain their complex phenotype.",2021.0,,M. Cerminara: None. M. Servetti: None. M. Squillario: None. L.,Pisciotta: None. G. Spirito: None. M.T. Divizia: None. M. Lerone:,"After the observation of a patient with deleterious variants inmultiple genes (FrontGenet, https://doi.org/10.3389/ fgene.2021.625564 ), we extended the search for possible oligogenic mechanisms to a cohort of 30 ASD trio families.",,ASD trio,[],"['ASD', 'trio']"
859,566,"A Complex cases with Autism Spectrum Disorder (ASD), developmental delay, hyperactivity and sleep distur bance explained by oligogenic mechanisms Maria Cerminara 1, Martina Servetti1,2, Margherita Squillario2, Livia Pisciotta1,3, Giovanni Spirito4,5, Maria Teresa Divizia2, Margherita Lerone2, Elisa De Grandis1,6, Silvia Boeri6, Lino Nobili1,6, Diego Vozzi5, Remo Sanges4,5, Federico Zara1,2, Stefano Gustincich5, Aldamaria Puliti1,2 1Department of Neurosciences, Rehabil itation, Ophthalmology, Genetics, Maternal and Child Health (DiNOGMI ), University of Genova, Genova, Italy,2Medical Genetics Unit, IRCCS Istituto Giannina Gaslini, Genova, Italy,3Child Neuropsychiatry Unit, ASST Fatebenefratelli Sacco, Milano, Italy,4Area of Neuroscience, Scuola Int ernazionale Superiore di Studi Avanzati (SISSA), Trieste, Italy,5Department of Neuroscience and Brain Technologies, Istituto Italiano di Tecnologia (IIT), Genova, Italy,6Child Neuropsychiatry Unit, IRCCS Istituto Giannina Gaslini, Genova, Italy",P09.140,," Introduction : Genetic diagnosis of complex ASD cases is often difcult. Emerging evidence suggest s that various genetic compo nents can account for these cases according to an oligogenic model. After the observation of a patient with deleterious variants inmultiple genes (FrontGenet, https://doi.org/10.3389/ fgene.2021.625564 ), we extended the search for possible oligogenic mechanisms to a cohort of 30 ASD trio families. Methods : Whole exome sequencing was performed and potentially deleterious variants prioritized by custom ltering strategies including the use of ORVAL (Oligogenic Resource for Variant Analysis Platform) and enrichment analysis of candidategenes with GeneCodis4. Results : Two cases showed possible deleterious rare variants, each in 3 different genes. A male patient was carrying 2 maternally inherited variants, one hemizygous in BCOR and one heterozygous inMYO9B , genes associated to cognitive and behaviour impair ment. A third heterozygous paternally inherited variant affected HTR1E , a serotonin receptor hypothesized to play a role in autism like behaviour and sleep disturbance. The second case, anothermale patient, had 2 maternally inherited variants, one hemizygousinZC4H2 , associated to developmental delay, and one hetero zygous in ALDH5A1 , associated to behaviour and sleep impair ment. A further paternally inherited variant affected CPLX3 , involved in neurotransmitter release, hypothesized to be impli cated in neurodevelopmental delay. Implicated genes revealed enrichment in ASD associated biological processes and pathways.As our previously described patient, these two patients presentedcomplex ASD phenotype.Conclusions : About 10% of patients from our ASD cohort showed rare deleterious variants in multiple genes that seem to fully explain their complex phenotype.",2021.0,,M. Cerminara: None. M. Servetti: None. M. Squillario: None. L.,Pisciotta: None. G. Spirito: None. M.T. Divizia: None. M. Lerone:,"Implicated genes revealed enrichment in ASD associated biological processes and pathways.As our previously described patient, these two patients presentedcomplex ASD phenotype.Conclusions : About 10% of patients from our ASD cohort showed rare deleterious variants in multiple genes that seem to fully explain their complex phenotype.",,ASD associated biological processes,[],"['ASD', 'associated', 'biological', 'process']"
859,566,"A Complex cases with Autism Spectrum Disorder (ASD), developmental delay, hyperactivity and sleep distur bance explained by oligogenic mechanisms Maria Cerminara 1, Martina Servetti1,2, Margherita Squillario2, Livia Pisciotta1,3, Giovanni Spirito4,5, Maria Teresa Divizia2, Margherita Lerone2, Elisa De Grandis1,6, Silvia Boeri6, Lino Nobili1,6, Diego Vozzi5, Remo Sanges4,5, Federico Zara1,2, Stefano Gustincich5, Aldamaria Puliti1,2 1Department of Neurosciences, Rehabil itation, Ophthalmology, Genetics, Maternal and Child Health (DiNOGMI ), University of Genova, Genova, Italy,2Medical Genetics Unit, IRCCS Istituto Giannina Gaslini, Genova, Italy,3Child Neuropsychiatry Unit, ASST Fatebenefratelli Sacco, Milano, Italy,4Area of Neuroscience, Scuola Int ernazionale Superiore di Studi Avanzati (SISSA), Trieste, Italy,5Department of Neuroscience and Brain Technologies, Istituto Italiano di Tecnologia (IIT), Genova, Italy,6Child Neuropsychiatry Unit, IRCCS Istituto Giannina Gaslini, Genova, Italy",P09.140,," Introduction : Genetic diagnosis of complex ASD cases is often difcult. Emerging evidence suggest s that various genetic compo nents can account for these cases according to an oligogenic model. After the observation of a patient with deleterious variants inmultiple genes (FrontGenet, https://doi.org/10.3389/ fgene.2021.625564 ), we extended the search for possible oligogenic mechanisms to a cohort of 30 ASD trio families. Methods : Whole exome sequencing was performed and potentially deleterious variants prioritized by custom ltering strategies including the use of ORVAL (Oligogenic Resource for Variant Analysis Platform) and enrichment analysis of candidategenes with GeneCodis4. Results : Two cases showed possible deleterious rare variants, each in 3 different genes. A male patient was carrying 2 maternally inherited variants, one hemizygous in BCOR and one heterozygous inMYO9B , genes associated to cognitive and behaviour impair ment. A third heterozygous paternally inherited variant affected HTR1E , a serotonin receptor hypothesized to play a role in autism like behaviour and sleep disturbance. The second case, anothermale patient, had 2 maternally inherited variants, one hemizygousinZC4H2 , associated to developmental delay, and one hetero zygous in ALDH5A1 , associated to behaviour and sleep impair ment. A further paternally inherited variant affected CPLX3 , involved in neurotransmitter release, hypothesized to be impli cated in neurodevelopmental delay. Implicated genes revealed enrichment in ASD associated biological processes and pathways.As our previously described patient, these two patients presentedcomplex ASD phenotype.Conclusions : About 10% of patients from our ASD cohort showed rare deleterious variants in multiple genes that seem to fully explain their complex phenotype.",2021.0,,M. Cerminara: None. M. Servetti: None. M. Squillario: None. L.,Pisciotta: None. G. Spirito: None. M.T. Divizia: None. M. Lerone:,"Implicated genes revealed enrichment in ASD associated biological processes and pathways.As our previously described patient, these two patients presentedcomplex ASD phenotype.Conclusions : About 10% of patients from our ASD cohort showed rare deleterious variants in multiple genes that seem to fully explain their complex phenotype.",,ASD phenotype,[],"['ASD', 'phenotype']"
859,566,"A Complex cases with Autism Spectrum Disorder (ASD), developmental delay, hyperactivity and sleep distur bance explained by oligogenic mechanisms Maria Cerminara 1, Martina Servetti1,2, Margherita Squillario2, Livia Pisciotta1,3, Giovanni Spirito4,5, Maria Teresa Divizia2, Margherita Lerone2, Elisa De Grandis1,6, Silvia Boeri6, Lino Nobili1,6, Diego Vozzi5, Remo Sanges4,5, Federico Zara1,2, Stefano Gustincich5, Aldamaria Puliti1,2 1Department of Neurosciences, Rehabil itation, Ophthalmology, Genetics, Maternal and Child Health (DiNOGMI ), University of Genova, Genova, Italy,2Medical Genetics Unit, IRCCS Istituto Giannina Gaslini, Genova, Italy,3Child Neuropsychiatry Unit, ASST Fatebenefratelli Sacco, Milano, Italy,4Area of Neuroscience, Scuola Int ernazionale Superiore di Studi Avanzati (SISSA), Trieste, Italy,5Department of Neuroscience and Brain Technologies, Istituto Italiano di Tecnologia (IIT), Genova, Italy,6Child Neuropsychiatry Unit, IRCCS Istituto Giannina Gaslini, Genova, Italy",P09.140,," Introduction : Genetic diagnosis of complex ASD cases is often difcult. Emerging evidence suggest s that various genetic compo nents can account for these cases according to an oligogenic model. After the observation of a patient with deleterious variants inmultiple genes (FrontGenet, https://doi.org/10.3389/ fgene.2021.625564 ), we extended the search for possible oligogenic mechanisms to a cohort of 30 ASD trio families. Methods : Whole exome sequencing was performed and potentially deleterious variants prioritized by custom ltering strategies including the use of ORVAL (Oligogenic Resource for Variant Analysis Platform) and enrichment analysis of candidategenes with GeneCodis4. Results : Two cases showed possible deleterious rare variants, each in 3 different genes. A male patient was carrying 2 maternally inherited variants, one hemizygous in BCOR and one heterozygous inMYO9B , genes associated to cognitive and behaviour impair ment. A third heterozygous paternally inherited variant affected HTR1E , a serotonin receptor hypothesized to play a role in autism like behaviour and sleep disturbance. The second case, anothermale patient, had 2 maternally inherited variants, one hemizygousinZC4H2 , associated to developmental delay, and one hetero zygous in ALDH5A1 , associated to behaviour and sleep impair ment. A further paternally inherited variant affected CPLX3 , involved in neurotransmitter release, hypothesized to be impli cated in neurodevelopmental delay. Implicated genes revealed enrichment in ASD associated biological processes and pathways.As our previously described patient, these two patients presentedcomplex ASD phenotype.Conclusions : About 10% of patients from our ASD cohort showed rare deleterious variants in multiple genes that seem to fully explain their complex phenotype.",2021.0,,M. Cerminara: None. M. Servetti: None. M. Squillario: None. L.,Pisciotta: None. G. Spirito: None. M.T. Divizia: None. M. Lerone:,"Implicated genes revealed enrichment in ASD associated biological processes and pathways.As our previously described patient, these two patients presentedcomplex ASD phenotype.Conclusions : About 10% of patients from our ASD cohort showed rare deleterious variants in multiple genes that seem to fully explain their complex phenotype.",,ASD cohort,[],"['ASD', 'cohort']"
863,672,"A Detection of a rare ADNP variant causing Helsmoortel van der Aa syndrome: A Case Report Boban Dobrevski 1, Aleksandar Petlichkovski1, Meri Kirijas1, Gorjan Milanovski1, Todor Arsov1, Teodora Brnjarchevska Blazevska1, Olivija Enska Mladenovska1, Olgica Sibinovska1, Elena Shukarova Angelovska2 1Ss",P11.059,," Cyril and Methodius University in Skopje, Faculty of Medicine Skopje, Institute of Immunobiology and Human Genetics, Skopje, Macedonia, The Former Yugoslav Republic of,2Ss. Cyril and Methodius University in Skopje, Faculty of Medicine Skopje, PHIUniversity Clinic for child diseases, Skopje, Macedonia, The Former Yugoslav Republic of. Introduction: Helsmoortel van der Aa syndrome, or Intellectual Disability Autosomal Dominant 28 (MDR28, OMIM 61 5873) is a rare neurodevelopmental genetic disorder affecting about 1 9/100 000 individuals (0.17% of patients with i ntellectual disability and autism). The broad and variable spectrum of clinical manifestations includesglobal developmental delay, autistic features and neuropsychiatric or behavioral issues, seizures and distinct dysmorphic facial features. We report a case of a nine month old girl with delayed motordevelopment (delays in sitting and holding head up), general hypotonia, dysmorphic facial featur es (prominent forehead, discrete strabismus) and noticeable happy demeanor. Materials and Methods: The initial metabolic screen and array CGH results were normal and the additional genetic testing included an NGS gene panel of 37 spinal muscular atrophy associated genes (AARS1, ASAH1, ASCC1, ATP7A, BICD2, BSCL2,CHCHD10, DCTN1, DNAJB2, DYNC1H1, EMILIN1, EXOSC3, EXOSC8,FBXO38, GARS1, HEXA, HSPB1, HSPB3, HSPB8, IGHMBP2, LAS1L, PLEKHG5, RBM7, REEP1, SCO2, SETX, SIGMAR1, SLC25A21, SLC5A7, SPTAN1, SYT2, TRIP4, TRPV4, UBA1, VAPB, VRK1, WARS1) includingADNP using Illumina NGS platform, SMN1/SMN2 deletion/duplica tion by MLPA and AR repeat by PCR analysis. Results: The genetic testing identi ed a heterozygous patho genic ADNP frameshift variant c.539_542delTTAG, p.Val180 Glyfs 17, not present in the databases of human genetic variation (gnomAD) and reported as pathogenic in 6 other cases (ClinVar). The variant is predicted to create a premature stopcodon and protein truncation and results in a loss of function ofADNP, affecting chromatin packing and transcription. Conclusion: New sequencing technologies, such as gene panel testing, allow early diagnosis and better management of raregenetic diseases.",2021.0,,B. Dobrevski: None. A. Petlichkovski: None. M. Kirijas: None.,G. Milanovski: None. T. Arsov: None. T. Brnjarchevska,"The broad and variable spectrum of clinical manifestations includesglobal developmental delay, autistic features and neuropsychiatric or behavioral issues, seizures and distinct dysmorphic facial features.",,autistic features,[],"['autistic', 'feature']"
864,678,D Diagnosis and veri cation of the autosomal dominant form of Kabuki makeup syndrome in a child with congenital heart disease,P11.066,," Clinical case Iryna Lastivka 1, Vita Antsupova2, Ljudmila Brisevac3, Larysa Sheiko3, Iana Ushko2, Volodymyr Davydiuk4Abstracts from the 54thEuropean Society of Human Genetics (ESHG) Conference 344 European Journal of Human Genetics (2022) 30:88  6081Bukovinian State Medical University, Chernivtsi, Ukraine,2Bohomo lets National Medical University, Kyiv, Ukraine,3Shupyk National Medical Academy of Postgraduate Education, Kyiv, Ukraine, 4National Pirogov Memorial Medical University, Vinnitsa, Ukraine. Introduction: Kabuki Makeup Syndrome (KMS) OMIM 147920 is a rare genetic disease characterized by phenotypic traits, mental retardation, and autistic symptoms. KMS is caused by pathogenicmutations in the genes KMT2D, KDM6A. Mutation of the KMT2Dgene is inherited by autosomal dominant type; mutation of the KDM6A gene is inherited X linked dominantly. Materials and Methods: A clinical case of KMS in a 2 year old girl. Syndromological, ""Face2gene"", cytogenetic, moleculargenetic, instrumental methods of examination were used. Results: Girl from the third planned pregnancy; which was on the background of the threat of miscarriage, polyhydramnios,hypothyroidism. The baby was born at 36 weeks of pregnancy weighing 2930 g, length 49 cm, on the Apgar scale 8/8 points. Phenotype: cleft palate, protruding ear shells, arched eyebrows,long oblique eye slits, blue sclera, epicanthus, ectropion of thelower eyelids, wide tip of the nose, hypoplasia of the nails on the V ngers of the wrists of the hands, congenital, muscular hypotension, delay of stato kinetic development. Syndromologicaldiagnostics was performed using the diagnostic program ""Face2 gene""; suspected KMS; cytogenetic, molecular genetic research is recommended to verify the diagnosis. Karyotype of a child 46,XX. Molecular genetic analysis revealed a pathogenic mutation(c.11884C>T) (p.Gln3962 ) in the KMT2D gene, which is associated with an autosomal dominant type of KMS (MedGen UID: 893727). Conclusions: Diagnosis of KMS is possible by speci c pheno typic characteristics. Veri cation of the diagnosis is based on the results of molecular genetic analysis. The prognosis of this disease depends on the severity of heart disease and intelligence.",2021.0,,I. Lastivka: None. V. Antsupova: None. L. Brisevac: None. L.,Sheiko: None. I. Ushko: None. V. Davydiuk: None.,"Introduction: Kabuki Makeup Syndrome (KMS) OMIM 147920 is a rare genetic disease characterized by phenotypic traits, mental retardation, and autistic symptoms.",,autistic symptoms,[],"['autistic', 'symptom']"
869,1026,"D Mosaicism: challenges for next generation sequen cing analysis Louisa Sanchez 1, Evelyn Douglas1, David Lawrence2, Julien Soubrier1, Song Gao1, Lesley McGregor3, Christopher Barnett3, Karin Kassahn1, Sui Yu1, Kathryn Friend1 1SA Pathology, North Adelaide, Australia,2CCB ACRF Cancer Genomics Facility, Adelaide, Australia,3Women s and Children s Hospital, North Adelaide, Australia",P16.017,," It has been estimated that 0.5 8.3% of apparently de novo pathogenic variants in autosomal dominant disorders are in fact inherited from a parent with low level mosaicism for the variant (variant allele frequency (VAF) of 2 29%). This has signi cant implications for recurrence risk in future pregnancies, and therefore must be given due consideration when analysing next generation sequencing (NGS) data. Automated trio analysis pipelines ltering for de novo variants may discard these variants as inherited, depending on their parameters. A secondary analysis comparing VAF in the proband and apparently unaffected parents can be used to identify theseinherited de novo variants in clinically relevant genes. Using this approach, we have detected a mosaic TGFBR2 variant (VAF of 20%) in a clinically unaffected individual with multiple children with Marfan syndrome. It has also lead to the identi cation of a heterozygous HECW2 variant in a patient with intellectual disability and severe autistic features. The patient s clinically unaffected father was mosaic for this change (VAF of 30%). Additional challenges surrounding the identi cation of mosai cism in NGS data include determining the clinical signi cance of variants detected with a low VAF in affected probands, and analysis of appropriate tissue types in cases of suspected somaticmosaicism.L. Sanchez: None. E. Douglas: None. D. Lawrence: None. J. Soubrier: None. S. Gao: None. L. McGregor: None. C. Barnett: None. K. Kassahn: None. S. Yu: None. K. Friend: None.",2021.0,,,,It has also lead to the identi cation of a heterozygous HECW2 variant in a patient with intellectual disability and severe autistic features.,,autistic features,[],"['autistic', 'feature']"
873,3," A cross disorder dosage sensitivity map of the human genome Ryan Lewis Collins 1, Joseph T",PL2.3,," Glessner2, Eleonora Porcu3, Lisa Marie Niestroj4, Jacob Ulirsch5, Georgios Kellaris6, Daniel P. Howrigan5, Selin Everett1, Kiana Mohajeri1, Xander Nuttle1, Chelsea Lowther1, Jack Fu1, Philip M. Boone1, Farid Ullah6, Kaitlin E. Samocha7, Konrad Karczewski5, Diane Lucente1, The Epi25 Consortium, James F. Gusella1, Hilary Finucane5, Ludmilla Matyakhina8, Swaroop Ara dhya9, Jeanne Meck8, Dennis Lal4, Benjamin M. Neale5, Jennelle C.Hodge10, Alexandre Reymond3, Zoltan Kutalik3, Nicholas Katsanis6, Erica E. Davis6, Hakon Hakonarson2, Shamil Sunyaev11, Harrison Brand1, Michael E. Talkowski1 1Massachusetts General Hospital, Boston, MA, USA,2Children s Hospital of Philadelphia, Philadelphia, PA, USA,3University of Lausanne, Lausanne, Switzerland,4University of Cologne, Cologne, Germany,5Broad Institute of Massachusetts Institute of Technology (M.I.T.) and Harvard, Cambridge, MA, USA,6Lurie Children s Hospital, Chicago, IL, USA,7Wellcome Sanger Institute, Hinxton, United Kingdom,8GeneDx, Inc., Gaithersburg, MD, USA,9Invitae Corp., Cambridge, MA, USA,10Indiana University School of Medicine, Indianapolis, IN, USA,11Brigham and Women s Hospital, Boston, MA, USA. Rare copy number variants (rCNVs) contribute to a broad spectrum of human diseases. Most disease association studies ofrCNVs have focused on haploinsuf ciency caused by deletions, while our understanding of triplosensitivity caused by duplications remains rudimentary. We meta analyzed rCNVs from 753,994individuals across 30 primarily neurological disease phenotypes todiscover 114 rCNV disease associations at 52 distinct loci surpassing genome wide signi cance ( P,3.72x10 6), 42% of which involve duplications. Further, we statistically ne mapped 38 novel triplosensitive disease genes ( e.g.,GMEB2 ), including three known haploinsuf cient genes that we now reveal as bidirectionally dosage sensitive ( e.g.,ANKRD11 ). We found that disease associated rCNV segments were enriched for genesconstrained against damaging coding variation and identi ed likely dominant driver genes for about one third (32%) of rCNV segments based on de novo mutations from exome sequencing studies of developmental disorders. However, most of the rCNVsshowing genome wide signi cant association were incompletely penetrant (mean odds ratio ,11.6) and we also identi ed two examples of noncoding disease associated rCNVs ( e.g., intronic CADM2 deletions). Finally, we developed a statistical model to predict dosage sensitivity for all genes, which de ned 3,006 haploinsuf cient and 295 triplosensitive genes where the effect sizes of rCNVs were comparable to deletions of genes constrainedagainst truncating mutations. These dosage sensitivity scores classi ed disease genes across molecular mechanisms, prioritized pathogenic de novo rCNVs in children with autism, and revealed features that distinguished haploinsuf cient and triplosensitive genes. Collectively, the cross disorder rCNV maps and metrics derived here set the foundation for future studies of dosage sensitivity throughout the human genome.",2021.0,,R.L. Collins: None. J.T. Glessner: None. E. Porcu: None. L.,Niestroj: None. J. Ulirsch: None. G. Kellaris: None. D.P.,"These dosage sensitivity scores classi ed disease genes across molecular mechanisms, prioritized pathogenic de novo rCNVs in children with autism, and revealed features that distinguished haploinsuf cient and triplosensitive genes.",children with autism,,"['child', 'with', 'autism']",[]
880,91," A combined omic analysis revealed autism linked NLGN3 as a new candidate gene associated to GnRH neuron development and disease Roberto Oleari1, Antonella Lettieri1, Stefano Manzini1, Alyssa J",C05.3,," J. Paganoni1, Paolo Grazioli2, Marco Busnelli1, Helen L. Storr3, Valentina Massa2, Sasha R. Howard4,Anna Cariboni1 1Department of Pharmacological and Biomolecular Sciences, Milan, Italy,2Department of Health Sciences, University of Milan, Milan, Italy, Milan, Italy,3Queen Mary University of London, London, United Kingdom,4Queen Mary University of London, Milan, United Kingdom. During development, gonadotropin releasing hormone (GnRH) neurons are born in the nasal placode and migrate to the hypothalamus, where they position to regulate sexual reproduc tion. Defective GnRH neuron development may lead to GnRH deciency (GD) which is characterized by absent or delayed puberty. Several GD causative genes have been identi ed so far, but half of the cases are still idiopathic. The employment ofcomplementary research approaches may be useful to identify additional genes implicated in GD pathogenesis. Here we combined for the rst time in the eld the transcriptomic analysis of GnRH neurons with exome sequencing data from GD patientsto identify novel candidate genes. As a proof of principle, we identi ed a pathogenic variant in the autism linked Neuroligin 3 (NLGN3 ) gene in a patient with severe delayed puberty and autistic traits. We demonstrated that NLGN3 is enriched in GnRH neurons at late developmental stages. Further we found that NLGN3 overexpression in an immature model of immortalizedGnRH neurons promoted neurite extension whereas the novelNLGN3 mutation formed a truncated protein, thus supporting its pathogenic potential. Overall, our results highlighted how the combination of gene expression and exome sequencing data is areliable approach to identify novel candidate gene for GD such aNLGN3, an autism linked gene that we found for the rst time associated to GD.",2021.0,,R. Oleari: None. A. Lettieri: None. S. Manzini: None. A.J.J.,Paganoni: None. P. Grazioli: None. M. Busnelli: None. H.L. Storr:,"As a proof of principle, we identi ed a pathogenic variant in the autism linked Neuroligin 3 (NLGN3 ) gene in a patient with severe delayed puberty and autistic traits.",,autistic traits,[],"['autistic', 'trait']"
887,187,,,,"C54Loss of desmoplakin isoform I causes severe  in neurons may be involved in the pathogenesis in a subset of  arrhythmogenic left and right ventricular cardiomyopathy,  individuals with autism. The involvement of these three genes in the  palmoplantar keratoderma and woolly hair regulated secretory pathway is currently under study by means of  E. E. Norgett1, A. Uz\x9emc\x9e2, O. Uyguner2, A. Dindar3, H. Kayserili2, K. Nisli3, E.  RNAi-mediated gene knock-down. Dupont4, N. Severs4, M. Yuksel-Apak2, D. P. Kelsell1, B. Wollnik2  1Institute of Cell and Molecular Science, Barts and The London School  ",2004.0,,,,"C54Loss of desmoplakin isoform I causes severe  in neurons may be involved in the pathogenesis in a subset of  arrhythmogenic left and right ventricular cardiomyopathy,  individuals with autism.",individuals with autism,,"['individual', 'with', 'autism']",[]
891,261,,,,"P0025Mutations of the TBX5 gene in patients with Holt-Oram  syndrome had increased risk for CHD (p<0.05). However there was  syndrome no statistical relationship between advanced maternal age and the  W. Heinritz1, A. Kujat1, S. Spranger2, H. Heilbronner3, S. Demuth4, A. Bier5, M.  presence of CHD. Tihanyi6, S. Mundlos7, C. Gruenauer-Kloevekorn8, U. G. Froster1  Sixteen patients had normal physical examination but an abnormal  1Institute of Human Genetics, University of Leipzig, Leipzig, Germany, 2Private  echocardiogram 9 patients had ASD secundum, 2 had isolated VSD,  Practice of Human Genetics, Bremen, Germany, 3Olga Hospital, Stuttgart,  2 had inlet VSD and one had pulmoner stenosis. We noticed that  Germany, 4Private Practice of Human Genetics, Erfurt, Germany, 5University of  these defects were not serious cardiopathies. Technology, Dresden, Germany, 6Zala County Hospital, Zalaegerszeg, Hungary,  In conclusion every patient with DS should have cardiac evaluation  7Institute of Medical Genetics at the Charite - Campus Virchow, Berlin, Germa- including the echocardiographical examination, especially during  ny, 8Dept. of Ophthalmology at the Martin-Luther-University, Halle, Germany. the newborne period. However",2004.0,,,,"Tihanyi6, S. Mundlos7, C. Gruenauer-Kloevekorn8, U. G. Froster1  Sixteen patients had normal physical examination but an abnormal  1Institute of Human Genetics, University of Leipzig, Leipzig, Germany, 2Private  echocardiogram 9 patients had ASD secundum, 2 had isolated VSD,  Practice of Human Genetics, Bremen, Germany, 3Olga Hospital, Stuttgart,  2 had inlet VSD and one had pulmoner stenosis.",,ASD secundum,[],"['ASD', 'secundum']"
892,326,,,,"P0068Early hematopoietic zinc nger gene (EHZF) is disrupted  The patient was mentally severely retarded otherwise her phenotype  in a boy with multiple congenital anomalies, autism and mental  was the same as 19 years before. The ultrasound examination of the  retardation. pelvic region demonstrated no ovarian and uterus-like structures. At  L. Castiglia, D. Luciano, O. Galesi, M. Fichera, L. Grillo, D. Greco, C. Romano  the cytogenetic analysis at 550 band resolution 45,X/46,X,idic(Xq)/ Oasi Institute for Research on Mental Retardation, Troina, Italy. 47,X,idic(Xq),idic(Xq) (8%/87%/5%) karyotype was proved. A 3-year-old boy with multiple congenital anomalies, mental  The correlation of genotypic and phenotypic ndings at the  retardation and autistic behaviour was previously reported to carry  examinations performed at two different times is striking. Namely, at  a de novo reciprocal translocation: 46, XY, rcp (218)(p13q11.2).  the age of 13 mental development was at average and no bleeding  He had intrauterine growth retardation, microcephaly at birth and  disorder was established, while at present severe mental retardation  low birthweight. An history of frequent upper respiratory infections  and mild hemophilia A were veried.Clinical genetics 96 is associated with a reversed CD4/CD8 ratio. The phenotype is now  were normal. She was hypotonic and hypermobile, and her gait  made up of microcephaly, narrow forehead with frontal bossing,  was ataxic. Neither dystopia canthorum nor iris heterochromia were  hypertelorism, epicanthic folds, long ears, at philtrum, cupid bow  noted, but there was moderate retinal depigmentation. Sweat, saliva  mouth, narrow palate, single palmar crease on the left hand and 5th- and tears were normally produced. Cardiovascular investigations  nger clinodactyly. were normal, as well as anorectal manometry. Brain MRI showed  Using BAC clones, we mapped the translocation breakpoints  hypersignals in the periventricular region. Mutation screening of  using uorescence in situ hybridisation (FISH). Two overlapping  SOX10 revealed a de novo heterozygous mutation (",2004.0,,,,"A 3-year-old boy with multiple congenital anomalies, mental  The correlation of genotypic and phenotypic ndings at the  retardation and autistic behaviour was previously reported to carry  examinations performed at two different times is striking.",,autistic behaviour,[],"['autistic', 'behaviour']"
894,376,,,,"P0100The Results of Cytogenetic Analysis in 150 Autistic  ULB, Brussels, Belgium, 9Hopital Erasme, Brussels, Belgium. Patients BOF syndrome consists of branchial defect, dysmorphic face  M. Havlovicov\x861, D. Novotn\x861, E. Koc\x86rek1, M. Hrdlicka2, Z. Sedl\x86cek1  (dolichocephaly, sparse hair, high forehead, malar hypoplasia, small  1Institute of Biology and Medical Genetics, 2nd Medical Faculty, University  chin), ocular anomaly (asymmetry, coloboma, microphtalmia), wide  Hospital Motol, Prague, Czech Republic, 2Department of Child Psychiatry, 2nd  nasal bridge, prominent nose, abnormal upper lip and philtrum,  Medical School, University Hospital Motol, Prague, Czech Republic. some type of cleft (lip, palate, pseudocleft) and renal anomaly. Pre- The autistic disorder was rst described by Leo Kanner sixty years  , postnatal growth retardation, developmental and mental delay  ago. This complex developmental disability is characterized by  are associated ndings. Presence of thymic remnant in cervical  social and communicative impairments, repetitive and stereotyped  tissue could be characteristic. Autosomic dominant inheritance was  behaviours and interests. The prevalence of autism in the general  postulated but no causal gene was identied so far. Mutations in  population is about 1 in 1000 with four males affected for one female.  Eya1 gene - implicated in branchio-oto-renal (BOR) syndrome- were  In approximately 15% of the cases, autism is associated with known  not found in BOF syndrome. We present two unrelated infants with  genetic disorders. probable BOF syndrome born from non-consanguineous healthy  Nearly one third of the specic genetic causes of autism are due to  parents. Both patients developed the above described dysmorphism,  chromosomal disorders. They account for less than 5% of all cases of  microphtalmia, feeding difculty and hypotonia but no hemangioma.  autism, although this estimate varies. Patient 1 presented with pseudocleft, right branchial mass and  We performed a detailed genetic analysis of 150 autistic patients  an unilateral pyelo-ureteral junction stenosis. The histology of the  focused on cytogenetic investigation. In our cohort, 7 subjects were  entire cervical lesion failed to identify thymic remnant (branchial  identied as having chromosome anomalies (4.7%). One patient  cyst). Patient 2 presented facial asymmetry, left renal agenesis and  exhibited a de novo balanced translocation, 2 patients inherited a  hypoplastic ",2004.0,,,,"Pre- The autistic disorder was rst described by Leo Kanner sixty years  , postnatal growth retardation, developmental and mental delay  ago.",,autistic disorder,[],"['autistic', 'disorder']"
894,376,,,,"P0100The Results of Cytogenetic Analysis in 150 Autistic  ULB, Brussels, Belgium, 9Hopital Erasme, Brussels, Belgium. Patients BOF syndrome consists of branchial defect, dysmorphic face  M. Havlovicov\x861, D. Novotn\x861, E. Koc\x86rek1, M. Hrdlicka2, Z. Sedl\x86cek1  (dolichocephaly, sparse hair, high forehead, malar hypoplasia, small  1Institute of Biology and Medical Genetics, 2nd Medical Faculty, University  chin), ocular anomaly (asymmetry, coloboma, microphtalmia), wide  Hospital Motol, Prague, Czech Republic, 2Department of Child Psychiatry, 2nd  nasal bridge, prominent nose, abnormal upper lip and philtrum,  Medical School, University Hospital Motol, Prague, Czech Republic. some type of cleft (lip, palate, pseudocleft) and renal anomaly. Pre- The autistic disorder was rst described by Leo Kanner sixty years  , postnatal growth retardation, developmental and mental delay  ago. This complex developmental disability is characterized by  are associated ndings. Presence of thymic remnant in cervical  social and communicative impairments, repetitive and stereotyped  tissue could be characteristic. Autosomic dominant inheritance was  behaviours and interests. The prevalence of autism in the general  postulated but no causal gene was identied so far. Mutations in  population is about 1 in 1000 with four males affected for one female.  Eya1 gene - implicated in branchio-oto-renal (BOR) syndrome- were  In approximately 15% of the cases, autism is associated with known  not found in BOF syndrome. We present two unrelated infants with  genetic disorders. probable BOF syndrome born from non-consanguineous healthy  Nearly one third of the specic genetic causes of autism are due to  parents. Both patients developed the above described dysmorphism,  chromosomal disorders. They account for less than 5% of all cases of  microphtalmia, feeding difculty and hypotonia but no hemangioma.  autism, although this estimate varies. Patient 1 presented with pseudocleft, right branchial mass and  We performed a detailed genetic analysis of 150 autistic patients  an unilateral pyelo-ureteral junction stenosis. The histology of the  focused on cytogenetic investigation. In our cohort, 7 subjects were  entire cervical lesion failed to identify thymic remnant (branchial  identied as having chromosome anomalies (4.7%). One patient  cyst). Patient 2 presented facial asymmetry, left renal agenesis and  exhibited a de novo balanced translocation, 2 patients inherited a  hypoplastic ",2004.0,,,,"Patient 1 presented with pseudocleft, right branchial mass and  We performed a detailed genetic analysis of 150 autistic patients  an unilateral pyelo-ureteral junction stenosis.",,autistic patients,[],"['autistic', 'patient']"
895,395,,,,"P0107An additional case of the KBG syndrome 1Department of Pediatrics, University of Tartu, Tartu, Estonia, 2Tallinns Children  B. Demeer1, N. Bednarek2, Z. Belkadi3, M. Khoury3, C. Eschard4, D. Gaillard5,  Hospital, Tallinn, Estonia, 3Childrens Clinic, Tartu University Clinics, Tartu,  M. Doco-Fenzy1  Estonia, 4Department of Human Biology and Genetics, University of Tartu,  1Genetic Department, CHRU, Reims, France, 2Pediatric Department B,  Tartu, Estonia, 5Medical Genetics Center, United Laboratories, Tartu University  Childrens Hospital, Reims, France, 3Pediatric Department, CHG, Laon,  Clinics, Tartu, Estonia. France, 4Pediatric Department A , Childrens Hospital, Reims, France, 5genetic  Prader-Willi syndrome (PWS) is a genetic disorder characterized  department, CHRU, Reims, France. by obesity, acromicria, mental retardation and hypogonadism.  We report the case of a child who was sent for genetic diagnosis  In neonatal age PWS is expressed differently, mainly by severe  on the association of growth retardation, facial dysmorphism and  muscular hypotonia and feeding difculties. Some authors have  mental retardation. Pregnancy had been complicated by oligoamnios,  described neonatal presentation of PWS, but most of them have not  unique ombilical artery and severe intrauterine growth retardation.  focused on distinctive craniofacial features and have not presented  His mother suffered from a unilateral hearing loss and her height was  photographs. We introduce here 4 newborns with PWS diagnosed  at -1,5 SD. The patient was born prematurely by caesarean section  during 1st month of age and present their photographs. at 29 GW (BW: 650g, BL: 31 cm, BHC: 24.8 cm ). At 4 years of  All four patients (3f/1m) were born at term. Two of them had low  age, the boy showed growth delay (-2SD) and a characteristic facial  birth weight (2316g and 2700g) and cephalhaematomas. Soon  appearance including broad forehead, hypertelorism, strabismus,  after birth all patients showed apathy or lethargy, central muscular  slight mongoloid slanting of the palpebral ssures, marked  hypotonia, almost absent weak cry, no interest to food, aided feeding  anteversion of the nostrils, and retrognathia. Lips were thin and the  and termolability. Their faces were hypomimic with insufcient  upper lip was shaped like a hunters bow. He had malpositionned  opening of the eyes. They had distinctive facial features, high  medial superior teeth and oligodontia. His hands were short. The  prominent forehead, narrow bifrontal diameter, down-turned corners  subcutaneous fatty tissue was not much developed and he had  of the mouth, micrognathia and dysplastic ears. The last case was  caf\x8d au lait spots on his back, his hair was thick. He had severe  recognized immediately due to the similarity with the third one. In  developmental delay with speech defect and autistic features. He  one patient the PWS was caused by 15q11-13 microdeletion, in one  suffered from night myoclonies and partial seizures. by unbalanced 1415 translocation causing 15q11-13 microdeletion  Investigations showed a pelvic left kidney on the intravenous  and in two by maternal UPD15.Four years ago we started systematic  urography, enlarged sub-arachnoidal spaces on brain MRI,  search for PWS patients in Estonia. Attention to the complex clinical  brachycephaly and fused ",2004.0,,,,In  developmental delay with speech defect and autistic features.,,autistic features,[],"['autistic', 'feature']"
896,409,,,,"S424 , at Xq23-24 in one family with  cryptogenic epilepsy. affected male members presented with non-specic MR and  Objective: practically healthy boy at 10 years stopped in psychomotor  verbal disability. We report three generations of single family with  development, then the cognitive disorders increased. In 13 years  cytogenetically visible deletion of Xq23 region.Case report: The  darkening of the skin has developed, hyperpigmentation of nipples  36-year-old pregnant woman was referred to genetic counselling  and genitalia. From 14 years the patient has monthly primary- because of MR and autism in her family. Her parents were second- generalized tonic-clonic epileptic seizures, which are appearing  degree cousins. Three brothers were severely mentally retarded one  after arousing or falling asleep. At the checkup in 16 years the  showing autistic behaviour. The Fragile X syndrome was excluded.  local neurological signs are absent, the subcortical dementia is  The patient and her mother showed the same karyotype: 46,X,delX(q revealled, psychomotor disorders too. Cerebral T2-weighted MR  23),t(112)(p36.2q24.31). The same interstitial deletion was found in  demonstrates conuent, symmetrical, hyperintense lesions of the  both brothers. An unbalanced translocation resulting in partial trisomy  white matter bilaterally. Adrenals on RCT reduce in size, cortex is  1p and monosomy 12q was found in autistic brother. The cytogenetic  thin. In blood analyses: ACTH 377,8 pmol/l (N - 2,2-13,4), cortisol  analysis of amniotic uid cells revealed an affected male fetus with  144,0 nmol/l (N - 190-650). In t urine analyses: general cortisol 228  interstitional deletion Xq23 and balanced translocation 1p12q. The  nmol/day (N - 300-750). EEG: diffuse disorders of electrical activity,  pregnancy was terminated.Conclusion: Our family represents the  epileptiform activity not revealled. Treatment: substitute glucocorticoid  further evidence that certain regions of the X chromosome were  therapy. Never got of systematic antiepileptic treatment. After  enriched for genes responsible for MR. We propose that Xq23  starting Depakine Chrono 1500 mgs a day therapy the sezures  region should be considered for precise cytogenetic and molecular  are stopped, but the phenomenas of adrenal insufciency and  diagnosis in such cases. The involvement of 1p and 12q region in the  dementia are increasing.Conclusion: Synthetic ACTH analogues are  peculiar phenotype of one brother, showing also elements of autism,  used as antiepileptic drugs in some forms of epilepsies. Possible,  indicate the need for further analysis. The molecular analysis will be  hyperproduction of ACTH is explained the rarity of epileptic sezures  performed in order to get precise information about breakpoint sites  at ALD. However, it is necessary to take a possibility of presence of  and chromosomal segments involved. epilepsy.Clinical genetics 107 ",2004.0,,,,At the checkup in 16 years the  showing autistic behaviour.,,autistic behaviour,[],"['autistic', 'behaviour']"
896,409,,,,"S424 , at Xq23-24 in one family with  cryptogenic epilepsy. affected male members presented with non-specic MR and  Objective: practically healthy boy at 10 years stopped in psychomotor  verbal disability. We report three generations of single family with  development, then the cognitive disorders increased. In 13 years  cytogenetically visible deletion of Xq23 region.Case report: The  darkening of the skin has developed, hyperpigmentation of nipples  36-year-old pregnant woman was referred to genetic counselling  and genitalia. From 14 years the patient has monthly primary- because of MR and autism in her family. Her parents were second- generalized tonic-clonic epileptic seizures, which are appearing  degree cousins. Three brothers were severely mentally retarded one  after arousing or falling asleep. At the checkup in 16 years the  showing autistic behaviour. The Fragile X syndrome was excluded.  local neurological signs are absent, the subcortical dementia is  The patient and her mother showed the same karyotype: 46,X,delX(q revealled, psychomotor disorders too. Cerebral T2-weighted MR  23),t(112)(p36.2q24.31). The same interstitial deletion was found in  demonstrates conuent, symmetrical, hyperintense lesions of the  both brothers. An unbalanced translocation resulting in partial trisomy  white matter bilaterally. Adrenals on RCT reduce in size, cortex is  1p and monosomy 12q was found in autistic brother. The cytogenetic  thin. In blood analyses: ACTH 377,8 pmol/l (N - 2,2-13,4), cortisol  analysis of amniotic uid cells revealed an affected male fetus with  144,0 nmol/l (N - 190-650). In t urine analyses: general cortisol 228  interstitional deletion Xq23 and balanced translocation 1p12q. The  nmol/day (N - 300-750). EEG: diffuse disorders of electrical activity,  pregnancy was terminated.Conclusion: Our family represents the  epileptiform activity not revealled. Treatment: substitute glucocorticoid  further evidence that certain regions of the X chromosome were  therapy. Never got of systematic antiepileptic treatment. After  enriched for genes responsible for MR. We propose that Xq23  starting Depakine Chrono 1500 mgs a day therapy the sezures  region should be considered for precise cytogenetic and molecular  are stopped, but the phenomenas of adrenal insufciency and  diagnosis in such cases. The involvement of 1p and 12q region in the  dementia are increasing.Conclusion: Synthetic ACTH analogues are  peculiar phenotype of one brother, showing also elements of autism,  used as antiepileptic drugs in some forms of epilepsies. Possible,  indicate the need for further analysis. The molecular analysis will be  hyperproduction of ACTH is explained the rarity of epileptic sezures  performed in order to get precise information about breakpoint sites  at ALD. However, it is necessary to take a possibility of presence of  and chromosomal segments involved. epilepsy.Clinical genetics 107 ",2004.0,,,,"Adrenals on RCT reduce in size, cortex is  1p and monosomy 12q was found in autistic brother.",,autistic brother,[],"['autistic', 'brother']"
904,2157,,,,"P0835Presence of elevated lactate, lactate/pyruvate ratio and  Analysis of the patientsclinical and molecular data demonstrated that  acylcarnitine prole in patients with autism. all ve patients with the intermediate phenotype carried at least one  S. E. Carlo1, N. Arciniegas1, J. Acevedo2, N. Ramirez3, A. Reis1, A. S. Cornier1  severe mutation. No association between the onset of pulmonary  symptoms and genotype was observed. Finally, the presence of  1Ponce School of Medicine, Ponce, PR, United States, 2University of Puerto  W32X, the most frequent allele among Italian NPD type B population,  Rico, Arecibo, PR, United States, 3Mayaguez Medical Center, Mayaguez, PR,  and R600P as compound heterozygotes in association with severe  United States. mutations suggested a benecial effect for both mutations. Autism is dened behaviorally as a syndrome consisting of abnormal  social skills development, sensorimotor decits, and communication  ",2004.0,,,,"P0835Presence of elevated lactate, lactate/pyruvate ratio and  Analysis of the patientsclinical and molecular data demonstrated that  acylcarnitine prole in patients with autism.",patients with autism,,"['patient', 'with', 'autism']",[]
905,2158,,,,"P0833Screening for ARX gene mutations is indicated for males  problems. The study of this disorder has intensied because  with mental retardation associated with West syndrome and/or  incidence is as high as 6 in 1000 individuals. Although etiology is  dystonia, or in XLMR families linked to Xp22.1 unknown, neuropsychiatry problems, lead poisoning, genetic and  M. Coss\x8de1, H. Hichri1, B. Demeer1, L. Faivre2, C. Philippe3, V. Laugel4, C.  metabolic disorders have been implied in the pathophysiology of the  Weber5, B. Leheup6, A. de Saint-Martin4, D. Devys5, J. Mandel1  disease. The clinical phenotype is divided according to the level of  functioning of the individual ranging from autism as the most severe  1Laboratoire de diagnostic g\x8dn\x8dtique, CHRU, Strasbourg, France, 2Centre de  pervasive developmental disorder and Asperger syndrome. These  g\x8dn\x8dtique, H\x98pital dEnfants, Dijon, France, 3Laboratoire de G\x8dn\x8dtique, CHRU,  patients are usually referred to Genetic clinics for evaluation. Nancy, France, 4Service de P\x8ddiatrie 1, CHRU, Strasbourg, France, 5INSERM  65 patients with the diagnosis of autism or pervasive developmental  U184, IGBMC, Strasbourg, France, 6Service de M\x8ddecine Infantile III et G\x8dn\x8dti- disorder were evaluated. Thorough past medical history and physical  que clinique, CHRU, Nancy, France. examination was performed and family history was taken via  The ARX gene (X-linked Aristaless Gene), localised in Xp22.1,  pedigree. Laboratory evaluation included plasma amino acid levels,  has recently been implicated in both syndromic form of X linked  plasma lactate, pyruvate and ammonia levels, urine organic acids,  mental retardation (associated with West syndrome and/or dystonia)  plasma carnitine and acylcarnitine proles and if dysmorphic features  and in non-specic form. A duplication of 24 bp in exon 2 (428- were identied blood chromosomes were also included. Out of the 65  451dup(24)bp) was found to be a recurrent mutation. This duplication  patients 49 returned with completed metabolic work up. In this group  leads to an expansion of a polyalanine tract in the ARX protein. of 49 patients 18 had a diagnosis of autism and 31 of PDD, only one  The ARX gene was screened for mutations in ve males with mental  patient was female, average age was 5.4 years. Sixty percent of the  retardation associated with West syndrome and/or dystonia. The  patients had elevated lactate levels",2004.0,,,,"The clinical phenotype is divided according to the level of  functioning of the individual ranging from autism as the most severe  1Laboratoire de diagnostic g\x8dn\x8dtique, CHRU, Strasbourg, France, 2Centre de  pervasive developmental disorder and Asperger syndrome.",,Asperger syndrome,[],"['Asperger', 'syndrome']"
